STEP-UP

kt MEDICINE

ONE EDITION Steven Agabegi Elizabeth Agabegi

>» GOLD STANDARD for clerkship, shelf exam, and USMLE Step 2 review

> More than 7,000 QUICK HITS and CLINICAL PEARLS

: > BOARD-STYLE QUESTIONS with accurate and insightful explanations (available in print and online—more than 400 questions!)

LEAD EDITORS Mark D. Duncan Ke lley C h uan g

STEP-UP MEDICINE ONE EDITION

StevenAgabegi,MD ElizabethAgabegi,MD LEADEDITORS MarkD.Duncan,MD KelleyChuang,MD

@. Wolters Kluwer Philadelphia + Baltimore + New York + London Buenos Aires * Hong Kong + Sydney + Tokyo

AcquisitionsEditor:MattHauber DevelopmentEditor:AmyMillholen EditorialCoordinator:KaylaSmull/AnnetteFerran EditorialAssistant:ParisaSaranj MarketingManager:MikeMcMahon ProductionProjectManager:BridgettDougherty DesignCoordinator:SteveDruding ManufacturingCoordinator:MargieOrzech-Zeranko PrepressVendor:Aptara,Inc.

Fifthedition

Copyright©2020WoltersKluwer.

Copyright © 2016 Wolters Kluwer. Copyright © 2013, 2009 Wolters Kluwer Health / Lippincott Williams & Wilkins.Copyright©2005Allrightsreserved.Thisbookisprotectedbycopyright.Nopartofthisbookmaybe reproducedortransmittedinanyformorbyanymeans,includingasphotocopiesorscanned-inorotherelectronic copies,orutilizedbyanyinformationstorageandretrievalsystemwithoutwrittenpermissionfromthecopyright owner, except for brief quotations embodied in critical articles and reviews. Materials appearing in this book preparedbyindividualsaspartoftheirofficialdutiesasU.S.governmentemployeesarenotcoveredbytheabove- mentioned copyright. To request permission, please contact Wolters Kluwer at Two Commerce Square, 2001 MarketStreet,Philadelphia,PA19103,viaemailatpermissions@lww.com,orviaourwebsiteatshop.lww.com (productsandservices).

987654321

PrintedinChina

LibraryofCongressCataloging-in-PublicationData

Names:Agabegi,StevenS.,author.|Duncan,MarkD.,editor. Title: Step-up to medicine / Steven Agabegi, MD and Elizabeth D. Agabegi, MD; lead

editors,MarkD.Duncan,MD,KelleyChuang,MD.

Description:Fifthedition.|Philadelphia:WoltersKluwer,[2020]|Includesbibliographical referencesandindex.

Identifiers:LCCN2019001690|ISBN9781975103620 Subjects: LCSH: Internal medicine–Outlines, syllabi, etc. | Clinical clerkship–Outlines, syllabi,etc.|Physicians–Licenses–UnitedStates–Examinations–Studyguides.|BISAC: MEDICAL/Education&Training.
======================================
Classification:LCCRC59.A332019|DDC616.0076–dc23 LCrecordavailableathttps://lccn.loc.gov/2019001690

Thisworkisprovided“asis,”andthepublisherdisclaimsanyandallwarranties,expressorimplied,includingany warrantiesastoaccuracy,comprehensiveness,orcurrencyofthecontentofthiswork.

Thisworkisnosubstituteforindividualpatientassessmentbaseduponhealthcareprofessionals’examinationof each patient and consideration of, among other things, age, weight, gender, current or prior medical conditions, medicationhistory,laboratorydataandotherfactorsuniquetothepatient.Thepublisherdoesnotprovidemedical adviceorguidanceandthisworkismerelyareferencetool.Healthcareprofessionals,andnotthepublisher,are solely responsible for the use of this work including all medical judgments and for any resulting diagnosis and treatments.

Given continuous, rapid advances in medical science and health information, independent professional verification of medical diagnoses, indications, appropriate pharmaceutical selections and dosages, and treatment options should be made and healthcare professionals should consult a variety of sources. When prescribing medication, healthcare professionals are advised to consult the product information sheet (the manufacturer’s

packageinsert)accompanyingeachdrugtoverify,amongotherthings,conditionsofuse,warningsandsideeffects andidentifyanychangesindosagescheduleorcontraindications,particularlyifthemedicationtobeadministered isnew,infrequentlyusedorhasanarrowtherapeuticrange.Tothemaximumextentpermittedunderapplicable law,noresponsibilityisassumedbythepublisherforanyinjuryand/ordamagetopersonsorproperty,asamatter ofproductsliability,negligencelaworotherwise,orfromanyreferencetoorusebyanypersonofthiswork.

shop.lww.com

ADVISORYBOARD

KARISSABRITTEN,MD ResidentPhysician DepartmentofMedicine DavidGeffenSchoolofMedicineatUCLA LosAngeles,California

DHANANJAYCHATTERJEE,MD ResidentPhysician DepartmentofMedicine DavidGeffenSchoolofMedicineatUCLA LosAngeles,California

KELLEYCHUANG,MD ClinicalInstructor DepartmentofInternalMedicine DavidGeffenSchoolofMedicineatUCLA Hospitalist,VAGreaterLosAngelesHealthcareSystem LosAngeles,California

MARKDUNCAN,MD ClinicalInstructor DepartmentofMedicine UniversityofColoradoAnschutzMedicalCampus Denver,Colorado

SARAHJENSEN,MD ResidentPhysician DepartmentofMedicine DavidGeffenSchoolofMedicineatUCLA LosAngeles,California

EMILYLIANG,BA MedicalStudent DavidGeffenSchoolofMedicineatUCLA LosAngeles,California

NICHOLASVILLANO,MD

ResidentPhysician DepartmentofMedicine DavidGeffenSchoolofMedicineatUCLA LosAngeles,California

STANLEYYUAN,BA MedicalStudent DavidGeffenSchoolofMedicineatUCLA LosAngeles,California
======================================
REVIEWERS

Theauthorsandpublisherwouldliketothankthefollowingstudentreviewerswho providedvaluableinputinrevisingthenewedition,aswellasthemanystudent readerswhohaveprovidedongoingfeedbacksincethebook’soriginalpublication.

SALVATOREAIELLO

EDWARDBURKHARDT

SMITDELIWALA

FLORENCEDOO

WALEEDKHAN

YOONKOOKKIM

MATTMOY

ANTHONIAOJO

KAILAPOMERANZ

MICHAELREZAEE

SHANNONSANCHEZ

LAURENSARTOR

RACHELSLUDER

FAROOQUSMANI

PREFACE

It is hard to believe that it has been 14 years since the first edition of Step-Up to Medicinewaspublished.Nowinitsfifthedition,thesuccessofthisbookhasalways beenlinkedtoitsin-depth,yetconcisecoverageofeverymedicaltopicthatastudent willencounterduringtheclinicalyearsofmedicalschoolandcorrespondingNBME shelfexaminations.

ThisfiftheditionofStep-UptoMedicinehasbeenextensivelyrevisedandedited basedonconstructivefeedbackfromstudents,residents,andfaculty.Tothisend,we recruited a stellar team of medical professionals, led by Dr. Mark Duncan and Dr. Kelley Chuang, to update every topic and enrich the content of each chapter. We would like to acknowledge and sincerely thank these physicians for offering their expertiseandvaluabletimeinthisendeavor.ThequalityofthiseditionofStep-Upto Medicineistheresultoftheirtirelessefforts.

We hope you find this new edition of Step-UptoMedicine a valuable study tool during your clinical years of medical school. We welcome any feedback or at suggestions you may have agabegs@ucmail.uc.edu.

SteveandLizAgabegi

CONTENTS

AdvisoryBoard Reviewers Preface

1 DISEASESOFTHECARDIOVASCULARSYSTEM

IschemicHeartDisease CongestiveHeartFailure Arrhythmias Tachyarrhythmias Bradyarrhythmias DiseasesoftheHeartMuscle PericardialDiseases ValvularHeartDisease CongenitalHeartDiseases DiseasesoftheVasculature CardiacNeoplasms Shock

2 DISEASESOFTHEPULMONARYSYSTEM

ObstructiveLungDiseases LungNeoplasms DiseasesofthePleura InterstitialLungDisease RespiratoryFailure DiseasesofthePulmonaryVasculature MiscellaneousTopics

3 DISEASESOFTHEGASTROINTESTINALSYSTEM DiseasesoftheColon DiseasesoftheLiver DiseasesoftheGallbladderandBiliaryTract DiseasesoftheAppendix

DiseasesofthePancreas GastrointestinalBleeding DiseasesoftheEsophagus DiseasesoftheStomach DiseasesoftheSmallIntestine InflammatoryBowelDisease

4 ENDOCRINEANDMETABOLICDISEASES

DiseasesofthePancreas DiseasesoftheThyroidGland DiseasesofthePituitaryGland DiseasesoftheParathyroidGlands DiseasesoftheAdrenalGlands

5 DISEASESOFTHECENTRALANDPERIPHERALNERVOUS SYSTEMS

CerebrovascularDisease(Stroke) MovementDisorders Dementia AlteredMentalStatus DemyelinatingDisease NeuromuscularDiseases NeurocutaneousSyndromes SpinalCordDiseases MiscellaneousConditions
======================================
6 CONNECTIVETISSUEANDJOINTDISEASES

ConnectiveTissueDiseases Crystal-InducedArthritides MyopathiesandPainSyndromes SeronegativeSpondyloarthropathies Vasculitis

7 DISEASESOFTHERENALANDGENITOURINARYSYSTEM

RenalFailure ProteinuriaandHematuria

GlomerularDisease(Glomerulonephropathies) TubulointerstitialDiseases RenalCysticDiseases RenalVascularDisease StonesandObstructions Neoplasms MiscellaneousConditions

8 FLUIDS,ELECTROLYTES,ANDACID–BASEDISORDERS

VolumeDisorders Sodium Calcium Potassium Magnesium Phosphate Acid–BaseDisorders

9 HEMATOLOGICDISEASESANDNEOPLASMS

Anemias MicrocyticAnemias NormocyticAnemias MacrocyticAnemias HemolyticAnemias PlateletDisorders DisordersofCoagulation Anticoagulation PlasmaCellDisorders Lymphomas Leukemias MyeloproliferativeDisorders

10 INFECTIOUSDISEASES

InfectionsoftheUpperandLowerRespiratoryTracts InfectionsoftheCentralNervousSystem InfectionsoftheGastrointestinalTract InfectionsoftheGenitourinaryTract SexuallyTransmittedDiseases

WoundandSoftTissueInfections InfectionsoftheBonesandJoints ZoonosesandArthropod-BorneDiseases CommonFungalInfections OtherFungalInfections CommonParasiticInfections FeverandSepsis MiscellaneousInfections

11 DISEASESOFTHESKINANDHYPERSENSITIVITY

DISORDERS KeyDefinitions CommonSkinDisorders AcneiformEruptions AtopicandContactDermatitis PapulosquamousEruptions AllergicReactions OtherInflammatoryandAutoimmuneDisorders SkinConditionsRelatedtoInfectionsandInfestations BacterialInfections ViralInfections FungalInfections Infestations BenignandMalignantSkinLesions BenignSkinLesions MalignantSkinLesions

12 AMBULATORYMEDICINE

CardiovascularDiseases Headache UpperRespiratoryDiseases GastrointestinalDiseases MusculoskeletalProblems OverviewofMusculoskeletalExaminationManeuvers DiseasesoftheEye SleepDisorders MiscellaneousTopics

APPENDIX

RadiographicInterpretation ElectrocardiogramInterpretation PhysicalExaminationPearls WorkupandManagementofCommonProblems BasicStatisticsandEvidence-BasedMedicine End-of-LifeIssuesandInformedConsent

Questions Answers Index

1
======================================
ok

DiseasesoftheCardiovascularSystem DhananjayChatterjee

u/booksseller02

IschemicHeartDisease

StableAnginaPectoris

A.GeneralCharacteristics 1. Stableanginapectorisisduetofixedatheroscleroticlesionsthatnarrowthemajor

coronaryarteries.Coronaryischemiaisduetoanimbalancebetweenblood supplyandoxygendemand,leadingtoinadequateperfusion.Stableanginaoccurs whenoxygendemandexceedsavailablebloodsupply.

2. Majorriskfactors

a. Diabetesmellitus(DM)—worstriskfactor b. Hyperlipidemia—elevatedlow-densitylipoprotein(LDL) c. Hypertension(HTN)—mostcommonriskfactor d. Cigarettesmoking e. Age(men>45years;women>55years) f. Familyhistoryofprematurecoronaryarterydisease(CAD)ormyocardial infarction(MI)infirst-degreerelative:Men<55years;women<65years

g. Lowlevelsofhigh-densitylipoprotein(HDL)

3. Lesscommonriskfactorsincludeend-stagerenaldisease(ESRD)on hemodialysis,humanimmunodeficiencyvirus(HIV)infection,historyof mediastinalradiation.Minorriskfactors(lessclearsignificance)includeobesity, sedentarylifestyle(lackofphysicalactivity),stress,excessalcoholuse.

4. PrognosticindicatorsofCAD

a. Leftventricularfunction(ejectionfraction[EF])

e

e

Normal>50% If<50%,associatedwithincreasedmortality

b. Vessel(s)involved(severity/extentofischemia)

e

e

Leftmaincoronaryartery—poorprognosisbecauseitsuppliesapproximately two-thirdsoftheheart Two-orthree-vesselCAD—worseprognosis

Quick HIT

CADcanhavethefollowingclinicalpresentations:

Asymptomatic Stableanginapectoris Unstableangina Myocardialinfarction(MI)—eitherNSTEMIorSTEMI Suddencardiacdeath

TypicalAnginalChestPain

e

e

¢

Substernal Worsewithexertion Betterwithrestornitroglycerin

B.ClinicalFeatures 1. Chestpainorsubsternalpressuresensation

a. Lastslessthan10to15minutes(usually1to5minutes) b. Frighteningchestdiscomfort,usuallydescribedasheaviness,pressure,

squeezing,tightness;rarelydescribedassharporstabbingpain

c. Painisoftengradualinonset

2. Broughtonbyfactorsthatincreasemyocardialoxygendemand,suchasexertion, stress,ordrugs(i.e.,cocaineormethamphetamines)

3. Relievedwithrestornitroglycerin 4. NotethatischemicpaindoesNOTchangewithbreathingnorwithbodyposition. Also,patientswithischemicpaindonothavechestwalltenderness.Ifanyof thesearepresent,thepainislesslikelytobeduetoischemia.
======================================
C.Diagnosis(ofCAD) 1. NotethatphysicalexaminationinmostpatientswithCADisnormal(seeClinical

1. Note that physical examination in most patients with CAD is normal (see Clinical Pearl 1-1).

Pearl1-1). 2. RestingECG

a. Usuallynormalinpatientswithstableangina b. QwavesareconsistentwithapriorMI c. IfST-segmentorT-waveabnormalitiesarepresentduringanepisodeofchest

pain,thentreatasunstableangina.

3. Stresstest—usefulforpatientswithanintermediatepretestprobabilityofCAD baseduponage,gender,andsymptoms.

Quick HIT

Stresstestingisusedinthefollowingsituations:

¢

e

¢

Toconfirmdiagnosisofangina ToevaluateresponsetotherapyinpatientswithdocumentedCAD ToidentifypatientswithCADwhomayhaveahighriskofacutecoronaryevents

a. StressECG

HighestsensitivityifpatientshavenormalrestingECG,suchthatchangescan benoted.PatientswithbaselineECGabnormalitiessuchasleftbundlebranch

e

e

e

e

e

block(LBBB),pre-existingST-segmentchanges,orleftventricular hypertrophy(LVH),shouldNOTundergostressECGtesting. TestinvolvesrecordingECGbefore,during,andafterexerciseonatreadmill. 75%sensitiveifpatientsareabletoexercisesufficientlytoincreaseheartrate to85%ofmaximumpredictedvalueforage.Aperson’smaximumheartrateis calculatedbysubtractingagefrom220(220−age). Exercise-inducedischemiaresultsinsubendocardialischemia,producingST- segmentdepression.SothedetectionofischemiaonastressECGtestisbased onthepresenceofST-segmentdepression. Otherpositivefindingsincludeonsetofheartfailureorventriculararrhythmia duringexerciseorhypotension. Patientswithapositivestresstestresultshouldundergocardiac catheterization.

Quick HIT

ExercisestressECGisanidealinitialtestifabletoexerciseandhaveanormalrestingECG(readily availableandrelativelyinexpensive).

b. Stressechocardiography

e

e

e

Performedbeforeandimmediatelyafterexercise.Exercise-inducedischemiais evidencedbywallmotionabnormalities(e.g.,akinesisorhypokinesis)not presentatrest.Thisstudyislessreliableinpatientswithexistingwallmotion abnormalitiesorloweredEF. FavoredbymanycardiologistsoverstressECG.Itismoresensitivein detectingischemia,canassessLVsizeandfunction,candiagnosevalvular disease,andcanbeusedtoidentifyCADinthepresenceofpre-existingECG abnormalities(seeClinicalPearl1-2). Again,patientswithapositivetestresultshouldundergocardiac catheterization.

c. Informationgainedfromastresstestcanbeenhancedbystressmyocardial perfusionimagingafterIVadministrationofaradioisotopesuchasthallium201 duringexercise.
======================================
Quick HIT

Astresstestisgenerallyconsideredpositiveifthepatientdevelopsanyofthefollowingduringexercise: ST-segmentdepression,chestpain,hypotension,orsignificantarrhythmias.

Viablemyocardialcellsextracttheradioisotopefromtheblood.No radioisotopeuptakemeansnobloodflowtoanareaofthemyocardium.

e

Itisimportanttodeterminewhethertheischemiaisreversible,thatis,whether areasofhypoperfusionareperfusedovertimeasbloodfloweventually equalizes.Areasofreversibleischemiamayberescuedwithpercutaneous coronaryintervention.(PCI)orcoronaryarterybypassgraft(CABG). Irreversibleischemia,however,indicatesinfarctedtissuethatcannotbe salvaged. Perfusionimagingincreasesthesensitivityandspecificityofexercisestress tests,butisalsomoreexpensive,subjectsthepatienttoradiation,andisoften nothelpfulinthepresenceofanLBBB.

CLINICALPEARL1-1

ThereAreTwoConditionsTermedSyndromeX 1. MetabolicSyndromeX

e

e

Anycombinationofhypercholesterolemia,hypertriglyceridemia,impairedglucosetolerance, diabetes,hyperuricemia,HTN. Keyunderlyingfactorisinsulinresistance(duetoobesity).

2. SyndromeX

e

e

¢

Exertionalanginawithnormalcoronaryarteriogram:Patientspresentwithchestpainafterexertion buthavenocoronarystenosesatcardiaccatheterization. Exercisetestingandnuclearimagingshowevidenceofmyocardialischemia. Prognosisisexcellent.

CLINICALPEARL1-2

TypesofStressTests

Test

MethodofDetectingIschemia

ExerciseECG Exerciseordobutamine echocardiogram Exerciseordipyridamole perfusionstudy (thallium/technetium)

ST-segmentdepression Wallmotionabnormalities Decreaseduptakeofthenuclearisotope duringexercise

4. Ifthepatientcannotexercise,performapharmacologicstresstest.

a. IVadenosine,dipyridamole,ordobutaminecanbeused.Thecardiacstress inducedbytheseagentstakestheplaceofexercise.Thiscanbecombinedwith anECG,anechocardiogram,ornuclearperfusionimaging.

b. IVadenosineanddipyridamolecausegeneralizedcoronaryvasodilation.Since diseasedcoronaryarteriesarealreadymaximallydilatedatresttoincreaseblood flow,theyreceiverelativelylessbloodflowwhentheentirecoronarysystemis pharmacologicallyvasodilated.Theseagentsareusedforperfusionimaging.

c. Dobutamineincreasesmyocardialoxygendemandbyincreasingheartrate, bloodpressure,andcardiaccontractility.Thisistypicallyusedinstressecho studies.

5. Cardiaccatheterizationwithcoronaryangiography(seeClinicalPearl1-3;Figure 1-1).

a. Coronaryangiography—definitivetestforCAD.Oftenperformedwith concurrentPCIorforpatientsbeingconsideredforrevascularizationwith CABG.
======================================
b. Thisisthetestofchoiceforpatientswithveryhighpre-testprobabilityofCAD. c. Contrastisinjectedintocoronaryvesselstovisualizeanystenoticlesions.This

definesthelocationandextentofcoronarydisease.

d. IfCADissevere(e.g.,leftmainorthree-vesseldisease,ortwo-vesseldisease withconcurrentDM),referpatientforsurgicalrevascularization(CABG).1

CLINICALPEARL1-3

CardiacCatheterization 1. Mostaccuratemethodofdeterminingaspecificcardiacdiagnosis. 2. Providesinformationonhemodynamics,intracardiacpressuremeasurements,cardiacoutput,oxygen

saturation,etc.

3. Coronaryangiography(seebelow)isalmostalwaysperformedaswellforvisualizationofcoronaryarteries. 4. Therearemanyindicationsforcardiaccatheterization(generallyperformedwhenrevascularizationorother

surgicalinterventionisbeingconsidered):

e

¢

e

Afterapositivestresstest. AcuteMIwithintentofperformingangiogramandPCI. Inapatientwithanginainanyofthefollowingsituations:Whennoninvasivetestsarenondiagnostic, anginathatoccursdespitemedicaltherapy,anginathatoccurssoonafterMI,andanyanginathatisa diagnosticdilemma. Ifapatientisseverelysymptomaticandurgentdiagnosisandmanagementarenecessary. Forevaluationofvalvulardisease,andtodeterminetheneedforsurgicalintervention.

¢

CoronaryArteriography(Angiography) 1. MostaccuratemethodofidentifyingthepresenceandseverityofCAD;thestandardtestfordelineating

coronaryanatomy.

2. Mainpurposeistoidentifypatientswithseverecoronarydiseasetodeterminewhetherrevascularizationis needed.RevascularizationwithPCIinvolvingaballoonand/orastentcanbeperformedatthesametimeas thediagnosticprocedure.

3. Coronarystenosis>70%maybesignificant(i.e.,itcanproduceangina).

FIGURE 1.1

Coronaryangiogram.Injectionoftherightcoronaryartery showsastenosisinthemidportionofthevessel,indicatedbythearrow.

(CourtesyofPinakB.Shah,MD,BrighamandWomen’sHospital,Boston,MA.)

D.Treatment 1. Riskfactormodification

a. SmokingcessationcutsCADriskinhalfby1yearafterquitting. b. HTN—vigorousBPcontrolreducestheriskofCAD,especiallyindiabetic

patients.

c. Hyperlipidemia—reductioninserumcholesterolwithlifestylemodificationsand HMG-CoAreductaseinhibitors(statins)reduceCADrisk.Again,goalLDLis <70mg/dLinpatientswithknownCAD.

d. DM—typeIIdiabetesisconsideredtobeacardiovascularheartdisease

equivalent,andstrictglycemiccontrolshouldbestronglyemphasized. e. Obesity—weightlossmodifiesotherriskfactors(diabetes,HTN,and

hyperlipidemia)andprovidesotherhealthbenefits.

f. Exerciseiscritical;itminimizesemotionalstress,promotesweightloss,and helpsreduceotherriskfactors.

g. Diet:Reduceintakeofsaturatedfat(<7%totalcalories)andcholesterol(<200 mg/day).
======================================
Quick HIT

Standardofcareforstableanginaincludes:

e

e

Drugsthatimprovemortality:aspirin,high-intensitystatins(orinsomecasesaPCSK9inhibitorto lowerLDLevenfurther) Drugsthatrelieveangina:β-blockers,nitrates,calciumchannelblockers,andranolazine

Quick HIT

Sideeffectsofβ-blockers:

e

e

Erectiledysfunctioninmales InabilitytoincreaseHRinresponsetoexercise

Sideeffectsofnitrates:

e Headache

Headache Orthostatichypotension Tolerance Syncope

¢

e

e

2. Medicaltherapy

a. Aspirin

e

e

IndicatedinallpatientswithCAD Decreasesmorbidity—reducesriskofMI

b. Lipid-loweringtherapy

e

e

HMG-CoAreductaseinhibitors(statins)lowerLDLandreduceriskofCV death PCSK9inhibitorslowerLDLevenfurtherthanstatinsandhavebeenfoundto reduceCVeventsinpatientsonstatintherapywithLDLlevelsabove70

c. β-Blockers—blocksympatheticstimulationoftheheart

ReduceHR,BP,andcontractility,therebydecreasingcardiacwork(i.e.,β- blockerslowermyocardialoxygenconsumption) Havebeenshowntoreducethefrequencyofcoronaryevents d. Nitrates—causecoronaryvasodilationandsystemicvenodilation Relieveangina;reducepreloadmyocardialoxygendemand

e

e

e

Maypreventanginawhentakenbeforeexertion Effectonprognosisisunknown;mainbenefitissymptomaticrelief Canbeadministeredorally,sublingually,transdermally,intravenously,orin pasteform.Forchronicangina,oralortransdermalpatchesareused.Foracute coronarysyndromes(seebelow),eithersublingual,paste,orIVformsareused.

e. Calciumchannelblockers(CCBs)

Causecoronaryvasodilationandafterloadreduction,reducecontractility Addtoantianginaltherapywhenβ-blockersandnitratesarenotfullyeffective

e

3. Revascularization

3. Revascularization

a. ControversialforpatientswithstableCAD,asstudiessuggestnoimprovement inmortalityandMI(whencomparedtomedicaltherapyalone).Perguidelines, revascularizationisindicatedforstableanginarefractorytomedicaltherapyfor symptomcontrol.

b. Twomethods—PCIandCABG—seeClinicalPearl1-4.

4. Managementdecisions(generalguidelines)—riskfactormodificationandaspirin areindicatedinallpatients.Managepatientsaccordingtooverallrisk

a. Milddisease(normalEF,mildangina,single-vesseldisease)
======================================
e

e

Nitrates(forsymptomsandasprophylaxis)andaβ-blockerareappropriate ConsiderCCBsifsymptomscontinuedespitenitratesandβ-blockers

b. Moderatedisease(normalEF,moderateangina,two-vesseldisease)

Iftheaboveregimendoesnotcontrolsymptoms,considercoronary angiographytoassesssuitabilityforrevascularization(eitherPCIorCABG)

c. Severedisease(reducedEF,severeangina,andthree-vessel/leftmainorleft anteriordescending[LAD]disease)

e

e

CoronaryangiographyandconsiderforCABG AvoidCCBswithreducedEF

Quick HIT

TheCOURAGEtrialshowedessentiallynodifferenceinall-causemortalityandnonfatalMIsbetweenpatients withstableanginatreatedwithmaximalmedicaltherapyaloneversusmedicaltherapywithPCIandbaremetal stenting.Ofnote,mostPCIisnowdonewithdrug-elutingstentswhicharesuperiortobaremetalstentswith regardtoriskofstentthrombosisandrecurrentMI.

UnstableAnginaPectoris

A.GeneralCharacteristics 1. Pathophysiology

a. Withunstableangina,oxygendemandisunchanged.Supplyisdecreased secondarytoreducedrestingcoronaryflow.Thisisincontrasttostableangina, whichisduetoincreaseddemand.

b. Unstableanginaissignificantbecauseitindicatesstenosisthathasenlargedvia thrombosis,hemorrhage,orplaquerupture.Itmayleadtototalocclusionofa coronaryvessel.

CLINICALPEARL1-4

PercutaneousCoronaryIntervention

Consistsofbothcoronaryangioplastywithaballoonandstenting. Shouldbeconsideredinpatientswithone-,two-,orthree-vesseldisease.Evenwiththree-vesseldisease, mortalityandfreedomfromMIhavebeenshowntobeequivalentbetweenPTCAwithstentingand CABG.Theonlydrawbackisthehigherfrequencyofrevascularizationproceduresinpatientswho receivedastent. Bestifusedforproximallesions. Restenosisisasignificantproblem(upto40%withinfirst6months);however,ifthereisnoevidence ofrestenosisat6months,itusuallydoesnotoccur.Newtechniquesandtechnologicimprovementssuch asdrug-elutingstentsareattemptingtoreducethisproblem.

CoronaryArteryBypassGrafting

e¢

e

WhileCABGremainsthestandardofcareatsomeinstitutionsforpatientswithhigh-riskdisease,the PRECOMBATandSYNTAXtrailshaveshownthatPTCAwithstentingmaybeasgoodasCABGeven inpatientswithleftmainCAD.CABGisstillusedastheprimarymethodofrevascularizationina smallnumberofpatientswithSTEMI.Inaddition,itmaybeindicatedinpatientswithcardiogenic shockpost-MI,aftercomplicationswithPCI,inthesettingofventriculararrhythmias,andwith mechanicalcomplicationsafteracuteMI. MainindicationsforCABG:Three-vesseldiseasewith>70%stenosisineachvessel.Leftmain coronarydiseasewith>50%stenosis,leftventriculardysfunction.

2. Thefollowingpatientsmaybesaidtohaveunstableangina:

a. Patientswithchronicanginawithincreasingfrequency,duration,orintensityof chestpain
======================================
b. Patientswithnew-onsetanginathatissevereandworsening c. Patientswithanginaatrest

3. ThedistinctionbetweenunstableanginaandNSTEMIisbasedentirelyoncardiac enzymes.Thelatterhaselevationoftroponinorcreatinekinase-MB(CK-MB). BothunstableanginaandNSTEMIlackST-segmentelevationsandpathologicQ waves.

4. UnstableanginahasahigherriskofMIanddeaththanstableangina,andpatients withthisdiagnosisshouldbehospitalized.Itsmanagementisencompassedin AcuteCoronarySyndrome.

Quick HIT

AcuteCoronarySyndrome(ACS)

e

e

Theclinicalmanifestationsofatheroscleroticplaqueruptureandcoronaryocclusion Termgenerallyreferstounstableangina,NSTEMI,orSTEMI

Quick HIT

Stresstestingonlydetectsflow-limitinghigh-gradelesions.Thus,canstillhaveMIdespitenegativestresstest becausemechanismofMIisacuteplaqueruptureontoamoderatelesion.

B.Diagnosis(seeStableAngina) 1. PerformadiagnosticworkuptoexcludeMIinallpatients. 2. Patientswithunstableanginahaveahigherriskofadverseeventsduringstress testing.Thesepatientsshouldbestabilizedwithmedicalmanagementbefore stresstestingorshouldundergocardiaccatheterizationinitially.

C.Treatment 1. Hospitaladmissiononafloorwithcontinuouscardiacmonitoring.EstablishIV

accessandgivesupplementaloxygenifpatientsarehypoxic.Providepaincontrol withnitrates(below)andopioidsifpainrefractorytonitratetherapyalone.

2. Aggressivemedicalmanagementisindicated—treatasinMIexceptfor fibrinolysis.Mortality-loweringtherapyincludesdualantiplatelettherapy(DAPT) withaspirinandaP2Y12inhibitor,heparin,andβ-blockers.

a. Aspirin(325-mgdose) b. P2Y12inhibitor(clopidogrel,ticagrelor,prasugrel).Themostcommonlyused agentisclopidogrel—showntoreducetheincidenceofMIinpatientswith unstableanginacomparedwithaspirinaloneintheCUREtrial.Thisbenefit persistswhetherthepatientundergoesrevascularizationwithPCIornot. Patientspresentingwithunstableanginashouldgenerallybetreatedwithaspirin andclopidogrelfor9to12months,inaccordancewiththeCUREtrial.This maybealteredhowever,accordingtothebleedingriskofeachpatient.The PLATOtrialshowedthatticagrelorhadareducedriskofdeath,MI,orstroke comparedtoclopidogrelwhenusedforACS,withoutanelevatedriskof bleeding.Prasugrelhasthehighestriskofbleedingandistheleastcommonly used.

c. β-Blockers—first-linetherapyiftherearenocontraindications

d. Low–molecular-weightheparin(LMWH)issuperiortounfractionatedheparin. Goalistopreventprogressionordevelopmentofaclot
======================================
e

e

Shouldbecontinuedforatleast48hours Enoxaparinisthedrugofchoicebasedonclinicaltrials(seeQuickHiton ESSENCEtrial)

e. Nitratesarefirst-linetherapyforchestpain f. GlycoproteinIIb/IIIainhibitors(abciximab,tirofiban,eptifibatide)canbe

helpfuladjuncts,ifpatientisundergoingPCI

g. High-intensitystatin(atorvastatin40or80mg)startedwithin4daysofACScan reduceriskofrecurrentMIorstroke

h. Oxygenifpatientishypoxic i. Morphineiscontroversial—providesgoodpainreliefbutmaymaskworsening

symptoms

j. Replacementofdeficientelectrolytes,especiallyK+andMg2+,tolower arrhythmiarisk

Quick HIT

TheESSENCEtrialshowedthatinunstableanginaandnon–ST-segmentelevationMI,riskofdeath,MI, orrecurrentanginawaslowerintheenoxaparingroupthanintheheparingroupat14days,30days,and1 year.Theneedforrevascularizationwasalsolowerintheenoxaparingroup.

Quick HIT

Thrombolytictherapy(fibrinolysis)hasNOTbeenproventobebeneficialinunstableangina.Thisisonly indicatedinSTEMIwhennoaccesstourgentcatheterizationforPCI.

3. Cardiaccatheterization/revascularization

a. Morethan90%ofpatientsimprovewiththeabovemedicalregimenwithin1to 2days.

b. Thechoiceofinvasivemanagement(earlycatheterization/revascularization

within48hours)versusconservativemanagement (catheterization/revascularizationonlyifmedicaltherapyfails)iscontroversial. Ifpatientrespondstomedicaltherapy,performastresstesttoassessneedfor catheterization/revascularization.ManypatientswithUAthatiscontrolled withmedicaltherapyeventuallyrequirerevascularization. Ifmedicaltherapyfailstoimprovesymptomsand/orECGchangesindicative ofischemiapersistafter48hours,thenproceeddirectlyto catheterization/revascularization.AdditionalindicationsforPCIinclude hemodynamicinstability,ventriculararrhythmias,andnewmitralregurgitation (MR)ornewseptaldefect.

e

e

TheTIMIriskscorecanbeusedtoguidethedecisiononconservativeversus moreaggressivetreatment.

4. Aftertheacutetreatment

a. Continueaspirin(orotherantiplatelettherapy),β-blockers(metoprolol),nitrates,

andstatintherapy b. Reduceriskfactors
======================================
e

e

e

Smokingcessation,weightloss Treatdiabetes,HTN Treathyperlipidemia—patientswithanyformofCADshouldbestartedonan HMG-CoAreductaseinhibitorregardlessofLDLlevel.Clinicaltrialsofstatins haveshowntheefficacyofsuchtherapyforsecondarypreventioninCAD(see QuickHitonCAREtrial)

Quick HIT

TheCAREtrial:PatientswithpriorhistoryofMIwererandomizedtotreatmentwithstatinsorplacebo.The statingrouphadareducedriskofdeath(by24%),areducedriskofstroke(by31%),andareductioninneedfor CABGorcoronaryangioplasty(by27%).

Variant(Prinzmetal)Angina

Involvestransientcoronaryvasospasmthatusuallyisaccompaniedbyafixed atheroscleroticlesionbutcanalsooccurinnormalcoronaryarteries. Episodesofanginaoccuratrestandareassociatedwithventriculararrhythmias, someofwhichmaybelifethreatening.Theanginaclassicallyoccursatnight. HallmarkistransientST-segmentelevation(notdepression)onECGduringchest pain,whichrepresentstransmuralischemia. Coronaryangiographyisadefinitivetest—displayscoronaryvasospasmwhenthe patientisgivenIVergonovineoracetylcholine(toprovokevasoconstriction). Vasodilators—CCBsandnitrateshavebeenproventobehelpful.Riskfactor modificationincludingsmokingcessationandlipidloweringisalsoindicatedwhere appropriate.

MyocardialInfarction

A.GeneralCharacteristics 1. MIisduetonecrosisofmyocardiumasaresultofaninterruptionofbloodsupply

(afterathromboticocclusionofacoronaryarterypreviouslynarrowedby atherosclerosis).

a. Mostcasesareduetoacutecoronarythrombosis:Atheromatousplaqueruptures intothevessellumen,andthrombusformsontopofthislesion,whichcauses occlusionofthevessel.

b. MIisassociatedwitha30%mortalityrate;halfofthedeathsareprehospital. c. MostpatientswithMIhavehistoryofangina,riskfactorsforCAD,orhistoryof

arrhythmias.

B.ClinicalFeatures 1. Chestpain

a. Intensesubsternalpressuresensation;oftendescribedas“crushing”and“an elephantstandingonmychest.”

b. Radiationtoneck,jaw,arms,orback,commonlytotheleftside. c. Similartoanginapectorisincharacteranddistributionbutmuchmoresevere andlastslonger.Unlikeinangina,painmaynotrespondtonitroglycerin.

d. Somepatientsmayhaveepigastricdiscomfort.

2. Canbeasymptomaticinuptoone-thirdofpatients;painlessinfarctsoratypical presentationsmorelikelyinpostoperativepatients,theelderly,diabeticpatients, andwomen. 3. Othersymptoms
======================================
a. Dyspnea b. Diaphoresis c. Weakness,fatigue d. Nauseaandvomiting e. Senseofimpendingdoom f. Syncope

4. Suddencardiacdeath—usuallyduetoventricularfibrillation(VFib)

Quick HIT

Thecombinationofsubsternalchestpainpersistingforlongerthan30minutesanddiaphoresisstronglysuggests acuteMI.

Quick HIT

RightventricularinfarctwillpresentwithinferiorECGchanges,hypotension,elevatedjugularvenouspressure, hepatomegaly,andclearlungs.Preloaddependent—doNOTadministernitratesordiureticsasthesecancause cardiovascularcollapse.

Quick HIT

ST-segmentelevationindicatesaninfarction75%ofthetime.ST-segmentdepressionindicatesaninfarction only25%ofthetime.

C.Diagnosis 1. ECG(Figure1-2;seealsoTable1-1andClinicalPearl1-5)

a. Markersforischemia/infarctioninclude:

e

e

©

e

PeakedTwaves:Occurveryearlyandmaybemissed ST-segmentelevationindicatestransmuralinjuryandcanbediagnosticofan acuteinfarct Qwaves:Evidencefornecrosis(specific)—Qwavesareusuallyseenlate; typicallynotseenacutely T-waveinversionissensitivebutnotspecific ST-segmentdepression:Subendocardialinjury

e

b. Categoriesofinfarcts

e

¢

ST-segmentelevationinfarct:Transmural(involvesentirethicknessofwall); tendstobelarger Non–ST-segmentelevationinfarct:Subendocardial(involvesinnerone-third toone-halfofthewall);tendstobesmaller,andpresentationissimilartoUA —cardiacenzymesdifferentiatethetwo

FIGURE 1.2

ECGshowinganteriorwallmyocardialinfarction—all12

leads. (FromDavisD.QuickandAccurate12-LeadECGInterpretation.3rded.Philadelphia,PA:

LippincottWilliams&Wilkins;2000:203.)
======================================
Note:AugmentedECGleadsfromaVLindicatetheleftarm,andfromaVFindicatetheleftfoot.

2. Cardiacenzymes—currentlythediagnosticgoldstandardformyocardialinjury (Figure1-3)

a. Troponins(TroponinIandT)—mostimportantenzymetesttoorder

Increaseswithin3to5hoursandreturnstonormalin5to14days;reachesa peakin24to48hours. GreatersensitivityandspecificitythanCK-MBformyocardialinjury. ObtainserumlevelsofeithertroponinTortroponinIonadmission,andagain every6hoursfor18to24hours. TroponinIcanbefalselyelevatedinpatientswithrenalfailure;thusfollowing trendoflevelsisimportant.

b. CK-MB—lesscommonlyused

Increaseswithin4to8hoursandreturnstonormalin48to72hours;reachesa peakin24hours. Whenmeasuredwithin24to36hoursofonsetofchestpain,hasgreaterthan 95%sensitivityandspecificity. LevelsoftotalCKandCK-MBshouldbemeasuredonadmissionandevery8 hoursthereafterfor24hours. Mosthelpfulindetectingrecurrentinfarctiongivenquickerreturntobaseline thantroponin.

Quick HIT

Cardiacenzymesaredrawnserially—onceonadmissionandevery6hoursuntilthreesamplesareobtained.The higherthepeakandthelongerenzymelevelsremainelevated,themoreseverethemyocardialinjuryandthe worsetheprognosis.

Quick HIT

InMI,aspirin,ticagrelor,β-blockers,andACEinhibitorsaretheonlyagentsshowntoreducemortality.

CLINICALPEARL1-5

CardiacMonitoringforaPatientWithanAcuteMI

BPandHR:HTNincreasesafterloadandthusoxygendemand,whereashypotensionreducescoronaryand tissueperfusion.Bothnitratesandmorphinecancausehypotension. Rhythmstripwithcontinuouscardiacmonitor:Watchfordysrhythmias.NotethatPVCscanlowerstroke volumeandcoronaryarteryfillingtime.AhighfrequencyofPVCsmaypredictVFiborVT. Auscultatetheheart(thirdandfourthheartsounds,frictionrub,andsoon)andlungs(cracklesmayindicate LVfailure,pulmonaryedema). Hemodynamicmonitoring(CVP,PCWP,SVR,cardiacindex[CI])withapulmonaryarterycatheteris indicatedifthepatientishemodynamicallyunstable.MonitoringishelpfulinassessingtheneedforIVfluids and/orvasopressors.

Troponins Multiples of MI threshold MI threshold 1 2 3 a 5 6 7 8 9 10 Days after onset of infarction
======================================
FIGURE 1.3

EvolutionofserumbiomarkersinacuteMI.CurveM

indicatesthedetectionofmyoglobinintheserumbeforeother biomarkers.SerumCK(orCK-MBisoenzyme)beginstoincrease3to 8hoursaftertheonsetoftheacuteinfarctandpeaksat24hours. Cardiactroponinsarehighlysensitiveformyocardialinjuryand remaindetectableintheserumformanydaysaftertheacuteinfarct. (FromLillyLS.PathophysiologyofHeartDisease.3rded.Philadelphia,PA:LippincottWilliams

&Wilkins;2011:175,Figure7.9.)

D.Treatment 1. Admitpatienttoacardiacmonitoredfloor(CCU)andestablishIVaccess.Give

supplementaloxygenforhypoxiaandanalgesics(nitrates,morphine—seebelow). 2. Medicaltherapy

a. Aspirin

e

e

Antiplateletagentreducescoronaryreocclusionbyinhibitingplatelet aggregationontopofthethrombus Hasbeenshowntoreducemortalityandshouldbepartoflong-term maintenancetherapy

b. P2Y12inhibitors(clopidogrel,ticagrelor)

e

e

e

Usedinconjunctionwithaspirin;havebeenshowntoreducerecurrentMI TicagrelorhasimprovedmortalitycomparedtoclopidogrelinthePLATOtrial (itsuseislimitedbycost,frequentdosing,andcommonsideeffectofdyspnea) DurationoftherapydependsondecisiontoperformPCIversusCABG,risk factorsofpatient

c. β-Blockers

BlockstimulationofHRandcontractilitytoreduceoxygendemandand decreasetheincidenceofarrhythmias Reduceremodelingofthemyocardiumpost-MI Havebeenshowntoreducemortalityandshouldbepartofmaintenance therapy d. ACEinhibitors

e

e

Initiatewithinhoursofhospitalizationiftherearenocontraindications Havebeenshowntoreducemortalityandshouldbepartoflong-term maintenancetherapy

e. Statins

e

e

e¢

Reduceriskoffurthercoronaryevents Stabilizeplaquesandlowercholesterol ThePROVEIT-TIMI22trialshowedthesuperiorityofstartingatorvastatin80

e

mgoverotherstatinsbeforedischargingaSTEMIpatient Shouldbepartofmaintenancetherapy

f. Oxygen

Maylimitischemicmyocardialinjuryinhypoxicpatients.Doesnotimprove mortalityinpatientswithnormaloxygensaturation.

g. Nitrates

e

e

Dilatecoronaryarteries(increasesupply)andreducechestpain Venodilation(decreasepreloadandthusdemand)

h. Morphine
======================================
e

e

e

Analgesia Causesvenodilation,whichdecreasespreloadandthusoxygenrequirements Maymaskseverityofsymptoms,mayaffectlevelsofantiplateletdrugs

i. Heparin

e

e

InitiateinallpatientswithMI;preventsprogressionofthrombus;however,has notbeenshowntodecreasemortality LMWH,specificallyenoxaparin,ispreferredoverunfractionatedheparin,as shownintheExTRACT-TIMI25trialaswellasarecentmeta-analysis. EnoxaparinwasshowntodecreasetheriskofrecurrentMIversus unfractionatedheparin.

Quick HIT

TheCAPRICORNtrialshowedthattheβ-blockercarvedilolreducestheriskofdeathinpatientswithpost- MILVdysfunction.

Quick  HIT  ThefollowingareindicatedinpatientswithMI:  Aspirin P2Y12inhibitor Nitroglycerinforchestpain β-Blocker ACEinhibitor Heparin Oxygenifhypoxic Morphineifchestpainunrelievedwithnitrates 

3. Revascularization

a. Benefithighestwhenperformedearly(within90minutesofhospitalarrivalfor

patientswithSTEMIornewLBBB) b. Shouldbeconsideredinallpatients.

c. Revascularizationoptionsincludethrombolysis,PCI,orCABG—seeClinical Pearl1-6.

e

e

SeveralstudieshaveshownenhancedsurvivalandlowerratesofrecurrentMI andintracranialbleedingwhenPCIperformedbyskilledpersonnelischosen overthrombolysis.Forpatientswithadelayedpresentation,fibrinolysisalone maybeabetteroption. Urgent/emergentCABGistypicallyperformedonlyinthesettingof mechanicalcomplicationsofanacuteMI,cardiogenicshock,life-threatening ventriculararrhythmias,orafterfailureofPCI.Itisalmostneverperformedin theacutesettingonastablepatient.

Quick HIT

Rememberthatpatientscanhavearecurrentinfarctiononsamehospitaladmission.CK-MBisthemost helpfullaboratorytesttodetectthisifpatientdevelopsrecurrentchestpain.

Quick HIT

HeparinisusedforunstableanginaandMI(bothNSTEMIandSTEMI).ItisNOTusedforstable angina.

d. P2Y12inhibitors—evidencesuggeststhatthebenefitofclopidogrelorticagrelor isadditivetotheeffectsofaspirin.Clopidogrelorticagrelortherapyshouldbe initiatedinallpatientswhoundergoPCIandreceiveastent.Dualantiplatelet treatmentwithaspirinandaP2Y12inhibitor(clopidogrelorticagrelor)should continueforatleast30daysinpatientswhoreceiveabaremetalstent,andat least12monthsinpatientswhoreceiveadrug-elutingstent.

CLINICALPEARL1-6
======================================
MethodsofRevascularization PercutaneousCoronaryIntervention

e

e

e¢

ThisisthepreferredtreatmentforSTEMIaslongasitcanbeperformedexpeditiously(doortoballoon timelessthan90minutes)andbyskilledpersonnel. Alsopreferredinpatientswithcontraindicationsforthrombolytictherapy;noriskofintracranial hemorrhage. PRAMItrialshowedthatPTCAreducesmortalitymorethantPA.

ThrombolyticTherapy

e

e

ThrombolytictherapyremainsanimportanttreatmentmodalitysincePCIisstillavailableonlyat specializedcenters.Itisusefulforpatientswhopresentlater,andforthoseinwhomPCIis contraindicated. Earlytreatmentiscrucialtosalvageasmuchofthemyocardiumaspossible.Administerassoonas possibleupto24hoursaftertheonsetofchestpain.Outcomeisbestifgivenwithinthefirst6hours.

u/booksseller02

e

e

e

Indications:ST-segmentelevationintwocontiguousECGleadsinpatientswithpainonsetwithin6 hourswhohavebeenrefractorytonitroglycerin. Alteplasehasbeenshowntohavethebestoutcomesamongthrombolyticmedications,andisthefirst choiceinmanycenters,despiteitshighcosts.Alternativesincludestreptokinase,tenecteplase,reteplase, lanoteplase,andurokinase. InEDsetting,themainreasontoinitiatetherapywiththrombolytics/angioplastyiswhetherthereisST- segmentelevationonECG.

AbsoluteContraindicationstoThrombolyticTherapy

Trauma:RecentheadtraumaortraumaticCPR Previousstroke Recentinvasiveprocedureorsurgery Dissectingaorticaneurysm Activebleedingorbleedingdiathesis

CoronaryArteryBypassGrafting

e

e

e

Lessoftenusedthantheothertwointheacutesetting. BenefitsofCABGincludelowratesofevent-freeandreintervention-freesurvival. Itremainstheprocedureofchoiceinpatientswithseveremultivesseldiseaseandcomplexcoronary anatomy.

Quick HIT

Allpatientsinitiallytreatedconservatively(i.e.,withoutrevascularization)forUA/NSTEMIshouldhavea stresstestbeforeleavingthehospitaltodeterminetheneedforangiography(whichinturndeterminesthe needforangioplastyorCABG).

4. Rehabilitation

a. Cardiacrehabilitationisaphysician-supervisedregimenofexerciseandrisk factorreductionafterMI.

b. Showntoreducesymptomsandprolongsurvival.
======================================
E.ComplicationsofAcuteMI 1. Pumpfailure(congestiveheartfailure[CHF])(Figure1-4)

a. Mostcommoncauseofin-hospitalmortality b. Ifmild,treatmedically(ACEinhibitor,diuretic) c. Ifsevere,mayleadtocardiogenicshock;invasivehemodynamicmonitoringor supportwithinotropesordevicesmaybeindicated(seeCardiogenicShockon page64)

Quick HIT

PatientswhosufferanacuteMIhaveahighriskofstrokeduringthenext5years.ThelowertheEFand theolderthepatient,thehighertheriskofstroke.

MostcommoncauseofdeathinthefirstfewdaysafterMIisventriculararrhythmia(eitherVTorVFib).

2. Arrhythmias

a. Prematureventricularcontractions(PVCs)—conservativetreatment (observation)indicated;noneedforantiarrhythmicagents

b. Atrialfibrillation(AFib) c. Ventriculartachycardia(VT)–sustainedVTrequirestreatment:Ifpatientis

hemodynamicallyunstable,electricalcardioversionisindicated.Ifpatientis hemodynamicallystable,startantiarrhythmictherapy—seetreatmentofVT

MI Ventricular + Contractility <> Tissue necrosis Electrical thrombus instability A Cardiogenic ‘ Embolism * Ischemia Abeey ae Hypotension Arrhythmias + Coronary perfusion Expansion Papillary muscle Ventricular Ventricular Pericardial of infarct infarction/ septal rupture inflammation ischemia defect | Pericarditis Mitral regurgitation Cardiac tamponade CHF or shock

FIGURE 1.4

ComplicationsofMI.

(AdaptedfromLillyLS.PathophysiologyofHeartDisease.5thed.Philadelphia,PA:

LippincottWilliams&Wilkins;2011:183,Figure7.12.)

d. VFib—immediateunsynchronizeddefibrillationandCPRareindicated(see Arrhythmiasonpage21)

e. Acceleratedidioventricularrhythmdoesnotaffectprognosis;notreatment neededinmostcases

f. Paroxysmalsupraventriculartachycardia(PSVT)—fortreatment,see Arrhythmias

g. Sinustachycardia

Maybecausedbypain,anxiety,fever,pericarditis,medications,etc. Worsensischemia(increasesmyocardialoxygenconsumption) Treatunderlyingcause(analgesicsforpain,acetaminophenforfever,etc.)

e

e

h. Sinusbradycardia

e

e

e

AcommonoccurrenceinearlystagesofacuteMI,especiallyright- sided/inferiorMI. Maybeaprotectivemechanism(reducesmyocardialoxygendemand). Notreatmentisrequiredotherthanobservation.Ifbradycardiaissevereor symptomatic(hemodynamiccompromise),atropinemaybehelpfulin increasingHR.

i. Asystole
======================================
e

e

e

Veryhighmortality. TreatmentshouldbeginwithelectricaldefibrillationforVFib,whichismore commonincardiacarrestandmaybedifficulttoclearlydifferentiatefrom asystole. Ifasystoleisclearlythecauseofarrest,transcutaneouspacingisthe appropriatetreatment.

j. AVblock

e

e

e

Associatedwithischemiainvolvingconductiontracts. First-andsecond-degree(typeI)blocksdonotrequiretherapy. Second-(typeII)andthird-degreeblocks:Prognosisisdireinthesettingofan anteriorMI—emergentplacementofatemporarypacemakerisindicated(with laterplacementofapermanentpacemaker).IninferiorMI,prognosisisbetter, andIVatropinemaybeusedinitially.Ifconductionisnotrestored,a temporarypacemakerisappropriate.Canusepositivechronotropic medicationstomaintainHRandbloodpressures(i.e.,isoproterenolor dopamine)whileawaitingplacementoftemporarypacemaker.

Quick HIT

AfteranMI,allpatientsshouldbedischargedhomewithaspirin,β-blocker,statins,andanACEinhibitor, andaP2Y12inhibitorifindicated.

3. Recurrentinfarction(extensionofexistinginfarctionorreinfarctionofanew area)

a. Bothshort-andlong-termmortalityareincreased. b. Diagnosisisoftendifficult.

Cardiacenzymesarealreadyelevatedfromtheinitialinfarction.Troponin

e

levelsremainelevatedforaweekormore,soarenotusefulhere.CK-MB returnstonormalfaster,andsoareelevationofCK-MBafter36to48hours maybeduetorecurrentinfarction. IfthereisrepeatST-segmentelevationonECGwithinthefirst24hoursafter infarction,suspectrecurrentinfarctionorLVaneurysm.

c. Treatment:RepeatthrombolysisorurgentcardiaccatheterizationandPCI. ContinuestandardmedicaltherapyforMI.

4. Mechanicalcomplications

a. Freewallrupture

e

e

e

e

Acatastrophic,usuallyfataleventthatoccursduringthefirst2weeksafterMI (90%within2weeks,mostcommonly1to4daysafterMI) 90%mortalityrate Usuallyleadstohemopericardiumandcardiactamponade Treatment:Hemodynamicstabilization,immediatepericardiocentesis,and surgicalrepair

b. Ruptureofinterventricularseptum

e

¢

e

Greaterpotentialforsuccessfultherapythanwithafreewallrupture,although thisisalsoacriticalevent;emergentsurgeryisindicated Occurswithin10daysafterMI Likelihoodofsurvivalcorrelateswithsizeofthedefect

c. Papillarymusclerupture
======================================
e

e

e

ProducesacuteMR(presentswithnewmurmur) Ifsuspected,obtainanechocardiogramimmediately Emergentsurgeryisneeded(mitralvalvereplacementisusuallynecessary),as wellasafterloadreductionwithsodiumnitroprussideorintra-aorticballoon pump(IABP)

d. Ventricularpseudoaneurysm

Incompletefreewallrupture(myocardialruptureiscontainedbypericardium) Bedsideechocardiogrammayshowthepseudoaneurysm Surgicalemergencybecauseventricularpseudoaneurysmstendtobecomea freewallrupture e. Ventricularaneurysm

e

e

e

e

Rarelyrupture(incontrasttopseudoaneurysms) Associatedwithahighincidenceofventriculartachyarrhythmias Medicalmanagementmaybeprotective Surgerytoremoveaneurysmmaybeappropriateinselectedpatients

5. Acutepericarditis

a. Theincidencehasdecreasedsharplysincetheintroductionofrevascularization

techniques.

b. Treatmentconsistsofaspirin(whichisalreadystandardintreatmentofMI). c. NSAIDsandcorticosteroidsarecontraindicated(mayhindermyocardialscar

formation).

6. Dresslersyndrome(“postmyocardialinfarctionsyndrome”)

a. Immunologicallybasedsyndromeconsistingoffever,malaise,pericarditis,

leukocytosis,andpleuritis,occurringweekstomonthsafteranMI b. Aspirinisthemosteffectivetherapy.Ibuprofenisasecondoption.

Quick HIT

Ifyoususpectacardiaccauseofthepain,sublingualnitroglycerinisappropriate.Alsogiveaspirinifthepatient doesnothaveableedingdisorder.

ChestPain

A.DifferentialDiagnosis 1. Heart,pericardium,vascularcauses

a. Stableangina,variantangina b. ACS c. Pericarditis d. Aorticdissection

2. Pulmonary:Pulmonaryembolism(canhavepainwithpulmonaryinfarction), pneumothorax,pleuritis(pleuralpain),pneumonia,statusasthmaticus

3. GI:Gastroesophagealrefluxdisease(GERD),diffuseesophagealspasm,peptic ulcerdisease,esophagealrupture

4. Chestwall:Costochondritis,musclestrain,ribfracture,herpeszoster 5. Psychiatric:Panicattacks,anxiety,somatization 6. Cocaine/methamphetamineusecancauseanginaorMI

Quick HIT

Ifnitroglycerinrelievesthepain,acardiaccauseismorelikely(althoughnitratesalsorelievepainfromdiffuse esophagealspasm).
======================================
Quick HIT

Ifchestpainispleuritic,positional,orreproducedwithchestwallpalpation,acardiaccausemaybelesslikely.

B.ApproachtoTreatingaPatientWithChestPain 1. Ruleoutanylife-threateningcauses.TheseincludeACS,aorticdissection,

pericarditiswithcardiactamponade,pulmonaryembolus,tensionpneumothorax, andesophagealrupture

2. Assessvitalsigns 3. Developafocusedhistory

a. Characterofthepain(pressure,squeezing,tearing,sharp,stabbing,etc.) b. Locationofpain c. Severityofpain d. Durationofpain e. Settinginwhichpainoccurred(duringexertion,atrest,aftermeal) f. Radiationofpain g. Aggravatingoralleviatingfactors(e.g.,meal,exertion,rest,respiration) h. Doesthepatienthaveacardiachistory?Askaboutresultsofpreviousstress tests,echocardiograms,cardiaccatheterization,orofanyprocedures(PCIor

CABG)

i. Ifthepatienthasahistoryofangina,askhowthisepisodediffersfromprevious ones(moresevere?longerduration?)

4. Performafocusedphysicalexamination,withattentiontocardiopulmonary, abdominal,andmusculoskeletalexamination

5. Orderancillarytests

a. ObtainECGinalmostallcases b. Cardiacenzymes(CK,CK-MB,troponin)dependingonclinicalsuspicion c. Obtainchestradiograph(CXR)inalmostallcases d. Underappropriateclinicalsetting,workupthepatientforpulmonaryembolism

(PE)(seePulmonarysection)

6. Developadiagnosis

decisionofwhethertoinitiateacardiacworkupisdependentonapatient’s overallriskofCADandtheclinicalpresentation.Ifpatientisyoungandwithout riskfactors,treatforGERDandfollowupifpainrecurs.(Anxietymaybea causebutisdifficulttodiagnoseandusuallyonlyconsideredafterrulingout cardiaccausesfirst.)Anolderpatientwithriskfactorsshouldundergoacardiac workup.

b. Thereisnofail-proofalgorithmforapproachingchestpain.Ingeneral,havea greaterindexofsuspicionforischemiccausesintheelderly,diabetic populations,andthosewithahistoryofCAD(seeMIsection).

Quick HIT

Acommonpresentationisapatientwithchronicstableanginawhopresentswithsymptomssuggestiveof unstableangina.Thefollowingaretheinitialsteps:

¢

¢

¢

e

ObtainECGandcardiacenzymes Giveaspirin BeginIVheparinifnocontraindications(i.e.,activebleeding,recentlife-threateningbleed) Admissiontohospitalforworkupasdescribedabove
======================================
CongestiveHeartFailure

A.GeneralCharacteristics 1. CHFisaclinicalsyndromeresultingfromtheheart’sinabilitytomeetthebody’s circulatorydemandsundernormalphysiologicconditions.Itisthefinalcommon pathwayforawidevarietyofcardiacdiseases(seealsoClinicalPearl1-7).

1. CHF isa clinical syndrome resulting from the heart’s inability to meet the body’s circulatory demands under normal physiologic conditions. It is the final common pathway for a wide variety of cardiac diseases (see also Clinical Pearl 1-7). 2. Pathophysiology (Figure 1-5)

2. Pathophysiology(Figure1-5) a. Frank–Starlingrelationship

e

e

Inanormalheart,increasingpreloadresultsingreatercontractility. Whenpreloadislow(atrest),thereislittledifferenceinperformancebetween anormalandafailingheart.However,withexertionafailingheartproduces relativelylesscontractilityandsymptomsoccur(Figure1-6).

Quick HIT

Often,bothsystolicanddiastolicdysfunctionsarepresentsimultaneously.

3. HeartFailurewithreducedEjectionFraction(HFrEF)orsystolicdysfunction

a. Owingtoimpairedcontractility(reducedEF<40%) b. Causesinclude:

IschemicheartdiseaseorafterarecentMI—infarctedcardiacmuscledoesnot pumpblood(decreasedEF) idiopathic HTN

e

e

e HTN

CLINICALPEARL1-7

High-OutputHeartFailure

¢

e

Inhigh-outputheartfailure,anincreaseincardiacoutputisneededfortherequirementsofperipheral tissuesforoxygen. Causesinclude:

Chronicanemia Pregnancy Hyperthyroidism AVfistulas Wetberiberi(causedbythiamine[vitaminB1]deficiency) Pagetdiseaseofbone MR Aorticinsufficiency

e

e« MR

e

Theconditionslistedaboverarelycauseheartfailurebythemselves.However,iftheseconditionsdevelop

¢

inthepresenceofunderlyingheartdisease,heartfailurecanresultquickly.

Activation of sympathetic nervous system Activation of renin-angiotensin— aldosterone system Systemic vasoconstriction and volume retention AVenous return, resulting inA preload. This maintains CO. However, in severe CHF, preload does not result inAcardiac output (see Frank—Starling mechanism). ALVEDV causesALVEDP, which is transmitted back to pulmonary veins and leads to symptoms of pulmonary congestion.
======================================
FIGURE 1.5 PathophysiologyofCHF.

Myocarditis(postviral,giantcell,autoimmune) Drugs:Alcohol,cocaine,methamphetamines,chemotherapy(anthracyclines andtrastuzumab) Infiltrativedisease(amyloidosis,sarcoidosis,hemochromatosis,Wilson disease) Radiationtherapy Thyroiddisease Peripartumcardiomyopathy

e

e

¢

Infectiousdisease(Chagasdisease,HIV,endocarditiscausingvalvulardisease) Valvularheartdisease(usuallyMR,aorticstenosisorregurgitation) High-outputheartfailure(severeanemia,duetoAVfistulas,pregnancy,severe thiaminedeficiency) Congenital/hereditary

Normal heart Failing heart Stroke volume Preload

FIGURE 1.6

Frank–Starlingrelationship.

4. HeartFailurewithpreservedEjectionFraction(HFpEF)ordiastolicdysfunction a. Owingtoimpairedventricularfillingduringdiastole(eitherimpairedrelaxation

orincreasedstiffnessofventricleorboth).

b. Echocardiogramshowsimpairedrelaxationofleftventricle. c. Causesinclude:

e

e

e

HTNleadingtomyocardialhypertrophy—mostcommoncauseofdiastolic dysfunction Valvulardiseasessuchasaorticstenosis(AS),mitralstenosis,andaortic regurgitation Restrictivecardiomyopathy(e.g.,amyloidosis,sarcoidosis,hemochromatosis intheirearlyphases)

B.ClinicalFeatures 1. Symptomsofleft-sidedheartfailure(seealsoClinicalPearl1-8)

a. Dyspnea—difficultybreathingsecondarytopulmonarycongestion/edema b. Orthopnea—difficultybreathingintherecumbentposition;relievedby

elevationoftheheadwithpillows

c. Paroxysmalnocturnaldyspnea(PND)—awakeningafter1to2hoursofsleep duetoacuteshortnessofbreath(SOB)

d. Nocturnalcough(nonproductive)—worseinrecumbentposition(same pathophysiologyasorthopnea)

e. ConfusionandmemoryimpairmentoccurinadvancedCHFasaresultof inadequatebrainperfusion

f. Diaphoresisandcoolextremitiesatrest—occurindesperatelyillpatients (NYHAclassIV)

2. Signsofleft-sidedheartfailure

a. DisplacedPMI(usuallytotheleft)duetocardiomegaly b. PathologicS3(ventriculargallop)

Rapidfillingphase“into”anoncompliantleftventricularchamber Maybenormalfindinginchildren;inadults,usuallyassociatedwithCHF Maybedifficulttohear,butisamongthemostspecificsignsofCHF Heardbestatapexwithbellofstethoscope ThesequenceinthecardiaccycleforS3:S3followsS2(ken-tuck-Y)

c. S4gallop
======================================
e

e

e

Soundofatrialsystoleasbloodisejectedintoanoncompliant,orstiff,left ventricularchamber Heardbestatleftsternalborderwithbellofstethoscope ThesequenceinthecardiaccycleforS4:S4precedesS1(TEN-nes-see)

d. Crackles/ralesatlungbases

e

e

Causedbyfluidspillingintoalveoli;indicatespulmonaryedema Ralesheardoverlungbasessuggestatleastmoderateseverityofleft ventricularheartfailure

e. Dullnesstopercussionanddecreasedtactilefremitusoflowerlungfieldscaused bypleuraleffusion

f. Increasedintensityofpulmoniccomponentofsecondheartsoundsuggests pulmonaryHTN(heardoverleftuppersternalborder)

CLINICALPEARL1-8

NewYorkHeartAssociation(NYHA)Classification

NYHAclassI:Symptomsonlyoccurwithvigorousactivities,suchasplayingasport.Patientsarenearly asymptomatic.

NYHAclassII:Symptomsoccurwithprolongedormoderateexertion,suchasclimbingaflightofstairsor carryingheavypackages.Slightlimitationofactivities. NYHAclassIII:Symptomsoccurwithusualactivitiesofdailyliving,suchaswalkingacrosstheroomor gettingdressed.Markedlylimiting. NYHAclassIV:Symptomsoccuratrest.Incapacitating.

Quick HIT

TeststoorderforanewpatientwithCHF:

CBC(anemia) BMP(assessforrenalinjuryduetovolumeoverload,orcardiorenalsyndrome) CardiacenzymestoruleoutMI BNP Chestx-ray(pulmonaryedema,cardiomegaly,ruleoutCOPD) ECG Echocardiogram(estimateEF,ruleoutpericardialeffusion)

BNP

ECG

3. Symptoms/signsofright-sidedheartfailure

a. Peripheralpittingedema—pedaledemalacksspecificityasanisolatedfinding. Intheelderly,itismorelikelytobesecondarytovenousinsufficiency

b. Nocturia—duetoincreasedvenousreturnwithelevationoflegs c. Jugularvenousdistention(JVD) d. Hepatomegaly/hepatojugularreflux e. Ascites f. Rightventricularheave(foundwithpulmonaryHTN)

4. Givenenoughtime,left-sidedheartfailurecanleadtoright-sidedheartfailure (mostcommoncauseright-sidedheartfailure)

a. Patientsmaypresentwithsign/symptomsofbothright-andleft-sidedHF

C.Diagnosis 1. Chestx-ray(CXR)(Figure1-7)

a. Cardiomegaly b. KerleyBlinesareshorthorizontallinesnearperipheryofthelungnearthe

b. Kerley B lines are short horizontal lines near periphery of the lung near the costophrenic angles, and indicate pulmonary congestion secondary to dilation of pulmonary lymphatic vessels

costophrenicangles,andindicatepulmonarycongestionsecondarytodilationof pulmonarylymphaticvessels c. Prominentinterstitialmarkings d. Pleuraleffusion

2. Echocardiogram(transthoracic)

a. Initialtestofchoice—shouldbeperformedwheneverCHFissuspectedbasedon history,examination,orCXR.

b. Usefulindeterminingwhethersystolicordiastolicdysfunctionpredominates, anddetermineswhetherthecauseofCHFisduetoamyocardial,valvular,or

pericardialprocess.

c. EstimatesEF(veryimportant):Patientswithsystolicdysfunction(EF<40%) shouldbedistinguishedfrompatientswithpreservedleftventricularfunction (EF>40%).

d. Showschamberdilationand/orhypertrophy.
======================================
FIGURE 1.7

A:Chestradiographshowingcardiogenicpulmonaryedema.B:Anotherexampleof cardiogenicpulmonaryedema;notecardiomegaly(patienthadCHF). (AfromMergoPJ.ImagingoftheChest—ATeachingFile.Philadelphia,PA:Lippincott Williams&Wilkins;2002:50,Figure24A.)(BfromSternEJ,WhiteCS.ChestRadiology Companion.Philadelphia,PA:LippincottWilliams&Wilkins;1999:38,Figure5-4.)

3. B-typenatriureticpeptide(BNP)isreleasedfromtheventriclesinresponseto ventricularvolumeexpansionandpressureoverload.

a. BNPlevels>100pg/mLcorrelatestronglywiththepresenceofdecompensated CHF.(Unitofmeasurementvaries.)

b. BNPmaybeusefulindifferentiatingbetweendyspneacausedbyCHFand COPD.

c. N-terminalpro-BNP(NT-proBNP)isanewerassaywithsimilarpredictive valueasBNP.Thenormalrangeforthisvaluedependsontheageofthepatient, butanNT-proBNP<300virtuallyexcludesthediagnosisofHF.

d. BNPmaybefalselylowinobesepatients.

4. ECGisusuallynonspecificbutcanbeusefulfordetectingchamberenlargement andpresenceofischemicheartdiseaseorpriorMI.

5. Radionuclideventriculographyusingtechnetium-99m(“nuclear ventriculography”).Alsocalledmultigatedacquisition(MUGA)scan.

6. Cardiaccatheterizationcanprovidevaluablequantitativeinformationregarding diastolicandsystolicdysfunction,andcanclarifythecauseofCHFifnoninvasive testresultsareequivocal.ConsidercoronaryangiographytoexcludeCADasan underlyingcauseofCHF.

7. Stresstesting

a. Identifiesischemiaand/orinfarction b. Quantifieslevelofconditioning c. Candifferentiatecardiacversuspulmonaryetiologyofdyspnea d. AssessesdynamicresponsesofHR,heartrhythm,andBP

Quick HIT

HTNisacommoncauseofCHFandshouldbetreated.Goalistoreducepreloadandafterload.

Quick HIT

MonitoringapatientwithCHF:

e

¢

e

Weight—unexplainedweightgaincanbeanearlysignofworseningCHF Clinicalmanifestations(exercisetoleranceiskey);peripheraledema Laboratoryvalues(electrolytes,K,BUN,creatininelevels;serumdigoxinlevel,ifapplicable)

D.Treatment 1. Systolicdysfunction

a. Generallifestylemodification

Sodiumrestriction(lessthan4g/day) Fluidrestriction(1.5to2.0Ldaily) Weightloss Smokingcessation Restrictalcoholuse Exerciseprogram Allpatientsshouldmonitorweightdailytodetectfluidaccumulation Annualinfluenzavaccineandpneumococcalvaccinerecommended

b. Diuretics

¢
======================================
e

e

Mosteffectivemeansofprovidingsymptomaticrelieftopatientswith moderatetosevereCHF Recommendedforpatientswithsystolicfailureandvolumeoverload Havenotbeenshowntoreducemortalityorimproveprognosis,justfor symptomcontrol.Goalisreliefofsignsandsymptomsofvolumeoverload

¢

e

(dyspnea,peripheraledema) Loopdiuretics:Furosemide(Lasix)—usuallyused.Otheroptionsinclude bumetanide(Bumex)andtorsemide Thiazide-likediuretics:Metolazoneandchlorothiazide.Usedtoaugment diuresiswithloopdiuretics

Quick HIT

TheRALEStrialshowedthatspironolactonereducesmorbidityandmortalityinpatientswithclassIIIorIV heartfailurewithEF<35%.Itiscontraindicatedinrenalfailure(creatinine>2).

c. Therapiestoimproveoutcomes:Standardtherapyincludesthefollowing

(medicationsinparentheseshavebeenshowntoimprovemortalityinHFrEF): ACEinhibitor(enalapril,lisinopril,captopril)orARB(valsartan,losartan, candesartan) β-Blockers(metoprololsuccinate,carvedilol,bisoprolol) Aldosteroneantagonists(spironolactone,eplerenone),ifEF<35% PrimarypreventionofsuddencardiacdeathwithICDimplantationifEF<35% onoptimalmedicaltherapy Hydralazineandnitrates(isosorbidedinitrate)areaneffectivecombination therapyforAfricanAmericanpatientswithHFrEF.Thesearealsooftenused forpatientswhocannottakeACEi/ARBoraldosteroneantagonistsdueto renaldysfunction Sacubitril/valsartanisanangiotensinreceptor/neprilysininhibitor(ARNI)that canbeusedinpatientswithEF<35%withmaximallytoleratedACEiorARB, andhasbeenshowntoimprovemortality(PARADIGM-HFtrial) Ivabradineisafunnychannelinhibitorthathasbeenshowntoreduce hospitalizationsinpatientswithreducedEFandHR>70onmaximally toleratedβ-blockertherapy DigoxinwasonceregularlyusedforHFrEF,buthasnotbeenshownto improvemortality

e

e

e

e

e

e

e

e

2. HFpEF:Fewtherapeuticoptionsavailable;patientsaretreatedsymptomatically (NOmedicationshaveprovenmortalitybenefit)

e

e

e

Diureticsareusedforsymptomcontrol(volumeoverload) Patientsshouldcontinuesaltandfluidrestriction,takedailyweights Nootherdrugclasseshavebeenshowntoproducesignificantmortalitybenefit inrandomizedcontrolledtrials

3. GeneralprinciplesintreatmentofHF(seeClinicalPearls1-9and1-10)
======================================
Quick HIT

MostcommoncauseofdeathfromHFissuddendeathfromventriculararrhythmias.Ischemiaprovokes ventriculararrhythmias.

AcuteDecompensatedHeartFailure

A. Findings:

A. Acutedyspneaassociatedwithelevatedleft-sidedfillingpressures,withorwithout pulmonaryedema.

B. MostcommonlyduetoLVsystolicordiastolicdysfunction. C. Flashpulmonaryedemareferstoasevereformofheartfailurewithrapid

accumulationoffluidinthelungs.

B. Diagnosis

A. Differentialincludespulmonaryembolism,asthma,andpneumonia,allofwhich cancauserapidrespiratorydistress.

B. DiagnostictestsincludeECG,CXR,ABG,B-typenatriureticpeptide(BNP), echocardiogram,andpossiblecoronaryangiogramifindicated.

CLINICALPEARL1-9 GeneralPrinciplesintheTreatmentofCHF Noonesimpletreatmentregimenissuitableforallpatients.

Thefollowingisageneralguideline,buttheorderoftherapymaydifferamongpatientsand/orwithphysician

preferences. MildCHF(NYHAClassesItoII)

e

¢

¢

Mildrestrictionofsodiumintake(no-added-saltdietof4-gsodium)andphysicalactivity. Startaloopdiureticifvolumeoverloadorpulmonarycongestionispresent. UseanACEinhibitorasafirst-lineagent.

MildtoModerateCHF(NYHAClassesIItoIII)

e

e

Startadiuretic(loopdiuretic)andanACEinhibitor. Addaβ-blockerifmoderatedisease(classIIorIII)ispresentandtheresponsetostandardtreatmentis suboptimal.

ModeratetoSevereCHF(NYHAClassesIIItoIV)

¢

e

Canadddigoxin(toloopdiureticandACEinhibitor)forthereliefofsymptomsinpatientswithsystolic dysfunction.(Itdoesnotimprovemortality.) AddspironolactoneoreplerenoneifEF<35%

CLINICALPEARL1-10

¢

Ventricularassistdevice(VAD).Workonthesedeviceshasbeenoccurringforthepastfivedecades,and mostoftheproductsonthemarketnowrepresentresearchthatwasdone30yearsago.Thereisgreatpotential forthesedevicesasmoreresearchisconductedandcliniciansbecomemoreexperiencedintheiradvantages anddrawbacks. VADsmaybeusedtosupporttheleftventricle(LVAD),rightventricle(RVAD),orbothventricles(BiVAD). Thepumpisimplantedintheabdominalcavitywithcannulationtotheheart.Thesystemcontrollerand batteryarewornexternally. Thesedevicesmayallowforapatientrequiringcontinuoushospitalizationtoeventuallybedischargedwith
======================================
e

e

e

relativelystraightforwardoutpatientfollow-up.Patientsmaylivewiththesedevicesforayearormore. Lifelonganticoagulationwithheparinorwarfarinisessentialwithoutexceptionsasthesedevicesarevery thrombogenic. VADsmayalsobeusedforhemodynamicsupportrelatedtotheacutetreatmentofaSTEMIorothercardiac pathology(i.e.,whilerecoveringfromaseverecaseofmyocarditis).

Quick HIT

ACEinhibitors

¢

¢

¢

Causevenousandarterialdilation,decreasingpreloadandafterloadandthusbloodpressure. ACEinhibitorsreducemortality(CooperativeNorthScandinavianEnalaprilSurvivalStudy[CONSENSUS] andStudiesofLeftVentricularDysfunction[SOLVD]trials),prolongsurvival,andalleviatesymptomsin mild,moderate,andsevereHFrEF. MonitorBP,potassium,andcreatinine.

C. Treatment

A. Oxygenationandventilatoryassistancewithnonrebreatherfacemask,noninvasive positivepressureventilation,orevenintubationasindicated.

B. Diureticstotreatvolumeoverloadandcongestivesymptoms—thisisthemost importantintervention.Decreasespreload.

C. Nitrates—IVnitroglycerin(venodilator)inpatientswithouthypotension. Decreasespreload.

D. Patientswhohavepulmonaryedemadespiteuseofoxygen,diuretics,andnitrates maybenefitfromuseofinotropicagents(dobutamine).Digoxintakesseveral weekstoworkandisnotindicatedinanacutesetting.

E. Dietarysodiumandfluidrestriction.

Quick HIT

AngiotensinIIreceptorblockers(ARBs):

CanbeusedinpatientsunabletotakeACEinhibitorsduetosideeffectofcough

β-Blockers(specificallymetoprololsuccinate,carvedilol,andbisoprololhavebeenshowntoreduce mortality):

e

e

e

ProventodecreasemortalityinpatientswithHFrEF. ReportedtoimprovesymptomsofHF;mayslowprogressionofheartfailurebyslowingdowntissue remodeling.Thedecreaseinheartrateleadstodecreasedoxygenconsumption. β-Blockershaveantiarrhythmic,anti-ischemic,andantianginaleffect.

PrematureComplexes

A.PrematureAtrialComplexes 1. Thisearlybeatariseswithintheatria,firingonitsown. 2. Causesincludeadrenergicexcess,drugs,alcohol,tobacco,electrolyteimbalances,

ischemia,hypoxia,andinfection.

3. OnECG,lookforearlyPwavesthatdifferinmorphologyfromthenormalsinus Pwave(becausethesePwavesoriginatewithintheatriaandnotthesinusnode).

4. QRScomplexisnormalbecauseconductionbelowtheatriaisnormal.Thereis usuallyapausebeforethenextsinusPwave.

5. Prematureatrialcomplexes(PACs)arefoundinmorethan50%ofnormaladults whoundergoHoltermonitoringandareofnosignificanceinanormalheart,but maybeaprecursorofischemiainadiseasedheart.

6. MaycausepalpitationsorgiverisetoPSVTs. 7. Usuallyasymptomaticanddonotrequiretreatment.Monitorforincreased frequency.Ifsymptomatic(e.g.,palpitations),β-blockersmaybehelpful.
======================================
B.PrematureVentricularComplexes 1. Thisearlybeatfiresonitsownfromafocusintheventricleandthenspreadsto

theotherventricle(Figure1-8).

2. PVCscanoccurinpatientswithorwithoutstructuralheartdisease.Causes includehypoxia,electrolyteabnormalities,stimulants,caffeine,medications,and structuralheartdisease.

3. Sinceconductionisnotthroughnormalconductionpathways,butratherthrough ventricularmuscle,itisslowerthannormal,causingawideQRS.

4. Wide,bizarreQRScomplexesfollowedbyacompensatorypauseareseen;aP waveisnotusuallyseenbecauseitis“buried”withinthewideQRScomplex. 5. PVCsappearinmorethan50%ofmenwhoundergo24-hourHoltermonitoring. 6. Mostpatientsareasymptomatic.Somepatientsmayhavepalpitationsand

dizzinessrelatedtoPVCs.Ifsymptomatic,β-blockersmaybeused.

7. PresenceofPVCsinpatientswithnormalheartsisassociatedwithincreased mortality.

8. IfapatientisfoundtohavefrequentPVCs,workupforunderlyingstructuralheart diseaseshouldbeinitiatedwhichmayrequirespecifictreatment.

9. Patientswithfrequent,repetitivePVCsandunderlyingheartdiseaseareat increasedriskforsuddendeathduetocardiacarrhythmia(especiallyVFib).Order anelectrophysiologicstudybecausepatientsmaybenefitfromanICDorablation.

E He = artes ~ HH +H H ae H Hf + H Ht i i = Ht HH aes is:

FIGURE 1.8

Normalsinusrhythmwithprematureventricular

contraction. (FromNettinaSM.TheLippincottManualofNursingPractice.9thed.Philadelphia,PA:

LippincottWilliams&Wilkins;2010:433,Figure13-14.)

Quick HIT

Aldosteroneantagonists(spironolactone,eplerenone)

IndicatedforHFrEFwithEF<35% Improveall-causemortality,CVmortality,andhospitalizations Cancausehyperkalemia,henceBMPshouldbemonitored(donotstartifcreatinine>2.5inmenor2in women)

Tachyarrhythmias AtrialFibrillation

A.GeneralCharacteristics 1. Multiplefociintheatriafirecontinuouslyinachaoticpattern,causingatotally irregular,rapidventricularrate.Insteadofintermittentlycontracting,theatria quivercontinuously.

2. Atrialrateisover400bpm,butmostimpulsesareblockedattheAVnodeso ventricularraterangesbetween75and175.

3. PatientswithAFibandunderlyingheartdiseaseareatamarkedlyincreasedrisk foradverseevents,suchasthromboembolismandhemodynamiccompromise.
======================================
Quick HIT

Digoxin

¢

e

e

Positiveinotropicagent. Providesshort-termsymptomaticrelief(usedtocontroldyspneaandwilldecreasefrequencyof hospitalizations)buthasnotbeenshowntoimprovemortality,thusisnotafirstlinetreatment. Serumdigoxinlevelshouldbecheckedperiodically.

Signsofdigoxintoxicity:

e

¢

e

GI:Nausea/vomiting,anorexia Cardiac:Ectopic(ventricular)beats,AVblock,AFib CNS:Visualdisturbances,disorientation

B.Causes 1. Heartdisease:CAD,MI,HTN,mitralvalvedisease 2. Historyofcardiacsurgery(scarcanpredisposetoectopicfociofactivity) 3. Pulmonarydisease,includingPE,COPD,anycauseofhypoxia 4. Hyperthyroidism 5. Systemicillness(e.g.,sepsis,malignancy) 6. Stress(e.g.,postoperative,pain) 7. Excessivealcoholintake(“holidayheartsyndrome”) 8. Pericarditis 9. Hyperadrenergicstates:Pheochromocytoma,cocaineormethamphetamineuse 10. Extremesofactivity(sedentarylifestyle,excessexercisesuchasmarathon

running)

C.ClinicalFeatures 1. Fatigueandexertionaldyspnea

2. Palpitations,dizziness,angina,orsyncopemaybeseen 3. Anirregularlyirregularpulse 4. Bloodstasis(secondarytoineffectivecontraction)leadstoformationof

intramuralthrombi(oftenintheleftatrialappendage),whichcanembolizetothe brain,causingischemicstroke

D.Diagnosis 1. ECGfindings:Irregularlyirregularrhythm(irregularRRintervalsand

excessivelyrapidseriesoftiny,erraticspikesonECGwithawavybaselineand noidentifiablePwaves)

E.Treatment 1. AcuteAFibinahemodynamicallyunstablepatient:Immediateelectrical

cardioversiontosinusrhythm(Figure1-9;seeClinicalPearl1-11)

2. AcuteAFibinahemodynamicallystablepatient

a. Ratecontrol

e

e

e

Targetheartrateis<110bpm(lenientratecontrolwasfoundtobenoninferior tostrictratecontrolintheRACEIItrial). β-Blockersarepreferredagent.CCBs(suchasdiltiazem)areanalternativeif patientdoesnothaveHFrEF. Ifleftventricularsystolicdysfunctionispresent,idealchoiceismetoprolol succinateasitwilltreatbothHFrEFandAFibratecontrol.Canalsoconsider digoxinoramiodarone(usefulforrhythmcontrol).

Hemodynamically stable? Rate control Immediate electrical cardioversion Duration of AFib >48 hr? Yes or unknown — Anticoagulate for 3 wk a Thrombus in left atrium? No>
======================================
FIGURE 1.9

Acutemanagementofatrialfibrillation.

Quick HIT

Calciumchannelblockers(CCBs)playnoroleintreatmentofCHFandsomemayactuallyraisemortality.

Quick HIT

ThefollowingmedicationsarecontraindicatedinpatientswithCHF:

¢

¢

e¢

e

Metformin—maycausepotentiallylethallacticacidosiswithrenaldysfunction Thiazolidinediones—causesfluidretention NSAIDsmayincreaseriskofCHFexacerbation Someantiarrhythmicagentsthathavenegativeinotropiceffects

Thefollowingdeviceshavebeenshowntoreducemortalityinselectpatients:

«

¢

AnICDlowersmortalitybyhelpingpreventsuddencardiacdeath(whichisthemostcommoncauseof deathinCHF).Itisindicatedforpatientsatleast40dayspost-MI,EF<35%,andclassIIorIIIsymptoms despiteoptimalmedicaltreatment. Cardiacresynchronizationtherapy(CRT):Thisisbiventricularpacemaker—indicationsaresimilartoICD exceptthesepatientsalsohaveprolongedQRSduration>130ms.MostpatientswhomeetcriteriaforCRT arealsocandidatesforICDandreceiveacombineddevice.

Cardiactransplantationisthelastalternativeiftheabovedonotcontrolsymptoms.

Quick HIT

Theoverall5-yearmortalityforallpatientswithCHFisabout50%.

Quick HIT

TheCardiacArrhythmiaSuppressionTrial(CAST)IandCASTIIstudiesshowedthattheuseofantiarrhythmic drugstosuppressPVCsafterMIincreasestheriskofdeath.

Quick HIT

PVCs

¢

e

e

Couplet:TwosuccessivePVCs Bigeminy:SinusbeatfollowedbyaPVC Trigeminy:TwosinusbeatsfollowedbyaPVC

CLINICALPEARL1-11

CardioversionVersusDefibrillation Cardioversion

¢

e

DeliveryofashockthatisinsynchronywiththeQRScomplex:Purposeistoterminatecertain dysrhythmiassuchasPSVTorVT;anelectricshockduringTwavecancauseVfib,sotheshockistimed nottohittheTwave. Indications:AFib,atrialflutter,VTwithapulse,SVT

Defibrillation

¢

¢

DeliveryofashockthatisnotinsynchronywiththeQRScomplex:Purposeistoconvertadysrhythmiato normalsinusrhythm. Indications:VFib,VTwithoutapulse.

AutomaticImplantableDefibrillator

e

e

Devicethatissurgicallyplaced:Whenitdetectsalethaldysrhythmia,itdeliversanelectricshockto defibrillate.Itdeliversasetnumberofshocksuntilthedysrhythmiaisterminated. Indications:VFiband/orVTthatisnotcontrolledbymedicaltherapy.
======================================
Quick HIT

PatientswithAFibinthepresenceofunderlyingheartdiseasehaveanespeciallyhighriskofembolizationand hemodynamiccompromise.

Quick HIT

ThetreatmentofAFibandatrialflutteraresimilar.Therearethreemaingoals:

e

e

e

Ratecontrol:Goalventricularrate<110 Assessneedforanticoagulation Rhythmcontrol:Restorenormalsinusrhythmiffirstpresentationorsymptomatic

b. Anticoagulationtopreventcardioemboliccerebrovascularaccident(CVA)

e

e

e

¢

¢

e

RiskstratifypatientsforbleedingcomplicationswiththeCHA2DS2-VASc score. Thisisascoringcalculatorusedtoestimateannualstrokeriskinapatientwith AFiboratrialflutter.Itassigns1pointeachtopresenceofheartfailure,HTN, age65to74,diabetes,femalesex,vasculardisease,and2pointseachtoage >75,andhistoryofCVA.Thehigherthescore,thehighertheannualstroke risk. ForpatientswithCHADSVASCscore>1,anticoagulationisgenerally indicatedunlesshighbleedingrisk. ChoiceofanticoagulantdependsonetiologyofAFiboratrialflutter.For patientswithmechanicalvalves,mitralvalvulardisease,orventricularassist devices,warfarinistheonlyoralanticoagulantavailable.Forotherpatients, directoralanticoagulants(DOACs)canbeused. DOACsapprovedforAFibincludefactorXainhibitors(apixaban, rivaroxaban,edoxaban)anddirectthrombininhibitors(dabigatran).These agentsdonotrequirelabmonitoring.DabigatranistheonlyDOACwithan FDA-approvedreversalagent. AnINRof2to3istheanticoagulationgoalrangeforwarfarin. Acutewarfarin-associatedbleedingcanbereversedwithfreshfrozenplasma (FFP),prothrombincomplexconcentrate(PCC).

e

c. Rhythmcontrol(cardioversion)

Candidatesforcardioversionincludethosewhoarehemodynamicallyunstable, thosewhoaresymptomatic,andthosewhoarehavingtheirfirstevercaseof AFib.

e

e

e

e

e

e

Thatbeingsaid,norandomizedcontroltrialhaseverfoundtherhythmcontrol strategytoimprovemortalitycomparedtoratecontrol. Ifrhythmcontrolisselectedasatreatmentstrategy,electricalcardioversionis preferredoverpharmacologiccardioversion.Attemptsshouldbemadeto controlventricularratebeforeattemptingDCcardioversion. IfAFibpresentfor>48hours(orunknownperiodoftime),riskof embolizationduringcardioversionissignificant(2%to5%).Anticoagulate patientsfor3weeksbeforeandatleast4weeksaftercardioversion. Toavoidwaiting3weeksforanticoagulation,obtainatransesophageal echocardiogram(TEE)toimagetheleftatrium(LA).Ifnothrombusis present,startIVheparinandperformcardioversionwithin24hours.Patients stillrequire4weeksofanticoagulationaftercardioversion. Usepharmacologiccardioversiononlyifelectricalcardioversionfailsorisnot feasible:Parenteralibutilide,procainamide,flecainide,sotalol,andamiodarone arechoices. AFibablationisanewertherapyforrhythmcontrol,whichisusuallyreserved forsymptomaticpatientsrefractorytoelectricalandpharmacologic cardioversion,orthosewithHFrEFandhighAFibburden.
======================================
Quick HIT

TheAFFIRMtrialshowedthatratecontrolisnoninferiortorhythmcontrolintreatmentofAFib.

Quick HIT

RiskofCVAinpatientswithAFib.2SeeTable1-2.

3. ChronicAFib

a. Ratecontrolwithaβ-blockerorCCB b. Anticoagulation

e

e

Patientswith“lone”AFib(i.e.,AFibintheabsenceofunderlyingheartdisease orothercardiovascularriskfactors)underage65donotrequire anticoagulationbecausetheyareatlowriskforembolization(aspirinmaybe appropriate). Treatallotherpatientswithchronicanticoagulation.

AtrialFlutter

A.GeneralCharacteristics 1. Pathophysiology

a. Oneirritableautomaticityfocusintheatriafiresatabout250to350bpm

(typicallyverycloseto300bpm),givingrisetoregularatrialcontractions. b. Atrialratebetween250and350,around300bpm.Thelongrefractoryperiodin theAVnodeallowsonlyoneoutofeverytwoorthreeflutterwavestoconduct totheventricles.

2. Causes

a. Heartdisease:Heartfailure(mostcommonassociation),rheumaticheartdisease,

CAD

b. COPD,otherhypoxicpulmonarydisease c. Atrialseptaldefect(ASD) d. VerysimilarriskfactorstoAFib

TABLE1-2 AtrialFibrillationAnnualStrokeRisk
======================================
FIGURE 1.10

Atrialflutter.

(FromNettinaSM.TheLippincottManualofNursingPractice.9thed.Philadelphia,PA:

LippincottWilliams&Wilkins;2010:431,Figure13-12.)

B.Diagnosis 1. ECGprovidesasaw-toothbaseline,withaQRScomplexappearingafterevery secondorthird“tooth”(Pwave).Saw-toothflutterwavesarebestseeninthe inferiorleads(II,III,aVF)(Figure1-10).

C.Treatment 1. SamegeneraltreatmentstrategiesasAFib 2. However,atrialflutterablationishighlysuccessfulandcanbeusedtoavoidlong-

termanticoagulationifriskfactorspresent.

MultifocalAtrialTachycardia

Usuallyoccursinpatientswithseverepulmonarydisease(e.g.,COPD). ECGfindings:VariableP-wavemorphologyandvariablePRandRRintervals.At leastthreedifferentP-wavemorphologiesarerequiredtomakeanaccurate diagnosis(Figure1-11). Thediagnosisofwanderingatrialpacemakerisidenticalexceptthattheheartrateis between60and100bpm(i.e.,nottachycardic). CanalsobediagnosedbyuseofvagalmaneuversoradenosinetoshowAVblock withoutdisruptingtheatrialtachycardia. Treatmentdirectedattheunderlyingdisease,improvingoxygenationandventilation (strongassociationbetweenMATandlungdisease).Ifleftventricularfunctionis preserved,acceptabletreatmentsincludeCCBs,β-blockers,digoxin,amiodarone,IV flecainide,andIVpropafenone.IfLVfunctionisnotpreserved,usedigoxin, diltiazem,oramiodarone.Electricalcardioversionisineffectiveandshouldnotbe used.

ParoxysmalSupraventricularTachycardia

A.GeneralCharacteristics 1. Pathophysiology(mostoftenduetoreentry)(Figure1-12)

a. AVnodalreentranttachycardia

e

¢

e

e

Twopathways(onefastandtheotherslow)withintheAVnode,sothe reentrantcircuitiswithintheAVnode Mostcommoncauseofsupraventriculartachyarrhythmia(SVT) InitiatedorterminatedbyPACs ECG:NarrowQRScomplexeswithnodiscerniblePwaves(Pwavesareburied withintheQRScomplex).Thisisbecausethecircuitisshortandconductionis rapid,soimpulsesexittoactivateatriaandventriclessimultaneously.Can sometimeshaveretrogradePwaves,orPwaveswhichoccurafterQRS complex

b. OrthodromicAVreentranttachycardia

e

¢

e

e

Anaccessorypathwaybetweentheatriaandventriclesthatconducts retrogradely Calleda“concealedbypasstract,”andisacommoncauseofSVTs InitiatedorterminatedbyPACsorPVCs ECG:NarrowQRScomplexeswithPwaveswhichmayormaynotbe discernible,dependingontherate.Thisisbecausetheaccessorypathwayisat somedistancefromtheAVnode(reentrantcircuitislonger),andthereisa differenceinthetimingofactivationoftheatriaandventricles

* 100-200/1 ES \ aaa spies + H+ iz H - H rH eeegea es HEE Bonteatests i H : i Hot ie + a Pats EEL EEE SHEE Ht tH eee eaeeee (a ee agi Ht H HH +f crs tae Ht Hits f t tite eH I: : aH H 7 : PEE Hed if FH THAR eases aes EH : aaa Sa -- Hott Hind: HH : Huge Bau tgied cazedtateeieces 4 HHH HH aH eRe eee eH SHH HEH
======================================
FIGURE 1.11

ECGofmultifocalatrialtachycardiawithdifferentP- waveconfigurations,varyingPRintervals,andanirregularrate. VisibleectopicPwavesareindicatedbyarrows. (FromDavisD.QuickandAccurate12-LeadECGInterpretation.3rded.Philadelphia,PA:

LippincottWilliams&Wilkins;2000:414.)

2. Causes

a. Ischemicheartdisease b. Digoxintoxicity—paroxysmalatrialtachycardiawith2:1blockisthemost

commonarrhythmiaassociatedwithdigoxintoxicity

c. AVnodalreentranttachycardia(AVNRT) d. Atrialflutterwithrapidventricularresponse e. AVreentranttachycardia(accessorypathway) f. Excessivecaffeineoralcoholconsumption

FIGURE 1.12

ECGshowingPSVT.

(FromHarwood-NussA,WolfsonAB,LindenCL,etal.TheClinicalPracticeofEmergency

Medicine.5thed.Philadelphia,PA:LippincottWilliams&Wilkins;2010:483,Figure84.1.)

Quick HIT

Inaccordancewiththeelectricalconductingsystemoftheheart(SAnode,atria,AVnode,bundleofHis,bundle branches,Purkinjefibers),tachycardiascanbequicklyseparatedintotwocategoriesbasedonthewidthofthe QRScomplex.

«

e

NarrowQRScomplexessuggestthatthearrhythmiaoriginatesatorabovetheleveloftheAVnode. WideQRScomplexessuggestthatthearrhythmiaoriginatesoutsideofthenormalconductingsystemor thereisasupraventriculararrhythmiawithcoexistingabnormalityintheHis–Purkinjesystem.

B.Treatment 1. ManeuversthatstimulatethevagusnervedelayAVconductionandthusblockthe

reentrymechanism:TheValsalvamaneuver,carotidsinusmassage,breath holding,andheadimmersionincoldwater(orplacinganicebagtotheface) 2. Acutetreatment

e

e

e

e

Pharmacologictherapy IVadenosine—agentofchoiceduetoshortdurationofaction;worksby inhibitingAVnodalactivity.Isusedbothasdiagnostic(toseeunderlyingatrial rhythm)andtherapeuticagent(toterminatecertainSVTslikeAVNRTand AVRT). IVdiltiazem(CCB)andIVmetoprolol(β-blocker)ordigoxinarealternativesin patientswithpreservedleftventricularfunction. DCcardioversionifdrugsarenoteffectiveorifunstable;almostalways successful.

3. Prevention

a. Pharmacologictherapy:CCBsorβ-blockers. b. RadiofrequencycatheterablationofeithertheAVnodeortheaccessorytract (dependingonwhichistheaccessorypathway)ispreferredifepisodesare recurrentandsymptomatic.
======================================
Wolff–Parkinson–White(WPW)Syndrome

A.GeneralCharacteristics 1. Anaccessoryconductionpathwayfromatriatoventriclesthroughthebundleof

Kentcausesprematureventricularexcitationbecauseitlacksthedelayseeninthe AVnode.

2. Mayleadtoaparoxysmaltachycardia,whichcanbeproducedbytwopossible mechanisms:

a. Orthodromicreciprocatingtachycardia(orthodromicAVRT)

e

e

TheimpulsetravelsthroughtheAVnode(anterogradelimb)anddepolarizes theventricles.Thenittravelsbackthroughtheaccessorypathway(the retrogradelimb)anddepolarizestheatriaagain,creatingareentryloop. Nodeltawavesbecauseconductionoccursretrogradeovertheaccessory pathway.

b. Supraventriculartachycardias(AFiboratrialflutter)

Usually,AVnodeonlyallowscertainimpulsestogettoventricles.Withan accessorypathway,allormostoftheimpulsesmaypasstotheventricles.A fastventricularratemayoccurandcausehemodynamiccompromise.

Quick  HIT  SideEffectsofAdenosine  Headache Flushing SOB Chestpressure Nausea 

B.Diagnosis 1. ECG:Narrowcomplextachycardia,ashortPRinterval(usually<100ms),anda

deltawave(upwarddeflectionseenbeforetheQRScomplex)

C.Treatment 1. Radiofrequencycatheterablationofonearmofthereentrantloop(i.e.,ofthe

accessorypathway)isaneffectivetreatment.Medicaloptionsinclude procainamideorquinidine.

2. AvoiddrugsactiveontheAVnode(e.g.,digoxin,CCBs,β-blockers,adenosine) becausetheymayaccelerateconductionthroughtheaccessorypathway,resulting inVFib.TypeIAantiarrhythmics(i.e.,procainamide)arebetterchoices,asthey willsuppressconductionthroughtheaccessorypathwayinstead.

VentricularTachycardia

A.GeneralCharacteristics 1. DefinedasrapidandrepetitivefiringofthreeormorePVCsinarow,atarateof

between100and250bpm

2. AVdissociationispresent,thatis,sinusPwavescontinuewiththeircycle,

unaffectedbythetachycardia 3. OriginatesbelowthebundleofHis 4. Causes

a. CADwithpriorMIisthemostcommoncause b. Activeischemia,hypotension c. Cardiomyopathies,especiallythosewithinfiltrationintomyocardiumsuchas

sarcoidosis

d. Ventricularscartissue e. Congenitaldefects f. LongQTsyndrome(resultsintorsadesdepointes) g. Drugtoxicity

5. SustainedversusnonsustainedVT

a. SustainedVT(persistsintheabsenceofintervention)
======================================
e

e

e

¢

Lastslongerthan30secondsandisoftensymptomatic Canbeassociatedwithmarkedhemodynamiccompromise(i.e.,hypotension) and/ordevelopmentofmyocardialischemia Alife-threateningarrhythmia CanprogresstoVFibifuntreated

b. NonsustainedVT

e

e

e

Brief,self-limitedrunsofVT Usuallyasymptomatic WhenCADandLVdysfunctionarepresent,itisanindependentriskfactorfor suddendeath.Therefore,patientswithnonsustainedVTshouldbethoroughly evaluatedforunderlyingCADandLVdysfunction.

6. PrognosisdependsonthepresenceofCADandonwhetherVTissustainedor nonsustained.VTafteranMIusuallyhasapoorprognosis,especiallyifitis sustained.Inpatientswithnounderlyingheartcondition,theprognosisisgood.

Quick HIT

VTorVFibcauses75%ofepisodesofcardiacarrest.

Quick HIT

TorsadesdepointesisarapidpolymorphicVT.ItisadangerousarrhythmiathatoftencanleadtoVFib.

ItisassociatedwithmanyfactorsthatprolongtheQTinterval. RiskfactorsforlongQTinclude:hypokalemia,hypomagnesemia,hypocalcemia,drugs(antiemetics, antipsychotics,SSRIs,TCAs,macrolideandfluoroquinoloneantibiotics,amongothers),andcongenitallong QTsyndrome. IVmagnesiumprovidescardiacstabilization. Electricalcardioversionforunstablepatients.Mayrequiredrugstoincreaseheartratesuchasisoproterenol toshortenQTintervalwhileunderlyingcauseisaddressed. Addresstheunderlyingcause.

B.ClinicalFeaturesofVT 1. Palpitations,dyspnea,lightheadedness,angina,impairedconsciousness(syncope

ornear-syncope)

2. Maypresentwithsuddencardiacdeath 3. Signsofcardiogenicshockmaybepresent 4. Maybeasymptomaticifrateisslow 5. PhysicalfindingsincludecannonAwavesintheneck(secondarytoAV

dissociation,whichresultsinatrialcontractionduringventricularcontraction)and anS1thatvariesinintensity

C.Diagnosis 1. ECG:WideandbizarreQRScomplexes(Figure1-13). 2. QRScomplexesmaybemono-orpolymorphic.

a. InmonomorphicVT,allQRScomplexesareidentical. b. InpolymorphicVT,theQRScomplexesaredifferent.

3. UnlikePSVT,VTdoesnotrespondtovagalmaneuversoradenosine.

D.Treatment 1. Identifyandtreatreversiblecauses

— or ps Suess Shoes sessesees: ceettsssesess i persses sSsssessrssessies ef jsaaanec: ES
======================================
FIGURE 1.13

Ventriculartachycardia.

(FromNettinaSM.TheLippincottManualofNursingPractice.9thed.Philadelphia,PA:

LippincottWilliams&Wilkins;2010:434,Figure13-16.)

Quick HIT

AlwayssuspectVTinapatientwithawide(>0.12second)QRStachycardia.

2. SustainedVT

a. HemodynamicallystablepatientswithmildsymptomsandsystolicBP>90— pharmacologictherapy

Advancedcardiaclifesupport(ACLS)guidelinesrecommendIVamiodarone

b. Hemodynamicallyunstablepatientsorpatientswithseveresymptoms

e

e

ImmediatesynchronousDCcardioversion FollowwithIVamiodaronetomaintainsinusrhythm

c. Ideally,allpatientswithsustainedVTshouldundergoplacementofanICD, unlessEFisnormal(thenconsideramiodarone)

Quick HIT

e

e

ItisimportanttodistinguishmonomorphicVTfromSVTwithaberrantconduction. Widecomplextachycardiainadultswithahistoryofstructuralheartdiseaseismuchmorelikelytobe duetoVTthanSVTwithaberrancy.

3. NonsustainedVT

a. Ifnounderlyingheartdiseaseandasymptomatic,donottreat.Thesepatientsare notatincreasedriskofsuddendeath.

b. Ifthepatienthasunderlyingheartdisease,arecentMI,evidenceofleft ventriculardysfunction,orissymptomatic,orderanelectrophysiologicstudy:If itshowsinducible,sustainedVT,ICDplacementisappropriate.

c. Pharmacologictherapyissecond-linetreatment.However,amiodaronehasthe bestresultsofalloftheantiarrhythmicagents.

VentricularFibrillation

A.GeneralCharacteristics 1. Multiplefociintheventriclesfirerapidly,leadingtoachaoticquiveringofthe

ventriclesandnocardiacoutput.

2. MostepisodesofVFibbeginwithVT(exceptinthesettingofacute ischemia/infarction).

3. Recurrence

a. IfVFibisnotassociatedwithacuteMI,recurrencerateishigh(upto30% withinthefirstyear).Thesepatientsrequirechronictherapy:Eitherprophylactic antiarrhythmictherapy(amiodarone)orimplantationofanICD.

b. IfVFibdevelopswithin48hoursofanacuteMI,long-termprognosisis favorableandtherecurrencerateislow(2%at1year).Chronictherapyisnot requiredinthesepatients.

4. Fatalifuntreated

Quick HIT

IfapatientwithunderlyingheartdiseaseisfoundtohavenonsustainedVT,animplantabledefibrillatorhasbeen showntobethemosteffectivetreatment.
======================================
Quick HIT

Cardiacarrestandsuddencardiacdeatharenotsynonymous:

Cardiacarrest:Suddenlossofcardiacoutput;potentiallyreversibleifcirculationandoxygendeliveryare promptlyrestored.

Suddencardiacdeath:Unexpecteddeathwithin1hourofsymptomonsetsecondarytoacardiaccause.

B.Causes 1. Ischemicheartdiseaseisthemostcommoncause 2. Antiarrhythmicdrugs,especiallythosethatcausetorsadesdepointes(prolonged

QTintervals)

3. AFibwithaveryrapidventricularrateinpatientswithWolff–Parkinson–White (WPW)syndrome

Quick HIT

Narrowcomplextachycardiasoriginateaboveventricles.Widecomplextachycardiasoriginatewithinventricles andaremoreominousbecausetheyaremorelikelytoprogresstoVFib.

C.ClinicalFeatures

1. CannotmeasureBP;absentheartsoundsandpulse 2. Patientisunconscious 3. Ifuntreated,leadstoeventualsuddencardiacdeath

FIGURE 1.14

Ventricularfibrillation.

(FromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.4thed.

Philadelphia,PA:LippincottWilliams&Wilkins;2000:499,Figure76.24.)

D.Diagnosis 1. ECG:NoatrialPwavescanbeidentified(Figure1-14) 2. NoQRScomplexescanbeidentified 3. Insum,nowavescanbeidentified;thereisaveryirregularrhythm

E.Treatment 1. Thisisamedicalemergency!ImmediatedefibrillationandCPRare

indicated.

a. InitiateunsynchronizedDCcardioversion(defibrillation)immediately.Ifthe equipmentisnotready,startCPRuntilitis.

b. Giveuptothreesequentialshockstoestablishanotherrhythm;assessthe rhythmbetweeneach.

2. IfVFpersists:

a. ContinueCPR. b. Intubationmaybeindicated. c. Epinephrine(1-mgIVbolusinitially,andthenevery3to5minutes)—this

increasesmyocardialandcerebralbloodflowanddecreasesthedefibrillation threshold.

3. Otheroptionsiftheaboveproceduresfail(refractoryVFib):

a. IVamiodaronefollowedbyshock—ACLSguidelinesrecommendtheuseof amiodaroneoverotherantiarrhythmicagentsinrefractoryVFib.

b. Lidocaine,magnesium,andprocainamidearealternativesecond-linetreatments.

4. Ifcardioversionissuccessful:

a. MaintaincontinuousIVinfusionoftheeffectiveantiarrhythmicagent.IV

amiodaronehasbeenshowntobeeffective.

b. Implantabledefibrillatorshavebecomethemainstayofchronictherapyin patientsatcontinuedriskforVF.Long-termamiodaronetherapyisan alternative.
======================================
Quick HIT

e

¢

DrugscannotconvertVFibbythemselves.Defibrillationiskey,alongwithCPRandepinephrine. Defibrillationdoesnotworkforasystole.PerformCPRandadministerepinephrine.

Quick HIT

PulselessElectricalActivity(PEA)

¢

¢

Occurswhenelectricalactivityisonthemonitorbuttherearenopulses(evenwithDoppler),andcarriesa grimprognosis. Treatpossiblecauses(hypoxia,hypovolemia,hypotension,hyperkalemia,acidosis,tamponade,tension pneumothorax,toxins,PE,MI)andmedicateaccordingtoACLSguidelines.

Bradyarrhythmias

SinusBradycardia

Sinusrate<60bpm:Clinicallysignificantwhenrateispersistently<45bpm Causesincludeischemia,increasedvagaltone,antiarrhythmicdrugs;maybea normalfindingintrainedathletes Canbeasymptomatic;patientsmaycomplainoffatigue,inabilitytoexercise, angina,orsyncope Atropinecanelevatethesinusratebyblockingvagalstimulationtothesinoatrial node.Acardiacpacemakermayberequiredifbradycardiapersistswithsymptoms orsyncope

SickSinusSyndrome

Sinusnodedysfunctioncharacterizedbyapersistentspontaneoussinusbradycardia. Patientsusuallyelderly. Symptomsincludedizziness,confusion,syncope,fatigue,andCHF. Pacemakerimplantationmayberequired(seeClinicalPearl1-12).

CLINICALPEARL1-12

CardiacPacemakers 1. Devicethatdeliversdirectelectricalstimulationtotheheartwhentheheart’snaturalpacemakerisunableto

doso

2. Therearethreetypes:

e

e

Permanentimplantablesystemforlong-termtreatment Temporarysystems—eithertranscutaneous(withelectrodepadsoverchest)ortransvenous—bothusean externalpulsegeneratorthatpatientcansecuretothewaistwithstraps

3. OnECG,cardiacpacingisnotedbythepresenceofa“spike.” 4. Indications

e

e

Sinusnodedysfunctionisthemostcommonindication Symptomaticheartblock—MobitzIIsecond-degreeblockandcompleteheartblock(evenif asymptomatic) Symptomaticbradyarrhythmias Tachyarrhythmiastointerruptrapidrhythmdisturbances

FIGURE 1.15

A:First-degreeAVblock.B:TypeIsecond-degreeAVblock.C:TypeIIsecond-degreeAV block.D:TypeIIIblock.

(AfromNettinaSM.TheLippincottManualofNursingPractice.9thed.Philadelphia,PA: LippincottWilliams&Wilkins;2010:436,Figure13-18.)(BfromHumesDH,DuPontHL, GardnerLB,etal.Kelley’sTextbookofInternalMedicine.4thed.Philadelphia,PA:Lippincott Williams&Wilkins;2000:500,Figure76.25.)(CfromHumesDH,DuPontHL,GardnerLB,etal. Kelley’sTextbookofInternalMedicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins; 2000:501,Figure76.27.)(DfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookof InternalMedicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:502,Figure 76.30.)
======================================
AVBlock

A.First-DegreeAVBlock 1. PRintervalisprolonged(>0.20second)(Figure1-15). 2. AQRScomplexfollowseachPwave. 3. DelayisusuallyintheAVnode. 4. Benignconditionthatdoesnotrequiretreatment.

Quick HIT

Second-degreeMobitztypeIIandthird-degreeAVblocksrequirepacemakerimplantation.

B.Second-DegreeAVBlock(IncludesMobitzTypesIandII) 1. MobitztypeI(Wenckebach)

a. CharacterizedbyprogressiveprolongationofPRintervaluntilaPwavefailsto conduct

b. SiteofblockisusuallywithintheAVnode c. Benignconditionthatdoesnotrequiretreatment

2. MobitztypeII

a. Pwavefailstoconductsuddenly,withoutaprecedingPRintervalprolongation; therefore,theQRSdropssuddenly

b. Oftenprogressestothird-degreeAVblock c. SiteofblockiswithintheHis–Purkinjesystem d. Pacemakerimplantationisnecessary

C.Third-Degree(Complete)AVBlock 1. Absenceofconductionofatrialimpulsestotheventricles;nocorrespondence

betweenPwavesandQRScomplexes

2. Aventricularpacemaker(escaperhythm)maintainsaventricularrateof25to40 bpm

a. CharacterizedbyAVdissociation b. Pacemakerimplantationisnecessary.

DiseasesoftheHeartMuscle

DilatedCardiomyopathy

Forcauses,clinicalfeatures,diagnosis,andmanagementofdilatedcardiomyopathy, seeHFrEFsectionofthischapter.

HypertrophicCardiomyopathy

A.GeneralCharacteristics 1. Mostcasesareinheritedasanautosomal-dominanttrait.However,spontaneous

mutationsmayaccountforsomecases.

2. Pathophysiology

a. Themainproblemisdiastolicdysfunctionduetoastiff,hypertrophiedventricle withelevateddiastolicfillingpressures.

b. ThesepressuresincreasefurtherwithfactorsthatincreaseHRandcontractility (suchasexercise)ordecreaseleftventricularfilling(e.g.,theValsalva maneuver).

c. Patientsmayalsohaveadynamicoutflowobstructionduetoasymmetric hypertrophyoftheinterventricularseptum.

B.ClinicalFeatures 1. Symptoms

a. Dyspneaonexertion b. Chestpain(angina) c. Syncope(ordizziness)afterexertionortheValsalvamaneuver d. Palpitations e. Arrhythmias(AFib,ventriculararrhythmias)—duetopersistentlyelevatedatrial

pressures

f. Cardiacfailureduetoincreaseddiastolicstiffness g. Suddendeath—sometimesseeninayoungathlete;maybethefirst

manifestationofdisease

h. Somepatientsmayremainasymptomaticformanyyears

2. Signs
======================================
a. SustainedPMI b. LoudS4 c. Systolicejectionmurmur

Decreaseswithsquatting,lyingdown,orstraightlegraise(duetodecreased outflowobstruction) IntensityincreaseswithValsalvaandstanding(decreasesLVsizeandthus increasestheoutflowobstruction) Decreaseswithsustainedhandgrip(increasedsystemicresistanceleadsto decreasedgradientacrossaorticvalve) Bestheardatleftlowersternalborder(LLSB)

d. Rapidlyincreasingcarotidpulsewithtwoupstrokes(bisferiouspulse)

Quick HIT

Standing,theValsalva,andlegraisemaneuversdiminishtheintensityofallmurmursexceptMVPand hypertrophiccardiomyopathy(HCM).Thesemaneuversdecreaseleftventricularvolume. SquattingincreasestheintensityofallmurmursexceptMVPandHCM. SustainedhandgripdiminishestheintensityofHCMmurmur.Sustainedhandgripincreasessystemic resistance.

C.Diagnosis 1. Echocardiogramestablishesthediagnosis 2. Clinicaldiagnosisandfamilyhistory

D.Treatment 1. Asymptomaticpatientsgenerallydonotneedtreatment,butthisiscontroversial. Nostudieshaveshownanyalterationintheprognosiswiththerapy,sotreatment generallyfocusesonreducingsymptoms.

2. Allpatientsshouldavoidstrenuousexercise,includingcompetitiveathletics. 3. Symptomaticpatientsshouldusenegativelyinotropicdrugs.

a. β-Blockersshouldbetheinitialdrugusedinsymptomaticpatients;theyreduce symptomsbyimprovingdiastolicfilling(asHRdecreases,durationindiastole increases),andalsoreducemyocardialcontractilityandthusoxygen consumption.

b. CCBs(verapamiloranothernon-DHPCCB).

¢

e

Canbeusedifpatientisnotrespondingtoβ-blocker. Reducesymptomsbysimilarmechanismasβ-blockers.

c. Disopyramidecanbeaddedtoeitherβ-blockerorCCBtoimprovesymptoms. d. Diuretics:Usewithcaution,astheycancausevolumedepletion,leadingtoLV

outflowtractobstruction.

e. IfAFibispresent,treataccordingly(seeAtrialFibrillation). f. Surgery

e

e

e

Alcoholseptalablationisalessinvasiveprocedurethanmyomectomythatcan lowerthebulkoftheinterventricularseptumandrelieveobstructive symptoms. Myomectomyhasahighsuccessrateforrelievingsymptoms.Itinvolvesthe excisionofpartofthemyocardialseptum.Itisreservedforpatientswith severedisease. Mitralvalvereplacementisnowrarelyperformed.Repairsometimes performedatthetimeofsurgicalmyomectomy.
======================================
RestrictiveCardiomyopathy

A.GeneralCharacteristics 1. Infiltrationofthemyocardiumresultsinimpaireddiastolicventricularfillingdue

todecreasedventricularcompliance.

2. Systolicdysfunctionisvariableandusuallyoccursinadvanceddisease. 3. Lesscommonthandilatedandhypertrophiccardiomyopathies.

B.CausesofRestrictiveCardiomyopathy 1. Amyloidosis 2. Sarcoidosis 3. Hemochromatosis 4. Scleroderma 5. Carcinoidsyndrome 6. Chemotherapyorradiationinduced 7. Idiopathic

C.ClinicalFeatures 1. Elevatedfillingpressurescausedyspneaandexerciseintolerance. 2. Right-sidedsignsandsymptomsarepresentforthesamereason.

D.Diagnosis 1. Echocardiogram

a. Thickenedmyocardiumandpossiblesystolicventriculardysfunction b. Increasedrightatrium(RA)andLAsizewithnormalLVandRVsize c. Inamyloidosis,myocardiumappearsbrighterormayhaveaspeckled

appearance

2. ECG:Lowvoltagesorconductionabnormalities,arrhythmias,AFib 3. Endomyocardialbiopsymaybediagnostic

E.Treatment 1. Treatunderlyingdisorder

a. Hemochromatosis:Phlebotomyordeferoxamine b. Sarcoidosis:Glucocorticoidsforacuteflares c. Amyloidosis:Treatunderlyingcauseofamyloidosis,considerorgan transplantationifsevereend-organdisease(i.e.,heart,kidney,liverif transthyretinamyloidosis)

d. TreataccordingtoEF(HFrEFtherapyorHFpEFtherapy)

2. Usediureticsandvasodilators(forpulmonaryandperipheraledema)cautiously, becauseadecreaseinpreloadmaycompromisecardiacoutput

Myocarditis

Inflammationofthemyocardium,withmanypossiblecauses,includingviruses (e.g.,Coxsackie,parvovirusB19,humanherpesvirus6),bacteria(e.g.,groupA streptococcusinrheumaticfever,Lymedisease,mycoplasma,etc.),SLE, medications(e.g.,sulfonamides);canalsobeidiopathic. Maybeasymptomatic,ormaypresentwithfatigue,fever,chestpain,pericarditis, CHF,arrhythmia,orevendeath. Theclassicpatientisayoungmale. Lookforelevationsincardiacenzymelevelsanderythrocytesedimentationrate. Treatmentissupportive.Treatunderlyingcausesifpossible,andtreatany complications.

PericardialDiseases

AcutePericarditis

A.GeneralCharacteristics 1. Inflammationofthepericardialsac—maybeanisolatedfindingorpartofan

underlyingdisorderorgeneralizeddisease

2. Causes

a. Idiopathic(probablypostviral):Mostcasesofidiopathicpericarditisare presumedtobepostviral,usuallyprecededbyarecentflu-likeillnessorby upperrespiratoryorGIsymptoms

b. Infectious:Viral(e.g.,Coxsackievirus,echovirus,adenovirus,EBV,influenza, HIV,hepatitisAorB),bacterial(tuberculosis),fungal,toxoplasmosis

c. AcuteMI(first24hoursafterMI) d. Uremia e. Collagenvasculardiseases(e.g.,SLE,scleroderma,rheumatoidarthritis,

sarcoidosis)

f. Neoplasm—especiallyHodgkinlymphoma,breast,andlungcancers g. Drug-inducedlupussyndrome(procainamide,hydralazine) h. AfterMI:(Dresslersyndrome)—usuallyweekstomonthsafterMI i. Aftersurgery—postpericardiotomysyndrome j. Amyloidosis k. Radiation l. Trauma

3. Themajorityofpatientsrecoverwithin1to3weeks.Aminorityofpatientshave aprolongedcourseorrecurrentsymptoms

4. Complications
======================================
a. Pericardialeffusion b. Cardiactamponade—canoccurinupto15%ofpatients;closeobservationis

important

B.ClinicalFeatures 1. Chestpain(mostcommonfinding)

a. Oftensevereandpleuritic(candifferentiatefrompainofMIbecauseof associationwithbreathing).

b. Oftenlocalizedtotheretrosternalandleftprecordialregionsandradiatestothe trapeziusridgeandneck.

c. Painispositional:Itisaggravatedbylyingsupine,coughing,swallowing,and

deepinspiration.Painisrelievedbysittingupandleaningforward.

d. Painisnotalwayspresent,dependingonthecause(e.g.,usuallyabsentin rheumatoidpericarditis).

2. Feverandleukocytosismaybepresent 3. Patientmaygivesymptomsofprecedingviralillnesssuchasanonproductive

coughordiarrhea

4. Pericardialfrictionrub

a. Notalwayspresent,butitisveryspecificforpericarditis b. Causedbyfrictionbetweenvisceralandparietalpericardialsurfaces c. Scratching,high-pitchedsoundwithuptothreecomponents.Patientsmayhave

anyorallofthethreecomponents:

e

e

e

Atrialsystole(presystolic) Ventricularsystole(loudestandmostfrequentlyheard) Earlydiastole

d. Heardbestduringexpirationwithpatientsittingupandwithstethoscopeplaced firmlyagainstthechest

e. Frictionrubmaycomeandgooveraperiodofseveralhours,andcanvary greatlyinintensity

Quick HIT

Diagnosticcriteriaofacutepericarditis(needatleast2/4): Classicpleuriticchestpainwithpositionalcomponent Pericardialfrictionrub ECGchanges—diffuseSTelevations;PRdepression,PRelevationinaVR Pericardialeffusion(seenonchestx-rayorechocardiogram)

C.Diagnosis 1. ECGshowsfourchangesinsequence

a. DiffuseSTelevationandPRdepression,withPRelevationinleadaVR b. STsegmentreturnstonormal—typicallyaround1week c. T-waveinverts—doesnotoccurinallpatients d. Twavereturnstonormal

2. Echocardiogramifpericarditiswitheffusionissuspected

D.Treatment 1. Mostcasesareself-limitedandresolvein2to6weeks. 2. Treattheunderlyingcauseifknown. 3. First-linetherapyishigh-doseNSAIDs(aspirin,ibuprofen,naproxen,or

indomethacin).Colchicineisrecommendedasadjunctivetherapyinadditionto

NSAIDs.

4. GlucocorticoidsmaybetriedifpaindoesnotrespondtoNSAIDs,butshouldbe avoidedifatallpossible,astheyareassociatedwithahighrateofrecurrent pericarditis.

5. Relativelyuncomplicatedcasescanbetreatedasanoutpatient.However,patients withmoreworrisomesymptomssuchasfeverandleukocytosisandpatientswith worrisomefeaturessuchaspericardialeffusionshouldbehospitalized.
======================================
ConstrictivePericarditis

A.GeneralCharacteristics 1. Fibrousscarringofthepericardiumleadstorigidityandthickeningofthe

pericardium,withobliterationofthepericardialcavity.

2. Pathophysiology

a. Afibrotic,rigidpericardiumrestrictsthediastolicfillingoftheheart. b. Ventricularfillingisunimpededduringearlydiastolebecauseintracardiac volumehasnotyetreachedthelimitdefinedbythestiffpericardium. c. Whenintracardiacvolumereachesthelimitsetbythenoncompliant

pericardium,ventricularfillingishaltedabruptly.(Incontrast,ventricularfilling isimpededthroughoutdiastoleincardiactamponade.)

3. Causes

a. Inmostpatients,thecauseisneveridentifiedandisidiopathicorrelatedtoa previousviralinfection.

b. Othercausesincluderecurrentpericarditis,uremia,radiationtherapy, tuberculosis,chronicpericardialeffusion,tumorinvasion,connectivetissue disorders,andpriorsurgeryinvolvingthepericardium.

Quick HIT

DiastolicDysfunctioninConstrictivePericarditis

Earlydiastole:Rapidfilling

Latediastole:Haltedfilling

B.ClinicalFeatures 1. Patientsappearveryill 2. Patientswithconstrictivepericarditistypicallypresentinoneofthetwoways: a. Withsymptomscharacteristicoffluidoverloadsuchasedema,ascites,and

pleuraleffusions

b. Withsymptomsrelatedtothediminishedcardiacoutputsuchasdyspneaon

exertion,fatigue,decreasedexercisetolerance,andcachexia c. Patientcanpresentwithacombinationofbothofthesefindings

3. Signsinclude:

a. JVD—mostprominentphysicalfinding;centralvenouspressure(CVP)is elevatedanddisplaysprominentxandydescents

b. Kussmaulsign—JVP(venouspressure)paradoxicallyincreasesduring inspiration

c. Pericardialknock—correspondingtotheabruptcessationofventricularfilling

d. Ascites e. Dependentedema

4. Maybedifficulttodistinguishfromrestrictivecardiomyopathy—mayrequire echoorcardiaccatheterizationtodistinguishtheseentities

Quick HIT

Ifapatienthasclinicalsignsofcirrhosis(ascites,hepatomegaly)anddistendedneckveins,performteststorule outconstrictivepericarditis.

Quick HIT

Often,constrictivepericarditisprogressestoworseningcardiacoutputandtohepaticand/orrenalfailure. Surgicaltreatment(pericardiectomy)isindicatedinmanycases,buthashighriskofmorbidityandmortality.
======================================
C.Diagnosis 1. ECG

a. NonspecificchangessuchaslowQRSvoltages,generalizedT-waveflattening orinversion,leftatrialabnormalities.

b. AFibismoreoftenseeninadvanceddiseasebutoveralloccursinfewerthan halfofallpatients.

2. Echocardiogram

a. Increasedpericardialthicknessisseeninabouthalfofallpatients. b. Asharphaltinventriculardiastolicfillingandatrialenlargementcanalsobe

seen.

3. CTscanandMRImayalsoshowpericardialthickeningandcalcifications,and canaidgreatlyinthediagnosis.

4. Cardiaccatheterization

a. Elevatedandequaldiastolicpressuresinallchambers. b. Ventricularpressuretracingshowsarapidydescent,whichhasbeendescribed

asadipandplateauora“squarerootsign.”

Quick HIT

Echocardiogramistheimagingstudyofchoicefordiagnosisofpericardialeffusionandcardiactamponade physiology(hasahighsensitivity).

Quick HIT

Pericardialeffusionisimportantclinicallywhenitdevelopsrapidlybecauseitmayleadtocardiactamponade.

D.Treatment 1. Treattheunderlyingcondition 2. Diureticsmaybeextremelyhelpfulintreatingfluidoverloadsymptoms 3. Surgicalpericardiectomy

PericardialEffusion

A.GeneralCharacteristics 1. Definedasanycauseofacutepericarditis(seeabove)thatcanleadtoexudation

offluidintothepericardialspace

2. Canoccurinassociationwithascitesandpleuraleffusioninsaltandwater retentionstatessuchasCHF,cirrhosis,andnephroticsyndrome

3. Isoftenasymptomaticandsuspectedbasedonthesymptomsoftheunderlying condition

4. Maybeacuteorchronic.Acuteeffusionshavehigherriskofprogressingto tamponade

B.ClinicalFeatures 1. Allphysicalexaminationsignsareextremelynonspecificandoftendonotaidin

thediagnosisbutmayinclude:

a. Muffledheartsounds b. SoftPMI c. Dullnessatleftlungbase(becauseitmaybecompressedbypericardialfluid) d. Pericardialfrictionrubmayormaynotbepresent

C.Diagnosis 1. Echocardiogram

a. Imagingprocedureofchoice:Confirmsthepresenceorabsenceofasignificant effusion

b. Mostsensitiveandspecificmethodofdeterminingwhetherpericardialfluidis present;canshowaslittleas20mLoffluid

c. Shouldbeperformedinallpatientswithacutepericarditistoruleoutaneffusion
======================================
2. CXR

a. CXRshowsenlargementofcardiacsilhouettewhen>250mLoffluidhas accumulated

b. Cardiacsilhouettemayhaveprototypical“waterbottle”appearance c. Anenlargedheartwithoutpulmonaryvascularcongestionsuggestspericardial

effusion

3. ECG

a. MayshowlowQRSvoltagesandT-waveflatteningbutshouldnotbeusedto diagnosepericardialeffusion

b. Electricalalternans(seedefinitionbelowunderCardiacTamponade)suggestsa massivepericardialeffusionandtamponade

4. CTscanorMRI—veryaccurate,butoftenunnecessarygiventheaccuracyofan

echocardiogram

5. Pericardialfluidanalysis—mayclarifythecauseoftheeffusion

a. Orderproteinandglucosecontent,cellcountanddifferential,cytology,specific gravity,hematocrit,Gramstain,acid-faststains,mycobacterialPCR,fungal smear,cultures,LDHcontent

D.Treatment 1. Dependsonpatient’shemodynamicstability. 2. Pericardiocentesisisnotindicatedunlessthereisevidenceofcardiactamponade. Analysisofpericardialfluidcanbeusefulifthecauseoftheeffusionisunknown.

3. Iftheeffusionissmallandclinicallyinsignificant,arepeatechocardiogramin1 to2weeksisappropriate.

CardiacTamponade

A.GeneralCharacteristics 1. Definedasaccumulationofpericardialfluid.Itistherateoffluidaccumulation

thatisimportant,nottheamount.

a. Twohundredmillilitersoffluidthatdevelopsrapidly(i.e.,bloodsecondaryto trauma)cancausecardiactamponade.

b. Twolitersoffluidmayaccumulateslowlybeforecardiactamponadeoccurs. Whenfluidaccumulatesslowly,thepericardiumhastheopportunitytostretch andadapttotheincreasedvolume(i.e.,relatedtoamalignancy).

2. Pathophysiology

a. Pericardialeffusionthatmechanicallyimpairsdiastolicfillingoftheheart. b. Characterizedbytheelevationandequalizationofintracardiacand

intrapericardialpressures.

e

e

e

PressuresintheRV,LV,RA,LA,pulmonaryartery,andpericardiumequalize duringdiastole. Ventricularfillingisimpairedduringdiastole. Decreaseddiastolicfillingleadstodecreasedstrokevolumeanddecreased cardiacoutput.

CardiacTamponade PressuresintheRV,LV,RA,LA,pulmonaryartery,andpericardiumequalizeduringdiastole.

3. Causes

a. Penetrating(lesscommonlyblunt)traumatothethorax,suchasgunshotand stabwounds

b. Iatrogenic:Central-lineplacement,pacemakerinsertion,pericardiocentesis,etc. c. Pericarditis,progressivepericardialeffusion d. Post-MIwithfreewallrupture e. Aorticdissection
======================================
B.ClinicalFeatures 1. Cardiactamponadeisaclinicaldiagnosis.Echocardiographycanbehelpfulin

confirmingtamponadephysiology,butthediagnosiscanbemadewithoutit.The keyfindingsareBecktriadandpulsusparadoxus

2. Becktriad:Hypotension,muffledheartsounds,elevatedJVP(distendedneck veins,whosevenouswaveformsshowprominentxdescentandabsentydescent)

3. Pulsusparadoxus(tamponadephysiology)

a. Exaggerateddecreaseinarterialpressureduringinspiration(>10mmHgdrop). b. Thishappensbecauseduringinspirationanddiastole,bloodflowsintotheRV,

andwiththeeffusioncompressingthefreewalloftheRV,itwillexpandintothe interventricularseptumandlimitthefillingoftheLV,resultingindiminished strokevolumeandthereforebloodpressure.

c. Canbedetectedbyadecreaseintheamplitudeofthefemoralorcarotidpulse duringinspiration.

Pulsegetsstrongduringexpirationandweakduringinspiration.

4. Narrowedpulsepressure(duetodecreasedstrokevolume).

Quick HIT

BeckTriad(CardiacTamponade)

¢

¢

e

Hypotension Muffledheartsounds ElevatedJVP

C.Diagnosis 1. Echocardiogram

a. Mustbeperformedifsuspicionoftamponadeexistsbasedon history/examination

b. Usuallydiagnostic;themostsensitiveandspecificnoninvasivetestfor determiningtamponadephysiology

2. CXR

a. Enlargementofcardiacsilhouettewhen>250mLhasaccumulated b. Clearlungfields

3. ECG

a. Electricalalternans(alternatebeatvariationinthedirectionoftheECG waveforms)—duetopendularswingingoftheheartwithinthepericardialspace, causingamotionartifact

b. Findingsareneither100%sensitivenorspecific.ECGshouldnotbeusedto

diagnosetamponade 4. Cardiaccatheterization

a. Showsequalizationofpressuresinallchambersoftheheart b. Showselevatedrightatrialpressurewithlossoftheydescent

D.Treatment 1. Nonhemorrhagictamponade

a. Ifpatientishemodynamicallystable

e¢

e

Monitorcloselywithechocardiogram,CXR,ECG Ifpatienthasknownrenalfailure,dialysisismorehelpfulthan pericardiocentesis

b. Ifpatientisnothemodynamicallystable

e

e

Pericardiocentesisisindicated Ifnoimprovementisnoted,fluidchallengemayimprovesymptoms

2. Hemorrhagictamponadesecondarytotrauma

a. Ifthebleedingisunlikelytostoponitsown,emergentsurgeryisindicatedto repairtheinjury

b. Pericardiocentesisisonlyatemporizingmeasureandisnotdefinitivetreatment. Surgeryshouldnotbedelayedtoperformpericardiocentesis
======================================
ValvularHeartDisease

MitralStenosis

A.GeneralCharacteristics 1. Almostallcasesareduetorheumaticheartdisease.(Patientmaynotrecalla

historyofrheumaticfever.)

2. Pathophysiology

a. Immune-mediateddamagetothemitralvalve(duetorheumaticfever)causedby cross-reactivitybetweenthestreptococcalantigenandthevalvetissueleadsto scarringandnarrowingofthemitralvalveorifice.

b. Mitralstenosisresultsinelevatedleftatrialandpulmonaryvenouspressure leadingtopulmonarycongestion.

c. Anythingthatincreasesflowacrossthemitralvalve(exercise,tachycardia,and soon)exacerbatesthepulmonaryvenousHTNandassociatedsymptoms. d. Long-standingmitralstenosiscanresultinpulmonaryHTNandultimatelycan

resultinrightventricularfailure(RVF).

e. Long-standingmitralstenosiscanalsoleadtoAFibduetoincreasedleftatrial pressureandsize.

f. Patientsareusuallyasymptomaticuntilthemitralvalveareaisreducedto approximately1.5cm2(normalvalveareais4to5cm2).

B.ClinicalFeatures 1. Symptoms

a. Exertionaldyspnea,orthopnea,PND b. Palpitations,chestpain c. Hemoptysis—astheelevatedLApressurerupturesanastomosesofsmall

bronchialveins

d. Thromboembolism—oftenassociatedwithAFib e. IfRVfailureoccurs,ascitesandedemamaydevelop

2. Signs

a. Mitralstenosismurmur.

Theopeningsnapisfollowedbyalow-pitcheddiastolicrumbleand presystolicaccentuation.Thismurmurincreasesinlengthasthedisease worsens. Heardbestwithbellofstethoscopeinleftlateraldecubitusposition. b. S2isfollowedbyanopeningsnap.ThedistancebetweenS2andtheopening snapcangiveanindicationastotheseverityofthestenosis.Thecloserthe

openingsnapfollowsS2,theworseisthestenosis.

c. MurmurisfollowedbyaloudS1.AloudS1maybethemostprominentphysical finding.

d. Withlong-standingdisease,willfindsignsofRVF(e.g.,rightventricularheave, JVD,hepatomegaly,ascites)and/orpulmonaryHTN(loudP2).

e. Allsignsandsymptomswillincreasewithexerciseandduringpregnancy.

C.Diagnosis 1. CXR:Leftatrialenlargement(early) 2. Echocardiogram—mostimportanttestinconfirmingdiagnosis

a. Leftatrialenlargement b. Thick,calcifiedmitralvalve c. Narrow,“fishmouth”–shapedorifice d. SignsofRVF,ifadvanceddisease
======================================
D.Treatment 1. Medical

a. Diuretics—forpulmonarycongestionandedema. b. β-Blockers—todecreaseheartrate(increasediastolictimetoimproveLVfilling

andLAemptying)andcardiacoutput.

2. Surgical(forseveredisease)

a. Percutaneousballoonvalvuloplastyusuallyproducesexcellentresults. b. Opencommissurotomyandmitralvalvereplacementareotheroptionsif

valvotomyiscontraindicated.

3. Management

a. Notherapyisrequiredinasymptomaticpatients. b. Diureticscanbeusedifthepatienthasmildsymptoms. c. Ifsymptomsaremoresevere,surgicaltreatmentisrecommended. d. IfAFibdevelopsatanytime,treataccordingly(seediscussiononAFib).

AorticStenosis

A.GeneralCharacteristics 1. Pathophysiology

a. CausesobstructiontoLVoutflow,whichresultsinLVH. b. Whentheaorticvalveareafallsbelow1cm2,cardiacoutputfailstoincrease

withexertion,causingangina(butmaybenormalatrest).

c. Withlong-standingAS,theLVdilates,causingprogressiveLVdysfunction. d. WithsevereAS,LVdilationpullsthemitralvalveannulusapart,causingMR.

d. With severe AS, LV dilation pulls the mitral valve annulus apart, causing MR.

2. Causes

a. Calcificationofacongenitallyabnormalbicuspidaorticvalve. b. Calcificationoftricuspidaorticvalveinelderly. c. Rheumaticfever.

3. Course

a. Patientsareoftenasymptomaticforyears(untilmiddleoroldage)despite severeobstruction.

b. Developmentofangina,syncope,orheartfailureisasignofpoorprognosis. Survivalissimilartothatofthenormalpopulationbeforethedevelopmentof thesethreeclassicsymptoms.Withoutsurgicalintervention,thesurvivalispoor:

e

e

e

Angina(35%)—averagesurvival,3years Syncope(15%)—averagesurvival,2years Heartfailure(50%)—averagesurvival,1.5years

Quick HIT

Altogether,onlyone-fourthofpatientswithsymptomaticASsurvives3yearsintheabsenceofaorticvalve replacement(i.e.,the3-yearmortalityrateis75%withoutsurgery).

B.ClinicalFeatures 1. Symptoms a. Angina b. Syncope—usuallyexertional c. Heartfailuresymptoms,suchasdyspneaonexertion,orthopnea,orPND

2. Signs

a. Murmur

e

e

e

Harshcrescendo–decrescendosystolicmurmur Heardinsecondrightintercostalspace Radiatestocarotidarteries

b. SoftS2.S2mayalsobesinglesincetheaorticcomponentmaybedelayedand mergeintoP2.Thesofterthemurmur,themoreseveretheAS
======================================
c. S4withprogressivedisease d. Parvusettardus—diminishedanddelayedcarotidupstrokes e. SustainedPMI f. Precordialthrill

C.Diagnosis 1. CXRfindings:Calcificaorticvalve,enlargedLV/LA(late) 2. ECGfindings:LVH,LAabnormality 3. Echocardiography:Hasreplacedcardiaccatheterizationasstandardtestfor

hemodynamicandvalvemeasurementsfordiagnosisofAS.Showsthickened, calcifiedaorticvalveleafletswithlimitedmobility.Keymeasurementsfor diagnosisandseverityarediminishedvalveareaandincreasedventricular-aortic pressuregradient

4. ExercisestresstestingisindicatedforasymptomaticpatientswithsevereASto confirmasymptomaticstatus.Thesepatients,despitehavingsevereAS,donot requireintervention.Shouldnotbeperformedinsymptomaticpatients

a. Nowusedprimarilyinpatientsinwhomechocardiographyisnondiagnostic(i.e., poorvisualizationofvalve,difficultyobtainingpressuregradientswithDoppler)

b. Usefulinsymptomaticpatientsbeforesurgerybecauseitcanalsoreveal coronaryanatomy,allowingthesurgeontodobothCABGandaorticvalve replacementinpatientswithbothCADandsevereAS

Quick HIT

ManagementofASisstraightforward: Ifasymptomatic:Notreatment Ifsymptomatic:Surgicalaorticvalvereplacementortranscatheteraorticvalvereplacement(TAVR) dependingonpatientrisk

D.Treatment 1. Medicaltherapyhasalimitedrole.

Surgicaltherapy:Aorticvalvereplacementisthetreatmentofchoice.Itis indicatedinallsymptomaticpatients.Thereisevidence(PARTNERA, PARTNERIItrials)thatTAVRisnoninferior(mortality,strokerisk)tosurgical AVRinpatientswithhighandintermediatesurgicalrisk.

AorticRegurgitation

A.GeneralCharacteristics 1. Pathophysiology

a. Alsocalledaorticinsufficiency;thisconditionisduetoinadequateclosureof theaorticvalveleaflets.Regurgitantbloodflowincreasesleftventricularend- diastolicvolume.

b. LVdilationandhypertrophyoccurinresponseinordertomaintainstroke volumeandpreventdiastolicpressurefromincreasingexcessively.

c. Overtime,thesecompensatorymechanismsfail,leadingtoincreasedleft-sided andpulmonarypressures.

d. TherestingleftventricularEFisusuallynormaluntiladvanceddisease.

2. Course

a. Forchronicaorticregurgitation,survivalis75%at5years.
======================================
Afterthedevelopmentofangina,deathusuallyoccurswithin4years. Afterthedevelopmentofheartfailure,deathusuallyoccurswithin2years. b. Foracuteaorticregurgitation,mortalityisparticularlyhighwithoutsurgical

repair.

B.Causes 1. Acute

a. Infectiveendocarditis b. Trauma c. Aorticdissection d. Iatrogenicasduringafailedreplacementsurgery

2. Chronic

a. Primaryvalvular:Rheumaticfever,bicuspidaorticvalve,Marfansyndrome, Ehlers–Danlossyndrome,ankylosingspondylitis,SLE

b. Aorticrootdisease:Syphiliticaortitis,osteogenesisimperfecta,aorticdissection, Behçetsyndrome,Reitersyndrome,systemicHTN

Quick HIT

OtherPhysicalFindingsinAorticInsufficiency

¢

¢

¢

DeMussetsign:Headbobbing(rhythmicaljerkingofhead) Müllersign:Uvulabobs Duroziezsign:Pistol-shotsoundheardoverthefemoralarteries

C.ClinicalFeatures

1. Symptoms

a. Maybesymptomaticformanyyears b. Dyspneaonexertion,PND,orthopnea c. Palpitations—worsewhenlyingdown d. Angina e. Cyanosisandshockinacuteaorticregurgitation(medicalemergency)

2. Physicalexamination

a. Widenedpulsepressure—markedlyincreasedsystolicBP,withdecreased diastolicBP.

b. Diastolicdecrescendomurmurbestheardatleftsternalborder. c. Corriganpulse(water-hammerpulse)—rapidlyincreasingpulsethatcollapses suddenlyasarterialpressuredecreasesrapidlyinlatesystoleanddiastole;can bepalpatedatwristorfemoralarteries.

d. AustinFlintmurmur—low-pitcheddiastolicrumbleduetocompetingflow anterogradefromtheLAandretrogradefromtheaorta.Itissimilartothe murmurappreciatedinmitralstenosis.

e. DisplacedPMI(downandtotheleft)andS3mayalsobepresent. f. Murmurintensityincreaseswithsustainedhandgrip.Handgripincreases

systemicvascularresistance(SVR),whichcausesanincreased“backflow” throughtheincompetentaorticvalve.

D.Diagnosis 1. CXRfindings:Enlargedcardiacsilhouette,dilatedaorta 2. ECGfindings:LVH 3. Echocardiogram—Performseriallyinchronic,stablepatientstoassessneedfor

surgery

a. AssessLVsizeandfunction b. Lookfordilatedaorticrootandreversalofbloodflowinaorta c. Inacuteaorticregurgitation,lookforearlyclosureofmitralvalve

4. Cardiaccatheterization:Toassessseverityofaorticregurgitationanddegreeof LVdysfunction

E.Treatment 1. IfasymptomaticwithnormalLVfunction,notherapyindicated 2. IfasymptomaticwithsevereARandLVdysfunction,ACEinhibitororARB

indicatedforafterloadreduction

3. Ifsymptomatic:Saltrestriction,diuretics,afterloadreduction(i.e.,ACEinhibitors orARBs),HFrEFtherapyifheartfailure(i.e.,β-blocker,aldosteroneantagonist, digoxininselectedcases),andrestrictiononstrenuousactivity

4. Definitivetreatmentissurgery(aorticvalvereplacement).Thisshouldbe

consideredinsymptomaticpatients,orinthosewithsignificantLVdysfunction onechocardiogram.

5. AcuteAR(e.g.,post-MI):Medicalemergency—emergentaorticvalve replacement!
======================================
MitralRegurgitation

A.GeneralCharacteristics 1. Pathophysiology

a. Acute

e

e

AbruptelevationofleftatrialpressureinthesettingofnormalLAsizeand compliance,causingbackflowintopulmonarycirculationwithresultant pulmonaryedema Cardiacoutputdecreasesbecauseofdecreasedforwardflow,sohypotension andshockcanoccur

b. Chronic

¢

e

e

GradualelevationofleftatrialpressureinthesettingofdilatedLAandLV (withincreasedleftatrialcompliance) LVdysfunctionoccursduetodilation PulmonaryHTNcanresultfromchronicbackflowintopulmonaryvasculature

2. Causes a. Acute

e

e

e

Endocarditis(mostoftenStaphylococcusaureus) Papillarymusclerupture(frominfarction)ordysfunction(fromischemia) Chordaetendineaerupture

b. Chronic

Mitralvalveprolapse(MVP) Rheumaticfever Marfansyndrome Cardiomyopathycausingdilationofmitralannulus

3. Prognosis

a. Acuteformisassociatedwithmuchhighermortality b. SurvivalisrelatedtoextentofLVcavitydilation

B.ClinicalFeatures 1. Symptoms

a. Dyspneaonexertion,PND,orthopnea b. Palpitations c. Pulmonaryedema

2. Signs

a. Holosystolicmurmur(startswithS1andcontinuesonthroughS2)attheapex, whichradiatestothebackorclaviculararea,dependingonwhichleafletis involved

b. AFibisacommonfinding c. Otherfindings:DiminishedS1,wideningofS2,S3gallop;laterallydisplaced

PMI;loud,palpableP2

C.Diagnosis 1. CXRfindings:Cardiomegaly,dilatedLV,pulmonaryedema. 2. Echocardiogram:MR;dilatedLAandLV;decreasedLVfunction.Shouldbe

performedseriallyinpatientswithknownMR.

D.Treatment 1. Medical

a. Afterloadreductionwithvasodilatorsisrecommendedforsymptomaticpatients only;theyarenotrecommendedinmostasymptomaticpatientsastheymay maskprogressionofthedisease

b. ChronicanticoagulationifpatienthasAFib c. IABPcanbeusedasabridgetosurgeryforacuteMR(decreasesafterloadand

favorsnormalflow,notregurgitantflow)

2. Surgical

a. Mitralvalverepairorreplacement b. Mustbeperformedbeforeleftventricularfunctionistooseverelycompromised c. Patientswithveryhighsurgicalrisk,severesymptoms,andfavorableanatomy

maybecandidatesfortranscathetermitralvalverepair
======================================
TricuspidRegurgitation

A.GeneralCharacteristics 1. Tricuspidregurgitation(TR)resultsfromafailureofthetricuspidvalvetoclose completelyduringsystole,causingregurgitationofbloodintotheRA.Itis estimatedthatupto70%ofnormaladultshavemild,physiologicTRasseenon high-resolutionechocardiography.Amuchsmallerpercentageofpeopleare actuallysymptomatic.

2. Causes—upto90%ofcasesoccurinpeoplewithanatomicallynormalvalve leafletsandchords.

a. TRisusuallysecondarytoRVdilation.AnycauseofRVdilationcanresultin enlargementofthetricuspidorifice.

e

e

e

¢

Leftventricularfailureisthemostcommoncause. Rightventricularinfarction. InferiorwallMI. Corpulmonale,secondarytopulmonaryHTN.

b. Tricuspidendocarditis—seeninIVdrugusers. c. Maybesecondarytorheumaticheartdisease;usuallyaccompaniedbymitral

andaorticvalvedisease.

d. Ebsteinanomaly—congenitalmalformationoftricuspidvalveinwhichthereis downwarddisplacementofthevalveintotheRV.

e. Othercausesincludecarcinoidsyndrome,SLE,andmyxomatousvalve degeneration.

B.ClinicalFeatures 1. UsuallyasymptomaticunlessthepatientdevelopssymptomsofRHF/pulmonary

HTN

2. SignsandsymptomsofRVF(ascites,hepatomegaly,edema,JVD) 3. Pulsatileliver 4. ProminentVwavesinjugularvenouspulsewithrapidydescent 5. InspiratoryS3alongLLSBmaybepresent 6. Blowingholosystolicmurmur

a. AtLLSB b. Intensifiedwithinspiration;reducedduringexpirationortheValsalvamaneuver

7. RightventricularpulsationalongLLSB 8. AFibcanbepresentwithsevereatrialdilation

C.Diagnosis 1. Echocardiogram

a. QuantifiesamountofTR b. Identifiesprolapse/flailoftricuspidvalveleaflets c. EstimatespulmonarypressuresbasedonseverityofTRvelocity d. ECG:RVandRAenlargement

D.Treatment 1. TreatanyunderlyingetiologyofsymptomaticTR 2. Diureticsforvolumeoverloadandvenouscongestion/edema 3. Treatleft-sidedheartfailure,endocarditis,orpulmonaryHTN 4. SevereregurgitationmaybesurgicallycorrectedifpulmonaryHTNisnotpresent

a. Nativevalverepairsurgery b. Valvuloplastyoftricuspidring c. Valvereplacementsurgery:Rarelyperformed

MitralValveProlapse
======================================
A.GeneralCharacteristics 1. MVPisdefinedasthepresenceofexcessiveorredundantmitralleaflettissuedue tomyxomatousdegenerationofmitralvalveleafletsand/orchordaetendineae. Theredundantleaflet(s)prolapsetowardtheLAinsystole,whichresultsinthe auscultatedclickandmurmur.

2. MVPiscommoninpatientswithgeneticconnectivetissuedisorders,suchas Marfansyndrome,osteogenesisimperfecta,andEhlers–Danlossyndrome.

3. MVPisacommoncauseofMRindevelopedcountries. 4. Arrhythmiasandsuddendeathareveryrare.

Quick HIT

KeySignsofMVP Systolicclicks MidsystolicrumblingmurmurthatincreaseswithstandingandtheValsalvamaneuveranddecreaseswith squatting

B.ClinicalFeatures 1. Symptoms

a. Mostpatientsareasymptomaticfortheirentirelives. b. Palpitationsandatypicalchestpainmayoccur. c. TIAsduetoembolifrommitralvalvehavebeenreported,butareveryrare.

2. Signs

a. Midsystolicorlatesystolicclick(s). b. Mid-to-latesystolicmurmur. c. Somepatientshavemidsystolicclickwithoutthemurmur;othersmayhavethe

murmurwithouttheclick.

d. StandingandtheValsalvamaneuverincreasemurmurandclickbecausethese maneuversreduceLVchambersize,allowingtheclickandmurmurtooccur earlierinsystole.

e. SquattingdecreasesmurmurandclickbecauseitincreasesLVchambersize, thusdelayingtheonsetoftheclickandmurmur.

C.Diagnosis 1. Echocardiogramisthemostuseful. 2. Mostpatientsareasymptomatic,sodiagnosisistypicallymadeonthebasisofthe

murmurandechocardiogramalone.

D.Treatment

1. Ifpatientisasymptomatic,reassurance.ThereissomeassociationbetweenMVP andanxiety,soallpatientsshouldbereassuredaboutthebenignnatureofthis condition.

2. Forchestpain,β-blockershavebeenuseful,buttheyareunlikelytoberequired. 3. Surgeryisrarelyrequired.Theconditionisgenerallybenign.

RheumaticHeartDisease

A.GeneralCharacteristics 1. Rheumaticheartdiseaseoccursasacomplicationofstreptococcalpharyngitis

(groupAstreptococcus).

2. Acuterheumaticfeverisanimmunologicallymediatedsystemicprocessthatmay progresstorheumaticheartdisease.

3. Rheumaticheartdiseasedescribesthechronicvalvularabnormalitiessecondaryto acuterheumaticfever.

4. Themostcommonvalvularabnormalityismitralstenosis,butpatientsmayhave aorticortricuspidinvolvementaswell.

5. Theincidenceofrheumaticheartdiseasehasfallendrasticallyinindustrialized countriesandwithwidespreadantibioticusage,butremainsasignificantcauseof morbidityandmortalityindevelopingcountries.

B.DiagnosisofAcuteRheumaticFever(requirestwomajorcriteriaoronemajor andtwominorcriteria)

1. Majorcriteria
======================================
a. Migratorypolyarthritis b. Erythemamarginatum c. Cardiacinvolvement(e.g.,pericarditis,CHF,valvedisease) d. Chorea e. Subcutaneousnodules

2. Minorcriteria

a. Fever b. Elevatederythrocytesedimentationrate c. Polyarthralgias d. Priorhistoryofrheumaticfever e. ProlongedPRinterval f. Evidenceofprecedingstreptococcalinfection

C.Treatment 1. Treatstreptococcalpharyngitiswithapenicillin(penicillinoramoxicillin), cephalosporin,ormacrolide(azithromycinorclarithromycin)antibioticif penicillinallergytopreventrheumaticfever.

2. AcuterheumaticfeveristreatedwithNSAIDs.C-reactiveproteinisusedto monitortreatment.

3. Treatthevalvularpathologyofrheumaticheartdisease.

InfectiveEndocarditis

A.GeneralCharacteristics 1. Infectiveendocarditisisdefinedasaninfectionoftheendocardialsurfaceofthe

heart(usuallyinvolvesthecuspsofthevalves)

2. Classifications(canbeclassifiedasacuteorsubacute)

Quick HIT

Alwayssuspectendocarditisinapatientwithanewheartmurmurandunexplainedfeverorbacteremia.

a. Acuteendocarditis

a. MostcommonlycausedbyStaphylococcusaureus(highlyvirulent) b. Occursonanormalheartvalve c. Ifuntreated,fatalinlessthan6weeks

b. Subacuteendocarditis

¢

e

e

Causedbylessvirulentorganisms,suchasStreptococcusviridansand Enterococcus Occursondamagedheartvalves Ifuntreated,takesmuchlongerthan6weekstocausedeath

3. Organisms

a. Nativevalveendocarditis

Streptococcusviridansisthemostcommonorganisminnativevalve endocarditis. OthercommonorganismsincludeStaphylococcusspecies(Staphylococcus aureusmorecommonlythanStaphylococcusepidermidis)andEnterococci. Streptococcusbovisisassociatedwithincreasedriskofactivecolonic malignancy HACEKgroupoforganisms:Haemophilus,Actinobacillus,Cardiobacterium, Eikenella,andKingella. b. Prostheticvalveendocarditis

Staphylococciarethemostcommoncausesofearly-onsetendocarditis; symptomsappearwithin60daysofsurgery(Staphylococcusepidermidismore commonlythanStaphylococcusaureus). Streptococciarethemostcommoncauseoflate-onsetendocarditis;symptoms appear60daysaftersurgery. c. EndocarditisinIVdrugusers
======================================
e

e

Frequentlypresentswithright-sidedendocarditis. Staphylococcusaureusisthemostcommoncause.

OtherorganismsincludeEnterococciandStreptococci.Fungi(mostly Candida)andgram-negativerods(mostlyPseudomonas)arelesscommon causes. 4. Complications

a. Heartfailureduetovalvulardamage b. Paravalvularabscess(canresultinconductionabnormalitiessuchasAVblock) c. Varioussolidorgandamagefromshoweredemboli:Septicpulmonaryemboli, intramuscularabscesses,Rothspots(retinal),Janewaylesions(microabscesses inextremities),septicarthritis,epiduralspinalabscess,renalabscesses,cerebral embolicausingCVAorbrainabscess

d. Glomerulonephritis e. Oslernodes(immunologicdepositionsinextremities,painful),splinter

hemorrhagesinnailbeds

Quick HIT

TEEisbetterthantransthoracicechocardiography(TTE)inthediagnosisofendocarditisforespeciallymitral valvepathologyandsmallaorticvegetations.MostpatientsshouldgetTTEasaninitialscreeningtest.

Quick HIT

Infectiveendocarditisisalmostalwaysfatalifleftuntreated.

B.Diagnosis 1. Dukeclinicalcriteria(Table1-3):Twomajorcriteria,onemajorandthreeminor criteria,orfiveminorcriteriaarerequiredtodiagnoseinfectiveendocarditis. 2. Ofnote,echocardiographicevidenceofvegetationsisnotnecessarytomakethe diagnosisaslongassufficientDukecriteriahavebeenmet.Treatmentshouldbe initiatedifclinicalsuspicionishigh.

C.Treatment 1. Threesetsofbloodculturesshouldbedrawnpriortoinitiatingantibiotictherapy 2. Parenteralantibioticsbasedoncultureresultsforextendedperiods(4to6weeks) 3. Ifculturesarenegativebutthereishighclinicalsuspicion,treatempiricallywith vancomycinplusanaminoglycoside(usuallygentamicin)untiltheorganismcan beisolated

4. IfpatienthasintracardiacdevicessuchaspacemakerorICD,thesemustbe removed

5. Earlysurgicalinterventioniswarrantedforpatientswith:

acuteheartfailureduetovalvulardamage

e

e

e

¢

left-sidedinfectiveendocarditiswithhighlyresistantorganisms(including MRSA) infectiveendocarditiscomplicatedbyheartblockorintracardiacabscess persistentbacteremiaorfeverslasting5to7daysafterantibioticinitiation recurrentinfectioninthosewithprostheticvalves
======================================
TABLE1-3 DukeCriteria

Major

Major

Minor

e

¢

Sustainedbacteremiabyanorganismknowntocause endocarditis Endocardialinvolvementdocumentedbyeither echocardiogram(vegetation,abscess,valveperforation, prostheticdehiscence)orclearlyestablishednewvalvular regurgitation

Predisposingcondition(abnormalvalve orabnormalriskofbacteremia) Fever Vascularphenomena:Septicarterialor pulmonaryemboli,mycoticaneurysms, intracranialhemorrhage,Janewaylesionsa Immunephenomena: Glomerulonephritis,Oslernodes,bRoth spots,crheumatoidfactor Positivebloodculturesnotmeeting majorcriteria Positiveechocardiogramnotmeeting majorcriteria

¢

e Fever

e

Note:Definitive(i.e.,highlyprobable)diagnosisiftwomajor,oronemajorplusthreeminor,orfiveminor criteriaarepresent. aJanewaylesionsarepainlesserythematouslesionsonpalmsandsoles.

bOslernodesarepainful,raisedlesionsoffingers,toes,orfeet.

cRothspotsareoval,retinalhemorrhageswithaclear,palecenter.

ReprintedfromDurackDT,LukesAS,BrightDK.Newcriteriafordiagnosisofinfectiveendocarditis:utilization ofspecificechocardiographicfindings.DukeEndocarditisService.AmJMed1994;96(3):200–209.Copyright© 1994Elsevier.Withpermission.

D.Prophylaxis Scopeofpatientswhoqualifyforprophylaxisismuchnarrowerthaninthepast.Must have both a qualifying cardiac indication AND procedure to warrant antibiotic prophylaxis. 1. Qualifyingcardiacindications

a. Prostheticheartvalves(includingmechanical,bioprosthetic,andtranscatheter valves)

b. Historyofinfectiveendocarditis c. Congenitalheartdisease

e

e

Unrepairedcyanoticcongenitalheartdisease Repairedcongenitalheartdisease,withprostheticmaterial,duringfirst6 monthsafterprocedure

d. Cardiactransplantwithvalvulopathy

2. Qualifyingprocedures

a. Dentalproceduresinvolvingmanipulationofgingivalmucosaorperiapical regionofteeth(extractions,implants,periodontalsurgery,cleaningwhen bleedingexpected)

b. Proceduresinvolvingbiopsyorincisionofrespiratorymucosa c. Proceduresinvolvinginfectedskinormusculoskeletaltissue

Quick HIT

DoNOTgiveantibioticsforendocarditisprophylaxisfor:

¢

¢
======================================
Nativemitralvalveprolapse/stenosis RoutineGI(endoscopy)orGU(cystoscopy)procedures

NonbacterialThromboticEndocarditis(MaranticEndocarditis) Associatedwithdebilitatingillnessessuchasmetastaticcancer(foundinupto20% ofcancerpatients). Steriledepositsoffibrinandplateletsformalongtheclosurelineofcardiacvalve leaflets. Vegetationscanembolizetothebrainorperiphery. Althoughtheuseofheparinmaybeappropriate,nostudieshaveconfirmedits efficacy.

NonbacterialVerrucousEndocarditis(Libman–Sacks Endocarditis)

TypicallyinvolvestheaorticvalvesinindividualswithSLE Characterizedbytheformationofsmallwartyvegetationsonbothsidesofvalve leafletsandmaypresentwithregurgitantmurmurs Rarelygivesrisetoinfectiveendocarditis,butcanbeasourceofsystematic embolization TreatunderlyingSLEandanticoagulate

CongenitalHeartDiseases AtrialSeptalDefect

A.GeneralCharacteristics(Types) 1. Ostiumsecundum(mostcommon—80%ofcases)—occursincentralportionof

interatrialseptum

2. Ostiumprimum—occurslowintheseptum 3. Sinusvenosusdefects—occurshighintheseptum

Quick HIT

Congenitalheartdiseaseaccountsforonly2%ofheartdiseaseinadults.

B.Pathophysiology 1. OxygenatedbloodfromtheLApassesintotheRA,increasingrightheartoutput

andthuspulmonarybloodflow.

2. Leadstoincreasedworkoftherightsideoftheheart:Asshuntsizeincreases,RA andRVdilationoccurswithpulmonary-to-systemicflowratiosgreaterthan 1.5:1.0.

3. PulmonaryHTNisaserioussequela,butisrareinASD.

C.ClinicalCourse 1. Patientsareusuallyasymptomaticuntilmiddleage(around40). 2. Thereafter,symptomsmaybeginandincludeexerciseintolerance,dyspneaon

exertion,andfatigue.

3. Ifmild,patientscanliveanormallifespan.

D.ClinicalFeatures 1. Mildsystolicejectionmurmuratpulmonaryareasecondarytoincreased

pulmonarybloodflow

2. FixedsplitS2 3. Diastolicflow“rumble”murmuracrosstricuspidvalveareasecondaryto

increasedbloodflow

4. Inadvanceddisease,signsofRVfailuremaybeseen

E.Diagnosis 1. TEEisdiagnostic(betterthanTTE).Contrastechocardiographycanimprove

resolution.Aso-called“bubblestudy”isatypeofcontrastechowhichinvolves

injectingmicrobubblesandwatchingthemcrossthedefectviaaright-to-left shunt.ThisisoftenusedtoaidindiagnosisofASDs.

2. CXR:Largepulmonaryarteries;increasedpulmonarymarkings. 3. ECG:Rightbundlebranchblockandrightaxisdeviation;atrialabnormalitiescan

alsobeseen(e.g.,fibrillation,flutter).

F.Complications 1. PulmonaryHTN—doesnotoccurbefore20yearsofage,butisacommonfinding

inpatientsover40

2. Eisenmengerdiseaseisalatecomplicationseeninaminorityofpatients,in whichirreversiblepulmonaryHTNleadstoreversalofshunt,heartfailure,and cyanosis

3. Rightheartfailure 4. Atrialarrhythmias,especiallyAFib 5. StrokecanresultfromparadoxicalemboliorAFib
======================================
G.Treatment 1. Unlesstheyareverylarge,mostdefectsdonotrequireclosure. 2. Surgicalrepairwhenpulmonary-to-systemicbloodflowratioisgreaterthan

1.5:1.0or2:1orifpatientissymptomatic.

VentricularSeptalDefect

A.GeneralCharacteristics 1. Ventricularseptaldefectisthemostcommoncongenitalcardiacmalformation 2. Pathophysiology

a. BloodflowsfromtheLV(highpressure)intotheRV(lowpressure)througha hole,resultinginincreasedpulmonarybloodflow.Aslongasthepulmonary vascularresistance(PVR)islowerthantheSVR,theshuntislefttoright.Ifthe PVRincreasesabovetheSVR,theshuntreverses.

b. LargedefectseventuallyleadtopulmonaryHTN,whereassmalldefectsdonot changepulmonaryvascularhemodynamics.

B.ClinicalFeatures 1. Symptoms

a. Asmallshuntproducesnosymptoms.Manyoftheseclosespontaneously. b. AlargeshuntwithoutelevatedPVR(andthusleft-to-rightshunt)givesriseto

CHF,growthfailure,andrecurrentlowerrespiratoryinfections.

c. AlargeshuntwithveryhighPVR(Eisenmengerreaction)givesrisetoSOB, dyspneaonexertion,chestpain,syncope,andcyanosis.

2. Signs

a. Harsh,blowingholosystolicmurmurwiththrill

e

e

e

Atfourthleftintercostalspace Murmurincreaseswithhandgripmaneuveranddecreaseswithstanding Thesmallerthedefect,theloudertheholosystolicmurmur

b. Sternallift(RVenlargement,RVheave) c. AsPVRincreases,thepulmonarycomponentofS2increasesinintensity d. Aorticregurgitationmaybeseeninsomepatients

C.Diagnosis 1. ECG:BiventricularhypertrophypredominateswhenPVRishigh. 2. CXR

a. Enlargementofthepulmonaryartery. b. Enlargementofcardiacsilhouette:AsPVRincreases(andleft-to-rightshunt

decreases),heartsizedecreases,butpulmonaryarterysizeincreases.

3. Echocardiogramshowstheseptaldefect.

D.Complications 1. Endocarditis 2. Progressiveaorticregurgitation

3. Heartfailure 4. PulmonaryHTNandshuntreversal(Eisenmenger)

E.Treatment 1. EndocarditisprophylaxisisimportantbutisNOTcurrentlyrecommendedfor

patientswithuncomplicatedVSDandnohistoryofendocarditis.

2. Surgicalrepairisindicatedifthepulmonaryflowtosystemicflowratioisgreater

than1.5:1.0or2:1,aswellasforpatientswithinfectiveendocarditis. 3. Fortheasymptomaticpatientwithasmalldefect,surgeryisnotindicated.
======================================
CoarctationoftheAorta

A.GeneralCharacteristics 1. Narrowing/constrictionofaorta,usuallyatoriginofleftsubclavianarterynear ligamentumarteriosum,whichleadstoobstructionbetweentheproximaland distalaorta,andthustoincreasedleftventricularafterload.

Quick HIT

Inwomen,coarctationoftheaortamaybeassociatedwithTurnersyndrome.

B.ClinicalFeatures 1. HTNinupperextremitieswithhypotensioninlowerextremities 2. Well-developedupperbodywithunderdevelopedlowerhalf 3. Midsystolicmurmurheardbestovertheback 4. Symptomsincludeheadache,coldextremities,claudicationwithexercise,andleg

fatigue

5. Delayedfemoralpulseswhencomparedtoradialpulses 6. PrevalenceofcoarctationoftheaortaisincreasedinpatientswithTurner

syndrome

C.Diagnosis 1. CTangiogramofthechestisdiagnostic 2. ECGshowsLVH 3. CXR

a. Notchingoftheribs b. “Figure3”appearanceduetoindentationoftheaortaatthesiteofcoarctation,

withdilationbeforeandafterthestenosis

D.Complications 1. SevereHTN 2. Ruptureofcerebralaneurysms 3. Infectiveendocarditis 4. Aorticdissection

E.Treatment 1. Standardtreatmentinvolvessurgicaldecompression. 2. Percutaneousballoonaortoplastyorstentingisalsoanoptioninselectedcases.

PatentDuctusArteriosus

A.GeneralCharacteristics 1. Communicationbetweenaortaandpulmonaryarterythatpersistsafterbirth. 2. Duringfetallife,prostaglandinsandlowoxygentensionmaintaintheductus

arteriosus.Bloodisshuntedawayfromnonfunctioninglungs;normallycloses withindaysafterbirth.

3. Becomesaleft-to-rightshuntinlifeoutsidethewombifitremainspatent(blood flowsfromaortaintopulmonaryartery).

4. Associatedwithcongenitalrubellasyndrome,highaltitude,andprematurebirths. 5. Pathophysiology

a. Largeleft-to-rightshuntingresultsinvolumeoverload,pulmonaryHTN,and right-sidedheartfailure.

b. Cyanosisoccurslate. c. Mayeventuallyseereversalofbloodflow.

Quick HIT

TheleadingcausesofdeathinadultswithPDAareheartfailureandinfectiveendocarditis.

B.ClinicalFeatures 1. Maybeasymptomatic 2. Signsofheartfailure 3. LoudP2(signofpulmonaryHTN) 4. LVH:Secondarytoleft-to-rightshunt 5. Rightventricularhypertrophy:SecondarytopulmonaryHTN 6. Continuous“machinerymurmur”atleftsecondintercostalspace(bothsystolic

anddiastoliccomponents)

7. Widepulsepressureandboundingperipheralpulses 8. Lowerextremityclubbing:Toesmorelikelythanfingerstobecyanotic

(differentialcyanosis)
======================================
Quick HIT

AdultswithPDAusuallyhavenormalpulmonarypressures.

C.Diagnosis 1. CXR

a. Increasedpulmonaryvascularmarkings b. Dilatedpulmonaryartery

c. Enlargedcardiacsilhouette d. Sometimescalcificationsofductusarteriosus

2. Echocardiographyrevealsthepatentductusand/orturbulentbloodflow

D.Treatment 1. Ifpulmonaryvasculardiseaseisabsent:Surgicalligation. 2. IfseverepulmonaryHTNorright-to-leftshuntispresent,donotcorrectpatent

ductusarteriosus(PDA).Surgeryiscontraindicated.

3. Indomethacinindicatedforclosure.ProstaglandinE1canbeusedtokeepthePDA open(maybeneededinthefaceofothercardiacabnormalitiessuchas transpositionofthegreatvessels).

TetralogyofFallot

A.GeneralCharacteristics 1. Characterizedbyfourcardiacabnormalities:Ventricularseptaldefect,right ventricularhypertrophy,pulmonaryarterystenosisoratresia,andoverriding aorta.

2. Theexactembryologicvariantisunknown,butthefourabnormalitieslikelyarise secondarytodefectsinthedevelopmentoftheinfundibularseptum.

3. TetralogyofFallot(TOF)typicallyoccurssporadically,butmayalsobepartofa syndrome.

B.ClinicalFeatures 1. Cyanosisisthemostcommonsymptom. 2. Degreeofclinicalsymptomsdependslargelyonthedegreeofrightventricular

outflowobstruction.

3. PatientsexperienceTetspells—theywillsquatafterexertionsuchasexerciseor cryingspellinaninfant.ThismaneuverincreasesSVR,whichhelpsshuntblood fromtheRVtothelungsinsteadoftheaorta.Oxygen,morphine,andβ-blockers mayalsobeneededifthepatientcontinuestobecyanotic.

4. Murmuristypicallycrescendo–decrescendoinnatureandheardbestattheleft uppersternalborder.

C.Diagnosis 1. Echocardiographyisthediagnosticmodalityofchoice.Thistestcanclearly definethefourabnormalitiesaswellasprovideimportantinformationabout aorticarchanatomy.

2. EKGmayshowenlargedRAandRV. 3. CXRclassicallyshowsboot-shapedheart. 4. Cardiaccatheterizationmayberequiredinsomepatientstofullydefinethe

anatomy.

D.Treatment 1. Treatmentissurgical.Mostpatientshavesurgerywithinthefirstyearoflife. Twenty-yearsurvivalratesaftersurgeryareabove80%.Themostcommon causesofdeatharesuddencardiacdeathandheartfailure.

2. Complicationsaftersurgeryincludearrhythmias,pulmonaryregurgitation, residualoutflowobstruction,andheartfailure.
======================================
DiseasesoftheVasculature

HypertensiveEmergency

A.GeneralCharacteristics 1. Hypertensiveemergency:SystolicBP≥180and/ordiastolicBP≥120inaddition toend-organdamage—immediatetreatmentisindicated(seeClinicalPearl1- 13).

2. ElevatedBPlevelsalonewithoutend-organdamage—referredtoashypertensive urgency.Hypertensiveurgenciesrarelyrequireemergencytherapyandcanbe managedwithattemptstolowerBPoveraperiodof24hours.

3. WheneverapatientpresentswithmarkedlyelevatedBP,itiscriticaltoassessthe followingsystemsforend-organdamage.

a. Eyes:Papilledema b. CNS

e

e

Alteredmentalstatusorintracranialhemorrhage Hypertensiveencephalopathymaydevelop(suspectwhenBPismarkedly elevated:240/140orhigher,alongwithneurologicfindingssuchasconfusion)

c. Kidneys:Renalfailureoroliguria d. Heart:Unstableangina,MI,HFwithpulmonaryedema,aorticdissection e. Lungs:Pulmonaryedema

4. Hypertensiveemergencymayleadtoposteriorreversibleencephalopathy

syndrome(PRES)—aradiographicconditionwhichispostulatedtobecausedby autoregulatoryfailureofcerebralvesselsaswellasendothelialdysfunction. a. Despitethename,thesyndromemaynotalwaysbereversibleandcanaffect

regionsotherthantheposteriorregionofthebrain.

b. Symptomsincludeinsidiousonsetofheadache,alteredlevelofconsciousness, visualchanges,andseizures.Theclassicradiographicfindingisposterior cerebralwhitematteredema.

c. Mostpatientsarehypertensive,butmaybenormotensive.Elevatedblood pressuresoverwhelmtheautoregulatorymechanismsofthecerebralvessels, leadingtoarteriolardilationandextravasationoffluidintothebrain.

d. DiagnosewithclinicalfindingsandbrainMRI.Firsttreatmentstepistolower BP,usuallywithIVmedications.Othertreatmentstepsincludecorrecting electrolyteabnormalitiesandstoppingseizuresiftheyoccur.

B.Causes 1. Noncompliancewithantihypertensivetherapy

2. Cushingsyndrome

CLINICALPEARL1-13 IfapatientpresentswithsevereheadacheandmarkedlyelevatedBP: ThefirststepistolowertheBPwithanantihypertensiveagent. ThesecondstepistoorderaCTscanoftheheadtoruleoutintracranialbleeding(subarachnoidhemorrhageis inthedifferentialdiagnosisforsevereheadache). IftheCTscanisnegative,onemayproceedtoalumbarpuncture.

3. Drugssuchascocaine,LSD,methamphetamines 4. Hyperaldosteronism 5. Eclampsia 6. Vasculitis 7. Alcoholwithdrawal 8. Pheochromocytoma 9. Noncompliancewithdialysis 10. Renalarterystenosis(atherosclerosisorfibromusculardysplasia) 11. Polycystickidneydisease
======================================
Quick HIT

LowerBPwithIVinfusionsofmedicationssuchasCCBs(nicardipine),β-blockers(labetalol,esmolol),and nitrates(nitroglycerin,nitroprusside).

C.ClinicalFeatures 1. Severeheadache 2. Visualdisturbances 3. Alteredmentation

D.Treatment 1. Hypertensiveemergencies

a. Reducemeanarterialpressureby25%in1to2hours.Thegoalisnotto immediatelyachievenormalBP,buttogetthepatientoutofdanger,thenreduce BPgraduallytoallowcerebralautoregulationtomaintaincerebralperfusion withchangingsystemicbloodpressures.

b. Ifsevere(diastolicpressure>130)orifhypertensiveencephalopathyispresent, IVagents,suchasesmolol,nitroprusside,labetalol,ornitroglycerin,are appropriate.HydralazinecanbegivenasanIVpushaswell.

c. Inpatientswhoareinlessimmediatedanger,oralagentsareappropriate. Optionsincludecaptopril,clonidine,labetalol,nifedipine,anddiazoxide.

2. Hypertensiveurgencies:BPshouldbeloweredwithin24hoursusingoralagents.

Quick HIT

Hypertensiveemergency—evidenceofend-organdamage;useIVmedications Hypertensiveurgency—noevidenceofend-organdamage;usePOmedications

AorticDissection

A.GeneralCharacteristics 1. Predisposingfactors

a. Long-standingsystemicHTN(presentin70%ofpatients) b. Cocaineuse(mayberemote) c. Trauma d. Connectivetissuediseases,suchasMarfanandEhlers–Danlossyndrome e. Bicuspidaorticvalve f. Coarctationoftheaorta g. Thirdtrimesterofpregnancy h. Pre-existingaorticaneurysm i. Intimalulcerduetoatherosclerosis 2. Stanfordclassification(Figure1-16)

a. TypeA(proximal)involvestheascendingaorta(includesretrogradeextension fromdescendingaorta).

b. TypeB(distal)islimitedtothedescendingaorta(distaltothetake-offofthe subclavianartery).

Quick HIT

Aorticdissection

«

¢

TypeA=ascending;treatmentissurgical TypeB=descending;treatmentismedical

B.ClinicalFeatures 1. Severe,tearing/ripping/stabbingpain,typicallyabruptinonset,eitherinthe

anteriororbackofthechest(oftentheinterscapularregion)

a. Anteriorchestpainismorecommonwithproximaldissection(typeA). b. Interscapularbackpainismorecommonwithdistaldissection(typeB).

2. Diaphoresis 3. Mostarehypertensive,butsomemaybehypotensive 4. PulseorBPasymmetrybetweenlimbs 5. Aorticregurgitation(especiallyproximaldissections) 6. Neurologicmanifestations(hemiplegia,hemianesthesia)duetoobstructionof

carotidartery

7. TypeAdissectioncanprogresstocoronaries(causingMI)orpericardium (causingcardiactamponade)
======================================
Quick HIT

Thediagnosisofaorticdissectioncanbedifficulttomakebecausetheclassicclinicalfindingsoftenarenot apparent.Theuseofthrombolytictherapyinpatientswithaorticdissectionwhohavebeenincorrectlydiagnosed ashavinganacuteMIcanhavefatalconsequences.

FIGURE 1.16

Aorticdissection.A:Dissectionofascendingaorta.B:

Dissectionofdescendingaorta. (ModifiedfromHarwood-NussA,WolfsonAB,LindenCH,etal.TheClinicalPracticeof

EmergencyMedicine.3rded.Philadelphia,PA:LippincottWilliams&Wilkins;2000:212,Figure 51.1.)

C.Diagnosis 1. CXRshowswidenedmediastinum(>8mmonAPview).

2. CTangiogram(CTA)andMRIarebothhighlyaccurate;MRItakeslongerto perform,makingitlessidealintheacutesetting.Thefalselumenofthedissection planeappearslargeronCTandMRI.

3. TEEhasaveryhighsensitivityandspecificity;itisnoninvasiveandcanbe performedatthebedside.

4. Aorticangiographywasoncethegoldstandard,andhaslargelybeenreplacedby CTA.Itcanbeusedforpatientsinwhomnoninvasiveimagingisnondiagnostic, orduringendovascularinterventionfordissection.

Quick HIT

CTAandTEEarethepreferredtestsinthediagnosisofacuteaorticdissection.CTAismuchmorereadily availableinemergencyrooms.TEEisveryaccurateandisidealintheunstablepatientbecauseitcanbe performedatthebedside.

D.Treatment 1. Initiatemedicaltherapyimmediately

a. IVβ-blockers(labetalol,esmolol)tolowerheartrateanddiminishtheforceof leftventricularejection,thusreducingshearstressonintima

b. GoalsystolicBP100to120mmHg,tobeachievedassoonaspossibleto minimizeshearstress.Canbeaccomplishedwithβ-blockers,orcanaddsodium nitroprusside

2. FortypeAdissections—surgicalmanagement

a. MostcasesoftypeAdissectionsshouldbetreatedassurgicalemergenciesto preventcomplicationssuchasMI,aorticregurgitation,orcardiactamponade

b. Opensurgeryisstillthestandardofcare c. Highriskofmortality,1%to2%perhouraftersymptomonsetwithout

intervention

3. FortypeBdissections—medicalmanagement

a. Lowerbloodpressureasquicklyaspossible.First-linedrugsincludeIVβ- blockerssuchaslabetalol,esmolol

b. Paincontrolwithmorphineorhydromorphone c. Unrelentingsymptomsmayrequiresurgicaltreatment—bothopenand

endovascularsurgicaloptionsexist
======================================
AbdominalAorticAneurysm

A.GeneralCharacteristics 1. Abdominalaorticaneurysm(AAA)isanabnormallocalizeddilationoftheaorta.

MostAAAsoccurbetweentherenalarteriesandiliacbifurcation.

2. Theincidenceincreaseswithage.AAAsarerarebeforetheageof50.The averageageattimeofdiagnosisis65to70years.

3. AAAsaremuchmorecommoninmen,thoughmorelikelytoruptureinwomen atagivensize.

B.Causes 1. Multifactorial—inmostcases,thereisatheroscleroticweakeningoftheaortic

wall.

2. Otherpredisposingfactorsincludetrauma,HTN,vasculitis,smoking,andpositive familyhistory.

3. Syphilisandconnectivetissueabnormalities(e.g.,Marfandisease)areassociated withthoracicaneurysms,buttheymayinvolvetheloweraortaaswell.

C.ClinicalFeatures 1. Usuallyasymptomaticanddiscoveredoneitherabdominalexaminationora

radiologicstudydoneforanotherreason

2. Senseof“fullness” 3. Painmayormaynotbepresent—ifpresent,locatedinthehypogastriumand

lowerbackandusuallythrobbingincharacter.

4. Pulsatilemassonabdominalexamination 5. Symptomssuggestingexpansionandimpendingruptureincludethefollowing: a. Suddenonsetofseverepaininthebackorlowerabdomen,radiatingtothe

groin,buttocks,orlegs

b. GreyTurnersign(ecchymosesonbackandflanks)andCullensign(ecchymoses aroundumbilicus)aresignsofretroperitonealbleeding.Neitherisverysensitive forrupturedAAA 6. RuptureofanAAA

a. Thetriadofabdominalpain,hypotension,andapalpablepulsatileabdominal massindicatesarupturedAAAandemergentlaparotomyisindicated.No furtherdiagnostictestingisneededwiththisconstellationofsymptoms; however,patientsmaypresentwithonlyoneortwocomponentsofthistriad

b. Cardiovascularcollapse c. Syncopeornear-syncope,secondarytosuddenhemorrhage d. Nauseaandvomiting

D.Diagnosis 1. Ultrasound

a. Testofchoicetoevaluateboththelocationandsizeoftheaneurysm b. 100%sensitiveindetectingAAAs

2. CTscan

a. 100%sensitiveindetectingAAAs b. Takeslongertoperformthanplainradiographsorultrasound;shouldonlybe

usedinhemodynamicallystablepatients

c. CTisthescanofchoiceforpreoperativeplanning

E.Treatment 1. Unrupturedaneurysms.

a. Managementlargelydependsonsizeoftheaneurysm.

¢
======================================
e

DatafromtheADAMtrialandUK-SAThaveshownthatiftheaneurysm is>5cmindiameterorsymptomatic,surgicalresectionwithsynthetic graftplacementisrecommended.(Theinfrarenalaortaisreplacedwitha fabrictube.)Thiscanoftenbedoneendovascularlybyaccessingthe femoralartery.Thediameterofthenormaladultinfrarenalaortaisabout2 cm. Themanagementofasymptomaticaneurysms<5cmiscontroversial.Periodic imagingisrecommendedtofollowupgrowth.Growthofmorethan1cmina yearsuggestselevatedrisk.No“safe”sizeexistshowever,andsmallAAAs canrupture.

b. Otherfactorstoconsiderarethepatient’slifeexpectancy(patientmaybemore likelytodieofothermedicalillnesses),andtheriskofsurgery.

2. RupturedAAAs:Emergencysurgicalrepairisindicated.Allofthesepatientsare unstable.

a. Whileopenrepairremainsthegoldstandard,somerupturedAAAsmaybe repairedendovascularlyaswellwithstents.

Quick HIT

Lerichesyndrome:Atheromatousocclusionofdistalaortajustabovebifurcationcausingbilateralclaudication, impotence,andabsent/diminishedfemoralpulses.

CLINICALPEARL1-14

EvaluationofaPatientWithPAD

Evaluatethecardiovascularsystem(HTN,carotidbruits,murmurs,AAA). Assessarterialpulses. Inspectlowerextremitiesforcolorchange,ulcers,muscleatrophy,hairloss,thickenedtoenails,etc. Considerthefollowingtests:ECG,CBC,renalfunctiontests,andcoagulationprofile(factorVLeiden, antithrombinIII,proteinsCandS).

PeripheralArterialDisease(ChronicArterialInsufficiency)

A.GeneralCharacteristics 1. Peripheralarterialdisease(PAD)isanocclusiveatheroscleroticdiseaseofthe

lowerextremities(seealsoClinicalPearl1-14)

2. PatientswithPADusuallyhavecoexistingCAD(withCHF,historyofMI,andso on)andotherchronicmedicalproblems(e.g.,diabetes,lungdisease)

3. Sitesofocclusion/stenosis

a. Superficialfemoralartery(inHuntercanal)isthemostcommonsite b. Poplitealartery c. Aortoiliacocclusivedisease

4. Riskfactors

a. Smokingisbyfarthemostimportantriskfactor b. CAD,hyperlipidemia,HTN c. Diabetes—prevalenceismarkedlyincreasedinthesepatients

5. Prognosis

a. Ifthepatienthasintermittentclaudication,theprognosisisgenerallygood b. Patientswithrestpainorischemiculcershavetheworstprognosis(especiallyin

diabeticsorsmokers)
======================================
B.ClinicalFeatures 1. Symptoms(seealsoClinicalPearl1-14)

a. Intermittentclaudication

¢

e

Crampinglegpainthatisreliablyreproducedbysamewalkingdistance (distanceisveryconstantandreproducible) Painiscompletelyrelievedbyrest

b. Restpain(continuous)

e

e

e

e

Usuallyfeltoverthedistalmetatarsals,wherethearteriesarethesmallest Oftenprominentatnight—awakenspatientfromsleep Hangingthefootoversideofthebedorstandingrelievespain—extra perfusiontoischemicareasduetogravity Restpainisalwaysworrisome—suggestssevereischemiasuchthatfrank gangreneofinvolvedlimbmayoccurintheabsenceofintervention

2. Signs

a. Diminishedorabsentpulses,muscularatrophy,decreasedhairgrowth,thick

toenails,anddecreasedskintemperature b. Ischemiculceration(usuallyonthetoes)

Localizedskinnecrosis

e

e

Secondarytolocaltraumathatdoesnotheal(duetoischemiclimb) Tissueinfarction/gangreneinend-stagedisease

c. Pallorofelevationandruborofdependency(inadvanceddisease)

Quick HIT

e

e

Femoralorpoplitealdiseasecausescalfclaudication. Aortoiliacocclusivediseasecausesbuttockandhipclaudication(inadditiontothecalves).

C.Diagnosis 1. Ankle-to-brachialindex(ABI):RatioofthesystolicBPattheankletothesystolic

BPatthearm

a. NormalABIisbetween0.9and1.3 b. ABI>1.3isduetononcompressiblevesselsandindicatesseveredisease c. ClaudicationusuallywhenABI<0.7 d. RestpainusuallywhenABI<0.4

2. Pulsevolumerecordings

a. Excellentassessmentofsegmentallimbperfusion b. Pulsewaveformsrepresentthevolumeofbloodperheartbeatatsequentialsites

downtheleg

c. Alargewaveformindicatesgoodcollateralbloodflow d. Noninvasiveusingpressurecuffs

3. Arteriography(contrastinvesselsandradiographs) a. GoldstandardfordiagnosingandlocatingPAD

Quick HIT

Patientswithcalcifiedarteries(especiallythosewithDM)havefalseABIreadings(vesselsarenot compressible).

D.Treatment 1. Conservativemanagementforintermittentclaudication.

a. Smokingcessation(theimportanceofthiscannotbeoveremphasized). Smokingislinkedtoprogressionofatherosclerosisandcausesvasoconstriction (furtherdecreasingbloodflow).

b. Graduatedexerciseprogram:Walktopointofclaudication,rest,andthen continuewalkingforanothercycle.

c. Footcare(especiallyimportantindiabeticpatients). d. Atheroscleroticriskfactorreduction(controlofhyperlipidemia,HTN,weight,

diabetes,andsoon).
======================================
e. Avoidextremesoftemperature(especiallyextremecold). f. Aspirinalongwithclopidogrelhasshownslightimprovementsinsymptom

relief.Theyareoftenusedinthesepatientsforstroke/MIprevention.

g. CilostazolisaPDEinhibitorwhichactsbothbysuppressingplateletaggregation andbydirectlydilatingarterioles.

Quick HIT

Diabeticpatientshaveanamputationratefourtimesgreaterthanthatofnondiabeticpatients.

2. Surgicaltreatment

a. Indications:Restpain,ischemiculcerations(tissuenecrosis),severesymptoms refractorytoconservativetreatmentthataffectqualityoflifeorwork. b. Options

b. Options

e

e

Angioplasty—balloondilationwithorwithoutstenting.Giventheminimal risksandgoodchanceofsymptomaticreliefforpatients,thismaybe performedoneormoretimesbeforeabypassisdone.Notusefulwhen performedonbelow-the-kneelesions Surgicalbypassgrafting—hasa5-yearpatencyrateof70%(immediate successrateis80%to90%).

AcuteArterialOcclusion

A.GeneralCharacteristics 1. Acuteocclusionofanartery,usuallycausedbyembolization.Thecommon femoralarteryisthemostcommonsiteofocclusion.Lesscommonly,insitu thrombosisisthecause.

2. Sourcesofemboli

a. Heart(85%)

AFibisthemostcommoncauseofembolusfromtheheart Post-MI Postarterialprocedure(i.e.,coronaryangiogram,peripheralangiogram) Endocarditis Myxoma b. Aneurysms c. Atheromatousplaque

B.ClinicalFeaturesofAcuteLimbIschemia(RemembertheSixPs) 1. Pain—acuteonset.Thepatientcantellyoupreciselywhenandwhereit

happened.Thepainisverysevere,andthepatientmayhavetositdownormay falltotheground(Table1-4).

2. Pallor 3. Polar(cold) 4. Paralysis 5. Paresthesias 6. Pulselessness(useDopplertoassesspulses)

TABLE1-4 PADVersusAcuteArterialOcclusion
======================================
Restpain—surgery

Acutearterial occlusion SixPs—pallor,pain,pulselessness,paresthesias, paralysis,polar(cold) Arteriogram Anticoagulation,emergent surgery

C.Diagnosis 1. Angiogram(CTAvs.invasiveangiogram)todefinesiteofocclusion 2. ECGtolookforMI,AFib 3. Echocardiogramforevaluationofcardiacsourceofemboli—valves,thrombus,

shunts

D.Treatment 1. Maingoal:Assessviabilityoftissuestosalvagethelimb. 2. Skeletalmusclecantolerate6hoursofischemia;perfusionshouldbe

reestablishedwithinthistimeframe.

3. ImmediatelyanticoagulatewithIVheparin. 4. EmergentsurgicalembolectomyisindicatedviacutdownandFogartyballoon.

Bypassisreservedforembolectomyfailure.

5. Thrombolyticscanalsobeinfusedintra-arterially.Doubleblindtrialscomparing intra-arterialthrombolyticssuchasrecombinanturokinasetosurgeryshowed mixedresults.

6. Treatanycomplicationssuchascompartmentsyndromethatmayoccur.

Quick HIT

TheFogartyballooncatheterisusedforembolectomy—thecatheterisinserted,theballoonisinflated,andthe catheterispulledout—theballoonbringstheemboluswithit.

CholesterolEmbolizationSyndrome

Thissyndromeisdueto“showers”ofcholesterolcrystalsoriginatingfroma proximalsource(e.g.,atheroscleroticplaque),mostcommonlytheabdominalaorta, iliacs,andfemoralarteries. Itisoftentriggeredbyasurgicalorradiographicintervention(e.g.,arteriogram),or bythrombolytictherapy. Itpresentswithsmall,discreteareasoftissueischemia,resultinginblue/blacktoes, renalinsufficiency,and/orabdominalpainorbleeding(thelatterisduetointestinal hypoperfusion). Treatmentissupportive.Anticoagulationnotsuggestedunlessotherindicationexists (mostoftheocclusionisatheroembolicdebris,notthrombus).ControlBP. Amputationorsurgicalresectionisonlyneededinextremecases.

MycoticAneurysm

Ananeurysmresultingfromdamagetotheaorticwallsecondarytoinfection Bloodculturesarepositiveinmostcases Treatment:IVantibioticsandsurgicalexcision

LueticHeart

Lueticheartisacomplicationofsyphiliticaortitis,usuallyaffectingmenintheir fourthtofifthdecadeoflife.Aneurysmoftheaorticarchwithretrogradeextension extendsbackwardtocauseaorticregurgitationandstenosisofaorticbranches,most commonlythecoronaryarteries. Treatment:IVpenicillinandsurgicalrepair.
======================================
DeepVenousThrombosis

A.GeneralCharacteristics 1. Cause:Virchowtriad(endothelialinjury,venousstasis,hypercoagulability)gives

risetovenousthrombosis(seealsoTable1-5)

2. Riskfactors a. Age>60 b. Malignancy c. Priorhistoryofdeepvenousthrombosis(DVT),PE,orvaricoseveins d. Hereditaryhypercoagulablestates(factorVLeiden,proteinsCandSdeficiency,

antithrombinIIIdeficiency)

e. Prolongedimmobilizationorbedrest f. Cardiacdisease,especiallyCHF g. Obesity h. Majorsurgery,especiallysurgeryofthepelvis(orthopedicprocedures) i. Majortrauma j. Pregnancy,oralcontraceptives/estrogenuse

Quick HIT

Ifasuperficialvenoussystemispatent,theclassicfindingsofDVT(erythema,pain,cords)willnotoccur becauseblooddrainsfromthesepatentveins.ThisiswhyonlyhalfofallpatientswithDVThavetheclassic findings.

B.ClinicalFeatures 1. Clinicalpresentationmaybesubtle 2. Classicfindings(allhaveverylowsensitivityandspecificity):

a. Lowerextremitypainandswelling(worsewithdependency/walking,betterwith elevation/rest)

b. Homanssign(calfpainonankledorsiflexion) c. Palpablecord d. Fever

Quick HIT

Only50%ofpatientswiththeclassicDVTfindingshaveaDVT,andonly50%ofpatientswithdocumented DVThavetheclassicfindings.

C.Diagnosis 1. Availablestudies

a. DoppleranalysisandDuplexultrasound

e

e

InitialtestforDVT;noninvasive,buthighlyoperatordependent Highsensitivityandspecificityfordetectingproximalthrombi(poplitealand femoral),notsofordistal(calfvein)thrombi

b. Venography

e

e

e

MostaccuratetestfordiagnosisofDVTofcalfveins Invasiveandinfrequentlyused Allowsvisualizationofthedeepandsuperficialvenoussystems,andallows assessmentofpatencyandvalvularcompetence

c. Impedanceplethysmography

e

e

e

e

e

AnoninvasivealternativetoDopplerultrasound Bloodconductselectricitybetterthansofttissue,soelectricalimpedance decreasesasbloodvolumeincreases HighsensitivityforproximalDVT,butnotfordistalDVT(calfveins) Poorspecificitybecausethereisahighrateoffalsepositives AsaccurateasDoppler,butlessoperatordependent

d. D-dimertesting

Hasaveryhighsensitivity(95%),butlowspecificity(50%);canbeusedto ruleoutDVTwhencombinedwithDopplerandclinicalsuspicion

2. Interpretationofdiagnostictests

a. Intermediate-to-highpretestprobabilityofDVT
======================================
e

e

IfDopplerultrasoundispositive,beginanticoagulation IfDopplerultrasoundisnondiagnostic,repeatultrasoundevery2to3daysfor upto2weeks

b. Low-to-intermediateprobabilityofDVT

e

e

IfDopplerultrasoundisnegative,thereisnoneedforanticoagulation; observationissufficient Repeatultrasoundin2days

D.Complications 1. Pulmonaryembolus(PE)canoriginatefromtheiliofemoral,pelvic,calf,ovarian, axillary,subclavian,andinternaljugularveins,aswellastheinferiorvenacava andcavernoussinusesoftheskull—seeChapter3fordiscussiononPE

2. Postthromboticsyndrome(chronicvenousinsufficiency)

a. OccursinapproximatelyhalfofallpatientswithacuteDVT b. ResidualvenousobstructionandvalvularincompetenceleadtoambulatoryHTN

(seesectionChronicVenousInsufficiency)

3. Phlegmasiaceruleadolens(painful,blue,swollenleg)

a. OccursinextremecasesofDVT—indicatesthatmajorvenousobstructionhas occurred.Oftenassociatedwithmalignancycausinghypercoagulablestate. b. Severelegedemacompromisesarterialsupplytothelimb,resultinginimpaired

sensoryandmotorfunction.

c. Venousthrombectomyisindicated.

E.Treatment 1. Anticoagulation

a. Preventsfurtherpropagationofthethrombus b. Multipleoptions:InjectableLMWH(e.g.,enoxaparin,dalteparin)(bestchoice

forDVT/PEassociatedwithmalignancy),DOACs(e.g.,apixaban,rivaroxaban, edoxaban,dabigatran),andwarfarin(requiresIVheparinbridgeasbelow). LMWHwasthepreferredchoiceforDVT/PEtreatmentinpatientswith malignancy,howeverarecentstudyshowedthatedoxabanwasnon-inferiorto dalteparin,andalsosignificantlyreducedVTErecurrencecomparedto dalteparin(thoughwithahigherbleedingrisk).

c. Ifwarfarinchosen:Heparinbolusfollowedbyaconstantinfusionandtitratedto maintainthePTTat1.5to2timesaPTT

d. StartwarfarinoncetheaPTTistherapeuticandcontinuefor3to6months. AnticoagulatetoINRat2to3

e. ContinueheparinuntiltheINRhasbeentherapeuticfor48hours

2. Thrombolytictherapy(streptokinase,urokinase,tissueplasminogenactivator [tPA])

a. Speedsuptheresolutionofclots b. IndicatedmainlyforpatientswithmassivePEwhoarehemodynamically

unstable(hypotensionwithSBP<90mmHg),andwithnocontraindicationsfor thrombolytics

c. HighriskofintracranialhemorrhagewithtPA(1%to2%)

3. Inferiorvenacavafilterplacement(Greenfieldfilter)

a. IndicationsfortreatmentofVTE

Ifabsolutecontraindicationtoanticoagulation(bleeding) Iffailureofappropriateanticoagulation b. EffectiveonlyinpreventingPE,notDVT

4. Methodsofprophylaxisaftersurgery

a. Mechanical
======================================
e

e

e

Legelevation,graduatedcompressionstockings,earlyambulation Pneumaticcompressionboots—intermittentlyinflateanddeflate,causing compressionofthelimb,usuallythecalves;veryeffective IVCfilterforpatientsathighriskforDVT/PEwhohaveanabsolute

contraindicationtootherformsofprophylaxis;forexample,aftertraumaor spinal/orthopedicsurgeryandhaveevidenceofbleeding

b. Pharmacologic

e

¢

HeparinorLMWH:UnfractionatedheparinorLMWHpostoperativelyuntil thepatientisambulatory Combinationofpneumaticcompressiondevicesandpharmacologic prophylaxismayprovidethegreatestprotection

Quick HIT

Low–Molecular-WeightHeparin

Haslongerhalf-lifethanunfractionatedheparinandcanbedosedoncedailyorBID Canbegivenonoutpatientbasis NoneedtofollowaPTTlevels Ismuchmoreexpensivethanunfractionatedheparin

ChronicVenousInsufficiency(VenousStasisDisease)

A.GeneralCharacteristics 1. Alsoreferredtoaspostphlebiticsyndrome 2. CVImayinvolvethesuperficial,deep,orbothvenoussystems 3. Anatomy

a. Thelowerextremityvenoussystemconsistsofthreesystems:Deep,superficial, andperforatingsystems.Valvesexistinallthreesystems,preventingretrograde bloodflow.

b. Theperforatingveinsconnectthesuperficialanddeepsystems.Valvesallow flowfromsuperficialtodeep,butnotviceversa.

Quick HIT

ManypatientswithahistoryofDVTeventuallydevelopCVI(80%).

4. Pathophysiology

a. HistoryofDVTistheunderlyingcauseinmanycases(suchahistorymightnot bedocumented).Thishastwomajoreffects:

e

e

Itcausesdestructionofvenousvalvesinthedeepvenoussystem.Valvular incompetenceresultsingravitationalpressureofthebloodcolumntobe transmittedtoankles. Valvesintheperforatorveinsarealsodamagedsecondarytothechronically elevateddeepvenouspressure,inhibitingtransmissionofbloodfrom superficialtodeep,asnormallyoccurs.

b. LeadstoambulatoryvenousHTN,whichhastwoundesirableeffects:

e

e

Interstitialfluidaccumulation,resultinginedema. ExtravasationofplasmaproteinsandRBCsintosubcutaneoustissues, resultinginbrawnyindurationandpigmentation(abrown-blackcolor)ofskin.

c. Eventuallyleadstoreducedlocalcapillarybloodflowandhypoxiaoftissues.
======================================
e

e

Evenmildtraumamayprecipitatetissuedeathandulcerformation. Venousulcersusuallydevelopmediallyfromtheinsteptoabovetheankle, overlyinganincompetentperforatorvein.

B.ClinicalFeatures 1. Swellingofthelowerleg

a. Whenchronic,causesanachingortightnessfeelingoftheinvolvedleg;often worseattheendoftheday

b. Symptomsareworsenedbyperiodsofsittingorinactivestanding

c. Legelevationprovidesreliefofsymptoms(theoppositeistrueinarterial insufficiency)

2. Chronicchangesinclude:

a. Skinchanges

e

e

Skinbecomesthin,atrophic,shiny,andcyanotic Brawnyindurationdevelopswithchronicity

b. Venousulcers

e

e

e

Lesspainfulthanulcersassociatedwitharterialinsufficiency Usuallylocatedjustabovethemedialmalleolus Oftenrapidlyrecur

Quick HIT

Ulcerformationisdirectlyproportionaltotheamountofswellingpresent.

C.Treatment 1. Beforethedevelopmentofulcers,strictadherencetothefollowingcontrolsstasis

sequelaeinmostpatients.

a. Legelevation:Periodsoflegelevationduringthedayandthroughoutthenight toalevelabovetheheart.

b. Avoidinglongperiodsofsittingorstanding. c. Heavy-weightelasticstockings(knee-length)arewornduringwakinghours.

2. Ifulcersdevelop,managementalsoentails:

a. Wet-to-drysalinedressings(threetimesdaily). b. Unnavenousboot(externalcompressionstocking)—bestchangedeveryweekto

10days.

e

e

Healingoccursin80%ofulcers.Compliancereducestherateofrecurrence. ForulcersthatdonothealwiththeUnnaboot:Applysplit-thicknessskin graftswithorwithoutligationofadjacentperforatorveins.

Quick HIT

Whensuperficialthrombophlebitisoccursindifferentlocationsoverashortperiodoftime,thinkofmigratory superficialthrombophlebitis(secondarytooccultmalignancy,oftenofthepancreas—Trousseausyndrome).

SuperficialThrombophlebitis

A.GeneralCharacteristics 1. Virchowtriadisagainimplicated(butpathophysiologyisnotentirelyclear) 2. Inupperextremities,usuallyoccursatthesiteofanIVinfusion 3. Inlowerextremities,usuallyassociatedwithvaricoseveins(inthegreater

saphenoussystem)—secondarytostaticbloodflowintheseveins

Quick HIT

Twoconditionsthatshouldnotbeconfusedwithsuperficialthrombophlebitisarecellulitisandlymphangitis.In theseconditions,swellinganderythemaaremorewidespread,andthereisnopalpable,induratedvein.

B.ClinicalFeatures 1. Pain,tenderness,induration,anderythemaalongthecourseofthevein 2. Atendercordmaybepalpated
======================================
c.Treatment 1. Noanticoagulationisrequired—rarelycausesPE.Onlyifthrombusextendsinto

thedeepsystem.

2. Localizedthrombophlebitis—amildanalgesic(aspirinorNSAIDs)elevation,and hotcompresses;continueactivity.

3. Suppurativethrombophlebitis—septicphlebitisisusuallyduetoinfectionofan IVcannula.Rednessextendsbeyondtheareaoftheveinandpurulentdrainage maybepresent.Removethecannulaandadministersystemicantibiotics.

CardiacNeoplasms

Primarytumorsoftheheartarerare(typicallylessthan0.1%ofthegeneral population). Metastasesfromotherprimarytumorsaremorecommon(75%ofcardiac neoplasms).Sitesoftheseprimarytumorsincludethelung,breast,skin,kidney, lymphomas,andKaposisarcomainpatientswithAIDS.

AtrialMyxoma

Anatrialmyxomaisabenigngelatinousgrowth,usuallypedunculatedandarising fromtheinteratrialseptumoftheheartintheregionofthefossaovalis.Itisthemost commonprimarycardiacneoplasm. Althoughbenign,atrialmyxomascanembolize,leadingtometastaticdisease,orcan causerelativevalvulardysfunction. Themajorityofmyxomasaresporadic,butautosomal-dominanttransmissionhas beennoted. Prototypicallypresentwithfatigue,fever,syncope,palpitations,malaise,andalow- pitcheddiastolicmurmurthatchangescharacterwithchangingbodypositions (diastolicplop). Treatment:Surgicalexcision.

BasicsofShock

A.GeneralCharacteristics 1. Shockishypotensioncausingend-organhypoperfusion.Itisamedicalemergency thatneedstobecorrectedrightaway,beforetheconditionbecomesirreversible.

TABLE1-6 HemodynamicChangesinShockStates
======================================
2. Presentswithtachycardia,adecreaseinBP,andmalfunctionofunderperfused organsystems,mostnotably:

a. Lacticacidosis b. Renal(anuria/oliguria) c. CNSdysfunction(alteredmentation)

3. Shockischaracterizedbyitseffectoncardiacoutput,SVR,andvolumestatus (volumestatusisassessedviajugularvenouspressureorpulmonarycapillary wedgepressure[PCWP]).Thehemodynamicchangesassociatedwithdifferent typesofshockaresetforthinTable1-6. 4. Therearefourmaincategoriesofshock:

e¢

¢

e

¢

Hypovolemic(poorintakeorexcessivelossoffluids) Cardiogenic(poorpumpingfunctionorcirculatoryoverload) Distributive(lowSVRandhighcardiacoutputstateswhichincludeseptic, anaphylactic,neurogenicshock,andseverehepaticfailure) Obstructive(i.e.,massivePE,cardiactamponade,tensionpneumothorax)

Quick HIT

Thefollowingsignsandsymptomsarecommontoallformsofshock:

Hypotension

Oliguria Tachycardia Alteredmentalstatus

¢ Oliguria

e

e

B.InitialApproachtoaPatientinShock 1. Afocusedhistoryandphysicalexaminationtodeterminepossiblecauseofshock. a. Fever,warmextremities,andapossiblesiteofinfectionsuggestsepticshock. b. Trauma,GIbleeding,vomiting,ordiarrheasuggestshypovolemicshock. c. Ifsignsofvolumeoverloadandcool,clammyextremitiesarepresent,this

suggestscardiogenicshock.

d. Ifspinalcordinjuryorneurologicdeficitsarepresent,neurogenicshockis likely.

e. Ifthepatienthasbeenexposedtoanewmedicationorallergen,consider anaphylacticshock.

2. Initialsteps:Simultaneouslystabilizethepatienthemodynamicallyanddetermine thecauseofshock.

a. Initiateworkup:CBC,BMP,infectiousworkup(bloodandurinecultures,chest imaging),ECG,considerbedsideechocardiographyifconcernforcardiogenic shock.

b. Establishtwolarge-boreIVsiffluidresuscitationindicated,andconsidera centralline,andanarteriallineifvasopressorsindicated.

c. Afluidbolus(multiplelitersofnormalsalineorlactatedRingersolution)should begiveninmostcases(exceptcardiogenicshock,asmorevolumewillworsen it).

d. Continuouspulseoximetry. e. Vasopressors(suchasnorepinephrine)maybegivenifthepatientremains

hypotensivedespitefluids.

f. Ifthediagnosisisstillinquestionaftertheabovetests,apulmonaryartery catheter(Swan–Ganzcatheter)mayhelpindiagnosis.

C.Treatment 1. ABCs(airway,breathing,andcirculation)shouldbeaddressedforall

patientsinshock.

2. Specifictreatmentisdescribedbelowforeachtypeofshock.Withtheexception ofcardiogenic(andsometimesneurogenic)shock,agenerousamountofIVfluid isusuallyrequiredtoresuscitatethepatient.Themoreadvancedthestageof shock,thegreaterthefluid(andblood)requirement.
======================================
CardiogenicShock

A.GeneralCharacteristics 1. Occurswhenheartisunabletogenerateacardiacoutputsufficienttomaintain

tissueperfusion

2. CanbedefinedasasystolicBP<90withurineoutput<20mL/hrandadequate leftventricularfillingpressure(LVfillingpressureusuallyelevatedincardiogenic shock)

B.Causes 1. AfteracuteMI—mostcommoncause 2. Decompensatedheartfailure 3. Aftercardiacarrest 4. Arrhythmias 5. Mechanicalabnormalities(valvulardefects,ventricularseptaldefect)

C.ClinicalFeatures 1. Ill-appearingpatientswithlowcardiacoutput,markedlyincreasedSVR(with

coolextremitiesduetovasoconstriction)

2. Engorgedneckveins—JVPelevated 3. Pulmonarycongestion

Quick HIT

Notethatjugularvenouspulseisonlyelevatedincardiogenicandobstructiveshock.

D.Diagnosis 1. ECG—lookforsignsofischemia(i.e.,ST-segmentchanges)orarrhythmia

(ventricularoratrialtachyarrhythmia).

2. Echocardiogram—candiagnoseavarietyofmechanicalcomplicationsofMI, identifyvalvedisease,estimateEF,lookforpericardialeffusion,etc.

3. HemodynamicmonitoringwithaSwan–Ganzcathetermaybeindicated:PCWP, pulmonaryarterypressure,cardiacoutput,cardiacindex,SVR—keepcardiac output>4L/min,cardiacindex>2.2,PCWP<18mmHg.

E.Treatment 1. ABCs 2. Identifyandtreatunderlyingcause

a. AcuteMI

Standardtreatment(seeMIsection)

EmergentrevascularizationwithPCI(orCABG)hasbeenshowntoimprove survival

b. Ifcardiactamponade,pericardiocentesis/surgery c. Surgicalcorrectionofvalvularabnormalities d. Treatmentofarrhythmias

3. Preloadreductionforpatientswithvolumeoverload:Loopdiuretics,dialysisif renalfailure,nitroglycerin(thoughthiscanworsenhypotension) 4. Inotropy

4. Inotropy

a. Dobutamine(inotrope)canbeusedtoincreaseinotropyandsimultaneously decreaseafterload(SVR),enhancingcardiacoutput

b. Dopamineornorepinephrinecanbeused.TheSOAPIItrialfoundthatfor patientswithcardiogenicshock,dopaminehadhigher28-daymortality comparedtonorepinephrine.

c. Milrinoneisaphosphodiesteraseinhibitorwhichincreasesinotropyand decreasesSVR.Itisoftenusedinconjunctionwithotherinotropes.

5. Afterloadreduction

a. IVagentslikesodiumnitroprussidecanbeusedtoquicklyreduceafterload. Thereisariskofhypotensionwithrapidlyincreasingthedose.

b. Oralagentslikehydralazineandcaptoprilcanreduceafterload,areshortacting.

6. IVfluidsarelikelytobeharmfulifleftventricularpressuresareelevated. Patientsusuallyneeddiuretics.

7. Whilecontroversial,IABPscanbeusedforhemodynamicsupport(seeClinical Pearl1-15).Effectsinclude:
======================================
a. Decreasedafterload b. Increasedcardiacoutput c. Decreasedmyocardialoxygendemand

8. Moreadvancedmechanicalsupportdevicessuchasextracorporealmembrane oxygenationandleftventricularassistdevices(percutaneouslyorsurgically implanted)canbeusedforpatientswithmoresevereshock,andareoutsidethe scopeofthistext.

CLINICALPEARL1-15

Intra-AorticBalloonPump

e

e

Adevicethatgives“mechanicalsupport”toafailingheart—itworksoppositetothenormalpumpingaction oftheheart,thatis,itservesto“pump”duringdiastoleand“relax”duringsystole. Aballooncatheterispositionedinthedescendingthoracicaortajustdistaltothesubclavianartery.It facilitatesventricularemptyingbydeflatingjustbeforetheonsetofsystole(reducingafterload)and increasescoronaryperfusionbyinflatingattheonsetofdiastole(increasingdiastolicpressure). Theneteffectisenhancedmyocardialoxygenationandincreasedcardiacoutput.

¢

Indicationsareanginarefractorytomedicaltherapy,mechanicalcomplicationsofMI,cardiogenicshock,low cardiacoutputstates,andasabridgetosurgeryinsevereAS.

Quick HIT

¢

e

Compensatorymechanismsbegintofailwhenmorethan20%to25%ofbloodvolumeislost. IfCVPislow,hypovolemicshockismostlikelypresent.

HypovolemicShock

A.GeneralCharacteristics 1. Primarypathophysiologicevents:Decreasedcirculatorybloodvolumeleadsto

decreasedpreloadandcardiacoutput.CompensatoryincreaseinSVR.

2. Therateofvolumelossisveryimportant.Theslowertheloss,thegreaterthe effectivenessofcompensatorymechanisms.Acutelossisassociatedwithhigher morbidityandmortality.

3. Patientswithsignificantmedicalcomorbidities(especiallycardiac)maybeunable tocompensatephysiologicallyintheearlystagesofhypovolemicshock.

4. Therearefour“classes”ofhypovolemicshock,basedontheseverityofvolume loss(Table1-7).

5. Causes

a. Hemorrhage Trauma GIbleeding Retroperitoneal b. Nonhemorrhagic

Voluminousvomiting Severediarrhea Severedehydrationforanyreason Burns Third-spacelossesinbowelobstruction

Burns

TABLE1-7 HemodynamicChangesinHypovolemicShock

T I 10-15 Normal Normal Normal Normal Normal Normal Normal Il 20-30 >100 Normal Decreased Delayed Mild tachypnea Anxious 20-30 mL/hr Ml 30-40 >120 weak Decreased Decreased Delayed Marked tachypnea Confused 20 mL/hr IV >40 >140 nonpal- Marked Marked Absent Marked tachypnea _—Lethargic, Negligible pable decrease decrease coma

B.Diagnosis Ifthediagnosisisunclearfromthepatient’svitalsignsandclinicalpicture,acentral venous line or a pulmonary artery catheter can give invaluable information for hemodynamic monitoring: Decreased CVP/PCWP, decreased cardiac output, increasedSVR(seeTable1-5).
======================================
C.Treatment 1. Airwayandbreathing—patientsinsevereshockandcirculatorycollapse

generallyrequireintubationandmechanicalventilation.

2. Circulation

a. Ifhemorrhageisthecause,applydirectpressure. b. IVhydration

e

¢

e

PatientswithclassIshockusuallydonotrequirefluidresuscitation.Patients withclassIIshockbenefitfromfluids,andpatientswithclassesIIIandIV requirefluidresuscitation. Givefluidbolusfollowedbycontinuousinfusionandreassess. Thehemodynamicresponsetothistreatmentguidesfurtherresuscitativeeffort.

c. Fornonhemorrhagicshock,bloodisnotnecessary.Crystalloidsolutionwith appropriateelectrolytereplacementisadequate.

Quick HIT

Monitoringurineoutputisthemostusefulindicatoroftheeffectivenessoftreatment.Apulmonaryartery catheterand/orcentralvenousline,ifavailable,areveryhelpfulinmonitoringaswell.

SepticShock

A.GeneralCharacteristics 1. Septicshockisdefinedashypotensioninducedbysepsisthatpersistsdespite

adequatefluidresuscitation.Thisresultsinhypoperfusionandcanultimatelylead tomultipleorgansystemfailureanddeath.

2. Commoncausesinclude(butarenotlimitedto)pneumonia,urinarytract

infection,meningitis,abscessformation,cholangitis,cellulitis,andperitonitis. 3. Clinically,thereisaprogressionfromsystemicinflammatoryresponsesyndrome (SIRS)tosepsis,tosepticshock,tomultiorgandysfunctionsyndrome—see ClinicalPearl1-15.

4. Pathophysiology

a. ThereisaseveredecreaseinSVRsecondarytoperipheralvasodilation. Extremitiesareoftenwarmduetovasodilation.

b. Cardiacoutputisnormalorincreased(duetomaintenanceofstrokevolumeand tachycardia).

c. EFisdecreasedsecondarytoareductionincontractility.

5. Canbecomplicatedbyadultrespiratorydistresssyndrome,ATN,DIC,multiple organfailure,ordeath.

Quick HIT

Septic(andothertypesofdistributiveshock)areassociatedwithsevereperipheralvasodilatation(flushing, warmskin).

Hypovolemic,cardiogenic,andobstructiveshockareassociatedwithperipheralvasoconstriction(coolskin).

B.ClinicalFeatures 1. Manifestationsrelatedtocauseofsepsis(e.g.,pneumonia,urinarytractinfection,

peritonitis)

2. SignsofSIRS(seeClinicalPearl1-16) 3. Signsofshock(hypotension,oliguria,lacticacidosis) 4. Patientmayhaveafeverormaybehypothermic(hypothermiaismorecommon

intheveryyoung,elderly,debilitated,andimmunocompromised)
======================================
C.Diagnosis 1. Septicshockisessentiallyaclinicaldiagnosis. 2. Asourceofinfectioncanaidindiagnosis,buttheremaybenoconfirmedsource

insomecases.

D.Treatment

1. FluidadministrationtoincreasemeanBP(initialbolusisusually30cc/kgofbody weight).

atmaximumdosages.Antibioticsformorerareorganismsorantifungal medicationsmayberequiredifthereisnoclinicalresponseorifsuspicionforan atypicalorganism(i.e.,immunocompromised).Ifculturesarepositive,antibiotics canbenarrowedbasedonsensitivitytesting.

3. Surgicaldrainageifnecessary. 4. Vasopressors(norepinephrine,vasopressin,phenylephrine)maybeusedif

hypotensionpersistsdespiteaggressiveIVfluidresuscitation.

CLINICALPEARL1-16

SystemicInflammatoryResponseSyndrome(SIRS) SIRS SIRSischaracterizedbytwoormoreofthefollowing:

e

¢

e

e

Fever(>38°C)orhypothermia(<36°C) Hyperventilation(rate>20bpm)orPaCO2<32mmHg Tachycardia(>90bpm) IncreasedWBCcount(>12,000cell/hpf,<4,000cells/hpf,or>10%bandforms)

Sepsis

WhenhaveasuspectedsourceofinfectionandSIRSispresent

SepticShock

Hypotensioninducedbysepsispersistingdespiteadequatefluidresuscitation

MultipleOrganDysfunctionSyndrome(MODS)

Alteredorganfunctioninanacutelyillpatient,usuallyleadingtodeath

Quick HIT

SepticshockisthemostcommoncauseofdeathintheICU.

NeurogenicShock

A.GeneralCharacteristics 1. Neurogenicshockresultsfromafailureofthesympatheticnervoussystemto

maintainadequatevasculartone(sympatheticdenervation)

2. Causesincludespinalcordinjury,severeheadinjury,spinalanesthesia, pharmacologicsympatheticblockade

3. CharacterizedbyperipheralvasodilationwithdecreasedSVR

B.ClinicalFeatures 1. Warm,well-perfusedskin 2. Urineoutputlowornormal 3. Bradycardiaandhypotension(buttachycardiacanoccur) 4. Cardiacoutputisdecreased,SVRlow,PCWPlowtonormal

C.Treatment 1. JudicioususeofIVfluidsasthemainstayoftreatment 2. Vasoconstrictorstorestorevenoustone,butcautiously 3. SupineorTrendelenburgposition 4. Maintainbodytemperature

ObstructiveShock

A.GeneralCharacteristics 1. Causedbyanobstructionofcirculation.Mostcommonlyduetomassive

pulmonaryembolism(PE)orlimitedfillingoftheheartduetoextrinsicpressure frompericardium(cardiactamponade)orthoraciccavity(tensionpneumothorax).

2. Cardiacoutputlimitedbyobstruction,SVRmakesacompensatoryincreaseto maintainsystemicbloodpressure.

3. UsuallymanifestswithelevatedJVPduetolimitedfillingofrightventricleor obstructionofpulmonarycirculationbyPE.

4. Treatmentrequiresdiagnosisofunderlyingdisease.Cardiactamponadeand tensionpneumothoraxareclinicaldiagnosesthatcanbemadeatbedside. 5. Supportivetreatmentusuallyinvolvesgivingfluidand/orvasopressorsto

maintainbloodpressuresuntildefinitivetherapycanbegiven.

6. Cardiactamponade:Requirespericardiocentesisorpericardialwindow. 7. Tensionpneumothorax:Requiresneedlethoracostomyfollowedbychesttube

placement.

8. MassivePE:Requiresthrombolysis(systemicorcatheter-directedtPA)or thrombectomy.
======================================
References

1. FarkouhME,DomanskiM,SleeperLA,etal.Strategiesformultivesselrevascularizationinpatientswith diabetes.NEnglJMed.2012;367(25):2375–2384.

2. HohnloserSH,DurayGZ,BaberU,HalperinJL.EurHeartJSuppl2008;10(supplH):H4–H10.Available fromhttps://doi.org/10.1093/eurheartj/sun029.

2

DiseasesofthePulmonarySystem KelleyChuang

ObstructiveLungDiseases

ChronicObstructivePulmonaryDisease

A.GeneralCharacteristics 1. Therearetwoclassictypesofchronicobstructivepulmonarydisease(COPD): chronicbronchitisandemphysema(seeTable2-1andClinicalPearl2-1)

a. Chronicbronchitisisaclinicaldiagnosis:chroniccoughproductiveofsputum foratleast3monthsperyearforatleast2consecutiveyears.

b. Emphysemaisapathologicdiagnosis:permanentenlargementofairspaces distaltoterminalbronchiolesduetodestructionofalveolarwalls.

c. Thetwooftencoexist.Pureemphysemaorpurechronicbronchitisisrare. d. COPDisthethirdleadingcauseofdeathintheUnitedStates.

2. Riskfactorsandcauses

a. Tobaccosmoke(indicatedinalmost90%ofCOPDcases) b. α1-Antitrypsindeficiency—riskisevenworseincombinationwithsmoking c. Environmentalfactors(e.g.,second-handsmoke) d. Chronicasthma—whichmaybeattributedtoasthma–COPDoverlapsyndrome

3. Pathogenesis

a. Chronicbronchitis

e

e

Excessmucusproductionnarrowstheairways;patientsoftenhavea productivecough. Inflammationandscarringinairways,enlargementinmucousglands,and smoothmusclehyperplasialeadtoobstruction.

b. Emphysema

e

e

Destructionofalveolarwallsisduetorelativeexcessinprotease(elastase) activity,orrelativedeficiencyofantiprotease(α1-antitrypsin)activityinthe lung.Elastaseisreleasedfrompolymorphonuclearneutrophils(PMNs)and macrophagesanddigestshumanlung.Thisisinhibitedbyα1-antitrypsin. TobaccosmokeincreasesthenumberofactivatedPMNsandmacrophages, inhibitsα1-antitrypsin,andincreasesoxidativestressonthelungbyfree- radicalproduction.

Pathology Centrilobularemphysema:

«

e

¢

Mostcommontype,seeninsmokers(rarelyinnonsmokers) Destructionlimitedtorespiratorybronchioles(proximalacini)withlittlechangeindistalacini Predilectionforupperlungzones

Panlobularemphysema:
======================================
e

e

e

Seeninpatientswithα1-antitrypsindeficiency Destructioninvolvesbothproximalanddistalacini Predilectionforlungbases

B.ClinicalFeatures 1. Symptoms

a. Anycombinationofcough,sputumproduction,anddyspnea(onexertionorat rest,dependingonseverity)maybepresent.

b. Earliestsymptomisexertionaldyspnea,whichmaybedifficulttodetectin patientswithsedentarylifestyleswhoavoidexertion.

2. Signs—thefollowingmaybepresent:

a. Prolongedexpiratorytimewithpursedlipbreathing b. Duringauscultation,end-expiratorywheezesonforcedexpiration,decreased

breathsounds,and/orinspiratorycrackles

c. Tachypnea,tachycardia d. Cyanosis e. Useofaccessoryrespiratorymuscles f. Hyperresonanceonpercussionanddistantheartsounds g. Signsofcorpulmonale

Quick  HIT  InCOPD:  TheFEV1/FVCratiois<0.70. FEV1isdecreased. TLCisincreased. Residualvolumeisincreased. 

TABLE2-1 COPD—EmphysemaandChronicBronchitis

PredominantEmphysema(“PinkPuffers”)

PredominantChronicBronchitis(“BlueBloaters”)

¢

e

¢

Patientstendtobethinduetoincreasedenergy expenditureduringbreathing. Whensitting,patientstendtoleanforward. Patientshaveabarrelchest(increasedAP diameterofchest).

«

¢

e

Patientstendtobeoverweightandcyanotic(secondaryto chronichypercapniaandhypoxemia). Chroniccoughandsputumproductionarecharacteristic. Signsofcorpulmonalemaybepresentinsevereorlong- standingdisease.

Tachypneawithprolongedexpirationthrough pursedlipsispresent.

Respiratoryrateisnormalorslightlyincreased.

Patientisdistressedandusesaccessorymuscles (especiallystrapmusclesinneck). Patientisinnoapparentdistress,andthereisnoapparentuse ofaccessorymuscles.

Quick HIT

FEV1istheamountofairthatcanbeforcedoutofthelungsin1second.ThelowertheFEV1,themore difficultyonehasbreathing.

C.Diagnosis 1. PFT(spirometry)—seeTable2-2andFigure2-1

a. Thisisthedefinitivediagnostictest. b. Obstructionisevidentbasedonthefollowing:

e

e

DecreasedFEV1anddecreasedFEV1/FVCratio—GOLDstagingisbasedon FEV1.FEV1≥80%ofpredictedvalueismilddisease,50%to80%ismoderate disease,30%to50%isseveredisease,and<30%isveryseveredisease. Increasedtotallungcapacity(TLC),residualvolume,andfunctionalreserve capacity(FRC)(indicatingairtrapping)(seeFigure2-2).AlthoughCOPD increasesTLC,theexcessvolumeinthelungisnotusefulbecauseitall becomesresidualvolumeanddoesnotparticipateingasexchange. Decreasedvitalcapacity.
======================================
e

Quick HIT

Todiagnoseairwayobstruction,onemusthaveanormalorincreasedTLCwithadecreasedFEV1.

CLINICALPEARL2-1

KeyPointsinTakingHistoryofCOPDPatients General

¢

e

e

¢

¢

¢

¢

Historyofcardiopulmonarydiseases Smokinghistory(duration,intensity,currentsmoker) Familyhistory—COPD,heartdisease,asthma Occupation—industrialdusts,fumes Overallhealth Historyofrespiratoryinfections—frequency,severity HistoryofhospitalizationsforCOPDorexacerbations Pulmonarymedications

e

PulmonarySymptoms

Dyspnea—quantitateseverity Cough Sputumproduction—quantity,quality,duration,hemoptysis Wheezing

Cough

AdaptedfromBurtonGG,HodgkinJE,WardJJ,eds.RespiratoryCare—AGuidetoClinicalPractice.4thed.Philadelphia,PA: LippincottWilliams&Wilkins;1997:1026,Table28-3.

TABLE2-2 ObstructiveVersusRestrictiveLungDisease
======================================
2. Chestradiograph(CXR)

a. LowsensitivityfordiagnosingCOPD;onlysevere,advancedemphysemawill showthetypicalchanges,whichinclude:

e

e

Hyperinflation,flatteneddiaphragm,enlargedretrosternalspace(seeFigure2- 3). Diminishedvascularmarkings.

b. Usefulinanacuteexacerbationtoruleoutcomplicationssuchaspneumoniaor pneumothorax.

3. Measureα1-antitrypsinlevelsinpatientswithapersonalorfamilyhistoryof prematureemphysema(≤45yearsold)oremphysemainnonsmokers

4. Arterialbloodgas(ABG)—chronicPCO2retention,decreasedPO2

Quick HIT

COPDleadstochronicrespiratoryacidosiswithmetabolicalkalosisascompensation.

D.Treatment 1. Modalities

a. Smokingcessation—themostimportantintervention.

e

e

Diseaseprogressionisacceleratedbycontinuedsmokingandcanbegreatly slowedbyitscessation. Ataroundage35,FEV1decreasesapproximately25to30mL/yr.Insmokers, therateofdeclineisfaster(three-tofourfold).Ifasmokerquits,therateof declineofFEV1slowstothatofsomeoneofthesameagewhohasnever smoked.However,quittingdoesnotresultincompletereversal.

¢

e

Smokingcessationprolongsthesurvivalratebutdoesnotreduceittothe levelofsomeonewhohasneversmoked(seeFigure2-4). Respiratorysymptomsimprovewithin1yearofquitting.

b. Inhaledanticholinergicdrugs(e.g.,ipratropiumbromide):bronchodilators. Sloweronsetofactionthantheβ-agonists,butlastlonger.Uselong-acting anticholinergics(e.g.,tiotropium)forpatientswithmoreseveresymptoms.

1. TLC (total lung capacity) = volume of air in the lungs after maximum inspiration 2. FRC (functional residual capacity) = volume of air in the lungs after a normal expiration 3. RV (residual volume) = volume of air in the lungs at maximal expiration 4. TV (tidal volume) = volume of air breathed in and out of the lungs during quiet breathing 5. VC (vital capacity) = volume of air expelled from the lungs during a maximum expiration vc

FIGURE 2.1

Lungvolumes.IC,inspiratorycapacity;ERV,expiratory reservevolume.

Quick HIT

ClinicalmonitoringofCOPDpatientsentailsthefollowing:

e

e

e

SerialFEV1measurements—thishasthehighestpredictivevalue Pulseoximetry Severityofsymptoms:exercisetolerance,cough,sputum,breathlessness
======================================
Quick HIT

Smokingcessationandhomeoxygentherapyaretheonlyinterventionsshowntolowermortality.

FEF so, Normal 3.2 Obstruction | 0.5 Restriction | 1.9 Normal 4 FEFs02% striction Absolute lung volume

FIGURE 2.2

Flowvolumeloops.Examplesofflowvolumecurvesina patientwithobstructivediseaseandapatientwithrestriction (diffuseinterstitialfibrosis),ascomparedwithahealthyperson. Volumesontheaxisareabsolutevolumestobettershowthe relationofflows(e.g.,FEF50%)tohyperinflationandrestriction. (RedrawnfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternal Medicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:2580,Figure 387.2.)

c. Inhaledβ2-agonists(e.g.,albuterol):bronchodilators.

Providesymptomaticrelief.Uselong-actingagents(e.g.,salmeterol)for patientsrequiringfrequentuse.

d. Combinationofβ-agonistalbuterolwithipratropiumbromide. Moreefficaciousthaneitheragentaloneinbronchodilation. Alsohelpswithadherencetotherapy(bothmedicationsinoneinhaler). e. Inhaledcorticosteroids(e.g.,budesonide,fluticasone):anti-inflammatory.

e

e

MayminimallyslowdownthedecreaseinFEV1overtime;however,many studieshavefailedtoshowanybenefitinpulmonaryfunction. Typicallyusedincombinationwithalong-actingbronchodilatorforpatients withsignificantsymptomsorrepeatedexacerbations.

Quick HIT

¢

e

TreatCOPDwithbronchodilators(anticholinergics,β2-agonists,orboth). Givesteroidsandantibioticsforacuteexacerbations.

Quick HIT

β-BlockersaregenerallycontraindicatedinacuteCOPDorasthmaexacerbations.

f. Theophylline(oral)—roleiscontroversial.

e

e

e

Mayimprovemucociliaryclearanceandcentralrespiratorydrive. Narrowtherapeuticindex,soserumlevelsmustbemonitored. Onlymodestlyeffectiveandhasmoresideeffectsthanotherbronchodilators. OccasionallyusedforpatientswithrefractoryCOPD.

FIGURE 2.3

ChestradiographsshowingapatientwithCOPD. (AfromDaffnerRH.ClinicalRadiology:TheEssentials.3rded.Philadelphia,PA:

LippincottWilliams&Wilkins;2007:136,Figure4.87A.)(BandCfromSternEJ,White CS.ChestRadiologyCompanion.Philadelphia,PA:LippincottWilliams&Wilkins; 1999:189,Figure13-1A,B.)

100 4— Nonsmoker 75 “*>.._ Susceptible smoker Se Stopped at “s. age 50 Disability ae \" ~~ Stopped at Death *s, age 65 Ra ec ee i pes ieltidlooe libicbstaee ue 50 25 FEV; 9 (% of value at age 25) se) 25 50 75 Age (years)
======================================
FIGURE 2.4

SmokingandCOPD.Age-relatedrateofdeclineinlung function(FEV1.0)inanonsmoker(top)andsusceptiblesmoker (bottom).Thedashedlinesindicatethebeneficialeffectsof smokingcessationwithmoderateandseveredisease.The accelerateddeclineinlungfunctionapproachesthenormalrate, significantlydelayingtheonsetofdisabilityanddeath. (RedrawnfromFletcherC,PetoR.Thenaturalhistoryofchronicairflowobstruction.Br

MedJ1977;1(6077):1645–1648withpermissionfromBMJPublishingGroupLtd.)

g. Phosphodiesterase-4inhibitors(e.g.,roflumilast).

e

e

Promotesmoothmusclerelaxationanddecreaseinflammation. Mayreduceriskoffrequentexacerbations.

Quick HIT

Systemicglucocorticoidsareonlyusedforacuteexacerbationsandshouldnotbeusedforlong-term treatment,evenforpatientswithsevereCOPD.

h. Oxygentherapy.

ShowntoimprovesurvivalandqualityoflifeinpatientswithCOPDand chronichypoxemia.

e

e

Somepatientsneedcontinuousoxygen,whereasothersonlyrequireitduring exertionorsleep.GetanABGtodetermineneedforoxygen(seeQuickHit). Long-standinghypoxemiamayleadtopulmonaryHTNandultimatelycor pulmonale.Continuousoxygentherapyfor≥18hr/dayhasbeenshownto reducemortalityinpatientswiththesecomplicationsbycontrollingpulmonary HTN.

i. Pulmonaryrehabilitation—education,exercise,physiotherapy:Amajorgoalis toimproveexercisetolerance.Pulmonaryrehabilitationimprovesfunctional statusandqualityoflife,andmayreducemortality.

Quick HIT

Criteriaforcontinuousorintermittentlong-termoxygentherapyinCOPD:

«

¢

e

¢

PaO255mmHgOR O2saturation≤88%(pulseoximetry),eitheratrestorduringexerciseOR PaO255to59mmHgpluspolycythemiaorevidenceofcorpulmonale Notethattheabovemustbeconsistentfindingsdespiteoptimalmedicaltherapy

j. Vaccination.

e

e

Influenzavaccinationannuallyforallpatients. VaccinationagainstStreptococcuspneumoniae—shouldbeofferedtoalladult patientswithCOPD,regardlessofage.Offeroncebeforeage65,thenonce overage65,andagainevery5to10years.

k. Antibioticsaregivenforacuteexacerbations(seebelow)—increasedsputum productioninvolumeorchangeincharacterorworseningshortnessofbreath.

l. Surgery—maybebeneficialinselectedpatients;carefullyweighpotential benefitswithrisks.Optionsinclude:
======================================
e

e

Lungresection Lungtransplantation

2. Treatmentguidelines—stepwisetherapybasedonseverityofsymptomsandprior

numberofexacerbationsorCOPD-relatedhospitalizations a. Lowriskofexacerbation(0to1exacerbationsinpastyear)

e

e

e

Beginwithashort-actingbronchodilator(anticholinergicand/orβ-agonist)as neededinametered-doseinhaler(MDI)formulation(withspacertoimprove delivery). Adddailylong-actingbronchodilator,ifmoresymptomatic. Inhaledglucocorticoidsmaybeusedaswell(seeabove).Usethelowestdose possible.

b. Highriskofexacerbation(2ormoreexacerbationsperyear)

Regularuseoflong-actingbronchodilator(anticholinergicand/orβ-agonist).

e

¢

¢

e

Addinhaledcorticosteroid,ifmoresymptomatic. Consideradditionalagents(roflumilastortheophylline). Continuousoxygentherapy(ifpatientishypoxemic). Pulmonaryrehabilitation.

3. AcuteCOPDexacerbation.Definition:Increaseddyspnea,sputumproduction, and/orcough.AcuteCOPDexacerbationcanleadtoacuterespiratoryfailure requiringhospitalization,andpossiblymechanicalventilation;potentiallyfatal. a. Bronchodilators(β2-agonist)aloneorincombinationwithanticholinergicsare

first-linetherapy.

b. Systemiccorticosteroidsareusedforpatientsrequiringhospitalization.Ashort courseoforalprednisoneiscommonpractice.Donotuseinhaledcorticosteroids inacuteexacerbations.

c. Antibiotics(azithromycin,doxycycline,orfluoroquinolones):Reservedfor thosewithmoderateorsevereexacerbationsrequiringhospitalization.

d. SupplementaloxygenisusedtokeepO2saturation88%to92%.Startwitha nasalcannula;afacemaskmayneedtobeused.

IfSaO2is>92%,thepatientisatriskofCO2retentionfromworseningV/Q mismatch,lossofhypoxemicrespiratorydrive,andtheHaldaneeffect.

e. Noninvasivepositivepressureventilation(NPPV)(bilevelpositiveairway pressure[BiPAP]orcontinuouspositiveairwaypressure[CPAP]):Studieshave shownabenefitinacuteexacerbations.Itmaydecreasethelikelihoodof respiratoryfailurerequiringinvasivemechanicalventilation.

f. Intubationandmechanicalventilationmayberequirediftheabovedonot stabilizethepatient.Intubate,ifincreasingRR,increasingPaCO2,and worseningacidosis.
======================================
Quick HIT

OneofthemaintreatmentgoalsforCOPDpatientsistoreducethenumberandseverityofexacerbations theyexperienceeachyear. Pulmonaryinfection(mostcommonlyviruses,followedbybacteriasuchasS.pneumoniae,Haemophilus influenzae,Mycoplasmapneumoniae,Moraxellacatarrhalis)isoneofthemainprecipitantsofaCOPD exacerbation.

E.Complications 1. Acuteexacerbations—mostcommoncausesareinfection,nonadherencewith

therapy,andcardiacdisease

2. Secondarypolycythemia(Hct>55%inmenor>47%inwomen)—compensatory responsetochronichypoxemia

3. PulmonaryHTNandcorpulmonale—mayoccurinpatientswithsevere,long-

standingCOPDwhohavechronichypoxemia

Quick HIT

IfapatientpresentswithCOPDexacerbation,thefollowingstepsareappropriate:

CXR β2-Agonistandanticholinergicinhalers Systemiccorticosteroids Antibiotics Supplementaloxygen NPPV,ifneeded(seeClinicalPearl2-9)

Asthma

A.GeneralCharacteristics 1. Characteristicallydefinedbythefollowingtriad:

a. Airwayinflammation b. Airwayhyperresponsiveness c. Reversibleairflowobstruction

2. Asthmacanbeginatanyage 3. Extrinsicversusintrinsicasthma a. Extrinsicasthma(mostcases)

e

e

Patientsareatopic,thatis,produceimmunoglobulinE(IgE)toenvironmental antigens.Maybeassociatedwitheczemaandhayfever. Patientsbecomeasthmaticatayoungage.

b. Intrinsicasthma—notrelatedtoatopyorenvironmentaltriggers

4. Triggersincludepollens,housedust,molds,cockroaches,cats,dogs,coldair, viralinfections,tobaccosmoke,medications(β-blockers,aspirin),andexercise

Quick HIT

Signsofacutesevereasthmaattacks:

e

e

Tachypnea,diaphoresis,wheezing,speakinginincompletesentences,anduseofaccessorymusclesof respiration. Paradoxicmovementoftheabdomenanddiaphragmoninspirationissignofimpendingrespiratoryfailure.

B.ClinicalFeatures 1. CharacterizedbyintermittentsymptomsthatincludeSOB,wheezing,chest

tightness,andcough.Symptomshavevariableseverityandmaynotbepresent simultaneously.Usuallyoccurwithin30minutesofexposuretotriggers.

2. Symptomsaretypicallyworseatnight. 3. Wheezing(commonlyduringexpiration,butcanoccurduringinspiration)isthe

mostcommonfindingonphysicalexamination(seeClinicalPearl2-2).
======================================
CLINICALPEARL2-2

“AllThatWheezesIsNotAsthma” Themostcommoncauseofwheezingisasthma.However,anyconditionthatmimicslargeairway bronchospasmcancausewheezing.

e¢

«

¢

CHF—duetoedemaofairwaysandcongestionofbronchialmucosa COPD—inflamedairwaysmaybenarrowed,orbronchospasmmaybepresent Cardiomyopathies,pericardialdiseasescanleadtoedemaaroundthebronchi

Lungcancer—duetoobstructionofairways(centraltumorormediastinalinvasion)

C.Diagnosis 1. Pulmonaryfunctiontests(PFTs)arerequiredfordiagnosis.Theyshowan obstructivepattern:decreaseinexpiratoryflowrates,decreasedFEV1,and decreasedFEV1/FVCratio(<0.70).

2. Spirometrybeforeandafterbronchodilatorscanconfirmdiagnosisbyproving reversibleairwayobstruction.Ifinhalationofabronchodilator(β2-agonist)results inanincreaseinFEV1orFVCbyatleast12%,airflowobstructionisconsidered reversible.

3. Peakflow(peakexpiratoryflowrate)—usefulmeasureofairflowobstruction. Patientsshouldself-monitortheirpeakflow:

a. Mildpersistentasthma:Periodicmonitoringissufficient.Increasethedoseof inhaledsteroid,ifthepeakflowdecreases.

b. Moderatepersistentasthma:Dailymonitoringisrequired.Increasethedoseof inhaledsteroid,ifthepeakflowdecreases.

c. Severepersistentasthma:Dailymonitoringisrequired.Initiateprednisone,ifthe peakflowdecreases.

Quick HIT

PFTsinasthma: 1. DecreasedFEV1,decreasedFVC,decreasedFEV1/FVCratio 2. IncreaseinFEV1>12%withalbuterol 3. DecreaseinFEV1>20%withmethacholineorhistamine

4. Bronchoprovocationtest.

a. MaybeusefulwhenasthmaissuspectedbutPFTsarenondiagnostic. b. Measureseasewithwhichairwaysnarrowinresponsetostimuli

(hyperresponsiveness).

c. Measureslungfunctionbeforeandafterinhalationofincreasingdosesof methacholine(muscarinicagonist);hyperresponsiveairwaysdevelop obstructionatlowerdoses.

Quick HIT

AlthoughasthmacanbediagnosedwithPFTsandspirometry,inanacutesetting(ED)whenpatientis SOB,peakflowmeasurementisquickestmethodofdiagnosis.

Quick HIT

Duringasthmaexacerbations,thepatienthyperventilates,leadingtolowPaCO2levels.Ifthepatientisno longerhyperventilating(CO2levelisnormalorhigh),thiscouldbeasignthatthepatientis decompensating(duetofatigue)andthatintubationmayberequired.

5. Chestx-ray

a. Normalinmildtomoderatecases;severeasthmarevealshyperinflation. b. Onlynecessaryinsevereasthmatoexcludeotherconditions(e.g.,pneumonia,

pneumothorax,pneumomediastinum,foreignbody).

6. ABGs

a. ABGsshouldbeconsideredifthepatientisinsignificantrespiratorydistress. Hypocarbiaiscommon.Hypoxemiamaybepresent.

b. IfthePaCO2isnormalorincreased,respiratoryfailuremayensue.
======================================
e

e

Rememberthatpatientswithanasthmaattackhaveanincreasedrespiratory rate,whichshouldcausethePaCO2todecrease.IncreasedPaCO2isasignof respiratorymusclefatigueorsevereairwayobstruction. Thepatientshouldbehospitalizedandmechanicalventilationconsidered.

D.Treatment 1. Availablemodalities(seeTable2-3).

a. Inhaledβ2-agonists.

e

e

Short-actingβ2-agonists(e.g.,albuterol)areusedforacuteattacks(rescue). Onsetis2to5minutes,durationis4to6hours. Long-actingversions(e.g.,salmeterol)areoftenusedincombinationwith inhaledcorticosteroidsforseveresymptoms.

Quick HIT

Avoidβ-blockersinasthmatics!

b. Inhaledcorticosteroidsformoderatetosevereasthma.

e

e

Preferredoveroralsteroidsduetofewersystemicsideeffects.(Oralsteroids arereservedforsevere,persistentasthma.) Ifusedonaregularbasis,airwayhyperresponsivenessdecreases,andthe frequencyofasthmaexacerbationsdecreases.

c. Montelukast—leukotrienemodifiers—limitedevidencebutmaybeusefulfor prophylaxisofmildexercise-inducedasthmaandforcontrolofmoderate persistentdisease.Theymayallowreductionsinsteroidandbronchodilator requirements. d. Theophylline

Canbeusefulinadditiontoinhaledcorticosteroidsforpersistentsymptoms
======================================
Note:Allpatientsshouldhaveintermittentshort-actinginhaledβ2-agonistsasneededpluslong-termcontrol medicationsbasedontheseverityoftheirasthma.

FromTheNationalAsthmaEducationandPreventionProgram,ExpertPanelReport2;1997.

Quick HIT

e

e

Sideeffectsofinhaledcorticosteroidsareduetooropharyngealdepositionandincludesorethroat,oral candidiasis(thrush),andhoarseness. UsingaspacerwithMDIsandrinsingthemouthafterusehelpminimizethesesideeffects.

Quick HIT

Foracuteasthmaexacerbation,testtoorder: 1. Peakexpiratoryflow—decreased 2. ABG—increasedA–agradient 3. Chestx-ray—ruleoutpneumonia,pneumothorax

2. Treatmentofacutesevereasthmaexacerbation(hospitaladmission).

a. Inhaledβ2-agonist(first-linetherapy).

VianebulizerorMDI(seeClinicalPearl2-3). Mainstaysofemergencytreatment—haveanonsetofactionofminutes. Assesspatientresponsetobronchodilators(clinicallyandwithpeakflows).

e

e

b. Corticosteroids

b. Corticosteroids

Traditionallygivenintravenouslyinitially,butmayalsobegivenorallyif

e

e

giveninequivalentdoses. TaperIVororalcorticosteroids,butonlywhenclinicalimprovementisseen. Initiateinhaledcorticosteroidsatthebeginningofthetaperingschedule.

c. Third-lineagentincludesIVmagnesium—notaseffectiveasβ-agonists; magnesiumhelpswithbronchospasmbutonlyusedinacutesevereexacerbation thathasnotrespondedtoabovemedications(albuterol,steroids,oxygen).

d. Supplementaloxygen(keepoxygensaturation>90%). e. Antibiotics,onlyifsuspicionofbacterialpneumonia(asmosttriggersareviral). f. Intubationforpatientsinrespiratoryfailureorimpendingrespiratoryfailure. g. Guidelinesfortreatmentarebasedonseverity.

Quick HIT

Complicationsofasthma: 1. Statusasthmaticus—doesnotrespondtostandardmedications 2. Acuterespiratoryfailure(duetorespiratorymusclefatigue) 3. Pneumothorax,atelectasis,pneumomediastinum

Quick HIT

e

e

Aspirin-sensitiveasthmashouldbeconsideredinpatientswithasthmaandnasalpolyps. Avoidaspirinoranynonsteroidalanti-inflammatorydrugsinthesepatientsbecausetheymaycauseasevere systemicreaction.

CLINICALPEARL2-3
======================================
MDIsandNebulizers

e

e

AnMDIwithaspacerisjustaseffectiveasanebulizer.Aspacerisaholdingchamberthatobviatestheneed tocoordinateinhalationanddepressionofthecanister,andthusmakestheuseofanMDIeasier.Itsuseleads toagreaterbronchodilatoreffectbecausemoreofthedrugisdepositedinsmallerairwaysandless accumulatesintheoropharynx. AnebulizerisnomoreeffectivethananMDI,butpatientsmayreportgreaterreliefofsymptomssimply becauseitprovidesmoremedication.Itmaybepreferredbypatientswithverysevereasthmaunresponsiveto MDIs.

Bronchiectasis

A.GeneralCharacteristics 1. Thereispermanent,abnormaldilationanddestructionofbronchialwallswith chronicinflammation,airwaycollapse,andciliaryloss/dysfunctionleadingto impairedclearanceofsecretions.

2. Lesscommontodaybecausemodernantibioticsareusedforrespiratory infections.

B.Causes 1. Recurrentinfections(airwayobstruction,immunodeficiency,allergic

bronchopulmonaryaspergillosis,mycobacterium)

2. Cysticfibrosis(CF)isthemostcommoncauseofbronchiectasis(accountsfor halfofallcases)

3. Primaryciliarydyskinesia(e.g.,Kartagenersyndrome) 4. Autoimmunedisease(rheumatoidarthritis,systemiclupuserythematosus,Crohn

disease,etc.)

5. Humoralimmunodeficiency(abnormallungdefense),airwayobstruction

Quick HIT

Avarietyofinfectionscancausebronchiectasisbydestroyinganddamagingthebronchialwallsandinterfering withciliaryaction.

C.ClinicalFeatures 1. Chroniccoughwithlargeamountsofmucopurulent,foul-smellingsputum 2. Dyspnea 3. Hemoptysis—duetoruptureofbloodvesselsnearbronchialwallsurfaces;usually mildandself-limited,butsometimescanbebriskandpresentsasanemergency

4. Recurrentorpersistentpneumonia

D.Diagnosis 1. High-resolutionCTscanisthediagnosticstudyofchoice. 2. PFTsrevealanobstructivepattern. 3. CXRisabnormalinmostcases,butfindingsarenonspecific. 4. Bronchoscopymaybehelpfulforinfectiousworkup.

E.Treatment 1. Antibioticsforacuteexacerbations—superimposedinfectionsaresignaledby

changeinquality/quantityofsputum,fever,chestpain,etc.

2. Bronchialhygieneisveryimportant.
======================================
a. Hydration b. Chestphysiotherapy(posturaldrainage,chestpercussion)tohelpremovethe

mucus

c. Inhaledbronchodilators

Quick HIT

Themaingoalintreatingbronchiectasisistopreventthecomplicationsofpneumoniaandhemoptysis.

CysticFibrosis

AutosomalrecessiveconditionpredominantlyaffectingCaucasians Defectinchloridechannelproteincausesimpairedchlorideandwatertransport, whichleadstoexcessivelythick,viscoussecretionsintherespiratorytract,exocrine pancreas,sweatglands,intestines,andgenitourinarytract Typicallyresultsinobstructivelungdiseasepatternwithchronicpulmonary infections(frequentlyPseudomonas),pancreaticinsufficiency,andotherGI complications Treatmentispancreaticenzymereplacement,fat-solublevitaminsupplements,chest physicaltherapy,vaccinations(influenzaandpneumococcal),treatmentofinfections withantibiotics,inhaledrecombinanthumandeoxyribonuclease(DNase),which breaksdowntheDNAinrespiratorymucusthatclogstheairways Traditionallyconsideredapediatrictopic;however,theprognosishasimproved significantly,withthemedianageofdeathnowover30yearsofage

LungNeoplasms LungCancer

A.GeneralCharacteristics 1. Pathologictypesaredividedintotwosubgroups:

a. Smallcelllungcancer(SCLC)—25%oflungcancers b. Non–smallcelllungcancer(NSCLC)—75%oflungcancers;includessquamous cellcarcinoma,adenocarcinoma,largecellcarcinoma,andbronchoalveolarcell carcinoma 2. Riskfactors

a. Cigarettesmoking—accountsfor>85%ofcases

Thereisalinearrelationshipbetweenpack-yearsofsmokingandriskoflung cancer. Adenocarcinomahasthelowestassociationwithsmokingofalllungcancers.

e

e Adenocarcinoma has the lowest association with smoking of all lung cancers. Second-hand smoke

b. Second-handsmoke c. Asbestos

e¢

e

Commoninshipbuildingandconstructionindustry,carmechanics,painting Smokingandasbestosincombinationsynergisticallyincreasetheriskoflung cancer

d. Radon—highlevelsfoundinbasements e. COPD—anindependentriskfactoraftersmokingistakenintoaccount

3. Staging

a. NSCLCisstagedviatheprimaryTNMsystem. b. SCLCisstageddifferently(thoughsomerecommendTNMstagingstillbe

used):
======================================
e

e

Limited—confinedtochestplussupraclavicularnodes,butnotcervicalor axillarynodes Extensive—outsideofchestandsupraclavicularnodes

Quick HIT

Inthediagnosisoflungcancer,itiscrucialtodifferentiatebetweensmallcell(25%)andnon–smallcell(75%) typesbecausethetreatmentapproachiscompletelydifferent(seebelow).Atissuediagnosisisnecessaryto makethisdifferentiation.

B.ClinicalFeatures 1. Localmanifestations(squamouscellcarcinomaismostcommonlyassociated

withthesesymptoms)

a. Airwayinvolvementcanleadtocough,hemoptysis,obstruction,wheezing, dyspnea

b. Recurrentpneumonia(postobstructivepneumonia)

Quick HIT

Unfortunately,signsandsymptomsaregenerallynonspecificforlungcancer,andbythetimetheyarepresent, diseaseisusuallywidespread.

2. Constitutionalsymptoms

a. Anorexia,weightloss,weakness b. Usuallyindicativeofadvanceddisease

3. Localinvasion

a. Superiorvenacava(SVC)syndrome—occursin5%ofpatients

¢

e

e

CausedbyobstructionofSVCbyamediastinaltumor MorecommonlyoccurswithSCLC Findings:facialfullness;facialandarmedema;dilatedveinsoveranterior chest,arms,andface;jugularvenousdistention(JVD)

b. Phrenicnervepalsy—occursin1%ofpatients

e

e

Destructionofphrenicnervebytumor;phrenicnervecoursesthroughthe mediastinumtoinnervatethediaphragm Resultsinhemidiaphragmaticparalysis

c. Recurrentlaryngealnervepalsy(3%ofpatients)—causeshoarseness d. Hornersyndrome—duetoinvasionofcervicalsympatheticchainbyanapical tumor.Symptoms:unilateralfacialanhidrosis(nosweating),ptosis,andmiosis

e. Pancoasttumor

e

e

e

Superiorsulcustumor—anapicaltumorinvolvingC8andT1–T2nerveroots, causingshoulderpainradiatingdownthearm Usuallysquamouscellcancers Symptoms:pain;upperextremityweaknessduetobrachialplexusinvasion; associatedwithHornersyndrome60%ofthetime

f. Malignantpleuraleffusion—occursin10%to15%ofpatients Prognosisisverypoor—equivalenttodistantmetastases

4. Metastaticdisease—mostcommonsitesarebrain,bone,adrenalglands,andliver 5. Paraneoplasticsyndromes

a. SyndromeofinappropriateADH:usuallyassociatedwithsmallcellcarcinoma (10%ofSCLCpatients)

b. Cushingsyndrome:duetoectopicACTHsecretion,typicallyassociatedwith

smallcellcarcinoma

c. Hypercalcemia:commonlyduetoPTH-likehormonesecretion,mostcommonly squamouscellcarcinoma

d. Hypertrophicpulmonaryosteoarthropathy:associatedwithbothadenocarcinoma andsquamouscellcarcinoma;severelong-bonepainmaybepresent,andleads todigitalclubbing.

e. Eaton–Lambertsyndrome:mostcommoninSCLC;clinicalpictureissimilar tothatofmyastheniagravis,withproximalmuscleweakness/fatigability, diminisheddeeptendonreflexes,paresthesias(morecommoninlower extremities)
======================================
Quick HIT

PrognosisofSCLC:Forlimiteddisease,5-yearsurvivalis10%to13%(mediansurvivalrangesfrom15to20 months).Forextensivedisease,5-yearsurvivalrateis1%to2%(mediansurvivalis8to13months).

Quick HIT

Forlungcancer,obtainaCXR,aCTscan,andatissuebiopsytoconfirmdiagnosisanddeterminehistologic type(SCLCorNSCLC).

C.Diagnosis 1. CXR

a. Mostimportantradiologicstudyfordiagnosis,butnotusedasascreeningtest b. Demonstratesabnormalfindingsinnearlyallpatientswithlungcancer c. Stabilityofanabnormalityovera2-yearperiodisalmostalwaysassociatedwith

abenignlesion

2. CTscanofthechestwithIVcontrast

a. Veryusefulforstaging b. Candemonstrateextentoflocalanddistantmetastasis c. Veryaccurateinrevealinglymphadenopathyinmediastinum d. ConsiderCTofabdomentoscreenformetastasestoadrenalglandsandliver

3. Cytologicexaminationofsputum

a. Diagnosescentraltumors(in80%)butnotperipherallesions b. Provideshighlyvariableresultswithlowyield;ifnegativeandclinicalsuspicion

ishigh,furthertestsareindicated

4. Fiberopticbronchoscopywithendobronchialultrasound

a. Canonlybeinsertedasfarassecondarybranchesofbronchialtree;firstchoice fordiagnosingcentralvisualizedtumorsbutnotperipherallesions

b. Thelargerandmorecentralthelesion,thehigherthediagnosticyield;for

visiblelesions,bronchoscopyisdiagnosticin>90%ofcases

5. Whole-bodypositronemissiontomography(PET)—providesadditional informationthatprimarytumorismalignant,detectslymphnodeandintrathoracic anddistantmetastases

6. Transthoracicneedlebiopsy(underfluoroscopicorCTguidance)

a. Needlebiopsyofsuspiciouspulmonarymassesishighlyaccurate,andisuseful fordiagnosingperipherallesionsaswell

b. Needlebiopsyisinvasiveandmustbeusedonlyinselectedpatients.Thisisa betterbiopsymethodforperipherallesions,whereascentral,peribronchial lesionsshouldbebiopsiedusingbronchoscopy

7. Mediastinoscopy

a. Allowsdirectvisualizationofthesuperiormediastinum b. Identifiespatientswithadvanceddiseasewhowouldnotbenefitfromsurgical

resection

Quick HIT

¢

e

CXRmayshowpleuraleffusion,whichshouldbetapped;thefluidshouldbeexaminedformalignantcells. RegardlessofthefindingsonCXRorCTscan,pathologicconfirmationisrequiredfordefinitivediagnosisof lungcancer.
======================================
Quick HIT

Alwaysperformabiopsyforintrathoraciclymphadenopathy(specificityformetastasisis60%).

D.Treatment 1. NSCLC

a. Surgeryisthebestoptionforlimiteddisease.

e

e

e

Adefinitivepathologicdiagnosismustbemadepriortosurgery. Patientswithmetastaticdiseaseoutsidethechestarenotcandidatesfor surgery. Recurrencemayoccurevenaftercompleteresection.

b. Radiationtherapyisanimportantadjuncttosurgery. c. Chemotherapyisofuncertainbenefit.Somestudiesshowamodestincreasein

survivalespeciallywithnovelimmunotherapyagents.Moretrialsareunderway.

2. SCLC

a. Forlimiteddisease,combinationofchemotherapyandradiationtherapyisused initially.

b. Forextensivedisease,chemotherapyisusedaloneasinitialtreatment.Ifpatient

respondstoinitialchemotherapytreatment,prophylacticwhole-brainirradiation decreasesincidenceofbrainmetastasesandprolongssurvival.

c. Surgeryhasalimitedrolebecausethesetumorsareusuallynonresectable.

Quick HIT

Theprognosisforlungcancerisgrim.Overall5-yearsurvivalforlungcancerpatientsis14%;85%of patientswithSCLChaveextensivediseaseatthetimeofpresentation,andofthesealmostalldiewithin2years.

Mostasymptomaticmassesarebenign.

SolitaryPulmonaryNodule

A.Asingle,well-circumscribednoduleusuallydiscoveredincidentallywithno associatedmediastinalorhilarlymphnodeinvolvement.Themainquestionis whetherthelesionismalignantandrequiresbiopsyorresection(seeFigure2-5).

B.Hasawidedifferentialdiagnosis(e.g.,infectiousgranuloma,bronchogenic carcinoma,hamartoma,bronchialadenoma),butonemustinvestigatethe possibilityofmalignancybecauseresectioncanleadtoacurewithearlydetection.

C.Severalfeaturesfavorbenignversusmalignantnodules: 1. Age—theolderthepatient,themorelikelyitismalignant—over50%chanceof

malignancyifpatientageisover60.

2. Smoking—ifhistoryofsmoking,morelikelytobemalignant. 3. Sizeofnodule—thelargerthenodule,themorelikelyitismalignant.Smallis<1

cm,large>2cm(>50%chanceofmalignancy).

4. Borders—Malignantnoduleshavemoreirregularborders.Benignlesionshave smooth/discreteborders.

5. Calcification—Eccentricasymmetriccalcificationsuggestsmalignancy.Dense, centralcalcificationsuggestsbenignlesion.

6. Changeinsize—enlargingnodulesuggestsmalignancy.

Solitary pulmonary nodule Old chest x-ray Nodule changed in Films not size for > 2 yr? available ¢ Stop workup CT with thin sections ¢ Follow yearly through nodule Suspicious for Benign malignancy ¢ Biopsy Follow every ¢ Resect 3 mo
======================================
FIGURE 2.5

Evaluationofasolitarypulmonarynodule.

(AdaptedfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.

4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:2574,Figure386.6.)

TABLE2-4 TypesofLungCancer

Cavitation on CXR NSCLC Squamous cell carcinoma Adenocarcinoma Large cell carcinoma SCLC 30% of all lung cancers 35% of all lung cancers—most common type 510% of all lung cancers 20-25% of all lung cancers Usually central Often peripheral Usually peripheral Central Pleural involvement in 20% of cases. Less closely associated with smoking than other types. Can be associated with pulmonary scars/fibrosis. Tend to narrow bronchi by extrinsic compression. Widespread metastases are common. 50-75% of patients have metastases outside the chest at the time of presentation.

D.Consideringtheabovefactors,onedesignatesthenoduleaslow,intermediate,or highprobabilityofbeingmalignant.

1. Low-probabilitynodules—serialCTscan 2. Intermediate-probabilitynodule,1cmorlarger—PETscan.IfPETpositive,

biopsy

3. High-probabilitynodule—biopsy(transbronchial,transthoracic,orvideo-assisted thoracoscopicsurgery)followedbylobectomy,ifappropriate.

E.PreviousCXRisveryhelpful:EveryeffortshouldbemadetofindapreviousCXR forcomparison.Ifthelesionisstableformorethan2years,itislikelybenign. Malignantlesionsgrowrelativelyrapidly(growthisusuallyevidentwithin months)(seeTable2-4).However,growthoveraperiodofdaysisusually nonmalignant(ofteninfectious/inflammatory)(seeTable2-5).

MediastinalMasses

A.Causes 1. Metastaticcancer(especiallyfromlungcancer)—mostcommoncauseof

mediastinalmassinolderpatients

2. Mostcommoncauseaccordingtolocation:

a. Anteriormediastinum:“FourTs”—thyroid,teratogenictumors,thymoma, terriblelymphoma

b. Middlemediastinum:lungcancer,lymphoma,aneurysms,cysts,Morgagni hernia

c. Posteriormediastinum:neurogenictumors,esophagealmasses,entericcysts, aneurysms,Bochdalekhernia
======================================
B.ClinicalFeatures 1. Usuallyasymptomatic

a. Whensymptomsarepresent,theyareduetocompressionorinvasionof adjacentstructures

b. Cough(compressionoftracheaorbronchi),sometimeshemoptysis c. Chestpain,dyspnea d. Postobstructivepneumonia e. Dysphagia(compressionofesophagus) f. SVCsyndrome g. Compressionofnerves

e

e

e

Hoarseness(recurrentlaryngealnerve) Hornersyndrome(sympatheticganglia) Diaphragmparalysis(phrenicnerve)

Quick HIT

IfCTscansuggestsabenignmassandthepatientisasymptomatic,observationisappropriate.

C.Diagnosis 1. ChestCTwithIVcontrastistestofchoice 2. UsuallydiscoveredincidentallyonaCXRperformedforanotherreason

DiseasesofthePleura

PleuralEffusion

A.GeneralCharacteristics 1. Causedbyoneofthefollowingmechanisms:increaseddrainageoffluidinto pleuralspace,increasedproductionoffluidbycellsinthepleuralspace,or decreaseddrainageoffluidfromthepleuralspace(seeFigure2-6)

2. Transudativeeffusions—pathophysiologyisduetoeitherelevatedcapillary pressureinvisceralorparenteralpleura(e.g.,CHF),ordecreasedplasmaoncotic pressure(e.g.,hypoalbuminemia)

3. Exudativeeffusions

a. Pathophysiology:causedbyincreasedpermeabilityofpleuralsurfacesor decreasedlymphaticflowfrompleuralsurfacebecauseofdamagetopleural membranesorvasculature(seeClinicalPearl2-4).

b. Ifanexudativeeffusionissuspected,performthefollowingtestsonthepleural fluid:differentialcellcount,totalprotein,LDH,glucose,pH,amylase, triglycerides,microbiology,andcytology.

c. ExudativeeffusionsmeetatleastoneofthefollowingofLight’scriteria (transudateshavenoneofthese):

e

e

e

Protein(pleural)/protein(serum)>0.5 LDH(pleural)/LDH(serum)>0.6 LDH>two-thirdstheupperlimitofnormalserumLDH

Quick HIT

Ifthepatienthasminimallungcompromise,pleuraleffusionsarewelltolerated,whereaspleuraleffusioninthe presenceoflungdiseasemayleadtorespiratoryfailure.

FIGURE 2.6

A:Uprightchestradiographshowingbluntingoftheright

costophrenicangle,typicalofasmallrightpleuraleffusion(this patienthadchronicliverdisease).B:Chestradiographshowingleft pleuraleffusion. (FromSternEJ,WhiteCS.ChestRadiologyCompanion.Philadelphia,PA:LippincottWilliams&

Wilkins;1999:375,Figure22-1A;376,Figure22-2A.)

CLINICALPEARL2-4

CausesofTransudativeandExudativePleuralEffusions Transudative

CHF
======================================
CHF Cirrhosis PE Nephroticsyndrome Peritonealdialysis Hypoalbuminemia Atelectasis

PE

Exudative

Bacterialpneumonia,TB Malignancy,metastaticdisease Viralinfection PE Collagenvasculardiseases

¢

PE

B.Causes 1. CHFisthemostcommoncause

2. Pneumonia(bacterial) 3. Malignancies:lung(36%),breast(25%),lymphoma(10%) 4. Pulmonaryembolism(PE) 5. Viraldiseases 6. Cirrhosiswithascites(alsoknownashepatichydrothorax)

Quick HIT

PleuralFluidPearls

Elevatedpleuralfluidamylase:esophagealrupture,pancreatitis,malignancy Milky,opalescentfluid:chylothorax(lymphinthepleuralspace) Franklypurulentfluid:empyema(pusinthepleuralspace) Bloodyeffusion:malignancy Exudativeeffusionsthatareprimarilylymphocytic:TB pH<7.2:parapneumoniceffusionorempyema

Quick HIT

Ifpleuralfluidglucoselevelis<60,considerrheumatoidarthritis.However,glucoseinpleuralfluidcanbelow withothercausesofpleuraleffusion:empyema,TB,esophagealrupture,malignancy,lupus.

C.ClinicalFeatures 1. Symptoms

a. Oftenasymptomatic b. Dyspneaonexertion c. Peripheraledema d. Orthopnea,paroxysmalnocturnaldyspnea

2. Signs

a. Dullnesstopercussion b. Decreasedbreathsoundsovertheeffusion c. Decreasedtactilefremitus

D.Diagnosis Canconfirmpresence/evaluatesizeofeffusionbythefollowing: 1. CXR(PAandlateral)—lookforthefollowing:

a. Bluntingofcostophrenicangle b. About250mLofpleuralfluidmustaccumulatebeforeaneffusioncanbe

detected.

c. Lateraldecubitusfilms:morereliablethanPAandlateralCXRsfordetecting smallpleuraleffusions;canalsodeterminewhetherfluidisfreeflowingor loculated

2. CTchest—morereliablethanCXRfordetectingeffusions 3. Thoracentesis

a. Thoracentesisisindicatedforevaluationofallnewpleuraleffusions.Itprovides adiagnosisin75%ofpatients,andevenwhenitisnotdiagnosticitprovides importantclinicalinformation.

b. Therapeutic—drainageprovidesreliefforlargeeffusions. c. Pneumothoraxisacomplicationseenin10%to15%ofthoracenteses,butit

requirestreatmentwithachesttubein<5%ofcases.Donotperform thoracentesisifeffusionis<10mmthickonlateraldecubitusCXR.
======================================
E.Treatment 1. Transudativeeffusions

a. Diureticsandsodiumrestriction b. Therapeuticthoracentesis—onlyifmassiveeffusioniscausingdyspnea

2. Exudativeeffusions:treatunderlyingdisease 3. Parapneumoniceffusions(pleuraleffusioninpresenceofpneumonia)

a. Uncomplicatedeffusions:antibioticsalone(inmostcases) b. Complicatedeffusionsorempyema

e

e

e

Chesttubedrainage Intrapleuralinjectionoffibrinolyticagents(streptokinase,urokinase,ortissue plasminogenactivator[tPA]);mayacceleratethedrainage Surgicallysisofadhesionsmayberequired

Empyema

A.Causes 1. Exudativepleuraleffusions,ifleftuntreated,canleadtoempyema(puswithinthe

pleuralspace).

2. Mostcasesoccurasacomplicationofbacterialpneumonia,butotherfociof infectioncanalsospreadtothepleuralspace(e.g.,mediastinitis,abscess).

B.ClinicalFeatures Theclinicalfeaturesarethoseoftheunderlyingdisease(pneumoniamostcommon).

C.Diagnosis CXRandCTscanofthechestaretherecommendedtests.

D.Treatment 1. Treatempyemawithaggressivedrainageofthepleura(viathoracentesis)and

antibiotictherapy.

2. Theinfectionisverydifficulttoeradicate,andrecurrenceiscommon,requiring repeateddrainage.

3. Ifempyemaissevereandpersistent,ribresectionandopendrainagemaybe necessary.

Quick HIT

e

e

Anuncomplicatedparapneumoniceffusionisanoninfectedpleuraleffusionsecondarytobacterial pneumonia. Anempyemaisacomplicatedparapneumoniceffusion,whichmeansthepleuraleffusionisinfected.

Pneumothorax

A.GeneralCharacteristics 1. Definedasairinthenormallyairlesspleuralspace. 2. Therearetwomajorcategories:spontaneousandtraumaticpneumothoraces. 3. Traumaticpneumothoracesareofteniatrogenic. 4. Spontaneouspneumothoraxoccurswithoutanytrauma.

a. Primary(simple)pneumothorax

Occurswithoutanyunderlyinglungdisease—thatis,in“healthy”individuals Causedbyspontaneousruptureofsubpleuralblebs(air-filledsacsonthelung) attheapexoflungs—escapeofairfromthelungintopleuralspacecauseslung tocollapse Morecommonintall,leanyoungmen Thesepatientshavesufficientpulmonaryreserve,sosevererespiratorydistress doesnotoccurinmostcases. Recurrencerateis50%in2years b. Secondary(complicated)pneumothorax
======================================
e

e

Occursasacomplicationofunderlyinglungdisease,mostcommonlyCOPD; otherunderlyingconditionsincludeasthma,interstitiallungdisease(ILD), neoplasms,CF,andtuberculosis(TB) Ismorelifethreateningbecauseoflackofpulmonaryreserveinthesepatients

Quick HIT

Spontaneouspneumothoraxhasahighrecurrencerate—50%in2years.

B.ClinicalFeatures 1. Symptoms

a. Ipsilateralchestpain,usuallysuddeninonset b. Dyspnea c. Cough

2. Physicalsigns

a. Decreasedbreathsoundsovertheaffectedside b. Hyperresonanceoverthechest c. Decreasedorabsenttactilefremitusontheaffectedside d. Mediastinalshifttowardthesideofthepneumothorax

C.Diagnosis CXRconfirmsthediagnosis—showsthevisceralpleuralline(seeFigure2-7)

D.Treatment 1. Primaryspontaneouspneumothorax

a. Ifsmallandpatientisasymptomatic:

e

e

Observation—shouldresolvespontaneouslyinapproximately10days Smallchesttube(withone-wayvalve)maybenefitsomepatients.

b. Ifpneumothoraxislargerand/orpatientissymptomatic:

e

e

Administrationofsupplementaloxygen,whichhelpswithresorptionofpleural air Needleaspirationorchesttubeinsertiontoallowairtobereleasedandlungto reexpand

2. Secondaryspontaneouspneumothorax—chesttubedrainage

TensionPneumothorax

A.GeneralCharacteristics 1. Accumulationofairwithinthepleuralspacesuchthattissuessurroundingthe openingintothepleuralcavityactasvalves,allowingairtoenterbutnotto escape.

2. Theaccumulationofairunder(positive)pressureinthepleuralspacecollapses theipsilaterallungandshiftsthemediastinumawayfromthesideofthe pneumothorax.

B.Causes 1. Mechanicalventilationwithassociatedbarotrauma 2. Cardiopulmonaryresuscitation 3. Trauma

C.ClinicalFeatures 1. Hypotension—cardiacfillingisimpairedduetocompressionofthegreatveins 2. Distendedneckveins 3. ShiftoftracheaawayfromthesideofthepneumothoraxonCXR(seeFigure2-8) 4. Decreasedbreathsoundsontheaffectedside 5. Hyperresonancetopercussiononthesideofthepneumothorax

D.Treatment 1. Mustbetreatedasamedicalemergency—Ifthetensioninthepleuralspaceis

notrelieved,thepatientislikelytodieofhemodynamiccompromise(inadequate cardiacoutputorhypoxemia).

2. Immediatelyperformchestdecompressionwithalarge-boreneedle(inthesecond orthirdintercostalspaceinthemidclavicularline),followedimmediatelyby chesttubeplacement.
======================================
Quick HIT

DonotobtainCXRifatensionpneumothoraxissuspected.Immediatelydecompressthepleuralspacevialarge- boreneedleorchesttube!

Swan-Ganz catheter (jugular approach) Tip endotracheal tube Nasogastric tube Swan-Ganz catheter tip in right pulmonary artery Left hemidiaphragm B c

FIGURE 2.7

A:Rightpneumothoraxseeninapatientonaventilator,with blackarrowsindicatingmediastinalshift.B:Chestradiographshowing arightpneumothorax(blackarrows)thatoccurredasacomplication ofplacementofacentralline.Thesesmallpneumothoracesareoften difficulttodetect.C:Largeleftpneumothorax(whitearrows). (AfromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins;1998:100,Figure6-41B.)(BfromSternEJ, WhiteCS.ChestRadiologyCompanion.Philadelphia,PA:LippincottWilliams&Wilkins;

1999:381,Figure22-9.)(CfromDaffnerRH.ClinicalRadiology:TheEssentials.2nded.

Philadelphia,PA:LippincottWilliams&Wilkins;1999:82,Figure4.11B.)

Quick HIT

Notallmesotheliomasaremalignant.Benignmesotheliomashaveanexcellentprognosis(andareunrelatedto asbestosexposure).

Endotracheal tube tip Nasogastric tube ‘Jugular central line tip in superior vena cava ea res, b v c

FIGURE 2.8

A:Exampleofarighttensionpneumothorax.Notethatthe

mediastinumisdisplacedtotheleft.B:Lefttensionpneumothorax.C: Lefttensionpneumothorax(whitearrows)withmediastinalshift(black arrows). (AfromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins;1998:100,Figure6-41C.)(BfromMergoPJ.

ImagingoftheChest—ATeachingFile.Philadelphia,PA:LippincottWilliams&Wilkins; 2002:258,Figure145.)(CfromTopolEJ.TextbookofCardiovascularMedicine.2nded. Philadelphia,PA:LippincottWilliams&Wilkins;2002:1050,Figure47.2.)

MalignantMesothelioma

Mostcasesaresecondarytoasbestosexposure. Dyspnea,weightloss,andcougharecommonfindings. Bloodyeffusioniscommon. Prognosisisdismal(fewmonths’survival).

Quick HIT

IfILDissuspected,askaboutthefollowing:

Medicationhistory,becausesomedrugsareknowntobetoxictolungs(chemotherapeuticagents,gold, amiodarone,penicillamine,andnitrofurantoin) Previousjobs,becauseoccupationalexposureisacauseofILD(asbestos,silicone,beryllium,coal) Pastmedicalhistory,asmanyconditionsareassociatedwithILD(connectivetissuedisease,inflammatory boweldisease,allergicrhinitis/asthma,ormalignancy)
======================================
InterstitialLungDisease

Overview

A.GeneralCharacteristics 1. ILDisdefinedasaninflammatoryprocessinvolvingthealveolarwall(resulting inwidespreadfibroelasticproliferationandcollagendeposition)thatcanleadto irreversiblefibrosis,distortionoflungarchitecture,andimpairedgasexchange.

2. Theprognosisishighlyvariableanddependsonthediagnosis. 3. Patientswithenvironmentaloroccupationallungdisease,especiallythosewith

asbestosis,arefrequentlyinvolvedinlawsuitsagainsttheiremployers.

B.Classification 1. Classifiedbasedonpathologicandclinicalcharacteristics 2. Environmentallungdisease

a. Coalworker’spneumoconiosis b. Silicosis c. Asbestosis d. Berylliosis

3. ILDassociatedwithgranulomas

a. Sarcoidosis—otherorgansinadditiontothelungsareinvolved b. Langerhanscellhistiocytosis c. Granulomatosiswithpolyangiitis(GPA,previouslyknownasWegener

granulomatosis)

d. Eosinophilicgranulomatosiswithpolyangiitis(EGPA,previouslyknownas Churg–Strausssyndrome)

4. Alveolarfillingdisease

a. Goodpasturedisease(anti-GBMantibodydisease) b. Idiopathicpulmonaryhemosiderosis c. Alveolarproteinosis

5. Hypersensitivitylungdisease

a. Hypersensitivitypneumonitis b. Eosinophilicpneumonia

6. Drug-induced—amiodarone,nitrofurantoin,bleomycin,phenytoin,illicitdrugs 7. Miscellaneous

a. Idiopathicpulmonaryfibrosis b. Cryptogenicorganizingpneumonia(COP)

c. ILDassociatedwithconnectivetissuedisorders:rheumatoidarthritis, scleroderma,systemiclupuserythematosus,mixedconnectivetissuedisease d. Radiationpneumonitis

d. Radiationpneumonitis

Quick HIT

Over100causesofILDhavebeenidentified.

Ingeneral,theclinicalfindingsandimagingstudyresultsarenonspecificanddonotpointtoadefinitive diagnosis.Oftenoneisconfrontedwiththequestionofwhethertoobtainatissuebiopsy.

C.ClinicalFeatures 1. Symptoms

a. Dyspnea(atfirstwithexertion;lateratrest) b. Cough(nonproductive) c. Fatigue d. Othersymptomsmaybepresentsecondarytoanothercondition(suchasa

connectivetissuedisorder)

2. Signs

a. Dry“velcro-like”ralesatthebasesarecommon b. Digitalclubbingiscommon(especiallywithidiopathicpulmonaryfibrosis)(see

Figure2-9andClinicalPearl2-5)

c. SignsofpulmonaryHTNandcyanosisinadvanceddisease
======================================
D.Diagnosis 1. CXR(seeFigure2-10)

a. Findingsareusuallynonspecific. b. Typicaldiffusechangesarenoted(reticular,reticulonodular,groundglass,

honeycombing).

FIGURE 2.9

Clubbingofthefinger.

(FromStedman’sMedicalDictionary.28thed.Philadelphia,PA:LippincottWilliams&

Wilkins;2005.)

2. High-resolutionCTscanshowstheextentoffibrosisbetterthanotherimaging modalities.

3. PFTs

a. Arestrictivepatternisnoted:FEV1/FVCratioisnormalorincreased.Alllung volumesarelow.BothFEV1andFVCarereduced,buttheratioisoften preserved.

b. Lowdiffusingcapacity(DLCO). 4. Oxygendesaturationduringexercise. 5. Bronchoalveolarlavage(fluidforcultureandcytology)—useiscontroversial

becauseresultsarequitevariable.

6. Tissuebiopsy.

a. ThisisoftenrequiredinpatientswithILD,thoughhigh-resolutionCTcanoften beusedtomakethediagnosiswithouttheneedforbiopsy.

b. Thiscanbedoneviafiberopticbronchoscopywithtransbronchialbiopsy(a limitedamountoftissuecanbeobtained,whichlimitsitsutility),openlung

biopsy,orvideo-assistedthoracoscopiclungbiopsy.

7. Urinalysis,iftherearesignsofglomerularinjury(forGoodpasturesyndromeand GPA)

Quick HIT

“Honeycomblung”referstoascarredshrunkenlungandisanend-stagefindingwithpoorprognosis.Airspaces aredilated,andtherearefibrousscarsintheinterstitium.ItcanarisefrommanydifferenttypesofILD.

InterstitialLungDiseasesAssociatedWithGranulomas

A.Sarcoidosis 1. Generalcharacteristics

a. Achronicsystemicgranulomatousdiseasecharacterizedbynoncaseating granulomas,ofteninvolvingmultipleorgansystems.Lungsarealmostalways involved.Etiologyunknown.

b. OccursmostoftenintheAfricanAmericanpopulation,especiallywomen. c. Seventy-fivepercentageofcasesoccurwhentheindividualis<40yearsofage. d. Sarcoidosiscarriesagoodprognosisinmajorityofpatients.

CLINICALPEARL2-5

ClubbingoftheFingers

e

Increasedconvexityofthenail—thedistalphalanxisenlargedduetoanincreaseinsofttissue. Ifapatienthasclubbing,getaCXRbecauselungdiseasemaybepresent. Chronichypoxiaistheunderlyingcauseinmostcases. Differentialdiagnosesvaryandincludepulmonarydiseases(lungcancer,CF,ILD,empyema,sarcoidosis, andmesothelioma),congenitalheartdisease,bacterialendocarditis,biliarycirrhosis,inflammatorybowel disease,andprimarybiliarycirrhosis. Digitalclubbingmaybeanidiopathicorprimaryfinding,suchasinfamilialclubbingorhypertrophic osteoarthropathy.
======================================
FIGURE 2.10

Exampleofinterstitiallungdisease:Chestradiograph

showsextensivepulmonaryfibrosis. (FromDaffnerRH.ClinicalRadiology:TheEssentials.2nded.Philadelphia,PA:Lippincott

Williams&Wilkins;1999:152,Figure4.89A.)

2. Clinicalfeatures

a. Constitutionalsymptoms

Malaise,fever,anorexia,weightloss Symptomsvaryinseverityandmaybeabsentinmanypatients. b. Lungs:drycough,dyspnea(especiallywithexercise),chestpain c. Skin(25%ofcases)

e

e

Erythemanodosum Plaques,subcutaneousnodules,maculopapulareruptions

d. Eyes(25%ofcases)—mayresultinsignificantvisualimpairment

Anterioruveitis(75%) Posterioruveitis(25%) Conjunctivitis e. Heart(5%ofcases) Arrhythmias Conductiondisturbances,suchasheartblock Suddendeath

f. Musculoskeletalsystem(25%to50%)

e

e

Arthralgiasandarthritis Bonelesions

g. Nervoussystem(5%)

CranialnerveVIIinvolvement(Bellpalsy) Opticnervedysfunction Papilledema Peripheralneuropathy

Quick HIT

¢

e

¢

Uptotwo-thirdsofpatientswithsarcoidosisexperienceresolution/improvementofsymptomsover severalyears. Approximately20%ofpatientsdevelopchronicdisease. From10%to20%ofpatientsareasymptomaticbuthaveCXRfindings.

Quick HIT

Cardiacdiseaseisthemostcommoncauseofdeath,althoughitisnotacommonfinding.

3. Diagnosis

a. Diagnosisisbasedonclinical,radiographic,andhistologicfindings. b. CXR—Bilateralhilaradenopathyisthehallmarkofthisdiseasebutisnot specific;itisseenin50%ofcases(seeFigure2-11).Fourstageshavebeen describedbasedonCXRfindings(seebelow).

c. Skinanergywithtuberculinskintest—typicalfindingbutnotdiagnostic

FIGURE 2.11

Chestradiographinapatientwithsarcoidosis.Note enlargementofmediastinalandhilarlymphnodes,aswellas diffuseinterstitialdisease,especiallyontheleft. (FromDaffnerRH.ClinicalRadiology:TheEssentials.2nded.Philadelphia,PA:

LippincottWilliams&Wilkins;1999:140,Figure4.75B.)

d. Angiotensin-convertingenzyme(ACE)iselevatedinseruminabout50%to 80%ofpatients.Thistesthelpssupportthediagnosis.However,other pulmonarydiseasesmaycauseanelevationinthisenzyme(lackssensitivityand specificity).
======================================
e. Hypercalciuriaandhypercalcemiaarecommon. f. Definitivediagnosisrequirestransbronchialbiopsy:

e

e

e

Mustseenoncaseatinggranulomas Byitselfisnotdiagnosticbecausenoncaseatinggranulomasarefoundinother diseases Mustbeusedinthecontextofclinicalpresentation

g. PFTs:decreasedlungvolumes(VCandTLC),decreasedDLCO(diffusing capacityforcarbonmonoxide),decreasedornormalFEV1/FVCratio

Quick HIT

Typicalpresentationofsarcoidosis:youngpatientwithconstitutionalsymptoms,respiratorycomplaints, erythemanodosum,blurredvision,andbilateralhilaradenopathy.

4. Stagingofsarcoidosis(onCXR)

a. StageI:bilateralhilaradenopathywithoutparenchymalinfiltrates(highestrate ofremission)

b. StageII:hilaradenopathywithparenchymalinfiltrates c. StageIII:diffuseparenchymalinfiltrateswithouthilaradenopathy(least

favorableprognosis)

d. StageIV:pulmonaryfibrosiswithhoneycombingandfibrocysticparenchymal changes

5. Treatment

a. Mostcasesresolveorsignificantlyimprovespontaneouslyin2yearsanddonot requiretreatment.

b. Systemiccorticosteroidsarethetreatmentofchoice.Theindicationsfor treatmentareunclear.However,patientswhoaresymptomaticorhaveactive lungdisease,pulmonaryfunctiondeterioration,conductiondisturbances,or severeskinoreyeinvolvementshouldbetreated.

c. Methotrexateorotherimmunosuppressiveagentscanbeusedinpatientswith progressivediseaserefractorytocorticosteroids.

B.PulmonaryLangerhansCellHistiocytosis 1. Chronicinterstitialpneumoniacausedbyabnormalproliferationofhistiocytes

1. Chronic interstitial pneumonia caused by abnormal proliferation of histiocytes (related to Langerhans cells of the skin).

(relatedtoLangerhanscellsoftheskin). 2. Mostpatients(90%)arecigarettesmokers. 3. Variantsofdiseaseincludeeosinophilicgranuloma(localizedtoboneorlung), andtwosystemicforms—Letterer–SiwediseaseandHand–Schüller–Christian syndrome.

4. Commonfindingsincludedyspneaandnonproductivecough. 5. Otherpossiblemanifestationsarespontaneouspneumothorax,lyticbonelesions,

anddiabetesinsipidus.

6. CXRhasahoneycombappearance,andCTscanshowscysticlesions. 7. Theprognosisandcoursearehighlyvariable.Corticosteroidsaresometimes

effective.Lungtransplantationmaybenecessary.
======================================
C.GranulomatosisWithPolyangiitis(PreviouslyWegenerGranulomatosis)

1. Rarediseasewithunknownetiology. 2. Characterizedbynecrotizinggranulomatousvasculitis. 3. Affectsvesselsoflungs,kidneys,upperairway,skin,andsometimesotherorgans. 4. Manifestationsofthediseaseincludeupperandlowerrespiratoryinfections,

glomerulonephritis,andpulmonarynodules.

5. Thegoldstandardfordiagnosisistissuebiopsy,butifthepatienttestspositivefor c-antineutrophilcytoplasmicantibodies,thelikelihoodofhavingthisconditionis high.

6. Treatmentusuallyincludesimmunosuppressiveagentsandglucocorticoids.

D.EosinophilicGranulomatosisWithPolyangiitis(PreviouslyChurg–Strauss Syndrome)

1. Granulomatousvasculitisisseeninpatientswithasthma. 2. Typicallypresentswithpulmonaryinfiltrates,rash,andeosinophilia. 3. Systemicvasculitismayresultinskin,muscle,andnervelesions. 4. Diagnosis:Basedonclinicalfindingsinassociationwithsignificanteosinophilia. 5. Associatedwithperinuclearantineutrophilcytoplasmicantibody. 6. Treatwithsystemicglucocorticoids.

Quick HIT

Antineutrophilcytoplasmicantibodies(ANCA)andassociatedILD:c-ANCA:GPAorWegener granulomatosis;p-ANCAEGPAorChurg–Strausssyndrome;mayalsobepositiveinanti-GBMantibodyor Goodpasturedisease

EnvironmentalLungDisease/Pneumoconiosis

A.CoalWorker’sPneumoconiosis 1. Mosthavesimplecoalworker’spneumoconiosis,whichusuallycausesno

significantrespiratorydisability.

2. Somepatientsmaydevelopcomplicatedpneumoconiosis,whichischaracterized byfibrosis(restrictivelungdisease).

3. Causes:inhalationofcoaldust,whichcontainscarbonandsilica.

Quick HIT

Pneumoconiosisisdefinedastheaccumulationofdustinthelungs,andthetissuereactiontoitspresence. Duststhathavebeenimplicated:silica,beryllium,asbestos,coaldust,graphite,carbonblack,aluminum,talc.

B.Asbestosis 1. Characterizedbydiffuseinterstitialfibrosisofthelungcausedbyinhalationof

asbestosfibers;predilectionforlowerlobes.

2. Developsinsidiouslymanyyears(>15to20years)afterexposure. 3. Increasedriskofbronchogeniccarcinoma(smokingissynergistic)and

malignantmesothelioma.

4. Symptomsandphysicalfindingsarenonspecific(seeaboveunderILD). 5. Diagnosismadebasedonclinicalfindingsandhistoryofexposuretoasbestos. 6. CXRshowshazyinfiltrateswithbilaterallinearopacitiesandmayshowpleural

plaques(especiallyinlowerlungregions).

7. Nospecifictreatmentisavailable.
======================================
Quick HIT

ClassicCXRfindingsinenvironmentallungdisease:

e

¢

Asbestosis:pleuralplaques Silicosis:“eggshell”calcifications

C.Silicosis 1. Localizedandnodularperibronchialfibrosis(upperlobesmorecommon). 2. Canbeacute(massiveexposureleadingtorapidonsetanddeath),orchronic

(symptomsyearsafterexposure—upto15yearsorlonger).

3. AssociatedwithanincreasedriskofTB. 4. Sourcesincludemining,stonecutting,andglassmanufacturing. 5. Exertionaldyspneaisthemainsymptom;coughwithsputumisalsoseen. 6. Therearerestrictivepulmonaryfunctionabnormalities. 7. Treatmentissupportiveandinvolvesremovalfromexposuretosilica.

D.Berylliosis 1. Likesilicosis,berylliosishasacuteandchronicforms. 2. Acutediseaseisadiffusepneumonitiscausedbymassiveexposuretoberyllium. 3. Chronicdiseaseisverysimilartosarcoidosis:granulomas,skinlesions,and

hypercalcemiamaybepresent.

4. Theberylliumlymphocyteproliferationtestisausefuldiagnosticbloodtest. 5. Giveglucocorticoidtherapyforbothacuteandchronicberylliosis.

InterstitialLungDiseaseAssociatedWithHypersensitivity

A.HypersensitivityPneumonitis(ExtrinsicAllergicAlveolitis) 1. Inhalationofanantigenicagenttothealveolarlevelinducesanimmune-mediated

pneumonitis.Chronicexposuremayleadtorestrictivelungdisease.

2. Avarietyoforganicdustsandchemicalshavebeenimplicated. 3. ThepresenceofserumIgGandIgAintheinhaledantigenisahallmarkfinding,

althoughmanymayhavetheseantibodieswithoutdevelopingdisease.

4. Theacuteformhasflu-likefeatures(e.g.,fever,chills,cough,dyspnea).CXR duringtheacutephaseshowspulmonaryinfiltrates.

5. Thechronicformismoreinsidiousandmoredifficulttodiagnose. 6. Treatmentinvolvesremovaloftheoffendingagentandsometimes

glucocorticoids.

Quick HIT

Somecausesofhypersensitivitypneumonitis:

e

Farmer’slung(moldyhay) Bird-breeder’slung(aviandroppings) Air-conditionerlung Bagassosis(moldysugarcane) Mushroomworker’slung(compost)

B.EosinophilicPneumonia 1. Feverandperipheraleosinophiliaarefeatures. 2. Eosinophilicpneumoniamaybeacuteorchronic. 3. CXRshowsperipheralpulmonaryinfiltrates. 4. Treatmentwithglucocorticoidsisusuallyveryeffective,butrelapsesmayoccur. C.NotethatthereissignificantoverlapbetweenthiscategoryandtheILDassociated

withgranuloma(e.g.,EGPAorChurg–Strausssyndrome).
======================================
AlveolarFillingDisease

A.Anti-GBMAntibodyorGoodpastureDisease 1. AutoimmunediseasecausedbyIgGantibodiesdirectedagainstglomerularand

alveolarbasementmembranes(typeIIhypersensitivityreaction).

2. Resultsinhemorrhagicpneumonitisandglomerulonephritis. 3. Ultimately,renalfailureisacomplicationofproliferativeglomerulonephritis. 4. Usuallypresentswithhemoptysisanddyspnea. 5. Diagnosismadebytissuebiopsy,serologicevidenceofantiglomerularbasement

membraneantibodies.

6. Prognosisispoor;treatwithplasmapheresis,cyclophosphamide,and corticosteroids.

B.PulmonaryAlveolarProteinosis 1. Rareconditioncausedbyaccumulationofsurfactant-likeproteinand

phospholipidsinthealveoli.

2. Usuallypresentswithdrycough,dyspnea,hypoxia,andrales. 3. CXRtypicallyhasaground-glassappearancewithbilateralalveolar

3. CXR typically has a ground-glass appearance with bilateral alveolar infiltrates that resemble a bat wing shape.

infiltratesthatresembleabatwingshape. 4. Lungbiopsyisrequiredfordefinitivediagnosis. 5. Treatmentiswithlunglavageandgranulocytecolony–stimulatingfactor. 6. Patientsareatincreasedriskofinfection,andcorticosteroidsshouldnotbegiven.

MiscellaneousInterstitialLungDiseases

A.IdiopathicPulmonaryFibrosis 1. Generalcharacteristics

a. Etiologyunknown;morecommoninmenandsmokers. b. Presentswithgradualonsetofprogressivedyspnea,nonproductivecough. c. Thisisadevastatingandunrelentingdisease.Althoughtheprognosisisvariable,

themeansurvivalisonly3to7yearsafterfirstdiagnosis.

2. Diagnosis

a. CXR:ground-glassorahoneycombedappearance;maybenormal. b. High-resolutionCTofchest:bibasilarreticularopacities,honeycombing,and

tractionbronchiectasis.

c. Definitivediagnosisrequiresopenlungbiopsyconsistentwithusualinterstitial pneumonia.

d. OthercausesofILDmustbeexcluded.

3. Treatment.Optionsarelimited.Themajorityofpatients(>70%)donotimprove withtherapyandexperienceprogressiveandgradualrespiratoryfailure.The followingcanbenefitsomepatients:

a. Supplementaloxygen. b. Newanti-fibroticagentssuchasnintedaniborpirfenidonehavebeenshownin

trialstoslowprogressionofmildandmoderatedisease.

c. Corticosteroidshavebeenusedhistoricallybutwithlittleornobenefitandhave significantsideeffects.

d. Lungtransplantation.
======================================
B.CryptogenicOrganizingPneumonitis(COP) 1. Aninflammatorylungdiseasewithsimilarclinicalandradiographicfeaturesto

infectiouspneumonia.

2. Associatedwithmanyentities(viralinfections,medications,connectivetissue disease).Mostcasesareidiopathic.

3. Features:cough,dyspnea,andflu-likesymptoms;bilateralpatchyinfiltrateson CXR.

4. Antibioticshavenotbeenfoundtobeeffective. 5. Spontaneousrecoverymayoccur,butcorticosteroidsareusedmostcommonly

(>60%ofpatientsrecover).

6. Relapsemayoccuraftercessationofsteroids(requiringresumptionofsteroids).

C.RadiationPneumonitis 1. Interstitialpulmonaryinflammation—occursin5%to15%ofpatientswho

undergothoracicirradiationforlungcancer,breastcancer,lymphoma,or thymoma.Mortalityandmorbidityarerelatedtotheirradiatedlungvolume,dose, patientstatus,andconcurrentchemotherapy.

2. Acuteformoccurs1to6monthsafterirradiation;chronicformdevelops1to2 yearslater—characterizedbyalveolarthickeningandpulmonaryfibrosis. 3. Features:low-gradefever,cough,chestfullness,dyspnea,pleuriticchestpain,

hemoptysis,acuterespiratorydistress.

4. CXRisusuallynormal. 5. CTscanisthebeststudy:diffuseinfiltrates(hallmark)withstraight-lineeffect conformingtoareaofradiation,ground-glassdensity,patchy/homogeneous consolidation,pleural/pericardialpleuraleffusions.Itisexcellentfordetecting recurrentcancerinirradiatedarea.

6. Thetreatmentofchoiceiscorticosteroidsforsymptomaticpatients.Prophylactic treatmentisnotusefulinhumans(usefulonlyinmice).

Quick HIT

e

e

Severehypoxemiacanresultinirreversibledamagetoorgans(CNSandcardiovascularsystemsmost affected)andmustbecorrectedrapidly. Severehypercapnia(andrespiratoryacidosis)canleadtodyspneaandvasodilationofcerebralvessels(with increasedintracranialpressureandsubsequentpapilledema,headache,impairedconsciousness,andfinally coma).

RespiratoryFailure AcuteRespiratoryFailure

A.GeneralCharacteristics 1. Acuterespiratoryfailureresultswhenthereisinadequateoxygenationofbloodor inadequateventilation(eliminationofCO2)orboth(seeClinicalPearls2-6and2- 7).Thefollowingaregeneralcriteriausedtodefineacuterespiratoryfailure:
======================================
a. Hypoxia(PaO2<60mmHg) b. Hypercapnia(partialpressureofCO2[PCO2]>50mmHg)

2. Thefollowingstructuresorsystemsareessentialcomponentsformaintaining normalrespiration.Dysfunctionorinterruptionofanycomponent(causesare listed)canpotentiallyleadtorespiratoryfailure.

a. CNS(brainandspinalcord)depressionorinsult—drugoverdose,stroke,trauma b. Neuromusculardisease—myastheniagravis,polio,Guillain–Barrésyndrome,

amyotrophiclateralsclerosis

CLINICALPEARL2-6

HypoxemiaPearls a. Todeterminetheunderlyingmechanismofhypoxemia,threepiecesofinformationareneeded:

e

«

e

PaCO2level A–agradient Responsetosupplementaloxygen

b. A–agradientisnormal,ifhypoventilationorlowinspiredPO2istheonlymechanism. c. IfV/Qmismatchorshuntingispresent,thenbothPaCO2andA–agradientareelevated;responseto

supplementalO2differentiatesbetweenthetwomechanisms.

c. Upperairway—obstructionduetoanumberofcauses,includingstenoses, spasms,orparalysis

d. Thoraxandpleura—mechanicalrestrictionduetokyphoscoliosis,flailchest, hemothorax

e. Cardiovascularsystemandblood—CHF,valvulardiseases,PE,anemia f. Lowerairwaysandalveoli—asthma,COPD,pneumonia,acuterespiratory

distresssyndrome(ARDS)

3. Classification—acuterespiratoryfailurecanbedividedintotwomajortypes (overlapoftenexists)

a. Hypoxemicrespiratoryfailure.

e

¢

e

LowPaO2withaPaCO2thatiseitherlowornormal—presentwhenO2 saturationis<90%despiteFiO2>0.6. Causesincludediseaseprocessesthatinvolvethelungitself(e.g.,ARDS, severepneumonia,pulmonaryedema). Ventilation/perfusion(V/Q)mismatchandintrapulmonaryshuntingarethe majorpathophysiologicmechanisms.

b. Hypercapnic(hypercarbic)respiratoryfailure—afailureofalveolarventilation.

e

e

e

Eitheradecreaseinminuteventilationoranincreaseinphysiologicdeadspace leadstoCO2retentionandeventuallyresultsinhypoxemia. Maybecausedbyanunderlyinglungdisease(COPD,asthma,CF,severe bronchitis) Mayalsooccurinpatientswithnounderlyinglungdiseasewhohaveimpaired ventilationduetoneuromusculardiseases,CNSdepression,mechanical restrictionoflunginflation,oranycauseofrespiratoryfatigue(e.g.,prolonged hyperventilationindiabeticketoacidosis[DKA])

4. Pathophysiology a. V/Qmismatch

¢
======================================
e

e¢

Causedbyadefectineitheralveolarventilation(e.g.,pulmonaryedema)or perfusion(e.g.,PE) Typicallyleadstohypoxiawithouthypercapnia(infact,PaCO2levelsare oftenlowornormal) Mostcommonmechanismofhypoxemia(especiallyinchroniclungdisorders) Responsivetosupplementaloxygen

e

CLINICALPEARL2-7

VentilationVersusOxygenation

¢

¢

VentilationismonitoredbyPaCO2:To↓PaCO2,onemusteither↑respiratoryrate(RR)or↑tidalvolume (VT).Notethatminuteventilation=RR×VT. OxygenationismonitoredbyO2saturationandPaO2:To↓PaO2intheventilatedpatient,onemusteither↓ FiO2or↓PEEP.

Notethatventilationandoxygenationareunrelated.O2saturationmaybe100%withaveryhighPaCO2,andthepatientcanbein ventilatoryfailure!

b. Shunting

e

¢

Littleornoventilationinperfusedareas(duetocollapsedorfluid-filled alveoli);venousbloodisshuntedintothearterialcirculationwithoutbeing oxygenated;representsoneendofthespectruminV/Qmismatch. Causesofshunts:atelectasisorfluidbuildupinalveoli(pneumoniaor

e

pulmonaryedema),directright-to-leftintracardiacbloodflowincongenital heartdiseases. Hypoxiaduetoashuntisnotresponsivetosupplementaloxygen.

c. Hypoventilation—leadstohypercapnia,withsecondaryhypoxemia. d. IncreasedCO2production(e.g.,sepsis,DKA,hyperthermia)resultsin

hypercapnicrespiratoryfailure.

e. Diffusionimpairment(e.g.,ILD)causeshypoxemiawithouthypercapnia.

B.ClinicalFeatures 1. Symptoms

a. Dyspnea—firstsymptom b. Coughmayormaynotbepresent,dependingontheunderlyingcause.

2. Signs—thefollowingmightbepresent:

a. Inabilitytospeakincompletesentences,useofaccessorymusclesofrespiration b. Tachypnea,tachycardia c. Cyanosis d. Impairedmentation(duetofatigueorhypercapnia,orifcauseofrespiratory

failureisCNSdepression)

C.Diagnosis 1. ABGanalysis—mayconfirmdiagnosisandhelpseverityofcondition;shouldbe

obtainedinmostcasesofrespiratoryfailure(seeFigure2-12)

a. Hypoxemia:MechanismsincludeV/Qmismatch,intrapulmonaryshunting,or hypoventilation.

b. Hypercapnia:causedbyhypoventilation(secondarytoavarietyofcauses). c. ArterialpH:Respiratoryacidosisoccurswhenhypercapniaispresent.However, iftherespiratoryfailureischronic,renalcompensationoccursandtheacidosisis lesssevere.

2. CXRorCTscanofthechest. 3. CBCandmetabolicpanel. 4. Ifcardiogenicpulmonaryedemaissuspected,considercardiacenzymes.
======================================
Quick HIT

Thealveolar–arterialoxygendifference(A–agradient)isnormalwhenhypoventilationisthecauseof hypoxemia.Itisincreasedinmostothercauses.

D.Treatment 1. Treatunderlyingdisorder(e.g.,withbronchodilators,corticosteroids,antibiotics,

dependingonthecause).

Not = Elevated cc Is A-a gradient [™ increased? Yes | Low inspired PaO, is cause Is the lowered PaO, improved with supplemental O2? No ‘ll V/Q mismatch | Shunt | of hypoxemia. Yes Hypoventilation alone does not account for hypoxemia. Another Hypoventilation Is A-a gradient increased? Hypoventilation alone accounts for hypoxemia. mechanism is present.

FIGURE 2.12

Evaluationofapatientwithhypoxemia.

TABLE2-6 OxygenDeliverySystems

Low Flow __ Nasal cannula 1-6 Up to 0.40 Easy to use, comfortable Simple face mask 5-10 0.40-0.60 Can deliver higher flow rates than nasal cannula High Flow —_‘ Venturi mask 4-10 Up to 0.40, but can Preferred in CO, retainers determine precise FiO, | because one can more to deliver (24%, 28%, precisely control 31%, 35%, 40%) oxygenation Nonrebreathing Up to 15 Variable, up to Can achieve higher FiO, at mask 0.70-0.90 lower flow rates High-flow nasal Up to 40 Up to 1.00 Higher flow rates than cannula simple nasal cannula “There are two sources of oxygen in the hospital: wall outlets and oxygen tanks (portable, large green tanks).

2. Providesupplementaloxygenifpatientishypoxemic(seeTable2-6andClinical Pearl2-8).

a. Hypoxemicrespiratoryfailure:Usethelowestconcentrationofoxygenthat providessufficientoxygenationtoavoidoxygentoxicity,whichisduetofree-

radicalproduction.

b. Hypercapnicrespiratoryfailure:Resultsfromhypoventilation.InCOPD patients,excessiveadministrationofoxygenresultsinV/Qmismatch,the Haldaneeffect,andlossofthehypoxemicrespiratorydrive.

3. ApplyNPPV(e.g.,CPAP,BiPAP)onlyforconsciouspatientswithpossible impendingrespiratoryfailure(seeClinicalPearl2-9).Ifthepatientcannot breatheonhisorherown,intubate!

4. Intubationandmechanicalventilationmaybeneededinbothtypesofrespiratory failure.
======================================
Quick HIT

Donotignorehypoxiainapatientwithhypercarbicrespiratoryfailure!

AcuteRespiratoryDistressSyndrome

A.GeneralCharacteristics 1. ARDSisadiffuseinflammatoryprocess(notnecessarilyinfectious)involving bothlungs—neutrophilactivation(duetoavarietyofcauses)inthesystemicor pulmonarycirculationsistheprimarymechanism(seeClinicalPearl2-10). 2. ARDSisnotaprimarydisease,butratheradisorderthatarisesduetoother

conditionsthatcauseawidespreadinflammatoryprocess.

CLINICALPEARL2-8

TechniquestoImproveTissueOxygenation

e

IncreaseFiO2 IncreasePEEP Extendinspiratorytimefraction Decubitus,upright,orpronepositioningbronchodilation Improveoxygendelivery:increasecardiacoutputorincreasehemoglobin Decreaseoxygenrequirements:decreaseworkofbreathing,fever,agitation Removepulmonaryvasodilators(e.g.,nitroprusside)

e

AdaptedfromBaumGL,CrapoJD,CelliBR,etal.,eds.TextbookofPulmonaryDiseases.Vol.II.7thed.Philadelphia,PA:Lippincott Williams&Wilkins;2003.ReprintedwithpermissionfromDr.JamesD.Crapo.

CLINICALPEARL2-9

NoninvasivePositivePressureVentilation

e

e

¢

NPPVisdeliveredaseitherBiPAPorCPAP.BiPAPcanbesetatseparateinspiratoryandexpiratorypressures (theinspiratorypressureishigherthantheexpiratory). Bothcanbegivenvianasalmaskorfull-facemask. NPPVisindicatedinpatientswithimpendingrespiratoryfailureinanattempttoavoidintubationand mechanicalventilation. Successratesarehighestinpatientswithhypercapnicrespiratoryfailure(especiallyCOPDpatients). NotethatNPPVshouldnotbeusedforlifesupportventilation,onlytotemporarilysupportthepatient’sown spontaneousbreathing. TouseNPPV,thepatientmustbeneurologicallyintact,awakeandcooperative,andabletoprotecttheairway. Ifnoimprovementisseen,BiPAPshouldbediscontinuedandconventionalendotrachealintubationand mechanicalventilationinitiated.

3. 2012Berlindefinition:

a. Acuteonset(<1weekofknownclinicalinsult). b. Bilateralinfiltratesonchestimaging. c. PulmonaryedemanotexplainedbyfluidoverloadorCHF(e.g.,noclinical

evidenceofCHForpulmonary–capillarywedgepressure[PCWP]<18mmHg).

d. AbnormalPaO2/FiO2ratio. 200to300:mildARDS 100to200:moderateARDS <100:severeARDS

4. Pathophysiology

a. Massiveintrapulmonaryshuntingofbloodisakeypathophysiologiceventin ARDS—severehypoxemiawithnosignificantimprovementon100%oxygen (requireshighPEEPtopropopenairways).Shuntingissecondaryto widespreadatelectasis,collapseofalveoli,andsurfactantdysfunction.
======================================
e

e

Interstitialedemaandalveolarcollapseareduetoanincreaseinlungfluid, whichleadstostifflungs,anincreaseinalveolar–arterialoxygendifference (A–agradient),andineffectivegasexchange. Notethattheeffectsoftheincreaseinpulmonaryfluidareidenticaltothose seenincardiogenicpulmonaryedema,butthecauseisdifferent:Anincrease inalveolar–capillarypermeabilitycausesARDS,whereascongestive hydrostaticforcescausecardiogenicpulmonaryedema.

b. Decreasedpulmonarycompliance—leadstoincreasedworkofbreathing. c. Increaseddeadspace—secondarytoobstructionanddestructionofpulmonary–

capillarybed.

d. Lowvitalcapacity,lowFRC.

Quick HIT

PatientswithsepsisorsepticshockhavethehighestriskofdevelopingARDS.

Quick HIT

ARDScanprogressrapidlyoverseveralhours.Initially,thedyspneamaybeexertional,butitcanrapidly advanceinseverity.

B.Causes 1. Sepsisisthemostcommonriskfactor—canbesecondarytoavarietyof

infections(e.g.,pneumonia,urosepsis,woundinfections)

2. Aspirationofgastriccontents 3. Severetrauma,fractures(e.g.,femur,pelvis),acutepancreatitis,multipleor

massivetransfusions,neardrowning

4. Drugoverdose,toxicinhalations 5. IntracranialHTN 6. Cardiopulmonarybypass

CLINICALPEARL2-10

RemembertheFollowingWhenExaminingaPatientWithARDS

e

¢

¢

¢

Physicalfindingsareusuallynonspecific. Becausethepatientisusuallyintubatedandonaventilator,decreasedunilateralbreathsoundsmaybedueto theETbeingintherightmainbronchusorpossiblyapneumothorax. Lookforpotentialsourcesofsepsisandcheckforanysignsofinfection:acuteabdomen,IVlines,wounds, decubitusulcers,etc. KeepinmindthatcardiogenicpulmonaryedemahastobedistinguishedfromARDS—lookforsignsof volumeoverload,CHF,JVD,edema,andhepatomegaly.

C.ClinicalFeatures 1. Dyspnea,tachypnea,andtachycardiaduetoincreasedworkofbreathing. 2. Progressivehypoxemia—notresponsivetosupplementaloxygen. 3. Patientsaredifficulttoventilatebecauseofhighpeakairwaypressuresdueto

stiff,noncompliantlungs.

D.Diagnosis 1. CXR—showsdiffusebilateralpulmonaryinfiltrates(seeFigure2-13) a. ThereisavariablecorrelationbetweenfindingsonCXRandseverityof hypoxemiaorclinicalresponse.Diuresisimprovesandvolumeoverload worsenstheinfiltrates—regardlessofCXRfindings,theunderlyingARDSmay ormaynotbeimproved.

b. CXRimprovementfollowsclinicalimprovementafter1to2weeksormore.
======================================
FIGURE

2.13 A:ChestradiographshowingtypicalfindingsinARDS.

B:AnotherexampleofARDS.AlsonotepresenceofanETand Swan–Ganzcentralvenouscatheter. (AfromMillerWT,MillerWTJr.FieldGuidetotheChestX-Ray.Philadelphia,PA:

LippincottWilliams&Wilkins;1999:4,Figure1.2B.)(BfromDaffnerRH.Clinical Radiology:TheEssentials.2nded.Philadelphia,PA:LippincottWilliams&Wilkins; 1999:175,Figure4.117A.)

2. ABG

a. Hypoxemia(PaO2<60) b. Initially,respiratoryalkalosis(PaCO2<40)ispresent,whichgiveswayto

respiratoryacidosisastheworkofbreathingincreasesandPaCO2increases.

c. Ifthepatientisseptic,metabolicacidosismaybepresent,withorwithout respiratorycompensation.

3. Pulmonaryarterycatheter—enablesadeterminationofPCWP.PCWPreflectsleft heartfillingpressuresandisanindirectmarkerofintravascularvolumestatus. a. PCWPisthemostusefulparameterindifferentiatingARDSfromcardiogenic

pulmonaryedema.

b. IfPCWPislow(<18mmHg),ARDSismorelikely,whereasifPCWPishigh (>18mmHg),cardiogenicpulmonaryedemaismorelikely.

c. However,routineplacementofpulmonaryarterycathetershasnotbeen showntobebeneficialinARDSorsepsis.

4. Bronchoscopywithbronchoalveolarlavage

a. Thismaybeconsideredifpatientisacutelyillandinfectionissuspected. b. Fluidcollectedcanbeculturedandanalyzedforcelldifferential,cytology,Gram

stain,andsilverstain.

Quick HIT

2012BerlindefinitionfordiagnosingARDS:

e

e

e

e

Hypoxemiathatisrefractorytooxygentherapy:ratioofPaO2/FiO2200to300ismild,100to200is moderate,and<100issevere BilateraldiffusepulmonaryinfiltratesonCXR NoevidenceofCHFclinicallyorPCWP≤18mmHg Respiratorysymptomsthatdevelopwithin1weekofknowninsult

E.Treatment 1. Oxygenation—trytokeepO2saturation>90%.

2. MechanicalventilationisbasedontheARDSNetstudies.Themostimportant principlesincludeusingahighPEEPwithlowtidalvolumes.Sedationandshort- termparalysismaybeneededtoimprovecompliancewithmechanicalventilation. 3. Fluidmanagement

a. Volumeoverloadshouldbeavoided.Alow–normalintravascularvolumeis preferred;thegoalshouldbeaCVP4to6cmH2O.Vasopressorsmaybeneeded tomaintainBP.

b. Ontheotherhand,patientswithsepsishavehighfluidrequirements,so determiningtheappropriatefluidmanagementmaybedifficult.

4. Treattheunderlyingcause,forexample,infection. 5. Donotforgettoaddressthepatient’snutritionalneeds.Tubefeedingsare

preferredoverparenteralnutrition(seeAppendix).
======================================
F.Complications 1. Permanentlunginjury—resultinginlungscarringorhoneycomblung 2. Complicationsassociatedwithmechanicalventilation

a. Barotraumasecondarytohigh-pressuremechanicalventilation,possiblycausing apneumothoraxorpneumomediastinum

b. Nosocomialpneumonia

3. Line-associatedinfections:centrallinesandpulmonaryarterycatheters(line infectionsepsis),urinarycatheters(UTI),andnasaltubes(sinusinfection)

4. Renalfailure—maybeduetonephrotoxicmedication,sepsiswithhypotension,or

underlyingdisease 5. Ileus,stressulcers 6. Multiorganfailure 7. Criticalillnessmyopathyandpolyneuropathy

MechanicalVentilation

A.GeneralCharacteristics 1. Intreatingrespiratoryfailure,mechanicalventilationhastwomajorgoals:to

maintainalveolarventilationandtocorrecthypoxemia.

2. Thedecisiontoinitiatemechanicalventilationshouldbeaclinicalone.Generally, patientswiththefollowingrequiremechanicalventilation:

a. Significantrespiratorydistress(e.g.,highRR)orrespiratoryarrest b. Impairedorreducedlevelofconsciousnesswithinabilitytoprotecttheairway

(lookforabsentgagorcoughreflex)

c. Metabolicacidosis(ifthepatientisunabletocompensatewithadequate hyperventilation)

d. Respiratorymusclefatigue e. Significanthypoxemia(PaO2<70mmHg)orhypercapnia(PaCO2>50mm

Hg);respiratoryacidosis(pH<7.2)withhypercapnia

Quick HIT

Ingeneral,erronthesideofcautionwhendecidingwhethertoinitiatemechanicalventilation.Intubationdoes notmeanthepatientwillhavetoremainontheventilatorindefinitely!

3. ABGsareusedtoassessresponsetoinitiationofmechanicalventilation. AcceptablerangesofgasvaluesincludeaPaO2of50to60withPaCO2of40to 50,andpHbetween7.35and7.50.

4. Generalprinciples

a. Initialsettingsshouldresttherespiratorymuscles. b. Thegoalistoreducethelikelihoodofbarotraumas(highstaticairwaypressures,

overinflation)andatelectasis(lowstaticairwaypressures,underinflation).

c. Avolume-cycledventilatorismostcommonlyused.

B.VentilatorSettings 1. Assistcontrol(AC)ventilation

a. Thisistheinitialmodeusedinmostpatientswithrespiratoryfailure. b. Guaranteesa“backup”minuteventilationthathasbeenpreset,butthepatient

canstillinitiatebreathsatafasterratethanthebackuprate.

c. ACandotherventilatormodescanbevolumetargetedorpressuretargeted.If volumetargetedisselected,theventilatorwillgiveapresettidalvolumefor eachbreathregardlessofthepressurerequiredtogivethatbreath(ensures ventilationbutcouldleadtohighpressuresandbarotrauma);ifpressuretargeted isselected,theventilatorwilldeliverafixedinspiratorypressureregardlessof

thetidalvolume(avoidsbarotraumasbutadequateventilationmaynotbe achieved).

d. Allbreathsinitiatedbythepatientaresupportedbytheventilator(incontrastto intermittentmandatoryventilation).
======================================
Quick HIT

e

«

AlwaysconfirmcorrectETplacementbylisteningforbilateralbreathsoundsandcheckingapost- intubationCXR. OnCXR,thetipoftheETtubeshouldbeapproximately2to5cmabovethecarina.

2. Synchronousintermittentmandatoryventilation(SIMV)

a. Patientscanbreatheontheirownabovethemandatoryratewithouthelpfrom theventilator(i.e.,thetidalvolumeoftheseextrabreathsisnotdeterminedby theventilator,asitisintheassist-controlmode).

b. Ifnospontaneousbreathisinitiatedbythepatient,thepredeterminedmandatory breathisdeliveredbytheventilator.

c. Mayincreaserespiratoryfatigueandprolongedmechanicalventilation.

3. CPAP

a. Positivepressure(0to20cmH2O)isdeliveredcontinuously(duringexpiration andinspiration)bytheventilator,butnobreathsaredelivered(patientbreathes onhisorherown).

4. Pressuresupportventilation(PSV)

a. Inspiratorypressureissettosupporteachpatient-triggeredbreath,witha constantPEEP.Thisismostlyusedduringweaningtrials(ClinicalPearl2-11). 5. Noninvasivemechanicalventilation

a. CPAP:Positivepressure(0to20cmH2O)isdeliveredcontinuously(during expirationandinspiration)bytheventilator,butnobreathsaredelivered(patient breathesonhisorherown).

b. BiPAP:SimilartoPSVbutdonewithafaceornasalmaskratherthan intubation.DeliversasetinspiratorypressurewithaconstantPEEP.

CLINICALPEARL2-11

ParameterstoConsiderinExtubationorWeaningFromtheVentilator:The MoreCriteriaThatAreMet,theMoreLikelyThatExtubationWillBe Tolerated

e

e

Whetherpatienthasanadequaterespiratorydriveandishemodynamicallystable Intactcough(whensuctioningsecretions)

¢

©

e

¢

PaO2/FiO2>200,PaCO2<45 O2saturationof>90%,PEEPof≤5cmH2O,FiO2<40%,RR<35breaths/min,minuteventilation≤12 L/min,vitalcapacity>10mL/kg Rapidshallowbreathingindex(RSBI,RRdividedbytidalvolume)<105 Negativeinspiratorypressure<−20cmH2Oormorenegative

C.KeyParameters 1. SettingsthataffectPaCO2:Minuteventilation(RR×VT)

a. Thisshouldbeadjustedtoachievethepatient’sbaselinePaCO2. b. Aninitialtidalvolume(VT)of4to8mL/kgisappropriateinmostcases(lower

tidalvolumesarerecommendedinpatientswithARDSandCOPD).

c. Arateof10to12breaths/minisappropriate.

2. SettingsthataffectPaO2:FiO2andPEEP

a. FiO2:TheinitialFiO2shouldbe100%.Quicklytitratedownandusethelowest possibleFiO2tomaintainaPaO2of50to60orhigher(orsaturation>90%)to avoidoxygentoxicity(theoretically,FiO2<60%isusuallysafe).

b. PEEPispositivepressuremaintainedattheendofapassiveexhalationtokeep alveoliopen.5cmH2Oisanappropriateinitialsetting.HighlevelsofPEEP increasetheriskofbarotrauma(injurytoairway=pneumothorax)anddecrease cardiacoutput(decreasedvenousreturnfromincreasedintrathoracicpressure).
======================================
Quick HIT

ThepresenceofanETtubedoesnotpreventaspirationfromoccurring.

Quick HIT

Whenapatientisventilatordependentfor2ormoreweeks,atracheostomyisusuallyperformedtoprevent tracheomalacia.

D.Complications 1. Anxiety,agitation,discomfort

a. Bothsedationandanalgesiaareimportant;paralyticsshouldbeusedduring intubationandcanbeusedafterintubationifthepatientcontinuestobeagitated andfightstheventilator.

2. Difficultywithtrachealsecretions—suctiononaregularbasis. 3. Ventilator-associatedpneumonia(riskis∼1%perday). 4. Barotrauma—causedbyhighairwaypressures. 5. Tracheomalacia(softeningofthetrachealcartilage)—duetotheprolonged

presenceofanendotrachealtube(ETT).

6. Laryngealdamageduringintubation. 7. Gastrointestinaleffects(stressulcersandcholestasis)—increasedriskin

mechanicallyventilatedpatients.Allpatientsshouldbeonaprotonpump inhibitor(PPI)orH2blocker.

gS...

DiseasesofthePulmonaryVasculature

PulmonaryHypertension

A.GeneralCharacteristics 1. Definedasameanpulmonaryarterialpressuregreaterthan25mmHgatrest 2. Therearemultiplepathophysiologicprocessesthatcancausepulmonary

hypertension(ClinicalPearl2-12):

a. Passiveduetoresistanceinthepulmonaryvenoussystem(e.g.,leftheartfailure, mitralstenosis,atrialmyxoma)

b. Hyperkinetic(left-to-rightcardiacshuntssuchasatrialseptaldefectorpatent ductusarteriosus)

c. Obstruction(e.g.,PE,pulmonaryarterystenosis) d. Pulmonaryvascularobliteration(e.g.,collagenvasculardiseases) e. Pulmonaryvasoconstriction(e.g.,chronichypoxemia,COPD,obstructivesleep

apnea[OSA])

CLINICALPEARL2-12

HowtoDeterminetheCauseofPulmonaryHTN

e

e

Performaseriesoftests(CXR,PFTs,ABGs,serology,echocardiogram,cardiaccatheterization).Thesetests willgiveyouenoughinformationtorecognizeheartdiseaseorlungdiseaseasthecauseofpulmonaryHTN. Ifthecauseisnotrevealed(neitherheartnorlung),thenobtainaV/Qscan:thisindicateseitherPEorprimary pulmonaryhypertension(pulmonaryarterialhypertension,PAH).NotethatPAHisadiagnosisofexclusion.

3. ClassificationofpulmonaryhypertensionisbasedontherevisedWHO classificationsystem:

a. Group1:Pulmonaryarterialhypertension(PAH)

Idiopathic,familial,veno-occlusivedisease,andPAHwithassociated conditions(connectivetissuedisorders,congenitalshunting,HIV,drugsand toxins) Anabnormalincreaseinpulmonaryarteriolarresistanceleadstothickeningof pulmonaryarteriolarwalls.ThisworsensthepulmonaryHTN,whichinturn causesfurtherwallthickening,thusleadingtoaviciouscycle. Thecauseisunknown;itusuallyaffectsyoungormiddle-agedwomen. Theprognosisispoor.Meansurvivalis2to3yearsfromthetimeofdiagnosis.
======================================
e

e

b. Group2:Leftheartdisease

Secondarytoanycauseofleftheartfailure,includingmitralstenosisand

mitralregurgitation

c. Group3:Lungdiseaseand/orchronichypoxemia

CausesincludeILD,COPD,OSA,andanyothercauseofchronichypoxemia

d. Group4:Chronicthromboembolicdisease

RecurrentPE(manypatientsdonothavesymptomsofPE),including nonthromboticetiologies(e.g.,tumoremboli)

e. Group5:Miscellaneous

Pulmonaryvascularcompression(e.g.,tumorsorlymphadenopathy), sarcoidosis,Langerhanscellhistiocytosis,etc.

B.ClinicalFeatures 1. Symptoms

a. Dyspneaonexertion b. Fatigue c. Chestpain—exertional d. Syncope—exertional(withseveredisease)

2. Signs

a. Loudpulmoniccomponentofthesecondheartsound(P2)andsubtleliftof sternum(signofRVdilatation)—Thesemaybetheonlyfindings,andyetthe patientmaystillhaveadevastatingdisease!

b. Whenrightventricularfailureoccurs,thecorrespondingsignsandsymptoms appear(JVD,hepatomegaly,ascites,peripheraledema).

C.Diagnosis 1. ECG:Oftensuggestsrightventricularhypertrophy—specifically,right-axis

deviationandrightatrialabnormalityarefrequentlypresent

2. CXR:Enlargedpulmonaryarterieswithorwithoutclearlungfieldsbasedonthe causeofpulmonaryhypertension

3. Echocardiogram

a. Dilatedpulmonaryartery b. Dilatation/hypertrophyofRAandRV c. AbnormalmovementofIVseptum(duetoincreasedrightventricularvolume)

4. Rightheartcatheterization:requiredforconfirmatorydiagnosisofpulmonary HTN.Revealsincreasedmeanpulmonaryarterypressure>25mmHg

D.Treatment 1. Onespecifictreatmentplancannotberecommendedduetothevarietyofcauses

ofpulmonaryHTN.IfthepulmonaryHTNissecondarytoanotherdisease process(e.g.,recurrentPE),thentheunderlyingdiseaseshouldbetreatedand

optimized.

2. VasoactiveagentsaretypicallyusedinPAH(Group1),sincetrialshavebeen doneinthisgroup.

a. Rightheartcatheterizationwithatrialofvasodilatorsshouldprecedetheuseof theseagents.

b. Vasoactiveagentsmaylowerpulmonaryvascularresistanceinsomepatients. Availableoptionsincludeinhalednitricoxide,phosphodiesteraseinhibitors (e.g.,sildenafil),oralCCBs,prostacyclins(e.g.,epoprostenol),andendothelin receptorantagonists(e.g.,bosentan).

3. Manypatientsrequirehomeoxygen,diuretics,andoccasionallyinotropes(e.g., digoxin).

4. Lungtransplantationinqualifiedpatients.
======================================
Quick HIT

Corpulmonaleisbestthoughtofastheright-sidedcounterparttoleftventricularheartdiseaseduetosystemic HTN.

CorPulmonale

A.GeneralCharacteristics 1. CorpulmonaleisdefinedasrightventricularhypertrophywitheventualRV failureresultingfrompulmonaryHTN,secondarytopulmonarydisease. 2. ThedefinitiondoesnotencompassanyofthecausesofpulmonaryHTNdueto

left-sidedheartdisease(suchasmitralstenosisorleft-to-rightshunts).

Quick HIT

Deathduetocorpulmonale:ManyCOPDpatientsdieofrightventricularfailuresecondarytochronic pulmonaryHTN.ManydeathsduetoPEresultfromacutepulmonaryHTNandrightventricularfailure.

B.Causes 1. ItismostcommonlysecondarytoCOPD. 2. OthercausesincluderecurrentPE,ILD,asthma,CF,sleepapnea,and

pneumoconioses.

C.ClinicalFeatures 1. Decreaseinexercisetolerance 2. Cyanosisanddigitalclubbing 3. Signsofrightventricularfailure:hepatomegaly,edema,JVD 4. Parasternallift

Quick HIT

Othersourcesofembolitothelungs:

e

e

e

e

¢

Fatembolism(long-bonefractures) Amnioticfluidembolism(duringorafterdelivery) Airembolism(traumatothorax,indwellingvenous/arteriallines) Septicembolism(IVdruguse) Schistosomiasis

D.Diagnosis 1. CXR:enlargementoftheRA,RV,andpulmonaryarteries 2. ECG:right-axisdeviation,Ppulmonale(peakedPwaves),rightventricular

hypertrophy

3. Echocardiogram:rightventriculardilatation,butnormalLVsizeandfunction; usefulinexcludingLVdysfunction

E.Treatment 1. Treattheunderlyingpulmonarydisorder.

2. Usediuretictherapycautiouslybecausepatientsmaybepreloaddependent. 3. Applycontinuouslong-termoxygentherapyifthepatientishypoxic. 4. AdministerdigoxinonlyifthereiscoexistentLVfailure. 5. Avarietyofvasodilatorshavebeenstudied;nodefiniteimprovementhasbeen

shownwiththeiruse.

Quick HIT

Ifapatientwithlong-bonefracturedevelopsdyspnea,mentalstatuschange,andpetechiae,thinkfatembolism. Respiratoryfailureanddeathcanensuerapidly.

PulmonaryEmbolism

A.GeneralCharacteristics 1. APEoccurswhenathrombusinanotherregionofthebodyembolizestothe

pulmonaryvasculartreeviatheRVandpulmonaryartery.Bloodflowdistaltothe embolusisobstructed.
======================================
Quick HIT

ComplicationsinpatientswithPEwhosurvivetheinitialeventinclude:

e

e

RecurrentPE PulmonaryHTN(upto5%ofpatients)

2. ConsiderPEanddeepvenousthrombosis(DVT)asacontinuumofoneclinical

entity(venousthromboembolism)—diagnosingeitherPEorDVTisanindication fortreatment. 3. Sourcesofemboli

a. LowerextremityDVT—PEisthemajorcomplicationofDVT.

¢

e

e

Mostpulmonaryemboliarisefromthrombosesinthedeepveinsoflower extremitiesabovetheknee(iliofemoralDVT). Pulmonaryembolicanalsoarisefromthedeepveinsofthepelvis. Althoughcalfveinthrombihavealowincidenceofembolizingtothelungs,in manypatientsthesethrombiprogressintotheproximalveins,increasingthe incidenceofPE.

b. UpperextremityDVTisararesourceofemboli(itmaybeseeninIVdrug abusers).

Quick HIT

Twoimportantstudiestoknow:

e

e

TheProspectiveInvestigationofPulmonaryEmbolismDiagnosis(PIOPED)isalandmarkstudy(JAMA 1990;263:2753).Guidestreatment,ifV/Qisperformed. TheChristopherStudy(JAMA2006;295:72–179).Guidestreatment,ifspiralCTisperformed.

CLINICALPEARL2-13

RiskFactorsforDVT/PE

e

e

¢

Age>60years Malignancy PriorhistoryofDVT,PE

Hereditaryhypercoagulablestates(factorVLeiden,proteinCandSdeficiency,antithrombinIIIdeficiency) Prolongedimmobilizationorbedrest,long-distancetravel Cardiacdisease,especiallyCHF Obesity Nephroticsyndrome Majorsurgery,especiallypelvicsurgery(orthopedicprocedures) Majortrauma Pregnancy,estrogenuse(oralcontraceptives)

Obesity

4. RiskfactorsarethoseforDVT(seeClinicalPearl2-13). 5. Pathophysiology

a. Emboliblockaportionofpulmonaryvasculature,leadingtoincreased

pulmonaryvascularresistance,pulmonaryarterypressure,andrightventricular pressure.Ifitissevere(largeblockage),acutecorpulmonalemayresult. b. Bloodflowdecreasesinsomeareasofthelung.Deadspaceiscreatedinareas

ofthelunginwhichthereisventilationbutnoperfusion.Theresulting hypoxemiaandhypercarbiadriverespiratoryeffort,whichleadstotachypnea.

c. Ifthesizeofthedeadspaceislarge(largePE),clinicalsignsaremoreovert (SOB,tachypnea).

6. Courseandprognosis

a. Mostoften,PEisclinicallysilent.Recurrencesarecommon,whichcanleadto developmentofchronicpulmonaryHTNandchroniccorpulmonale.

b. WhenPEisundiagnosed,mortalityapproaches30%.Asignificantnumberof casesareundiagnosed(asmanyas50%).

c. WhenPEisdiagnosed,mortalityis10%inthefirst60minutes.Ofthosewho survivetheinitialevent,approximately30%ofpatientswilldieofa recurrentPE,ifleftuntreated.MostdeathsareduetorecurrentPEwithin thefirstfewhoursoftheinitialPE.Treatmentwithanticoagulants decreasesthemortalityto2%to8%.
======================================
B.ClinicalFeatures 1. Symptoms(frequencyperthePIOPEDstudy)

a. Dyspnea(73%) b. Pleuriticchestpain(66%) c. Cough(37%) d. Hemoptysis(13%) e. Notethatonlyone-thirdofpatientswithPEwillhavesignsandsymptomsofa

DVT

f. SyncopeseeninlargePE

2. Signs(frequencyperthePIOPEDstudy)

a. Tachypnea(70%) b. Rales(51%)

c. Tachycardia(30%) d. S4(24%) e. IncreasedP2(23%) f. ShockwithrapidcirculatorycollapseinmassivePE g. Othersigns:low-gradefever,decreasedbreathsounds,dullnessonpercussion

Quick HIT

SignsandsymptomsarenotareliableindicatorsofthepresenceofPE.Thisoftenleadstoconfusionanddelay indiagnosisandtreatment.If,however,apatienthassymptomsofPEandaDVTisfound,onecanmakethe diagnosisofPEwithoutfurthertesting.

C.Diagnosis 1. ABGlevelsarenotdiagnosticforPE(seeClinicalPearl2-14).

a. PaO2andPaCO2arelow(thelatterduetohyperventilation)andpHishigh; thus,thereistypicallyarespiratoryalkalosis.

b. TheA–agradientisusuallyelevated.AnormalA–agradientmakesPEless likely,butcannotbereliedontoexcludethediagnosis.

CLINICALPEARL2-14

WorkupofPE ItisoftendifficulttodefinitivelydiagnoseorruleoutPE.Thefollowingtestsprovideanadequatebasisfor treatingPEwithanticoagulation:

¢

e

¢

Intraluminalfillingdefectsincentral,segmental,orlobularpulmonaryarteriesonCTA DVTdiagnosedwithultrasoundandclinicalsuspicion Positivepulmonaryangiogram(definitelyprovesPE)

ThefollowingcanessentiallyruleoutPE:

e

e

e

Low-probabilityV/Qscan(ornormalhelicalscan)andlowclinicalsuspicion Negativepulmonaryangiogram(definite) NegativeD-dimerassaypluslowclinicalsuspicion

AdaptedfromPIOPEDdata.JAMA1990;263:2753.

2. CXR—usuallynormal.

a. Atelectasisorpleuraleffusionmaybepresent. b. Themainusefulnessisinexcludingalternativediagnoses. c. Classicradiographicsigns,suchasHamptonhumporWestermarksign,are

rarelypresent.

3. Venousduplexultrasoundofthelowerextremities.

a. Ifthereisapositiveresult,treatwithIVanticoagulation(heparin);treatmentof DVTisthesameasforPE.Keepinmindthatwiththisapproach,afalse-

positiveultrasoundwillresultinanticoagulationofsomepatientswhodonot haveDVTorPE.Also,anegativeresultisnothelpful,asthepatientmaystill haveaPEdespitenoDVTonultrasound.

b. Thistestisveryhelpfulwhenpositive,butoflittlevaluewhennegative (negativeresultsoccurin50%ofpatientswithprovenPE).

4. V/Q(ventilation–perfusionlung)scan

a. Traditionally,thiswasthemostcommontestusedwhenPEissuspected,buthas beenreplacedbyCTangiography(CTA)astheinitialstudyofchoiceinmany medicalcenters.
======================================
b. PlaysanimportantroleindiagnosiswhenthereisacontraindicationtoCTA. Maybeusefulwhenthechestx-rayisclearandwhenthereisnounderlying cardiopulmonarydisease.

c. Interpretationofresults:canbeeithernormal,lowprobability,intermediate

probability,orhighprobability(treatmentguidelinesbasedonPIOPEDstudy). AnormalscanvirtuallyrulesoutPE—nofurthertestingisneeded—butascan isalmostnever“normal”inanyone. Ahigh-probabilityV/QscanhasaveryhighsensitivityforPE;treatwith heparin. Ifthereisloworintermediateprobability,clinicalsuspiciondetermines thenextstep.Ifclinicalsuspicionishigh,pulmonaryangiographyis indicated.Alternatively,performalowerextremityduplexultrasoundtoavoid pulmonaryangiography.Iftheduplexispositive,treatmentforDVTisthe sameasforPE.Iftheduplexisnegative/uncertain,thenpulmonary angiographyisindicatedtoexcludePE.

e

e

e

Quick HIT

IfCTAisnegativeforPE,andclinicalprobabilityofPEishigh,thereisa5%incidenceofPE.Sonegative resultsshouldbeinterpretedwithcaution,ifthepatienthasahighclinicalprobabilityofPE.

5. CTA

a. Hasbeenfoundtohavegoodsensitivity(>90%)andspecificity. b. Canvisualizeverysmallclots(assmallas2mm);maymissclotsinsmall

b. Can visualize very small clots (as small as 2 mm); may miss clots in small subsegmental vessels (far periphery).

subsegmentalvessels(farperiphery). c. Thetestofchoiceinmostmedicalcenters. d. Incombinationwithclinicalsuspicion,guidestreatment(seeFigure2-14). e. CTAcannotbeperformedinpatientswithsignificantrenalinsufficiencybecause

oftheIVcontrastthatisrequired.

Suspected PE Clinical Decision Rule (see Box 2-16) PE clinically unlikely PE clinically likely (Decision Rule score 4) (Decision Rule score >4) D-dimer Spiral CT scan Normal Abnormal No PE WE inconclusive present Cannot be performed Leg ultrasound No DVT treatment teat | <— present Nov V/Q scan or pulmonary arteriogram

FIGURE 2.14 embolism. Workupinapatientwithsuspectedpulmonary

6. Pulmonaryangiographyisthegoldstandard.

a. DefinitivelydiagnosesorexcludesPE,butisinvasive.Contrastinjectedinto thepulmonaryarterybranchafterpercutaneouscatheterizationofthe femoralvein.

b. Considerwhennoninvasivetestingisequivocalandriskofanticoagulation ishigh,orifthepatientishemodynamicallyunstableandembolectomymay berequired.Angiographyisrarelyperformedbecauseitcarriesa0.5% mortality.

7. D-dimerassay

a. D-dimerisaspecificfibrindegradationproduct;levelscanbeelevatedin patientswithPEandDVT.

b. D-dimerassayisafairlysensitivetest(90%to98%).Ifresultsarenormaland clinicalsuspicionislow,PEisveryunlikely.

c. Specificityislow—D-dimerresultsmayalsobeelevatedinMI,CHF,
======================================
pneumonia,andthepostoperativestate(orinanystateofacuteinflammation). AnycauseofclotorincreasedbleedingcanelevatetheD-dimerlevel. 8. Overall,theworkupofsuspectedPEisbasedonpretestprobability.TheWells criteria(ClinicalPearl2-15)isascoringsystemthattakesthisintoaccountand helpsguidetheworkup.

a. IfPEisunlikelybasedonthescoringsystem,thenthepretestprobabilityforPE islowandD-dimercanbeorderedtoexcludePE.IfPEislikely,CTAshouldbe performedgivenitshighsensitivityandspecificity.

Quick HIT

IfpretestprobabilityofPEislow,D-dimertestisagoodnoninvasivetesttoruleoutPE.SoifD-dimeris negative,youcanruleoutaclot.Butifitispositive,thisdoesnothelpyou.

Quick HIT

Starttherapeuticheparinasinitialtreatment.Alsostartwarfarinatthesametime.GoalistherapeuticINRof2to 3.

D.Treatment 1. Supplementaloxygentocorrecthypoxemia.Severehypoxemiaorrespiratory

failurerequiresintubationandmechanicalventilation.

CLINICALPEARL2-15

DichotomizedClinicalDecisionRuleforSuspectedAcutePulmonaryEmbolism (ModifiedWellsCriteria)
======================================
PreviousDVTorPE

1.5

Hemoptysis

Hemoptysis

1.0

Malignancy(currenttherapy,orinprevious6months,orpalliative) Score≤4indicatesthatPEisunlikely,score>4indicatesthatPEislikely. AdaptedfromWellsPS,AndersonDR,RodgerM,etal.Derivationofasimpleclinicalmodeltocategorizepatientsprobabilityofpulmonary embolism:increasingthemodelsutilitywiththeSimpliREDD-dimer.ThrombHaemost2000;83(3):416–420.Copyright©GeorgThieme VerlagKG.

1.0

2. Acuteanticoagulationtherapywitheitherunfractionatedorlow–molecular-weight heparintopreventanotherPE.Anticoagulationpreventsfurtherclotformation, butdoesnotlyseexistingemboliordiminishthrombussize.

a. Startimmediatelyonthebasisofclinicalsuspicion.Donotwaitforstudiesto confirmPEifclinicalsuspicionishigh.

b. Forunfractionatedheparin,giveonebolus,followedbyacontinuousinfusion for5to10days.ThegoalisanaPTTof1.5to2.5timescontrol.

e

e

e

HeparinactsbypromotingtheactionofantithrombinIII. Contraindicationstoheparinincludeactivebleeding,uncontrolledHTN,recent stroke,andheparin-inducedthrombocytopenia(HIT). Low–molecular-weightheparinhasbetterbioavailabilityandlower complicationratesthanunfractionatedheparin.Ithasbeenshowntobeatleast aseffectiveormoreeffectivethanunfractionatedheparin.

Quick HIT

WhyPEandDVTareproblematicforphysicians: Clinicalfindingsaresometimessubtleinboth. Noninvasiveimagingtestsdonotalwaysdetecteithercondition. Anticoagulationcarriessignificantrisk.

3. Oralanticoagulationwithwarfarinoroneofthenoveloralanticoagulants(e.g., rivaroxaban)forlong-termtreatment.

a. Canstartwarfarinwithheparinonday1. b. TargetINRwithwarfarinforPEtreatmentis2to3. c. Ifusinganoveloralanticoagulant(e.g.,rivaroxabanorapixaban),concurrent

treatmentwithheparinduringinitiationisnotnecessaryasthesemedicationsare effectiveimmediately.

d. Continuefor3to6monthsormore,dependingonriskfactors.Somepatientsat significantriskforrecurrentPE(e.g.,malignancy,hypercoagulablestate)may beconsideredforlifelonganticoagulation.

INRisawayofreportingthePTinastandardizedfashion. WarfarinincreasesINRvalues. “Therapeutic”INRisusuallybetween2and3.Notableexceptionsarecertainprostheticmechanical heartvalves,prophylaxisofrecurrentMI,andtreatmentofantiphospholipidantibodysyndrome,for which2.5to3.5isrecommended.

4. Thrombolytictherapy—forexample,streptokinase,tPA.
======================================
a. Speedsupthelysisofclots. b. Thereisnoevidencethatthrombolysisimprovesmortalityratesinpatientswith

b. There is no evidence that thrombolysis improves mortality rates in patients with PE. Therefore, its use is not well defined at this point.

PE.Therefore,itsuseisnotwelldefinedatthispoint. c. Situationsinwhichthrombolysisshouldbeconsidered:

PatientswithmassivePEwhoarehemodynamicallyunstable(persistent hypotension). Patientswithevidenceofrightheartfailure(thrombolysiscanreversethis). d. Catheter-directedthrombolysishaslowersystemicsideeffectsandshouldbe

consideredinpatientsathighriskforsystemicfibrinolysisorsurgery.

5. Inferiorvenacavainterruption(IVCfilterplacement).

a. Usehasbecomemorecommonbutreductioninmortalityhasnotbeen conclusivelydemonstrated.

b. PatientswhohaveIVCfilterplacedareathigherriskofrecurrentDVT(but lowerriskofrecurrentPE).

c. ComplicationsofIVCfilterplacement(rare):filtermigrationormisplacement, filtererosionandperforationofIVCwall,andIVCobstructionduetofilter thrombosis.

d. Indicationsinclude:

ContraindicationtoanticoagulationinapatientwithdocumentedDVTorPE. Acomplicationofcurrentanticoagulation. FailureofadequateanticoagulationasreflectedbyrecurrentDVTorPE. ApatientwithlowpulmonaryreservewhoisathighriskfordeathfromPE.

Quick HIT

IfanticoagulationiscontraindicatedinapatientwithPE,avenacavafilterisindicated.

6. Surgicalthrombectomy

a. Considerinpatientswithhemodynamiccompromise,alarge,proximal thrombus,andwhoarepoorcandidatesforfibrinolytics.

MiscellaneousTopics

PulmonaryAspiration

A.GeneralCharacteristics 1. Pulmonaryaspirationsyndromescanbeduetodifferenttypesofaspirates.

a. Acidicgastriccontents,whichareespeciallydamagingtothelungs. b. Aspirationoforopharyngealflora,whichcanleadtoinfection. c. Foreignbody/fluids(e.g.,chemicals).

2. Therightlungismostofteninvolvedduetoanatomy(rightmainbronchus followsastraighterpathdownward),particularlythelowersegmentsofthe rightupperlobeandtheuppersegmentsoftherightlowerlobe.

3. Predisposingfactors

a. Reducedlevelofconsciousness(e.g.,seizures,stroke,sedatingdrugs) b. Alcoholism c. Extubation(impairedpharyngealorlaryngealfunction) d. Excessivevomiting,ileus e. Tubefeeding,tracheostomytubes f. Anesthesia/surgery g. Neuromusculardiseases h. Esophagealdisorders(e.g.,achalasia,GERD,cancer)
======================================
Quick HIT

Aspirationpneumoniadevelopsin40%ofpatientswhoaspirate,usually2to4daysafteraspiration.Organisms areoftenmixed(aerobic–anaerobic).

B.ClinicalFeatures 1. Presentationisvariable.Somepatientsdevelopacuteonsetofrespiratorydistress. However,mostoften,thepatientappearswell,butlaterdevelopsrespiratory dysfunction(cough,shortnessofbreath,fever,tachypnea,hypoxemia,orfrothy sputum).

2. Itmaybeinitiallysilent,withdevelopmentofacuterespiratoryfailurewithno obviouscause.

3. Fevermayormaynotbepresent. 4. Mayleadtoobstructionoftheairwayswithlocalizedwheezing.

C.Diagnosis 1. FindingsonCXRarevariableandresembleinfiltratesthatmimicbacterial

pneumonia.Atelectasisandlocalareasofcollapsemayalsobepresent.

2. Differentiatingbetweenaspirationpneumonitisandaspirationpneumoniacanbe difficult.AspirationpneumonitiswillshowinfiltratesacutelyonCXR,whereas aspirationpneumoniatakesafewdaystodevelop.However,manyphysicians treatempiricallywithantibioticssinceitisoftendifficulttopredictwhichpatients willalsodeveloppneumoniawhenaspirationpneumonitisispresent (controversial).

Quick HIT

Aspirationcanleadtolungabscessifuntreated.Poororalhygienepredisposestosuchinfections.Foul-smelling sputumoftenindicatesanaerobicinfection.

D.Treatment 1. Ifaspirationwaswitnessed:ABCs(airway,breathing,andcirculation),

supplementaloxygen,andsupportivemeasures.

2. Ifaspirationpneumoniaissuspected,giveantibioticsthathaveanaerobicactivity (e.g.,clindamycin).

3. Ifobstructionispresent,earlybronchoscopyisindicated. 4. Preventioniscriticalinpatientsathighriskforaspiration:Keeptheheadofthe

bedelevated.Nasogastrictubescanbeconsideredtodecompressthestomach,but havenotbeenshowntodecreasetheriskofaspiration.

Dyspnea

A.GeneralCharacteristics 1. Distinguishacutefromchronicdyspnea. 2. Patientswithchronicdyspneausuallyhaveeitherheartorlungdiseaseorboth.It

maybedifficulttodistinguishbetweenthetwo.

3. ThemostcommoncausesofacutedyspneaincludeCHFexacerbation, pneumonia,bronchospasm,PE,andanxiety.

4. Assessthepatient’sbaselinelevelofactivity,whetherthedyspneaisnewinonset, anditsassociationwithexertion.

5. Ifthepatienthasahistoryofsmoking,cough,sputum,repeatedinfections,or occupationalexposure,lungdiseaseislikelytobethereasonforchronicdyspnea.
======================================
Quick HIT

Dependingonpatientpresentation,anyofthefollowingtestsmaybehelpfulindistinguishingbetweenlungand heartdiseases:

e CXR

CXR SputumGramstainandculture(ifpatienthassputum) PFTs ABGs ECG,echocardiogram

e

e PFTs

« ABGs

e

B.Causes 1. Cardiovascularcauses

a. CHF b. Ischemicheartdisease,acutemyocardialinfarction c. Pericarditis,cardiactamponade d. Arrhythmias e. Valvulardisease f. Congenitalheartdisease

2. Pulmonarycauses

a. Obstructivelungdiseases—COPD,asthma,bronchiectasis b. PE c. ARDS d. Pneumonia,TB,bronchitis e. Pleuraleffusion,pulmonaryedema f. Pneumothorax g. Upperairwayobstruction,foreignbodyaspiration h. ILD i. Chestwallabnormalities(kyphoscoliosis),ribfracture

3. Psychiatricdisease—generalizedanxietydisorder,panicattacks,hyperventilation 4. Systemiccauses—severechronicanemia,sepsis,DKA,GERD,medication

(narcoticoverdose)

5. Chestwallabnormalities—kyphoscoliosis,ribfracture,ankylosingspondylitis 6. Neuromusculardiseasesthatweakenrespiratorymuscles—myastheniagravis,

musculardystrophy

Quick HIT

PatientswithchronicCOPDcanalsoexperienceparoxysmalnocturnaldyspnea.Theirexcessiveairway secretionsaccumulateatnightcausingairwayobstruction,resultingindyspneathatawakensthepatientand forceshimorhertocleartheairway.Therefore,paroxysmalnocturnaldyspneaisnotspecifictoheartdisease.

C.Diagnosis 1. Thoroughhistoryandphysicalexamination,vitalsigns. 2. Pulseoximetry—normalis96%to100%onroomair.Beawarethatthebaseline

oxygensaturationofmanyCOPDpatientsischronicallylow.

3. ABG—maybeindicatedifoxygensaturationislowonpulseoximetry,if hypercarbiaissuspected,ortoevaluateforacid–baseabnormalities.

4. CXR—canrevealpneumothorax,pleuraleffusion,pulmonaryvascularcongestion secondarytoCHF,infiltratesduetopneumonia,ILD,andsoon.

5. CBC—toevaluateforanemia,infection. 6. ECG—mayshowventricularhypertrophyorevidenceofischemicheartdisease. 7. Echocardiogram—forfurtherevaluationofCHF,valvularheartdisease. 8. PFTs—performifalloftheabovearenormalorifobstructivelungdiseaseis

suspected.SeeTable2-7.

9. V/QscanorspiralCTscan—performifPEissuspected. 10. Bronchoscopy—indicatedifforeignbodyaspirationissuspected.
======================================
Quick HIT

AchronicCO2retainer(commoninCOPDpatients)usuallyhasnormalpHandincreasedHCO3levels.IfCO2 retentionisacute,pHwillbedecreasedandHCO3willbeclosertonormallevels.

TABLE2-7 ImportantPulmonaryStudies

Pulse oximetry © Measures percentage of oxygenated hemoglobin Follows a sigmoid curve in relationship to partial pressure of oxygen (Pa0,) in the arterial blood © Oxygen saturation of <88% is the established criterion for receiving home oxygen ¢ Useful in most categories of patients in whom pulmonary disease is suspected Also helpful in assessing a patient with dyspnea, whether acute or chronic ¢ Useful as a screening test because it is very sensitive for detecting gas exchange abnormalities © Not very specific © Sensitivity is increased during exercise Arterial blood Measures the partial pressures of For every 10 mm Hg increase or ¢ ABG is not necessary in all patients with gas (ABG) oxygen and carbon dioxide as wellas decrease in PaCO,, there should be a pulmonary dysfunction. Ask yourself the pH of the arterial blood. corresponding increase or decrease in whether the results of the ABG are going © Normal pH: 7.35-7.45 pH by 0.08. In general, if the change in to influence what you do for the patient © Normal PaO,: decreases with age pH is in the same direction as change before performing it. (90 is normal in a 20-yr-old person) —_in PaCO,, then the primary disorder is ¢ ABG is painful, and radial artery spasm © Normal PaCO,: 35-45 mm Hg metabolic. When there is an inverse can result in ischemia of the hand in relationship, the primary disorder is patients with radial-dominant circulation. respiratory. Spirometry ¢ From maximum inspiration, the ¢ Helps to distinguish obstructive from © Volumes are measured as percentages patient exhales as rapidly and restrictive lung disease. of predicted values based on age, height, forcibly as possible to maximum Useful in assessing degree of and sex. expiration. functional impairment as well as Incorrect measurement or technique may © Spirometer plots the change in monitoring effectiveness of treatment lead to false positives. lung volume against time (see lung (e.g., during asthma exacerbation). volumes below). © May detect respiratory impairment in asymptomatic patients (e.g., smokers).
======================================
Quick HIT

MassiveHemoptysis

Definedasmorethan500mLofbloodin24hours. Themostcommoncausesarebronchiectasisandbleedingdiathesis. Airwayprotectioniskey.Intubateifnecessary. Bronchoscopycanhelpidentifythebleedingsource. Usebronchialarteryembolizationorballoontamponadeoftheairwayifindicated.

D.Treatment 1. Treattheunderlyingcause. 2. Useintubationandmechanicalventilationinthefollowingsituations:

a. Ifimpendingrespiratoryfailureissuspected b. Ifpatientisunabletoprotectairway(e.g.,decreasedmentalstatus,stroke,drug

overdose)

c. Severehypoxiadespitesupplementaloxygen(PO2<50to60) d. Severehypercarbia(PCO2>50)

3. Exerciseandconditioningmayimproveperceptionofdyspnea.

Hemoptysis

A.GeneralCharacteristics 1. Definedasexpectorationofblood;hemoptysisvarieswidelyinseverityand

medicalsignificance.Theamountofblooddoesnotnecessarilycorrespondwith thegravityoftheunderlyingcause.

2. Differentialdiagnosis

a. Mostcommoncausesinclude: Bronchitis(50%ofcases) Lungcancer(bronchogeniccarcinoma) TB Bronchiectasis Pneumonia Manytimestheetiologyremainsidiopathicafterthoroughevaluation(upto 30%ofcases) b. Othercausesinclude:

Goodpasturesyndrome(anti-GBMantibodydisease) PEwithpulmonaryinfarction Aspergillomawithincavities Mitralstenosis(elevatedpulmonaryvenouspressure) Hemophilia

B.Diagnosis 1. Verifythathemoptysishastrulyoccurred.Forexample,superficialmouth lacerations,epistaxis,orhematemesismaybeconfusedwithhemoptysis.

2. Historyandphysical

a. Fever,nightsweats,andweightlosssuggestTB. b. FeversandchillsorahistoryofHIVsuggestseitherpneumoniaorTB. c. LookforriskfactorsforPE. d. Inthepresenceofacuterenalfailureorhematuria,Goodpasturesyndrome

shouldbeconsidered.

Evaluationofhemoptysis:

« CXR

CXR Fiberopticbronchoscopy CTscanofthechest

e

¢

3. Diagnosticstudies

a. CXR

e

e

Maybeaclearindicatorofapathogenicprocessorevendiagnostic—for example,iffungusball,irregularmass,granuloma,oropacityconsistentwith pulmonaryinfarctionispresent. AnormalCXRdoesnotexcludeaseriouscondition,especiallyPEandeven lungcancer.

b. Fiberopticbronchoscopy
======================================
e

¢

e

ShouldbeperformedevenifCXRisnormalandifthereisasignificant clinicalsuspicionforlungcarcinoma. Lookforasmalltumorthatmaynotbeevidentonaradiograph. Maylocalizethesiteofbleeding.

4. CTofchest—performedasacomplementtobronchoscopyorasasubstituteif therearecontraindicationstobronchoscopy.

C.Treatment 1. Treattheunderlyingcause. 2. Suppressthecoughifitisaggravatingthehemoptysis. 3. Correctbleedingdiathesis(althoughanticoagulationisthetreatmentforPE).

3

xX)

DiseasesoftheGastrointestinalSystem

SarahJensen

DiseasesoftheColon ColorectalCancer

A.GeneralCharacteristics 1. ThirdmostcommoncancerintheUnitedStatesinmenandwomen. 2. Virtually,allcolorectaltumorsarisefromadenomas.Majorityare

endoluminaladenocarcinomasarisingfromthemucosa.Rarely,carcinoid tumors,lymphomas,andKaposisarcomamaybepresent.

Quick HIT

NotethatsomeCRCsmaybleedintermittentlyornotatall.

3. Screening—refertoChapter12,AmbulatoryMedicine

a. Stool-basedscreeningtests b. Fecaloccultbloodtesting(FOBT)haspoorsensitivityandspecificity.Positive predictivevalueisonlyabout20%,butallpatientswithpositiveFOBTneeda colonoscopyregardless.

c. Fecalimmunochemicaltests(FIT)detecthumanhemoglobinandaremore specificforcolorectalcancer(CRC)thanFOBT.Screeningwiththistestcanbe doneyearlybutalsorequirecolonoscopyifpositive.

d. Digitalrectalexamination:Onlyabout10%oftumorsarepalpablebyrectal

examination. e. Colonoscopy

e

e

Mostsensitiveandspecifictest;thediagnosticstudyofchoiceforpatients withapositiveFOBT Diagnosticandtherapeutic(e.g.,biopsy,polypectomy)

f. Flexiblesigmoidoscopy

¢

e

Canbeusedtoreachtheareawhereapproximately50%to70%ofpolypsand cancersoccur(witha60-cmscope) Diagnosticinabouttwo-thirdsofallCRCs

g. Bariumenema

e

e

e

Nolongerrecommendedforscreening. Evaluatesentirecolon;complementarytoflexiblesigmoidoscopy. Anyabnormalfindingneedstobeevaluatedbycolonoscopy.

h. Carcinoembryonicantigen(CEA)—notusefulforscreening;usefulfor establishingbaseline,monitoringtreatmentefficacy,andrecurrencesurveillance.

CEAdoeshaveprognosticsignificance:PatientswithpreoperativeCEA>5 ng/mLhaveaworseprognosis.
======================================
Quick HIT

Coloncancerscreeningbeginsatage50.Ifonefamilymemberhascoloncancer,beginatage40,or10 yearsbeforeageofonsetoffamilymember.

4. ClinicalstagingisdonewithCTscanofchest,abdomen,andpelvisandby physicalexamination(ascites,hepatomegaly,lymphadenopathy).

5. Patternofspread

a. Directextension—circumferentiallyandthenthroughthebowelwalltolater invadeotherabdominoperinealorgans

b. Hematogenous

e

e

Portalcirculationtoliver—liverismostcommonsiteofdistantspread Lumbar/vertebralveinstolungs

c. Lymphatic—regionally d. Transperitonealandintraluminal

Quick HIT

About20%ofpatientshavedistantmetastaticdiseaseatpresentation.

B.RiskFactors 1. Age—everyoneovertheageof50yearsisatincreasedrisk 2. Adenomatouspolyps

a. Thesearepremalignantlesions,butmostdonotdevelopintocancer. b. Villousadenomashavehighermalignantpotentialthantubularadenomas. c. Thelargerthesize,andthegreaterthenumberofpolyps,thehighertheriskof

cancer.

3. PersonalhistoryofpriorCRCoradenomatouspolyps 4. Inflammatoryboweldisease(IBD)

a. Bothulcerativecolitis(UC)andCrohndiseaseposeanincreasedriskforCRC, butUCposesagreaterriskthanCrohndisease.

b. IncidenceofCRCis5%to10%at20yearsand12%to20%at30yearswith UC.BeginsurveillancecolonoscopyforCRC8yearsfollowingthediagnosisof IBD.

5. Familyhistory

a. Multiplefirst-degreerelativeswithCRC. b. Anyfirst-degreerelativediagnosedwithCRCoradenomaunderage60.

6. Dietaryfactors

a. High-fat,low-fiberdietsassociatedwithahigherriskofCRC

7. Majorpolyposissyndromes

a. Familialadenomatouspolyposis(FAP)

e

e

e

Autosomaldominantdiseasecausedbyhereditarymutationsinthe adenomatouspolyposiscoli(APC)tumorsuppressorgene. Characterizedbyhundredsofadenomatouspolypsinthecolon.Thecolonis alwaysinvolved,andtheduodenumisinvolvedin90%ofcases.Polypsmay alsoforminthestomach,jejunum,andileum. InallFAPcases,theriskofCRCis100%bythethirdorfourthdecadeoflife. Prophylacticcolectomyisusuallyrecommended.

e

b. Gardnersyndrome

e

e

e

VariantofFAP,autosomaldominant. Polypsplusosteomas,dentalabnormalities,benignsofttissuetumors,desmoid tumors,sebaceouscysts. RiskofCRCis100%byapproximatelyage40.
======================================
c. Turcotsyndrome

e

e

Canbeinheritedasautosomaldominantorrecessive. Polypspluscerebellarmedulloblastomaorglioblastomamultiforme.

d. Peutz–Jeghers

e

e

e

e

e

Autosomaldominant. SingleormultiplehamartomasthatmaybescatteredthroughtheentireGI tract:insmallbowel(78%),colon(60%),stomach(30%). Pigmentedspotsaroundlips,oralmucosa,face,genitalia,andpalmar surfaces. Unlikeadenomas,hamartomashaveavery-lowmalignantpotential. Slightlyincreasedincidenceofvariouscarcinomas(e.g.,stomach,ovary, breast,cervix,testicle,lung). IntussusceptionorGIbleedingmayoccur.

e

e. Familialjuvenilepolyposiscoli Rare;presentsinchildhood. OnlysmallriskofCRC. Between10andhundredsofjuvenilecolonpolyps.

f. HereditarynonpolyposisCRC—withoutadenomatouspolyposis

e

e

LynchsyndromeI(site-specificCRC)—early-onsetCRC;absenceof antecedentmultiplepolyposis. LynchsyndromeII(cancerfamilysyndrome)—allfeaturesofLynchIplus increasednumberandearlyoccurrenceofothercancers(e.g.,femalegenital

tract,skin,stomach,pancreas,brain,breast,biliarytract).

C.ClinicalFeatures 1. Thepresenceofsymptomsistypicallyamanifestationofrelativelyadvanced

1. The presence of symptoms is typically a manifestation of relatively advanced disease. Symptoms include melena or hematochezia, abdominal pain, change in bowel habits, or unexplained iron deficiency anemia

disease.Symptomsincludemelenaorhematochezia,abdominalpain,changein bowelhabits,orunexplainedirondeficiencyanemia 2. Signsandsymptomspotentiallycommontoalllocations

a. Abdominalpainisthemostcommonpresentingsymptom.Canbecausedby partialobstructionorperitonealdissemination.RememberthatCRCisthemost commoncauseoflargebowelobstructioninadults.Colonicperforationcan leadtoperitonitisandisthemostlife-threateningcomplication.

Quick HIT

ThesensitivityofindividualsymptomsfordiagnosingCRCispoor.

b. Weightloss c. Bloodinstool d. Maybeasymptomatic

3. Signsandsymptomsbasedonspecificlocationoftumor

a. Right-sidedtumors

¢

¢

¢

e

Obstructionisunusualbecauseofthelargerluminaldiameterallowingfor largetumorgrowthtogoundetected.Thececumhasthelargestluminal diameterofanypartofthecolon. Commonfindings:occultbloodinstool,irondeficiencyanemia,andmelena. Changeinbowelhabitsisuncommon. Triadofanemia,weakness,rightlowerquadrant(RLQ)mass(occasionally)is present.

Rightside:Melenaismorecommon.Leftside:Hematocheziaismorecommon.

b. Left-sidedtumors
======================================
e

e

e

e

e

Smallerluminaldiameter—signsofobstructionmorecommon Changeinbowelhabitsmorecommon—alternatingconstipation/diarrhea; narrowingofstools(“pencilstools”) Hematocheziamorecommon Rectalcancer(20%to30%ofallCRCs) Symptomsincludehematochezia(mostcommon),tenesmus,rectalmass,and

feelingofincompleteevacuationofstoolduetomass.

Quick HIT

Rectalcancerhasahigherrecurrencerateandalower5-yearsurvivalratethancoloncancer.

D.Treatment 1. SurgeryistheonlycurativetreatmentofCRC.Surgicalresectionoftumor-

containingbowelaswellasresectionofregionallymphatics

2. CEAlevelshouldbeobtainedbeforesurgery(seebelow) 3. Utilityofadjuvanttherapy(chemotherapyorradiationtherapy)dependsonthe

3. Utility of adjuvant therapy (chemotherapy or radiation therapy) depends on the stage of tumor and is beyond the scope of this book

stageoftumorandisbeyondthescopeofthisbook 4. Follow-upisimportant,andvariesamongphysicians

a. Stoolguaiactest b. AnnualCTscanofabdomen/pelvisandCXRforupto5years c. Colonoscopyat1yearandthenevery3years d. CEAlevelsarecheckedperiodically(every3to6months)

e

e

e

AsubsequentincreaseinCEAisasensitivemarkerofrecurrence Often,second-lookoperationsarebasedonhighCEAlevelspostresection VeryhighelevationsofCEAsuggestliverinvolvement

5. About90%ofrecurrencesoccurwithin3yearsaftersurgery

Quick HIT

Radiationtherapyisnotindicatedinthetreatmentofcoloncancer,althoughitisusedintreatingrectalcancer.

ColonicPolyps

A.NonneoplasticPolyps—benignlesionswithnomalignantpotential 1. Hyperplastic(metaplastic)polypsarethemostcommon(90%)nonneoplastic

polyps;generallyremainsmallandasymptomatic.

2. Nospecifictherapyrequired,buttheycanbedifficulttodistinguishfrom neoplasticpolypsandsoarecommonlyremoved.

3. Juvenilepolyps(typicallyinchildrenyoungerthan10years)arehighlyvascular andcommon,sotheyshouldberemoved.

4. Inflammatorypolyps(pseudopolyps)areassociatedwithUC.

Quick HIT

Polypsmaybeisolatedormayoccuraspartofinheritedpolyposissyndromes,whichhaveavery-high malignantpotential.

B.AdenomatousPolyps—benignlesions,buthavesignificantmalignantpotential; precursorsofadenocarcinoma.

1. Canbeoneofthreetypesofadenoma

a. Tubular(mostcommon;upto60%to80%ofcases)—smallestriskof malignancy
======================================
b. Tubulovillous—intermediateriskofmalignancy c. Villous—greatestriskofmalignancy

2. Candeterminemalignantpotentialbythefollowing:

a. Size—thelargerthepolyp,thegreaterthemalignantpotential b. Histologictype c. Atypiaofcells d. Shape—sessile(flat,morelikelytobemalignant)versuspedunculated(ona

stalk)

Quick HIT

¢

¢

¢

Mostpolypsarefoundintherectosigmoidregion. Mostpatientsareasymptomatic. Insymptomaticpatients,rectalbleedingisthemostcommonsymptom.

C.Treatment—completeremovalofpolyp

Diverticulosis

A.GeneralCharacteristics 1. Causedbyincreasedintraluminalpressure—innerlayerofcolonbulges

throughthefocalareaofweaknessinthecolonwall(usuallyanareaofblood vesselpenetration).

2. Riskfactors

a. Low-fiberdiets:Constipationcausesintraluminalpressurestoincrease. b. Positivefamilyhistory.

3. Prevalenceincreaseswithage. 4. Themostcommonlocationisthesigmoidcolon.However,diverticulamay

occuranywhereinthecolon.

Quick HIT

Diverticulosis(pouchesinthecolonwall)shouldbedistinguishedfromdiverticulitis(inflammationorinfection ofdiverticula).Diverticulitisisacomplicationofdiverticulosis.

B.ClinicalFeatures 1. Usuallyasymptomaticanddiscoveredincidentallyonimaging(e.g.,CT abdomen/pelvis)orwhenacomplicationoccurs(diverticularbleedor diverticulitis)

2. Vagueleftlowerquadrant(LLQ)discomfort,bloating,constipation/diarrheamay bepresent.

3. Only10%to20%becomesymptomatic(i.e.,developcomplications—seebelow).

Quick HIT

¢

¢

Complicationsofdiverticulosisincludepainlessrectalbleedinganddiverticulitis. Complicationsofdiverticulitisincludebowelobstruction,abscess,andfistulas.

C.Diagnosis 1. Bariumenemaisthetestofchoice. 2. Abdominalx-raysareusuallynormalandarenotdiagnosticfordiverticulosis.

D.Treatment 1. High-fiberfoods(suchasbran)toincreasestoolbulk 2. Psyllium(ifthepatientcannottoleratebran)

E.Complications

1. Painlessrectalbleeding(upto40%ofpatients)

a. Bleedingisusuallyclinicallyinsignificantandstopsspontaneously.Nofurther treatmentisnecessaryinthesepatients.

b. Bleedingcanbesevereinabout5%ofpatients.Inmanycases,thebleeding stopsspontaneously.Colonoscopymaybeperformedtolocatethesiteof bleeding(mesentericangiographyincertaincases).Ifbleedingispersistent and/orrecurrent,surgery(segmentalcolectomy)maybeneeded.

2. Diverticulitis(15%to25%ofpatients)

a. Occurswhenfecesbecomeimpactedinthediverticulum,leadingtoerosionand microperforation.

b. Canbecomplicated(seealsoClinicalPearl3-1)oruncomplicated. Uncomplicateddiverticulitisaccountsformostcasesandreferstodiverticulitis withoutthecomplicationslistedinClinicalPearl3-1.

CLINICALPEARL3-1
======================================
ComplicationsofDiverticulitis

e

¢

¢

e

Abscessformation(canbedrainedeitherpercutaneouslyunderCTguidanceorsurgically) Colovesicalfistula—accountsfor50%offistulassecondarytodiverticulitis;50%closespontaneously Obstruction—duetochronicinflammationandthickeningofbowelwall Freecolonicperforation—uncommonbutcatastrophic(leadstoperitonitis)

c. Clinicalfeatures:fever,LLQpain,leukocytosis.

Otherpossiblefeatures:alterationinbowelhabits(constipationordiarrhea), vomiting,andsometimesapainfulmassonrectalexaminationifinflammation isneartherectum.

Quick HIT

Diverticulitisrecursinabout30%ofpatientstreatedmedically,usuallywithinthefirst5years.

d. Diagnostictests

e¢

e

e

CTscan(abdomenandpelvis)withoralandIVcontrastisthetestof choice;itmayrevealaswollen,edematousbowelwalloranabscess. AbdominalradiographshelpinexcludingotherpotentialcausesofLLQpain, andcanruleoutileusorobstruction(indicatedbyair–fluidlevels,distention), andperforation(indicatedbyfreeair). Bariumenemaandcolonoscopyarecontraindicatedinacutediverticulitis duetotheriskofperforation.

Quick HIT

¢

e

Diverticulosis—bariumenemaisthetestofchoice. Diverticulitis—CTscanisthetestofchoice(bariumenemaandcolonoscopycontraindicated).

e. Treatment

UncomplicateddiverticulitisismanagedwithIVantibiotics,bowelrest(NPO), IVfluids.Mildepisodescanbetreatedonoutpatientbasisifpatientisreliable andhasfewornocomorbidconditions.Ifsymptomspersistafter3to4days, surgery,resectionoftheinvolvedsegment,maybenecessary.Antibiotics continuedfor7to10days.Aftersuccessfultreatment,aboutone-thirdhas recurrence.Surgeryrecommendedforrecurrentepisodes. Complicateddiverticulitis—surgeryindicated.

Quick HIT

Asmanyas25%ofpatientswithbleedingarteriovenousmalformationshaveaorticstenosis.However,nocause- and-effectrelationshiphasbeenproven.

AngiodysplasiaoftheColon(ArteriovenousMalformations, VascularEctasia)

Tortuous,dilatedveinsinsubmucosaofthecolon(usuallyproximal)wall. AcommoncauseoflowerGIbleedinginpatientsoverage60. Bleedingisusuallylowgrade,but15%ofpatientsmayhavemassivehemorrhageif veinsrupture. Diagnosedbycolonoscopy(preferredoverangiography). Inabout90%ofpatients,bleedingstopsspontaneously. Itcanfrequentlybetreatedbycolonoscopiccoagulationofthelesion.Ifbleeding persists,arighthemicolectomyshouldbeconsidered.
======================================
Quick HIT

e

e

Acutemesentericischemiaismuchmorecommonthanchronicmesentericischemia. Patientswithacutemesentericischemiaoftenhavepre-existingheartdisease(e.g.,congestiveheartfailure, CAD).

AcuteMesentericIschemia

A.Introduction 1. Resultsfromacompromisedbloodsupply,usuallytothesuperiormesenteric

vessels.

2. Therearefourtypes(threeareduetoarterialdisease,oneduetovenousdisease): a. Arterialembolism(50%ofcases):Almostallemboliareofacardiacorigin

(e.g.,atrialfibrillation,MI,valvulardisease).

b. Arterialthrombosis(25%ofcases).

Mostofthesepatientshaveatheroscleroticdisease(e.g.,coronaryartery disease[CAD],PVD,stroke)atothersites. Acuteocclusionoccursoverpre-existingatheroscleroticdisease.Theacute eventmaybeduetoadecreaseincardiacoutput(e.g.,resultingfromMI, CHF)orplaquerupture. Collateralcirculationhasusuallydeveloped. c. Nonocclusivemesentericischemia(20%ofcases).

e

e

Splanchnicvasoconstrictionsecondarytolowcardiacoutput. Typicallyseenincriticallyillelderlypatients.

d. Venousthrombosis(<10%ofcases).Manypredisposingfactors—infection, hypercoagulablestates,oralcontraceptives,portalHTN,malignancy, pancreatitis.

3. Theoverallmortalityrateforalltypesofacutemesentericischemiaisabout60% to70%.Ifbowelinfarctionhasoccurred,themortalityratecanexceed90%.

Quick HIT

DifferencesinPresentationofTypesofAcuteMesentericIschemia: Embolic—symptomsaremoresuddenandpainfulthanothercauses Arterialthrombosis—symptomsaremoregradualandlessseverethanemboliccauses Nonocclusiveischemia—typicallyoccursincriticallyillpatients Venousthrombosis—symptomsmaybepresentforseveraldaysorevenweeks,withgradualworsening

B.ClinicalFeatures 1. Classicpresentationisacuteonsetofsevereabdominalpaindisproportionate

tophysicalfindings.Painisduetoischemiaandpossiblyinfarctionofintestines, analogoustoMIinCAD.

a. Theabdominalexaminationmayappearbenignevenwhenthereissevere ischemia.Thiscanleadtoadelayindiagnosis.

b. Theacutenessandtheseverityofpainvarydependingonthetypeofacute mesentericischemia(seeQuickHit).

2. Anorexia,vomiting. 3. GIbleeding(mild). 4. Peritonitis,sepsis,andshockmaybepresentinadvanceddisease.
======================================
Quick HIT

e

¢

Signsofintestinalinfarctionincludehypotension,tachypnea,lacticacidosis,fever,andalteredmentalstatus (eventuallyleadingtoshock). Checkthelactatelevelifacutemesentericischemiaissuspected.

C.Diagnosis 1. Mesentericangiographyisthedefinitivediagnostictest. 2. Obtainaplainfilmoftheabdomentoexcludeothercausesofabdominalpain. 3. “Thumbprinting”canbeseenonbariumenemaduetothickenededematous

mucosalfolds.

D.Treatment 1. Supportivemeasures:IVfluidsandbroad-spectrumantibiotics 2. Directintra-arterialinfusionofpapaverine(vasodilator)intothesuperior

2. Direct intra-arterial infusion of papaverine (vasodilator) into the superior mesenteric system during arteriography is the therapy of choice for all arterial causes of acute mesenteric ischemia. This relieves the occlusion and vasospasm.

mesentericsystemduringarteriographyisthetherapyofchoiceforallarterial causesofacutemesentericischemia.Thisrelievestheocclusionandvasospasm. 3. Directintra-arterialinfusionofthrombolyticsorembolectomymaybeindicated

insomepatientswithembolicacutemesentericischemia.

4. Heparinanticoagulationisthetreatmentofchoiceforvenousthrombosis. 5. Surgery(resectionofnonviablebowel)maybeneededinalltypesofacute

mesentericischemiaifsignsofperitonitisdevelop.

ChronicMesentericIschemia

Causedbyatheroscleroticocclusivediseaseofmainmesentericvessels(celiac artery,superiorandinferiormesentericarteries). Abdominalangina—dullpain,typicallypostprandial(whenthereisincreased demandforsplanchnicbloodflow);analogoustoanginalpainofCAD. Significantweightlossmayoccurduetoabdominalangina. Mesentericarteriographyconfirmsthediagnosis. Surgicalrevascularizationisdefinitivetreatmentandleadstopainreliefin90%of cases.

PatientswithOgilviesyndromeareusuallyillandcommonlyhaveahistoryofrecentsurgeryormedicalillness.

OgilvieSyndrome

Anunusualprobleminwhichsigns,symptoms,andradiographicevidenceoflarge bowelobstructionarepresent,butthereisnomechanicalobstruction. Commoncausesincluderecentsurgeryortrauma,seriousmedicalillnesses(e.g., sepsis,malignancy),andmedications(e.g.,narcotics,psychotropicdrugs, anticholinergics). Thediagnosiscannotbeconfirmeduntilmechanicalobstructionofthecolonis excluded. Treatmentconsistsofstoppinganyoffendingagentandsupportivemeasures(IV fluids,electrolyterepletion). Decompressionwithgentleenemasornasogastricsuctionmaybehelpful. Colonoscopicdecompressionisusuallysuccessfuliftheabovemeasuresfail. Surgicaldecompressionwithcecostomyorcolostomyisalastresort.
======================================
Quick HIT

Wheneverthereiscolonicdistentionandthecolondiameterexceeds10cm,bowelisatriskofimpending ruptureleadingtoperitonitisandevendeath;decompressimmediately.

ColonicVolvulus

A.GeneralCharacteristics 1. Definedastwistingofaloopofintestineaboutitsmesentericattachmentsite. 2. Mayresultinobstructionorvascularcompromisewiththepotentialfornecrosis

and/orperforationifuntreated.

3. Themostcommonsiteisthesigmoidcolon(75%ofallcases). 4. Cecalvolvulusaccountsfor25%ofallcases. 5. Riskfactors

a. Chronicillness,age,institutionalization,andCNSdiseaseincreaseriskof sigmoidvolvulus.

b. Cecalvolvulusisduetocongenitallackoffixationoftherightcolonandtends tooccurinyoungerpatients.

c. Chronicconstipation,laxativeabuse,antimotilitydrugs. d. Priorabdominalsurgery.

B.ClinicalFeatures 1. Acuteonsetofcolickyabdominalpain 2. Obstipation,abdominaldistention 3. Anorexia,nausea,vomiting

C.Diagnosis 1. Plainabdominalfilms.

a. Sigmoidvolvulus—Omegaloopsign(orbentinner-tubeshape)indicatesa dilatedsigmoidcolon.

b. Cecalvolvulus(distentionofcecumandsmallbowel)—Coffeebeansign indicatesalargeair–fluidlevelinRLQ.

2. Sigmoidoscopy—preferreddiagnosticandtherapeutictestforsigmoidvolvulus (notforcecalvolvulus);leadstosuccessfultreatment(untwistingand decompression)inmanycases.

3. Bariumenema—revealsthenarrowingofthecolonatthepointwhereitistwisted (“bird’sbeak”).

D.Treatment 1. Sigmoidvolvulus:Nonoperativereduction(decompressionviasigmoidoscopy)is successfulin>70%ofcases.Therecurrencerateishigh,soelectivesigmoid colonresectionisrecommended.

2. Cecalvolvulus:Emergentsurgeryisindicated.

Donotperformabariumenemaifstrangulationissuspected!

DiseasesoftheLiver

AcuteLiverFailure

A.GeneralCharacteristics 1. Acuteliverfailurereferstoanacute,severeliverinjurywithconcurrent

encephalopathyandimpairedsyntheticliverfunction.

2. Inordertodiagnose,patientsmustnothaveunderlyingliverdiseaseorcirrhosis priortoinsult.

3. Typically,timecourseofillnessislessthan26weeks.

B.Causes 1. Alargenumberofinsultscancauseacuteliverfailure.Mostnotablyareas

follows:

a. Acetaminophen b. HepatitisA,B,C,D,E c. Autoimmunehepatitis d. Wilsondisease e. Ischemichepatopathy f. Budd–Chiaridisease g. Acutefattyliverofpregnancy/HELLPsyndrome h. Metastasis i. Sepsis j. Toxins

C.Diagnosis 1. Diagnosisrequiresthreecomponents:encephalopathy,INR>1.5(impaired

syntheticliverfunction)andelevatedliverenzymes.

2. Patientsmayalsopresentwithjaundice,hepatomegaly,abdominaltenderness,and thrombocytopenia.

3. Etiologyofdiseasecandeterminedthoughhistory,physicalexam,laboratory tests,andimagingstudies(CTabdomen/pelvis,MRI,abdominalUS).Aliver biopsymaybenecessary.
======================================
Quick HIT

SignsofAcuteLiverFailure(anyofthefollowingmaybepresent):

¢

e

¢

Coagulopathy Jaundice Hypoglycemia(liverstoresglycogen)

e

e

e

e

Hepaticencephalopathy Infection ElevatedLFTvalues Anycomplicationassociatedwithcirrhosis

D.Management 1. Patientsshouldbewatchedcloselyastheycanquicklydecompensate.Eligibility forlivertransplantshouldbeconsideredearly,although40%ofpatientswill recoverwithsupportivecare(nutritionalsupportandtreatingcomplications).

2. Treatunderlyingcauseifapplicable. 3. Encephalopathy—monitorwithneurologicchecksevery2hours.Consider

lactulosetherapy,althoughnotshowntoimproveoveralloutcomes.

4. Cerebraledemariskofelevatedintracranialpressure(ICP)andbrainstem herniation(amajorcauseofmorbidityandmortality).ConsidermonitoringICPin patientswithadvancingencephalopathy.TreatelevatedICPwithmannitol.

5. Livertransplantation.Eightypercent1-yearsurvivalposttransplant

Cirrhosis

A.GeneralCharacteristics 1. Cirrhosisisachronicliverdiseasecharacterizedbyfibrosis,disruptionofthe

liverarchitecture,andwidespreadnodulesintheliver.Thefibroustissuereplaces damagedordeadhepatocytes.

2. Cirrhosisisgenerallyirreversiblewhenadvanced.Inearlystages,specific treatmentofthecauseofcirrhosismayimproveorreversethecondition.The pointatwhichthediseasebecomesirreversibleisnotclear.

3. Thedistortionofliveranatomycausestwomajorevents.

a. Decreasedbloodflowthroughtheliverwithsubsequenthypertensioninportal circulation(portalhypertension)—thishaswidespreadmanifestations, includingascites,peripheraledema,splenomegaly,andvaricosityofveins“back stream”inthecirculation(e.g.,gastric/esophagealvarices,hemorrhoids).

b. Hepatocellularfailurethatleadstoimpairmentofbiochemicalfunctions,such asdecreasedalbuminsynthesisanddecreasedclottingfactorsynthesis.

4. Assessmentofhepaticfunctionalreserve.

a. Child–Pughscore(seeTable3-1)estimateshepaticreserveinliverfailure.Itis usedtomeasurediseaseseverityandisapredictorofmorbidityandmortality.

b. Child’sclassCindicatesmostseveredisease,andChild’sclassAindicates milderdisease.

c. ModelforEnd-StageLiverDisease(MELD)scoreisaseverityscaletopredict 3-monthsurvival.Scoringisalsousedtoprioritizepatientsawaitingliver transplant.Calculationdependsonpatient’sserumbilirubin,serumcreatinine, andINR.AnincreasedMELDscoreincirrhoticpatientsisassociatedwithan increased3-monthmortalityrisk.

TABLE3-1 Child–PughClassificationtoAssessSeverityofLiverDisease

Ascites Mild—moderate Severe Bilirubin(mg/dL) <2.0 2.0-3.0 >3.0 Encephalopathy Mild—moderate Severe INR ratio Al 1.7-2.3 22:3 Albumin >3.5 2.8-3.5 <2.8 Class A—5 to 6 points total (least severe liver disease), 85% 2-year survival Class B—7 to 9 points total (moderate—severe liver disease), 57% 2-year survival Class C—10 to 15 points total (severe liver disease), 35% 2-year survival
======================================
B.Causes 1. Alcoholicliverdisease—mostcommoncause

a. Referstoarangeofconditionsfromfattyliver(reversible,duetoacute ingestion)tocirrhosis(irreversible)

b. Fifteenpercentto20%ofheavydrinkersdevelopalcoholiccirrhosis 2. ChronichepatitisBandCinfections—nextmostcommoncauses 3. Nonalcoholicsteatohepatitis(NASH) 4. Drugs(e.g.,acetaminophentoxicity,methotrexate) 5. Autoimmunehepatitis 6. Primarybiliarycirrhosis(PBC),secondarybiliarycirrhosis 7. Inheritedmetabolicdiseases(e.g.,hemochromatosis,Wilsondisease) 8. Hepaticcongestionsecondarytoright-sidedheartfailure,constrictivepericarditis 9. α1-Antitrypsin(AAT)deficiency 10. Hepaticveno-occlusivedisease—canoccurafterbonemarrowtransplantation

C.ClinicalFeatures 1. Somepatientshavenoovertclinicalfindings,especiallyearlyinthedisease. 2. Patientsmayhavesignsorsymptomssuggestiveofoneormoreofthe

complicationsofcirrhosis(seebelow).

Quick HIT

Classicsignsofchronicliverdisease:

e Ascites

Ascites Varices Gynecomastia,testicularatrophy Palmarerythema,spiderangiomasonskin

e Varices

e

e

¢

e

Hemorrhoids Caputmedusa

D.Complications 1. PortalHTN

a. Clinicalfeaturesarelistedabove.Bleeding(hematemesis,melena, hematochezia)secondarytoesophagogastricvaricesisthemostlife-threatening complicationofportalHTN.

b. Diagnosebasedonabovefeatures.Paracentesiscanhelpindiagnosis. c. Treatthespecificcomplication.Usetransjugularintrahepaticportosystemic

shunt(TIPS)tolowerportalpressure.

2. Varices

a. Esophageal/gastric

e

e

e

e

e

e

e

e

Varicealhemorrhagehasahighmortalityrate.Patientswithcirrhosisshouldbe evaluatedforthepresenceofvaricesandriskofhemorrhage.Ifvaricesare present,prophylacticmeasuresareindicated(suchasnonselectiveβ- blocker). Clinicalfeaturesincludemassivehematemesis,melena,andexacerbationof hepaticencephalopathy. Esophagealvaricesaccountfor90%ofvarices,andgastricvaricesfor10%. Initialtreatmentishemodynamicstabilization(givefluidstomaintainBP).See ClinicalPearl3-2formethodsaimedatstoppingbleeding. IVantibioticsaregivenprophylactically. IVoctreotideisinitiatedandcontinuedfor3to5days. PerformemergentupperGIendoscopy(oncepatientisstabilized)for diagnosisandtotreatthehemorrhageeitherwithvaricealligationor sclerotherapy. Givenonselectiveβ-blockers(propranolol,timolol,nadolol)aslong-term therapytopreventrebleeding.
======================================
Quick HIT

Onceapatientdevelopscomplicationsofcirrhosis,theyhave“decompensated”disease,withhigh morbidityandmortality.

Quick HIT

TreatmentofbleedingesophagealvaricesinvolvespharmacologictreatmentwithIVoctreotidein additiontoendoscopictreatment(sclerotherapyorvaricealligation).

b. Rectalhemorrhoids

c. Caputmedusae(distentionofabdominalwallveins)

3. Ascites(seealsoClinicalPearl3-3)

a. AccumulationoffluidintheperitonealcavityduetoportalHTN(increased hydrostaticpressure)andhypoalbuminemia(reducedoncoticpressure).Ascites isthemostcommoncomplicationofcirrhosis.Patientswithoutportal hypertensiondonotdevelopascites.

b. Clinicalfeatures:abdominaldistention,shiftingdullness,andfluidwave. c. Abdominalultrasoundcandetectaslittleas30mLoffluid.

CLINICALPEARL3-2

TreatmentofBleedingEsophagealVarices

Varicealligation/banding

¢

e

e

Initialendoscopictreatmentofchoice. Effectivecontrolofactivebleeding. Lowerrateofrebleedingthansclerotherapy.

Endoscopicsclerotherapy

¢

¢

¢

Sclerosingsubstanceisinjectedintovaricesduringendoscopy. Thiscontrolsacutebleedingin80%to90%ofcases. Upto50%ofpatientsmayhaverebleeding.

IVvasopressin

¢

e

Thisisanalternativetooctreotide,butisrarelyusedduetotheriskofcomplications. Vasoconstrictionofmesentericvesselsreducesportalpressure.

IVoctreotideinfusion

e

e

Hasreplacedvasopressinasfirst-linetherapy;causessplanchnicvasoconstrictionandreduces portalpressure. Fewersideeffectsthanvasopressin.

e

Otheroptionsincludeesophagealballoontamponade(Sengstaken–Blakemoretubeisatemporary measure),repeatsclerotherapy,TIPS,surgicalshunts,andlivertransplantation.

d. DiagnosticparacentesisdetermineswhetherascitesisduetoportalHTNor anotherprocess.

e

e

e

Indicationsincludenew-onsetascites,worseningascites,andsuspected spontaneousbacterialperitonitis(SBP)(seebelow). Examinecellcount,ascitesalbumin,Gramstain,andculturetoruleout infection(e.g.,SBP). Measuretheserumascitesalbumingradient.Ifitis>1.1g/dL,portalHTNis verylikely.If<1.1g/dL,portalHTNisunlikely,andothercausesmustbe considered.
======================================
Quick HIT

Ascitescanbemanagedbysaltrestrictionanddiureticsinmostcases.

e. Treatment

e

e

e

Alow-sodiumdietanddiuretics:spironolactone(usedtoreduceaccumulation offluid)andfurosemide(usedtopreventhyperkalemiacausedby spironolactone). Performtherapeuticparacentesisiftenseascites,shortnessofbreath,orearly satietyispresent. PeritoneovenousshuntorTIPStoreduceportalHTN

Quick  HIT  ComplicationsofLiverFailure(notethemnemonicAC,9H)  Ascites Coagulopathy Hypoalbuminemia Portalhypertension Hyperammonemia Hepaticencephalopathy Hepatorenalsyndrome Hypoglycemia Hyperbilirubinemia/jaundice Hyperestrinism HCC 

4. Hepaticencephalopathy

a. Toxicmetabolites(therearemany,butammoniaisbelievedtobemost important)thatarenormallydetoxifiedorremovedbytheliveraccumulateand reachthebrain.

b. Occursin50%ofallcasesofcirrhosis,withvaryingseverity.

CLINICALPEARL3-3

DifferentialDiagnosisofAscites

Cirrhosis,portalHTN CHF Chronicrenaldisease Massivefluidoverload Tuberculousperitonitis Malignancy Hypoalbuminemia Peripheralvasodilationsecondarytoendotoxin-inducedreleaseofnitrousoxide,whichleadsto increasedreninsecretion(andthussecondaryhyperaldosteronism) Impairedliverinactivationofaldosterone

CHF

e

c. Precipitantsincludealkalosis,hypokalemia(e.g.,duetodiuretics),sedating drugs(narcotics,sleepingmedications),GIbleeding,systemicinfection,and

hypovolemia. d. Clinicalfeatures

e

e

e

e

Decreasedmentalfunction,confusion,poorconcentration,evenstuporor coma Asterixis(“flappingtremor”)—havethepatientextendthearmsanddorsiflex thehands.(However,thisisnotaspecificsign.) Rigidity,hyperreflexia Fetorhepaticus—mustyodorofbreath

e. Treatment

e

e

Lactulosepreventsabsorptionofammonia.Metabolismoflactuloseby bacteriainthecolonfavorsformationofNH4 GItract,therebypromotingexcretionofammonia. Rifaximin(antibiotic):killsbowelflora;sodecreasesammoniaproductionby intestinalbacteria.Historically,neomycinwasused,butrifaximinhaslessside effectswithsameefficacy. Diet—limitproteinto30to40g/day.

e

Quick HIT
======================================
MonitoringPatientsWithCirrhosis

e

e

e

Orderperiodiclaboratoryvaluesevery3to4months(CBC,renalfunctiontests,electrolytes,LFTs,and coagulationtests). Performanendoscopytodeterminethepresenceofesophagealvarices. IfHCCissuspected,performaCT-guidedbiopsyfordiagnosis.

5. Hepatorenalsyndrome—indicatesend-stageliverdisease

a. Progressiverenalfailureinadvancedliverdisease,secondarytorenal hypoperfusionresultingfromvasoconstrictionofrenalvessels.

b. Oftenprecipitatedbyinfectionordiuretics. c. Thisisafunctionalrenalfailure—kidneysarenormalintermsofmorphology, andnospecificcausesofrenaldysfunctionareevident.Thisconditiondoesnot respondtovolumeexpansion.

d. Clinicalfeatures:azotemia,oliguria,hyponatremia,hypotension,lowurine sodium(<10mEq/L).

e. Treatment:Livertransplantationistheonlycure.Ingeneral,theprognosisis verypoor,andtheconditionisusuallyfatalwithoutlivertransplantation.

6. SBP—infectedasciticfluid;occursinupto20%ofpatientshospitalizedfor ascites.

a. Usuallyoccursinpatientswithascitescausedbyend-stageliverdisease; associatedwithhighmortalityrate(20%to30%).

b. Hasahighrecurrencerate(upto70%infirstyear). c. Etiologicagents.

e

e

e

Escherichiacoli(mostcommon) Klebsiella Streptococcuspneumoniae

d. Clinicalfeatures:abdominalpain,fever,vomiting,reboundtenderness.SBPmay leadtosepsis.

Quick HIT

SBP:Lookforfeverand/orchangeinmentalstatusinapatientwithknownascites.

e. Diagnosisisestablishedbyparacentesisandexaminationofasciticfluidfor WBCs(especiallyPMNs),Gramstainwithculture,andsensitivities.

e

e

WBC>500,PMN>250. Positiveascitesculture;culture-negativeSBPiscommonaswell.

Quick HIT

IfSBPisnottreatedearly,mortalityishigh.Therefore,indexofsuspicionshouldbehighanddiagnostic paracentesisbedoneearly.

f. Treatment

e

¢

Broad-spectrumantibiotictherapy:givespecificantibioticonceorganismis identified. Clinicalimprovementshouldbeseenin24to48hours.Repeatparacentesisin 2to3daystodocumentadecreaseinasciticfluidPMN(<250).

7. Hyperestrinism—duetoreducedhepaticcatabolismofestrogens

a. Spiderangiomas—dilatedcutaneousarterioleswithcentralredspotandreddish extensionsthatradiateoutwardlikeaspider’sweb
======================================
b. Palmarerythema c. Gynecomastia d. Testicularatrophy

8. Coagulopathy—secondarytodecreasedsynthesisofclottingfactors.

a. Prolongedprothrombintime(PT);PTTmaybeprolongedwithseveredisease. b. VitaminKsupplementationineffectivebecauseitcannotbeusedbydiseased

b. Vitamin K supplementation ineffective because it cannot be used by diseased liver.

liver.

c. Treatcoagulopathywithfreshfrozenplasma.

Hepatocellular carcinoma (HCC)—present in 10% to 25% of patients with cirrhosis.AllpatientswithcirrhosisshouldbescreenedforHCC,mostcommonly

withserumAFPmeasurementandliverultrasoundevery6months.

E.Treatment 1. Treatunderlyingcause—forexample,abstinencefromalcohol,interferonsfor

hepatitisBandC.

2. Avoidagentsthatmaycauseinjurytoliver,suchasacetaminophenandalcohol. 3. Oncecirrhosisdevelops,aimtreatmentatmanaginganycomplicationsthatarise, asdescribedabove.Themostseriouscomplicationsarevaricealbleeding,ascites, andhepaticencephalopathy.

4. Livertransplantationistheonlyhopeforacure.Abstinencefromalcoholfor morethan6monthsisrequiredbeforeapatientiseligiblefortransplantation. Decisiontoproceedtolivertransplantationdependsonqualityoflife,severityof disease,andabsenceofcontraindications.

WilsonDisease

A.GeneralCharacteristics 1. Anautosomalrecessivediseaseofcoppermetabolism. 2. MutationsintheATP7Bgeneleadtoimpairmentofcopperexcretionintobile, andincorporationofcopperintoceruloplasmin,acopper-bindingproteinthatis necessaryforcopperexcretion.

3. Therefore,copperaccumulatesinlivercells.Ashepatocytesdie,copperleaksinto plasmaandaccumulatesinvariousorgans,includingkidney,cornea,andbrain. 4. Thediseaseismostoftenapparentduringchildhood/adolescence(afterage5),

andthemajorityofcasespresentbetweenages5and35.

B.ClinicalFeatures 1. Clinicalfeaturesareduetocopperdepositioninvariousorgans. 2. Liverdisease(mostcommoninitialmanifestation):Manifestationsvaryandmay

includeacutehepatitis,cirrhosis,andfulminanthepaticfailure.

3. Kayser–Fleischerrings(yellowishringsincornea)arecausedbycopper depositionincornea;theydonotinterferewithvision(Figure3-1).

4. CNSfindingsareduetocopperdepositionintheCNS.

a. Extrapyramidalsigns—parkinsoniansymptoms(restingtremor,rigidity, bradykinesia),chorea,drooling,incoordinationduetocopperdepositioninbasal ganglia.

b. Psychiatricdisturbances—depression,neuroses,personalitychanges,psychosis.

5. Renalinvolvement—aminoaciduria,nephrocalcinosis.
======================================
Quick HIT

AlkalinephosphataseisnormalorlowinWilsondiseaseascopperinterfereswithitssynthesis.

FIGURE 3.1

Kayser–Fleischerring.

(FromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.4thed.

Philadelphia,PA:LippincottWilliams&Wilkins;2000,Figure105.4.)

C.Diagnosis 1. Diagnosisismadebydeterminingthefollowing(patientsmayhavemanyoronly

afewofthesefindings):

a. Hepaticdisease—elevatedaminotransferases;impairedsynthesisofcoagulation factorsandalbumin.

b. Decreasedserumceruloplasminlevels(seenin90%ofpatients),although rangeswithinnormaldonotexcludethediagnosis.

c. Liverbiopsy—significantlyelevatedcopperconcentration. 2. Ifdiagnosed,first-degreerelativesmustbescreenedaswell.

D.Treatment 1. Chelatingagents—forexample,D-penicillamine,whichremovesanddetoxifies

theexcesscopperdeposits

2. Zinc

a. Preventsuptakeofdietarycopper b. Givenalone(topresymptomaticorpregnantpatients)orinconjunctionwith

chelatingagents(tosymptomaticpatients)

3. Livertransplantation(ifunresponsivetotherapyorfulminantliverfailure) 4. Monitorpatient’scopperlevels,urinarycopperexcretion,ceruloplasmin,andliver

function;physicalexaminationforsignsofliverorneurologicdisease; psychologicalhealth

Quick HIT

Secondaryhemochromatosis(ironoverload)canoccurwithmultipletransfusionsorinchronichemolytic anemias.

Hemochromatosis

A.GeneralCharacteristics 1. Anautosomalrecessivediseaseofironabsorption 2. Excessiveironabsorptionintheintestineleadstoincreasedaccumulationofiron (asferritinandhemosiderin)invariousorgans.Overmanyyears,fibrosisin involvedorgansoccurssecondarytohydroxylfreeradicalsthataregeneratedby theexcessiron. 3. Affectedorgans

a. Liver(primaryorgan) b. Pancreas c. Heart d. Joints e. Skin f. Thyroid,gonads,hypothalamus

4. Thisisaninheriteddisease,soscreenthepatient’ssiblings.Earlydiagnosisand treatmentbeforedevelopmentofcomplications(primarilycirrhosis,butalsoheart diseaseanddiabetes)improvesurvival.

Quick HIT

Hemochromatosis:Earlyinthediseasecourse,mildelevationofALTandASTlevelsmaybetheonly abnormalitiesthatarenotedbecausethepatientisusuallyasymptomatic.Obtainironstudies.Iftheironlevelis elevated,orderaliverbiopsytoconfirmthediagnosis.

B.ClinicalFeatures 1. Mostpatientsareasymptomaticinitially. 2. Findingsmayincludesignsofliverdisease,fatigue,arthritis,

impotence/amenorrhea,abdominalpain,andcardiacarrhythmias.
======================================
C.Complications 1. Cirrhosis

a. CirrhosisincreasestheriskofHCCby200-fold. b. Thepresenceofliverdiseaseisaprimaryfactorindeterminingtheprognosis.

2. Cardiomyopathy—CHF,arrhythmias 3. Diabetesmellitus—duetoirondepositioninthepancreas 4. Arthritis—mostcommonsitesarethesecondandthirdmetacarpophalangeal

joints,hips,andknees.

5. Hypogonadism—impotence,amenorrhea,lossoflibido 6. Hypothyroidism

7. Hyperpigmentationofskin(resemblessuntan,“bronzelike”)

D.Diagnosis 1. Markedlyelevatedserumironandserumferritin 2. Elevatedironsaturation(transferrinsaturation) 3. Decreasedtotaliron–bindingcapacity(TIBC) 4. Genetictestingforetiologicmutations(goldstandardfordiagnosis)

E.Treatment 1. Performrepeatedphlebotomies—thisisthetreatmentofchoiceandimproves

survivaldramaticallyifinitiatedearlyinthecourseofthedisease.

2. Treatanycomplications(e.g.,CHF,diabetes,hypothyroidism,arthritis). 3. Considerlivertransplantationinadvancedcases.

HepatocellularAdenoma

Benignlivertumor,mostoftenseeninyoungwomen(15to40yearsofage).Oral contraceptiveuse,femalesex,andanabolicsteroidusearethemainriskfactors. Patientmaybeasymptomatic;hepatocellularadenomamaybediscovered incidentallyonabdominalimagingstudies.RUQpainorfullnessmaybepresent. Malignantpotentialisverylow(<1%).However,theadenomamayrupture,leading tohemoperitoneumandhemorrhage. DiagnosismadebyCTscan,ultrasound,orhepaticarteriography(mostaccuratebut invasive). Treatment:Discontinueoralcontraceptives;surgicallyresecttumors>5cmthatdo notregressafterstoppingoralcontraceptives(otherwisethereisariskofrupture).

CavernousHemangiomas

Vasculartumorsthatareusuallysmallandasymptomatic.Theyarethemost commontypeofbenignlivertumor. Asthesizeofthetumorincreases(e.g.,duetopregnancyoruseoforal contraceptives),thesymptomsincreaseandincludeRUQpainormass. Complications(uncommonunlesstumorisverylarge)includerupturewith hemorrhage,obstructivejaundice,coagulopathy,CHFsecondarytoalargeAV shunt,andgastricoutletobstruction. DiagnosewithultrasoundorCTscanwithIVcontrast.Biopsycontraindicated becauseofriskofruptureandhemorrhage. Mostcasesdonotrequiretreatment.Considerresectionifthepatientissymptomatic orifthereisahighriskofrupture(aswithlargetumors).
======================================
FocalNodularHyperplasia

Thisbenignlivertumorwithoutmalignantpotentialoccursinwomenof reproductiveage.Thereisnoassociationwithoralcontraceptives. Itisusuallyasymptomatic.Hepatomegalymaybepresent.Treatmentnotnecessary inmostcases.

HepatocellularCarcinoma(MalignantHepatoma)

A.GeneralCharacteristics 1. HCCaccountsformorethan80%ofprimarylivercancersand,althoughrarein theUnitedStates,accountsformostdeathsduetocancersworldwide.High-risk areasincludeAfricaandAsia. 2. Therearetwopathologictypes

a. Nonfibrolamellar(mostcommon)

e

e

UsuallyassociatedwithhepatitisBorCandcirrhosis Usuallyunresectablewithveryshortsurvivaltime(months)

b. Fibrolamellar

e

¢

e

UsuallynotassociatedwithhepatitisBorCorcirrhosis Moreoftenresectable;relativelylongersurvivaltime Seenmostcommonlyinadolescentsandyoungadults

Quick HIT

ThemostcommonmalignantlivertumorsareHCCsandcholangiocarcinomas.Themostcommonbenignliver tumoristhehemangioma.

B.RiskFactors 1. Cirrhosis,especiallyinassociationwithalcoholorhepatitisBorC;HCC

developsin10%ofcirrhoticpatients.

2. Chemicalcarcinogens:forexample,aflatoxin,vinylchloride,Thorotrast 3. AATdeficiency 4. Hemochromatosis,Wilsondisease 5. Schistosomiasis 6. Hepaticadenoma(10%riskofmalignanttransformation) 7. Cigarettesmoking 8. Glycogenstoragedisease(type1)

C.ClinicalFeatures 1. Abdominalpain(painfulhepatomegaly) 2. Weightloss,anorexia,fatigue 3. Signsandsymptomsofchronicliverdisease—portalHTN,ascites,jaundice,

splenomegaly

4. Paraneoplasticsyndromes—erythrocytosis,thrombocytosis,hypercalcemia, carcinoidsyndrome,hypertrophicpulmonaryosteodystrophy,hypoglycemia,high cholesterol

Quick HIT

PrognosisofHCC

e

e

Ifunresectable:lessthan1year Ifresectable:25%ofpatientsarealiveat5years

D.Diagnosis 1. Liverbiopsy—requiredfordefinitivediagnosis 2. Laboratorytests—hepatitisBandCserology,liverfunctiontests(LFTs),

coagulationtests

3. Imagingstudies—ultrasound,CTscan(chest,abdomen,pelvis);MRIorMRAif

surgeryisanoption(providesmoredetailabouttheanatomyofthetumor) 4. Tumormarkerelevation(AFP)isusefulasascreeningtool.AFPlevelmaybe elevatedin40%to70%ofpatientswithHCC,andisalsohelpfulinmonitoring responsetotherapy.
======================================
Quick HIT

HCCislikelyinapatientwithcirrhosiswhohasapalpablelivermassandelevatedAFPlevel.

E.Treatment 1. Liverresection(inthe10%ofpatientswhohaveresectabletumors) 2. Livertransplantationifdiagnosisismadeearly 3. Ifunresectable,considertranscatheterarterialchemoembolization(TACE),

radiofrequencyablation,orselectiveinternalradiationtherapy

NonalcoholicSteatohepatitis

Histologyoftheliverisidenticaltothatinpatientswithalcoholicliverdisease,but thesepatientsdonothaveahistoryofalcoholuse! Associatedwithobesity,hyperlipidemia,diabetesmellitus(somepatientshavenone ofthese). Usuallyasymptomaticandhasabenigncourse(butcirrhosisdevelopsin10%to 15%) Typicallydiscoveredonroutinelaboratorytests(mildelevationinalanine aminotransferase[ALT]andaspartateaminotransferase[AST]) Treatmentisnotclearlyestablished.

Hemobilia

Referstoblooddrainingintotheduodenumviathecommonbileduct(CBD).The sourceofbleedingcanbeanywherealongthebiliarytract,theliver,orthe ampullaryregion. Causes—trauma(mostcommon),papillarythyroidcarcinoma,surgery(e.g., cholecystectomy,CBDexploration),tumors,andinfection. Clinicalfeatures—GIbleeding(melena,hematemesis),jaundice,andRUQpain. Arteriogramisdiagnostic.UpperGIendoscopyshowsbloodcomingoutofthe ampullaofVater. Treatment—resuscitation(mayrequiretransfusion).Ifbleedingissevere,surgeryis necessary(optionsincludeligationofhepaticarteriesorarteriogramwith embolizationofvessel).

LiverCysts

A.PolycysticLiverCysts

Autosomaldominant,usuallyassociatedwithpolycystickidneydisease.Polycystic kidneydiseaseoftenresultsinrenalfailureandisthemaindeterminantofprognosis, whereaslivercystsrarelyleadtohepaticfibrosisandliverfailure. Usuallyasymptomatic;somepatientshaveabdominalpainandupperabdominal mass. Treatmentisunnecessaryinmostcases.

B.HydatidLiverCysts

CausedbyinfectionfromthetapewormEchinococcusgranulosusor,less commonly,Echinococcusmultilocularis.Cystsmostcommonlyoccurintheright lobeoftheliver. Smallcystsareasymptomatic;largercystsmaycauseRUQpainandruptureintothe peritonealcavity,causingfatalanaphylacticshock. Treatmentissurgicalresection(cautiontoavoidspillingcontentsofthecystintothe peritonealcavity).Mebendazoleisgivenaftersurgery.

Themostcommonlocationforliverabscess(bothpyogenicandamebic)istherightlobe.
======================================
LiverAbscess

A.PyogenicLiverAbscess

Mostcommoncauseisbiliarytractobstruction—obstructionofbileflowallows bacterialproliferation.OthercausesincludeGIinfection(e.g.,diverticulitis, appendicitis),withspreadviaportalvenoussystem,andpenetratinglivertrauma (e.g.,gunshotwound,surgery). CausativeorganismsincludeEscherichiacoli,Klebsiella,Proteus,Enterococcus, andanaerobes. Clinicalfeaturesincludefever,malaise,anorexia,weightloss,nausea,vomiting, RUQpain,andjaundice.Patientsappearquiteill. DiagnosedbyultrasoundorCTscan;elevatedLFTs. Fatalifuntreated.Treatment(IVantibioticsandpercutaneousdrainageofabscess) reducesmortalitytoabout5%to20%.Surgicaldrainageissometimesnecessary.

B.AmebicLiverAbscess

Mostcommoninmen(9:1),particularlymenwhohavesexwithmen.Transmitted throughfecal–oralcontact. Causedbyintestinalamebiasis(Entamoebahistolytica)—theamoebaereachthe liverviathehepaticportalvein. Clinicalfeatures—fever,RUQpain,nausea/vomiting,hepatomegaly,diarrhea. Serologictesting(immunoglobulinGenzymeimmunoassay)establishesdiagnosis. LFTsareoftenelevated.TheEntamoebahistolyticastoolantigentest(detects protozoainstool)isnotsensitive.Imagingstudies(ultrasound,CT)identifythe abscess,butitisdifficulttodistinguishfromapyogenicabscess. IVmetronidazoleiseffectivetreatmentinmostcases.Therapeuticaspirationofthe abscess(image-guidedpercutaneousaspiration)maybenecessaryiftheabscessis large(highriskofrupture),orifthereisnoresponsetomedicaltherapy.

Pyogenicandamebicabscessesarepotentiallylifethreatening,ifnotdetectedearly.

Budd–ChiariSyndrome

A.GeneralCharacteristics 1. Liverdiseasecausedbyocclusionofhepaticvenousoutflow,whichleadsto

hepaticcongestionandsubsequentmicrovascularischemia.

2. Thecourseisvariable,butmostcasesareindolent,withgradualdevelopmentof portalHTNandprogressivedeteriorationofliverfunction.

3. Rarelythediseaseissevereandleadstoacuteliverfailure,whichmaybefatal withoutimmediatetherapy.

B.Causes—hypercoagulablestates,myeloproliferativedisorders(e.g.,polycythemia vera),pregnancy,chronicinflammatorydiseases,infection,variouscancers, trauma.Conditionisidiopathicinupto40%ofcases.

C.ClinicalFeatures(resemblethoseofcirrhosis)—hepatomegaly,ascites,abdominal pain(RUQ),jaundice,varicealbleeding.

D.Diagnosis—hepaticvenography;serumascitesalbumingradient>1.1g/dL.
======================================
E.Treatment 1. Medicaltherapy(e.g.,anticoagulation,thrombolytics,diuretics)isusually

unsatisfactory.

2. Surgeryiseventuallynecessaryinmostcases(balloonangioplastywithstent placementininferiorvenacava,portacavalshunts).

3. Livertransplantationifcirrhosisispresent.

CLINICALPEARL3-4

BilirubinMetabolism

Eightypercentofbilirubinisderivedfromhemoglobin(RBCbreakdown).Therestcomesfrommyoglobin breakdownandliverenzymes. Hemoglobinisconvertedtobilirubininthespleen.Thisunconjugatedbilirubincirculatesinplasma,boundto albumin.Thisbilirubin–albumincomplexisnotwatersoluble;therefore,itisnotexcretedinurine.Inthe liver,itdissociatesfromalbumin,andthebilirubinisconjugatedandexcretedintotheintestine,where bacteriaactonittoproduceurobilinogenandurobilin. Therefore,unconjugatedhyperbilirubinemiaresultswhenthereisadefectbeforehepaticuptake.Conjugated hyperbilirubinemiaresultswhenthereisadefectafterhepaticuptake.

Quick HIT

ThreeMajorCausesofJaundice

Hemolysis

Hemolysis Liverdisease

Biliaryobstruction

Jaundice

A.GeneralCharacteristics 1. Yellowcolorationofskin,mucousmembranes,andscleraeduetooverproduction

orunderclearanceofbilirubin(seealsoClinicalPearl3-4)

2. Clinicaljaundiceusuallybecomesevidentwhentotalbilirubinis>2mg/dL 3. Conjugatedversusunconjugatedbilirubin

a. Conjugated(direct)

¢

e

e

Looselyboundtoalbuminandthereforewatersoluble. Whenpresentinexcess,itisexcretedinurine.Therefore,darkurineisonly seenwithconjugatedbilirubinemia! Nontoxic.

b. Unconjugated(indirect)

e

¢

e

Tightlyboundtoalbuminandthereforenotwatersoluble. Cannotbeexcretedinurineevenifbloodlevelsarehigh. Toxic—unboundformcancrossblood–brainbarrierandcauseneurologic deficits.

Quick HIT

Darkurineandpalestoolssignaladiagnosisofconjugatedhyperbilirubinemia.

B.Causes 1. Conjugatedhyperbilirubinemia—urinepositiveforbilirubin(seealso

ClinicalPearl3-5)

a. Decreasedintrahepaticexcretionofbilirubin

Hepatocellulardisease(viraloralcoholichepatitis,cirrhosis) Inheriteddisorders(Dubin–Johnsonsyndrome,Rotorsyndrome) Druginduced(oralcontraceptives) PBC Primarysclerosingcholangitis(PSC)

PBC
======================================
CLINICALPEARL3-5

Cholestasis

e

¢

e

¢

Thisreferstoblockageofbileflow(whetherintra-orextrahepatic)witharesultantincreasein conjugatedbilirubinlevels. Clinicalfindings Jaundice,graystools,darkurine Pruritus(bilesaltdepositioninskin)

Elevatedserumalkalinephosphatase Elevatedserumcholesterol(impairedexcretion) Skinxanthomas(localaccumulationofcholesterol) Malabsorptionoffatsandfat-solublevitamins

b. Extrahepaticbiliaryobstruction

¢

e

e

e

e

Gallstones Carcinomaofheadofthepancreas Cholangiocarcinoma Periampullarytumors Extrahepaticbiliaryatresia

2. Unconjugatedhyperbilirubinemia—urinenegativeforbilirubin

a. Excessproductionofbilirubin—hemolyticanemias b. Reducedhepaticuptakeofbilirubinorimpairedconjugation

Gilbertsyndrome

¢

Occursinupto7%ofthepopulation—autosomaldominantconditionin whichthereisdecreasedhepaticuridinediphosphate(UDP)glucuronyl transferaseactivity. Commoncauseofisolatedelevationofunconjugatedbilirubin. Exacerbatedbyfasting(crashdiets),fever,alcohol,andinfection. Asymptomaticinmostcases,butoccasionallymildjaundicemaybepresent. Liverbiopsyresultsarenormal,andusualalynotreatmentisnecessary.

e

¢

Drugs(e.g.,sulfonamides,penicillin,rifampin,radiocontrastagents) Crigler–Najjarsyndrome

e

e

Type1—CompleteabsenceofUDP-glucuronosyltransferaseinhepatictissue. Severeunconjugatedbilirubinemia,oftenresultinginbraindamageatbirth. Type2—ReducedUDP-glucuronosyltransferaseactivity,butcanbedetected inhepatictissue.Notassevereastype1.

e

e

Physiologicjaundiceofthenewborn(immaturityofconjugatingsystem) Diffuseliverdisease(hepatitis,cirrhosis)

Quick HIT

Ifthereisnohemolysis,isolatedunconjugatedhyperbilirubinemiamayindicateGilbertsyndrome,whichis usuallyasymptomatic.

C.Diagnosis 1. Serumlevelsoftotalconjugatedandunconjugatedbilirubin(Figure3-2). 2. Ifunconjugatedhyperbilirubinemia:CBC,reticulocytecount,haptoglobin,LDH, andperipheralsmearmayaidindiagnosisofhemolysisasthecauseofjaundice.

3. Ifconjugatedhyperbilirubinemia,LFTsmaypointtothecause. 4. Ultrasound(orCTscan)toassessbiliarytractforobstructionoranatomic

changes.

5. Additionaltests(e.g.,endoscopicretrogradecholangiopancreatography[ERCP], percutaneoustranshepaticcholangiography[PTC])—dependingonthefindingsof theabovetests.

6. Liverbiopsymaybeindicatedinsomecasestodeterminecauseofhepatocellular injury.
======================================
Quick HIT

e

e

ALTisprimarilyfoundintheliver. ASTisfoundinmanytissues(e.g.,skeletalmuscle,heart,kidney,brain).

D.Treatment 1. Treattheunderlyingcause.

LiverFunctionTests

A.Aminotransferases(ALTandAST) 1. ALTismoresensitiveandspecificthanASTforliverdamage. 2. ALTandASTusuallyhaveasimilarincrease.Theexceptionisinalcoholic

hepatitis,inwhichtheAST–ALTratiomaybe>2:1.

3. IfALTandASTlevelsaremildlyelevated(lowhundreds),thinkofchronicviral hepatitisoracutealcoholichepatitis.

4. IfALTandASTlevelsaremoderatelyelevated(highhundredstothousands), thinkofacuteviralhepatitis.

5. IfALTandASTlevelsareseverelyelevated(>10,000),extensivehepatic necrosishasoccurred.Typicalcasesare:

a. Ischemia,shockliver(prolongedhypotensionorcirculatorycollapse) b. Acetaminophentoxicity c. Severeviralhepatitis

6. Notethatlivertransaminasesareoftennormalorevenlowinpatientswith cirrhosis(withoutanyactivecellnecrosis)ormetastaticliverdisease,becausethe numberofhealthyfunctioninghepatocytesismarkedlyreduced.

History Physical exam Labs (LFTs)-ALT, AST, bilirubin, ALK-P, albumin, PT Conjugated Unconjugated Suspected hyperbilirubinemia hyperbilirubinemia intrahepatic disease based on LFTs +» Dubin—-Johnson See test for syndrome differentia--hemolysis Noninvasive + Rotor syndrome and Gilbert syndrome imaging (U/S, CT) most common * Specific tests: Viral serology AMA, ANA, SMA Ceruloplasmin Direct duct Fe/TIBC visualization a,—Antitrypsin level (ERCP or PTC) * Stop drugs + Consider liver biopsy * Consider CT scan to tule out structural disease Obstruction + Medical management vs. visualized? observation AMA = Antimitochondrial antibody ANA = Antinuclear antibody ERCP = Endoscopic retrograde cholangiopancreatography Fe/TIBC = Iron/total iron—binding capacity PTC = Percutaneous transhepatic cholangiogram Relief of SMA = Smooth muscle antibody obstruction U/S = Ultrasound + Surgical + Endoscopic + Percutaneous

FIGURE 3.2

Evaluationofjaundice.

7. ThefollowingcancauseanelevationinALTorASTlevelsinasymptomatic patients(notethemnemonic):

a. Autoimmunehepatitis b. HepatitisB c. HepatitisC d. Drugsortoxins e. Ethanol f. Fattyliver(triglyceridemia) g. Growths(tumors) h. Hemodynamicdisorders(e.g.,CHF) i. Iron(hemochromatosis),copper(Wilsondisease),orAATdeficiency

B.AlkalinePhosphatase(ALK-P):Notspecifictoliver—alsofoundinbone,gut, andplacenta.

1. ALK-Piselevatedwhenthereisobstructiontobileflow(e.g.,cholestasis)inany partofthebiliarytree.Normallevelsmakecholestasisunlikely.

2. Iflevelsareveryhigh(10-foldincrease),thinkofextrahepaticbiliarytract obstructionorintrahepaticcholestasis(e.g.,PBCordrug-inducedcirrhosis). 3. Iflevelsareelevated,measurethegamma-glutamyl-transferase(GGT)levelto

makesuretheelevationishepaticinorigin(ratherthanboneorintestinal).Ifthe GGTlevelisalsoelevated,thisstronglysuggestsahepaticorigin.IftheGGT levelisnormalbutALK-Piselevated,considerpregnancyorbonedisease.
======================================
Quick HIT

e

e

Inalcoholichepatitis,theASTlevelisalmostnever>500,andtheALTlevelisalmostnever>300. ThehighertheAST–ALTratio,thegreaterthelikelihoodthatalcoholiscontributingtotheabnormalLFTs.

C.Bilirubin(seeJaundicesection)

Quick HIT

LFTPearls

¢

¢

CholestaticLFTs:markedlyelevatedalkalinephosphataseandGGT;ALTandASTareslightlyelevated Hepatocellularnecrosisorinflammation:normalorslightlyelevatedalkalinephosphatase;markedlyelevated ALTandAST

D.GGTisoftenusedtoconfirmthattheALK-Pelevationisofhepaticorigin(see above).

E.Albumin—decreasedinchronicliverdisease,nephroticsyndrome,malnutrition,

andinflammatorystates(e.g.,burns,sepsis,trauma).

F.ProthrombinTime(PT) 1. TheliversynthesizesclottingfactorsI,II,V,VII,IX,X,XII,andXIII,the

functionofwhichisreflectedbyPT.

2. PTisnotprolongeduntilmostoftheliver’ssyntheticcapacityislost,which correspondstoadvancedliverdisease.

DiseasesoftheGallbladderandBiliaryTract Cholelithiasis

eee

A.GeneralCharacteristics 1. Cholelithiasisreferstostonesinthegallbladder(i.e.,gallstones). 2. Typesofstones.

a. Cholesterolstones(yellowtogreen)—associatedwiththefollowing:

Obesity,diabetes,hyperlipidemia Multiplepregnancies,oralcontraceptiveuse Crohndisease,ilealresection Advancedage NativeAmericanancestry Cirrhosis Cysticfibrosis b. Pigmentstones

e

e

Blackstonesareusuallyfoundinthegallbladderandareassociatedwitheither hemolysis(e.g.,sicklecelldisease,thalassemia,hereditaryspherocytosis, artificialcardiacvalves)oralcoholiccirrhosis. Brownstonesareusuallyfoundinbileductsandareassociatedwithbiliary tractinfection.

c. Mixedstoneshavecomponentsofbothcholesterolandpigmentstones,and accountforthemajorityofstones.

Quick HIT

Cholestasisreferstoobstructionofbileflowfromanycause.IfLFTsrevealcholestasis,obtainanabdominalor RUQultrasound.

B.ClinicalFeatures 1. Mostcasesareasymptomatic.Majorityofpatientsfoundtohaveincidental

gallstoneswillremainasymptomatic.

2. Biliarycolicisthecardinalsymptomofgallstonesandisduetotemporary obstructionofthecysticductbyagallstone.Painoccursasthegallbladder contractsagainstthisobstruction.

a. PainistypicallylocatedintheRUQorepigastriumandmaybemild,moderate, orsevere.

b. Patientsclassicallyreportpainaftereatingandatnight.

c. Boassign—referredrightsubscapularpainofbiliarycolic.
======================================
Quick HIT

One-thirdofpatientswithbiliarycolicdevelopacutecholecystitiswithin2years.

C.Complications 1. Cholecystitis(chronicoracute)withprolongedobstructionofcysticduct. 2. Choledocholithiasiswithitsassociatedcomplications—seebelow. 3. Gallstoneileus 4. Malignancy

Quick HIT

Paininacutecholecystitisissecondarytogallbladderwallinflammation,whereasthepainofbiliarycolicis secondarytothecontractionofthegallbladderagainsttheobstructedcysticduct.Also,thepainofacute cholecystitispersistsforseveraldays,whereasthepainofbiliarycoliclastsonlyafewhours.

D.Diagnosis 1. RUQultrasoundhashighsensitivityandspecificity(>95%)forstones>2mm. 2. CTscanandMRIarealternatives.

E.Treatment 1. Notreatmentifthepatientisasymptomatic. 2. Electivecholecystectomyforpatientswithrecurrentboutsofbiliarycolic.

AcuteCholecystitis

A.GeneralCharacteristics 1. Obstructionofthecysticduct(notinfection)inducesacuteinflammationofthe

gallbladderwall.

2. Chroniccholecystitismaydevelopwithrecurrentboutsofacutecholecystitis. 3. Tenpercentofpatientswithgallstonesdevelopacutecholecystitis.

Quick HIT

SignsofBiliaryTractObstruction

Elevatedalkalinephosphatase,increasedGGT Elevatedconjugatedbilirubin Jaundice Pruritus Clay-coloredstools Darkurine

B.ClinicalFeatures 1. Symptoms

a. PainisalwayspresentandislocatedinRUQorepigastrium;itmayradiateto

therightshoulderorscapula. b. Nauseaandvomiting,anorexia

2. Signs

a. RUQtenderness,reboundtendernessinRUQ b. Murphysignispathognomonic—inspiratoryarrestduringdeeppalpationofthe

RUQ;notpresentinmanycases

c. Hypoactivebowelsounds d. Low-gradefever,leukocytosis

C.Diagnosis 1. RUQultrasoundisthetestofchoice.

a. Highsensitivityandspecificity b. Findingsincludethickenedgallbladderwall,pericholecysticfluid,distended

gallbladder,andpresenceofstone(s).

2. CTscanisasaccurateasultrasoundbutismoresensitiveinidentifying complicationsofacutecholecystitis(e.g.,perforation,abscess,pancreatitis).

3. Radionuclidescan(hepatoiminodiaceticacid[HIDA])

a. Usedwhenultrasoundisinconclusive.Itssensitivityandspecificityparallelthat ofultrasound.IfHIDAscanisnormal,acutecholecystitiscanberuledout.

b. ApositiveHIDAscanmeansthegallbladderisnotvisualized.

c. Ifgallbladderisnotvisualized4hoursafterinjection,diagnosisofacute cholecystitisisconfirmed.
======================================
Quick HIT

AcutecholecystitisisasyndromeofRUQpain,fever,andleukocytosisassociatedwithgallbladder inflammation.

Quick HIT

ComplicationsofCholecystitis Gangrenouscholecystitis Perforationofgallbladder Emphysematouscholecystitis Cholecystoentericfistulawithgallstoneileus Empyemaofgallbladder

D.Treatment 1. Patientshouldbeadmitted.ConservativemeasuresincludehydrationwithIV fluids,bowelrest(NPO),IVantibiotics,analgesics,correctionofelectrolyte abnormalities.

2. Surgery—cholecystectomyisindicatedinmostpatientswithsymptomatic gallstones.Earlycholecystectomyispreferred(first24to48hours).Recurrence ratewithnonsurgicaltreatmentisashighas70%.Inmostpatients,early cholecystectomyispreferred.

3. Incriticallyillpatientswithhighsurgicalrisk,percutaneouscholecystostomytube placementfordrainageofthegallbladderisanalternativetoimmediatesurgery.

Quick HIT

GallstoneIleus

Gallstoneentersbowellumenviacholecystoentericfistula—gets“stuck”interminalileumandcauses obstruction. Accountsfor1%to2%ofbowelobstructions.

Quick HIT

Complicationsofacutecholecystitisincludegangreneandgallbladderperforation,whichcanbelifethreatening.

AcalculousCholecystitis

Acutecholecystitiswithoutstonesobstructingthecysticduct(upto10%ofpatients withacutecholecystitis). Usuallyidiopathicandseeninpatientswithsevereunderlyingillness;possibly associatedwithdehydration,ischemia,burns,severetrauma,andapostoperative state. Signsandsymptomsarethesameasforacutecholecystitis. Diagnosismaybedifficultbecausepatientswiththisconditionareoftenseverelyill andhaveothermedicalproblems;soclinicalfeaturesarelessapparent. Emergentcholecystectomyisthetreatmentofchoice.Forpatientswhoaretooillfor surgery,performpercutaneousdrainageofthegallbladderwithcholecystostomy.

Choledocholithiasis

A.GeneralCharacteristics 1. ReferstogallstonesintheCBD(seeTable3-2) 2. Primaryversussecondarystones

a. PrimarystonesoriginateintheCBD(usuallypigmentedstones). b. SecondarystonesoriginateinthegallbladderandthenpassintotheCBD (usuallycholesterolormixedstones).Theseaccountfor95%ofallcases.

Quick  HIT  ComplicationsofCBDStones  Cholangitis Obstructivejaundice Acutepancreatitis Biliarycolic Biliarycirrhosis 
======================================
B.ClinicalFeatures 1. Patientsmaybeasymptomaticforyears. 2. Symptoms,whenpresent,includeRUQorepigastricpainandjaundice.

Quick HIT

PatientswithCBDstonesmaybeasymptomaticforyears.However,unlikepatientswithcholelithiasis,inwhich biliarycolicmayleadtoacutecholecystitis,theonsetofsymptomsincholedocholithiasiscansignalthe developmentoflife-threateningcomplicationssuchascholangitisandacutepancreatitis.

C.Diagnosis 1. Laboratorytests—totalanddirectbilirubinlevelsareelevated,aswellasALK-P. 2. RUQultrasoundisusuallytheinitialstudy,butisnotasensitivestudyfor

choledocholithiasis.ItdetectsCBDinonly50%ofcases,soitcannotbeusedto ruleoutthisdiagnosis.

3. ERCPisthegoldstandard(sensitivityandspecificityof95%)andshouldfollow ultrasound.ERCPisdiagnosticandtherapeutic(seebelow).

4. PTCisanalternativetoERCP.

D.Treatment 1. ERCPwithsphincterotomyandstoneextractionwithstentplacement(successful

in90%ofpatients).

2. Laparoscopiccholedocholithotomy(inselectcases)

Quick HIT

Dothefollowinginpatientswithcholangitis:

Bloodcultures IVfluids IVantibioticsafterbloodculturesobtained DecompressCBDwhenpatientstable.

TABLE3-2 CholelithiasisVersusCholedocholithiasis
======================================
Cholangitis

A.GeneralCharacteristics 1. Infectionofbiliarytractsecondarytoobstruction,whichleadstobiliarystasisand

bacterialovergrowth.

a. Choledocholithiasisaccountsfor60%ofcases. b. Othercausesincludepancreaticandbiliaryneoplasm,postoperativestrictures,

invasiveproceduressuchasERCPorPTC,andcholedochalcysts.

2. Cholangitisispotentiallylifethreateningandrequiresemergencytreatment.

B.ClinicalFeatures 1. Charcottriad:RUQpain,jaundice,andfever—thisclassictriadispresentinonly

50%to70%ofcases.

2. Reynoldspentad:Charcottriadplussepticshockandalteredmentalstatus(CNS depression—e.g.,coma,disorientation).

3. Patientisacutelyill,andabdominalsymptomsmaybelackingormaygo unrecognized.

Quick HIT

Reynoldspentadisahighlytoxicstatethatrequiresemergencytreatment.Itcanberapidlyfatal.

C.Diagnosis 1. RUQultrasoundistheinitialstudy. 2. Laboratoryfindings—hyperbilirubinemia,leukocytosis,mildelevationinserum

transaminases.

3. Cholangiography(PTCorERCP).

a. Thisisthedefinitivetest,butitshouldnotbeperformedduringtheacutephase ofillness.Oncecholangitisresolves,proceedwithPTCorERCPtoidentifythe underlyingproblemandplantreatment.

b. PerformPTCwhentheductsystemisdilated(perultrasound)andERCPwhen theductsystemisnormal.

Quick HIT

RUQultrasoundisveryaccurateindetectinggallstonesandbiliarytractdilatation,butnotveryaccuratein detectingCBDstones.

D.Treatment 1. IVantibioticsandIVfluids

a. Closemonitoringofhemodynamics,BP,andurineoutputisimportant. b. Mostpatientsrespondrapidly.Oncethepatienthasbeenafebrilefor48hours,

cholangiography(PTCorERCP)canbeperformedforevaluationofthe underlyingcondition.

2. DecompressCBDviaPTC(catheterdrainage);ERCP(sphincterotomy),or laparotomy(T-tubeinsertion)oncethepatientisstabilized,oremergentlyifthe conditiondoesnotrespondtoantibiotics.

Hepaticabscessisthemostseriousanddreadedcomplicationofacutecholangitis—ithasahighmortality rate.

CarcinomaoftheGallbladder

Mostareadenocarcinomasandtypicallyoccurintheelderly. Associatedwithgallstonesinmostcases;otherriskfactorsincludecholecystoenteric fistulaandporcelaingallbladder(Figure3-3). Clinicalfeaturesarenonspecificandsuggestextrahepaticbileductobstruction: jaundice,biliarycolic,weightloss,anorexia,andRUQmass.Palpablegallbladderis asignofadvanceddisease. Difficulttoremovewithsurgery:cholecystectomyversusradicalcholecystectomy (withwedgeresectionofliverandlymphnodedissection)dependingondepthof invasion. Prognosisisdismal—morethan90%ofpatientsdieofadvanceddiseasewithin1 yearofdiagnosis.Diseaseoftengoesundetecteduntilitisadvanced.
======================================
Quick HIT

PorcelainGallbladder

e

e

Definition:intramuralcalcificationofthegallbladderwall. Prophylacticcholecystectomyisrecommendedbecauseapproximately50%ofpatientswithporcelain gallbladderwilleventuallydevelopcancerofthegallbladder.

PrimarySclerosingCholangitis

A.GeneralCharacteristics 1. Achronicidiopathicprogressivediseaseofintrahepaticand/orextrahepaticbile ductscharacterizedbythickeningofbileductwallsandnarrowingoftheir lumens;leadstocirrhosis,portalhypertension,andliverfailure(Table3-3). 2. ThereisastrongassociationwithUC(lesssowithCrohndisease).UCispresent in50%to70%ofpatientswithPSC;oftentheUCmaydominatetheclinical picture.(Note:ThecourseofPSCisunaffectedbyacolectomydoneforUC.)

Quick HIT

ComplicationsofPSC

¢

e

e

Cholangiocarcinoma(inupto20%to30%ofpatients). Recurrentboutsofcholangitis(inabout15%ofpatients). Canprogresstosecondarybiliarycirrhosis,portalHTN,andliverfailure.

FIGURE 3.3

Porcelaingallbladder.Notethethinlayerofmineralization

surroundingthegallbladderwall. (CasecourtesyofA.ProfFrankGaillard,Radiopaedia.org,rID:12409.)

B.ClinicalFeatures 1. Signsandsymptomsbegininsidiously. 2. Chroniccholestasisfindings,includingjaundiceandpruritus;allpatients

eventuallypresentwithchronicobstructivejaundice.

3. Othersymptoms:fatigue,malaise,weightloss.

C.Diagnosis 1. ERCPandPTCarediagnosticstudiesofchoice—seemultipleareasofbead-like

stricturingandbead-likedilatationsofintra-andextrahepaticducts.

2. LaboratorytestsshowcholestaticLFTs.

D.Treatment 1. Thereisnocurativetreatmentotherthanlivertransplantation. 2. Whenadominantstricturecausescholestasis,ERCPwithstentplacementfor

2. When a dominant stricture causes cholestasis, ERCP with stent placement for biliary drainage and bile duct dilatation may relieve symptoms.

biliarydrainageandbileductdilatationmayrelievesymptoms. 3. Usecholestyramineforsymptomaticrelief(todecreasepruritus).

TABLE3-3 PrimaryBiliaryCirrhosisVersusPrimarySclerosingCholangitis
======================================
PrimaryBiliaryCholangitis

A.GeneralCharacteristics 1. PBCisachronicandprogressivecholestaticliverdiseasecharacterizedby

destructionofintrahepaticbileductswithportalinflammationandscarring (Table3-3).

2. Itisaslowlyprogressivediseasewithavariablecourse.Itmayprogressto cirrhosisandend-stageliverfailure.

3. Itisanautoimmunediseasethatisoftenassociatedwithotherautoimmune disorders.

4. Itismostcommoninmiddle-agedwomen.

Quick HIT

EtiologyofSecondaryBiliaryCirrhosis.Thisdiseaseoccursinresponsetochronicbiliaryobstructionfrom thefollowing:

¢

¢

©

e

Long-standingmechanicalobstruction Sclerosingcholangitis Cysticfibrosis Biliaryatresia

B.ClinicalFeatures 1. Fatigue 2. Pruritus(earlyincourseofdisease) 3. Jaundice(lateincourseofdisease) 4. RUQdiscomfort 5. Xanthomataandxanthelasmata 6. Osteoporosis 7. PortalHTN(withresultantsequelae)

C.Diagnosis 1. Laboratoryfindings

a. CholestaticLFTs(elevatedALK-P) b. Positiveantimitochondrialantibodies(AMAs)foundin90%to95%of patients.Thisisthehallmarkofthedisease(specificityof98%).Ifserumis positiveforAMAs,performaliverbiopsytoconfirmdiagnosis

c. Elevatedcholesterol,HDL d. ElevatedimmunoglobulinM

2. Liverbiopsy(percutaneousorlaparoscopic)toconfirmthediagnosis. 3. AbdominalultrasoundorCTscantoruleoutbiliaryobstruction.

D.Treatment 1. Treatmentissymptomaticforpruritus(cholestyramine)andosteoporosis

(calcium,bisphosphonates,vitaminD).

2. Ursodeoxycholicacid(ahydrophilicbileacid)hasbeenshowntoslow progressionofthedisease.

3. Livertransplantationistheonlycurativetreatmentavailable.

Cholangiocarcinoma

A.GeneralCharacteristics 1. Tumorofintra-orextrahepaticbileducts:mostareadenocarcinomas. 2. Meanageofdiagnosisisintheseventhdecade. 3. Locatedinthreeregions:proximalthirdoftheCBD(mostcommon,alsocalled Klatskintumor),distalextrahepatic(bestchanceofresectability),intrahepatic (leastcommon).

4. Prognosisisdismal—survivalislessthan1yearafterdiagnosis. 5. Riskfactors

a. PSCisthemajorriskfactorintheUnitedStates. b. OtherriskfactorsincludeUC,choledochalcysts,andClonorchissinensis

infestation(inHongKong).
======================================
Quick HIT

KlatskinTumors

¢

e

TumorsinproximalthirdofCBD—involvethejunctionofrightandlefthepaticducts. Verypoorprognosisbecausetheyareunresectable.

B.ClinicalFeatures 1. Obstructivejaundiceandassociatedsymptoms:darkurine,clay-coloredstools,

1. Obstructive jaundice and associated symptoms: dark urine, clay-colored stools, and pruritus.

andpruritus. 2. Weightloss

C.Diagnosis 1. Cholangiography(PTCorERCP)fordiagnosisandassessmentofresectability. 2. Ifthepatienthasanunresectabletumor(morelikelythecasewithproximalthan distalbileducttumors),stentplacementisanoptionduringeitherPTCorERCP andmayrelievebiliaryobstruction.

D.Treatment 1. Mostpatientsdonothaveresectabletumorsatdiagnosis. 2. Thesurvivalrateislowdespiteaggressivechemotherapy,stenting,orbiliary

drainage.

CholedochalCysts

Cysticdilatationsofbiliarytreeinvolvingeithertheextra-orintrahepaticducts,or both;morecommoninwomen(4:1). Clinicalfeatures:epigastricpain,jaundice,fever,andRUQmass. Complications:cholangiocarcinoma(mostfearedcomplication—riskisabout20% over20years),hepaticabscess,recurrentcholangitis/pancreatitis,rupture,biliary obstruction,cirrhosis,andportalHTN. Ultrasoundisthebestnoninvasivetest,andERCPisdefinitivefordiagnosis. Treatmentissurgery:completeresectionofthecystwithabiliary-enteric anastomosistorestorecontinuityofbiliarysystemwithbowels.

BileDuctStricture

Mostcommoncauseisiatrogenicinjury(e.g.,priorbiliarysurgerysuchas cholecystectomy,livertransplantation).Othercausesincluderecurring choledocholithiasis,chronicpancreatitis,andPSC. Clinicalfeaturesarethoseofobstructivejaundice. Complicationscanbelifethreatening:secondarybiliarycirrhosis,liverabscess,and ascendingcholangitis. Treatmentinvolvesendoscopicstenting(preferred)orsurgicalbypassifobstruction iscompleteorifendoscopictherapyfails.

BiliaryDyskinesia

MotordysfunctionofthesphincterofOddiwhichleadstorecurrentepisodesof biliarycolicwithoutanyevidenceofgallstonesondiagnosticstudiessuchas ultrasound,CTscan,andERCP. DiagnosisismadebyHIDAscan.Oncethegallbladderisfilledwithlabeled radionuclide,givecholecystokinin(CCK)intravenously;thendeterminetheejection fractionofthegallbladder.Iftheejectionfractionislow,dyskinesiaislikely. Treatmentoptionsincludelaparoscopiccholecystectomyandendoscopic sphincterotomy.
======================================
Quick HIT

CCKisthehormonethatrelaxesthesphincterofOddiandcontractsthegallbladder.

DiseasesoftheAppendix AcuteAppendicitis

A.GeneralCharacteristics 1. Pathogenesis

a. Thelumenoftheappendixisobstructedbyhyperplasiaoflymphoidtissue(60% ofcases),afecalith(35%ofcases),aforeignbody,orotherrarecauses(parasite orcarcinoidtumor[5%ofcases]).

b. Obstructionleadstostasis(offluidandmucus),whichpromotesbacterial growth,leadingtoinflammation.

c. Distentionoftheappendixcancompromisebloodsupply.Theresulting ischemiacanleadtoinfarctionornecrosisifuntreated.Necrosiscanresultin appendicealperforation,andultimatelyperitonitis.

2. Peakincidenceisintheteenstomid-20s.Prognosisisfarworseininfantsand elderlypatients(higherrateofperforation).

Quick HIT

PerforationofAppendix

¢

e

e

Complicates20%ofcases. Riskfactors:delayintreatment(>24hours)andextremesofage. Signsofappendicealrupture(highfever,tachycardia,markedleukocytosis,peritonealsigns,toxic appearance).

B.ClinicalFeatures 1. Symptoms

a. Abdominalpain—Classicallystartsintheepigastrium,movestowardumbilicus, andthentotheRLQ.Withdistentionoftheappendix,theparietalperitoneum maybecomeirritated,leadingtosharppain.

b. Anorexiaalwayspresent.Appendicitisisunlikelyifthepatientishungry. c. Nauseaandvomiting(typicallyfollowpain).

2. Signs

a. TendernessinRLQ(maximaltendernessatMcBurneypoint:two-thirdsofthe distancefromtheumbilicustotherightanteriorsuperioriliacspine).

b. Reboundtenderness,guarding,diminishedbowelsounds. c. Low-gradefever(mayspikeifperforationoccurs). d. Rovsingsign:deeppalpationinLLQcausesreferredpaininRLQ. e. Psoassign:RLQpainwhenrightthighisextendedasthepatientliesontheleft

side.

f. Obturatorsign:paininRLQwhenflexedrightthighisinternallyrotatedwhen patientissupine.

Quick HIT

Acuteappendicitisisaclinicaldiagnosis.Laboratoryfindings(mildleukocytosis)areonlysupportive. Radiographsorotherimagingstudiesareunnecessaryunlessthediagnosisisuncertainorthepresentationis atypical.

C.Diagnosis 1. Acuteappendicitisisaclinicaldiagnosis. 2. Laboratoryfindings(mildleukocytosis)areonlysupportive. 3. Imagingstudiesmaybehelpfulifdiagnosisuncertainorinatypicalpresentations. a. CTscan(sensitivity98%to100%)—lowersthefalse-positiveratesignificantly. b. Ultrasound(sensitivityof90%).
======================================
D.Treatment 1. Appendectomy(usuallylaparoscopic).Upto20%ofpatientswhoarediagnosed withacuteappendicitisarefoundtohaveanormalappendixduringsurgery. Becausetheillnessispotentiallylifethreatening,thisisanacceptableriskeven duringpregnancy.

2. Low-riskpatientsmaybeconsideredformedicalmanagementalonewith antibioticstoavoidsurgery.Closefollow-upisnecessaryincaseurgentsurgeryis required.

Quick HIT

Carcinoidsyndromedevelopsin10%ofpatientswithcarcinoidtumors.

e

e

¢

Excessserotoninsecretioncanleadtocarcinoidsyndrome,whichismanifestedbycutaneousflushing, diarrhea,sweating,wheezing,abdominalpain,andheartvalvedysfunction. Riskfactorsofmetastasisincreasewiththesizeofthetumor.Metastasesarerarewithappendicealtumors. Ilealtumorshavethegreatestlikelihoodofmalignancy. Surgicalresectionisthetreatmentofchoice.

CarcinoidTumorsandCarcinoidSyndrome

Carcinoidtumorsoriginatefromneuroendocrinecellsandsecreteserotonin. Themostcommonsiteforthesetumorsistheappendix,buttheycanbefoundina varietyoflocations(e.g.,smallbowel,rectum,bronchus,kidney,pancreas).

DiseasesofthePancreas

AcutePancreatitis

A.GeneralCharacteristics 1. Thereisinflammationofthepancreasresultingfromprematurelyactivated pancreaticdigestiveenzymesthatinvokepancreatictissueautodigestion. 2. Mostpatientswithacutepancreatitishavemildtomoderatedisease,butupto 25%haveseveredisease.Therearetwoformsofacutepancreatitis,mildand severe:

a. Mildacutepancreatitisismostcommonandrespondswelltosupportive treatment.

b. Severeacutepancreatitis(necrotizingpancreatitis)hassignificantmorbidityand mortality.

B.Causes 1. Gallstones(40%)—thegallstonepassesintothebileductandblockstheampulla

1. Gallstones (40%)—the gallstone passes into the bile duct and blocks the ampulla of Vater

ofVater

2. Alcoholabuse(30%) 3. Post-ERCP—pancreatitisoccursinupto10%ofpatientsundergoingERCP 4. Viralinfections(e.g.,mumps,CoxsackievirusB) 5. Drugs—sulfonamides,thiazidediuretics,furosemide,estrogens,HIVmedications,

Drugs—sulfonamides, thiazide diuretics, furosemide, estrogens, HIV medications, and many other drugs have been implicated

andmanyotherdrugshavebeenimplicated 6. Postoperativecomplications(highmortalityrate) 7. Autoimmunepancreatitis 8. Scorpionbites 9. Pancreasdivisum(controversial) 10. Pancreaticcancer 11. Hypertriglyceridemia,hypercalcemia 12. Uremia 13. Bluntabdominaltrauma(mostcommoncauseofpancreatitisinchildren)
======================================
Quick HIT

Mostcasesofacutepancreatitisareduetoalcoholorgallstones(70%to80%).Recurrencesarecommonin alcoholicpancreatitis.

Quick HIT

Causesofacutepancreatitis—GETSMASHED G—gallstones E—ethanol T—trauma S—steroids M—mumps A—autoimmune S—scorpionstings/spiderbites H—hyperlipidemia,hypercalcemia,hyperparathyroidism E—ERCP D—drugs

C.ClinicalFeatures 1. Symptoms

a. Abdominalpain,usuallyintheepigastricregion

e

e

Mayradiatetoback(50%ofpatients) Oftensteady,dull,andsevere;worsewhensupineandaftermeals

b. Nauseaandvomiting,anorexia

2. Signs

a. Low-gradefever,tachycardia,hypotension,leukocytosis b. Epigastrictenderness,abdominaldistention c. Decreasedorabsentbowelsoundsindicatepartialileus d. Thefollowingsignsareseenwithhemorrhagicpancreatitisasbloodtracksalong

fascialplanes:

¢

e

e

GreyTurnersign(flankecchymoses) Cullensign(periumbilicalecchymoses) Foxsign(ecchymosisofinguinalligament)

Quick HIT

Thediagnosisofacutepancreatitisisusuallymadebasedonclinicalpresentation.Laboratorystudiesare supportive,andCTscanisconfirmatory.

Quick HIT

Thelevelofeitheramylaseorlipasedoesnotreliablypredicttheseverityofdisease.

D.Diagnosis 1. Mustfulfilltwoofthreecriteria:classicalclinicalpresentation(epigastricpain

thatradiatestotheback),labfindings,andimagingfindings.

2. Laboratorystudies

a. Serumlipaseandamylase.Lipaseismorespecific. b. LFTs—toidentifycause(gallstonepancreatitis). c. Hyperglycemia,hypoxemia,andleukocytosismayalsobepresent. d. Orderthefollowingforassessmentofprognosis(seeTable3-4—Ranson

criteria):glucose,calcium,hematocrit,BUN,arterialbloodgas(PaO2,base deficit),LDH,AST,WBCcount.

3. Abdominalradiograph

a. Hasalimitedroleinthediagnosisofacutepancreatitis. b. Morehelpfulinrulingoutotherdiagnoses,suchasintestinalperforation(free

air).Thepresenceofcalcificationscansuggestchronicpancreatitis.

c. Insomecases,onemayseeasentinelloop(areaofair-filledbowelusuallyin LUQ,whichisasignoflocalizedileus)oracoloncut-offsign(air-filled segmentoftransversecolonabruptlyendingor“cuttingoff”attheregionof pancreaticinflammation).

4. Abdominalultrasound
======================================
a. Canhelpinidentifyingcauseofpancreatitis(e.g.,gallstones). b. Usefulforfollowinguppseudocystsorabscesses.

Quick HIT

Hypocalcemiathatresultsfromacutepancreatitisisduetofatsaponification:fatnecrosisbindscalcium.
======================================
5. CTscanoftheabdomen

a. Mostaccuratetestfordiagnosisofacutepancreatitisandforidentifying complicationsofthedisease.

b. Indicatedinpatientswithsevereacutepancreatitis.

6. IndicationsforERCP:

a. Severegallstonepancreatitiswithbiliaryobstruction. b. Toidentifyuncommoncausesofacutepancreatitisifdiseaseisrecurrent.

Quick HIT

Pseudocystsmaybepresentatsitesdistantfromthepancreas.

E.Complications 1. Pancreaticnecrosis(maybesterileorinfected)

a. Sterilepancreaticnecrosis—infectionmaydevelop,buthalfofallcasesresolve spontaneously.ThesepatientsshouldbemonitoredcloselyinanICU. Prophylacticantibioticsarecontroversialbutifnecrosisinvolvesmorethan30% ofpancreas,antibioticsshouldbestronglyconsidered.

b. Infectedpancreaticnecrosis—resultsinmultipleorganfailurein50%ofcases andhashighmortalityrate;surgicaldebridementandantibioticsareindicated.

c. TheonlywaytodistinguishsterilefrominfectednecrosisisviaCT-guided percutaneousaspirationwithGramstain/cultureoftheaspirate.

2. Pancreaticpseudocyst

a. Encapsulatedfluidcollectionthatappears2to3weeksafteranacuteattack— unlikeatruecyst,itlacksanepitheliallining.

b. Complicationsofuntreatedpseudocystsincluderupture,infection,gastricoutlet obstruction,fistula,hemorrhageintocyst,andpancreaticascites.Itmayimpinge onadjacentabdominalorgans(e.g.,duodenum,stomach,transversecolon)if largeenough;oriflocatedintheheadofthepancreas,itmaycausecompression oftheCBD.

c. Diagnosis:CTscanisthestudyofchoice. d. Treatment

e

e

Cysts<5cm:observation Cysts>5cm:draineitherpercutaneouslyorsurgically

3. Hemorrhagicpancreatitis

a. CharacterizedbyCullensign,GreyTurnersign,andFoxsign b. CTscanwithIVcontrastisthestudyofchoice

4. Adultrespiratorydistresssyndrome—alife-threateningcomplicationwithhigh mortalityrate.

5. Pancreaticascites/pleuraleffusion—themostcommoncauseisinflammationof peritonealsurfaces.

6. Ascendingcholangitis—duetogallstoneintheampullaofVater,leadingto infectionofbiliarytract;seesectiononcholangitis.

7. Pancreaticabscess(rare)—developsover4to6weeksandislesslifethreatening
======================================
thaninfectedpancreaticnecrosis.

Quick HIT

Mostpatientswithacutepancreatitisrespondtosupportivecareofpaincontrol,bowelrest,IVfluids,and correctionofelectrolyteabnormalitiesanddonotrequireanyfurthertherapy.

F.Treatment 1. Patientswithmildacutepancreatitis:

a. Bowelrest(NPO)—goalistorestthepancreas. b. IVfluids—patientsmayhavesevereintravascularvolumedepletion.Correct electrolyteabnormalities.Balancedcrystalloids(lactatedRingersolution)are superiortonormalsaline,asnormalsalinecancausehyperchloremicmetabolic acidosis.Acidosiswillincreasepancreaticzymogenactivitywhichwillthen worsenautodigestion.

c. Paincontrol,butbecautiousingivingnarcotics.Fentanylandmeperidine preferredovermorphinewhichcausesanincreaseinsphincterofOddipressure.

d. Nasogastrictube,ifseverenausea/vomitingorileuspresent;routineuseis controversial.

e. Allpatientswithgallstonepancreatitisshouldhavecholecystectomyafter recoveryfrompancreatitis.ThesepatientsmaybenefitfromearlyERCP.

2. Patientswithseverepancreatitis:

a. AdmittotheICU. b. Earlyenteralnutritioninthefirst72hoursisrecommendedthrougha

nasojejunaltube.

c. Ifthesevereacutepancreatitishasnotresolvedinafewdays,supplemental parenteralnutritionshouldbestarted.

d. Ifmorethan30%ofthepancreasisnecrosed,prophylacticantibiotics (imipenem)shouldbeconsideredtopreventinfection(whichhashighmorbidity andmortality).

G.Prognosis 1. Ransoncriteriaareusedtodetermineprognosisandmortalityrates. 2. PatientswithmorethanthreeorfourRansoncriteriashouldbemonitoredinan

ICUsetting.

ChronicPancreatitis

A.GeneralCharacteristics 1. Persistentorcontinuinginflammationofthepancreas,withfibrotictissue

replacingpancreaticparenchyma,andalterationofpancreaticducts(areasof stricture/dilation);eventuallyresultsinirreversibledestructionofthepancreas.

2. Theendocrineandexocrinefunctionsofthepancreasareimpaired. 3. Causes

a. Chronicalcoholismisthemostcommoncause(>80%ofcases). b. Othercausesincludehereditarypancreatitis,tropicalpancreatitis,andidiopathic

chronicpancreatitis.
======================================
Quick HIT

Thecombinationofchronicepigastricpainandcalcificationsonplainabdominalfilmsisdiagnosticforchronic pancreatitis.Theclassictriadofsteatorrhea,diabetesmellitus,andpancreaticcalcificationonplainfilmsorCT scanisalsodiagnostic.

B.ClinicalFeatures 1. Severepainintheepigastrium;recurrentorpersistentabdominalpain.

a. Oftenaccompaniedbynauseaandvomiting. b. Maybeaggravatedbyanepisodeofbingedrinkingalcohol,orbyeating. c. Radiatestothebackin50%ofcases.

2. Weightloss,duetomalabsorption,alcoholabuse,anddiabetes;steatorrhea secondarytomalabsorption.

Quick HIT

Chronicpancreatitispresentsaschronicunrelentingpainwithepisodicflare-ups.

C.Diagnosis 1. CTscan(Figure3-4)istheinitialstudyofchoice.Itmayshowcalcificationsnot seenonplainfilms.Mildtomoderatecasesmaynotbedetectable,soanormal CTscandoesnotnecessarilyruleoutchronicpancreatitis.

2. Abdominalradiograph—thepresenceofpancreaticcalcificationsis95%specific, butisfoundinonly30%ofcases.

3. ERCPisthegoldstandard,butisnotdoneroutinelybecauseitisinvasive. 4. Laboratorystudiesarenothelpfulindiagnosis.Serumamylaseandlipaselevels

arenotelevatedinchronicpancreatitis.

D.Complications 1. Narcoticaddiction—probablythemostcommoncomplication. 2. Diabetesmellitus/impairedglucosetolerance

a. CausedbyprogressivelossofisletsofLangerhans b. Eventuallyappearsinupto70%ofpatients

3. Malabsorption/steatorrhea

a. Causedbypancreaticexocrineinsufficiency—occurswhenpancreaticenzyme secretiondecreasessignificantly.

b. Alatemanifestationofchronicpancreatitis

4. Pseudocystformation 5. Pancreaticductaldilation 6. CBDobstruction(mayoccursecondarytofibrosisinheadofgland) 7. VitaminB12malabsorption 8. Effusions(e.g.,pleural,pericardial,peritoneal) 9. Pancreaticcarcinoma—patientswithchronicpancreatitishaveanincreasedrisk.

FIGURE 3.4

A:CTscanofchronicpancreatitis.Notetheareaof calcification(smallarrow)andapseudocyst(largearrow)inthehead ofthepancreas.B:TypicalfindingsonERCPinchronicpancreatitis. Notetheareasofstricture(largearrow)andductdilatation(small arrow)throughoutthepancreaticduct.Thiscreatesa“chainoflakes” appearance. (FromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.4thed.

Philadelphia,PA:LippincottWilliams&Wilkins,2000:958,Figures117.9and117.10,

respectively.)
======================================
E.Treatment 1. Nonoperativemanagement

a. Narcoticanalgesicsforpain b. Bowelrest(NPO) c. PancreaticenzymesandH2blockers(givensimultaneously)

e

e

PancreaticenzymesinhibitCCKreleaseandthusdecreasepancreatic secretionsaftermeals. H2blockersinhibitgastricacidsecretion,preventingdegradationofthe pancreaticenzymesupplementsbygastricacid.

d. Insulin—maybenecessaryduetoseverepancreaticendocrineinsufficiency. e. Alcoholabstinence f. Frequent,small-volume,low-fatmeals—mayimproveabdominalpain.

2. Surgery—maingoalisreliefofincapacitatingabdominalpain.

a. Pancreaticojejunostomy(pancreaticductdrainageproceduretodecompressthe dilatedpancreaticduct)—mostcommonprocedure

b. Pancreaticresection(distalpancreatectomy,Whippleprocedure)

PancreaticCancer

A.GeneralCharacteristics 1. Mostcommoninelderlypatients(75%ofpatientsare>60yearsold);rarebefore

age40;morecommoninAfricanAmericans.

2. Anatomiclocation

a. Pancreatichead(75%ofcases) b. Pancreaticbody(20%ofcases) c. Pancreatictail(5%to10%ofcases)

3. Riskfactors

a. Cigarettesmoking(mostclearlyestablishedrisk) b. Chronicpancreatitis c. Diabetes d. Heavyalcoholuse e. Exposuretochemicals—benzidineandβ-naphthylamine

4. Theprognosisisdismal:mostpatientsdiewithinmonthsofdiagnosis.

B.ClinicalFeatures 1. Abdominalpain(90%ofpatients)—maybeavagueanddullache. 2. Jaundice

Quick HIT

Painlessjaundiceisnotcommoninpancreaticcancer!

a. Mostcommonwithcarcinomaofheadofpancreas—lessthan10%ofpatients withcancerinvolvingbodyandtailofpancreashavejaundice.

b. IndicatesobstructionofintrapancreaticCBDandisasignofadvanceddisease. 3. Weightloss(commonduetodecreasedfoodintakeandmalabsorption);anorexia 4. Recentonsetofglucoseintolerance,butthediabetesismild. 5. Depression,weakness,fatigue 6. Migratorythrombophlebitis—developsin10%ofcases 7. Courvoisiersign(palpablegallbladder)—presentin30%ofpatientswithcancer

involvingheadofpancreas;presentswithoutpain.

Quick HIT

Theearlyclinicalfindingsofpancreaticcancerareveryvagueandnonspecific.Bythetimeadiagnosisismade, mostpatientshaveanincurablelevelofadvanceddisease.
======================================
C.Diagnosis 1. ERCPisthemostsensitivetestfordiagnosingpancreaticcancer.Itcanalso distinguishcanceroftheheadofthepancreasfromtumorsoftheCBD, duodenum,ampulla,andlymphomas,whichhavemorefavorableprognosis. 2. CTscanisthepreferredtestfordiagnosisandassessmentofdiseasespread. 3. Tumormarkers.

a. CA19-9(sensitivityof83%andspecificityof82%). b. CEA(sensitivityof56%andspecificityof75%).

Quick HIT

AortoentericFistulaisararebutlethalcauseofGIbleeding.Theclassicpresentationisapatientwithahistory (sometimesdistant)ofaorticgraftsurgerywhohasasmallGIbleedinvolvingtheduodenumbeforemassive, fatalhemorrhagehourstoweekslater.Performendoscopyorsurgeryduringthissmallwindowofopportunityto preventdeath.

D.Treatment 1. Surgicalresection(Whippleprocedure)istheonlyhopeforacure;however,only aminorityoftumorsareresectable(roughly10%).Theprognosisisgrimeven afterresection,witha5-yearsurvivalrateof10%.

2. Ifthetumorisunresectableandbiliaryobstructionispresent,performPTCor ERCPwithstentplacementacrosstheobstructionforpalliation.

GastrointestinalBleeding

A.GeneralCharacteristics 1. UpperGIbleedingreferstoasourceofbleedingabovetheligamentofTreitzin

theduodenum.

2. LowerGIbleedingisclassicallydefinedasbleedingbelowtheligamentofTreitz.

B.Causes 1. UpperGIbleeding

a. Pepticulcerdisease(PUD)—duodenalulcer(25%ofcases),gastriculcer(20% ofcases),gastritis(25%ofcases)

b. Refluxesophagitis c. Esophagealvarices(10%ofcases)—venousbleeding d. Gastricvarices e. Gastricerosions,duodenitis f. Mallory–Weisstear g. Hemobilia

Quick HIT

AlowerGIbleed(orpositiveoccultbloodtestofstool)inpatientsover40iscoloncanceruntilproven otherwise.

h. Dieulafoyvascularmalformation—submucosaldilatedarteriallesionsthatcan causemassiveGIbleeding

i. Aortoentericfistulas—afteraorticsurgery(askaboutprioraortic aneurysm/graft)

j. Neoplasm—bleedingisnotrapid—usuallynotanemergency

Quick HIT

About80%ofepisodesofupperGIbleedingstopspontaneouslyandonlyneedsupportivetherapy.

2. LowerGIbleeding

a. Diverticulosis(40%ofcases)—mostcommonsourceofGIbleedinginpatients overage60;usuallypainless.

b. Angiodysplasia(40%ofcases)—secondmostcommonsourceinpatientsover
======================================
age60.

c. IBD(UC,Crohndisease)

d. Colorectalcarcinoma e. Colorectaladenomatouspolyps f. Ischemiccolitis g. Hemorrhoids,analfissures h. Smallintestinalbleeding—diagnosedbyexcludingupperGIandcolonic

bleeding

Quick HIT

e

©

Bleedingfromthesmallbowelmaymanifestasmelenaorhematochezia. Colonicsourcesofbleedingpresentwitheitheroccultbloodinthestoolorhematochezia.

C.ClinicalFeatures 1. Typeofbleeding:

a. Hematemesis—vomitingblood;suggestsupperGIbleeding(bleedingproximal toligamentofTreitz).Indicatesmoderatetoseverebleedingthatmaybe ongoing.

b. “Coffeegrounds”emesis—suggestsupperGIbleedingaswellasalowerrate ofbleeding(enoughtimeforvomitustotransforminto“coffeegrounds”).

c. Melena—black,tarry,liquid,foul-smellingstool.

Quick HIT

AlwaysaskpatientswithGIbleedingiftheytookanyNSAIDs/aspirin,clopidogrel,oranticoagulants.

e

e

¢

e

Causedbydegradationofhemoglobinbybacteriainthecolon;presenceof melenaindicatesthatbloodhasremainedinGItractforseveralhours. Thefurtherthebleedingsiteisfromtherectum,themorelikelymelenawill occur. Notethatdarkstoolscanalsoresultfrombismuth,iron,spinach,charcoal, andlicorice. MelenasuggestsupperGIbleeding90%ofthetime.Occasionally,thejejunum orileumisthesource.Itisunusualformelenatobecausedbyacoloniclesion, butifitis,theascendingcolonisthemostlikelysite.

Quick HIT

HematemesisandmelenaarethemostcommonpresentationsofacuteupperGIbleed,andpatientsmay havebothsymptoms.Occasionally,abriskupperGIbleedpresentsashematochezia.

d. Hematochezia—brightredbloodperrectum.

e

e

ThisusuallyrepresentsalowerGIsource(typicallyleftcolonorrectum). Considerdiverticulosis,arteriovenousmalformations,hemorrhoids,andcolon cancers. ItmayresultfrommassiveupperGIbleedingthatisbleedingverybriskly(so thatblooddoesnotremainincolontoturnintomelena—seeabove).This oftenindicatesheavybleeding,andpatientoftenhassomedegreeof hemodynamicinstability.AnupperGIsourceispresentinabout5%to10%of patientswithhematochezia. Occultbloodinstool—sourceofbleedingmaybeanywherealongGItract.

©
======================================
Quick HIT

AnelevatedPTmaybeindicativeofliverdysfunction,vitaminKdeficiency,aconsumptivecoagulopathy, orwarfarintherapy.

2. Signsofvolumedepletion(dependingonrateandseverityofbloodloss). 3. Symptomsandsignsofanemia(e.g.,fatigue,pallor,exertionaldyspnea).

CLINICALPEARL3-6

TeststoOrderinPatientsWithGIBleeding Hematemesis—AnupperGIendoscopyistheinitialtest. Hematochezia—Firstruleoutananorectalcause(e.g.,hemorrhoids).Colonoscopyshouldbetheinitialtest becausecoloncanceristhemainconcerninpatientsoverage50. Melena—UpperendoscopyisusuallytheinitialtestbecausethemostlikelybleedingsiteisintheupperGI tract.Orderacolonoscopyifnobleedingsiteisidentifiedfromtheendoscopy. Occultblood—Colonoscopyistheinitialtestinmostcases(coloncanceristhemainconcern).Orderan upperendoscopyifnobleedingsiteisidentifiedfromthecolonoscopy.

Quick HIT

IfyoususpectlowerGIbleeding,stillexcludeupperGIbleedingbeforeattemptingtolocalizethesiteofthe lowerGIbleed.

D.Diagnosis 1. Laboratorytests(seealsoClinicalPearl3-6andFigure3-5)

a. Stoolguaiacforoccultblood. b. Hemoglobin/hematocritlevel(maynotbedecreasedinacutebleeds):A

hemoglobinlevel>7to8g/dLisgenerallyacceptableinyoung,healthypatients withoutactivebleeding.However,mostelderlypatients(especiallythosewith cardiacdisease)shouldhaveahemoglobinlevel>10g/dL.

c. Alowmeancorpuscularvolume(MCV)issuggestiveofirondeficiencyanemia

(chronicbloodloss).Patientswithacutebleedinghavenormocyticredblood cells.

d. Coagulationprofile(plateletcount,PT,PTT,INR). e. LFTs,renalfunction. f. TheBUN–creatinineratioiselevatedwithupperGIbleeding.Thisissuggestive ofupperGIbleedingifpatienthasnorenalinsufficiency.Thehighertheratio, themorelikelythebleedingisfromanupperGIsource.

Quick HIT

InitialStepsinanyPatientWithGIBleeding

e

e

e

Vitalsigns:DecreasedBP,tachycardia,orposturalchangesinBPorHRaresignsofsignificant hemorrhage.However,vitalsignsmayalsobenormalwhensignificanthemorrhageispresent. Resuscitationisthefirststep(e.g.,IVfluids,transfusion). Performrectalexamination(hemocculttest).

lron-deficient anemia . Clinical follow-up, repeat guaiac test Upper Gl symptoms Colonoscopy Colonoscopy plus upper endoscopy
======================================
FIGURE 3.5

EvaluationofoccultGIbleeding.

2. Upperendoscopy

a. MostaccuratediagnostictestinevaluationofupperGIbleeding. b. Bothdiagnosticandpotentiallytherapeutic(coagulatebleedingvessel).

3. Nasogastrictube

a. NotrequiredfordiagnosisofpatientswithupperGIbleed.Historicallyhasbeen

usedtodetermineifGIbleedoriginatingfromanupperorlowerGIsource. Studieshavenotdemonstratedbenefitinclinicaloutcomes.

4. Anoscopyorproctosigmoidoscopycanexcludeananal/rectalsource.Performthis ifthereisnoobviousbleedingfromhemorrhoids.

5. ColonoscopyidentifiesthesiteofthelowerGIbleedin>70%ofcases,andcan alsobetherapeutic(seebelow).

6. Ableedingscan(radionuclidescanning)revealsbleedingevenwithalowrateof bloodloss.Itdoesnotlocalizethelesion;itonlyidentifiescontinuedbleeding.Its roleiscontroversial,butitmayhelpdeterminewhetherarteriographyisneeded.

7. Arteriographydefinitivelylocatesthepointofbleeding.

a. MostlyusedinpatientswithlowerGIbleeding. b. Shouldbeperformedduringactivebleeding. c. Potentiallytherapeutic(embolizationorintra-arterialvasopressininfusion).

8. Exploratorylaparotomy—lastresort.

E.Treatment 1. Ifpatientishemodynamicallyunstable,resuscitationisalwaystoppriority.

RemembertheABCs.Oncethepatientisstabilized,obtainadiagnosis(seealso ClinicalPearl3-7).

a. Supplementaloxygen. b. Placetwolarge-boreIVlines.GiveIVfluidsorbloodifpatientisvolume

depleted.

c. Drawbloodforhemoglobinandhematocrit,PT/INR,PTT,andplateletcount. Monitorhemoglobinevery4to8hoursuntilthepatientishemoglobinstablefor atleast24hours.

d. Typeandcross-matchadequateblood(PRBCs).Transfuseastheclinical conditiondemands(e.g.,shock,patientswithcardiopulmonarydisease).

2. Treatmentdependsonthecause/sourceofthebleed.

a. UpperGIbleeding.

e

e

e

Esophagogastroduodenoscopy(EGD)withcoagulationofthebleedingvessel. Ifbleedingcontinues,repeatendoscopictherapyorproceedwithsurgical intervention(ligationofbleedingvessel). Ifableedingulcerisconsidered,startaprotonpumpinhibitor(PPI). IncreasinggastricpHimprovesclotting. Ifsuspectingavaricealbleed(e.g.,inpatientswithcirrhosis),startoctreotide.

b. LowerGIbleeding.

¢
======================================
e

e

Colonoscopy—polypexcision,injection,laser,cautery Arteriographywithembolization Surgicalresectionofinvolvedarea—lastresort

3. Indicationsforsurgery:

a. HemodynamicallyunstablepatientswhohavenotrespondedtoIVfluid, transfusion,endoscopicintervention,orcorrectionofcoagulopathies.

CLINICALPEARL3-7

FactorsThatIncreaseMortalityinGIBleeding

Age>65years Severityofinitialbleed Extensivecomorbidillnesses Onsetorrecurrenceofbleedingwhilehospitalizedforanothercondition Needforemergencysurgery Significanttransfusionrequirements Diagnosis(esophagealvariceshavea30%mortalityrate) Endoscopicstigmataofrecenthemorrhage

b. Severeinitialbleedorrecurrenceofbleedafterendoscopictreatment. c. Continuedbleedingformorethan24hours. d. Visiblevesselatbaseofulcer(30%to50%chanceofrebleed). e. Ongoingtransfusionrequirement(fiveunitswithinfirst4to6hours).

DiseasesoftheEsophagus

EsophagealCancer

A.GeneralCharacteristics 1. Therearetwopathologictypes.Inthepast,squamouscellcarcinoma(SCC)

accountedforupto90%ofcases.However,theincidenceofadenocarcinomahas increaseddramaticallyintheUnitedStates,anditnowaccountsforupto50%of newcases.

a. SCC

e

¢

e

IncidenceishigherinAfricanAmericanmenthaninothergroups. Mostcommonlocationsaretheupperandmidthoracicesophagus.Aboutone- thirdmaybeindistal10cmofesophagus. Riskfactorsarealcoholandtobaccouse,diet(nitrosamines,betelnuts, chronicingestionofhotfoodsandbeveragessuchastea),human papillomavirus,achalasia,Plummer–Vinsonsyndrome,causticingestion,and nasopharyngealcarcinoma.

b. Adenocarcinoma

e

e¢

e

MorecommoninCaucasiansandmen(5:1overwomen). Mostcommonindistalthirdoftheesophagus/gastroesophagealjunction(in 80%ofcases). Riskfactors:GERDandBarrettesophagusaremainriskfactors;alcoholand tobaccomaynotbeasimportantasinSCC.

Quick HIT

BarrettEsophagusisacomplicationoflong-standingacidrefluxdiseaseinwhichthereiscolumnar metaplasiaofthesquamousepithelium.PatientswithBarrettesophagusareatincreasedriskofdeveloping adenocarcinomaoftheesophagus.Monitorthesepatientswithroutineendoscopicsurveillance.

2. Theprognosisispoor:Five-yearsurvivalrateisabout30%to40%if locoregionaldisease,butonly5%ifdistantmetastasispresentatdiagnosis. 3. Staging

a. StageI—tumorinvadeslaminapropriaorsubmucosa;nodesnegative b. StageIIa—tumorinvadesmuscularispropriaoradventitia;nodesnegative c. StageIIb—tumorinvadesuptomuscularispropria;positiveregionalnodes d. StageIII—tumorinvadesadventitia(positiveregionalnodes)ortumorinvades

adjacentstructures(positiveornegativenodes)

e. StageIV—distantmetastasis
======================================
B.ClinicalFeatures 1. Dysphagia—mostcommonsymptom(initiallysolidsonly,thenprogressionto

liquids)

2. Weightloss—secondmostcommonsymptom 3. Anorexia 4. Odynophagia(painwithswallowing)—alatefindingthatsuggests

extraesophagealinvolvement(mediastinalinvasion)

5. Hematemesis,hoarsenessofvoice(recurrentlaryngealnerveinvolvement) 6. Aspirationpneumonia,respiratorysymptomsduetoinvolvementof

tracheobronchialtree

7. Tracheoesophagealorbronchoesophagealfistula 8. Chestpain

C.Diagnosis 1. Bariumswallowisusefulinevaluationofdysphagia.Apresumptivediagnosis

canbemade.

2. Upperendoscopywithbiopsyandbrushcytologyisrequiredfordefinitive diagnosis.Itconfirmsthediagnosisin95%ofcases.

3. Transesophagealultrasoundhelpsdeterminethedepthofpenetrationofthetumor andisthemostreliabletestforstaginglocalcancer.

4. Fullmetastaticworkup(e.g.,CTscanofthechest/abdomen,CXR,bonescan).

D.Treatment 1. Palliationisthegoalinmostpatientsbecausethediseaseisusuallyadvancedat

presentation.

2. Surgery(esophagectomy)maybecurativeforpatientswithdiseaseinstage0,1, or2A.

3. Chemotherapyplusradiationbeforesurgeryhasbeenshowntoprolongsurvival morethansurgeryalone.

Achalasia

A.GeneralCharacteristics 1. Acquiredmotordisorderofesophagealsmoothmuscleinwhichthelower esophagealsphincter(LES)failstocompletelyrelaxwithswallowing,and abnormalperistalsisofesophagealbodyreplacesnormalperistalsis.

2. Absolutecriteriafordiagnosis

a. IncompleterelaxationoftheLES b. Aperistalsisofesophagus

B.Causes 1. ThemajorityintheUnitedStatesareidiopathic. 2. IntheUnitedStates,adenocarcinomaofproximalstomachisthesecondmost

commoncause.

3. Worldwide,Chagasdiseaseisanimportantcause.

C.ClinicalFeatures 1. Dysphagia(odynophagiaislesscommon)

a. Equaldifficultyswallowingsolidsandliquids(incontrasttoesophagealcancer, inwhichdysphagiaforsolidsstartsfirst,thanlaterforliquids).

b. Patientstendtoeatslowlyanddrinklotsofwatertowashdownfood.Also,they maytwisttheirbody,extendtheirneck,orwalkabouttheroominaneffortto forcefoodintothestomach.

c. Itisexacerbatedbyfasteatingandemotionalstress.

2. Regurgitation

a. Foodgets“stuck”intheesophagusandthencomesbackup. b. Regurgitationmayleadtoaspiration.

3. Chestpain 4. Weightloss 5. Recurrentpulmonarycomplicationssecondarytoaspiration,whichmaycause

lungabscess,bronchiectasis,orhemoptysis
======================================
Quick HIT

Patientswithachalasiahaveasevenfoldincreaseintheriskofesophagealcancer(usuallysquamouscell)—it occursin10%ofpatients15to25yearsaftertheinitialachalasiadiagnosis.Oftentumorsgounnoticed(even whenlarge)duetoadilatedesophagusandchronicdysphagia.Therefore,performsurveillanceesophagoscopy todetectthetumoratanearlystage.

D.Diagnosis

1. Bariumswallow(Figure3-6)—“bird’sbeak”—beak-likenarrowingofdistal

esophagusandalarge,dilatedesophagusproximaltothenarrowing. 2. UpperGIendoscopy—toruleoutsecondarycausesofachalasia(gastric

carcinoma)andretentionesophagitisoresophagealcancer.

3. Manometry—toconfirmthediagnosis;revealsfailureofLESrelaxationand aperistalsisofesophagealbody.

E.Treatment 1. Instructpatientonadaptivemeasures:chewfoodtoconsistencyofpeasoup beforeswallowing;sleepwithtrunkelevated;avoideatingbeforesleep.

2. Medicaltherapy

a. Antimuscarinicagents(dicyclomine)—usuallyunsatisfactory b. Sublingualnitroglycerin,long-actingnitrates,andcalciumchannelblockers

e

e¢

Mayimproveswallowinginearlystagesofachalasia(beforeesophageal dilatationoccurs) Mostusefulintheshort-termtreatmentofachalasia(beforemoredefinitive therapy)

3. InjectionofbotulinumtoxinintotheLESduringendoscopy

a. BlockscholinergicactivityintheLES

FIGURE 3.6

Radiographsofachalasia(A)anddiffuseesophageal

spasm(B). (FromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.

4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:821,Figure106.4.)

b. Canbeeffectiveinupto65%ofcases;however,repeatproceduresneedtobe performedevery2years.

4. Forcefuldilatation—mechanical,pneumatic,orhydrostatic

a. Pneumaticballoondilatationismosteffective b. LowersbasalLEStonebydisruptingthemuscularring c. Canbeeffective,butthereisa5%riskofperforation

ThereisnoCureforAchalasia.Treatmentmodalities(includingsurgery)areonlypalliative.

5. Surgical

a. “Hellermyotomy”—circularmusclelayerofLESisincised b. Usuallyreservedforpatientswhodonotrespondtodilationtherapy

6. Earlyresultsarepromising(80%to90%ofpatientsexperiencegoodtoexcellent palliationofdysphagiaat1year).

7. Long-termdataareneeded.
======================================
Quick HIT

Itcanbedifficulttodistinguishthechestpainofdiffuseesophagealspasm(DES)fromcardiacchestpain. Therefore,manypatientsundergoacardiacworkup,includingcardiaccatheterization,toruleoutischemic causesofchestpain,beforeanesophagealcauseisinvestigated.

DiffuseEsophagealSpasm

A.GeneralCharacteristics 1. Nonperistalticspontaneouscontractionoftheesophagealbody—severalsegments oftheesophaguscontractsimultaneouslyandpreventappropriateadvancementof foodbolus.

2. Incontrasttoachalasia,sphincterfunctionisnormal(normalLESpressure).

B.ClinicalFeatures 1. Thereisnoncardiacchestpainthatmimicsanginaandmayradiatetothejaw,

arms,andback.

2. Dysphagiaiscommon;however,regurgitationoffoodisuncommon.

C.Diagnosis 1. Esophagealmanometryisdiagnostic—simultaneous,multiphasic,repetitive

contractionsthatoccurafteraswallow;sphincterresponseisnormal.

2. UpperGIbariumswallow(“corkscrewesophagus”)—in50%,whichrepresents multiplesimultaneouscontractions.

D.Treatment 1. Ingeneralthereisnocompletelyeffectivetherapy—treatmentfailureratesare

high.

2. Medicaltreatmentinvolvesnitratesandcalciumchannelblockers(decreases amplitudeofcontractions).Tricyclicantidepressantsmayprovidesymptomatic relief.

3. Esophagomyotomyisusuallynotperformed,anditsefficacyiscontroversial. Somesupportitsuse,whereasothersonlyrecommenditwhenapatientis incapacitatedbysymptoms.

EsophagealHiatalHernias

A.GeneralCharacteristics There are two types of hiatal hernias: sliding (type 1) and paraesophageal (type 2) (Figure3-7) 1. Slidinghiatalhernias(type1)accountfor>90%ofcases.Boththe

gastroesophagealjunctionandaportionofthestomachherniateintothethorax throughtheesophagealhiatus(sothatthegastroesophagealjunctionisabovethe diaphragm).ThisisacommonandbenignfindingthatisassociatedwithGERD.

hernias,thestomachherniatesintothethoraxthroughtheesophagealhiatus,but thegastroesophagealjunctiondoesnot;itremainsbelowthediaphragm.Type3 herniashaveelementsoftype1andtype2hernias,andboththefundusandthe GEjunctionherniatethroughthehiatus.Type4herniasincludeorgansotherthan thestomachintheherniasac.
======================================
Quick HIT

e

¢

Paraesophagealherniastendtoenlargewithtime,andtheentirestomachmayultimatelymoveintothe thorax. Type3hernias(combinationoftype1and2)aretreatedastype2hernias(surgically).

B.ClinicalFeatures 1. Themajorityofcasesisasymptomaticandisdiscoveredincidentally. 2. Possiblesymptomsincludeheartburn,chestpain,anddysphagia. 3. ComplicationsofslidinghiatalherniasincludeGERD(mostcommon),reflux

esophagitis(withriskofBarrettesophagus/cancer),andaspiration.

4. Complicationsofparaesophagealherniasarepotentiallylifethreateningand includeobstruction,hemorrhage,incarceration,andstrangulation.

Quick HIT

IfapatientwithGERDalsohasahiatalhernia,theherniaoftenworsensthesymptomsofGERD.

C.Diagnosis—bariumupperGIseriesandupperendoscopy

D.Treatment 1. Type1herniasaretreatedmedically(withantacids,smallmeals,andelevationof theheadaftermeals);15%ofcasesmayrequiresurgery(Nissenfundoplication), ifthereisnoresponsetomedicaltherapyorifthereisevidenceofesophagitis. 2. Type2–4herniasaretreatedwithelectivesurgeryduetotheriskoftheabove

complications.

Mallory–WeissSyndrome

Thisisamucosaltearat(orjustbelow)thegastroesophagealjunctionasaresultof forcefulvomitingorretching.Itusuallyoccursafterrepeatedepisodesofvomiting, butitmayalsooccurafterjustoneepisode. Itismostcommonlyassociatedwithbingedrinkinginalcoholics,butanydisorder thatcausesvomitingcaninducethemucosaltear. Hematemesisisalwayspresent—itvariesfromstreaksofbloodinvomitusto massivebrightredblood. Upperendoscopyisdiagnostic. Mostcases(90%)stopbleedingwithoutanytreatment. Treatmentissurgery(oversewingthetear)orangiographicembolizationifbleeding continues,butthisisrarelynecessary.Acidsuppressionisusedtopromotehealing.

Quick HIT

Duringforcefulvomiting,themarkedincreaseinintra-abdominalpressureistransmittedtotheesophagus.This canleadtotwoconditions,dependingontheseverityandlocationofthetear.

e

e

Ifthetearismucosalandatthegastroesophagealjunction,itisreferredtoasMallory–Weisssyndrome. Ifatearistransmural(causingesophagealperforation),itisreferredtoasBoerhaavesyndrome.
======================================
Plummer–VinsonSyndrome(UpperEsophagealWebs)

Keyfeatures:upperesophagealweb(causesdysphagia),irondeficiencyanemia, koilonychia(spoon-shapedfingernails),andatrophicoralmucosa. TenpercentofpatientsdevelopSCCoftheoralcavity,hypopharynx,oresophagus; therefore,thisisconsideredapremalignantlesion. Treatment:esophagealdilatation;correctnutritionaldeficiency.

Type! Phrenoesophageal ligament Longitudinal muscle Gastroesophageal Circular muscle junction (GEJ) . Diaphragm Diaphragm Crural fibers Peritoneum Phrenoesophageal GEJ

FIGURE 3.7

Typesofesophagealhiatalhernias.

(FromMulhollandMH,AlboD,DalmanR,etal.OperativeTechniquesinSurgery.Philadelphia, PA:LippincottWilliams&Wilkins;2014.)

SchatzkiRing(DistalEsophagealWebs)

Acircumferentialringintheloweresophagusthatisalwaysaccompaniedbya slidinghiatalhernia. Itisusuallyasymptomatic,butmildtomoderatedysphagiamaybepresent. Ifthepatientissymptomatic(buthasnoreflux),consideresophagealdilatation.If thepatienthasreflux,consideranti-refluxsurgery. Usuallyduetoingestionofalkali,acids,bleach,ordetergents(e.g.,insuicide attempts). Ingestingalkaliismoredangerousthaningestingacidbecauseitmayleadto liquefactivenecrosisoftheesophaguswithfull-thicknessperforation.Acidingestion doesnotcausefull-thicknessdamage(onlycausesnecrosisofesophagealmucosa). Complications:strictureformationandriskofesophagealcancer. Treatmentisesophagectomyiffull-thicknessnecrosishasoccurred.Patientshould avoidvomiting,gastriclavage,andalloralintake(cancompoundtheoriginal injury).Givethepatientsteroidsandantibioticsaswell.Performbougienage (dilation)foresophagealstricture.

EsophagealDiverticula

Mostesophagealdiverticulaarecausedbyanunderlyingmotilitydisorderofthe esophagus(Figure3-8). Zenkerdiverticulumisthemostcommontype;foundinupperthirdofthe esophagus. Failureofthecricopharyngealmuscletorelaxduringswallowingleadstoincreased intraluminalpressure.Thiscausesoutpouchingofmucosathroughanareaof weaknessinthepharyngealconstrictors. Clinicalfeaturesincludedysphagia,regurgitation,halitosis(badbreath),weightloss, andchroniccough. Itistypicallyseeninpatients>50yearsold. Tractiondiverticulaarelocatedinthemidpointoftheesophagusnearthetracheal bifurcation.Itisduetotractionfromcontiguousmediastinalinflammationand adenopathy(pulmonarytuberculosis).Tuberculosiscauseshilarnodescarring, whichcausesretractionoftheesophagus.Itisusuallyasymptomaticanddoesnot requiretreatment. Epiphrenicdiverticulaarefoundinlowerthirdofesophagus.Itisusually associatedwithspasticesophagealdysmotilityorachalasia.Symptomsofdysphagia aremoreoftenrelatedtotheunderlyingmotilitydisorder,unlessthediverticulumis verylarge. Bariumswallowisthebestdiagnostictestfordiverticula. TreatmentofZenkerdiverticulaissurgery.Cricopharyngealmyotomyhasexcellent results.Treatmentofepiphrenicdiverticulaisesophagomyotomy.Diverticulectomy isofsecondaryimportanceinbothcases.
======================================
Quick HIT

Anunderlyingmotilitydisorderisthecauseofbothproximal(Zenker)anddistal(epiphrenic)esophageal diverticula.Surgicaltreatmentisaimedatcorrectingthemotilitydisorder(i.e.,myotomy).Diverticulectomyis ofsecondaryimportance.

Mechanical obstruction Motility problem * Chronic heartburn/GERD + Regurgitation + Weight loss Scleroderma | Achalasia | * Chronic heartburn/GERD * No weight loss arane | Esophageal carcinoma + Age >50 + Weight loss

FIGURE 3.8

Causesofdysphagia.

Quick HIT

Ifgastric/esophagealcontentsleakintothemediastinumorpleura,infectionandsepticsequelaemayresult.

EsophagealPerforation

Etiology:blunttrauma,medicaltubesandinstruments,forcefulvomiting (Boerhaavesyndrome)thatisassociatedwithalcoholicbingesandbulimia. Clinicalfeatures:pain(severeretrosternal/chest/shoulderpain),tachycardia, hypotension,tachypnea,dyspnea,fever,Hammansign(“mediastinalcrunch” producedbytheheartbeatingagainstair-filledtissues),pneumothorax,orpleural effusion. Contrastesophagramisdefinitivediagnosticstudy(solublegastrografinswallow preferred). CXRusuallyshowsairinthemediastinum. Ifthepatientisstableandtheperforationissmall(drainingintolumen),medical managementisappropriate:IVfluids,NPO,antibiotics,andH2blockers. Ifpatientisillandtheperforationislarge(orifthereiscommunicationintopleural cavity),surgeryshouldbeperformedwithin24hoursofpresentation(successrateis higher).

Quick HIT

Thetimeintervalbetweenesophagealperforationandsurgeryisthemostimportantfactorindetermining survival.Ifsurgeryisdelayedbeyond24hours,themortalityrateandthelikelihoodoffistulization increase.

Quick HIT

MostcasesofPUDareduetoH.pyloriinfectionandNSAIDuse.Itcanbedifficulttodeterminethecauseina patientwithH.pyloriinfectionwhoalsousesNSAIDs.Bothmayberesponsible.Therefore,ifindoubt,testfor H.pylori.

DiseasesoftheStomach PepticUlcerDisease

A.Causes 1. Mostcommoncauses

a. Helicobacterpyloriinfection b. NSAIDs—inhibitprostaglandinproduction,whichleadstoimpairedmucosal

defenses

c. Acidhypersecretorystates,suchasZollinger–Ellisonsyndrome

2. OtherriskfactorsassociatedwithhigherriskofPUD(havenotbeenshowntobe

causative) a. Smoking b. Alcoholuse c. Emotionalstressanddietaryfactors(suchascoffeeandspiceintake)havenot

beenshowntobeassociatedwithhigherriskofPUD.
======================================
B.ClinicalFeatures 1. Epigastricpain

a. Achingorgnawinginnature b. Nocturnalsymptomsandtheeffectoffoodonsymptomsarevariable(see

Table3-5).

2. MaybecomplicatedbyupperGIbleeding. 3. Othersymptoms:nausea/vomiting,earlysatiety,andweightloss.

Quick HIT

Gastriculcersrequireabiopsytoruleoutmalignancy;duodenalulcersdonotrequirebiopsy.

C.Diagnosis 1. Endoscopy

a. Mostaccuratetestindiagnosingulcers. b. Essentialindiagnosisofgastriculcersbecausebiopsyisnecessarytoruleout

malignancy.

c. Preferredwhensevereoracutebleedingispresent(canperformelectrocautery ofbleedingulcers).

Quick HIT

Ifapepticulcerisuncomplicated,abariumstudyorendoscopyisnotneededinitially.Initiateempiric therapy.However,ifyoususpectanyofthecomplicationsofPUD,orderconfirmatorystudies.

d. CanobtainendoscopicbiopsyfordiagnosisofH.pylori.

2. Bariumswallow

a. Sometimesusedinitiallybutislessreliablethanendoscopy. b. Double-contrasttechniquespreferredduetoimprovedaccuracy.

3. Laboratorytest—fordiagnosisofH.pyloriinfection

a. Biopsy:Histologicevaluationofendoscopicbiopsyisthegoldstandard.

TABLE3-5 DuodenalVersusGastricUlcers
======================================
b. Stoolantigentest—Highsensitivityandeaseoftestingmakesthisidealfor screening.

c. Ureasedetectionviaureabreathtestishighlysensitiveandspecific.It

documentsactiveinfectionandhelpstoassesstheresultsofantibiotictherapy. d. Serology(lowerspecificity)—ThepresenceofantibodiestoH.pyloridoesnot necessarilyindicatecurrentinfection—antibodiestoH.pyloricanremain elevatedformonthsorevenyearsaftereradicationofinfection.

Thefollowingmayleadtofalse-negativetestresults:PPIs,bismuth,many antibiotics,andupperGIbleeding.

4. Serumgastrinmeasurement—ifconsideringZollinger–Ellisonsyndromeasa diagnosis.

D.Treatment 1. Medical—MajorityofpatientswithPUDcanbesuccessfullytreatedbycuringH.

pyloriinfection,avoidanceofNSAIDs,andappropriateuseofantisecretory drugs.

a. Supportive(patientdirectives) Discontinueaspirin/NSAIDs. Restrictalcoholusebutdonotrestrictanyfoods. Stopsmoking,decreaseemotionalstress. Avoideatingbeforebedtime(eatingstimulatesnocturnalgastricacidlevels).

b. Acidsuppressiontherapy

e

e

e

PPIs—omeprazole(Prilosec),lansoprazole(Prevacid),blockH+/K+ATPase pumpdirectlyinparietalcellmembrane.Firstlineoftherapy,mosteffective antisecretoryagents. H2receptorblockers—cimetidine(Tagamet)andranitidine(Zantac).Block histamine-basedparietalcellacidsecretion.LesseffectivethanPPIs. Antacids—somewhatoutdatedforprimarytherapyandmoreappropriately usedforadjunctivetherapy/symptomaticrelief.Examplesincludealuminum hydroxide(Mylanta),calciumcarbonate(Tums),bismuthsubsalicylate(Pepto- Bismol).

Quick  HIT  AcidSuppressionTherapy  PPIs Esomeprazole Omeprazole Lansoprazole Pantoprazole Rabeprazole 

TABLE3-6 HelicobacterpyloriEradication

Triple therapy —_ PP! plus amoxicillin and Twice daily dosing More expensive than bis- clarithromycin muth-based triple therapy Quadruple PPI, bismuth subsalicy- Half the time as triple therapy Expense of PPI therapy late, metronidazole, and —_(a 1-week program as opposed tetracycline to 2 weeks for triple therapy), yet has similar eradication results. Useful in patients with tisk for macrolide resistance

c. EradicateH.pyloriwithtripleorquadrupletherapy(seeTable3-5).Once infectioniscleared,therateofrecurrenceisverylow.
======================================
e

¢

Forinitialtherapy,tripletherapy(PPI,amoxicillin,andclarithromycin)for14 days. Quadrupletherapy(PPI,bismuth,metronidazole,andtetracycline)indicated forpatientswithriskfactorsformacrolideresistance.

d. Cytoprotection

e

e

Sucralfate—facilitatesulcerhealing.Mustbetakenfrequently,iscostly,and cancauseGIupset. Misoprostol—reducesriskforulcerformationassociatedwithNSAIDtherapy. Costly,andcancauseGIupset(commonsideeffect).

e. Treatmentregimens

e

e

e

e

IfH.pyloritestispositive,begineradicationtherapywitheithertripleor quadrupletherapy(seeTable3-6).Alsobeginacidsuppressionwithantacids, anH2blocker,oraPPI. IfthepatienthasanactiveNSAID-inducedulcer,stopNSAIDuse(mayswitch toacetaminophen).AlsobeginwitheitheraPPIormisoprostol.Continuefor4 to8weeks,dependingonseverity.TreattheH.pyloriinfectionasaboveif present. Antisecretorydrugscanbediscontinuedafter4to6weeksinpatientswith uncomplicatedulcerswhoareasymptomatic.Patientsatincreasedriskof recurrence(especiallyifunderlyingcauseofulcerisnotreversed)maybenefit frommaintenancetherapy. H.pylori–negativeulcersthatareNOTcausedbyNSAIDscanbetreatedwith antisecretorydrugs(eitherH2blockersorPPI).

2. Surgical

a. Rarelyneededelectively b. RequiredforthecomplicationsofPUD(bleeding,perforation,gastricoutlet

obstruction)(seeTable3-7andFigure3-9)

AcuteGastritis

Acutegastritisreferstoinflammationofthegastricmucosa. Therearemultiplecauses:NSAIDs/aspirin;H.pyloriinfection;alcohol,heavy cigarettesmoking,orcaffeine;extremephysiologicstress(e.g.,shock,sepsis, burns). Itcaneitherbeasymptomaticorcauseepigastricpain.Therelationshipbetween eatingandpainisnotconsistent(i.e.,foodmayeitheraggravateorrelievethepain). Ifepigastricpainislowormoderateandisnotassociatedwithworrisome symptoms/findings,empirictherapywithacidsuppressionisappropriate.Stop NSAIDs. Ifthereisnopositiveresponseafter4to8weeksoftreatment,consideradiagnostic workup.IncludeupperGIendoscopyandultrasound(toruleoutgallstones),andtest forH.pyloriinfection. IfH.pyloriinfectionisconfirmed,antibiotictherapyisindicated(seeTable3-6).
======================================
Quick HIT

UpperGIendoscopyisthebesttestforevaluatingapatientwithepigastricpain.ItcandiagnosePUD,gastritis, andesophagitis.Itcanalsoruleoutcancersoftheesophagusandstomach,andH.pyloriinfectionwithbiopsy.

TABLE3-7 ComplicationsofPepticUlcerDisease

Acute, severe abdominal Perforation Upright CXR (free airunder Emergency surgery toclose per- © Can progress to sepsis pain, signs of peritonitis, diaphragm), CT scan is foration and perform definitive and death if untreated hemodynamic instability the most sensitive test for ulcer operation (such as highly perforation (detects free selective vagotomy or truncal abdominal air) vagotomy/pyloroplasty) Gastric Outlet Nausea/vomiting (poorly Barium swallow and upper Initially, nasogastric suction; Most common with duodenal Obstruction digested food), epigastric endoscopy; saline load replace electrolyte/volume ulcers and type Ill gastric fullness/early satiety, test (empty stomach with deficits; supplement nutrition ulcers weight loss a nasogastric tube, add if obstruction is long standing. 750-mL saline, aspirate after Surgery is eventually necessary 30 min—test is positive if in 75% of patients aspirate >400 mL) GI Bleeding Bleeding may be slow Stool guaiac, upper GI Resuscitation; diagnose site Peptic ulcer disease is (leading to anemic symp- toms) or can be rapid and severe (leading to shock) endoscopy (diagnostic and therapeutic) of bleed via endoscopy and treat; perform surgery for acute bleeds that require transfusion of 26 units of blood the most common cause of upper GI bleeding

ChronicGastritis

ThemostcommoncauseisH.pyloriinfection(over80%ofcases). Autoimmunegastritisleadstochronicatrophicgastritiswithserumantiparietaland anti-intrinsicfactorantibodies(andpossibledevelopmentofperniciousanemia). MostpatientswithchronicgastritisduetoH.pyloriareasymptomaticandnever developcomplications.Theconditionmaymanifestasepigastricpainsimilarto PUD.Otherassociatedsymptomssuchasnausea/vomitingandanorexiaarerare. ComplicationsincludePUD,gastriccarcinoma,andmucosa-associatedlymphoid tissuelymphoma. UpperGIendoscopywithbiopsyisthetestofchoicefordiagnosisofchronic gastritis.Othertestsshouldbeusedtofindthecause(usuallyH.pylori). Ifthepatientissymptomatic,treatmentinvolvesH.pylorieradicationwithtripleor quadrupletherapy(seeTable3-6).

ae Gastric fundus air A B
======================================
FIGURE 3.9

duodenalulcerandacuteabdomen.Thecurvedarrowshowsfree subdiaphragmaticairduetotheperforatedulcer.Thestraightarrows showthediaphragmsbilaterally.B:Chestradiograph(upright) showingbilateralsubdiaphragmaticintraperitonealair.Doublearrows representrightandlefthemidiaphragms.Notethebilateral subdiaphragmaticair(straightandcurvedarrows).Thereisairinthe gastricfundusaswellasfreeairsurroundingthegastricfundus. (FromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins;1998:103,Figure6-46,and159,Figure8-22, respectively.)

Quick HIT

MetastasesofGastricCarcinoma

Krukenbergtumor—metastasistotheovary Blumershelf—metastasistotherectum(pelviccul-de-sac)—canpalpateonrectalexamination SisterMaryJosephnode—metastasistotheperiumbilicallymphnode Virchownode—metastasistothesupraclavicularfossanodes Irishnode—metastasistotheleftaxillaryadenopathy

GastricCancer

A.GeneralCharacteristics 1. Themajorityareadenocarcinomas. 2. GastriccancerisrareintheUnitedStates(morecommoninJapan). 3. Morphology

a. Ulcerativecarcinoma—ulcerthroughalllayers b. Polypoidcarcinoma—solidmassprojectsintostomachlumen c. Superficialspreading—mostfavorableprognosis d. Linitisplastica—“leatherbottle”—infiltratesearlythroughalllayers,stomach

wallisthickandrigid,poorprognosis

B.RiskFactors 1. Severeatrophicgastritis,intestinalmetaplasia,gastricdysplasia 2. Adenomatousgastricpolyps,chronicatrophicgastritis 3. H.pyloriinfection—three-tosixfoldincreaseinrisk 4. Postantrectomy—manycasesreportedafterBillrothIIanastomosis(15to20

yearsaftersurgery)

5. Perniciousanemia—threefoldincreaseinrisk 6. Ménétrierdisease—10%ofthesepatientsdevelopcancer 7. Highintakeofpreservedfoods(highsalt,nitrates,nitrites—smokedfish) 8. BloodtypeA

C.ClinicalFeatures 1. Abdominalpainandunexplainedweightlossaremostcommonsymptoms. 2. Reducedappetite,anorexia,dyspepsia,earlysatiety 3. Nauseaandvomiting,anemia,melena,guaiac-positivestool

D.Diagnosis 1. Endoscopywithmultiplebiopsies—mostaccuratetest 2. BariumupperGIseries—lessaccurate,butcancomplementupper

endoscopy/biopsyfindings

3. AbdominalCTscan—forstagingandtodetectpresenceofmetastases 4. FOBT
======================================
E.Treatment 1. Surgicalresectionwithwide(>5cm)margins(totalorsubtotalgastrectomy)with

extendedlymphnodedissection.

2. Chemotherapymaybeappropriateinsomecases.

GastricLymphoma

Atypeofnon-Hodgkinlymphomathatarisesinthestomach. Clinicalfeaturesaresimilartothoseofadenocarcinomaofthestomach(e.g., abdominalpain,weightloss,anorexia). Complicationsincludebleeding,obstruction,andperforation(possiblypresentedas anemergency). EGDwithbiopsyisthestandardfordiagnosis(sameasadenocarcinomaof stomach). Treatmentdependsonthestageofthediseaseandthepresenceofcomplications. Optionsincludesurgicalresection,radiation,andchemotherapy.

Quick HIT

SBO

e

¢

Proximalobstruction:frequentvomiting,severepain,minimalabdominaldistention Distalobstruction:lessfrequentvomitingandsignificantabdominaldistention

DiseasesoftheSmallIntestine SmallBowelObstruction

A.GeneralCharacteristics 1. Therearethreemainpointsofdifferentiationtoconsiderinsmallbowel

obstruction(SBO).

a. Partialversuscompleteobstruction

e

e¢

Withpartialobstruction,patientsareabletopassgasorhavebowel movements,asopposedtocompleteobstruction. However,patientswithcompleteobstructionmayoccasionallybeabletopass gasorstoolbecausetheymayhaveresidualstoolorgasinthecolon.

b. Closedloopversusopenloopobstruction

Withclosedloopobstruction,thelumenisoccludedattwopointsbyan adhesivebandorherniaring.Thiscancompromisethebloodsupply,requiring emergentsurgery.

c. ProximalversusdistalSBO

Distalobstructioncausesdistentionofproximalbowelsegments,making diagnosiseasieronplainradiograph.

Quick HIT

Excessivelyhighintraluminalpressuremaycompromisebloodsupply,leadingtostrangulation.Thiscan leadtoshock,gangrene,peritonitis,orperforationofbowel—alldevastatingcomplications.

2. Pathophysiology

a. DehydrationisakeyeventinSBO.Intestinaldistentioncausesreflex vomiting,increasedintestinalsecretionproximaltothepointofobstruction,and decreasedabsorption.Thisleadstohypochloremia,hypokalemia,andmetabolic alkalosis.

b. Theresultinghypovolemialeadstosystemicfindingssuchastachycardia, hypotension,tachypnea,alteredmentalstatus,andoliguria.
======================================
Quick HIT

LargeBowelObstruction

e

e

e

Causes:coloncancer(mostcommoncause),volvulus,adhesions,hernias ResultsinlessfluidandelectrolytedisorderthanSBO SeeFigure3-10forradiographicfindings

B.Causes 1. Adhesionsfrompreviousabdominalsurgery—mostcommoncauseinadults. 2. Incarceratedhernias—secondmostcommoncause. 3. Malignancy,intussusception,Crohndisease,carcinomatosis,andsuperior mesentericarterysyndrome(compressionofthirdportionofduodenum).

FIGURE 3.10

A:AnAPsupinefilmoflargebowelobstruction.Notethe dilatedair-filledproximalcolonwithanabsenceofairinthedistal colon.B:AnAPuprightfilmoflargebowelobstruction.Notemultiple colonair–fluidlevels(curvedarrow). (FromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins;1998:158,Figure8-21AandB.)

C.ClinicalFeatures 1. Crampingabdominalpain—ifpainiscontinuousandsevere,strangulationmaybe

present.

2. Nausea,vomiting—maybefeculent 3. Obstipation(absenceofstoolandflatus) 4. Abdominaldistention

D.Diagnosis 1. Abdominalplainfilms—dilatedloopsofsmallbowel,air–fluidlevelsproximalto pointofobstruction(onuprightfilm),andminimalgasincolon(ifcomplete SBO)(Figure3-11)

2. Bariumenema—toruleoutcolonicobstructionifplainfilmsdonotdistinguish smallfromlargebowelobstruction;bariumenemaidentifiessiteofobstruction. 3. UpperGIseries—withsmallbowelfollow-throughifabovearenotdiagnostic.

Colon splenic flexure Transverse colon Small intestine Ascending colon

FIGURE 3.11

prominentvalvulaeconniventes(arrows).Airisconfinedtothesmall bowel,withnoobviousairinthecolon.Notesurgicalclipsfrom previoussurgery.B:AnAPuprightfilminthesamepatientasshown inA.Noteair–fluidlevelsinthesmallbowel(arrows)withlittleorno distalbowelgas.C:AnAPsupinefilmofpostoperativeileus.Notethe

presenceofairthroughouttheentireGItract. (FromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins,1998:157,Figure8-20aandc,and156,Figure

8-19a.)

Quick HIT

ManifestationsofstrangulatedbowelinSBOincludefever,severeandcontinuouspain,hematemesis,shock,gas inthebowelwallorportalvein,abdominalfreeair,peritonealsigns,andacidosis(increasedlacticacid).
======================================
E.Treatment 1. Nonoperativemanagement—appropriateifbowelobstructionisincompleteand

thereisnofever,tachycardia,peritonealsigns,orleukocytosis.

a. IVfluidstoestablishadequateurineoutput;addpotassiumtofluidstocorrect hypokalemia(whichistypicallypresent)

b. Nasogastrictubetoemptystomach(gastricdecompression) c. Antibiotics

2. Surgeryisindicatedforcompleteobstruction,forpartialobstructionthatis persistentand/orassociatedwithconstantpain,orifstrangulationissuspected. Performanexploratorylaparotomywithlysisofadhesionsandresectionofany necroticbowel.

ParalyticIleus

Peristalsisisdecreasedorabsent(nomechanicalobstructionispresent). Causesincludemedications(e.g.,narcotics,drugswithanticholinergiceffects), postoperativestate(afterabdominalsurgery),spinalcordinjury,shock,metabolic disorders(especiallyhypokalemia),andperitonitis. Abdominalplainfilmsshowauniformdistributionofgasinthesmallbowel,colon, andrectum(incontrasttosmallbowelorcolonicobstruction). Failuretopasscontrastmediumbeyondafixedpointisdiagnostic. TreatmentinvolvesIVfluids,NPO,correctionofelectrolyteimbalances(especially hypokalemia),nasogastricsuctionifnecessary,andplacementofalongtubeifileus persistspostoperatively.

Paralyticileusresolveswithtimeorwhenthecauseisaddressedmedically.Surgeryisusuallynotneeded.

CeliacSprue

Characterizedbyhypersensitivitytogluten(inwheatproducts). Prevalenceoftheconditioninfirst-degreerelativesisapproximately10%. Resultsindiarrhea(mostcommonsymptom),weightloss,abdominaldistention, bloating,weakness,andfatigue. Patientsmaysufferfromvitamindeficiencysecondarytofatmalabsorption,leading toosteoporosis(vitaminDdeficiency),easybleeding(vitaminKdeficiency),and megaloblasticanemia(secondarytoimpairedfolateandvitaminB12absorption). Dermatitisherpetiformis(papulovesicularlesionseenontheextensorsurfaces) isfoundin10%to20%ofpatientswithceliacdisease. Biopsyinproximalsmallbowelrevealsflatteningofvilli,whichcauses malabsorption. Strictadherencetoagluten-freedietisessential.

WhippleDisease

RarediseasecausedbyinfectionbythebacteriumTropherymawhipplei. Inflammationsecondarytotheinfectiondamagesvilliinthesmallintestine Weightloss,diarrhea,jointpain,andarthritisarecommonsymptomsbutclinical presentationisextremelyvariable. Diagnosisismadebyvisualizationofperiodicacid-Schiffstain(PAS)–positive macrophagesinthelaminapropriacontainingnon–acid-fastgram-positive bacilli. Treatmentiswithantibiotictherapyfor1to2years.
======================================
TropicalSprue

Alsoknownas“environmentalenteropathy,”occursinpeoplewholiveinorvisit tropicalareas. Unknownetiology,believedtobecausedbyovergrowthofbacteria. Similarsymptomstoceliacsprueincludingweightloss,diarrhea,cramps,fatigue, malabsorption. Abnormalflatteningofvillicanbeobservedduringendoscopy. Treatwithantibioticsandfolicacidfor6monthsorlonger.

Quick HIT

EpidemiologyofIBD

¢

¢

e

MorecommoninCaucasiansthanotherracialgroups ParticularlycommoninJewishpopulations Meanageofonsetis15to35years

InflammatoryBowelDisease CrohnDisease(“RegionalEnteritis”)

eee

A.GeneralCharacteristics 1. Crohndiseaseisachronictransmuralinflammatorydiseasethatcanaffectany

partoftheGItract(mouthtoanus)butmostcommonlyinvolvesthesmallbowel (terminalileum).

2. Distribution:Therearethreemajorpatternsofdisease:

a. Fortypercentofpatientshavediseaseintheterminalileumandcecum. b. Thirtypercentofpatientshavediseaseconfinedtothesmallintestine. c. Twenty-fivepercentofpatientshavediseaseconfinedtothecolon. d. Rarely,otherpartsofGItractmaybeinvolved(stomach,mouth,esophagus).

3. Pathology

3. Pathology

a. Terminalileumisthehallmarklocation,butothersitesofGItractmayalso beinvolved.

b. Skiplesions—discontinuousinvolvement c. Fistulae d. Luminalstrictures e. Noncaseatinggranulomas f. Transmuralthickeningandinflammation(full-thicknesswallinvolvement)—

resultsinnarrowingofthelumen.

g. Mesenteric“fatcreeping”ontotheantimesentericborderofsmallbowel.

Quick HIT

Crohndiseasehasachronic,indolentcoursecharacterizedbyunpredictableflaresandremissions.The effectivenessofmedicaltreatmentdecreaseswithadvancingdisease,andcomplicationseventuallydevelop, requiringsurgery.Thereisnocure,andrecurrenceiscommonevenaftersurgery.

B.ClinicalFeatures 1. Diarrhea(usuallywithoutblood) 2. Malabsorptionandweightloss(common) 3. Abdominalpain(usuallyRLQ),nausea,andvomiting 4. Fever,malaise 5. Extraintestinalmanifestationsin15%to20%ofcases(uveitis,arthritis,

ankylosingspondylitis,erythemanodosum,pyodermagangrenosum,aphthous oralulcers,cholelithiasis,andnephrolithiasis)(seealsoClinicalPearl3-8)
======================================
C.Diagnosis 1. Endoscopy(sigmoidoscopyorcolonoscopy)withbiopsy—typicalfindingsare aphthousulcers,cobblestoneappearance,pseudopolyps,patchy(skip)lesions.

2. Bariumenema 3. UpperGIwithsmallbowelfollow-through

CLINICALPEARL3-8

ExtraintestinalManifestationsofIBD

Eyelesions Episcleritis—parallelsboweldiseaseactivity Anterioruveitis—independentcourse Skinlesions Erythemanodosum—especiallyinCrohndisease;parallelsboweldiseaseactivity Pyodermagangrenosum—especiallyinUC;parallelsboweldiseaseactivityin50%ofcases. Arthritis—mostcommonextraintestinalmanifestationofIBD Migratorymonoarticulararthritis—parallelsboweldiseaseactivity(coincideswithexacerbationofcolitis) Ankylosingspondylitis—patientswithUChavea30timesgreaterincidenceofankylosingspondylitisthan thegeneralpopulation;thecourseisindependentofthecolitis. Sacroiliitis—doesnotparallelboweldiseaseactivity Thromboembolichypercoagulablestate—canleadtodeepvenousthrombosis(DVT),pulmonaryembolism (PE),oracardiovascularaccident(CVA) Idiopathicthrombocytopenicpurpura Osteoporosis GallstonesinCrohndisease(ilealinvolvement) SclerosingcholangitisinUC

D.Complications 1. Fistulae—betweencolonandothersegmentsofintestine(enteroenteral),bladder

(enterovesical),vagina(enterovaginal),andskin(enterocutaneous)

2. Anorectaldisease(in30%ofpatients)—fissures,abscesses,perianalfistulas 3. SBO(in20%to30%ofpatients)isthemostcommonindicationforsurgery. a. Initially,itisduetoedemaandspasmofbowelwithintermittentsignsof

obstruction;later,scarringandthickeningofbowelcausechronicnarrowingof lumen.

4. Malignancy—increasedriskofcolonicandsmallboweltumors(butlesscommon thanriskofmalignancyinUC).

5. MalabsorptionofvitaminB12andbileacids(bothoccurinterminalileum). 6. Cholelithiasismayoccursecondarytodecreasedbileacidabsorption. 7. Nephrolithiasis—increasedcolonicabsorptionofdietaryoxalatecanleadto

calciumoxalatekidneystones.

8. Aphthousulcersoflips,gingiva,andbuccalmucosa(common) 9. Toxicmegacolon—lesscommoninCrohndiseasethaninUC

10. Growthretardation 11. Narcoticabuse,psychosocialissuesduetochronicity,andoftendisablingnature

ofthedisease
======================================
Quick HIT

PatientsmayhavevagueabdominalpainanddiarrheaforyearsbeforeadiagnosisofCrohndiseaseis considered.

E.Treatment 1. Medical

a. Systemiccorticosteroids(prednisone)—usedasinitialtherapyforlow-risk patientswithdiffusediseaseorleft-sidedcolondisease.Attempttaperwhen clinicallyimproved.Ifunabletotaper,considerimmunosuppressantorbiologic agent(below)

b. Budesonide—usedinlow-riskpatientswithmilddiseaseinileumorrightcolon. Attempttaperwhenclinicallyimproved.Ifunabletotaper,consider immunosuppressantorbiologicagent(below).

c. Biologicagent(TNFinhibitor)canbeusedasmonotherapyorincombination withthiopurine(azathioprineor6-mercaptopurine)ormethotrexateinpatients withmoderatetoseveredisease.

2. Surgical(eventuallyrequiredinmostpatients)

a. ReservedforcomplicationsofCrohndiseaseorforthosewhohavepersistent

symptomsdespitebestmedicalmanagement b. Involvessegmentalresectionofinvolvedbowel c. Diseaserecurrenceaftersurgeryishigh.Upto50%ofpatientsexperience

diseaserecurrenceat10yearspostoperatively.

d. IndicationsforsurgeryincludeSBO,fistulae(especiallybetweenboweland bladderorvagina),disablingdisease,andperforationorabscess.

3. Nutritionalsupplementationandsupport—parenteralnutritionissometimes necessary.

UlcerativeColitis

A.GeneralCharacteristics 1. UCisachronicinflammatorydiseaseofthecolonorrectalmucosa(seealso

Table3-8).

2. Itmayoccuratanyage(usuallybeginsinadolescenceoryoungadulthood). 3. Distribution:UCinvolvestherectuminallcasesandcaninvolvethecolon

eitherpartiallyorentirely,butisalwayscontinuous.Therearenoskiplesionsas areseeninCrohndisease.

a. Rectumalone(in10%ofcases) b. Rectumandleftcolon(in40%ofcases) c. Rectum,leftcolon,andrightcolon(in30%ofcases) d. Pancolitis(in30%ofcases)
======================================
e. ThesmallbowelisnotusuallyinvolvedinUC,butitmayreachthedistalileum inasmallpercentageofpatients(“backwashileitis”in10%ofcases)

4. Thecourseisunpredictableandvariableandischaracterizedbyperiodic exacerbationsandperiodsofcompleteremission.Lessthan5%ofpatientshave aninitialattackwithoutanyrecurrence.

5. Pathology

a. Uninterruptedinvolvementofrectumand/orcolon b. Inflammationisnottransmural(asitisinCrohndisease).Itislimitedtothe

mucosaandsubmucosa.

c. PMNsaccumulateinthecryptsofthecoloncausingcryptabscesses.

B.ClinicalFeatures(widerangesofpresentationareseen) 1. Hematochezia(bloodydiarrhea)

2. Abdominalpain 3. Bowelmovementsarefrequentbutsmall 4. Fever,anorexia,andweightloss(severecases) 5. Tenesmus(rectaldryheaves) 6. Extraintestinalsymptoms(e.g.,jaundice,uveitis,arthritis,skinlesions)—see

ClinicalPearl3-8

Quick HIT

PatientswithUCmayhavenonbloodydiarrheaatfirst,witheventualprogressiontobloodydiarrhea.

A.Diagnosis:performthefollowinginitialstudies 1. StoolculturesforClostridiumdifficile,ova,andparasitestoruleoutinfectious

diarrhea.

2. Fecalleukocytes

a. WBCscanappearinUC,ischemiccolitis,orinfectiousdiarrhea. 3. Colonoscopytoassesstheextentofdiseaseandthepresenceofany

complications.

D.Complications 1. Irondeficiencyanemia 2. Hemorrhage 3. Electrolytedisturbancesanddehydrationsecondarytodiarrhea 4. Strictures,benignandmalignant(usuallymalignant) 5. Coloncancer—Theriskcorrelateswithextentanddurationofcolitis.Indistal

proctitisthereisnoincreasedriskofCRC.

6. Sclerosingcholangitis(SC)—Doesnotcorrelatewithboweldiseaseandisnot preventedbycolectomy.

7. Cholangiocarcinoma—HalfofallbileductcancersareassociatedwithUC 8. ToxicmegacolonistheleadingcauseofdeathinUCandaffects<5%ofpatients.

Itisassociatedwiththeriskofcolonicperforation.

9. Growthretardation 10. Narcoticabuse 11. Psychosocialissues(e.g.,depression)duetochronicityandoftendisablingnature

ofthedisease

E.Treatment 1. Medical(Figure3-12)

a. Sulfasalazine(topicalapplicationasasuppository)—themainstayoftreatment. Preferredovertopicalsteroidsandcanbeusedasmaintenancetherapy.

Remissionratesashighas93%havebeenreported.
======================================
e

e

Itiseffectiveinmaintainingremissions.5-ASA(mesalamine)istheactive component. 5-ASAenemascanbeusedforproctitisanddistalcolitis.

b. Oralglucocorticoids—usedwhenpatientsfailtorespondtotopicalandoral5- ASAtherapy(above).Ifadequateclinicalresponseisachieved,attemptstotaper offofglucocorticoidsshouldoccurafter2to4weeks.Canbeusedin conjunctionwith5-ASA(topicalandoral)forpatientswithseverecolitis. c. TNFinhibitors(infliximab,adalimumab)andthiopurines(6-mercaptopurine,

azathioprine)canbeusedinpatientswhodonotrespondtocorticosteroidsorfor severedisease.

Upper abdomen / Lower abdomen | Surgery consult | Assess quality + Ulcer + IBS + Nonulcer dyspepsia + Diverticulitis + Reflux + Lactose intolerance * Biliary colic + Dysmenorrhea * Chronic pancreatitis + Endometriosis * Cancer (stomach, * Chronic pelvic pain pancreas, liver) * Inguinal hernia + IBS + IBD * Cancer (colon, pelvic) Epigastric | Periumbilical } RLQ RUQ LLQ LUQ + Ulcer + Early appendicitis + Appendicitis + Cholecystitis + Diverticulitis + Pancreatitis + Nonulcer dyspepsia + Gastroenteritis + Perforated ulcer * Cholangitis + PID * Splenic disease + Biliary colic + Mesenteric ischemia + PID + Ulcer + Ectopic pregnancy * Subphrenic abscess + Reflux + Small bowel + Ectopic pregnancy + Hepatitis + Ovarian cyst + Pneumonia MI obstruction * Ovarian cyst + Pneumonia + Inguinal hernia *PE + Inguinal hernia *PE + Epididymitis IBD = Inflammatory bowel disease + Epididymitis * Testicular torsion IBS = Irritable bowel syndrome * Testicular torsion + IBD MI = Myocardial infarction + IBD + Ureteral stone PE = Pulmonary embolus + Ureteral stone PID = Pelvic inflammatory disease “Red flags" include peritoneal signs such as rigid abdomen, guarding, and rebound tenderness.

FIGURE 3.12

Approachtothediagnosisofnontraumaticabdominal

paininadults. (AdaptedfromSloanePD,SlattLM,EbellMH,etal.EssentialsofFamilyMedicine.4th

ed.Philadelphia,PA:LippincottWilliams&Wilkins;2002:245,Figure16.2.)

d. Immunosuppressiveagentsinpatientswithrefractorydiseasemayprevent relapsesbutarenoteffectiveforacuteattacks.

2. Surgical—oftencurative(unlikeCrohndisease)andinvolvestotalcolectomy. Indicationsforsurgeryinclude:

a. Severediseasethatisdebilitating,refractory,andunresponsivetomedical therapy

b. Toxicmegacolon(riskofperforation),obstruction(duetostricture),severe hemorrhage,perforation
======================================
c. Fulminantexacerbationthatdoesnotrespondtosteroids d. Evidenceofcoloncancerorincreasedriskofcoloncancer e. Growthfailureorfailuretothriveinchildren f. Systemiccomplications

Quick HIT

Sulfasalazineismetabolizedbybacteriato5-ASAandsulfapyridine.5-ASAistheeffectivemoietyofthedrug, andsulfapyridinecausesthesideeffects.

4

EndocrineandMetabolicDiseases SarahJensen

DiseasesofthePancreas

DiabetesMellitus

A.GeneralCharacteristics 1. Classification(seealsoTable4-1).

a. TypeIDM—approximately5%ofalldiabeticpatients.

e

e

¢

Thisischaracterizedbyaseveredeficiencyofinsulin.Patientsrequire insulintolive. Theonsetistypicallyinyouth(beforeage20),butcanoccuratanyage. Notrelatedtoobesity.

b. TypeIIDM—90%ormoreofalldiabeticpatients.

e

e

e

Insulinlevelsareusuallynormaltohighbutmaydiminishovermanyyearsof havingdiabetes. Insulinresistanceduetoobesityplaysamajorrole. Itoftengoesundiagnosedformanyyears.

c. Impairedfastingglucose

e

e

©

e

Fastingglucosebetween100and125mg/dLora2-hourpostprandialglucose between140and199mg/dL. Impairedglucosetoleranceisdefinedasabloodglucosebetween140and199 mg/dL2hoursaftera75-goralglucosetolerancetest. OnetofivepercentannualincreaseinriskofdevelopingtypeIIdiabetes. Increasedriskforcardiovasculardisease.

Quick HIT

HypertriglyceridemiawithHDLdepletionisthecharacteristiclipidprofileofinsulinresistanceandpoorly controlleddiabetes.

2. PathogenesisoftypeIdiabetes(seealsoClinicalPearls4-1and4-2)

a. Anautoimmunedisease—Theimmunesystemmediatesthedestructionofβ-

cells.

b. Itdevelopsingeneticallysusceptibleindividualswhoareexposedtoan environmentalfactorthattriggerstheautoimmuneresponse;β-celldestruction ensues.

c. OvertType1DMdoesnotappearuntilabout90%ofβ-cellsaredestroyed.

3. PathogenesisoftypeIIdiabetes.

a. Riskfactors

e

e

e

Obesity(greatestriskfactor) Genetics Age(insulinproductiondecreaseswithage)

b. Obesityplaysamajorrole

¢

e

Obesityisassociatedwithincreasedplasmalevelsoffreefattyacids,which makemusclesmoreinsulinresistant,reducingglucoseuptake.Therefore, obesityexacerbatesinsulinresistance. Intheliver,freefattyacidsincreasetheproductionofglucose.

c. LackofcompensationintypeIIdiabeticpatients
======================================
e

e

Innormalindividuals,thepancreassecretesmoreinsulininresponsetofree fattyacids,thusneutralizingtheexcessglucose. IntypeIIdiabeticpatients,freefattyacidsfailtostimulatepancreaticinsulin secretion.Therefore,compensationdoesnotoccurandhyperglycemia develops;β-cellsbecomedesensitizedtoglucose,leadingtodecreasedinsulin secretion.

Quick HIT

Diabetesisdiagnosedbyoneofthefollowing: 1. Twofastingglucosemeasurementsgreaterthan126mg/dL 2. Singleglucoselevelof200mg/dLwithsymptoms,withrepeatconfirmation 3. Two-hour75-goralglucosetolerancetestgreaterthanorequalto200mg/dL,withrepeatconfirmation 4. HemoglobinA1c>6.5%

TABLE4-1 ComparisonofTypeIandIIDiabetesMellitus
======================================
CLINICALPEARL4-1

DawnPhenomenonandSomogyiEffect

¢

¢

e

e

Bothcausemorninghyperglycemia. Thedawnphenomenonisprobablyduetoanincreaseinthenocturnalsecretionofgrowthhormone.This phenomenonisindependentoftheSomogyieffect. TheSomogyieffectisareboundresponsetonocturnalhypoglycemia—thatis,counterregulatorysystemsare activatedinresponsetohypoglycemia,leadingtomorninghyperglycemia. Ifmorninghyperglycemiaispresent,checktheglucoselevelat3:00am.Iftheglucoseleveliselevated,the patienthasthedawnphenomenonandhisorhereveninginsulinshouldbeincreasedtoprovideadditional coverageintheovernighthours.Iftheglucoselevelislow,thepatienthastheSomogyieffectandhisorher eveninginsulinshouldbedecreasedtoavoidnocturnalhypoglycemia.

CLINICALPEARL4-2

GeneralPrinciplesinOutpatientManagementandMonitoringofAllDiabetic Patients

¢

e

e

e

e

e

e

¢

e

MonitorHbA1clevelevery3months.KeepingHbA1c<7istheobjective(althoughdifficulttoachieve) becauseitisassociatedwithamarkedreductioninriskformicrovascularcomplications. Alldiabeticpatientsshouldmonitordailyglycemiclevelswithhomebloodglucosedeterminations.Patients oninsulintherapyshouldcheckbloodglucoselevelsbeforemealsandatbedtime.Monitoringbloodglucose 90to120minutesaftermealsenablesthepatienttocontrolpostprandialhyperglycemiaandshouldbe stronglyencouraged. Screenformicroalbuminuriaatleastonceperyearindiabeticpatientswithnoevidenceofnephropathy. PrescribeACEinhibitororARBifurinetestispositiveformicroalbuminuria. CheckBUNandcreatininelevelatleastonceperyear. Ordereyescreeningyearlybyanophthalmologisttoscreenfordiabeticretinopathy. Checkthefeetateveryvisit.Referhigh-riskpatientstoafootcarespecialist(e.g.,podiatrist).Patientsshould checktheirfeetregularlyforulcersandneuropathy. Checkcholesterollevelsatleastonceperyear.GivestatinmedicationifLDLisabove100mg/dL. TakeBPateveryvisit.GiveACEinhibitororARBifBPisgreaterthan130/80mmHg. Dailyaspirininalldiabeticsoverage30unlesscontraindicated. Pneumococcalvaccine.

¢

e

TABLE4-2 DiagnosticCriteriaforDiabetesMellitus
======================================
B.Diagnosis 1. Testingrecommendations(seealsoTable4-2).

a. Screenalladultsbetweenages40and70every3years. b. Forthosewithriskfactorsfordiabetes(obesity,familyhistory,historyof

b. For those with risk factors for diabetes (obesity, family history, history of gestational diabetes), start screening earlier. Some recommend early screening for African Americans and Native Americans.

gestationaldiabetes),startscreeningearlier.Somerecommendearlyscreening forAfricanAmericansandNativeAmericans. c. Testanyonewithsignsorsymptomsofdiabetes.

2. Performanyoneofthefollowingtestsontwoseparatedays(seeTable4-2).

a. Fastingplasmaglucose—criteriaforDM:glucose>126mg/dL.

Ifbetween100and126mg/dL,performa75-goralglucosetolerancetest (althoughthisisrarelydone)orrecheckfastingglucose.

b. Randomplasmaglucose—criteriaforDM:glucose>200mg/dLinapersonwith diabeticsymptoms.

c. Two-hourpostprandialplasmaglucoselevel—criteriaforDM:glucose>200 mg/dLafteradministrationoftheequivalentofa75-gglucoseload(more sensitivethanfastingglucoselevel,butlessconvenient).

d. HemoglobinA1c—criteriaforDM:A1c>6.5%(repeattestshouldoccur>3 monthslaterasopposedtothenextday).Manyusethisaspreferredscreening method.

Quick HIT

Whileevaluatingadiabeticpatient,focuson:

The feet

Thefeet Vasculardisease(CAD,PVD) Neurologicdisease(neuropathies) Eyes(retinopathy) Renaldisease Infectiousdisease

C.ClinicalPresentation 1. TypeI(seeTable4-3andFigure4-1)

a. Symptomsdevelopquicklyoverdaystoweeks. b. Sometimessymptomsappearafteranillness. c. Patientsoftenpresentwithacutediabeticketoacidosis(DKA).

TABLE4-3 SymptomsofDiabetesMellitus

Symptom

Symptom Polyuria

Polyuria

Cause

Glucoseinrenaltubulecausesosmoticretentionofwater,causingadiuresis
======================================
Stage 1: Genetic susceptibility Stage 2: Autoimmune process of f-cell destruction begins. Normal insulin is released. Stage 3: As B-cell destruction continues, insulin release is decreased. Glucose level is still normal. Stage 4: Overt diabetes mellitus. Patient is insulin dependent at this point. C-peptide is still present. Stage 5: No C-peptide present Stage 1 Stage 2 | Stage3 | Stage 4 | Stage5 B-cell mass ' ' 1 ‘ 1 i ‘ ' D ' 1 ' ' ‘ 1 ' ‘ ‘ ‘ ' D 1 ‘ ' ' ' ' ' ' ' ‘ ' ‘ ‘ ' ' ' ' ' 1 ' ' ' 1 ' n ‘ — oe t Age Autoimmune Inadequate process insulin begins production

FIGURE 4.1

ProgressionoftypeIdiabetesmellitus.

2. TypeII

a. Thisisusuallydiscoveredonscreeningurinalysisorbloodsugarmeasurement. Sometimesthediagnosisismadeduringevaluationforotherdiseases(e.g., heart,kidney,neurologic,infection).

b. Symptomaticpatientsmaypresentwithpolyuria,polydipsia,polyphagia, fatigue,blurredvision,weightloss,and/orcandidalvaginitis.Thesesymptoms areusuallynotedinretrospect,afterelevatedbloodglucosehasbeen documented.

c. Patientswhohavenotroutinelysoughtmedicalattentionmaypresentwith complicationssuchasmyocardialischemia,stroke,intermittentclaudication, impotence,peripheralneuropathy,proteinuria,orretinopathy.

Quick HIT

OptimalTreatmentforTypeIIDiabeticPatients

Glycemiccontrol

BPcontrol—(<130/85) Optimizationofserumlipids—goals:LDL≤100,HDL≥40.Checklipidsannually. Smokingcessation Dailyaspirin(ifnotcontraindicated) Inspectfeetateveryvisit Dilatedeyeexaminationyearly Urinealbumin–creatinineratioannually MeasureA1cevery3to6months.

D.Treatment 1. DietandexerciseshouldideallybetheonlyinterventionsinmosttypeIIdiabetic

patients.

a. Dietandexerciseareespeciallyeffectiveinobeseandsedentarypatients(who constitutethemajorityoftypeIIdiabeticpatients).

b. Mostpatients,however,donotloseenoughweighttocontrolglucoselevels throughdietandexercisealone,andwillrequirepharmacologictreatment. c. Glycemiccontrolminimizesrisksfornephropathy,neuropathy,andretinopathy inbothType1and2DM,anddecreasesriskforcardiovasculardiseaseforType 1DM.

2. Oralhypoglycemicdrugs(seeTable4-4)

a. UsetheseintypeIIdiabeticpatientswhenconservativetherapy(dietand exercise)fails.
======================================
b. Startwithoneagent;metforminisbestinitialdrugtherapy.Ifmonotherapyfails, usetwoagentsfromdifferentclassesincombination.Eachagenthasadvantages anddisadvantages,soclinicaljudgmentisrequiredinselectingtheagent. c. Metforminblocksgluconeogenesis.Itiscontraindicatedinpatientswithrenal

failure.

d. Otheroralhypoglycemicsinclude:

Sulfonylureas Thiazolidinediones(glitazones) GLP-1agonist α-Glucosidaseinhibitors(acarbose,miglitol) Pramlintide DPP-4inhibitor SGLT2inhibitor Repaglinide/nateglinide

Quick HIT

InsulinVersusNoninsulinAgentsinTypeIIDiabetes

Ifthepatienthasseverehyperglycemia(fastingglucose>240mg/dL),insulintypicallyistheagentof choice,whethertypeIortypeIIdisease.

NoninsulinagentsareeffectiveintypeIIdiseasewithmoderatehyperglycemia(fastingglucosebetween140 and240mg/dL).

e. TherearenumerousstudiesevaluatingcardiovascularbenefitsofSGLT2 inhibitortherapyinhigh-riskCVDpatients.

f. Inpatientswithrelativelymilddisease,useofthesedrugs(aloneorin combination)canbringglucoselevelstonormal,butpatientswithsevere diseaseoftendonotrespondadequately.Therefore,manytypeIIdiabetic patientseventuallyrequireinsulin(seebelow).

g. Donotgivetopatientswhocannoteat(e.g.,becauseofillnessorsurgery).

TABLE4-4 NoninsulinDiabetesMedications

TreatmentofDiabetes

TypeIdiabeticpatientsrequireinsulintolive. TypeIIdiabeticpatientsrequireexerciseanddiet(initialsteps)aswellasoralhypoglycemicdrugs.The currentemphasisistotreataggressivelyandmovequicklytoinsulinifneededtooptimizeHbA1c.

3. Insulin(seeTable4-5).

a. Methodofadministration.

e

e

Self-administeredbySCinjectioninabdomen,buttocks,arm,andleg. Givenintravenouslyforemergencyketoacidosis.

TABLE4-5 TypesofInsulin

Human insulin lispro 15 min 2-4 hrs Regular insulin 30-60 min 4-6 hrs Only type that can be given intravenously NPH insulin/lente insulin 2-4 hrs 18-28 hrs Most widely used form of insulin Insulin detemir 2 hrs 6-24 hrs Duration is dose-dependent 70/30 mixture 30 min 10-16 hrs 70% NPH, 30% regular Glargine (Lantus) 3-4 hrs 24 hrs Given at bedtime

b. Regimens

MosttypeIdiabeticpatientsrequire0.5to1.0unit/kgperdaytoachieve
======================================
e

e

acceptableglycemiccontrol. Startwithaconservativedose(0.2units/kg)andadjusttheregimenaccording tothepatient’sglucoselevels. Manydifferentregimensexist,andeverypatienthasuniqueneeds(seeTable 4-5).

c. Intensiveinsulintherapy

Long-actinginsulinisgivenoncedailyintheevening.Regularinsulinisgiven 30to45minutesbeforeeachmeal,andshouldbeadjustedaccordingto preprandialhomeglucosemeasurements. Thesemoreaggressivetherapieshavebeenshowntosignificantlydecreasethe incidenceofdiabetescomplicationssuchasretinopathyandmicroalbuminuria whencomparedtopriorregimens.Allattemptsshouldbemadetogetpatients onmoreaggressivetreatmentprotocols. Withintensiveinsulintherapy,theriskforhypoglycemiaisaserious concern. Alternatively,acontinuousSCinfusionofinsulincanbegivenviaaninsulin pump.Preprandialbolusesaregiveninadditiontothebasalinfusion. d. Ifthepatientisunable/unwillingtocarryoutanintensiveinsulinprogram:

¢

e

e

Give70/30unitsbeforebreakfastandbeforetheeveningmealforbasal coverage. Giveashort-actinginsulin(regular)forprandialcontrolifnecessary. Adjustdosesaccordingtofastingand4PMglucosedeterminations.

e. Inpatientmanagementofdiabeticpatients(slidingscale).

e

e

e

¢

e

Aninsulinslidingscale(SSI)ofregularinsulindosesgivenaccordingto bedsidefinger-stickglucosedeterminationsishelpfulincontrollingblood glucoselevelsinthehospitalsetting. SSIshouldbeusedinadditiontoaregimenoflong-actinginsulin.Ifgiven alone,hyperglycemiausuallyresults. Monitorbloodglucosefourtimesperday:beforemealsandatbedtime. Onceinsulintherapyisstarted,abloodglucosegoalof140to180mg/dL shouldbetargetedformostpatients. Ifthehomeinsulindoseisunclear,orifthepatientanticipatesgreater requirementsofinsulinduetoanillness,usethefollowingapproachtoadjust appropriateinsulindoses:

e

e

e

Takethetotalnumberofunitsofregularinsulinthatthepatientrequiredin1 day(whileontheslidingscale). Addtwo-thirdsofthistotheprebreakfastdoseandone-thirdbeforedinner.It shouldbegivenas70/30(i.e.,70%NPH/30%regular). Inpractice,rememberthatoftenpatientswillbeplacedonabasal-bolus

dosingwithlong-andshort-actinginsulinwithmeals.

f. Modifyinginsulindoses(seealsoClinicalPearl4-3)
======================================
e

e

e

e

Physicalactivity—dependingontheintensityoftheactivity,decreaseinsulin dosage1to2unitsper20to30minutesofactivity. Duringillness,administeralloftheroutineinsulin.ManyepisodesofDKA occurduringepisodesofillness. Stressandchangesindietrequiredosingadjustments. Patientsundergoingsurgeryshouldgetone-thirdtoone-halfoftheusualdaily insulinrequirementthatday,withfrequentmonitoringandadjustmentsas necessary.

4. Surgicaltreatment—Surgicalweightlosstherapy(i.e.,gastricbypass)isan effectivetreatmentforsomepatients,includingadolescents.Additionally,islet celltransplantationoffersdefinitivetreatmentforselectedqualifiedpatients.

CLINICALPEARL4-3

MonitoringGlucoseLevelsinDM

e

e

e

HbA1cgivesanestimateofthedegreeofglucosecontrolover2to3months. TheAmericanDiabetesAssociationrecommendsatreatmentgoalofHbA1c<7.0%.Ingeneral,HbA1c>10% ispoorcontrol,8.5%to10%isfaircontrol,7.0%to8.5%isgoodcontrol,and<7.0%isidealaslongasthe patientisnotexperiencinghypoglycemicepisodes. TheAmericanDiabetesAssociationrecommendskeepingfastingbloodglucoselevel<130mg/dLandpeak postprandialbloodglucose<180mg/dL.

ChronicComplicationsofDiabetesMellitus

A.MacrovascularComplications 1. Themainproblemisacceleratedatherosclerosis,whichputspatientsat increasedriskofstroke,MI,andCHF(Figure4-2).Theaccelerated atherosclerosisindiabeticsisthereasonthetargetBPislowerindiabetics (130/80)thaningeneralpopulation(140/90),andthereasonthetargetLDLis lowerindiabetics(<100mg/dL).Thecauseofacceleratedatherosclerosisisnot known,althoughglycationoflipoproteinsandincreasedplatelet adhesiveness/aggregationarethoughttobetwopotentialcauses.Inaddition,the processoffibrinolysismaybeimpairedindiabeticpatients. 2. Themanifestationsofatherosclerosisincludethefollowing:

a. Coronaryarterydisease(CAD).

e

¢

e

RiskofCADistwotofourtimesgreaterindiabeticthaninnondiabetic persons. Mostcommoncauseofdeathindiabeticpatients. Silentmyocardialinfarctionsarecommon.

b. Peripheralvasculardisease—inupto60%ofdiabeticpatients. c. Cerebrovasculardisease(strokes).
======================================
Quick HIT

Theriskofcoronaryeventsisgreatlyreducedifthepatientcaneliminateorreduceothermajorcardiovascular riskfactors(smoking,HTN,hyperlipidemia,obesity).

CVA (stroke) Retinopathy, cataracts, glaucoma Heart disease Gastroparesis Nephropathy Impotence Peripheral vascular disease Neuropathy

FIGURE 4.2

Chroniccomplicationsofdiabetesmellitus.

CLINICALPEARL4-4

RadiocontrastAgentsinDiabeticPatients

¢

e

PatientswithdiabetesandCKDareparticularlysusceptibletodevelopingradiocontrast-inducedacuterenal failure. IfIVcontrastisnecessary,givegeneroushydrationbeforeadministeringthecontrastagenttoavoid precipitatingacuterenalfailure.

B.MicrovascularComplications Risk can be markedly reduced by achieving tight glucose control (see also Clinical Pearl4-4) 1. Diabeticnephropathy—mostimportantcauseofend-stagerenaldisease(ESRD)

a. Pathologictypes

e

e

e

Nodularglomerularsclerosis(Kimmelstiel–Wilsonsyndrome)—hyaline depositioninoneareaofglomerulus—pathognomonicforDM Diffuseglomerularsclerosis—hyalinedepositionisglobal.Thisalsooccursin HTN. Isolatedglomerularbasementmembranethickening.

b. Microalbuminuria/proteinuria

e

e

¢

e

¢

e

Ifmicroalbuminuriaispresent,strictglycemiccontroliscritical.Tightblood glucosehasbeenshowntolimitprogressionfrommicroalbuminuriatoclinical proteinuria. Withouteffectivetreatment,thealbuminuriagraduallyworsens—HTNusually developsduringthetransitionbetweenmicroalbuminuriaandprogressive proteinuria.PersistentHTNandproteinuriacauseadecreaseinglomerular filtrationrate(GFR),leadingtorenalinsufficiencyandeventuallyESRD. HTNincreasestheriskofprogressionofdiabeticnephropathytoESRD. ControlBPaggressively. InitiateACEinhibitorsorARBimmediately.Theseagentsareprovento decreasetherateofprogressionofnephropathy. Microalbuminuriaisthescreeningtest!Ifyouwaitforthedipsticktobe positiveforprotein,youhavewaitedtoolong.Rememberthat microalbuminuriameanslevelsofalbuminarebetween30and300mgper24 hours.Butthedipstickforurinebecomestracepositiveat300mgofprotein per24hours. Itusuallytakes1to5yearsformicroalbuminuriatoadvancetofull-blown proteinuria.However,withpropertreatment(i.e.,usingACEinhibitorsto controlBP)thiscanbeprolonged.

c. Oncediabeticnephropathyhasprogressedtothestageofproteinuriaorearly renalfailure,glycemiccontroldoesnotsignificantlyinfluenceitscourse.ACE inhibitorsanddietaryrestrictionofproteinarerecommended.
======================================
Quick HIT

DefinitionofMicroalbuminuria

¢

e

30to300mg/day Albumin–creatinineratioof0.02to0.20

2. Diabeticretinopathy

a. Prevalenceisapproximately75%after20yearsofdiabetes.Annualscreening ofalldiabeticpatientsbyanophthalmologistisrecommended.

b. Background(nonproliferative)retinopathyaccountsforthemajorityofcases.

e

e

e

Funduscopicexaminationshowshemorrhages,exudates,microaneurysms,and venousdilatation. Thesepatientsareusuallyasymptomaticunlessretinaledemaorischemia involvesthecentralmacula. Edemaofthemaculaistheleadingcauseofvisuallossindiabeticpatients.

c. HTNandfluidretentionexacerbatethiscondition. d. Proliferativeretinopathy

e

e

¢

Keycharacteristicsarenewvesselformation(neovascularization)andscarring. Twoseriouscomplicationsarevitreoushemorrhageandretinaldetachment. Canleadtoblindness.Laserphotocoagulationisthetreatment.

Quick HIT

Ocularproblemsindiabeticpatientsincludecataracts,retinopathy,andglaucoma. DiabeticretinopathyistheleadingcauseofblindnessintheUnitedStates.

Hyperglycemia > * GFR >| Microalbuminuria = Proteinuria >| +GFR > ESAD | *

FIGURE 4.3

controlhasbeenshowntosloworpreventprogressionfrom microalbuminuriatoproteinuria.Thisisthecriticalstage(marked bystar)—onceproteinuriadevelops,glycemiccontroldoeslittleto controlthecourseandwilleventuallyleadtoESRD.

3. Diabeticneuropathy(Figure4-3)

a. Peripheralneuropathy(distalsymmetricneuropathy)

e

¢

e

Usuallyaffectssensorynervesina“stocking/glovepattern”—Typicallybegins infeet,laterinvolveshands(longestnervesaffectedfirst).Numbnessand paresthesiasarecommon. Lossofsensationleadstothefollowing:ulcerformation(patientsdonotshift theirweight)withsubsequentischemiaofpressurepointareas;Charcotjoints. Painfuldiabeticneuropathy—hypersensitivitytolighttouch;severe“burning” pain,especiallyatnight,thatcanbedifficulttotolerate.Treatmentiswith gabapentin,tricyclicantidepressants,orpregabalin.

Quick HIT

TheDiabetesControlandComplicationsTrialshowedthattightglucosecontrolreducestheriskof microvasculardiseaseby50%to60%.However,whetheritcanreducetheriskofmacrovasculardisease remainstobeproven.ItisthemacrovascularcomplicationsthatcausedeathinthemajorityoftypeIIdiabetic patients.

b. CNcomplications—secondarytonerveinfarction.

¢
======================================
e

MostofteninvolvesCNIII,butmayalsoinvolveCNVIandIV. Diabeticthirdnervepalsy:eyepain,diplopia,ptosis,inabilitytoadductthe eye;butthepupilsarespared.

c. Mononeuropathies—secondarytonerveinfarction.

e

e

e

Mediannerveneuropathy,ulnarneuropathy,commonperonealneuropathy. Diabeticlumbosacralplexopathy—severe,deeppaininthethigh;atrophyand weaknessinthighandhipmuscles;recoverytakesweekstomonths. Diabetictruncalneuropathy—painindistributionofoneoftheintercostal nerves.

d. Autonomicneuropathy

Impotenceinmen(mostcommonpresentation) Neurogenicbladder—retention,incontinence Gastroparesis—chronicnauseaandvomiting,earlysatiety Constipationanddiarrhea(alternating) Posturalhypotension

4. Diabeticfoot

a. Causedbyacombinationofarterydisease(ischemia)andnervedisease (neuropathy)—canleadtoulcers/infectionsandmayrequireamputation.

b. Withneuropathy,thepatientdoesnotfeelpain,sorepetitiveinjuriesgo unnoticedandultimatelyleadtononhealing.

c. Inaddition,neuropathymaymasksymptomsofPVD(claudication/restpain).

Also,calcificmedialarterialdiseaseiscommonandcancauseerroneouslyhigh BPreadingsinlowerextremities. 5. Increasedsusceptibilitytoinfection

a. ThisresultsfromimpairedWBCfunction,reducedbloodsupply,and neuropathy.Woundhealingisimpairedindiabeticpatients,andthiscanbe problematicpostoperatively.

b. Diabeticpatientsareatincreasedriskforthefollowinginfections:cellulitis, candidiasis,pneumonia,osteomyelitis,andpolymicrobialfootulcers.

c. Infectionsofischemicfootulcersmayleadtoosteomyelitisandmayrequire amputation.

C.SpecificTreatmentofChronicDiabeticComplications 1. Macrovasculardisease—treatmentinvolvesreductionofriskfactors(e.g.,BP

reduction,lipid-loweringagents,smokingcessation,exercise),adailyaspirin(if notcontraindicated),andstrictglycemiccontrol.

2. Nephropathy—ACEinhibitors,benefitsofwhichinclude: a. Slowprogressionofmicroalbuminuriatoproteinuria. b. SlowdeclineofGFR.

3. Retinopathy—Treatmentinvolvesreferraltoanophthalmologistandpossible photocoagulation.

4. Neuropathy—Treatmentiscomplex.Pharmacologicagentsthatmaybehelpful includeNSAIDs,tricyclicantidepressants,andgabapentin.Forgastroparesis,a promotilityagentsuchasmetoclopramidecanbehelpful,inadditiontoexercise andalow-fatdiet.

5. Diabeticfoot—Thebesttreatmentisprevention:regularfootcare,regular podiatristvisits.Amputationisalastresort.
======================================
AcuteComplicationsofDiabetesMellitus

A.DiabeticKetoacidosis 1. Generalcharacteristics

a. DKAisanacute,life-threateningmedicalemergencythatcanoccurinbothtype IandtypeIIdiabeticpatients(morecommonintypeI).

b. Pathogenesis

e

e

Thisissecondarytoinsulindeficiencyandglucagonexcess,bothofwhich contributetoacceleratedseverehyperglycemiaandacceleratedketogenesis. Severehyperglycemialeadstoanosmoticdiuresis,whichcausesdehydration andvolumedepletion.

c. ConsequencesofDKAincludehyperglycemia,ketonemia,metabolicacidosis, andvolumedepletion.

Quick HIT

KeyFeaturesofDKA Hyperglycemia Positiveserumorurineketones Metabolicacidosis

2. Precipitatingfactors

a. Anytypeofstressorillness(e.g.,infectiousprocess,trauma,myocardial infarction,stroke,recentsurgery,sepsis,GIbleeding)

b. Inadequateadministrationofinsulin

3. Clinicalfeatures

a. Nauseaandvomiting b. Kussmaulrespiration—rapid,deepbreathing c. Abdominalpain(morecommoninchildren)thatmaymimicacuteabdomen—

oftenwithguardingandrigidity

d. “Fruity”(acetone)breathodor e. Markeddehydration,orthostatichypotension,tachycardia—volumedepletionis

alwayspresent

f. Polydipsia,polyuria,polyphagia,weakness g. Alteredconsciousness,drowsiness,andfrankcomamayoccurifnottreated h. Symptomsusuallyoccurrapidly,typicallyinlessthan24hours

4. Diagnosis

a. Hyperglycemia:serumglucosetypically>450mg/dLand<850mg/dL(in certainconditions,e.g.,alcoholingestion,thepatientmaybeeuglycemic) b. Metabolicacidosis

e

e

BloodpH<7.3andserumHCO3 Increasedaniongap—duetoproductionofketones(acetoacetateandβ- hydroxybutyrate)

c. Ketonemia(serumpositiveforketones)andketonuria

e

e

Serumlevelsofacetoacetate,acetone,andβ-hydroxybutyratearegreatly increased. WhenDKAisaccompaniedbycirculatorycollapse,serumandurinemaybe falselynegativeforketones.Thisisbecauselactateproductionresultsinless acetoacetateandmoreβ-hydroxybutyrateproduction,andacetoacetateisthe onlyketoacidthatcanbemeasuredbynitroprussideagents.

d. KetonemiaandacidosisarerequiredforthediagnosisofDKA.
======================================
Quick HIT

DifferentialDiagnosisofDKA

Alcoholicketoacidosis Hyperosmolarhyperglycemicnonketoticsyndrome(HHNS) Hypoglycemia(alteredmentalstatus,abdominalpain,andacidosisarepossible) Sepsis Intoxication(e.g.,methanol,ethanol,salicylates,isopropylalcohol,paraldehyde,ethyleneglycol)

Sepsis

5. Otherlaboratoryvalueabnormalities

a. Hyperosmolarity b. Hyponatremia—Serumsodiumdecreases1.6mEq/Lforevery100mg/dL

increaseinglucoselevelbecauseoftheosmoticshiftoffluidfromtheICFtothe ECFspace.Totalbodysodiumlevelisnormal.Thisgenerallydoesnotrequire treatment.

c. Otherelectrolytedisturbances

Potassium—Becauseoftheacidosis,hyperkalemiamaybepresentinitially, althoughtotalbodypotassiumislow.Asinsulinisgiven,itcausesashiftof potassiumintocells,resultinginahypokalemia.Thiscanhappenvery rapidly.Phosphateandmagnesiumlevelsmayalsobelow.

6. Treatment a. Insulin

¢

¢

¢

Giveinsulinimmediatelyafterthediagnosisisestablished. Giveaprimingdoseof0.1units/kgofregularinsulin(IV)followedbyan infusionof0.1units/kg/hr.Thisissufficienttoreplacetheinsulindeficitin mostpatients.Becertainthatthepatientisnothypokalemicbeforegiving insulin. Continuetheinsulinuntiltheaniongapclosesandmetabolicacidosisis

corrected,thenbegintodecreasetheinsulin.GiveSCinsulinwhenthepatient startseatingagain.

b. Fluidreplacement(normalsaline)

¢

e

Givefluidsimmediatelyafterthediagnosisisestablished. Add5%glucoseoncethebloodglucosereaches200mg/dLtoprevent hypoglycemia.

c. ReplacepotassiumprophylacticallywithIVfluids.

e

e¢

Initiatewithin1to2hoursofstartinginsulin.Ensureadequaterenalfunction (measureurineoutput)beforeadministeringthese. Monitorpotassium,magnesium,andphosphatelevelsverycloselyandreplace asnecessary.

−replacementiscontroversialandisnotnecessaryinmostcases.

Quick HIT

IfapatientpresentswithDKA:

e

¢

¢

Takeahistoryandperformaphysicalexamination. Orderlaboratorytests:bloodglucose,arterialbloodgas,CBC,electrolytes,BUN,creatinine,andurinary analysis. OrderECG,CXR,andcultures. InitiateIVfluids. IfKis<3.3mEq/L,holdinsulinandgive20to30mEq/hruntilserumKis>3.3.IfKis3.3to5.2,give potassiumwithIVfluidstomaintainagoalof4to5mEq/Linserum.IfK>5.2,donotgiveanywithIVF, butcontinuetomonitorevery2hours. Giveinsulin(holdifK<3.3asabove). AdmittotheICUoraverycloselymonitoredfloorbed.
======================================
e

Quick HIT

TreatmentofDKA:insulin,fluids,potassium.OnlyinitiateinsulinonceserumK>3.3mEq/L.

B.HyperosmolarHyperglycemicNonketoticSyndrome 1. Generalcharacteristics(seealsoTable4-6)

a. Astateofseverehyperglycemia,hyperosmolarity,anddehydrationistypically seeninelderlytypeIIdiabeticpatients.

b. Pathogenesis

e

e

Lowinsulinlevelsleadtohyperglycemia.Severehyperglycemiacausesan osmoticdiuresis,leadingtodehydration. Ketogenesisisminimalbecauseasmallamountofinsulinisreleasedtoblunt counterregulatoryhormonerelease(glucagon),andthusketonesarenot producedinexcessastheyareinDKA.

Ketosisandacidosisaretypicallyabsentorminimal. Severedehydrationisduetocontinuedhyperglycemic(osmotic)diuresis.The patient’sinabilitytodrinkenoughfluids(eitherduetolackofaccessin elderly/bedriddenpatientsortoaninadequatethirstdrive)tokeepupwith urinaryfluidlossesexacerbatesthecondition.

c. PrecipitatingeventsaresimilartothoseofDKA.

Quick HIT

ComplicationsofTreatmentofDKA

e

¢

Cerebraledema—ifglucoselevelsdecreasetoorapidly Hyperchloremicnongapmetabolicacidosis—duetorapidinfusionofalargeamountofsaline

Quick HIT

Anumberofnameshavebeenusedforthisclinicalentity,includingHHNS,hyperosmolarhyperglycemic nonketoticcoma(HHNC),andhyperosmolarnonacidoticdiabetes.

TABLE4-6 DiabeticKetoacidosisVersusHyperosmolarHyperglycemic NonketoticSyndrome
======================================
2. Clinicalfeatures a. Thirst,polyuria b. Signsofextremedehydrationandvolumedepletion—hypotension,tachycardia c. CNSfindingsandfocalneurologicsignsarecommon(e.g.,seizures)—

secondarytohyperosmolarity.

d. Lethargyandconfusionmaydevelop,leadingtoconvulsionsandcoma.

Quick HIT

HHNShasahighermortalityratethanDKA,butitislesscommonthanDKA.ThismaybebecausemanyHHNS

patientsareelderlywithothercomorbidconditions(e.g.,heart,renal,orpulmonarydisease).

3. Diagnosis

a. Hyperglycemia:serumglucosetypicallyhigherthanDKAandfrequently>900 mg/dL.

b. Hyperosmolarity:serumosmolarity>320mOsm/L. c. SerumpH>7.3(noacidosis);serumHCO3 d. BUNisusuallyelevated.Prerenalazotemiaiscommon.

4. Treatment

a. Fluidreplacementismostimportant(normalsaline):1Linthefirsthour, anotherliterinthenext2hours.Mostpatientsrespondwell.Switchtohalf normalsalineoncethepatientstabilizes.

¢

e

e

Glucoselevelsareloweredasthepatientisrehydrated,butthepatientstill requiresinsulin.Whenglucoselevelsreach300mg/dL,add5%glucose(D5 1/2NS).NotedifferenceingoalfromDKA. Veryrapidloweringofbloodglucosecanleadtocerebraledemainchildren (justasinDKA). Inpatientswithcardiacdiseaseorrenalinsufficiency,avoidvolumeoverload (canleadtoCHF),butgenerousfluidsarestillneeded.

b. Insulin:ChecktoensureserumK>3.3priortoinitiating.Aninitialbolusof0.1 U/kgasIVbolus,followedbyacontinuouslow-doseinfusion(0.1U/kg/hr)is usuallyappropriate.

Quick HIT

KeyFeaturesofHHNS

e

e

e

¢

Severehyperosmolarity(>320mOsm/L) Hyperglycemia(>600mg/dL) Dehydration Acidosisandketosisareabsent(unlikeinDKA)

Obesity

A.GeneralCharacteristics 1. BMI≥30kg/m2 2. Aboutone-thirdofUSpopulationisobese(withanincreasingprevalencein

adults,adolescents,andchildren).

3. Obesityisassociatedwithanincreasedriskofhypertension,dyslipidemia, diabetesmellitus,cardiovasculardisease,andosteoarthritis.

B.Causes 1. Resultofchronicmismatchesinenergybalance(energyintake>energy

expenditure)

2. Energybalancedeterminedbyseveralvariables,includingmetabolicrate, appetite,diet,andphysicalactivity.

3. Thesefactorsthatdetermineenergybalanceareinfluencedbybothgenetictraits andenvironmentalbehaviors(suchasexcessivefoodintake,decreasedphysical activity).

4. Drug-induced(lesscommon)—glucocorticoids,antipsychotics,antidepressants, oralhypoglycemics,andantiepileptics

5. NeuroendocrinedisorderssuchasCushingsyndromeandpolycysticovarian syndrome(PCOS)
======================================
Quick HIT

BMIClassification:

Underweight—BMI<18.5kg/m2 Normalweight—BMI≥18.5kg/m2and<25kg/m2 Overweight—BMI≥25kg/m2and<30kg/m2 Obese—BMI≥30kg/m2 Severeobesity—BMI≥40kg/m2

C.Diagnosis 1. Alladultsshouldbescreenedbymeasuringheight,weight,andcalculatingbody

massindex(BMI)

2. BMI=bodyweight(kg)/height2(meters) 3. Overweightandobesepatientshouldbefurtherscreenedwithwaist

. Overweight and obese patient should be further screened with waist

circumferencetoassessabdominalobesity.

4. Waistcircumferenceof≥40inchesinmenand≥35inchesinwomenisconsidered elevatedandcorrespondswithanincreasedcardiometabolicrisk.

5. Patientswithabdominalobesityareatincreasedriskforheartdisease,diabetes, hypertension,dyslipidemia,andnonalcoholicfattyliverdisease(NAFLD).

D.Treatment 1. Themaintreatmentforobesityisdietingandphysicalexercise. 2. Medicationsifdietingandphysicalexercisefail.Orlistat(pancreaticlipase inhibitor),lorcaserin(selective5-HT2Creceptoragonist),andcombination phentermineandtopiramate(exactmechanismofactionunknown),have shownsomebenefit.

3. Bariatricsurgeryremainsthemosteffectivetreatmentforobesity.Ithasbeen associatedwithlong-termweightloss,improvementinobesity-related complications,anddecreasedmortality.

4. BariatricsurgeryshouldonlybeattemptedinpatientswithaBMIof40kg/m2or greaterwhohavefailedasufficientexerciseanddietregimen(regardlessofuseof obesitymedication)andwhopresentwithobesity-relatedcomorbidconditions suchashypertension,diabetesmellitus,andhyperlipidemia.

Hypoglycemia

A.GeneralCharacteristics 1. Theprimaryorganatriskinhypoglycemiaisthebrain—Thebrainuses

glucoseasitsmainenergysourceexceptwhenusingketonebodiesduringfasting (seealsoClinicalPearl4-5).

2. Unlikeothertissues,thebraincannotusefreefattyacidsasanenergysource. 3. Hypoglycemiaisreallyduetoanimbalancebetweenglucagonandinsulin. 4. Ifthereisnocorrelationbetweenthesymptomsandlowglucoselevels(e.g.,

patienthassymptomswhenglucoselevelsarenormal),anunderlyingdisorderof glucosemetabolismisunlikely(i.e.,thepatientdoesnothavetruehypoglycemia).
======================================
B.Causes 1. Drug-induced—takingtoomuchinsulinisacommonproblemindiabeticpatients

attemptingtightcontroloftheirdisease.

2. Factitioushypoglycemia

a. Ifthepatienttookinsulinsurreptitiously,therewillbeahighbloodinsulinlevel andalowbloodC-peptidelevelbecauseexogenousinsulindoesnotcontainC- peptide.

b. Patientstakingexogenousinsulinwillalsodevelopanti-insulinantibodies, whichcanbemeasured.

c. Ifthepatienttooksulfonylurea,checkurineorserumforlevelsofthisdrug. d. Insulinoma

3. Ethanolingestion—dueto:

a. Poornutritionthatleadstodecreasedglycogen(andlossofglycogenolysis). b. Metabolismofalcoholthatlowersnicotinamideadeninedinucleotidelevelsand

decreasesgluconeogenesis.

4. Postoperativecomplicationsaftergastricsurgery(duetorapidgastricemptying) 5. Reactive(idiopathic)hypoglycemia—symptomsoccur2to4hoursafterameal;

rarelyindicatesaseriousunderlyingdisorder

6. Adrenalinsufficiency 7. Liverfailure 8. Criticalillness 9. Disordersofcarbohydratemetabolism(e.g.,glycogenstoragediseases)—usually

diagnosedatamuchyoungerage.

CLINICALPEARL4-5

PhysiologicResponsestoHypoglycemia

e

e

Whenglucoselevelsapproachthelow80s,insulinlevelsdecrease—Thisdecreaseisnormallyenoughto preventhypoglycemia. Asglucoselevelsdecreasefurther,glucagonlevelsincrease.Glucagonisthefirstlineofdefenseagainst moreseverehypoglycemia. Epinephrineisthenexthormonetocombathypoglycemia.Cortisolandothercatecholaminesalsoplayarole. Asglucoselevelsdecreaseintothe50sandbelow,symptomsbegin.

Quick HIT

Ifapatientpresentswithhypoglycemiaofunknowncause,measure:

e

«

e

e

Plasmainsulinlevel C-peptide Anti-insulinantibodies Plasmaandurinesulfonylurealevels

Quick HIT

HypoglycemicUnawareness

e

e

Indiabeticpatients,ifsevereneuropathyispresent,theautonomicresponse(epinephrine)tohypoglycemiais notactivated.Thisleadstoneuroglycopenicsymptoms. Itiscommonfordiabeticpatientstobecomehypoglycemicwithconventionaltherapy(insulinororal hypoglycemics).Withlongstandingdiseaseinwhichtheylosetheirneurogenicsymptomresponseto hypoglycemia,patientsdonotrecognizetheimpendinghypoglycemiaandmayevenhaveaseizureorentera coma.

C.ClinicalFeatures 1. Symptomsoccuratabloodglucoselevelof40to50mg/dL. 2. Elevatedepinephrinelevelscausesweating,tremors,increasedBPandpulse,

anxiety,andpalpitations.

3. Neuroglycopenicsymptoms—decreasedglucoseforthebrain(CNSdysfunction), resultinginirritability,behavioralchanges,weakness,drowsiness,headache, confusion,convulsions,coma,andevendeath.
======================================
D.Diagnosis 1. Bloodglucoselevel—Symptomsgenerallybeginwhenlevelsdropbelow50.

However,thereisnocutoffvaluetodefinehypoglycemia.

2. Whippletriadisusedtodiagnosetruehypoglycemia(i.e.,hypoglycemiadueto underlyingdisease).(SeetheInsulinomasection.)

3. Laboratorytests—formeasurementofseruminsulin,C-peptide,andglucose whensymptomsoccur.Anovernightfastmaybesufficienttoproducesymptoms.

4. 72-hourfast(24hoursisusuallysufficient)—usedtodiagnoseinsulinomaif suspected.

E.Treatment

1. Acutetreatmentofhypoglycemia.

a. Ifthepatientcaneat,givesugar-containingfoods;ifnot,give1/2to2ampules ofD50Wintravenously.

b. RepeatadministrationofD50Wasnecessary,butswitchtoD10Wasclinical

conditionimprovesandglucoselevelisapproximately>100mg/dL. 2. Appropriatemanagementofunderlyingcause(e.g.,diabetes,insulinoma). 3. Ifreactivehypoglycemiaissuspected,dietaryinterventionsareappropriate. 4. Ifthepatientisanalcoholic(orsuspectedalcoholic),givethiaminebefore

administeringglucosetoavoidWernickeencephalopathy.

Insulinoma

A.GeneralCharacteristics 1. Insulin-producingtumorarisingfromtheβ-cellsofthepancreas 2. AssociatedwithMENIsyndrome 3. Usuallybenign(inupto90%ofthecases)

B.ClinicalFeatures Hypoglycemia,whichleadsto: 1. Sympatheticactivation—diaphoresis,palpitations,tremors,highbloodpressure,

anxiety

2. Neuroglycopenicsymptoms—headache,visualdisturbances,confusion,seizures, coma

C.Diagnosis 1. 72-hourfast(seealsoTable4-7).

a. Thepatientbecomeshypoglycemic.Normally,theinsulinlevelshoulddecrease ashypoglycemiadevelops.

b. Inpersonswithinsulinoma,insulindoesnotrespondappropriatelyto hypoglycemia.Itmaydecreaseorincrease,oritmaynotchange.Nevertheless, theinsulinlevelsarestillhigherthantheywouldbeinanormalindividualfor anygivenglucoseconcentration.

2. Whippletriad.

a. Hypoglycemicsymptomsbroughtonbyfasting. b. Bloodglucose<50mg/dLduringsymptomaticattack. c. Glucoseadministrationbringsreliefofsymptoms.

3. Elevatedfastingseruminsulinlevel.C-peptidelevelsshouldalsobeelevated, whichdistinguishesinsulinomafromexogenousinsulinadministration.

TABLE4-7 LaboratoryValuesinHyperinsulinemicHypoglycemia 

Insulinoma t i i T Surreptitious insulin stele a) J Lt Sulfonylurea abuse 7 I ? Normal
======================================
D.Treatment

Surgicalresectionoftumor(upto80%to90%curerate)

Zollinger–EllisonSyndrome(ZES,Gastrinoma)

Apancreaticisletcelltumorthatsecreteshighgastrin,whichleadstoprofound gastricacidhypersecretion,resultinginulcers. Upto60%aremalignant;20%associatedwithMENI(80%aresporadic);90% locatedinthe“gastrinomatriangle”(formedbythefollowingpoints:cysticduct superiorly,junctionofsecondandthirdportionsoftheduodenuminferiorly,and neckofpancreasmedially). Possiblecomplications:GIhemorrhage,GIperforation,gastricoutlet obstruction/stricture,andmetastaticdisease(liveristhemostcommonsite). Clinicalfeatures:pepticulcers,diarrhea,weightloss,abdominalpain. Secretininjectiontestisdiagnostictestofchoice.Normally,secretininhibitsgastrin secretion.InpatientswithZES,gastrinlevelsincreasesubstantiallyafterbeing givensecretin. FastinggastrinleveliselevatedinpatientswithZES. Normalbasalacidoutputis<10mEq/hr;inpatientswithZES,itis>15mEq/hr. Treatmentconsistsofhigh-doseprotonpumpinhibitors. AllpatientswithZESshouldundergoexplorationtoattemptcurativeresection(20% ofpatientsarecuredwithcompleteresection).Ifthereiswidelymetastaticor incurablegastrinoma,debulkingsurgeryandchemotherapyareindicated.

Glucagonoma

Aglucagon-producingtumorlocatedinthepancreas. Clinicalmanifestationsincludenecrotizingmigratoryerythema(usuallybelowthe waist),glossitis,stomatitis,DM(mild),andhyperglycemia(withlowaminoacid levelsandhighglucagonlevels). Treatmentissurgicalresection.

Somatostatinoma

Arare,malignantpancreatictumor;metastasesusuallyarepresentbydiagnosis. Poorprognosis Classictriadofgallstones,diabetes,andsteatorrhea

VIPoma(Verner–MorrisonorWateryDiarrhea,Hypokalemia, AchlorhydriaSyndrome)

Ararepancreatictumor(>50%aremalignant). Clinicalfeaturesincludewaterydiarrhea(leadingtodehydration,hypokalemia, acidosis),achlorhydria(VIPinhibitsgastricacidsecretion),hyperglycemia,and hypercalcemia. Treatmentissurgicalresection.

DiseasesoftheThyroidGland Hyperthyroidism

A.Causes 1. Gravesdisease(diffusetoxicgoiter)isthemostcommoncause—80%ofall

cases.

a. Anautoimmunedisorder:Athyroid-stimulatingimmunoglobulin(IgG)antibody bindstotheTSHreceptorsonthesurfaceofthyroidcellsandtriggersthe synthesisofexcessthyroidhormone.

b. Seenmostofteninyoungerwomen.Commonlyassociatedwithother autoimmunedisorders.

c. Aradioiodidescanshowsdiffuseuptakebecauseeverythyroidcellis hyperfunctioning.
======================================
2. Plummerdisease(multinodulartoxicgoiter)—15%ofallcases.

a. CharacterizedbyhyperfunctioningareasthatproducehighT4andT3levels, therebydecreasingTSHlevels.Asaresult,therestofthethyroidisnot functioning(atrophyduetodecreasedTSH).

b. Consequently,patchyuptakeappearsonthethyroidscan. c. Morecommoninelderlypatients,andmorecommoninwomenthanmen.

3. Toxicthyroidadenoma(singlenodule)—2%ofallcases. 4. Hashimotothyroiditisandsubacute(granulomatous)thyroiditis(bothcancause

transienthyperthyroidism).

5. Othercauses(rare)

a. Postpartumthyroiditis(transienthyperthyroidism) b. Iodine-inducedhyperthyroidism c. Excessivedosesoflevothyroxine(e.g.,iatrogenicbyhealthcareprovideror

surreptitiousself-administration)

Quick HIT

HyperthyroidismintheElderly

e

¢

Intheelderly,classicsymptomsofhyperthyroidism(e.g.,nervousness,insomnia,hyperactivity)maybe absent.Theonlymanifestationsmaybeweightloss,weakness,and/oratrialfibrillation. Considerhyperthyroidismbeforeassumingthatanelderlypatientwithunexplainedweightlosshas depressionoroccultmalignancy.

B.ClinicalFeatures 1. Symptoms

a. Nervousness,insomnia,irritability b. Handtremor,hyperactivity,tremulousness c. Excessivesweating,heatintolerance d. Weightlossdespiteincreasedappetite e. Diarrhea f. Palpitations(duetotachyarrhythmias) g. Muscleweakness

Quick HIT

TherearethreesignsofhyperthyroidismspecifictoGravesdisease:

e

e

e

Exophthalmos Pretibialmyxedema Thyroidbruit

2. Signs

a. Thyroidgland

Gravesdisease:adiffuselyenlarged(symmetric),nontenderthyroidgland;a bruitmaybepresent. Subacutethyroiditis:anexquisitelytender,diffuselyenlargedgland(witha viralillness). PlummerdiseaseandHashimotothyroiditis(ifmultinodularityispresent): thyroidglandisbumpy,irregular,andasymmetric. Toxicadenoma:singlenodulewithanotherwiseatrophicgland.

b. Extrathyroidal

Eyes:Proptosis,duetoedemaoftheextraocularmusclesandretro-orbital tissue,isahallmarkofGravesdisease(butnotalwayspresent).Irritationand excessivetearingarecommonduetocornealexposure.Lidretractionmaybe theonlysigninmilderdisease(Figure4-4).Lidlagmaybepresent. Cardiovasculareffects:arrhythmias(sinustachycardia,atrialfibrillation,and prematureventricularcontractions),elevatedBP Skinchanges:warmandmoist,pretibialmyxedema(edemaovertibial surfaceduetodermalaccumulationofmucopolysaccharides) Neurologic:briskdeeptendonreflexes,tremor
======================================
FIGURE 4.4

Exophthalmos(thyrotoxicosis).

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Photo25.9.)

C.Diagnosis 1. SerumTSHlevel(low)—initialtestofchoice:IfTSHisnormalorhigh,

hyperthyroidismisunlikely.(TSH-inducedhyperthyroidismisquiteuncommon.)

2. Nextorderthyroidhormonelevels:T4levelshouldbeelevated. 3. TestingtheT3levelisusuallyunnecessarybutmaybehelpfulifTSHlevelislow andfreeT4isnotelevated,becauseexcessT3alonecancausehyperthyroidism.

4. Othertests(lesscommonlyusedbutoftentested).

a. RadioactiveT3uptake.

e

e

e

¢

Givesinformationregardingthestatusofthyroid-bindingglobulin(TBG). Thepatientisgiven“resin”andradioactiveT3.RadioactiveT3willonlybind totheresinwhenthereisno“space”leftonTBG.Bymeasuringhowmuch radioactiveT3bindstotheresin,youaremeasuringhowmuchTBGis availabletobind.Forexample,iflargeamountsofradioactiveT3arebinding totheresin,thefewer“unoccupied”spotsareavailableonTBG;thiscanbe seeninhyperthyroidismwhenhighlevelsofT4“occupy”thoseTBGsites. Theimportanceofthistestisthatithelpsdifferentiatebetweenelevations inthyroidhormonesduetoincreasedTBGfromtruehyperthyroidism (duetoanactualincreaseinfreeT4). ConsiderhyperthyroidismwhenthethyroidglandisproducingexcessT4. Inthiscase,allofthebindingsitesonTBGwillbeboundbyT4,soradioactive T3uptakewillincrease.

ConsiderpregnancywhenthereishighTBG.Therearemorebindingsites forradioactiveT3,soradioactiveT3uptakedecreases.Therefore,highTBG productionleadstolowradioactiveT3uptake.

b. Freethyroxineindex(FTI).

e

e

e

e¢

FTIisproportionaltoactualfreeT4concentration;itiscalculatedtocorrectfor changesinthyroidbindingproteins. FTI=(radioactiveT3uptakexserumtotalT4)/100. FTI=(patient’sradioactiveT3uptake/normalradioactiveT3uptake)×totalT4. NormalFTIvaluesare4to11.FTIshouldnotchange(asT4decreases, radioactiveT3uptakeincreasesandviceversa). InfrequentlyorderedduetonewermethodsofmeasuringfreeT4directly.

e

Quick HIT

ThyroidHormonesandTBG

T4isconvertedtoT3bydeiodinationoutsideofthethyroid. T3ismorebiologicallyactivethanT4. MostofT4(andT3)isreversiblyboundtoTBGandisinactive. FactorsthatincreaseTBG(andthereforetotalT4)includepregnancy,liverdisease,oralcontraceptives,and aspirin.
======================================
D.TreatmentTypes 1. Pharmacologic

a. Thionamides—Methimazoleandpropylthiouracil(PTU)inhibitthyroid hormonesynthesis,andPTUalsoinhibitsconversionofT4toT3.Treatment withthionamidesresultsinlong-termremissioninaminorityofpatients;a majorserioussideeffectisagranulocytosis.Othersideeffectssharedbyboth methimazoleandPTUincludeskinrash,arthralgias,andhepatotoxicity. b. β-Blockers—foracutemanagementofsomesymptomssuchaspalpitations,

tremors,anxiety,tachycardia,sweating,andmuscleweakness.

c. Sodiumipodateoriopanoicacid—lowersserumT3andT4levelsandcauses rapidimprovementofhyperthyroidism;appropriateforacutemanagementof severehyperthyroidismthatisnotrespondingtoconventionaltherapy.

Quick HIT

Forallpatientstakingantithyroidmedication,considermonitoringtheleukocytecountforagranulocytosisona regularbasis.

2. Radioiodine131(131I).

a. Causesdestructionofthyroidfollicularcells. b. MostcommontherapyintheUnitedStatesforGraveshyperthyroidism. c. Maincomplicationishypothyroidismandoccursinmajorityofpatients. d. Ifthefirstdosedoesnotcontrolthehyperthyroidismwithin6to12months,then

administeranotherdose.

e. Contraindicatedduringpregnancyandbreastfeedingduetoriskofcretinism (stuntedphysicalandmentalgrowthfromseverehypothyroidism).

Quick HIT

Thyroidcellsaretheonlycellsinthebodythatabsorbiodine.Therefore,givingradioactiveiodinedestroysonly thyroidcells.

3. Surgical—subtotalthyroidectomy.

a. Veryeffective,butonly1%ofpatientswithhyperthyroidismaretreatedwith surgeryduetothefollowingsideeffects:permanenthypothyroidism(30%), recurrenceofhyperthyroidism(10%),recurrentlaryngealnervepalsy(1%),and permanenthypoparathyroidism(1%).

b. Oftenreservedforpatientswithverylargegoiters(morecommonintoxic multinodulargoiter),thosewhoareallergictoantithyroiddrugs,orpatientswho prefersurgeryovermedication.

c. Watchforclinicalmanifestationsofhypocalcemiaaftersurgerythatmaynot returntonormalduetoparathyroidinflammationoraccidentalremoval.

E.Treatment 1. Forimmediatecontrolofadrenergicsymptomsofhyperthyroidism(ofanycause):

β-blocker(propranolol).

2. FornonpregnantpatientswithGravesdisease.
======================================
a. Startmethimazole(inadditiontotheβ-blocker). b. Taperβ-blockerafter4to8weeks(oncemethimazolestartstotakeeffect). c. Continuemethimazolefor1to2years.Measurethyroid-stimulatingIgG

antibodyat12months.Ifitisabsent,thendiscontinuetherapy.Ifrelapseoccurs, thenresumemethimazoleforabout1moreyearorconsiderradioiodinetherapy.

3. ForpregnantpatientswithGravesdisease.

a. Endocrinologyconsultisindicatedbeforestartingtreatment. b. PTUispreferred.

4. Radioactiveiodineablationtherapy.

a. Leadstohypothyroidismovertimeinmanypatients. b. Considertherapywith131Iforthefollowingpatients:

ElderlypatientswithGravesdisease.

e

e

Patientswithasolitarytoxicnodule. PatientswithGravesdiseaseinwhomtherapywithantithyroiddrugsfails (e.g.,duetorelapse,agranulocytosis).

ThyroidStorm

Thisisarare,life-threateningcomplicationofthyrotoxicosischaracterizedbyan acuteexacerbationofthemanifestationsofhyperthyroidism. Thereisusuallyaprecipitatingfactor,suchasinfection,DKA,orstress(e.g.,severe trauma,surgery,illness,childbirth). Highmortalityrate:upto20%ofpatientsenteracomaordie. Clinicalmanifestationsincludemarkedfever,tachycardia,agitationorpsychosis, confusion,andGIsymptoms(e.g.,nausea,vomiting,diarrhea). ProvidesupportivetherapywithIVfluids,coolingblankets,andglucose. Giveantithyroidagents(PTUevery2hours).Followwithiodinetoinhibitthyroid hormonerelease. Administerβ-blockersforcontrolofheartrate.Givedexamethasonetoimpair peripheralgenerationofT3fromT4andtoprovideadrenalsupport.

Quick HIT

Thetermshyperthyroidismandthyrotoxicosisareinterchangeableandrefertohyperfunctioningthyroiddisease. Thyroidstormisamedicalemergencywithlife-threateningsequelae.

CLINICALPEARL4-6

MyxedemaComa

e

Arareconditionthatpresentswithadepressedstateofconsciousness,profoundhypothermia,andrespiratory depression. Maydevelopafteryearsofsevereuntreatedhypothyroidism. Precipitatingfactorsaretrauma,infection,coldexposure,andnarcotics. Amedicalemergency,withahighmortalityrate(50%to75%)evenwithtreatment. ProvidesupportivetherapytomaintainBPandrespiration.GiveIVthyroxineandhydrocortisonewhile carefullymonitoringthehemodynamicstate.
======================================
Hypothyroidism

A.GeneralCharacteristics 1. Theonsetofsymptomsisusuallyinsidious,andtheconditionmaygoundetected

foryears(seealsoClinicalPearl4-6).

2. Sometimesadiagnosisismadesolelyonlaboratoryevidenceinanasymptomatic patient.

B.Causes 1. Primaryhypothyroidismisthefailureofthethyroidtoproducesufficientthyroid

hormone.Thisaccountsforabout95%ofallcases.

a. Hashimotodisease(chronicthyroiditis)—mostcommoncauseofprimary hypothyroidism.

b. Iatrogenic—secondmostcommoncauseofprimaryhypothyroidism;results frompriortreatmentsofhyperthyroidism,including:

e

e

e

Radioiodinetherapy Thyroidectomy Medications(e.g.,lithium)

2. Secondaryhypothyroidism(duetopituitarydisease;i.e.,deficiencyofTSH)and tertiaryhypothyroidism(duetohypothalamicdisease;i.e.,deficiencyofTRH) accountforlessthan5%ofcases.BothareassociatedwithalowfreeT4anda lowTSHlevel.

Quick HIT

Hashimotothyroiditisisassociatedwithotherautoimmunedisorders(e.g.,lupus,perniciousanemia). PatientswithHashimotothyroiditisareatanincreasedriskofthyroidcarcinomaandthyroidlymphoma.

C.ClinicalFeatures 1. Symptoms

a. Fatigue,weakness,lethargy b. Heavymenstrualperiods(menorrhagia),slightweightgain(10to30lb)—

patientsarenottypicallyobese

c. Coldintolerance d. Constipation e. Slowmentation,inabilitytoconcentrate(mildatfirst,inlaterstagesdementia

e. Slow mentation, inability to concentrate (mild at first, in later stages dementia can occur), dull expression

canoccur),dullexpression f. Muscleweakness,arthralgias g. Depression

h. Diminishedhearing

2. Signs

a. Dryskin,coarsehair;thickened,puffyfeatures b. Hoarseness c. Nonpittingedema(edemaduetoglycosaminoglycanininterstitialtissues,not

waterandsalt)

d. Carpaltunnelsyndrome e. Slowrelaxationofdeeptendonreflexes f. Lossoflateralportionofeyebrows g. Bradycardia h. Goiter(Hashimotodisease—goiterisrubbery,nontender,andevennodular; subacutethyroiditis—goiterisverytenderandenlarged,althoughnotalways symmetrically.)

i. Historyofupperrespiratoryinfectionandfever(subacutethyroiditis).
======================================
CLINICALPEARL4-7

SubclinicalHypothyroidism

Thyroidfunctionisinadequate,butincreasedTSHproductionmaintainsT4levelwithinthereferencerange ofnormalcy;therefore,TSHleveliselevatedandT4levelisnormal. Lookfornonspecificormildsymptomsofhypothyroidism,aswellaselevatedserumLDLlevels. Treatwiththyroxineifpatientsdevelopgoiter,hypercholesterolemia,symptomsofhypothyroidism, significantlyelevatedTSHlevel(>10μU/mL),orwomenattemptingpregnancy.

D.Diagnosis 1. HighTSHlevel—mostsensitiveindicatorofhypothyroidism(seealsoClinical

Pearl4-7).

2. LowTSHlevelinsecondaryhypothyroidism. 3. LowfreeT4level(orfreeT4index)inpatientswithclinicallyovert

Low free Ty level (or free T, index) in patients with clinically overt hypothyroidism. Free T, may be normal in subclinical cases.

hypothyroidism.FreeT4maybenormalinsubclinicalcases. 4. Increasedantimicrosomalantibodies(Hashimotothyroiditis). 5. Otherlaboratoryvalueabnormalitiesthatmaybepresent:

a. ElevatedLDLanddecreasedHDLlevels. b. Anemia—mildnormocyticanemiaisthemostcommon.

Quick HIT

TSHistheprimarytestinscreeningforthyroiddysfunction.AlsoorderalipidprofileandaCBC.

E.Treatment

Levothyroxine(T4)—treatmentofchoice 1. Effectisevidentin2to4weeks;highlyeffectiveinachievingeuthyroidstate. 2. Convenientonce—dailymorningdose. 3. Treatmentiscontinuedindefinitely. 4. MonitorTSHlevelandclinicalstateperiodically.

Thyroiditis

A.Subacute(Viral)Thyroiditis(subacutegranulomatousthyroiditis) 1. Causes—usuallyfollowsaviralillness;associatedwithHLA-B35 2. Clinicalfeatures

a. Prodromalphasethatlastsafewweeks(fever,flu-likeillness) b. Itcancausetransienthyperthyroidismduetoleakageofhormonefrominflamed thyroidgland.Thisisfollowedbyaeuthyroidstateandthenahypothyroidstate (ashormonesaredepleted).

c. Painful,tenderthyroidgland(maybeenlarged).

3. Diagnosis

a. Radioiodineuptakeislowbecausethyroidfollicularcellsaredamagedand cannottrapiodine.

b. LowTSHlevelsecondarytosuppressionbyincreasedT4andT3levels;high erythrocytesedimentationrate(ESR).

4. Treatment

a. UseNSAIDsandaspirinformildsymptoms;corticosteroids,ifthepainismore severe.

b. Mostpatientshaverecoveryofthyroidfunctionwithinafewmonthsto1year.
======================================
B.SubacuteLymphocyticThyroiditis(painlessthyroiditis,silentthyroiditis) 1. Atransientthyrotoxicphaseof2to5monthsmaybefollowedbyahypothyroid

phase.Thehypothyroidphaseisusuallyself-limitedandmaybetheonly manifestationofthisdiseaseifthehyperthyroidphaseisbrief.

2. Lowradioactiveiodineuptake—differentiatesitfromGravesdiseaseduring thyrotoxicphase.

3. Similartosubacute(viral)thyroiditis,onlywithoutthepainortendernessofthe thyroidgland.

CLINICALPEARL4-8

Thyroid-AssociatedOphthalmopathy(TAO)

e

¢

e

¢

TAOisanautoimmuneattackontheperiorbitalconnectivetissueandextraocularmuscles. Clinicalfindingsincludelidretraction(“thyroidstare”),proptosis,eyelidedema,lagophthalmos(inabilityto closeeyelidscompletely),anddiplopia. Patientsmaybehypothyroid,hyperthyroid(Gravesdisease),oreuthyroidwhenTAOpresents.Most euthyroidpatientswillgoontodevelopthyroiddysfunctionwithin2yearsofdevelopingTAO. TreatmentofthyroiddysfunctionhaslittleeffectonthecourseofTAO.TAOisusuallyself-limited,but surgerymayberequiredifdiseaseissevere.Oralsteroidsmayalsobehelpful.

C.ChronicLymphocyticThyroiditis(Hashimotothyroiditis,lymphocytic thyroiditis)

1. Mostcommoncauseofautoimmunethyroiddisorder;morecommoninwomen. 2. Causes

a. Geneticcomponent—familyhistoryiscommon. b. Antithyroidantibodiesarepresentinthemajorityofpatients.

3. Clinicalmanifestations(seealsoClinicalPearl4-8)

a. Goiteristhemostcommonfeature. b. Slowdeclineinthyroidfunctioniscommon.Hypothyroidismispresentin20%

ofcaseswhenfirstdiagnosedbutoftenoccurslaterindisease.

4. Diagnosis

a. Thyroidfunctionstudiesarenormal(unlesshypothyroidismispresent). b. Antithyroidantibodies:antiperoxidaseantibodies(presentin90%ofpatients),

antithyroglobulinantibodies(presentin50%).

c. Irregulardistributionof131Ionthyroidscan—notrequiredfordiagnosis.

5. Treatment—thyroidhormone(toachieveeuthyroidstate)

D.FibrousThyroiditis(Riedelthyroiditis) 1. Fibroustissuereplacesthyroidtissue,leadingtoafirmthyroid. 2. Surgerymaybenecessaryifcomplicationsoccur. 3. Patientmaybehypothyroidaswell,inwhichcasethyroidhormoneshouldbe

prescribed.
======================================
ThyroidNodules

A.GeneralCharacteristics 1. Cancerisfoundin4%to10%ofnodulesthatareinvestigated. 2. Asolitarynodulecanbeeitherthyroidcancerorabenignadenoma.However,

multinodularconditionsmaycauseconfusionbecauseonlyoneofthesenodules maybepalpable.

3. Themostimportantfunctionofthephysicalexaminationisthedetectionofthe thyroidnodule,ratherthanthedeterminationofitsbenignormalignantstatus.

4. Tobedetectableonpalpation,anodulemustbeatleast1cmindiameter. 5. Malignancyissuggestedbythefollowing:

a. Ifthenoduleisfixedinplaceandnomovementoccursonswallowing b. Unusuallyfirmconsistencyorirregularityofthenodule c. Ifthenoduleissolitary d. Historyofradiationtherapytotheneck e. Historyofrapiddevelopment f. Vocalcordparalysis(recurrentlaryngealnerveparalysis) g. Cervicaladenopathy h. Elevatedserumcalcitonin i. Familyhistoryofthyroidcancer

CLINICALPEARL4-9

Fine-NeedleAspiration

e

PatientshouldfirstbeevaluatedwithultrasoundandTSHlevel. Aneedleisinsertedintothenodule,andcellsareaspiratedandthenexaminedunderamicroscope. False-positiveandfalse-negativeratesapproach5%. Thisistheonlytestthatcanreliablydifferentiatebetweenbenignandmalignantnodules. Ultrasounddifferentiatesbetweensolidandcysticnodules,buteithermaybemalignant. Onthethyroidscan,“cold”nodulesaremorelikelytobemalignantthan“hot,”butthisisnotreliable. FNAfindings: Probablecancer(15%):Mostofthesearereallycancers.Surgeryisindicated. Indeterminate(19%):Athyroidscanshouldbeperformed,andifthelesionis“cold”bythescan,surgical resectionisindicatedbecauseabout20%oftheselesionsarefoundtobemalignant. Benign(66%):Mostofthesearebenign.Observefor1year,thenfollowupwithanultrasound. Follicularneoplasm:Surgeryisrecommendedbecauseitisdifficulttodistinguishbetweenbenignand malignantfollicularcellsonhistology.

B.Diagnosis 1. Initialworkupshouldincludehistory,physicalexam,ultrasoundofneckand

TSH.

2. Fine-needleaspiration(FNA)biopsy(seealsoClinicalPearl4-9)

a. FNAhasasensitivityof95%andaspecificityof95%.Therefore,ifFNAshows abenignnodule,thenoduleislikelytobebenign.

b. However,FNAbiopsieshave5%false-negativeresults,sofollowupwith periodicFNAifthyroidnodularitypersists.Benignlesionsshouldcontinueto showconsistentlybenigncytology.

c. FNAisreliableforallcancers(papillary,medullary,anaplastic)except follicular.

3. Thyroidscan(radioactiveiodine)(Figure4-5)

a. Thyroidscanplaysasupplementalrole.ItisperformediftheFNAbiopsyis indeterminate.ItisalsoperformedinpatientswithalowTSH,asthesepatients aremorelikelytohaveahyperfunctioningnodule.

b. Itgivesgraphicrepresentationsofthedistributionofradioactiveiodineinthe gland—usefulinidentifyingwhetherthyroidnodulesshowdecreased(“cold”) orincreased(“hot”)accumulationofradioactiveiodinecomparedwithnormal paranodulartissue.Nodulesareclassifiedas“cold”(hypofunctional),“warm” (normallyfunctioning),or“hot”(hyperfunctional).

c. ItshouldbelimitedtopatientswhoseFNAbiopsyresultssuggestneoplasm.(It isnotcosteffectivetoscanallpatientswiththyroidnodules.)Whensuchlesions are“cold”onscan,thyroidlobectomyisrecommended.
======================================
FIGURE 4.5

A123Ithyroidscanshowingalarge“cold”nodule(arrow).

(FromFishmanMC,HoffmanAR,KlausnerRD,etal.Medicine.5thed.Philadelphia,PA:

LippincottWilliams&Wilkins;2004:185,Figure22-1.)

4. Thyroidultrasound

a. Differentiatesasolidfromacysticnodule;mostcancersaresolid. b. Canidentifynodules1to3mmindiameter. c. Cysticmasseslargerthan4cmindiameterarenotmalignant. d. Cannotdistinguishbetweenbenignandmalignantthyroidnodules.

ThyroidCancer

A.GeneralCharacteristics 1. Riskfactors

a. Headandneckradiation(duringchildhood) b. GardnersyndromeandCowdensyndromeforpapillarycancer c. MENtypeIIformedullarycancer

Quick HIT

Ingeneral,mostpatientswiththyroidcancerdonotdieofthyroidcancer(althoughthisdependsonthetypeof thyroidcancer).

2. Types(seealsoClinicalPearl4-10)

a. Papillarycarcinoma

Accountsfor70%to80%ofallthyroidcancers Leastaggressivethyroidcancer—slowgrowthandslowspreadingwith excellentprognosis. Mostimportantriskfactorisahistoryofradiationtothehead/neck. Spreadsvialymphaticsinneck;frequentlymetastasizestocervicallymph nodes(cervicallymphadenopathy);distantmetastasisisrare. Positiveiodineuptake

b. Follicularcarcinoma

Accountsfor15%ofallthyroidcancers;avidlyabsorbsiodine. Prognosisisworsethanforpapillarycancer—itspreadsearlyviaa hematogenousroute(brain,lung,bone,liver).Distantmetastasisoccursin 20%ofpatients;lymphnodeinvolvementisuncommon. Maybeassociatedwithiodinedeficiency. Tumorextensionthroughthetumorcapsuleorvascularinvasiondistinguishes itfromabenignadenoma.Atissuesampleisthereforeneededfordiagnosis. Moremalignantthanpapillarycancer,butthesearealsoslowgrowing. OnevariantistheHürthlecellcarcinoma—characteristiccellscontain abundantcytoplasm,tightlypackedmitochondria,andovalnucleiwith prominentnucleoli.Thesetumorsareradioiodineresistant.

c. Medullarycarcinoma

Accountsfor2%to3%ofallthyroidcancers One-thirdsporadic,one-thirdfamilial,one-thirdassociatedwithMENII (alwaysscreenforpheochromocytoma) Arisesfromtheparafollicularcells(Ccells)—producescalcitonin

Moremalignantthanfollicularcancerbutlesssothananaplasticcancer— survivalofapproximately10years
======================================
Quick HIT

HürthleCellTumor

e

e

e

Avariantoffollicularcancerbutmoreaggressive. Spreadbylymphatics;doesnottakeupiodine. Treatment:totalthyroidectomy.

Quick HIT

Papillarycarcinomaisthemostcommontypeofthyroidcancertodevelopafterradiationexposure(accounts for80%to90%ofpostradiationcancersofthethyroid).

CLINICALPEARL4-10

Nodules

“Cold”Nodules

“Hot”Nodules

e

¢

¢

Decreasediodineuptake=hypofunctioningnodule. Significantriskofmalignancy—approximately20%ofcoldnodulesaremalignant. Ofallnodules,70%to90%arecoldandmostofthesearebenign.Therefore, scanningmayindicateagreatlyreducedriskofmalignancyinanodulethatiswarm orhot,butitdoesnotyieldmuchadditionalinformationinanodulethatiscold.

e

e

Increasediodine uptake= hyperfunctioning nodule. Rarely associatedwith malignancy.

d. Anaplasticcarcinoma

Accountsfor5%ofallthyroidcancers;mostlyseeninelderlypatients Highlymalignant Mayarisefromalongstandingfollicularorpapillarythyroidcarcinoma Prognosis(grim)—deathtypicallyoccurswithinafewmonths.Mortalityis usuallyduetoinvasionofadjacentorgans(trachea,neckvessels)

B.Diagnosis 1. Thyroidhormonelevel(frequentlynormal) 2. Calcitoninlevel(ifmedullarycarcinoma) 3. Refertothesectiononthyroidnodulesfordiagnosticapproach.

C.Treatment 1. Papillarycarcinoma

a. Lobectomywithisthmusectomy. b. Totalthyroidectomyiftumoris>3cm,tumorisbilateral,tumorisadvanced,or

distantmetastasesarepresent.

c. Adjuvanttreatment:TSHsuppressiontherapy;radioiodinetherapyforlarger tumors.

2. Follicularcarcinoma—totalthyroidectomywithpostoperativeiodineablation. 3. Medullarycarcinoma—totalthyroidectomy;radioiodinetherapyusually

unsuccessful.Modifiedradicalneckdissectionisalsoindicatedwhenthereis lymphnodeinvolvement(mostcases).

4. Anaplasticcarcinoma—chemotherapyandradiationmayprovideamodest improvementinsurvival.Palliativesurgeryforairwaycompromisemaybe needed.

DiseasesofthePituitaryGland

PituitaryAdenomas

A.GeneralCharacteristics 1. Pituitaryadenomasaccountforabout10%ofallintracranialneoplasms. 2. Almostallpituitarytumorsarebenign.Theymaygrowinanydirectioncausing

“parasellar”signsandsymptoms.

3. Size:microadenoma(diameter≤10mm);macroadenoma(diameter>10mm).
======================================
B.ClinicalFeatures 1. Hormonaleffectsoccurduetohypersecretionofoneormoreofthefollowing

hormones:

a. Prolactin—seethefollowingsectiononhyperprolactinemia b. GH—resultsinacromegaly(orgigantismifepiphysealclosurehasnotoccurred;

seeninthepediatricpopulation)

c. Adrenocorticotropichormone(ACTH)—resultsinCushingdisease d. TSH—resultsinhyperthyroidism

2. Hypopituitarism—compressionofhypothalamic-pituitarystalk;GHdeficiency andhypogonadotropichypogonadismarethemostcommonproblems.

3. Masseffects a. Headache b. Visualdefects—Bitemporalhemianopsia(duetocompressionofopticchiasm) isthemostcommonfinding,butitdependsonthesizeandsymmetryofthe tumor.

C.Diagnosis 1. MRIistheimagingstudyofchoice 2. Pituitaryhormonelevels

D.Treatment 1. Transsphenoidalsurgeryisindicatedinmostpatients(exceptpatientswith

1. Transsphenoidal surgery is indicated in most patients (except patients with prolactinomas, for which medical management can be tried first).

prolactinomas,forwhichmedicalmanagementcanbetriedfirst). 2. Radiationtherapyandmedicaltherapyareadjunctsinmostpatients.

Hyperprolactinemia

A.Causes 1. Prolactinoma

a. Mostcommoncauseofhyperprolactinemia b. Mostcommontypeofpituitaryadenoma(upto40%)

2. Medications(e.g.,psychiatricmedications,H2blockers,metoclopramide, verapamil,estrogen)

3. Pregnancy 4. Renalfailure 5. Suprasellarmasslesions(cancompresshypothalamusorpituitarystalk) 6. Hypothyroidism 7. Idiopathic

Quick HIT

HighlevelsofprolactininhibitsecretionofGnRH.ThisleadstodecreasedsecretionofLHandFSH,whichin turnleadstodecreasedproductionofestrogenandtestosterone(seeClinicalFeatures).

B.ClinicalFeatures 1. Men

a. Hypogonadism,decreasedlibido,infertility,impotence b. Galactorrheaorgynecomastia(uncommon) c. Parasellarsignsandsymptoms(visualfielddefectsandheadaches)

2. Women

a. Premenopausal:menstrualirregularities,oligomenorrheaoramenorrhea, anovulationandinfertility,decreasedlibido,dyspareunia,vaginaldryness,risk ofosteoporosis,galactorrhea

b. Postmenopausal:parasellarsignsandsymptoms(lesscommonthaninmen)
======================================
Quick HIT

Parasellarsignsandsymptoms(masseffectsofthetumor)aremoreprevalentinmenthaninwomen.Thisis largelybecausetheearlysymptomsinmen(e.g.,impotence)areoftenattributedtopsychologicalcausesand medicalevaluationisdelayed,allowingforlargertumorgrowth.

C.Diagnosis 1. Elevatedserumprolactinlevel. 2. OrderapregnancytestandTSHlevel,becausebothpregnancyandprimary hypothyroidismareonthedifferentialdiagnosisforhyperprolactinemia.

3. CTscanorMRItoidentifyanymasslesions.

D.Treatment 1. Treattheunderlyingcause(e.g.,stopmedication,treathypothyroidism). 2. Ifprolactinomaisthecauseandthepatientissymptomatic,treatwith

bromocriptine,adopamineagonistthatsecondarilydiminishestheproduction andreleaseofprolactin.Continuetreatmentforapproximately2yearsbefore attemptingcessation.Cabergoline(anotherdopamineagonist)maybebetter toleratedthanbromocriptineandisoftenchosenasfirst-linetherapy.

3. Considersurgicalinterventionifsymptomsprogressdespiteappropriatemedical therapy.However,therecurrencerateaftersurgeryishigh.

Quick HIT

Microadenomas(<10mmdiameter)tendtoeitherremainthesamesizeorregresswithtime.Only10%to20% continuetogrow.

Acromegaly

A.GeneralCharacteristics 1. Acromegalyisbroadeningoftheskeleton,whichresultsfromexcesssecretionof pituitaryGHafterepiphysealclosure(ifbeforeepiphysealclosure,gigantism [excessiveheight]results).

2. ItisalmostalwayscausedbyaGH-secretingpituitaryadenoma(represents10% ofpituitaryadenomas).

Quick HIT

Cardiovasculardisease(cardiomyopathy)isthemostcommoncauseofdeathinpatientswithacromegaly.

B.ClinicalFeatures 1. Growthpromotion

a. Softtissueandskeletonovergrowth b. Coarseningoffacialfeatures c. Abnormallylargehandandfootsize(askaboutincreasingglove/ringsize) d. Organomegaly e. Arthralgiaduetojointtissueovergrowth f. Hypertrophiccardiomyopathy g. Enlargedjaw(macrognathia)

2. Metabolicdisturbances

a. GlucoseintoleranceandDMin10%to25%ofpatients b. Hyperhidrosis

3. Parasellarmanifestations

a. Headache b. Superiorgrowthleadstocompressionoftheopticchiasm,whichresultsin

visualloss(bitemporalhemianopsia)
======================================
c. Lateralgrowthleadstocavernoussinuscompression d. Inferiorgrowthleadstosphenoidsinusinvasion e. HTN,sleepapnea

Quick HIT

OtherLaboratoryAbnormalitiesinPatientsWithAcromegaly

e

e

Hyperprolactinemia(tumorsecretesprolactinandgrowthhormone)—30%ofpatients Elevationsinserumglucose,triglycerides,andphosphatelevels

C.Diagnosis

1. IGF-1,alsoknownassomatomedinC,shouldbesignificantlyelevatedin acromegaly.

2. Oralglucosesuppressiontest—glucoseloadfailstosuppressGH(asitshouldin healthyindividuals).ThisconfirmsthediagnosisiftheIGF-1levelisequivocal.

3. MRIofthepituitary. 4. ArandomGHlevelisnotusefulbecausethereiswidephysiologicfluctuationof

GHlevels.

D.Treatment 1. Transsphenoidalresectionofpituitaryadenoma—treatmentofchoice 2. RadiationtherapyifIGF-1levelsstayelevatedaftersurgery. 3. OctreotideorothersomatostatinanalogtosuppressGHsecretion

Craniopharyngioma

TumorsofthesuprasellarregionarisingfromembryologicremnantsofRathke pouch. Thesetumorscomprise20%to25%ofallpituitarymasslesions(pituitary adenomaismostcommon). Theyresultinvisualfielddefects(bitemporalhemianopsia)duetocompressionof theopticchiasmandmayalsocauseheadaches,papilledema,andchangesin mentation. TheyarediagnosedbybrainMRI. Theymaycausehyperprolactinemia,diabetesinsipidus,orpanhypopituitarism. Treatmentissurgicalexcision(totalorpartialresection)withorwithoutradiation therapy.

Calcificationofthesuprasellarregionseenonbrainimagingisnearlydiagnosticofcraniopharyngioma.

Hypopituitarism

A.GeneralCharacteristics 1. Allorsomeofthehormonesreleasedfromtheanteriorpituitarymaybeabsent. 2. Lossofhormonesisunpredictable,butLH,FSH,andGHareusuallylostbefore

TSHandACTH.

3. Clinicalmanifestationsdependonwhichhormonesarelost.

B.Causes 1. Hypothalamicorpituitarytumoristhemostcommoncause. 2. Othercauses:radiationtherapy,Sheehansyndrome,infiltrativeprocesses(e.g.,

sarcoidosis,hemochromatosis),headtrauma,cavernoussinusthrombosis,surgery.

C.ClinicalFeatures 1. ReducedGH:growthfailure(decreasedmusclemassinadults),increasedLDL,

increasedriskofheartdisease,increasedLDL

2. Reducedprolactin:failuretolactate 3. ReducedACTH:adrenalinsufficiency 4. ReducedTSH:hypothyroidism 5. Reducedgonadotropins(LHandFSH):infertility,amenorrhea,lossofsecondary

sexcharacteristics,diminishedlibido

6. Reducedantidiuretichormone(ADH)(ifhypothalamiclesion):diabetesinsipidus 7. Reducedmelanocyte-stimulatinghormone(MSH):decreasedskinandhair

pigmentation

D.Diagnosis 1. Lowlevelsoftargethormoneswithlowornormallevelsoftrophichormones(it isthesuppressionofthetrophichormonethatisimportant,althoughtheabsolute levelmaybeinthenormalreferencerange) 2. MRIofthebrain(maymissmicroadenomas)
======================================
E.Treatment 1. Replacementofappropriatehormones 2. Womenwhowanttoconceiveshouldbereferredtoanendocrinologist

DiabetesInsipidus

A.GeneralCharacteristics 1. Twoforms

a. CentralDIisthemostcommonform—duetolowADHsecretionbyposterior pituitary.

b. NephrogenicDI—ADHsecretionisnormalbuttubulescannotrespondtoADH.

2. Causes

a. CentralDI

e

e

e

Idiopathic—50%ofallcases Trauma—surgery,headtrauma Otherdestructiveprocessesinvolvingthehypothalamus,includingtumors, sarcoidosis,tuberculosis,syphilis,Hand–Schüller–Christiandisease, eosinophilicgranuloma,andencephalitis

b. NephrogenicDI—themostcommoncauseinadultsischroniclithiumuse.Other causesincludehypercalcemia,pyelonephritis,anddemeclocyclineuse.Itmay alsobecongenital—causedbymutationsintheADHreceptorgeneorthe aquaporin-2gene.

Quick HIT

Ifapatientpresentswithpolyuriaandpolydipsia,considerthefollowingfirstinthedifferentialdiagnosis:

¢

e

e

e

Diabetesmellitus Diureticuse Diabetesinsipidus Primarypolydipsia

B.ClinicalFeatures 1. Polyuriaisahallmarkfinding:5to15Ldaily;urineiscolorless(becauseitisso

dilute).

2. Thirstandpolydipsia—hydrationismaintainedifthepatientisconsciousandhas accesstowater.

3. Hypernatremiaisusuallymildunlessthepatienthasanimpairedthirstdrive.

Quick HIT

e

e

Primarypolydipsiaisusuallyseeninpatientswithpsychiatricdisturbances. Ifthepatientisdeprivedofwater,urineosmolaritywillincreaseappropriately.

C.Diagnosis

1. Urine—lowspecificgravityandlowosmolalityindicateDI 2. Plasmaosmolality

a. Normal:250to290mOsm/kg b. Primarypolydipsia:255to280mOsm/kg c. DI:280to310mOsm/kg

3. Awaterdeprivationtest(dehydrationtest)isrequiredtomakethediagnosis(see

Table4-8) a. Procedure

e

e

Withholdfluids,andmeasureurineosmolalityeveryhour. Whenurineosmolalityisstable(<30mOsm/kghourlyincreasefor3hours), inject2gdesmopressinsubcutaneously.Measureurineosmolality1hourlater.

b. Response—seeTable4-8

4. ADHlevel(notthetestofchoice;takesalongtimetogetresults)

a. LowincentralDI b. NormalorelevatedinnephrogenicDI
======================================
D.Treatment 1. CentralDI

a. Desmopressin(DDAVP)istheprimarytherapyandcanbegivenbynasalspray, orally,orbyinjection.

b. ChlorpropamideincreasesADHsecretionandenhancestheeffectofADH. c. Treattheunderlyingcause.

2. NephrogenicDI—treatwithsodiumrestrictionandthiazidediuretics.

a. Thesedepletethebodyofsodium,whichleadstoincreasedreabsorptionof sodiumandwaterintheproximaltubules.

b. Thereabsorptionofsodiumandwaterintheproximaltubulesmeansthatless waterreachesthedistaltubules,leadingtodecreasedurinevolumeand increasedwaterretention.

SyndromeofInappropriateSecretionofAntidiureticHormone

A.GeneralCharacteristics 1. Pathophysiology

a. ExcessADHissecretedfromtheposteriorpituitaryoranectopicsource. Elevatedlevelsleadtowaterretentionandexcretionofconcentratedurine.This hastwomajoreffects:hyponatremiaandvolumeexpansion.

b. Despitevolumeexpansion,edemaisnotseeninsyndromeofinappropriate secretionofantidiuretichormone(SIADH).Thisisbecausenatriuresis (excretionofexcessivesodiuminurine)occursdespitehyponatremia. c. Reasonsfornatriuresis

e

¢

e

Volumeexpansioncausesanincreaseinatrialnatriureticpeptide(ANP)which increasesurinesodiumexcretion. Volumeexpansionleadstoadecreaseinproximaltubularsodiumabsorption. Therenin–angiotensin–aldosteronesystemisinhibited,andthussodiumis excretedintheurine.

Quick HIT

InSIADH,volumeexpansionoccursduetowaterretention,butedemaispreventedduetonatriuresis.

Quick HIT

HyponatremiaPearls

e

e

e«

Hypovolemichyponatremia—volumecontracted Hypervolemichyponatremia—volumeexpandedwithedema SIADH—volumeexpandedwithoutedema

B.Causes 1. Neoplasms(e.g.,inlung,pancreas,prostate,bladder),lymphomas,leukemia 2. CNSdisorders(e.g.,stroke,headtrauma,infection) 3. Pulmonarydisorders(e.g.,pneumonia,tuberculosis) 4. Ventilatorswithpositivepressure 5. Medication(e.g.,vincristine,selectiveserotoninreuptakeinhibitors[SSRIs],

chlorpropamide,oxytocin,morphine,desmopressin)

6. Postoperativestate(e.g.,asaresultofanesthesia,pain,orstress)

C.ClinicalFeatures 1. Acutehyponatremia—Osmoticwatershiftsleadtoincreasedintracellularfluid volume.Signsandsymptomsaresecondarytobrainswellingandareprimarily

neurologic.

a. Lethargy,somnolence,weakness b. Canleadtoseizures,coma,ordeathifuntreated.

2. Chronichyponatremia

a. Maybeasymptomatic b. Anorexia,nausea,andvomiting c. CNSsymptomsarelesscommonbecausechroniclossofsodiumandpotassium frombraincellsdecreasesbrainedema(duetosecondarywatershiftsfromICF toECF).
======================================
D.Diagnosis 1. SIADHisadiagnosisofexclusionafterothercausesofhyponatremiahavebeen

ruledout.Thefollowinghelpinsupportingthediagnosis:

a. Hyponatremiawithinappropriatelyconcentratedurine;plasmaosmolality<280 mOsmperkg.

b. Lowserumuricacidlevel c. LowBUNandcreatinine d. Normalthyroidandadrenalfunction,aswellasrenal,cardiac,andliverfunction e. MeasurementofplasmaandurineADHlevel f. Absenceofsignificanthypervolemia

Quick HIT

MajorcharacteristicsofSIADH

Hyponatremia Volumeexpansionwithoutedema Natriuresis HypouricemiaandlowBUN Normalorreducedserumcreatininelevelbecauseofdilution Normalthyroidandadrenalfunction

E.Treatment 1. Correcttheunderlyingcause,ifknown. 2. Forasymptomaticpatients

a. Waterrestrictionisusuallysufficient. b. Usenormalsalineincombinationwithaloopdiureticiffasterresultsare

desired.

c. Lithiumcarbonateordemeclocyclineareotheroptions(withsideeffects)—both inhibittheeffectofADHinthekidney.

3. Forsymptomaticpatients a. Restrictwaterintake.

b. Giveisotonicsaline.Hypertonicsalinemayoccasionallybeindicatedinsevere cases.

4. Donotraisetheserumsodiumconcentrationtooquickly.Rapidfluxofwater intotheextracellularfluidcanresultincentralpontinemyelinolysis(orosmotic demyelinationsyndrome).Ageneralguidelineisthattherateofsodium replacementshouldnotexceed0.5mEq/L/hr.

DiseasesoftheParathyroidGlands

Hypoparathyroidism

A.Causes 1. Removalofglandsduringheadandnecksurgeryaccountforthemajorityofcases

—thyroidectomy,parathyroidectomy,radicalsurgeryforheadandneck malignancies.

2. Nonsurgicalhypoparathyroidismisrare.

Quick HIT

Pseudohypoparathyroidism

e

e

End-organresistancetotheactionofPTH Laboratoryvaluefindings:hypocalcemia,hyperphosphatemia,highPTH,lowurinarycAMP

B.ClinicalFeatures 1. Cardiacarrhythmias 2. Ricketsandosteomalacia 3. Increasedneuromuscularirritabilityduetohypocalcemia

a. Numbness/tingling—circumoral,fingers,toes b. Tetany

e

¢

e

Hyperactivedeeptendonreflexes Chvosteksign—Tappingthefacialnerveelicitscontractionoffacialmuscles. Trousseausign—InflatingtheBPcufftoapressurehigherthanthepatient’s systolicBPfor3minuteselicitscarpalspasms.

c. Grandmalseizures

4. Basalgangliacalcifications 5. ProlongedQTintervalonECG—Hypocalcemiashouldalwaysbeinthe

differentialdiagnosisofaprolongedQTinterval

6. Cataracts
======================================
C.Diagnosis 1. Lowserumcalcium 2. Highserumphosphate 3. SerumPTHinappropriatelylow 4. LowurinecAMP

D.Treatment

1. IVcalciumgluconateinseverecases,oralcalciuminmildtomoderatecases. 2. VitaminDsupplementation(calcitriol). 3. NotethatbothvitaminDandcalciumreplacementcanincreaseurinarycalcium

excretion,precipitatingkidneystones.Therefore,administerwithcautiontoavoid hypercalciuria.Thegoalistokeepserumcalciumat8.0to8.5mg/dL.

PrimaryHyperparathyroidism

A.GeneralCharacteristics 1. OneormoreglandsproduceinappropriatelyhighamountsofPTHrelativetothe

serumcalciumlevel.

2. Mostcommoncauseofhypercalcemiaintheoutpatientsetting.

B.Causes 1. Adenoma(80%ofcases)—majorityinvolveonlyonegland 2. Hyperplasia(15%to20%ofcases)—allfourglandsusuallyaffected 3. Carcinoma(<1%ofcases)

C.ClinicalFeatures 1. “Stones”

a. Nephrolithiasis b. Nephrocalcinosis

2. “Bones”

a. Boneachesandpains b. Osteitisfibrosacystica(“browntumors”)—predisposespatienttopathologic

fractures(Figure4-6)

3. “Groans”

a. Musclepainandweakness b. Pancreatitis c. Pepticulcerdisease d. Gout e. Constipation

4. “Psychiatricovertones”—depression,fatigue,anorexia,sleepdisturbances,

anxiety,lethargy 5. Othersymptoms:

a. Polydipsia,polyuria b. HTN,shortenedQTinterval c. Weightloss

D.Diagnosis 1. Laboratory(seealsoClinicalPearl4-11)

a. Calciumlevels(hypercalcemia)—whencalculatingcalciumlevels,beawareof albuminlevels.Calculatetheionizedfractionorgetanionizedcalciumlevel.

FIGURE 4.6

X-rayoftheclavicleinapatientwithosteitisfibrosacystica

(“browntumors”),adiseaseinwhichcysticbonespacesarefilledwith brownfibroustissue.Browntumorspredisposepatientstopathologic fractures. (FromBeckerKL,BilezikianJP,BrennerWJ,etal.PrinciplesandPracticeofEndocrinologyand

Metabolism.3rded.Philadelphia,PA:LippincottWilliams&Wilkins;2001.)

CLINICALPEARL4-11

SecondaryHyperparathyroidism

CharacterizedbyanelevatedconcentrationofPTHandaloworlow-normalserumcalciumlevel. Causedbychronicrenalfailure(mostcommoncause),aswellasvitaminDdeficiencyandrenal hypercalciuria. Treatmentdependsonthecause:ifvitaminDdeficiency,givevitaminD;ifrenalfailure,givecalcitrioland oralcalciumsupplementsplusdietaryphosphorusrestriction.
======================================
b. PTHlevels

e

e

Shouldbeelevatedrelativetoserumcalciumlevel Notethatinthepresenceofhypercalcemia,anormalPTHlevelis“abnormal” (i.e.,normalisstilltoohigh)becausehighcalciumlevelsshouldsuppressPTH secretion.

c. Hypophosphatemia d. Hypercalciuria

e. UrinecAMPiselevated f. Chloride/phosphorusratioof>33isdiagnosticofprimaryhyperparathyroidism (33-to-1rule).Chlorideishighsecondarytorenalbicarbonatewasting,adirect effectofPTH.

2. Radiographs

a. Subperiostealboneresorptionusuallyonradialaspectofsecondandthird phalanges,butcanappearinanylocation(seeFigure4-6)

b. Osteopenia

E.Treatment 1. Surgicalremovalistheonlydefinitivetreatment,butnotallpatientsrequireit.If thepatientisover50yearsofageandisasymptomatic(withnormalbonemass andrenalfunction),surgerymaynotbeneeded.

a. Primaryhyperparathyroidismduetohyperplasia—Allthefourglandsare removed.Asmallamountofparathyroidtissueisplacedintheforearmmuscle toretainparathyroidfunction.Ifhyperplasiarecurspostoperatively,surgeryis thenlimitedtothearmandwillnotinvolvetheneck.

b. Primaryhyperparathyroidismduetoadenoma—Surgicalremovalofthe adenomaiscurative.

c. Primaryhyperparathyroidismduetocarcinoma—Removethetumor,ipsilateral thyroidlobe,andallenlargedlymphnodes.

2. Medical—Encouragefluids.Givediuretics(furosemide)toenhancecalcium excretionifhypercalcemiaissevere.Donotgivethiazidediureticsastheyinduce calciumretention.

Quick HIT

RelativeIndicationsforSurgeryinPrimaryHyperparathyroidism

e

e

e

e

e

Age<50years Markeddecreaseinbonemass Nephrolithiasis,renalinsufficiency Markedlyelevatedserumcalciumlevelorepisodeofseverehypercalcemia Urinecalcium>400mgin24hours

DiseasesoftheAdrenalGlands

eee

CushingSyndrome

A.GeneralCharacteristics 1. Cushingsyndromeresultsfromexcessivelevelsofglucocorticoidsduetoany

cause.Cortisolistheprincipalglucocorticoid.

2. CushingdiseaseresultsfromanACTH-secretingpituitaryadenoma,thusa pituitarycauseofCushingsyndrome(seebelow).

Quick HIT

EffectsofCortisol(generallycatabolic)

e

e

e

e

Impairedcollagenproduction,enhancedproteincatabolism Anti-insulineffects(leadingtoglucoseintolerance) Impairedimmunity(hasinhibitoryeffectsonPMNs,Tcells) Enhancescatecholamineactivity(HTN)

B.Causes 1. IatrogenicCushingsyndromeisthemostcommoncause,andisduetoprescribed prednisoneorothersteroids.Androgenexcessisabsentbecausetheexogenous steroidsuppressesandrogenproductionbytheadrenals.

2. Cushingdiseaseisthesecondmostcommoncauseandleadstobilateraladrenal hyperplasia.Androgenexcessiscommon.

3. Adrenaladenomasandcarcinomas(10%to15%) 4. EctopicACTHproduction(10%to15%)

a. ACTH-secretingtumorstimulatesthecortisolreleasefromtheadrenalglands withoutthenormalnegativefeedbackloopbecausethesourceoftheACTHis outsidethepituitarygland.

b. Morethantwo-thirdsaresmallcellcarcinomasofthelung.Bronchialcarcinoid andthymomamaybethecause.
======================================
C.ClinicalFeatures 1. Changesinappearance:centralobesity,hirsutism,moonfacies,“buffalohump,”

purplestriaeonabdomen,lanugohair,acne,easybruising

2. HTN 3. Decreasedglucosetolerance(diabetes) 4. Hypogonadism—menstrualirregularityandinfertility 5. Masculinizationinfemales(androgenexcess,seeFigure4-7)—onlyseenin

ACTH-dependentforms

6. Musculoskeletal—proximalmusclewastingandweaknessduetoprotein catabolism,osteoporosis,asepticnecrosisoffemoralheadespeciallywith exogenoussteroiduse

7. Psychiatricdisturbances—depression,mania 8. Increasedlikelihoodofinfections(duetoimpairedimmunity)

Quick HIT

Somesignsandsymptomsinpatientswithhighcortisol(e.g.,obesity,HTN,osteoporosis,DM)arenonspecific andlesshelpfulindiagnosingthepatient.Ontheotherhand,easybruising,typicalstriae,myopathy,and virilizingsignsaremorehelpfulindiagnosis.

D.Diagnosis 1. Initialscreening(Table4-9).Twoofthreefollowingtestsneedtobepositivein

ordertogivethediagnosisofCushingsyndrome:

a. Anovernight,low-dosedexamethasonesuppressiontestistheinitialscreening test.Givethepatient1mgofdexamethasoneat11pm.Measuretheserum cortisollevelat8am.

e

e

Iftheserumcortisolis<5,Cushingsyndromecanbeexcluded.Thistestis verysensitive. Iftheserumcortisolis>5(andoften>10),thepatienthasCushingsyndrome. Orderahigh-dosedexamethasonesuppressiontesttodeterminewhetherthe causeisCushingdisease,anadrenaltumor,oranectopicACTHtumor.

b. The24-hoururinaryfreecortisollevelisanotherexcellentscreeningtest;values greaterthanfourtimesnormalarerareexceptinCushingsyndrome.

c. Latenightsalivarycortisol;salivacollectedpriortopatient’sbedtime.Upper limitsofnormalandconcentrationsfordiagnosiswilldependoncommercial assayused.Thismeasurementshouldbedonetwice.

2. ACTHlevel—OnceyouestablishadiagnosisofCushingsyndrome,measurethe ACTHlevel.Ifitislow,thecauseofhighcortisollevelsislikelyanadrenal tumororhyperplasia,notapituitarydiseaseoranectopicACTH-producing tumor.

FIGURE 4.7

Androgenexcessmanifestingasmasculinizationinfemales,

onlyseeninACTH-dependentformsofCushingsyndrome. (FromRubinE.EssentialPathology.3rded.Philadelphia,PA:LippincottWilliams&Wilkins;

2000.)
======================================
3. High-dosedexamethasonesuppressiontest.

a. InCushingdisease,theresultisadecrease(>50%)incortisollevels. b. IfcortisolsuppressiondoesnotoccurandplasmaACTHlevelsarehigh,an

b. If cortisol suppression does not occur and plasma ACTH levels are high, an ectopic ACTH-producing tumor is likely the diagnosis.

ectopicACTH-producingtumorislikelythediagnosis. 4. CRHstimulationtest—CRHisadministeredintravenously.

a. IfACTH/cortisollevelsincrease(deemeda“response”),thenCushingdiseaseis thediagnosis.

b. IfACTH/cortisollevelsdonotincrease(deemed“noresponse”),thenthepatient haseitherectopicACTHsecretionoranadrenaltumor.

5. Oncehormonalstudieshaveestablishedthesiteofdisease,imagingisthenext step(CTscanorMRI).

Quick HIT

PatientswithCushingdiseasemayhavehyperpigmentationduetoelevatedACTHlevels,whereaspatients withCushingsyndromeduetoothercauseswillnothavehyperpigmentation.

E.Treatment 1. IatrogenicCushingsyndrome:taperingofglucocorticoid 2. PituitaryCushingsyndrome:surgery(transsphenoidalablationofpituitary

adenoma)—usuallysafeandeffective.

3. Adrenaladenomaorcarcinoma:surgery(adrenalectomy) 4. Whensurgeryiscontraindicatedorunsuccessful,orpatientisawaitingsurgical

treatment,medicaltherapiesareappropriate.Adrenalenzymeinhibitors(suchas ketoconazole)inhibitthesynthesisofcortisolandthuscanbeusedasmedical therapy.

Quick HIT

Any24-hoururinecollection(i.e.,24-hoururinecollectionofmetanephrinesandcatecholaminesfor pheochromocytoma)shouldalsotesttheamountofurinecreatininetodetermineifthepatienthasprovidedan appropriatesample.

Pheochromocytoma

A.GeneralCharacteristics 1. Pheochromocytomasareraretumorsthatproduce,store,andsecrete

catecholamines.

2. Ninetypercentfoundinadrenalmedulla(10%extra-adrenal). 3. Curableifdiagnosedandtreated,butmaybefatalifundiagnosed. 4. Arisefromthechromaffincellsoftheadrenalmedullaorfromthesympathetic

gangliaifextra-adrenal.

B.ClinicalFeatures 1. HTN—BPispersistentlyhigh,withepisodesofsevereHTN(paroxysmal). 2. Severepoundingheadache 3. Inappropriateseveresweating 4. Tachycardia 5. Palpitations,withsuddensevereHTN 6. Anxiety 7. Feelingofimpendingdoom 8. Laboratoryfindings:hyperglycemia,hyperlipidemia,hypokalemia
======================================
C.Diagnosis 1. Urinescreen—testforthepresenceofthefollowingbreakdownproductsof

1. Urine screen—test for the presence of the following breakdown products of catecholamines:

catecholamines: a. Metanephrine b. Vanillylmandelicacid,homovanillicacid,normetanephrine

testtourinemetanephrines,especiallywhenclinicalsuspicionishigh. Urine/serumepinephrineandnorepinephrinelevels—iftheepinephrinelevelis elevated,thetumormustbeadrenalorneartheadrenalgland(organof Zuckerkandl)becausenonadrenaltumorscannotmethylatenorepinephrineto epinephrine.

3. Tumorlocalizationtests—CT,MRI.

Quick HIT

Ruleof10sforPheochromocytomaTumors

10%arefamilial 10%arebilateral(suspectMENtypeII) 10%aremalignant 10%aremultiple 10%occurinchildren 10%areextra-adrenal(moreoftenmalignant)—ThemostcommonsiteistheorganofZuckerkandl,whichis

locatedattheaorticbifurcation.

D.Treatment 1. Surgicaltumorresectionwithearlyligationofvenousdrainageisthetreatmentof choice.Ligationlowersthepossibilityofcatecholaminerelease/crisisbytyingoff drainage.

a. Patientsshouldbetreatedwithα-blockade(typicallyphenoxybenzamine)for 10to14dayspriortosurgeryaswellasβ-blockade(i.e.,propranolol)for2to3 dayspriortosurgery.

b. Theα-blockadeisusedtocontrolBP,andtheβ-blockadeisusedtodecrease tachycardia.

c. Laparoscopicadrenalectomycanbesafelyperformedformostsmall-to medium-sizedpheochromocytomas.

Quick HIT

Considerpheochromocytomaasthediagnosisifthefollowingarepresent:

Headache Profusesweating Palpitations Tachycardia Apprehensionorsenseofimpendingdoom

PrimaryHyperaldosteronism

A.GeneralCharacteristics 1. Excessiveproductionofaldosteronebytheadrenalglandsindependentofany regulationbytherenin–angiotensinsystem(seealsoClinicalPearl4-12) 2. ExcessmineralocorticoidsincreasetheactivityoftheNa+/K+pumpsinthe

corticalcollectingtubules.

a. SodiumretentioncausesECFvolumeexpansionandHTN. b. Potassiumlossresultsinhypokalemia.

3. Excessaldosteronealsoincreasesthesecretionofhydrogenionsintothelumenof themedullarycollectingtubulesresultinginmetabolicalkalosis.
======================================
CLINICALPEARL4-12

MultipleEndocrineNeoplasia(MEN)Syndrome

Aninheritedconditionwiththepropensitytodevelopmultipleendocrinetumors. Autosomaldominantinheritancewithincompletepenetrance. Types

e

e

e Types

MENtypeI(Wermersyndrome)—“3Ps”

¢

e

e

Parathyroidhyperplasia(in90%ofthepatientswithMENI) Pancreaticisletcelltumors(intwo-thirdsofthepatientswithMENI)—ZES(50%),insulinoma(20%) Pituitarytumors(intwo-thirdsofthepatientswithMENI)

MENtypeIIA(Sipplesyndrome)—“MPH”

¢

e

¢

e

Medullarythyroidcarcinoma(in100%ofthepatientswithMENIIA) Pheochromocytoma(inmorethanone-thirdofthepatientswithMENIIA) Hyperparathyroidism(in50%ofthepatientswithMENIIA)

¢

MENtypeIIB—“MMMP”

e

Mucosalneuromas(in100%ofthepatientswithMENIIB)—inthenasopharynx,oropharynx,larynx, andconjunctiva Medullarythyroidcarcinoma(in85%ofthepatientswithMENIIB)—moreaggressivethaninMEN IIA Marfanoidbodyhabitus Pheochromocytoma

B.Causes 1. Adrenaladenoma(intwo-thirdsofthecases)—aldosteroneproducingadenoma

(Connsyndrome)

2. Adrenalhyperplasia(inone-thirdofthecases)—almostalwaysbilateral 3. Adrenalcarcinoma(in<1%ofthecases)

Quick HIT

Alwayssuspecthyperaldosteronisminahypertensivepatientwithhypokalemiawhoisnotonadiuretic.

C.ClinicalFeatures 1. HTN(mostcommonclinicalfeature);mayotherwisebeasymptomatic 2. Headache,fatigue,weakness 3. Polydipsia,nocturnalpolyuria(duetohypokalemia) 4. Absenceofperipheraledema

Quick HIT

Theprevalenceofadrenalincidentalomaisontherisewiththemorewidespreaduseofimagingtechniques. Anadrenalincidentalomaisanonfunctioningadrenaltumor.Mostarebenign,buttheriskofmalignancy increaseswithincreasingsize.Treatbyfirstrulingoutafunctioningtumorandthenresectanytumorgreater than6cm(highriskofmalignantdisease).

D.Diagnosis 1. Ratiooftheplasmaaldosteroneleveltoplasmarenin—Ascreeningtestin

primaryhyperaldosteronismrevealsinappropriatelyelevatedlevelsofplasma aldosteronewithcoexistentdecreasedplasmareninactivity.Therefore,ifthe plasmaaldosterone-to-reninratiois>30,evaluatefurther.

2. Fordefinitivediagnosis,oneofthetwotestsisusuallyperformed.

a. Salineinfusiontest
======================================
e

e

Infusionofsalinewilldecreasealdosteronelevelsinnormalpatientsbutnotin thosewithprimaryaldosteronism. Ifaldosteronelevelsare<8.5ng/dLaftersalineinfusion,primary aldosteronismmayberuledout.

b. Oralsodiumloading

Thepatientisgivenahighsaltdietfor3days.Serumandurineelectrolytes, aldosterone,andcreatininearemeasuredonthethirdday.Highurine aldosteroneinthesettingofhighurinesodium(todocumentappropriate sodiumloading)confirmsthediagnosis.

Quick HIT

ItisimportanttodistinguishadenomafromhyperplasiabecauseHTNassociatedwithhyperplasiaisnotbenefited bybilateraladrenalectomy,whereasHTNassociatedwithadenomaisusuallyimproved/curedbyremovalofthe adenoma.

3. Todiagnosethecauseofprimaryaldosteronism:

a. Adrenalvenoussamplingforaldosteronelevels—Ahighlevelofaldosteroneon onesideindicatesanadenoma.Highlevelsonbothsidesindicatebilateral hyperplasia.

b. Renin–aldosteronestimulationtest—Recumbencyoruprightpositionsare assumed,followedbymeasurementofserumaldosterone. c. Imagingtests

c. Imagingtests

e

e

e

CTscan/MRIofadrenals—maydemonstrateadenomaorhyperplasia anatomically. Iodocholesterolscanning—afunctionalapproachtodifferentiatingbetween adenomaandhyperplasia. Arteriography/venography(retrograde).

E.Treatment 1. Foradenoma—Surgicalresection(adrenalectomy)isoftencurative. 2. Forbilateralhyperplasia

a. Spironolactoneinhibitstheactionofaldosterone. b. Surgeryisnotindicated.

AdrenalInsufficiency

A.Causes 1. Primaryadrenalinsufficiency(Addisondisease)(seealsoClinicalPearl4-13). a. Idiopathic(thoughttobeautoimmunedisease)isthemostcommontypeinthe

industrializedworld.

b. Infectiousdiseases—theseincludetuberculosis(mostcommoncause

worldwide)andfungalinfections.Causesalsoincludecytomegalovirus, cryptococcus,toxoplasmosis,andpneumocystis. c. Iatrogenic—forexample,abilateraladrenalectomy. d. Metastaticdisease—fromlungorbreastcancer.

Quick HIT

ThemostcommoncauseofAddisondiseaseworldwideistuberculosis;autoimmunediseaseisthemostcommon causeintheWesternworld.However,themostcommoncauseofadrenalinsufficiencyoverall(99%ofallcases) isabruptcessationofexogenousglucocorticoids.
======================================
CLINICALPEARL4-13

AdrenalCrisis

e

e

©

¢

Anacuteandseverelysymptomaticstageofadrenalinsufficiencythatcanincludeseverehypotensionand cardiovascularcollapse,abdominalpain(canmimicanacuteabdomen),acuterenalfailure,anddeath. Anystress(e.g.,trauma,infection,surgery)canprecipitateanadrenalcrisis. Canbefatalifuntreated. TreatwithIVhydrocortisone,IVfluids(severallitersofnormalsalinewith5%dextrose),andasearchforthe underlyingconditionthatprecipitatedthecrisis.

2. Secondaryadrenalinsufficiency

a. Patientsonlong-termsteroidtherapy—Thisisthemostcommoncauseof secondaryadrenalinsufficiencytoday.Whenthesepatientsdevelopaserious illnessorundergotrauma,theycannotreleaseanappropriateamountofcortisol becauseofchronicsuppressionofCRHandACTHbytheexogenoussteroids. Therefore,symptomsofadrenalinsufficiencyresult.

b. Hypopituitarism(rare)—duetoavarietyofinsults. 3. Tertiaryadrenalinsufficiency—hypothalamicdisease.

Quick HIT

MostCommonClinicalFindingsofAdrenalInsufficiency

Weightloss Weakness Pigmentation Anorexia Nausea Posturalhypotension Abdominalpain Hypoglycemia

Nausea

B.ClinicalFeatures 1. Lackofcortisol

a. GIsymptoms—anorexia,nauseaandvomiting,vagueabdominalpain,weight loss

b. Mentalsymptoms—lethargy,confusion,psychosis. c. Hypoglycemia—Cortisolisagluconeogenichormone. d. Hyperpigmentation

Thisisacommonfindinginprimaryadrenalinsufficiency;notseenin secondaryadrenalinsufficiency.Insecondaryadrenalinsufficiency,ACTH levelsarelow,nothigh. LowcortisolstimulatesACTHandMSHsecretion. e. Intolerancetophysiologicstressisafearedcomplication.

2. Lowaldosterone(onlyseeninprimaryadrenalinsufficiencybecausealdosterone dependsontherenin–angiotensinsystem,notACTH).Resultsin:

a. Sodiumloss,causinghyponatremiaandhypovolemia,whichmayleadto: Hypotension,decreasedcardiacoutput,anddecreasedrenalperfusion. Weakness,shock,andsyncope.

b. Hyperkalemia(duetoretentionofpotassium).

Quick HIT

Hyperpigmentationandhyperkalemiaappearinprimary,notsecondary,adrenalinsufficiency.

Quick HIT

Themostcommonpresentationofsecondaryadrenalinsufficiencyisapatientwhohasbeenonlong-term steroidswhostopsthemsuddenly(i.e.,forsurgery)orwhohasanincreasedneed(infection).Treatmentiseasy —givecorticosteroidsuntilthepatientisstableclinically.
======================================
C.Diagnosis 1. Decreasedplasmacortisollevel(Figure4-8). 2. PlasmaACTHlevel—iflow,thisimpliesasecondaryadrenalinsufficiency

(ACTH-dependentcause).

3. StandardACTHtest.

a. Thisisadefinitivetestforprimaryadrenalinsufficiency;giveanIVinfusionof

syntheticACTH,andmeasureplasmacortisolattheendoftheinfusion. b. Inprimaryadrenalinsufficiency,cortisoldoesnotincreasesufficiently. c. Insecondaryadrenalinsufficiency,cortisolfailstorespondtoACTHinfusion,

asinprimaryadrenalinsufficiency(theadrenalsarenotusedtobeing stimulated,sotheydonotrespondrightaway).However,ifthetestisrepeated for4or5days,theadrenalseventuallyrespondnormally.

4. Performimagingtests(MRIofbrain—pituitary/hypothalamus)ifsecondaryor tertiaryadrenalinsufficiencyisdiagnosed.

D.Treatment 1. Primaryadrenalinsufficiency:dailyoralglucocorticoid(hydrocortisoneor

prednisone)anddailyfludrocortisone(mineralocorticoid).

2. Secondaryadrenalinsufficiency:sameasinprimaryadrenalinsufficiency,except thatmineralocorticoidreplacementisnotnecessary.

Plasma cortisol level +*ACTH, +aldosterone, trenin + ACTH, aldosterone normal, renin normal Primary adrenal insufficiency Secondary adrenal insufficiency * Check other pituitary hormones ¢ Pituitary MRI

FIGURE 4.8

Algorithmforthediagnosisofadrenalinsufficiency.

(AdaptedfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.

4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:2730,Figure407-5.)

CongenitalAdrenalHyperplasia

A.GeneralCharacteristics 1. Autosomalrecessivedisease. 2. Ninetypercentofthecasesaredueto21-hydroxylasedeficiency.11-hydroxylase

deficiencyisthenextmostcommoncause.

Quick HIT

Congenitaladrenalhyperplasia(CAH)isaverytreatablecondition.Affectedfemalepatientswilldevelop normallyandwillbefertileiftreatedearly.

B.ClinicalFeatures 1. Decreasedcortisolandaldosteroneproductionarethemainevents.Increased

ACTHsecretion(duetothelackofnegativefeedback)causesadrenal overstimulation,andthus,hyperplasia.

2. Asprecursorsofcortisolandaldosteronebuildup,theyareshuntedtowardthe synthesisofandrogens(e.g.,DHEA,testosterone),causingvirilization. 3. Virilizingfeatures.

a. Femaleinfantsarebornwithambiguousexternalgenitaliabutnormalfemale ovariesanduterus.

b. Maleinfantshavenogenitalabnormalities.

4. Saltwastingform(moresevereformofdisease).

a. Emesis,dehydration,hypotension,andshockcandevelopinfirst2to4weeksof life.
======================================
b. Hyponatremiaandhyperkalemiaduetolackofaldosterone. c. Hypoglycemiaduetolackofcortisol.

C.Diagnosis 1. Highlevelsof17-hydroxyprogesteroneintheserum.Neonatalscreeningfor21- hydroxylasedeficiencyisapprovedinall50states,leadingtoearlydiagnosisin manycases.

D.Treatment 1. Medically—Usecortisolandmineralocorticoidreplacement;thisshutsoffthe excessACTHsecretionvianegativefeedback.Bewareofundertreatmentand overtreatment.

2. Surgically—Earlycorrectionoffemalegenitalabnormalitiesisgenerally recommended.

5

ok

DiseasesoftheCentralandPeripheral NervousSystems

MarkDuncan

CerebrovascularDisease(Stroke) IschemicStroke(CerebralInfarction)

eee

A.GeneralCharacteristics 1. Epidemiology

a. Stroke,orcerebrovascularaccident(CVA),isthethirdmostcommoncauseof deathintheUnitedStates.

b. Itistheleadingcauseofneurologicdisability.

Quick HIT

TypesofStrokes

e

e

Ischemicstrokes(∼85%ofcases) Hemorrhagicstrokes(∼15%ofcases)

2. Classesofischemicstroke

a. Transientischemicattack(TIA)—seebelow b. ReversibleischemicneurologicdeficitisthesameasTIAexceptforthe

b. Reversible ischemic neurologic deficit is the same as TIA except for the duration of symptoms. It lasts longer than 24 hours, but resolves in less than 2 weeks. This term is not commonly used.

durationofsymptoms.Itlastslongerthan24hours,butresolvesinlessthan2 weeks.Thistermisnotcommonlyused. c. Evolvingstrokeisastrokethatisworsening. d. Completedstrokeisoneinwhichthemaximaldeficithasoccurred.

3. TIAs(seeClinicalPearl5-1)

a. ATIAisaneurologicdeficitthatlastsfromafewminutestonomorethan24 hours(butusuallylastslessthan30minutes).

e

e

StrokemaybeindistinguishablefromaTIAatthetimeofpresentation: Durationofsymptomsisthedistinguishingfeature. SymptomsaretransientwithaTIAbecausereperfusionoccurs,eitherbecause ofcollateralcirculationorbecauseofthebreakingupofanembolus.

b. Theblockageinbloodflowdoesnotlastlongenoughtocausepermanent infarction.

c. ATIAisusuallyembolic.However,transienthypotensioninthepresenceof severecarotidstenosis(>75%occlusion)canleadtoaTIA.

d. OnceapatienthasaTIA,thereisahighriskofstroke.Theriskisincreased withindaysoftheTIA;theriskofstrokeat30daysand5yearsis∼10%and 30%,respectively.

e. EvaluationafterTIA:brainandneurovascularimaging,ECGandcardiac

monitoring(inpatienttelemetryifadmitted,plusambulatorymonitoringfor severalweeksafter),echocardiogram,andlabs(CBC,chemistry,lipids,diabetes screening,andothersdependingonhistoryandriskfactors).

4. Riskfactors

a. ThemostimportantriskfactorsareageandHTN.Othersincludesmoking,DM, hyperlipidemia,atrialfibrillation,coronaryarterydisease(CAD),familyhistory ofstroke,previousstroke/TIA,andcarotidbruits.

b. Inyoungerpatients,riskfactorsincludeoralcontraceptiveuse,hypercoagulable states(e.g.,proteinCandSdeficiencies,antiphospholipidantibodysyndrome), vasoconstrictivedruguse(e.g.,cocaine,amphetamines),polycythemiavera,and sicklecelldisease.
======================================
Quick HIT

TheABCD2scoreisoftenusedasariskstratificationtooltoidentifypatientsathighestriskofearlystroke (validatedtopredictstrokeriskwithin2days)thatrequireemergencyassessment.

e Age

Age BloodpressureelevationshortlyafterTIA Clinicalfeaturesofstroke DurationofTIAsymptoms Diabetes

¢

¢

¢

e Diabetes

CLINICALPEARL5-1

TIAsCanInvolveEithertheCarotidortheVertebrobasilarSystem CarotidSystem

e

e

Temporarylossofspeech;paralysisorparesthesiasofcontralateralextremity;clumsinessofonelimb Amaurosisfugax(anexampleofaTIA):transient,curtain-likelossofsightinipsilateraleyedueto microembolitotheretina

VertebrobasilarSystem(i.e.,VertebrobasilarTIAs)

e

¢

Decreasedperfusionoftheposteriorfossa Dizziness,doublevision,vertigo,numbnessofipsilateralfaceandcontralaterallimbs,dysarthria,hoarseness, dysphagia,projectilevomiting,headaches,anddropattacks

B.Causes 1. EmboliareacommoncauseofTIA/CVA(Figure5-1).Possibleoriginsofan

embolusinclude:

a. Heart(mostcommon):Typicallyduetoembolizationofmuralthrombusin patientswithatrialfibrillation.

b. Internalcarotidartery. c. Aorta.

d. Paradoxical:Emboliarisefrombloodclotsintheperipheralveins,passthrough septaldefects(atrialseptaldefect,apatentforamenovale,orapulmonaryAV fistula),andreachthebrain.

Quick HIT

Rememberthesecausesofstroke: Ischemiaduetoatherosclerosis Atrialfibrillationwithclotembolitobrain Septicembolifromendocarditis

2. Thromboticstroke—Atheroscleroticplaquesmaybeinthelargearteriesofthe neck(carotidarterydisease,whichmostcommonlyinvolvesthebifurcationofthe commoncarotidartery),orinmedium-sizedarteriesinthebrain(especiallythe middlecerebralartery[MCA]).

Quick HIT

Thesourceofanembolicstrokeisevaluatedby:

Echocardiogram Vascularimaging(e.g.,carotidDopplers) ECG,ambulatorycardiacmonitoringfor30days

3. Lacunarstroke—smallvesselthromboticdisease

a. Causesapproximately20%ofallstrokes;usuallyaffectssubcorticalstructures (basalganglia,thalamus,internalcapsule,brainstem)andnotthecerebralcortex

b. Predisposingfactor:AhistoryofHTNispresentin80%to90%oflacunar infarctions.Diabetesisanotherimportantriskfactor.

c. Narrowingofthearteriallumenisduetothickeningofvesselwall(notby thrombosis).

d. ThearteriesaffectedincludesmallbranchesoftheMCA,thearteriesthatmake upthecircleofWillis,andthebasilarandvertebralarteries(seeClinicalPearl5- 2).

e. Whenthesesmallvesselsocclude,smallinfarctsresult;whentheyheal,theyare calledlacunes.

Stroke | " Primary Ischemic stroke ¢ Intraparenchymal * Subarachnoid 85% 20% 25% 20% 30% 5% Atherosclerotic Penetrating 4 4 ; Other cerebrovascular artery disease Caen GHyaeerns unusual 3 ai embolism stroke disease ("Lacunes") causes * Atrial fibrillation * Prothrombic states * Valve disease * Dissections * Ventricular thrombi * Arteritis * Many others * Migraine/vasospasm * Drug abuse Hypoperfusion Arteriogenic emboli * Many others
======================================
FIGURE 5.1

Etiologyofstroke.

(RedrawnfromVerstraeteM,FusterV,TopolEJ,eds.CardiovascularThrombosis:

ThrombocardiologyandThromboneurology.2nded.Philadelphia,PA:LippincottWilliams&

Wilkins;1998:586,Figure34-2.)

4. Nonvascularcauses—Examplesincludelowcardiacoutputandanoxia(may causeglobalischemiaandinfarction).

CLINICALPEARL5-2

SubclavianStealSyndrome

¢

Causedbystenosisofsubclavianarteryproximaltooriginofvertebralartery—exerciseofleftarmcauses reversalofbloodflowdowntheipsilateralvertebralarterytofillthesubclavianarterydistaltothestenosis becauseitcannotsupplyadequatebloodtoleftarm Leadstodecreasedcerebralbloodflow(blood“stolen”frombasilarsystem) Causessymptomsofvertebrobasilararterialinsufficiency(seeClinicalPearl5-1) BPinleftarmislessthaninrightarm;decreaseinpulseinleftarm Upperextremityclaudication Treatment:surgicalbypass

C.ClinicalFeatures 1. Thromboticstroke—Theonsetofsymptomsmayberapidorstepwise.

Classicallythepatientawakensfromsleepwiththeneurologicdeficits(see

Table5-1). 2. Embolicstroke

a. Theonsetofsymptomsisveryrapid(withinseconds),anddeficitsaremaximal initially.

b. Clinicalfeaturesdependonthearterythatisoccluded.TheMCAismost commonlyaffected,andneurologicdeficitsseeninMCAinvolvementinclude:

¢

e

e

Contralateralhemiparesisandhemisensoryloss. Aphasia(ifdominanthemisphereisinvolved)—for90%ofpopulationthisis leftcerebraldominance. Apraxia,contralateralbodyneglect,confusion(ifnondominanthemisphereis involved).

3. Lacunarstroke—Clinicalfeaturesarefocalandusuallycontralateralpuremotor orpuresensorydeficits.Lacunarstrokeincludesfourmajorsyndromes:

a. Puremotorlacunarstroke—iflesioninvolvestheinternalcapsule. b. Puresensorylacunarstroke—iflesioninvolvesthethalamus. c. Ataxichemiparesis—incoordinationipsilaterally. d. Clumsyhanddysarthria.

Quick HIT

Acarotidbruithastwocauses:

e¢

e

Murmurreferredfromtheheart Turbulenceintheinternalcarotidartery(possiblestrokerisk)

Quick HIT

MostcommonlocationinvolvestheMCA—resultsincontralateralweakness,sensoryloss,andhyperreflexia.
======================================
TABLE5-1 DeficitsSeeninStroke

Distribution

Distribution

Locationand/orTypeofDeficiency

Anterior cerebralartery

Contralaterallowerextremityandface

Middlecerebral artery

Aphasia,contralateralhemiparesis

Ipsilateral:ataxia,diplopia,dysphagia,dysarthria,andvertigoContralateral:homonymous hemianopsiawithbasilar—PCAlesions

Lacunar

Internal capsule

Puremotorhemiparesis Dysarthria,clumsyhand

Pons Thalamus

Puresensorydeficit

PCA,posteriorcerebralartery.

Quick HIT

UsesofCTScanoftheHeadintheED

¢

e

e

e

Todifferentiateischemicfromhemorrhagicinfarction Identifies95%ofSAHs(andallbleeds>1cm) Identifiesabscess,tumor Identifiessubduralorepiduralhematoma

D.InitialAssessment 1. Historyandneurologicexam(includingtheNationalInstitutesofHealthStroke

Scale,NIHSS).TheNIHSSscoreonadmissionpredictsstrokeoutcomes.

2. Brainimaging(CTorMRI)

a. CTscanoftheheadwithoutcontrastispreferredatmostcentersdueto availabilityandtimeconstraints,anditdifferentiatesanischemicfroma hemorrhagicinfarction.IschemicstrokesappearasdarkareasontheCTscan (hemorrhagicstrokesappearwhite—Figure5-2).Itmaytake24to48hoursto visualizeaninfarctonCT.

b. MRIofthebrainismoresensitivethanCT;itidentifiesallinfarcts,anddoesso earlierthanCTscan.Ninety-fivepercentofinfarctsidentifiedonMRIwithin24 hours.

c. Thebrainimagingmodalitycanbecombinedwithneurovascularimagingat somecenters(e.g.,CTwithCTA,MRIwithMRA).

3. ECG—acuteMIoratrialfibrillationmaybethecauseofembolicstrokes. 4. Labs:accucheck,CBC,electrolytes,creatinine,coags,cardiacenzymesandothers

basedonpatientfactors.

Quick HIT

Ifayoungpatient(<50)presentswithstroke,lookforvasculitis,hypercoagulablestate,andthrombophilia. Orderthefollowing:

¢

ProteinC,ProteinS,antiphospholipidantibodies FactorVLeidenmutation ANA,ESR,rheumatoidfactor VDRL/RPR,Lymeserology Transesophagealechocardiogram(TEE)

E.Complications 1. Progressionofneurologicinsult.

2. Cerebraledemaoccurswithin1to2daysandcancausemasseffectsforupto10 days.Hyperventilationandmannitolmaybeneededtolowerintracranialpressure (ICP).

3. Hemorrhageintotheinfarction—rare. 4. Seizures—fewerthan5%ofpatients.

F.Treatment 1. Acute—Supportivetreatment(airwayprotection,oxygen,IVfluids)isinitiated. Earlyrecognitionofthecauseofstrokeisunreliable,andearlytreatmentis critical.Therefore,choosetherapiesthathavebroadefficacyandsafety.

a. Thrombolytictherapy(t-PA)
======================================
e

¢

e

Ifadministeredwithin4.5hoursoftheonsetofanacuteischemicstroke, improvedclinicaloutcomeisseenat3months. Donotgivet-PAifthetimeofstrokeisunknown,ifmorethan4.5hourshave passed,orifthepatienthasanyofthefollowing:uncontrolledHTN,bleeding disorder,istakinganticoagulantsorhasahistoryofrecenttraumaorsurgery. Thesepatientsareatincreasedriskforhemorrhagictransformation. Ift-PAisgiven,thereisriskofintracranialhemorrhage.Therefore,donot giveaspirinforthefirst24hours,performfrequentneurologicchecks(every hour),andcarefullymonitorBP.(KeepBP<185/110mmHg.)

FIGURE 5.2

CTscanofapatientwithastrokefromanonhemorrhagic

infarct(arrow). (FromFishmanMC,HoffmanAR,KlausnerRD,etal.Medicine.5thed.Philadelphia,PA:

LippincottWilliams&Wilkins;2004:593,Figure64-7.)

b. Ineligiblepatientswithlargearteryocclusionwhopresentwithin6hours, endovascularthrombectomyhasbeenstudiedinmultiplelargerandomized controlledtrialsandissuperiortothrombolytictherapywitht-PA.Newstudies aresupportingthatthewindowfortherapycouldbeextendedfrom6hoursupto 16or24hoursfromthetimepatientwaslastknowntobewell.

c. Aspirinshouldbegivenasearlyaspossible(unlesst-PAisused),andideally within48hoursofstrokeonset.

d. Anticoagulants(e.g.,heparin)havenotbeenproventohaveefficacyinacute stroke.However,DVT/VTEprophylaxisshouldbegivenduringhospitalization.

e. Assessthepatient’sabilitytoprotecthisorherairway,keepNPO,protect againsthypo-orhyperglycemia,avoidfever,andelevatetheheadofthebed30 degreestopreventaspiration.

2. BPcontrol—Ingeneral,donotgiveantihypertensiveagentsinthefirst24hours unlessoneofthefollowingthreeconditionsispresent:

a. Thepatient’sBPisveryhigh(systolic>220,diastolic>120,ormeanarterial pressure>130mmHg).

b. Thepatienthasasignificantmedicalindicationforantihypertensivetherapy. Examplesinclude:

AcuteMI Aorticdissection Severeheartfailure Hypertensiveencephalopathy

c. Thepatientisreceivingt-PA—aggressivebloodpressurecontrolisnecessaryto reducethelikelihoodofbleeding.

Quick HIT

Ifstrokeiscausedbyembolifromacardiacsource,anticoagulationisthetreatment.
======================================
Quick HIT

Treatmentofstrokesisprophylactic.Onceastrokehasoccurred,thereisnothingthatcanbedonetosalvage thedeadbraintissue.Thegoalistopreventischemiceventsinthefuture.

3. Preventionofstrokerecurrence

a. Lifestyleandpharmacotherapyforriskfactors(HTN,DM,smoking, hyperlipidemia,obesity).

b. Long-termantiplatelettherapy(e.g.,aspirin). c. Highintensitystatin. d. Anticoagulationforcardioembolicstrokes. e. Surgeryforstrokesduetocarotidarterydisease(Figure5-3).

¢

e

Symptomaticpatients—threemajorstudieshaveestablishedthebenefitof carotidendarterectomyinsymptomaticpatientswithcarotidarterystenosisof >70%.(TheNASCETtrialwasthemostinfluential.) Asymptomaticpatients—fourmajorstudieshaveinvestigatedthebenefitof carotidendarterectomyinasymptomaticpatients.Threefoundnobenefit.One study(ACAS)foundthatinasymptomaticpatientswhohaveacarotidartery stenosisof>60%,thebenefitsofsurgeryareverysmall.Therefore,in asymptomaticpatients,reductionofatheroscleroticriskfactorsanduseof aspirinarerecommended.

Quick HIT

Ifcarotidstenosisis>70%andpatientissymptomatic,carotidendarterectomyisindicated.

17.5% Hl Medical Rx Wi Carotid endarterectomy Ipsilateral stroke rate (%/year) Symptomatic carotid Asymptomatic carotid stenosis (>70%) stenosis (>60%) NASCET ACAS

FIGURE

5.3 Effectofcarotidendarterectomyincarotidstenosis.

NASCET,NorthAmericanSymptomaticCarotidEndarterectomy Trial;ACAS,asymptomaticcarotidatherosclerosisstudy. (RedrawnfromVerstraeteM,FusterV,TopolEJ,eds.CardiovascularThrombosis:

ThrombocardiologyandThromboneurology.2nded.Philadelphia,PA:LippincottWilliams&

Wilkins;1998:590,Figure34-4.)

HemorrhagicStroke

A.IntracerebralHemorrhage 1. Generalcharacteristics

a. ICHisassociatedwithahighmortalityrate(50%at30days).Forthosewho survive,thereissignificantmorbidity.

b. Hematomaformationandenlargementmayleadtolocalinjuryandincreasein intracerebralpressure.

Quick HIT

Twomajorcategoriesofhemorrhagicstroke: ICH—bleedingintobrainparenchyma SAH—bleedingintotheCSF;outsidebrainparenchyma

2. Causes

a. HTN(particularlyasuddenincreaseinBP)isthemostcommoncause(50% to60%ofcases).
======================================
e

e

HTNcausesaruptureofsmallvesselsdeepwithinthebrainparenchyma. ChronicHTNcausesdegenerationofsmallarteries,leadingto microaneurysms,whichcanruptureeasily. Itistypicallyseeninolderpatients;riskincreaseswithage.

b. Ischemicstrokemayconverttoahemorrhagicstroke. c. Othercausesincludeamyloidangiopathy(10%),anticoagulant/antithrombolytic

use(10%),braintumors(5%),andAVmalformations(5%).

Quick HIT

Cocaineisoneofthemaincausesofstrokeinyoungpatients.ICH,ischemicstroke,andSAHareall associatedwithcocaineuse.

3. Locations

a. Basalganglia(66%) b. Pons(10%) c. Cerebellum(10%) d. Othercorticalareas

4. Clinicalfeatures

a. Abruptonsetofafocalneurologicdeficitthatworsenssteadilyover30to90 minutes

b. Alteredlevelofconsciousness,stupor,orcoma

c. Headache,vomiting d. SignsofincreasedICP

Quick HIT

PupillaryfindingsinICHandcorrespondinglevelofinvolvement

e

¢

e

Pinpointpupils—pons Poorlyreactivepupils—thalamus Dilatedpupils—putamen

5. Diagnosis

a. CTscanoftheheaddiagnoses95%ofICH(maymissverysmallbleeds) (Figure5-4).

b. Coagulationpanelandplatelets—checkthesetoevaluateforbleedingdiathesis.

6. Complications a. IncreasedICP b. Seizures c. Rebleeding d. Vasospasm e. Hydrocephalus f. SIADH 7. Treatment

a. AdmissiontotheICU b. ABC’s(airway,breathing,andcirculation)—airwaymanagementisimportant duetoalteredmentalstatusanddecreasedrespiratorydrive.Patientsoften requireintubation.

c. BPreduction

ElevatedBPincreasesICPandcancausefurtherbleeding.However, hypotensioncanlowercerebralbloodflow,worseningtheneurologicdeficits. Therefore,BPreductionmustbegradual. TreatmentisindicatedifsystolicBPis>180ortheMAPis>130.CommonIV agentsusedincludenicardipine,labetalol,nitroprusside,andothers. d. InitialmanagementofelevatedICPincludeselevatingtheheadofthebedto

30degreesandappropriatesedationandpaincontrol.Mannitol(osmoticagent) isoftenusedtolowerICP;otheroptionsincludehyperventilation,barbiturates, neuromuscularblockade,andCSFdrainage.

e. Ifthepatientisonanticoagulationoranantiplateletagent,reversalagents(e.g., vitaminKforwarfarin,protaminesulfateforheparin,prothrombincomplex concentrateforwarfarinandtheneweroralanticoagulants,etc.).

f. Useofsteroidsisharmfulandisnotrecommended.

g. Rapidsurgicalevacuationofcerebellarhematomascanbelifesaving.However, surgeryisnothelpfulinmostcasesofICH.
======================================
FIGURE 5.4

A:SpontaneousICHhemorrhageinahypertensivepatient. B:OnCTscan,ischemicstrokeappearsdark,whereashemorrhagic strokeappearswhite. (AfromDaffnerRH,ed.ClinicalRadiology:TheEssentials.2nded.Philadelphia,PA:Lippincott

Williams&Wilkins;1999:526,Figure12.37A.)(BfromDaffnerRH,ed.ClinicalRadiology:The Essentials.2nded.Philadelphia,PA:LippincottWilliams&Wilkins;1999:528,Figure12.40B.)

Quick HIT

CommonSitesofSAH

e

e

e

Junctionofanteriorcommunicatingarterywithanteriorcerebralartery Junctionofposteriorcommunicatingarterywiththeinternalcarotidartery BifurcationoftheMCA

B.SubarachnoidHemorrhage 1. Generalcharacteristics

a. Mortalityratecanbeashighas40%to50%at30days. b. Locations—Saccular(berry)aneurysmsoccuratbifurcationsofarteriesofthe

circleofWillis.

Quick HIT

Polycystickidneydiseaseisassociatedwithberryaneurysms.

2. Causes

a. Rupturedsaccular(berry)aneurysmsarethemostcommoncause—hashigher morbidityandmortalitythanothercauses.

b. Traumaisalsoacommoncause. c. AVmalformation.

Quick HIT

Caution:Ophthalmologicexaminationismandatorytoruleoutpapilledema.Ifpapilledemaispresent,do notperformanLP—youmaycauseaherniation.RepeattheCTscanfirst.

3. Clinicalfeatures

a. Sudden,severe(oftenexcruciating)headacheintheabsenceoffocalneurologic symptoms;classicdescriptionis“theworstheadacheofmylife”butmayalso bemoresubtle.

b. Sudden,transientlossofconsciousness—inapproximately50%ofpatients. c. Vomiting(common). d. Meningealirritation,nuchalrigidity,andphotophobia—cantakeseveralhoursto

develop.

e. Death—25%to50%ofpatientsdiewiththefirstrupture.Thosewhosurvive

willrecoverconsciousnesswithinminutes. f. Retinalhemorrhages—inupto30%ofpatients.

4. Diagnosis

a. NoncontrastCTscan—identifiesthemajorityofsubarachnoidhemorrhages (SAHs).However,CTscanmaybenegativeinupto10%ofcases.

b. Performlumbarpuncture(LP)iftheCTscanisunrevealingornegative andclinicalsuspicionishigh.LPisdiagnostic.

¢

e

BloodintheCSFisahallmarkofSAH.(Becertainthatitisnotbloodfroma traumaticspinaltap.) Xanthochromia(yellowcoloroftheCSF)isthegoldstandardfordiagnosisof SAH.XanthochromiaresultsfromRBClysis.Xanthochromiaimpliesthat bloodhasbeeninCSFforseveralhoursandthatitisnotduetoatraumatic tap.

c. OnceSAHisdiagnosed,orderacerebralangiogram.Itisthedefinitivestudyfor detectingthesiteofbleeding(forsurgicalclipping).
======================================
5. Complications

a. Rerupture—occursinupto30%ofpatients. b. Vasospasm—occursinupto50%ofpatients(moreoftenwithaneurysmal

SAH);cancauseischemia/infarctionandthereforestroke.

c. Hydrocephalus(communicating)—secondarytobloodwithinthesubarachnoid spacehinderingnormalCSFflow.

d. Seizuresmayoccur(bloodactsasanirritant). e. SIADH 6. Treatment

a. Minimallyinvasive—consultinterventionalneuroradiology.Recentstudieshave shownendovascularcoilingtohavebetteroutcomesthansurgicalclipping.

b. Surgical—consultneurosurgery.Surgicallycliptheaneurysmtoprevent rebleeding.

c. Medical—therapyreducestherisksofrebleedingandcerebralvasospasm.

e

Bedrestinaquiet,darkroom. Stoolsoftenerstoavoidstraining(increasesICPandriskofrerupture). Analgesiaforheadache(acetaminophen). IVfluidsforhydration. ControlofHTN—lowertheBPgraduallybecausetheelevationinBPmaybea compensationforthedecreaseincerebralperfusionpressure(secondaryto increasedICPorcerebralarterialnarrowing). Calciumchannelblocker(nimodipine)forvasospasm—lowerstheincidenceof cerebralinfarctionbyone-third.

Quick HIT

Thebasalganglia/striatalregionnormallyoperatesasabalancedsystemcomprisingthedopaminergicsystem andthecholinergicsystem.InParkinsondisease,thedopaminergicpathwayiscompromised,andthecholinergic systemoperatesunopposed.Therefore,thegoaloftreatmentiseithertoenhancedopamine’sinfluenceorto inhibitacetylcholine’sinfluence.

MovementDisorders

ParkinsonDisease

A.GeneralCharacteristics 1. Parkinsondiseaseisthemostcommonhypokineticmovementdisorder. 2. Onsetisusuallyafterage50years. 3. Parkinsondiseaseisessentiallyaclinicaldiagnosis.Laboratorystudiesplayno

roleindiagnosis.

4. ParkinsonismreferstosymptomsandsignsofParkinsondiseaseandcanresult frommanyconditions(e.g.,medications).Upto10%ofpatientswith Parkinsonismwillhave“Parkinson-plussyndromes”:

a. Multiplesystematrophy:parkinsonismplusoneofthefollowingsubtypes: dysautonomia(Shy–Dragersyndrome),cerebellarataxia(MSA-C),ordystonia (MSAwithpredominantparkinsonism).

b. Progressivesupranuclearpalsy:parkinsonismplusprominentoculomotor deficits.

c. Corticobasaldegeneration:parkinsonism(usuallyasymmetric)plusimpaired cognition,dystonia,sensorydeficits,andmyoclonus.
======================================
CLINICALPEARL5-3

ProgressiveSupranuclearPalsy(PSP)

e

e

e

PSPisadegenerativeconditionofthebrainstem,basalganglia,andcerebellum,mostcommonlyaffecting middle-agedandelderlymen. LikeParkinsondisease,PSPcausesbradykinesia,limbrigidity,cognitivedecline,andfollowsaprogressive course. UnlikeParkinsondisease,PSP Doesnotcausetremor Doescauseophthalmoplegia

B.ClinicalFeatures 1. Pill-rollingtremoratrest(worsenswithemotionalstress)(seeClinicalPearl5-3).

1. Pill-rolling tremor at rest (worsens with emotional stress) (see Clinical Pearl 5-3). Tremor goes away when performing routine tasks.

Tremorgoesawaywhenperformingroutinetasks. 2. Bradykinesia—slownessofvoluntarymovements. 3. Rigidityischaracteristic.“Cogwheelrigidity”referstoaratchet-likejerking,

whichcanbeelicitedbytestingthetoneinonelimbwhilethepatientclenchesthe oppositefist.

4. Poorposturalreflexes;difficultyinitiatingthefirststep,andwalkingwithsmall

shufflingsteps;stoopedposture.

5. Masked(expressionless)facies;decreasedblinking. 6. Dysarthriaanddysphagia,micrographia(smallhandwriting). 7. Impairmentofcognitivefunction(dementia)inadvanceddisease. 8. Autonomicdysfunctioncanleadtoorthostatichypotension,constipation,

increasedsweating,andoilyskin.

9. Personalitychangespresentinearlystages.Patientsbecomewithdrawn,apathetic, anddependentonothers.Depressioniscommonandcanbesignificant—causes worseningofparkinsoniansymptoms.

10. Followsprogressivecourse—significantdisabilityusuallypresentswithin5to10 years;indirectlyleadstoincreasedmortality.

Quick HIT

Lewybodies(hyalineinclusionbodies)areakeyneuronalfindinginthebrainsofpatientswithParkinson disease.

Quick HIT

TheclinicalfeaturesofParkinsondiseasecanberememberedwiththemnemonicTRAP:Tremor,Rigidity, Akinesia,Posturalinstability.

C.Treatment 1. Nocure—goalsaretodelaydiseaseprogressionandrelievesymptoms. 2. Carbidopa-levodopa(Sinemet)—drugofchoicefortreatingparkinsonian

symptoms.

a. Asthenameimplies,itisacombinationoflevodopa(L-Dopa)andcarbidopa. b. ItamelioratesallthesymptomsofParkinsondisease.Itisthemosteffectiveof

alltheantiparkinsoniandrugs.

c. Sideeffects.
======================================
e

e

Dyskinesias(involuntary,oftenchoreicmovements)canoccurafter5to 7yearsoftherapy.Thisisamajorconcern,andmaywarrantdelayininitiating carbidopa-levodopaforaslongaspossible. Nausea/vomiting,anorexia,HTN,hallucinations.

d. Levodopadoesshowan“on–off”phenomenon(overthecourseoftheday) duringtreatment,whichleadstofluctuationsinsymptoms.Thisisduetodose– responserelationships.Itoftenoccursinadvanceddisease.

MedicationsThatCauseParkinsonianSideEffects

¢

¢

e

Neurolepticdrugs(chlorpromazine,haloperidol,perphenazine) Metoclopramide Reserpine

Quick HIT

PatientswithtremorasamajorsymptomofParkinsondiseasehaveabetterprognosisthanthosewhohave bradykinesiaasapredominantfinding.

3. Dopamine-receptoragonists(bromocriptine,pramipexole).

a. Maycontrolsymptomsanddelayneedforlevodopaforseveralyears. b. Initiateoneoftheseagentswhenyouhaveestablishedthediagnosis.Youmay

uselevodopaandoneoftheseagentsatthesametime.

c. Pramipexoleisthemostcommonlyused. d. Thesecanbeusefulforsuddenepisodesofhesitancyorimmobility(described

as“freezing”).

4. Selegiline—itinhibitsmonoamineoxidaseBactivity(increasesdopamine activity)andreducesmetabolismoflevodopa.Itisanadjunctiveagent,andis oftenusedinearlydisease.Ithasmildsymptomaticbenefit.

5. Amantadine(antiviralagent)—mildbenefit,mostlyforearlyormilddisease. 6. Anticholinergicdrugs.

a. Trihexyphenidylandbenztropine. b. Thesemaybeparticularlyhelpfulinpatientswithtremorasamajorfinding.Do

notuseinolderpatientsordementedpatients.

7. Amitriptyline—usefulinthetreatmentofParkinsondiseasebothasan anticholinergicagentandasanantidepressant.

8. Surgery(deepbrainstimulation)—ifpatientdoesnotrespondtomedicationsorin patientswhodevelopseverediseasebeforeage40years.

HuntingtonChorea

A.GeneralCharacteristics 1. Autosomaldominant,solackoffamilyhistorymakesthisdiagnosisunlikely. 2. Onsetisbetween30and50yearsofage.Symptomsworsensteadily,with15

yearsbeingthetypicaldurationfromonsettodeath.

3. Itiscausedbyamutationonchromosome4(expandedtripletrepeatsequence)— CAGleadstoalossofGABA-producingneuronsinthestriatum.

B.ClinicalFeatures 1. Chorea—involvingtheface,headandneck,tongue,trunk,andextremities. 2. Alteredbehavior—irritability,personalitychanges,antisocialbehavior,

depression,obsessive-compulsivefeatures,and/orpsychosis.

3. Impairedmentation—progressivedementiaisakeyfeature;90%ofpatientsare dementedbeforeage50years.

4. Gaitisunsteadyandirregular.Ultimatelybradykinesiaandrigidityprevail. 5. Incontinence.
======================================
Quick HIT

AlwayskeepWilsondiseaseinmindinayoungpatientwithmovementdisorders(seeChapter3).

C.Diagnosis 1. MRIshowsatrophyoftheheadofcaudatenuclei. 2. DNAtestingconfirmsthediagnosis.Geneticcounselingplaysanimportantrole.

D.Treatment Treatment is symptomatic—there is no curative treatment. Dopamine blockers may help with the psychosis and improve chorea. Anxiolytic and antidepressant therapy maybenecessary.

Tremor

A.PhysiologicTremor 1. Causes(seeTable5-2) a. Fear,anxiety,fatigue b. Metaboliccauses:hypoglycemia,hyperthyroidism,pheochromocytoma c. Toxiccauses(e.g.,alcoholwithdrawal,valproicacid,lithium,methylxanthines

—caffeineandtheophylline)

2. Treatment:Treattheunderlyingcause,ifknown;otherwise,notreatmentis necessary

TABLE5-2 CommonTremorsandAssociatedFeatures

Characteristic Rest With action—"intention With certain postures (e.g., Setting tremor” arms outstretched) or certain tasks (e.g., handwriting) Description Pill-rolling Coarse Fine Etiology Idiopathic or adverse Multiple possible etiol- Often familiar effect of neuroleptic ogies Associated Rigidity, bradykinesia, Ataxia, nystagmus, Head tremor, vocal tremu- Features shuffling gait dysarthria lousness Improved By Action Rest (no tremor at rest) Alcohol

B.EssentialTremor 1. Common;inherited(autosomaldominant)inuptoone-thirdofpatients. 2. Itisinducedorexacerbatedbyintentionalactivity,suchasdrinkingfromacupor useofutensils,andismarkedlydecreasedbyalcoholuse(usefulindiagnosis). 3. Distortedhandwritingisoftenpresent.Notethatbradykinesia,rigidity,shuffling

gait,orposturalinstabilityareallabsent.

4. Treatwithpropranolol.

Quick HIT

ThereisnoknownassociationbetweenessentialtremorandParkinsondisease.

C.NeurologicDiseases(e.g.,Parkinsondisease,cerebellardisease,Wilsondisease)

Ataxia

A.GeneralCharacteristics 1. Gaitinstability 2. Lossofbalance 3. Impairedlimbcoordination

B.Causes 1. Acquiredcauses:alcoholintoxication,vitaminB12orthiaminedeficiency,

cerebellarinfarctionorneoplasm,demyelinatingdisease(multiplesclerosis[MS], AIDS),andtertiarysyphilis(tabesdorsalis)

2. Inheritedcauses

a. Friedreichataxia
======================================
e

e

Autosomalrecessiveinheritance,onsetbyyoungadulthood Presentswithataxia,nystagmus,impairedvibratorysense,andproprioception

b. Ataxiatelangiectasia

e

e

e

Autosomalrecessiveinheritance,childhoodonset SymptomssimilartothoseofFriedreichataxiaplustelangiectases Increasedincidenceofcancer

C.Treatment Treatunderlyingcauseifpossible.

RestlessLegSyndrome

Acommondisordermanifestingasanuncomfortablesensationtomovethelegs (sometimesthearmsaswell),thatusuallyoccursduringtheeveningandatrest. Thepathophysiologyisunclear,butitcanbeassociatedwithirondeficiencyand certainmedications. Treatirondeficiencyorwithdrawoffendingmedicationsifpossible.If pharmacologictherapyisindicated,thendopamineagonistsaretypicallyused(e.g., pramipexole,ropinirole).

TouretteSyndrome

A.GeneralCharacteristics 1. Associatedwithobsessive-compulsivedisorder. 2. Onsetbeforeage21years. 3. Thoughttohaveautosomaldominantinheritancepattern. 4. NotallpatientswithticshaveTourettesyndrome. 5. NotallpatientswithTourettesyndromeexperiencecoprolalia(involuntary

swearing).

Quick HIT

Tics

¢

¢

¢

Motortics(e.g.,facialgrimace,blinking,headjerking,shouldershrugging) Phonictics(e.g.,grunting,sniffing,clearingthroat,coprolalia,repetitionofwords) Conditionsthatmustberuledoutincludeseizures,tardivedyskinesias,andHuntingtondisease.

B.ClinicalFeatures(occurfrequentlyandregularly).Musthavebothmotorand phonictics.

1. Motortics(multiple) 2. Phonictics(atleastonekind)

C.Treatment(ifsymptomsareaffectingthepatient’squalityoflife;patient educationisimportant)

1. Clonidine 2. Pimozide 3. Haloperidol

Overview

A.GeneralCharacteristics 1. Dementiaisaprogressivedeteriorationofintellectualfunction,typically

characterizedbypreservationofconsciousness.

2. Themostimportantriskfactorfordementiaisincreasingage.

Quick HIT

ForgetfulnessVersusDementia

«

e

Somedegreeofmemorylossisacceptedasanormalpartofaging.Itmaybedifficulttodistinguishthis condition,sometimesreferredtoasbenignforgetfulnessofelderlypatients,fromtruedementia. Ingeneral,benignforgetfulnessdoesnotadverselyaffectnormalday-to-daylivingorbaselinefunctioning, butitmaybeariskfactorforprogressivedementiassuchasAlzheimerdisease.
======================================
B.DifferentialDiagnosisofDementia 1. Primaryneurologicdisorders(seeClinicalPearl5-4)

a. Alzheimerdisease—accountsfor66%ofallcasesofdementia(seethesection onAlzheimerdiseasebelow).

b. Vasculardementia,ormulti-infarctdementia,isastepwisedeclineduetoa seriesofcerebralinfarctions.

c. Space-occupyinglesions,suchasbraintumororchronicsubduralhematoma. d. Normalpressurehydrocephalus—triadofdementia,gaitdisturbance,and

urinaryincontinence;normalCSFpressureanddilatedventricles.

e. DementiawithLewybodies(seesectionbelow). f. Frontotemporaldementia(Pickdisease)—clinicallysimilartoAlzheimer

disease.

g. Otherneurologicconditions:MS,Parkinsondisease,Huntingtondisease,Wilson

disease. 2. Infections

a. HIVinfection(AIDS-relateddementia) b. Neurosyphilis c. CryptococcalinfectionofCNS d. Creutzfeldt–Jakobdisease(spongiformencephalopathy) e. Progressivemultifocalleukoencephalopathy

CLINICALPEARL5-4

CausesofDementia PotentiallyReversibleCausesofDementia

e

¢

e

Hypothyroidism Neurosyphilis VitaminB12/folatedeficiency/thiaminedeficiency Medications Normalpressurehydrocephalus Depression Subduralhematoma

IrreversibleCausesofDementia

Alzheimerdisease Parkinson,Huntington Multi-infarctdementia DementiawithLewybodies,Pickdisease Unresectablebrainmass HIVdementia Korsakoffsyndrome Progressivemultifocalleukoencephalopathy Creutzfeldt–Jakobdisease

3. Metabolicdisorders

a. Thyroiddisease(hypothyroidismorhyperthyroidism) b. VitaminB12deficiency c. Thiaminedeficiency—commoninalcoholics;ifuntreatedcanleadtoKorsakoff

dementia(irreversible)

d. Niacindeficiency

4. Drugsandtoxins

a. Drugabuse;chronicalcoholism(maycausedementiaindependentfrom thiaminemalnutrition)

b. Toxicsubstances:anilinedyes,metals(e.g.,lead)

5. Pseudodementia(depression)—severedepressionmaycauseadeclinein cognitionthatisdifficulttodistinguishclinicallyfromAlzheimerdisease,butis responsivetoantidepressanttherapy

C.ClinicalApproachtoDementia 1. Patienthistory—Askpatientsandtheirfamilymembersaboutthenatureofonset,

specificdeficits,physicalsymptoms,andcomorbidconditions.Reviewall medications,aswellasfamilyandsocialhistory.

2. Physicalexamination.

a. Focusonathoroughneurologicexaminationandmentalstatusexamination.

b. Gaitanalysisoftenshedslightonmovementdisorders,masslesions,and nonpressurehydrocephalus.

3. Laboratoryandimagingstudies—Considerthefollowingwheninvestigatingthe causeofdementia:CBCwithdifferential,chemistrypanel,thyroidfunctiontests (TSH),vitaminB12,folatelevel,VDRL(syphilis),HIVscreening,andCTscanor MRIofthehead.
======================================
D.TreatmentandManagement 1. Treatreversiblecauses. 2. Avoidand/ormonitordosesofmedicationswithadversecognitivesideeffects (glucocorticoids,opiates,sedativehypnotics,anxiolytics,anticholinergics, lithium).

3. Treat/controlcomorbidmedicalconditions;forexample,diabetes,HTN, depression,visualandhearingimpairment.

4. Pharmacologictherapymaybeofbenefit(seespecificdiseasesbelow). 5. Amultidisciplinaryapproachincludessupportgroupsforcaregivers/familiesof

patientswithirreversibledementias.

AlzheimerDisease

A.GeneralCharacteristics 1. Epidemiology

a. AlzheimerdiseaseisaverycommoncauseofdeathintheUnitedStates. b. Prevalenceincreaseswithage—Approximately10%to15%ofindividualsover age65,and15%to30%ofindividualsoverage80haveAlzheimerdisease. However,manywilldieofothercausesfirst.

2. Riskfactors

a. Age b. Familyhistory(especiallyforearly-onsetAlzheimerdisease) c. Downsyndrome

3. Etiologyisunknown,butaheritablecomponentmaybepresent.Chromosomes 21,14,and19havebeenlinkedtoAlzheimerdisease.

4. Pathology(notedatautopsy):

a. Quantityofsenileplaques(age-specific)—focalcollectionsofdilated,tortuous neuriticprocessessurroundingacentralamyloidcore(amyloidβ-protein).

b. Quantityofneurofibrillarytanglescontainingabnormaltauproteins. c. Neuronallossandprominentatrophy.

Quick HIT

MostimportantriskfactorforAlzheimerdiseaseisage.

Quick HIT

PatientswithAlzheimerdiseaseoftenhavecerebralatrophysecondarytoneuronalloss.Ventricleswill correspondinglybeenlarged.

B.ClinicalFeatures 1. Beginsinsidiouslybuttendstoprogressatasteadyrate. 2. Theaveragetimefromonsettodeathis5to10years(withsomevariability). 3. Stages

a. Earlystages—mildforgetfulness,impairedabilitytolearnnewmaterial,poor performanceatwork,poorconcentration,changesinpersonality,impaired judgment(e.g.,inappropriatehumor).

b. Intermediatestages—memoryisprogressivelyimpaired.Patientsmaybeaware ofthecondition,yetdenialisoftenpresent.Visuospatialdisturbancesare common(gettinglostinafamiliarplaceanddifficultyfollowingdirections).

Patientsmayrepeatquestionsoverandover.

c. Laterstages—assistanceisneededforactivitiesofdailyliving.Patientshave difficultyrememberingthenamesofrelatives/friendsormajoraspectsoftheir lives.Paranoiddelusions(e.g.,victimoftheft)andhallucinationsarecommon.

d. Advanceddisease—completedebilitationanddependenceonothers,

incontinence(bowel/bladder);patientmayevenforgethisorherownname. e. Deathisusuallysecondarytoinfectionorothercomplicationsofadebilitated

state.
======================================
C.Diagnosis 1. Alzheimerdiseaseisessentiallyaclinicaldiagnosis;excludeothercausesfirst. 2. CTscanorMRIshowingdiffusecorticalatrophywithenlargementofthe

ventriclesstrengthensthediagnosis.

Quick HIT

AlzheimerDisease:Treatment/Prevention

¢

e

Notreatmenthasbeenfoundtohaveasignificanteffectoncognitiveeffects. HormonereplacementtherapyisassociatedwithalowerriskofdevelopingAlzheimerdisease.

D.Treatment 1. Cholinesteraseinhibitors—brainsofpatientswithAlzheimerdiseasehavelower levelsofacetylcholine.Avoidanticholinergicmedications!Optionsinclude donepezil,rivastigmine,andgalantamine.

a. Currentlythefirst-lineagent.

2. Certaindietarysupplements(ginkgo,lecithin)havenotbeenproventobe beneficial.

3. VitaminEcanbetriedinmildtomoderatedementia.Inonestudy,megadosesof vitaminE(2,000IU/day)sloweddiseaseprogressionandpreservedfunctionin peoplewithmoderatelysevereAlzheimerdisease.

4. Memantinecanbeaddedinmoderatetoseveredementia.

Quick HIT

PatientswithADhavedecreasedacetylcholinesynthesisandthusimpairedcorticalcholinergicfunction. Cholinesteraseinhibitorsincreasecholinergictransmissionbyinhibitingcholinesterase.

DementiaWithLewyBodies

DementiawithLewybodieshasfeaturesofbothAlzheimerdiseaseandParkinson disease,butprogressionmaybemorerapidthaninAlzheimerdisease. Initially,visualhallucinationspredominate.Othersymptomsincludeextrapyramidal featuresandfluctuatingmentalstatus. Thesepatientsaresensitivetotheadverseeffectsofneurolepticagents,whichoften exacerbatesymptoms. TreatmentissimilartothatforAlzheimerdisease,withneurolepticagents(for hallucinationsandpsychoticfeatures).Selegilinemayslowtheprogressionof disease.

AChEmedications(e.g.,donepezil)areonlyindicatedforAlzheimerdementiaandLewybodydementia.No specifictherapyforothercausesofdementia.

AlteredMentalStatus

Delirium

Differential diagnosis of AMS can be remembered by the mnemonic MOVE STUPID:

Metabolicdisorders(e.g.,hypercalcemia) Oxygen Vascular(e.g.,MI,CVA) Endocrine(e.g.,hypoglycemia) Seizure Trauma Uremia Psychiatric Infectious Drugs
======================================
CLINICALPEARL5-5

AlteredMentalStatus

¢

e

e

Consciousnessreliesonarousalandcognition.Arousalisdependentonanintactbrainstem(reticular activatingsysteminbrainstem).Cognitionisdependentonanintactcerebralcortex. Alteredmentalstatus,diminishedlevelofconsciousness(drowsiness,stupor,coma),andconfusionare causedbymanyofthesameconditionsandareoftenvariationsofthesametheme. Depressedlevelofconsciousnessandcomacanbecausedbyavarietyofdisorders.Tohelpinclassification andtoorganizeone’sthinking,itisusefultoorganizethesecausesintotwocategories:

¢

¢

Diffuseinjurytothebrainduetoanymetabolic,systemic,ortoxicdisorder Focalintracranialstructurallesions—forexample,hemorrhage,infarction,tumor

A.GeneralCharacteristics 1. Deliriumisanacuteperiodofcognitivedysfunctionduetoamedicaldisturbance

orcondition(seeClinicalPearl5-5)(seeTable5-3).

2. Elderlypatientsareespeciallypronetodelirium.

B.Causes

C.ClinicalFeatures 1. Incontrasttobothdementiaandpsychosis,deliriumischaracterizedbyarapid

deteriorationinmentalstatus(overhourstodays),afluctuatinglevelof awareness,disorientation,andattention.

2. Deliriummayoftenbeaccompaniedbyacuteabnormalitiesofperception,suchas hallucinations.

3. Patientsmaybeagitated(i.e.,hyperactivedelirium),orhaveaslow,blunted responsiveness(i.e.,hypoactivedelirium).

4. Thestrongestriskfactorispreexistingcognitiveimpairment.
======================================
D.Diagnosis 1. ThemostcommondeliriumscreeningtestistheConfusionAssessmentMethod (CAM),whichisbasedonfourfeatures:acuteonsetwithafluctuatingcourse, inattention,disorganizedthinking,andanalteredlevelofconsciousness. 2. Workupofdeliriumdependsonsuspectedcontributingfactorsandreversible

causes.Itislargelybasedonagoodhistoryandphysicalexam(withadetailed neurologicexamandmentalstatusassessment),especiallywithagoodreviewof medications.Lab,imaging,andprocedures(e.g.,lumbarpuncture)workupis patient-specific.

E.Treatment 1. Treattheunderlyingcause. 2. Deliriumprecautionswhileinthehospital:frequentreorientation,familiarobjects andfaces(i.e.,familyatthebedside),maintaininganormalsleep–wakecycle withblindsopenduringtheday,andcorrectingsensoryimpairments(hearing aids,glasses,etc.).

3. Avoidrestraintsandpharmacologicmanagementofagitationasmuchaspossible;

ifabsolutelynecessary,antipsychoticslikehaloperidolmaybeused.

Coma

A.GeneralCharacteristics 1. Acomaisadepressedlevelofconsciousnesstotheextentthatthepatientis

completelyunresponsivetoanystimuli.

2. Causes

a. Structuralbrainlesionsthatcauseacomaareusuallybilateralunlessthey produceenoughmasseffecttocompressthebrainstemortheoppositecerebral hemisphere(seeClinicalPearl5-6).

b. Globalbraindysfunction(e.g.,metabolicorsystemicdisorders) c. Psychiatriccauses—conversiondisordersandmalingeringmaybedifficultto

differentiatefromatruecoma.

B.Approach 1. Initialsteps

a. Assessvitalsigns.ABC’stakepriority. b. Alwaysassumeunderlyingtrauma(stabilizecervicalspine)andassessthe

patientforsignsofunderlyingcausesoftrauma.

c. AssessthelevelofconsciousnessusingtheGlasgowComaScale(seeTable5- 4).Repeatthisseriallybecauseitcanchange.

Quick HIT

AssessingtheCauseofaComa

e

¢

¢

e

Abnormalpupillarylightreflex—structuralintracraniallesions(hemorrhage,mass);drugsthataffectthepupil (morphine,atropine-likeagents);anoxicencephalopathy;recenteyedrops Bilateralfixed,dilatedpupils—severeanoxia Unilateralfixed,dilatedpupil—herniationwithCNIIIcompression Pinpointpupils—narcotics,ICH
======================================
CLINICALPEARL5-6

DifferentialDiagnosisofAMSCanBeRememberedbytheMnemonicMOVE STUPID

Metabolicdisorders(e.g.,hypercalcemia) Oxygen Vascular(e.g.,MI,CVA) Endocrine(e.g.,hypoglycemia) Seizure Trauma Uremia Psychiatric

Oxygen

Seizure

Uremia

Infectious Drugs

e

e Drugs

2. Approachtodiagnosingthecauseofcoma.

a. Rapidmotorexamination—ifasymmetryisnotedinmovements,amasslesion isthelikelycause.Metabolicorsystemiccausesofcomadonotproduce asymmetricmotorabnormalities.

b. Brainstemreflexes(seeClinicalPearl5-7).
======================================
Pupillarylightreflex—Ifthepupilsareroundandsymmetricallyreactive (constricttobrightlight),themidbrainisintactandnotthecauseofcoma. Anisocoria(asymmetricpupils)maybeasignofuncalherniation.Keepin mindthatcertaineyedropsorsystemicmedicationsmayalterpupilsize. Eyemovements—ifthecervicalspineisuninjured,performtheoculocephalic test(“doll’seyes”).Whentheheadisturnedtooneside,theeyesshouldmove conjugatelytotheoppositedirectionifthebrainstemisintact. Ifthepatientisbreathingonherorhisown,thebrainstemisfunctioning. c. Laboratorytests—CBC,electrolytes,calciumBUN,creatinine,glucose,plasma

c. Laboratory tests—CBC, electrolytes, calcium BUN, creatinine, glucose, plasma osmolarity, arterial blood gas, ECG.

osmolarity,arterialbloodgas,ECG. d. Toxicologicanalysisofbloodandurine. e. CTorMRIofthebrain. f. LP—ifmeningitisorSAHissuspected.

Quick HIT

“Lockedin”Syndrome

«

¢

e

Mimicscoma,becausepatientsarecompletelyparalyzed(withsparingofmusclesrequiredforrespiration, blinking,andverticaleyemovement). Patientsarefullyawareoftheirsurroundingsandcapableoffeelingpain. Thisisusuallycausedbyinfarctionorhemorrhageoftheventralpons.

C.Treatment 1. Correctreversiblecausesandtreattheunderlyingproblem(ifidentified)—control airway;givesupplementaloxygen,naloxone(fornarcoticoverdose),dextrose(for hypoglycemia).Givethiaminebeforeaglucoseload.Correctanyabnormalitiesin BP,electrolytes,orbodytemperature.

2. Identifyandtreatherniation—loweringtheICPiscritical.

CLINICALPEARL5-7

BrainDeathVersusPersistentVegetativeState

Criteriafordiagnosingbraindeath:

«

¢

Irreversibleabsenceofbrainandbrainstemfunction—unresponsiveness,apneadespiteadequate oxygenationandventilation,nobrainstemreflexes(pupils,calorics,gag,cornea,doll’seyes). Nodrugintoxicationormetabolicconditionthatcanreversiblyinhibitbrainfunction. Corebodytemperature>32°C/89.6°F.Braindeathcannotbeestablishedinthepresenceofhypothermia. Clinicalevidenceorimagingstudythatprovidesacausativeexplanationforbraindeath. ExaminationsmustberepeatedorEEGperformed.EEGshowsisoelectricactivity(electricalsilence). InmostUSstates,ifapatientisproventobebraindead,thephysicianhastherighttodisconnectlife support—thepatientislegallydead.(Obviously,sensitivityandconsiderationmustbedemonstratedtothe family.Theymustbeinformedandgivenachancetosaygoodbyetotheirlovedone.) Patientsina“vegetativestate”arecompletelyunresponsive(comatose),buteyesareopenandtheyappear awake.Mayhaverandomheadorlimbmovements.Patientmayhavenohopeofmeaningfulrecoverybutdo notmeetbraindeathcriteria.Ethicalandlegalissuessurroundingsupportivemeasuresaremuchmore complicated.
======================================
DemyelinatingDisease

eee

MultipleSclerosis

A.GeneralCharacteristics 1. Pathology

a. SelectivedemyelinationofCNS—multifocalzonesofdemyelination(plaques) arescatteredthroughoutthewhitematter.Classiclocationofplaquesisatthe anglesofthelateralventricles.

b. Demyelinationprimarilyinvolveswhitematterofthebrainandspinalcord; tendstosparethegraymatter/axonsandtheperipheralnervoussystem. However,improvedimagingtechniquesareshowingthatcorticaldemyelination maybemoreprevalentthanpreviouslyappreciated.

c. Commonlyinvolvedtracts:pyramidalandcerebellarpathways,medial longitudinalfasciculus,opticnerve,posteriorcolumns.

2. WomenaretwotothreetimesmorelikelythanmentohaveMS. 3. Etiologyisunknown,butisprobablysecondarytotheinterplayofenvironmental,

immunologic,andgeneticfactors.

Quick HIT

MSisaclinicaldiagnosisbasedonmultipleCNSlesionsseparatedbytimeandspace.Thismaybeclinical findingsalone,ormorecommonlyacombinationofclinicalfindingswithradiologicalfindings.

B.ClinicalFeatures 1. Transientsensorydeficits

a. Mostcommoninitialpresentation. b. Decreasedsensationorparesthesiasinupperorlowerlimbs.

2. Fatigue—oneofthemostcommoncomplaints 3. Motorsymptoms—mainlyweaknessorspasticity

a. Mayappearinsidiouslyoracutely. b. Causedbypyramidaltractinvolvement(uppermotorneuroninvolvement). c. Spasticity(suchaslegstiffness)canimpairthepatient’sabilitytowalkand

maintainbalance.

d. Canleadtoweaknesswithprogressiontoparaparesis,hemiparesis,or quadriparesis.

RelapsesofMSproducesymptomsforlongerthan24hours.Theyaverageoneperyear,butusuallydecreasein frequencyovertime.

4. Visualdisturbances a. Opticneuritis

¢

e

Monocularvisualloss(inupto20%ofpatients),oftenwithpainduringeye movement. Mayhavecentralscotoma(blackspotincenterofvision)ordecreased pupillaryreactiontolight.

b. Internuclearophthalmoplegia—stronglysuggeststhediagnosis.

Alesioninthemediallongitudinalfasciculusresultsinipsilateralmedialrectus palsyonattemptedlateralgaze(adductiondefect)andhorizontalnystagmusof abductingeye(contralateraltosideoflesion).Diplopiacanoccur. 5. Cerebellarinvolvement—cancauseataxia,intentiontremor,dysarthria. 6. Lossofbladdercontrol—consequenceofuppermotorneuroninjuryinspinal

cord.

7. Autonomicinvolvement—maypresentasimpotenceand/orconstipation. 8. Cerebralinvolvement—mayoccurinadvancedillnessandmanifestsasmemory loss,personalitychange,andemotionallability;anxietyanddepressionare common.

9. Neuropathicpain—afrustratingbutcommoncomplaintthatmanifestsas hyperesthesiaandtrigeminalneuralgia.

C.Course 1. Mostpatientsatinitialpresentationareintheir20sto30sandpresentwitha localizingdeficitsuchasopticneuritis,one-sidedweakness,ornumbness. PatientsmayormaynotgoontodevelopMS.Theinitialpresentationistermeda clinicallyisolatedsyndrome,sinceitisnotsufficienttofulfillMSdiagnostic criteria.

2. Relapsing-remittingMSisthepatternofflares(relapses)followedbyeitherfull recoveryorpartialrecoverywithresidualdeficits,creatinganewbaseline. 3. SecondaryprogressiveMSoftenstartswitharelapse-remittingpattern,then

changestoagradualworseningofdiseasethatmayormaynotinvolveobvious flares.

4. PrimaryprogressiveMShasaprogressivecourseofaccumulatingdisabilityfrom theonset,andrepresentsabout10%ofpatients.
======================================
D.Diagnosis 1. Thediagnosisisessentiallyclinical—suspectitinyoungadultswithrelapsingand

remittingneurologicsignsandsymptomsthataredifficulttoexplain(dueto

involvementofdifferentareasofCNSwhitematter).Nevertheless,onsuspicion, ordertheMRIandconsiderLP(discussedbelow),becauseitisimportantto diagnoseMSwithasmuchcertaintyaspossibleduetotheimplications surroundingthemanagementapproach.

a. The2017McDonaldCriteriaforthediagnosisofMSrequiresrulingoutmore likelyneurologicdiseasesanddemonstratingCNSlesionsseparatedintimeand space.Thediagnosiscanbeconfirmedwithonlyoneclinicalattack,aslongas thereissupportingradiologic(MRI)orlaboratory(CSF-specificoligoclonal bands)evidence.

2. MRIisthemostsensitivetestandisdiagnosticinthemajorityofcases.

a. ThenumberoflesionsontheMRIisnotnecessarilyproportionaltodisease severityorspeedofprogression.

3. LPandCSFanalysis—AlthoughnolaboratorytestsarespecificforMS,

oligoclonalbandsofimmunoglobulinGarepresentin90%ofMSpatients. 4. Evokedpotentialscansuggestdemyelinationofcertainareasbymeasuringthe speedofnerveconductionwithinthebrain:newlyremyelinatednerveswill conductsensoryimpulsesmoreslowly.

Quick HIT

DiagnosticTestsforMS(helpfulhints)

e

¢

e

MRIisabnormalin90%ofMSpatients. CSFisabnormalin90%ofMSpatients. Evokedpotentialsareabnormalin90%ofMSpatients.

E.Treatment 1. Treatmentofacuteattacks.

a. High-doseIVcorticosteroidscanshortenanacuteattack.Oralsteroidshavenot shownthesameefficacy.

b. Plasmaexchangemaybeusedforpatientswithapoorresponsetosteroids. c. Studieshaveshownthattreatmentofacuteexacerbationsdoesnotalterthe

outcomeorcourseofMS.

d. Mostacuteattacksresolvewithin6weekswithorwithouttreatment.

2. Disease-modifyingtherapy.

a. Therearemanynewertherapies,andmanagementoptionsareevolving.Therapy shouldbestartedearlytoavoidprogressive,irreversibledisability.

b. Theolderinjectiontherapiesareeffectiveandincludeinterferon-basedtherapies (e.g.,interferonβ-1a)orglatiramer.

c. Natalizumabisaveryeffectiveinfusiontherapy,especiallyforthosewithactive disease,thoughitincreasedtheriskofprogressivemultifocal

leukoencephalopathy.

d. Ifconvenienceisapriority,thenoraloptionsincludedimethylfumarate, teriflunomide,andfingolimod.

3. Symptomatictherapy:
======================================
a. Baclofenordantroleneformusclespasticity. b. Carbamazepineorgabapentinforneuropathicpain. c. Treatdepressionifindicated.

Quick HIT

ThereisnocureforMS.Therearetwoprimarygoals:

e

e

Preventrelapses Relievesymptomsofacuteexacerbations

Quick HIT

IVsteroidshelphastenrecoveryoftheacuteepisodeinMSbutdonotresultinanyimprovementinlong-term outcome.

Guillain–BarréSyndrome

A.GeneralCharacteristics 1. Inflammatorydemyelinatingpolyneuropathythatprimarilyaffectsmotornerves, buthasmanyvariants(e.g.,MillerFishersyndrome).Themostcommonformof Guillain–Barrésyndromeisacuteinflammatorydemyelinatingpolyneuropathy. 2. Usuallyprecededbyaviralormycoplasmainfectionoftheupperrespiratoryor

GItract.OthercommoninfectionsincludeCampylobacterjejuni,CMV,hepatitis, andHIV.

3. MayalsooccurinHodgkindisease,lupus,aftersurgery,orafterHIV seroconversion.

B.ClinicalFeatures 1. Abruptonsetwithrapidlyascendingweakness/paralysisofallfourextremities;

frequentlyprogressestoinvolverespiratory,facial,andbulbarmuscles.

a. Usuallysymmetric(butnotalways). b. Weaknessmaybemildorsevere. c. Weaknessusuallyprogressesfromdistaltocentralmuscles. d. Ifgeneralizedparalysisispresent,itcanleadtorespiratoryarrest.

2. Extremitiesmaybepainful,butsensorylossisnottypical. 3. Sphinctercontrolandmentationaretypicallyspared. 4. Autonomicfeatures(e.g.,arrhythmias,tachycardia,posturalhypotension)are

dangerouscomplications.

Quick HIT

PrognosisforGuillain–BarréSyndrome

¢

e

Signsofrecoverywithin1to3weeksafteronsetfavoragoodprognosis.Ifillnesscontinuesforalonger period(e.g.,beyond6weeks),achronicrelapsingcourseismorelikelyandprognosisislessfavorable. Itmaytakemonthsbeforethepatientrecovers.Aminorityofpatientsexperiencerecurrentattacks,andabout 5%dieduetorespiratoryfailure,pneumonia,orarrhythmias.

C.Diagnosis 1. CSFanalysis—elevatedprotein,butnormalcellcount. 2. Electrodiagnosticstudies—decreasedmotornerveconductionvelocity.

D.Treatment 1. Carefullymonitorpulmonaryfunction.Mechanicalventilationmaybenecessary. 2. AdministerIVimmunoglobulinifthepatienthassignificantweakness.If progressioncontinues,plasmapheresismayreduceseverityofdisease. 3. Donotgivesteroids.TheyarenothelpfulinGuillain–Barrésyndrome.

DiagnosismadebyacombinationofCSFfluidanalysis,clinicalfindings,andnerveconductionvelocities.
======================================
NeuromuscularDiseases

eee

MyastheniaGravis

A.GeneralCharacteristics 1. Autoimmunedisorder—Autoantibodiesaredirectedagainstthenicotinic

acetylcholinereceptorsoftheneuromuscularjunction,whichleadstoareduced postsynapticresponsetoacetylcholineandresultsinsignificantmusclefatigue.

2. Musclesthatarestimulatedrepeatedly(e.g.,extraocularmuscles)areproneto fatigue.

3. Thepeakincidenceinwomenisage20to30;inmen,50to70.Itismore commoninwomen.

Quick HIT

InGuillain–Barrésyndrome,rapidprogressiontorespiratoryfailurecanoccurwithinhours.Therefore,a timelyandaccuratediagnosisiscritical.IfyoususpectGuillain–Barrésyndrome,immediatelyadmitthepatient tothehospitalformonitoring.

B.ClinicalFeatures 1. Skeletalmuscleweakness—withpreservationofsensationandreflexes.

a. Weaknessisexacerbatedbycontinueduseofmuscleandimprovedbyrest(see ClinicalPearl5-8).Symptomsworsentowardtheendoftheday(duetofatigue). b. Involvedmusclesvaryandmayincludethefollowing:

e

e

Cranialmuscles:extraocularmuscles,eyelids(ptosis),facialmuscles(facial weakness,difficultyinchewing,slurredspeech). Limbmuscles(proximalandasymmetric).

2. Ptosis,diplopia,andblurredvision—mostcommoninitialsymptoms. 3. Generalizedweakness,dysarthria,anddysphagia. 4. Theconditionprogressesslowlywithperiodicexacerbations.Myastheniccrisis

isamedicalemergencythatoccursin15%ofpatients.Diaphragmand intercostalfatigueresultinrespiratoryfailure,oftenrequiringmechanical ventilation.

Quick HIT

Myastheniagravismaybelimitedtoextraocularmuscles,especiallyinelderlypatients.

C.Diagnosis

1. Acetylcholinereceptorantibodytestisthetestofchoice(mostspecific). Nevertheless,20%ofpatientswithclinicalmanifestationsofmyastheniagravis maybe“antibodynegative.”

CLINICALPEARL5-8

Lambert–EatonMyasthenicSyndrome

e

¢

¢

e

Associatedwithsmallcelllungcancer Causedbyautoantibodiesdirectedagainstpresynapticcalciumchannels Clinicalfeaturesincludeproximalmuscleweaknessandhyporeflexia Distinguishedfrommyastheniagravisinthatsymptomsimprovewithrepeatedmusclestimulation

2. EMGshowsadecrementalresponsetorepetitivestimulationofmotornerves. 3. ACTscanofthethoraxcanruleoutthymoma.Thymomaispresentinonly10% to15%ofpatients,butthethymusishistologicallyabnormalin75%ofpatients.

4. Edrophonium(Tensilon)test—anticholinesterase(AChE)medicationscause markedimprovementofsymptoms,butahighfalse-positiveratelimitsutility.
======================================
D.Treatment 1. AChEinhibitors—forexample,pyridostigmine.

a. InhibitingAChEincreasesconcentrationofacetylcholineatthesynapseby decreasingthebreakdownofacetylcholine.

b. Thisisasymptomaticbenefitonly.

2. Thymectomy.

a. Thisprovidesasymptomaticbenefitandcompleteremissioninmanypatients, evenintheabsenceofathymoma.

b. Althoughusuallybenign,thymomaisanabsoluteindicationforthymectomy.

3. Immunosuppressivedrugs.

a. UsecorticosteroidsforpatientswithapoorresponsetoAChEinhibitors. b. Azathioprineandcyclosporinearealternativethird-lineagents.

4. Plasmapheresisremovesantibodiestoacetylcholinereceptors.Useitifallelse failsorifthepatientisinrespiratoryfailure.

5. IVimmunoglobulintherapyisnowsometimesusedforacuteexacerbations. 6. Monitorserialforcedvitalcapacities.Aforcedvitalcapacityof15mL/kg(about 1L)isgenerallyanindicationforintubation.Patientsinmyastheniccrisishave alowthresholdforintubation—donotwaituntilthepatientishypoxic.

Quick HIT

Medicationsthatexacerbatesymptomsofmyastheniagravis

Antibiotics—aminoglycosides,fluoroquinolones,andothers β-Blockers Antiarrhythmics—quinidine,procainamide,andlidocaine

DuchenneMuscularDystrophy

A.GeneralCharacteristics 1. X-linkedrecessive(almostexclusivelyinmales)diseaseinvolvingamutationon agenethatcodesforthedystrophinprotein(dystrophinisabsentcausingmuscle cellstodie).

2. Characteristically,thereisnoinflammation.

B.ClinicalFeatures 1. Muscleweaknessisprogressive,symmetric,andstartsinchildhood.Proximal musclesprimarilyaffected(pelvicgirdle).Eventuallyinvolvestherespiratory muscles.

2. Gowersmaneuver—patientuseshandstogetupfromfloorbecausetheweakness intheproximallowerextremitymusclesmakesitdifficulttoarisewithout support.

3. Enlargedcalfmuscles—truemusclehypertrophyatfirst,followedby pseudohypertrophyasfatreplacesmuscle.

4. Ultimatelyresultsinwheelchairconfinement,respiratoryfailure,anddeathin thirddecade.

C.Diagnosis 1. Serumcreatinephosphokinase—levelsaremarkedlyelevated. 2. DNAtestinghasnowreplacedmusclebiopsyfordiagnosis.

D.Treatment 1. Prednisoneisbeneficialandisassociatedwithasignificantincreaseinstrength, musclefunction,andpulmonaryfunctionandmayreduceriskofscoliosis. Chronicsteroidtreatmentdoeshavesideeffects,butitisrecommendedforboys5 yearsofageandolderwhosemotorskillsaredeclining.

2. Surgerytocorrectprogressivescoliosisisoftennecessaryoncepatientbecomes wheelchairdependent.
======================================
Quick HIT

OtherHereditaryCausesofMuscleWeakness

Mitochondrialdisorders:associatedwithmaternalinheritanceandraggedredmusclefibers GlycogenstoragediseasessuchasMcArdledisease(autosomalrecessive,musclecrampingafterexercise duetoglycogenphosphorylasedeficiency)

BeckerMuscularDystrophy

LesscommonthanDuchennemusculardystrophy AlsoX-linkedrecessive SimilartoDuchennemusculardystrophy,butthereislateronsetandalesssevere course.Somedystrophinispresent.

NeurocutaneousSyndromes

NeurofibromatosisTypeI(vonRecklinghausenDisease)

Autosomaldominantdiseasecharacterizedbycaféaulaitspots,neurofibromas, CNStumors(gliomas,meningiomas),axillaryoringuinalfreckling,irishamartomas (Lischnodules),bonylesions. Cutaneousneurofibromas—maybedisfiguring. Complicationsincludescoliosis,pheochromocytomas,opticnervegliomas,renal arterystenosis,anderosivebonedefects.Musculoskeletalmanifestationsinclude spinaldeformityandcongenitaltibialdysplasia. Complicationsmayrequiretreatment.Surgicallyexciseanysymptomatic neurofibromas.

Quick HIT

Otherfeaturesthatmaybepresentinneurofibromatosispatients(bothtypes)

e Seizures

Seizures Mentalretardation,learningdisabilities Shortheight Macrocephalic

¢

e

¢

NeurofibromatosisTypeII

Autosomaldominantdisease;lesscommonthantypeIneurofibromatosis. Clinicalfeaturesincludebilateral(sometimesunilateral)acousticneuromas(classic finding),multiplemeningiomas,caféaulaitspots,neurofibromas(muchless commonthantypeI),andcataracts.

Inpatientswithneurofibromatosis,prognosisdependsonthetypeandnumberoftumorsandtheirlocation. Mostpatientscanfunctionwell.

TuberousSclerosis Usuallyautosomaldominant. Presentswithcognitiveimpairment,epilepsy,andskinlesions(includingfacial angiofibromas,adenomasebaceum). Retinalhamartomas,renalangiomyolipomas,andrhabdomyomasoftheheartmay alsobepresent. Treatcomplications.

Sturge–WeberSyndrome

Acquireddisease. Keypathologicfeatureisthepresenceofcapillaryangiomatosesofthepiamater. Classicfeatureisfacialvascularnevi(port-winestain). Epilepsyandmentalretardationareusuallypresent. Treatmentofepilepsyisoftenthemainstayoftreatment.
======================================
VonHippel–LindauDisease

Autosomaldominant. Importantfeaturesarecavernoushemangiomasofthebrainorbrainstem,renal angiomas,andcystsinmultipleorgans. Associatedwithrenalcellcarcinoma. Associatedwithpheochromocytomas.

SpinalCordDiseases

Syringomyelia

Centralcavitationofthecervicalcordduetoabnormalcollectionoffluidwithinthe spinalcordparenchyma(Figure5-5). MostcommonlyassociatedwithArnold–Chiarimalformation.Othercausesare posttraumatic,postinfectious,tetheredcord,intramedullarytumors. Clinicalfeatures—mostoftenasymptomaticanddiscoveredincidentallyonMRI obtainedforotherreasons.Symptomsmayincludebilaterallossofpainand temperaturesensationovertheshouldersina“cape-like”distribution(lateral spinothalamictractinvolvement),preservationoftouch,thoracicscoliosisand muscleatrophyofthehandsmayoccur. DiagnosedbyMRI. Treatmentdependsonsizeofsyrinx,symptoms,andassociatedfindings(Chiari, tetheredcord).Evaluationbyneurosurgeryrecommended.

FIGURE 5.5

Classiclesionsofthespinalcord.A:Syringomyelia.B:

Hemisectionofthespinalcord(Brown-Séquardsyndrome). (FromFixJD.High-YieldNeuroanatomy.2nded.Philadelphia,PA:LippincottWilliams&

Wilkins;2000:46,Figure8-2HandE,respectively.)

Brown-SéquardSyndrome

Spinalcordhemisection(i.e.,lesioninvolvingeithertherightorthelefthalfofthe spinalcord),usuallyatthecervicallevels(wherespinalcordenlarges)(seeFigure5- 5). Causesincludetrauma(e.g.,fracture,stabwound)thatcauseshemisectionofspinal cordormostcommonly,acrushinjurytoonesideofspinalcord,tumors,and abscesses(lesscommon). Clinicalfeatures:contralaterallossofpainandtemperature(spinothalamictract), ipsilateralhemiparesis(corticospinaltract),andipsilaterallossof position/vibration(dorsalcolumns). Prognosisforneurologicrecoveryisverygood.

TransverseMyelitis

Thisisarareconditionthatspecificallyaffectsthetractsacrossthehorizontalaspect ofthespinalcordatagivenlevel.Thethoracicspineisthemostcommonly involved. Thecauseisusuallyunknown,butitcanoccurafterviralinfections.Progressionis usuallyrapid. Clinicalfeaturesincludelowerextremityweaknessorplegia,backpain,sensory deficitsbelowthelevelofthelesion,andsphincterdisturbance(especiallyurinary retention). MRIwithcontrastistheimagingstudyofchoice. High-dosesteroidtherapyisoftenused,butevidencesupportingitsuseisequivocal. Theprognosisishighlyvariableandunpredictable,rangingfromfullrecoveryto death.
======================================
HornerSyndrome

A.GeneralCharacteristics 1. Resultsfromtheinterruptionofcervicalsympatheticnerves 2. Canbepreganglionic(centrallesions)orpostganglionic(distaltosuperior

cervicalganglion);theformerismoreworrisomeandrequiresmorethorough evaluation

B.ClinicalFeatures 1. Ipsilateralptosis—milddroopingoflid(levatorpalpebraestillintact) 2. Ipsilateralmiosis—“pinpointpupil” 3. Ipsilateralanhidrosis(decreasedsweatingonforehead)—maybedifficultto

detect

C.Causes 1. Idiopathic(mostcases) 2. Pancoasttumor(pulmonaryneoplasmofthesuperiorsulcusatlungapex) 3. Internalcarotiddissection 4. Brainstemstroke 5. Necktrauma(cervicalspineinjury)

Poliomyelitis

Poliovirusaffectstheanteriorhorncellsandmotorneuronsofspinalcordand brainstem.Causeslowermotorneuroninvolvement. Characteristicfeaturesincludeasymmetricmuscleweakness(legsmorecommonly involved);absentdeeptendonreflexes;flaccid,atrophicmuscles;andnormal sensation. Bulbarinvolvement(ofCNIXandCNX)in10%to15%ofcasescanleadto respiratoryandcardiovascularimpairment. Notreatmentisavailable,althoughpoliomyelitisisentirelypreventableby vaccination.

MiscellaneousConditions

Vertigo

A.GeneralCharacteristics(ClinicalPearl5-9) 1. Vertigoreferstoadisturbanceofthevestibularsystemcharacterizedbya

sensationofspinningorhallucinationofmovement.

2. Itisimportanttoidentifythecommoncomplaintof“dizziness”asvertigo(“room spinning”)orlightheadedness(presyncopalsymptomsfromcerebral hypoperfusion).

3. Theinitialgoalistodeterminewhetherthecauseofthevertigoisperipheral (innerear)orcentral(e.g.,tumor,CVA).

4. Peripheralvertigoisusuallybenign,butcentralvertigocanhaveserious consequences.

5. Forpatientwithongoingsymptoms(continuousvertigo),performaHINTStestto ruleoutbrainstemorcerebellarstroke.HINTSisathree-parttestandstandsfor HeadImpulse,Nystagmus,andTestforSkew.Thepresenceofallthreeofthe followingsuggestsaperipherallesion,andisaccurateinrulingoutacentral lesion:abnormalheadimpulsetest,thepresenceofunidirectional,horizontal,or torsionalnystagmus,andabsentskew.
======================================
Quick HIT

Inapatientwithvertigo,goalistodifferentiatebetweenperipheral(benign)andcentral(worrisome)vertigo(see Table5-5).TheHINTSexammayhelpdifferentiatecentralfromperipheralvertigoandmaybemoresensitive thanMRIforacutestroke!

B.TypesofPeripheralVertigo 1. Benignpositionalvertigo(BPV).

a. Vertigoisexperiencedonlyinspecificpositionsorduringchangeinposition andlastsforafewmoments.Ithasanabruptonsetassoonastheparticular positionisassumed.

b. Usuallypresentsinpatientsover60yearsold.Treatwithmeclizine. c. Recoveryisusuallycomplete(resolveswithin6months).

Quick HIT

Hearinglossandtinnitusonlyoccurwithperipheralvertigo.Focalneurologicproblemsonlyoccurwithcentral vertigo.

2. Ménièredisease.

a. Triadofvertigo,tinnitus,andhearingloss. b. Attacksmaylastforhourstodaysandrecurseveralmonthsoryearslater. c. Thehearinglosseventuallybecomespermanent. d. Treatwithsodiumrestrictionanddiuretics.

3. Acutelabyrinthitis—duetoviralinfectionofthecochleaandlabyrinth;maylast forseveraldays.

4. Ototoxicdrugs(aminoglycosides,someloopdiuretics). 5. Acousticneuroma(schwannoma)ofthe8thcranialnerve—ataxia,gait

unsteadiness,nystagmus,hearingloss,tinnitus.

Quick HIT

Meclizineisusefulforvertigoandasanantiemetic.Ithasanticholinergicandantihistamineeffects.

CLINICALPEARL5-9

Vertigo CentralVertigo

¢

e

Gradualonset;otherneurologic(brainstem)findingsarepresentinmostcases(e.g.,weakness,hemiplegia, diplopia,dysphagia,dysarthria,facialnumbness).Lookforcardiovascularriskfactors. Accompanyingnystagmuscanbebidirectionalorvertical(doesnotoccurinperipheralvertigo).

PeripheralVertigo

¢

e

Lesionsarecochlearorretrocochlear. Abruptonset,nausea/vomiting,headpositionhasstrongeffectonsymptoms.Otherbrainstemdeficitsare absent,exceptfortinnitus/hearingloss.
======================================
C.CausesofCentralVertigo 1. MS—demyelinationofvestibularpathwaysofbrainstem 2. Vertebrobasilarinsufficiency 3. Migraine-associatedvertigo—headachemayormaynotbepresent

Syncope

A.GeneralCharacteristics 1. Syncopereferstoatransientlossofconsciousness/posturaltonesecondaryto acutedecreaseincerebralbloodflow.Itischaracterizedbyrapidrecoveryof consciousnesswithoutresuscitation.

2. Seizureisacauseofacutealteredmentalstatus,butisnottechnicallyacauseof syncope.

B.Causes 1. Cardiac

a. Cardiacsyncopeisusuallysuddenandwithoutprodromalsymptoms—for example,thepatient’sfacehitsthefloor.

b. Acardiaccauseofsyncopeisthemostimportanttoconsiderandruleout,since syncopemaybethefirstmanifestationofalife-threateningcardiaccondition. c. Causes

e

¢

e

Arrhythmias(e.g.,sicksinussyndrome,ventriculartachycardia,AVblock, rapidsupraventriculartachycardia). Obstructionofbloodflow(e.g.,aorticstenosis,hypertrophiccardiomyopathy, pulmonaryHTN,atrialmyxoma,prolapsedmitralvalve,severeasymmetric septalhypertrophy). Pulmonaryembolismcantheoreticallycausesuddenobstructionofbloodflow andtemporarycerebralhypoperfusion,leadingtosyncope.ThePESITtrialin 2016foundthatforhighriskpatientsadmittedtothehospitalforsyncope,1in 6patientswerefoundtohaveaPE(thesefindingsindicatethatPEismore commoninthispatientgroupthanpreviouslyappreciated,thoughthistrial doesnotnecessarilyprovethatthePEwasthecauseofsyncope).

Quick HIT

Prognosisofsyncopeisgenerallygood,unlesscardiacdiseaseistheunderlyingcause.

2. Vasovagalsyncope(“neurocardiogenic,”or“reflexsyncope”)

a. Mostcommoncauseofsyncope;mayaccountforupto50%ofallcasesof syncope.

b. Mostpeoplehaveoneepisode,butforsomeitisarecurrentproblem. c. Cluestodiagnosis

e

e

Emotionalstress,pain,fear,extremefatigue,orclaustrophobicsituationsas precipitatingfactors. Premonitorysymptoms(pallor,diaphoresis,lightheadedness,nausea,dimming

e

e

ofvision,roaringintheears). Canoccuratanyage,butifthefirstepisodeisafterage40,bereluctantto makethisdiagnosis. Tilt-tablestudycanreproducethesymptomsinsusceptiblepeople.

d. Pathophysiology
======================================
e

e

Normally,standingupcausesbloodtopoolinthelowerextremities(leadingto adecreaseincardiacoutput,strokevolume,andBP).Thesechangesare compensatedforbyincreasedsympathetictone(leadingtovasoconstriction andtachycardia),anddecreasedparasympathetictone. Inpatientswithvasovagalsyncope,thecompensatoryresponseisinterrupted inafewminutesbyaparadoxicalwithdrawalofsympatheticstimulationanda replacementbyenhancedparasympathetic(vagal)activity.Thisleadstoan inappropriatebradycardia,vasodilation,markeddecreaseinBP,andcerebral perfusion.

e. Treatment

e

e

e

Canusuallybereversedbyassumingthesupinepostureandelevatingthelegs. β-Blockersanddisopyramide. Prognosisisexcellent(thereisnoheartdiseaseorarrhythmias).

f. Prevention—avoidcircumstancesthatprecipitateattack.

Quick HIT

Vasovagalandorthostaticsyncopeoccurwhenthepatientisupright(sittinguporstanding).Theydonotoccur whenthepatientisrecumbent.

3. Orthostatichypotension

a. Causesincludeintravascularvolumedepletion,autonomicinsufficiency(e.g., primaryautonomicinsufficiencyfromParkinsondisease,orsecondaryfrom diabetes),age-relatedlossofvasomotorreflexes,anddrugs.

b. Commoninelderlypeople;diabetics(autonomicneuropathy);patientstaking ganglionic-blockingagents,vasodilators,diuretics.

c. Suddenstandingandprolongedstandingaretheprecipitatingcauses. d. Itisalsoassociatedwithpremonitorysymptoms(lightheadedness,nausea,etc.). e. Treatwithincreasedsodiumintakeandfluids.Considerfludrocortisoneif recurrent.Remembertotreatotherunderlyingcausesifidentified(suchas withdrawalofoffendingmedication).

Quick HIT

Ifsyncopeoccurswithexertion,assessforpotentiallylife-threateningcausessuchashypertrophic

cardiomyopathyoraorticstenosis.

Quick HIT

Syncopeisuncommoninsettingofastroke,unlessthevertebrobasilarsystemisinvolved.

4. Severecerebrovasculardisease

a. Ararecauseofsyncope. b. ATIAinvolvingthevertebrobasilarcirculationmayleadtosyncope(“drop

attacks”).

c. Onepracticallyneverseesdizziness(orvertigo)inisolationwithvertebrobasilar insufficiency—therewillalwaysbeotherdeficitsaswell.
======================================
Quick HIT

Evaluatingsyncope

Themostimportantfactorsindecisionmakinginsyncopepatientsarepresence/absenceofstructuralheart diseaseandabnormalECG.

C.Diagnosis 1. First,attempttoruleoutconditionsthatarelifethreatening(e.g.,MI,hemorrhage,

andarrhythmias)(Figure5-6).

2. Themaingoalistodifferentiatebetweencardiacandnoncardiacetiologies, becausetheprognosisispoorestforthosewithunderlyingheartdisease. 3. History

a. Threekeyelementsneedtobedetermined:eventsbefore,during,andafterthe syncopalepisode.

b. Checkthepatient’smedications—thisisespeciallyimportantinelderlypatients. c. Seekreportsfromwitnessesofthesyncopalevent.

4. Physicalexamination(prioritygiventocardiovascularsystem)

a. BPandpulsemeasurementsinsupine,sitting,andstandingpositions(orthostatic vitalsigns).

b. Mentalstatus(postictalstate). c. Murmurs(aorticstenosis,hypertrophiccardiomyopathy).

5. Diagnosis

a. ECGshouldbeobtainedinallpatientswithsyncope,andmayidentifylife- threateningcauses(ventriculartachycardia,otherarrhythmias,ischemia).

b. CBC,metabolicpanel,andotherlabsbasedonthehistoryandphysicalmaybe appropriate.

c. Echocardiographyifstructuralheartdiseaseissuspected.

d. Additionaldiagnostictestsmaybeindicated,andincludeambulatoryECG monitoring,exercisetesting,carotidsinusmassage,neurologicstudiessuchas EEGorneurovascularimaging,andelectrophysiologicstudies.Tilt-tabletesting wasfrequentlyusedtodiagnosevasovagalsyncopeinthepast,butisnow controversial.

History, physical examination, routine labs, ECG Cardiac etiology Noncardiogenic etiology suspected (history of structural heart i disease, abnormal ECG IES eh ical aa) e , of structural heart Specific testing * Such as echocardiography, cardiac catheterization, lung scan, CT scan of head exertional symptoms, sudden syncope) disease) Further investigation * Echocardiogram to evaluate for HCM, AS, MS, atrial myxoma Holter monitor and/or event monitor to evaluate for arrhythmias during symptoms * Electrophysiologic studies (EPS) if Holter monitor or event monitor is nondiagnostic Exercise stress test if ischemic heart disease is suspected Recurrent First episodes episode Tilt-table test, Stop psychiatric workup evaluation
======================================
FIGURE 5.6

Syncopeflowchart.

(AdaptedfromHeavenDJ,SuttonR.Syncope.CritCareMed2000;28(10Suppl):118,Fig.1.

Copyright©2000LippincottWilliams&Wilkins.)

Seizures

A.GeneralCharacteristics 1. Aseizureoccurswhenthereisasuddenabnormaldischargeofelectricalactivity

inthebrain(seeClinicalPearl5-10).

2. Thediagnosisofepilepsyisreservedforasyndromeofrecurrent,idiopathic seizures.Theultimatecauseofseizuresinepilepsyisunknown.

B.Causes(fourM’s,fourI’s) 1. Metabolicandelectrolytedisturbances—hyponatremia,waterintoxication, hypoglycemiaorhyperglycemia,hypocalcemia,uremia,thyroidstorm, hyperthermia.

2. Masslesions—brainmetastases,primarybraintumors,hemorrhage. 3. Missingdrugs.

a. Noncompliancewithanticonvulsantsinpatientswithepilepsy—thisisthe mostcommonreasonforpoorseizurecontrolinepileptics.

b. Acutewithdrawalfromalcohol,benzodiazepines,barbiturates.

CLINICALPEARL5-10

ImportantAspectsofH&PinaPatientPresentingWithaSeizure Acquireadescriptionoftheseizurefrombystanders(e.g.,postictalstate,lossofcontinence). Determinewhatisthebaselinestateforthepatient.Isthepatientaknownepileptic?Lookintomissed dosesofantiepileptics,oranyrecentchangeindosages/medications. Examinethepatientforanyinjuries—headorspine,fractures,posteriorshoulderdislocation,tongue lacerations,bowel/bladderincontinence. LookforsignsofincreasedICP. Performacompleteneurologicexamination.

4. Miscellaneous

a. Pseudoseizures—nottrueseizuresbutarepsychiatricinorigin;areoften difficulttodistinguishfromtrueseizureswithoutanEEG.

b. Eclampsia—Apreeclampticpregnantwomanseizingnolongerhas preeclampsia!Theonlydefinitivetreatmentforeclampsiaisdelivery,buta magnesiuminfusionisthepharmacologictreatmentofchoice.

c. Hypertensiveencephalopathy—severehypertensioncancausecerebraledema.

5. Intoxications—cocaine,lithium,lidocaine,theophylline,metalpoisoning(e.g., mercury,lead),carbonmonoxidepoisoning.

6. Infections—septicshock,bacterialorviralmeningitis,brainabscess. 7. Ischemia—stroke,TIA(commoncauseofseizureinelderlypatients). 8. IncreasedICP—forexample,duetotrauma.

C.TypesofEpilepticSeizures 1. Partialseizure—accountsfor70%ofpatientswithepilepsyolderthan18yearsof age(Figure5-7).Itbeginsinonepartofthebrain(typicallythetemporallobe) andinitiallyproducessymptomsthatarereferabletotheregionofthecortex involved.

a. Simplepartialseizure.

¢
======================================
e

Consciousnessremainsintact.Theseizureremainslocalizedbutmayevolve intoacomplexpartialseizure. Mayinvolvetransientunilateralclonic–tonicmovement.

b. Complexpartialseizure.

¢

e

e

Consciousnessisimpaired;postictalconfusion. Automatisms(last1to3minutes)—purposeless,involuntary,repetitive movements(suchaslipsmackingorchewing);patientsmaybecome aggressiveifrestraintisattempted. Olfactoryorgustatoryhallucinations.

Quick HIT

Partialseizuresmayevolveintogeneralizedseizures.Whenthishappens,itiscalledsecondarygeneralization.

Quick HIT

Itisimportant(althoughsometimesdifficult)todifferentiatebetweenabsence(petitmal)andcomplexpartial seizuresbecausetheirtreatmentsaredifferent.Also,absenceseizuresdisappearinadulthood,whereascomplex partialseizuresdonot.

2. Generalizedseizure—characterizedbylossofconsciousness.Involvesdisruption ofelectricalactivityintheentirebrain.

a. Tonic–clonic(grandmal)seizure—bilaterallysymmetricandwithoutfocal onset.

e

e

e

e

e

Beginswithsuddenlossofconsciousness—afalltotheground. Tonicphase—Thepatientbecomesrigid;trunkandlimbextensionoccurs.The patientmaybecomeapneicduringthisphase. Clonicphase—Thisismusculaturejerkingofthelimbsandbodyforatleast30 seconds. Thepatientthenbecomesflaccidandcomatosebeforeregaining consciousness. Postictalconfusionanddrowsinessarecharacteristicandcanlastforhours, although10to30minutesismoretypical. Otherfeaturesmayincludetonguebiting,vomiting,apnea,andincontinence

e

(urineand/orfeces).

Epileptic seizures Are seizures partial or generalized? i Partial a Generalized | Is consciousness impaired? Are they convulsive? Yes No Yes No ¥ v v v Complex Simple Tonic-clonic or Absence partial seizures partial seizures myoclonic seizures seizures Phenytoin and carbamazepine are | Ethosuximide drugs of choice and valproic acid may be used

FIGURE 5.7

Epilepticseizureflowchart.

(AdaptedfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternal Medicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:2866,Figure 426.1.)

b. Absence(petitmal)seizure.
======================================
e

e

e

e

Typicallyinvolvesschool-agechildren—usuallyresolvesaschildgrowsolder. Patientseemstodisengagefromcurrentactivityand“stareintospace”—then returnstotheactivityseveralsecondslater;patientlooks“absentminded” duringtheseepisodes,whichareoftenconfusedwith“daydreaming.” Episodesarebrief(lastingafewseconds)butmaybequitefrequent(upto100 timesperday). Impairmentofconsciousnessbutnolossofposturaltoneorcontinence,andno postictalconfusion. Minorclonicactivity(eyeblinksorheadnodding)inupto45%ofcases.

e

D.Diagnosis 1. Ifthepatienthasaknownseizuredisorder(epileptic),checkanticonvulsantlevels —Thisisusuallytheonlytestthatisneeded.Becausetherapeuticanticonvulsant levelsarevariable,onedosemaybetoxicforonepatientandtherapeuticfor

another.Therefore,taketherangegiveninlaboratoryreportsasageneral guideline.

2. Ifthepatienthistoryisunclearorifthisisthepatient’sfirstseizure:

a. CBC,electrolytes,bloodglucose,LFTs,renalfunctiontests,serumcalcium, urinalysis.

b. EEG

e

e

AlthoughtheEEGisthemosthelpfuldiagnostictestinthediagnosisofa seizuredisorder,anabnormalEEGpatternaloneisnotadequateforthe diagnosisofseizures. AnormalEEGinapatientwithafirstseizureisassociatedwithalowerriskof recurrence.

c. CTscanofthehead—toidentifyastructurallesion. d. MRIofthebrain—withandwithoutgadolinium(firstwithout).

e

¢

Animportantpartoftheworkupofapatientwithafirstseizure. MoresensitivethanaCTscaninidentifyingstructuralchanges,butnot alwayspractical(e.g.,inanunstablepatient).

e. LPandbloodcultures—ifpatientisfebrile.

Quick HIT

LaboratoryValuestoCheckImmediatelyinanUnfamiliar,SeizingPatient

Serumcalcium Serumsodium SerumglucoseorAccu-Chek BUN

e

e

e

« BUN

E.Treatment 1. Generalprinciples.

a. Forallseizures,ABCstakepriority:Secureairwayandrollpatientontohisside topreventaspiration.

b. Patientswithahistoryofseizures(epilepsy).

e

e

Seizuresinthesepatientsareusuallyduetononcompliancewith anticonvulsanttherapy.(Evenonemisseddosecanresultinsubtherapeutic levels.)Givealoadingdoseoftheanticonvulsantmedicationandcontinuethe regularregimenasbefore. Thesepatientsshouldbechronicallymanagedbyaneurologist.Treatmentwith oneofthestandardantiepilepticdrugsprovidesadequatecontrolin70%of adultpatients.Inanother15%to20%,acombinationregimencontrols seizures. Ifseizurespersist,increasethedosageofthefirstanticonvulsantuntilsignsof
======================================
e

e

toxicityappear.Addaseconddrugiftheseizurescannotbecontrolledwiththe drugoffirstchoice. Iftheseizuresarecontrolled,havethepatientcontinuethemedicationforat least2years.Ifthepatientremainsseizurefree,taperthemedication(s) cautiously.ConfirmthisdecisionwithalackofseizureactivityontheEEG.

Quick HIT

StatusEpilepticus

Referstoprolonged,sustainedunconsciousnesswithpersistentconvulsiveactivityinaseizingpatient Amedicalemergency,withamortalityrateofupto20% Maybecausedbypoorcompliancewithmedication,alcoholwithdrawal,intracranialinfection,neoplasm,a metabolicdisorder,oradrugoverdose Managementinvolvesestablishinganairway,andgivingIVdiazepam,IVphenytoin,and50-mgdextrose. TreatresistantcaseswithIVphenobarbital.

c. Patientwithafirstseizure.

e

e

e

e

EEGandneurologyconsult—firststeps. Anticonvulsanttherapy—weighrisksandbenefitsoftreatmentandtheriskof recurrencebeforeinitiating. WithanormalEEG,theriskofrecurrenceisrelativelylow(15%inthefirst year),comparedtotheriskwithanabnormalEEG(41%inthefirstyear). Donottreatpatientswithasingleseizure.Antiepilepticdrugsarestartedif EEGisabnormal,brainMRIisabnormal,patientisinstatusepilepticus.

2. Anticonvulsantagents.

a. Forgeneralizedtonic–clonicseizuresandpartialseizures:

e

e

Phenytoinandcarbamazepinearethedrugsofchoice.Theyareequally effective,andside-effectprofilesaresimilar. Otheroptionsincludephenobarbital,valproate,andprimidone.

b. Forpetitmal(absence)seizures,ethosuximideandvalproicacidarethedrugsof choice.

Quick HIT

Rememberthatanticonvulsantsareteratogenic.(Doapregnancytestbeforeprescribing!)

AmyotrophicLateralSclerosisor“LouGehrigDisease”

A.GeneralCharacteristics 1. Adisorderaffectingtheanteriorhorncellsandcorticospinaltractsatmanylevels. Corticobulbarinvolvementiscommonaswell.Thepresenceofupperandlower motorneuronsignsisahallmarkofamyotrophiclateralsclerosis(ALS).Note thatonlythemotorsystemisinvolved.

2. Onsetisusuallybetween50and70yearsofage.(LouGehrigwasunusually young[inhis30s]whenthediseasedeveloped.)OccurrenceofALSbeforeage40 isuncommon.

3. Only10%ofcasesarefamilial,withtheremainderbeingsporadic. 4. Prognosisisdismal:80%mortalityrateat5years;100%mortalityrateat10

years.
======================================
Quick HIT

InitiallyALScaninvolvevirtuallyanymuscle,butasthediseaseprogresses,everyregionofthebodybecomes symmetricallyinvolved.

B.ClinicalFeatures 1. Progressivemuscleweaknessisthehallmarkfeature

a. Usuallyfirstnotedinthelegsorarms,butthenspreadstoothermusclegroups b. Noassociatedpain c. Muscleatrophy

2. Musclecrampsandspasticity 3. Fasciculations(unnoticedbypatient) 4. Impairedspeechandswallowing;dysphagiacanleadtoaspiration 5. Respiratorymuscleweakness—dyspneaonexertion,andlater,atrest;orthopnea;

sleepapnea;end-stageALSischaracterizedbyrespiratoryfailure

6. Weightlossandfatigue 7. Thefollowingarenormalandunaffected,eveninlatestages:

a. Bowelandbladdercontrol b. Sensation c. Cognitivefunction d. Extraocularmuscles e. Sexualfunction

C.Diagnosis 1. ThereisnospecificdiagnostictestforALS.EMGandnerveconductionstudies

canconfirmdegenerationoflowermotorneuronsandcanruleoutneuromuscular

junctiondisorders.

2. Clinicalorelectricalevidence

a. Involvementoftworegions(probableALS) b. Involvementofthreetofourregions(definiteALS)—affectedregionsinclude

bulbar(face,larynx,tongue,jaw),cervical,thoracic,andlumbosacral

D.Treatment 1. Treatmenthasbeenverydisappointingandismainlysupportive. 2. Riluzoleisaglutamate-blockingagent—itmaydelaydeathbyonly3to5

months.

Aphasia

A.GeneralCharacteristics 1. Aphasiaisthelossordefectoflanguage(e.g.,inspeaking,fluency,reading,

writing,comprehensionofwrittenorspokenmaterial).

2. Mostlesionsthatcauseaphasiainvolvethedominanthemisphere.

a. In95%ofright-handedpeople,theleftcerebralhemisphereisdominantfor language.

b. In50%ofleft-handedpeople,thelefthemisphereisdominantforlanguage (however,therighthemispherealsohaslanguagefunctionsinmostleft-handed people).

3. Therearefourtypesofaphasia(describedbelow):Wernickeaphasia,Broca aphasia,conductionaphasia,andglobalaphasia.

Quick HIT

EMGandNerveConductionStudies

EMGmeasuresthecontractilepropertiesofskeletalmuscles Lowermotorneuronlesions:fibrillationsandfasciculationsatrest Myopathy:Noelectricalactivityatrest(asexpected),butamplitudedecreaseswithmusclecontraction Nerveconductionstudies Demyelinationdecreasesnerveconductionvelocity(MS,Guillain–Barrésyndrome) Repetitivestimulationcausesfatigue(myastheniagravis)
======================================
B.Causes 1. Stroke(mostcommoncause) 2. Traumatobrain 3. Braintumor 4. Alzheimerdisease

Quick HIT

Themostcommoncauseofaphasiaiscerebrovasculardisease.Inaphasia,whenspeechisfluent,thelesionis posteriortothecentralsulcus.Whenspeechisnonfluent,thelesionisanteriortothecentralsulcus.

C.TypesofAphasia 1. Wernickeaphasia

a. Receptive,fluentaphasia b. Impairedcomprehensionofwrittenorspokenlanguage(keyfeature) c. Speechisgrammaticallycorrectandisfluidbutdoesnotmakemuchsense.

Patientsarticulatewellbutoftenusethewrongwordsbecausetheycannot

understandtheirownwords.

2. Brocaaphasia

a. Expressive,nonfluentaphasia b. Speechisslowandrequireseffort c. Thepatientusesshortsentences(asfewwordsaspossible)withoutgrammatical

c. The patient uses short sentences (as few words as possible) without grammatical construction. The content is appropriate and meaningful

construction.Thecontentisappropriateandmeaningful d. Goodcomprehensionoflanguage(writtenandspoken) e. Oftenassociatedwitharighthemiparesisandhemisensoryloss

3. Conductionaphasia

a. Disturbanceinrepetition b. PathologyinvolvestheconnectionsbetweenWernickeandBrocaareas

4. Globalaphasia

a. Disturbanceinallareasoflanguagefunction(e.g.,comprehension,speaking, reading,fluency)

b. Oftenassociatedwitharighthemiparesis

D.TreatmentofAphasia 1. Mostpatientsspontaneouslyrecoverorimprovewithinthefirstmonth. 2. Speechtherapyishelpful,butisunlikelytobeofmuchbenefitafterthefirstfew

months.

BellPalsy

A.GeneralCharacteristics 1. Thisreferstohemifacialweakness/paralysisofmusclesinnervatedbyCNVII

duetoswellingofthecranialnerve.

2. Theprognosisisverygood;80%ofpatientsrecoverfullywithinweeksto months.

B.Causes 1. Causeisoftenuncertain. 2. Possibleviraletiology(herpessimplex)—immunologicandischemicfactors

implicatedaswell.

3. Upperrespiratoryinfectionisacommonprecedingevent.

C.ClinicalFeatures There is acute onset of unilateral facial weakness/paralysis. Both upper and lower partsofthefaceareaffected.

D.Diagnosis 1. Diagnosisisclinical,butconsiderLymediseaseinendemicareasasthetreatment

approachisdifferent.

2. DonotusesteroidsifLymeissuspected! 3. ConsiderEMGtestingifparesisfailstoresolvewithin10days.

E.Treatment 1. Usuallynoneisrequired,asmostcasesresolvein1month. 2. Shortcourseofsteroidtherapy(prednisone)andacyclovir,ifnecessary. 3. Patientshouldweareyepatchatnighttopreventcornealabrasion(corneais

exposedduetoweaknessoforbicularisoculimuscle).

4. SurgicaldecompressionofCNVIIisindicatediftheparalysisprogressesorif testsindicatedeterioration.
======================================
Quick HIT

DifferentialDiagnosisforFacialNervePalsy

Trauma(e.g.,temporalbone,forcepsdelivery) Lymedisease Tumor(acousticneuroma,cholesteatoma,neurofibroma) Guillain–Barrésyndrome(palsyisusuallybilateral) Herpeszoster

TrigeminalNeuralgia(TicDouloureux)

A.GeneralCharacteristics 1. Trigeminalneuralgiaisoneofthemostpainfulconditionsknowntomankind. 2. Usuallyidiopathicinorigin.

B.ClinicalFeatures 1. Brief(secondstominutes)butfrequentattacksofsevere,lancinatingfacialpain 2. Involvesthejaw,lips,gums,andmaxillaryarea(ophthalmicdivisionisless

commonlyaffected)

3. Recurrentattacksmaycontinueforweeksatatime. 4. Nomotororsensoryparalysis

Quick HIT

TrigeminalNeuralgia

¢

¢

¢

Complete,spontaneousresolutionin85%ofcases Mildresidualdiseasein10%ofcases Noresolutionin5%ofcases

C.Diagnosis 1. Clinicaldiagnosis 2. MRI—toruleoutcerebellopontineangletumor

D.Treatment 1. Drugofchoiceiscarbamazepine(usuallyeffectiveinrelievingpain);other choicesarebaclofenandphenytoin,eitheraloneorincombinationwith carbamazepine.

2. Considersurgicaldecompressionifmedicaltherapyfails. 3. Patientstypicallyexperiencearemitting/relapsingcourse.Overtime,painmay

becomemorerefractorytotreatment.

HowtoLocalizeaNeurologicLesion

A.Introduction 1. Generally,neurologicdeficitscanbelocalizedtooneofthefollowing10sites:

a. Cerebralcortex b. Subcorticalarea c. Cerebellum d. Brainstem e. Spinalcord f. Plexus(plexopathy) g. Roots(radiculopathy) h. Peripheralnerve(peripheralneuropathy) i. Neuromuscularjunction j. Muscle(myopathy)

2. Lesionsineachoftheabovesitespresentwithdifferentneurologicfindings.A goodunderstandingofthedeficitsthataccompanyeachlesioncanhelpwith localization.

B.CerebralCortex 1. Lesionsinthecerebralcortexoftencausetwomaindeficits:

a. Contralateralmotororsensorydeficits(dependingonwhichregionofthe cortexisinvolved)

b. Aphasia

2. Thehemiparesisseenwithcorticallesionsprimarilyaffectstheface,arms,and trunk.Thelegsmaybeaffected,buttypicallythatdeficitisnotassevere.Thisis becausetheneuronsthatcontrolthelowerextremitiesareintheinterhemispheric fissure(seehomunculusinFigure5-8).

3. Aphasiaiscommonwhenthelefthemisphereisinvolved.Visual-spatialdeficits aremorecommonwhentherighthemisphereisinvolved.
======================================
C.SubcorticalLesions 1. Theseinvolvetheinternalcapsule,cerebralpeduncles,thalamus,andpons. 2. Thehemiparesisisusuallycomplete(face,arm,leg)becausetheneurons

controllingthesestructuresallmergetogethersubcorticallyandareveryclose together.

D.Cerebellum Incoordination,intentiontremor,ataxia

E.Brainstem

1. Cranialnerveandspinalcordfindings. 2. Thereisacrossedhemiplegia(deficitonipsilateralfaceandcontralateralbody)

becausethecorticospinaltract,dorsalcolumns,andspinothalamictractscrossbut thecranialnervesdonot.

F.SpinalCord 1. Withacuteinjuries,spinalshockmaybepresentanduppermotorneuronsigns

maynotbeapparentinitially.

2. Thepatientpresentswithuppermotorneuronsigns(spasticity,increaseddeep tendonreflexes,clonus,positiveBabinskisign),butthesesignsmaybepresent withlesionsinthebrainstemandcortical/subcorticalregionsaswell.

3. Thereisadecreaseinsensationbelowasharpbandintheabdomen/trunk.A pinprickisfeltabovethislevelbutnotbelowit.Thisispathognomonicforspinal corddisease—thelevelofthelesioncorrespondstothesensorylevel.

G.Plexus(Plexopathy) 1. Deficits(motorandsensory)involvemorethanonenerve.Findingsarevariable

dependingonwhichpartoftheplexusisinvolved.

2. Traumaisthemostcommoncauseoverall,especiallyforthebrachialplexus.A postsurgicalhematomainthepelvisisamorecommoncauseinlumbosacral plexopathy.

3. Plexusesthatarecommonlyinvolvedinclude:

a. Brachialplexus—Erb–Duchennetypeisthemorecommon(uppertrunk—C5-6 roots).Lowertrunk(C8-T1)islesscommon.

b. Lumbosacralplexus(L5-S3).

H.Roots(Radiculopathy) 1. Painisakeyfinding. 2. Thisaffectsagroupofmusclessuppliedbyaspinalroot(myotome)andasensory areasuppliedbyaspinalroot(dermatome).Therefore,thedistributionofaffected areascanhelpdifferentiatethisfromaperipheralneuropathyoraplexopathy.

3. Patientsmaypresentwithweakness,atrophy,andsensorydeficitsina dermatomalpattern;mayincludefasciculationsanddiminisheddeeptendon reflexes.

Postcentral gyrus tex o cor Leg area e Trunk area £ Arm area Head area Face area Thalamus Medial lemniscus Midbrain Medial lemniscus Medial lemniscus Decussation of medial lemniscus at the junction between the spinal cord and the brainstem Cervical cord Lumbosacral cord
======================================
FIGURE 5.8

A:Dorsalcolumn–mediallemniscuspathway.

(AfromFixJD.High-YieldNeuroanatomy.2nded.Philadelphia,PA:LippincottWilliams&

Wilkins;2000:39,Figure7-2.)

Cerebral cortex (postcentral gyrus) Medulla Lateral spinothalamic tract Spinal cord Decussation occurs almost Free nerve endings immediately, within one or two spinal cord vertebral B segments

FIGURE 5.8

B:Thelateralspinothalamictract.

(BfromFixJD.High-YieldNeuroanatomy.2nded.Philadelphia,PA:LippincottWilliams& Wilkins;2000:41,Figure7-3.)

FIGURE 5.8

C:Thelateralandventralcorticospinal(pyramidal)tracts.

(CfromFixJD.High-YieldNeuroanatomy.2nded.Philadelphia,PA:LippincottWilliams&

Wilkins;2000:42,Figure7-4.)

I.PeripheralNerve(PeripheralNeuropathy) 1. Weaknessismoreprominentdistallyattheoutset(asopposedtomuscle

myopathy[seebelow])—usuallyasymmetric.

2. Presentswithdiminisheddeeptendonreflexes;mayincludesensorychanges (numbness,paresthesias,tingling),muscleatrophy,andfasciculations.

3. Canbeduetodiabetes(nerveinfarction),trauma,entrapment,orvasculitis. 4. Commonneuropathiesincluderadial/ulnar/median/musculocutaneousnerves,

longthoracicnerve,axillarynerve,commonperonealnerve,andfemoralnerve.

J.NeuromuscularJunction 1. Fatigabilityisthekeyfinding.Musclesbecomeweakerwithuseandrecoverwith

rest.

2. Normalsensation,noatrophy

K.Muscle(Myopathy) 1. Myopathyreferstoacquireddisease(dystrophytoinheritedconditions). 2. Symmetricweaknessaffectsproximalmusclesmorethandistalmuscles

(shouldersandhipmuscles).

3. Presentswithnormalreflexes,butthesemaydiminishlateinthediseasein

comparisontomuscleweakness. 4. Normalsensation,nofasciculations. 5. Muscleatrophymayoccurlateduetodisuse(incontrasttorapidatrophyinmotor

neurondisease).

6

xX)

ConnectiveTissueandJointDiseases

EmilyLiang

ConnectiveTissueDiseases

SystemicLupusErythematosus

A.GeneralCharacteristics 1. Anautoimmunedisorderleadingtoinflammationandtissuedamageinmultiple

organsystems.

2. Systemiclupuserythematosus(SLE)isanidiopathicchronicinflammatory diseasewithgenetic,environmental,andhormonalfactors.

3. Thepathophysiologyinvolvesautoantibodyproduction,depositionofimmune complexes,complementactivation,andaccompanyingtissue destruction/vasculitis.

EpidemiologyofSLE

¢
======================================
e

e

e

Womenofchildbearingageaccountfor90%ofcases,butmenhavemoreseveredisease. African-AmericanpatientsaremorefrequentlyaffectedthanCaucasianpatients. Milderinelderlypatients;moresevereinchildren. Usuallyappearsinlatechildhoodoradolescence.

4. Types

a. SpontaneousSLE. b. Cutaneouslupuserythematosus(skinlesionswithoutsystemicdisease) c. Drug-inducedlupus d. ANA-negativelupus—associatedfindings

e

e

e

e

Arthritis,Raynaudphenomenon,subacutecutaneouslupus Serology:Ro(anti-SS-A)orantiphospholipidantibody-positive,ANAnegative Riskofneonatallupusininfantsofaffectedwomen ANAnegativitycanbeinfluencedbylaboratorytestingmethods,disease duration,andtreatment

Quick HIT

ClinicalFindingsAssociatedWithNeonatalLupus

e

¢

e

Skinlesions Cardiacabnormalities(AVblock,transpositionofthegreatvessels) Valvularandseptaldefects

B.ClinicalFeatures

1. Constitutionalsymptoms:Fatigue,malaise,fever,weightloss 2. Cutaneous:Butterflyrash(erythematousrashovercheeksandbridgeofnose— foundinone-thirdofpatients)(Figure6-1),photosensitivity,discoidlesions (erythematousraisedpatcheswithkeratoticscaling),oralornasopharyngeal ulcers,alopecia,Raynaudphenomenon(vasospasmofsmallvesselswhen exposedtocold,usuallyinfingers—foundinabout20%ofcases)

3. Musculoskeletal:Arthralgias(maybethefirstsymptomofthedisease—foundin 90%ofpatients),arthritis(inflammatoryandsymmetric,rarelydeformingasin rheumatoidarthritis[RA]),myalgiawithorwithoutmyositis

4. Cardiac:Pericarditis,endocarditis(Libman–Sacksendocarditisisaserious complication),myocarditis

5. Pulmonary:Pleuritis(mostcommonpulmonaryfinding),pleuraleffusion, pneumonitis(mayleadtofibrosis),pulmonaryHTN(rare)

6. Hematologic:Hemolyticanemiawithanemiaorreticulocytosisofchronic disease,leukopenia,lymphopenia,thrombocytopenia

7. Renal:Proteinuria>0.5g/day(mayhavenephroticsyndrome),cellularcasts, glomerulonephritis(mayhavehematuria),azotemia,pyuria,uremia,HTN 8. Immunologic:Impairedimmuneresponseduetomanyfactors,including

Immunologic: Impaired immune response due to many factors, including autoantibodies to lymphocytes, abnormal T-cell function, and immunosuppressive medications; often associated with antiphospholipid syndrome

autoantibodiestolymphocytes,abnormalT-cellfunction,andimmunosuppressive medications;oftenassociatedwithantiphospholipidsyndrome 9. GI:Nausea/vomiting,dyspepsia,dysphagia,pepticulcerdisease 10. CNS:Seizures,psychosis(maybesubtle),depression,headaches,TIA,

cerebrovascularaccident

11. OtherfindingsincludeconjunctivitisandanincreasedincidenceofRaynaud phenomenonandSjögrensyndrome
======================================
FIGURE 6.1

SLEbutterflyrash.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Figure25.24.)

ClinicalCourseofSLE

e

e

Achronicdiseasecharacterizedbyexacerbationsandremissions Malarrash,jointpain,andfatiguearethemostcommoninitialfindings.Withmoreadvanceddisease,renal, pulmonary,cardiovascular,andnervoussystemsareaffected.

C.Diagnosis 1. Diagnosisismadebasedonthe2012SLICCcriteria.Thepatientmusthaveat

least4criteria(atleast1clinicalcriteriaand1immunologiccriteria)ORbiopsy- provenlupusnephritiswithapositiveANAoranti-dsDNA.

2. Autoantibodiesinlupus:

a. ANA:Sensitivebutnotspecific;almostallpatientswithSLEhaveelevated serumANAlevels(seeClinicalPearl6-1,Figure6-2,andTable6-1)

b. Anti-dsDNA(in70%):veryspecific(butnotsensitive) c. Anti-Smith(in30%):veryspecific(butnotsensitive)(seeTable6-2) d. Antiphospholipidantibodypositivity,asdeterminedbypositivelupus

anticoagulant,false-positiveRPR,medium-orhigh-titeranticardiolipinantibody

level,orpositiveanti-β-2glycoprotein(seeClinicalPearl6-2)

e. AntihistoneAbs(in70%)arepresentin>95%ofcasesofdrug-inducedlupus (seeClinicalPearl6-3).Ifnegative,drug-inducedlupuscanbeexcluded.

f. Ro(SS-A)andLa(SS-B)arefoundin15%to35%.Associatedwith:

Sjögrensyndrome SubacutecutaneousSLE Neonatallupus(withcongenitalheartblock) Complementdeficiency(C2andC4) ANA-negativelupus

CLINICALPEARL6-1

UsefulCriteriaforDiagnosingSLE 2012SLICCCriteria: Clinicalcriteria,intheabsenceofothercauses: 1. Acutecutaneouslupus 2. Chroniccutaneouslupus 3. Oralornasalulcers 4. Nonscarringalopecia 5. Synovitisinvolvingtwoormorejoints 6. Serositis 7. Renal:urineprotein-to-creatinineratio(or24-hoururineprotein)representing500-mgproteinover24hours

ORredbloodcellcasts

8. Neurologic 9. Hemolyticanemia

10. Leukopeniaorlymphopenia 11. Thrombocytopenia Immunologiccriteria: 1. ANA 2. Anti-dsDNA 3. Anti-Smith 4. Antiphospholipidantibodypositivity 5. Lowcomplement(C3,C4,CH50) 6. Coombspositivity(inabsenceofhemolyticanemia)

ANA positive Order additional tests (see text) Diagnostic criteria for SLE (4 of 11) met? ANA negative Probably NOT SLE IP Consider other diagnose Yes No v Diagnose SLE Defer diagnosis and/or consider other diagnoses
======================================
FIGURE 6.2

DiagnosisofSLE.

(AdaptedfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine. 4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:1387,Figure178-3.)

Quick HIT

ConditionsinWhichANAsAreElevated

SLE RA

Scleroderma Sjögrensyndrome Mixedconnectivetissuedisease Polymyositisanddermatomyositis Drug-inducedlupus

D.Treatment 1. Avoidsunexposurebecauseitcanexacerbatecutaneousrashes 2. NSAIDs—forlessseveresymptoms 3. Eitherlocalorsystemiccorticosteroids—foracuteexacerbations 4. Systemicsteroidsforseveremanifestations 5. Bestlong-termtherapyisantimalarialagentssuchashydroxychloroquine—for constitutional,cutaneous,andarticularmanifestations.Hydroxychloroquineis continuedasapreventativemeasureevenafterresolutionofsymptoms.Baseline andsubsequentannualeyeexaminationsareneededbecauseofretinaltoxicity.

6. Cytotoxicagentssuchascyclophosphamide—foractiveglomerulonephritis 7. Monitorthefollowingandtreatappropriately:

a. Renaldisease,whichproducesthemostsignificantmorbidity b. HTN

TABLE6-1 CommonLaboratoryMarkersinRheumatologicDiseases
======================================
vasculitis,trauma,malignancy, pancreatitis)

Iflevelsaremarkedlyelevated(>15),bacterial infectionislikelypresent

Quick HIT

SteroidsarethebesttreatmentforSLEpatientswithacuteflare.

Hydroxychloroquineforlong-termtreatmentforSLEcancauseretinaltoxicity.

Scleroderma(SystemicSclerosis)

A.GeneralCharacteristics 1. Achronicconnectivetissuedisorderthatcanleadtowidespreadfibrosis. 2. Pathophysiology:Cytokinesstimulatefibroblasts,causinganabnormalamountof collagendeposition.Itisthehighquantityofcollagenthatcausestheproblems associatedwiththisdisease(compositionofthecollagenisnormal).

3. Sclerodermaismorecommoninwomen.Averageageofonsetis35to50years. 4. Therearetwotypesofscleroderma:Diffuse(20%)andlimited(80%)(seeTable

6-3)

Quick HIT

ThemostcommoncausesofdeathinSLEareopportunisticinfectionsandrenalfailure.

B.ClinicalFeatures 1. Raynaudphenomenon

a. Presentinalmostallpatients;usuallyappearsbeforeotherfindings b. Causedbyvasospasmandthickeningofvesselwallsinthedigits

Quick HIT

Onlydiffusesclerodermaformhasrenal,lung,andheartinvolvement.

TABLE6-2 HLAAssociationsWithRheumaticDiseases  Disease  AssociatedHLA  SLE  HLA-DR2andHLA-DR3  Sjögrensyndrome  HLA-DR3  RA  HLA-DR4  Ankylosingspondylitis,Reitersyndrome,psoriaticarthritis  HLA-B27 

CLINICALPEARL6-2

AntiphospholipidAntibodySyndrome

e

AhypercoagulablestatethatcanbeidiopathicorassociatedwithSLE(orothercollagenvascular diseasessuchasscleroderma) Typicalfindings

Recurrentvenousthrombosis—pulmonaryembolismisarisk

¢

Recurrentarterialthrombosis Recurrentfetalloss(abortions) Thrombocytopenia Livedoreticularis Laboratoryfindings:Presenceoflupusanticoagulant,anticardiolipinantibody,orboth.Prolonged PTTorPTisnotcorrectedbyaddingnormalplasma Treatmentislong-termanticoagulation(INRof2.5to3.5) APAantibodiesreactwithcardiolipin,areagentinVDRLandRPRtestsleadingtofalsepositives

e

c. Canleadtodigitalischemia,withulcerationandinfarction/gangrene d. Coldtemperatureandstressbringaboutcolorchangesoffingers—blanching

first,thencyanotic,andthenredfromreactivehyperemia

2. Cutaneousfibrosis

a. Tighteningofskinofthefaceandextremities(sclerodactylyreferstoaclaw- likeappearanceofthehand)

b. Canleadtocontractures,disability,anddisfigurement

3. GIinvolvement

a. Occursinmostpatients(bothdiffuseandlimited) b. Findingsincludedysphagia/refluxfromesophagealimmobility(upto90%of

patients),delayedgastricemptying,constipation/diarrhea,abdominaldistention, andpseudo-obstruction.Prolongedacidrefluxmayeventuallyleadto esophagealstrictures.
======================================
Quick HIT

DifferentialDiagnosisofRaynaudPhenomenon

Primary—nootherdisorderexists Scleroderma SLE Mixedconnectivetissuedisease Vasculitis(e.g.,Buergerdisease) Certainmedications(e.g.,β-blockers,nicotine,bleomycin) Disordersthatdisruptbloodfloworvessels,suchasthromboangiitisobliterans

SLE

4. Pulmonaryinvolvement

a. Mostcommoncauseofdeathfromscleroderma b. Interstitialfibrosisand/orpulmonaryHTNmayalsobepresent

5. Cardiacinvolvement:pericardialeffusions,myocardialinvolvementthatcanlead toCHF,arrhythmias

6. Renalinvolvement(renalcrisis—rapidmalignanthypertension)occursinpatients withdiffusedisease(raretoday)

Quick HIT

Thedegreeofskininvolvementpredictsprognosis:Diffusesclerodermahasaworseprognosisthanlimited scleroderma.

C.Diagnosis 1. Diagnostictestsareoflimitedutility.AlmostallpatientshaveelevatedANAs

(highsensitivity,lowspecificity).

2. Anticentromereantibodyisveryspecificforthelimitedform. 3. AntitopoisomeraseI(antiscleroderma-70)Abisveryspecificforthediffuse

form.

4. Bariumswallow(esophagealdysmotility)andpulmonaryfunctiontestareusedto detectcomplications.

CLINICALPEARL6-3

Drug-InducedLupus

¢

e

¢

¢

e

Certaindrugsmayproducealupus-likesyndromethatissimilartoSLEexceptthatitdoesnotaffectthe CNSorkidneys. IfrenalorCNSinvolvementispresent,itisnotdrug-inducedlupus.Inaddition,theclassicbutterflyrash, alopecia,andulcersaretypicallynotseenindrug-inducedlupus. Mostpatientsimproveafterwithdrawaloftheoffendingdrug.Therefore,theprognosisisobviouslymore favorable. Commonlyimplicatedagentsincludehydralazine,procainamide,isoniazid,chlorpromazine,methyldopa,and quinidine. Laboratoryfindingsindrug-inducedlupus:Antihistoneantibodiesarealwayspresent;thereisanabsenceof anti-dsDNAandanti-SmAb.

TABLE6-3 DiffuseVersusLimitedScleroderma
======================================
Esophagealmotilitydysfunction Sclerodactylyofthefingers Telangiectases(overthedigitsandunderthenails)

D.Treatment 1. Noeffectivecure,andtreatmentissymptomaticdependingontheorgansinvolved 2. NSAIDsformusculoskeletalpains 3. H2blockersorprotonpumpinhibitorsforesophagealreflux 4. Raynaudphenomenon—avoidcoldandsmoking,keephandswarm;ifsevere,use

calcium-channelblockers

5. ACEinhibitorsareusedtopreventandtreatrenalhypertensivecrisis 6. Forseverediffuseskinandorganinvolvement,systemicimmunosuppressionis

indicated

Quick HIT

«

e

TwentypercentofpatientswithsclerodermahaveSjögrensyndrome. InpatientswithSjögrensyndrome,searchforoccultlymphoma(lookforlymphadenopathyand hepatosplenomegaly).

SjögrenSyndrome

A.GeneralCharacteristics 1. Sjögrensyndromeisanautoimmunediseasemostcommoninwomen. Lymphocytesinfiltrateanddestroythelacrimalandsalivaryglands.

2. Amultiorgandisease(canalsoinvolvetheskin,lungs,thyroid,vessels,andliver) 3. PrimaryversussecondarySjögrensyndrome

a. PrimarySjögrensyndrome:Dryeyesanddrymouth,alongwithlymphocytic infiltrationoftheminorsalivaryglands(onhistology);patientsdonothave anotherrheumatologicdisease

b. SecondarySjögrensyndrome:Dryeyesanddrymouthalongwithaconnective tissuedisease(RA,systemicsclerosis,SLE,polymyositis)

4. Patientshaveincreasedriskofnon-Hodgkinlymphoma.Malignancyisthemost commoncauseofdeath.

B.ClinicalFeatures 1. Dryeyes—burning,redness,blurredvision,keratoconjunctivitissicca 2. Drymouthandtoothdecay 3. Arthralgias,arthritis,fatigue 4. Interstitialnephritisandvasculitis

C.Diagnosis 1. ANAsarepresentin95%ofpatients.Rheumatoidfactor(RF)ispresentin50%

to75%ofpatientswithsecondarydisease.

2. Ro(SS-A)ispresentin60%ofpatients,andLa(SS-B)(morespecific)ispresent in40%ofpatients.

3. Schirmertest:Filterpaperinsertedineyetomeasurelacrimalglandoutput (degreeofwettinginaspecifiedtimeperiod)—highsensitivityandspecificity.

4. Salivaryglandbiopsy(liporparotid)isthemostaccuratebutnotneededfor diagnosis.

Quick HIT

PatientswithantibodiestoRo(SS-A)areatincreasedriskofhavingachildwithneonatalSLE(withcongenital heartblock).
======================================
D.Treatment 1. PilocarpineorCevimeline(muscarinicagoniststhatenhanceoralandocular

secretions)

2. Artificialtearsfordryeyes

3. Goodoralhygiene 4. NSAIDs,steroidsforarthralgias,arthritis 5. PatientswithsecondarySjögrensyndrome—therapyforconnectivetissuedisease

MixedConnectiveTissueDisease

Mixedconnectivetissuediseaseisan“overlap”syndromewithclinicalfeatures similartothoseofSLE,RA,systemicsclerosis,andpolymyositis.Findings consistentwitheachofthesediseasesdonotnecessarilyoccursimultaneously.It usuallytakessometimeforapatterntobeidentifiedandadiagnosisofmixed connectivetissuediseasetobemade. Clinicalfindingsincludepulmonaryinvolvement,esophagealdysfunction, polyarthritis,sclerodactyly,cutaneousmanifestations,myopathy,andRaynaud phenomenon. Thepresenceofanti-U1-RNPAbsisakeylaboratoryfinding.HighANAandRF maybepresent. Treatmentvariesaccordingtowhichspecificdiseasepredominates.

Quick HIT

RAisunlikelyif:

¢

e

e

JointdistributionisnotsymmetricOR DIPsareinvolvedOR Morningstiffnessisabsent

RheumatoidArthritis

A.GeneralCharacteristics 1. RAisachronicinflammatoryautoimmunediseaseinvolvingthesynoviumof

joints.Theinflamedsynoviumcancausedamagetocartilageandbone.

2. Itisasystemicdiseasethathasmanyextra-articularmanifestations(seebelow). 3. Theusualageofonsetis20to40years;itismorecommoninwomenthanin

men(3:1).

4. Etiologyisuncertain.Itmaybecausedbyaninfectionoraseriesofinfections (mostlikelyviral),butgeneticpredispositionisnecessary.

Quick HIT

Muchofthejointdamagethatultimatelyleadstodisabilityoccursearlyindisease,soearlytreatmentwith DMARDsiscritical.

B.ClinicalFeatures 1. Inflammatorypolyarthritis(jointswellingisthemostcommonsign)—caninvolve

everyjointinthebodyexcepttheDIPjoints(Figure6-3).

a. Morningstiffnesslasting>1hour—improvesasthedayprogresses. b. Jointscommonlyinvolvedincludejointsofthehands(PIP,MCP)andwrists,

knees,ankles,elbows,hips,andshoulders.

c. Characteristichanddeformities.

e

e

¢

UlnardeviationoftheMCPjoints(Figure6-4A). BoutonnièredeformitiesofthePIPjoints(PIPflexed,DIPhyperextended) (Figure6-4C). Swan-neckcontracturesofthefingers(MCPflexed,PIPhyperextended,DIP flexed)(Figure6-4B).

Quick  HIT  PoorPrognosticIndicatorsinRA  HighRFtiters Subcutaneousnodules Erosivearthritis 

2. Constitutionalsymptomscanbeprominent(seeTable6-4).
======================================
a. Low-gradefever,weightloss. b. Fatiguecanbeprominentbecausethisisasystemicdisease.

3. CervicalspineinvolvementiscommonatC1-C2(subluxationandinstability),

butitislesscommoninthelowercervicalspine.

a. Instabilityofthecervicalspineisapotentiallylife-threateningcomplicationof RA.Mostpatientsdonothaveneurologicinvolvement,butiftheydo,itcanbe progressiveandfatalifnottreatedsurgically.

Patient has an acute attack, which subsides, and never has an attack = again (10%) g ® ) A Time Undulating course—periods of exacerbations and remissions (20%) J = @ > ® o B Time Patient has periods of exacerbations and "remissions," but "remissions" 2 are really improvements, as & patients are symptomatic at all 3 times to some extent (65%) Cc Time Severe, progressive course (5%) 2 = @ > 2 7) D Time

FIGURE 6.3

TheclinicalcourseofRAcanbegroupedintofour classesofpatients.

b. Thisisseenin30%to40%ofpatients.AllpatientswithRAshouldhave cervicalspineradiographsbeforeundergoinganysurgery(duetoriskof

neurologicinjuryduringintubation).However,disease-modifyingantirheumatic drugs(DMARDs)havedramaticallyreducedtheneedforcervicalspinesurgery inRApatients.

Quick HIT

InRA,changesinjointsareusuallymoreextensivethaninOAbecausetheentiresynoviumisinvolvedin RA.Notethatosteophytes(characteristicofOA)arenotpresentinRA.

4. Cardiacinvolvementmayincludepericarditis,pericardialeffusions,conduction abnormalities,andvalvularincompetence.

5. Pulmonaryinvolvement—usuallypleuraleffusions;interstitialfibrosismayoccur. 6. Ocularinvolvement—episcleritisorscleritis. 7. Softtissueswelling(ratherthanbonyenlargement). 8. Dryingofmucousmembranes:Sjögrenxerostomia. 9. Subcutaneousrheumatoidnodulesoverextensorsurfacesmayalsooccurin visceralstructures—forexample,lungs,pleura,pericardium(Figure6-5).

a. PathognomonicforRA. b. Nearlyalwaysoccursinseropositivepatients(i.e.,thosewithRF).

C.Diagnosis 1. Laboratoryfindings(seeClinicalPearl6-4)

a. HightitersofRFareassociatedwithmoreseverediseaseandaregenerally nonspecific.RFiseventuallypresentin80%ofpatientswithRA(maybeabsent earlyinthedisease),butisalsopresentinupto3%ofthehealthypopulation.
======================================
FIGURE 6.4

Rheumatoidarthritis.A:Ulnardeviationat

metacarpophalangealjoints.B:Swan-neckdeformity.C: Boutonnièredeformity. (FromHunderGG.AtlasofRheumatology.3rded.Philadelphia,PA:LippincottWilliams

&Wilkins;2000:11,Figures1-27,1-28,and1-29A,respectively;andCurrMed2002:11.)

e

e

RFtitersrarelychangewithdiseaseactivityandarenotusefulforfollowing patients. Helpfulindeterminingprognosis.Hightiters→moreseveredisease.

b. Anticitrullinatedpeptide/proteinantibodies(ACPA)—sensitivityis50%to75%, specificityisover90%.

c. ElevatedESR,C-reactiveprotein. d. Anemiaofchronicdisease.
======================================
Alsoanemia,thrombocytopenia,andlymphadenopathy AssociatedwithhightitersofRFandextra-articulardisease Increasedsusceptibilitytoinfection Usuallyoccursfairlylateinthediseaseprocess

Blood

e

e

Anemiaofchronicdisease:Mild,normocytic,normochromicanemia Thrombocytosis

Vasculitis

Vasculitis

Amicrovascularvasculitis—canprogresstomesentericvasculitis,PAN,orother vascularsyndromes

FIGURE 6.5

Rheumatoidnodulesofthehand.

(FromStedmanTL.Stedman’sMedicalDictionaryfortheHealthProfessionsandNursing:

Illustrated.6thed.Philadelphia,PA:LippincottWilliams&Wilkins;2007.)

CLINICALPEARL6-4

DiagnosisofRA 1. Inflammatoryarthritisofmultiplejoints(higherlikelihoodif3ormorejointsinvolved)—MCP,PIP,

wrist,elbow,knee,ankle,MTPjoints

2. Symptomslastingatleast6weeks 3. ElevatedESRandCRP 4. PositiveserumRForACPA

Quick HIT

PatientswithdiagnosisofRAwhohaveapositiveRF,ACPA,orbothareatahigherriskofdeveloping erosivejointdamage—earlytreatmentwithDMARDsisindicated.

2. Radiographs(Figure6-6).NotrequiredforadiagnosisofRAbutmayhavethe followingcharacteristicfindings.

a. Lossofjuxta-articularbonemass(periarticularosteoporosis)nearthefinger joints.

b. Narrowingofthejointspace(duetothinningofthearticularcartilage)is usuallyseenlateinthedisease.

c. Bonyerosionsatthemarginsofthejoint.

3. Synovialfluidanalysis(seeTable6-5)isnonspecific.

Quick HIT

RadiographshavebecomelessimportantindiagnosisofRA,asjointabnormalitiesoccurverylate.DMARDs startedwellbeforeradiographsindicateabnormality.

D.Treatment 1. Goalistominimizepainandswelling,preventdiseaseprogression,andhelp

patientremainasfunctionalaspossible.

2. Exercisehelpstomaintainrangeofmotionandmusclestrength. 3. Symptomatictreatment.

a. NSAIDsarethedrugsofchoiceforpaincontrol. b. Corticosteroids(lowdose)—usetheseifNSAIDsdonotprovideadequaterelief.

Short-termtreatmentmaybeappropriatebutavoidlong-termuse.

FIGURE 6.6

Posteroanteriorradiographsofthehandshowingthe typicalpatternofinvolvementfor(A)osteoarthritis(osteophytes, subchondralsclerosis,jointspacenarrowing)(arrows)and(B) rheumatoidarthritis(periarticularerosions,osteopenia)(arrows). (AandBfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternal
======================================
Medicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:1463,Figures

190.4AandB.)

TABLE6-5 SynovialFluidAnalysis

Normal Clear <200 <25% Noninflammatory Clear, yellow: Possi- <2,000 <25% RBCs if traumatic arthritis (OA/trauma) __ bly red if traumatic Inflammatory Cloudy yellow >5,000 50-70% Positively birefringent arthritis (RA, gout, crystals with pseudogout; pseudogout, Reiter negatively birefringent syndrome) crystals with gout Septic arthritis (bac- Turbid, purulent Usually >50,000 >70% Synovial fluid culture terial, tuberculosis) positive for most cases of bacterial arthritis, except gonococcal (only 25% are positive)

Quick HIT

VariantsofRA

e

e

¢

Feltysyndrome:anemia,neutropenia,splenomegaly,andRA. JuvenileRA:beginsbefore18yearsofage.Extra-articularmanifestationsmaypredominate(Still disease)orarthritismaypredominate. Caplansyndrome:RAassociatedwithpneumoconiosis.

4. DMARDs

a. Generalprinciples

e

e

e

Canreducemorbidityandmortality(bynearly30%)—bylimiting complications,slowingprogressionofdisease,andpreservingjointfunction Shouldbeinitiatedearly(atthetimeofdiagnosis) Theyhaveaslowonsetofaction(6weeksorlongerforeffecttobeseen),so begintreatingRAwhilewaitingforthedisease-modifyingtherapytotake effect.GraduallytaperanddiscontinueNSAIDsandcorticosteroidsonce effectsareevident

b. Methotrexate—bestinitialDMARD

e

e

e

Initialimprovementisseenin4to6weeks. SideeffectsincludeGIupset,oralulcers(stomatitis),mildalopecia,bone marrowsuppression(coadministerwithfolinicacid),hepatocellularinjury, andidiosyncraticinterstitialpneumonitis,whichmayleadtopulmonary fibrosis.Itincreasesliverenzymesinsomepatients. Closelymonitorliverandrenalfunction Supplementwithfolate.

e

Quick HIT

Combinationtherapywithfirst-linedrugs(methotrexate,hydroxychloroquine,andsulfasalazine) produceshigherremissionrates.

c. Alternatives:leflunomide,sulfasalazine,hydroxychloroquine d. Antitumornecrosisfactor(anti-TNF)inhibitingagents(etanercept,infliximab, etc.)—usedifmethotrexatedoesnotfullycontrolthedisease.RequiresPPD screeningbecauseofriskofreactivationofTB.

e. Non-TNFbiologics(abatacept,rituximab,tofacitinib)arealsooptionsifdisease activityremainshighdespitemethotrexate.

5. Surgery(inseverecases)

a. Synovectomy(arthroscopic)decreasesjointpainandswellingbutdoesnot preventx-rayprogressionanddoesnotimprovejointrangeofmotion

b. Jointreplacementsurgeryforseverepainunresponsivetoconservativemeasures

MethotrexateisthemainstayoftherapyinRA.
======================================
Crystal-InducedArthritides

Gout

A.GeneralCharacteristics 1. Goutisaninflammatorymonoarticulararthritiscausedbythecrystallizationof monosodiumurateinjoints(Figure6-7)(seeTable6-6).Hyperuricemiaisa hallmarkofthedisease,butitdoesnotbyitselfindicategout.

2. Ninetypercentofpatientsaremenover30yearsofage.Womenarenotaffected untilaftermenopauseduetodecreasedestrogen-mediatedurinaryurateexcretion.

Olecranon bursa Elbow Wrist Fingers 1st a Knee Ankle Subtalar Midfoot

FIGURE 6.7

Gout:commonsitesofinvolvement.MTP,

metatarsophalangealjoint. (FromStollerJK,AhmadM,LongworthDL.TheClevelandClinicIntensiveReviewof

InternalMedicine.3rded.Philadelphia,PA:LippincottWilliams&Wilkins;2002:374, Figure30.6.)

3. Pathogenesis

a. Increasedproductionofuricacid.

e

¢

e

Hypoxanthine-guaninephosphoribosyltransferasedeficiency—forexample,in Lesch–Nyhansyndrome Phosphoribosylpyrophosphatesynthetaseoveractivity Increasedcellturnoverassociatedwithseveralconditions,includingcancer chemotherapy,chronichemolysis,andhematologicmalignancies

b. Decreasedexcretionofuricacid(accountsfor90%ofcases)

e

e

e

Renaldisease NSAIDs,diuretics Acidosis

4. Pathophysiologyofinflammation

a. PMNsplayakeyroleintheacuteinflammationofgout. b. Itdevelopswhenuricacidcrystalscollectinthesynovialfluidasthe

extracellularfluidbecomessaturatedwithuricacid.

c. IgGscoatmonosodiumuratecrystals,whicharephagocytizedbyPMNs,leading tothereleaseofinflammatorymediatorsandproteolyticenzymesfromthe PMNs,whichthenresultininflammation.

TABLE6-6 MajorArthritides

Onset Insidious Insidious Sudden Common locations Weight-bearing joints Hands (PIP, MCP), wrists, Great toe, ankles, (knees, hips, lumbar/ ankles, knees knees, elbows cervical spine), hands Presence of inflam- No Yes Yes mation Radiographic Narrowed joint space, Narrowed joint space, Punched-out erosions changes osteophytes, subchondral bony erosions with overhanging rim sclerosis, subchondral cysts of cortical bone Laboratory findings § Elevated ESR, RF, anemia Crystals Other features ¢ No systemic findings © Systemic findings— © Tophi ¢ Bouchard nodes and Heberden nodes in hands extra-articular manifestations common e Ulnar deviation, swan- neck, and boutonniére deformity © Nephrolithiasis
======================================
B.ClinicalFeatures(fourstages) 1. Asymptomatichyperuricemia.

a. Increasedserumuricacidlevelintheabsenceofclinicalfindingsofgout,may bepresentwithoutsymptomsfor10to20yearsorlonger.

b. Shouldnotbetreatedbecauseover95%ofpatientsremainasymptomatic.

2. Acutegoutyarthritis.

Quick HIT

PrecipitantsofanAcuteGoutyAttack

e

Decreaseintemperature Dehydration Stress(emotionalorphysical) Excessivealcoholintake Starvation

a. Peakageofonsetis40to60yearsofageformen. b. Initialattackusuallyinvolvessuddenonsetofexquisitepain.Painoftenwakes

thepatientfromsleep.

Mostoftenaffectsthebigtoe—thefirstmetatarsophalangealjoint(podagra). Othercommonjointsaffectedareanklesandknees.

c. Painandcelluliticchanges—erythema,swelling,tenderness,andwarmth. d. Fevermayormaynotbepresent. e. Asitresolves,thepatientmayhavedesquamationofoverlyingskin.

3. Intercriticalgout.

a. Anasymptomaticperiodaftertheinitialattack.Thepatientmaynothave anotherattackforyears.

b. Sixtypercentofpatientshavearecurrencewithin1year.Somepatients(fewer than10%)neverhaveanotherattackofgout.

c. Thereisa75%likelihoodofasecondattackwithinthefirst2years. d. Attackstendtobecomepolyarticularwithincreasedseverityovertime.

4. Chronictophaceousgout.

a. Occursinpeoplewhohavehadpoorlycontrolledgoutformorethan10to20

years. b. Tophi

DoaGramstainandcultureofthesynovialfluidtoruleoutsepticarthritis,whichisthemost worrisomediagnosisonthedifferentiallist.

e

¢

Aggregationsofuratecrystalssurroundedbygiantcellsinaninflammatory reaction. Tophicausedeformityanddestructionofhardandsofttissues.Injoints,they leadtodestructionofcartilageandbone,triggeringsecondarydegeneration anddevelopmentofarthritis.Theymaybeextra-articular.

c. Commonlocationsoftophi:Extensorsurfaceofforearms,elbows,knees, Achillestendons,andpinnaofexternalear.

Quick HIT

ComplicationsofGout

¢

e

Nephrolithiasis—riskissmall(lessthan1%peryear) Degenerativearthritisoccursinlessthan15%ofpatients.

C.Diagnosis 1. Jointaspirationandsynovialfluidanalysis(underapolarizingmicroscope)isthe

onlywaytomakeadefinitivediagnosis—needle-shapedandnegatively birefringenturatecrystalsappearinsynovialfluid.

2. Serumuricacidisnothelpfulindiagnosisbecauseitcanbenormalevenduring anacutegoutyattack.

3. Radiographsrevealpunched-outerosionswithanoverhangingrimofcortical boneinadvanceddisease.
======================================
Quick HIT

Inacutegout,avoidaspirin(canaggravatetheproblem),acetaminophen(hasnoanti-inflammatoryproperties), andurate-loweringdrugs(initiationduringflaremayworsenorprolongtheflare).Initiateurate-lowering pharmacotherapyoncetheacuteflarehasresolved.

D.Treatment 1. Inallstages,avoidsecondarycausesofhyperuricemia.

a. Medicationsthatincreaseuricacidlevels(thiazideandloopdiuretics) b. Obesity c. Reducealcoholintake. d. Reducedietarypurineintake.Limitintakeofseafood/redmeat.

2. Acutegout.

a. Bedrestisimportant.Earlyambulationmayprecipitatearecurrence. b. NSAIDs

Treatmentofchoiceinacutegout(indomethacinistraditionallyused,butother NSAIDsareeffective).

c. Colchicine

e

e

e

AnalternativeforpatientswhocannottakeNSAIDsordidnotrespondto NSAIDs. Effectivebutlessfavoredbecause80%oftreatedpatientsdevelopsignificant nausea/vomiting,abdominalcramps,andseverediarrhea.Compliancetendsto belowduetothesesideeffects. Dosemustbereducedinrenalinsufficiencyandcancausecytopenia.

d. Corticosteroids

e

e

Oralprednisone(7-to10-daycourse)ifpatientdoesnotrespondtoorcannot tolerateNSAIDsandcolchicine. Intra-articularcorticosteroidinjections(ifonlyonejointisinvolved)— dramaticreliefofsymptoms.

3. Prophylactictherapy.

a. Waituntilpatienthashadatleasttwoacutegoutyattacksbeforeinitiating prophylactictherapy.Thisisbecausethesecondattackmaytakeyearstooccur (ifatall),andsotherisk-to-benefitratioforprophylacticmedicationisnot favorableafteronegoutyattack.Thepresenceoftophiisalsoanindicationfor prophylactictherapy.

b. Whengivingprophylaxis,addeithercolchicineoranNSAIDfor3to6months topreventanacuteattack.ThecolchicineorNSAIDcanthenbediscontinued, andthepatientcanremainontheuricosuricagentorallopurinolindefinitely. c. Thechoiceofwhethertouseuricosuricdrugsorallopurinoldependsonhow

muchuricacidisexcretedintheurineina24-hourperiod.

e

e

Uricosuricdrugs(probenecid,sulfinpyrazone)—ifthe24-hoururineuricacid is<800mg/day,thisindicatesundersecretionofurate.Thesedrugsincrease renalexcretionofuricacid;usethemonlyinpatientswithnormalrenal function.Theyarecontraindicatedifthepatienthasahistoryofrenalstones. Xanthineoxidaseinhibitors(allopurinol,febuxostat)—ifthe24-hoururineuric acidis>800mg/day,thisindicatesoverproduction.Thesedrugsdecreaseuric acidsynthesis.UnlikeNSAIDsanduricosuricdrugs,theyarenot contraindicatedinkidneydysfunction.WatchoutforStevens–Johnson syndromewithallopurinolandcardiovasculareventswithfebuxostat.Uricases (pegloticase,rasburicase)—Thesedrugscatalyzetheconversionofurateinto allantoin,amoresolublepurinedegradationproduct.Theymaycause infusionreactions.
======================================
Pseudogout(CalciumPyrophosphateDepositionDisease)

A.GeneralCharacteristics 1. Calciumpyrophosphatecrystalsdepositinjoints,leadingtoinflammation. 2. Riskfactors.

a. DepositionincreaseswithageandwithOAofthejoints.Therefore,pseudogout iscommoninelderlypatientswithdegenerativejointdisease.

b. Otherconditionsthatmayincreasecrystaldepositioninclude hemochromatosis,hyperparathyroidism,hypothyroidism,andBartter syndrome.

Quick HIT

Presentationofpseudogoutissimilartogout,buttypicallyoccursinlargerjoints(knee).

B.ClinicalFeatures 1. Themostcommonjointsaffectedarekneesandwrists. 2. Itisclassicallymonoarticular,butcanbepolyarticular.

C.Diagnosis 1. Jointaspirateisrequiredfordefinitivediagnosis—weaklypositively

birefringent,rod-shapedandrhomboidalcrystalsinsynovialfluid(calcium pyrophosphatecrystals)(Figure6-8)

2. Radiographs—chondrocalcinosis(cartilagecalcification)

D.Treatment 1. Treattheunderlyingdisorder(ifidentified) 2. Symptomaticmanagementissimilartothatforgout

First-linetherapyincludesNSAIDs Colchicineisusefulforprophylaxis Intra-articularsteroidinjections,particularlywithtriamcinolone 3. Totaljointreplacementisappropriateifsymptomsaredebilitating

Hand P (swelling, erythema, fever), + ESR, possible synovial fluid aspiration and analysis Synovial fluid aspiration and analysis Inflammatory Noninflammatory Osteoarthritis * Gonococcal *RA ° Viral *SLE «Lyme * Scleroderma + Reiter * Psoriatic arthritis syndrome * Other autoimmune * Rheumatic fever disease Consider: * Trauma * Coagulopathy * Tumor * Avascular necrosis * Charcot joint

FIGURE 6.8

Evaluationofjointpain.

MyopathiesandPainSyndromes IdiopathicInflammatoryMyopathies

A.GeneralCharacteristics 1. Classification

a. Polymyositis(doesnotinvolveskin) b. Dermatomyositis(associatedwithcharacteristicskinrash)

B.Causes 1. Pathologicchangesinmuscle

a. Dermatomyositis—humoralimmunemechanisms b. Polymyositisandinclusionbodymyositis—cell-mediatedprocess

C.ClinicalFeatures 1. Featurescommontobothpolymyositisanddermatomyositis(seeClinicalPearl6-
======================================
eUMcALrEA

5) CLINICALPEARL6-5

DiagnosticCriteriaforPolymyositis Iftwooffirstfour→possiblepolymyositis Ifthreeoffirstfour→probablepolymyositis Ifallfour→definitepolymyositis

e

Symmetricproximalmuscleweakness Elevationinserumcreatinephosphokinase EMGfindingsofamyopathy Biopsyevidenceofmyositis Characteristicrashofdermatomyositis

a. Symmetricalproximalmuscleweaknessthatdevelopssubacutelyoverweeks orseveralmonths

e

e

Theearliestandmostseverelyaffectedmusclegroupsaretheneckflexors, shouldergirdle,andpelvicgirdlemuscles Distalextremityweaknessislessfrequentandtypicallylesssevere

b. Myalgiain33%ofpatients c. Dysphagiainupto30%ofpatients(involvementofstriatedmuscleintheupper

GItract)

d. Morecommoninfemalepatients e. AssociatedfindingsincludeCHF,conductiondefects,arthralgias,andinterstitial

lungdisease

2. Featuresuniquetodermatomyositis

a. Heliotroperash(butterfly)—aroundeyes,bridgeofnose,cheeks b. Gottronpapules—papular,erythematous,scalylesionsovertheknuckles(MCP,

PIP,DIP)

c. Vsign—rashontheface,neck,andanteriorchest d. Shawlsign—rashonshouldersandupperback,elbows,andknees e. Periungualerythemawithtelangiectases f. Subcutaneouscalcificationsinchildren—canbeextremelypainful g. AssociatedwithvasculitisoftheGItract,kidneys,lungs,andeyes(more

commoninchildren)

h. Thereisanincreasedincidenceofmalignancyinolderadults(lung,breast, ovary,GItract,andmyeloproliferativedisorders).Oncedermatomyositisis diagnosed,makeanefforttouncoveranoccultmalignancy.Dermatomyositis associatedwithmalignancyoftenremitsoncethetumorisremoved.

D.Diagnosis 1. Laboratory

a. CKlevelissignificantlyelevated.CKlevelscorrespondtothedegreeofmuscle necrosis,soonecanmonitorthediseaseseverity.

b. LDH,aldolase,AST,ALTarealsoelevated. c. ANAinover50% d. Antisynthetaseantibodies(anti-Jo-1antibodies)—abruptonsetoffever,

crackedhands,Raynaudphenomenon,interstitiallungdiseaseandfibrosis, arthritis;doesnotrespondwelltotherapy

e. Antisignalrecognitionparticle

e

e

Cardiacmanifestations(common) Worstprognosisofallsubsets

f. Anti-Mi-2antibodies—betterprognosis

2. EMG—abnormalin90%ofpatients 3. Musclebiopsy
======================================
a. Showsinflammationandmusclefiberfibrosis b. Dermatomyositis—perivascularandperimysial c. Polymyositisandinclusionbodymyositis—endomysial

Quick HIT

Inclusionbodymyositisisthe“oddballofinflammatorymyopathies”forthefollowingreasons:Affectsmale patientsmorethanfemalepatients,absenceofautoantibodies,distalmuscleinvolvement,andrelativelylow creatinekinase(CK);prognosisispoor.

E.Treatment 1. Corticosteroidsaretheinitialtreatment 2. Steroid-sparingimmunosuppressiveagents(toreducesteroid-inducedside

effects)—methotrexate,azathioprine

3. Physicaltherapy

InclusionBodyMyositis

A.GeneralCharacteristics

Morecommoninmen(elderly) Insidiousonsetofslowlyprogressiveproximalanddistalweakness,oftenleadsto delayindiagnosis Thereisearlyweaknessandatrophyofquadriceps,forearmflexors,andtibialis anteriormuscles.Involvementisasymmetrical.Facialweaknessoccursinone-third ofpatients,anddysphagiainone-halfofpatients. Patientscanalsohavelossofdeeptendonreflexes(nervesarenotinvolvedin polymyositisanddermatomyositis) Extramuscularmanifestationsarerare Diagnosis—slightelevationofCKlevels(relativelylow) Poorresponsetotherapy Notassociatedwithautoantibodies

Quick HIT

About10%ofpeoplewithpolymyalgiarheumaticadeveloptemporalarteritis;upto40%to50%ofpeople withtemporalarteritishavecoexistingpolymyalgiarheumatica.

PolymyalgiaRheumatica

A.GeneralCharacteristics 1. Usuallyoccursinelderlypatients(rarebeforetheageof50).Themeanageof

onsetis70,anditismorecommoninwomen.

2. Thecauseisunknown,butanautoimmuneprocessmayberesponsible.Thereisa possiblegeneticlink(associationwithHLA-DR4allele).

3. Self-limiteddisease(durationof1to2years).

B.ClinicalFeatures 1. Hipandshouldermusclepain(bilateral)

a. Oftenbeginsabruptly(butmaybegradual) b. Stiffnessinshoulderandhipregionsafteraperiodofinactivityisthemost

prominentsymptom

c. Painoccursonmovement;musclestrengthisnormal d. Profoundmorningstiffnessiscommon

2. Constitutionalsymptomsareusuallypresent:Malaise,fever,depression,weight loss,andfatigue

3. Jointswelling

a. Upto20%ofpatientshavesynovitisinknees,wrists,orhandjoints(canbe confusedwithRA)

b. Synovitisandtenosynovitisaroundtheshouldermayleadtorotatorcuff tendonitisoradhesivecapsulitis

4. Signsandsymptomsoftemporalarteritis(ifpresent)
======================================
C.Diagnosis 1. Essentiallyaclinicaldiagnosis 2. ESRisusuallyelevatedandaidsindiagnosis

a. Almostalways>50,frequently>100 b. Correlateswithdiseaseactivity

D.Treatment:corticosteroids 1. Responseusuallyoccurswithin1to7days.Corticosteroidsarenotcurative,but

areeffectiveinsuppressinginflammationuntilthediseaseresolvesitself.

2. After4to6weeks,begintotaperslowly. 3. Mostpatients(60%to70%)canstopcorticosteroidswithin2years.Afew

patientshavesymptomsforupto10years.

Fibromyalgia

A.GeneralCharacteristics 1. Adultwomenaccountfor80%to90%ofcases. 2. Chronicnonprogressivecoursewithwaxingandwaninginseverity;many

patientsimprovewithtime.

3. Keytodiagnosis:multipletriggerpoints(pointsthataretendertopalpation)

a. Symmetrical. b. Eighteencharacteristiclocationshavebeenidentified,includingocciput,neck,

shoulder,ribs,elbows,buttocks,andknees.

4. Etiologyisunknown—somatizationisnotaprovencause.

B.ClinicalFeatures 1. Stiffness,bodyaches(musculoskeletal),fatigue.

a. Painisconstantandaching,andisaggravatedbyweatherchanges,stress,sleep deprivation,andcoldtemperature.Itisworseinthemorning.

b. Rest,warmth,andmildexerciseimprovethepain. 2. Sleeppatternsaredisrupted,andsleepisunrefreshing. 3. Anxietyanddepressionarecommon.

C.Diagnosis 1. Diagnosticcriteria

a. Widespreadpainincludingaxialpainforatleast3months b. Paininatleast11ofthe18possibletenderpointsites

2. Therearenospecificconfirmatorytestsforfibromyalgia,therefore,itisimportant toruleout/considerthefollowingconditions:Myofascialsyndromes,rheumatoid disease,polymyalgiarheumatica,ankylosingspondylitis,spondyloarthropathy, chronicfatiguesyndrome,Lymedisease,hypothyroidism,polymyositis, depressionandsomatizationdisorder,andhypertrophicosteoarthropathy.

D.TreatmentandManagement 1. Advisethepatienttostayactiveandengageinlowintensityexercise. 2. First-linetreatmentforfibromyalgiaisamitriptyline. 3. Localanestheticattriggerpointsisusedacutely. 4. Milnacipran(SNRI)andpregabalinarealsoused. 5. Cognitivebehavioraltherapy;considerpsychiatricevaluation.
======================================
SeronegativeSpondyloarthropathies AnkylosingSpondylitis

A.GeneralCharacteristics 1. StrongassociationwithHLA-B27(90%ofpatients)(seeTable6-2),however,

presenceofHLA-B27shouldnotbeconsidereddiagnostic(seeClinicalPearl6- 6).

2. Threetimesmorecommoninmalethaninfemalepatients. 3. Bilateralsacroiliitisisaprerequisiteformakingthediagnosis. 4. Onsetisinadolescenceoryoungadulthood. 5. Itischaracterizedby“fusion”ofthespineinanascendingmanner(fromlumbar

tocervicalspine).

6. Course.

a. Thereisaslowprogression,butthecourseishighlyvariable;acute exacerbationsarecommon.

b. Lifeexpectancyisusuallynormal. c. Thefirst10yearsofthediseasecangiveanindicationoflong-termseverity.

B.ClinicalFeatures 1. Lowbackpainandstiffness(secondarytosacroiliitis)—limitedmotioninlumbar

spine

2. Neckpainandlimitedmotionincervicalspine—occurslaterincourseofdisease

CLINICALPEARL6-6

SeronegativeSpondyloarthropathies Diseasesthatbelongtoseronegativespondyloarthropathiesincludethefollowing:

e

e

¢

e

¢

Ankylosingspondylitis Reactivearthritis(andReitersyndrome) Psoriaticarthritis ArthropathyofIBD Undifferentiatedspondyloarthropathies

Seronegativespondyloarthropathieshavethefollowingincommon:

e

e

©

e

e

e

NegativeRF StrongassociationwithHLA-B27antigen Oligoarthritis(asymmetrical) Enthesitis(inflammationatsitesofinsertionoffascia,ligament,ortendontobone) Inflammatoryarthritis(axialandsacroiliacjoints) Extra-articularfeatures(eyes,skin,genitourinarytract) Familialpredisposition

e

3. Enthesitis—inflammationattendinousinsertionsintobone(Achillestendonand supraspinatustendon)

Quick HIT

Inankylosingspondylitis,lowbackpainandstiffnessarecharacteristicallyworseinthemorningandbetter asthedayprogresses.Theyimprovewithactivityandahotshowerandworsenwithrestorinactivity.

4. Withextensivespinalinvolvement,thespinebecomesbrittleandisproneto fractureswithminimaltrauma.Severespinalcordinjurycanoccurwithsuch trauma.

5. Chestpainanddiminishedchestexpansion—duetothoracicspineinvolvement 6. Shoulderandhippain—mostcommonlytheperipheraljointsareaffected 7. Constitutionalsymptoms—fatigue,low-gradefever,weightloss 8. Extra-articularmanifestations

a. Eyeinvolvement(mostcommon)—acuteanterioruveitisoriridocyclitis b. Otherextra-articularfeaturesarerare,butmayinvolvethefollowingsystems: Cardiac(AVheartblockandaorticinsufficiency),renal,pulmonary,and nervoussystems

9. Lossoflumbarlordosiscanoccurasdiseaseadvances,leadingtoinabilityto standupright.Whensevereandsymptomatic,thismayrequirespine reconstruction.
======================================
Quick HIT

ComplicationsofAnkylosingSpondylitis

Restrictivelungdisease Caudaequinasyndrome Spinefracturewithspinalcordinjury Osteoporosis Spondylodiscitis

C.Diagnosis 1. Imagingstudiesoflumbarspineandpelvis(plainfilm,MRI,orCT)reveal

sacroiliitis—scleroticchangesinthesacroiliacarea.Eventually,thevertebral columnsfuse,producing“bamboospine.”

2. ElevatedESRinupto75%ofpatients(duetoinflammation)—nonspecific 3. HLA-B27isnotnecessaryfordiagnosis.Presentin8%ofgeneralpopulation

D.Treatment 1. NSAIDs(indomethacin)forsymptomaticrelief 2. Anti-TNFmedications(etanercept,infliximab)

3. Physicaltherapy(maintaininggoodposture,extensionexercises) 4. Surgerymaybenecessaryinsomepatientswithseverespinaldeformity 5. Patientswithankylosingspondylitiswhosustainevenminortraumaandwho

complainofneckorbackpainshouldbestrictlyimmobilizedtopreventspinal cordinjuryuntilthoroughimagingstudies(includingCTscanandpossiblyMRI) areobtained.

ReactiveArthritis/ReiterSyndrome

A.GeneralCharacteristics 1. Reactivearthritisisasymmetricinflammatoryoligoarthritisoflowerextremities (upperextremitieslesscommon)(seeTable6-7).Thearthritisisprecededbyan infectiousprocessthatisremotefromthesiteofarthritis(1to4weeksprior), usuallyafterentericorurogenitalinfections.

2. ItoccursmostlyinHLA-B27–positiveindividuals. 3. Reitersyndromeisanexampleofreactivearthritis,butmostpatientsdonothave theclassicfindingsofReitersyndrome(arthritis,uveitis,andurethritis),sothe termreactivearthritisisnowused.
======================================
4. TheorganismsusuallyassociatedwithreactivearthritisincludeSalmonella, Shigella,Campylobacter,Chlamydia,Yersinia.

Quick HIT

Reactivearthritisisaclinicaldiagnosis.Ifanypatienthasacuteasymmetricarthritisthatprogressessequentially fromonejointtoanother,reactivearthritisshouldbeinthedifferentialdiagnosis.

B.ClinicalFeatures 1. Lookforevidenceofinfection(GIorgenitourinary)1to4weeksbeforetheonset

ofsymptoms.

2. Asymmetricarthritis—newjointsmaybeinvolvedsequentiallyoverdays.Joints arepainful,witheffusionsandlackofmobility.

3. Fatigue,malaise,weightloss,andfeverarecommon. 4. Jointpainmaypersistorrecuroveralong-termperiod.

Quick HIT

Thetermundifferentiatedspondyloarthropathyisusedwhenapatienthasfeaturesofreactivearthritisbut thereisnoevidenceofpreviousinfection(intheGIorgenitourinarytract)andtheclassicfindingsofReiter syndromeareabsent.

C.Diagnosis Send synovial fluid for analysis (to rule out infection or crystals). There is no test specifictoreactivearthritis.

D.Treatment 1. NSAIDsarefirst-linetherapy. 2. Ifthereisnoresponse,thentrysulfasalazineandimmunosuppressiveagentssuch

asazathioprine.

3. Antibioticuseiscontroversial—usuallynotgiven.

PsoriaticArthritis

Developsin10%to30%ofpatientswithpsoriasis. Itistypicallygradualinonset.Patientsusuallyhaveskindiseaseformonthstoyears beforearthritisdevelops. Usuallyasymmetricandpolyarticular.Characteristicdactylitis(“sausagedigits”) andnailpittingmayalsobepresent. Upperextremitiesmostofteninvolved;smallerjointsmorecommonthanlarge joints. InitialtreatmentisNSAIDs,butpersistentarthritismayrequiremethotrexateoranti- TNFagents.Steroidsaretypicallynotused.

VasculitisOverview

1. Vasculitisreferstoinflammationwithinbloodvesselwalls. 2. Vasculitidesareclassifiedbasedonthesizeofthevesselsinvolved:

a. Large-vessel:aortaandmajorbranches b. Medium-vessel:mediumarteries c. Small-vessel:smallarteriesandcapillaries.FurthersubdividedintoANCA-

associatedvasculitidesandimmunecomplexvasculitides.

d. Variable-vessel

Large-VesselVasculitides
======================================
Temporal/GiantCellArteritis

A.GeneralCharacteristics 1. Vasculitisofunknowncause;typicalpatientis>50yearsofage;twiceascommon

inwomenasmen(seeClinicalPearl6-7).

2. Thetemporalarteriesaremostfrequentlyaffected,butitmayinvolveother arteries,suchastheaortaorcarotids.Carotidbruits,decreasedpulsesinthearms, andaorticregurgitationmayalsobeobserved.

3. Associatedwithincreasedriskofaorticaneurysmandaorticdissection.

B.ClinicalFeatures 1. Constitutionalsymptomsofmalaise,fatigue,weightloss,andlow-gradefever 2. Headaches—maybesevere 3. Visualimpairment(inonly25%to50%)

a. Causedbyinvolvementofophthalmicartery b. Opticneuritis;amaurosisfugax;mayleadtoblindnessinupto50%ifnot

treatedearlyandaggressively

4. Jawpainwithchewing—intermittentclaudicationofjaw/tonguewhenchewing 5. Tendernessovertemporalartery;absenttemporalpulse 6. Palpablenodules 7. Fortypercentofpatientsalsohavepolymyalgiarheumatica

Quick HIT

KeystoDiagnosingTemporalArteritis

e

e

e

¢

Age>50years Newheadache Tender/palpabletemporalartery HighESR Jawclaudication

C.Diagnosis 1. ESRelevated(butnormalESRdoesnotexcludethediagnosis) 2. Biopsyofthetemporalarteryhasasensitivityof90%.Asinglenegativebiopsy

doesnotexcludethediagnosis.

D.Treatment 1. Usehigh-dosesteroids(prednisone)earlytopreventblindness.

a. Starttreatmentimmediately,eveniftemporalarteritisisonlysuspected.Donot

waitforbiopsyresults.Ifvisuallossispresent,admitthepatienttothehospital

forIVsteroids;otherwise,startoralprednisone. CLINICALPEARL6-7

Vasculitis

Inallofthevasculiticsyndromes,bloodvesselsareinflamedandvascularnecrosiscanresult. Findingsdependonthesizeofthevesselinvolvedandthelocationofinvolvement(targetorgan ischemia). Ifanypatienthasasystemicillnessthathasnotbeenexplainedbyanotherprocess(orhasischemia involvingoneormoresystems),entertainthediagnosisofvasculitis. Classifiedaccordingtosizeofvessel Largevessel:Takayasuarteritis,temporalarteritis Mediumvessel:PAN,Kawasakidisease(pediatric) Smallvessel:

e

e

ANCA-associated:GPA,EGPA,microscopicpolyangiitis Immunecomplex:cryoglobulinemic,IgAvasculitis(pediatric)

Variablevessel:Behçetsyndrome

b. Ifthediagnosisisconfirmed,continuetreatmentforatleast4weeks,thentaper gradually,butmaintainsteroidtherapyforupto2to3years.Relapseislikelyto occurifsteroidsarestoppedprematurely.
======================================
Quick HIT

Iftemporalarteritisissuspected,beginprednisoneandorderatemporalarterybiopsy.

2. FollowuponESRlevelstomonitoreffectivenessoftreatment. 3. Visuallossinoneeyemaybetemporaryorpermanent.Promptandaggressive

steroidtreatmentisprimarilygiventopreventinvolvementoftheothereye,butit mayimprovethevisualoutcomeintheaffectedeyeaswell.

4. Evenifuntreated,thediseaseisusuallyeventuallyself-limitinginmostpatients, althoughvisionlossmaybepermanent.

Quick HIT

SuspectTakayasuarteritisinayoungwomanwith:

e

e

e

Decreased/absentperipheralpulses DiscrepanciesofBP(armvs.leg) Arterialbruits

TakayasuArteritis

A.GeneralCharacteristics 1. MostcommoninyoungAsianwomen

2. Granulomatousvasculitisofaorticarchanditsmajorbranches—leadingto fibrosisandpotentiallycausingtostenosisornarrowingofvessels

3. Diagnosedviaarteriogram

B.ClinicalFeatures 1. Constitutionalsymptoms—fever,nightsweats,malaise,arthralgias,fatigue 2. Painandtendernessoverinvolvedvessels 3. Absentpulsesincarotid,radial,orulnararteries;aorticregurgitationmaybe

present

4. Signsandsymptomsofischemiaeventuallydevelopinareassuppliedbyinvolved vessels

5. Severecomplicationsincludelimbischemia,aorticaneurysms,aortic regurgitation,stroke,andsecondaryHTNduetorenalarterystenosis.Themain prognosticpredictoristhepresenceorabsenceofthesecomplications.

6. Causesvisualdisturbancesduetoocularinvolvementandhemorrhageofretinal arteries

C.Treatment 1. Steroidssuchasprednisonemayrelievethesymptoms. 2. TreatHTN. 3. Surgeryorangioplastymayberequiredtorecannulatestenosedvessels.Bypass

graftingissometimesnecessary.

Medium-VesselVasculitides

PolyarteritisNodosa

A.GeneralCharacteristics 1. Vasculitisofmedium-sizedvesselsinvolvingthenervoussystemandGItract 2. CanbeassociatedwithhepatitisB,HIV,anddrugreactions 3. Pathophysiology:PMNinvasionofalllayersandfibrinoidnecrosisplusresulting intimalproliferationleadtoreducedluminalarea,whichresultsinischemia, infarction,andaneurysms

4. Necrosisissegmented,leadingto“rosarysign”asaresultofaneurysms
======================================
Quick HIT

ThereisnopulmonaryinvolvementinPAN(whichdistinguishesitfromGPA).

B.ClinicalFindings 1. Earlysymptomsarefever,weakness,weightloss,myalgias,arthralgias,and

abdominalpain(bowelangina).

2. OtherfindingsareHTN,mononeuritismultiplex,andlivedoreticularis.

C.Diagnosis 1. Diagnosisismadebybiopsyofinvolvedtissueormesentericangiography. 2. ESRisusuallyelevated,andp-ANCAmaybepresent. 3. Testforfecaloccultblood.

D.PrognosisandTreatment Theprognosisispoor,butisimprovedtoalimitedextentwithtreatment.Startwith corticosteroids.Ifsevere,addcyclophosphamide.

ANCA-associatedSmall-VesselVasculitides

GranulomatosisWithPolyangiitis(GPA),FormerlyCalledWegener Granulomatosis

A.GeneralCharacteristics Vasculitispredominantlyinvolvingthekidneysandupperandlowerrespiratorytract (sometimesotherorgansaswell)

Quick HIT

MostpatientswithGPAalsohavesinusdisease,pulmonarydisease,andglomerulonephritis.Renaldisease accountsforthemajorityofdeaths.

B.ClinicalFeatures 1. Upperrespiratorysymptoms(e.g.,sinusitis);purulentorbloodynasaldischarge 2. Oralulcers(maybepainful) 3. Pulmonarysymptoms(cough,hemoptysis,dyspnea) 4. Renalinvolvement(glomerulonephritis—mayhaverapidlyprogressiverenal

failure)

5. Eyedisease(conjunctivitis,scleritis) 6. Musculoskeletal(arthralgias,myalgias) 7. Trachealstenosis 8. Constitutionalfindings(e.g.,fever,weightloss)

C.Diagnosis 1. Chestradiographisabnormal(nodulesorinfiltrates). 2. Laboratoryfindings:MarkedlyelevatedESR,anemia(normochromic

normocytic),hematuria,positivec-ANCAin90%ofpatients—sensitiveand specific;thrombocytopeniamaybepresent.

3. Openlungbiopsyconfirmsdiagnosis.

D.PrognosisandTreatment 1. Prognosisispoor—mostpatientsdiewithin1yearafterthediagnosis. 2. Acombinationofcyclophosphamideandcorticosteroidscaninduceremissions

inmanypatients,butarelapsemayoccuratanytime.

3. Considerrenaltransplantationifthepatienthasend-stagerenaldisease(ESRD).

EosinophilicGranulomatosisWithPolyangiitis(EGPA),PreviouslyCalled Churg–StraussSyndrome

Vasculitisinvolvingmanyorgansystems(respiratory,cardiac,GI,skin,renal,

neurologic) Clinicalfeaturesincludeconstitutionalfindings(fever,fatigue,weightloss), prominentrespiratorytractfindings(asthma,dyspnea),skinlesions(subcutaneous nodules,palpablepurpura),aswellaseosinophilia. Diagnosisismadebybiopsyoflungorskintissue(prominenceofeosinophils).Itis associatedwithp-ANCA. Theprognosisispoorwitha5-yearsurvivalof25%(deathisusuallyduetocardiac orpulmonarycomplications).Withtreatment(steroids),the5-yearprognosis improvesto50%.
======================================
MicroscopicPolyangiitis

LikeGPA,commonlyinvolvestheskin(palpablepurpura),lungs(cough,dyspnea, hemoptysis,pulmonaryfibrosis,pulmonaryhypertension),andkidneys (glomerulonephritis) UnlikeGPA,doesnottypicallyhavenasopharyngealinvolvement CanalsobedistinguishedfromGPAbybiopsy,whichshowsnecrotizingvasculitis withoutgranulomas

ImmuneComplexSmall-VesselVasculitides

CryoglobulinemicVasculitis

Causedbydepositionofcryoglobulins,whichareimmunoglobulinsthatprecipitate incoldtemperatures ClassifiedintoTypeI,TypeII,andTypeIIIbasedonthetypeandclonalityof immunoglobulins MostcommoncauseischronicHCVinfection.OthercausesincludechronicHBV infection,HIVinfection,andothercausesofchronicliverdisease(e.g.,autoimmune hepatitis,primarybiliarycirrhosis). Proposedmechanismisdepositionofantigen-antibodycomplexes(suchasHCV antibodies)insmallvessels,whichleadstocomplementactivationand inflammation.Liverdiseasemaycontributetodecreasedimmunecomplex clearance,whichleadstogreatertissuedepositionanddiseaseactivity. Commonclinicalmanifestationsincludepalpablepurpura,renaldisease, arthralgias/arthritis,peripheralneuropathy,andhypocomplementemia.Pulmonary andCNSinvolvementarerare. Diagnosisismadeclinically,bythepresenceofcirculatingcryoglobulins,andbya biopsyshowingleukocytoclasticvasculitis(inflammationwithpolymorphonuclear leukocytenucleardebris).PatientsshouldbetestedforunderlyingHCV,HBV,and HIV.

Variable-VesselVasculitis

BehçetSyndrome

Anautoimmune,multisystemvasculiticdisease;causeisunknown. Clinicalfeatures:painful,sterileoralandgenitalulcerations(pathergy),arthritis (kneesandanklesmostcommon),eyeinvolvement(uveitis,opticneuritis,iritis, conjunctivitis),CNSinvolvement(meningoencephalitis,intracranialHTN),fever, andweightloss. Diagnosisismadebybiopsyofinvolvedtissue(laboratorytestsarenothelpful). Treatmentissteroids,whicharehelpful. OftenpresentsinMiddleEasterners.

7

oe

DiseasesoftheRenalandGenitourinary System

NickVillano

RenalFailure AcuteKidneyInjury A.GeneralCharacteristics

Quick HIT

TypesofAKI(seeFigure7-1)
======================================
e

¢

¢

PrerenalAKI—decreaseinrenalbloodflow(60%to70%ofcases) IntrinsicAKI—damagetorenalparenchyma(25%to40%ofcases) PostrenalAKI—urinarytractobstruction(5%to10%ofcases)

1. Definition:Arapiddeclineinrenalfunction,withanincreaseinserumcreatinine level(whilethecutoffforriseincreatininewhichqualifiesasan“injury”is controversial,anincreaseofaslittleas0.3mg/dLmayhaveclinicalrelevance, whiletraditionaldefinitionsdescribearelativeincreaseof50%oranabsolute increaseof0.5to1.0mg/dL)(Figure7-1).Thecreatininemaybenormaldespite amarkedlyreducedglomerularfiltrationrate(GFR)intheearlystagesofacute kidneyinjury(AKI)duetothetimeittakesforcreatininetoaccumulateinthe body.Thisconditionisalsocalledacuterenalfailure(ARF). 2. OneconsensusdefinitionofAKIiscalledtheRIFLEcriteria.

a. RISK:1.5-foldincreaseintheserumcreatinineorGFRdecreaseby25%or urineoutput<0.5mL/kg/hrfor6hours.

b. INJURY:TwofoldincreaseintheserumcreatinineorGFRdecreaseby50%or urineoutput<0.5mL/kg/hrfor12hours.

c. FAILURE:ThreefoldincreaseintheserumcreatinineorGFRdecreaseby75% orurineoutputof<0.5mL/kg/hrfor24hours,oranuriafor12hours.

d. LOSS:Completelossofkidneyfunction(i.e.,requiringdialysis)formorethan 4weeks.

e. ESRD:Completelossofkidneyfunction(i.e.,requiringdialysis)formorethan 3months.

3. AKImaybenonoliguric,oliguric,oranuric.SevereAKImayoccurwithouta reductioninurineoutput(nonoliguricAKI).

a. Generalgoalsoftherapyarereversingtheinitialinsulttothekidneyand/or supportivecareasGFRrecovers,aswellaspreventingfulminantkidneyfailure requiringtemporaryorpermanenthemodialysis.

4. WeightgainandedemaaremostcommonfindingsinpatientswithAKI.Thisis duetoapositivewaterandsodium(Na+)balance.

5. Characterizedbyazotemia(elevatedBUNandCr).

a. ElevatedBUNisalsoseenwithcatabolicdrugs(e.g.,steroids),GI/softtissue bleeding(duetoRBCdigestionandre-absorptionofurea),anddietaryprotein intake.

b. ElevatedCrisalsoseenwithincreasedmusclebreakdownandvariousdrugs. ThebaselineCrlevelvariesproportionatelywithmusclemass.

6. Prognosis

a. Morethan80%ofpatientsinwhomAKIdevelopsrecovercompletely. However,prognosisvarieswidelydependingontheseverityofrenalfailureand othercomorbidities.

b. Theolderthepatientandthemoreseveretheinsult,theloweristhelikelihood ofcompleterecovery.

c. Themostcommoncauseofdeathisinfection(75%ofalldeaths),followedby cardiorespiratorycomplications.Othernonfatalcomplicationsincludechronic kidneyinjuryandneedfordialysis.

Acute renal failure ts ee Volume loss/ + Cardiac Hypotension Postrenal Glomerulo- Vascular Interstitial Acute tubular} sequestration output (65-15%) nephritis disorder disorder necrosis Intrarenal Extrarenal aieail Lee vessel vessel * Crystals + Pelvis/ureter + Proteins * Bladder/urethra
======================================
FIGURE 7.1

CausesofAKI.

B.Categories 1. Prerenalfailure(seealsoClinicalPearl7-1)

a. MostcommoncauseofAKI;potentiallyreversible b. Etiology(decreaseinsystemicarterialbloodvolumeorrenalperfusionleading torenalischemia)—cancomplicateanydiseasethatcauseshypovolemia,low cardiacoutput,orsystemicvasodilation

Quick HIT

MonitoringaPatientWithAKI

¢

e

e

Dailyweights,intake,andoutput(worseningvolumestatuscanbeanindicationforurgentdialysis) BP Serumelectrolytes(hyperkalemiaandacidosiscanalsobeindicationsforurgentdialysis,alsotend towardhyponatremiaandhyperphosphatemia) HbandHct(foranemia) Watchforsignsofinfection

Hypovolemia—dehydration,excessivediureticuse,poorfluidintake, vomiting,diarrhea,burns,hemorrhage CHF,cardiorenalsyndrome Hypotension(systolicBPbelow90mmHg),fromsepsis,excessive antihypertensivemedications,bleeding,dehydration Renalarterialobstruction(kidneyishypoperfuseddespiteelevatedblood pressure) Cirrhosis,hepatorenalsyndrome Inpatientswithdecreasedrenalperfusion,NSAIDs(constrictafferent arteriole),ACEinhibitors(causeefferentarteriolevasodilation),and cyclosporincanprecipitateprerenalfailure.

CLINICALPEARL7-1

DiagnosticApproachinAKI Historyandphysicalexamination. Thefirstthingtodoistodeterminethedurationofrenalfailure.AbaselineCrlevelprovidesthis information. ThesecondtaskistodeterminewhetherAKIisduetoprerenal,intrarenal,orpostrenalcauses.Thisis doneviaacombinationofH&Pandlaboratoryfindings.

¢

¢

e

SignsofvolumedepletionandCHForcirrhosissuggestaprerenaletiology. Signsofanallergicreaction(rash)suggestacuteinterstitialnephritis(anintrinsicrenaletiology). Asuprapubicmass,BPH,orbladderdysfunctionsuggestsapostrenaletiology.

¢

¢

e

e

Medicationreview Urinalysis Urinechemistry(FENaorFEUrea,osmolality,urineNa+,urineCr,urineBUN). Renalultrasound(toruleoutobstruction)

TABLE7-1 StudiestoDifferentiatePrerenalFromIntrinsicAKI    Prerenal  IntrinsicRenal  Urinalysis  Hyalinecasts  Abnormal  BUN/CrRatio  >20:1  <20:1  FENa  <1%  >2–3% 
======================================
c. Pathophysiology

e

e

e

RenalbloodflowdecreasesenoughtolowertheGFR,whichleadsto decreasedclearanceofmetabolites(BUN,Cr,uremictoxins). Becausetherenalparenchymaisundamaged,tubularfunction(andtherefore theconcentratingability)ispreserved.Therefore,thekidneyresponds appropriately,conservingasmuchsodiumandwateraspossible. ThisformofAKIisreversibleonrestorationofbloodflow;butif hypoperfusionpersists,ischemiaresultsandcanleadtoacutetubularnecrosis (ATN)(seebelow).

d. Clinicalfeatures—signsofvolumedepletion(drymucousmembranes, hypotension,tachycardia,decreasedtissueturgor,oliguria/anuria)
======================================
e. Laboratoryfindings

e

Oliguria—alwaysfoundinprerenalfailure(thisistopreservevolume) IncreasedBUN-to-serumCrratio(>20:1istheclassicratio)—becausekidney canreabsorbureatoincreasesodiumandwaterretention Increasedurineosmolality(>500mOsm/kgH2O)—becausethekidneyisable toappropriatelyreabsorbwater DecreasedurineNa+(<20mEq/Lwithfractionalexcretionofsodium[FENa] <1%)becauseNa+isavidlyreabsorbed Increasedurine–plasmaCrratio(>40:1)—becausemuchofthefiltrateis reabsorbed(butnotthecreatinine) Blandurinesediment,indicatinglackofsignificantcellulardamagetoglomeri ortubules

NotethatprerenalazotemiaandischemicAKIarepartofaspectrumofmanifestationsofrenal hypoperfusion.Thelatterdiffersinthatinjurytorenaltubularcellsoccurs.

2. Intrinsicrenalfailure(seeTable7-1andClinicalPearl7-2)

a. Kidneytissue(interstitium,glomeruli,tubules)isdamagedsuchthatglomerular filtrationandtubularfunctionaresignificantlyimpaired.Thus,kidneysare unabletoconcentrateurineeffectively.

b. Causes

e

e

e

e

Tubulardisease(ATN)—canbecausedbyischemia(mostcommoncause), nephrotoxins(seeClinicalPearls7-3and7-4) Glomerulardisease(acuteglomerulonephritis[GN])—forexample, Goodpasturesyndrome,granulomatosiswithpolyangiitis,poststreptococcal GN,lupus Vasculardisease—forexample,renalarteryocclusion,TTP,HUS Interstitialdisease—forexample,allergicinterstitialnephritis,oftenduetoa hypersensitivityreactiontomedication(seeTubulointerstitialDiseasessection)

CLINICALPEARL7-2

Rhabdomyolysis 1. Skeletalmusclebreakdowncausedbytrauma,crushinjuries,prolongedimmobility,seizures,snake

bites.

2. Releaseofmusclefibercontents(myoglobin)intobloodstream.Myoglobinistoxictokidneys,which canleadtoAKIviatubulardamageandobstruction.

3. Presentswithsequelaeofcelldeath:markedlyelevatedcreatinephosphokinase(CPK),hyperkalemia, hypocalcemia(duetoreleasedphosphate),hyperuricemia.

4. TreatwithIVfluids,mannitol(osmoticdiuretic)andbicarbonate(drivesKbackintocells).

CLINICALPEARL7-3

CausesofAcuteTubularNecrosis(ATN)

e

«

IschemicAKI Secondarytoseveredeclineinrenalbloodflow,asinshock,hemorrhage,sepsis,disseminated intravascularcoagulation,heartfailure. Ischemiaresultsinthedeathoftubularcells. NephrotoxicAKI Injurysecondarytosubstancesthatdirectlyinjurerenalparenchymaandresultincelldeath. Causesincludeantibiotics(aminoglycosides,vancomycin),radiocontrastagents,NSAIDs(especially inthesettingofCHF),poisons,myoglobinuria(frommuscledamage,rhabdomyolysis,strenuous exercise),hemoglobinuria(fromhemolysis),chemotherapeuticdrugs(cisplatin),andkappaand gammalightchainsproducedinmultiplemyeloma.

c. Clinicalfeaturesdependonthecause.Edemaisusuallypresent.Recoverymay bepossiblebuttakeslongerthaninprerenalfailure. d. Laboratoryfindings
======================================
e

e

e

e

DecreasedBUN-to-serumCrratio(<20:1,typicallycloserto10:1ratio)in comparisonwithprerenalfailure.BothBUNandCrlevelsarestillelevated, butlessureaisreabsorbedthaninprerenalfailureaskidneyisnolonger activelyreabsorbingit. IncreasedurineNa+(>40mEq/LwithFENa>2%to3%)—becauseNa+is poorlyreabsorbed Decreasedurineosmolality(<350mOsm/kgH2O)—becauserenalwater reabsorptionisimpaired Decreasedurine–plasmaCrratio(<20:1)—becausefiltratecannotbe reabsorbed

3. Postrenalfailure

a. LeastcommoncauseofAKI b. Obstructionofanysegmentoftheurinarytract(withintactkidney)causes

increasedtubularpressure(urineproducedcannotbeexcreted),whichleadsto decreasedGFR.Bloodsupplyandrenalparenchymaareintact.Notethatboth kidneysmustbeobstructed(e.g.,prostaticenlargement)forcreatininetorise.

Quick HIT

ThreeBasicTestsforPostrenalFailure

e

¢

¢

Physicalexamination—palpatethebladder Ultrasound—lookforobstruction,hydronephrosis Catheter—lookforlargevolumeofurine

c. Renalfunctionisrestoredifobstructionisrelievedbeforethekidneysare damaged.

d. Postrenalobstruction,ifuntreated,canleadtoATN. e. Causes

e

e

Urethralobstructionsecondarytoenlargedprostate(BPH)isthemostcommon cause Obstructionofsolitarykidney

CLINICALPEARL7-4

CourseofATN Onset(insult) Oliguricphase

¢

Azotemiaanduremia—averagelength10to14days Urineoutput Diureticphase

e

¢

Beginswhenurineoutputis>500mL/day Highurineoutputduetothefollowing:fluidoverload(excretionofretainedsalt,water,other solutesthatwereretainedduringoliguricphase);osmoticdiuresisduetoretainedsolutesduring oliguricphase;tubularcelldamage(delayedrecoveryofepithelialcellfunctionrelativetoGFR)

Recoveryphase—recoveryoftubularfunction

CLINICALPEARL7-5

UrineOsmolality 1. Urineosmolalityisameasureofurineconcentration.Thehighertheosmolality,themore

concentratedtheurine.

2. Dehydrationinahealthypersonleadstoincreaseinurineconcentration(osmolality)asfollows: Dehydrationcauseslowintravascularvolume,whichtriggersADHrelease,whichstimulates reabsorptionofwaterfromkidneytofillthevasculature.Increasedwaterreabsorptionleadsto moreconcentratedurine.

3. InATN,thetubulecellsaredamagedandcannotreabsorbwater(orsodium);sotheurinecannotbe concentrated,whichleadstolowurineosmolality.
======================================
Nephrolithiasis Obstructingneoplasm(bladder,cervix,prostate,andsoon) Retroperitonealfibrosis Ureteralobstructionisanuncommoncausebecauseobstructionmustbe bilateraltocauserenalfailure.

Quick HIT

DiagnosisofAKIisusuallymadebyfindingelevatedBUNandCrlevels.Thepatientisusuallyasymptomatic.

C.Diagnosis 1. Bloodtests(seealsoClinicalPearl7-5).

a. ElevationinBUNandCrlevels.BeawarethatsmallchangesinCrmayreflecta muchmoresignificantdecreaseinGFR.

b. Electrolytes(retentionofK+,PO4 3−,dropinHCO3 −indicatingacidosis, decreaseinNa+duetofluidretention)

c. Albuminlevelstomonitorfornephroticsyndrome d. CBCwithdifferential

Quick HIT

ObtaintheFollowinginAnyPatientWithAKI

¢

Urinalysis Urinechemistry Serumelectrolytes(Na+,K+,BUN,Cr),CBC Bladdercatheterizationtoruleoutobstruction(diagnosticandtherapeutic) Renalultrasoundtolookforobstruction

2. Urinalysis(Figure7-2andTable7-2).

a. Adipsticktestpositiveforprotein(3+,4+)suggestsintrinsicrenalfailuredueto glomerularinsult.

b. Microscopicexaminationoftheurinesediment:

Crystalsindicatepresenceofstones. Micro-organismsareseeninbothinfectionandnonpathogeniccolonization (differentiationmadebasedonsymptoms). GranularcastsdegenerationofcellsandproteinaggregatesseeninATN (“muddybrown”casts) Hyalinecastsaredevoidofcontents(seeninprerenalfailure). RBCcastsindicateglomerulardisease. WBCcastsindicaterenalparenchymalinflammation. Fattycastsindicatenephroticsyndrome.

3. Urinechemistry—todistinguishbetweendifferentformsofAKI.

a. UrineNa+,Cr,andosmolality:UrineNa+dependsondietaryintake. b. FENa:collecturineandplasmaelectrolytessimultaneously=

[(UNa)/(PNa)/(UCr)/PCr)×100],whereU=urineandP=plasma.

Valuesbelow1%suggestprerenalfailure. Valuesabove2%to3%suggestATN. FENaismostusefulifoliguriaispresent. Ifpatientisondiuretics,UNawillbeartificiallyelevatedandfractional excretionofurea(FEUrea)mustbeusedinstead.

c. Renalfailureindex5(uNa/[uCr/pCr])×100)

e

Valuesbelow1%suggestprerenalfailure. Valuesabove1%suggestATN.

Quick HIT

InevaluatingapatientwithAKI,firstexcludeprerenalandpostrenalcauses,andthen,ifnecessary, investigateintrinsicrenalcauses.

4. Urinecultureandsensitivities—ifinfectionissuspected. 5. Renalultrasound.

a. Primarilyusefulforevaluatingkidneysizeandforexcludingurinarytract obstruction(i.e.,postrenalfailure)—presenceofbilateralhydronephrosisor hydroureter

b. OrderformostpatientswithAKI—unlessthecauseoftheAKIisobvious andisnotpostrenal

Acute renal failure Rule out postrenal causes by H and P, Foley, renal ultrasound if needed Urinalysis a a Benign Muddy brown casts, RBC casts, WEC casts, | renal tubular cells/casts RBCs WBCs Consider prerenal Consider ATN Consider glomerular Consider causes disease * Pyelonephritis * Acute interstitial J nephritis Further laboratory evaluation: BUN/Cr ratio, FENa, urine Osm BUN/Cr > 20 BUN/Cr < 20 FENa < 1% FENa > 2-3% Urine Osm > 500 Urine Osm 250-300 { | Prerenal Intrinsic ARF
======================================
FIGURE 7.2

EvaluationofAKI.

6. CTscan(abdomenandpelvis)—maybehelpfulinsomecases;usuallydoneif renalultrasoundshowsanabnormalitysuchashydronephrosis

7. Renalbiopsy—usefuloccasionallyifthereissuspicionofacuteGNoracute allergicinterstitialnephritis

8. Renalarteriography—toevaluateforpossiblerenalarteryocclusion;shouldbe performedonlyifspecifictherapywillmakeadifference

TABLE7-2 UrinalysisFindingsinRenalFailure

Prerenal Benign sediment—few hyaline casts Negative Negative Intrarenal Acute tubular necrosis “Muddy brown” casts, renal tubular cells/ Trace Negative casts, granular casts Acute glomerulonephritis Dysmorphic RBCs, RBCs with casts, WBCs 4+ 3+ with casts, fatty casts Acute interstitial nephritis RBCs, WBCs, WBCs with casts, eosinophils 1+ 2+ Postrenal Benign; may or may not see RBCs, WBCs Negative Negative

Quick HIT

IntheearlyphaseofAKI,themostcommonmortalcomplicationsarehyperkalemiccardiacarrestand pulmonaryedema.

D.Complications 1. ECFvolumeexpansionandresultingpulmonaryedema—treatwithadiuretic

(furosemide)

2. Metabolic

a. Hyperkalemia—duetodecreasedexcretionofK+andthemovementof potassiumfromICFtoECFduetotissuedestructionandacidosis

b. Metabolicacidosis(withincreasedaniongap)—duetodecreasedexcretionof hydrogenions;ifsevere(below16mEq/L),correctwithsodiumbicarbonate c. Hypocalcemia—lossofabilitytoformactivevitaminDandrapiddevelopment

ofPTHresistance

d. Hyponatremiamayoccurifwaterintakeisgreaterthanbodylosses,orifa volume-depletedpatientconsumesexcessivehypotonicsolutions. (Hypernatremiamayalsobeseeninhypovolemicstates.)

e. Hyperphosphatemia—duetodecreasedclearance f. Hyperuricemia

3. Uremia—toxicendproductsofmetabolismaccumulate(especiallyfromprotein metabolism),leadingtosuchcomplicationsas:

a. Plateletdysfunction b. Immunedysfunction c. Pericarditis

d. Encephalopathy

4. Infection

a. AcommonandseriouscomplicationofAKI(occursin50%to60%ofcases). Thecauseisprobablymultifactorial,buturemiaitselfisthoughttoimpair immunefunction.

b. Examplesincludepneumonia,UTI,woundinfection,andsepsis.
======================================
E.Treatment 1. Generalmeasures(seealsoTable7-3).

a. Avoidmedicationsthatdecreaserenalbloodflow(NSAIDs)and/orthatare nephrotoxic(e.g.,aminoglycosides,radiocontrastagents).

b. Adjustmedicationdosagesforlevelofrenalfunction. c. Correctfluidimbalance.

Ifvolumedepleted,giveIVfluids.However,manypatientswithAKIare volumeoverloaded(especiallyiftheyareoliguricoranuric),sodiuresismay benecessary.

TABLE7-3 PrognosticFactorsinAKI  Severityofrenalfailure  MagnitudeofincreaseinCr    Presenceofoliguria    Fractionalexcretionofsodium    Requirementfordialysis    Durationofsevererenalfailure    Markedabnormalitiesonurinalysis  Underlyinghealthofpatient  Age Presence,severity,andreversibilityofunderlyingdisease  Clinicalcircumstances  Causeofrenalfailure    Severityandreversibilityofacuteprocess(es)    Numberandtypeofotherfailedorgansystems    Developmentofsepsisandothercomplications 

AdaptedfromSchrierRW,ed.DiseasesoftheKidneyandUrinaryTract.VolII.7thed.Philadelphia,PA:LippincottWilliams& Wilkins,2001:1128,Table41-14.

Thegoalistostrikeabalancebetweencorrectingvolumedeficitsandavoiding volumeoverload(whilemaintainingadequateurineoutput).Rememberthat urineoutputisareflectionofrenalbloodflow(volumestatus)andGFR (kidneyfunction).

¢

e

Monitorfluidbalancebydailyweightmeasurements(mostaccurateestimate) andintake–outputrecords. Besuretotakeintoaccountthepatient’scardiachistorywhenconsidering treatmentoptionsforfluidimbalances(i.e.,donotgiveexcessivefluidtoa patientwithCHF).

Quick HIT

RadiographiccontrastmediacancauseATN(typicallyveryrapidly)bycausingspasmoftheafferent arteriole.Itcanusuallybepreventedbypremedicatingwithsalinehydration.

d. Correctelectrolytedisturbancesifpresent. e. Optimizecardiacoutput.BPshouldbeapproximately120to140/80to90. f. Orderdialysisifsymptomaticuremia,intractableacidemia,hyperkalemia,or

volumeoverloaddevelop.Indicationsforurgentdialysisoftenrememberedby “AEIOU”mnemonic:Acidosis,Electrolytes,Intoxications(suchasin overdoses),volumeOverload,Uremia.

2. Prerenal

a. Treattheunderlyingdisorder(suchashypovolemicorcardiogenicshock). b. Givefluidstomaintaineuvolemiaandrestorebloodpressure—donotgiveto patientswithedemaorascites.Maybenecessarytostopantihypertensive medications.RememberthatNSisoftenpreferredunlessacidemiaispresent (mayworsenwithhyperchloremia),inwhichcaseLRcanbeused.
======================================
c. Eliminateanyoffendingagents(ACEinhibitors,NSAIDs). d. Ifpatientisunstable,Swan–Ganzmonitoringforaccurateassessmentof

intravascularvolume.

Quick HIT

WheneverapatienthaselevatedCrlevels,thefirstthingtodoistolookatpreviouslaboratorydatato determinethepatient’sbaselineCrlevel,ifpossible.ThishelpsdeterminewhetherthepatienthasAKI, CKD,orchronicrenalinsufficiency/failurewithsuperimposedAKI.(Thisconditionisknownas“acuteon chronic”renalfailure.)

3. Intrinsic

a. OnceATNdevelops,therapyissupportiveandrenalfunctiongenerallyrecovers. Eliminatethecause/offendingagent.

b. Ifoliguric,atrialoffurosemidemayhelptoincreaseurineflow.Thisimproves fluidbalance.

4. Postrenal—abladdercathetermaybeinsertedtodecompresstheurinarytract. Considerurologyconsultation.

a. Beawareofthepotentialforpost-obstructivediuresisandarapidincreasein urineoutputwhenobstructionisresolved,whichmayrequireIVfluid replacement.

Quick HIT

AzotemiareferstotheelevationofBUN. Uremiareferstothesignsandsymptomsassociatedwithaccumulationofnitrogenouswastesdueto impairedrenalfunction.Itisdifficulttopredictwhenuremicsymptomswillappear,butitrarelyoccurs unlesstheBUNis>60mg/dL.

ChronicKidneyDisease

A.GeneralCharacteristics 1. Chronickidneydisease(CKD)isdefinedaseitherdecreasedkidneyfunction

(GFR<60mL/min)orkidneydamage(structuralorfunctionalabnormalities)for atleast3months,regardlessofcause(seealsoTable7-4).
======================================
AdaptedfromSchrierRW,ed.DiseasesoftheKidneyandUrinaryTract.VolII.7thed.Philadelphia,PA:LippincottWilliams& Wilkins;2001:1098,Figure41-5.

2. Causes

a. Diabetesisthemostcommoncause(30%ofcases). b. HTNisresponsiblefor25%ofcases. c. ChronicGNaccountsfor15%ofcases. d. Interstitialnephritis,polycystickidneydisease,obstructiveuropathy. e. AnyofthecausesofAKImayleadtoCKDifprolongedand/oriftreatmentis

Any of the causes of AKI may lead to CKD if prolonged and/or if treatment is delayed.

delayed. 3. Pathophysiology

a. PlasmaCrvariesinverselywithGFR. b. CrclearanceisthemostcommonclinicalmeasureofGFR(althoughremember

thisisanindirectestimationandcanleadtomiscalculations).

c. AnincreaseinplasmaCrindicatesdiseaseprogression,whereasadecrease suggestsrecoveryofrenalfunction(assumingmusclemasshasnotchanged). MostlaboratoriesnowalsoreportanestimatedGFR(eGFR)eachtimethe creatinineisordered.

4. MorecommoninAfrican-AmericanthaninCaucasianpatients.

Quick HIT

DiabetesandhypertensionarethemostcommoncausesofESRD.

Quick HIT

ESRDisnotdefinedbyBUNorcreatininelevels.Itisclassicallyalossofkidneyfunctionthatleadsto laboratoryandclinicalfindingsofuremia.NewerdefinitionsuseCrCltoestimateGFR(CrCl<15mL/min distinguishedasESRD).

B.ClinicalFeatures—anyofthefollowingmaybepresent: 1. Cardiovascular

a. HTN

e

e

Secondarytosaltandwaterretention—decreasedGFRstimulatesrenin– angiotensinsystemandaldosteronesecretiontoincrease,whichleadstoan increaseinBP. RenalfailureisthemostcommoncauseofsecondaryHTN.

b. CHF—duetovolumeoverload,HTN,andanemia. c. Pericarditis(uremic).

2. GI(usuallyduetouremia).

a. Nausea,vomiting. b. Lossofappetite(anorexia).

3. Neurologic

a. Symptomsincludelethargy,somnolence,confusion,peripheralneuropathy,and uremicseizures.Physicalfindingsincludeweakness,asterixis,and hyperreflexia.Patientsmayshow“restlesslegs”—neuropathicpaininthelegs thatisonlyrelievedwithmovement.

b. Hypocalcemia(fromdecreasedvitaminDconversion)cancauselethargy, confusion,andtetany.

4. Hematologic

a. Normocyticnormochromicanemia(secondarytodeficiencyoferythropoietin) —maybesevere.

b. Bleedingsecondarytoplateletdysfunction(duetouremia).Plateletsdonot degranulateinuremicenvironment.

5. Endocrine/metabolic

a. Calcium–phosphorusdisturbances.

Decreasedrenalclearanceofphosphateleadstohyperphosphatemia,which resultsindecreasedrenalproductionof1,25-dihydroxyvitaminD.Thisleads tohypocalcemia,whichcausessecondaryhyperparathyroidism.
======================================
e

e

e

So,hypocalcemiaandhyperphosphatemiaareusuallyseen,butlong-standing secondaryhyperparathyroidismandcalcium-basedphosphatebindersmay sometimescausehypercalcemia.Thiscanbeduetoaparathyroidgland secretingexcessPTHwithoutresponsivenesstoplasmacalciumlevels,known astertiaryhyperparathyroidism. Secondaryhyperparathyroidismcausesrenalosteodystrophy,whichcauses weakeningofbonesandpossiblyfractures. Hyperphosphatemiamaycausecalciumandphosphatetoprecipitate,which causesvascularcalcificationsthatmayresultinnecroticskinlesions.Thisis calledcalciphylaxisandisusuallyirreversible.

Quick HIT

IncreasedsusceptibilitytoinfectionsisamajorcauseofmortalityinpatientswithCKD.

b. Sexual/reproductivesymptomsduetohypothalamic–pituitarydisturbancesand gonadalresponsetosexhormones:inmen,decreasedtestosterone;inwomen, amenorrhea,infertility,andhyperprolactinemia.

c. Pruritus(multifactorialetiology)—commonanddifficulttotreat.Dialysisand ultravioletlight.

Quick HIT

Hypocalcemialeadstosecondaryhyperparathyroidism,whichremovescalciumfrombones,makingthem weakandsusceptibletofracture.

6. Fluidandelectrolyteproblems(seeChapter8).

a. Volumeoverload—watchforpulmonaryedema. b. Hyperkalemia—duetodecreasedurinarysecretion. c. Hypermagnesemia—occurssecondarytoreducedurinaryloss. d. Hyperphosphatemia—seeabove. e. Metabolicacidosis—duetolossofrenalmass(andthusdecreasedproductionof

ammonia,whichthekidneysusetobufferexcretedacid)andthekidney’s inabilitytoexcreteH+itself.

7. Immunologic—uremiainhibitscellularandhumoralimmunity.

C.Diagnosis 1. Urinalysis—examinesediment(seeAKI).

a. LevelofproteinuriaisincreasinglybeingreportedalongsideGFRasitis associatedwithmorerapidprogressionofCKD.

2. MeasureCrclearancetoestimateGFR.

3. CBC(anemia,thrombocytopenia). 4. Serumelectrolytes(e.g.,K+,Ca2+,PO4 5. Renalultrasound—evaluatesizeofkidneys/ruleoutobstruction.

a. Smallkidneysaresuggestiveofchronicrenalinsufficiencywithlittlechanceof recovery.

b. Presenceofnormal-sizedorlargekidneysdoesnotexcludeCKD. c. Renalbiopsy—inselectcasestodeterminespecificetiology.
======================================
Quick HIT

InapatientwithCKD,symptomaticvolumeoverloadandseverehyperkalemiaarethemostcommon complicationsthatrequireurgentintervention.

D.Treatment 1. Diet

a. Lowprotein—to0.7to0.8g/kgbodyweightperday:datasuggeststhismay slowprogressionofCKD.

b. Usealow-saltdietifHTN,CHF,oroliguriaarepresent. c. Restrictpotassium,phosphate,andmagnesiumintake.

Quick HIT

Life-ThreateningComplicationsinCKD

e

e

e

Hyperkalemia—obtainanECG(beawarethatpotassiumlevelscanbehighwithoutECGchanges). Pulmonaryedemasecondarytovolumeoverload—lookforrecentweightgain. Infection(e.g.,pneumonia,UTI,sepsis).

2. ACEinhibitors—dilateefferentarterioleofglomerulus

a. Ifusedearlyon,theyreducetheriskofprogressiontoESRDbecausetheyslow theprogressionofproteinuria.

b. Usewithgreatcautionbecausetheycancausehyperkalemia.

3. BPcontrol

a. Strictcontroldecreasestherateofdiseaseprogression. b. ACEinhibitorsarethepreferredagents.Multipledrugs,includingdiuretics,may

berequired.

4. Glycemiccontrol(ifthepatientisdiabetic)preventsworseningofproteinuria. 5. Smokingcessationhasbeenassociatedwithslowerratesofprogression. 6. Correctionofelectrolyteabnormalities

a. Correcthyperphosphatemiawithcalciumcitrate(aphosphatebinder). b. Patientswithchronicrenaldiseasearegenerallytreatedwithlong-termoral

calciumandvitaminDinanefforttopreventsecondaryhyperparathyroidism anduremicosteodystrophy.

c. Acidosis—treattheunderlyingcause(renalfailure).Patientsmayrequireoral bicarbonatereplacement.

7. Anemia—treatwitherythropoietin,whichkidneysnormallysecrete. 8. Pulmonaryedema—arrangefordialysisiftheconditionisunresponsiveto

diuresis.

9. Pruritus—trycapsaicincreamorcholestyramineandUVlight 10. Dialysis(SeeindicationsintheDialysissection.) 11. Transplantationistheonlycure.

Dialysis

A.GeneralCharacteristics 1. Overview

a. Dialysisistheartificialmechanismbywhichfluidandtoxicsolutesareremoved fromthecirculationwhenthekidneyscannotdososufficiently.

b. Inallformsofdialysis,thebloodinterfaceswithanartificialsolution resemblinghumanplasma(calledthedialysate),anddiffusionoffluidand solutesoccursacrossasemipermeablemembrane.

c. Thetwomajormethodsofdialyzingapatientarehemodialysisand peritonealdialysis(discussedbelow).

d. ThemajorityofdialysispatientsintheUnitedStatesreceivehemodialysisat hospitalsordialysiscenters,butmoreandmorepatientsareoptingforchronic ambulatoryperitonealdialysis(CAPD).

e. Forpatientswithlife-threateningcomplicationsofAKI,continuousrenal replacementtherapy(CRRT)canbeusedforconstantrenalsupport.Thisalso avoidsthelargerfluidshiftsofintermittenthemodialysiswhich hemodynamicallyunstableorheartfailurepatientsmaynotbeabletohandle.
======================================
Quick HIT

AbsoluteIndicationsforDialysis

¢

Acidosis—significant,intractablemetabolicacidosis Electrolytes—severe,persistenthyperkalemia Intoxications—methanol,ethyleneglycol,lithium,aspirin Overload—hypervolemianotmanagedbyothermeans Uremia(severe)—basedonclinicalpresentation,notlaboratoryvalues(e.g.,uremicpericarditisor encephalopathyareabsoluteindicationsfordialysis)

B.WhentoInitiateDialysis 1. Generalsettingsinwhichdialysisisconsidered.

a. CKD—dialysisservesasabridgetorenaltransplantationorasapermanent treatmentwhenthepatientisnotatransplantationcandidate.

b. AKI—dialysisisoftenrequiredasatemporarymeasureuntilthepatient’srenal functionimproves,oftenduetoabsoluteindications(seeQuickHit).

c. Overdoseofmedicationsoringestionsofsubstancesclearedbythekidneys— some,butnotallmedicationsandtoxinscanbedialyzed(seeQuickHit).

2. Nonemergentindications

a. Note:CrandBUNlevelsarenotabsoluteindicationsfordialysis,however somenephrologistswilldecidetoinitiatedialysisonceaCKDpatient’sGFR dropsbelowacertainvalue.

b. Symptomsofuremia

e

e

e

Nauseaandvomiting Lethargy/deteriorationinmentalstatus,encephalopathy,seizures Pericarditis

Quick HIT

Creatininelevelisnotanabsoluteindicationfordialysis.

3. Emergentindications(usuallyinthesettingofrenalfailure)

a. Life-threateningmanifestationsofvolumeoverload

e

e

Pulmonaryedema Hypertensiveemergencyrefractorytoantihypertensiveagents

b. Severe,refractoryelectrolytedisturbances,forexample,hyperkalemia, hypermagnesemia

c. Severemetabolicacidosis d. Drugtoxicity/ingestions(particularlyinpatientswithrenalfailure):methanol,

ethyleneglycol,lithium,aspirin

Quick HIT

DialyzableSubstances

e

¢

e

e

Salicylicacid Lithium Ethyleneglycol Magnesium-containinglaxatives

C.Hemodialysis 1. Process

a. Thepatient’sbloodispumpedbyanartificialpumpoutsideofthebodythrough thedialyzer,whichtypicallyconsistsoffinecapillarynetworksof semipermeablemembranes.Thedialysateflowsontheoutsideofthese networks,andfluidandsolutesdiffuseacrossthemembrane.

b. Thepatient’sbloodmustbeheparinizedtopreventclottinginthedialyzer.

2. Frequency:Mosthemodialysispatientsrequire3to5hoursofdialysis3daysper
======================================
week. 3. Access

a. UsethecentralcatheterplacedusingtheSeldingertechniquemostofteninthe subclavianorjugularveinfortemporaryaccess.

b. Tunneledcathetersareplacedundertheskinwhichleadstoalowerrateof

infection.Thesecathetersareoftensuitableforuseupto6months.

c. Arteriovenousfistula.

e

e

e

Bestformofpermanentdialysisaccess. Itrequiresvascularsurgerytoconnecttheradialorbrachialarterytoveinsin theforearm. Anaudiblebruitandpalpablethrill(duetohighflow)overthefistulaindicates thatitispatent.Absenceofthesefindingsisabnormalandisconcerningfor thrombosisofthevessel.

d. Analternativetoanarteriovenousfistulaisanimplantablegraft—typically madeofpolytetrafluoroethylene(PTFE).

4. Alternativestotraditionalhemodialysis.

a. Continuousarteriovenoushemodialysis(CAVHD)andcontinuousvenovenous hemodialysis(CVVHD)areoftenusedinhemodynamicallyunstablepatients, suchasICUpatientswithAKI.Thisallowsforclosercontrolofelectrolytesand fluidstatus.

b. Lowerflowratesofbloodanddialysateenabledialysistooccurwhile minimizingrapidshiftsinvolumeandosmolalitywhichthesepatientsmaynot beabletotolerate.

c. Theyrequirehighlyefficientdialyzerstobeeffective.

5. Advantagesofhemodialysis.

a. Itismoreefficientthanperitonealdialysis.Highflowratesandefficient dialyzersshortentheperiodoftimerequiredfordialysis.

b. Itcanbeinitiatedmorequicklythanperitonealdialysis,usingtemporary vascularaccessintheemergentsetting.

6. Disadvantagesofhemodialysis.

a. Itislesssimilartothephysiologyofnaturalkidneyfunctionthanisperitoneal dialysis,predisposingthepatienttothefollowing:

e

e

Hypotensionduetorapidremovalofintravascularvolumeleadingtorapid fluidshiftsfromtheextravascularspaceintocells. Hypo-osmolalityduetosoluteremoval.

b. Requiresvascularaccess.

D.PeritonealDialysis 1. Process

a. Theperitoneumservesasthedialysismembrane.Dialysatefluidisinfusedinto theperitonealcavity,thenfluidsandsolutesfromtheperitonealcapillaries diffuseintothedialysatefluid,whichisdrainedfromtheabdomen.

b. Ahyperosmolar(high-glucose)solutionisused,andwaterisremovedfromthe bloodviaosmosis.

2. Frequency:dialysatefluidisdrainedandreplacedeveryhourinacuteperitoneal dialysis,butonlyonceevery4to8hoursinCAPD.

3. Access

a. WithCAPD,dialysateisinfusedintotheperitonealfluidviaanimplanted catheter.

b. Atemporarycatheterisusedforacuteperitonealdialysis.

4. Advantages
======================================
a. Thepatientcanlearntoperformdialysisonhisorherown. b. Itmimicsthephysiologyofnormalkidneyfunctionmorecloselythan

hemodialysisinthatitismorecontinuous.

5. Disadvantages

a. Highglucoseloadmayleadtohyperglycemiaandhypertriglyceridemia. b. Peritonitisisasignificantpotentialcomplication. c. Thepatientsmustbehighlymotivatedtoself-administerit. d. Cosmetic—thereisincreasedabdominalgirthduetodialysatefluid.

E.LimitationsandComplicationsofDialysis 1. Limitations—dialysisdoesnotreplicatethekidney’ssyntheticfunctions. Therefore,dialysispatientsarestillpronetoerythropoietinandvitaminD deficiency,withtheirassociatedcomplications.

2. Complicationsassociatedwithhemodialysis.

a. Hypotension—mayresultinmyocardialischemia,fatigue,andsoon. b. Therelativehypo-osmolalityoftheECFcomparedwiththebrainmayresultin

nausea,vomiting,headache,andrarely,seizuresorcoma.

c. “First-usesyndrome”—chestpain,backpain,andrarely,anaphylaxismayoccur immediatelyafterapatientusesanewdialysismachine.

d. Hemolysis:oftenduetoissueswithdialysatesolution e. Complicationsassociatedwithanticoagulation—hemorrhage,hematoma,etc. f. Infectionofvascularaccesssite—mayleadtosepsis. g. Hemodialysis-associatedamyloidosisofβ2-microglobulininbonesandjoints,

Hemodialysis-associated amyloidosis of B2-microglobulin in bones and joints, can lead to bilateral carpal tunnel syndrome.

canleadtobilateralcarpaltunnelsyndrome. 3. Complicationsassociatedwithperitonealdialysis.

a. Peritonitis,oftenaccompaniedbyfeverandabdominalpain—usuallycanbe treatedwithintraperitonealantibiotics;cloudyperitonealfluidiskeysign. b. Abdominal/inguinalhernia—increasedriskduetoelevatedintra-abdominal

pressures.

c. Hyperglycemia—especiallywithdiabeticpatients. d. Proteinmalnutrition.

ProteinuriaandHematuria

Proteinuria

Quick HIT

AsymptomaticProteinuria

e

«

Asymptomatictransientproteinuriahasanexcellentprognosis(nofurtherevaluationnecessary).Oftendueto feverorexercise. Asymptomaticpersistentproteinuriaandsymptomaticproteinuriarequirefurtherworkup(highchanceof renaldiseaseinthesepatients).

A.GeneralCharacteristics 1. Definedastheurinaryexcretionof>150mgprotein/24hours 2. Classification a. Glomerular
======================================
Duetoincreasedglomerularpermeabilitytoproteinsfromvariouscauses Canleadtonephroticsyndrome(seebelow) MaybeseeninalltypesofGN Proteinlosstendstobemoreseverethaninnonglomerularcauses

b. Tubular

e

e

e

Smallproteinsnormallyfilteredattheglomerulusthenreabsorbedbythe tubulesappearintheurinebecauseofabnormaltubules(i.e.,duetodecreased tubularreabsorption) Proteinuriaandkidneydamagetendstobelesssevereduetoalowerquantity andnephrotoxicityoftheassociatedproteins Causesincludesicklecelldisease,urinarytractobstruction,andinterstitial nephritis

c. Overflowproteinuria—increasedproductionofsmallproteinsoverwhelmsthe tubules’abilitytoreabsorbthem(e.g.,BenceJonesproteininmultiplemyeloma, myoglobininrhabdomyolysis)

d. Othercausesofproteinuria(allofthefollowingcanaffectrenalbloodflow):

e UTI

UTI Fever,heavyexertion/stress,CHF Pregnancy Orthostaticproteinuria—occurswhenthepatientisstandingbutnotwhen recumbent;self-limitedandbenign

e

e

e

3. Nephroticsyndrome

a. Keyfeatures

e

Urineproteinexcretionrate>3.5g/24hours Hypoalbuminemia—hepaticalbuminsynthesiscannotkeepupwiththese urinaryproteinlosses.Theresultisdecreasedplasmaoncoticpressure,which leadstoedema. Edema—thisisoftentheinitialcomplaint(frompedaledematoperiorbitalto anasarca,ascites,pleuraleffusion),andresultsfromhypoalbuminemia. Increasedaldosteronesecretionexacerbatestheproblem(increasessodium reabsorption). Hyperlipidemiaandlipiduria—increasedhepaticsynthesisofLDLandVLDL becauseliverisrevvingupalbuminsynthesis. Hypercoagulablestate(duetolossofcertainanticoagulantsintheurine)— increasedriskofthromboembolicevents(deepvenousthrombosis,pulmonary embolism,renalveinthrombosis). Increasedincidenceofinfection—resultsfromlossofimmunoglobulinsinthe urine,particularlysusceptibletopneumococcalinfections.

Quick  HIT  ThreeKeyFeaturesofNephroticSyndrome  Proteinuria Hypoalbuminemia Hyperlipidemia 

b. Nephroticsyndromeusuallyindicatessignificantglomerulardisease(either primaryorsecondarytosystemicillness)astheunderlyingcauseisabnormal glomerularpermeability.

c. Causes

Primaryglomerulardisease(50%to75%ofcasesofnephroticsyndrome)— membranousnephropathyismostcommoninadults(40%ofcases),followed byfocalsegmentalglomerulosclerosis(FSGS)(35%)and membranoproliferativeGN(15%).Minimalchangedisease(MCD)isthemost commoncauseinchildren(75%ofcases). Secondaryglomerularpathology:
======================================
e

Systemicdisease—diabetes,collagenvasculardisease,SLE,RA,Henoch– Schönleinpurpura,polyarteritisnodosa(PAN),granulomatosiswith polyangiitis. Amyloidosis,cryoglobulinemia. Drugs/toxins—captopril,heroin,heavymetals,NSAIDs,penicillamine. Infection—bacterial,viral,protozoal. Multiplemyeloma,malignantHTN,transplantrejection.

B.Diagnosis 1. Urinedipsticktest(readcolorchanges)

a. Specificforalbumin—detectsconcentrationsof30mg/dLorhigher b. Graded0,trace,1+(15to30mg/dL)through4+(>500mg/dL) c. Moresensitivetoalbuminthantoimmunoglobulins,thuscanleadtofalse-

negativeresultswhenpredominanturinaryproteinisglobulin(e.g.,lightchains inmyeloma)

2. Urinalysis(seeClinicalPearl7-6)

a. Initialtestonceproteinuriaisdetectedbydipsticktest. b. Examinationofurinesedimentisimportant.

e

e

e

RBCcastssuggestGN. WBCcastssuggestpyelonephritisandinterstitialnephritis. Fattycastssuggestnephroticsyndrome(lipiduria).

c. Ifurinalysisconfirmsthepresenceofprotein,a24-hoururinecollection(for albuminandCr)isappropriatetoestablishthepresenceofsignificant proteinuria.

CLINICALPEARL7-6

Urinalysis Collection—aclean-catch,midstreamurinesample(aftercleaningurethralmeatus)isusuallyadequatefor urinalysisandurinecultureinadults.

e

e

Urinalysisconsistsofthefollowingthreesteps: Visualinspectionofurine—examinecolor,clarity Dipstickreactions

e

e

e

e

¢

e

e

pH—thisdependsonacid–basestatus.Theaverageisabout6,butcanrangefrom4.5to8.0. Specificgravity—thisisdirectlyproportionaltourineosmolality(andthereforesoluteconcentration inurine).Normalis1.002to1.035.Itincreaseswithvolumedepletionanddecreaseswithvolume overload.Appropriatechangesinspecificgravitywithvolumestatusofthepatientindicateadequate tubularfunction(i.e.,renalconcentratingability). Protein—proteinuriaisdefinedas>150mg/day;nephroticsyndrome,>3.5g/day.Thefollowingare roughguidelines:Trace=50to150mg/day;1+=150to500mg/day;2+=0.5to1.5g/day;3+=2 to5g/day;4+=>5g/day. Glucose—excessiveglucoseindicatesdiabetes.Absenceofglucosuriadoesnotruleoutdiabetes, however. Blood—hematuria—seetext Ketones—DKA,starvation Nitrite—suggestspresenceofbacteriainurine,usuallyGNR Leukocyteesterase—suggestspresenceofWBCinurine;ifnegative,infectionisunlikely
======================================
e

Microscopicexaminationofurinesediment

¢

Lookforcasts,cells,bacteria,WBCs,RBCs(number,shape),crystals.

3. Testformicroalbuminuria

a. Correspondstoalbuminexcretionof30to300mg/day. b. Thisisbelowtherangeofsensitivityofstandarddipsticks.Specialdipstickscan detectmicrogramamountsofalbumin.Ifthetestresultispositive,performa radioimmunoassay(themostsensitiveandspecifictestformicroalbuminuria). c. Microalbuminuriacanbeanearlysignofdiabeticnephropathyandoften

presentsbeforeanyotherlaboratoryabnormalitiesorovertsignsor symptoms.

4. Otherteststodetermineetiology(mayormaynotbenecessarydependingon case)

a. Crclearance—besttestofrenalfunction/GFRestimation b. SerumBUNandCr c. CBC,vitaminD—todetectanemiaduetorenalfailure d. Serumalbuminlevel—variesinverselywithdegreeofproteinuria e. Renalultrasound—todetectobstruction,masses,cysticdisease f. Intravenouspyelogram(IVP)—todetectchronicpyelonephritis g. Immunologictests:ANAlevels(lupus),antiglomerularbasementmembrane

(Goodpasturesyndrome),hepatitisserology(causesofMN,MPGN), antistreptococcalantibodytiters(PSGN),complementlevels,cryoglobulin studies

h. Serumandurineelectrophoresis(myeloma) i. Renalbiopsy—ifnocauseisidentifiedbylessinvasivemeans

C.Treatment 1. Asymptomaticproteinuria.

a. Ifitistransient,nofurtherworkuportreatmentisnecessary. b. Ifitispersistent,furthertestingisindicated.StartbycheckingBPand

examiningurinesediment.Treattheunderlyingconditionandassociated problems(e.g.,hyperlipidemia).

2. Symptomaticproteinuria—furthertestingisalwaysrequired.

a. Treattheunderlyingdisease(diabetes,multiplemyeloma,SLE,MCD). b. ACEinhibitors(ARBcannottolerateACE)—thesedecreaseurinaryalbumin

loss.TheyareanessentialpartoftreatmentfordiabeticswithHTNandshould bestartedbeforefixedalbuminuriaispresent.

c. Diuretics—ifedemaispresent. d. Limitdietaryproteinandsodium. e. Treathypercholesterolemia(usingdietoralipid-loweringagent). f. Anticoagulateifthrombosisoccurs.Currently,thereisnotenoughdatato supportroutineprophylacticanticoagulationofthesepatientsandmustbe consideredonacase-by-casebasis.

g. Vaccinateagainstinfluenzaandpneumococcus—thereisanincreasedriskof
======================================
infectioninthesepatients.

Quick HIT

Grosshematuriaisacommonpresentingsigninpatientswithbladdercancer(upto85%ofcases)andpatients withrenalcellcarcinoma(upto40%ofcases).

Hematuria

A.GeneralCharacteristics 1. Hematuriaisdefinedas>3erythrocytes/HPFonurinalysis. 2. Microscopichematuriaismorecommonlyglomerularinorigin;grosshematuria

ismorecommonlynonglomerularorurologicinorigin.

3. Considergrosspainlesshematuriatobeasignofbladderorkidneycancer untilprovenotherwise.

4. ThismayleadtoobstructioniflargeclotsforminthelowerGUtract(potentially requiringbladdercatheterizationandirrigation).Excessivebloodlosscanleadto irondeficiencyanemia.

Quick HIT

Infection(cystitis,urethritis,prostatitis)accountsfor25%andstonesfor20%ofallcasesofatraumatic hematuria.

B.Causes 1. Intrarenal

a. Tumor(RCC),infection(pyelonephritis,abscess),stones,andtrauma b. Glomerulardisease,immunoglobulinAnephropathy c. Strenuousexercise(marathonrunning),fever—hematuriaisgenerallyharmless d. Polycystickidneydisease,simplecysts e. Sicklecelldisease f. Analgesicnephropathy(renalpapillarynecrosisandchronicinterstitial

nephritis)

g. Renalpapillarynecrosis

Quick HIT

Menstrualbloodcancontaminateaurinesampleandleadtoafalse-positivedipstickreadingforhematuria.

2. Ureter

a. Tumor,infection(pyelonephritis),stones,andtrauma b. Stricture

3. Lowerurinarytract(Bladder,Urethra,Prostate)

a. Tumor(bladder,prostate),infection(cystitis,prostatitis),stones,andtrauma

(Foleyplacement,invasiveprocedures) b. BPH—rarelycausesisolatedhematuria c. Chronicirritation

Quick HIT

Ifhematuriaismicroscopic,thinkofglomerulardisease.Ifgross,thinkofpostrenalcauses(trauma,stones, malignancy).Infectioncancauseeithergrossormicroscopichematuria.

4. Other

a. Systemicdiseases(SLE,rheumaticfever,Henoch–Schönleinpurpura, granulomatosiswithpolyangiitis,HUS,Goodpasturesyndrome,PAN)

b. Bleedingdisorders(e.g.,hemophilia,thrombocytopenia) c. Medications(cyclophosphamide,anticoagulants,salicylates,sulfonamides)

C.Diagnosis 1. Urinedipstick—sensitivityinidentifyinghematuriais>90%(Figure7-3). 2. Urinalysis—crucialinevaluationofhematuria.

Urinalysis, urine culture Reevaluate Positive Negative Dysmorphic RBCs, RBC casts, or . . proteinuria Persistent hematuria Coagulopathy KUB sSarehONy (Hz, :ANA, ANCA, Cs, Cy, antiglomerular basement antibody) 24-hr urine protein *GFR | Normal | Renal biopsy IVP, CT scan, urine cytology Treat | Further evaluation as needed: excretory urogram, ultrasound, cystoscopy with biopsy
======================================
FIGURE 7.3

Evaluationofhematuria.

Quick HIT

Ifthepatienthasnoothersymptomsassociatedwithhematuria,andthoroughworkupfailstoreveala cause,theprognosisisexcellent.(Thereisusuallymildglomerular/interstitialdisease.)

a. Examineurinesediment—thisisveryimportantinidentifyingpossiblerenal disease.

b. IfRBCcastsandproteinuriaarealsopresent,aglomerularcauseisalmost alwayspresent(usuallyGN).

c. Ifpyuriaispresent,sendforurineculture. d. Ifdipstickispositiveforblood,buturinalysisdoesnotrevealmicroscopic

hematuria(noRBCs),hemoglobinuriaormyoglobinuria(asinrhabdomyolysis) islikelypresent.

3. Urinespecimen—forcytology.

a. Todetectcancers(bladdercanceristhemainconcern). b. Ifsuspicionformalignancyishigh,performacystoscopytoevaluatethe bladderregardlessofcytologyresults.Thisisanecessityinnearlyall patientsover40orthosewithriskfactorsforbladdercancer.

4. Twenty-four–hoururine—testforCrandproteintoassessrenalfunction.Collect ifproteinuriaispresent.(Ifitisheavy,glomerulardiseaseislikely.)

5. Bloodtests—coagulationstudies,CBC,BUN/Cr. 6. IVP,CTscan,ultrasound—ifnocauseisidentifiedbytheabovetests;lookfor

stones,tumors,cysts,ureteralstrictures,orvascularmalformations.

7. Renalbiopsy—ifthereissuspicionofglomerulardisease.

D.Treatment:Treattheunderlyingcause;maintainurinevolume.

GlomerularDisease(Glomerulonephropathies)

Overview

A.GeneralCharacteristics 1. Canbeprimary(intrinsicrenalpathology)orsecondary(toasystemicdisease). Twoimportantcategoriesofglomerularpathologyarediseasesthatpresentwith nephroticsyndromeandthosethatpresentwithnephriticsyndrome.Many conditionshavefeaturesofboth.SeeTable7-5.
======================================
2. Thereisawiderangeintherateofdiseaseprogression,varyingfromdaysto weeksintheacuteglomerulardiseases,toyearsinthechronicdisorders.

Quick HIT

RapidprogressiveGNisaclinicalsyndromethatincludesanytypeofGNinwhichrapiddeteriorationofrenal functionoccursoverweekstomonths,leadingtorenalfailureandESRD.

B.Causes 1. GNisusuallycausedbyimmune-mediatedmechanisms. 2. Othermechanismsincludemetabolicandhemodynamicdisturbances.

C.ClinicalFeatures 1. Glomerulardisordersarecharacterizedbyimpairmentinselectivefiltrationof blood,resultinginexcretionoflargersubstancessuchasplasmaproteinsand bloodcells.Asdiseaseadvances,GFRdecreasesproportionately,leadingtorenal failureandthepossibleneedfordialysisand/ortransplantation.

2. Theclassicfeaturesareproteinuria,hematuria,orboth.Nephroticrange proteinuriaispathognomonicforglomerulardisease.

Quick HIT

PossiblePresentationsofGlomerularDisease

e

¢

e

¢

Isolatedproteinuria Isolatedhematuria Nephriticsyndrome—hematuria,HTN,azotemia Nephroticsyndrome—proteinuria,edema,hypoalbuminemia,hyperlipidemia

D.Diagnosis 1. Urinalysis(hematuria,proteinuria,RBCcasts) 2. Bloodtests(renalfunctiontests) 3. Needlebiopsyofthekidney

E.Treatmentdependsonthedisease,butofteninvolvessteroidsandcytotoxic agents.

PrimaryGlomerularDisorders

A.MinimalChangeDisease 1. Nephroticsyndrome—mostcommonpresentation(seealsoClinicalPearl7-7). 2. Mostcommoninchildren—Hodgkindiseaseandnon-Hodgkinlymphomahave

beenassociatedwithMCD.

3. Nohistologicabnormalitiesonlightmicroscopy;fusion/effacementoffoot processesonelectronmicroscopy.

4. Excellentprognosis;responsivetosteroidtherapy(4to8weeks),although relapsesmayoccur.

5. CurrentevidencepointstosystemicT-celldysfunctionasthemostlikelyroot causeofMCD.

B.FocalSegmentalGlomerulosclerosis 1. Ahistopathologiclesionwhichistheresultofawiderangeofdiseaseprocesses 2. Thisaccountsfor25%ofcasesofnephroticsyndromeinadultsandismore

commoninblacks.HematuriaandHTNareoftenpresent.

3. Ithasafairtopoorprognosis.Itisgenerallyresistanttosteroidtherapy—patients developrenalinsufficiencywithin5to10yearsofdiagnosis.Thecourseis progressivetoESRD.

4. Thetreatmentregimeniscontroversial,butremissionhasbeenachievedin50% ofpatientswiththeuseofcytotoxicagents,steroids,andimmunosuppressive agents.ACE/ARBsarealsocommonlyindicated.
======================================
C.MembranousGlomerulonephritis 1. Usuallypresentswithnephroticsyndrome;glomerularcapillarywallsare thickened.Mostcommonnephroticsyndromeinnondiabeticadults.

CLINICALPEARL7-7

GlomerularDisease(GD)VersusTubularDisease(TD) 1. TDisusuallyacute,whereasGDismorechronic. 2. TDisoftencausedbytoxins(NSAIDs,contrast,myoglobin,drugs);GDistypicallynotcausedby

toxins.

3. TDdoesnotcausenephroticsyndrome,GDdoes. 4. TDdoesnotneedbiopsy,GDoftendoes. 5. SteroidsusedforGD,notTD. 6. ImmunosuppressivemedicationsusedforGD,notTD.

2. Primarydiseaseisidiopathic(thisisthemostcommonetiology).Thesecondary formisduetoinfection(hepatitisCvirus,hepatitisBvirus,syphilis,malaria),

drugs(gold,captopril,penicillamine),neoplasm,orlupus.

3. Prognosisisfairtogoodandcourseisvariable;remissioniscommon(in40%of cases),butrenalfailuredevelopsin33%ofpatients.Steroidsdonotchange survivalrate.

D.IgANephropathy(BergerDisease) 1. Asymptomaticrecurrenthematuria/mildproteinuriaiscommon.Thisisthemost commoncauseofglomerularhematuria.Grosshematuria1to3daysafteran upperrespiratoryinfection(orotherviralinfectionorexercise)iscommon(as opposedtoweeksafteraURIinPSGN).

2. Renalfunctionisusuallynormal. 3. MesangialdepositionofIgAandC3areseenonelectronmicroscopy. 4. Theprognosisinmostpatientsisgoodwithpreservationofrenalfunction(renal

insufficiencymaydevelopin25%).

5. Someadvocatesteroidsforunstabledisease,butnotherapyhasbeenproventobe effective.

E.HereditaryNephritis(Alportsyndrome) 1. X-linkedorautosomaldominantinheritancewithvariablepenetrance 2. Featuresincludehematuria,pyuria,proteinuria,high-frequencyhearingloss

withoutdeafness,progressiverenalfailure

3. Noeffectivetreatment

SecondaryGlomerularDisorders

A.DiabeticNephropathy—mostcommoncauseofESRD(seeChapter4)

B.HypertensiveNephropathy—(seeRenalVasculatureDiseasesection)

C.Lupus—(seeChapter6)

D.MembranoproliferativeGN 1. Canpresentwithproteinuria/nephroticsyndromeorhematuria/nephritis 2. UsuallyduetohepatitisCinfection;othercausesincludehepatitisB,syphilis,and

lupus

3. Commonassociationwithcryoglobulinemia 4. Theprognosisispoor.Renalfailuredevelopsin50%ofpatients.Treatmentis

rarelyeffective.
======================================
E.PoststreptococcalGN—mostcommoncauseofnephriticsyndrome 1. OccursafterinfectionwithgroupAβ-hemolyticstreptococcalinfectionofthe

upperrespiratorytract(orskin—impetigo).TheGNdevelopsabout10to14days afterinfection.Primarilyaffectschildren(ages2to6years).

2. Featuresincludehematuria,edema,HTN,lowcomplementlevels,and proteinuria.

3. Antistreptolysin-Omaybeelevated. 4. Itisself-limited(usuallyresolvesinweekstomonths)withanexcellent

prognosis.SomecasesdevelopintorapidlyprogressiveGN(morecommonlyin adults).

5. Therapyisprimarilysupportive:antihypertensives,loopdiureticsforedema;the useofantibioticsiscontroversialbuthavenotbeenshowntopreventdisease whengivenduringacutestreptococcalinfection.Steroidsmaybehelpfulin severecases.

F.GoodpastureSyndrome 1. ClassictriadofproliferativeGN(usuallycrescentic),pulmonaryhemorrhage,and

IgGantiglomerularbasementmembraneantibody.

2. Clinicalfeatures:rapidlyprogressiverenalfailure,hemoptysis,cough,and dyspnea

3. Lungdiseaseprecedeskidneydiseasebydaystoweeks. 4. Renalbiopsyshowslinearimmunofluorescencepattern. 5. Treatwithplasmapheresistoremovecirculatinganti-IgGantibodies.

Cyclophosphamideandsteroidscandecreasetheformationofnewantibodies.

G.Dysproteinemias—amyloidosis,lightchain/heavychaindiseases

H.SickleCellNephropathy—(seeRenalVascularDiseasesection)

I.HIVNephropathy 1. Characteristicsincludeproteinuria,edema,andhematuria. 2. HistopathologymostoftenresemblesacollapsingformofFSGS. 3. Treatwithprednisone,ACEinhibitors,andantiretroviraltherapy.

J.GranulomatosisWithPolyangiitis—(seeChapter6).

K.PAN—(seeChapter6).

TubulointerstitialDiseases AcuteInterstitialNephritis

A.GeneralCharacteristics 1. Inflammationinvolvinginterstitium(tissuethatsurroundsglomeruliandtubules)

Quick HIT

DiagnosingAIN Inthesettingofrecentinfectionand/orstartofanewmedication,lookforallergicsymptoms(rash,fever, generalaches/pains)andsigns/symptomsofAKI.

2. Accountsfor10%to15%ofcasesofAKI 3. Causes

a. Acuteallergicreactiontomedicationisthemostcommoncause—for example,penicillins,cephalosporins,sulfadrugs,diuretics(furosemide, thiazide),anticoagulants,phenytoin,rifampin,allopurinol,protonpump inhibitors.

b. Infection(especiallyinchildren)—duetoavarietyofagents,including Streptococcusspp.andLegionellapneumophila.
======================================
c. Collagenvasculardiseases—forexample,sarcoidosis. d. Autoimmunediseases—forexample,SLE,Sjögrensyndrome.

Quick HIT

ThediagnosisofAINcanbemadeifthepatientisknowntohavebeenexposedtooneoftheoffendingagents, andhasthefollowing:rash,fever,acuterenalinsufficiency,andeosinophilia.

B.ClinicalFeatures 1. Acuteinterstitialnephritis(AIN)causesintrinsicAKIanditsassociated

symptoms.

2. Rash,fever,andeosinophiliaaretheclassicalfindings. 3. Pyuriaandhematuriamaybepresent.

C.Diagnosis 1. Renalfunctiontests(increasedBUNandCrlevels) 2. Urinalysis

a. Eosinophilsintheurinesuggestthediagnosis,giventheproperhistoryand

findings.

b. WBCandwhitecellcastsareoftenseen. c. Mildproteinuriaormicroscopichematuriamaybepresent.

3. NotethatitisoftenimpossibletodistinguishAINfromATNbasedonclinical groundsalone.Renalbiopsyistheonlywaytodistinguishbetweenthetwo,butis usuallynotperformedgivenitsinvasiveness.

Quick HIT

AcuteVersusChronicInterstitialNephritis

¢

¢

Acuteinterstitialnephritiscausesarapiddeteriorationinrenalfunctionandisassociatedwithinterstitial eosinophilsorlymphocytes. Chronicinterstitialnephritishasamoreindolentcourseandisassociatedwithtubulointerstitialfibrosisand atrophy.

D.Treatment 1. Removingtheoffendingagentisusuallyenoughtoreversetheclinicalfindings.If creatininecontinuestoincreaseafterstoppingtheoffendingagent,steroidsmay help.

2. Treatinfectionifpresent.

RenalPapillaryNecrosis

Mostcommonlyassociatedwithanalgesicnephropathy,diabeticnephropathy,sickle celldisease,urinarytractobstruction,UTI,chronicalcoholism,andrenaltransplant rejection.(AcommonmnemonicisPOSTCARDS—Pyelonephritis,Obstruction, Sicklecelldisease,Tuberculosis,Cirrhosis,Analgesics,Renalveinthrombosis, Diabetes,Systemicvasculitis) Diagnosisistypicallymadebyexcretoryurogram—notechangeinpapillaor medulla. Variablecourse:somepatientshaverapidprogression,andothershaveamore indolent,chroniccourse. Sloughed,necroticpapillaecancauseureteralobstruction(presentswithflankpain andhematuria). Treattheunderlyingcause,andstoptheoffendingagents(e.g.,NSAIDs).
======================================
Quick HIT

AnalgesicNephropathyPearls

e

e

e

Analgesicnephropathyisaformoftoxicinjurytothekidneyduetoexcessiveuseofover-the-counter analgesics(thosethatcontainphenacetin,acetaminophen,NSAIDs,oraspirin). Itcanmanifestasinterstitialnephritis(acuteorchronic)orrenalpapillarynecrosis. Itmayleadtoacuteorchronicrenalfailure.

RenalTubularAcidosis

A.GeneralCharacteristics 1. Renaltubularacidosis(RTA)isadisorderoftherenaltubulesthatleadstoa

nonaniongaphyperchloremicmetabolicacidosis(throughdifferentmechanisms detailedbelow).Glomerularfunctionisnormal(seeTable7-6).

2. ItischaracterizedbyadecreaseintheH+excretedintheurine,leadingto acidemiaandurinealkalosis.

3. TherearethreetypesofRTA(types1,2,and4).(Type3RTAisatermthatisno longerused.)

B.Type1(Distal) 1. ThedefectisaninabilitytosecreteH+atthedistaltubule(thusbicarbonate

cannotbedissociatedfromprotonsandrecycledtofurtherbuffertheblood).This inabilitytoacidifytheurineandgeneratenewbicarbonateresultsinmetabolic acidosis.AlthoughnormallytheurinepHcanbeaslowas4.7,indistalRTAthe urinepHcannotbeloweredbelow6,regardlessoftheseverityofmetabolic acidosis.

2. Itleadstoincreasedexcretionofions(sodium,calcium,potassium,sulfate, phosphate),withthefollowingeffects:

a. DecreaseinECFvolume b. Hypokalemia(defectinH+/K+pumpinalpha-intercalatedcell) c. Renalstones/nephrocalcinosis(duetoincreasedcalciumandphosphate

c. Renal stones/nephrocalcinosis (due to increased calcium and phosphate excretion into alkaline urine)

excretionintoalkalineurine) d. Rickets/osteomalaciainchildren

3. Leadstohypokalemic,hyperchloremic,nonaniongapmetabolicacidosis 4. Symptomsaresecondarytonephrolithiasisandnephrocalcinosis.Upto70%of

patientshavekidneystones.

5. Causes:congenital,multiplemyeloma,nephrocalcinosis,nephrotoxicity(e.g., amphotericinBtoxicity),autoimmunediseases(lupus,Sjögrensyndrome), medullaryspongekidney,andanalgesicnephropathy.

6. Treatment

a. Correctacidosiswithsodiumbicarbonate.Thiscanalsohelppreventkidney stones,whichisamajorgoaloftherapy.

b. Administerphosphatesalts(promotesexcretionoftitratableacid).
======================================
TABLE7-6 RenalTubularAcidosis(RTA)

Type

Type

DistinguishingCharacteristics

1(distal)

•InabilitytosecreteH+
======================================
C.Type2(Proximal) 1. ThedefectisaninabilitytoreabsorbHCO3

−attheproximaltubule,resultingin increasedexcretionofbicarbonateintheurineandmetabolicacidosis.The patientalsolosesK+andNa+intheurine.

2. Characterizedbyhypokalemic,hyperchloremicnonaniongapmetabolicacidosis (asintype1RTA)

3. Causes

a. Fanconisyndrome(inchildren),definedasageneralizedproximalresorption defect

b. Cystinosis,Wilsondisease,leadtoxicity,multiplemyeloma(monoclonal gammopathiesarethemajorcauseinadults),nephroticsyndrome,amyloidosis, acetazolamide

c. Theexcretionofmonoclonallightchainsisacommonfeature,somultiple myelomashouldalwaysberuledoutinapatientwithproximalRTA. 4. Nephrolithiasisandnephrocalcinosisdonotoccur(astheydointype1RTA). 5. Treatment:treattheunderlyingcause.

a. Donotgivebicarbonatetocorrecttheacidosisbecauseitwillbeexcretedinthe urine.

b. Sodiumrestrictionincreasessodiumreabsorption(andthusbicarbonate reabsorption)intheproximaltubule.

D.Type4 1. Thisisthenameforthenormalaniongapmetabolicacidosisthatresultsfromany conditionthatisassociatedwithhypoaldosteronism,orincreasedrenalresistance toaldosterone.

2. Itiscommoninpatientswithinterstitialrenaldiseaseanddiabeticnephropathy. 3. ItischaracterizedbydecreasedNa+absorptionanddecreasedH+andK+

secretioninthedistaltubule.

4. UnlikeothertypesofRTA,type4resultsinhyperkalemiaandacidicurine

(althoughanonaniongapmetabolicacidosisstilloccurs).

5. Nephrolithiasisandnephrocalcinosisarerare.

HartnupSyndrome

Autosomalrecessiveinheritanceofdefectiveaminoacidtransporter Resultsindecreasedintestinalandrenalreabsorptionofneutralaminoacids,suchas tryptophan,causingnicotinamide(niacinanalog)deficiency Clinicalfeaturesaresimilartothoseofpellagra:dermatitis,diarrhea,ataxia,and psychiatricdisturbances. Givesupplementalnicotinamideifthepatientissymptomatic.

FanconiSyndrome

Fanconisyndromeisahereditaryoracquiredproximaltubuledysfunctionthatleads todefectivetransportofsomeofthefollowing:glucose,aminoacids,sodium, potassium,phosphate,uricacid,andbicarbonate.Recallthattheproximaltubuleis theprimarysiteofresorptioninthenephron. Itisassociatedwithglucosuria,phosphaturia(leadstoskeletalproblems: rickets/impairedgrowthinchildren;osteomalacia,osteoporosis,andpathologic fracturesinadults),proteinuria,polyuria,dehydration,type2RTA,hypercalciuria, andhypokalemia. Treatwithphosphate,potassium,alkaliandsaltsupplementation,aswellas adequatehydration.
======================================
RenalCysticDiseases

AutosomalDominantPolycysticKidneyDisease

A.GeneralCharacteristics 1. Polycystickidneydiseasemaybeinheritedasanautosomaldominantor autosomalrecessivetrait.Autosomaldominantpolycystickidneydisease (ADPKD)isthemostcommongeneticcauseofCKD(Figure7-4).

2. Thecourseisvariable,butESRDcommonlydevelopsin50%ofthepatients(by late50sor60s);remainderhaveanormallifespan.Renalfailureoccursfrom cystsreplacingrenalparenchymaovertime,aswellasrecurrentepisodesof pyelonephritisandnephrolithiasis.

FIGURE 7.4

Therenalultrasounddemonstratespolycystickidneydisease. (FromKawamuraDM,NolanTD.DiagnosticMedicalSonography:AbdomenandSuperficial Structures.4thed.Philadelphia,PA:WoltersKluwer;2018,Figure5-23F.)

B.ClinicalFeatures 1. Hematuria:usuallyvisibleandthoughttobeduetoruptureofcystsintothe

collectingsystem

2. Abdominalpain:sourcesincludepyelonephritis,stones,andhemorrhaginginto cysts

3. HTN(in>50%ofthecases) 4. Palpablekidneysonabdominalexamination 5. Complications/associatedfindings

a. Intracerebralberryaneurysm(in5%to20%ofcases)—mostdonot rupture

b. Infectionofrenalcysts;bleedingintocysts c. Renalfailure(lateinthedisease) d. Kidneystones e. Heartvalveabnormalities(especiallymitralvalveprolapse) f. Cystsinotherorgans(liver,spleen,pancreas,brain) g. Diverticula(colon) h. Hernias(abdominal/inguinal)

Quick  HIT  ADPKDpresentswith:  Pain Hematuria Infection Hypertension Kidneystones 

C.Diagnosis 1. Ultrasoundisconfirmatory—multiplecystsappearonthekidney. 2. CTscanandMRIarealternatives.

D.Treatment 1. Nocurativetherapyisavailable. 2. Draincystsifsymptomatic. 3. Treatinfectionwithantibiotics. 4. ControlHTNandothercardiovascularriskfactors.

AutosomalRecessivePolycysticKidneyDisease

A.GeneralCharacteristics 1. Autosomalrecessivepolycystickidneydisease(ARPKD)waspreviouslycalled infantilepolycystickidneydisease.Itischaracterizedbycystspredominantlyin therenalcollectingductsaswellashepaticfibrosis.

2. ItislesscommoncomparedtotheADPKD,thoughthetrueincidenceisunknown sincemanyaffectednewbornsdiewithoutproperdiagnosis.

3. AswithADPKD,thereisawidevariabilityinthelevelofrenalimpairment. However,mostpatientsultimatelywillexperienceprogressiverenalfailure.

B.ClinicalFeatures 1. Liverinvolvementisalwayspresent,andmaybethedominantclinicalfeature,

especiallyinolderindividuals.

a. HepaticcomplicationsincludeportalHTNandcholangitis.

2. Kidneysareincreasedinsizewhichmaycausesevereabdominaldistension. 3. HTN 4. Pulmonaryinsufficiencysecondarytopulmonaryhypoplasiaandenlarged kidneyslimitingdiaphragmaticmovementmaybesevere.Pulmonary complicationsaretheleadingcauseofmorbidityandmortalityintheneonatal period.

5. NewbornswithsevereARPKDmaypresentwithPottersyndrome,whichisthe constellationofclinicalfeaturesassociatedwithdecreasedamnioticfluid (oligohydramnios).Pottersyndromeischaracterizedbyhypoplasiaofthelungs, limbabnormalities(e.g.,clubfeet),andcharacteristicabnormalfacies.
======================================
C.Diagnosis 1. Somecasesaredetectedprenatallyduetothewidespreaduseofultrasoundduring

1. Some cases are detected prenatally due to the widespread use of ultrasound during pregnancy. Less severe cases may not be detected until much later.

pregnancy.Lessseverecasesmaynotbedetecteduntilmuchlater. 2. Oligohydramniosduringpregnancyusuallyindicatesseveredisease. 3. Ultrasoundwillshowcharacteristicrenalcystsintheabsenceofrenalcystsin eitherparent.Ultrasoundwillalsoshowhepatomegalyanddilatedbileducts. 4. Moleculargenetictestingmayconfirmthediseaseincaseswherethediagnosisis

unclear.

D.Treatment 1. Nocurativetherapyisavailable. 2. Managerespiratoryissuesinnewborns,andtreatESRDwithrenalreplacement

therapy.

MedullarySpongeKidney

Characterizedbycysticdilationofthecollectingducts(Figure7-5) Maypresentwithhematuria,UTIs,ornephrolithiasis,canoftenalsobe asymptomatic Thoughttobeassociatedwithhyperparathyroidismandparathyroidadenoma DiagnosedbyIVP Notreatmentisnecessaryotherthanthepreventionofstoneformationandthe treatmentofrecurrentUTIs

FIGURE 7.5

Excretoryurograminapatientwithmedullarysponge

kidney,showingmultiplesphericalorovaldilatationsofmedullary collectingductsinallpapillarygroupsoftherightkidney,givinga “bouquetsofflowers”appearance. (FromSchrierRW.DiseasesoftheKidneyandUrinaryTract.8thed.Philadelphia,PA:Wolters

KluwerHealth/LippincottWilliams&Wilkins;2007,Figure17-8.)

SimpleRenalCysts

Verycommon(50%ofthepeopleoverage50);incidenceincreaseswithage Maybesingleormultiple;usuallyasymptomaticanddiscoveredincidentallyon abdominalultrasoundorotherimagingstudy Occasionallyassociatedwithhematuriaorpainfromrupture,infection,or hypertension Notreatmentisnecessaryinmostcases

RenalVascularDisease

RenalArteryStenosis(RenovascularHypertension)

A.GeneralCharacteristics 1. Renalarterystenosiscausesadecreaseinbloodflowtothejuxtaglomerular apparatus.Asaresult,therenin–angiotensin–aldosteronesystembecomes activated,leadingtoHTN.

2. ThisisthemostcommoncauseofsecondaryHTN.

B.Causes 1. Atherosclerosis

a. Accountsfortwo-thirdsofthecases(mostofteninelderlymen) b. Bilateralinuptoone-thirdofthecases c. Smokingandhighcholesterollevelsarepredisposingfactors.

2. Fibromusculardysplasia

a. Usuallyseeninyoungfemales b. Bilateralin50%ofpatients
======================================
Quick HIT

ACEinhibitorsshouldbeusedcarefullyinpatientswithrenovascularHTN.

C.ClinicalFeatures 1. HTN—lookforasuddenonsetofHTNinapatientwithoutafamilyhistory,that

1. HTN—look for a sudden onset of HTN in a patient without a family history, that is severe (may cause malignant HTN), and/or that is refractory to multiple antihypertensive agents.

issevere(maycausemalignantHTN),and/orthatisrefractorytomultiple antihypertensiveagents. 2. Decreasedrenalfunction 3. Abdominalbruit(RUQ,LUQ,orepigastrium)ispresentin50%to80%of

patients;itisespeciallycommoninpatientswithfibromuscularhyperplasia.

Quick HIT

SuspectrenovascularHTNinthefollowingsituations:

e

e

e

e

MalignantHTN SuddenonsetofHTN HTNthatsuddenlyworsens HTNthatdoesnotrespondtostandardmedicaltherapy

D.Diagnosis 1. Renalarteriogramisthegoldstandard,butcontrastdyecanbenephrotoxic—do

notuseitinpatientswithrenalfailure.

2. MRAisanewtestthathashighsensitivityandspecificity.Themagneticdyeis notnephrotoxicsoitcanbeusedinpatientswithrenalfailure.

3. DuplexDopplerultrasonographyoftherenalarteriesandcontrastenhancedCT scanmayalsobehelpfulinsomecases.

E.Treatment 1. Revascularizationwithpercutaneoustransluminalrenalangioplasty(PRTA)isthe

initialtreatmentinmostpatients;ithasahighersuccessrateandalower restenosisratewithfibromusculardysplasiathanwiththeatherosclerotictype.

2. SurgeryifPRTAisnotsuccessful(bypass). 3. Conservativemedicaltherapy(ACEinhibitors,calciumchannelblockers)maybe triedaloneorincombinationwithrevascularizationprocedures.ACEinhibitors mayinhibitkidneys’naturalmechanismtoincreaseGFRwhenRBFislowfrom stenosis(efferentarterioleconstriction)andthusshouldbeusedcarefully.

RenalVeinThrombosis

Maybeseeninthefollowingclinicalsettings:nephroticsyndrome(duetoincreased riskofVTE),invasionofrenalveinbyrenalcellcarcinoma,trauma,pregnancy/oral contraceptives,extrinsiccompression(retroperitonealfibrosis,aorticaneurysm, lymphadenopathy),orseveredehydration(ininfants) Clinicalfeaturesdependontheacuityandseverityoftheprocessandinclude decreasedrenalperfusion(canleadtorenalfailure),flankpain,HTN,hematuria, andproteinuria.Chronicthrombosesarelargelyasymptomaticbutmayleadto progressiverenaldamageorPE. Diagnostictestsincludeselectiverenalvenographyvisualizingtheoccluding thrombus(definitivestudy)orIVP. Anticoagulatetopreventpulmonaryembolism.
======================================
AtheroembolicDiseaseoftheRenalArteries

Referstoshowersofcholesterolcrystalsthatdislodgefromplaquesinlargearteries andembolizetotherenalvasculature. Canoccurinotherorgansaswell,suchastheretina,brain,orskin RefertocholesterolembolizationsyndromeinChapter1.

HypertensiveNephrosclerosis

A.Definition:SystemicHTNincreasescapillaryhydrostaticpressureinthe glomeruli,leadingtobenignormalignantsclerosis.

1. Benignnephrosclerosis—hypertrophicthickeningoftheglomerularafferent arteriolesandglomerulithemselves(globalorfocalsegmental)developsin patientswithlong-standingHTN.

a. ResultsinmildtomoderateincreaseinCrlevels,microscopichematuria,and mildproteinuria

b. AdvanceddiseasecanleadtoESRD.

Quick HIT

NephrosclerosisduetoHTNisthesecondmostcommoncauseofESRD(diabetesisthemostcommon cause).

2. Malignantnephrosclerosis—thisacceleratedvariantofnephrosclerosistypically maydevelopinapatientwithmalignanthypertensionorwithlong-standing benignHTN.

a. CharacterizedbyarapiddecreaseinrenalfunctionandacceleratedHTNdueto diffuseintrarenalvascularinjury.Itisalsoknownasacutehypertensive nephrosclerosis.

b. African-Americanmenarethemostsusceptible. c. Clinicalmanifestationsinclude:

e

e

e

MarkedlyelevatedBP(papilledema,cardiacdecompensation,CNSfindings). Renalmanifestations:arapidincreaseinCr,proteinuria,hematuria,RBCand WBCcastsinurinesediment,andsometimesnephroticsyndrome Microangiopathichemolyticanemiamayalsobepresent.

B.Treatment 1. Themostimportanttreatmentforbothbenignandmalignantformsiscontrolling theBP(seeChapter12).Itisnotclearwhichbloodpressureagentsshouldbe usedinthechronicsetting,orhoweffectivetheyareoncefrankalbuminuriais present.Caremustalsobetakentoavoidacutelydroppingrenalperfusion.

2. Inadvanceddisease,treatasforCKD.Dialysismayberequired.

Scleroderma

Inrarecases,thismaycausemalignantHTN.SeeChapter6.

SickleCellNephropathy

Ifischemicinjurytotherenaltubulesoccurs(duetohemodynamicchangesor nephrotoxins),thereisincreasedriskofdehydration(fromimpairedurine concentration),precipitatingsicklingcrises. ThissicklingofRBCsinthemicrovasculatureleadstoinfarction.Inthekidneythis occursmostlyintherenalpapilla.Sequelaeofrecurrentpapillaryinfarctioninclude papillarynecrosis,ATN,andrenalfailure,aswellasahighfrequencyofUTIs. Nephroticsyndromecanalsodevelop(whichcanleadtorenalfailure). ItprogressestoESRDinapproximately5%ofthepatients. ACEinhibitorsmaybehelpful.
======================================
Quick HIT

CausesofHypercalciuriaandHyperoxaluria

Causesofhypercalciuria

e

e

e

e

¢

e

e

↑Intestinalabsorptionofcalcium,notusuallyfromdietalone ↓Renalreabsorptionofcalcium,leadingto↑renalexcretionofcalcium ↑Bonereabsorptionofcalcium Primaryhyperparathyroidism Sarcoidosis Malignancy VitaminDexcess Acidemia,leadingtodisplacementofcalciumfromalbumin

e

Causesofhyperoxaluria

e

Severesteatorrheaofanycausecanleadtocalciumoxalatestones(duetocalciumbindingtofatinsteadof oxalateinintestineandthus↑absorptionoffreeoxalate) Smallboweldisease,Crohndisease Pyridoxinedeficiency VitaminCexcess Ethyleneglycolingestion

StonesandObstructions

Nephrolithiasis

A.GeneralCharacteristics 1. Nephrolithiasisisthedevelopmentofstoneswithintheurinarytract. 2. Sitesofobstruction

a. Ureterovesicularjunction—mostcommonsiteofimpaction b. Calyxofthekidney c. Ureteropelvicjunction d. Intersectionoftheureterandtheiliacvessels(nearthepelvicbrim)

3. Riskfactors

a. Ingeneral,precipitationisdependentonfactorswhichaffecttherelative concentrationofcertainstone-formingsubstanceswithintheurineaswellas urinepH.

b. Lowfluidintake—mostcommonandpreventableriskfactorwhichcan predisposetoconcentrationofurineandprecipitationofcrystals

c. Familyhistory d. Conditionsknowntoprecipitatestoneformation(e.g.,gout[hyperuricemia], Crohndisease[hyperoxaluria],hyperparathyroidism[hypercalciuria],type1 RTA[increasedurinepH])

e. Medications(e.g.,loopdiuretics[hypercalciuria],acetazolamide[increased urinepH],antacids,chemotherapeuticdrugsthatcausecellbreakdown[uricacid stones],medicationswhichcanthemselvesprecipitateinthenephrons [acyclovir,sulfadiazine])

f. Malegender(threetimesmorelikelytohaveurolithiasis) g. UTIs(especiallywithurease-producingbacterialeadingtostruvitestones) h. Dietaryfactors—lowcalciumandhighoxalateintake,bothofwhichleadto hyperoxaluria(highcalciumintakeitselfisrarelyassociatedwithincreased stones) 4. Typesofstones

a. Calciumstones(mostcommonform)

e

e

e

e

Accountfor80%to85%ofurinarystones;composedofcalciumoxalateor calciumphosphate(lessoften)orboth Bipyramidalorbiconcaveovals Radiodense(i.e.,visibleonanabdominalradiograph) Secondarytohypercalciuriaandhyperoxaluria,whichcanbeduetoavariety ofcauses
======================================
AcidicurinepHpromotescalciumoxalatestoneformationwhileabasicpH inducescalciumphosphatestones b. Uricacidstones(secondmostcommon)

e

e

e

e

Accountfor10%ofstones Flatsquareplates Stonesareradiolucent(cannotbeseenonanabdominalradiograph)— requireCT,ultrasound,orIVPfordetection. Theseareassociatedwithhyperuricemia,secondarytogoutorto chemotherapeutictreatmentofleukemiasandlymphomaswithhighcell destruction.Thereleaseofpurinesfromdyingcellsleadstohyperuricemia. ApersistentlyacidicurinepH(<5.5)promotesuricacidstoneformation.

e

c. Struvitestones(staghornstones)

e

e

¢

e

e

Accountfor5%to10%ofstones Radiodense(visibleonanabdominalradiograph);rectangularprisms OccurinpatientswithrecurrentUTIsduetourease-producingorganisms (Proteus,Klebsiella,Serratia,Enterobacterspp.) Theyarefacilitatedbyalkalineurine:urea-splittingbacteriaconvertureato ammonia,thusproducingthealkalineurine. Theresultantammoniacombineswithmagnesiumandphosphatetoform struvitecalculi,whichmayinvolvetheentirerenalcollectingsystem.

d. Cystinestones

e

e

e

Accountfor1%ofurinarystones Geneticpredisposition—cystinuria(autosomalrecessive),usuallyseenin children Hexagon-shapedcrystalsarepoorlyvisualized.

5. Clinicalcourse

a. Ifastoneis>1cm,itisunlikelytopassspontaneously.Stones<0.5cmusually dopassspontaneously.

b. Recurrenceiscommon.Upto50%ofthepatientshaverecurrenceswithin10 yearsofhavingthefirststone.

Quick HIT

ClassicPresentationofNephrolithiasis

e

e

Suddenonsetofcolickyflankpainthatradiatesintogroin Urinalysisshowinghematuria

B.ClinicalFeatures 1. Renalcolic—referstothepainassociatedwithpassingakidneystoneintothe

ureter,withureteralobstructionandspasm

a. Descriptionofpain—beginssuddenlyandsoonmaybecomesevere(patient cannotsitstill—usuallywrithesinexcruciatingpain).Painmayoccurinwaves orparoxysms.

b. Locationofpain—beginsintheflankandradiatesanteriorlytowardthegroin

(i.e.,followspathofthestone) 2. Nauseaandvomitingarecommon. 3. Hematuria(inover90%ofthecases) 4. UTI

C.Diagnosis 1. Laboratorytesting

a. Urinalysis
======================================
e

e

Revealseithermicroscopicorgrosshematuria RevealsanassociatedUTIifpyuriaorbacteriuriaarepresent Examinetheurinarysedimentforcrystals(calcium,cystine,uricacid,or struvitecrystals) DeterminetheurinarypH—alkalineurinemightindicatethepresenceof urease-producingbacteriathatcauseaninfectionstone.Acidicurineis suggestiveofuricacidstones.

b. Urineculture—obtainifinfectionissuspected. c. Twenty-four–hoururine—collecttoassessCr,calcium,uricacid,oxalate,and citratelevels.Usuallydoneforpatientswithrecurrentstonestoassessrisk factorsandetiology.

d. Serumchemistry—obtainBUNandCrlevels(forevaluationofrenalfunction,if kidneyparenchymaarenotdamagedthiswilllikelybenormal)andalso calcium,uricacid,andphosphatelevels.

e. Stoneanalysis:patientcanstrainurineforstones,whichcanthenbesentfor analysisofchemicalcomposition.

Quick HIT

Hematuriapluspyuriaindicatesastonewithconcomitantinfection.

2. Imaging

a. Plainradiographofthekidneys,ureter,andbladder(KUB)(Figure7-6)

e

Initialimagingtestfordetectingstones Cystineanduricacidstonesarenotusuallyvisibleonplainfilms.

b. CTscan(spiralCT)withoutcontrast

e

e

Goldstandardfordiagnosis.Mostsensitivetestfordetectingstones Allstones,evenradiolucentonessuchasuricacidstonesandcystinestones, arevisibleontheCTscan.

c. IVP

¢

e

Mostusefultestfordefiningdegreeandextentofurinarytractobstruction Thisisusuallynotnecessaryforthediagnosisofrenalcalculi.IVPmaybe appropriatefordecidingwhetherapatientneedsproceduraltherapy.

d. Renalultrasonography

e

e

e

Helpsindetectinghydronephrosisorhydroureter False-negativeresultsarecommoninearlyobstruction.Also,thereisalow yieldinvisualizingthestone. Procedureofchoiceinpatientswhocannotreceiveradiation(i.e.,pregnant patients)

Quick HIT

Havingthestoneforanalysisisveryhelpfulbothintreatmentandinpreventingrecurrence.Likewise,reporting ahistoryofstonesandtheircomposition(ifdetermined)isveryhelpful.Thepatientshouldattempttorecover thestonethatispassed(strainurine).

& “it a oe ee ao = ee 2 ead _-v" } a \ Tape! 4 " ap 7 i = ° 1 . fa pe SX " ¥ 5 BJ -” a. » ¥ , 7
======================================
FIGURE 7.6

Abdominalfilm(KUB)ofrenalcalculi.

(FromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins;1998:206,Figure10-20A.)

D.Treatment 1. Generalmeasures(foralltypesofstones)

a. Analgesia:IVmorphine,parenteralNSAIDs(ketorolac) b. Vigorousfluidhydration—beneficialinallformsofnephrolithiasis c. Alpha-1blockers(tamsulosin)maybeusedtofacilitatestonepassage. d. Antibiotics—ifUTIispresent e. Outpatientmanagementisappropriateformostpatients.Indicationsforhospital

admissioninclude:

Painnotcontrolledwithoralmedications Anuria(usuallyinpatientswithonekidney) RenalcolicplusUTIand/orfever Largestone(>1cm)thatisunlikelytopassspontaneously

2. Specificmeasures(basedonseverityofpain)

a. Mildtomoderatepain:highfluidintake,oralanalgesiawhilewaitingforstone topassspontaneously(givethepatientaurinestrainer)

b. Severepain(especiallywithvomiting) PrescribeIVfluidsandpaincontrol. ObtainaKUBandanIVPtofindthesiteofobstruction. Ifastonedoesnotpassspontaneouslyafter3days,considerurologyconsult.

c. Surgicalinterventionisnecessaryincasesofongoingobstructionandpersistent painnotcontrolledbynarcotics,signsofinfection/sepsis,kidneyinjury/failure, orfailuretorespondtoconservativemeasures.

e

e

e

Extracorporealshockwavelithotripsy(mostcommonmethod)breaksthestone apartusingsoundwaves;oncethecalculusisfragmented,thestonecanpass spontaneously.Bestforstonesthatare>5mmbut<2cmindiameter. Iflithotripsyfailsorifstoneis>2cmindiameter,percutaneousor ureteroscopicnephrolithotomy(surgicalstoneremoval)isindicated. Ifobstructioniscomplicatedbyinfection,renalinsufficiencyorfailure,urgent interventionviastentornephrostomytubeisindicated.

3. Preventionofrecurrences

a. Dietarymeasures

e

e

e

Highfluidintakeisessential(keepurinevolumeat2L/day) Limitanimalproteinintakeinpatientswithhyperuricosuria(uricacidstones). Advisepatienttonottorestrictcalciumintheirdietaslowerintakeis associatedwithhyperoxaluriaandincreasedstones(unlessinrarecaseswhen dietaryintakeisidentifiedaslikelyetiologyofstones).

b. Pharmacologicmeasures
======================================
e

e

Thiazidediureticsreduceurinarycalciumandhavebeenfoundtolower recurrencerates,especiallyinpatientswithhypercalciuria. Allopurinoliseffectiveinpreventingrecurrenceinpatientswithhighuricacid levelsintheurine.

UrinaryTractObstruction

A.GeneralCharacteristics 1. Canleadtorenalinsufficiencyandhydronephrosis(dilationofurinarytract,

specificallythepelvisandcalyces)

2. Morecommoninmen(duetoBPHandprostatecancer) 3. UrinarytractobstructiondoesnotusuallycauseAKIunlesstheobstructionis

bilateralorthereispre-existingrenaldamage.

4. Classification

a. Acuteversuschronicobstruction

Acuteobstruction—clinicalfeaturesaresuddeninonset. Chronicobstruction—thiscausesprogressiverenalfailure/uremia,recurrent infections,andbladdercalculi. b. Lowerversusuppertractobstruction

e

e

Lowertractobstruction(belowureterovesicaljunction)—affectsurination Uppertractobstruction(aboveureterovesicaljunction)—typicallycausesrenal colic

c. Completeversuspartialobstruction d. Unilateralversusbilateralobstruction(ifuppertract)

5. Degreeofdamagetokidneysandlikelihoodofreturntonormalrenalfunctionis dependentontheseverityanddurationoftheobstruction.

6. Causes

a. Lowertractobstruction BPH,prostatecancer Urethralstricture,stone Neurogenicbladder(multiplesclerosis,diabetes) Trauma(pelvicfractureorstraddleinjury) Bladdercancer b. Uppertractobstruction

e

e

Intrinsiccauses—kidneystones,bloodclots,sloughedpapilla(RPN),crystal deposition(e.g.,uricacid),tumors,strictures,ureteropelvicorureterovesical junctiondysfunction Extrinsiccauses—pregnancy,tumors(gynecologic,metastatic),abdominal aorticaneurysm,retroperitonealfibrosis,endometriosis,prolapse,hematomas, Crohndisease,diverticulitis

Evaluationofurinarytractobstruction

e

e

e

History:Durationofsymptoms,UTIs,historyofnephrolithiasis,historyofsurgery Physical:Suprapubicmass(distendedbladder),flankmass(hydronephrosis) FeaturesofCKD

B.ClinicalFeatures(dependonduration,location,cause,anddurationof obstruction)

1. Renalcolicandpain—thisismorecommonwithacuteobstruction(kidney stones,sloughedpapilla,bloodclot);painmaymanifestonlyduringurination. Chronicobstructionmaybeasymptomatic.

2. Suprapubicpainanddistention—maybeseeninlowerurinarytractobstruction 3. Urineoutputmaybenormal,thougholiguria/anuriamaybeseenincomplete

obstruction(usuallyinlowertractobstruction).

4. Signs/symptomsofUTI,whichcanbearesultofurinarystasisorstones 5. Hypertension,particularinoliguricpatientsduetosodium/fluidretention 6. Renalfailure
======================================
C.Diagnosis 1. Renalultrasoundistheinitialtest—itshowsurinarytractdilation.Itisvery

sensitiveandspecificforidentifyinghydronephrosis

2. Urinalysis(mayrevealhematuriaorproteinuria),standardlaboratorytests(e.g., CBC,electrolytes,BUN,Cr)

3. KUB—canrevealstones 4. Intravenousurogram—alsocalledIVP

a. Goldstandardfordiagnosisofureteralobstruction b. Contraindicatedifthepatientispregnant,isallergictocontrastmaterial,orhas

renalfailure

5. Voidingcystourethrography—forlowertractobstruction 6. Cystoscopy—toevaluateurethraandbladder 7. CTscan—tohelpidentifythecauseofobstruction

Quick HIT

IfapatienthasanacuteobstructionandaUTI,emergentdiagnostictests(renalultrasoundorexcretory urogram)areindicated.Interveneimmediatelytorelievetheobstruction.

D.Treatment 1. Treatmentdependsonduration,severity,location,andcauseoftheobstruction. 2. Locationofobstruction

a. Lowerurinarytractobstruction

Urinarycatheter—foracuteobstruction(canbediagnosticandtherapeutic), urethralcatheterisfirstchoicebutifpassageisdifficultorcontraindicated,

e

e

suprapubiccathetermaybeused. Dilatationorinternalurethrotomy—ifcauseisurethralstrictures Prostatectomy—ifBPHisthecause

b. Upperurinarytractobstruction

e

e

Nephrostomytubedrainage—foracuteobstruction,particularlyinurgent settingwhenkidneyfunctionisimpairedorinfectionispresentandsource controlisneeded Ureteralstent(throughcystoscope)—ifureteralobstruction

3. Durationandseverityofobstruction

a. Acutecompleteobstruction—painorrenalfailuremaybepresent.Thisrequires immediatetherapy.

b. Acutepartialobstruction—usuallyduetostones(seetheTreatmentsectionof Nephrolithiasis)

c. Chronicpartialobstruction—thisrequiresimmediatetherapyonlywhen infection,severesymptoms,renalfailure,orurinaryretentionispresent.

Neoplasms ProstateCancer

eee

A.GeneralCharacteristics:Prostatecanceristhesecondmostcommonformof cancerinmenworldwide(seealsoClinicalPearl7-8).Ninety-fivepercentare adenocarcinomaswhichariseintheperipheral(outermost)zoneoftheprostate. 1. Riskfactors

a. Age(mostimportantriskfactor) b. African-Americanrace

CLINICALPEARL7-8
======================================
Prostate-SpecificAntigen,DigitalRectalExamination,andTransrectal Ultrasonography

e

e

e

e

IfPSAlevel>10ng/mL,TRUSwithbiopsyisindicated,regardlessofDREfindings. IfDREisabnormal,TRUSwithbiopsyisindicated,regardlessofPSAlevel. IfPSAis<4.0ng/mLandDREisnegative,annualfollow-upisindicated. IfPSAis4.1to10.0andDREisnegative,biopsyisusuallyrecommended.

c. High-fatdiet d. Positivefamilyhistory e. Exposuretoherbicidesandpesticides—certainoccupations,suchasfarmingand

workinindustrialchemicalindustry,presentahigherrisk.

B.ClinicalFeatures 1. Earlystages—itismostcommonlyasymptomatic.Cancerbeginsintheperiphery oftheglandandmovescentrally.Thus,obstructivesymptomsoccurlate.Infact, bythetimeprostatecancercausesurinaryobstruction,itoftenhasmetastasizedto boneorlymphnodes.

2. Asthecancergrowslocally—symptomsduetoobstructionoftheurethraoccuras theotherzonesoftheprostateareaffected:difficultyinvoiding,dysuria,and increasedurinaryfrequency.

3. Advancedstages/metastasis—bonepainfrommetastases(mostcommonly vertebralbodies,pelvis,andlongbonesinlegs),weightloss.

Quick HIT

Vertebralmetastasismaymanifestitselfaslowbackpaininanelderlymanwithprostatecancer.

C.Diagnosis 1. Digitalrectalexamination(DRE).

a. Carcinomaischaracteristicallyhard,nodular,andirregular. b. Normalprostatefeelslikeathenareminence.Cancerfeelslikeaknuckle.Men withinduration,asymmetry,orpalpablenodularityofprostateneedabiopsy, especiallyifoverage45.

c. IfDREisabnormal,transrectalultrasonography(TRUS)withbiopsyis indicated,regardlessoftheprostate-specificantigen(PSA)level.

d. Whenpalpable,60%to70%havespreadbeyondtheprostate.

2. PSA

a. Notusedroutinelyasascreeningtestastheabsoluteriskreductionofdeath fromprostatecancerissmall(growthisveryslowandmostwilldieofother causes)andtheharmfromunnecessarybiopsiesandinterventionsmaybemore significant.

b. PSAisnotcancerspecific.PSAlevelsalsoincreaseasaresultofthefollowing:

Prostaticmassage(butDREdoesnotchangePSAlevels) Needlebiopsy Cystoscopy BPH Prostatitis Advancedage

BPH
======================================
Quick HIT

ThecombinationofDREandPSAlevelscandetectupto60%ofprostatecancerswhiletheyarestill localized.

c. RefinementsofthePSAassay—somestrategiesforimprovingthediagnostic capabilityofthePSAtestinclude:

e

e

¢

e

Age-adjustedPSA(becausePSAnormallyincreaseswithage). PSAvelocity—analysisoftherateofincreaseinthelevelwithtime. Quantifyingfreeandprotein-boundformsofserumPSA—PSAproducedby prostatecancertendstobeboundbyplasmaproteins,whereasPSAproduced bynormalcellsismorelikelytobefreeinplasma. PSAdensity—correlationofPSAlevelswithprostatevolume.

Quick HIT

KeypointsaboutPSA:

1. ThehigherthePSA,thehigherthecancerrisk 2. NormalPSAdoesnotruleoutprostatecancer

3. Notusedasascreeningtest 4. Ifpatientrequeststhetest,orderit

3. TRUSwithbiopsy

a. Mayneedtorepeatbiopsiesfordefinitivediagnosis b. Indications

e

e

e

PSA>10ng/dL(orpossiblylower).IfPSAis>10,chanceoffindingcanceris over50%. PSAvelocity>0.75peryear AbnormalDRE

4. Othertestsintheevaluationincludeabonescan,plainradiographsofthepelvis andspine,andaCTscanofthepelvistoevaluateformetastaticdisease.

Quick HIT

StagesofProstateCancer

«

«

e

«

StageA—nonpalpable,confinedtoprostate StageB—palpablenodule,butconfinedtoprostate StageC—extendsbeyondcapsulewithoutmetastasis StageD—metastaticdisease

D.Treatment 1. Localizeddisease(toprostate)—thisisusuallyacurabledisease.Thedefinitive

therapyisradicalprostatectomy.However,watchfulwaitingiswarrantedinolder men(i.e.,thosewhoseremainingnaturallifeexpectancyis<10years)whoare asymptomatic.Mostcommoncomplicationsofprostatectomyareerectile dysfunctionandurinaryincontinence.

2. Locallyinvasivedisease—giveradiationtherapyplusandrogendeprivation (notcurative,butdecreasesthelocalspread).

3. Metastaticdisease—reducetheamountoftestosteronewithanyofthefollowing: a. Orchiectomy(removestestes)—morecommoninpatientswhoarenoncompliant

withmedicaltherapy.

b. Antiandrogens. c. GnRHagonists—causecontinuousstimulationofreceptorinsteadofnormal pulsatileactivation,leadingtosuppressionofluteinizinghormonerelease (leuprolide).

d. GnRHantagonists—suppresstestosteronebybindingtoandblockingreceptors inthepituitarywithoutcausingatransientsurgeofLHorFSH(degarelix).
======================================
RenalCellCarcinoma

A.GeneralCharacteristics 1. Itistwiceascommoninmenasinwomen. 2. Renalcellcarcinoma(RCC)comprisesabout85%ofprimaryrenalcancers

(transitionalcelloftherenalpelvisisthesecondmostcommon).

3. Mostcasesaresporadic;lessthan2%occuraspartofautosomaldominantvon Hippel–Lindausyndrome.Thepathogenesisisunknown.

4. Usuallydiscoveredwhenlocalizedtokidneyorwithregionallymphnodespread 5. Areasofmetastasisincludethelung,liver,brain,andbone.Tumorthrombuscan

invadetherenalveinorinferiorvenacava,resultinginhematogenous dissemination.

Quick HIT

Upto20%to30%ofcasesofrenalcellcarcinomaarediscoveredincidentallyonaCTscanorultrasound performedforotherreasons.

B.RiskFactors 1. Cigarettesmoking 2. Analgesics(highuse),particularphenacetin-containingmedicationsbut

acetaminophen,NSAIDs,andaspirinhavealsobeenimplicated.

3. Adultpolycystickidneydisease 4. Chronicdialysis(multicysticdiseasedevelops) 5. Exposuretoheavymetals(mercury,cadmium) 6. Hypertension 7. Obesity

C.ClinicalFeatures 1. Hematuriaisthemostcommonsymptom(grossormicroscopic)—occursin70%

ofthepatients.

2. Abdominalorflankpain—occursin50%ofthepatients 3. Abdominal(flank)mass—occursin40%ofthepatients 4. Findingsseeninmanyneoplasms:Weightloss,fever,anemiaofchronic

inflammation

5. Paraneoplasticsyndromes(uncommon)—thesetumorscanectopicallysecrete erythropoietin(causingpolycythemia),PTH-likehormone(causing hypercalcemia),renin(causingHTN),cortisol(causingCushingsyndrome),or gonadotropins(causingfeminizationormasculinization).

Quick HIT

Theclassictriadofhematuria,flankpain,andabdominalmassoccursinlessthan10%ofpatientswithrenalcell carcinoma.

D.Diagnosis 1. AbdominalCT(withandwithoutcontrast)—optimaltestfordiagnosisand

1. Abdominal CT (with and without contrast)—optimal test for diagnosis and staging; perform if ultrasound shows a mass or cysts. Cannot distinguish benign and malignant solid masses, both are usually empirically resected.

staging;performifultrasoundshowsamassorcysts.Cannotdistinguishbenign andmalignantsolidmasses,bothareusuallyempiricallyresected. 2. Renalultrasound—occasionallyusedfordetectionofrenalmassandto

distinguishfromcyst

E.Treatment 1. Partialnephrectomy(openorlaparoscopic)canbeusedforsmallertumors,

particularlywhenbilateralorwithassociatedgeneticsyndrome,tosaverenal parenchymaandfunction.

2. Radicalnephrectomy(excisionofkidneyandadrenalgland,includingGerota fasciawithexcisionofnodaltissuealongtherenalhilum)whenanyinvasioninto surroundingvasculatureoradiposeisnoted.

3. Foradvanceddisease,debulkingsurgeryandadjuvantchemotherapyisoften used.
======================================
BladderCancer

A.GeneralCharacteristics 1. Bladdercarcinomaisthemostcommontypeoftumorofthegenitourinarytract;

90%ofbladdercancersaretransitionalcellcarcinomas.Transitionalcell carcinomascanoccuranywherefromthekidneytothebladder(e.g.,renalpelvis, ureter),but90%ofthesecarcinomasareinthebladder.

2. Themostcommonrouteofspreadisdirectlocalextensiontosurroundingtissues (ratherthanhematologic/lymphaticdissemination).

3. Itislikelytorecurafterremoval. 4. Riskfactors

a. Cigarettesmoking(themajoridentifiedriskfactor) b. Industrialcarcinogens(anilinedye,azodyes) c. Long-termtreatmentwithcyclophosphamide(maycausehemorrhagiccystitis

andincreasetheriskoftransitionalcellcarcinoma)

Quick HIT

Transitionalcellcarcinomaaccountsfor90%ofallbladdercancers.Othertypesaresquamouscell(5%)and adenocarcinoma(2%).

B.ClinicalFeatures 1. Initialpresentingsignishematuriainmostcases(painlesshematuriaisthe

classicpresentation).Itismorelikelytobegross,butcanbemicroscopicaswell.

2. Irritablebladdersymptoms,suchasdysuria,frequency,and/orurgency 3. Painorobstructivesymptomsmaybeseenwhencarcinomabecomesmore

invasive.

4. Physicalexamisusuallyunremarkable.

C.Diagnosis 1. Urinalysisandurineculture—todetectRBCsandconfirmhematuriaasredurine

mayalsobeduetovariousfoodsormedications(e.g.,beets,dyes, phenazopyridine,myoglobin,Serratia)andtoruleoutinfection

2. Urinecytology—todetectmalignantcells 3. Cystoscopyandbiopsy—definitivetestwhichshouldbeperformedinallpatients

>40yearsoldorwithriskfactorsforbladdercancer

4. ChestradiographandCTscan—forstaging 5. IVPissuperioratdetectingcertainsmalltumorsofureterorrenalpelvis,itcan

alsobeusedifCTunavailable.

D.Treatment(dependsonthestageofthedisease)

1. Stage0(superficial,limitedtomucosa;alsoknownascarcinomainsitu)— intravesicalchemotherapy

2. StageA(involveslaminapropria)

a. Transurethralresectionofthebladdertumor b. Tendstorecur,sofrequentcystoscopyandremovalofrecurrenttumorsare

indicated

3. StageB(muscleinvasion)—radicalcystectomy,lymphnodedissection,removal ofprostate/uterus/ovaries/anteriorvaginalwall,andurinarydiversion(e.g.,ileal conduit)

a. Extensionofthetumorintothemuscularlayerisanimportantbranching pointoftherapyasitindicatesradicalcystectomyhasbecomenecessaryto preventfurtherspread

4. StageC(extendstoperivesicularfat)—treatmentisthesameasforstageB 5. StageD(metastasistolymphnodes,abdominalorgans,ordistantsites)—consider

cystectomyandsystemicchemotherapy
======================================
TesticularCancer

A.GeneralCharacteristics 1. Mostcommoninmen20to35yearsofage,butcanoccurinmenofanyage 2. Hasarelativelyhighcureratecomparedwithothercancers 3. Types

a. Germcelltumors(accountfor95%ofalltesticularcancers)—mostcommonin men20to40yearsofage;curablein>95%ofthecases

e

e

Seminomas(35%)—mostcommon;slowgrowthandlateinvasion;most radiosensitive Nonseminomatous(65%)—usuallycontaincellsfromatleasttwoofthe followingfourtypes(mixedcelltype):embryonalcarcinoma(highmalignant potential,hemorrhageandnecrosisarecommon;metastasestotheabdominal lymphaticsandthelungsmayoccurasanearlyevent);choriocarcinoma(most aggressivetype;rare;metastasesusuallyoccurbytimeofdiagnosis);teratoma (rarelymetastasize);yolksaccarcinoma(rareinmen,usuallyoccursinyoung boys)

Quick HIT

Inapatientwithascrotalmass,performacarefulphysicalexaminationtodetermineitssiteoforigin becausetesticularcancersarealmostalwaysmalignant,whereasextratesticulartumorswithinthe scrotumarealmostalwaysbenign.

b. Nongermcelltumors(accountfor5%ofalltesticularcancers)—areusually benign

Leydigcelltumorsarehormonallyactive—mostarebenignandaretreated withsurgery.Prognosisispoorifmetastasisoccurs.Theymaysecreteavariety ofsteroidhormones,includingestrogenandandrogens,andareassociatedwith precociouspubertyinchildrenandgynecomastiainadults. Sertolicelltumorsareusuallybenign.

B.RiskFactors 1. Cryptorchidism—surgicalcorrectionreducesbutdoesnoteliminaterisk 2. Klinefeltersyndrome

C.ClinicalFeatures 1. Painlessmass/lump/firmnessofthetesticle—becauseoflackofpain,maygo

unnoticedbythepatientuntiladvanced.

2. Whilepainisrare,a“dullache”inthepelvisisoftendescribed. 3. Gynecomastiamaybepresentbecausesomeofthenonseminomatousgermcell

tumorsproducegonadotropins.

Quick HIT

DifferentialDiagnosisofTesticularCancer

Varicocele—dilated,tortuousveinsintesticle Testiculartorsion Spermatocele(testicularcyst) Hydrocele(fluidintesticle) Epididymitis Lymphoma

D.Diagnosis 1. Physicalexamination(testicularmass) 2. Testicularultrasound—initialtestforlocalizingthetumor 3. Tumormarkers—helpfulindiagnosis,staging,andmonitoringresponseto

3. Tumor markers—helpful in diagnosis, staging, and monitoring response to therapy
======================================
therapy a. β-hCG

e

e

Alwayselevatedinchoriocarcinoma Maybeelevatedinothertypesofnonseminomatousgermcelltumorsaswell

b. AFP

e

e

Increasedinembryonaltumors(in80%ofthecases) ChoriocarcinomaandseminomaneverhaveanelevatedAFP

4. CTscanandchestradiographforstaging 5. BiopsyisNOTperformedduetoconcernforseeding/metastasizingthetumor

Quick HIT

Staging(Boden–Gibb)ofTesticularCancer

e

«

«

StageA—confinedtotestis/cord StageB—retroperitoneallymphnodespread(belowdiaphragm) StageC—distantmetastasis

E.Treatment 1. Iftesticularcancerissuspectedbasedonphysicalexaminationorultrasound,the

testicleshouldberemovedsurgically(toconfirmdiagnosis).Aninguinal approachisusedbecauseascrotalincisionmayleadtotumorseedingofthe scrotum.

2. Afterorchiectomy,performaCTscanofthechest,abdomen,andpelvisfor staging.

3. Performβ-hCGandAFPmeasurementafterorchiectomyforcomparisonwiththe preoperativevalues.

4. Furthertreatmentdependsonthehistologyofthetumor.

a. Seminoma—inguinalorchiectomyandradiation(veryradiosensitive). b. Nonseminomatousdisease—orchiectomyandretroperitoneallymphnode

dissectionwithorwithoutchemotherapy.

Quick HIT

Ayoungmanwithafirm,painlesstesticularmassshouldbepresumedtohavetesticularcanceruntilproven otherwise.

PenileCancer

Thepeakincidenceofthistumorisinmenintheirseventhdecade. Circumcisionmayhaveaprotectiveeffectbecausepenilecancerisveryrarein thosewhohavebeencircumcised. ItisassociatedwithherpessimplexvirusandHPV18infection. Itpresentsasanexophyticmassonthepenis. Treatmentoftheprimarydiseaseislocalexcision.

MiscellaneousConditions TesticularTorsion

Quick HIT

Epididymitismaybedifficulttodifferentiatefromtesticulartorsion.

Twistingofthespermaticcordleadingtoarterialocclusionandvenousoutflow obstruction;ischemiacanleadtotesticularinfarction. Usuallyseeninadolescentsfollowingtraumaorphysicalactivity. Acuteseveretesticularpain,swollenandtenderscrotum,andanelevatedtesticle(as twistingoccurs,thetesticlemovestoahigherpositioninscrotum,the“bellclapper deformity”).Absenceofcremastericreflexisalsoseen. TesticularultrasoundwithDopplershouldbeperformedimmediately,torsionis suggestedbytheabsenceofnormalarterialpulsations. Thisisasurgicalemergency:immediatesurgicaldetorsionandorchiopexytothe scrotum(performbilaterallytopreventtorsioninthecontralateraltesticle).If surgeryisdelayedbeyond6hours,infarctionmayoccur,andthetesticlemay notbesalvageable. Orchiectomyifanonviabletesticleisfound.
======================================
Epididymitis

Infectionoftheepididymis.Thecommonoffendingorganisminchildrenandelderly patientsisEscherichiacoli;inyoungmen,sexuallytransmitteddiseasesaremore common(gonorrhea,Chlamydia). Aswollen,tendertesticle;dysuria;fever/chills;scrotalpain;andascrotalmass. Intactcremastericreflex. Ruleouttesticulartorsionwithultrasound,andadministerantibiotics.

Donotconfusetesticularcancerwithtesticulartorsionorepididymitis.

8

xX)

Fluids,Electrolytes,andAcid–Base Disorders

NickVillano

VolumeDisorders

ApproachtoVolumeDisorders

A.NormalBodyFluidCompartments 1. Men:total-bodywater(TBW)=60%ofbodyweight(Figure8-1). 2. Women:TBW=50%ofbodyweight. 3. PercentageofTBWdecreaseswithageandincreasingobesity(TBWdecreases

becausefatcontainsverylittlewater).

4. Distributionofwater.

a. Intracellularfluid(ICF)istwo-thirdsofTBW(or40%ofbodyweight)—the largestproportionofTBWisinskeletalmusclemass.

b. Extracellularfluid(ECF)isone-thirdofTBW(or20%ofbodyweight).

Plasmaisone-thirdofECF,one-twelfthofTBW,and5%ofbodyweight. Interstitialfluidistwo-thirdsofECF,one-fourthofTBW,and15%ofbody weight. 5. Waterexchange

a. Normalintake:Average1,500mLinfluidstakenPOperday;500mLinsolids orproductofoxidation.

b. Normaloutput.

e

¢

e

From800to1,500mLinurineperdayisthenormalrange.Minimumurine outputtoexcreteproductsofcatabolismisabout500to600mL/day,assuming normalrenalconcentratingability. Outputof250mL/dayoccursinstool. From600to900mL/dayininsensiblelossesoccurs.Thisishighlyvariable butincreaseswithfever,sweating,hyperventilation,andtracheostomies (unhumidifiedair)—seebelow.

c. RemembertheStarlingequationandforces:fluidshiftdependsonhydrostatic andoncoticpressures.

d. Asosmolalityoffluids(ECForICF)changes(e.g.,hyponatremia, hyperglycemia),waterwillshiftfreelythroughthepermeablecellmembranesto maintainisotonicity,whichwillleadtoachangeinthedistributionofTBW.

Quick HIT

Forbodyfluidcompartments,rememberthe60-40-20rule.

«

e

e

TBWis60%ofbodyweight(50%forwomen). ICFis40%ofbodyweight. ECFis20%ofbodyweight(interstitialfluid15%andplasma5%).
======================================
Quick HIT

Threereasonsforoliguria:

¢

e

¢

Lowbloodflowtokidney(eitherfromvolumedepletionorcardiac/hepaticcongestion) Kidneyproblem Postrenalobstruction(placeaFoleycatheter)

B.AssessingVolumeStatus 1. Thisisnotasimpletaskasphysicalexamandobjectivedataisnotoriously undependable.Forexample,apatientwithlowerextremityedemamaybe euvolemic,ormaybetotal-bodyoverloadedbutintravascularlydepleted.Skin turgorandmucousmembranesareverydifficulttoassessandarenotalways reliableindicatorsofvolumestatus.PatientswithCHFmayhaveeither pulmonaryedemaoranasarca,dependingonwhichventricleisinvolved. 2. Trackinginputandoutputisnotanexactscienceeitherbecausethereisno

accuratewayofcalculatinginsensiblelosses.Monitoringurineoutputisvery importantintheassessmentofvolumestatus:Normalurineoutputininfantsis morethan1.0mL/kg/hr,whilenormalurineoutputforanadultisgenerally regardedas0.5to1.0mL/kg/hr.Aslongasthekidneysarefunctioningproperly andintheabsenceofobstruction,lowurineoutputreflectsanappropriate responsetolowrenalbloodflow,eitherfromvolumedepletionorloweffective circulativevolume(asinCHF,cirrhosis).

Total body water (TBW) Intracellular Extracellular 2/3 of TBW 1/3 of TBW Plasma Interstitial 1/12 of TBW 1/4 of TBW Venous fluid Arterial fluid (85% of plasma) (15% of plasma)

FIGURE 8.1

Bodyfluidcompartments.

3. Dailyweightsmaygiveamoreaccurateassessmentofvolumetrends. 4. Keepinmindthelargerpictureofthepatient’scondition.

a. Insensiblelosses:Thesemaycauseanunderestimationoffluidneeds.In general,patientswithsepsis,fever,burns,oropenwoundshavehighinsensible losses(andhighermetabolicdemands).Foreachdegreeofatmospheric temperatureover37°C,thebody’swaterlossincreasesbyapproximately100 mL/day.

b. Oncoticpressure:Patientswithliverfailure,nephroticsyndrome,orany conditioncausinghypoalbuminemiatendtothird-spacefluidoutofthe vasculatureandmaybetotal-bodyhypervolemicbutintravascularlydepleted.

c. PatientswithESRDareverypronetohypervolemiaforobviousreasons.

C.FluidReplacementTherapy 1. Normalsaline(NS)

a. Uses:mostcommonresuscitativefluidusedtoincreaseintravascularvolumeif thepatientisdehydratedorhaslostblood

b. Cautions:

Chlorideloadwilltendtocausenon-gaphyperchloremicmetabolicacidosis withlargeboluses
======================================
e

e

Rememberonly25%ofNSfluidvolumegivenwillstayintravascular UsewithcautioninpatientswithCHFunlessthepatientneedsurgent resuscitationduetotruevolumedepletion

Quick HIT

Ifapatientisreceivinghypotonicsolutions(1/2NS,1/4NS),waterisinitiallytransferredfromtheECFto intracellularspacetoequilibrateosmoticpressuresinbothcompartments.

2. D51/2NS

a. Uses:Oftenthestandardmaintenancefluid(oftengivenwith20mEqofKCl/L offluid),canbeusedwithoutD5indiabeticpatients

b. Benefits:Hassomeglucose,whichcansparemusclebreakdown,andhaswater forinsensiblelosses

3. D5W

a. Uses:

e

e

Usedtodilutepowderedmedicines Oftenusedtoprovidefreewatertocorrecthypernatremia

b. Cautions:

¢

e

Onlyone-twelfthremainsintravascularbecauseitdiffusesintotheTBW compartment,sonoteffectiveinmaintainingintravascularvolume Usewithcautionindiabeticpatients

4. LactatedRingersolution

a. Uses:

Thisisexcellentforreplacementofintravascularvolume;itisnota maintenancefluid.Itisthemostcommontraumaresuscitationfluid.

b. Benefits:

DoesnotcausehyperchloremicmetabolicacidosislikeNS

c. Cautions:

Donotuseifhyperkalemiaisaconcern(containspotassium)

5. Colloidsolutions(e.g.,albumin)

resuscitationhasbeencontroversial.Whiletheydo,intheory,provide intravascularoncoticpressurewhichsalinesolutionsdonot,theyhavenot shownclearbenefitinlargetrials,areexpensive,andmaycauseharmin criticallyillandTBIpatientsduetoshiftofalbuminintotheinterstitialspace. Theyarecurrentlynotthefluidofchoice.

Hypovolemia

A.Causes 1. Inadequateintake 2. Trauma,openwounds,sequestrationoffluidintosofttissueinjuries 3. GIlossesduetovomiting,nasogastricsuction,diarrhea,fistuladrainage,etc. 4. Polyuria—forexample,diabeticketoacidosis(DKA) 5. Third-spacingduetoascites,effusions,bowelobstruction,crushinjuries,burns 6. Sepsis,intra-abdominalandretroperitonealinflammatoryprocesses 7. Insensiblelosses—evaporatorylossesthroughtheskin(75%)andtherespiratory

tract(25%)

B.ClinicalFeatures 1. CNSfindings:mentalstatuschanges,sleepiness,apathy,coma 2. Cardiovascularfindings(duetodecreaseinplasmavolume):orthostatic

hypotension,tachycardia,decreasedpulsepressure,decreasedcentralvenous pressure(CVP),andpulmonarycapillarywedgepressure(PCWP),canalsobe thoughtofintermsoftheClassesofHypovolemicShock:

a. ClassI(<750mLestimatedbloodloss[EBL]):Vitalsignsnormal,minimal symptoms

b. ClassII(750to1,500mLEBL):Tachycardiaandtachypnea,normalBP, decreasedurineoutput

c. ClassIII(1,500to2,000mLEBL):Abovesymptomsandhypotensionatrest, verydecreasedurineoutput(<20cc/hr)

d. ClassIV(>2,000mLEBL):Abovesymptomsandlittletonourineoutput e. Notethattheinitialsignsofhypovolemia/hemorrhagemaybesubtleincluding tachycardiawithanormalBP,onceBPfallsusuallyatleast30%bloodvolume hasbeenlost

3. Skin:poorskinturgor,hypothermia,coolandpaleextremities(dueto vasoconstriction),drytongueandaxilla

4. Ileus,weakness 5. Decreasedurineoutput,eithercompensatorytoconservefluidorasa

manifestationofacuterenalfailureduetoprerenalazotemia(fractionalexcretion ofsodium<1%and/orBUN/creatinine>20)

6. Rememberthatoncethesesymptomsofend-organdamagearepresent,patient hasenteredshockandtypicallyhaslost20%to30%oftheirtotalbloodvolume.
======================================
C.Diagnosis 1. Monitorurineoutputanddailyweights.Ifthepatientiscriticallyillandhas

cardiacorrenaldysfunction,considerplacingaSwan–Ganzcatheter(tomeasure

CVPandPCWP).

2. Elevatedserumsodium,lowurinesodium,andaBUN/Crratioof>20:1suggest hypoperfusiontothekidneys,whichusually(notalways)representshypovolemia.

3. Hematocrit:3%increaseforeachliterofdeficit,unlessotherwiselowereddueto hemorrhage.Howevernotethathematocritmaybenormalinacutebloodlossas fluidhasnotyethadtimetotransitionfrominterstitialspacebacktovasculature.

4. Theconcentrationofformedelementsintheblood(RBCs,WBCs,platelets, plasmaproteins)increaseswithanECFdeficitanddecreaseswithanECFexcess.

Quick HIT

Donotcombinebolusfluidswithdextrose(whichcanleadtohyperglycemia)orpotassium(whichcanleadto hyperkalemia).

D.Treatment 1. Correctvolumedeficit.

a. Usebolustoachieveeuvolemia.Beginwithisotonicsolution(lactatedRinger’s orNS).

b. TargetingeuvolemiaviafrequentmonitoringofHR,BP,urineoutput,and weightisessential.

c. Maintainurineoutputat0.5to1mL/kg/hr. d. Bloodloss—replacebloodlosswithcrystalloidata3:1ratio.Asstatedabove, initialhematocritmaynotreflectactualquantityofbloodlost.Therefore,inthe acutetraumasetting,replacetheestimatedbloodlost.

2. Maintenancefluid.

a. D51/2NSsolutionwith20mEqKCl/Listhemostcommonadultmaintenance fluid.(Dextroseisaddedtoinhibitmusclebreakdown.)

b. Therearetwomethodsofcalculatingtheamountofmaintenancefluid(see ClinicalPearl8-1).

Hypervolemia

Quick HIT

Mostcasesofedemaresultfromrenalsodiumretention.

A.Causes 1. Iatrogenic(parenteraloverhydration) 2. Fluid-retainingstates:CHF,nephroticsyndrome,cirrhosis,ESRD

B.ClinicalFeatures 1. Weightgain 2. Vitalsignsinsomecasesmayshowhypotensionandhemodynamicinstability(as indecompensatedheartfailure)ortachypneaandhypoxiaifpulmonaryedemais present.

3. Physicalexamsignsoffluidoverload:

a. Peripheral(usuallypitting)edema(pedalorsacral) b. Ascites:flankbulginganddullness(mostsensitive),fluidwave(mostspecific),

andshiftingdullness

c. Pulmonaryedema:manifestingasralesordullnessatthelungbases d. Jugularvenousdistention:maybedifficulttoevaluateinobesepatientsorifTR

ispresent

4. Labsmayshowlowhematocritandalbuminconcentration,hyponatremia 5. ElevatedCVPandPCWPonSwan–GanzCatheter
======================================
Quick HIT

SignsofVolumeOverload

e

e

e

Elevatedjugularvenouspressure Pulmonaryrales—duetopulmonaryedema Peripheraledema

C.Treatment 1. Fluidrestriction 2. Judicioususeofdiuretics 3. Monitorurineoutputanddailyweights,andconsiderSwan–Ganzcatheter

placementdependingonthepatient’scondition.

4. Ifpatientishemodynamicallyunstableandinitialattemptsareunsuccessful, urgentdialysismayrarelybeindicated(recallvolumeoverloadisoneofthe AEIOUindications,seeChapter7).

OverviewofSodiumHomeostasis

A.SaltandWaterRegulation 1. Na+regulationisintimatelyassociatedwithwaterhomeostasis,yetitisregulated

byindependentmechanisms.

2. ChangesinNa+concentrationareareflectionofwaterhomeostasis,whereas changesinNa+content(andsubsequently,fluidvolume)areareflectionofNa+ homeostasis.

3. DisturbanceofNa+balancemayleadtohypovolemiaorhypervolemia,and disturbanceofwaterbalancemayleadtohyponatremiaorhypernatremia.

B.SodiumHomeostasis 1. Sodiumisactivelypumpedoutofcellsandisthereforerestrictedtothe extracellularspace.ItisthemainosmoticallyactivecationoftheECF.

2. AnincreaseinsodiumintakeresultsinanincreaseinECFvolume,whichresults inanincreaseinGFRandsodiumexcretion.Thisoccurspartiallythroughrelease ofANPandBNPbytheheartanddecreaseofrenalreninrelease,whichtogether promotenatriuresisandinhibitnorepinephrine,epinephrine,aldosterone,and ADHrelease.

3. AdeclineintheextracellularcirculatingvolumeresultsinadecreasedGFRanda reductioninsodiumexcretion.Thisisaresponsetothesympatheticnervous systemincreasingcardiacoutputaswellasadecreaseinrenalperfusionpressure resultinginactivationoftherenin–angiotensin–aldosteronesystem.Aldosterone increasessodiumreabsorptionandpotassiumsecretionfromthelatedistal tubules.

4. DiureticsinhibitNa+reabsorptionthroughvariousmechanismsintherenal tubularsystem.FurosemideandotherloopdiureticsinhibittheNa+–K+–Cl− transporterinthethickascendinglimboftheloopofHenle,whereasthiazide diureticsinhibittheNa+–Cl−cotransporterattheearlydistaltubule.However,the majorityofNa+reabsorptionoccursintheproximaltubule.
======================================
Quick HIT

e

e

Aldosteroneincreasessodiumreabsorption,waterthenfollows. ADHincreaseswaterreabsorptionalone.

C.WaterHomeostasis

1. Osmoreceptorsinthehypothalamusarestimulatedbyplasmahypertonicity (usually>295mOsm/kg);activationofthesestimulatorsproducesthirst.

2. Hypertonicplasmaalsostimulatesthesecretionofantidiuretichormone(ADH) fromtheposteriorpituitarygland.WhenADHbindstoV2receptorsintherenal collectingducts,waterchannelsaresynthesizedandmorewaterisreabsorbed.

3. ADHissuppressedasplasmatonicitydecreases. 4. Ultimately,theamountofwaterintakeandoutput(includingrenal,GI,and

insensiblelossesfromtheskinandtherespiratorytract)mustbeequivalentover timetopreserveasteadystate.

5. Whenasteadystateisnotachieved,hyponatremiaorhypernatremiausually occurs.

Hyponatremia

Quick HIT

e

¢

Hyponatremiaandhypernatremiaarecausedbytoomuchortoolittlewater. Hypovolemiaandhypervolemiaarecausedbytoolittleortoomuchsodium.

A.GeneralCharacteristics 1. Thisreferstotoomuchwaterinrelationtosodiumintheserum. 2. ItistypicallydefinedasaplasmaNa+concentration<135mmol/L. 3. SymptomsusuallybeginwhentheNa+levelfallsto<120mEq/L.Animportant

exceptionisincreasedintracranialpressure(ICP)(e.g.,afterheadinjury).AsECF osmolalitydecreases,watershiftsintobraincells,furtherincreasingICP. (Therefore,itiscriticaltokeepserumsodiumnormalorslightlyhighinsuch patients.)

Quick HIT

Excessivewaterintakealonerarelyleadstohyponatremiabecausethekidneyshaveagreatcapacitytoexcrete water.

B.CausesandClassification(basedonserumosmolality) 1. Hypotonichyponatremia—“truehyponatremia”—serumosmolality<280 mOsm/kg(canbemeasuredorcalculatedusingsodium,BUN,andglucose)

a. Hypovolemic

e

e

Lowurinesodium(<10mEq/L)—impliesincreasedsodiumretentionbythe kidneystocompensateforextrarenallosses(e.g.,diarrhea,vomiting, nasogastricsuction,diaphoresis,third-spacing,burns,pancreatitis)ofsodium- containingfluid. Highurinesodium(>20mEq/L)—renalsaltlossislikelyduetotubular dysfunction—forexample,diureticexcess,decreasedaldosterone(i.e.,RTA typeIV,causesincludeACEinhibitorsandARBs),ATN.

b. Euvolemic—noevidenceofECFexpansionorcontractiononclinicalgrounds

SIADH:CausesarenumerousandincludeCNSpathologies,malignancy(most commonlysmallcelllungcancer),surgery(postoperativehyponatremia), drugs(e.g.,SSRIs,oxytocin,carbamazepine,haloperidol,cyclophosphamide, certainantineoplasticagents),infections(HIV,pulmonaryinfections),and more Hypothyroidism:mechanismnotfullyunderstood

Adrenalinsufficiency:causeismultifactorial Psychogenicpolydipsia Administration/intakeofarelativeexcessoffreewater—ifapatientisgiven D5W(orotherhypotonicsolution)toreplacefluids,orifwateraloneis consumedafterintensiveexertion(withprofusesweating) Lowdietarysoluteintake:kidneysexcretefreewaterbydilutingurine, howeverallurinemustcontainsomesolute;thereforeindividualswithpoor diets(beerdrinkers,elderlypersonswith“teaandtoast”diet)witharelative deficiencyofthesesoluteswillbelimitedindailyfreewaterexcretion c. Hypervolemic(lowurinesodium)—Thisisduetowater-retainingstates.The

relativeexcessofwaterinrelationtosodiumresultsinhyponatremia.

e CHF
======================================
CHF Nephroticsyndrome(renalfailure) Liverdisease

e

e

2. Isotonichyponatremia(pseudohyponatremia)

a. Anincreaseinplasmasolids(e.g.,proteinsorlipids)artificiallylowersthe plasmasodiumconcentrationmeasurementvialaboratoryartifact,butthe amountofsodiuminplasmaisnormal(hence,pseudohyponatremia). b. Thiscanbecausedbyanyconditionthatleadstoelevatedproteinorlipidlevels. 3. Hypertonichyponatremia

3. Hypertonichyponatremia

a. Causedbythepresenceofosmoticsubstancesthatcauseanosmoticshiftof wateroutofcells.Thesesubstancescannotcrossthecellmembraneand thereforecreateosmoticgradients

b. Thesesubstancesinclude:

e¢

e

Glucose—Hyperglycemiaincreasesosmoticpressure,andwatershiftsfrom cellsintoECFleadingtoadilutionalhyponatremia.Forevery100mg/dL increaseinbloodglucoselevelabovenormal,theserumsodiumlevel decreasesabout3mEq/L.NotethattheactualsodiumcontentintheECFis unchanged. Mannitol,sorbitol,glycerol,maltose Radiocontrastagents

e

Quick HIT

Asopposedtoacutewaterintoxication,whenhyponatremiadevelopsgradually(overafewdays),theclinical featuresdonotappearuntilarelativelylowersodiumlevelisreached.

C.ClinicalFeatures 1. Neurologicsymptomspredominate—causedby“waterintoxication”—osmotic

watershifts,whichleadstoincreasedICFvolume,specificallybraincellswelling orcerebraledema

a. Headache,delirium,irritability b. Muscletwitching,weakness c. Hyperactivedeeptendonreflexes

2. IncreasedICP,seizures,coma 3. GI—nausea,vomiting,ileus,waterydiarrhea 4. Cardiovascular—hypertensionduetoincreasedICP 5. Increasedsalivationandlacrimation 6. Oliguriaprogressingtoanuria—maynotbereversibleiftherapyisdelayedand

acuterenalfailuredevelops

D.Diagnosis 1. Plasmaosmolality—lowinapatientwithtruehyponatremia(Figure8-2) 2. Urineosmolality

a. Lowifthekidneysarerespondingappropriatelybydilutingtheurine—for example,primarypolydipsia

b. ElevatedifthereareincreasedlevelsofADH—forexample,SIADH,CHF,and hypothyroidism

3. Urinesodiumconcentration

a. UrineNa+shouldbelowinthesettingofhyponatremia b. UrineNa+concentration20to40mmol/LisconsistentwithSIADH,salt-

wastingnephropathyorhypoaldosteronism.Diureticsmayproducethisaswell

c. UrineNa+concentration<25mmol/Lisconsistentwithhypovolemia

Hypertonic hyponatremia (presence of osmotic substances) ¢ Hyperglycemia ¢ Mannitol, glycerol High (9298) aid Measure serum osmolality Normal : —-» Pseudohyponatremia (280-295) (*tproteins, tTGs) Low (<280) True hyponatremia Low (total body Na is low) Normal High Hypovolemic | Euvotemic | Hypervolemic * SIADH ° CHF Psychogenic polydipsia Nephrotic syndrome * Postoperative ¢ Liver disease ¢ Hypothyroidism Measure urine Nat* r gl 7 Extrarenal Renal salt loss salt loss * Diarrhea, vomiting * Excessive diuretic use Diaphoresis ¢ Low aldosterone * Third spacing °ATN
======================================
FIGURE 8.2

Evaluationofhyponatremia.

(AdaptedfromHarwood-NussA,WolfsonAB.TheClinicalPracticeofEmergencyMedicine.3rd

ed.Philadelphia,PA:LippincottWilliams&Wilkins,2001:849,Figure173-1.)

E.Treatment 1. Isotonicandhypertonichyponatremias—diagnoseandtreattheunderlying

disorder.

2. Hypotonichyponatremia.

a. Mild(Na+120to130mmol/L)—withholdfreewater,andallowthepatientto

reequilibratespontaneously.InSIADH,salttabletscanalsobeused. b. Moderate(Na+110to120mmol/L)—loopdiuretics(givenwithsalineto

preventrenalconcentrationofurineduetohighADH).

c. Severe(Na+<110mmol/L)orifsymptomatic—givehypertonicsalineto increaseserumsodiumby1to2mEq/L/hruntilsymptomsimprove.

e

e

e

HypertonicsalinerapidlyincreasesthetonicityofECF. Donotincreasesodiummorethan8mmol/Lduringthefirst24hours.An overlyrapidincreaseinserumsodiumconcentrationmayproducecentral pontinedemyelination. Rateofcorrection:Maximum8mEq/Lin24hourstopreventovercorrection andosmoticdemyelinationsyndrome,howeverinsymptomaticpatientsaim forcorrecting4to6mEq/Linfirst6hours.Makesuretochecksodiumlevels frequently.

Quick HIT

Mostcasesofhypernatremiaareduetothefollowingtypesoffreewaterloss:

e

e

Nonrenalloss:insensibleloss,GItract(diarrhea) Renalloss:osmoticdiuresis,diabetesinsipidus

Hypernatremia

Quick HIT

Excessivelyrapidcorrectionofhypernatremiacanleadtocerebraledemaaswatershiftsintobraincells. Therefore,therateofcorrectionshouldnotexceed12mEq/L/day(shouldbe<8mEq/Linthefirst24hours).

A.GeneralCharacteristics 1. DefinedasaplasmaNa+concentration>145mmol/L 2. Referstoexcesssodiuminrelationtowater;canresultfromwaterlossor,rarely,

sodiuminfusion

3. AssessECFvolumeclinically,asfollows(Figure8-3):

a. Hypovolemichypernatremia(sodiumstoresaredepleted,butrelativelymore waterhasbeenlost)

e

e

Renalloss—fromdiuretics,osmoticdiuresis(mostcommonlydueto glycosuriaindiabetics),renalfailure Extrarenalloss—fromdiarrhea,diaphoresis,respiratorylosses

b. Isovolemichypernatremia(sodiumstoresnormal,waterlost)

e

e

Diabetesinsipidus:central(usuallyduetoCNSpathologies)orperipheral (causesincludelithiumtoxicity,hypercalcemia,hypokalemia,renal disease,drugs) Insensiblerespiratory(tachypnea)

c. Hypervolemichypernatremia(sodiumexcess)—occursinfrequently
======================================
e

Iatrogenic—mostcommoncauseofhypervolemichypernatremia(e.g.,large amountsofparenteralNaHCO3,TPN) Exogenousglucocorticoids Cushingsyndrome Saltwaterdrowning Primaryhyperaldosteronism

Quick HIT

Clinicalfeaturesofhypernatremiaaresecondarytoosmoticeffectsonthebrain(watershiftsoutofbraincells, leavingthemdehydrated).Symptomsaremoreprominentandseverewhensodiumlevelsincreaserapidly.

B.ClinicalFeatures 1. Neurologicsymptomspredominate

a. Alteredmentalstatus,restlessness,weakness,focalneurologicdeficits b. Canleadtoconfusion,seizures,coma

2. Tissuesandmucousmembranesaredry;salivationdecreases

| Clinically assess ECF volume Depleted Hypovolemic Hypernatremia Normal lsovolemic Hypernatremia Loss of Nat and water, but more water loss than Nat loss Loss of water only Nat stores normal Expanded Hypervolemic Hypematremia Gain of Nat and water, but more Nat gain than water gain * Osmotic diuresis (glycosuria) ¢ Renal failure ¢ Extrarenal loss ¢ Diarrhea (GI losses) ¢ Diaphoresis (skin losses) ¢ Respiratory losses Causes Causes ¢ Renal loss ¢ Diabetes insipidus * Diuretics ¢ Insensible respiratory (tachypnea) Causes * latrogenic * NaHCOg therapy TPN ¢ Exogenous glucocorticoids * Cushing's syndrome ¢ Saltwater drowning ¢ Primary hyperaldosteronism

FIGURE 8.3

Evaluationofhypernatremia.

(AdaptedfromGlasscockRJ,MassrySG.MassryandGlassock’sTextbookofNephrology.4thed.

Philadelphia,PA:LippincottWilliams&Wilkins,2000.)

CLINICALPEARL8-1

CalculationofMaintenanceFluids

100/50/20rule:

e

¢

e

100mL/kgforfirst10kg,50mL/kgfornext10kg,20mL/kgforevery1kgover20 Dividetotalby24forhourlyrate Forexample,fora70kgman:100×10=1,000;50×10=500,20×50kg=1,000.Total=2,500.Divide by24hours:104mL/hr

4/2/1rule:

e

e

4mL/kgforfirst10kg,2mL/kgfornext10kg,1mL/kgforevery1kgover20 Forexample,fora70kgman:4×10=40;2×10=20;1×50=50.Total=110mL/hr

C.Diagnosis 1. Urinevolumeshouldbelowifthekidneysarerespondingappropriately. 2. Urineosmolalityshouldbe>800mOsm/kg. 3. Desmopressinshouldbegiventodifferentiatenephrogenicfromcentraldiabetes

insipidusifdiabetesinsipidusissuspected(seeChapter4).
======================================
D.Treatment 1. Hypovolemichypernatremia—GiveisotonicNaCltoachieveeuvolemiaand

restorehemodynamicsinitially.Correctionofhypernatremiacanwaituntilthe patientishemodynamicallystable,thenreplacethefreewaterdeficit(seeClinical Pearl8-1).

2. Isovolemichypernatremia—Patientswithdiabetesinsipidusrequirevasopressin (nephrogenicDI,unlesshereditary,israrelycomplete),lowsodiumdiet,and thiazidediuretics.Prescribeoralfluids,orifthepatientcannotdrink,giveD5W.

3. Hypervolemichypernatremia—Givediuretics(suchasfurosemide,tocorrect volumestatus)andD5W(toachievenormalsodiumconcentration)toremove excesssodium.Dialyzepatientswithrenalfailure.

Quick HIT

Calculatingfreewaterdeficit Waterdeficit=TBW(1−actualNa+÷desiredNa+)

CalciumMetabolism

A.NormalSerumCalcium:Thenormalserumcalcium(Ca2+)rangeis8.5to10.5 mg/dL.Calciumbalanceisregulatedbyhormonalcontrol,butthelevelsarealso affectedbyalbuminandpH.

1. Albumin

a. Calciuminplasmaexistsintwoforms:

e

e

Protein-boundform:mostcalciumionsareboundtoalbumin,sothetotal calciumconcentrationfluctuateswiththeprotein(albumin)concentration. Freeionizedform:physiologicallyactivefraction;undertighthormonal control(PTH),independentofalbuminlevels.

b. Inhypoalbuminemia,thetotalcalciumislow,butionizedcalciumisnormal,and canbeestimatedbythefollowingformula:totalcalcium—(serumalbumin× 0.8).

2. ChangesinpHaltertheratioofcalciumbinding.AnincreaseinpHincreasesthe bindingofcalciumtoalbumin.Therefore,inalkalemicstates(especiallyacute respiratoryalkalosis),totalcalciumisnormal,butionizedcalciumislowandthe patientfrequentlymanifeststhesignsandsymptomsofhypocalcemia.

B.HormonalControl 1. PTH—↑plasmaCa2+and↓plasmaPO4

3−byactingon:

a. Bone:↑boneresorption b. Kidney:↑Ca2+reabsorption,↓PO4 c. Gut:activationofvitaminD

3−reabsorption

2. Calcitonin—↓plasmaCa2+and↓plasmaPO4 3−byactingon:

a. Bone:↓boneresorption b. Kidney:↓Ca2+reabsorption,↑PO4 c. Gut:↓postprandialCa2+absorption

3−reabsorption

3. VitaminD—↑plasmaCa2+and↑plasmaPO4 3−byactingon:

a. Bone:↑boneresorption b. Kidney:↑Ca2+reabsorption,↑PO4 c. Gut:↑Ca2+absorption,↑PO4

3−reabsorption
======================================
reabsorption

Quick HIT

MaintenanceofcalciumbalanceisafunctionofPTH,calcitonin,andvitaminD,andtheirtargetorgansbone, kidney,andgut.

Hypocalcemia

A.Causes 1. Hypoparathyroidism(mostcommoncause)—usuallyduetosurgeryonthe

thyroidgland(withdamagetonearbyparathyroids)

2. Renalinsufficiency—mainlyduetodecreasedproductionof1,25-dihydroxy vitaminD.

3. VitaminDdeficiency 4. Hyperphosphatemia—PO4 phosphatedeposition

3−precipitateswithCa2+resultingincalcium

5. Hypomagnesemia—resultsindecreasedPTHsecretion.Malabsorption—for example,shortbowelsyndrome,leadingtolowvitaminDormagnesium

6. Pseudohypoparathyroidism—autosomalrecessivediseasecausingcongenitalend- organresistancetoPTH(soPTHlevelsareactuallyhigh);alsocharacterizedby mentalretardationandshortmetacarpalbones

7. Hypoalbuminemia—clinicallyirrelevantasionized(metabolicallyactive) componentisnormal.

8. Alkalemia—asabove,increaseinpHcausesincreasedcalciumbinding,serum levelswillbenormalbutclinicallyimportantasionizedfractionislow

9. Acutepancreatitis—depositionofcalciumdepositslowersserumCa2+levels 10. Bloodtransfusion(withcitratedblood)—calciumbindstocitrate 11. Osteoblasticmetastases 12. DiGeorgesyndrome—causedbyadeletiononchromosome22.Absenceof

thymicshadowonchestx-ray

Quick HIT

Ionizedcalciummaybelowwithnormalserumcalciumlevelsinacutealkaloticstates.

B.ClinicalFeatures 1. Asymptomatic 2. Ricketsandosteomalacia 3. Increasedneuromuscularirritability

a. Numbness/tingling—circumoralinfingers,intoes b. Tetany

e

e

e

Hyperactivedeeptendonreflexes Chvosteksign—tappingafacialnerveleadstoacontraction(twitching)of facialmuscles Trousseausign—InflateBPcufftoapressurehigherthanthepatient’ssystolic BPfor3minutes(occludesbloodflowinforearm).Thiselicitscarpalspasms.

c. Seizures

4. Basalgangliacalcifications 5. Cardiacmanifestations

a. Arrhythmias b. ProlongedQTintervalonECG—hypocalcemiashouldalwaysbeinthe

differentialdiagnosisforaprolongedQTinterval

Quick HIT

Hospitalizedpatientsfrequentlyhavelowserumalbuminconcentrations.Therefore,ifyouseealowcalcium level,lookatthealbuminlevel(itisusuallylowaswell).Alowserumionizedcalciumlevelismuchless common.

C.Diagnosis 1. Toevaluatefortheabove-listedetiologies,obtainthefollowing:BUN,Cr,

magnesium,albumin,andionizedcalcium.Amylase,lipase,andliverfunction testsmayalsobewarranted.

3−:highinrenalinsufficiencyandinhypoparathyroidism,lowin 2. SerumPO4 primaryvitaminDdeficiency

3. PTH
======================================
a. Lowinhypoparathyroidism b. ElevatedinvitaminDdeficiency,CKD c. Veryhighinpseudohypoparathyroidism

D.Treatment 1. Ifsymptomatic,provideemergencytreatmentwithIVcalciumgluconate. 2. Forlong-termmanagement,useoralcalciumsupplements(calciumcarbonate)

2. For long-term management, use oral calcium supplements (calcium carbonate) and vitamin D.

andvitaminD. 3. ForPTHdeficiency.

a. ReplacementtherapywithvitaminD(orcalcitriol)plusahighoralcalcium intake.

b. Thiazidediuretics—lowerurinarycalciumandpreventurolithiasis.

4. Itisalsoimportanttocorrecthypomagnesemia.Itisverydifficulttocorrectthe calciumlevelifthemagnesiumisnotreplacedfirst.

Hypercalcemia

A.Causes 1. Endocrinopathies

a. Hyperparathyroidism—increasedCa2+,lowPO4 3–,usuallyduetoanadenoma (mostcommoncauseinoutpatients)

b. Renalfailure—usuallyresultsinhypocalcemia,butsometimessecondary hyperparathyroidismdesensitizestheparathyroidtocalciumlevelsandelevates PTHlevelshighenoughtocausehypercalcemia(thisisknownastertiary hyperparathyroidism)

c. Pagetdiseaseofthebone—duetoosteoclasticboneresorption d. Hyperparathyroidism,acromegaly,Addisondisease

2. Malignancies(mostcommoncauseininpatients)

a. Metastaticcancer—bonymetastasesresultinbonedestructiondueto osteoclasticactivity.Mosttumorsthatmetastasizetobonecausebothosteolytic andosteoblasticactivities(prostatecancer,mainlyosteoblastic;breastand kidneycarcinoma,usuallyosteolytic)

b. Multiplemyeloma—secondarytotwocauses

e

e

Lysisofbonebytumorcells Releaseofosteoclast-activatingfactorbymyelomacells

c. TumorsthatreleasePTH-likehormone(e.g.,squamouscellcancerssuchas lung,head,andneck)

d. TumorsthatreleasePTH(lung,ovariancancers) e. TumorsthatreleasevitaminD(e.g.,lymphomas)

3. Pharmacologic

a. VitaminDintoxication—increasedGIabsorptionofcalcium b. Milk-alkalisyndrome—hypercalcemia,alkalosis,andrenalimpairmentdueto

excessiveintakeofcalciumandcertainabsorbableantacids(calciumcarbonate, milk)

c. Drugs—thiazidediuretics(inhibitrenalexcretion),lithium(increasesPTHlevels insomepatients,e.g.,squamouscellcarcinoma)

4. Other
======================================
a. Sarcoidosis—increasedGIabsorptionofcalcium b. Familialhypocalciurichypercalcemia—distinguishedfromprimary

hyperparathyroidismbyalowurinecalciumexcretionversusanormalorhigh urinecalciumexcretioninprimaryhyperparathyroidism

B.ClinicalFeatures 1. “Stones”(duetochronichypercalciuriaratherthanhypercalcemiaalone)

a. Nephrolithiasis b. Nephrocalcinosis

2. “Bones”

a. Boneachesandpains b. Osteitisfibrosacystica(“browntumors”)predisposestopathologicfractures

3. “Gruntsandgroans”

a. Musclepainandweakness b. Pancreatitis c. Pepticulcerdisease d. Gout e. Constipation

4. “Psychiatricovertones”—depression,fatigue,anorexia,sleepdisturbances, anxiety,lethargy

5. Otherfindings

a. Polydipsia,polyuria b. NephrogenicDI c. Hypertension d. Weightloss e. ECG—shortenedQTinterval f. Patientsmaybeasymptomatic

Quick HIT

e

e

Inhypercalcemia,ECGshowsshorteningoftheQTinterval. Inhypocalcemia,ECGshowsaprolongationoftheQTinterval.

C.Diagnosis 1. Samelaboratorytestsasinhypocalcemia 2. RadioimmunoassayofPTH:elevatedinprimaryhyperparathyroidism,lowin

occultmalignancy

3. RadioimmunoassayofPTH-relatedprotein:elevatedinmalignancy 4. Bonescanorbonesurveytoidentifylyticlesions 5. UrinarycAMP:markedlyelevatedinprimaryhyperparathyroidism

D.Treatment 1. Patientsusuallydonotrequiremanagementbeyondcorrectionofunderlying

etiologyunlesshypercalcemiaissevere(>14mg/dL)orsignificantsymptomsare present.

2. Increaseurinaryexcretioninallpatients.

a. IVfluids(NS)—firststepinmanagement

b. Diuretics(furosemide)—furtherinhibitcalciumreabsorption

3. Inhibitboneresorptioninpatientswithosteoclasticdisease(e.g.,malignancy).

a. Bisphosphonates(pamidronate) b. Calcitonin

4. GiveglucocorticoidsifvitaminD-relatedmechanisms(intoxication, granulomatousdisorders)andmultiplemyelomaarethecauseofthe hypercalcemia.However,glucocorticoidsareineffectiveinmostotherformsof hypercalcemia.

5. Usehemodialysisforrenalfailurepatients. 6. Phosphateiseffectivebutincurstheriskofmetastaticcalcification.

PotassiumMetabolism NormalK+levels:3.5to5.0mEq/L. Locationinthebody—mostofthebody’spotassium(98%)isintracellular. Hypokalemia—alkalosisandinsulinadministrationmaycausehypokalemia becausetheycauseashiftofpotassiumintothecells. Hyperkalemia—acidosisandanythingresultingincelllysisincreaseserumK+ (bothforceK+outofcellsintotheECF). Potassiumsecretion—mostoftheexcretionofpotassiumoccursthroughthe kidneys(80%);theremainderoccursviatheGItract.Aldosteroneplaysan importantroleinrenalpotassiumsecretion.
======================================
Quick HIT

SerumpotassiumisaffectedbypH:alkalosiscanleadtohypokalemia,whereasacidosiscanleadto hyperkalemia.

Hypokalemia

A.Causes 1. GIlosses

a. Vomitingandnasogastricdrainage(volumedepletionandmetabolicalkalosis alsoresult)

b. Diarrhea c. Laxativesandenemas d. Intestinalfistulas—particularlyafterinflammatoryboweldisorderssuchas

Crohn’sordiverticulitis

e. Decreasedpotassiumabsorptioninintestinaldisorders

Quick HIT

Diarrheaisacommoncauseofbothhypokalemiaandnon-AGmetabolicacidosis.

Quick HIT

ThepresenceorabsenceofHTNisusefulindifferentiatingthecausesofhypokalemia.Ifthepatientis hypertensive,excessivealdosteroneactivityislikely.Ifthepatientisnormotensive,eitherGIorrenalloss ofK+islikely.

2. Renallosses a. Diuretics b. Renaltubularorparenchymaldisease c. Primaryandsecondaryhyperaldosteronism d. Excessiveglucocorticoids—duetomineralocorticoidactionathighserumlevels e. Magnesiumdeficiency f. Barttersyndrome—chronicvolumedepletionsecondarytoanautosomal-

recessivedefectinsaltreabsorptioninthethickascendinglimboftheloopof Henleleadstohyperplasiaofjuxtaglomerularapparatus,whichleadsto increasedreninlevelsandsecondaryaldosteroneelevations.

Quick HIT

AlwaysmonitorK+levelsinpatientstakingdigoxin.Itiscommonforthesepatientstobetakingdiuretics aswell(forCHF),whichcancausehypokalemia.Hypokalemiapredisposesthepatienttodigoxin toxicity.

3. Othercauses

a. Insufficientdietaryintake

b. Insulinadministration c. CertainantibioticsespeciallyamphotericinB d. Profusesweating e. Epinephrine(β2-agonists)—hypokalemiaoccursin50%to60%oftrauma

patients,perhapsduetoincreasedepinephrinelevels

Quick HIT

Arrhythmiasarethemostdangerouscomplicationsofhypokalemia.ECGchangesinhypokalemiaappearas follows:

e

e

Twaveflattensout;ifsevere,Twaveinverts Uwaveappears

B.ClinicalFeatures 1. Arrhythmias—prolongsnormalcardiacconduction

a. Exacerbatesdigitalistoxicity b. FlatteningofTwavesonEKG.Uwavesappearifsevere 2. Muscularweakness,fatigue,paralysis,andmusclecramps 3. Decreaseddeeptendonreflexes 4. Paralyticileus 5. Polyuriaandpolydipsia 6. Nausea/vomiting
======================================
Quick HIT

Interpretationofurinepotassiuminhypokalemia

¢

e

LowwithGIlosses(<20mEq/L) Highwithrenallosses(>20mEq/L)

C.Treatment 1. Identifyandtreattheunderlyingcause(Figure8-4). 2. Discontinueanymedicationsthatcanaggravatehypokalemia. 3. OralKClisthepreferred(safest)methodofreplacementandisappropriatein

mostinstances.AlwaysretesttheK+levelsafteradministration.

a. Using10mEqofKClusuallyincreasesK+levelsby0.1mEq/L,itwillincrease levelsmoreinpatientswithrenalinsufficiencyduetodecreasedclearance.

b. Itcomesinslow-actingandfast-actingforms.

4. IVKClcanbegivenifhypokalemiaissevere(<2.5),ifthepatientcannottake PO,orifthepatienthasarrhythmiassecondarytohypokalemia.

a. Giveslowlytoavoidhyperkalemia.

b. MonitorK+concentrationandmonitorcardiacrhythmwhengivingIV

potassium. c. Infusionpearls.

e

e

e

Maximuminfusionrateof10mEq/hrinperipheralIVline. Maximuminfusionrateof20mEq/hrincentralline. Mayadd1%lidocainetobagtodecreasepain(potassiumburns!)

5. Aswithcalcium,itisdifficulttocorrectthepotassiumlevelifany hypomagnesemiaisnotcorrectedfirst.

Hyperkalemia

A.Causes 1. Increasedtotal-bodypotassium

a. Renalfailure(acuteorchronic) b. Hypoaldosteronestates:Addisondisease,hyporeninemichypoaldosteronism,

ACEinhibitors,potassium-sparingdiuretics(spironolactone)

c. Iatrogenic–excessivedosesofpotassium(usecautionwhenadministering potassiuminpatientswithrenalfailure)andcertainmedications(e.g., trimethoprim-sulfamethoxazole)

d. Bloodtransfusion—usuallyduetolysedcells

* Insulin excess * Metabolic alkalosis Repeat K+ level * Epinephrine Urine K+ < 20 mEq/L Urine K+ > 20 mEq/L Extrarenal K+ loss Renal K* loss Check ABG (PH, bicarbonate levels) Check ABG (pH, bicarbonate levels) == == == == * Decreased K* intake (rare) Gl tract losses Renal tubular acidosis ¢ Laxative abuse * Diarrhea * Carbonic anhydrase * Copious perspiration ¢ Fistula administration (acetazolamide) ¢ Villous adenoma * DKA ¢ Ureterosigmoidostomy

FIGURE

Diagnostic evaluation of hypokalemia.

(AdaptedfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternal

Medicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:1165,Figure146-

2.)
======================================
Quick HIT

Hyperkalemiainhibitsrenalammoniasynthesisandreabsorption.Thus,netacidexcretionisimpairedand resultsinmetabolicacidosis.ThisfurtherexacerbateshyperkalemiaduetoK+movementoutofcells.

2. Redistribution—translocationofpotassiumfromintracellulartoextracellular space

a. Acidosis(notablynotseeninlacticorketoacidosis) b. Tissue/cellbreakdown—rhabdomyolysis(musclebreakdown),chemotherapy,

hemolysis,burns

c. GIbleeding d. Insulindeficiency—insulinstimulatestheNa+-K+-ATPaseandcausesK+toshift

intocells.Therefore,insulindeficiencyandhypertonicity(highglucose) promoteK+shiftsfromICFtoECF

e. Rapidadministrationofβ-blocker

3. Pseudohyperkalemia(spurious)

a. ThisreferstoanartificiallyelevatedplasmaK+concentrationduetoK+ movementoutofcellsimmediatelybeforeoraftervenipuncture.Contributing factorsincludeprolongeduseofatourniquetwithorwithoutrepeatedfist clenching.ThiscancauseacidosisandsubsequentK+lossfromcells. Nevertheless,plasma(notserum)K+shouldbenormal.(Repeatthetestto confirmthis.)

b. Additionally,ifthesampleisnotprocessedquickly,someredbloodcellswill hemolyzeandcausespillageofK+leadingtoafalselyelevatedresult.Thetest shouldberepeatedinthiscase.

c. Othercontributingfactorsincludeleukocytosisandthrombocytosis.

¢ Laboratory error/artifact * Acidosis (metabolic) * Hemolysis, thrombocytosis, ¢ Insulin deficiency leukocytosis ¢ B-blockers, ¢ Tight or prolonged succinylcholine, tourniquet use digitalis overdose Check renal function (creatinine, GFR) Repeat K+ level Normal renal function Aldosterone level Renal failure * Hyporeninemic ¢ Potassium-sparing diuretics hypoaldosteronism (spironolactone, amiloride, triamterene) * Addison's disease ¢ Tubular disorders * ACE inhibitors * Sickle cell nephropathy SLE ¢ Amyloidosis

FIGURE 8.5

Diagnosticevaluationofhyperkalemia.

(AdaptedfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.

4thed.Philadelphia,PA:LippincottWilliams&Wilkins,2000:1168,Figure147-1.)

Quick HIT

ECGchangesinhyperkalemiabecomeprominentwhenK+>6andinclude:
======================================
PeakedTwaves(by10mm) AprolongedPRinterval WideningofQRSandmergingofQRSwithTwave Ventricularfibrillationandcardiacarrest(withincreasinglevelsofK+)

B.ClinicalFeatures 1. Arrhythmias—Themostimportanteffectofhyperkalemiaisontheheart(Figure 8-5).CheckanECGimmediatelyinahyperkalemicpatient.Withincreasing potassium,ECGchangesprogressthroughtall,peakedTwaves,QRSwidening, PRintervalprolongation,lossofPwaves,andfinallyasine-wavepattern.

2. Muscleweaknessand(rarely)flaccidparalysis 3. Decreaseddeeptendonreflexes 4. Respiratoryfailure 5. Nausea/vomiting,intestinalcolic,diarrhea 6. Acidosisduetodecreasedammoniumformationinrenaltubules

Quick HIT

Ofallelectrolytedisturbances,hyperkalemiaisthemostdangerousandcanbethemostrapidlyfatal.

C.Treatment 1. Ifthehyperkalemiaissevere,orifECGchangesarepresent,firstgiveIV

calcium.

a. Calciumstabilizestherestingmembranepotentialofthemyocardialmembrane —thatis,itdecreasesmembraneexcitability.

b. Usecautioningivingcalciumtopatientsondigoxin.(Hypercalcemia

predisposesthepatienttodigoxintoxicity.) 2. Shiftpotassiumintotheintracellularcompartment.

a. Glucoseandinsulin—WorksviastimulationofNa+/K+pump.Glucosealone willstimulateinsulinfromβ-cells,butexogenousinsulinismorerapid(andthus shouldbeoneofthefirststepsinmanagement).Givebothtoprevent hypoglycemia.

b. Betaagonists(e.g.,albuterol)—AlsoworksviastimulationofNa+/K+pump. TransientmanagementinthosewithsymptomsorEKGchanges.

c. Sodiumbicarbonate—IncreasespHlevel,whichshiftsK+intocellsviaH+/K+ pump.Similartoβagonists,anemergencymeasureinseverehyperkalemia.

3. Removepotassiumfromthebody.

a. Kayexalate—GIpotassiumexchangeresin(Na+/K+exchangeinGItract) absorbsK+inthecolon,preventingreabsorption(passedinstool,thusrelianton patientbeingabletodefecate).

b. Diuretics(furosemide)—Effectisvariableandthusisrarelyusedas

monotherapy. c. Hemodialysis.

MostrapidandeffectivewayofloweringplasmaK+.

Reservedforintractablehyperkalemia(usuallyover7)andforthosewithrenal failure.

eee

Overview

NormalMg2+levels:1.8to2.5mg/dL. Locationinthebody—Mostofthemagnesiuminthebody(two-thirds)isinbones. Theremainder(one-third)isintracellular.Only1%ofmagnesiumisextracellular. Influencesonmagnesiumexcretion—Manyhormonescanalterurinary magnesiumexcretion(e.g.,insulin/glucagons,PTH,calcitonin,ADH,andsteroids). Magnesiumabsorptionandbalance—About30%to40%ofdietarymagnesiumis absorbedintheGItract,butthispercentageincreaseswhenmagnesiumlevelsare low.Thekidneyhasagreatcapacitytoreabsorbmagnesiumandisthemajor regulatorofmagnesiumbalance.
======================================
Hypomagnesemia

Quick HIT

Hypomagnesemiamakeshypokalemiaandhypocalcemiamoredifficulttotreat.

A.Causes 1. GIcauses

a. Malabsorption,steatorrheicstates(mostcommoncause) b. Prolongedfasting c. Fistulas d. PatientsreceivingTPNwithoutMg2+supplementation

2. Alcoholism(commoncause)—duetoincreasedurinaryexcretionaswellas frequentlyconcomitantdiarrhea,pancreatitis,andpoordiet

3. Renalcauses a. SIADH b. Diuretics(oftenseeninpatientsbeingtreatedforheartfailureexacerbation) c. GitelmanandBarttersyndrome d. Drugs:gentamicin,amphotericinB,cisplatin e. Renaltransplantation

4. Othercauses:postparathyroidectomy,DKA,thyrotoxicosis,lactation,burns, pancreatitis,cisplatin

B.ClinicalFeatures 1. MarkedneuromuscularandCNShyperirritability

a. Muscletwitching,weakness,tremors b. Hyperreflexia,seizures c. Mentalstatuschanges

2. Effectoncalciumlevels:coexistinghypocalcemiaiscommonbecauseof decreasedreleaseofPTHandboneresistancetoPTHwhenMg2+islow

3. Effectonpotassiumlevels

a. Coexistinghypokalemia—inupto50%ofcases,usuallyduetoetiologywhich leadstolossofboth

b. Inmuscleandmyocardium,wheneitherintracellularMg2+orK+decreases,a correspondingdecreaseintheothercationtakesplace

4. ECGchanges—prolongedQTinterval,T-waveflattening,andultimately,torsade depointes

C.Treatment

1. Formildhypomagnesemia—oralMg2+(e.g.,magnesiumoxide) 2. Forseverehypomagnesemia—parenteralMg2+(e.g.,magnesiumsulfate)

Hypermagnesemia

A.Causes 1. Renalfailure(mostcommoncause) 2. Early-stageburns,massivetraumaorsurgicalstress,severeECFvolumedeficit,

severeacidosis

3. Excessiveintakeofmagnesium-containinglaxativesorantacidscombinedwith

renalinsufficiency 4. Adrenalinsufficiency 5. Rhabdomyolysis 6. Iatrogenic—usuallyintheobstetricsettinginwomenwithpreeclampsiaor

eclampsiabeingtreatedwithmagnesiumsulfate

B.ClinicalFeatures 1. Nausea,weakness 2. Facialparesthesias 3. Progressivelossofdeeptendonreflexes(classicallythefirstsign) 4. ECGchangesresemblethoseseenwithhyperkalemia(increasedP-Rinterval,

widenedQRScomplex,andelevatedTwaves)

5. Somnolenceleadingtocomaandmuscularparalysisoccurlate 6. Deathisusuallycausedbyrespiratoryfailureorcardiacarrest
======================================
Quick HIT

Hyperkalemiaandhypermagnesemiahavesomesimilaretiologies,causesuppressionofmuscularfunction,and inducesimilarEKGchanges,soalwayscheckmagnesiumwhensuspectinghyperkalemia!

C.Treatment 1. Withholdexogenouslyadministeredmagnesium. 2. PrescribeIVcalciumgluconateforemergentsymptoms(cardioprotectionasin

hyperkalemia).

3. Administersalineandfurosemide. 4. Orderdialysisinrenalfailurepatients. 5. Preparetointubateifrespiratorydepressionissevere.

Quick HIT

PlasmaPhosphateConcentration

Normal:3.0to4.5mg/dL Hypophosphatemia:<2.5mg/dL Hyperphosphatemia:>5mg/dL

Overview

Normalphosphatelevels:3.0to4.5mg/dL. Locationinthebody—Mostofthephosphorusisinthebones(85%);theremainder isintracellularinsofttissues(15%)andaverysmallamount(0.1%)inECF. Influenceonphosphateabsorption—VitaminDcontrolsphosphorusabsorptionin theGItract. Phosphateexcretionandbalance—PTHcontrolsphosphorusexcretioninthekidney —PTHincreasesrenalphosphorusexcretionbyinhibitingreabsorption.The functionofthekidneyinmaintainingphosphatebalanceisveryimportant.

Hypophosphatemia

A.Causes 1. Decreasedintestinalabsorptionduetoalcoholabuse,vitaminDdeficiency, malabsorptionofphosphate,excessiveuseofphosphate-bindingantacids, hyperalimentation(TPN),and/orstarvation

2. Increasedrenalexcretion

a. ExcessPTHstates(vitaminDdeficiency,hyperparathyroidism) b. Hyperglycemia(glycosuria),oncogenicosteomalacia,ATN,renaltubular

acidosis,andsoon

c. Hypokalemiaorhypomagnesemia

3. Othercauses:respiratoryalkalosis,anabolicsteroids,severehyperthermia,DKA, hungrybonesyndrome(depositionofbonematerialafterparathyroidectomy)

Quick HIT

ThemostcommoncausesofseverehypophosphatemiaarealcoholabuseandDKA.

B.ClinicalFeatures 1. None,ifthehypophosphatemiaismild. 2. Anyofthefollowing,ifthehypophosphatemiaissevere,primarilyduetoalack

ofavailableATPand2,3DPG,thelattercausingdecreasedO2releasefromRBC:

a. Neurologic:encephalopathy,confusion,seizures,numbness,paresthesias b. Musculoskeletal:muscularweakness,myalgias,bonepain,rickets/osteomalacia c. Hematologic:hemolysis,RBCdysfunction,WBCdysfunction,platelet

dysfunction

d. Cardiac:cardiomyopathyandmyocardialdepressionsecondarytolowATP levels,mayleadtocardiacarrest
======================================
e. Rhabdomyolysis f. Anorexia g. Difficultyinventilatorweaning

C.Treatment 1. Ifmild(>1mg/dL),oralsupplementation:Neutra-Phoscapsules,K-Phostablets,

milk(excellentsourceofphosphate)

2. Ifsevere/symptomaticorifpatientisNPO:parenteralsupplementation

Hyperphosphatemia

A.Causes 1. DecreasedrenalexcretionofPO4

3−duetorenalinsufficiency(mostcommon cause),bisphosphonates,hypoparathyroidism,vitaminDintoxication,and/or tumorcalcinosis

3−repletionorPO4 3−enemas)

2. Increasedphosphateadministration(e.g.,PO4 3. Rhabdomyolysis,celllysis,oracidosis(releasesPO4

3−intotheECF)

B.ClinicalFeatures 1. Thisresultsinmetastaticcalcificationandsofttissuecalcifications;acalcium– phosphorusproduct(serumcalcium×serumphosphorus)>70indicatesthat calcificationislikelytooccur.Acalcium-phosphateproduct<55isusuallythe goalforCKDpatientstopreventcalcification.

2. Theassociatedhypocalcemiacanleadtoneurologicchanges(tetany, neuromuscularirritability).

C.Treatment 1. Phosphate-bindingantacidscontainingaluminumhydroxideorcarbonate(bind

phosphateinbowelandpreventitsabsorption)

2. Hemodialysis(ifpatienthasrenalfailure)

Acid–BaseDisorders

MetabolicAcidosis

A.GeneralCharacteristics 1. MetabolicacidosisischaracterizedbydecreasedbloodpHandadecreased

plasmabicarbonateconcentration(seeClinicalPearl8-2).Thegoalistoidentify theunderlyingconditionthatiscausingthemetabolicacidosis.

2. Aniongap(AG)—Ausefulmeasurementforidentifyingthecauseofacidosis, whetherduetoarelativeexcessofchloridewithrespecttobicarbonate(normal gap)oranabundanceofotheracids(highgap)

a. AG(mEq/L)=[Na+]−([Cl−]+[HCO3 b. Reflectsionspresentinserumbutunmeasured(i.e.,proteins,phosphates,

organicacids,sulfates).

c. Normalvaluesare5to15mEq/L,butthisvariestosomeextent. d. Alwayscheckalbuminlevelandadd2.5togapforevery1g/dLbelow4.

CLINICALPEARL8-2

EffectsofAcidosisandAlkalosis

Acidosis

e

Rightshiftinoxygen–hemoglobindissociationcurvediminishestheaffinityofhemoglobinfor oxygen(soincreasesoxygendeliverytotissues) DepressesCNS Decreasespulmonarybloodflow Arrhythmias Impairsmyocardialfunction Hyperkalemia
======================================
e

Alkalosis

e

¢

e

e

Decreasescerebralbloodflow Leftshiftinoxygen–hemoglobindissociationcurveincreasestheaffinityofhemoglobinforoxygen (sodecreasesoxygendeliverytotissues) Arrhythmias Tetany,seizures

3. Pathophysiology(Figure8-6).

a. Aniongapmetabolicacidosis:Whenafixedacid(lacticacid,ketones,salicylic acid)isadded,theH+isbufferedbythebicarbonatesystem.CO2isformedand removedbylungs(respiratorycompensation).H++HCO3 −↔H2O −levelsdecreaseinECFandtheconjugatebasesoftheacidinthe +CO2.HCO3

serumnowexistasunmeasuredanionswhichraisethemeasuredgap.Withtime, kidneysreabsorbmoreHCO3

b. Non-aniongapmetabolicacidosis:Bicarbonateislostwithoutbeingusedasa buffertoanaddedacid,usuallyinGItractorurine,orchlorideconcentration relativelyincreases.

c. Threesituationscanarise:

e

e

e

ThechangeinAGequalsthechangeinHCO3 metabolicacidosis—theadditionofacidcausestheAGtoincrease proportionally. ThechangeinAGislessthanthechangeinHCO3 AGacidosisPLUShighAGacidosis—Ifaftertheadditionofacid,the HCO3 HCO3 ThechangeinAGisgreaterthanthechangeinHCO3 metabolicalkalosisPLUShighAGacidosis—whenyouhaveahighAG,the −,soHCO3 acidhastobebufferedbyHCO3 decrease,itmeansyoustartedatahigherHCO3

FIGURE 8.6

AnincreaseinlactateresultsinadecreaseinHCO3 −(dueto −to buffering)inECF.ThekidneysmustthenreabsorbmoreHCO3 maintainpH.

= AG Anion gap a) HCO,” A Bicarbonate concentration a S s = ST 5 HCO; 25 B Bicarbonate concentration 1 15 * a S s = < cn aad 5 HCOs; = 25 c Bicarbonate concentration

FIGURE 8.7

thechangeinHCO3 −.Asyouaddacid,HCO3 increasesproportionately.B:NormalaniongapacidosisPLUShigh aniongapacidosis.ThechangeinAGislessthanthechangein HCO3 thenyoustartedatalowerHCO3 highaniongapacidosis.ThechangeinAGisgreaterthanthechange −.Ifaftertheadditionofacid,thedecreaseinHCO3 inHCO3 −level(*). thanexpected,thenyoustartedatahigherHCO3

Quick HIT

Thebicarbonatelevelobtainedinaserumchemistrypanel(venousCO2)isameasuredvalue(morereliable), whereasthelevelobtainedinanarterialbloodgasisacalculatedvalue(lessreliable).
======================================
B.Causes 1. IncreasedAGacidosis(seealsoClinicalPearl8-3)

a. Ketoacidosis

e

e

e

Diabetesmellitus Prolongedstarvation Prolongedalcoholabuse

CLINICALPEARL8-3

ArterialBloodGasInterpretation

CO2level

e

e

Ifelevated,thinkofeitherrespiratoryacidosisorcompensationformetabolicalkalosis. Iflow,thinkofeitherrespiratoryalkalosisorcompensationformetabolicacidosis.

-level HCO3

e

e

e

Ifelevated,thinkofeithermetabolicalkalosisorcompensationforrespiratoryacidosis. Iflow,thinkofeithermetabolicacidosisorcompensationforrespiratoryalkalosis. Thebaseexcess/basedeficitvaluesinthearterialbloodgasindicatetheamountofacidorbasethat isneededtotitratetheplasmapHto7.40(withaPaCO2of40).

Quick HIT

Salicylateoverdosecausesbothprimaryrespiratoryalkalosisandprimarymetabolicacidosis.

b. Lacticacidosis—canoccurinmanydifferentconditions

e

e

e

Lowtissueperfusion(decreasedoxygendeliverytotissues) Shockstates(septic,cardiogenic,hypovolemic) Excessiveexpenditureofenergy(e.g.,seizures)

+excretion(thusdecreasingnetacid)—decreased c. Renalfailure—decreasedNH4 excretionoforganicanions,sulfate,andphosphateincreasesAG

d. Intoxication

e

¢

e

Salicylate(aspirin) Methanol Ethyleneglycol

−is 2. NormalAGacidosis(hyperchloremicmetabolicacidosis)—ThelowHCO3 associatedwithhighCl−,sothattheAGremainsnormal.

a. Renallossofbicarbonate

e

e

− Proximaltubularacidosis—thisischaracterizedbydecreasedHCO3 reabsorption.Causesincludemultiplemyeloma,cystinosis,andWilson disease. Distaltubularacidosis—thisischaracterizedbytheinabilitytomakeHCO3 CausesincludeSLE,Sjögrensyndrome,andtakingamphotericinB. Carbonicanhydraseinhibition(e.g.,acetazolamide—adiuretic)

e

b. GIlossofHCO3

−lossindiarrhea(mostcommoncauseofnon-AGacidosis)

Diarrhea—HCO3 Pancreaticfistulas—pancreaticsecretionscontainhighHCO3 Smallbowelfistulas Ureterosigmoidostomy—colonsecretesHCO3

levels

e

e

exchange for Cl-

e

c. Insufficientexcretionofdailyacidload

Hypoaldosteronestates:Addison’sdisease,spironolactone,amiloride, triamterene CKD
======================================
e

e CKD

d. Chlorideexcess

Primarilyduetoiatrogenicsalineinfusions

C.ClinicalFeatures 1. Hyperventilation(deeprhythmicbreathing),alsoknownasKussmaulrespiration a. Thisisatypicalcompensation(i.e.,response)forametabolicacidosisandisa cardinalfeatureofmetabolicacidosis;itisusuallyseeninseveremetabolic acidosis(pH<7.20).

b. Itislessprominentwhentheacidosisischronic.

2. Decreasedcardiacoutputanddecreasedtissueperfusion. a. Occurswithseveremetabolicacidosis(bloodpH<7.2). b. Acidosisdiminishestissueresponsivenesstocatecholamines.Thiscanleadtoan undesirablechainofevents:poortissueperfusion→lacticacidosis→decreased cardiacoutput→hypotension→furtherdecreaseintissueperfusion.

D.Diagnosis 1. Historyisimportant. 2. CalculatetheAG. 3. Ifgapispresent,calculatetheDeltaGap=(Measuredaniongap−12)+HCO3

a. Deltagap>26±2:Concurrentmetabolicalkalosis b. Deltagap<20±2:Concurrentnon-aniongapmetabolicacidosis

4. Ifnogapispresent,urineaniongapcanbemeasured(UNa++UK+−UCl-)

+(renaletiologyofacidosisduetoinability a. Ifpositive,suggestslowurinaryNH4

ofrenaltubulestoexcreteacid,likelyRTA) b. Ifnegative,suggestsappropriateurinaryNH4

+(nonrenalcauseofacidosis)

−)+8±2. 5. CalculateWinterformula:expectedPaCO2=1.5(measuredHCO3

a. Predictstheexpectedrespiratorycompensation(PaCO2level)tometabolic acidosis:IfthePaCO2doesnotfallwithinanacceptablerange,thenthepatient hasarespiratoryacid–basedisorderaswell.

b. IfthePaCO2fallswithinthepredictedrange,thenthepatienthasasimple metabolicacidosiswithanappropriatesecondaryhypocapnia.

metabolicacidosiswithrespiratoryacidosis(i.e.,theyareunderbreathing).This isaseriousfindingbecausethisfailureofcompensationcanbeasignof impendingrespiratoryfailure.Theclassicexampleisanasthmaticchild whohasaPaCO2thatgoesfromabnormaltonormalwithnotreatment. Thisisabadsign,anditprobablymeansthechildwillneedemergent intubationshortly.

d. IftheactualPaCO2islowerthanthecalculatedPaCO2,thenthepatienthas metabolicacidosiswithrespiratoryalkalosis(i.e.,theyareoverbreathing).

Quick HIT

Withmetabolicacidosis,PaCO2shoulddecrease.Withmetabolicalkalosis,PaCO2shouldincrease.Thisis normalrespiratorycompensation.Failureofrespiratorycompensationindicatesanadditionalprimary respiratoryacid–basedisorder.
======================================
E.Treatment

1. Treatmentvariesdependingonthecause. 2. Sodiumbicarbonateissometimesneeded(especiallyfornormalAGacidosisand withrenaldysfunction)insevereacidosistomaintainapHofnolowerthan7.20. Incorrectingmetabolicacidosis,realizethatthisHCO3 thebrain.Duringthistime,hyperventilationcontinues.Therefore,PaCO2remains lowwhileHCO3 −]). HCO3

3. Mechanicalventilationmayberequiredifthepatientisfatiguedfromprolonged hyperventilation,especiallyinDKA.

MetabolicAlkalosis

Quick HIT

Whileevaluatingapatientwithmetabolicalkalosis,thefirststepistodeterminewhethertheECFvolumehas contractedorexpanded,andwhy.

A.GeneralCharacteristics 1. MetabolicalkalosisischaracterizedbyanincreasedbloodpHandplasmaHCO3 2. Uncomplicatedmetabolicalkalosisistypicallytransient,becausekidneyscan

−. normallyexcretetheexcessHCO3

3. Considertwoeventsinmetabolicalkalosis:

a. Eventthatinitiatesthemetabolicalkalosis(lossofH+viagastricdrainage, −concentrationduetoECFvolume vomiting,andsoon),orincreasedHCO3 contraction

b. Mechanismthatmaintainsthemetabolicalkalosisduetothekidney’sinability − toexcretetheexcessHCO3

Quick HIT

Exogenousbicarbonateloading(administeringbicarbonate)cancausemetabolicalkalosis,butthisusually occursinESRD.

B.Causes 1. Saline-sensitivemetabolicalkalosis(urinechloride<10mEq/L)—characterized −lossand/orRAAS

byECFcontractionandhypokalemia,usuallyduetoHCO3 systemactivation.

− a. Vomitingornasogastricsuction—WhenthepatientlosesHCl,gastricHCO3 generationoccurs,whichcausesalkalosis.

−contentremains b. Diuretics—ThesedecreasetheECFvolume.BodyHCO3 −increasesbecauseofECFcontraction. normal,butplasmaHCO3

c. Villousadenomaofcolon,diarrheawithhighchloridecontent.

2. Saline-resistantmetabolicalkalosis(urinechloride>20mEq/L)—characterized byECFexpansionandhypertension(duetoincreasedmineralocorticoids).

a. Mostaresecondarytoadrenaldisorders(primaryhyperaldosteronism). Increasedlevelsofmineralocorticoidsecretionleadtoincreasedtubular reabsorptionofNa+andHCO3 −,andanexcessivelossofCl−,K+,andH+inthe urine.TheresultismetabolicalkalosisandexpansionoftheECFcompartment

(becauseofincreasedNa+reabsorption).

b. OthercausesincludeCushingsyndrome,severeK+deficiency,Bartter syndrome,anddiureticabuse.
======================================
Quick HIT

Itisusefultodistinguishbetweenthefollowing:

¢

¢

Metabolicalkalosiswithvolumecontraction(usuallyduetofluidloss—e.g.,vomitingordiuretics) Metabolicalkalosiswithvolumeexpansion(usuallyduetopathologyofadrenalgland).Aneasywayto makethisdistinctionisviathechlorideconcentrationintheurine.

C.ClinicalFeatures 1. Therearenocharacteristicsignsorsymptoms. 2. Thepatient’smedicalhistoryismosthelpful(lookforvomiting,gastricdrainage,

diuretictherapy,andsoon).

D.Diagnosis 1. ElevatedHCO3 2. Hypokalemiaiscommon(duetorenallossofK1). 3. PaCO2iselevatedasacompensatorymechanism(duetohypoventilation).Itis rareforacompensatoryincreaseinPaCO2toexceed50to55mmHg(the respiratoryratetoachievethisissolowthatPaO2wouldbedecreased).Ahigher valueimpliesasuperimposedrespiratoryacidosis.

4. Theurinechloridelevelisveryimportantindistinguishingbetweensaline- sensitiveandsaline-resistanttypes.

E.Treatment 1. Treattheunderlyingdisorderthatcausedthemetabolicalkalosis. 2. NSpluspotassiumwillrestoretheECFvolumeifthepatientisvolume

contracted.

3. Addresstheunderlyingcause(orprescribespironolactone)ifthepatientis volumeexpanded.

RespiratoryAcidosis

Quick HIT

AnydisorderthatreducesCO2clearance(i.e.,inhibitsadequateventilation)canleadtorespiratoryacidosis.

A.GeneralCharacteristics 1. DefinedasareducedbloodpHandPaCO2>40mmHg. 2. Renalcompensation(increasedreabsorptionofHCO3

−)beginswithin12to24 hoursandtakes5daysorsotocomplete.

B.Causes—alveolarhypoventilation 1. Primarypulmonarydiseases—forexample,COPD,airwayobstruction 2. Neuromusculardiseases—forexample,myastheniagravis 3. CNSmalfunction—injurytobrainstem 4. Drug-inducedhypoventilation(e.g.,frommorphine,anesthetics,orsedatives)— narcoticoverdoseinpostoperativepatientsisapossibility(lookforpinpoint pupils).

5. Respiratorymusclefatigue

Quick HIT

IncreasedPaCO2→increasedcerebralbloodflow,→increasedCSFpressure,whichresultsingeneralizedCNS depression.

C.ClinicalFeatures 1. Somnolence,confusion,andmyoclonuswithasterixis. 2. Headaches,confusion,andpapilledemaaresignsofacuteCO2retention.

D.Diagnosis 1. ElevationofHCO3 2. Determineifacuteorchronicacidosis.Clinicalhistoryisimportant,thoughitcan alsobecalculated;forevery10mmHgincreaseinPaCO2,pHwilldecrease roughly:
======================================
a. 0.07inacuteacidosis b. 0.03inchronicacidosis c. Intermediatevaluessuggestamixedpicture 3. Calculateifrenalcompensationisappropriate:

a. Acuterespiratoryacidosis

e

e

ThereisanimmediatecompensatoryelevationofHCO3 Thereisanincreaseof1mmol/Lforevery10mmHgincreaseinPaCO2.

b. Chronicrespiratoryacidosis

e

e

Renaladaptationoccurs,andHCO3 mmHgincreaseinPaCO2. Thisisgenerallyseeninpatientswithunderlyinglungdisease,suchaschronic obstructivepulmonarydisease(COPD).

E.Treatment 1. Verifypatencyoftheairway. 2. IfPaO2islow(<60mmHg),initiatesupplementaloxygen.Caution:Inpatients whoare“CO2retainers”(e.g.,COPDpatients),oxygencanexacerbatethe respiratoryacidosis,soadministeroxygenjudiciously.(Seethediscussionunder AcuteRespiratoryFailureinChapter2.)

3. Correctreversiblecauses. 4. Anymeasuretoimprovealveolarventilation.

a. Aggressivepulmonarytoilet. b. Correctreversiblepulmonarydisease(e.g.,treatpneumonia). c. Removeobstruction. d. Ifthereisdrug-inducedhypoventilation,cleartheagentfromthebody

(naloxone!).

e. Administerbronchodilators.

5. Intubationandmechanicalventilationmaybenecessarytorelievetheacidemia andhypoxiathatresultfromhypoventilation.Thefollowingsituationsrequire intubation:

a. Severeacidosis. b. PaCO2>60orinabilitytoincreasePaO2withsupplementaloxygen. c. Ifpatientisobtundedorshowsdeteriorationinmentalstatus. d. Impendingrespiratoryfatigue(ensueswithprolongedlaboredbreathing).

RespiratoryAlkalosis

A.GeneralCharacteristics 1. CharacterizedbyanincreasedbloodpHanddecreasedPaCO2. 2. Chronicityofdiseasecan,asinrespiratoryacidosis,bedeterminedbyclinical historyorestimatedthroughchangeinpH.Forevery10mmHgdecreasein PaCO2,pHwillincreaseroughly:

a. 0.07inacutealkalosis b. 0.03inchronicalkalosis

3. InordertomaintainbloodpHwithinthenormalrange,HCO3mustdecrease,so −excretionincreases).However,thisdoes

renalcompensationoccurs(i.e.,HCO3 notoccuracutely,butratheroverthecourseofseveralhours. a. Acutely,foreach10mmHgdecreaseinPaCO2,plasmaHCO3

−decreasesby2 mEq/LandbloodpHincreasesby0.08mEq/L.

−decreases b. Chronically,foreach10mmHgdecreaseinPaCO2,plasmaHCO3 by5to6mEq/LandbloodpHdecreasesby0.02mEq/L.
======================================
Quick HIT

PaCO2isprimarilydeterminedbyrespiratoryrateandtidalvolume.

B.Causes—alveolarhyperventilation 1. Anxiety 2. Pulmonaryembolism,pneumonia,asthma 3. Sepsis 4. Hypoxia—leadstoincreasedrespiratoryrate 5. Mechanicalventilation 6. Pregnancy—increasedserumprogesteronelevelscausehyperventilation 7. Liverdisease(cirrhosis) 8. Medication(salicylatetoxicity) 9. Hyperventilationsyndrome

Quick HIT

Anydisorderthatincreasestherespiratoryrateinappropriatelycanleadtorespiratoryalkalosis.

C.ClinicalFeatures 1. Symptomsaremostlyrelatedtodecreasedcerebralbloodflow(vasoconstriction):

lightheadedness,dizziness,anxiety,paresthesias,andperioralnumbness

2. Tetany(indistinguishablefromhypocalcemia) 3. Arrhythmias(inseverecases)

D.Treatment 1. Correcttheunderlyingcause. 2. Sometimesthisdoesnotneedtobetreated(e.g.,inthecaseofpregnancy). 3. AninhaledmixturecontainingCO2orbreathingintoapaperbagmaybeuseful.

9

xX)

HematologicDiseasesandNeoplasms

KarissaBritten

BasicsofAnemia

Quick HIT

HistoricalFindingstoConsiderinPatientsWithAnemia

e

e

¢

e

Familyhistory(e.g.,hemophilia,G6PDdeficiency,thalassemia) Bleeding(e.g.,recenttrauma/surgery,hematemesis,melena) Chronicillnesses(e.g.,renalfailure,autoimmunediseases,malignancies) Ingestions(e.g.,alcohol,medications)

A.GeneralCharacteristics 1. Anemiaisdefinedasareductioninthenumberofcirculatingredbloodcells,as

measuredbyhemoglobin(Hb)orhematocrit(Hct).

2. Whenredcellmassdecreases,severalcompensatorymechanismsmaintain oxygendeliverytothetissues,including:

a. Increasedcardiacoutput b. Increasedoxygenextractionratio c. Rightwardshiftoftheoxyhemoglobincurve(increased2,3-diphosphoglycerate

[2,3-DPG])

d. Expansionofplasmavolume

3. Symptomsofanemiaarehighlyvariable,dependingontheseverityofanemia,the rateatwhichitdeveloped,andtheunderlyingoxygendemandsofthepatient.If anemiadevelopsrapidly,symptomsaremorelikelytobepresent,becausethereis littletimeforphysiologiccompensation.Iftheonsetisgradual,compensatory mechanismsareabletomaintainadequateoxygendeliverytotissues,and symptomsmaybeminimalorabsent.

4. Asageneralrule,bloodtransfusionisnotrecommendedunlesseitherofthe followingistrue:
======================================
a. TheHbconcentrationis<7g/dLOR b. Thepatientrequiresincreasedoxygen-carryingcapacity(e.g.,patientswith

coronaryarterydiseaseorsomeothercardiopulmonarydisease)

B.ClinicalFeatures 1. Fatigue 2. Dyspnea 3. Headache 4. Palpitations

5. Tachycardia 6. Pallor—bestnotedintheconjunctiva 7. Signs/symptomsoftheunderlyingcause:orthostaticlightheadedness,syncope,or hypotensionifacutebleeding;jaundiceifhemolyticanemia;bloodinstoolifGI bleeding

Quick HIT

PseudoanemiaordilutionalanemiareferstoadecreaseinHbandHctsecondarytodilution(i.e.,secondaryto acutevolumeinfusionoroverload).

C.Diagnosis 1. DecreasedHbandHct

a. FormulaforconvertingHbtoHct:Hb×3=Hct(1unitofpackedRBCs [PRBCs]increasesHblevelby1pointandHctby3points)

b. Hbof7to8providessufficientoxygen-carryingcapacityformostpatients— anemiaisnottoleratedaswellinpatientswithimpairedcardiacfunction(see ClinicalPearl9-1) 2. Reticulocyteindex

a. Reportsthenumberofreticulocytespresentasapercentageofthetotalnumber ofRBCs

b. Thereticulocytecountisanimportantinitialtestinevaluatinganemiabecauseit

indicateswhethereffectiveerythropoiesisisoccurringinthebonemarrow. c. Effectiveerythropoiesisisdependentonadequaterawmaterials(iron,vitamin B12,folate)inthebonemarrow,absenceofintrinsicbonemarrowdisease(e.g., aplasticanemia),adequateerythropoietinfromthekidney,andsurvivalof reticulocytes(noprematuredestructionbeforeleavingthebonemarrow)—see ClinicalPearl9-2.

d. Areticulocyteindex>2%impliesthebonemarrowisrespondingtoincreased RBCrequirements

e. Areticulocyteindex<2%impliesinadequateRBCproductionbythebone

marrow 3. RBCindices

a. Meancorpuscularvolume(MCV)istheaveragesizeofapatient’sRBCs b. Meancorpuscularhemoglobin(MCH)istheaverageHbcontentofapatient’s

RBCs

c. Meancorpuscularhemoglobinconcentration(MCHC)istheaverageHb concentrationineachRBC

d. RDWisthevariationinRBCsize

4. Peripheralbloodsmear

CLINICALPEARL9-1

TransfusionPearls

PRBCs(containnoplateletsorclottingfactors)

e

Mixwithnormalsalinetoinfusefaster(notwithlactatedRingersolutionbecausecalciumcauses coagulationwithintheIVline) Eachunitraisesthehematocritby3to4points Eachunitmaybegiventoanadultforover90to120minutes AlwayscheckCBCafterthetransfusioniscompleted

FFP
======================================
Containsalloftheclottingfactors ContainsnoRBCs/WBCs/platelets GivenforhighPT/PTT,coagulopathy,anddeficiencyofclottingfactors—FFPcanbegivenifyoucannot waitforvitaminKtotakeeffect,orifpatienthasliverfailure(inwhichcasevitaminKwillnotwork) FollowupPTandPTTtoassessresponse

Cryoprecipitate

ContainsfactorVIIIandfibrinogen ForhemophiliaA,decreasedfibrinogen(DIC)andvWD Platelettransfusions—1unitraisesplateletcountby10,000 Wholebloodonlyformassivebloodloss Foranypatientwithmassivebloodloss,theidealratioofplatelets:FFP:PRBCswhicharetransfusedshould be1:1:1.Additionally,duringmassivebloodtransfusions,bloodshouldbewarmedtopreventadecreasein corebodytemperature.

Quick HIT

IfHbandHctrevealanemia,thenextteststoobtaintodeterminecauseofanemiaarereticulocytecountand MCV.

Quick HIT

Notethatallcausesofanemiaareinitiallynormocyticbecauseittakessometimefortheabnormal-sizedRBCs tooutnumberthenormal-sizedones.

CLINICALPEARL9-2

HemolyticTransfusionReactionsAreDividedIntoIntravascularand ExtravascularHemolysis

Intravascularhemolysis(alsocalledacutehemolyticreactions):

Veryseriousandlife-threatening—causedbyABO-mismatchedbloodtransfusedintopatient(usuallydue toclericalerror).Forexample,ifBbloodisgiventoatypeApatient,anti-BIgMantibodiesattachtoall oftheinfusedBRBCs,activatethecomplementpathway,andproducemassiveintravascularhemolysisas C9punchesholesthroughRBCmembranes.

e

¢

e

Symptomsincludefever/chills,nausea/vomiting,painintheflanks/back,chestpain,anddyspnea Complicationsincludehypovolemicshock(hypotension,tachycardia),DIC,andrenalfailurewith hemoglobinuria Managementinvolvesstoppingthetransfusionimmediatelyandaggressivelyreplacingthefluidtoavoid shockandrenalfailure,epinephrineforanaphylaxis,dopamine/norepinephrineasneededtomaintain bloodpressure

Extravascularhemolysis(alsocalleddelayedhemolytictransfusionreaction):

e

e

e

«

Extravascularhemolysisislesssevereandinmostcasesisself-limited;itmayoccurwithin3to4weeks afteratransfusion ItiscausedbyoneoftheminorRBCantigens.Forexample,ifapatientisKellantigen-negativeandhas anti-KellIgGantibodiesfromapreviousexposuretotheantigen,reexposureofhermemoryBcellsto KellantigenonRBCswillresultinsynthesisofIgGanti-Kellantibodies.Theseantibodiescoatallofthe Kellantigen-positivedonorRBCs,whichwillberemovedextravascularlybymacrophagesinthespleen, liver,andbonemarrow. Symptomsaresubtleandincludefever,jaundice,andanemia Notreatmentrequired—theprognosisisgood

¢

D.DiagnosingtheCauseofAnemia(GeneralApproach) 1. Ifthereticulocyteindexis<2%,indicatinganinadequatebonemarrowresponse,

examinetheperipheralbloodsmearandRBCindices(Figure9-1).

a. Ifmicrocyticanemia(MCV<80),thedifferentialdiagnosisincludesthe following:
======================================
e

e

e

e

Irondeficiencyanemia—mostcommoncause Anemiaofchronicdisease—ironispresentinthebodybutisnotavailablefor hemoglobinsynthesisduetoiron-trappinginmacrophages Thalassemia—defectivesynthesisofglobinchains Sideroblasticanemia(includesleadpoisoning,pyridoxinedeficiency,toxic effectsofalcohol)—defectivesynthesisofprotoporphyrinsleadingtoiron accumulationinmitochondria

= Blood Hemolytic loss? anemia? Microcytic Normocytic Macrocytic Look for Check for (<80) (80-99) (>100) source haptoglobin, LDH, bilirubin levels * Aplastic anemia * BM fibrosis ¢Tumor * Anemia of chronic disease «Renal failure Fe normal +Fe, Z + TIBC faletesstiny ory Iron deficiency anemia Both Fe and TIBC decreased pe my Diagnostic | Suspect Anemia of chronic disease

FIGURE 9.1

Evaluationofanemia.

b. Ifmacrocyticanemia(MCV>100),thedifferentialdiagnosisincludesthe following:

e

e

e

VitaminB12orfolatedeficiency(MCVincreasessignificantly)—defective DNAsynthesisleadingtonucleardefectsinRBCs Liverdisease(MCVincreasesupto115)—abnormalincorporationofplasma lipoproteinsintoRBCmembranesaltersRBCshapeandincreasestheir volume Stimulatederythropoiesis(MCVincreasesupto110)—reticulocytesarelarger thanmatureRBCs,resultinginanincreaseinpolychromatophilicRBCs Alcoholism

e

Hypothyroidism

c. Ifnormocyticanemia(MCV80to100),thedifferentialdiagnosisincludesthe following:

Aplasticanemia—bonemarrowfailure Bonemarrowfibrosis Bonemarrowinfiltration Anemiaofchronicdisease Renalfailure—decreasederythropoietinproductionresultsindecreased erythropoiesis

2. Ifthereticulocyteindexis>2%,indicatinganadequatebonemarrowresponse, thedifferentialdiagnosisincludesthefollowing:

a. Acutebloodloss b. Hemolysis

Quick HIT

Thefirststepinevaluationoftheanemicpatientistoassessvolumestatusandhemodynamicstability,inorder toidentifyanyactivebleeding.Ifhemodynamicallyunstable,transfusePRBCsbeforeattemptingtofindthe source.

MicrocyticAnemias IronDeficiencyAnemia

Quick HIT

Inelderlypatientswithirondeficiencyanemia,youmustruleoutcoloncancer.
======================================
Quick HIT

Pica(thecravingfornonfooditems)andpagophagia(thecravingforice)havebeenassociatedwithiron- deficiencyanemia.

A.Causes 1. Chronicbloodloss 2. Mostcommoncauseofirondeficiencyanemiainadults 3. Menstrualbloodlossisthemostcommonsource—intheabsenceofmenstrual

bleeding,GIbloodlossismostlikely

4. Dietarydeficiency/increasedironrequirements,whichareprimarilyseeninthe followingthreeagegroups:

5. Infantsandtoddlers—occursespeciallyifthedietispredominantlyhumanmilk, whichislowiniron;childreninthisagegroupalsohaveanincreased requirementforironduetoacceleratedgrowth

6. Adolescents—increasedrequirementforironduetorapidgrowth;adolescent womenareparticularlyatriskduetolossofmenstrualblood

7. Pregnantwomen—pregnancyincreasesironrequirements

B.Diagnosis 1. Ironstudies(seeTable9-1) a. Decreasedserumferritin b. IncreasedTIBC/transferrinlevels c. Decreasedtransferrinsaturation d. Decreasedserumiron

2. Peripheralbloodsmear—revealsmicrocytic,hypochromicRBCs(Figure9-2) 3. Bonemarrowbiopsy—revealsabsenceofstainableiron;thistestistechnically thegoldstandard,buttypicallyonlyindicatediflaboratoryevidenceofiron deficiencyanemiaispresentandnosourceofbloodlossisfound

4. GuaiacstooltestorcolonoscopyifGIbleedingissuspected—coloncancerisa

commoncauseofGIbleedingintheelderly

TABLE9-1 IronStudiesinMicrocyticAnemias  SerumFerritin  SerumIron  TIBC  RDW    IronDeficiencyAnemia  Low  Low  High  High  AnemiaofChronicDisease  Normal/high  Low  Normal/low  Normal  Thalassemia  Normal/high  Normal/high  Normal  Normal/high 

& Ps & ‘* ~ ‘ ¥ ry - ~ 4 ra ‘ ‘eh @ 3 . ‘ ‘ \~ ° >. 6 wel | < ° & w . 4 7 + ( 2 ; t La . » - Pa

FIGURE 9.2

Bloodsmear:irondeficiencyanemia.

(FromPereiraI,GeorgeT,ArberD.AtlasofPeripheralBlood.Philadelphia,PA:WoltersKluwer

Health/LippincottWilliams&Wilkins;2011.)

Quick HIT

TheMCHandMCHCareoflittlevalueclinically.Theyareneithersensitivenorspecificforanydiagnosis. However,MCVisveryvaluableindiagnosingthecauseofanemia.

Quick HIT

TheRDWmeasuresthevariationinRBCsize.TheRDWisusuallyabnormalinirondeficiency,butisgenerally normalinalloftheothermicrocyticanemias.
======================================
C.Treatment 1. Oralironreplacement(ferroussulfate)

a. Atrialofironreplacementtherapymaybegiventoyoung,otherwisehealthy, menstruatingwomenwithoutinvestigatingforadditionalsourcesofbloodloss (inmenandpostmenopausalwomen,attempttodeterminethesourceofblood lossfirst)

b. Sideeffectsincludeconstipation,nausea,anddyspepsia

2. Parenteralironreplacement

a. IrondextrancanbeadministeredIVorIM b. Rarelynecessarybecausemostpatientsrespondtooralirontherapy—maybe

usefulinpatientswithpoorgutabsorption,patientswhorequiremoreironthan oraltherapycanprovide,patientswhocannottolerateoralferroussulfate,or certainheartfailurepatients

3. Bloodtransfusionisnotrecommendedunlessanemiaissevereorthepatienthas cardiopulmonarydisease

Thalassemias

A.GeneralCharacteristics 1. Inheriteddisorderscharacterizedbyreducedproductionofeithertheα-orβ-

globinchainofhemoglobin

2. β-Thalassemias

a. β-Chainproductionisdecreased,butthesynthesisofα-chainsisunaffected b. Excessα-chainsbindtoanddamagetheRBCmembrane c. Severitydependsonthenumberofallelesmutatedandtheseverityofthese

mutations

d. ItismostoftenfoundinpeopleofMediterranean,MiddleEastern,andIndian

ancestry 3. α-Thalassemias

a. Thereisadecreaseinα-chains,whichareacomponentofalltypesof hemoglobins

b. Excessβ-globinchainsformtetramers,whichareabnormalhemoglobins c. Severitydependsonthenumberofallelesthataredeleted/mutated,rangingfrom

anasymptomaticcarrierstatetofetaldeath

Quick HIT

Ifirondeficiencyanemiaissuspected,buttheanemiadoesnotrespondtoirontherapy,obtainahemoglobin electrophoresistoruleoutα-andβ-thalassemia.

B.β-Thalassemias 1. β-Thalassemiamajor(Cooleyanemia;homozygousβ-chainthalassemia)

a. Clinicalfeatures

e

Severeanemiabeginninginlateinfancy Jaundiceanddarkurine Massivehepatosplenomegaly Expansionofmarrowspace—cancausedistortionofbonesandresultin “crew-cut”appearanceonskullX-ray Growthretardationandfailuretothrive Ifuntreated,deathoccurswithinthefirstfewyearsoflifesecondaryto progressiveCHF

b. Diagnosis

e¢

e

Hemoglobinelectrophoresis—revealselevatedHbFandHbA2 Peripheralbloodsmear—revealsmicrocytic,hypochromicanemia;targetcells maybeseen(Figure9-3)

c. Treatment
======================================
FrequentPRBCtransfusionsarerequiredtosustainlife 2. β-Thalassemiaminor(heterozygousβ-chainthalassemia)

a. Characterizedbyasymptomaticcarrierstateormildanemia b. Diagnosedwithhemoglobinelectrophoresis c. Peripheralbloodsmearrevealsmicrocytic,hypochromicRBCs d. Treatmentusuallynotnecessary(patientsarenottransfusion-dependent)

3. β-Thalassemiaintermedia

a. Characterizedbyanemiasofvaryingseverity b. Diagnosedwithhemoglobinelectrophoresis c. Peripheralbloodsmearrevealsmicrocytic,hypochromicRBCs d. Mostindividualsarenottransfusion-dependentinchildhood,butmanywill

becometransfusion-dependentinadulthood

Quick HIT

Ironoverloadcandevelopinpatientswithtransfusion-dependentthalassemia.Ifuntreated,thiscanleadtoCHF andothersymptomsofhemochromatosis.Theseindividualsareoftentreatedwithdeferoxamine,aniron- chelatingagent.

C.α-Thalassemias 1. Silentcarriers(mutation/deletionofonlyoneα-locus)

a. Asymptomatic b. NormalHbandHctlevel c. Notreatmentnecessary

2. α-Thalassemiatrait/minor(mutation/deletionoftwoα-loci)

a. Characterizedbymildanemia b. Peripheralbloodsmearrevealsmicrocytic,hypochromicRBCs c. Notreatmentnecessary

3. HbHdisease(mutation/deletionofthreeα-loci) a. Characterizedbyanemiasofvaryingseverity b. HemoglobinelectrophoresisshowsHbH c. Peripheralbloodsmearrevealsmicrocytic,hypochromicRBCs d. Mostindividualsarenottransfusion-dependent,butmanyrequireperiodic

transfusionsduringepisodesofincreasedhemolysis(e.g.,infection)

4. Mutation/deletionofallfourα-loci

a. Eitherfatalatbirth(hydropsfetalis)orshortlyafterbirth

FIGURE 9.3

Bloodsmear:thalassemia.Targetcells(arrows)and

circulatingnucleatedredbloodcells(arrowhead). (FromRubinR,StrayerDS,RubinE.Rubin’sPathology:ClinicopathologicFoundationsof

Medicine.6thed.Philadelphia,PA:WoltersKluwerHealth/LippincottWilliams&Wilkins;

2012:962,Figure20-15.)

Themostcommontypeofthalassemiaisthalassemiaminor(withβ-thalassemiaminorbeingmorecommonthan α-thalassemiaminor).Bothoftheseconditionscanbemistakenforirondeficiencyanemia.

SideroblasticAnemia
======================================
CausedbyabnormalityinRBCironmetabolismleadingtopathologicirondeposits inRBCmitochondria Maybehereditaryoracquired—acquiredcausesincludedrugs(e.g., chloramphenicol,INH,alcohol),exposuretolead,collagenvasculardisease,and neoplasticdisease(e.g.,myelodysplasticsyndromes) Characterizedbyringedsideroblastsinbonemarrow,increasedserumiron, increasedserumferritin,normalTIBC,andnormal/elevatedTIBCsaturation(which distinguishesitfromirondeficiencyanemia) Treatmentinvolvesremovingoffendingagentsandtransfusingasnecessary—may alsoconsiderpyridoxine

NormocyticAnemias AnemiaofChronicDisease

eee

Occursinthesettingofchronicinfection(e.g.,tuberculosis,lungabscess), malignancy(e.g.,lung,breast,Hodgkindisease),inflammation(e.g.,rheumatoid arthritis,systemiclupuserythematosus[SLE]),ortrauma—thereleaseof inflammatorycytokineshasasuppressiveeffectonerythropoiesis Generallymildandwelltolerated Maybedifficulttodifferentiatefromirondeficiencyanemia Laboratoryfindingsincludelowserumiron,normal-to-lowTIBC/serumtransferrin, andincreasedserumferritin Peripheralbloodsmearusuallyrevealsnormocyticandnormochromicanemia,but maybemicrocyticandhypochromicaswell Nospecifictreatmentisnecessaryotherthantreatmentoftheunderlyingprocess— donotgiveiron

AplasticAnemia

A.GeneralCharacteristics 1. Bonemarrowfailureleadingtopancytopenia(i.e.,anemia,neutropenia,

thrombocytopenia)

2. Causes

a. Idiopathic—majorityofcases b. Radiationexposure c. Medications(e.g.,chloramphenicol,sulfonamides,gold,carbamazepine) d. Viralinfection(e.g.,humanparvovirus,hepatitisC,hepatitisB,Epstein–Barr

virus[EBV],cytomegalovirus[CMV],herpeszoster,varicella,HIV)

e. Chemicalexposure(e.g.,benzene,insecticides)

B.ClinicalFeatures 1. Signs/symptomsofanemia:fatigue,dyspnea,headache,palpitations,pallor 2. Signs/symptomsofthrombocytopenia:petechiae,easybruising 3. Increasedincidenceofinfections—duetoneutropenia 4. Cantransformintoacuteleukemia

C.Diagnosis 1. Pancytopenia 2. Peripheralbloodsmear—revealsnormocyticanemiawithdecreasedneutrophils

andplatelets

3. Bonemarrowbiopsy(fordefinitivediagnosis)—revealshypocellularmarrowand theabsenceofprogenitorsofallthreehematopoieticcelllines
======================================
Quick HIT

PerniciousanemiaisaspecialcaseofvitaminB12deficiency.Itisanautoimmunedisorderresultingin inadequateproductionofintrinsicfactor,whichleadstoimpairedabsorptionofvitaminB12intheterminal ileum.

D.Treatment 1. Discontinuationofoffendingagentsortreatmentofanyknownunderlyingcauses 2. TransfusionofPRBCsandplateletsasnecessary—usejudiciously 3. Bonemarrowtransplantation

MacrocyticAnemias VitaminB12Deficiency

A.GeneralCharacteristics 1. VitaminB12servesasacofactorintwoimportantreactionsrequiredfornormal

erythropoiesisandCNSfunctioning:

a. Theconversionofhomocysteinetomethionine b. Theconversionofmethylmalonyl-CoAtosuccinyl-CoA 2. ThemaindietarysourcesofvitaminB12aremeatandfish 3. Afteringestion,vitaminB12isboundtointrinsicfactor(producedbygastric

parietalcells)soitcanbeabsorbedbytheterminalileum

4. VitaminB12storesintheliverareplentifulandcansustainanindividualfor3or moreyears

5. Causes

a. Mostcommonlyduetoimpairedabsorption(eithervialackofintrinsicfactoror lackofabsorptiveilealsurface)

b. Perniciousanemia—lackofintrinsicfactorduetoautoimmunedestruction;most commoncauseintheWesternhemisphere

c. Gastrectomy—lackofintrinsicfactorduetoremovalofparietalcells d. Inadequatedietaryintake(e.g.,strictvegetarianism,alcoholism) e. Crohndiseaseorresectionofterminalileum(approximatelythelast100cm) f. OtherorganismscompetingforvitaminB12(i.e.,Diphyllobothriumlatum

infestation[fishtapeworm]andblindloopsyndrome[bacterialovergrowth])

Quick HIT

Inapatientwithmegaloblasticanemia,itisimportanttodeterminewhetherfolateorvitaminB12deficiencyis thecausepriortoinitiatingtreatment.FolatesupplementscanimprovetheanemiaofvitaminB12deficiency,but nottheneurologicimpairment.Therefore,ifthevitaminB12deficiencyremainsuntreated,irreversible neurologicdiseasecanresult.

Quick HIT

NotethatpatientswithvitaminB12deficiencycanhavemoderate-to-severeneurologicsymptomswithlittle-to- noanemia(i.e.,bloodcountsmaybenormal).Delayindiagnosisandtreatmentmayleadtoirreversible neurologicdisease.

B.ClinicalFeatures 1. Soretongue(stomatitisandglossitis) 2. Neuropsychiatricchanges/dementia—lookforvitaminB12deficiencyinthe

workupfordementia

3. Neuropathyandsubacutecombineddegenerationofthespinalcord— distinguishesvitaminB12deficiencyfromfolatedeficiency

a. Leadstoalossofposition/vibratorysensationinlowerextremities,ataxia,and uppermotorneuronsigns(increaseddeeptendonreflexes,spasticity,weakness, Babinskisign)

b. Canleadtourinaryandfecalincontinence,impotence
======================================
C.Diagnosis 1. Peripheralbloodsmear—revealsmegaloblastic(macrocytic)anemiawith

hypersegmentedneutrophils(Figure9-4)

2. LowserumvitaminB12level 3. Elevatedserummethylmalonicacidandhomocysteinelevels—mostusefulifthe

vitaminB12levelisborderline

4. Antibodiestointrinsicfactor(forthediagnosisofperniciousanemia) 5. SchillingtestwashistoricallyusedtodetermineifB12deficiencyisdueto

perniciousanemia,butisnolongerroutinelyperformed:

a. AdministerIMdoseofunlabeledvitaminB12tosaturatebindingsites b. AdministeroraldoseofradioactivevitaminB12 c. MeasuretheamountofradioactivevitaminB12inurineandplasmatodetermine

theamountabsorbedinthegut

d. RepeattheadministrationoforalradioactivevitaminB12withtheadditionof intrinsicfactor

e. Ifmalabsorptionisthecauseofdeficiency,addingintrinsicfactorwillnot changestudyresults.However,ifperniciousanemiaispresent,theadditionof intrinsicfactorwillimprovetheamountofvitaminB12absorbed.

FIGURE 9.4

Bloodsmear:hypersegmentedneutrophil(vitaminB12

deficiency). (FromAndersonSC.Anderson’sAtlasofHematology.Philadelphia,PA:LippincottWilliams&

Wilkins;2003.)

D.Treatment 1. Cyanocobalamin(vitaminB12)IM—parenteraltherapyispreferred

FolateDeficiency

Quick HIT

TheserumhomocysteinelevelisincreasedinbothfolatedeficiencyandvitaminB12deficiency.However, serummethylmalonicacidlevelsareonlyseeninvitaminB12deficiency.

A.GeneralCharacteristics 1. FolateplaysanimportantroleinDNAsynthesis 2. Greenvegetablesandfolicacid–supplementedfoodsarethemaindietarysources

offolate

3. Folicacidstoresinthebodyarelimited,andinadequateintakeovera3-month periodcanleadtodeficiency

4. Causes

a. Inadequatedietaryintake(e.g.,“teaandtoast”diet,alcoholism)—mostcommon cause

b. Long-termuseoforalantibiotics c. Increasedfolaterequirements(e.g.,pregnancy,chronichemolysis) d. Useoffolateantagonists(e.g.,methotrexate) e. Anticonvulsantmedications(e.g.,phenytoin) f. Malabsorptivesyndromes(e.g.,celiacdisease) g. Hemodialysis

B.ClinicalFeatures 1. SimilartothoseofvitaminB12deficiency,butnoneurologicsymptoms 2. Signs/symptomsofanemia:fatigue,dyspnea,headache,palpitations,pallor 3. Neuropsychiatricchanges/dementia—lookforfolatedeficiencyintheworkupfor

dementia
======================================
C.Diagnosis 1. Peripheralbloodsmear—revealsmegaloblastic(macrocytic)anemiawith

hypersegmentedneutrophils

2. Lowserumfolatelevel 3. Elevatedserumhomocysteinelevel—methylmalonicacidlevelsarenormal

D.Treatment 1. Dailyoralfolicacidreplacement

HemolyticAnemias

Overview

A.GeneralCharacteristics 1. HemolysisreferstotheprematuredestructionofRBCsduetoavarietyofcauses. 2. Bonemarrowistypicallynormalandrespondsappropriatelybyincreasing

erythropoiesis,leadingtoanelevatedreticulocytecount.However,if erythropoiesiscannotkeepupwiththedestructionofRBCs,anemiaresults.

3. Hemolyticanemiacanbeclassifiedaccordingtocause,site,chronicity,or mechanismofdestruction.

4. Hemolyticanemiasareclassifiedbasedoncauseasfollows:

a. HemolysisduetoabnormalityextrinsictoRBC—mostcasesareacquired:

e

¢

e

Immunehemolysis Mechanicalhemolysis(e.g.,prostheticheartvalves,microangiopathic hemolyticanemia) Medications,burns,toxins(e.g.,snakebite,brownreclusespiderbite), infections(e.g.,malaria,clostridium)

b. HemolysisduetointrinsicRBCdefects—mostcasesareinherited:

e¢

e¢

e

Hemoglobinabnormality(e.g.,sicklecellanemia,hemoglobinCdisease, thalassemias) Membranedefects(e.g.,hereditaryspherocytosis,paroxysmalnocturnal hemoglobinuria[PNH]) Enzymedefects(e.g.,glucose-6-phosphatedehydrogenase[G6PD]deficiency, pyruvatekinasedeficiency)

5. Hemolyticanemiasareclassifiedbasedonthepredominantsiteofhemolysisas follows:

a. Intravascularhemolysis—withinthecirculation b. Extravascularhemolysis—withinthereticuloendothelialsystem,primarilythe

spleen

Quick HIT

Ethnicbackground,familyhistoryofjaundice/anemia,andmedicationsareallrelevantaspectsofthehistoryof apatientwithhemolyticanemia.

Quick HIT

MechanicalheartvalvescanhemolyzeRBCsandleadtohemolyticanemia.

Quick HIT

ExpectedLaboratoryResultsinHemolyticAnemia Elevatedreticulocytecount,LDH,indirectbilirubin DecreasedhaptoglobinandHb/Hct

Quick HIT

PhysicalinjurytoRBCsleadstothepresenceoffragmentedRBCscalledschistocytesorhelmetcellsonthe bloodsmear.ThiscanoccurinTTP,DIC,andpatientswithprostheticheartvalves.
======================================
B.ClinicalFeatures 1. Signs/symptomsofanemia:fatigue,dyspnea,headache,palpitations,pallor 2. Jaundice 3. Darkurinecolorifintravascularprocess—duetohemoglobinuria,notbilirubin 4. Hepatosplenomegaly,cholelithiasis,andlymphadenopathyifchronic 5. Signs/symptomsofunderlyingdisease(e.g.,bonecrisesinsicklecelldisease)

C.Diagnosis 1. LowHb/Hct—leveldependsondegreeofhemolysisandreticulocytosis 2. Elevatedreticulocytecount—duetoincreasedRBCproduction 3. Peripheralbloodsmear

a. Schistocytessuggestintravascularhemolysis(“trauma”ormechanical hemolysis)(Figure9-5)

b. Spherocytesorhelmetcellssuggestextravascularhemolysis(dependingonthe cause)

c. SickledRBCsifsicklecellanemia d. HeinzbodiesifG6PDdeficiency

4. Lowhaptoglobin(especiallywithintravascularhemolysis)—haptoglobinbindsto freehemoglobin,sodecreasedlevelssuggesthemoglobinreleasesecondaryto RBCdestruction

5. ElevatedLDH—releasedwhenRBCsaredestroyed 6. Elevatedindirect(unconjugated)bilirubin—duetodegradationofhemeasRBCs

aredestroyed

7. PositivedirectCoombstestifautoimmunehemolyticanemia(AIHA)—detects antibodyorcomplementonRBCmembrane

8. Positiveosmoticfragilitytest(seebelow)

FIGURE 9.5

Bloodsmear:schistocytes.

(FromAndersonSC.Anderson’sAtlasofHematology.Philadelphia,PA:LippincottWilliams& Wilkins;2003.)

D.Treatment 1. Treatunderlyingcause 2. TransfusionofPRBCsifsevereanemiaispresentorpatientishemodynamically

compromised

3. Folatesupplementation—folateisdepletedinhemolysis

SickleCellDisease

A.GeneralCharacteristics 1. SickleCellAnemia

a. AutosomalrecessivedisorderresultingfromtheinheritanceoftwoHbSgenes (homozygous),causingnormalHbAtobereplacedbythemutantHbS

b. HbSisdistinguishedfromHbAbyitssubstitutionofanunchargedvalinefora

negativelychargedglutamicacidatthesixthpositionoftheβ-chain c. Underreducedoxygenconditions(e.g.,acidosis,hypoxia,changesin

temperature,dehydration,andinfection)theHbSmoleculespolymerize, causingtheRBCstosickle.SickledRBCsobstructsmallvessels,leadingto ischemia(seeClinicalPearl9-3).

2. Sicklecelltrait
======================================
a. ResultsfromtheinheritanceofoneHbSgene(heterozygous) b. 1in12peopleofAfricandescentarecarriers,butsicklecelltraitalsoappearsin

individualsofItalian,Greek,andSaudiArabiandescent

c. Patientswithsicklecelltraitarenotanemicandhaveanormallifeexpectancy d. Sicklecelltraitisassociatedwithisosthenuria,theinabilitytoconcentrateor diluteurine—patientswillhaveaconstantosmolalityonurinalysistesting

e. Screeningcanidentifyasymptomaticindividualswithsicklecelltrait,forwhom geneticcounselingmaybeprovided

3. Prognosis

a. Ingeneral,sicklecelldiseasereduceslifeexpectancy,withamediansurvivalof 58yearsintheUnitedStates

b. Factorsthathavebeenassociatedwithincreasedmortalityratesincludegreater frequencyofhospitalization,acutechestsyndrome,andrenalinsufficiency

c. Themostcommoncausesofdeathincludeacutechestsyndromeandmultiorgan failure

CLINICALPEARL9-3

AlmostEveryOrganCanBeInvolvedinSickleCellDisease

Blood—chronichemolyticanemia,aplasticcrises Heart—high-outputCHFduetoanemia CNS—stroke GItract—gallbladderdisease(stones),splenicinfarctions,abdominalcrises Bones—painfulcrises,osteomyelitis,avascularnecrosis Lungs—infections,acutechestsyndrome Kidneys—hematuria,papillarynecrosis,renalfailure Eyes—proliferativeretinopathy,retinalinfarcts Genitalia—priapism

Quick HIT

Sicklecellcrisesvaryinseverityandfrequencyamongpatients.Somehavemanypainfuleventsrequiring multiplehospitalizationsperyear,whileothershaveveryfew.Eachepisodeistypicallyfollowedbyaperiodof remission.

Quick HIT

Vaso-occlusivecrisesareduetoobstructionofmicrocirculationbysickledRBCs.Thisleadstoischemiain variousorgans,producingthecharacteristic“painfulcrises.”

B.ClinicalFeatures 1. Manifestationsofchronic,hemolyticanemia

a. Pallorand/orjaundice b. Gallstonedisease(pigmentedgallstones) c. Delayedgrowthandmaturation(especiallyinboys) d. High-outputheartfailure

2. Manifestationsofacutevaso-occlusion

a. Paincrises—mostcommonclinicalmanifestation b. Vaso-occlusionresultsinboneinfarction,causingseverepain c. Bonepainusuallyinvolvesmultiplesites(e.g.,tibia,humerus,femur)andmay

ormaynotbebilateral
======================================
d. Painisself-limitingandusuallylasts2to7days e. Hand-footsyndrome(dactylitis)

e

¢

e

Painfulswellingofdorsaofhandsandfeetseenininfancyandearlychildhood (usually4to6months) Oftenthefirstmanifestationofsicklecelldisease Causedbyavascularnecrosisofthemetacarpalandmetatarsalbones

f. Acutechestsyndrome

e

e

e

Clinicalpresentationsimilartopneumonia Characterizedbychestpain,respiratorydistress,pulmonaryinfiltrates,and hypoxia Duetorepeatedepisodesofpulmonaryinfarctions

g. Splenicinfarction

e

e

Recurrentepisodeseventuallyleadtoautosplenectomy,wherebythespleenis reducedtoasmall,calcifiedremnant Thespleenislargeinchildhoodbutisnolongerpalpableby4yearsofage

h. Priapism

e

e

e

e

Erectionduetovaso-occlusion,usuallylastingbetween30minutesand3 hours Usuallysubsidesspontaneously,afterurineispassed,afterlightexercise,or afteracoldshower Atrialofhydralazine,nifedipine,orantiandrogens(e.g.,stilbestrol)may preventfurtherepisodes Sustainedpriapism(i.e.,lastingmorethan3hours)israre(lessthan2%),but isamedicalemergency

i. Renalpapillarynecrosis—common,affectingupto20%ofpatients

e

e

Characterizedbyhematuria(usuallypainless) Seldomrequireshospitalizationandmayceasespontaneously

j. Stroke—primarilyinchildren k. Myocardialinfarction l. Avascularnecrosisofjoints—mostcommoninhipandshoulder

Quick HIT

SplenicSequestrationCrisis

e

«

Suddenpoolingofbloodintothespleenresultsinrapiddevelopmentofsplenomegalyandhypovolemic shock Apotentiallyfatalcomplicationofsicklecelldisease(andβ-thalassemia)occurringmorecommonlyin children(becausetheyhaveintactspleens)

3. Manifestationsofchronicvaso-occlusion

a. Chroniclowerextremityulcers—mostcommonoverlateralmalleoli b. Ophthalmologiccomplications(e.g.,retinalinfarcts,vitreoushemorrhage,

proliferativeretinopathy,retinaldetachment)

c. Chronicpain 4. Aplasticcrises

a. UsuallyprovokedbyaviralinfectionsuchashumanparvovirusB19,which reducestheabilityofthebonemarrowtocompensateforchronichemolysis 5. Infectiouscomplications

5. Infectiouscomplications

a. Functionalaspleniaresultsinincreasedsusceptibilitytoinfections(particularly encapsulatedbacteriasuchasHaemophilusinfluenzae,Streptococcus pneumoniae)

b. PredispositiontoSalmonellaosteomyelitis(encapsulatedorganism)
======================================
FIGURE 9.6

Bloodsmear:sicklecelldisease.

(FromAndersonSC.Anderson’sAtlasofHematology.Philadelphia,PA:LippincottWilliams&

Wilkins;2003.)

C.Diagnosis 1. Anemia—mostcommonfinding 2. Peripheralbloodsmear—revealssickle-shapedRBCs(Figure9-6) 3. Hemoglobinelectrophoresis—requiredfordiagnosis,althoughmostpatientsare

diagnosedonnewbornscreening

D.Treatment 1. Preventionofcrises

a. Avoidhighaltitudes—lowoxygentensioncanprecipitatecrisis b. Maintainfluidintake—dehydrationcanprecipitatecrisis c. Treatinfectionspromptly—infection/fevercanprecipitatecrisisandshouldbe

consideredamedicalemergency

2. Preventionofinfections

a. EarlyvaccinationforS.pneumoniae,H.influenzae,andNeisseriameningitidis b. Prophylacticpenicillinforchildren<5yearsofage

3. Hydroxyurea

a. Indicatedforadultswithsevere/symptomaticsicklecelldisease,frequentpain crises,severe/recurrentacutechestsyndrome,orchronicpain

b. EnhancesHbFlevels,whichreducessickling c. Reducesvaso-occlusiveevents,includingpaincrisesandacutechestsyndrome

4. Managementofanemia

a. Folicacidsupplementation b. Bloodtransfusionasnecessary—baseneedfortransfusiononthepatient’s

clinicalconditionandnotonHblevels(e.g.,thepresenceofvaso-occlusive phenomenalikeacutechestsyndrome,stroke,orcardiacdecompensation)

5. Managementofpaincrises

a. Hydration—oralhydrationifmildepisode,IVfluids(normalsaline)for moderate/severeepisodes

b. Morphineforpaincontrol—donotunderestimatepatient’spain

6. Bonemarrowtransplantation—hasbeenperformedsuccessfullytocuresicklecell anemia,butisnotroutinelyperformedduetomatcheddonoravailabilityandrisk ofcomplications

HereditarySpherocytosis

Quick HIT

CausesofSpherocytosis

Hereditaryspherocytosis G6PDdeficiency ABOincompatibility(butnotRhincompatibility) Hyperthermia AIHA

AIHA

A.GeneralCharacteristics 1. Hereditaryspherocytosisiscausedbytheautosomaldominantinheritanceofa

defectinthegenecodingforspectrinandotherRBCproteins

2. ThereisalossofRBCmembranesurfaceareawithoutareductioninRBC volume,necessitatingasphericalshape.ThesphericalRBCsbecometrappedand destroyedinthespleen(bymacrophages)—hencethetermextravascular hemolysis.
======================================
B.ClinicalFeatures 1. Hemolyticanemia—canbesevere 2. Jaundice 3. Splenomegaly 4. Gallstones 5. Occasionalhemolyticcrises

C.Diagnosis 1. Microcyticanemia 2. Elevatedreticulocytecount 3. ElevatedMCHC 4. Peripheralbloodsmear—revealsspherocytes(sphere-shapedRBCs)(Figure9-7) 5. NegativedirectCoombstest—helpstodistinguishhereditaryspherocytosis(HS)

fromAIHA(alsocharacterizedbyspherocytes)

6. Eosin-5-maleimide(EMA)bindingtesting 7. EMAisadyethatbindstoseveralproteinspresentontheRBCmembrane 8. Spherocyteshaveareducednumberoftheseproteinspresentontheirmembranes

andwilldemonstratedecreasedEMAbindingontesting

9. Osmoticfragilitytesting

a. TeststheabilityofRBCstoswellinagradedseriesofhypotonicsolutions b. Becauseoftheirreducedsurfaceareatovolumeratio,spherocytesareless

tolerantofswellingandwillruptureearlier(inmoreconcentratedsolutions)than

normalRBCs(theyareosmoticallyfragile)

Quick HIT

Followingsplenectomy,patientsmustbeimmunizedagainstencapsulatedorganisms—N.meningitidis,S. pneumoniae,H.influenzae.

D.Treatment 1. Bloodtransfusionasnecessary 2. Splenectomyinpatientswithsymptomaticormoderate/severeanemia

FIGURE 9.7

Bloodsmear:spherocytes(hereditaryspherocytosis). (FromStrayerDS,RubinE.Rubin’sPathology:ClinicopathologicFoundationsofMedicine.7th

ed.Philadelphia,PA:WoltersKluwerHealth/LippincottWilliams&Wilkins;2014:1094,Figure 26-17.)

Glucose-6-PhosphateDehydrogenaseDeficiency

A.GeneralCharacteristics 1. X-linkedrecessivedisorderthatprimarilyaffectsmen 2. MostcommoninheritedRBCenzymaticdefect 3. Knownprecipitantsincludesulfonamides,nitrofurantoin,primaquine,

dimercaprol,favabeans,andinfection

4. Specificvariantsaremorecommonincertainpopulations:

a. G6PDA−variant

e

e

e

e

AmildformofG6PDdeficiencypresentin10%ofAfrican-Americanmen Inthisform,enzymaticactivityispreservedinyoungRBCs,butdeclinesas RBCsage Becausehemolysisislimitedtotheolder,enzyme-deficientRBCs,hemolytic episodesareusuallymildandself-limited Hemolyticepisodesareusuallytriggeredbyinfectionorbycertaindrugs,such asantimalarials(e.g.,primaquine)andsulfur-containingantibiotics(e.g., sulfonamideortrimethoprimsulfamethoxazole)

b. G6PDMediterraneanvariant
======================================
e

e

e

e

MoresevereformofG6PDdeficiencymostcommoninindividualsof Mediterraneandescent Inthisform,themajorityofRBCsareenzyme-deficient(youngaswellasold RBCs) Causesseverehemolyticanemia,especiallywhenexposedtofavabeans Mayrequiretransfusionsuntiltheincitingagentiseliminatedfromthebody

Quick HIT

e

¢

DeficiencyofG6PDresultsintheaccumulationofH2O2inRBCs,whichdenaturesHbandprecipitates HeinzbodyformationwithinRBCs. HeinzbodiesattachtoRBCmembranes,reducingtheirflexibilityandmakingthempronetosplenic sequestration.

B.ClinicalFeatures 1. Episodichemolyticanemia—usuallyinducedbydrugs,foods,orillness 2. Darkurine 3. Jaundice

C.Diagnosis 1. Anemia,elevatedLDH,decreasedhaptoglobin,andelevatedindirectbilirubin

(duringepisodesofhemolysis)

2. Peripheralbloodsmear

a. “Bitecells”—RBCsthatappeartohave“bites”takenoutofthem,secondaryto phagocytosisofHeinzbodiesbysplenicmacrophages(Figure9-8)

b. Heinzbodies—abnormalhemoglobinprecipitateswithinRBCs

3. G6PDassay—revealsdeficientNADPHformation 4. DecreasedG6PDlevelisdiagnostic—importanttonotethatG6PDlevelsmaybe normalduringacutehemolyticepisodes,becauseRBCsmostdeficientinG6PD havealreadybeendestroyed;repeatingthetestatalaterdatefacilitatesdiagnosis

eve Ve~ CG “Fs ° @ e 00 é a ~ oe . @ @? 7 e0. 0 A ”* ‘ Oe @ a2 0g @0°°IC*6@ 7 ) 24 ° © a 9 20 °@ ca

FIGURE 9.8

Bloodsmear:bitecells(Glucose-6-phosphatedehydrogenase

deficiency). (FromFarhiDC,ChaiCC,EdelmanAS,etal.PathologyofBoneMarrowandBloodCells.

Philadelphia,PA:LippincottWilliams&Wilkins;2004.)

D.Treatment 1. Avoiddrugsorotherexposuresthatprecipitatehemolysis 2. Maintainhydration 3. Bloodtransfusionasnecessary

AutoimmuneHemolyticAnemia

A.GeneralCharacteristics 1. ProductionofautoantibodiestoRBCmembraneantigen(s)whichleadsto

hemolysis

2. Thetypeofantibodyproduced(IgGorIgM)determinestheprognosis,siteof RBCdestruction,andresponsetotreatment

3. Thecourseisvariable,buttendstobemorefulminantinchildrenthaninadults 4. WarmAIHA—morecommonthancoldAIHA

a. AutoantibodyisIgG,whichbindsoptimallytoRBCmembranesat37°C (“warm”temperatures)

b. Resultsinextravascularhemolysis—theprimarysiteofRBCsequestrationisthe spleen,andsplenomegalyisacommonfeature

c. Maybeprimary/idiopathicorsecondarytolymphomas,leukemias(e.g.,chronic lymphocyticleukemia),othermalignancies,collagenvasculardiseases (especiallySLE),anddrugs(e.g.,α-methyldopa)

5. ColdAIHA

a. AutoantibodyisIgM,whichbindsoptimallytotheRBCmembraneat0°to5°C (“cold”temperatures)

b. Resultsincomplementactivationandintravascularhemolysis—primarysiteof RBCsequestrationistheliver

c. Maybeprimary/idiopathic(especiallyintheelderly)orsecondarytoinfection (e.g.,Mycoplasmapneumoniaeinfection,infectiousmononucleosis)
======================================
B.ClinicalFeatures 1. Signs/symptomsofanemia:fatigue,dyspnea,headache,palpitations,pallor 2. Jaundiceifsignificanthemolysisispresent 3. Signs/symptomsoftheunderlyingdisease

C.Diagnosis 1. Anemiawithelevatedreticulocytecount 2. ElevatedLDH 3. Decreasedhaptoglobin 4. Elevatedindirectbilirubin 5. Peripheralbloodsmear—revealsspherocytesifwarmAIHA,orRBCaggregates

ifcoldAIHA

6. DirectCoombstest

a. IfpositiveforIgGonRBCs,suggestsadiagnosisofwarmAIHA b. IfpositiveforcomplementaloneonRBCs,suggestsadiagnosisofcoldAIHA

7. PositivecoldagglutinintiterifcoldAIHA

D.Treatment 1. Thetherapeuticapproachdependsonthetypeofautoantibodycausingthe

1. The therapeutic approach depends on the type of autoantibody causing the hemolysis

hemolysis 2. WarmAIHA

a. Glucocorticoids—mainstayoftherapy b. Splenectomy—forpatientswhoseconditiondoesnotrespondtoglucocorticoids c. Rituximab—forpatientswhoseconditiondoesnotrespondtosplenectomy d. Immunosuppression(azathioprineorcyclophosphamide)—forpatientswhose

conditiondoesnotrespondtosplenectomy

e. RBCtransfusionsasnecessary f. Folicacidsupplementation

3. ColdAIHA

a. Avoidingexposuretocold—preventsboutsofhemolysis b. Rituximab c. Variouschemotherapyagents d. RBCtransfusionsasnecessary e. Steroidsarenotbeneficial

ParoxysmalNocturnalHemoglobinuria

A.GeneralCharacteristics 1. Acquireddisorderthataffectshematopoieticstemcellsandcellsofallblood

lineages

2. Causedbyadeficiencyofproteinsthatanchorcomplement-inactivatingproteins tobloodcellmembranes.Thisdeficiencyresultsinanunusualsusceptibilityto complement-mediatedlysisofRBCs,WBCs,andplatelets.

B.ClinicalFeatures 1. Signs/symptomsofanemia:fatigue,dyspnea,headache,palpitations,pallor 2. Signs/symptomsofchronicintravascularhemolysis:paroxysmalhemoglobinuria

(darkurine),jaundice

3. Pancytopenia 4. Thrombosis—primarilyofvenoussystems(e.g.,ofthehepaticveins[Budd–

Chiarisyndrome])

5. Mayevolveintoaplasticanemia,myelodysplasia,myelofibrosis,andacute leukemia

6. Abdominal,back,andmusculoskeletalpain

C.Diagnosis 1. Normocyticanemiawithelevatedreticulocytecount 2. ElevatedLDH 3. Reducedhaptoglobin 4. Elevatedindirectbilirubin 5. Peripheralbloodsmear—revealsnormochromic,normocyticRBCs 6. Flowcytometryofanchoredcellsurfaceproteins(CD55,CD59)
======================================
D.Treatment 1. Eculizumab—monoclonalantibodythatservesasacomplementinhibitor,for patientswithsignificantdiseasemanifestations(e.g.,transfusiondependence, renalinsufficiency,orthrombosis)

2. Folicacidsupplementation 3. Bloodtransfusionasnecessary 4. Bonemarrowtransplantation—potentiallycurative

PlateletDisorders Thrombocytopenia

A.GeneralCharacteristics 1. Definedasplateletcount<150,000(normalrangeis150,000to400,000/mL

[Figure9-9])

2. Causes

a. Decreasedproduction

e

e

e

Bonemarrowfailure:acquired(e.g.,aplasticanemia),congenital(e.g.,Fanconi syndrome),congenitalintrauterinerubella Bonemarrowinvasion:tumors,leukemia,fibrosis Bonemarrowinjury:drugs(e.g.,ethanol,gold,cancerchemotherapyagents, chloramphenicol),chemicals(e.g.,benzene),radiation,infection

b. Increaseddestruction

e

e

Immune:infection,drug-induced,immunethrombocytopenicpurpura(ITP), SLE,heparin-inducedthrombocytopenia(HIT)type2,HIV-associated thrombocytopenia Nonimmune:disseminatedintravascularcoagulation(DIC),thrombotic thrombocytopenicpurpura(TTP),HITtype1

c. Sequestrationfromsplenomegaly d. Dilutional—aftertransfusionsorhemorrhage e. Pregnancy—usuallyanincidentalfinding(especiallythirdtrimester)butcan

alsooccurinsettingofpreeclampsiaoreclampsia(rememberHELLP syndrome)

Platelet disorders 1 Quantitative disorders Qualitative disorders Abnormal platelet counts Normal platelet count but abnormality in platelet function Thrombocytopenia | Thrombocytosis | Acquired Hereditary * | Production ¢ Drugs (ASA, NSAIDs, *vWD * t Destruction antibiotics, high-dose _* Bernard-Soulier * Sequestration PCN) syndrome (see text) Reactive (most cases) Autonomous | ¢ Uremia—uremic * Glanzmann's toxins affect VWF Xill thrombasthenia * Iron deficiency * Myeloproliferative biochemistry * Liver disease * Splenectom diseases—polycythemia . pa y vyorai Polyoy * Bone marrow disorders thrombocytosis ¢ Essential thrombocytosis (leukemias, myelo- * Inflammatory diseases * CML prolerative'disorders) (IBD) ° Dysproteinemias (multiple myeloma) ¢ Antiplatelet antibodies ¢ Cardiopulmonary bypass (partial degranulation of platelets) ¢ Malignancy (Gl, lung)
======================================
FIGURE 9.9 Classificationofplateletdisorders.

Quick HIT

HIT

e

e

HITtype1:Heparindirectlycausesplateletaggregation,leadingtoamilddropinplatelets;seen<48hours afterinitiatingheparin;notreatmentisneeded. HITtype2:Heparininducesantibody-mediatedinjurytoplatelets,leadingtoasignificantdropincounts; seen3to12daysafterinitiatingheparin;heparinshouldbediscontinuedimmediately.

B.ClinicalFeatures 1. Cutaneousbleeding:petechiae(mostcommonindependentareas),purpura,

ecchymosesatsitesofminortrauma

2. Mucosalbleeding:epistaxis,menorrhagia,hemoptysis,bleedinginGIand genitourinary(GU)tracts

3. Excessivebleedingafterproceduresorsurgery(whenplateletcount<50,000) 4. IntracranialhemorrhageandheavyGIbleeding(whenplateletcount<10,000)—

canbelife-threatening

5. Donotseeheavybleedingintotissues(hematomas)orjoints(hemarthroses)like whatisseenincoagulationdisorders(e.g.,hemophilia)

C.Diagnosis 1. Decreasedplateletcount 2. Peripheralbloodsmear 3. Bonemarrowbiopsy—mayberequiredifprimaryhematologicdisorderis

suspected

D.Treatment 1. Removeanyoffendingdrugs(e.g.,aspirin,NSAIDs)andtreattheunderlying

cause

2. Platelettransfusionasnecessary—dependingonthecauseandseverityof thrombocytopenia
======================================
Immune(Idiopathic)ThrombocytopenicPurpura

A.GeneralCharacteristics 1. IgGautoantibodiestohostplateletscoatanddamageplatelets,whicharethen

removedbysplenicmacrophages(seealsoTable9-2)

2. Maybeacuteorchronic:

a. Acuteform

e

e

e

Usuallyseeninchildren Precededbyaviralinfectioninmostcases Usuallyself-limited—80%ofcasesresolvespontaneouslywithin6months

b. Chronicform

e

e

Usuallyseeninadults,mostcommonlyinwomen20to40yearsofage Spontaneousremissionsarerare

B.ClinicalFeatures 1. Manypatientshaveminimalbleedingsymptomsdespiteextremelylowplatelet

counts(<5,000/mL)

2. Cutaneousbleeding:petechiae,purpura,ecchymosesatsitesofminortrauma 3. Mucosalbleeding:epistaxis,menorrhagia,hemoptysis,GI/GUbleeding 4. Splenomegalyisnotseen

C.Diagnosis 1. Decreasedplateletcount(frequentlylessthan20,000)—remainderoftheblood

countisnormal

2. Peripheralbloodsmear—revealsdecreasedplatelets

D.Treatment 1. Glucocorticoids—mainstayoftherapy 2. IVimmuneglobulin(IVIG)—saturatesthereticuloendothelialsystembinding sitesforplatelet-boundself-immunoglobulin,decreasingplateletuptakeand destructionbythespleen;typicallyreservedforpatientswithactivebleeding 3. Splenectomy—inducesremissionin70%to80%ofthecasesofchronic,steroid-

3. Splenectomy—induces remission in 70% to 80% of the cases of chronic, steroid- resistant ITP

resistantITP

4. Rituximab,thrombopoietinreceptoragonists(e.g.,eltrombopag),andsome immunosuppressiveagentshavebeenusedsuccessfullyinsplenectomy-resistant patients

5. Platelettransfusionsasnecessary—forpatientswithseverebleedingandplatelet counts<30,000

ThromboticThrombocytopenicPurpura

A.GeneralCharacteristics 1. TTPisararedisorderinwhichpatientslackfunctionalADAMTS13,aprotease thatcleavesvonWillebrandfactor(vWF),resultinginthebuild-upofultralarge vWFmultimersintheblood

2. Thisbuild-upofvWFmultimersleadstotheformationofmicrothrombithat consumeplatelets,occludesmallvessels,andcausemechanicaldamagetoRBCs (microangiopathichemolyticanemia[MAHA])

3. TTPisalife-threateningemergencythatcaninvolveanyorgan.Itishighly responsivetotherapy(seebelow),butleadstodeathifleftuntreated.
======================================
Quick HIT

TTPandHUS

e

e

e

ThereisnoconsumptionofclottingfactorsinTTP,soPTandPTTarenormal. TTP=HUS+fever+alteredmentalstatus HUS=microangiopathichemolyticanemia+thrombocytopenia+renalfailure

B.ClinicalFeatures 1. Signs/symptomsofhemolyticanemia:fatigue,dyspnea,pallor,jaundice 2. Signs/symptomsofthrombocytopenia:petechiae,purpura 3. Acuterenalfailure—typicallymild 4. Fever 5. Fluctuating,transientneurologicsigns/symptoms—canrangefromconfusionto

hemiplegia

Quick HIT

AlthoughTTPandHUSmaypresentsimilarly,renalfailureisamorecommonclinicalfeatureofHUS,while encephalopathyisacommonfeatureofTTP.

C.Diagnosis 1. Anemia 2. Thrombocytopenia 3. ElevatedLDH 4. Decreasedhaptoglobin 5. Elevatedindirectbilirubin 6. Peripheralbloodsmear—revealsschistocytes

D.Treatment

1. Plasmapheresis(largevolume)—beginassoonasdiagnosisisestablished,canbe stoppedonceplateletcountrecovers

2. Corticosteroids

Heparin-InducedThrombocytopenia

Complicationofexposuretoheparincausedbyautoantibodiestotheheparin-platelet factor4complex Rememberthe“4T’s”:thrombocytopenia(decreaseinplateletcounttypically >50%),timing(onsettypically5to10daysafterfirstheparinexposure),thrombosis (secondarytoplateletclumping),andlackofothercausesforthrombocytopenia Diagnosisisconfirmedwithantiplateletfactor4antibodytestingorserotonin releaseassay Treatedbydiscontinuingheparinandinitiatinganticoagulation(e.g.,thrombin inhibitorsuchaslepirudin,argatroban,anddabigatran) AvoidheparininthefutureinanypatientwhohasdevelopedanepisodeofHIT

MaincomplicationofHITisvenousthrombosis(e.g.,DVTorPE).

Bernard–SoulierSyndrome

Autosomalrecessivedisease Disorderofplateletadhesion(tosubendothelium)duetodeficiencyofplatelet glycoproteinGPIb-IX Onperipheralbloodsmear,plateletsareabnormallylarge Plateletcountitselfisonlymildlyreduced

Quick HIT

TheristocetinassaycanbeusedtotestforvWD.

GlanzmannThrombasthenia

Autosomalrecessivedisease DisorderofplateletaggregationduetodeficiencyinplateletglycoproteinGPIIb-IIIa Bleedingtimeisprolonged Plateletcountitselfisnormal
======================================
DisordersofCoagulation vonWillebrandDisease

A.GeneralCharacteristics 1. Mostcommoninheritedbleedingdisorder,affecting1to3%ofthepopulation 2. AutosomaldominantdisordercharacterizedbydeficiencyordefectoffactorVIII-

relatedantigen(vWF)(seealsoTable9-3)

3. vWFenhancesplateletaggregationandadhesion(thefirststepsinclotformation) andactsasacarrieroffactorVIIIinblood

4. Therearethreemajorsubtypeswithvaryingseverity: a. Type1(mostcommon)—decreasedlevelsofvWF b. Type2(lesscommon)—exhibitsqualitativeabnormalitiesofvWF c. Type3(leastcommon)—absentvWF(veryseveredisease)
======================================
Quick HIT

FactorVIIIhastwoportions:thecoagulantportion(factorVIIIcoagulantprotein)andanantigenicportion (factorVIIIantigenicprotein).ThelatterissynonymouswithvWF.

Quick HIT

OthercausesofimpairedplateletfunctionincludeuremiaandtheuseofNSAIDsoraspirin.

Quick HIT

e

e

Ingeneral,thebleedingseeninvWDismuchmilderthanthatofhemophilia—spontaneoushemarthrosesdo notoccur. Inmanypatients,diagnosisisnotmadeuntilprolongedbleedingisnotedaftersurgeryortrauma.

Quick HIT

First-linetreatmentforvWDisdesmopressin.Ifnoresponse,givefactorVIIIconcentrate.

Quick HIT

Suspecthemophiliaifunsuspectedhemorrhageoccursinamalepatientwithapositivefamilyhistory.

B.ClinicalFeatures 1. Cutaneousbleeding:easybruising 2. Mucosalbleeding:epistaxis,menorrhagia(affectsmorethan50%ofwomenwith

vonWillebrandDisease[vWD]),bleedingafterdentalextraction

3. GIbleedingispossible

C.Diagnosis 1. Prolongedbleedingtimewithnormalplateletcount 2. PTTmaybeprolonged—normalPTTdoesnotexcludethediagnosis 3. DecreasedplasmavWF 4. DecreasedfactorVIIIactivity 5. Reducedristocetin-inducedplateletaggregation

D.Treatment 1. DDAVP(desmopressin)—inducesreleaseofvWFfromendothelialcells

a. Treatmentofchoicefortype1vWD b. Lesseffectiveinpatientswithtype2vWD c. Ineffectiveinthosewithtype3vWD

2. FactorVIIIconcentrates(containinghigh–molecular-weightvWF)

a. ForallpatientswithvWD(anytype)aftermajortraumaorduringsurgery b. Recommendedfortype3vWD(andtype2patientsnotresponsivetoDDAVP)

3. Avoidaspirin/NSAIDsandintramuscularinjections—canexacerbatebleeding tendency

HemophiliaA

A.GeneralCharacteristics 1. X-linkedrecessivedisorderaffectingprimarilymales(approximately1in10,000

malepatients)

2. CausedbydeficiencyordefectoffactorVIIIcoagulantprotein 3. BleedingtendencyisrelatedtodegreeoffactorVIIIactivity(seeTable9-4)

B.ClinicalFeatures 1. Hemarthrosis(bleedingintojoints)—kneeisthemostcommonsite,butanyjoint canbeinvolved;progressivejointdestructioncanoccursecondarytorecurrent bleeding

2. Intracranialbleeding—commoncauseofdeath;anyheadtraumaispotentially life-threateningandrequiresurgentevaluation

3. Intramuscularhematomas 4. Retroperitonealhematomas 5. Hematuriaorhemospermia
======================================
TABLE9-4 ClassificationofSeverityofHemophilia

Classification

Amount(or Activity)of FactorVIII

ClinicalFeature

Subclinical

Subclinical

10%ofnormal factorVIII

Usuallyasymptomatic

MildfactorVIIIdeficiency

5–10%of normalfactor VIII

Bleedingafterinjuries/surgery

ModeratefactorVIIIdeficiency

1–5%ofnormal factorVIII

Rarespontaneousbleeding;severebleeding aftertraumaorsurgery

SeverefactorVIIIdeficiency—accountsfor about60%ofallcases;diagnosedininfancyor earlychildhood <1%ofnormal factorVIII Spontaneousbleedinginjoints(hemarthrosis) andsofttissues;severehemorrhageafter surgeryandtrauma

Quick HIT

DetectionofFactorVIIIInhibitor

¢

e

Ifnormalplasmaismixedwithplasmafromahemophiliapatient,PTTbecomesnormal. IfPTTfailstonormalize,thisisdiagnosticofthepresenceofafactorVIIIinhibitor.

C.Diagnosis 1. ProlongedPTT(seealsoTable9-4)

2. LowfactorVIIIcoagulantlevelwithnormallevelsofvWF

D.Treatment 1. FactorVIIIreplacement—maybeadministeredepisodically(e.g.,foracute bleedingepisodes,priortoplannedsurgery/dentalwork)orcontinuously (typicallyinpatientswith>2episodesofhemarthrosisorbleeding)

2. DDAVP—maybehelpfulinpatientswithmilddisease 3. Acutehemarthrosis

a. Analgesia—codeinewithorwithoutacetaminophen(avoidaspirinandNSAIDs) b. Immobilizationofthejoint c. Icepacks

Quick HIT

e

¢

e

e

PT:reflectsextrinsicpathway(prolongedbywarfarin) PTT:reflectsintrinsicpathway(prolongedbyheparin) Thrombintime:measureoffibrinogenconcentration Bleedingtime:reflectsplateletfunction

HemophiliaB

X-linkedrecessivedisorder MuchlesscommonthanhemophiliaA CausedbydeficiencyoffactorIX ClinicalfeaturesareidenticaltothoseofhemophiliaA TreatmentinvolvesadministrationoffactorIXconcentrates—DDAVPdoesnotplay aroleintreatment

DisseminatedIntravascularCoagulation

A.GeneralCharacteristics 1. Disseminatedintravascularcoagulation(DIC)ischaracterizedbyabnormal

activationofthecoagulationcascadeandformationofmicrothrombithroughout themicrocirculation,leadingtotheconsumptionofplatelets,fibrin,and coagulationfactors

2. Widespreadthrombicausefibrinolyticmechanismstobeactivated,which subsequentlyleadstohemorrhage(bleedingandthrombosisoccur simultaneously)

3. Mostcommonincriticallyillpatients,butcanoccurinhealthypatientsaswell 4. Causes

a. Infection(especiallygram-negativesepsis,althoughanyinfectioncancause DIC)—mostcommoncause

b. Obstetriccomplications(e.g.,amnioticfluidemboli,retaineddeadfetus, abruptioplacentae)—placentaanduterushaveincreasedtissuefactor

c. Majortissueinjury(e.g.,trauma,majorsurgery,burns,fractures) d. Malignancy(especiallylung,pancreas,prostate,GItract,acutepromyelocytic

leukemia[APL])
======================================
e. Shock/circulatorycollapse f. Snakevenom(rattlesnakes)

Quick HIT

e

¢

e

NormalPT=11to15seconds NormalPTT=25to40seconds Normalbleedingtime=2to7minutes

Quick HIT

Wheneveracoagulopathyispresent,includevitaminKdeficiencyandliverdiseaseinthedifferentialdiagnosis (inadditiontoDIC):

e

e

Liverdisease:PTandPTTareelevated,butTT,fibrinogen,andplateletsareusuallynormal VitaminKdeficiency:PTisprolonged,butPTT,TT,plateletcount,andfibrinogenlevelSarenormal

Quick HIT

ComplicationsofDIC

e

e

Hemorrhage—intracranialbleedingisacommoncauseofdeath Thromboembolism—stroke,PE,bowelinfarction,acuterenalfailure,arterialocclusion

Quick HIT

AllcriticallyillpatientsareatriskforDIC.

B.ClinicalFeatures 1. Bleeding—morecommoninacutecases

a. Superficialhemorrhage(e.g.,ecchymoses,petechiae,purpura) b. BleedingfromGItract,GUtract,gingival,ororalmucosa c. Oozingfromsitesofcatheters,proceduresorincisions

2. Thrombosis—morecommoninchroniccases 3. End-organinfarctionmayoccur,especiallyintheCNSandkidney

C.Diagnosis 1. Prolongedbleedingtime,PT,PTT,andTT—duetoconsumptionofcoagulation

factorsandplatelets(seeTable9-5)

2. ElevatedD-dimerandfibrinsplitproducts—duetoactivationoffibrinolytic system

3. Decreasedfibrinogenlevel—normal/elevatedfibrinogenessentiallyrulesoutthe diagnosis

4. Decreasedplateletcount 5. Peripheralbloodsmear—revealsschistocytesduetoshearingofRBCsby

microthrombiinthemicrocirculation

D.Treatment 1. Treattheunderlyingcause(e.g.,sepsis,malignancy) 2. Supportivemeasuresifseverehemorrhageispresent(onlytemporizing

measures):

a. Bloodtransfusionasnecessary b. Platelettransfusionforplateletcounts<50,000 c. Cryoprecipitate(replacesclottingfactorsandfibrinogen)orFFP(replaces

clottingfactors)forsignificantlyprolongedPT/PTTorsignificantlydecreased fibrinogen

d. Anticoagulationtopreventthrombosisiscontroversial—typicallyonlygivenin rarecasesinwhichthrombosisdominatestheclinicalpicture

e. OthersupportivemeasuresincludeoxygenandIVfluids
======================================
aNL,normal.

VitaminKDeficiency

Quick HIT

Thefat-solublevitaminsincludevitaminsA,D,E,andK.

Quick HIT

VitaminKdeficiencyismostcommonlyseenincriticallyillpatients(especiallythosewhoareNPOand/or receivingantibiotics).

A.GeneralCharacteristics 1. Severalclottingfactors(II,VII,IX,andX;proteinsCandS)dependonvitamin Kforsynthesisbytheliver,whereitservesasakeycofactorinposttranslational modification(γ-carboxylation)

2. VitaminKisobtainedthroughdietarysources(e.g.,leafygreenvegetables)and

synthesisbyintestinalbacterialflora 3. CausesofvitaminKdeficiencyinclude:

a. Broad-spectrumantibiotics—duetosuppressionofgutflora b. Inadequatedietaryintake c. Totalparenteralnutrition(TPN)—unlessvitaminKisadded d. Malabsorptionoffat-solublevitamins(e.g.,smallboweldisease,inflammatory

boweldisease,obstructivejaundice)

Quick HIT

FactorVIIhastheshortesthalf-life(3to5hours)ofallclottingfactors,soprolongedPTisthefirstlaboratory finding.

B.ClinicalFeatures 1. Petechiae 2. Purpura 3. Easybruising 4. Gingivalbleeding 5. Melena 6. Hematuria

C.Diagnosis 1. ProlongedPT—firstlaboratoryfindingduetotheshorthalf-lifeoffactorVII 2. ProlongedPTT—followsasothercoagulationfactorsdiminish

D.Treatment 1. VitaminKreplacement(oralorsubcutaneous)—maytakeseveraldaysforPTto

returntonormal

2. FFPifbleedingissevereandemergencytreatmentisnecessary

CoagulopathyofLiverDisease

Quick HIT

ProlongedPTisapoorprognosticindicatorincirrhosisbecausesynthesisofclottingfactorsisnotsignificantly impaireduntilliverdiseaseisadvanced.

Quick HIT

CoagulopathyofliverdiseasemaypresentsimilarlytoDICwithprolongedPT/PTTandlowfibrinogen. However,schistocyteswillbepresentonbloodsmearinDIC.

Quick HIT

PatientswithATIIIdeficiencydonotrespondtoheparin.HeparinrequiresthepresenceofATIII.

A.GeneralCharacteristics 1. Allclottingfactorsareproducedbytheliver(exceptvWF) 2. Theoverallprognosisforpatientswiththistypeofcoagulopathyisverypoor,

sinceliverdiseasemustbesevereforcoagulopathytodevelop

3. Causesofcoagulopathyinliverfailure: a. Decreasedsynthesisofclottingfactors b. DecreasedvitaminKabsorptionduetocholestasis c. Thrombocytopeniacausedbysplenicsequestrationofplatelets(theresultof

splenomegalyduetoportalhypertension)
======================================
B.ClinicalFeatures 1. Bleeding—GIbleedingismostcommonandisprimarilyduetovarices (secondarytoportalhypertension),butisexacerbatedbycoagulopathy

C.Diagnosis 1. ProlongedPTandPTT(especiallyPT) 2. Thrombocytopenia

D.Treatment 1. CryoprecipitateorFFPifbleedingispresent 2. VitaminKifcholestasisispresent 3. DVTprophylaxisifhospitalized—althoughINRiselevated,patientsareoften

pronetoclots(not“auto-anticoagulated”)

HypercoagulableStates

Quick HIT

PatientswithantiphospholipidantibodysyndromeusuallyhaveaprolongedPTTduringlaboratorytesting.This isbecausetheantibodyinterfereswiththetest,andisafalseprolongation.

A.GeneralCharacteristics 1. FactorVLeiden(activatedproteinCresistance)

a. Inheritedcauseofhypercoagulability(autosomaldominant) b. CausedbymutationinfactorVgene c. MostcommonhereditaryhypercoagulabilitydisorderamongCaucasians d. ProteinCunabletoinactivatemutatedfactorV,leadingtounregulated

prothrombinactivationandincreasedthrombosis

2. Antithrombin(AT)IIIdeficiency

a. Inheritedcauseofhypercoagulability(autosomaldominant) b. ATIIIinhibitsthrombin,soitsdeficiencyleadstoincreasedthrombosis

3. ProteinCdeficiency

a. Inheritedcauseofhypercoagulability(autosomaldominant) b. ProteinCinhibitsfactorsVandVIII,soitsdeficiencyleadstounregulated

fibrinsynthesisandthrombosis

4. ProteinSdeficiency

a. Inheritedcauseofhypercoagulability(autosomaldominant) b. ProteinSisacofactorofproteinC,soitsdeficiencyleadstodecreasedprotein

Cactivityandthrombosis

5. Antiphospholipidantibodysyndrome

a. Acquiredcauseofhypercoagulability b. Causedbyautoantibodiestophospholipid-bindingproteins,includinglupus

anticoagulant,anticardiolipin,andβ2-microglobulin

c. Canpresentwitharterialorvenousthrombosis,recurrentfetalloss,or thrombocytopenia

6. Prothrombingenemutation 7. Hyperhomocysteinemia

Quick HIT

Inmanycases,inheritedhypercoagulablediseasescausethromboticeventsonlywhenotherriskfactors(e.g., immobilization,pregnancy)arealsopresent.

Quick HIT

e

¢

Checkforanysecondaryhypercoagulablestatesorriskfactors(seeClinicalPearl9-4)inanypatientwitha DVT,PE,oranythromboticevent,especiallyifrecurrent. Itisveryimportanttoidentifythepatientwithaninheritedhypercoagulablestatebecauseprophylactic anticoagulationshouldbestartedandgeneticcounselingmaybeappropriate.
======================================
B.ClinicalFeatures 1. Recurrentvenousthromboembolisms(e.g.,DVTandPE)—hypercoagulable

disordersareusuallynotdiagnoseduntilthepatienthashadseveralepisodesof DVTorPE(seeClinicalPearl9-4)

2. Thrombosisinunusualsites(e.g.,mesentericveins,inferiorvenacava,renal veins,cerebralveins)

3. Firstthromboticeventbeforeage40 4. FamilyhistoryofDVT,PE,orrecurrentthromboticevents

C.Diagnosis 1. FunctionalassaysareavailableforAT,antiphospholipidantibodies,proteinC,

proteinS,factorVLeiden,prothrombingenemutation,and hyperhomocysteinemia

CLINICALPEARL9-4

SecondaryHypercoagulableStatesorRiskFactors

Malignancy(especiallypancreas,GI,lung,andovaries) Antiphospholipidantibodysyndrome Pregnancy—upto2monthspostpartum Immobilization Myeloproliferativedisorders Oralcontraceptives Postoperativestate(especiallyafterorthopedicprocedures) Trauma Nephroticsyndrome HITorDIC PNH Heartfailure

e

e

e

¢

e

¢

¢

e Trauma

¢

e

e PNH

e

D.Treatment 1. StandardtreatmentforDVTorPEasinpatientswithoutprimaryhypercoagulable

states

2. Permanentanticoagulationforpatientswithrecurrentthromboembolicevents

Anticoagulation

Heparin

A.MechanismofAction 1. PotentiatestheactionofATIIItoprimarilyinhibitclottingfactorsIIaandXa,

preventingconversionoffibrinogentofibrin

2. ProlongsPTT 3. Half-lifeofstandardheparinis1hour(half-lifeislongerforLMWHs—3to24

hours,dependingontheproduct)

Quick HIT

OptionsforDVTProphylaxisinHospitalizedPatients

e LMWH

LMWH Low-doseunfractionatedheparin Pneumaticcompressionboots

e

e

B.IndicationsforUse 1. Venousthromboembolism(e.g.,DVT,PE) 2. Atrialfibrillationinacutesetting 3. Acutecoronarysyndromes(e.g.,unstableangina,myocardialinfarction) 4. DVTprophylaxisinhospitalizedpatients

C.Administration 1. Therapeuticdosingusuallygivenintravenouslyasaninitialbolusfollowedby

continuousIVinfusion

2. Prophylacticdosingusuallygivensubcutaneously 3. MonitoredusingPTTorantifactorXalevels—therapeuticPTTisusually60to90

seconds,althoughthisvariesdependingontheclinicalsituation

D.AdverseEffects 1. Bleeding 2. HIT—skinnecrosismayoccurasaconsequence 3. Osteoporosis—withchronicuse,lowerincidencewithLMWHs 4. Transientalopecia 5. Reboundhypercoagulabilityafterdiscontinuation—duetodepressionofATIII
======================================
E.Contraindications 1. HistoryofHIT

2. Activebleeding(e.g.,GIbleeding,intracranialbleeding) 3. Severethrombocytopenia 4. UsewithcautioninsevereHTNorafterrecentsurgery(especiallyofeyes,spine,

brain)

Quick HIT

AdministerFFPifseverebleedingoccurs(forpatientsoneitherwarfarinorheparin).

F.ReversingtheEffectsofHeparinandLMWHs 1. Thehalf-lifeofstandardheparinisshort,soitseffectswillceasewithin4hoursof

discontinuation—LMWHhasalongerhalf-life

2. Protaminesulfatewillreversetheeffectsofheparin,ifnecessary

Low–Molecular-WeightHeparin

A.MechanismofAction 1. LMWHsprimarilyinhibitfactorXa(equivalentinhibitionoffactorXaas

standardheparin,butlessinhibitionoffactorIIa[thrombin])

2. CannotbemonitoredbyPTorPTTbecausetheydonotaffecteither 3. Examplesincludeenoxaparin,dalteparin,andtinzaparin

B.IndicationsforUse 1. Similartostandardheparin(e.g.,DVT/PE,ACS,DVTprophylaxis) 2. Usedwithincreasingfrequencyascomparedtostandardheparinduetogreater convenience(e.g.,subcutaneousadministration,lessfrequentmonitoring)and decreasedriskofsideeffects(e.g.,HIT,osteoporosis)

3. Moreexpensivethanstandardheparin,butoftenmorecost-effectiveinthelong runduetoreducedtesting,nursingtime,andlengthofhospitalstay

4. Preferredanticoagulantinpatientswithmalignancy

C.Contraindications 1. Similartostandardheparin(e.g.,historyofHIT,activebleeding,severe

thrombocytopenia)

2. Usewithcautioninpatientswithrenaldysfunction—LMWHexcretedvia kidneys

Warfarin

A.MechanismofAction 1. InhibitsactionofvitaminKepoxidereductase,anenzymerequiredforthehepatic synthesisofvitaminK-dependentcoagulationfactors,leadingtoadecreasein factorsII,VII,IX,X,andproteinsCandS

2. CausesprolongationofPT(andincreaseinINR) 3. Anticoagulanteffectbeginsafter4to5daysofuse,requiringtheuseofa

concurrentheparin“bridge”ifimmediateanticoagulationisrequired.Once warfarinistherapeutic(viaINRmonitoring),stopheparinandcontinuewarfarin alone.

B.IndicationsforUse 1. Thromboembolismprophylaxis(e.g.,DVT/PE,strokesecondarytoatrial

fibrillation)

2. Preferredanticoagulantforpatientswithmechanicalheartvalvesor antiphospholipidantibodysyndrome

C.Administration 1. Givenorally 2. Heparinmustbeinitiatedfirsttoavoidwarfarin-inducedskinnecrosis(seebelow) 3. OncePTTistherapeuticonheparinalone,initiatewarfarin 4. Continueheparinforatleast4daysafterstartingwarfarin 5. OnceINRistherapeuticonwarfarin,stoptheheparin 6. MonitoredviaINR—inmostcases,INRof2to3istherapeutic(patientswith

mechanicalheartvalveshavegoalINRof2.5to3.5)
======================================
D.AdverseEffects 1. Bleeding 2. Skinnecrosis—rarebutseriouscomplicationcausedbyrapiddecreaseinprotein

C(avitaminK–dependentinhibitoroffactorsVaandVIIIa)

E.Contraindications 1. Activebleeding 2. Pregnancy—warfarinisateratogen 3. Usewithcautioninalcoholicsoranypatientpronetofrequentfallsdueto

potentialforintracranialbleeding

F.ReversingtheEffectsofWarfarin 1. Discontinuewarfarin—takes5daystocorrectduetothelonghalf-lifeofwarfarin 2. AdministervitaminK—takes12to24hourstocorrectduetothetimerequired

forthelivertosynthesizenewclottingfactors

3. TransfuseFFP—maytakeupto8hourstocorrectduetothetimerequiredfor transfusion

4. Administerunactivatedprothrombin-complexconcentrates(PCC)—replaces vitaminK-dependentcoagulationfactorsandcorrectswithin10minutesof administration

Quick HIT

Ifrapidreversalofacutebleedingfromwarfarinisindicated,givevitaminK,FFP,andPCC.

DirectOralAnticoagulants(DOACs)orTarget-SpecificOral Anticoagulants(TSOACs)

A.Mayalsobereferredtoasnoveloralanticoagulants(NOACs)or B.DirectfactorXainhibitors(e.g.,Rivaroxaban,Apixaban,Edoxaban) 1. InhibitfactorXadirectly(asopposedtopotentiatingATIIIlikeheparin) 2. CurrentlyapprovedfortreatmentofDVT/PE,DVT/PEprophylaxis,andstroke

prophylaxisinpatientswithatrialfibrillation

C.Directthrombin(factorII)inhibitors(e.g.,Lepirudin,Argatroban,Dabigatran) 1. Inhibitthrombindirectly 2. CurrentlyapprovedfortreatmentofHIT

Oncology

Adetaileddescriptionofmanycancerscanbefoundintheappropriateanatomical chapterofthisbook(i.e.,lungcancersinpulmonarychapter,coloncancerinGI).

Epidemiology

Inorderofoccurrence,themostcommoncancersinmalesareprostate,lung,and colon.Thecancerwiththehighestmortalityinmalesislung,followedbyprostate andcolon. Inorderofoccurrence,themostcommoncancersinfemalesarebreast,lung,and colon.Thecancerwiththehighestmortalityinfemalesislung,followedbybreast andcolon. Thenumberoneavoidableriskfactorformostcancersissmoking.Allpatients shouldbeencouragedtostopsmoking. Otheretiologicagentsincancerincludeviruses(e.g.,hepatitisB/Cfor hepatocellularcarcinoma,HPVincervicalcancer),chemicals(e.g.,asbestos, ethanol,aflatoxin,cadmium,silica),andUVlight.
======================================
CancerPreventionandScreening

Breastcancer—mammogramevery2yearsbeginningatage40yearsforfemales Cervicalcancer—HPVvaccine(Gardasil)approvedformalesandfemalesages9to 26;papsmearsevery3yearsforfemalesages21to30(evenifnotsexuallyactive) andevery5yearswithHPVco-testingforfemalesages30to65 Colorectalcancer(CRC)—colonoscopyevery10yearsforaverageriskindividuals startingatage50;iffirst-degreerelativewithCRC,beginscreeningatage40or10 yearsbeforetheageofdiagnosisofrelative(whicheverisearlier) Prostatecancer—noconsensusthatscreeningwithprostate-specificantigen(PSA) testingdecreasesmortality Lungcancer—screenanypreviousorcurrentsmokerwithminimum30packyear historyages55to80usinglow-doseCTannually(NLSTtrialshowed20% reductioninmortalityinCTcohortvs.chestx-raycohort)

PrinciplesofCancerStagingandTherapy

Cancerisusuallytreatedusingthreemodalities:surgery,chemotherapy,and radiation Clinicalstagingisusuallyperformedbyclinicalexaminationandimaging techniques(PET,CT,MRIscans).TNMstagingismostcommonlyemployed:T (T1–T4)describesthesizeoftheprimarytumorandwhetherithasinvadedany nearbytissue,N(N1–N3)describesextentoftumorspreadtoregionallymphnodes, andM(M0orM1)indicatespresenceorabsenceofanydistantmetastaticdisease. Pathologicstagingisdefinedaftersurgicalresectionandcangivemoreprecise informationwithregardstolocalordistantspreadofthetumor

A.SurgicalOncology 1. Goalistoresectprimarytumorwithnegativemargins 2. Manytimesthesesurgeriesinvolveexcisionorsamplingoflocoregionallymph

nodes

3. Workcloselywithmedicalandradiationoncologiststodetermineoptimal treatmentplanbasedonaccurateclinicalstagingandevidence-basedmedicine

B.RadiationOncology 1. BasicsofRadiationTherapy

a. Therapyusingionizingradiationthatisgeneratedbyeithermegavoltagelinear accelerators,heavyions(e.g.,protons,neutrons,carbonions),orradioisotopes (e.g.,iodine-131forthyroidcancer)

b. Canbegivenviaanexternalbeam(EBRTorstereotacticradiosurgery),sealed sourcethatisimplantedinornearatumor(brachytherapy),orasaradiation sourceconjugatedtoantibodies(radioimmunotherapy)

2. MechanismofAction

a. PhotonsinteractwithbiologicmatteranddamageDNAeitherdirectlyor indirectly(throughgenerationofreactiveoxygenspecies)

b. DNAdouble-strandbreaksarethecriticaldeterminantofcellularresponseto radiationandeventualcelldeath

3. ClinicalRadiationOncology

a. Radiationisprimarilyusedinconjunctionwithsurgeryasadjuvanttherapyto preventlocaltumorrecurrence

b. Withtheadventofnewtechnologiesthatallowfordoseescalationwhilesparing normaltissues,radiationcanalsobeusedasdefinitivetherapy(e.g.,stereotactic radiosurgeryforinoperablebraintumorsandearlystagelungcancers)oras neoadjuvanttherapy(i.e.,toshrinktumorspriortosurgery)
======================================
C.MedicalOncology 1. Chemotherapy

a. Primarilyusedwhencancerhasspreadregionallyorsystemically b. Alsousedintheadjuvantsetting(topreventtumorrecurrence)andneoadjuvant

setting(todecreasesizeoftumorpriortoresection)

c. Chemotherapyisdefinitivetherapyformostleukemiasandcanbeusedto consolidatediseaseorinducearemission

2. Mechanismsofaction

a. Acomprehensivelistofchemotherapeuticagentsistoovasttobecoveredinthis section,butkeycategoriesincludeDNAalkylatingagents(e.g.,melphalan, cyclophosphamide,cisplatin,carboplatin),antimetabolites(e.g.,methotrexate, cytarabine,gemcitabine,fluorouracil),antimicrotubuleagents(e.g.,vincristine, paclitaxel,docetaxel),topoisomeraseinhibitors(e.g.,irinotecan,topotecan),and anthracyclines(e.g.,doxorubicin,daunorubicin,bleomycin)

b. Nextgenerationchemotherapeuticagents

e

e¢

Targetedtherapiesinterferewithspecificmutationsthatgiverisetocancer— examplesincludeimatinib(targetsthetyrosinekinasethatisaberrantly upregulatedinthemajorityofchronicmyelogenousleukemias),trastuzumab (blocksHer2/neureceptorinbreastcancerswithamplificationofthis oncogene),andcetuximab(epidermalgrowthfactorreceptorinhibitor) Immunotherapyagentstargetvariousimmunesystemcheckpoints—examples includenivolumab(inhibitsPD-1receptor)

Quick HIT

Oncologicemergencieswhichnecessitateimmediatetreatmentincludehypercalcemia(IVfluids,diuretics, bisphosphonates),spinalcordcompression(steroids,MRI,surgicalconsult),pericardialtamponade (pericardiocentesis),andtumorlysissyndrome(IVfluids,correctionofelectrolyteabnormalities).

BreastCancer

A.Riskfactorsincludepriorhistoryofbreastcancer,age,familyhistoryofbreast cancer,femalegender,priorthoracicradiation,smoking,alcoholconsumption,and anythingwhichincreasesthenumberofmenstrualcycles(earlymenarche,late menopause,nulliparity)

B.Breastcancerisrareinwomenunder35—thinkoffibroadenomaifayoung womanpresentswitharound,movablemasswhichchangesinsizeoverthe courseofthemenstrualcycle

C.Thedifferentialdiagnosisforabreastmassatanyageincludescysts(benignifnot bloodyafteraspirationanddoesnotrecur)andfibrocysticchanges(bilateralbreast paincausedbycyclichormonalstimulation)

D.Thepremalignantinsitubreastcancersareductalcarcinomainsitu(DCIS)and lobularcarcinomainsitu(LCIS)—distinguishedhistologically:

1.

DCIS represents a broad spectrum of disease which arises from the ductal

elementsofthebreast.Itisoftenfoundonscreeningmammogram,andamass mayormaynotbepresent.Asthisisamarkerforthepossibledevelopmentof invasiveductalcarcinoma(typicallyinthesamebreast),treatwithlumpectomy (ormastectomyifnegativemarginscannotbeachieved).Radiationandsystemic chemotherapyareusedlessoftendependingonthespecificlesioninquestion. 2. LCISarisesfromthelobularelementsofthebreast.Thelesionistypicallyfound incidentallyduringbiopsyofanotherbreastlesion,andamassisrarelypalpable. Itleadstoanincreasedriskofbreastcancerineitherbreast.Unfortunately, removalofthelesiondoesnotreducetheriskofprogressiontoinvasivecancer. Treatmentisvariable,butmayincludecloseobservation,selectiveestrogen receptormodulators,andprophylacticbilateralmastectomy.

E.Thetwomostcommontypesofbreastcancerareinvasiveductalcarcinoma, accountingforover70%ofinvasivecancers,andinvasivelobularcarcinoma 1. Patientsmaypresentwithapalpablemass,palpablelymphnodes,skindimpling,

nippleretraction,ornosymptomsatall(foundonmammogram)

2. Diagnosisshouldbeconfirmedwithtissuebiopsy,whichshouldincludetesting fortheestrogen/progesteronereceptorandHer-2/neuamplificationstatus

3. Treatmenttypicallybeginswithsurgerywithadjuvantradiotherapy(ifthetumor hasnotspreadtosentinellymphnodes)todecreasetumorrecurrence

4. Adjuvantchemotherapyisrequiredforlargelesionsinpremenopausalwomen, butistypicallynotnecessaryforallsmalllesions(typically<1cm)without lymphnodeinvolvement

5. Postmenopausalwomenwithlargelesionsorlymphnodeinvolvementmay receiveeitherchemotherapyorTamoxifen/Herceptin,dependingonthestatusof
======================================
theestrogenreceptor

PlasmaCellDisorders

MonoclonalGammopathyofUndeterminedSignificance

Commonintheelderly(upto10%inpatients>75yearsofage) Asymptomatic,premalignantclonalplasmacellproliferation Diagnosisisconfirmedbythepresenceofmonoclonalprotein(M-protein)spike <3.0gand<10%plasmacellsinbonemarrowwithoutevidenceofmultiple myeloma(i.e.,lyticbonelesions,anemia,hypercalcemia,orrenalinsufficiency) Fewerthan20%ofpatientsdevelopmultiplemyelomain10to15years,butalmost allpatientswithmultiplemyelomahaveaprecedingmonoclonalgammopathyof undeterminedsignificance(MGUS) Nospecifictreatmentisnecessary(justcloseobservation)

Quick HIT

ThesignsofmultiplemyelomacanberememberedusingthemnemonicCRAB:Calcium(hypercalcemia), Renalfailure,Anemia,andBonelesions(lytic)

Quick HIT

Diagnosticcriteriaformultiplemyelomaincludeatleast10%abnormalplasmacellsinbonemarrowplusoneof thefollowing:

¢

e

e

M-proteinintheserum M-proteinintheurine Lyticbonelesions(well-definedradiolucenciesonradiographs)

Quick HIT

AlmostallpatientswithmultiplemyelomahaveanM-proteinineithertheserumorurine.

MultipleMyeloma

A.GeneralCharacteristics 1. Multiplemyelomaischaracterizedbytheneoplasticproliferationofasingle

1. Multiple myeloma is characterized by the neoplastic proliferation of a single plasma cell line that produces monoclonal immunoglobulin, leading to enormous copies of one specific immunoglobulin (usually of the IgG or IgA type)

plasmacelllinethatproducesmonoclonalimmunoglobulin,leadingtoenormous copiesofonespecificimmunoglobulin(usuallyoftheIgGorIgAtype) 2. Incidenceisincreasedafterage50anditistwiceascommoninAfrican-

AmericanpatientsasinCaucasianpatients

3. Theetiologyisunclear 4. Asthediseaseprocessadvances,bonemarrowelementsarereplacedby

malignantplasmacells,resultinginanemia,leukopenia,andthrombocytopenia

B.ClinicalFeatures 1. Lyticbonelesions—resultinsignificantbonepain(especiallyinthelowback,

chest,andjaw),pathologicfractures,andlossofheightsecondarytocollapseof vertebrae

2. Anemia—presentinmostpatientsduetobonemarrowinfiltrationandrenal failure

3. Renalfailure—duetomyelomanephrosis(immunoglobulinprecipitationinrenal tubules)andhypercalcemia

4. Recurrentinfections(especiallyofthelungorurinarytract)—mostcommon causeofdeath,duetolackofnormalimmunoglobulins

5. Cordcompression—mayoccursecondarytoaplasmacytomaorfracturedbone fragment
======================================
C.Diagnosis 1. Serumandurineproteinelectrophoresis(SPEP/UPEP)—revealsmonoclonal

proteinspike(M-spike)duetoamalignantcloneofplasmacellssynthesizinga singleIg(usuallyIgG,althoughspecificsubtypecanbedeterminedvia immunofixation)

2. Low-doseCT,PET/CT,orMRI—reveallyticbonelesions 3. Bonemarrowbiopsy(requiredfordiagnosis)—reveals>10%abnormalplasma

cells

4. Hypercalcemia—duetobonedestruction 5. Elevatedserumtotalprotein—duetoparaproteinsinblood(hyperglobulinemia) 6. Elevatedcreatinine—duetorenaldamage 7. Anemia,leukopenia,orthrombocytopenia(especiallyinadvanceddisease)—due

tobonemarrowinvasion

8. Peripheralbloodsmear—revealsnormocyticanemiawithRBCsinrouleaux formation(RBCsresembleastackofpokerchipsasaresultofclumpingcaused

byhyperglobulinemia)(Figure9-10)

9. Urinalysis—revealslargeamountsoffreelightchainscalledBenceJonesprotein

FIGURE 9.10

Rouleauxformation(multiplemyeloma).

(FromAndersonSC.Anderson’sAtlasofHematology.Philadelphia,PA:LippincottWilliams&

Wilkins;2003.)

D.Treatment 1. IncontrasttothepremalignantconditionsMGUSandsmolderingmultiple myeloma,patientswithMMandend-organdamagerequiretreatment

2. Thepreferredtreatmentishigh-dosechemotherapywithautologous hematopoieticcelltransplantation(HCT)

3. Bisphosphonatesforpatientswithoneormoreskeletallesions

Quick HIT

e

¢

Radiographsshowpunched-outlyticlesions,osteoporosis,orfracturesin75%ofpatientswithmultiple myeloma Osteolyticlesionsaresecondarytothereleaseofosteoclast-activatingfactorbytheneoplasticplasmacells

Quick HIT

Multiplemyelomahasapoorprognosiswithamediansurvivalof2to4yearswithtreatment(andonlyafew monthswithouttreatment).The5-yearsurvivalrateisabout10%.

Quick HIT

Hyperviscositysyndromecanleadtoretinalvesseldilationwithresultinghemorrhageandpossibleblindness.

Quick HIT

Lymphomasarecancersofthelymphaticsystem Therearetwotypes:Hodgkindiseaseandnon-Hodgkindisease(NHL) Lymphadenopathyisusuallythefirstfindinginlymphomas

WaldenströmMacroglobulinemia

MalignantproliferationofplasmacytoidlymphocytesthatproduceIgMparaprotein, averylargeproteinthatcauseshyperviscosityoftheblood DiagnosisisconfirmedbythepresenceofanIgMmonoclonalgammopathyand >10%plasmacytoidlymphocytesonbonemarrowbiopsy Clinicalfeaturesincludefatigue,weightloss,neurologicsymptoms, lymphadenopathy,splenomegaly,anemia,abnormalbleeding,BenceJones proteinuria,andhyperviscositysyndrome(duetoelevatedIgM) Thereisnodefinitivecure—usechemotherapyandplasmapheresisfor hyperviscositysyndromes
======================================
Lymphomas HodgkinLymphoma

A.GeneralCharacteristics 1. Bimodalagedistribution:X1=15to30yearsofage;X2=>50yearsofage 2. Lymphnodehistologydividesthediseaseintofoursubtypes:

a. Lymphocytepredominance(5%)—fewReed–SternbergcellsandmanyBcells b. Nodularsclerosis(70%)—occursmorefrequentlyinwomen;bandsofcollagen

envelopepoolsofReed–Sternbergcells

c. Mixedcellularity(25%)—largenumbersofReed–Sternbergcellsina pleomorphicbackground

d. Lymphocytedepletion(<1%)—lackinginmixofreactivecells;associatedwith theworstprognosis

3. Stagingisbasedonphysicalexamination,CTscan(chest,abdomen,pelvis),and bonemarrowbiopsy.AnnArborstagingsystem:

a. Stages

e

e

e

e

StageI:confinedtosinglelymphnode(oroneextralymphaticsite) StageII:involvementoftwoormorelymphnodesbutconfinedtosameside ofdiaphragm StageIII:bothsidesofdiaphragminvolved StageIV:disseminationofdiseasetoextralymphaticsites

b. Suffixes

e

e

A:Nosymptoms B:Fever,weightloss,nightsweats—presenceoftheseconstitutional symptomsworsenstheprognosis

Quick HIT

ThehistologicsubtypedoesnotgreatlyinfluencetheprognosisofHodgkindisease(withtheexceptionofthe lymphocyte-depletedtype,whichhastheworstprognosis).Treatmentiseffectiveinmostpatientswiththeother histologictypesofHodgkindisease.

Quick HIT

Chemotherapyandradiationtherapyincombinationachievecureratesofover70%inHodgkindisease.

Quick HIT

KeyEpidemiologicAssociationsWithNHL BurkittlymphomainregionsofAfrica PatientswithHIVandHIV-associatedlymphomas AdultT-celllymphomainJapanandtheCaribbean

Quick HIT

ItisbeyondthescopeofthischaptertogiveadetailedaccountofeachspecifictypeofNHL.Focusonthe generalclinicalpresentationsaswellascertaincommonlytestedpathologicfeatures(seehighlightedpointsin Table9-6).

B.ClinicalFeatures 1. Painlesslymphadenopathy—mostcommonsymptom

a. Mayinvolvesupraclavicular,cervical,axillary,ormediastinallymphnodes b. Spreadsbycontinuityfromonelymphnodetoadjacentnodes

2. Bsymptoms(e.g.,fever,nightsweats,weightloss) 3. Pruritis 4. Cough—secondarytomediastinallymphnodeinvolvement
======================================
C.Diagnosis 1. Lymphnodebiopsy

a. RevealsReed–Sternbergcells—requiredtomakethediagnosis(Figure9-11) Large,neoplasticcellwithtwoormorenuclei—resembleowl’seyes UsuallyB-cellphenotype Maybefoundinotherneoplasms

b. Revealsinflammatorycellinfiltrates—distinguishesHodgkinlymphomafrom NHL

e

e

TheinflammatorycellspresentarereactivetotheReed–Sternbergcells Theseincludeplasmacells,eosinophils,fibroblasts,andTandBlymphocytes

2. CXRandCTscan(chest,abdomen)—mayreveallymphnodeinvolvement 3. Bonemarrowbiopsy—mayrevealbonemarrowinvolvement 4. Leukocytosiswitheosinophilia

FIGURE 9.11

Reed–Sternbergcells(Hodgkinlymphoma).

(FromAndersonSC.Anderson’sAtlasofHematology.Philadelphia,PA:LippincottWilliams&

Wilkins;2003.)

Quick HIT

Rituximab,amonoclonalantibodyagainstCD20antigen,isoftenusedincombinationwithCHOPtherapyto treatNHLandothercancerswithbetteroutcomesthanCHOPalone.

Quick HIT

StagingNHL

StageI:singlelymphnodeinvolved(oroneextralymphaticsite) StageII:twoormorelymphnodesonthesamesideofthediaphragm StageIII:lymphnodeinvolvementonbothsidesofthediaphragm StageIV:disseminatedinvolvementofoneormoreextralymphaticorganswithorwithoutlymphnode involvement

D.Treatment 1. Consistsmainlyofchemotherapyandradiationtherapytotheinvolvedfield

2. StagesIandIIareusuallytreatedwithacombinationofchemotherapyand radiation,althoughchemotherapyalonemaybeacceptableforsomepatients 3. StagesIIIBandIVrequirechemotherapy

Non-HodgkinLymphoma

A.GeneralCharacteristics 1. NHLisadiversegroupofsolidtumorswhichoccurswiththemalignant

transformationandgrowthofBorTlymphocytes(ortheirprecursors)inthe lymphaticsystem

a. Thetypeoflymphocyteinvolvedanditslevelofdifferentiationdeterminethe courseofthediseaseanditsprognosis

b. B-celllymphomasaccountfor85%ofallcases,whileT-celllymphomas accountfor15%ofallcases

c. Thediseaseusuallystartsinlymphnodesandmayspreadtobloodandbone marrow

2. NHListhesixthmostcommoncauseofcancer-relateddeathintheUnitedStates 3. NHListwiceascommonasHodgkindisease,andpatientswithNHLtendtohave

3. NHL is twice as common as Hodgkin disease, and patients with NHL tend to have more advanced disease at presentation than patients with Hodgkin disease
======================================
moreadvanceddiseaseatpresentationthanpatientswithHodgkindisease 4. Themeanageofonsetvarieswithsubtype,butthereisanincreasedoverall

incidencewithincreasingage

5. Riskfactors a. HIV/AIDS b. Immunosuppression(e.g.,organtransplantrecipients) c. Historyofcertainviralinfections(e.g.,EBV,HTLV-1) d. HistoryofHelicobacterpylorigastritis(riskofprimaryassociatedgastric

lymphoma)

e. Autoimmunedisease(e.g.,HashimotothyroiditisorSjögrensyndrome[riskof mucosa-associatedlymphoidtissue])

6. Classification

a. Therearemorethan20differentsubtypesofNHL,arrangedintoseveralunique classificationsystems

b. Onesuchclassificationsystemstratifiessubtypesaccordingtohistologicgrade: lowgrade(orindolent),intermediategrade,andhighgrade(seeTable9-6)

Quick HIT

e

e

e

Low-gradelymphomas:Cureisrare.Mediansurvivalis5to7years. Intermediate-gradelymphomas:Fiftypercentofpatientscanbecuredwithaggressivetherapy.Median survivalisabout2years. High-gradelymphomas:Upto70%canbecuredwithaggressivetherapy.Mediansurvivalwithouttreatment isafewmonths.

B.ClinicalFeatures

1. Painlesslymphadenopathy—sometimestheonlymanifestationofdisease

a. Lymphnodesareusuallyfirmandmobile b. Mostofteninvolvessupraclavicular,cervical,andaxillarynodes

2. Bsymptoms—lesscommonthaninHodgkinlymphoma 3. Hepatosplenomegaly 4. Anemia,leukopenia,orthrombocytopenia—duetobonemarrowinvolvement

C.Diagnosis 1. Lymphnodebiopsy—anylymphnode>1cmpresentformorethan4weeksthat

cannotbeattributedtoinfectionshouldbebiopsied

2. CXRandCTscan(chest,abdomen,pelvis)—mayreveallymphnodeinvolvement 3. Bonemarrowbiopsy—mayrevealbonemarrowinvolvement 4. Elevatedalkalinephosphataseifboneorliverinvolvement 5. Elevatedliverfunctiontestsorbilirubinifliverinvolvement 6. Anemia,leukopenia,orthrombocytopeniaifbonemarrowinvolvement

TABLE9-6 Non-HodgkinLymphomas
======================================
aNotalltypesforeachgradeareincludedinthistable.

Quick  HIT  CHOPtherapyconsistsof: Cyclophosphamide Hydroxydaunomycin(doxorubicin) Oncovin(vincristine) Prednisone 

D.Treatment 1. VariesdependingonthestageandsubtypeofNHL 2. IndolentformsofNHLarerarelycurable,buthavea5-yearsurvivalrateof75%.

Thesepatientsaretreatedinavarietyofways,includingobservation, chemotherapy,andradiationtherapy.

3. Intermediateandhigh-gradeNHLsmaybecurablewithaggressivetreatments, butifcompleteremissionisnotachieved,survivalisusuallylessthan2years.In general,aggressiveformsaretreatedwithmultipleregimensofcombination chemotherapy(e.g.,CHOP)andradiationtherapy.

4. Somepatientsmaybenefitfromhigh-dosechemotherapywithbonemarrow transplantation.

Leukemias AcuteLeukemias

eee

Quick HIT

Acuteleukemiasaccountfor60%ofallleukemias,25%areCLLand15%areCML.

Quick HIT

GeneralEvaluationinPatientsWithLeukemias(acuteorchronic)

e

Evidenceofinfection Evidenceofbleedingoreasybruising Lymphadenopathy,hepatosplenomegaly Signsofanemia Fatigue,weightloss

Quick HIT

Fortestingpurposes,theageofapatientcanbeasimpleyetimportantaidtoconfirmingthecorrectleukemia diagnosis.Patientslessthan15mostlikelyhaveALL,whilethosegreaterthan65typicallyhaveCLL.AMLand CMLbothtypicallypresentfromage40to60.

A.GeneralCharacteristics 1. Twotypes

a. Acutemyelogenousleukemia(AML)

e

e

e

e

e

¢

Neoplasmofmyelogenousprogenitorcells AMLoccursmostlyinadults(accountsfor80%ofadultacuteleukemias) Riskfactorsincludeexposuretoradiation,myeloproliferativesyndromes, Downsyndrome,andpriorchemotherapy(e.g.,alkylatingagents) Responsetotherapyisnotasfavorableasinacutelymphoblasticleukemia Poorprognosticindicatorsincludeolderage,presenceofothermedical comorbidities,andhistoryofexposuretocytotoxicagentsand/orradiation therapy OneimportantvariantofAMLisacutepromyelocyticleukemia(APL).This conditionischaracterizedbyt(15;17)andoftenpresentswithpancytopenia. Patientsmaybeverysick,sotreatmentshouldbestartedwithall-transretinoic acid(ATRA)withoutdelayalongwithconcurrentchemotherapyoncethe diagnosisisconfirmed(seeClinicalPearl9-5).

b. Acutelymphoblasticleukemia(ALL)
======================================
e

e

e

e

e

Neoplasmofearlylymphocyticprogenitorcells—histologyrevealsa predominanceoflymphoblasts ALListhemostcommonmalignancyinchildrenunderage15intheUnited States Itistheleukemiamostresponsivetotherapy Poorprognosticindicatorsincludeage<2or>9,WBC>105/mm3,and/orCNS involvement PresenceofanyofthefollowingisassociatedwithanincreasedriskforCNS involvement:B-cellphenotype,increasedLDH,rapidleukemiccell proliferation

2. Manypatientswithacuteleukemiascanbecurediftreatedaggressively.Ifleft untreated,themostaggressiveacuteleukemiascanbefatalwithinmonths.

B.ClinicalFeatures 1. Anemiaanditsassociatedsigns/symptoms(e.g.,dyspnea,pallor) 2. Increasedriskofbacterialinfections—duetoneutropenia

a. Pneumonia,urinarytractinfection,cellulitis,pharyngitis,esophagitis b. Associatedwithhighmorbidityandmortality(potentiallylife-threatening) 3. Thrombocytopeniaandassociatedsigns/symptoms(e.g.,epistaxis,bleedingat

3. Thrombocytopenia and associated signs/symptoms (e.g., epistaxis, bleeding at puncture sites, petechiae/purpura, ecchymoses)

puncturesites,petechiae/purpura,ecchymoses) 4. Splenomegaly,hepatomegaly,lymphadenopathy 5. Boneandjointpain—duetoinvasionofperiosteum 6. Diffuseorfocalneurologicdysfunction(e.g.,meningitis,seizures)—duetoCNS

involvement

7. Testicularinvolvement(ALL) 8. Anteriormediastinalmass(T-cellALL) 9. Skinnodules(AML)

CLINICALPEARL9-5

Leukemias

e

e

LeukemiasarecharacterizedbyneoplasticproliferationofabnormalWBCs.AstheseabnormalWBCs accumulate,theyinterferewiththeproductionofnormalWBCs,aswellastheproductionoferythrocytes andplatelets,resultinginanemiaandthrombocytopenia. Leukemiasareclassifiedintwoways:

BythetypeofWBCaffected

e

e

Ifgranulocytesormonocytesareaffected,myelogenousleukemiaispresent Iflymphocytesareaffected,lymphocyticleukemiaispresent

e

Bythematurityofcellsaffectedandtherapidityofdiseaseprogression

Acuteleukemiasarecharacterizedbyrapidprogressionandaffectimmaturecells(i.e.,immaturecells

¢

proliferatebeforematuration) Chronicleukemiasprogressslowlyandaffectmaturecells
======================================
Quick HIT

Auerrods(granulesandeosinophilicrodsinsidemalignantcells)arepresentinAMLbutnotALL.

Quick HIT

TumorLysisSyndrome

Thisisapotentialcomplicationofchemotherapyseeninacuteleukemia,high-gradeNHL,andsolidcancers withveryhightumorburden Rapidcelldeathwithreleaseofintracellularcontentscauseshyperkalemia,hyperphosphatemia,and hyperuricemia Treatasamedicalemergency

C.Diagnosis 1. Leukopeniaorleukocytosis—WBCcountisvariable(from1,000/mm3to

100,000/mm3),butalwaysaccompaniedbysignificantnumbersofblastcells (immaturecells)inperipheralblood

2. Anemia 3. Thrombocytopenia 4. Electrolytedisturbances(e.g.,hyperuricemia,hyperkalemia,hyperphosphatemia) 5. Bonemarrowbiopsy(requiredfordiagnosis)

a. InALL,revealsproliferationofblastsofthelymphoidlineage(>20%) b. InAML,revealsproliferationofblastsofthemyeloidlineage(>20%)andAuer

rods,especiallyifitistheAPLphenotype(Figure9-12)

D.Treatment 1. Treatmentofemergencies

a. Antibioticsasnecessaryforinfection b. Bloodtransfusionasnecessaryforanemia c. Platelettransfusionasnecessaryforbleeding

2. Aggressive,combinationchemotherapyinhighdosesforseveralweeksis appropriatetoobtainremission(i.e.,absentleukemiccellsinbonemarrow).Once remissionoccurs,maintenancetherapyisusedformonthsoryearstoprevent recurrence.

a. ALL:Morethan75%ofchildrenwithALLachievecompleteremission (comparedwith30%to40%ofadults).Relapses,whentheyoccur,usually respondtotreatment.Withaggressivetherapy,survivalratesinchildrencanbe upto15yearsorlonger.Upto50%ofpatientsarecured.

b. AML:Thisismoredifficulttotreatanddoesnotrespondaswellto chemotherapy.Survivalratesareconsiderablylowerdespiteintensivetreatment. Bonemarrowtransplantationgivesthebestchanceofremissionorcure.

3. Bonemarrowtransplantation

ChronicLymphocyticLeukemia

A.GeneralCharacteristics 1. CLListhemostcommonleukemiaintheWesternworld,andthemostcommon leukemiathatoccursafterage50.MostpatientswithCLLare>60yearsofage. 2. Causedbythemonoclonalproliferationoflymphocytesthataremorphologically maturebutfunctionallydefective(i.e.,theydonotdifferentiateintoantibody- manufacturingplasmacells)

3. Ingeneral,thisistheleastaggressivetypeofleukemia,andCLLpatientssurvive longerthanthosewithacuteleukemiasorchronicmyeloidleukemia(CML).The naturalhistoryisvariable,butmayfollowaprolongedindolentcourse.Many patientsdieofothercauses.

4. ThemostrecentWHOclassificationdescribesCLLasidenticaltotheindolent NHLB-cellneoplasmsmalllymphocyticleukemia(SLL).Thatis,theyare consideredthesamediseaseatdifferentstages.
======================================
FIGURE 9.12

Auerrods(acutemyelogenousleukemia). (FromHandinRI,LuxSE,StosselTP.Blood:PrinciplesandPracticeofHematology.

Philadelphia,PA:LippincottWilliams&Wilkins;2003.ReprintedwithpermissionfromDr. RobertHandin.)

Quick HIT

AIHAscanbeseeninpatientswithCML.

Quick HIT

Rememberthatthecellsofthemyeloidlineageincludeerythrocytes,granulocytes,andplatelets.

Quick HIT

DifferentiatingBenignLeukemoidReactionFromCMLLeukemoidReaction

e

e

e

Usuallynosplenomegaly Increasedleukocytealkalinephosphatase Historyofaprecipitatingevent(e.g.,infection)

B.ClinicalFeatures 1. Usuallyasymptomaticattimeofdiagnosis—maybediscoveredsecondaryto

abnormalitiesonroutinelabs

2. Painlesslymphadenopathy(usuallycervical) 3. Hepatosplenomegaly 4. Frequentrespiratoryorskininfections—duetoimmunedeficiency 5. Inmoreadvanceddisease:fatigue,weightloss,pallor,skinrashes,easybruising,

bonetenderness,and/orabdominalpain

C.Diagnosis 1. Leukocytosis—WBCtypically50,000to200,000 2. Anemia 3. Thrombocytopenia 4. Neutropenia 5. Peripheralbloodsmear

a. Revealsabsolutelymphocytosis—almostentirelymature,smalllymphocytes b. Revealssmudgecells—“fragile”leukemiccellsthatrupturewhenplacedon

glassslide

6. Flowcytometry—revealsclonalpopulationofBcells 7. Bonemarrowbiopsy—revealspresenceofinfiltratingleukemiccellsinbone

marrow

D.Treatment 1. Patientswithasymptomaticdiseasearetypicallyobserved 2. RegimensforsymptomaticCLLvarywiththeageofthepatient:youngerpatients oftenreceiveacombinationoffludarabineandrituximab,whileolderpatients typicallyreceiveibrutinib(aninhibitorofBrutontyrosinekinase)

3. Prognosisisvariabledependingonthenumberoflymphoidtissuesinvolvedand thepresenceorabsenceofanemia/thrombocytopenia

ChronicMyeloidLeukemia

A.GeneralCharacteristics 1. Neoplastic,clonalproliferationofmyeloidstemcells 2. Patientsareusually>40yearsofage 3. CMLfollowsanindolent(chronic)courseformanyyearsbeforeittransformsto acuteleukemia.Theend-stageofthediseasecourseisusuallyanacutephase (alsoknownasablastcrisis),whichisanacceleratedphaseofblastand promyelocyteproduction.

BCRgeneonchromosome22withtheABL1geneonchromosome9isknownas thePhiladelphiachromosome.Theabnormalchromosomeresultsina constitutivelyactivetyrosinekinaseprotein,whichistargetedbyimatinib.Note thatpatientswithoutthePhiladelphiachromosomehaveshortersurvivaltimes andrespondmorepoorlytotreatment.
======================================
Quick HIT

TreatCMLwithTKIs(e.g.,imatinib,dasatinib,ornilotinib).

B.ClinicalFeatures 1. Mostpatients(85%)presentinthechronicphaseandmaybeasymptomaticatthe

timeofdiagnosis—diseasediscoveredonroutinelabs

2. Constitutionalsymptoms(e.g.,fevers,nightsweats,anorexia,weightloss) 3. Recurrentinfections 4. Anemiaanditsassociatedsigns/symptoms 5. Thrombocytopeniaanditsassociatedsigns/symptoms 6. Hepatosplenomegaly 7. Lymphadenopathy 8. Patientsmayalsopresentinmoreadvancedstages(i.e.,theacceleratedphaseor

blastcrisis)

Quick HIT

ImatinibiscurrentstandardofcareforCML.

C.Diagnosis 1. Leukocytosiswitheosinophilia—WBCsfrom50,000to200,000 2. Thrombocytosis 3. Peripheralbloodsmear—revealsincreasednumbersofimmaturegranulocytes,

anemia,thrombocytosis,andbasophilia

4. Bonemarrowbiopsy—increasednumbersofimmaturegranulocytes

D.Treatment 1. TreatmentforCMLisoneofthegreatstoriesofmodernmedicine.Afterthe mechanismofdiseasewaselucidated,theoraltyrosinekinaseinhibitor(TKI) imatinibwasdeveloped.Thisdrugtargetsthedysfunctionalchimericprotein BCR-ABLformedbythet(9,22)Philadelphiachromosome.Second-generation TKIsarenowavailable.

2. Unfortunately,patientswhopresentinablastcrisisstillhaveverypooroutcomes. TheTKIscanstillbeattemptedinthesepatients.Stemcelltransplantationisalso anoption.

MyeloproliferativeDisorders PolycythemiaVera

Quick HIT

Anoften-testedpresentationforPVisapatientwhocomplainsofseverepruritusafterahotbathorshower.

A.GeneralCharacteristics 1. Malignantclonalproliferationofhematopoieticstemcellsleadingtoexcessive

erythrocyteproduction

2. TheincreaseinRBCmassoccursindependentoferythropoietin 3. Themediansurvivalwithtreatmentisabout9to14years 4. MutationsintheJAK2tyrosinekinasearefoundin>90%ofcases

B.ClinicalFeatures 1. Signs/symptomsofhyperviscosity:headache,dizziness,weakness,transient

visualdisturbances,dyspnea

2. Thromboticphenomena(e.g.,DVT,PE,CVA,MI,portalveinthrombosis) 3. Aquagenicpruritis 4. Facialplethora 5. Hepatosplenomegaly 6. HTN

Quick HIT

DiagnosticCriteriaforPolycythemiaVera Musthaveallthreemajorcriteriaorthefirsttwomajorcriteriaplusanytwominorcriteria:
======================================
MajorCriteria

e

¢

e

ElevatedHb(men>16.5g/dL;women>16.0g/dL) Bonemarrowbiopsywithtrilineagehypercellularity(erythroid,granulocytic,andmegakaryocytic proliferation) JAK2V617ForJAK2exon12mutation

MinorCriteria

Serumerythropoietinlevelbelownormal

C.Diagnosis 1. Ruleoutcausesofsecondarypolycythemia(e.g.,hypoxemia,carbonmonoxide

exposure)

2. ElevatedRBCcount,hemoglobin,hematocrit(usually>50%) 3. Thrombocytosis 4. Leukocytosis 5. Decreasedserumerythropoietinlevels 6. ElevatedvitaminB12level 7. Hyperuricemia 8. Bonemarrowbiopsy—revealshypercellularitywithincreasedproliferationof

erythrocyte,granulocyte,andmegakaryocyteprecursors

D.Treatment 1. Repeatedphlebotomy—mainstayoftherapytolowerhematocrit 2. Aspirin 3. Hydroxyureaforpatientswithhistoryofthrombosis

MyelodysplasticSyndromes

Quick HIT

Hyperviscosityandelevatedtotalbloodvolumeinpolycythemiaveraaccountformostoftheclinicalfindings.

A.GeneralCharacteristics 1. Myelodysplasticsyndromesareaclassofacquiredmalignanthematopoieticstem

celldisorderscharacterizedbyineffectivehematopoiesis

2. Theresultispancytopenia,despiteanormalorhypercellularbonemarrow 3. Theyoccurmorecommonlyinelderlypatientsandareslightlymorecommonin

men

4. Theyareusuallyidiopathic,althoughexposuretoradiation,immunosuppressive agents,andcertaintoxinsareknownriskfactors

5. Theyareclassifiedintosubtypesaccordingtofindingsonbonemarrowbiopsy andperipheralbloodsmear

6. Theprognosis,althoughvariable,isgenerallypoor,andtheendresultisoften progressiontoacuteleukemia

Quick HIT

Thromboticandhemorrhagiccomplicationsinpolycythemiaveracanbelife-threatening.

B.ClinicalFeatures 1. Oftenasymptomaticintheearlystages—pancytopeniamaybeanincidental

findingonroutinelabs

2. Anemia 3. Thrombocytopenia 4. Neutropenia

Quick HIT

Clinicalfeaturesinmyelodysplasticsyndromesareduetobonemarrowfailureandmimicthoseofaplastic anemia.

C.Diagnosis 1. Anemiawithdecreasedreticulocytecount 2. Thrombocytopenia 3. Neutropenia 4. Peripheralbloodsmear—revealsnormocyticanemiawithHowell–Jollybodies,

basophilicstipplingofRBCs,agranularplatelets,orotherevidenceofdysplasia

5. Bonemarrowbiopsy—typicallyrevealsdysplasticmarrowcellswithblastsor ringedsideroblasts

6. Cytogeneticstudiesoftenrevealchromosomalabnormalitiesormutated oncogenes

D.Treatment 1. Supportivetreatment—mainstayoftreatment a. RBCandplatelettransfusionsasnecessary b. Erythropoietin—mayhelptoreducethenumberofbloodtransfusionsnecessary c. Granulocytecolony-stimulatingfactor—canbeaneffectiveadjunctivetreatment

forneutropenicpatients

d. Vitaminsupplementation(particularlywithvitaminsB6,B12,andfolate)— importantgiventheincreasedturnoverofmarrowcells

2. Chemotherapyandimmunosuppressiveagents—mayimprovesurvivalinsome patients

3. Bonemarrowtransplantation

EssentialThrombocythemia Definedasplateletcount>600,000/mm3 Itisadiseasewithhighmorbiditybutlowmortality Adiagnosisofexclusion—reactivethrombocytosis(duetoinfection,inflammation, bleeding)andothermyeloproliferativedisordersmustbeexcluded Itisprimarilymanifestedbythrombosis(e.g.,CVA),orparadoxicallyandless frequently,bleeding(duetodefectiveplateletfunction) Otherfindingsmayincludesplenomegaly,pseudohyperkalemia,elevatedbleeding time,anderythromelalgia(burningpainanderythemaoftheextremitiesdueto microvascularocclusions) Peripheralbloodsmearshowshypogranular,abnormallyshapedplatelets Bonemarrowbiopsyshowsanincreasednumberofmegakaryocytes JAK2tyrosinekinasemutationseenin40%to50%ofcases Treatmentusuallyinvolvesantiplateletagentssuchasanagrelideandlow-dose aspirin.Hydroxyureaissometimesusedforseverethrombocytosis.
======================================
10 InfectiousDiseases EmilyLiang

InfectionsoftheUpperandLowerRespiratory

Tracts

Pneumonia

Quick HIT

e

e

“Classic”CAPpresentswithasuddenchillfollowedbyfever,pleuriticpain,andproductivecough. The“atypicalpneumonia”syndrome,associatedwithMycoplasmaorChlamydiainfection,oftenbeginswith asorethroatandheadachefollowedbyanonproductivecoughanddyspnea.

A.GeneralCharacteristics 1. Therearetwotypesofpneumonia:community-acquiredandnosocomial

a. Community-acquiredpneumonia(CAP)

e

e

¢

Occursinthecommunityorwithinfirst72hoursofhospitalization Canbetypicaloratypical MostcommonbacterialpathogenisStreptococcuspneumoniae

b. Nosocomialpneumonia

Occursduringhospitalizationafterfirst72hours Mostcommonbacterialpathogensaregram-negativerods(Escherichia coli,Pseudomonas)andStaphylococcusaureus 2. Therearetworecommendedmethodsofprevention

a. Influenzavaccine—giveyearlytopeopleatincreasedriskforcomplicationsand tohealthcareworkers

b. Pneumococcalvaccine—forpatients>65yearsandforyoungerpeopleathigh risk(e.g.,thosewithheartdisease,cochlearimplants,sicklecelldisease, pulmonarydisease,diabetes,alcoholiccirrhosis,asplenia)

Quick HIT

MostcasesofCAPresultfromaspirationoforopharyngealsecretionsbecausethemajorityoforganismsthat causeCAParenormalinhabitantsofthepharynx.

Quick HIT

S.pneumoniaeaccountsforupto66%ofallcasesofbacteremicpneumonia,followedbyH.influenzae, influenzavirus,andLegionellaspp.

Quick HIT

Studieshaveshownthatifvitalsignsareentirelynormal,theprobabilityofpneumoniainoutpatientsislessthan 1%.

B.TypicalCAP 1. Commonagents

a. S.pneumoniae(60%) b. Haemophilusinfluenzae(15%) c. Aerobicgram-negativerods(6%to10%)—Klebsiella(andother

c. Aerobic gram-negative rods (6% to 10%)—Klebsiella (and other Enterobacteriaceae)

Enterobacteriaceae) d. S.aureus(2%to10%)

2. Clinicalfeatures

a. Symptoms

Acuteonsetoffeverandshakingchills Coughproductiveofthick,purulentsputum Pleuriticchestpain(suggestspleuraleffusion) Dyspnea

b. Signs

e

e

e

Tachycardia,tachypnea Lateinspiratorycrackles,bronchialbreathsounds,increasedtactileandvocal fremitus,dullnessonpercussion Pleuralfrictionrub(associatedwithpleuraleffusion)

3. Chestradiograph(CXR) a. Lobarconsolidation b. Multilobarconsolidationindicatesveryseriousillness
======================================
Quick HIT

“Atypical”pneumoniareferstoorganismsnotvisibleonGramstainandnotculturableonstandardbloodagar.

Quick HIT

SputumCultureCAP

e

e

ThevalueofroutinesputumcollectionforGramstainandcultureiscontroversial.TheInfectiousDisease SocietyofAmericahasrecentlyadvocatedperformingsputumGramstainandcultureinallpatients hospitalizedwithCAP. Agoodsputumspecimenhas>25PMNsand<10epithelialcellsperlow-powerfield.

C.AtypicalCAP

1. Commonagents

a. Mycoplasmapneumoniae(mostcommon) b. Chlamydiapneumoniae c. Chlamydiapsittaci d. Coxiellaburnetii(Qfever) e. Legionellaspp. f. Viruses:influenzavirus(AandB),adenoviruses,parainfluenzavirus,RSV

2. Clinicalfeatures

a. Symptoms

e

e

e

Insidiousonset—headache,sorethroat,fatigue,myalgias Drycough(nosputumproduction) Fevers(chillsareuncommon)

b. Signs

e

e

Pulse-temperaturedissociation—normalpulseinthesettingofhighfeveris suggestiveofatypicalCAP Wheezing,rhonchi,crackles

c. CXR

e

e

Diffusereticulonodularinfiltrates Absentorminimalconsolidation

D.Diagnosis 1. PAandlateralCXRrequiredtoconfirmthediagnosis(Figure10-1)(seealso

ClinicalPearls10-1and10-2).

a. Consideredsensitive—ifCXRfindingsarenotsuggestiveofpneumonia,donot treatthepatientwithantibiotics.

b. Aftertreatment,changesevidentonCXRusuallylagbehindtheclinical response(upto6weeks).

c. Changesincludeinterstitialinfiltrates,lobarconsolidation,and/orcavitation. d. False-negativechestradiographsoccurwithneutropenia,dehydration,infection withPCP(Pneumocystiscariniipneumonia),andearlydisease(<24hours).

FIGURE 10.1

ChestPA(A)andlateral(B)radiographs:Rightlower lobepneumonia(straightarrows).OnthePAradiograph,theright cardiacborderisclearlyvisible,andtherighthemidiaphragmis partiallysilhouetted(doublestraightarrows).Thesefindings indicatethattheinfiltrateisposteriororintherightlowerlobeas confirmedonthelateralradiograph(straightarrows). (FromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins,1998:110,Figure6–54AandB.)

CLINICALPEARL10-1
======================================
GeneralApproachtoDiagnosisofCAP Thefirsttaskistodifferentiatelowerrespiratorytractinfectionfromtheothercausesofcoughand fromupperrespiratoryinfection.

e

©

¢

Ifnasaldischarge,sorethroat,orearpainpredominates,upperrespiratoryinfectionislikely. Oncelowertractinfectionissuspected,thenexttaskistodifferentiatebetweenpneumoniaandacute bronchitis.Unfortunately,clinicalfeatures(cough,sputum,fever,dyspnea)arenotreliablein differentiatingbetweenthetwo. CXRistheonlyreasonablemethodofdifferentiatingbetweenpneumoniaandacutebronchitis.

Quick HIT

Patientsadmittedtothehospitalwithsuspectedpneumoniashouldget:

¢

e

©

¢

e

CXR(PAandlateral) Laboratorytests—CBCanddifferential,BUN,creatinine,glucose,electrolytes O2saturation Twopretreatmentbloodcultures Gramstainandcultureofsputum Antibiotictherapy

e

Quick HIT

RadiographicchangesandclinicalfindingsdonothelpinidentifyingthecausativepathogeninCAP.

Quick HIT

Testformicrobialdiagnosisforoutpatientsisnotrequired.EmpirictreatmentisoftensuccessfulifCAPis suspected.

2. PretreatmentexpectoratedsputumforGramstainandculture—lowsensitivity andspecificity,butstillworthwhiletestsbecauseantimicrobialresistanceisan increasingproblem.

a. SputumGramstain—trytoobtaininallpatients. Commonlycontaminatedwithoralsecretions. Agoodspecimenhasasensitivityof60%andspecificityof85%for identifyinggram-positivecocciinchains(S.pneumoniae).

b. Sputumculture—trytoobtaininallpatientsrequiringhospitalization.

Specificityisimprovedifthepredominantorganismgrowingontheculture mediacorrelateswiththeGramstain. 3. Specialstainsofthesputuminselectedcases.

a. Acid-faststain(Mycobacteriumspp.)iftuberculosis(TB)issuspected. b. Silverstain(fungi,P.carinii)forHIV/immunocompromisedpatients.

4. UrinaryantigenassayforLegionellainselectedpatients.

a. Thistestisverysensitive. b. Theantigenpersistsintheurineforweeks(evenaftertreatmenthasbeen

started).

5. Considertwopretreatmentbloodculturesfromdifferentsites.Bloodcultures positivein5%to15%ofcases.

CLINICALPEARL10-2

PneumoniaPearls
======================================
e

e

e

¢

Inalcoholics,thinkofKlebsiellapneumoniae;inimmigrants,thinkofTB. Innursinghomeresidents,consideranosocomialpathogenandpredilectionfortheupperlobes(e.g., Pseudomonas). HIV-positivepatientsareatriskforP.cariniiandM.tuberculosis,butarestillmorelikelytohaveatypical infectiousagent. Legionellapneumoniaiscommoninorgantransplantrecipients,patientswithrenalfailure,patientswith chroniclungdisease,andsmokersandpresentswithGIsymptomsandhyponatremia.Legionellapneumonia israreinhealthychildrenandyoungadults.

Quick HIT

Ifpatientishypoxicorhypotensive,admittohospital.

Quick HIT

ForuncomplicatedCAPinpatientswithoutsignificantcomorbidities,treatwithazithromycinorclarithromycin. Ifthepatienthascomorbidities,giveafluoroquinolone.

E.TreatmentofCAP 1. Decisiontohospitalize.

a. Thedecisiontohospitalizeortreatasanoutpatientisprobablythemost importantdecisiontobemadeandisbasedonseverityofdisease(seeTable 10-1).

b. Patientsarestratifiedintofiveclassesbasedonseverity(seeTable10-1).The pneumoniaseverityindexcanserveasageneralguideline,butclinicaljudgment iscriticalinmakingthisdecision.Thedecisiontoadmitthepatientisnotbased onaspecificorganism(onedoesnothavethisinformationwhenmakingthis decision).

2. Antimicrobialtherapy.

a. Becausethespecificcauseisusuallynotdeterminedoninitialevaluation, empirictherapyisoftenrequired.

b. Foroutpatients.

Inpeopleyoungerthan60yearsofage,themostcommonorganismsareS. pneumoniae,Mycoplasma,Chlamydia,andLegionella.Macrolides (azithromycinorclarithromycin)ordoxycyclinecoveralloftheseorganisms andarethefirst-linetreatment.Fluoroquinolonesarealternativeagents. Penicillinsorcephalosporinsdonotcovertheatypicalorganismsinthisage

e

e

group. Inolderadultsandpatientswithcomorbidities(morelikelytohavetypical CAP)orthosetreatedwithantibioticsinthelast3months,arespiratory fluoroquinolone(levofloxacin,moxifloxacin)PLUSamacrolideor amoxicillin-clavulanateisthefirst-lineagent. Foroutpatients,treatmentiscontinuedfor5days.Donotstoptreatmentuntil patienthasbeenafebrilefor48hours.

c. Forhospitalizedpatients,afluoroquinolonealoneorathird-generation cephalosporinPLUSamacrolide(i.e.,ceftriaxoneplusazithromycin)is appropriate.
======================================
Quick HIT

Foroutpatients,treatmentiscontinuedfor5days.Donotstoptreatmentuntilpatienthasbeenafebrilefor48 hours.

F.TreatmentofHospital-AcquiredPneumonia 1. Treatmentistailoredtowardgram-negativerods(anyofthefollowingthree

areappropriate):

a. Cephalosporinswithpseudomonalcoverage:ceftazidimeorcefepime b. Carbapenems:imipenem c. Piperacillin/tazobactam

2. Macrolidesarenotusedassingle-agenttherapy(astheyareinCAP)

Quick HIT

Pleuraleffusioniscommoninpatientswithpneumonia.Progressiontoempyema(infected,loculatedpleural fluid)requireschesttubedrainage.

Quick HIT

LungAbscessPearls

e

¢

Thedependentzonesofthelungsaremostlikelytobeinfectedbyaspiratedcontents—theposterior segmentsoftheupperlobesandsuperiorsegmentsofthelowerlobes. Aspiratedmaterialismorelikelytoaffecttherightlungbecausetherightmainstembronchusiswider, straighter,andshorter.

G.Complications 1. Pleuraleffusion(“parapneumoniceffusions”)—seeChapter2.

a. Canbeseeninmorethan50%ofpatientswithCAPonroutineCXR.Empyema isinfrequentinthesepatients.

b. Mostoftheseeffusionshaveanuncomplicatedcourseandresolvewith treatmentofthepneumoniawithantibiotics.

c. Thoracentesisshouldbeperformediftheeffusionissignificant(>1cmon lateraldecubitusfilm).SendfluidforGramstain,culture,pH,cellcount, determinationofglucose,protein,andLDHlevels.

2. Pleuralempyemaoccursin1%to2%ofallcasesofCAP(upto7%of hospitalizedpatientswithCAP).SeeChapter2.

3. Acuterespiratoryfailuremayoccurifthepneumoniaissevere.

Ventilator-AssociatedPneumonia

A.Patientsonmechanicalventilationareatriskofdevelopingpneumoniabecausethe normalmucociliaryclearanceoftherespiratorytractisimpaired(cannotcough). Also,positivepressureimpairstheabilitytoclearcolonization.

B.Findingstohelpwithdiagnosis:newinfiltrateonchestx-ray[AQ1],purulent secretionsfromendotrachealtube,fever,risingWBCcount.

C.Bronchoalveolarlavage(BAL)—bronchoscopepassedintolungstogetcultures. D.Treatmentiswithacombinationofthefollowingthreedifferentdrugs: 1. Cephalosporin(ceftazidimeorcefepime)ORbeta-lactamandbeta-lactamase

inhibitor(piperacillin/tazobactam)ORcarbapenem(imipenem).

2. AminoglycosideORfluoroquinolone. 3. VancomycinORlinezolid.
======================================
LungAbscess

A.GeneralCharacteristics 1. Abscessinthelungparenchymaresultswheninfectedlungtissuebecomes

necroticandformssuppurativecavitarylesions.Thetypicalcaseisaspirationofa largevolumeoforopharyngealcontentsorfood,withresultingpneumoniaand necrosiswhenadequatetreatmentisnotadministered.Mostpatientswhohave aspirationpneumoniaaretreatedpromptly,therebyavoidingabscessformation.

2. Bydefinition,alungabscessisformedbyoneormorecavities,each>2cmin diameter.

3. Lungabscessescanbecomplicationsofthefollowing:

a. Aspirationoforganisms. b. Acutenecrotizingpneumonia(gram-negativerods). c. Hematogenousspreadofinfectionfromdistantsite. d. Directinoculationwithcontiguousspread.

4. Causativeorganismsaremainlybacteriathatcolonizetheoropharynx.

a. Oralanaerobes:Prevotella,Peptostreptococcus,Fusobacterium,Bacteroides spp.

b. Otherbacteria:S.aureus,S.pneumoniae,andaerobicgram-negativebacilli

5. Epidemiology/riskfactors.

a. Themainriskfactorispredispositiontoaspiration.Thismaybeseeninpatients withimpairedconsciousness(alcoholism,seizures),dysphagia,neurologic conditions(CVA),ormechanicaldisruptionofnormaldefensemechanisms (nasogastricorendotrachealtube).

b. Poordentalhygieneincreasesthecontentoforalanaerobes. c. Edentulouspatientsarelesslikelytoaspirateoropharyngealsecretions.

B.ClinicalFeatures 1. Themajorityofcaseshaveanindolentonset;somepresentmoreacutely. 2. Commonsymptomsandsigns.

a. Cough—Foul-smellingsputumisconsistentwithanaerobicinfection.Itis sometimesbloodtinged.

b. Shortnessofbreath. c. Fever,chills. d. Constitutionalsymptoms:fatigue,malaise,weightloss.

C.Diagnosis 1. CXR

a. Thisrevealsthick-walledcavitationwithair–fluidlevels.

b. Lookforabscessindependent,poorlyventilatedlobes.

2. CTscanmaybenecessarytodifferentiatebetweenabscessandempyema. 3. SputumGramstainandculturehaslowsensitivityandspecificity. 4. Considerobtainingculturesviabronchoscopyortranstrachealaspirationrather

thansimpleexpectorationtoavoidcontaminationwithoralflora.

D.Treatment 1. Hospitalizationisoftenrequirediflungabscessisfound.Posturaldrainageshould

beperformed.

2. Antimicrobialtherapy.

a. Antibioticregimensincludecoverageforthefollowing:

¢
======================================
e

e

Gram-positivecocci—ampicillin/sulbactamoramoxicillin/clavulanicacid, ampicillin/sulbactam,orvancomycinforS.aureus. Anaerobes—clindamycinormetronidazole. Ifgram-negativeorganismsaresuspected,addafluoroquinoloneor ceftazidime.

b. ContinueantibioticsuntilthecavityisgoneoruntilCXRfindingshave improvedconsiderably—thismaytakemonths!

Tuberculosis

Quick HIT

TBisthemostcommoncauseofdeathduetoinfectionworldwide.

A.GeneralCharacteristics 1. Microbiology

a. CausedbyMycobacteriumtuberculosis b. Mycobacteriaareacid-fastbacilli(AFB)—consideredslowgrowingbuthardy

organisms

c. Inhibitedbythecellulararmoftheimmunesystem

2. Transmission

a. Transmissionoccursviainhalationofaerosolizeddropletscontainingtheactive organism

b. OnlythosepeoplewithactiveTBarecontagious(e.g.,bycoughing,sneezing) c. PeoplewithprimaryTBarenotcontagious

3. Pathophysiology a. PrimaryTB

e

e

e

¢

Bacilliareinhaledanddepositedintothelung,theningestedbyalveolar macrophages Survivingorganismsmultiplyanddisseminatevialymphaticsandthe bloodstream.Granulomasformand“walloff”themycobacteria.The granulomasinoxygen-richareas,suchasthelungs,allowtheseorganismsto remainviable(theyareaerobes).Aftertheresolutionoftheprimaryinfection, theorganismremainsdormantwithinthegranuloma AninsulttotheimmunesystemmayactivatetheTBatanytime Only5%to10%ofindividualswithprimaryTBwilldevelopactivediseasein theirlifetime

b. SecondaryTB(reactivation)

¢

e

e

e

Occurswhenthehost’simmunityisweakened(e.g.,HIVinfection, malignancy,immunosuppressants,substanceabuse,poornutrition) Usuallymanifestsinthemostoxygenatedportionsofthelungs—the apical/posteriorsegments ProducesclinicalmanifestationsofTB Canbecomplicatedbyhematogenousorlymphaticspread,resultinginmiliary TB

c. ExtrapulmonaryTB

e

e

e

Individualswithimpairedimmunitymaynotbeabletocontainthebacteriaat eithertheprimaryorthesecondarystageoftheinfection Thismayresultinactivediseasethroughoutthebody ItiscommoninpatientswithHIVbecausetheircellularimmunityisimpaired

4. Riskfactors(almostallpatientswithTBhaveoneormoreofthefollowing):

a. HIV-positivepatients b. Recentimmigrants(withinthepast5years) c. Prisoners d. Healthcareworkers e. ClosecontactsofsomeonewithTB f. Alcoholics g. Diabetics h. Glucocorticoid/immunosuppressantuse i. Hematologicmalignancy j. Injectiondrugusers
======================================
Quick HIT

RadiographicFindingsinPrimaryTB

¢

e

Ghoncomplex—calcifiedprimaryfocuswithanassociatedlymphnode Rankecomplex—whenGhoncomplexundergoesfibrosisandcalcification

Quick HIT

DiagnosisofTBischallenginginHIVpatientsbecause:

e

e

e

¢

PPDskintestresultisnegative. Patientshave“atypical”CXRfindings. Sputumsmearsaremorelikelytobenegative. Granulomaformationmaynotbepresentinthelatestages.

B.ClinicalFeatures 1. PrimaryTB

a. Usuallyasymptomatic b. Pleuraleffusionmaydevelop c. Iftheimmuneresponseisincomplete,thepulmonaryandconstitutional symptomsofTBmaydevelop.ThisisknownasprogressiveprimaryTB

2. Secondary(active)TB

a. Constitutionalsymptoms—fever,nightsweats,weightloss,andmalaiseare common

b. Coughprogressesfromdrycoughtopurulentsputum.Hemoptysissuggests advancedTB

c. Apicalralesmaybepresentonexamination

3. ExtrapulmonaryTB

a. Mayinvolveanyorgan.Thelymphnodes,pleura,genitourinarytract,spine,

intestine,andmeningesaresomeofthecommonsitesofinfection b. MiliaryTBreferstohematogenousdisseminationofthetuberclebacilli

e

e

e

Maybeduetoareactivationofdormant,disseminatedfocioranewinfection AlsocommoninpatientswithHIV Maypresentwithorganomegaly,reticulonodularinfiltratesonCXR,and choroidaltuberclesintheeye

C.Diagnosis 1. Musthaveahighindexofsuspicion,dependingonpatient’sriskfactorsand

presentation

2. CXR

a. Classicfindingsareupperlobeinfiltrateswithcavitations b. Otherpossiblefindings Pleuraleffusion(s) GhoncomplexandRankecomplex:evidenceofhealedprimaryTB Atypicalfindingscommoninimmunocompromisedpatients

3. Sputumstudies(sputumacid-fasttesting)

a. Definitivediagnosisismadebysputumculture—growthofM.tuberculosis b. Obtainthreemorningsputumspecimens—culturetakes4to8weeks c. PCRcandetectspecificmycobacterialDNAmorerapidly d. DiagnosisissometimesmadebyfindingAFBonmicroscopicexamination,but

thisisnotdefinitivebecauseothermycobacteriamaycolonizeairways

4. Tuberculinskintest(PPDtest)

exposedtoTB.ItisnotfordiagnosisofactiveTB,butratheroflatent(primary) TB(apositivechestx-rayisusedtodiagnoseactiveTB).PPDisnotascreening testforeveryone,onlypatientswithoneormoreoftheriskfactorsmentioned aboveshouldhavethistest.Ifpatientissymptomaticorhasabnormalchestx- ray,orderasputumacid-fasttest,notaPPD

b. InjectPPDintothevolaraspectofforearm.Measuretheamountofinduration 48to72hourslater.Positiveresultisinterpretedasfollows:
======================================
e

e

Patientswithnoriskfactors:induration≥15mm Certainhigh-riskpopulations(e.g.,thosewholiveinhigh-prevalenceareas, immigrantsinthelast5years,thehomeless,prisoners,healthcareworkers, nursinghomeresidents,closecontactofsomeonewithTB,alcoholics, diabetics):induration≥10mm

PatientswithHIV,steroidusers,organtransplantrecipients,closecontactsof thosewithACTIVETB,orthosewithradiographicevidenceofprimaryTB: induration≥5mm

Quick HIT

PatientspreviouslyvaccinatedwithBCGwillhaveapositivePPDtestbutthisdoesnotaffecttreatment decisions.

Quick HIT

INHshouldalwaysbestartedwithvitaminB6(pyridoxine)topreventsymptomsofB6deficiency,which includestomatitis,glossitis,cheilosis,convulsions,hyperirritability,peripheralneuropathy,and sideroblasticanemia.

c. IfapatienthasneverhadaPPDtestbefore,repeatthetestin1to2weeksifthe firsttestisnegative(firsttestmaybefalsenegative).Theresultsofthesecond test(whetherpositiveornegative)areusedformanagement

d. IfPPDtestispositive,achestx-rayisneededtoruleoutactivedisease.Once activediseaseisexcluded,9monthsofisoniazidtreatmentisinitiated.Apatient withapositivePPDtesthasa10%lifetimeriskofTB,andthisriskisreduced to1%after9monthsofisoniazidtreatment

e. ManypersonsbornoutsideofUnitedStateshavebeenBacilleCalmette–Guerin (BCG)-vaccinated,whichmaycauseapositivePPDskintest.However,this doesnotaffecttreatmentdecisions.IfapatienthasapositivePPDtest,isoniazid for9monthsisindicatedevenifthepatienthadpriorBCGvaccine

D.Treatment 1. PatientswithactiveTBmustbeisolateduntilsputumisnegativeforAFB.

a. First-linetherapyisafour-drugregimen:isoniazid(INH),rifampin, pyrazinamide,andethambutolorstreptomycin.

b. Theinitialtreatmentregimenconsistsof2monthsoftreatmentwiththefour- drugregimen.Theinitial2-monthphaseisfollowedbya4-monthphaseofINH andrifampin.

2. Prophylactictreatmentforlatent(primary)TB(i.e.,positivePPDskintest): consistsof9monthsofINHafteractiveTBhasbeenexcluded(negativeCXR, sputum,orboth).

Quick HIT

e

e

ForapositiveTBexposureandapositivePPDtest(butnoactivedisease),treatmentisINHonly. IfthepatienthasactiveTB,multiagenttherapyisindicated.
======================================
Quick HIT

AllTBmedicationscancausehepatotoxicity.Discontinuetreatmentonlyiflivertransaminasesrisetothreeto fivetimestheupperlimitofnormal.

Influenza

Anorthomyxovirustransmittedviarespiratorydroplets,typicallyoccurringin wintermonths. AntigenictypesAandBareresponsiblefortheclinicalsyndromeknownasthe “flu.” Annualepidemicsareduetominorgeneticreassortmentandusuallyarenotlife- threateningexceptintheveryyoung,theveryold,theimmunocompromised,and hostswithsignificantmedicalcomorbidities. Rarelyoccurringpandemicsareduetomajorgeneticrecombinationandareoften fatal,eveninyoung,otherwisehealthyhosts. Clinicalfindingsarearapidonsetoffever,chills,malaise,headache,nonproductive cough,andsorethroat.Nauseamayalsobepresent. Treatmentislargelysupportive.Antiviralagentsareavailablebuttheseareonly indicatedinpatientswithseveredisease(requiringhospitalization)orathighriskof complicationsandmustbegivenwithinthefirst48hoursofillness.Giveantibiotics onlyforsecondarybacterialinfections.(SeeChapter12forvaccination recommendations.) Aneuraminidaseinhibitor(zanamiviroroseltamivir)istherecommendedantiviral agent.

InfectionsoftheCentralNervousSystem

eee

Meningitis

A.GeneralCharacteristics 1. Thisreferstoinflammationofthemeningealmembranesthatenvelopthebrain andspinalcord.Itisusuallyassociatedwithinfectiouscauses,butnoninfectious causes(suchasmedications,SLE,sarcoidosis,andcarcinomatosis)alsoexist.

2. Pathophysiology

a. Infectiousagentsfrequentlycolonizethenasopharynxandrespiratorytract. b. ThesepathogenstypicallyentertheCNSviaoneofthefollowing:

e

e

¢

Invasionofthebloodstream,whichleadstohematogenousseedingofCNS. Retrogradetransportalongcranial(e.g.,olfactory)orperipheralnerves. Contiguousspreadfromsinusitis,otitismedia,surgery,ortrauma.

3. Canbeclassifiedasacuteorchronic,dependingononsetofsymptoms.

a. Acutemeningitis—onsetwithinhourstodays. b. Chronicmeningitis—onsetwithinweekstomonths;commonlycausedby

mycobacteria,fungi,Lymedisease,orparasites.

4. Anotherimportantdistinctionisbacterialversusaseptic(describedbelow). 5. Acutebacterialmeningitis.

a. Causes

Neonates—GroupBstreptococci,E.coli,Listeriamonocytogenes. Children>3months—Neisseriameningitidis,S.pneumoniae,H.influenzae. Adults(ages18to50)—S.pneumoniae,N.meningitidis,H.influenzae. Elderly(>50)—S.pneumoniae,N.meningitidis,L.monocytogenes,gram- negativebacilli. Immunocompromised—L.monocytogenes,gram-negativebacilli,S. pneumoniae. b. Complications
======================================
e

e

Seizures,coma,brainabscess,subduralempyema,DIC,respiratoryarrest. Permanentsequelae—deafness,braindamage,hydrocephalus.

6. Asepticmeningitis

a. Asepticmeningitisismostcommonlycausedbyavarietyofnonbacterial

pathogens,frequentlyvirusessuchasenterovirusandherpessimplexvirus (HSV).Itcanalsobecausedbycertainbacteria,parasites,andfungi. b. Itmaybedifficulttodistinguishitclinicallyfromacutebacterial

meningitis.Ifthereisuncertaintyindiagnosis,treatforacutebacterial

meningitis.

c. Itisassociatedwithabetterprognosisthanacutebacterialmeningitis.

Quick HIT

Acutebacterialmeningitisisamedicalemergencyrequiringpromptrecognitionandantibiotictherapy.Itis frequentlyfatal,evenwithappropriatetreatment.

Quick HIT

AcuteBacterialMeningitis(clinicalfeatures) Characteristictriadincludes:

Fever Nuchalrigidity Changeinmentalstatus

e Fever

¢

e

B.ClinicalFeatures 1. Symptoms(anyofthefollowingmaybepresent)

a. Headache(maybemoreseverewhenlyingdown) b. Fevers c. Nauseaandvomiting d. Stiff,painfulneck e. Malaise f. Photophobia g. Alterationinmentalstatus(confusion,lethargy,evencoma)

2. Signs(anyofthefollowingmaybepresent)

a. Nuchalrigidity:stiffneck,withresistancetoflexionofspine(maybeabsent) b. Rashes

¢

e

Maculopapularrashwithpetechiae—purpuraisclassicforN.meningitidis VesicularlesionsinvaricellaorHSV

c. IncreasedICPanditsmanifestations—forexample,papilledema,seizures d. Cranialnervepalsies e. Kernigsign—inabilitytofullyextendkneeswhenpatientissupinewithhips

flexed(90degrees)

e

e

Causedbyirritationofthemeninges Onlypresentinapproximatelyhalfofpatientswithbacterialmeningitis

f. Brudzinskisign—flexionoflegsandthighsthatisbroughtonbypassiveflexion ofneckforsamereasonasabove;alsopresentinonlyhalfofpatientswith bacterialmeningitis

g. Jolttest—worseningheadachewhenpatientisaskedtoturnheadbackandforth

quicklyatfrequencyofatleast3turnspersecond.Mostsensitiveandspecific foracutebacterialmeningitis.

C.Diagnosis 1. CSFexamination(LP)—Performthisifmeningitisisapossiblediagnosisunless thereisevidenceofaspace-occupyinglesion(seeTable10-2).Alsonotethe openingpressure.

a. ExaminetheCSF.CloudyCSFisconsistentwithapyogenicleukocytosis. b. CSFshouldbesentforthefollowing:cellcount,chemistry(e.g.,protein,

glucose),Gramstain,culture(includingAFB),andcryptococcalantigenorIndia ink.

c. Bacterialmeningitis—pyogenicinflammatoryresponseinCSF.
======================================
ElevatedWBCcount—PMNspredominate. Lowglucose. Highprotein. Gramstain—positivein75%to80%ofpatientswithbacterialmeningitis.
======================================
d. Asepticmeningitis—nonpyogenicinflammatoryresponseinCSF.

e

e

¢

e

Thereisanincreaseinmononuclearcells.Typicallyalymphocyticpleocytosis ispresent. Proteinisnormalorslightlyelevated. Glucoseisusuallynormal. CSFmaybecompletelynormal.

2. CTscanoftheheadisrecommendedbeforeperforminganLPiftherearefocal neurologicsignsorifthereisevidenceofaspace-occupyinglesionwith elevationsinICP.

3. Obtainbloodculturesbeforeantibioticsaregiven.

D.Treatment

1. Bacterialmeningitis.

a. Empiricantibiotictherapy—StartimmediatelyafterLPisperformed.IfaCT scanmustbeperformedorifthereareanticipateddelaysinLP,giveantibiotics first.PathogencanoftenstillbeidentifiedfromCSFseveralhoursafter administrationofantibiotics. b. Intravenous(IV)antibiotics.

e

e

e

InitiateimmediatelyiftheCSFiscloudyorifbacterialinfectionissuspected. Beginempirictherapyaccordingtothepatient’sage(seeTable10-3). ModifytreatmentasappropriatebasedonGramstain,culture,andsensitivity findings.

c. Steroids—ifsuspectS.pneumoniaeascausativeorganismtopreventcerebral

edema. d. Vaccination

e

e

e

Vaccinatealladults>65yearsforS.pneumoniae. VaccinateasplenicpatientsforS.pneumoniae,N.meningitidis,andH. influenzae(encapsulatedorganisms). VaccinateimmunocompromisedpatientsforN.meningitidis.

e. Prophylaxis(e.g.,rifampinorceftriaxone)—forallclosecontactsofpatients withmeningococcus.

2. Asepticmeningitis.

a. Nospecifictherapyotherthansupportivecareisrequired.Thediseaseisself- limited.

b. Analgesicsandfeverreductionmaybeappropriate.
======================================
Encephalitis

Quick HIT

Differentialdiagnosisinpatientswithfeverandalteredmentalstatus:infection

Sepsis,UTI/urosepsis,pneumonia,bacterialmeningitis,intracranialabscess,subduralempyema, medication/drugs Neurolepticmalignantsyndrome(haloperidol,phenothiazines) Deliriumtremens,metabolicderangements Thyroidstorm

A.GeneralCharacteristics 1. Encephalitisisadiffuseinflammationofthebrainparenchymaandisoftenseen

simultaneouslywithmeningitis

2. Itisusuallyviralinorigin.Nonviralcauses,however,mustalsobeconsidered a. Viralcauses

e

e

e

e

Herpes(HSV-1) Arbovirus—forexample,Easternequineencephalitis,WestNilevirus Enterovirus—forexample,polio Lesscommoncauses—forexample,measles,mumps,EBV,CMV,VZV, rabies,andpriondiseasessuchasCreutzfeldt–Jakobdisease

b. Nonviralinfectiouscauses

e

¢

Toxoplasmosis Cerebralaspergillosis

c. Noninfectiouscauses

e

e

Metabolicencephalopathies T-celllymphoma

3. Riskfactors

a. AIDS—patientswithAIDSareespeciallyatriskfortoxoplasmosiswhenthe CD4countis<200

b. Otherformsofimmunosuppression c. Travelinunderdevelopedcountries d. Exposuretoinsect(e.g.,mosquito)vectorinendemicareas e. Exposuretocertainwildanimals(e.g.,bats)inanendemicareaforrabies 4. Theoverallmortalityassociatedwithviralencephalitisisapproximately10%

B.ClinicalFeatures 1. Patientsoftenhaveaprodromeofheadache,malaise,andmyalgias. 2. Withinhourstodays,patientsbecomemoreacutelyill.

3. Patientsfrequentlyhavesignsandsymptomsofmeningitis(e.g.,headache,fever, photophobia,nuchalrigidity).

4. Inaddition,patientshavealteredsensorium,possiblyincludingconfusion, delirium,disorientation,andbehaviorabnormalities.

5. Focalneurologicfindings(e.g.,hemiparesis,aphasia,cranialnervelesions)and seizuresmayalsobepresent.

C.Diagnosis 1. Routinelaboratorytests(toruleoutnonviralcauses)includeCXR,urineand

bloodcultures,urinetoxicologyscreen,andserumchemistries.

2. PerformanLPtoexamineCSF,unlessthepatienthassignsofsignificantly increasedICP.

a. Lymphocytosis(>5WBC/mL)withnormalglucoseisconsistentwithviral encephalitis(similarCSFasinviralmeningitis).CSFculturesareusually negative.

b. CSFPCRisthemostspecificandsensitivetestfordiagnosingmanyvarious viralencephalitides,includingHSV-1,CMV,EBV,andVZV.

3. MRIofthebrainistheimagingstudyofchoice.
======================================
a. Canruleoutfocalneurologiccauses,suchasanabscess. b. IncreasedareasofT2signalinthefrontotemporallocalizationareconsistent

withHSVencephalitis.

4. EEGcanbehelpfulindiagnosingHSV-1encephalitis—itwouldshowunilateral orbilateraltemporallobedischarges.

5. Brainbiopsyisindicatedinanacutelyillpatientwithafocal,enhancinglesionon MRIwithoutacleardiagnosis.

Quick HIT

Notallbrainabscessesarebacterial—especiallyinimmunocompromisedhosts!

¢

©

ToxoplasmagondiiandfungiinpatientswithAIDS Candidaspp.,Aspergillusspp.,orzygomycosisinneutropenicpatients

D.Treatment 1. Supportivecare,mechanicalventilationifnecessary 2. Antiviraltherapy

a. Thereisnospecificantiviraltherapyformostcausesofviralencephalitis b. HSVencephalitis—acyclovirfor2to3weeks c. CMVencephalitis—ganciclovirorfoscarnet

3. Managementofpossiblecomplications

a. Seizures—requireanticonvulsanttherapy

b. Cerebraledema—treatmentmayincludehyperventilation,osmoticdiuresis,and steroids

InfectionsoftheGastrointestinalTract(seealso

Chapter3)

eee

ViralHepatitis

Quick HIT

¢

¢

HepatitisBisassociatedwithPAN. HepatitisCisassociatedwithcryoglobulinemia.

A.GeneralCharacteristics 1. Hepatitissimplymeansinflammationoftheliver.Therearemanynoninfectious

typesofhepatitis,suchasalcoholichepatitis,drug-inducedhepatitis,autoimmune hepatitis,andnumeroushereditarydiseasesthatcancausehepatitis.

2. Causesofviralhepatitis.

a. Therearefivewell-understood,maincategoriesofviralhepatitis:hepatitisA,B, C,D,andE.Hepatitisvirusesareoftenabbreviatedbytheirtype(i.e.,HAVis hepatitisAvirus,HBVishepatitisBvirus,andsoforth.)

b. OthervirusesthatcancauseoneformoranotherofhepatitisareEBV,CMV,and HSV.Thesearenotcommonlyassociatedwithhepatitisinimmunocompetent patients.

3. Transmissionvariesdependingonthespecificvirus.

a. HepatitisAandEaretransmittedviathefecal–oralrouteandaremoreprevalent indevelopingcountries.

b. HepatitisEisparticularlyprevalentinIndia,Pakistan,southeastAsia,andparts ofAfrica.

c. HepatitisBistransmittedparenterallyorsexually.Perinataltransmissionis
======================================
alsopossibleandisasignificanthealthissueinpartsofAfricaandAsia. d. HepatitisDrequirestheouterenvelopeofthehepatitisBsurfaceantigen

(HBSAG)forreplicationandthereforecanbetransmittedonlyasacoinfection withHBV,orasasuperinfectioninachronicHBVcarrier.

e. ThemainrouteoftransmissionforhepatitisCisparenteral,anditis thereforemoreprevalentinIVdrugusers.Sexualorperinataltransmissionisnot common.

f. HepatitisB,C,andDarethetypesthatcanprogresstochronicdisease.

Quick HIT

Ingeneral,HAVandHEVcauseamilderformofhepatitisanddonotbecomechronic.

B.ClinicalFeatures 1. Classifiedasacute(<6monthsofliverinflammation)orchronic(>6monthsof

persistentliverinflammation)(Figure10-2)

2. Acutehepatitishasawidespectrumofclinicalpresentations,rangingfrom virtuallyasymptomatictofulminantliverfailure

a. Generalclinicalfeatures

e

Jaundice—lookfirstinthesclera,becausethismaybethefirstplacejaundice canbedetected,especiallyinblackpatients Dark-coloredurinemaybepresent(duetoconjugatedhyperbilirubinemia) RUQpain Nauseaandvomiting Feverandmalaise Hepatomegalymayalsobepresent

b. Inseverecases,acutehepatitismayresultinliverfailureanditscomplications. Thisisknownasfulminanthepatitis(uncommon)andmaybelife-threatening.It occursmorecommonlyinhepatitisB,D,andEthaninothertypes. Complicationsinclude:

e

e

e

Hepaticencephalopathy—Lookforasterixisandpalmarerythema Hepatorenalsyndrome Bleedingdiathesis—thisoccursonlywhenliverfunctionisverycompromised

c. Sometimesacutehepatitismayonlypresentwithtransientflu-likesymptoms suchasfever,myalgias,andmalaise

d. AcuteHBVmayalsopresentwithaserumsickness-likeillness e. HepatitisCtypicallydoesnotcausesignificantacuteillness

Course of Hepatitis B Course of Hepatitis C Acute infection subclinical in 75% Acute infection subclinical in 70% Resolution Chronic hepatitis © Fulminant Chronic carrier Resolution Chronic hepatitis Fulminant (90%) (5%-10%) (<1%) (<5%) (10%-15%) (85%-90%) (<1%) Cirrhosis Cirrhosis + Develops in 10%-20% of all patients with + Develops in 25% of all patients with Hepatocellular Hepatocellular chronic hepatitis B + Develops 10-30 yrs carcinoma chronic hepatitis C + Develops 20-30 yrs carcinoma after onset | | Death, transplant after onset A B
======================================
FIGURE

A: Course of hepatitis B. B: Course of hepatitis C.

Quick HIT

Iftransaminasesaremarkedlyelevated(>500),thinkofacuteviralhepatitis,shockliver,ordrug-induced hepatitis.

3. Chronichepatitisalsohasawidevarietyofpresentations.Somepatientsare asymptomatic(“chroniccarriers”)andmayonlypresentwithlatecomplications ofhepatitis,suchascirrhosisorhepaticcellcarcinoma(HCC)

a. Chronichepatitisoccursafteracutehepatitisin1%to10%ofpatientswithHBV and>80%patientswithHCV

b. Itiscategorizedbasedonthegradeofinflammation,thestageoffibrosis,and theetiologyofdisease

c. TheriskofdevelopingcirrhosisorHCCis25%to40%inpatientswithchronic HBVand10%to25%inpatientswithchronicHCV

Quick HIT

LookforpositiveHBsAgandpositiveIgManti-HBctocheckforhepatitisBinfection.

C.Diagnosis 1. Serumserology—thepresenceofserumantigensandimmunoglobulinsisthe mostimportantfactorfordiagnosingviralhepatitis.Thesearehelpfulfor determiningtheacuityorchronicityofillnessaswellasadequateimmunity(see

ClinicalPearl10-3).

2. PCRisusedtodetectviralRNAtodiagnoseHCV. 3. LFTs—Elevationofserumtransaminasesisnotdiagnostic,butLFTsarehelpful. a. ALT(SGPT)istypicallyelevatedmorethanAST(SGOT)forallformsofviral

hepatitis(theoppositeofalcoholichepatitis).

b. Inacutehepatitis,ALTisusually>1,000.Itisgenerallynotashighasindrug- inducedhepatitis.

c. InchronicHBV,ALTcanalsobe>1,000,butthisvaries.InchronicHCV,ALT isgenerallylowerthanthisduetodestructionofhepatocytesfromlongevityof disease.

CLINICALPEARL10-3

HepatitisSerology HepatitisA

HepatitisAantibody(anti-HAV)

Anti-HAVisdetectableduringacuteinfectionandpersistsforlife,soitspresencedoesnotdistinguish betweenactivediseaseandimmunity.IgM-specificantibodydenotesacuteinfection.

HepatitisB HBsAg

e

e

¢

Presentinacuteorchronicinfection Detectableasearlyas1to2weeksafterinfection Itpersistsinchronichepatitisregardlessofwhethersymptomsarepresent.Ifvirusiscleared,thenHBsAg isundetectable

e

HepatitisBeantigen(HBeAg)

e

Reflectsactiveviralreplication,andpresenceindicatesinfectivity AppearsshortlyafterHBsAg Anti-HBsAgantibody(anti-HBs)

¢
======================================
e

PresentaftervaccinationorafterclearanceofHBsAg—usuallydetectable1to3monthsafterinfection Inmostcases,presenceofanti-HBsindicatesimmunitytoHBV

e

HepatitisBcoreantibody(anti-HBc) AssayofIgMandIgGcombined UsefulbecauseitmaybetheonlyserologicmarkerofHBVinfectionduringthe“windowperiod”in whichHBsAgisdisappearingandanti-HBsAgisnotyetdetectable Doesnotdistinguishbetweenacuteandchronicinfection,andpresencedoesnotindicateimmunity

Viralload

HBVDNAmeasuredbyPCR;ifitpersistsformorethan6weeks,patientislikelytodevelopchronic disease

HepatitisC

HepatitisCantibody

e

«¢

KeymarkerofHCVinfection Sometimesnotdetectableuntilmonthsafterinfection,soitsabsencedoesnotruleoutinfection

Viralload:HCVRNAmeasuredbyPCR

Detectable1to2weeksafterinfection—moresensitivethanHCVantibody

HepatitisD

HepatitisDantibody(anti-HDV)

e

e

PresenceindicatesHDVsuperinfection Theantibodymaynotbepresentinacuteillness,sorepeattestingmaybenecessary

D.Treatment 1. Active(vaccine)andpassive(immunoglobulin)immunizationareavailablefor

bothhepatitisAandB.Itisthestandardofcareforinfantsandhealthcareworkers tobevaccinatedforHBV(seeChapter12).

2. TravelersoftenreceivevaccinationsforHAV.Passiveimmunizationcanbegiven

forpeoplewhoareexposedtothevirus. 3. TreatmentforhepatitisAandEissupportive. 4. ChronicHBV—treatwithinterferon(IFN)-α.Alternatively,treatwith nucleotide/nucleosideanalogs(tenofovir,entecavir,lamivudine).

5. ChronicHCV—treatwithIFN-αandribavirin.

a. Interferon-freeregimens:Newerdirect-actingantiviralagents(e.g.,ledipasvir, sofosbuvir)cancurechronicHCV.Theyareveryexpensive.Treatmentregimen dependsonstageofliverfibrosis,treatmenthistory,andHCVgenotype.

b. Interferon-containingregimens:Peginterferonandribavirin.Associatedwitha highfrequencyofsideeffects,suchashematologictoxicity(neutropenia, thrombocytopenia,anemia),fatigue,flu-likesymptoms,andneuropsychiatric symptoms.

6. Considerlivertransplantationinadvanceddisease,althoughrecurrencecanoccur aftertransplantation.HepatitisCisthemostfrequentindicationforliver transplantationintheUnitedStates.
======================================
Botulism

A.GeneralCharacteristics 1. ResultsfromingestionofpreformedtoxinsproducedbysporesofClostridium

botulinum.Improperlystoredfood(e.g.,home-cannedfoods)canbe contaminatedwiththesespores.Toxinscanbeinactivatedbycookingfoodathigh temperatures(e.g.,100°C[212°F]for10minutes).

2. Woundcontaminationisanothersource. 3. Inhalationbotulismhasbeenreportedinlaboratoryworkersbutisnotacommon

occurrence.Couldbeapossiblebioterrorismweapon.

B.ClinicalFeatures 1. Theseverityofillnessrangeswidely,frommild,self-limitingsymptomsto

rapidlyfataldisease.

2. Abdominalcramps,nausea,vomiting,anddiarrheaarecommon. 3. Thehallmarkclinicalmanifestationissymmetric,descendingflaccid

paralysis.Itstartswithdrymouth,diplopia,and/ordysarthria.Paralysisoflimb musculatureoccurslater.

Quick HIT

Differentialdiagnosisoffood-bornebotulismincludes:

¢

Guillain–Barrésyndrome—characteristicallyascendingparalysis,butonevariety(Fischer)canbe descending Eaton–Lambertsyndrome Myastheniagravis—EMGstudiesdifferentiate Diphtheria Tickparalysis

C.Diagnosis 1. Thedefinitivediagnosisisidentificationoftoxininserum,stool,orgastric

contents(bioassay).

2. IdentifyingC.botulinumaloneinfoodisnotareliablediagnosticindicator.

D.Treatment 1. Admitthepatientandobserverespiratorystatusclosely.Gastriclavageishelpful

onlywithinseveralhoursafteringestionofsuspectedfood.

2. Ifsuspicionofbotulismishigh,administerantitoxin(toxoid)assoonas laboratoryspecimensareobtained(donotwaitfortheresults).

3. Forcontaminatedwounds—(inadditiontotheabove)woundcleansingand penicillin.

Intra-AbdominalAbscess

Causesincludespontaneousbacterialperitonitis,pelvicinfection(e.g.,tubo-ovarian abscess),pancreatitis,perforationoftheGItract,andosteomyelitisofthevertebral bodieswithextensionintotheretroperitonealcavity. Usuallypolymicrobialinorigin. DiagnoseusingCTscanorultrasound. Treatmenttypicallyinvolvesdrainageoftheabscess. Theantibioticregimenshouldincludebroadcoverageagainstgram-negativerods, enterococci,andanaerobes.

PseudomembranousColitis
======================================
A.GeneralCharacteristics 1. Thisisalsoreferredtoasantibiotic-associatedcolitisbecausemanypatientsdo

nothavegrosslyvisiblepseudomembranes.

2. AntibiotictreatmentkillsorganismsthatnormallyinhibitgrowthofClostridium difficile,leadingtoovergrowthofC.difficileandtoxinproduction.

3. Almostallantibioticshavebeenassociated,butthemostfrequentlyimplicated antibioticsareclindamycin,ampicillin,andcephalosporins.

4. Symptomsusuallybeginduringfirstweekofantibiotictherapy.However,upto6 weeksmayelapseafterstoppingantibioticsbeforeclinicalfindingsbecome apparent.

5. Diseaseseveritycanbeclassifiedasmild–moderate[AQ2],severe,orfulminant dependingontheWBCcount,serumcreatinine,andpresenceof hypotension/shock,ileus,ormegacolon.

Quick HIT

Complicationsofseverepseudomembranouscolitisthatmayrequiresurgery:

¢

¢

e

Toxicmegacolon Colonicperforation Anasarca,electrolytedisturbances

B.ClinicalFeatures 1. Profusewaterydiarrhea,usuallywithoutbloodormucus 2. Crampyabdominalpain 3. Toxicmegacolon(inseverecases)withriskofperforation

C.Diagnosis 1. DemonstrationofC.difficiletoxinsinstoolisdiagnostic,butresultstakeatleast

24hours(95%sensitivity).

2. Flexiblesigmoidoscopyisthemostrapidtestandisdiagnostic,butbecauseof discomfort/expense,itisinfrequentlyused(usuallyreservedforspecial situations).

3. Abdominalradiographisusedtoruleouttoxicmegacolonandperforation. 4. Leukocytosisisverycommon.

D.Treatment 1. Discontinuetheoffendingantibiotic,ifpossible. 2. Initialepisodeifmild–moderateorsevere:vancomycinorfidaxomicin. 3. Initialepisodeiffulminant:vancomycin.Ifileusispresent,addmetronidazole.

Subtotalcolectomyordivertingloopileostomywithcoloniclavagemaybe necessary.

4. Firstrecurrence:vancomycinorfidaxomicin 5. Secondorsubsequentrecurrence:vancomycin,fidaxomicin,orfetalmicrobiota

transplantation

6. Regardlessofchoiceofantibiotic,15%to35%ofsuccessfullytreatedpatients willhaverecurrencemayoccurwithin2to8weeksafterstoppingtheantibiotic. Thisoccursin15%to35%ofsuccessfullytreatedpatients.

InfectionsoftheGenitourinaryTract LowerUrinaryTractInfections
======================================
Quick HIT

Morethan90%ofuncomplicatedUTIsarecausedbyE.coli,S.saprophyticus,andEnterococcusspp.Asmall percentageiscausedbyProteus,Klebsiella,Enterobacter,andPseudomonas.

A.GeneralCharacteristics 1. Urinarytractinfections(UTIs)aremuchmorecommoninwomenthaninmen. Upto33%ofallwomenexperienceaUTIintheirlifetime.Themostcommon UTIisuncomplicatedacutecystitis.

2. ThemajorityofUTIsarecausedbyascensionofpathogensfromtheurethrato thebladder.Thesepathogensarefromfecalflorathathavecolonizedthevaginal area.

3. Commonorganisms.

a. E.coli(mostcommon)—causes80%ofcases. b. Otherorganisms—Staphylococcussaprophyticus,Enterococcus,Klebsiella, Proteusspp.,Pseudomonas,Enterobacter,andyeast(suchasCandidaspp.)

B.RiskFactors 1. Femalegender—greaterriskduetoshorterurethrallength 2. Sexualintercourse

a. OftenthetriggerofaUTIinwomen,thustheterm“honeymooncystitis” b. Useofdiaphragmsandspermicidesfurtherincreasesrisk(altersvaginal

colonization)

3. Pregnancy 4. Indwellingurinarycatheters—riskfactorforhospitalizedpatients 5. PersonalhistoryofrecurrentUTIs 6. Host-dependentfactors—increaseriskforrecurrentorcomplicatedUTIs

a. Diabetes—diabeticpatientsareatriskforupperUTIs b. Patientswithspinalcordinjury c. Immunocompromisedstate d. Anystructuralorfunctionalabnormalitythatimpedesurinaryflow(e.g.,

incompletevoiding,neurogenicbladder,BPH,vesicoureteralreflux,calculi)

7. Maleriskfactors

a. Uncircumcisedmalesareathigherriskduetobacterialcolonizationofthe

foreskin

b. Analintercourse c. Vaginalintercoursewithafemalecolonizedwithuropathogens

Quick HIT

Noninfectiouscausesofcystitisorcystitis-likesymptoms:

¢

¢

e

e

Cytotoxicagents(e.g.,cyclophosphamide) Radiationtothepelvis Dysfunctionalvoiding Interstitialcystitis

Quick HIT

Urinecultureandsensitivitymaymodifyantibiotictherapy,butmostUTIsaretreatedbasedonurinalysisand Gramstainresults.Obtainculturesunderthefollowingconditions:patientage≥65years,diabetes,recurrent UTIs,presenceofsymptomsfor7daysormore,useofadiaphragm.

Quick HIT

AsymptomaticBacteriuria

¢
======================================
e

Todiagnoseasymptomaticbacteriuria,twosuccessivepositivecultures(≥105CFU/mL)mustbepresent. Treatasymptomaticbacteriuriaonlyinpregnancyorbeforeurologicsurgery.

Quick HIT

OnUA,mostimportantfindingiswhitebloodcells.

C.ClinicalFeatures 1. Dysuria—commonlyexpressedasburningonurination 2. Frequency 3. Urgency 4. Suprapubictenderness 5. Grosshematuriaissometimespresent 6. InlowerUTIs,feverischaracteristicallyabsent

D.Diagnosis 1. Dipstickurinalysis

a. Positiveurineleukocyteesterasetest—presenceofleukocyteesterasereflects pyuria

b. Positivenitritetestforpresenceofbacteria(gram-negative)—nitritetestis sensitiveandspecificfordetectingEnterobacteriaceae.Butitlackssensitivity

forotherorganisms,soanegativetestshouldbeinterpretedwithcaution c. Combiningtheabovetwotestsyieldsasensitivityof85%andspecificityof

c. Combining the above two tests yields a sensitivity of 85% and specificity of 75%

75%

2. Urinalysis(clean-catchmidstreamspecimen)

a. Adequacyofcollection

Thepresenceofepithelial(squamous)cellsindicatesvulvarorurethral contamination Ifcontaminationissuspected,performastraightcatheterizationofthebladder

e

b. CriteriaforUTI

e

e

Bacteriuria:>1organismperoil-immersionfield.BacteriuriawithoutWBCs mayreflectcontaminationandisnotareliableindicatorofinfection Pyuriaisthemostvaluablefindingfordiagnosis:Greaterthanorequalto10 leukocytes/μLisabnormal

c. Otherfindings—hematuriaandmildproteinuriamaybepresent.Hematuriain andofitselfdoesnotrequireextendedtherapy

3. UrineGramstain

a. Acountof>105organisms/mLrepresentssignificantbacteriuria b. Itis90%sensitiveand88%specific

4. Urineculture

a. Confirmsthediagnosis(highspecificity).Obtainingaurinecultureiswarranted ifsymptomsarenotcharacteristicofUTI,ifacomplicatedinfectionis suspected,orifsymptomspersistdespitepriorantibiotictreatment

b. Traditionalcriteria:≥105CFU/mLofurinefromaclean-catchsample;missesup toone-thirdofUTIs

c. Colonycountsaslowas102to104CFU/mLareadequatefordiagnosisif clinicalsymptomsarepresent

5. Bloodcultures—onlyindicatedifpatientisillandurosepsisissuspected 6. IVP,cystoscopy,andexcretoryurographyarenotrecommendedunlessstructural

abnormalitiesorobstructionissuspected
======================================
Quick HIT

ComplicatedUTIiscausedbyfunctionalorstructuralabnormalitiesoftheurinarytractorunderlyingdisease. ThefollowinggroupsofpatientsareconsideredtohavecomplicatedUTI:

« Men

Men Diabetics,renalfailure Pregnancy Historyofpyelonephritisinlastyear Urinarytractobstruction,indwellingcatheter,stent,nephrostomytube Antibiotic-resistantorganism Immunocompromisedpatients(e.g.,HIVpatients,transplantrecipients)

E.Complications 1. ComplicatedUTI

a. AnyUTIthatspreadsbeyondthebladder(e.g.,pyelonephritis,prostatitis, urosepsis)—riskfactorsforupperUTI:pregnancy,diabetes,andvesicoureteral reflux

b. AnyUTIcausedbystructuralabnormalities,metabolicdisorder,orneurologic dysfunction

2. UTIduringpregnancy—increasedriskofpretermlabor,lowbirthweight,and othercomplications,especiallyinadvancedpregnancy

3. Recurrentinfections

a. Usuallyduetoinfectionwithneworganism,butsometimesisarelapsedueto unsuccessfultreatmentoftheoriginalorganism

b. Riskfactorsincludeimpairedhostdefenses,pregnancy,vesicoureteralreflux, andsexualintercourseinwomen

c. Generally,theconsequencesarenotsignificantunlessthepatientisatriskfor upperUTI

Quick HIT

ForuncomplicatedUTI,empirictreatmentisappropriate—donotwaitforcultureresults.

Quick HIT

IfcomplicatedUTI,extendantibiotictreatmentto7days.

F.Treatment 1. Acuteuncomplicatedcystitis—thatis,nonpregnantwomen.Severaloptionsexist:

a. OralTMP/SMX(Bactrim)for3days. b. Nitrofurantoin(5to7days)—donotgiveifearlypyelonephritisissuspected. c. Fosfomycin(singledose)—donotgiveifearlypyelonephritisissuspected. d. Amoxicillinisalesspopularalternativeduetoincreasingantimicrobial

resistance.

e. Fluoroquinolones(ciprofloxacinin3-dayregimen)isareasonablealternativeto theabove-mentionedagents.

f. Treatpresumptivelyforpyelonephritisiftheconditionfailstorespondtoashort courseofantibiotics.

g. Phenazopyridine(Pyridium)isaurinaryanalgesic;itcanbegivenfor1to3 daysfordysuria.

2. PregnantwomenwithUTI.

a. Treatwithampicillin,amoxicillin,ororalcephalosporinsfor7to10days. b. Avoidfluoroquinolones(cancausefetalarthropathy).

3. UTIsinmen.
======================================
a. Treataswithuncomplicatedcystitisinwomen,butfor7days. b. UrologicworkupisrequiredinallmenpresentingwithUTIunlessthereisan

obviousunderlyingriskfactor(catheterization,etc.).

4. Recurrentinfections.

a. Ifrelapseoccurswithin2weeksofcessationoftreatment,continuetreatmentfor 2moreweeksandobtainaurineculture.

b. Otherwisetreatasforuncomplicatedcystitis.Ifthepatienthasmorethantwo UTIsperyear,givechemoprophylaxis.

e

e

SingledoseofTMP/SMXafterintercourseoratfirstsignsofsymptoms. Alternativelow-doseprophylacticantibiotics(e.g.,low-doseTMP/SMX)for6 months.

Pyelonephritis

A.GeneralCharacteristics 1. Pyelonephritisisaninfectionoftheupperurinarytract.

a. Itisusuallycausedbyascendingspreadfromthebladdertothekidney. b. Uncomplicatedpyelonephritisislimitedtotherenalpyelocalyceal-medullary

region.

c. Vesicoureteralrefluxfacilitatesthisascendingspread.Seeaboveforotherrisk factors.

2. Organisms

a. E.coli(mostfrequentcause). b. Othergram-negativebacteriaincludeProteus,Klebsiella,Enterobacter,and

Pseudomonasspp.

c. Gram-positivebacteria(lesscommon)includeEnterococcusfaecalisandS. aureus.

3. Complications(unusual).

a. Sepsisoccursin10%to25%ofpatientswithpyelonephritis.Mayleadtoshock. b. Emphysematouspyelonephritis—causedbygas-producingbacteriaindiabetic

patients.

c. Chronicpyelonephritisandscarringofthekidneys—rareunlessunderlyingrenal diseaseexists.

B.ClinicalFeatures 1. Symptoms

a. Fever,chills b. Flankpain c. Symptomsofcystitis(mayormaynotbepresent) d. Nausea,vomiting,anddiarrhea(sometimespresent)

2. Signs

a. Feverwithtachycardia b. Patientsgenerallyappearmoreillthanpatientswithcystitis c. Costovertebralangletenderness—unilateralorbilateral d. Abdominaltendernessmaybepresentonexamination

C.Diagnosis 1. Urinalysis

a. Lookforpyuria,bacteriuria,andleukocytecasts b. Asincystitis,hematuriaandmildproteinuriamaybepresent

2. Urinecultures—obtaininallpatientswithsuspectedpyelonephritis

3. Bloodcultures—obtaininill-appearingpatientsandallhospitalizedpatients 4. CBC—leukocytosiswithleftshift 5. Renalfunction—thisisusuallypreserved.Impairmentisusuallyreversible,

especiallywithIVfluids

6. Imagingstudies—performtheseiftreatmentfailsorinanypatientwith complicatedpyelonephritis.Considerrenalultrasound,CT,IVP,orretrograde ureterogram
======================================
D.Treatment 1. Foruncomplicatedpyelonephritis.

a. Useoutpatienttreatmentifthepatientcantakeoralantibiotics.Treatbasedon Gramstain:

e

e

e

TMP/SMXorafluoroquinolonefor10to14daysiseffectiveformostgram- negativerods. Amoxicillinisappropriateforgram-positivecocci(enterococci,S. saprophyticus). Asingledoseofceftriaxoneorgentamicinisoftengiveninitiallybefore startingoraltreatment.

b. Repeaturineculture2to4daysaftercessationoftherapy. c. Ifsymptomsfailtoresolvewithin48hours,adjusttreatmentbasedonurine

culture.

d. Failuretorespondtoappropriateantimicrobialtherapysuggestsafunctionalor structuralabnormality;performaurologicinvestigation.

2. Ifthepatientisveryill,elderly,pregnant,unabletotolerateoralmedication,or hassignificantcomorbidities,orifurosepsisissuspected

a. HospitalizethepatientandgiveIVfluids. b. Treatwithantibiotics.

e

e

e

Startwithparenteralantibiotics(broad-spectrum)—ampicillinPLUS gentamicinorciprofloxacinarecommoninitialchoices. Ifbloodculturesarenegative,treatwithIVantibioticsuntilthepatientis afebrilefor24hours,thengiveoralantibioticstocompletea14-to21-day course. Ifbloodculturesarepositive(urosepsis),treatwithIVantibioticsfor2to3 weeks.

3. Forrecurrentpyelonephritis.

a. Ifrelapseisduetothesameorganismdespiteappropriatetreatment,treatfor6 weeks.

b. Ifrelapseisduetoaneworganism,treatwithappropriatetherapyfor2weeks.

Prostatitis

Quick HIT

AcuteVersusChronicProstatitis

e

¢

Acuteprostatitisisamoreseriousconditionthanchronicprostatitis,andurgenttreatmentisnecessary. Acuteprostatitisismuchmoreobviousclinically(fever,exquisitelytenderprostate),whereaschronic prostatitisisdifficulttodiagnosebecausetheprostatemaynotbetenderandfindingsarevariable.

A.GeneralCharacteristics 1. Acutebacterialprostatitis

a. Lesscommonthanchronicbacterialprostatitis b. Occursmorecommonlyinyoungermen c. Pathophysiology

Ascendinginfectionfromtheurethraandrefluxofinfectedurine Mayoccurafterurinarycatheterization Othercauses—directorlymphaticspreadfromtherectum Hematogenousspread(rare)

d. Gram-negativeorganismspredominate(e.g.,E.coli,Klebsiella,Proteus, Pseudomonas,Enterobacter,andSerratiaspp.)

2. Chronicbacterialprostatitis

a. Morecommonthanacutebacterialprostatitis;trueprevalenceisdifficultto determinebecausemanycasesareasymptomaticandarediagnosedincidentally
======================================
b. Itmostcommonlyaffectsmen40to70yearsofage c. Ithasthesameroutesofinfectionasacutebacterialprostatitis.Itmaydevelop

fromacutebacterialprostatitis

d. Organismsaresimilartothoseinacuteprostatitis

Quick HIT

Avoidprostaticmassageinpatientswithacutebacterialprostatitisbecauseitmayinducebacteremia.Infact, rectalexaminationmaybeskippedifthediagnosisisstraightforward.

B.ClinicalFeatures 1. Acuteprostatitis

a. Fever,chills—patientsmayappeartoxic. b. Irritativevoidingsymptoms—dysuria,frequency,andurgencyarecommon. c. Perinealpain,lowbackpain,andurinaryretentionmaybepresentaswell.

2. Chronicprostatitis

a. Patientsmaybeasymptomatic.Patientsdonotappearill.Feverisuncommon. b. PatientsfrequentlyhaverecurrentUTIswithirritativevoidingand/orobstructive

urinarysymptoms.

c. Thereisdull,poorlylocalizedpaininthelowerback,perineal,scrotal,or suprapubicregion.

C.Diagnosis 1. DRE—thereisaboggy,exquisitelytenderprostateinacutedisease.Inchronic

disease,prostateisenlargedandusuallynontender.

2. Urinalysis—numerous(sheetsof)WBCsarepresentinacutebacterialprostatitis. 3. Urinecultures—almostalwayspositiveinacuteprostatitis. 4. Chronicprostatitis—thepresenceofWBCsinexpressedprostaticsecretions

suggestsdiagnosis.Urineculturesmaybepositive(chronicbacterialprostatitis) ornegative(chronicnonbacterialprostatitis).

5. ObtainCBCandbloodculturesifpatientappearstoxicorifsepsisissuspected.

D.Treatment 1. Acuteprostatitis.

a. Ifitissevereandthepatientappearstoxic,hospitalizethepatientandinitiateIV antibiotics.

b. Ifitismild,treatonanoutpatientbasiswithantibiotics—TMP/SMXora fluoroquinoloneanddoxycycline.Treatfor4to6weeks.

c. Thepatientusuallyrespondstotherapy.

2. Chronicprostatitis.

a. Treatwithafluoroquinolone.Forchronicbacterialprostatitis,aprolonged courseisrecommendedbutdoesnotguaranteecompleteeradication.

b. Itisverydifficulttotreat.Recurrencesarecommon.

Quick HIT

Recurrentexacerbationsarecommoninchronicprostatitisifnottreatedadequately.RecurrentUTIisvery commoninthesepatients.

SexuallyTransmittedDiseases GenitalWarts
======================================
Quick HIT

Eightypercentofcasesofreactivearthritis(formerlyReitersyndrome)areassociatedwithchlamydialinfection.

ThesearecausedbyHPV. Theyarethemostcommonsexuallytransmitteddisease(STD). SeeChapter11,CommonDermatologicProblems,Inflammatory,Allergic,and AutoimmuneSkinConditions,Warts.

Chlamydia

Quick HIT

Chlamydiainfectionisariskfactorforcervicalcancer,especiallywhenthereisahistoryofmultipleinfections.

A.GeneralCharacteristics 1. ChlamydiaisthemostcommonbacterialSTD.Theorganismisanintracellular

pathogen.

2. Manypatientsarecoinfectedwithgonorrhea(upto40%ofwomenand20%of men).

3. Theincubationperiodis1to3weeks.

Quick HIT

ComplicationsofChlamydia

Complicationsinmenincludeepididymitisandproctitis. Complicationsinwomenincludepelvicinflammatorydisease,salpingitis,tubo-ovarianabscess,ectopic pregnancy,andFitz-Hugh–Curtissyndrome.Chlamydiaisaleadingcauseofinfertilityinwomendueto tubalscarring.

B.ClinicalFeatures 1. Manycasesareasymptomatic(80%ofwomen,50%ofmen). 2. Menwhoaresymptomaticmayhaveanyofthefollowing:dysuria,purulent

urethraldischarge,scrotalpainandswelling,andfever.

3. Womenwhoaresymptomaticmayhavepurulenturethraldischarge, intermenstrualorpostcoitalbleeding,anddysuria.

C.Diagnosis 1. Diagnostictestsincludeculture,enzymeimmunoassay,andmoleculartestssuch

asPCR.SerologictestsarenotusedforChlamydia.

2. Moleculardiagnostictestsarereplacingcultureasthescreeningtestofchoicedue tohighersensitivity.

3. Sexuallyactivewomenshouldbescreenedforchlamydialandgonorrheal infectioneveniftheyareasymptomatic.

D.Treatment 1. Azithromycin(oralonedose)ordoxycycline(oralfor7days). 2. Treatallsexualpartners.

Gonorrhea

Quick HIT

Ingonorrhea,infectionofthepharynx,conjunctiva,andrectumcanoccur.

A.GeneralCharacteristics 1. TheresponsibleorganismisNeisseriagonorrhoeae(agram-negative,

intracellulardiplococcalorganism).

2. Gonorrheaisusuallyasymptomaticinwomenbutsymptomaticinmen. Therefore,complicationsoccurmoreofteninwomenduetoundetecteddisease.

3. Itisalmostalwaystransmittedsexually(exceptwithneonataltransmission). 4. CoinfectionwithChlamydiatrachomatisoccursin30%ofpatients(more

commoninwomen).
======================================
Quick HIT

GonorrhealComplications

e

e

e

e

e

Pelvicinflammatorydisease,withpossibleinfertilityandchronicpelvicpain Epididymitis,prostatitis(uncommon) Salpingitis,tubo-ovarianabscess Fitz-Hugh–Curtissyndrome(perihepatitis)—RUQpain;elevatedLFTs Disseminatedgonococcalinfection

B.ClinicalFeatures 1. Men

a. Gonorrheaisasymptomaticinupto10%ofcarriers.Theseasymptomatic carrierscanstilltransmitthedisease

b. Mostmenhavesymptomsinvolvingtheurethra—forexample,purulent discharge,dysuria,erythemaandedemaofurethralmeatus,andfrequencyof urination

2. Women

a. Mostwomenareasymptomaticorhavefewsymptoms b. Womenmayhavesymptomsofcervicitisorurethritis—forexample,purulent

discharge,dysuria,intermenstrualbleeding,anddyspareunia

3. Disseminatedgonococcalinfection(occursin1%to2%ofcases;morecommon inwomen)—possiblefindings:

a. Fever,arthralgias,tenosynovitis(ofhandsandfeet) b. Migratorypolyarthritis/septicarthritis,endocarditis,orevenmeningitis c. Skinrash(usuallyondistalextremities)

C.Diagnosis 1. Gramstainofurethraldischargeshowingorganismswithinleukocytesishighly

specificforgonorrhea.

2. Obtainculturesinallcases—inmenfromtheurethra;inwomenfromthe endocervix.Maytreatempiricallybecausecultureresultstake1to2daysto return.

3. ConsidertestingforsyphilisandHIV. 4. Obtainbloodculturesifdiseasehasdisseminated.

D.Treatment 1. Ceftriaxone(IM,onedose)ispreferredbecauseitisalsoeffectiveagainst syphilis.Otheroptionsareoralcefixime,ciprofloxacin,orofloxacin.

2. Alsogiveazithromycin(onedose)ordoxycycline(for7days)tocovercoexistent chlamydialinfection.

3. Ifdisseminated,hospitalizethepatientandinitiateceftriaxone(IVorIMfor7 days).

HIVandAIDS

Quick HIT

Itisimportant(butoftendifficult)toidentifypatientswithprimaryHIVinfectionbecauseofthebenefitsof earlyantiretroviraltherapy.Ahighindexofsuspicionisnecessary.

A.GeneralCharacteristics 1. Pathophysiology

a. ThemostcommonvirusassociatedwithHIVistheHIVtype1humanretrovirus b. ThevirusattachestothesurfaceofCD4+Tlymphocytes(targetsofHIV-1);it entersthecellanduncoats,anditsRNAistranscribedtoDNAbyreverse transcriptase

c. BillionsofviralparticlesareproducedeachdaybyactivatedCD4cells.When thevirusentersthelyticstageofinfection,CD4cellsaredestroyed.Itisthe depletionofthebody’sarsenalofCD4cellsthatweakenshostcellular immunity

2. Transmissionisusuallysexualorparenteral.Otherthansemenandblood,fluids thattransmitthediseasearebreastmilkandvaginalfluid

a. Riskoftransmission:
======================================
Needlestickinjury—1in300 Vaginal(maletofemale)—1in1,000 Vaginal(femaletomale)—1in3,000 Analreceptive—1in100 Mothertochild—1in3withoutmedications.Withmedications,riskisunder2 in100

b. Cesareandeliveryisindicatedifviralloadisover1,000copies.IfCD4countis high(over500)andviralloadislow(under1,000),C-sectionisnotnecessary

3. Mortalityisusuallysecondarytoopportunisticinfection,wasting,orcancer 4. High-riskindividuals:menwhohavesexwithmen,IVdrugabusers,blood

transfusionrecipientsbefore1985(beforewidespreadscreeningofdonorblood), heterosexualcontactsofHIV-positiveindividuals,unbornandnewbornbabiesof motherswhoareHIVpositive

CLINICALPEARL10-4 HIVSerology CD4CellCount

¢

¢

¢

e

¢

Itisthebestindicatorofthestatusoftheimmunesystemandoftheriskforopportunisticinfectionsand diseaseprogression. ItisusedtodeterminewhentoinitiateantiretroviraltherapyandPCPprophylaxis.Itisalsousefulin assessingtheresponsetoantiretroviraltherapy. Ifuntreated(noretroviraltherapy),theCD4cellcountdecreasesatanaveragerateofabout50peryear. If>500,theimmunesystemisessentiallynormal.HIV-relatedinfectionorillnessisunlikely. If200to500,thereisanincreasedriskofHIV-relatedproblems,suchasherpeszoster,TB,lymphoma, bacterialpneumonias,andKaposisarcoma.However,manypatientsareasymptomaticattheseCD4levels. MostopportunisticinfectionsoccurwhentheCD4countfallsbelow200.

¢

ViralLoad(HIV-1RNALevels)

¢

e

¢

e

Usedtoassessresponsetoandadequacyofantiretroviraltherapy;providescomplementaryprognostic informationtotheCD4+count. Iftheviralloadisstill>50afterabout4monthsoftreatment,modificationintheregimenmaybeneeded. Donotstopantiretroviraltherapyevenifviralloadsareundetectableforyears.Latentlyinfectedcellscan leadtoreappearanceofviralRNAoncetherapyisstopped. MeasuretheplasmaHIVRNAlevelsandtheCD4cellcountatthetimeofdiagnosisandevery3to4months thereafter.

Quick HIT

ThecourseofHIVvariesconsiderablyfrompatienttopatient.However,thetypicalcoursecanbedividedinto thefollowingfourphases:primaryinfection,asymptomaticinfection,symptomaticinfection,andfull-blown AIDS.
======================================
Quick HIT

ThecombinationofELISAandWesternblotyieldsanoverallsensitivityandspecificityof>99%.

B.ClinicalFeatures 1. Primaryinfection(seealsoClinicalPearl10-4).

a. Amononucleosis-likesyndromeabout2to4weeksafterexposuretoHIV. Durationoftheillnessisbrief(3daysto2weeks).

b. Symptomsincludefever,sweats,malaise,lethargy,headaches, arthralgias/myalgias,diarrhea,sorethroat,lymphadenopathy,andatruncal maculopapularrash.

2. Asymptomaticinfection(seropositive,butnoclinicalevidenceofHIVinfection).

a. CD4countsarenormal(>500/mm3). b. Longestphase(lasts4to7years,butvarieswidely,especiallywithtreatment).

3. SymptomaticHIVinfection(pre-AIDS).

a. Firstevidenceofimmunesystemdysfunction. b. Withouttreatment,thisphaselastsabout1to3years. c. Thefollowingfrequentlyappear:

Persistentgeneralizedlymphadenopathy.

¢

Localizedfungalinfections(e.g.,onfingernails,toes,mouth). Recalcitrantvaginalyeastandtrichomonalinfectionsinwomen. Oralhairyleukoplakiaonthetongue. Skinmanifestationsthatincludeseborrheicdermatitis,psoriasisexacerbations, molluscum,andwarts. Constitutionalsymptoms(nightsweats,weightloss,anddiarrhea).

4. AIDS

a. Markedimmunesuppressionleadstodisseminatedopportunisticinfectionsand malignancies.

b. CD4countis<200cells/mm3. c. Pulmonary,GI,neurologic,cutaneous,andsystemicsymptomsarecommon(see

Table10-4).

C.Diagnosis 1. PCRRNAviralloadtest—patientswithacuteHIVinfectionhaveveryhighlevels

ofviremia.Thistestisrepeatedtoassesseffectivenessoftherapy.

2. p24antigenassay—lesscostlybutlesssensitivealternativetoviralloadtesting. 3. Seroconversionoccurs3to7weeksafterinfectionandconfirmsthediagnosis.

a. Enzyme-linkedimmunosorbentassay(ELISA)method.

e

e

e

ScreeningtestfordetectingantibodytoHIV;becomespositive1to12weeks afterinfection. AnegativeELISAessentiallyexcludesHIV(99%sensitive)ifthepatienthas nothadasubsequentexposurebeforetesting(beforeseroconversion). Ifpositive,Westernblottestshouldbeperformedforconfirmation.

b. WesternblottestisaspecifictestusedtoconfirmapositiveresultonanELISA
======================================
test.

4. DiagnosisofAIDS.

a. CDCdefinitionofAIDS:ApatientwithHIVhasAIDSifheorshehas(1)a CD4+T-cellcountbelow200,(2)aCD4+Tcellpercentageoftotal lymphocytesbelow14%,or(3)anAIDS-definingillness.(SeeTable10-5.)

TABLE10-3 ClinicalManifestationofAIDS
======================================
«

LeadingcauseofdeathinpatientswithAIDS OccurswhenCD4countisÄ200 Clinicalfindings:fever,nonproductivecough,shortnessofbreath(with exertionatfirst,thenoccurringatrest) CXR:diffuseinterstitialinfiltrates;negativeradiographsin10–15%of patientswithPCP Treatment:TMP-SMX(POorIV)for3wks;steroidtherapyifpatientis hypoxicorhaselevatedA–agradient Prophylaxis:OralTMP-SMX,1dosedaily,isrecommended

e

Tuberculosis (other infections)

NegativePPDtestresultsarefrequentamongAIDSpatientsdueto immunosuppression
======================================
D.Treatment 1. Antiretroviraltherapy(Table10-6)

a. Indications

e

e

SymptomaticpatientsregardlessofCD4count AsymptomaticpatientswithCD4count<500

b. Triple-drugregimensknownashighlyactiveantiretroviraltherapy(HAART): TotargetandpreventHIVreplicationatthreedifferentpointsalongthe replicationprocess,usetwonucleosidereversetranscriptaseinhibitorsandeither ofthefollowing:

e

e

Anonnucleosidereversetranscriptaseinhibitor Aproteaseinhibitor

c. MonitortheresponsetotreatmentusingplasmaHIVRNAload—thegoalisto reducetheviralloadtoundetectablelevels

d. ItisgenerallyrecommendedthatHAARTtherapybecontinuedinpregnant patientswithHIV

AntiretroviralTherapyinHIV

e

¢

Theimportanceofstrict(i.e.,100%)adherencetothetriple-drugregimencannotbeoveremphasized,because evenminordeviationsmayresultindrugresistance.Thishasbeenimprovedinrecentyearsbycombiningthe medicationsintoasinglepillforpatients. Donotinitiatetriple-drugtherapyinapatientwhoisnotwillingorabletofullycomplywiththeprescribed regimen.

2. Opportunisticinfectionprophylaxis

a. Pneumocysticpneumonia(PCP),formerlyP.carinii,nownamedPneumocystis jiroveci

¢

e

e

OccursinpatientswithAIDSwhenCD4cellcountis<200andpatientisnot onprophylaxis Dyspnea,drycough,fever Tests:chestx-ray(bilateralinterstitialinfiltrates),LDLlevel(alwayselevated), ABG(hypoxiaorincreasedA–agradient),sputumstainforpneumocystis (veryspecificbutnotsensitive),bronchoscopywithBAL(mostaccuratetest) TMP/SMXisthepreferredagent

e

b. TB

e

e

ScreenallpatientswithayearlyPPDtest PrescribeisoniazidpluspyridoxineifthepatienthaspositivePPD

c. Atypicalmycobacteria—Mycobacteriumaviumcomplex(MAC)

e

e

StartprophylaxiswhenCD4cellcountis<100 Clarithromycinandazithromycinareprophylacticagents

d. Toxoplasmosis

e

e

StartprophylaxiswhenCD4countis<100 TMP/SMXisthepreferredagent

3. Vaccination(nolive-virusvaccines!)

a. Pneumococcalpolysaccharidevaccine(Pneumovax)—every5to6years b. Influenzavaccine—yearly c. HepatitisBvaccine(ifnotalreadyantibody-positive)(SeeChapter12.)
======================================
TABLE10-4 AIDSIndicatorDiseases

Candidiasis,invasive

Cervicalcancer,invasive

Coccidioidomycosis,extrapulmonary

Cryptococcosis,extrapulmonary

Cryptosporidiosisof>1-moduration

Cytomegalovirusdiseaseoutsidelymphoreticularsystem

Encephalopathy,HIV-related

Herpessimplexinfectionof>1-modurationorvisceralherpessimplex

Salmonellabacteremia,recurrent

Histoplasmosis,extrapulmonary

Isosporiasisof>1-moduration

Kaposisarcoma

Lymphoma:primarycentralnervoussystem,immunoblastic,orBurkitt

Mycobacterialdisease,disseminatedorextrapulmonary

M.tuberculosisinfection

PCP

Pneumonia,recurrent(morethanoneepisodein1yr)

Progressivemultifocalleukoencephalopathy

Toxoplasmosis,cerebral

WastingsyndromeduetoHIV

ModifiedfromStollerJK,AhmadM,LongworthDL.TheClevelandClinicIntensiveReviewofInternal Medicine.3rded.Philadelphia,PA:LippincottWilliams&Wilkins,2002:188,Table15.6.

HerpesSimplex

A.GeneralCharacteristics 1. TherearetwotypesofHSV:HSV-1andHSV-2.Bothareveryprevalentinthe

generalpopulation(Figure10-3).

a. HSV-1istypicallyassociatedwithlesionsoftheoropharynx. b. HSV-2isassociatedwithlesionsofthegenitalia(seeTable10-7). c. Bothviruses,however,cancauseeithergenitalororallesions.
======================================
NonnucleosideReverseTranscriptaseInhibitors(NNRTIs)

Efavirenz (contraindicated inpregnancy) Nevirapine Delavirdine (contraindicated inpregnancy)

Noncompetitivelyinhibitreversetranscriptase.Do notrequirephosphorylation. Rashandhepatotoxicity.CNSsymptoms withefavirenz.

ProteaseInhibitors

Atazanavir Darunavir Fosamprenavir Indinavir (crystal-induced nephropathy)

Inhibitedprotease(polgene),whichcleaves polypeptideproducts.Allendin-navir.

Hyperglycemia,hyperlipidemia,GI intolerance,lipodystrophy

Ritonavir (“boost”by inhibitingP450) Saquinavir (“boost”by inhibitingP450)

IntegraseInhibitors

Raltegravir Elvitegravir Dolutegravir

Inhibitintegrationintohostcell.

Insomnia,dizziness

FusionInhibitors

Enfuvirtide Maraviroc Bindsgp41,inhibitsentry.BindsCCR-5,inhibits interactionwithgp120. Eosinophiliacausingskinreactionat injectionsite.

2. Pathophysiology:Afterinoculation,theHSVreplicatesinthedermisand epidermis,thentravelsviasensorynervesuptothedorsalrootganglia.Itresides asalatentinfectioninthedorsalrootganglia,whereitcanbereactivatedatany timeandreachtheskinthroughperipheralnerves.

3. Transmission

a. HSVistransmittedbycontactwithpeoplewhohaveactiveulcerationsor sheddingofvirusfrommucousmembranes.HSV-1istypicallyassociatedwith transmissionthroughnonsexualpersonalcontact(e.g.,kissing),andHSV-2 throughsexualcontact.

b. MostpeopleacquireHSV-1inchildhood,andmorethan80%ofadultshave beeninfectedwithHSV-1.

c. TheincidenceofHSV-2hasincreasedinrecentyears. d. Episodesofgenitalherpesfrequentlymaybeasymptomaticormayproduce

symptomsthatoftengounrecognized.Virusisstillshed,andtheinfectedperson iscontagious.

e. Contractingoneformofherpesconferssomedegreeofcross-immunity, renderingprimaryinfectionwiththeotherformofherpeslesssevere.

f. Infectionwithgenitalherpesisassociatedwithanincreasedriskofcontracting HIV.

FIGURE 10.3

Herpessimplexvirus.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia, PA:LippincottWilliams&Wilkins,2003,Figure19.13).

TABLE10-6 ClinicalManifestationsofGenitalUlcersWithRegional Lymphadenopathy

Primary syphilis 3-90 Clean ulcer, raised No Usually single 3-6 wks Primary herpes simplex 1-26 Grouped papules, Yes Often multiple 1-3 wks virus vesicles, pustules, ulcers Chancroid 1-21 Purulent ulcer, Yes Single in men, Progressive shaggy border multiple in women Lymphogranuloma 3-21 Papule, vesicle, ulcer © No Usually single Few days venereum Granuloma inguinale 8-80 Nodules, coalescing No Single or multiple Progressive granulomatous ulcers Primary syphilis Same time No Firm 80%, 70% bilateral Absent Primary herpes simplex Same time Yes Firm 80%, usually bilateral © Common virus Chancroid Same time Yes Fluctuant, may fistulize 50-65%, usually Uncommon unilateral Lymphogranuloma 2-6 wks later Yes Indurated, fluctuant, Unilateral, one-third Common venereum may fistulize bilateral Granuloma inguinale Variable = Suppurating 10% 15% pseudobubo From Stoller JK, Ahmad M, Longworth DL. The Cleveland Clinic Intensive Review of Internal Medicine. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2002:168, Table 14.3.
======================================
B.ClinicalFeatures 1. HSV-1

a. Primaryinfectionisusuallyasymptomaticandoftengoesunnoticed. b. Whensymptomatic,primaryinfectionisassociatedwithsystemicmanifestations

(e.g.,fevers,malaise)aswellasorallesions(describedbelow).

c. Orallesionsinvolvegroupsofvesiclesonpatchesoferythematousskin.Herpes labialis(coldsores)aremostcommononthelips(usuallypainful,healin2to6 weeks).

d. HSV-1isalsoassociatedwithBellpalsy.

RecurrencesofHSV

e

e

Recurrencesareassociatedwiththefollowing:stress,fever,infection,andsunexposure. Recurrentepisodestendtobecomeshorterindurationandlessfrequentovertime.

2. HSV-2

a. Primaryinfectionresultsinmoresevereandprolongedsymptoms,lastingupto

3weeksinduration.

b. Recurrentepisodesaremilderandofshorterduration,usuallyresolvingwithin

10days.Thereisalsoadecreaseinthefrequencyofepisodesovertime. c. Constitutionalsymptoms(e.g.,fever,headache,malaise)oftenpresentin

primaryinfection.

d. HSV-2presentswithpainfulgenitalvesiclesorpustules(seeFigure10-3).Other findingsaretenderinguinallymphadenopathyandvaginaland/orurethral discharge.

Quick HIT

HerpeticWhitlow

HSVinfectionofthefingercausedbyinoculationintoopenskinsurface.Commoninhealthcareworkers. Painfulvesicularlesionseruptatthefingertip. Itmaycausefeverandaxillarylymphadenopathy. Treatwithacyclovir.Donotmistakeforparonychia.IncisionanddrainageshouldNOTbedoneforherpetic whitlow.

3. DisseminatedHSV

a. Usuallylimitedtoimmunocompromisedpatients. b. Mayresultinencephalitis,meningitis,keratitis,chorioretinitis,pneumonitis,and

esophagitis.

c. Rarely,pregnantwomenmaydevelopdisseminatedHSV,whichcanbefatalto themotherandfetus.

4. NeonatalHSV(verticaltransmissionattimeofdelivery)isassociatedwith congenitalmalformations,intrauterinegrowthretardation(IUGR), chorioamnionitis,andevenneonataldeath.

5. Oculardisease—eitherformofherpessimplexcancausekeratitis,blepharitis,and keratoconjunctivitis.

C.Diagnosis 1. Thediagnosiscanbemadeclinicallywhencharacteristiclesionsarerecognized. 2. Ifthereisuncertainty,performthefollowingteststoconfirmthediagnosis.

a. Tzancksmear—quickesttest.
======================================
e

e

PerformbyswabbingthebaseoftheulcerandstainingwithWrightstain. Thisshowsmultinucleatedgiantcells.ItdoesnotdifferentiatebetweenHSV andVZV.

b. CultureofHSVisthegoldstandardofdiagnosis.

e

e

Performbyswabbingthebaseoftheulcer. Resultsareavailablewithin2to3days.

c. DirectfluorescentassayandELISA.

e

e

80%sensitive. Resultsavailablewithinminutestohours.

D.Treatment 1. Thereisnocureavailableforeithertypeofherpessimplex.Antiviraltreatment providessymptomaticreliefandreducesthedurationofsymptoms(seebelow).

2. Mucocutaneousdisease

a. Treatwithoraland/ortopicalacyclovirfor7to10days. b. Valacyclovirandfamciclovirhavebetteroralbioavailability. c. Oralacyclovirmaybegivenasprophylaxisforpatientswithfrequent

recurrences.

d. Foscarnetmaybegivenforresistantdiseaseinimmunocompromisedpatients. 3. DisseminatedHSVwarrantshospitaladmission.Treatwithparenteralacyclovir.

Syphilis

A.GeneralCharacteristics 1. ItiscausedbyTreponemapallidumspirochetesandtransmittedbydirectsexual

contactwithinfectiouslesions.

2. Itisasystemicillnesswithfourstages(seebelow).Thelatestagescanbe preventedbyearlytreatment.

Quick HIT

Primarysyphilisischaracterizedbyahardchancre(indurated,painlessulcerwithcleanbase).

B.ClinicalFeatures 1. Primarystage

a. Chancre—apainless,crater-likelesionthatappearsonthegenitalia3to4

weeksafterexposure(Figure10-4) b. Healsin14weeks,evenwithouttherapy c. Highlyinfectious—anyonewhotouchesthelesioncantransmittheinfection

2. Secondarystage

a. Thismaydevelop4to8weeksafterthechancrehashealed.Amaculopapular rashisthemostcharacteristicfindinginthisstage

b. Otherpossiblemanifestations:flu-likeillness,asepticmeningitis,hepatitis c. Patientsarecontagiousduringthisstage d. Aboutone-thirdofuntreatedpatientswithsecondarysyphilisdeveloplatent

syphilis

Quick HIT

Mostcommonpresentationsforsyphilisinclude:

©

e

¢

Genitallesion(chancre) Inguinallymphadenopathy Maculopapularrashofsecondarysyphilis

FIGURE 10.4

Chancreofprimarysyphilis.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins,2003,Figure19.15).

3. Latentstage

a. Latentstageisdefinedasthepresenceofpositiveserologictestresultsinthe absenceofclinicalsignsorsymptoms.Two-thirdsofthesepatientsremain asymptomatic;one-thirddeveloptertiarysyphilis

b. Itiscalledearlylatentsyphilisifserologyhasbeenpositivefor<1year.During thistime,thepatientmayrelapsebacktothesecondaryphase.

c. Itiscalledlatelatentsyphilisifserologyhasbeenpositivefor>1year.Patients
======================================
arenotcontagiousduringthistimeanddonothaveanysymptomsofthe disease. 4. Tertiarystage

a. One-thirdofuntreatedsyphilispatientsinthelatentphaseenterthisstage b. Itoccursyearsafterthedevelopmentoftheprimaryinfection(upto40years

later)

c. Majormanifestationsincludecardiovascularsyphilis,neurosyphilis,and gummas(subcutaneousgranulomas)

d. Neurosyphilisischaracterizedbydementia,personalitychanges,andtabes dorsalis(posteriorcolumndegeneration)

e. Itisveryrarenowadaysduetotreatmentwithpenicillin

C.Diagnosis

1. Dark-fieldmicroscopy(definitivediagnostictest)—examinesasampleofthe chancrewithvisualizationofspirochetes.Mayberequiredinpatientspresenting withchancrebecauseserologymightnotbepositiveyet.

2. Serologictests(mostcommonlyusedtests).

a. Nontreponemaltests—RPR,VDRL(mostcommonlyused).

e

e

Highsensitivity—idealforscreening. Specificityisonlyaround70%.Ifpositive,confirmationisnecessarywiththe specifictreponemaltests.

b. Treponemaltests—FTA-ABS,MHA-TP. Morespecificthannontreponemaltests Notforscreening,justforconfirmationofapositivenontreponemaltest.

3. AllpatientsshouldbetestedforHIVinfection.

Quick HIT

Diagnosisofsyphilis:firstobtainVDRLandRPR.Ifpositive,confirmwithFTA-ABS.

Quick HIT

RPRorVDRLmaybefalselypositiveinpatientswithSLE.

D.Treatment 1. Antibioticsareeffectiveinearlysyphilisbutlesssoinlatesyphilis. 2. Benzathinepenicilling(onedoseIM)isthepreferredagent.Ifthepatientis

allergictopenicillin,giveoralantibiotics(doxycycline,tetracycline)for2weeks.

3. Ifthepatienthaslatelatentsyphilisortertiarysyphilis,givepenicillininthree dosesIMonceperweek.

4. Repeatnontreponemaltestsevery3monthstoensureadequateresponseto treatment.Titersshoulddecreasefourfoldwithin6months.Iftheydonot,that maysignaltreatmentfailureorreinfection.

Chancroid

CausedbyHaemophilusducreyi,agram-negativerod. Transmissionthroughsexualcontact. Incubationperiodof2to10days Therearenosystemicfindings.Disseminatedinfectiondoesnotoccur. Clinicalfeatures:painfulgenitalulcer(s)thatcanbedeepwithraggedbordersand withapurulentbase(Figure10-5);unilateraltenderinguinallymphadenopathy (“buboes”)thatappears1to2weeksafterulcer. Diagnosisismadeclinically.RuleoutsyphilisandHSVandconsidertestingfor HIV.Noserologictestsareavailable,andcultureoftheorganismisnotpractical becauseitrequiresspecialmediathatarenotwidelyavailable. Treatmentoptionsincludeazithromycin(oral,onedose),ceftriaxone(IM,onedose), oranoralcourseofazithromycin,erythromycin,orciprofloxacin. Withtreatment,mostulcersresolvein1or2weeks.
======================================
Quick HIT

DiagnosisofChancroid Painfulgenitalulcer(s) Tenderlymphadenopathy Syphilisruledout(negativedark-fieldexaminationandnegativeserologictests) HSVruledoutbasedonclinicalpresentationornegativecultureforHSV

LymphogranulomaVenereum

AsexuallytransmitteddiseasecausedbyC.trachomatis. Clinicalfeatures—painlessulceratthesiteofinoculationthatmaygounnoticed.A fewweekslater,tenderinguinallymphadenopathy(usuallyunilateral)and constitutionalsymptomsdevelop. Ifuntreated,proctocolitismaydevelopwithperianalfissuresandrectalstricture; obstructionoflymphaticsmayleadtoelephantiasisofgenitals. Diagnosisismadebyserologictests(complementfixation,immunofluorescence). Thetreatmentisdoxycycline(oralfor21days).

PediculosisPubis(PubicLice)

Pediculosispubis(pubicliceor“crabs”)isacommonSTDcausedbyPhthiruspubis (thepubicorcrablouse). Itcanbetransmittedthroughsexualcontactorfomites(clothing,bedding,towels). Severepruritusinthegenitalregionischaracteristic.Otherhairyareasofthebody canbeinvolved. Diagnosisismadebyexaminationofhairundermicroscope(orpossiblywiththe nakedeye)—identificationofadultliceornits. Treatwithpermethrin1%shampoo(Elimite)—applytoallhairyregionsfromneck downandwashoffafterseveralhours.Sexualpartner(s)shouldalsobetreated. Combs,clothes,andbedlinensshouldbewashedthoroughly.

FIGURE 10.5

Chancroid.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins,2003,Figure19.14).

Quick HIT

Therearethreeformsofpediculosis:pediculosiscapitis(headlice),pediculosiscorpora(bodylice),and pediculosispubis(pubicliceor“crabs”).

WoundandSoftTissueInfections

Cellulitis

A.GeneralCharacteristics 1. Cellulitisisaninflammatoryconditionofskinandsubcutaneoustissue. 2. Itiscausedbyawidevarietyofbacteria,themostcommonbeinggroupA

streptococciorS.aureus.

3. Likelybacterialpathogensarebasedonpatienthistories.Bacteriagainentry throughbreaksintheskin:IVcatheters,incisions,immersioninwater,andbites orwounds.Venousstasisdiseases,lymphedema,anddiabeticulcersalsoare associatedwithcellulitis(seeTable10-8).

4. Ifuntreated,cellulitismayleadtopotentiallylife-threateningbacteremia.
======================================
Quick HIT

Patientswithcellulitisarepredisposedtorecurrencesinthesameareabecauseofdamagethatoccurstothelocal lymphaticvessels.

B.ClinicalFeatures 1. Classicfindingsofinflammation:erythema,warmth,pain,swelling 2. Fever(mayormaynotbepresent)

Quick HIT

Spreadtothefaceisaworrisomecomplicationofcellulitis,andanyevidenceoforbitalinvolvementisamedical emergencyrequiringurgentevaluationbyanophthalmologist.

C.Diagnosis 1. Thediagnosisisessentiallyclinical. 2. Obtainbloodculturesifthepatienthasafever. 3. Obtaintissueculturesifthereisawound,ulcer,orsiteofinfection. 4. Obtainimaging(plainfilm,MRI)ifthereissuspicionofdeeperinfection.

D.Treatment 1. Basetreatmentonsuspectedpathogensfromthepatienthistory.Mostpatients

requireparenteralantibiotictherapy.

2. TreatmentshouldcovergroupAstreptococciandMSSA(e.g.,oxacillin, cefazolin).Ifsuspected,MRSAshouldalsobecovered(e.g.,vancomycin).

3. ContinueIVantibioticsuntilsignsofinfectionimprove.Followupwithoral antibioticsfor2weeks.

Erysipelas

Erysipelasisacellulitisthatisusuallyconfinedtothedermisandlymphatics(see alsoClinicalPearl10-5). ItisusuallycausedbygroupAstreptococci(otherformsofstreptococciless commonly). Theclassicpresentationisawell-demarcated,fieryred,painfullesion,most commonlyonthelowerextremitiesandtheface.Highfeverandchillsmaybe present. Predisposingfactorsincludelymphaticobstruction(e.g.,afterradicalmastectomy), localtraumaorabscess,fungalinfections,diabetesmellitus,andalcoholism. Complicationsincludesepsis,localspreadtosubcutaneoustissues,andnecrotizing fasciitis. Treatmentforuncomplicatedcasesisoralpenicillinoramoxicillin;otherwisetreat asforcellulitis.Hasahighrateofrecurrence.
======================================
CLINICALPEARL10-5

DifferentiatingDeepVeinThrombosis(DVT)FromCellulitis

¢

e

e

Likecellulitis,acuteDVTalsopresentswitherythema,warmth,andtendernessintheaffectedextremity. InflammationinDVTisusuallyrestrictedtotheposteriorcalf. BecauseHomanssignandthepalpationofvenouscordsarenotsensitiveindetectingDVT,venousDoppler mustsometimesbeperformedtodifferentiatebetweencellulitisandacuteDVT.

NecrotizingFasciitis

Necrotizingfasciitisisalife-threateninginfectionofdeepsofttissuesthatrapidly tracksalongfascialplanes. CommonbacterialcausesincludeStreptococcuspyogenesandClostridium perfringens. Riskfactorsincluderecentsurgery,diabetes,trauma,andIVdruguse. Clinicalfeaturesmayincludefeverandpainoutofproportiontoappearanceofskin inearlystages,soahighindexofsuspicionisimportant.Extensionofinfection leadstothrombosisofmicrocirculation,resultingintissuenecrosis,discoloration, crepitus,andcutaneousanesthesia. Itmayrapidlyprogresstosepsis,toxicshocksyndrome(TSS),andmultiorgan failure. Antibacterialtreatmentaloneisnotsufficient.Rapidsurgicalexplorationand debridementisanabsolutenecessity! Broad-spectrumparenteralantimicrobialtherapyiswarranted.

Lymphadenitis

Thisisinflammationofalymphnode(singleormultiple)usuallycausedbylocal skinorsofttissuebacterialinfection(oftenhemolyticstreptococciand staphylococci). Itpresentswithfever,tenderlymphadenopathyofregionallymphnodes,andred streakingofskinfromthewoundorareaofcellulitis. Complicationsincludethrombosisofadjacentveins,sepsis,andevendeathif untreated. Helpfuldiagnosticstudiesincludebloodandwoundcultures. Itusuallyrespondswelltotreatment.Treatwithappropriateantibiotics(penicillinG, antistaphylococcalpenicillin,orcephalosporin)andwarmcompresses.Wound drainagemayultimatelybenecessary.

Tetanus

A.GeneralCharacteristics 1. Causes

a. ItiscausedbyneurotoxinsproducedbysporesofClostridiumtetani,agram- positiveanaerobicbacillus.

b. C.tetaniproliferatesandproducesitsexotoxinincontaminatedwounds.The exotoxinblocksinhibitorytransmittersattheneuromuscularjunction.

2. Patientsatriskarethosewhohaveincompleteornotetanusimmunization(see Chapter12).
======================================
Quick HIT

Thefollowingtypesofwoundsaremostlikelytoresultintetanus:

e

«

e

Woundscontaminatedwithdirt,feces,orsaliva Woundswithnecrotictissue Deeppuncturewounds

B.ClinicalFeatures 1. Theclassicandearliestsymptomishypertonicityandcontractionsofthemasseter

muscles,resultingintrismus,or“lockjaw.”

2. Progressestosevere,generalizedmusclecontractionsincluding: a. Risussardonicus—grinduetocontractionoffacialmuscles. b. Opisthotonos—archedbackduetocontractionofbackmuscles.

3. Sympathetichyperactivity.

Quick HIT

Theincubationperiodfortetanusrangesfromabout2daysto2weeks.Theonsetofsymptomsis characteristicallygradual(1to7days).

TABLE10-8 GuidetoTetanusImmunizationinWoundManagement

23 known Td doses No No No No <3 doses, unknown status, or >10 yrs since Yes No Yes Yes last booster Td, tetanus/diphtheria toxoid; TIG, tetanus immune globulin.

C.Diagnosis 1. Thediagnosisismainlyclinical. 2. Obtainwoundcultures,buttheyarenotareliablemeansofdiagnosis.

D.Treatment 1. AdmitthepatienttotheICUandproviderespiratorysupportifnecessary(see

alsoTable10-9).Givediazepamfortetany.

2. Neutralizeunboundtoxinwithpassiveimmunization—giveasingleIMdoseof tetanusimmuneglobulin(TIG).

3. Provideactiveimmunizationwithtetanus/diphtheriatoxoid(Td). 4. Thoroughlycleananddebrideanywoundswithtissuenecrosis. 5. Giveantibiotics(metronidazoleorpenicillinG),althoughefficacyissomewhat

controversial.

InfectionsoftheBonesandJoints

Osteomyelitis

A.GeneralCharacteristics 1. Osteomyelitisreferstoinflammatorydestructionofboneduetoinfection. 2. Therearetwomaincategoriesofosteomyelitis.

a. Hematogenousosteomyelitis(mostcommoninchildren)—occurssecondaryto sepsis.

b. Directspreadofbacteriafromanyofthefollowing:

e

e

e

Anadjacentinfection(e.g.,infecteddiabeticfootulcer,decubitusulcer). Trauma(e.g.,openfractures). Vascularinsufficiency(e.g.,peripheralvasculardisease).

3. ThemostcommonmicroorganismscausingosteomyelitisareS.aureusand coagulase-negativestaphylococci.

4. Osteomyelitiscaninvolveanybone.Commonlocationsincludelongbones(tibia, humerus,femur),footandankle,andvertebralbodies.
======================================
Quick HIT

CommonBugsinOsteomyelitis Cathetersepticemia:S.aureus Prostheticjoint:coagulase-negativestaphylococci Diabeticfootulcer:polymicrobialorganisms Nosocomialinfections:Pseudomonasspp. IVdrugabuse,neutropenia:fungalspecies,Pseudomonasspp. Sicklecelldisease:Salmonellaspp.

B.RiskFactors(forcomplicationsorchronicosteomyelitis) 1. Openfractures 2. Diabetesmellitus(causespredispositiontoinfectionandperipheralvascular

disease)

3. UseofillicitIVdrugs 4. Sepsis

Quick HIT

Upto10%ofpatientswithopenfractureseventuallydeveloposteomyelitis.Useoforthopedichardware increasesthisrisk(foreignbodyisthesiteofbacterialcolonization).

C.ClinicalFeatures 1. Painovertheinvolvedareaofboneisthemostcommonfinding. 2. Localizederythema,warmth,orswellingmaybepresent. 3. Systemicsymptoms(e.g.,fever,headache,fatigue)maybepresent,butare

inconsistentfindings.

4. Adrainingsinustractthroughtheskinmayforminchronicdisease.

D.Diagnosis 1. WBCcount—mayormaynotbeelevatedandisnotusefulfordiagnosis 2. ESRandCRP

a. Thesearefairlynonspecific,butifthesemarkersofinflammationareelevatedin theappropriateclinicalsetting,seriouslyconsideradiagnosisofosteomyelitis. However,anormalESRandCRPdonotexcludethediagnosis

b. BothESRandCRPareveryusefulinmonitoringtheresponsetotherapy

Quick HIT

OsteomyelitisofthevertebralbodyduetoM.tuberculosisiscalledPottdisease.

3. Needleaspirationofinfectedboneorbonebiopsy(obtainedinoperatingroom) —mostdirectandaccuratemeansofdiagnosis.Cultureresultscandetermine thespecificantibiotictherapy

4. Plainradiography

a. Theearliestradiographicchanges(periostealthickeningorelevation)arenot evidentforatleast10days

b. Lyticlesionsareonlyapparentinadvanceddisease

5. Radionucleotidebonescans—usuallypositivewithin2to3daysofinfection,but arerelativelynonspecific(canbepositiveinmetastaticbonedisease,trauma,or overlyingsofttissueinflammation)

6. MRIisgenerallythemosteffectiveimagingstudyfordiagnosing osteomyelitisandassessingtheextentofdiseaseprocess

E.Treatment Give IV antibiotics for extended periods (4 to 6 weeks). Initiate antibiotic therapy only after the microbial etiology is narrowed based on data from cultures, or if the patientishemodynamicallyunstable.Generalguidelines: 1. Empirictherapyrequiresantibioticswithhighbonepenetrationincluding cephalosporins(cefazolin,ceftriaxone,cefuroxime),fluoroquinolones (levofloxacin,ciprofloxacin,moxifloxacin),vancomycin,linezolid,daptomycin, andclindamycin.Rifampincanalsobeaddedasadjuncttohelpwithbiofilm

penetration.

2. Addanaminoglycosideandpossiblyaβ-lactamantibioticifthereisapossibility ofinfectionwithagram-negativeorganism.

3. Surgicaldebridementofinfectednecroticboneisanimportantaspectof treatment.
======================================
Quick HIT

Chronicosteomyelitisreferstobonenecrosisandsofttissuecompromiseortoarelapseofpreviouslytreated osteomyelitis.Itisverychallengingtotreatandalmostimpossibletocompletelyeradicate.

AcuteInfectiousArthritis

A.GeneralCharacteristics 1. Acuteinfectiousarthritisoccurswhenmicroorganisms(usuallybacteria)invade thejointspace(nottheboneitself),wheretheyreleaseendotoxinsandtrigger cytokinereleaseandneutrophilinfiltration.Theseinflammatoryreactions ultimatelyleadtoerosionanddestructionofthejoint.

2. Pathogenesis—microorganismspenetratethejointviathefollowingmechanisms:

a. Hematogenousspread—mostcommonroute. b. Contiguousspreadfromanotherlocusofinfection(e.g.,osteomyelitis,abscess,

orcellulitis).

c. Traumaticinjurytojoint. d. Iatrogenic(e.g.,fromarthrocentesis,arthroscopy).

Quick HIT

Ifpatienthasapainlessrangeofmotionofinvolvedjoint,septicarthritisisveryunlikely,eveninthepresenceof erythema.Micromotionofjointcausesseverepaininsepticarthritis.

3. Microbiology

a. Themostcommonoffenderisbacteria. b. Acutebacterialarthritiscanbecausedbyanyofthefollowing:

e

e

¢

S.aureusisthemostcommonagentoverallinadultsandchildren.Various streptococcalspeciesarealsofrequentlyinvolved. Animportantgram-negativeagentisN.gonorrhoeae.Gonococcalarthritisis themostcommoncauseofacuteinfectiousarthritisinyoung,sexually activeadults(seealsoClinicalPearl10-6). Considergram-negativeorganismssuchasPseudomonasaeruginosaor Salmonellaspp.ifthereisahistoryofsicklecelldisease,immunodeficiency, orIVdrugabuse.

4. Otherriskfactorsforacuteinfectiousarthritis. a. Priorjointdamage(e.g.,rheumatoidarthritis). b. Jointprosthesis c. Diabetesmellitus

CLINICALPEARL10-6

GonococcalArthritis

Thispresentswithacutemonoarthritisoroligoarthritis,andoftenprogresseswithindaysinamigratoryor

e

e

e

e

additivepattern. Knees,wrists,hands,andanklesarethemostcommonlyinvolved. Tenosynovitisisoftenpresentinthehandsandfeet. Fever,chills,andrash(macules,papules,and/orpustules)aresignsofdisseminatedgonococcalinfection.If thepatienthasdisseminatedgonococcalinfection,admittothehospital. Afterthejointisinitiallyaspirated,repeatedaspirationisunnecessary(unlikeinothercausesofseptic arthritis),andantibioticsaloneusuallyleadtoimprovement.Treatpresumptivelyforchlamydialinfection (e.g.,withdoxycycline). ConsidertestingforHIVandsyphilis.Educatethepatientabouttherisksofsexualpractices.

¢
======================================
Quick HIT

SepticArthritis

¢

e

Themostcommonjointaffectedistheknee.Thehip,wrist,shoulder,andanklemayalsobeinvolved. Patientswithimmunosuppressionorconnectivetissuediseasesmayhavepolyarticulararthritis(andaworse prognosis).

B.ClinicalFeatures 1. Thejointisswollen,warm,andpainful.

a. Therangeofmotion(activeorpassive)isverylimited. b. Aneffusioncanbepalpated.

2. Constitutionalsymptomssuchasfever,chills,andmalaisearecommon.

C.Diagnosis 1. Performajointaspiration(“tap”)andanalysisofsynovialfluidinallpatients suspectedofhavingasepticjoint.Orderthefollowingstudiesonaspirated synovialfluid.

a. WBCcountwithdifferential—usually>50,000WBCs/mm3with>80%PMNs —themosthelpfultest.

b. Gramstainoffluid—positiveinapproximately75%ofgram-positivecases,but only30%to50%ofgram-negativecases.

c. Culture—aerobicandanaerobic. d. Crystalanalysis—keepinmindthatacutegoutmaypresentlikesepticarthritis. e. PCRofsynovialfluid—thismaybeusefulifgonococcalarthritisissuspected

butGramstainandculturesarenegative.

2. Bloodculturesarepositivein>50%ofallcases(frequentlynegativein gonococcalarthritis).

3. Otherlaboratoryabnormalities.

a. Leukocytosis—presentinabouthalfofpatientswithasepticjoint. b. ElevatedESR—elevatedinupto90%ofpatientswithsepticjoint. c. ElevatedCRP—usefulinmonitoringclinicalimprovement.

4. Imagingstudies.

a. Plainradiographs—generallynotusefulunlessjointdamageissevere. b. CTorMRI—helpfulifthesacroiliacorfacetjointsareinvolved.

5. Obtainculturesfromappropriatemucosalsurfaces(e.g.,genitourinarytract)if gonococcalarthritisissuspected.

D.Treatment 1. Promptantibiotictreatment.

a. Donotdelayininitiatingantimicrobialtherapywhenacuteinfectiousarthritisis suspected.

b. IftheGramstainresultisnegativebutacutebacterialarthritisisstillsuspected, treatempiricallybasedontheclinicalscenario(seeTable10-10)untilculture andsensitivityresultsareavailable.

2. Drainage

option.However,surgicaldrainageisrecommendedtopreventfurtherdamage tothearticularcartilagethatoccurswithpersistentinfectiousprocess.Certain jointsareamenabletoarthroscopicdrainage(shoulder,knee)whereasothersare not(hip,wrist,elbow,ankle)andshouldbeopened.
======================================
TABLE10-9 MedicalTreatmentofAcuteBacterialArthritis
======================================
Quick HIT

ComplicationsofSepticArthritis

Destructionofjointandsurroundingstructures(e.g.,ligaments,tendons),leadingtostiffness,pain,andloss offunction Avascularnecrosis(ifhipisinvolved) Sepsis

¢

e

e Sepsis

ZoonosesandArthropod-BorneDiseases

LymeDisease

A.GeneralCharacteristics 1. ThreemajorendemicareasintheUnitedStates

a. Northeasternseaboard(fromMainetoMaryland) b. Midwest(northcentralstates—e.g.,Minnesota,Wisconsin) c. Westcoast(NorthernCalifornia)

Quick HIT

Lymediseaseisthemostcommonvector-borneillnessintheUnitedStates.Thepeakincidenceisinsummer months.Itisassociatedwithoutdooractivitiesinwoodedareas(e.g.,hiking,camping).

2. Incubationperiodis3to32days 3. Transmissioncycle

a. CausedbyspirocheteBorreliaburgdorferi b. Transmittedbyticks—commonlythedeertickIxodidaescapularis c. Thetickishostedbywhite-footedmice(immatureticks),white-taileddeer

(matureticks),andbriefandunfortunateencounterswithhumans

Quick HIT

e

e

Patientswithtickbitesshouldbefollowedupcloselyfortheappearanceoferythemamigrans,butthe majorityoftickbitesdonotresultininfection. AvaccineagainstB.burgdorferihasbeendevelopedbutwastakenoffthemarketduetolackofuseinthe medicalcommunity.

B.ClinicalFeatures 1. Stage1—early,localizedinfection.

a. Erythemamigransisthehallmarkskinlesionatsiteofthetickbite. Characteristicallyitisalarge,painless,well-demarcatedtarget-shapedlesion, commonlyseenonthethigh,groin,oraxilla(Figure10-6).

b. Multiplelesionssignifythathematogenousspreadhasoccurred(seebelow).

2. Stage2—early,disseminatedinfection.

a. Infectionspreadsvialymphaticsandthebloodstreamwithindaystoweeksafter theonsetoferythemamigrans.

b. Clinicalfeatures:intermittentflu-likesymptoms,headaches,neckstiffness,

fever/chills,fatigue,malaise,musculoskeletalpain.

c. Afterseveralweeks,about15%ofpatientsdeveloponeorseveralofthe following(usuallyresolvewithinseveralmonths):

Meningitis(BrudzinskiandKernigsignsnegative). Encephalitis. Cranialneuritis(oftenbilateralfacialnervepalsy). Peripheralradiculoneuropathy(motororsensory).

d. Withinweekstomonthsofonsetofsymptoms,about8%willhavecardiac manifestations(e.g.,AVblock,pericarditis,carditis).Theseusuallyonlylastfor severalweeks,butrecurrenceisnotuncommon.

3. Stage3—late,persistentinfection(monthstoyearsafterinitialinfection).

a. Arthritis—Thisoccursin60%ofuntreatedpatients;ittypicallyaffectsthelarge
======================================
joints(especiallyknees).Chronicarthritiswilldevelopinsomepatients. b. ChronicCNSdisease—subacute,mildencephalitis,transversemyelitis,or

axonalpolyneuropathy.

c. Acrodermatitischronicaatrophicans(arareskinlesion)—reddish-purpleplaques andnodulesontheextensorsurfacesofthelegs.

FIGURE 10.6

Erythemamigrans(Lymedisease).

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins,2003,Figure7.19).

C.Diagnosis 1. Clinicaldiagnosis—Inearly,localizeddisease,documentederythemamigransina

patientwithahistoryoftickexposureinanendemicareaobviatestheneedfor laboratoryconfirmation.Treatempirically.

2. Serologicstudies—mostimportantteststoconfirmaclinicalsuspicionof Lymedisease(seealsoClinicalPearl10-7)

a. ELISAisusedtodetectserumIgMandIgGantibodiesduringthefirstmonthof illness.

b. Westernblotisusedtoconfirmpositiveorequivocalresults.

D.Treatment 1. Earlylocalizeddisease.

a. Ifitisconfinedtotheskin,10daysofantibiotictherapyisadequate. b. Ifthereisanyevidenceofspreadbeyondtheskin,extendtreatmentto20to30

days.

c. ForearlyLymedisease.

Oraldoxycycline(for21days)—contraindicatedinpregnantwomenandin children<8yearsofage. Amoxicillinandcefuroximearealternativeagents. Erythromycinmaybegiventopregnantpatientswithpenicillinallergies. 2. Treatmentofcomplicationssuchasfacialnervepalsy,arthritis,orcardiacdisease isprolongedantibiotictherapy(30to60days).FormeningitisorotherCNS complications,treatwithIVantibioticsfor4weeks.

Quick HIT

Earlytreatmentwithantibioticsisextremelyimportantbecauselatersequelaeofdiseasecanusuallybe prevented.Treatmentinlaterstagesisusuallyeffective,butrecoverymaybedelayed.

CLINICALPEARL10-7

LymeSerology

e

¢

e

IgMantibodiespeak3to6weeksaftertheonsetofsymptoms.Ifafewmonthshavepassedsincetheonsetof disease,IgMlevelsarebasicallyworthless. IgGantibodiesslowlyincreaseandremainelevatedinpatientswithdisseminatedillness.Ifapatienthashad Lymediseaseinthepastandnowhassymptomsconsistentwithnewillness,IgGlevelswillnotindicate whethertheinfectionisacuteorchronic. PatientswithahistoryofdistantLymediseasemayhaveelevatedIgGlevelsdespiteadequateantibiotic treatment. IgGantibodiescross-reactwithT.pallidum,butpatientswithLymediseasewillnothaveapositiveVDRL.

¢
======================================
RockyMountainSpottedFever

A.GeneralCharacteristics 1. CausedbytheintracellularbacteriaRickettsiarickettsii. 2. Ticksfeedingonvariousmammalsserveasvectorsfordiseasetransmission. 3. Themajorendemicareasincludethesoutheastern,midwestern,andwestern UnitedStates.Peakincidenceisinthespringandsummermonthsdueto increasedoutdooractivity. 4. Pathophysiologyofdisease.

a. Organismsenterthehostcellsviatickbites,multiplyinthevascular endothelium,andspreadtodifferentlayersofthevasculature.

b. Damagetothevascularendotheliumresultsinincreasedvascularpermeability, activationofcomplement,microhemorrhages,andmicroinfarcts.

B.ClinicalFeatures 1. Theonsetofsymptomsistypically1weekafterthetickbite. 2. Itclassicallypresentswithasuddenonsetoffever,chills,malaise,nausea,

vomiting,myalgias,photophobia,andheadache.

3. Papularrashusuallyappearsafter4to5daysoffever.Rashstartsperipherally (wrists,forearms,palms,ankles,andsoles)butthenspreadscentrally(tothe restofthelimbs,trunk,andface).Itbecomesmaculopapular,andeventually petechial.

4. Itmayleadtointerstitialpneumonitis.

C.Diagnosis 1. Diagnosisisprimarilyclinical.Laboratoryabnormalitiesmayincludeelevated

liverenzymesandthrombocytopenia.

2. Acuteandconvalescentserologyandimmunofluorescentstainingofskinbiopsy areconfirmatorytests.

D.Treatment 1. Doxycycline—usuallygivenfor7days;givenintravenouslyifthepatientis

vomiting.

2. CNSmanifestationsorpregnantpatients—givechloramphenicol.

Malaria

A.GeneralCharacteristics 1. Aprotozoalinfectioncausedbyoneoffourorganisms

a. Plasmodiumfalciparum b. Plasmodiumovale c. Plasmodiumvivax d. Plasmodiummalariae

2. Prevalentintropicalclimates,partsofAfricaandtheMiddleEast 3. Transmittedviamosquitobiteinendemicareas

B.ClinicalFeatures 1. Symptomsmayincludefeverandchills,myalgias,headache,nausea,vomiting,

anddiarrhea.

2. Feverpatternvariesdependingoncause

a. P.falciparum—feverisusuallyconstant b. P.ovaleandP.vivax—feverusuallyspikesevery48hours c. P.malariae—feverusuallyspikesevery72hours

Quick HIT

Theonsetofillnessinmalariausuallyoccursweekstomonthsafterinfection,butitisdependentonthespecific cause.
======================================
C.Diagnosis 1. Identifyorganismonperipheralbloodsmear 2. BloodsmearmusthaveGiemsastain

Quick HIT

P.falciparuminfectionisbyfarthemostseriousandlife-threateningcauseofmalaria.

D.Treatment 1. Usechloroquinephosphateunlessresistanceissuspected.Inmanycountries,

chloroquineresistanceissoprevalentthatitshouldbeassumed.

2. Ifchloroquineresistanceissuspected,givequininesulfateandtetracycline.

Alternativeagentsareatovaquone–proguanilandmefloquine. 3. P.falciparuminfectionmayrequireIVquinidineanddoxycycline. 4. RelapsescanoccurinP.vivaxandP.ovaleinfectionasaresultofdormant

hypnozoitesintheliver.Adda2-weekregimenofprimaquinephosphateforthese

typesofmalarialinfection.

5. Prophylaxisisimportantfortravelerstoendemicregions.Mefloquineistheagent ofchoiceinchloroquine-resistantareas.Chloroquinecanbeusedinareaswhere chloroquineresistancehasnotbeenreported.

Quick HIT

Sideeffectsofmedicationscanbeafactorinchoosingappropriatemalariaprophylaxis:

Atovaquone–proguaniliscontraindicatedinpatientswithrenaldiseaseandpregnancy. Mefloquineiscontraindicatedinpatientswithseizuresandpsychiatricconditions. Chloroquineiswelltoleratedandcanbeusedinpregnancy.

PrimaquineiscontraindicatedinpatientswithG6PDdeficiencyduetoprecipitationofhemolyticanemia.

Rabies

A.GeneralCharacteristics 1. Adevastating,deadlyviralencephalitis 2. Contractedfromabiteorscratchbyaninfectedanimal(dog,bat,raccoon,fox,

coyote);infectionfromacornealtransplanthasbeendocumentedaswell

3. Moreprevalentindevelopingcountrieswhererabiesvaccinationofanimalsisnot widespread

B.ClinicalFeatures 1. Theincubationperiodtypicallyrangesfrom30to90days,butvaries

considerably.

2. Oncesymptomsarepresent,rabiesisalmostinvariablyfatal. 3. Symptoms(inprogressiveorder).

a. Painatsiteofbite. b. Prodromalsymptomsofsorethroat,fatigue,headache,nausea,and/orvomiting. c. Encephalitis—confusion,combativeness,hyperactivity,fever,andseizuresmay

bepresent.

d. Hydrophobia—inabilitytodrinkduetolaryngealspasm,hypersalivation (“foamingatmouth”),usuallyprogressestocomaanddeath.

e. Somepatientsmaypresentwithascendingparalysis.
======================================
C.Diagnosis 1. Virusorviralantigencanbeidentifiedininfectedtissue.Viruscanbeisolatedin

salivaaswell.

2. Fourfoldincreaseinserumantibodytiters. 3. HistologicidentificationofNegribodies(eosinophilicintracytoplasmicinclusion

bodies).

4. PCRdetectionofvirusRNA.

Quick HIT

Pre-exposureprophylaxis—Rabiesvaccineisavailableforat-riskindividuals(e.g.,thosewithpotential occupationalexposure,suchasveterinarians,wildlifeofficials,andlaboratoryworkers).

D.Treatment(PostexposureManagement) 1. Cleanthewoundthoroughlywithsoap. 2. Forwildanimalbites(e.g.,batorraccoon),theanimalshouldbecapturedif

possible,destroyed,andsenttoalaboratoryforimmunofluorescenceofbrain tissue.

3. Ifapatientwasbittenbyahealthydogorcatinanendemicarea,theanimal shouldbecapturedandobservedfor10days.Ifthereisnochangeintheanimal’s condition,thenitmostlikelydoesnothaverabies.

4. Forknownrabiesexposure,bothofthefollowingshouldbeperformed.

a. Passiveimmunization—administerthehumanrabiesimmunoglobulinto patients,intothewoundaswellintheglutealregion.

b. Activeimmunization—administertheantirabiesvaccineinthreeIMdosesinto thedeltoidorthighovera28-dayperiod.

TABLE10-10 OtherZoonosesandArthropod-borneDiseases

Leptospirosis Leptospira spp. Contaminated Rodents, farm Anicteric: rash, Isolation of Oral antibiotics: (spirochetes) water animals LAN,? T LFTs organism in blood doxycycline; if or urine CTX? severe, IV penicillin G Icteric: renal and/or liver failure, vasculitis, vascular collapse Ehrlichiosis Ehrlichia spp. Tick bite Deer Fever, chills, malaise Clinical; confirm Oral doxycycline (intracellular, +rash by serology x 1 week gram-negative Complications: renal bacteria) failure, Gl bleeding Tularemia Francisella tularensis Tick bite, animal Rabbits, other + Fever, headache, nau- _Isolation of IM streptomycin or (small gram-negative bites, handling rodents sea; ulcer at site of organism in blood — gentamicin bacillus) carcass tick bite; painful LAN or wound CTX Q fever C. burnetii Blood, ingestion Farmanimals Acute: constitutional Serology; CXR— Acute: doxycycline (gram-negative of infected milk, symptoms, nausea, multiple opacities —_ or fluoroquinolone organism) inhalation vomiting in acute illness Chronic: rifampin Chronic: endocarditis Cat scratch Bartonella henselae Scratch from a Cats, fleas LAN or lymphadenitis; Serology, clinical Usually self-limited; if disease (gram-negative flea-infested cat systemic symptoms severe, oral doxycy- bacillus) rare cline or ciprofloxacin “LAN, lymphadenopathy; CTX, culture.
======================================
OtherZoonoses

Table10-11coversleptospirosis,ehrlichiosis,tularemia,Qfever,andcatscratch fever.

CommonFungalInfections

Candidiasis

A.GeneralCharacteristics 1. Candidaspeciesareoval,buddingyeastsknownfortheirformationofhyphae

andlongpseudohyphae.Theynormallycolonizehumans,anditistheovergrowth oftheseorganismsthatresultsintheclinicalpathologyofcandidiasis

2. Candidaalbicansisthemostcommoncauseofcandidiasis 3. Riskfactorsforcandidiasis

a. Antibiotictherapy b. Diabetesmellitus c. Immunocompromisedhosts(increasedriskforbothmucocutaneousand

systemiccandidiasis)

B.ClinicalFeatures 1. Typicalpresentationisthemucocutaneousgrowth.Themostcommonaffected

areasare:

a. Vagina—“yeastinfection”

e

e

Thisresultsinathick,white,“cottagecheese-like”vaginaldischarge Thedischargecharacteristicallyispainlessbutdoescausepruritus

b. Mouth,oropharynx—“thrush”

e

e

e

Thiscausesthick,white,scrapableplaquesthatadheretotheoralmucosa Usuallypainless UnexplainedoralthrushshouldraisesuspicionofHIVinfection

c. Cutaneouscandidiasis

e

e

Thiscauseserythematous,erodedpatcheswith“satellitelesions”(Figure10-7) Itismorecommoninobesediabeticpatients;itappearsinskinfolds(e.g., axilla,groin,underneathbreasts)andinmaceratedskinareas

d. GItract(e.g.,esophagus)

e

e

Candidaesophagitismaycausesignificantodynophagia Itmayalsobeasymptomatic

2. Disseminatedorinvasivediseasemayoccurinimmunocompromisedhosts. Manifestationsincludesepsis/septicshock,meningitis,andmultipleabscessesin variousorgans.

FIGURE 10.7

Cutaneouscandidiasis(axilla).

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins,2003,Figure3.25).

C.Diagnosis 1. Mucocutaneouscandidiasisdiagnosisisprimarilyclinical;KOHpreparation

demonstratesyeast.

2. Invasivecandidiasisisdiagnosedbybloodortissueculture.

D.Treatment 1. Removeindwellingcathetersorcentrallines. 2. Acceptabletreatmentsfororopharyngealcandidiasis.

a. Clotrimazoletroches(dissolveinthemouth)fivetimesperday. b. Nystatinmouthwash(“swishandswallow”)threetofivetimesperday;onlyfor

oralcandidiasis.

c. Oralketoconazoleorfluconazoleforesophagitis.

3. Vaginalcandidiasis—miconazoleorclotrimazolecream. 4. Cutaneouscandidiasis—oralnystatinpowder,keepingskindry. 5. Forsystemiccandidiasis,useamphotericinBorfluconazole.New,alternative

antifungalagentsincludevoriconazoleandcaspofungin.
======================================
Aspergillus

A.GeneralCharacteristics 1. Aspergillusspp.sporesarefoundeverywhereintheenvironment.Typically,

diseaseoccurswhensporesareinhaledintothelung.

2. TherearethreemaintypesofclinicalsyndromesassociatedwithAspergillus(see clinicalfeaturesbelow).

3. Invasiveaspergillosisisusuallylimitedtoseverelyimmunocompromisedpatients. Itshouldbeconsideredinanyimmunocompromisedpatientwithfeverand respiratorydistressdespiteuseofbroad-spectrumantibiotics.

B.ClinicalFeatures 1. Allergicbronchopulmonaryaspergillosis.

a. AtypeIhypersensitivityreactiontoAspergillus. b. Itpresentswithasthmaandeosinophilia.Recurrentexacerbationsarecommon.

2. Pulmonaryaspergilloma.

a. Pulmonaryaspergillomaiscausedbyinhalationofsporesintothelung.Patients withahistoryofsarcoidosis,histoplasmosis,TB,andbronchiectasisareatrisk.

b. Itpresentswithchroniccough;hemoptysismaybepresentaswell. c. Itmayresolvespontaneouslyorinvadelocally.

3. Invasiveaspergillosis.

a. Thisoccurswhenhyphaeinvadethelungvasculature,resultinginthrombosis andinfarction.

b. Hostsaretypicallyat-riskpatientswithacuteleukemia,transplantrecipients, andpatientswithadvancedAIDS.

c. Itusuallypresentswithacuteonsetoffever,cough,respiratorydistress,and diffuse,bilateralpulmonaryinfiltrates.

d. Itistransmittedviahematogenousdissemination,andmayinvadethesinuses, orbits,andbrain.

C.Diagnosis 1. CXRrevealsadensepulmonaryconsolidationandsometimesafungusball. 2. Definitivediagnosisofinvasiveaspergillosisisbytissuebiopsy,butdiagnosisis

2. Definitive diagnosis of invasive aspergillosis is by tissue biopsy, but diagnosis presumed when Aspergillus is isolated from the sputum of a severely immunocompromised/neutropenic patient with clinical symptoms.

presumedwhenAspergillusisisolatedfromthesputumofaseverely immunocompromised/neutropenicpatientwithclinicalsymptoms. 3. Bloodculturesareusuallynothelpfulbecausetheyarerarelypositive.

D.Treatment 1. Forallergicbronchopulmonaryaspergillosis,patientsshouldavoidexposureto

Aspergillus;corticosteroidsmaybebeneficial.

2. Forpulmonaryaspergilloma,patientswithmassivehemoptysismayrequirea lunglobectomy.

3. Forinvasiveaspergillosis,treatwithIVamphotericinB,voriconazole,or caspofungin.

4. Suspicionofheadorbraininvolvementwarrantspromptevaluation(imaging studies).Surgerymayberequired.
======================================
Cryptococcosis

A.GeneralCharacteristics 1. CausedbyCryptococcusneoformans,abudding,roundyeastwithathick

polysaccharidecapsule

2. Associatedwithpigeondroppings 3. MostcommonlyseeninpatientswithadvancedAIDS 4. Infectionisduetoinhalationoffungusintolungs.Hematogenousspreadmay

involvethebrainandmeninges

B.ClinicalFeatures 1. CNSdisease—meningitisormeningoencephalitis;brainabscessisalsopossible a. CNSdiseaseisalife-threateningconditionthatrequiresaggressivetreatment

(seebelow).ItshouldalwaysbeonthedifferentialdiagnosisofanHIV-positive patientwithafeverandheadache.Ifuntreated,itisalmostinvariablyfatal.

b. Symptomsincludefever,headache,irritability,dizziness,confusion,and possiblyseizures.Theonsetmaybeinsidious.

2. Isolatedpulmonaryinfectionmayalsooccur.

C.Diagnosis 1. LPisabsolutelyessentialifmeningitisissuspected.

a. LatexagglutinationorELISAcandetectcryptococcalantigenintheCSF. b. Indiainksmearshowsencapsulatedyeasts. c. Cultureyieldscryptococcalcoloniesin3to7days.

2. Tissuebiopsyischaracterizedbylackofinflammatoryresponse. 3. Theorganismmayalsobepresentinurineandblood.

D.Treatment 1. UseamphotericinBwithflucytosineforapproximately2weeks,followedbyoral

fluconazole.

2. Thedurationoftherapyvariesdependingonfollow-upCSFcultures.

OtherFungalInfections

Table10-12coversblastomycosis,histoplasmosis,coccidioidomycosis,and sporotrichosis.

CommonParasiticInfections

Table10-13coverscryptosporidiosis,amebiasis,giardiasis,ascariasis,hookworm, pinworm(enterobiasis),tapeworm,andschistosomiasis.

FeverandSepsis FeverofUnknownOrigin

A.GeneralCharacteristics 1. Definingfeverofunknownorigin(FUO)

a. Classicallydefinedashavingthefollowingnecessarycriteria:

Fever>38.3°C(101°F) Continuing“onseveraloccasions”foratleast3weeks Nodiagnosisoverthistimeperioddespite1weekofinpatientworkup b. Becauseofchangesinmedicalpractice,thisdefinitionhasbeenaltered:Three

outpatientvisitsnowsubstitutefor1weekinthehospital

TABLE10-11 OtherImportantFungalInfections

TABLE10-12 ImportantParasiticInfections
======================================
Quick HIT

PersistenceoffeverintheICU,despiteantimicrobialtherapy,shouldraisetheindexofsuspicionfor:

Fungalinfection Antimicrobialresistance Infectionsrequiringsurgicalintervention(e.g.,occultabscess,woundnecrosis) Drugfever

2. Causes

a. Infection—mostcommoncause

TBandothermycobacterialinfection Occultabscesses(e.g.,hepatic,retroperitoneal) UTI/complicatedUTI Endocarditis Sinusitis HIV Infectiousmononucleosisandotherviruses Malariaandotherparasiticinfections

HIV

b. Occultneoplasmsarethesecondmostcommoncause,particularly:

Lymphoma(especiallyHodgkinlymphoma)

Leukemia

c. Collagenvasculardisease

SLE

SLE Stilldisease Polyarteritisnodosa(PAN) Temporalarteritis Polymyalgiarheumatica

d. Othercauses(innoparticularorder)

Granulomatousdisease(e.g.,sarcoidosis,Crohndisease) Drugfevers(e.g.,sulfonamides,penicillin,quinidine,barbiturates,“dietpills” [withphenolphthalein]) Pulmonaryembolism Hemolyticanemia FamilialMediterraneanfever Gout Subacutethyroiditis Factitiousillnesses

¢

e

Gout

B.ClinicalFeatures 1. Manifestationsthatmayaccompanyfeverbutarenotspecifictoanyspecific

entity

a. Chills—ironicsensationofcold,oftenwithshivering b. Rigors—severeformofchillswithpronouncedshiveringandchatteringofteeth c. Nightsweats d. Changeinmentalstatus—especiallyatextremesofage

2. LookforsystemicmanifestationsofsomeofthemorecommoncausesofFUO (e.g.,skinchanges,constitutionalsymptoms,anemia,weightloss).

Quick HIT

FUOisobviouslyatermofexclusion,andisnotitselfadiagnosis.Inpatientswithpersistentunexplained fevers,continuediagnostictestinguntilthecauseisfound.

C.Diagnosis 1. Carefulhistoryandphysicalexamination—withattentiontomedications,travel,

immunesystemcompetency,andreviewofsystems

2. Laboratorytests

a. CBCwithdifferential b. Urinalysis c. Culturesofblood,sputum,CSF,urine,andstoolwhenindicatedbyclinical

presentation

d. Analysisandcultureofabnormalfluidcollections(e.g.,joint,pleural) e. Complementassay f. PPDwhenTBisonthedifferential g. Otherlaboratoryvalues:LFTs,ESR,ANA,rheumatoidfactor,TSH

3. Imagingstudies

a. CXR,CTscanofthechestandabdomen—todetecttumorsandabscesses b. TaggedWBCscan—sometimeshelpful c. MRI,ultrasound,andechocardiogrammaybeappropriate,dependingonthe

clinicalsituation

4. Invasivediagnosticprocedures—biopsyoflymphnode,bonemarrow,orother
======================================
tissuewhenthereisahighsuspicionoftumororabscess 5. Observationissometimesnecessarytomakeadiagnosis

D.Treatment 1. Antibioticsandcorticosteroidsmaymaskthepatternsoffeverresponse(seealso ClinicalPearl10-8).Baseempirictreatmentwithantibioticsontheseverityof illness.

2. Ifthepatientisnotacutelyill,observationalonemaybeallthatisnecessaryto arriveataspecificdiagnosis.

3. InsomecasesofFUO,feversmayresolvespontaneouslywithouteverbeing diagnosed.

4. Thesenseofurgencyindeterminingthecauseofthefeversshouldbein proportiontotheseverityofillnessandthehost’simmunestatus.

CLINICALPEARL10-8

ApproachtoFever

e

«

e

Thereisnouniformlyaccepteddefinition,butmostsourcesdefinefeverasbodytemperature>37.5°C (99.5°F)measuredbyamodernoralthermometer. Measurement—Readingsobtainedusingrectalthermometersareslightlyhigherthanoraloraxillary thermometerreadings. Hyperthermiaversusfever.

e

Hyperthermiaisanelevationinbodytemperaturenotcausedby“raisingthethermostat”(i.e.,nochange inthehypothalamicset-point). Hyperthermiaisusuallycausedbytheinabilityofthebodytodissipateheat. Causesofhyperthermiaincludeneurolepticmalignantsyndrome,malignanthyperthermia,andheat stroke. Hyperthermiadoesnotrespondtoantipyretics,butrathertoexternalcoolingmeasures(e.g.,ice,fans)and medicationsspecifictothecause(e.g.,dantroleneformalignanthyperthermia). Feveroccurswhenthereisanelevationinthehypothalamicset-point.Itisanaturalresponsetoan inflammatoryprocess. Feverusuallyrespondstoantipyretics.

e

Treatafeverwithantipyreticswhen: Thefeverisreallyhyperthermia. Thefeverisdangerouslyhigh:>41°C(>105°F). Thepatientispregnant. Thereissignificantcardiopulmonarydisease(increasedoxygendemandmaycauseischemia). Thepatientwantssymptomaticrelief(chills,myalgias).

ToxicShockSyndrome

A.GeneralCharacteristics 1. TSSismostcommonlyassociatedwithmenstruatingwomenandtamponuse,but

canoccurinpatientsofallages,maleandfemale.

2. Otherriskfactorsincludesurgicalwounds,burns,nasalpacking,andinfected insectbites.

3. ItiscausedbyanenterotoxinofS.aureus,orlessfrequentlyanexotoxinofgroup AStreptococcus.Notethatitisthetoxinratherthanthebacteriathatcauses thepathologyassociatedwithTSS.
======================================
B.ClinicalFeatures 1. Theonsetofsymptomsischaracteristicallyabrupt 2. Symptomsmayinclude:

a. Flu-likesymptoms:highfevers,headache,myalgias b. Diffusemacular,erythematousrash c. Hyperemicmucousmembranes,“strawberrytongue” d. Warmskinduetoperipheralvasodilation(seeChapter1,Shock) e. Hypotension f. Nausea,vomiting,anddiarrheamayalsobepresent

3. Bydefinition,theremustbeinvolvementofatleastthreeorgansystems,which mayinclude:

a. GI—nausea,vomiting,anddiarrhea;elevationsofaminotransferases b. Renal—elevationsofBUNand/orcreatinine,pyuria c. Hematologic—thrombocytopenia d. Musculoskeletal—elevationsofcreatinekinaselevels e. CNS—confusion,disorientation(mustbepresentwhenfeverisabsent)

4. Multisystemorgandysfunctionorfailuremayoccur 5. Duringtheconvalescentphaseofillness,therashusuallydesquamatesoverthe

palmsandsoles

Quick HIT

e

e

Themortalityrateformenstrual-relatedTSSisnow<2%butisslightlyhigher(8%)fornon–menstrual- relatedTSS. PreviousTSSdoesnotconferimmunity.Infact,patientswithahistoryofTSSareatgreaterriskfor recurrentTSS.

C.Diagnosis 1. Ahighindexofclinicalsuspicionisimportant.

2. Bloodculturesareoftennegative. 3. Culturesmaybetakenfromthesuspectedsource,butthediagnosisisprimarily

clinical.

D.Treatment 1. Hemodynamicstabilizationshouldbethefirstconcernandmayrequire

aggressivefluidsandevenvasopressors.Patientisoftentreatedinaburn intensivecareunit.

2. Thesourceoftoxin(e.g.,tampon)shouldberemovedimmediately.Woundsmay requiredrainageordebridement.

3. Giveantistaphylococcaltherapy,suchasnafcillin,oxacillin,orvancomycin,ina veryillpatient.Clindamycinissometimesusedasadjunctivetherapy.

Catheter-RelatedSepsis

Centralvenouscathetersareacommoncauseoffeverandsepsisinthehospital, especiallyintheICU. ThemostcommonorganismsareS.aureusandStaphylococcusepidermidis. Riskfactorsforcatheter-relatedsepsisareemergentplacement,femorallines,and prolongedindwellingoftheline. Onlyhalfofallpatientswithcatheter-relatedsepsishaveclinicalevidenceof infectionatthesiteofinsertion(i.e.,erythema,purulence).Therefore,ahighindex ofsuspicionisrequired. Ifyoususpectcatheter-relatedsepsis,promptlyremovethecatheterandsendthetip forculture.Thisalonetypicallyleadstoresolutionoffeverandadecreasein leukocytosis.Antibioticsareusuallyinitiated.Narrowthespectrumoncethe organismisidentified.
======================================
Quick HIT

Catheter-relatedsepsisalmostalwaysinvolvescentralIVcatheters.Peripheralvenouscathetersandarterial cathetersarerarelyinvolved.

Quick HIT

¢

e

Neutropeniaisdefinedbyabsoluteneutrophilcount(ANC)<1,500/mm3(ANC:combinationofbandsand matureneutrophils). ANC<500/mm3correspondstoaseverelyincreasedriskofinfection.

NeutropenicFever

Commoncausesincludebonemarrowfailure(e.g.,duetotoxins,drugs),bone marrowinvasion(e.g.,fromhematologicmalignancy,metastaticcancer),and peripheralcauses(e.g.,hypersplenism,SLE,AIDS).Isolatedneutropenia (agranulocytosis)iscommonlycausedbydrugreactions. Becauseneutropeniaseverelycompromisesthepatient’sabilitytomountan inflammatoryresponse,fevermaybetheonlymanifestationofaraginginfection. Themostcommoninfectionsseeninneutropenicindividualsaretransient bacteremiaduetoguttranslocationofbacteria,cellulitis,andpneumonia. Obtainthefollowingforanyneutropenicpatientwithafever:CXR,panculture (blood,urine,sputum,linetips,wound),CBC,completemetabolicpanel. Placethepatientonreverseisolationprecautions(positive-pressureroom,masks, andstricthandwashingforthoseenteringthepatient’sroom). Givebroad-spectrumantibacterialagentsimmediatelyafterculturesaredrawn. Iffeverpersistsbeyond4to5daysdespitebroad-spectrumantibacterialtherapy, giveantifungalagents,suchasIVamphotericinB.ConsiderG-CSF.

MiscellaneousInfections

InfectiousMononucleosis

A.GeneralCharacteristics 1. CausedbyEBV(rarelybyCMVwhichcausesasimilarclinicalpicturebutis

milder)(seealsoTable10-13).

2. Itismostcommonlyseeninadolescentsandyoungadults,especiallycollege studentsandmilitaryrecruits(butmayoccuratanyage).Infectedchildrenoften experiencemildersymptomsornosymptoms.

3. Differentialdiagnosisinpatientswithfever,lymphadenopathy,andpharyngitis includesacuteHIVinfection,streptococcalinfection,CMV,ortoxoplasma infection.

a. Inpregnantpatients,itisimportanttoperformdiagnostictestsasHIV,CMV, andtoxoplasmainfectioncanhaveadverseeffectsonthefetus.

4. Transmission

a. Theusualmodeoftransmissionisthroughinfectedsaliva(e.g.,kissing,sharing food).

b. Mostadults(90%)havebeeninfectedwithEBVandarecarriersbutinfectious mononucleosisisuncommoninadults.
======================================
c. Oneinfectionusuallyconferslifelongimmunity. d. Theincubationperiodistypically2to5weeks.
======================================
B.ClinicalFeatures 1. Symptoms

a. Fever—temperaturesmaybeashighas40°C(104°F);feverusuallyresolves within2weeks

b. Sorethroat c. Malaise,myalgias,weakness—maylingerforseveralmonths

Quick HIT

Infectiousmononucleosisincludesfever,fatigue,tonsillarpharyngitis,andlymphadenopathy.

2. Signs

a. Lymphadenopathy—thisisfoundin>90%ofpatients.Tonsillarorcervical (especiallyposteriorcervical)lymphnodesmaybequiteenlarged,painful,and tender

b. Pharyngealerythemaand/orexudate—frequentlypresent c. Splenomegaly—presentinhalfofpatients d. Maculopapularrash—presentinapproximately15%ofpatients,butmuch

d. Maculopapular rash—present in approximately 15% of patients, but much higher if ampicillin is given

higherifampicillinisgiven e. Hepatomegaly—in10%ofcases f. Palatalpetechiaeandeyelid(periorbital)edema—mayoccurinaminorityof

cases

Quick HIT

Commonlaboratoryabnormalitiesincludelymphocytosis,elevatedaminotransferases.

C.Diagnosis 1. Serology

a. Monospottest—fordetectionofheterophileantibody

e

e

e

Heterophileantibodiesarepositivewithin4weeksofinfectionwithEBV mononucleosisandareundetectableby6months.Thus,apositivemonospot testindicatesacuteinfectionwithEBVmononucleosis HeterophileantibodiesdonotforminCMVmononucleosis Rapidheterophiletestsarehighlysensitiveandspecific,particularlyin adolescents

b. EBV-specificantibodytesting—performincasesinwhichdiagnosisisnot straightforward(usuallydonebyindirectimmunofluorescencemicroscopyorby ELISA)

2. Peripheralbloodsmear—usuallyrevealslymphocyticleukocytosiswithlarge, atypicallymphocytes

3. Throatculture—performifpharyngitisispresenttoruleoutasecondaryinfection withβ-hemolyticstreptococci

Quick HIT

CMVMononucleosis

¢

e

©

e

Mostcommonlyseeninsexuallyactiveadolescents/youngadults.MilderthanEBV-associatedIM. Characterizedbyfevers,chills,fatigue,headaches,andfrequently,splenomegaly Cervicallymphadenopathyandpharyngitisusuallyabsent Negativeforheterophileantibodies

D.Complications 1. Hepatitis 2. Neurologiccomplications(rare):meningoencephalitis,Guillain–Barrésyndrome,

Bellpalsy

3. Splenicrupture—rare 4. Thrombocytopenia,hemolyticanemia 5. Upperairwayobstructionduetolymphadenopathy—rare
======================================
Quick HIT

IfyoususpectIM,orderWBCcountwithdifferentialandamonospottest.Ifmonospottestispositive,no furthertestingneeded.Ifnegativeandclinicalsuspicionishigh,canrepeatmonospottest.

E.Treatment 1. Generally,nospecifictreatmentisindicated(oravailable)asmostpeoplerecover

completelywithin3to4months.Supportivecareincludes:

a. Rest,fluids b. Avoidanceofstrenuousactivitiesandcontactsportsuntilsplenomegalyresolves topreventsplenicrupture.Thisprecautionappliestoallpatients,eventhose withoutsplenomegalyonphysicalexamination(lowsensitivityfordetecting splenomegaly)

c. Analgesicstoreducetemperatureandpharyngealpain—NSAIDsor acetaminophen

2. Giveashortcourseofsteroidsifthereisairwaycompromise.Steroidshavealso beeneffectiveinpatientswiththrombocytopeniaorhemolyticanemia.Steroids arenotrecommendedforroutineIMwithoutcomplications

3. Whentoreturntosports—concernissplenicrupture.Patientsshouldwait3to4 weeksfromsymptomonsetbeforereturningtosportsassplenicruptureisvery rareafter4weeks

11

DiseasesoftheSkinand HypersensitivityDisorders

EmilyLiang

KEYDEFINITIONS

Note:exactsizedefinitionsvary,butbelowarecommondefinitionsused Dermatosis:anycutaneouslesion/groupoflesions;nonspecifictermusedtoinclude anytypeofskindisease Dermatitis:inflammationoftheskin Macule:circumscribedflatalterationsinskincolor≤1cm Patch:amacule>1cm Papule:solid,elevatedlesionwithnovisiblefluid≤0.5cm Nodule:asinglelesion(papule)>0.5cm Plaque:discreteelevatedlesions>0.5cm,oftenformedbyaconfluenceofpapules Vesicle:fluid-filled(serousfluid)lesionsthatareelevatedand≤0.5cm Pustule:fluid-filled(cloudy/purulentmaterialofnecroticinflammatorycells) Bullae:vesicle>0.5cm Wheal:rounded/flat-toppededematouselevationintheskin;oftenerythematous Telangiectasia:visible,dilatedbloodvesselinthesuperficialskinthatblanches Petechiae:small(1to2mm),nonblanchingerythematousmaculesthatresultfrom microhemorrhages Ecchymosis:nonblanchingandnonpalpablered/purplediscolorationoftheskinthat resultsfromextravasationofbloodintotheskin Palpablepurpura:palpable,nonblanchingred/purplediscolorationoftheskinthat resultsfromextravasationofbloodintotheskinwithaninflammatoryetiology(i.e., vasculitis)

COMMONSKINDISORDERS
======================================
AcneiformEruptions

AcneVulgaris

A.GeneralCharacteristics 1. Acnevulgarisisaninflammatoryconditionoftheskinthatismostprevalent

duringadolescence.

2. Pathogenesisismultifactorial:

a. Follicularhyperkeratinization. b. Increasedsebumproduction. c. Obstructionofsebaceousfollicles(bysebum)leadstotheproliferationof

Cutibacteriumacnes(ananaerobicbacterium,formerlyknownas Propionibacteriumacnes)inthesebum.

d. InflammationasaresultofC.acnesproliferation.

3. Riskfactorsaremalesex,puberty,Cushingsyndrome,oilycomplexion, androgens(duetoanycause),andmedications.

4. Classification:

a. Obstructiveacne:closedcomedones(whiteheads)oropencomedones (blackheads).

b. Inflammatoryacne:Lesionsprogressfrompapules/pustulestonodules,thento cysts,thenscars.

Quick HIT

e

¢

Thereisnoprovenlinkbetweenacneanddiet(e.g.,chocolate,fattyfoods). Oralcontraceptives(especiallysomeoftheneweroralcontraceptivepills)helpsomewomenwithacne.

B.Treatment 1. Generalguidelines:

a. Instructpatienttokeepaffectedareaclean(vigorouswashingisunnecessary); reduceordiscontinueacne-promotingagents(certainmake-up,creams,oils, steroids,androgens).

b. Ittakesabout6weekstonoticetheeffectsofmedications(skinmaygetworse beforeitgetsbetter).Startwithonedrugtoassessitsefficacy.

2. Mildtomoderateacne:

a. Beginwithtopicalbenzoylperoxide(2.5%)—shouldbeappliedonceortwice daily.Itdestroysacne-causingbacteriaandpreventspluggingofporesbydrying theskin.

b. Addtopicalretinoidsiftheabovefails.Theycausepeelingoftheskin,which preventscloggingofpores.

c. Addtopicalerythromycinortopicalclindamycin—bothacttosuppressC. acnes.

3. Moderatetoseverenodularpustularacne:

a. Addonsystemicantibiotictherapy:tetracycline,minocycline,doxycycline, erythromycin,clindamycin,azithromycin,andTMP-SMX.

b. Addoralretinoids(e.g.,isotretinoin)forsevere,recalcitrant,nodularacnethatis notresponsivetotheabovetreatments.Oralretinoidsareextremelyteratogenic. Allfemalepatientsmusthavetwonegativepregnancytestsbeforestartingoral isotretinoin.Inaddition,theyshouldusetwoformsofbirthcontrolfor1month beforestartingthemedicationthrough1monthafterstoppingthemedication.
======================================
Quick HIT

Donotgivesystemicantibioticsunlessthepatientisalreadyontopicalbenzoylperoxide,topicaltretinoin,and topicalantibioticsandtheresponseisinadequate.

Rosacea

Achronicconditionresultinginreddeningoftheface(mainlytheforehead,nose, andcheeks).Itoftenappearsverysimilartoacne,butunlikeacneitfirststartsin middleage. MostlyaffectsCaucasianwomenbetween30and50yearsofage. Themostcommonskinfindingsincludeerythema,telangiectasia,papules,and pustuleswithredness,typicallyaffectingtheface.Unlikeacnevulgaris,thereareno comedones(Figure11-1). Inseverecases,skincanbecomethickenedandgreasy—onthenose,itcreatesa bulbousappearancecalledrhinophyma(mostlyseeninmen). Treatmentoferythemaandflushing:avoidalcohol,hotbeverages,extremesof temperature,andemotionalstressors.Ifinadequate,topicalbrimonidinecanbeused. Treatmentofpapulesandpustules:startwithtopicalmetronidazolegel;alternatives areazelaicacidandtopicalivermectin.Ifinadequate,mayaddsystemicantibiotics (e.g.,tetracycline),andthenoralisotretinoinasalastoption.

FIGURE 11.1

Rosacea.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia, PA:LippincottWilliams&Wilkins;2003,Figure1.14.)

HidradenitisSuppurativa

Inflammatoryskinconditionaffectingintertriginousareas(axillaisthemost commonsite),causingnodules,abscesses,anddrainingsinustractsthatcanresultin scarring. Morecommoninwomen,andtypicalonsetinsecondorthirddecadeoflife.Strong relationshipwithsmoking. Pathogenesisincludesfollicularocclusionandsubsequentrupture,leadingtoacute inflammation. Treatmentisbasedonseverityofdisease.Formilddisease,topicalclindamycinmay beused.Formoderatedisease,oralantibiotics,oralretinoids,orhormonaltherapy maybeused;iftheseareinadequate,adalimumabmaybeused.Forsevereextensive disease,surgicalexcisionisoftenrequired.

AtopicandContactDermatitis

AtopicDermatitis(Eczema)

Theterms“dermatitis”and“eczema”areoftenusedinterchangeably.Thereare severalcommondermatoses(atopicdermatitis,contactdermatitis,stasisdermatitis, etc.)thatinvolvedry,inflamed,andpruriticlesions.Thetermeczemamost commonlyreferstoatopicdermatitis. Eczemaismorefrequentinchildrenbutalsooccursinadultsandcommonly involvesflexorsurfaces(e.g.,antecubitalandpoplitealfossae,wrists).Itis commonlyassociatedwithapersonalorfamilyhistoryofatopy(seasonalallergies, asthma). Managementinvolvesfirsteliminatingtriggers(allergens,frequentbathingwithout moisturizing,heat,lowhumidity)andadjunctssuchasantihistaminesforpruritus. Topicalsteroidsshouldbeusedforaffectedareas,withthepotencyofsteroids chosenbasedonseverity.Topicalcalcineurininhibitors(i.e.,tacrolimus)canbeused ifthereisaninadequateresponsetohighpotencysteroids.
======================================
ContactDermatitis

A.GeneralCharacteristics 1. Therearetwoformsofcontactdermatitis:irritantandallergic. 2. Irritantcontactdermatitisismorecommonandresultsfromachemicalor

physicalinsulttotheskin(e.g.,contactwithdetergents,acids,oralkalis,orfrom frequenthandwashing).

a. Aprevioussensitizingeventisnotneededtoproducetherash(i.e.,itisnotan immunologicreaction).

b. Therashbeginsshortlyafterexposuretotheirritant(incontrasttotheallergic type,whichbeginsseveralhourstoafewdayslater).

3. Allergiccontactdermatitisisadelayed-typehypersensitivity(typeIV) reaction.

a. Nohistoryofatopyisnecessaryforallergiccontactdermatitistooccur.Itcan occurinanyone.

b. Sensitizationoftheskinoccurs1to2weeksafterthefirstexposuretothe allergen.Subsequentexposureleadstodermatitishourstodaysafterthe reexposure.Therefore,dermatitisdevelopsonlyinpatientswhohavealready beensensitizedtotheallergen.Commonallergensincludepoisonivy,oak,and sumac;iodine;nickel;rubber;topicalmedications(e.g.,neomycin,topical anesthetics);andcosmetics.

B.ClinicalFeatures 1. Theappearanceoftherashdependsonthestage.

a. Acutestage:erythematouspapulesandvesicleswithoozing(Figure11-2); edemamaybepresent.

b. Chronicstage:crusting,thickening,andscaling;lichenification. 2. Therashisusuallyverypruriticandisfoundonlyinexposedareas. 3. Theintervalbetweenexposureandappearanceoftherashvaries,butisusually

fromseveralhourstoaslongas4to5days.

FIGURE 11.2

Contactdermatitis.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Figure2.41.)

C.Diagnosis 1. Diagnosisisusuallymadeclinicallybasedonhistoryandexamination. 2. Patchtesting(toidentifytheallergenthatcausedtheallergicreaction)isindicated ifthediagnosisisindoubt,therashdoesnotrespondtotreatment,ortherash recurs.

Quick HIT

Donotconfuseallergiccontactdermatitiswithanyofthefollowing:

¢

e

¢

e

Irritantcontactdermatitis—rashisusuallyidenticaltothatseeninallergiccontactdermatitis,excepttherash beginsverysoonafterexposure Atopicdermatitis—onsetisininfancyorchildhood Seborrheicdermatitis Psoriasis
======================================
D.Treatment 1. Avoidthecontactallergen! 2. Applycooltapwatercompresses. 3. Applytopicalcorticosteroids. 4. Prescribesystemiccorticosteroids(e.g.,prednisone,1mg/kg/day)forsevere

cases.Continuefor10to14daysandthentaper.

PapulosquamousEruptions

Psoriasis

A.GeneralCharacteristics 1. Psoriasisisduetoabnormal(markedlyaccelerated)proliferationofskincells. Becauseofthis,theskindoesnothavetimetomaturenormally.Thisleadsto defectivekeratinization,whichcausesthescaling.

2. Thecauseisunknown,butgeneticsarebelievedtobeimportant. 3. Thisisachronicconditioncharacterizedbyexacerbationsandremissions—it improvesduringthesummer(sunexposure)andworsensinthewinter(dries skin).

4. Traumatotheskin(e.g.,infection,abrasion)cancauselocalflaresatthesiteof injury,whichistermedtheKoebnerphenomenon.

5. Uptothree-fourthsofpatientshavesomewhatlocalizeddisease(<20%to25%of bodysurfacearea[BSA]).

6. Lessthan10%ofpatientsdeveloppsoriaticarthritis(seeChapter6).

Quick HIT

Thereisnocureforpsoriasis,butthediseasecanbemanaged.

B.ClinicalFeatures 1. Themostcommonclinicalsubtypeischronicplaquepsoriasis;othervariations

includepustularpsoriasis,guttatepsoriasis,nailpsoriasis,andothers.

2. Lesionsarewell-demarcated,erythematouspapulesorplaquesthatarecoveredby

thick,silveryscaling;pruritusisrarelypresent(Figure11-3). 3. Auspitzsign—removalofthescalecausespinpointbleeding. 4. Itcaninvolveanypartofthebody,butthemostcommonareasaretheextensor surfacesofextremities(knees,elbows),scalp,interglutealcleft,palms,and soles.

5. Pittingofthesurfaceofnails,oronycholysis(distalseparationofthenailfrom thenailbed).

C.Treatment 1. Topicaltherapy

a. Corticosteroidsandemollientsarethemostcommonlyprescribedfirst-line agents.

FIGURE 11.3

Psoriasis.

(FromStedmanTL.Stedman’sMedicalDictionaryfortheHealthProfessionsandNursing:

Illustrated.6thed.Philadelphia,PA:LippincottWilliams&Wilkins;2007.)

b. CalcipotrieneandcalcitriolarevitaminDderivativesthathavebecomefirst-or second-lineagents.Theyareveryeffectiveinmostpatients.

c. Tarshaveanunpleasantodor,sotheyarelessdesirabletouse.Patientsshould usetarsfor4to6weeksbeforeexpectingtoseeabenefit.Tarsaremore effectiveincombinationtherapyandareassociatedwithan80%to90% remissionrate.

d. Otheroptionsincludetazarotene(avitaminAderivative),anthralin,andtopical calcineurininhibitors.

e. Combinationtherapy(e.g.,steroidsandcalcipotriene)ismoreeffectivethan eitheragentalone.

f. Phototherapy(withultravioletlight)shouldbeusedformoderate–severe psoriasisiffeasible.

2. Systemictreatmentisindicatedinpatientswithseverepsoriasis.Optionsinclude immune-modulatingtherapy(e.g.,methotrexate,infliximab,cyclosporine),oral retinoids(e.g.,acitretin),andcombinationsoftheseagentswithphototherapy.
======================================
Quick HIT

Oralsteroidsshouldbeavoidedinpsoriasis,sincediscontinuationcancauseflaringandcanprecipitate erythroderma.

SeborrheicDermatitis

A.GeneralCharacteristics 1. Achronic,idiopathic,inflammatoryskindisorderthatoccursinallagegroups. 2. Verycommonproblem(affects5%ofthepopulation),especiallyinpatientswith

oilyskin.

3. Exacerbatingfactors:anxiety,stress,fatigue,hormonalfactors. 4. Commonlocations:scalp(dandruff),hairline,behindears,externalearcanal, foldsofskinaroundnose,eyebrows,armpits,underbreasts,groinarea(skin folds).

5. Maybecomplicatedbysecondarybacterialinfection.

Quick HIT

Seborrheicdermatitisisachronicconditionwithnocure.Therapymaybeneededindefinitelyforcontrolof symptoms.

B.ClinicalFeatures 1. Mildcasesmanifestasdandruff. 2. Severecasesyellowish,oily,andthickflakesappearneareyelashes,intheear

canal,onthemiddlechest,behindtheears,andotherskinfolds.

3. Scalypatcheswithsurroundingareasofmildtomoderateerythema(Figure11-4). 4. Usuallyasymptomatic,butpruritus,skinlesions,andhairlosscanoccurifleft

untreated.

C.Treatment 1. Sunlightexposureoftenhelps. 2. Dandruffshampoo(over-the-counter)isusuallyadequate. 3. Topicalketoconazole(todecreaseyeastcountonskin)hasbeenfoundtobe

effective.

4. Topicalcorticosteroidsforseverecases.

FIGURE 11.4

Seborrheicdermatitis.

(FromGoodheartHP.Goodheart’sSame-SiteDifferentialDiagnosis:ARapidMethodof DiagnosingandTreatingCommonSkinDisorders.Philadelphia,PA:LippincottWilliams& Wilkins;2010.)

PityriasisRosea

Papulosquamouseruption—initially,“heraldpatches”thatresembleringworm (multipleround/ovalpatches)appear,andthenageneralizedrashwithmultipleoval- shapedlesionsappears.TherashisclassicallydescribedashavingaChristmas tree–typeappearance(Figure11-5). Itisnotcontagiousandispossiblyrelatedtoherpestype7. Itiscommononthetrunkandupperarmsandthighs,andisusuallynotfoundonthe face.Pruritusisoftenpresent,andvariesinseverity. Itspontaneouslyremitswithinafew(6to8)weekswithouttreatment.Thereisno treatmentotherthanantihistaminesforpruritus.Recurrencesarerare.
======================================
LichenPlanus

Chronic,inflammatorymucocutaneouslesionsofunknownetiology.Itmaybe associatedwithhepatitisCandcertaindrugs. (4Ps):Pruritic,polygonal,purple,flat-toppedpapules. Mostcommonlyseenonwrists,shins,oralmucosa,andgenitalia. Treatwithsteroids.

AllergicReactions Urticaria(Hives)

Urticariaiscausedbythereleaseofmediatorsfrommastcells,witharesultant increaseinvascularpermeability.Itmaybeacute(<6weeks)orchronic.

FIGURE 11.5

Pityriasisrosea.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Figure4.3.)

FIGURE

11.6 Urticaria.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,FigureG.11.)

Urticariacanbeprecipitatedbyfood,drugs,latex,animaldander,pollen,dust, plants,infections,cold/heat,andcertainmedicalconditions(e.g., hypocomplementemicurticarialvasculitis). Findings—migratoryedematouswheals(hives)thatoftenquicklyappearandthen disappear.Theyblanchwithpressure,andmaycauseintensepruritusorstinging. Lesionsgetworsewithscratching(Figure11-6). Treatmentinvolvesremovaloftheoffendingagent.Antihistaminesareeffectivefor symptomaticrelief.Systemiccorticosteroidsmayhelpinmoreseverecases.

Quick HIT

Unlikeerythemamultiforme,urticariahasaclearorpinkcenterandisblanchable.

Angioedema

Themechanismissimilartothatinurticaria,thoughangioedemaoccursdeeperin theskin(i.e.,fluidextravasationoccursindeeperlayersofskin/subcutaneous tissue).Angioedemaandurticariacanoccursimultaneouslyorindependently. Angioedemacanbecausedbyanyoftheprecipitantsofurticaria.ACEinhibitors areaspecificcauseofangioedema(reactionusuallyoccurswithin1weekof initiatingthedrug). Unlikeurticaria,whichcanoccuranywhere,angioedemausuallyaffectstheeyelids, lipsandtongue,genitalia,hands,orfeet.

Quick HIT

Hereditaryangioedema:autosomaldominantconditioncausedbyC1esteraseinhibitordeficiency, characterizedbyrecurrentepisodesofangioedema;canbelife-threatening

Angioedemaresultsinnonpitting,puffyskinwithfirmswellingthatismoretender and“burning”thanpruritic(becausetherearefewermastcells/sensorynerve endingsindeepertissues)(Figure11-7). AngioedemacaninvolvetheGItract,causingnausea/vomitingandabdominalpain (canbesosevereastomimicacuteabdomen). Severeangioedemacanleadtopotentiallylife-threateningairwayobstruction. Treatmentissimilartotreatmentofurticaria.GiveSCepinephrineforlaryngeal edemaorbronchospasm.
======================================
FIGURE 11.7

Angioedema.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Figure20.1.)

Anaphylaxis

Themostsevereformofallergy,anaphylaxisisasystemic,life-threateningallergic reactioncausedbyamassivereleaseofmastcellmediators(usuallyatypeI hypersensitivityreaction)thatoccurswithinsecondstominutes. Numerouscauseshavebeenidentified,includingfoods(mostcommoncause), medications,radiocontrastagents,bloodproducts,venoms(e.g.,fromsnakes),insect stings,latex,hormones,ragweed/molds,andvariouschemicals. Clinicalfindingsincludeskinandmucosalsigns(mostcommonandearlyfindings; urticaria,swollenlipsandtongue,periorbitaledema),respiratorysigns(dyspnea, wheeze,airwayobstruction),GIsigns(nausea/vomiting,crampyabdominalpain), andcardiovascularsigns(tachycardia,hypotension,shock). Treatmentofanaphylaxis:

e

¢

e

e

ABCs—securetheairway(intubationmaybenecessary)andprovidesupplemental oxygen,treathypotensionwithrapidinfusionofIVfluids. GiveIMepinephrineimmediately;mayrequireseveraldosesof0.3to0.5mg(1 mg/mLpreparation).Ifnotresponding,prepareIVepinephrineinfusion. Ifstillwheezingdespiteepinephrine,givealbuterolforbronchospasm. Adjunctstoconsider:antihistamines(bothH1andH2blockerssuchas diphenhydramineandranitidine)andcorticosteroids.Thesearelessimportantfor theacutemanagementofanaphylaxis.

DrugReactions

Overview

Anadversedrugreactionisnotnecessarilyanallergicdrugreaction(seealso ClinicalPearl11-1).Adversedrugreactionsincludedrugsideeffects,drug–drug interactions,drugtoxicityandassociatedillnesses,anddrugallergy.Mostcasesof adversedrugreactionsarenotrelatedtoallergy(only10%haveatrueallergic basis). Manypatientswhostatetheyare“allergic”toamedicationbelievethemselvestobe allergicbecausetheyhavebeenincorrectlylabeledwithoutdirectimmunologic evidence.However,giventheseriousrisksofatruedrugallergy,oneshouldavoid thesuspectedmedication. β-Lactamantibiotics(penicillins),aspirin,NSAIDs,andsulfadrugsaccountfor morethan80%ofallcasesofdrugallergy.Otherdrugsimplicatedincludeinsulin, localanesthetics,ACEinhibitors,andradiocontrastagents. Drug-inducedhypersensitivityreactionsmostcommonlymanifestastypeIV reactionswithdiffusemaculopapulareruptions;however,allfourhypersensitivity mechanismscanserveastheunderlyingmechanism,andclinicalfindingscanvary widelyandcanaffectmultipleorgansystems(e.g.,interstitialnephritis, pneumonitis,cardiovascularcollapsefromanaphylaxis,etc.).
======================================
Quick HIT

Allergicreactionstypicallyappearwithin1monthofinitiatingthedrug.Itisuncommonforadrug reactiontooccurwithinlessthan1weekofinitiatingthedrug.

FixedDrugEruption

TypicallycausedbyantibioticsorNSAIDs,fixeddrugeruptioncharacteristically appearsearly(withinhours)afterreexposuretotheprecipitatingmedicationinthe samebodylocation. Apurplepatchwilltypicallyappear,anduponreexposuremorelesionscandevelop. Thelesionstypicallyresolvespontaneously,leavinganareaofpostinflammatory hyperpigmentation.

CLINICALPEARL11-1

TypesofHypersensitivityReactions

©

e

©

TypeI:IgE-mediated(e.g.,anaphylaxis,asthma) TypeII:IgG-(orIgM-)andcytotoxiccell-mediated(e.g.,Goodpasturedisease,pemphigusvulgaris) TypeIII:antigen–antibodycomplexes(e.g.,SLE,Arthusreaction,serumsickness)

TypeIV:T-cell–mediated(delayedhypersensitivity)(e.g.,allergiccontactdermatitis,tuberculosis,transplant rejection)

AcuteGeneralizedExanthematousPustulosis(AGEP)

AGEPpresentswithfever,leukocytosis,andaskineruptionofsmallpustulesonan erythematousbackground.Theeruptiontypicallyoccurswithinhoursordaysafter exposuretothedrug,andtypicallybeginsonthefaceandneckandthenspreadsto thetrunkandlimbs. Antibioticsarethemostcommonculprit,andtreatmentissupportive(discontinuing themedicationandtopicalsteroids).

DrugReactionWithEosinophiliaandSystemicSymptoms(DRESS)

Asystemicreactionthattypicallyoccurs2to6weeksafterstartingamedication (longerlatencythanotherdrugreactions).Initialsymptomsincludefever, lymphadenopathy,facialedema,andadiffuse,morbilliformskineruption.The reactioncanprogresstoinvolvemultipleorgansystems,mostcommonlytheliver, kidneys,andlung. Themostcommonprecipitatingmedicationsareallopurinol,antiepileptics,sulfa drugs,vancomycin,minocycline,anddapsone. Diagnosisismadeusingaclinicalscoringsystembasedonhistoryofexposuretoa commonmedication,typicalexaminationfindings(e.g.,fever,morbilliform eruption),andlaboratoryabnormalities(eosinophilia,abnormalliverenzymes,acute kidneyinjury). Afterwithdrawaloftheoffendingagent,treatmentmayinvolvesteroidsifthereis significantlungorkidneyinvolvement,andliverinvolvementcansometimes progresstoacuteliverfailurerequiringtransplant.

EMiscausedbyinfectionin90%ofcases.Viral,bacterial,andfungalinfectionscanallcauseEM,buttwo common(andcommonlytested)associationsareHSVandMycoplasma.
======================================
ErythemaMultiforme

Erythemamultiforme(EM)isaninflammatoryskinconditionthathasbeen describedonthesamespectrumofStevens–Johnsonsyndrome(SJS)andtoxic epidermalnecrolysis(TEN),butnewerresearchsuggeststhatitisadistinctentity. EMischaracterizedbyerythematousmacules/papulesthatresembletargetlesions (“bull’s-eyelesions”)thatcanbecomebullous(Figure11-8).Skinlesionsmaybe pruriticandpainful,andoftenaffectthepalms,soles,andmouth. EMcanbecausedbymedications,thoughthemajorityofcasesarecausedby infections(especiallyHSV).Themostcommonprecipitatingmedicationsare

antibiotics,sulfadrugs,antiepileptics,andNSAIDs.OthercausesofEMinclude autoimmunedisease,malignancy,vaccines,andradiation. Treatmentisdirectedattheunderlyingetiology(e.g.,acyclovirforHSV).Topical steroidsandoralantihistaminesareusedforsymptomaticrelief;oralsteroidscanbe usedformoreseverecases.

Quick HIT

The“ruleofnines”isthequickestmethodofestimatingtheaffectedBSA—theheadis9%,eacharmis9%, eachlegis18%,andeachsideofthetrunk(anteriorandposterior)is18%(e.g.,forarashcoveringbotharms andhalfthechest,thetotalaffectedBSAis27%).Alternatively,forsmallerareas,thepalmandfingerstogether are1%.

Stevens–JohnsonSyndromeandToxicEpidermalNecrolysis

SJSandTENarepartofadiseasecontinuumofseveremucocutaneouseruptions. Theyaredermatologicemergencies. SJSinvolves<10%BSA,andTENinvolves>30%BSA.SJS/TENoverlap describespatientswith10%to30%BSAinvolvement.

FIGURE 11.8

Erythemamultiforme.A:Bulla.B:Target(oriris)lesion. (FromBickleyLS,SzilagyiP.Bates’GuidetoPhysicalExaminationandHistoryTaking.8thed. Philadelphia,PA:LippincottWilliams&Wilkins;2003,Table4.8.)

Themajorityofcasesarecausedbymedications(mostcommonlyantiepileptics,

sulfaantibiotics,allopurinol,nevirapine,andNSAIDs),thoughuptoathirdofcases havenoapparenttrigger.Mycoplasmaisaknowninfectiousprecipitant. Skinlesionsaretypicallycoalescingerythematousmaculesandtargetlesionsthat progresstovesicles/bullaewithextensiveskinnecrosisandsloughing.Mucosal involvementisverycommoninbothSJSandTEN. Potentiallylife-threatening(mortalityrateis10%forSJSand30%forTEN). Othercomplicationsincludemassivefluidandelectrolyteloss,secondaryinfections andsepsis,andmultiorganfailure. Management:admittoICUorburnunit.Withdrawthesuspectedmedication; aggressiverehydrationandsymptomaticmanagement.Urgentdermatologyand ophthalmologyconsultationisindicated.
======================================
Erythroderma

Alife-threateningdermatologicemergencythatcauseserythemaandscalingthat involves90%ormoreofthepatient’sBSA. Erythrodermamaybecausedbymedicationsoraflareofanexistingdermatitis (suchasatopicdermatitisorpsoriasis,especiallyafterabruptdiscontinuationoforal steroids).Alargenumberofcasesareidiopathic.Otherlesscommonassociations includetheSezarysyndrome(cutaneousT-celllymphoma),otherhematologicand solidorganmalignancies,autoimmunedisease(lupus),andinfections. Treatmentinvolvesintensiveskincare(emollients,dressings,warmandhumid environment),oralantihistaminesandtopicalsteroids,andaddressingthe underlyingcondition.

OtherInflammatoryandAutoimmuneDisorders

ErythemaNodosum

Erythemanodosumappearsaspainful,red,subcutaneous,elevatednodules, typicallylocatedovertheanterioraspectofthetibia(lesscommonlyonthetrunkor arms)(Figure11-9).Itisself-limitedandusuallyresolveswithinafewweeks.Low- gradefever,malaise,andjointpainmayprecedetherash. Itismuchmorecommoninwomen(especiallyyoungwomen)thaninmen. Manycauses:Streptococcusinfection,tuberculosis,otherbacterial,viral,andfungal infections,sarcoidosis,inflammatoryboweldisease,Behçetdisease,pregnancy, medications(e.g.,oralcontraceptives,sulfadrugs,amiodarone,antibiotics),syphilis, tuberculosis,malignancy,andothers.Manycasesareidiopathic.

FIGURE 11.9

Erythemanodosum.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia, PA:LippincottWilliams&Wilkins;2003,Figure25.17.)

Performthefollowingtohelpdeterminetheunderlyingcondition:chestradiograph

(forsarcoidosis,tuberculosis,otherinfections),antistreptolysin-Otiter,CBC, erythrocytesedimentationrateandC-reactiveprotein,andtuberculinskintestor interferon-gammareleaseassay.Additionaltestsshouldbebasedonpatientfactors (pregnancytestinfemales,STIscreen,etc.). Treattheunderlyingcondition,ifknown. Prescribebedrest,legelevation,NSAIDs,andheatforsymptoms.Potassiumiodide mayhelp.

PyodermaGangrenosum

Aneutrophilicdermatosisthatmostcommonlypresentswithulceratinglesionsthat displaypathergy(traumamakesthelesionworse,soavoiddebridement). PyodermagangrenosumiscommonlyassociatedwithIBD,hematologicdisease (especiallyIgAmonoclonalgammopathy),andrheumatologicdisease(rheumatoid arthritis,seronegativespondyloarthritis,andothers). Treatmentinvolvesnontraumaticwoundcareandtopicalagents(highpotency steroidsortacrolimus).Ifsevereorfailstorespondtoinitialmeasures,then alternativesincludesystemicdapsoneorminocycline,orimmunomodulating therapiessuchascyclosporine.
======================================
BullousPemphigoid

Multiplesubepithelialblistersonabdomen,groin,andextremities(Figure11-10). Elderlypeoplearemostcommonlyaffected. Blistersarelesseasilyrupturedthaninpemphigusvulgaris. Autoimmunecondition;nomalignantpotentialbutmaybepersistent. Treatwithsystemicortopicalglucocorticoids.

PemphigusVulgaris

Autoimmuneblisteringconditionresultinginlossofnormaladhesionbetweencells (acantholysis)(Figure11-11). Startsinoralmucosa;maybecomegeneralized. Blistersrupture,leavingpainfulerosions. Mostcommonlyaffectselderlypeople,oftenfatalifuntreated. Autoantibodies(usuallyIgG)directedagainsttheadhesionmoleculedesmoglein. Treatwithsystemicglucocorticoidsandotherimmunosuppressants. Pemphigusmaybethepresentingsymptomsofmalignanciessuchasnon-Hodgkin lymphoma,chroniclymphocyticleukemia,andCastlemandisease.

FIGURE 11.10

Bullouspemphigoid.

(FromElderDE,ElenitsasR,RubinAI,IoffredaM,MillerJ,MillerIIIOF.AtlasandSynopsisof Lever’sHistopathologyoftheSkin.3rded.Philadelphia,PA:LippincottWilliams&Wilkins;

2012.)

FIGURE 11.11

Pemphigusvulgaris.

(FromElderD,ElenitsasR,JohnsonB,etal.SynopsisandAtlasofLever’sHistopathologyofthe Skin[ClinicalFigureIVD3.b].Philadelphia,PA:LippincottWilliams&Wilkins;1999.)

Vitiligo

Chronic,depigmentingconditionduetounknowncause;hereditarycomponentis suspected Sharplydemarcatedareasofskinbecomeamelanotic—mostcommonontheface Associatedwithdiabetesmellitus,hypothyroidism,perniciousanemia,andAddison disease Topicalglucocorticoidsandphotochemotherapyareusedtopromoterepigmentation withvaryingdegreesofsuccess

SKINCONDITIONSRELATEDTOINFECTIONSAND INFESTATIONS

BacterialInfections(SeeChapter10)

ViralInfections

Warts

A.GeneralCharacteristics 1. WartsarecausedbyHPVandaretransmittedviaskin-to-skincontact.Forgenital

warts,transmissionisviaintimatesexualcontact.

2. Types

a. Thecommonwart(Verrucavulgaris)—mostcommontype.

e

e

Mayoccuranywhere,butthemostcommonsitesincludeelbows,knees, fingers,andpalms. Appearance:flesh-coloredorwhitishwithahyperkeratoticsurface.

b. Theflatwart(Verrucaplana).
======================================
e¢

e

Commonsitesincludethechin/face,dorsumofhands,andlegs. Appearsflesh-coloredwithsmoothpapulesandaflatsurface.

c. Theplantarwart(Verrucaplantaris).

e

e

Solitaryormultiplewartsfoundontheplantarsideofthefoot;cancausefoot painiflocatedonpressureareas(e.g.,metatarsalhead,heel). Appearance:fleshcoloredwitharough,hyperkeratoticsurface.

d. Anogenitalwart(Condylomaacuminatum).

¢

e

e

MostcommonSTD,commonlyassociatedwithHPV6and11(Figure11-12). HPV(types16,18)infectioncanleadtocervicalcancerinwomen(Papsmear isimportant),andprotectivevaccinesareavailable. Appearance:singleormultiplesoft,fleshygrowthsonthegenitalia,perineum, andanus.

FIGURE 11.12

Humanpapillomavirus(genitalwart).

(FromWilkinsonEJ,StoneIK.AtlasofVulvarDisease.Baltimore:Williams&Wilkins;1994,

Figure17.9a.)

Quick HIT

Mostwartsdisappearspontaneouslywithin1to2years.However,iftheconditionisleftuntreated,morewarts canappear.

B.Treatment 1. Firstlineistypicallysalicylicacidorcryotherapy(freezingwithliquidnitrogen). 2. Forrefractorywarts,optionsinclude5-FU,intralesionalbleomycin,topicalor intralesionalimmunotherapy(e.g.,Candidaantigen),surgicaltherapy,laser therapy,imiquimod,andmanyothers.

Quick HIT

Wartscanberecurrentandmayrequiremultipletreatments(despitethemethodoftherapychosen).

MolluscumContagiosum

Acommon,self-limitedviralinfectioncausedbyapoxvirus;commoninsexually activeyoungadultsandinchildren. Itmanifestsassmallpapules(2to5mm)withcentralumbilication.Lesionsare asymptomatic.InHIV-positivepatients,lesionscanbeextensive(Figure11-13). Itistransmittedviaskin-to-skincontact(sexualcontactcanleadtogenital involvement)andishighlycontagious. Oftenregressesspontaneously,butmultipletreatmentmodalitiesareeffective(e.g., curettage,dropscontainingpodophyllinandcantharidin,cryosurgery),butscarring isalwaysarisk.

FIGURE 11.13

Molluscumcontagiosum.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Figure6.13.)

FIGURE 11.14

Herpeszoster.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia, PA:LippincottWilliams&Wilkins;2003,Figure6.33.)
======================================
HerpesZoster(Shingles)

A.GeneralCharacteristics 1. Causedbyreactivationofthevaricella-zostervirus,whichremainsdormantinthe dorsalrootgangliaandisreactivatedintimesofstress,infection,orillness;only occursinthosewhohavepreviouslyhadchickenpox.

2. Itistypicallyseeninpatientsover50yearsofage.Inpatientslessthan50years ofage,suspectanimmunosuppressedstate.

3. Contagiouswhenopenvesiclespresentandonlyforthosewhohaveneverhad chickenpoxorareimmunocompromised(ornewborns).Zosterisnotas contagiousaschickenpox.

Quick HIT

ComplicationsofZoster Postherpeticneuralgia Occursmostfrequentlyinpatientsolderthan50years Manifestsasexcruciatingpainthatpersistsafterthelesionshavecleared,anddoesnotrespondtoanalgesics Canbechronicanddebilitating Uveitis Dissemination Meningoencephalitis,deafness

B.ClinicalFeatures 1. Severepainandrashinadermatomaldistribution.Paincomesbeforethe rash.Rashischaracterizedbygroupedvesiclesonanerythematousbase.If severe,low-gradefeverandmalaisemaybepresent.

2. Themostcommonsitesofinvolvementarethethorax(mostcases)andtrigeminal distribution(especiallyophthalmicdivision).Affectedsitescanalsoincludeother cranialnerves,aswellasarmsandlegs(Figure11-14).

3. Rarelylife-threatening,evenifdisseminationoccurs.Herpeszosterismore severe,however,inimmunocompromisedpatients.

C.Treatment 1. Keepthelesionscleananddry. 2. Prescribeanalgesicsforpainrelief(aspirinoracetaminophen;codeineifneeded).

Inseverecases,administeralocalinjectionoftriamcinoloneinlidocaine.

3. Prescribeantiviralagents(acyclovir,famciclovir,valacyclovir)toreducethepain,

decreasethelengthofillness,andreducetheriskofpostherpeticneuralgia. 4. Theuseofcorticosteroidstodecreasetheincidenceofpostherpeticneuralgia

remainscontroversial.

5. Livevaccinehasbeenshowntobeeffectiveinreducingthenumberofcasesof

shinglesinpatientsovertheageof60inadditiontoreducingtheseverityand durationofpostherpeticneuralgiainpatientswhodoendupwiththedisease.The vaccineshouldberecommendedtoallpatientsover60whodonothave contraindications.
======================================
FungalInfections

Dermatophytes

Dermatophytesaresuperficialfungithatinfectcutaneousepithelium,nails,andhair. ThethreemaingeneraofdermatophytesareTrichophyton,Microsporum,and Epidermophyton. ImportantdermatophyteinfectionsarecoveredinTable11-1. ScrapelesionsanduseKOHpreparationtovisualizethefungus.

TABLE11-1 ImportantDermatophyteInfections

Tinea corporis Body/trunk Allages Pinkish, annular Direct microscopy: visu- Topical antifungals (e.g., (“ringworm”) lesions alization of hyphae from ketoconazole, miconazole) skin scrapings with KOH preparation Tinea capitis Scalp Children Areas of scaling with © Direct microscopy Oral griseofulvin (antifungal) hair loss + pruritus © Wood lamp: if hairs fluoresce, Microsporum spp. is the cause. If not, Trichophyton spp. is the cause. Tinea unguium Nails Elderly people Thick, opacified nails Direct microscopy (nail Oral griseofulvin (antifungal) (onychomycosis) scrapings) Tinea pedis Feet—web Young adults Scaling, erythema, Direct microscopy Topical antifungals, good (“athlete’s foot”) spaces of toes pruritus foot hygiene Tinea cruris (“Jock Groin, inner thighs Adults: males _—Areas of scaling, Direct microscopy Topical antifungals, good itch”) > females erythema: spares hygiene scrotum

TineaVersicolor

Acommonsuperficialfungalinfectionwhichislikelycausedbyseveralspeciesin theMalasseziagroup,whicharepartofthenormalskinflora(Figure11-15). Characteristiclesionsarewelldemarcatedandmostcommonlyaffectthetrunk.As thenameimplies,lesionsmaybehyper-orhypopigmentedandcanrangeincolor frombrowntotantowhite. Adolescentsandyoungadultsaremostcommonlyaffected,thoughalmostanyage canbeaffected. Hot/humidweather,excessivesweating,andskinoilsmaycontributeto transformationfromnormalskinfloratopathologiccondition. DiagnosisshouldbemadewithKOHprep,whichwillshowthe“spaghettiand meatballs”patternconsistentwithbothhyphaeandyeastballs. Treatmentconsistsoforalortopicalantifungals,dependingontheseverityofthe disease.Seleniumsulfidelotionmayalsobehelpful.

Quick HIT

Treattineacapitisandonychomycosiswithoralantifungalagents.Othersaretreatedwithtopicalantifungals.
======================================
FIGURE 11.15

Tineaversicolor.

(CourtesyofPaulS.Matz,MD.VisualDiagnosisandTreatmentinPediatrics.Philadelphia,PA: LippincottWilliams&Wilkins;2006.)

Scabies

A.GeneralCharacteristics 1. CausedbythehumanskinmiteSarcoptesscabiei. 2. Highlycontagious—transmittedviaskin-to-skincontactorthroughtowels,bed

linens,orclothes.

3. Pathogenesis—themitestunnelintotheepidermis,layeggs,anddepositfeces (calledscybala).AdelayedtypeIVhypersensitivityreactiondevelopstowardthe mites,eggs,andfeces,causingintensepruritus.

4. Commonlocationsincludethefingers,interdigitalareas,andwrists.Inmore extensiveinfestations,theelbows,feet,ankles,penis,scrotum,buttocks,and axillae.Thehead,neck,palms,andsolesaretypicallyspared.

B.ClinicalFeatures 1. Severepruritus—thisisoftenthemostsevereduringthenight. 2. Burrows—linearmarks(severalmillimetersinlength)representthetunneledpath ofthemite.Thereistypicallyadarkdotatoneend,representingthefemalemite.

2. Burrows—linear marks (several millimeters in length) represent the tunneled path of the mite. There is typically a dark dot at one end, representing the female mite. 3. Scratching may lead to excoriations.

3. Scratchingmayleadtoexcoriations. 4. Eczematousplaques,crustedpapules,orsecondarybacterialinfectionmay

develop(Figure11-16).

Quick HIT

Suspectscabiesinanypatientwhohaspersistent,generalized,severepruritus.

C.Diagnosis 1. Lookforcharacteristicburrowsonhands,wrists,andankles,andinthegenital

region.

2. Confirmthediagnosisbyscrapingtheburrowwithascalpelandexaminingit underamicroscopetodetectthepresenceofmites,ova,orscybala.

D.Treatment 1. Specificmedications.

a. Permethrin5%creamisoftenusedasfirst-linetreatment;itcausesparalysisof theparasite(actsonnervecellmembrane).

Shouldbeappliedtoeveryareaofthebody(headtotoe),evenunder fingernailsandtoenails,aroundthegenitalarea,andinthecleftofthe

buttocks.Patientsshouldleavecreamonovernight(>8to10hours)andwash itoffthenextmorning.Somerecommendasecondtreatment1to2weeks later.

b. Otheroptionsincludeoralivermectin,topicallindane(γ-benzene-hexachloride), andothers.
======================================
FIGURE 11.16

Scabies.

(FromStedmanTL.Stedman’sMedicalDictionaryfortheHealthProfessionsandNursing:

Illustrated.7thed.Philadelphia,PA:LippincottWilliams&Wilkins;2012.)

2. Generalrecommendations.

a. Treatallclosecontactsofthepatientsimultaneously(evenifasymptomatic) withPermethrin5%cream.

b. Thepatientisnolongercontagiousafteronetreatment,althoughpruritusmay continueforafewweeksasdeadmitesareshedfromtheskin.Usetopical corticosteroidsandoralantihistaminestocontrolpruritusduringthistime.

c. Thoroughlywashallunderwearandbedlinens.

BENIGNANDMALIGNANTSKINLESIONS

BenignSkinLesions

ActinicKeratosis(AlsoCalledSolarKeratosis)

Small,rough,scalylesionsduetoprolongedandrepeatedsunexposure(Figure11- 17). Mostcommonlyseeninfair-skinnedpeople.Lesionsaretypicallyontheface. Prevention:advisepatientstoavoidexcessivesunexposureandtousesunscreen. Althoughtheriskofmalignanttransformationislow(1in1,000),biopsyisstill recommendedforhyperkeratoticactinickeratosislesionstoexcludeSCC. Additionally,lesionswhichbecomeindurated,tender,orbleedspontaneouslymust bebiopsiedtoexcludeSCC. Treatmentoptionsincludesurgicalremoval(scraping),freezingwithliquidnitrogen, orapplicationoftopical5-FUformultiplelesions(destroyssun-damagedskin cells).

Onceapatienthasdevelopedactinickeratosiswithexcessivesunexposure,otherlesionsmaydevelop,even withoutfurthersunexposure.

SeborrheicKeratosis

Theseareverycommonskinlesionsthatbegintoappearaftertheageof30years. Hereditary—theyprobablyareautosomaldominant,andareharmlessgrowthswith nomalignantpotential. Thereisnoassociationwithsunlight. Theycanbelocatedanywhere,butarecommononthefaceandtrunk.Theyincrease innumberwithtime,andsomepatientshavemanyofthem. Theyareslightlyelevatedplaques,graduallyturningdarkerincolor,andappearasif theywere“stuck”ontheskin(Figure11-18). Treatmentisnotnecessaryandisonlyforcosmeticreasons:Liquidnitrogen cryotherapyorcurettageiseffectiveandeasilyperformedintheofficesetting.

FIGURE 11.17

Actinickeratosis.

(FromStedmanTL.Stedman’sMedicalDictionaryfortheHealthProfessionsandNursing: Illustrated.6thed.Philadelphia,PA:LippincottWilliams&Wilkins;2007.)
======================================
FIGURE 11.18

Seborrheickeratosis.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia, PA:LippincottWilliams&Wilkins;2003,Figure21.13.)

Keratoacanthoma

Epithelialtumorswhichclinicallyresemblesquamouscellcarcinoma(SCC). CurrentdebatecentersonwhetherthisisasubtypeofSCCoraseparateentity altogether. LesionsgrowVERYquickly.Thelesionsprogresstothetypicaldomewithcentral cratercontainingkeratinousmaterialoverthecourseofseveralweeks.Thistypeof growthisveryrareforSCC. Treatmentinvolvesobservation,asmanyofthesewillregressspontaneouslyover severalmonths.

MalignantSkinLesions

eee

BasalCellCarcinoma

Basalcellcarcinoma(BCC)isthemostcommonskincancer(accountsfor60% to75%ofallskincancers). Itarisesfromthebasallayerofcellsintheepidermis. Themostimportantriskfactorissunexposure. Itoccursmostfrequentlyinfair-skinnedindividualswhoburneasilyandinvolves sun-exposedareas,suchastheheadandneck(thenoseisthemostcommonsite). Theclassicappearanceisapearly,smoothpapulewithrollededgesandsurface telangiectases(threePs:pearly,pink,papule)(Figure11-19). Metastasisisextremelyrare,butcanbelocallydestructive. Surgicalresectioniscurative.

FIGURE 11.19

Basalcellcarcinoma.

FIGURE 11.20

Squamouscellcarcinoma.

(FromStedmanTL.Stedman’sMedicalDictionaryfortheHealthProfessionsandNursing: Illustrated.6thed.Philadelphia,PA:LippincottWilliams&Wilkins;2007.)

SquamousCellCarcinoma

SCCislesscommonthanBCC.(SCCaccountsforlessthan20%ofallskin cancers.) Itarisesfromepidermalcellsundergoingkeratinization. Sunlightexposureisthemostimportantriskfactor.Concomitantactinickeratoses, chronicskindamage,andimmunosuppressivetherapyarealsoriskfactors. Itistypicallydescribedasacrusting,ulceratednoduleorerosion(Figure11-20). ThelikelihoodofmetastasisishigherthanwithBCC,butmuchlowerthanwith melanoma. Theprognosisisexcellentifitiscompletelyexcised(95%curerate).Lymphnode involvement,however,carriesapoorprognosis.

Quick HIT

Marjolinulcer:anSCCarisingfromachronicwoundsuchasapreviousburnscar(tendstobeveryaggressive)
======================================
Quick HIT

Womenwithmalignantmelanomahaveabetterprognosisthanmen(withequivalentlesions).

Melanoma

A.GeneralCharacteristics 1. Mostaggressiveformofskincancerandthenumberonecauseofdeathdueto

skincancer.

2. Increasingincidenceworldwide 3. Riskfactors

a. Faircomplexion;primarilyaffectsCaucasianpatients,especiallythosewithany

ofthefollowing: Inabilitytotan Easilysunburned Redhairand/orfreckles Numerousmoles

e

e

e

e

Quick HIT

SpitzNevi

e

¢

Well-circumscribed,raisedlesioncommonlyconfusedwithmelanoma;colorvaries. Completeexcisionisrecommended.

b. Sunexposure,especiallyfor:

e

e

Patientswithahistoryofseveresunburnbeforetheageof14years Patientslivinginasunnyclimate

c. Familyhistoryofmelanoma(e.g.,first-degreerelative) d. Genodermatoses(e.g.,xerodermapigmentosa) e. Increasingage f. Largenumbersofnevi(moles)

e

e

Althoughmostmelanomasarisedenovo,theymayarisefrompre-existing neviinupto50%ofcases Anychangeinanevusisconcerningbecauseitmayindicatemalignancyor malignanttransformation.Lookforcolorchange,bleeding,ulceration,ora papulearisingfromthecenterofanexistingnevus

g. Dysplasticnevussyndrome

e

e

Numerous,atypicalmoles—thesetendtobelargewithindistinctbordersand variationsincolor.Thechancesofasingledysplasticnevusbecominga melanomaaresmall Ifdysplasticnevussyndromeandafamilyhistoryofmelanomaarepresent, theriskofdevelopingmelanomaapproaches100%

h. Giantcongenitalnevi—theriskofmelanomaisabout5%to8%.Prophylactic

excisionisrecommended

FIGURE 11.21

Malignantmelanoma.

(FromGoodheartHP.Goodheart’sPhotoguideofCommonSkinDisorders.2nded.Philadelphia,

PA:LippincottWilliams&Wilkins;2003,Figure21.20.)

4. Growthphases

a. Radial(initial)growthphase

e

e

Growthispredominantlylateralwithintheepidermis Thereisagoodprognosiswithsurgicalresectionbecausemetastasisis unlikely

b. Vertical(later)phase

e

e

¢

Growthextendsintothereticulardermisorbeyond Lymphaticorhematogenousmetastasismayoccur Depthofinvasionisthemostimportantindicatorofprognosis

B.ClinicalFeatures 1. Amelanomamaypresentwithsomeorallofthefollowingfeatures:

a. Asymmetry b. Borderirregularity c. Colorvariegation—rangingfrompinktobluetoblack d. Diametergreaterthan6mm e. Evolution—changesinsize,shape,orcolor(Figure11-21)
======================================
C.Diagnosis 1. Excisionbiopsyisthestandardofcarefordiagnosisofanysuspiciouslesion. a. Shavebiopsyandpunchbiopsyarelessaccuratethanexcisionbiopsyin

assessingthedepthofinvasion.

b. Acceptableskinmarginsare1to3cmformostlesions,asdeterminedbydepth ofinvasion.

2. Lymphnodedissectionisappropriateifnodesarepalpable.

D.Treatment 1. Earlydetectionisthemostimportantwaytopreventdeath,becauseprognosisis

directlyrelatedtodepthofinvasion.

2. Surgicaloptionsexist,andevensurgicalexcisionofmetastases(termed metastasectomy)maybebeneficial.

3. Foradvanceddisease,immunotherapyortargetedtherapies(e.g.,BRAF inhibition)maybeoffered.

Quick HIT

SitesofMetastases

Lymphnodes,skin,subcutaneous(59%) Lung(36%) Liver(20%) Brain(20%)—commoncauseofdeath Bone(17%) GItract(7%)

12 AmbulatoryMedicine StanleyYuan

CardiovascularDiseases

eee

Hypertension

A.GeneralCharacteristics 1. Essentialhypertension(HTN)(i.e.,thereisnoidentifiablecause)appliesto

morethan95%ofcasesofHTN.

2. SecondaryHTNhasmanyidentifiablecauses.

a. Renal/renovasculardisease—renalarterystenosis(mostcommoncauseof secondaryHTN),chronicrenalfailure,polycystickidneys.

b. Endocrinecauses—hyperaldosteronism,thyroidorparathyroiddisease,Cushing syndrome,pheochromocytoma,acromegaly.

c. Medications—oralcontraceptives,decongestants,estrogen,appetite suppressants,chronicsteroids,tricyclicantidepressants(TCAs),nonsteroidal anti-inflammatorydrugs(NSAIDs).

d. Coarctationoftheaorta. e. Cocaine,otherstimulants. f. Obstructivesleepapnea(OSA).

Quick HIT

BirthcontrolpillsarethemostcommonsecondarycauseofHTNinyoungwomen.

Quick HIT

PathophysiologyoftheEffectsofHTNontheHeart

e

e

Increasedsystemicvascularresistance(afterload)→concentricleftventriclehypertrophy(LVH)→ decreasedLVfunction.Asaresult,thechamberdilates→symptomsandsignsofheartfailure. HTNacceleratesatherosclerosis,leadingtoahigherincidenceofCAD(aswellasperipheralvasculardisease andstroke).

B.RiskFactors 1. Age—bothsystolicanddiastolicBPincreasewithage. 2. Gender—morecommoninmen(gapnarrowsoverage60);menhavehigher

complicationrates.

3. Race—itistwiceascommoninAfrican-AmericanpatientsthaninCaucasian patients;African-Americanpatientshavehighercomplicationrates(stroke,renal failure,heartdisease).

4. Obesity,sedentarylifestyle,dyslipidemia.

5. Familyhistory. 6. Increasedsodiumintake—thiscorrelateswithincreasedprevalenceinlarge

populations,butnotinindividuals;individualsusceptibilitytotheeffectsofhigh saltintakevaries.

7. Alcohol—intakeofmorethan2ozofliquor,8ozofwine,or24ozofbeerper dayisassociatedwithHTN.
======================================
Quick HIT

TargetOrganDamage

e

e

e

e

e

Heart—LVH,MI,CHF Brain—stroke,TIA Chronickidneydisease Peripheralarterialdisease,AAA,aorticdissection Retinopathy

C.Definitions 1. Classification(foradults>18years)

a. Normal—systolicBP<120anddiastolicBP<80 b. Elevated—systolicBP120to139ordiastolicBP80to89 c. StageI—systolicBP140to159ordiastolicBP90to99 d. StageII—systolicBP≥160ordiastolicBP≥100

2. Hypertensiveurgency—severeHTN(typicallysystolicBP>180and/or diastolicBP>120)inanasymptomaticpatient

3. Hypertensiveemergency—severeHTNwithend-organdamage(e.g., neurologicchanges,myocardialischemia,aorticdissection)

CNS (intracerebral hemorrhage, encephalopathy) Eyes (hemorrhages, exudates, papilledema) Aortic dissection Heart (CHF, CAD, Ml) Kidneys (renal failure)

FIGURE 12.1

Complicationsofuncontrolledhypertension.

D.Complications 1. ThemajorcomplicationsofHTNarecardiaccomplications(coronaryartery disease[CAD],CHFwithleftventricularhypertrophy[LVH]),stroke,and renalfailure(Figure12-1).Theseaccountforthemajorityofdeathsassociated withuntreatedHTN.

2. HTNaffectsthefollowingorgans(targetorgandamage):

a. Cardiovascularsystem

e

¢

¢

e

e

Effectsontheheartaremostimportant.HTNisamajorriskfactorforCAD, withresultantanginaandMI. CHFisacommonend-resultofuntreatedHTNasLVHoccurs. MostdeathsduetoHTNareultimatelyduetoMIorCHF. HTNpredisposesthepatienttoperipheralarterydisease(PAD). HTNisassociatedwithincreasedincidenceofabdominalaorticaneurysm (AAA)andaorticdissection.

Quick HIT

HTNisanasymptomaticdisease(“silentkiller”)—itcausesinsidiousdamagetothefollowingtargetorgans: heart,eyes,CNS,andkidneys.

Quick HIT

PatientswithasystolicBPof120to129areconsideredprehypertensiveandrequirelifestylemodificationsto preventcardiovasculardisease.

FIGURE 12.2

Cottonwoolspots(hypertension).

(FromStollerJK,AhmadM,LongworthDL.TheClevelandClinicIntensiveReviewofInternal

Medicine.3rded.Philadelphia,PA:LippincottWilliams&Wilkins;2002,Figure6.1.)

b. Eyes(retinalchanges)

e

e

e

Earlychanges—arteriovenousnicking(discontinuityintheretinalvein secondarytothickenedarterialwalls)andcottonwoolspots(infarctionofthe nervefiberlayerintheretina)cancausevisualdisturbancesandscotomata (Figure12-2). Moreseriousdisease—hemorrhagesandexudates. Papilledema—anominousfindingseenwithseverelyelevatedBP.

c. CNS
======================================
Increasedincidenceofintracerebralhemorrhage.

e

e

Increasedincidenceofotherstrokesubtypesaswell(transientischemicattacks [TIAs],ischemicstroke,andlacunarstroke). HypertensiveencephalopathywhenBPisseverelyelevated(uncommon).

d. Kidney

e

e

Arteriosclerosisofafferentandefferentarteriolesandglomerulus—called nephrosclerosis. DecreasedGFRanddysfunctionoftubules—witheventualrenalfailure.

Quick HIT

GoalsinEvaluatingaPatientWithHTN

¢

e

e

e

Lookforsecondarycauses(maybetreatable). Assessdamagetotargetorgans(heart,kidneys,eyes,CNS). Assessoverallcardiovascularrisk. Maketherapeuticdecisionsbasedontheabove.

Quick HIT

DefinitionofHTN BP>130/80ingeneralpopulation(includingpatientswithdiabetesandrenaldisease)

E.Diagnosis 1. BPmeasurement

a. UnlessthepatienthassevereHTNorevidenceofend-organdamage,never diagnoseHTNonthebasisofoneBPreading.Establishthediagnosisonthe basisofatleasttworeadingsover4ormoreweeksapart

b. ObservethefollowingtoobtainanaccurateBPreading

Thearmshouldbeatheartlevel,andthepatientshouldbeseatedcomfortably Havethepatientsitquietlyforatleast5minutesbeforemeasuringBP Makesurethepatienthasnotingestedcaffeineorsmokedcigarettesinthepast 30minutes(bothelevateBPtemporarily) Useacuffofadequatesize(acuffthatistoosmallcanfalselyelevateBP readings).Thebladderwithinthecuffshouldencircleatleast80%ofthearm 2. Orderthefollowinglaboratoryteststoevaluatetargetorgandamageandassess

overallcardiovascularrisk

a. Urinalysis b. Chemistrypanel:serumK1,BUN,Cr c. Fastingglucose(ifpatientisdiabetic,checkformicroalbuminuria) d. Lipidpanel e. ECG

3. Ifthehistoryandphysicalexamination(H&P)orlaboratorytestssuggesta secondarycauseofHTN,orderappropriatetests

F.Treatment 1. Managementgoals(Table12-1). 2. Lifestylechanges,listedinorderofeffectonBPreduction:

a. WeightlosslowersBPsignificantly.Inpatientswithcentralobesity(whooften havecoexistingdiabetes,hyperlipidemia,andotherriskfactors),weightlossis particularlyimportantbecausemultipleriskfactorsarereducedconcomitantly.

b. Followalow–saturated-fatdietrichinfruits,vegetables,andlow-fatdairy products(DASHdiet).

c. Exerciseregularly.RegularaerobicexercisecanlowerBP(andreduceoverall cardiovascularrisk).

d. Reducesaltintake.ReductionindietarysalthasbeenshowntoreduceBP. Recommendeitherano-added-saltdiet(4gsodium/day)oralow-sodiumdiet (2g/day).

e. Avoidexcessivealcoholconsumption.Alcoholhasapressoraction,and excessiveusecanincreaseBP.

f. Others—stopunnecessarymedicationsthatmaycontributetoHTN.Engagein appropriatestressmanagementpractices.

3. Pharmacologictreatment(sevenclassesofdrugs)(Table12-2).

a. Thiazidediuretics.
======================================
e

e

Because“salt-sensitive”HTNismorecommoninAfrican-Americanpatients, diureticsareagoodinitialchoiceforthesepatients(thoughacalciumchannel blockerisequallyrecommendedasafirst-lineoption). Agoodoptioninpatientswithosteoporosis(increasescalciumreabsorptionin thenephron).

Quick HIT

Alwaysobtainapregnancytestinreproductiveagewomenbeforestartinganantihypertensivemedication. Thiazides,ACEinhibitors,calciumchannelblockers,andARBsarecontraindicatedinpregnancy.β-Blockers andhydralazinearesafe.

Quick HIT

Ifapatientpresentswithmoderate-to-severeHTN,considerinitiatingtherapyrightawayinsteadofwaiting1to 2monthstoconfirmdiagnosisandstarttreatment.

b. β-Blockers—decreaseHRandcardiacoutputanddecreasereninrelease.

AgoodoptioninpatientswithCHF,CAD,oratrialfibrillation;apooroption

inpatientswithobstructivelungdisease,heartblock,ordepression.

c. ACEinhibitors.

Inhibittherenin–angiotensin–aldosteronesystem(RAAS)byinhibitingthe conversionofangiotensinItoangiotensinII.AngiotensinIInormallycauses vasoconstriction,aldosteronerelease,andventricularremodeling.

TABLE12-1 SideEffectsofAntihypertensiveMedications

Medication SideEffects

Hypokalemia,hyperuricemia,hyperglycemia,elevationofcholesterolandtriglyceridelevels, metabolicalkalosis,hyperuricemia,hypomagnesemia

β-Blockers Bradycardia,bronchospasm,sleepdisturbances(insomnia),fatigue,mayincreaseTGsand decreaseHDL,depression,sedation,maymaskhypoglycemicsymptomsindiabeticpatientson insulin

ACE inhibitors

Acuterenalfailure,hyperkalemia,drycough,angioedema,skinrash,alteredsenseoftaste

Calcium channel blockers

Dihydropyridines(e.g.,amlodipine):peripheraledema Nondihydropyridines(e.g.,verapamil,diltiazem):heartblock

e

e

ACEalsoactstodegradebradykinin,soinhibitionresultsinexcesslevelsin thelungthatcancauseachronicdrycough. Preferredinalldiabeticpatientsbecauseoftheirprotectiveeffecton kidneys;alsoagoodoptionforpatientswithCHF,CAD.

d. AngiotensinIIreceptorblockers(ARBs).

e

e

AlsoinhibitRAAS. ARBshavethesamebeneficialeffectsonthekidneyindiabeticpatientsas ACEinhibitorsanddonotcauseachroniccough;ACEinhibitorsandARBs shouldnotbeusedincombination.
======================================
Quick HIT

Unlessthereisacompellingindicationtouseaspecificdrugclass,itmakeslittledifferencewhethertheinitial drugisathiazidediuretic,calciumchannelblocker,ACEinhibitor,orARB.

e. Calciumchannelblockers—causevasodilationofarteriolarvasculature. f. α-Blockers—decreasearteriolarresistance.

Maybeofbenefitifthepatienthasconcurrentbenignprostatichyperplasia (BPH)butthesearenotconsideredfirst-orsecond-lineagents.

g. Vasodilators(hydralazineandminoxidil)—notcommonlyused;typicallygiven incombinationwithβ-blockersanddiureticstopatientswithrefractoryHTN.

Quick HIT

TreatmentwithACEinhibitorsandARBsisassociatedwithdecreasedriskofnew-onsetdiabetesinpatients withHTN.

4. Generalprinciplesoftreatment.

a. BPshouldbeloweredto<140/90mmHgforpatients<60yearsold,and <150/90mmHgforpatients≥60yearsold.Ifpatients≥60yearsoldpreviously toleratedaBPgoal<140/90mmHg,theirtreatmentdoesnotneedtobe changed.

b. EachoftheantihypertensiveagentsisroughlyequallyeffectiveinloweringBP. However,thereisgreatvariabilityinhowpatientsrespondtoeachdrug.The threeclassesofdrugsthatareusedforinitialmonotherapyarethiazidediuretics, long-actingcalciumchannelblockers(mostoftenadihydropyridine),andACE inhibitors/ARBs.β-Blockersarenotcommonlyusedasinitialmonotherapyin theabsenceofaspecificindicationbecauseofadverseeffectsonsome cardiovascularoutcomesespeciallyinelderlypatients.

Quick HIT

MostpatientseventuallyneedmorethanonedrugtoattaingoalBP(especiallydiabetics,obesepatients,and thosewithrenalfailure).

c. Drugtreatmentisoftenlifelong.However,patientswithverymildHTNmaybe abletobeweanedoffmedicationiftheirBPcanbeloweredandcontrolledwith nonpharmacologicmeasures,suchaslifestylemodifications.However,these patientsneedfrequentBPchecks.

Quick HIT

If“whitecoathypertension”issuspected,therearetwooptionsfordeterminingwhethertheincreasedBP persistsoutsidetheoffice.

¢

e

Twenty-four–hourambulatorybloodpressuremonitoringisthemosteffective. Homebloodpressuremonitoringisanalternative.

d. ALLHATtrialcomparedchlorthalidone,amlodipine,lisinopril,anddoxazosinin patientswithessentialHTNandatleastoneCADriskfactor.Thedoxazosinarm wasterminatedearlybecauseofanincreasedriskofCHFcomparedto chlorthalidone.Theotherthreeagentsweresimilarinregardstoratesoffatal CADandnonfatalMI,howeverchlorthalidonereducedratesofCAD,stroke, CHF,andanginawhencomparedtolisinopril.

e. ACCOMPLISHtrialshowedthattreatmentwithantihypertensivecombination

therapy—theACEinhibitorbenazeprilplusthecalciumchannelblocker amlodipine—wasmoreeffectivethantreatmentwiththeACEinhibitorplus diuretic.Basedonthistrial,itmakessensetostartmonotherapywitheithera calciumchannelblockeroranACEinhibitor,sothattheothercanbeaddedif combinationtherapyisneeded.Despitethefindingsofthistrial,thiazide diureticsremainacommoninitialdrugchoice.
======================================
Quick HIT

Cardiovascularriskfactors:smoking,diabetes,hypercholesterolemia,ageover60,familyhistory,malesex (higherthanforfemaleonlyuntilmenopause)

Clinicalriskfactors:presenceofCAD,PAD,orpriorMI;anymanifestationsoftargetorgandisease—LVH, retinopathy,nephropathy;strokeorTIA

f. Ifthepatient’sresponsetooneagentisnotadequate,therearetwooptions:

e

e

Increasethedoseofthefirstagenttothemaximumdose. Addasecondmedication(thiazide,calciumchannelblocker,ACEinhibitor,or ARB);iftargetBPnotachieved,increasethedoseofeachasnecessaryuntil themaximumdoseisachieved.

g. Ifapatient’sresponseisstillinadequatewithtwoagents,considerathirdagent andreferraltoanHTNspecialist.

h. Thedecisionofwhentostartpharmacologictreatmentisbasedonthepatient’s totalcardiovascularrisk,notjusttheelevationinBP.

ForanylevelofBPelevation,thepresenceofcardiovascularriskfactors and/orcomorbidconditionsdramaticallyacceleratestheriskfromHTN,and thereforemodifiesthetreatmentplan.Estimationofoverallriskdependson cardiovascularriskfactorsandclinicalriskfactors(seeClinicalPearl12-1).

Quick HIT

Patientsatincreasedriskforcoronaryarterydisease(e.g.,strongfamilyhistoryand/orobesity)shouldbe screenedwithafastinglipidprofileevery5yearsstartingatage20.Forpatientswithoutriskfactors,screen startingatage45forwomenandage35formen.

CLINICALPEARL12-1

RiskFactorsforCADinEvaluationofPatientsWithHyperlipidemia

Currentcigarettesmoking(dose-dependentrisk) HTN Diabetesmellitus LowHDLcholesterol(<35mg/dL);highHDL(>60mg/dL)isanegativeriskfactor(subtract1fromtotal)

¢

« HIN

e

e

Age

e

e

Male:>45yearsofage Female:>55yearsofage

e

e

Malegender—ifyoucountasariskfactor,donotcountage FamilyhistoryofprematureCAD

e

«

MI/suddendeathinmalefirst-degreerelative<55yearsofage MI/suddendeathinfemalefirst-degreerelative<65yearsofage

Hyperlipidemias

A.GeneralCharacteristics 1. Hyperlipidemiaisoneofthemostimportant(andmodifiable)riskfactorsfor

CAD.Itcausesacceleratedatherosclerosis.

2. Hyperlipidemiamaybeaprimarydisorder,suchasafamilialdyslipidemia syndrome,orsecondarytoanothercause.

3. Classificationofdyslipidemiasyndromes—typesIIA,IIB,andIVaccountfor over80%ofalloffamilialdyslipidemias(Table12-3)

4. Secondarycausesofhyperlipidemia
======================================
a. Endocrinedisorders—hypothyroidism,DM,Cushingsyndrome b. Renaldisorders—nephroticsyndrome,uremia c. Chronicliverdisease d. Medications—glucocorticoids,estrogen,thiazidediuretics,β-blockers e. Pregnancy 5. Riskfactors

a. Diet

e

e

e

SaturatedfattyacidsandcholesterolcauseelevationinLDLandtotal cholesterol High-caloriedietsdonotincreaseLDLorcholesterollevels(are“neutral”)but doincreasetriglyceride(TG)levels AlcoholincreasesTGlevelsandHDLlevelsbutdoesnotaffecttotal cholesterollevels

TABLE12-2 DyslipidemiaSyndromes

Type | Exogenous hyperlipidemia Chylomicrons Diet Type lla Familial hypercholesterolemia LDL Statins Niacin Cholestyramine Type IIb Combined hyperlipoproteinemia LDL + VLDL Statins Niacin Gemfibrozil Type Ill Familial dysbetalipoproteinemia IDL Gemfibrozil Niacin Type IV Endogenous hyperlipidemia VLDL Niacin Gemfibrozil Statins Type V Familial hypertriglyceridemia VLDL + chylomicrons Niacin Gemfibrozil IDL, intermediate density lipoprotein.

b. Age—cholesterollevelsincreasewithageuntilapproximatelyage65.The increaseisgreatestduringearlyadulthood—about2mg/dLperyear

c. Inactivelifestyle,abdominalobesity d. Familyhistoryofhyperlipidemia e. Gender—mengenerallyhavehighercholesterollevelsthanwomen;when womenreachmenopause,cholesterollevelsthenequalizeandmayevenbe higherinwomenthaninmen

f. Medications

Thiazides—increaseLDL,totalcholesterol,TG(VLDL)levels β-Blockers(propranolol)—increaseTGs(VLDL)andlowerHDLlevels Estrogens—TGlevelsmaybefurtherincreasedinpatientswith hypertriglyceridemia CorticosteroidsandHIVproteaseinhibitorscanelevateserumlipids g. Geneticmutationsthatpredisposetothemostseverehyperlipidemias h. Secondarycausesofdyslipidemia(seeabove)

6. RoleoflipidsinCADrisk

a. LDLcholesterol

e

e

Accountsfortwo-thirdsoftotalcholesterol.CADriskisprimarilyduetothe LDLcomponentbecauseLDListhemostatherogenicofalllipoproteins LDLcholesterolisnotdirectlymeasured.Itiscalculatedasfollows:LDL=

totalcholesterol−HDL−TG/5

b. Totalcholesterol

TheriskofCADincreasessharplywhentotalcholesterolisabove240mg/dL c. HDLcholesterol
======================================
e

e

e

Itsprotectiveeffect(removesexcesscholesterolfromarterialwalls)isatleast asstrongastheatherogeniceffectofLDL Forevery10mg/dLincreaseinHDLlevels,CADriskdecreasesby50% HighHDL(>60mg/dL)isa“negative”riskfactor(counteractsoneriskfactor) forCAD

d. Thetotalcholesterol-to-HDLratio—thelowerthetotalcholesterol-to-HDL ratio,thelowertheriskofCAD

Ratioof5.0isaverage(standard)risk Ratioof10isdoubletherisk Ratioof20istripletherisk Ratioof<4.5isdesirable

e. TGs—elevatedTGsareassociatedwithcoronaryrisk,butitisunknownwhether thisassociationiscausal.ItisuncertainwhetherloweringTGlevelreduces coronaryrisk.

Quick HIT

EstrogenReplacementTherapyinPostmenopausalWomen RecentHERStrialshowednobenefitofhormonereplacementtherapyoncardiovascularoutcomesinwomen withestablishedCHD.However,thestudydidnotaddresstheissueinwomenwithoutCHD.Theresultsare somewhatcontroversial.

B.ClinicalFeatures 1. Mostpatientsareasymptomatic. 2. Thefollowingmaybemanifestationsofseverehyperlipidemia:

a. Xanthelasma—yellowplaquesoneyelids. b. Xanthoma—hard,yellowishmassesfoundontendons(fingerextensors,Achilles

tendon,plantartendons).

3. Pancreatitiscanoccurwithseverehypertriglyceridemia.

C.Diagnosis 1. Lipidscreening(seeHealthMaintenancesection)—measuretotalcholesteroland HDLlevels(nonfastingisacceptable).Ifeitherisabnormal,thenorderafull fastinglipidprofile.

2. AfullfastinglipidprofileincludesTGlevelsandcalculationofLDLlevels. 3. Considercheckinglaboratoryteststoexcludesecondarycausesof

hyperlipidemia.

a. TSH(hypothyroidism). b. LFTs(chronicliverdisease). c. BUNandCr,urinaryproteins(nephroticsyndrome). d. Glucoselevels(diabetes).

Quick HIT

StatinshavebeenshowntosignificantlyreduceratesofMI,stroke,andcoronaryandall-causemortalityin prospectiveplacebo-controlledtrials.

D.Treatment 1. NewguidelinesissuedbytheACC/AHAin2013havedramaticallychangedlipid

management.

a. Thelong-termgoalisthesame:toreducemorbidityandmortalityfromCAD. b. Keydifferencesofthenewguidelinescomparedtothepreviousguidelines

(AdultTreatmentPanelIII):
======================================
e

e

e

Targetingspecificcholesterolgoalsisnolongerrecommended. TheuseofnonstatinmedicationstolowerLDLisgenerallynotrecommended. Theuseofanewriskcalculatortocalculateapatient’s10-yearriskof atheroscleroticcardiovasculardisease(ASCVD)(foundonlineat http://my.americanheart.org/cvriskcalculator).

Quick HIT

PotencyofHMGCoAreductaseinhibitors(“statins”):

¢

¢

¢

Highintensity:atorvastatin40to80mg,rosuvastatin20to40mg Moderateintensity:atorvastatin10to20mg,rosuvastatin5to10mg,simvastatin20to40mg,lovastatin40 mg,pravastatin40to80mg,fluvastatinXL80mg(or40mgtwicedaily),pitavastatin2to4mg Lowintensity:simvastatin10mg,pravastatin10to20mg,lovastatin20mg,fluvastatin20to40mg, pitavastatin1mg

2. TherapyforASCVDriskreduction.

a. Statintherapyisrecommendedforfourcategoriesofpatients(Table12-4). b. Dietarytherapyisimportantbeforeandduringstatintherapy.Loweringfat

intake(especiallysaturatedfats)reducesserumcholesterolmorethanlowering cholesterolintake.Foodsrichinomega-3fattyacids(suchasfish)are particularlybeneficial.Withanintensivediet,LDLcanbereducedbyan averageof10%,asfollows:<30%oftotalcaloriesfromfat;withfewerthan 10%fromsaturatedfat;<300mg/dayofcholesterol.

c. Exerciseandweightloss—reduceriskofCAD.

e

e

ExerciseincreasesHDLandreducesotherCADriskfactorsbyloweringBP andenhancingtheefficiencyofperipheraloxygenextraction. Weightlossreducesmyocardialworkaswellastheriskofdiabetes.

d. Smokingcessation. e. Drugtherapy—seeTable12-5.AvailableagentsincludeHMGCoAreductase

inhibitors(statins),niacin,bile-acidsequestrants,andgemfibrozil.

e

e

Patientsgivendrugtherapyshouldalmostalwaysbetreatedwithastatin. Statinscanreducerelativecardiovascularriskbyabout20%to30%regardless ofbaselineLDLlevels. Theotherclassesofdrugsshouldonlybeusedifapatientdoesnottolerate statintherapy.

Quick HIT

PatientsshouldhavetheirASTandALTmeasuredbeforestartingastatin,andafteronlyifsymptomsof hepatotoxicityareevident.ItisnolongerrecommendedtoroutinelymonitorASTandALTafterstartingastatin.

3. TherapyforhighTGlevels—thedataarefairlylimitedregardingwhichpatients shouldbetreatedandwhichmedicationtouse.

a. First-linetherapyisweightloss,aerobicexercise,glycemiccontrolindiabetics, andlow-fatdiet.
======================================
b. Medicationsincludefibrates,nicotinicacid(niacin),andfishoil. c. StatinsshouldbeconsideredeveninpatientswithhighTGlevelsbecauseof

theircardioprotectiveeffects.

TABLE12-3 UpdatedCholesterolTreatmentGuidelines

FourCategoriesofPatientsAged>21yrsWhoBenefitFromStatinTherapya

Category

RecommendedTherapy

ClinicalASCVDb,c

High-intensitystatin

LDLcholesterol≥190mg/dL

High-intensitystatin

Diabeticpatientsaged40–75yrswithLDLcholesterol70– 189mg/dL

¢«

e

ASCVDriskscore<7.5%,moderate-intensity statin ASCVDriskscore≥7.5%,high-intensitystatin

Nondiabeticpatientsaged40–75yrswithLDLcholesterol 70–189mg/dL ASCVDriskscore≥7.5%,moderate-tohigh- intensitystatin

aThenewguidelinesdonotmakerecommendationsforpatientsaged>75yrs,withNYHAclassII–IVheart failure,orwithend-stagerenaldiseaseundergoinghemodialysisduetoinsufficientevidencefromrandomized controlledtrials. bASCVD,atheroscleroticcardiovasculardisease.

cIncludespatientswithacutecoronarysyndromesorahistoryofMI,stableorunstableangina,coronaryorother arterialrevascularization,stroke,TIA,orperipheralarterialdiseasefromatherosclerosis.

ModifiedfromStoneNJ,RobinsonJ,LichtensteinAH,etal.2013ACC/AHAGuidelinesonthetreatmentof bloodcholesteroltoreduceatheroscleroticcardiovascularriskinadults:AReportoftheAmericanCollegeof Cardiology/AmericanHeartAssociationTaskForceonPracticeGuidelines.Circulation.2014;129:S1–S45.

TABLE12-4 DrugTherapyforHyperlipidemia

HMG CoA reductase Lower LDL levels (most Have been shown to reduce mortality from Monitor LFTs. Harmless elevation in muscle inhibitors (statins) potent for lowering LDL) cardiovascular events and significantly enzymes (CPK) may occur Minimal effect on HDL reduce total mortality. and TG levels Drugs of choice for ASCVD risk reduction Niacin Lowers TG levels Do not use in diabetic patients (may Flushing effect (cutaneous flushing of face/ Lowers LDL levels worsen glycemic control) arms; pruritus may be present) Increases HDL levels Most potent agent for increasing HDL Check LFTs and CPK levels as with statin levels and lowering TG levels drugs Bile acid-binding resins Lowers LDL Effective when used in combination with Adverse Gl side effects, poorly tolerated (cholestyramine, colestipol) Increases TG levels statins or niacin to treat severe disease in high-risk patients Fibrates (gemfibrozil) Lower VLDL and TG Primarily for lowering TG levels Gl side effects (mild) Increase HDL Mild abnormalities in LFTs Gynecomastia, gallstones, weight gain, and myopathies are other side effects CPK, creatine phosphokinase.
======================================
TensionHeadache

A.GeneralCharacteristics 1. Causeisunknown;maybesimilartothatofmigraines(seebelow)(seealso

ClinicalPearls12-2and12-3)

2. Usuallyworsensthroughouttheday;precipitantsincludeanxiety,depression,and stress

3. Mildmigrainescaneasilybeconfusedwithtensionheadachesandviceversa

Quick HIT

EmergencyEvaluationofHeadache

¢

e

ObtainanoncontrastCTscantofirstruleoutanytypeofintracranialbleed. However,smallbleeds(subarachnoidhemorrhage)maybemissedbyCTscan,soalumbarpuncturemaybe necessary(topotentiallyvisualizethepresenceofbloodbreakdownproducts).

B.ClinicalFeatures 1. Painissteady,aching,“vise-like,”andencirclestheentirehead(tightband-like

painaroundthehead).

a. Usuallygeneralized,butmaybethemostintensearoundtheneckorbackof head.

b. Canbeaccompaniedbytendermuscles(posteriorcervical,temporal,frontal).

2. Tightnessinposteriorneckmuscles.

CLINICALPEARL12-2

DifferentialDiagnosisofHeadache

e

e

Primaryheadachesyndromes—migraines,clusterheadache,tensionheadache Secondarycausesofheadache(“VOMIT”)

Vascular—subarachnoidhemorrhage,subduralhematoma,epiduralhematoma,intraparenchymal hemorrhage,temporalarteritis Othercauses—malignantHTN,pseudomotorcerebri,post-lumbarpuncture,pheochromocytoma Medication/drugrelated—nitrates,alcoholwithdrawal,chronicanalgesicuse/abuse Infection—meningitis,encephalitis,cerebralabscess,sinusitis,herpeszoster,fever Tumor

¢

Tumor

CLINICALPEARL12-3

HeadacheRedFlags

Suddenonsetwithinsecondstominutes. Worstheadacheofthepatient’slife. New-onsetheadachethatthepatienthasneverexperiencedbefore,especiallyovertheageof50years. Headachepattern:increaseinseverityandfrequencyovertime,worseafterlyingdown. Mentalstatuschangeoranyfocalneurologicsymptoms/signs. New-onsetheadacheassociatedwithheavyexertionorheadtrauma. New-onsetheadacheassociatedwithfever,stiffneck,orrash. New-onsetheadacheinapatientwithHIVinfectionorcancer.

C.Treatment 1. Attempttofindthecausalfactor(s).Evaluatethepatientforpossibledepression

oranxiety.Stressreductionisimportant.

2. NSAIDs(suchasaspirin)andacetaminophenarethestandardtreatmentfor mild/moderateheadaches.

3. Ifheadachesaresevere,medicationsthatareusedformigraines(triptans)maybe appropriate,giventhedifficultyindistinguishingbetweenthesetwoentities.
======================================
ClusterHeadaches

A.GeneralCharacteristics 1. Veryrare—thoughtbysometobeavariantofmigraineheadache 2. Usuallyoccursinmiddle-agedmen 3. Subtypes

a. Episodicclusterheadaches(90%ofallcases)—last2to3months,with remissionsofmonthstoyears

b. Chronicclusterheadaches(10%ofallcases)—last1to2years;headachesdo notremit

B.ClinicalFeatures 1. Excruciatingperiorbitalpain(“behindtheeye”)—almostalwaysunilateral 2. Clusterheadacheisdescribedasa“deep,burning,searing,orstabbingpain.”Pain

maybesoseverethatthepatientmayevenbecomesuicidal

3. Accompaniedbyipsilaterallacrimation,facialflushing,nasalstuffiness/discharge 4. Usuallybeginsafewhoursafterthepatientgoestobedandlastsfor30to90 minutes;awakenspatientfromsleep(butdaytimeclusterheadachescanalso occur)

5. Attacksoccurnightlyfor2to3monthsandthendisappear.Remissionsmaylast fromseveralmonthstoseveralyears

6. Worsewithalcoholandsleep

C.Treatment 1. Acuteattacks

a. Sumatriptan(Imitrex)andinhaledO2arethefirst-linetreatments

2. Prophylaxis

a. Ofalltheheadachetypes,clusterheadachesarethemostresponsiveto prophylactictreatment.Offerallpatientsprophylacticmedication.Verapamil takendailyisthedrugofchoice

b. Ergotamine,methysergide,lithium,andcorticosteroids(prednisone)are alternativeagents

c. Theseagentscauseresolution(ormarkedreduction)ofthenumberofheadaches within1week

Migraine

A.GeneralCharacteristics 1. Aninheriteddisorder(probablyanautosomaldominanttraitwithincomplete

penetrance)

2. Thepathogenesisisnotclearlydefined,butserotonindepletionplaysamajorrole 3. Morecommoninwomenthanmen;morecommoninthosewithafamilyhistory;

typicallyoccursonetotwotimespermonth

4. Types

a. Migrainewithaura(15%ofcases)—“classicmigraine.”Auraisusuallyvisual (flashinglights,scotomata,visualdistortions),butcanbeneurologic(sensory disturbances,hemiparesis,dysphasia)

b. Migrainewithoutaura(85%ofcases)—“commonmigraine” c. Menstrualmigraine

e

e

Occursbetween2daysbeforemenstruationandthelastdayofmenses;linked toestrogenwithdrawal Treatmentissimilartothatofnonmenstrualmigraineexceptthatestrogen supplementationissometimesadded

d. Statusmigrainosus—lastsover72hoursanddoesnotresolvespontaneously

5. Thefollowingcanprovokeamigraine: a. Hormonalalteration(menstruation) b. Stress,anxiety c. Sleepingdisturbances(lackofsleep) d. Certaindrugs/foods—chocolate,cheese,alcohol,smoking,oralcontraceptive

pills

e. Weatherchangesandotherenvironmentalfactors
======================================
Quick HIT

VisualAurainMigraine

Theclassicpresentationisabilateralhomonymousscotoma.Bright,flashing,crescent-shapedimageswith jaggededgesoftenappearonapage,obscuringtheunderlyingprint.Theaurausuallylasts10to20minutes. Apatientmayhaveisolatedvisualmigraines(asabove)withoutheadaches.

B.ClinicalFeatures 1. Prodromalphase(occursin30%ofpatients)

a. ConsistsofsymptomsofexcitationorinhibitionoftheCNS:elation, excitability,increasedappetiteandcravingforcertainfoods(especiallysweets); alternatively,depression,irritability,sleepiness,andfatiguemaybemanifested

b. Mayprecedetheactualmigraineattackbyupto24hours

2. Severe,throbbing,unilateralheadache(notalwaysonthesameside)

a. Lasts4to72hours b. Attimes,itmaybegeneralizedovertheentireheadandmaylastfordaysifnot

treated

c. Painisaggravatedbycoughing,physicalactivity,orbendingdown d. Variablepainquality—“throbbing”or“dullandachy”

3. Othersymptomsincludenauseaandvomiting(inasmanyas90%ofcases), photophobia,andincreasedsensitivitytosmell

Quick HIT

Manypatientswhoarelabeledashavingmigrainesactuallyhavereboundanalgesicheadaches.Theseoccur morefrequently(every1to2days)thanmigraines.Theseheadachesdonotrespondtodrugsusedtotreat migraines.Weanpatientfromanalgesics.Donotusenarcotics!

C.Treatment 1. Acuteattacksofmigraine

a. Ifmigrainesaremild,analgesicssuchasNSAIDsoracetaminophenmaybe effective.Iftheyarenoteffective,tryeitherdihydroergotamine(DHE)ora triptan

b. DHE—aserotonin(5-HT1)receptoragonist

e

¢

Thisishighlyeffectiveinterminatingmigrainepain.ItisavailableforSC,IM, IV,ornasaladministration Contraindications—CAD,pregnancy,TIAs,PAD,sepsis

c. Sumatriptan—amoreselective5-HT1receptoragonistthanDHEorother triptans

e

e

¢

Actsrapidly(within1hour)andishighlyeffective Shouldnotbeusedmorethanonceortwiceperweek Contraindications—CAD,pregnancy,uncontrolledHTN,basilarartery migraine,hemiplegicmigraine,useofMAOI,SSRI,orlithium

d. Ifnoneoftheavailablemigrainemedicationswork,itisunlikelythatthepatient issufferingfromamigraineheadache
======================================
Quick HIT

Mostpatientsexperienceadecreaseinthenumberandintensityofheadachesastheyage.

2. Prophylaxis(mustbetakendaily)

a. Considerprophylaxisforpatientswithweeklyepisodesthatareinterferingwith activities.Beforeinitiatingprophylacticmedications,thepatientshouldmake

attemptstoavoidanyknownprecipitantsofthemigraines

b. First-lineagentsincludeamitriptyline(TCAs)andpropranolol(β-blocker). Propranololismosteffectiveoftheprophylacticmedicationsformigraines c. Second-lineagentsincludeverapamil(calciumchannelblocker),valproicacid

(anticonvulsant),andmethysergide

d. NSAIDsareeffectiveformenstrualmigraines

UpperRespiratoryDiseases Cough

A.GeneralCharacteristics 1. Coughcanbedividedintoacute(lessthan3weeksduration)andchronic(more

than3weeksduration)

2. Ifthecauseisbenign,coughusuallyresolvesinafewweeks.Ifacoughlastsfor longerthan1month,furtherinvestigationiswarranted

3. Causes

a. Conditionsthatareusuallyassociatedwithothersymptomsandsigns

e

e

e

Upperrespiratoryinfections(URIs)—thisisprobablythemostcommoncause ofacutecough Pulmonarydisease—pneumonia,chronicobstructivepulmonarydisease (COPD),pulmonaryfibrosis,lungcancer,asthma,lungabscess,tuberculosis CHFwithpulmonaryedema

b. Isolatedcoughinpatientswithnormalchestradiograph

e

e

e

e

e

Smoking Postnasaldrip—maybecausedbyURIs(viralinfections),rhinitis(allergicor nonallergic),chronicsinusitis,orairborneirritants Gastroesophagealrefluxdisease(GERD)—especiallyifnocturnalcough (whenlyingflat,refluxworsensduetopositionanddecreasedlower esophagealsphincter[LES]tone) Asthma—coughmaybetheonlysymptomin5%ofcases ACEinhibitors—maycauseadrycough(byinhibitingbradykininbreakdown, leadingtoincreasedbradykininproduction)

Quick HIT

PostnasalDrip Themucosalreceptorsinthepharynxandlarynxarestimulatedbysecretionsofthenoseandsinusesthatdrain intothehypopharynx.

B.Diagnosis 1. Usuallynotestsareindicatedinapatientwithacutecough. 2. CXRisindicatedonlyifapulmonarycauseissuspected,ifthepatienthas

hemoptysis,orifthepatienthasachroniccough.Italsomaybeappropriateina long-termsmokerinwhomCOPDorlungcancerisapossibility.

3. CBCifinfectionissuspected. 4. Pulmonaryfunctiontestingifasthmaissuspectedorifcauseisunclearina

patientwithchroniccough.

5. Bronchoscopy(ifthereisnodiagnosisafteraboveworkup)tolookfortumor, foreignbody,ortrachealweb.
======================================
Quick HIT

CausesofChronicCoughinAdults

Smoking Postnasaldrip GERD Asthma

¢

¢

e GERD

e Asthma

C.Treatment 1. Treattheunderlyingcause,ifknown 2. Smokingcessation,ifsmokingisthecause 3. Postnasaldrip—treatthiswithafirst-generationantihistamine/decongestant

preparation.Ifsinusitisisalsopresent,considerantibiotics.Forallergicrhinitis, consideranonsedatinglong-actingoralantihistamine(loratadine)

4. Nonspecificantitussivetreatment

a. Unnecessaryinmostcases,becausecoughusuallyresolveswithspecific treatmentofthecause

b. Maybehelpfulinthefollowingsituations:

e

e

e

Ifcauseisunknown(andthusspecifictherapycannotbegiven) Ifspecifictherapyisnoteffective Ifcoughservesnousefulpurpose,suchasclearingexcessivesputum productionorsecretions

c. Medications Codeine Dextromethorphan Benzonatate(TessalonPerles)capsules

d. Agentsusedtoimprovetheeffectivenessofantitussivemedicationsinclude expectorantssuchasguaifenesinandwater

Quick  HIT  Itisoftendifficulttodistinguishbetweenaviralandabacterialinfection.  CommonFeaturesofViralVersusBacterialURIs  Feature  Viral  Bacterial 
======================================
AcuteBronchitis

A.GeneralCharacteristics 1. Virusesaccountforthemajorityofcases. 2. Laboratorytestsarenotindicated.Obtainachestradiographonlyifyoususpect pneumonia;thereisnoinfiltrateorconsolidationinacutebronchitis(presenceof fever,tachypnea,crackles,egophonyonauscultation,ordullnesstopercussion suggestspneumonia).

B.ClinicalFeatures 1. Cough(withorwithoutsputum)isthepredominantsymptom—itlasts1to2 weeks.Inasignificantnumberofpatients,thecoughmaylastfor1monthor longer.

2. Chestdiscomfortandshortnessofbreathmaybepresent. 3. Fevermayormaynotbepresent.

C.Treatment 1. Antibioticsareusuallynotnecessary—mostcasesareviral. 2. Coughsuppressants(codeine-containingcoughmedications)areeffectivefor

symptomaticrelief.

3. Bronchodilators(albuterol)mayrelievesymptoms.

TheCommonCold

A.GeneralCharacteristics 1. The“commoncold”isthemostcommonupperrespiratorytractinfection.

Childrenaremorefrequentlyaffectedthanadults.Susceptibilitydependsonpre- existingantibodylevels.

2. Causedbyviruses(identificationofvirusisnotimportant).

a. Rhinovirusesarethemostcommon(atleast50%ofcases)—therearemorethan 100antigenicserotypes,soreinfectionwithanotherserotypecanleadto symptoms(nocross-immunityamongtheserotypes).

b. Othervirusesincludecoronavirus,parainfluenzaviruses(typesA,B,andC), adenovirus,coxsackievirus,andRSV.

3. Hand-to-handtransmissionisthemostcommonroute. 4. Complicationsincludesecondarybacterialinfection(bacterialsinusitisor

pneumonia).Thesesecondaryinfections(especiallypneumonia)areveryrare.

5. Mostresolvewithin1week,butsymptomsmaylastupto10to14days.

Quick HIT

e

¢

e

Thecommoncoldissynonymouswithacuterhinosinusitis—inflammationandcongestionofmucous membranesofnasalandsinuspassages. Inmostcases,itisverydifficulttodistinguishbetweenthecommoncold(viralrhinosinusitis)andacute bacterialsinusitisonthebasisofclinicalfeatures. Sneezing/rhinorrhea,nasaldischarge(whetherclear,purulent,orcolored),nasalobstruction,andfacial pain/headachesoccurinboth.

B.ClinicalFeatures 1. Rhinorrhea,sorethroat,malaise,nonproductivecough,nasalcongestion. 2. Feverisuncommoninadults(suggestsabacterialcomplicationorinfluenza),but

isnotunusualinchildren.
======================================
C.Treatment(Symptomatic) 1. Adequatehydration

a. Loosenssecretionsandpreventsairwayobstruction b. Canbeachievedbyincreasingfluidintakeandinhalingsteam

2. Restandanalgesics(aspirin,acetaminophen,ibuprofen)—forreliefofmalaise, headache,fever,aches

3. Coughsuppressant(dextromethorphan,codeine) 4. Nasaldecongestantspray(Neo-Synephrine)forlessthan3days 5. Oralfirst-generationantihistaminesforrhinorrhea/sneezing

Quick HIT

Manyofthesymptomsseenwiththecommoncoldarealsoseenininfluenza,butaremoresevereinthelatter. Fever,headache,myalgias,andmalaisearemuchmorepronouncedwithinfluenza.

Sinusitis

A.GeneralCharacteristics 1. Thereisinflammationoftheliningoftheparanasalsinuses,oftendueto

infection.Mucosaledemaobstructsthesinusopenings(ostia),trappingsinus secretions

2. Mostcasesofacutesinusitisoccurasacomplicationofthecommoncoldorother URIs.(However,fewerthan1%ofURIsleadtoacutesinusitis.)Mayalsobe causedbynasalobstructionduetopolyps,deviatedseptum,orforeignbody 3. Classification

a. Acutebacterialsinusitis—usuallyduetoStreptococcuspneumoniae,

Haemophilusinfluenzae,oranaerobes b. Othertypes—viral,fungal,orallergic

4. Themostcommonsinusesinvolvedarethemaxillarysinuses

Quick HIT

Sinusitisisusuallyself-limited,butcanbeassociatedwithhighmorbidity.Itcanbelife-threateningifthe infectionspreadstoboneortotheCNS.

B.ClinicalFeatures 1. Acutesinusitis

a. Nasalstuffiness,purulentnasaldischarge,cough b. Sinuspainorpressure(locationdependsonwhichsinusisinvolved)—pain

worsenswithpercussionorbendingheaddown

e

e

e

Maxillarysinusitis(mostcommon)—painoverthecheeksthatmaymimic painofdentalcaries Frontalsinusitis—paininthelowerforehead Ethmoidsinusitis—retro-orbitalpain,orpainintheupperlateralaspectofthe nose

c. Feverin50%ofcases

2. Chronicsinusitis

a. Nasalcongestion,postnasaldischarge b. Painandheadacheareusuallymildorabsent;feverisuncommon c. Bydefinition,symptomsshouldbepresentforatleast2to3months d. Inadditiontotheorganismslistedforacutesinusitis,patientswithahistoryof

multiplesinusinfections(andcoursesofantibiotics)areatriskforinfectionwith S.aureusandgram-negativerods
======================================
Quick HIT

Ifapatienthasacoldbeyond8to10days,orifthecoldsymptomsimproveandthenworsenafterafewdays (“double-sickening”),consideracutebacterialsinusitis(maybeasecondarybacterialinfectionafteraprimary viralillness).

C.Diagnosis 1. Diagnosisisbasedonclinicalfindings.Consideracutebacterialsinusitisifa

patienthasacoldformorethan8to10daysorhasprolongednasalcongestion. 2. Physicalexamination.

a. Lookforpurulentdischargedrainingfromoneoftheturbinates. b. Performtransilluminationofmaxillarysinuses(noteimpairedlight

transmission)—theroommustbecompletelydarkwithastronglightsource.

c. Palpateoverthesinusesfortenderness(notareliablefinding).

3. Imagingstudies—usuallynotindicatedinroutinecommunity-acquiredinfections.

a. Conventionalsinusradiographs—lookforair–fluidlevelsinacutedisease. b. ACTscan(coronalview)issuperiortoaplainradiograph.Itshouldbe

performedincomplicateddiseaseorifsurgeryisbeingplanned.

Quick HIT

Treatwithantibioticsanddecongestantsfor1to2weeks,dependingonseverity.Ifthereisnoimprovement after2weeksoftherapy,thensinusfilmsandapenicillinase-resistantantibioticareappropriate.ConsiderENT consultation.Becauseoftheanatomicdifficultiesindrainage,thecourseofacutesinusitistakeslongerto resolvethanotherURIs.

D.Complications 1. Mucocele,polyps 2. Orbitalcellulitis—usuallyoriginatingfromethmoidsinusitis 3. Osteomyelitisofthefrontalbonesormaxilla 4. Cavernoussinusthrombosis(rare) 5. Veryrare—epiduralabscess,subduralempyema,meningitis,andbrainabscess—

duetocontiguousspreadthroughboneorviavenouschannels

E.Treatment 1. Acutepurulentsinusitis

a. Generalmeasures/adviceforthepatient Salinenasalsprayaidsdrainage Avoidsmokeandotherenvironmentalpollutants

b. Decongestants(pseudoephedrineoroxymetazoline) Facilitatesinusdrainageandrelievecongestion

e

e

Availableinbothtopicalandsystemicpreparations Givefornomorethan3to5days

c. Antibiotics

Amoxicillin,amoxicillin-clavulanate,TMP/SMX,levofloxacin,moxifloxacin, andcefuroximearegoodchoices.

d. Antihistamines

e

e

Reserveforpatientswithallergies;usediscriminatelybecauseofthe“drying effect” Loratadine(Claritin),fexofenadine(Allegra),chlorpheniramine(Chlor- Trimeton)

e. Nasalsteroids(fluticasone,beclomethasone)—maybeworthatrialifsinusitisis secondarytoallergicrhinitisorifthereisconcurrentallergicrhinitis

2. Chronicsinusitis
======================================
a. Treatwithabroad-spectrumpenicillinase-resistantantibiotic b. Refertoanotolaryngologist—endoscopicdrainagemaybenecessary

Quick HIT

Antihistamineshaveadryingeffect(makingsecretionsthicker)andcansometimesworsencongestion.Ifthis occurs,avoiddecongestantswithantihistamines.

Laryngitis

Usuallyviralinorigin;mayalsobecausedbyMoraxellacatarrhalisandH. influenzae Commoncauseofhoarseness;coughmaybepresentalongwithotherURI symptoms Typicallyself-limiting Patientshouldrestvoiceuntillaryngitisresolvestoavoidformationofvocalnodules

SoreThroat

A.GeneralCharacteristics 1. Causesofsorethroat

a. Virusesarebyfarthemostcommoncause(adenovirus,parainfluenza, rhinovirus,Epstein–Barrvirus,herpessimplex)

b. ThemainconcernisinfectionwithgroupAβ-hemolyticstreptococcusdue tothepossibilityofrheumaticfever

c. Otherorganisms

Chlamydia,Mycoplasma Gonococci(oralsex) Corynebacteriumdiphtheriae—pseudomembranecoveringpharynx Candidaalbicans(ifimmunosuppressed,onantibiotics,orseverelyill) 2. Viralversusbacterialinfection—oftendifficulttodistinguish,butifpatienthasa

coughandrunnynose,viralismorelikely

Quick HIT

Thinkofthefollowingifapatienthasasorethroat:

e

¢

¢

¢

Viralinfection Tonsillitis(usuallybacterial) Strepthroat Mononucleosis

Quick HIT

Only50%ofpatientswithpharyngealexudateshavestrepthroat,andonly50%ofpatientswithstrepthroat haveexudates.

B.Diagnosis 1. Throatculture—takes24hours,butismoreaccuratethanrapidstreptest 2. Rapidstreptest—resultswithin1hour,butwillnotindicatewhethersorethroatis

causedbyabacteriumotherthanStreptococcusoravirus

a. Centorcriteria:helpspredictthelikelihoodofStrepthroatandtheappropriate management

e

e

e

e

Onepointeachforhistoryoffever,tonsillarexudates,tenderanteriorcervical lymphadenopathy,absenceofcough,age<15;age>44subtractsonepoint –1,0,or1point:Noantibiotic,nothroatculture 2or3points:Throatculture,treatwithantibioticifthroatcultureispositive 4or5points:Treatempiricallywithanantibiotic

3. Ifmononucleosisissuspected,obtaintheappropriatebloodtests(Monospot)
======================================
C.Treatment 1. Ifstrepthroat—penicillinfor10days(erythromycinifpatienthaspenicillin

allergy)

2. Ifviral—symptomatictreatment(seebelow) 3. Ifmononucleosis—adviserestandacetaminophen/ibuprofenforsymptoms;avoid

contactsportssincethereissplenomegalyandariskofsplenicrupture

4. Symptomatictreatmentofsorethroat

a. Acetaminophenoribuprofen b. Garglingwithwarmsaltwater c. Useofahumidifier d. Suckingonthroatlozenges,hardcandy,flavoredfrozendesserts(suchas

Popsicles)

Quick HIT

Mostcases(upto90%)ofdyspepsia/heartburnareduetoPUD,GERD,gastritis,ornonulcerdyspepsia.

GastrointestinalDiseases

Dyspepsia

A.GeneralCharacteristics 1. “Dyspepsia”referstoaspectrumofepigastricsymptoms,includingheartburn,

“indigestion,”bloating,andepigastricpain/discomfort.

2. Dyspepsiaisextremelycommon,andsometimesisconfusedwithangina. 3. Etiology

a. GIcauses—pepticulcerdisease(PUD),GERD,nonulcerdyspepsia

(functionaldyspepsia),gastritis,hepatobiliarydisease(cholecystitis,biliary colic),malignancy(gastric,esophageal),pancreaticdisease(pancreatitis, pseudocyst,cancer),esophagealspasm,hiatalhernia.

b. Othercausesincludelactoseintolerance,malabsorption,DM(gastroparesis), andirritablebowelsyndrome(IBS).

Quick HIT

NonulcerDyspepsia

e

e

Adiagnosisofexclusionafterappropriatetests(includingendoscopy)doesnotrevealaspecificcause. Dyspepsiasymptomsmustbepresentforatleast4weekstomakethediagnosisofnonulcerdyspepsia.

B.Diagnosis 1. Basethedecisiontoperformtestsonclinicalpresentationandresponsetoempiric

therapy.

2. Endoscopyisthetestofchoiceforevaluationofdyspepsia.

a. Itcanidentifyanesophagealstrictureorulcer,cancer,andrefluxesophagitis. b. Itshouldnotberoutinelyperformedinallpatientswithdyspepsia.Some

generalindicationsinclude:

e

Patientswithalarmingsymptoms—weightloss,anemia,dysphagia,or obstructivesymptoms. Patients>55yearsofagewithnew-onsetdyspepsia. PatientswithrecurrentvomitingoranyevidenceofupperGIbleeding. Patientswhodonotrespondtoempirictherapy(seebelow). PatientswithsignsofcomplicationsofPUD. Patientswithrecurrentsymptoms. Patientswithevidenceofsystemicillness.

3. NoninvasivetestingforHelicobacterpylori:anoptionifthepatientdoesnot

requireanEGD.
======================================
a. Ureabreathtest:detectsactiveinfection. b. Serology:cannotreliablydetermineactiveinfection(antibodiesmaypersistafter

H.pyloriiscleared).

c. Stoolantigentest:detectsactiveinfection. d. Results

e

e

Ifpositive,treatforH.pylori. Ifnegative,PUDisunlikelyandthepatientlikelyhaseitherGERDor nonulcerdyspepsia(treatempirically—seebelow).

C.Treatment 1. Treatthecauseifknown 2. Advisethepatientto:

a. Avoidalcohol,caffeine,andotherfoodsthatirritatethestomach b. Stopsmoking c. Raisetheheadofthebedwhensleeping d. Avoideatingbeforesleeping

3. Useaprotonpumpinhibitor(PPI)trialfor8weeks.Endoscopyisindicatedifthis failstorelievesymptoms

4. EradicationofH.pyloriinfection—seeChapter3[AQ1]

Quick HIT

IfGERDisassociatedwithdysphagia,thissuggeststhedevelopmentofpepticstricture.Alternatively,a motilitydisorderorcancermaybepresent.

GastroesophagealRefluxDisease

A.GeneralCharacteristics 1. GERDisamultifactorialproblem.InappropriaterelaxationoftheLES

(decreasedLEStone)istheprimarymechanism,leadingtoretrogradeflowof stomachcontentsintotheesophagus.Otherfactorsthatmaycontributeinclude:

a. Decreasedesophagealmotilitytoclearrefluxedfluid b. Agastricoutletobstruction c. Ahiatalhernia(commonfindinginpatientswithGERD) d. Dietaryfactors(e.g.,alcohol,tobacco,chocolate,high-fatfoods,coffee)—may

decreaseLESpressureandexacerbatethecondition

2. GERDisaverycommoncondition.Itsprevalenceincreaseswithage

Quick HIT

Diagnostictestsareusuallynotnecessaryfortypical,uncomplicatedcasesofGERD,andtherapycanbe initiated.Testsareindicatedinatypical,complicated,orpersistentcases(despitetreatment).Endoscopyshould beperformedifworrisomesymptoms(anemia,weightloss,ordysphagia)arepresent.

B.ClinicalFeatures 1. Heartburn,dyspepsia

a. Retrosternalpain/burningshortlyaftereating(especiallyafterlargemeals) b. Exacerbatedbylyingdownaftermeals c. Maymimiccardiacchestpain(whichmayleadtounnecessaryworkupfor

ischemicheartdisease)

2. Regurgitation 3. Waterbrash—reflexsalivaryhypersecretion 4. Cough—duetoeitheraspirationofrefluxedmaterialorareflextriggeredbyacid

refluxintotheloweresophagus

5. Hoarseness,sorethroat,feelingalumpinthethroat 6. Earlysatiety,postprandialnausea/vomiting
======================================
Quick HIT

GERDisachronicdisorder.Regularfollow-upisrecommendedtoidentifyanycomplications(e.g.,Barrett esophagus,stricture,esophagitis).

C.Diagnosis 1. Endoscopywithbiopsy—thetestofchoicebutnotnecessaryfortypical

uncomplicatedcases.

a. Indicatedifheartburnisrefractorytotreatment,orisaccompaniedbydysphagia, odynophagia,orGIbleeding.

b. Abiopsyshouldalsobeperformedtoassesschangesinesophagealmucosa.

2. UpperGIseries(bariumcontraststudy)—thisisonlyhelpfulinidentifying complicationsofGERD(strictures/ulcerations),butcannotdiagnoseGERDitself.

3. Twenty-four–hourpHmonitoringintheloweresophagus—thisisthemost sensitiveandspecifictestforGERD.Itisthegoldstandard,butisusually unnecessary.

4. Esophagealmanometry—useifamotilitydisorderissuspected.

D.Complications 1. Erosiveesophagitis—thesepatientsareathighriskofdevelopingcomplications suchasstricture,ulcer,orBarrettesophagus.Thesepatientsarecandidatesfor long-termPPItherapy(seebelow).

2. Pepticstricture

a. Consistsoffibroticringsthatnarrowthelumenandobstructthepassageoffood b. Presentswithdysphagia;maymimicesophagealcancer c. EGDcanconfirmthediagnosis.Dilationshouldbeperformed

3. Esophagealulcer—possiblecauseofupperGIbleeding 4. Barrettesophagus—occursin10%ofpatientswithchronicreflux

a. Thenormalstratifiedsquamousepitheliumofthedistalesophagusisreplacedby columnarepithelium.Dysplasticchangesmayoccur,withriskof adenocarcinoma

b. PatientswhohavehadsymptomaticGERDforatleast5years(andcanundergo surgeryifcancerisfound)shouldbescreenedforthepossibilityofBarrett esophagus

c. Endoscopywithbiopsyisrequired.IfthepatienthasdocumentedBarrett esophaguswithoutanydysplasticchanges,periodicsurveillanceisappropriate (every3years)

d. Medicaltreatment—long-termPPIs

5. Recurrentpneumonia(duetorecurrentpulmonaryaspiration)—thecytologic aspiratefindingonbronchoscopythatcandiagnoseaspirationofgastriccontents islipid-ladenmacrophages(fromphagocytosisoffat)

6. Pittingofdentalenamel(dentalerosion);gingivitis 7. Laryngitis,pharyngitis

E.Treatment 1. Initialtreatment:

a. Behaviormodification—diet(avoidfattyfoods,coffee,alcohol,orangejuice, chocolate;avoidlargemealsbeforebedtime);sleepwithtrunkofbodyelevated;

stopsmoking

b. Antacids—aftermealsandatbedtime

2. AddanH2blocker—canbeusedinsteadoforinadditiontoantacidsformildand intermittentsymptoms

3. IfabovetreatmentfailsorpatienthassevereGERD(e.g.,erosiveesophagitis), switchtoaPPI

4. Antirefluxsurgeryforsevereorresistantcases

a. Indicationsforsurgery

Intractability(failureofmedicaltreatment) Respiratoryproblemsduetorefluxandaspirationofgastriccontents Severeesophagealinjury(ulcer,hemorrhage,stricture,Barrettesophagus)
======================================
e

e

b. Typesofsurgery

Nissenfundoplication(maybedoneopenorlaparoscopically)—procedureof choiceforapatientwithnormalesophagealmotility Partialfundoplication—whenesophagealmotilityispoor c. Outcomeofsurgery—excellentresultshavebeenreported

Diarrhea

A.GeneralCharacteristics 1. Mostcasesofdiarrheaareacute,benign,andself-limited(seealsoClinicalPearl 12-4).Somecasesarechronicandmaybeassociatedwithunderlyingdisease. 2. Acutediarrheaisdiarrheathatlastslessthan2to3weeks;chronicdiarrhealasts

morethan4weeks.

Norwalkvirusarethemostcommon).Mostsevereformsofacutediarrheaare duetobacterialinfections(Shigella,Escherichiacoli,Salmonella, Campylobacter,Clostridiumperfringens,Clostridiumdifficile).Protozoathatmay causediarrheaincludeGiardialamblia,Entamoebahistolytica,and Cryptosporidium.

4. Elderlyandimmunocompromisedpatients(e.g.,withHIV,transplantation patients)arevulnerabletodiarrhealillnessesduetoimpairedimmunity.In patientswithHIV,diarrheacanbecausedbyMycobacteriumavium- intracellulare,Cryptosporidium,Cyclospora,orCMV.

CLINICALPEARL12-4

DiarrheaPearls

Acutediarrheaisusuallyduetoinfection(virus,bacteria,andparasite)ormedications. Ifnauseaandvomitingarepresent,suspectviralgastroenteritisorfoodpoisoning. Iffoodpoisoningisthecause,diarrheaappearswithinhoursofthemeal. Rememberthatoccultbloodinthestoolmaybepresentinalltypesofacuteinfectiousdiarrhea,butitis muchlesscommontohavegrossblood. AfindingoffeverandbloodtogetheristypicalofinfectionwithShigella,Campylobacter,Salmonella(may alsobewithoutblood),orenterohemorrhagicE.coli. Nofeverandnobloodistypicalofinfectionwithviruses(rotavirus,Norwalkvirus),enterotoxicE.coli,and foodpoisoning(S.aureus,C.perfringens).

B.Causes 1. Acutediarrhea

a. Infection—virusesmostcommon(viralgastroenteritis),followedbybacteria,

thenparasites b. Medications

e

e

Antibiotics(mostcommoncause)—antibiotic-associateddiarrheaiscausedby C.difficiletoxinin25%ofcases(seeChapter3) Othersincludelaxatives,prokineticagents(cisapride),antacids,digitalis, colchicine,alcohol,magnesium-containingantacids,andchemotherapeutic agents

c. Malabsorption(e.g.,lactoseintolerance) d. IschemicbowelinelderlypatientswithhistoryofPADandbloodydiarrhea,

d. Ischemic bowel in elderly patients with history of PAD and bloody diarrhea, along with abdominal pain
======================================
alongwithabdominalpain e. Intestinaltumors(veryrare)

2. Chronicdiarrhea

a. IBS(mostcommoncause,butisadiagnosisofexclusion) b. Inflammatoryboweldisease(IBD) c. Medications—seeabove d. Infection—seeabove,bacterialenterocolitis(Shigella,Salmonella,

Campylobacter,enteroinvasiveE.coli)

e. Coloncancer f. Diverticulitis g. Malabsorptionsyndromes—pancreaticinsufficiency,celiacdisease,shortbowel

syndrome,ischemicbowel,bacterialovergrowth

h. Postsurgical(e.g.,gastrectomy,vagotomy) i. Endocrinecauses(hyperthyroidism,Addisondisease,diabetes,gastrinoma,

VIPoma)

j. Fecalimpaction—becauseonlyliquidstoolcanpassaroundtheimpaction k. Laxativeabuse(factitiousdiarrhea) l. Immunocompromisedpatientswithacuteinfectiousdiarrhea

C.Diagnosis 1. Laboratorytestsareusuallyunnecessaryinacutediarrhea(seealsoClinicalPearl

12-5andFigure12-3)

2. Someindicationsfordiagnosticstudies

a. Chronicdiarrheaordiarrheathatisprolonged b. Severeillnessorhighfever c. Presenceofbloodinthestool/highsuspicionforIBD d. Severeabdominalpain e. Immunodeficiency f. Signsofvolumedepletion

Quick HIT

Assessvolumestatus(dehydrationisaconcern),performanabdominalexamination,andcheckstoolforoccult bloodinpatientswithdiarrhea.Inmildtomoderatecasesofacutediarrhea,furtherworkupisunnecessary.

CLINICALPEARL12-5

ImportantPartsoftheHistoryinaPatientWithDiarrhea

Isthestoolbloodyormelanotic? Arethereanyothersymptoms(e.g.,fever,abdominalpain,vomiting)? Isthereanyoneinthefamilyorgroupwithasimilarillness? HastherebeenanyrecenttraveloutsidetheUnitedStates,oranyhikingtrips(parasiticinfections)? Aresymptomslinkedtoingestionofcertainfoods(e.g.,milk)? Arethereanymedicalproblems(e.g.,AIDS,hyperthyroidism)? Havetherebeenrecentchangesinmedications(e.g.,antibioticswithinthepastfewweeks)?

History, physical examination No complications Complications + Bloody stool + Systemic symptoms, fever Symptomatic treatment * Dehydration + Rehydration + Abdominal pain, * Consider loperamide nausea/vomiting Microscopic examination of stool for WBC Stool culture, consider C. difficile toxin Positive Negative Treat | Does diarrhea persist longer than expected? Yes v Flexible sigmoidoscopy with biopsy
======================================
FIGURE 12.3

Approachtothepatientwithacutediarrhea.

(AdaptedfromHumesDH,DontHL,GardnerLB,etal.Kelley’sTextbookofInternalMedicine.4th

ed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:748,Figure99.1.)

3. Laboratoryteststoorder

a. CBC—lookforanemia,WBCelevation b. Stoolsample—forpresenceoffecalleukocytes

e

e

e

Iffecalleukocytesareabsent,thereisnoneedtoorderstoolculturesbecause theyareunlikelytogrowpathogenicorganisms(unlessinvasivebacterial enteritisissuspectedorthepatienthasbloodydiarrhea) Iffecalleukocytesarepresentandthepatienthasmoderatetoseverediarrhea, considersendingstoolforcultureand/orC.difficiletoxinassay,andconsider empirictreatmentwithanantibiotic FecalleukocytesarepresentinCampylobacter,Salmonella,Shigella, enteroinvasiveE.coliinfection,andC.difficile;absentinstaphylococcalor clostridialfoodpoisoning;andabsentinviralgastroenteritis

Quick HIT

Laboratoryteststoconsider:

¢

StoolWBCs Stoolforovaandparasites(O&P) Stoolculture StoolforC.difficiletoxinassay StoolforGiardiaantigen

c. Stoolsample—testthreesamplesforpresenceofovaandparasites.Orderthisif aparasiteissuspected.ForGiardia,orderenzyme-linkedimmunosorbentassay (ELISA)testforantigen

d. Bacterialstoolculture

e

e

¢

Thishaslowsensitivity(andisanexpensivetest),andusuallydoesnotaffect treatmentoroutcome Itshouldnotbeorderedroutinely.Someindicationsinclude:ifinvasive bacterialenteritisissuspected,ifthepatienthasmoderatetosevereillnessor fever,ifthepatientrequireshospitalization,andifthestoolsampleispositive forfecalleukocytes Mostlaboratorytestsexaminestoolcultureforonlythreeorganisms:Shigella, Salmonella,andCampylobacter

e. Stoolsample—measureforC.difficiletoxinifthepatienthasbeentreatedwith

antibioticsrecently.Notethatthistesthasafalse-negativerateof10%.Treatthe patientempiricallyevenbeforelaboratoryresultsarebackifthesuspicionis high

f. Colonoscopy/flexiblesigmoidoscopy—maybeconsideredforpatientswith bloodinthestoolorforpatientswithchronicdiarrheaforwhichacausecannot beidentified

g. CTscanmaybehelpfulifIBDordiverticulitisissuspected;colonoscopyshould notbeperformedduringaflareduetotheriskofbowelperforation
======================================
Quick HIT

Salmonella,Campylobacter,Shigella,andenteroinvasiveE.colicausediarrheawithfecalleukocytesandoften blood.

Quick HIT

Themostcommonelectrolyte/acid–baseabnormalitiesseenwithseverediarrheaaremetabolicacidosisand hypokalemia.

D.Treatment 1. Acutediarrheaistypicallyself-limitedanddoesnotrequirehospitalization.

However,considerhospitalizationforanyofthefollowingreasons:

a. Dehydration(especiallyinelderlypatients) b. PatientsinitiallyunabletotolerateorholddownPOfluids c. Bloodydiarrhea(withprofuseorbriskbleeding) d. Highfever,toxicappearance

2. Theidentificationofthespecificagentresponsibleforacuteinfectiousdiarrheais notcriticalwithregardtotreatment.Treatthediarrheaaccordingtothepatient’s medicalhistoryandclinicalcondition

3. Specifictherapy

a. Rehydrate;monitorelectrolytesandreplaceifnecessary b. Treattheunderlyingcause(e.g.,stoporchangemedication,advisealactose-free

diet).ConsideratrialofNPOstatustoseeifdiarrheastops

c. Considerantibiotics.Useofantibioticsininfectiousdiarrheahasbeenshownto decreasethedurationofillnessby24hours(regardlessoftheetiologicagent). Therefore,considera5-daycourseofciprofloxacininpatientswhohave moderatetoseveredisease.Antibioticsaredefinitelyrecommendedinthe followingsituations:

Patienthashighfever,bloodystools,orseverediarrhea—quinolonesare appropriate

e

e

¢

Stoolculturegrowsoneofthepathogenicorganisms(seeTable12-6) Patienthastraveler’sdiarrhea C.difficileinfection—usemetronidazole

4. Loperamide(Imodium)isanantidiarrhealagentthatshouldonlybegivenif diarrheaismildtomoderateandisnotrecommendedinpatientswithfeveror withbloodintheirstool

Constipation

A.Causes 1. Diet—lackoffiber 2. Medications—anticholinergicdrugs(antipsychotics),antidepressants,narcotic analgesics,iron,calciumchannelblockers,aluminum-orcalcium-containing antacids,laxativeabuse,anddependence

3. IBS 4. Obstruction—colorectalcancer(CRC)(alwayskeepthisinmind!),analstricture,

4. Obstruction—colorectal cancer (CRC) (always keep this in mind!), anal stricture, hemorrhoids, anal fissure

hemorrhoids,analfissure 5. Ileus,pseudo-obstruction 6. Anorectalproblems—hemorrhoids,fissures 7. Endocrine/metaboliccauses—hypothyroidism,hypercalcemia,hypokalemia,

uremia,dehydration

8. Neuromusculardisorders—Parkinsondisease,multiplesclerosis,CNSlesions,
======================================
scleroderma,DM(autonomicneuropathy) 9. Congenitaldisorders—Hirschsprungdisease

TABLE12-5 CommonPathogensResponsibleforAcuteInfectiousDiarrhea

Acute viral Myalgias, Possible, No 48-72 hrs, Fecal-oral route © Most common cause of acute gastroenteritis malaise, headache, lowgrade symptoms may diarrhea in the United States (rotavirus, watery diarrhea, linger for up to Look for similar illness in family Norwalk virus) abdominal pain, 1 wk members nausea/vomiting Salmonella Abdominal pain, Possible Yes Resolves Food (domestic Symptoms appear 24-48 hrs after diarrhea, nausea, within 1 wk fowl and their ingesting food. No treatment is and vomiting (rarely longer) © eggs—most required except in immunocompro- common); mised patients or in cases of enteric fecal-oral route fever (caused by Salmonella typhij— as well rare in the United States. Ciprofloxa- cin (Cipro) is the preferred agent Shigella Diarrhea, abdominal _ Possible Yes Resolves Fecal-oral route ‘Treat with a fluoroquinolone pain, tenesmus; within 1 wk more common nausea, vomiting (4-5 days) than food less common Staphylococcus Abdominal pain, No No Within 24 hrs — Food(e.g.,ham, Exposed people become il! within food poisoning nausea and vomit- poultry, potato 1-6 hrs (e.g., after a picnic). Can ing, diarrhea salad, any food be quite severe and may require containing hospitalization mayonnaise)

B.Diagnosis 1. LaboratoryteststhatmaybenecessaryincludeTSH,serumcalciumlevels,CBC

(ifcoloncancerissuspected),andelectrolytes(ifobstructionissuspected).

2. Alwaysattempttoruleoutobstruction.

a. IfH&Pissuggestiveofobstruction,orderabdominalfilms. b. Considerflexiblesigmoidoscopyinselectcases(ifanobstructingcolorectal

massissuspected).

3. Arectalexaminationmayhelpidentifyfissures,hemorrhoids,fecalimpaction,or masses.

4. Ifnocauseisfoundaftertheabovemeasures,andconservativetreatmentdoesnot help,morespecializedtestsareavailable—forexample,radiopaquemarkertransit study,anorectalmotilitystudy.

Quick HIT

ComplicationsofChronicConstipation

¢
======================================
e

e

e

Hemorrhoids Rectalprolapse Analfissures Fecalimpaction

C.Treatment 1. Dietandbehavioralmodificationarethemostimportantaspectsoftreatment.

Advisethepatientto:

a. Increasephysicalactivity. b. Eathigh-fiberfoods. c. Increasefluidintake.

2. Bulklaxativesarepreferredoverosmoticlaxativesinpatientsthatdonotrespond todietandlifestylechanges.

3. Useanenema,suchasadisposableFleetenema,fortemporaryreliefifnobowel movementoccursdespitetheabovemeasuresorifthepatientisbedridden.

4. Ifobstructionispresent,urgentsurgeryconsultationisindicated.

IrritableBowelSyndrome

A.GeneralCharacteristics 1. IBSreferstoanidiopathicdisorderassociatedwithanintrinsicbowelmotility

dysfunction(abnormalrestingactivityofGItract)thataffects10%to15%ofall adults.

2. Commonassociatedfindingsincludedepression,anxiety,andsomatization. Psychiatricsymptomsoftenprecedebowelsymptoms.Symptomsare exacerbatedbystressandirritantsintheintestinallumen.

3. Alllaboratorytestresultsarenormal,andnomucosallesionsarefoundon sigmoidoscopy.IBSisabenignconditionandhasafavorablelong-term prognosis.

4. Symptomsshouldbepresentforatleast3monthstodiagnoseIBS.

B.ClinicalFeatures 1. Changeinfrequency/consistencyofstool—diarrhea,constipation(oralternating

diarrheaandconstipation)

2. Crampingabdominalpain(relievedbydefecation)—locationvarieswidely,but sigmoidcolonisthecommonlocationofpain

3. Bloatingorfeelingofabdominaldistention

C.Diagnosis 1. Thisisaclinicaldiagnosis,andadiagnosisofexclusion. 2. RomeIIIdiagnosticcriteria:recurrentabdominalpain/discomfort≥3daysper

monthinthelast3months,and≥2ofthefollowing:

a. Pain/discomfortimproveswithdefecation. b. Symptomonsetisassociatedwithachangeinthefrequencyofthestool. c. Symptomonsetisassociatedwithachangeintheformofthestool.

3. InitialteststhatmayhelpexcludeothercausesincludeCBC,renalpanel,fecal occultbloodtest,stoolexaminationforovaandparasites,erythrocyte sedimentationrate,andpossiblyaflexiblesigmoidoscopy.Orderthesetestsonly ifthereissuspicionofothercausesforthesymptoms.
======================================
Quick HIT

DifferentialDiagnosisofIBS Coloncancer,IBD,drugs,mesentericischemia,celiacdisease,ischemiccolitis,giardiasis,pseudo-obstruction, depression,somatization,intermittentsigmoidvolvulus,megacolon,bacterialovergrowthsyndrome, endometriosis.

D.Treatment

1. Formildsymptoms,dietandlifestylechanges(e.g.,avoidingdairyproducts, excesscaffeine).Managethesymptomsbelowasindicated:

a. Diarrhea—diphenoxylate,loperamide. b. Constipation—colace,psyllium,cisapride. c. Abdominalpain—antispasmodics(e.g.,pinaverium,trimebutine,peppermintoil,

cimetropium/dicyclomine),antidepressants,rifaximin.

Quick HIT

ThefollowingmustbefrequentlyexcludedindiagnosingIBS:

Obstruction(plainabdominalfilm) IBD Lactoseorsorbitolintolerance Malignancy(inolderpatientsorthosewithfamilyhistory)—colonoscopy,occultbloodinstool

NauseaandVomiting

A.GeneralCharacteristics 1. Themostcommoncausesareviralgastroenteritisandfoodpoisoning.However,

othermoreemergentdiseasesmustbekeptinmind.

2. Manyconditionspresentwithotherprominentsymptoms(e.g.,abdominalpain, diarrhea,fever)inadditiontonausea/vomiting.

Quick HIT

Gastroenteritis

¢

e

Typicallycausedbyanenterovirus,andisseeningroupsamongfamilymembers,colleagues,andsoon. Diarrheaisoftenpresentaswell,butmayappearlater.

B.Approach 1. Questionstoaskwhentakingthehistory:Recentfoodintake(Unusualfoods? Timeofonsetofvomitinginrelationtofoodintake?Didanyoneelseeatthat food?)(ClinicalPearl12-6).Aresymptomsrelatedtomeals?Askabout medicationsandrecentchanges/additions.Isthereahistoryofabdominalsurgery (obstruction)orrecentsurgery?Aretherefamilymemberswithasimilarillness?

2.

Define the vomitus

a. Bilious—obstructionisdistaltoampullaofVater b. Feculent—distalintestinalobstruction,bacterialovergrowth,gastrocolicfistula c. Vomitingofundigestedfood—esophagealproblemmorelikely(achalasia,

stricture,diverticulum)

d. Projectilevomiting—increasedintracranialpressureorpyloricstenosis e. Coffee-groundmaterialorblood—GIbleeding

3. Accompanyingsymptoms

a. Diarrheaandfeverpointtoaninfectiousprocess(gastroenteritis) b. Abdominalpainpointstoobstruction,acuteinflammatoryconditions(e.g.,

peritonitis,cholecystitis)

c. Headache,visualdisturbances,andotherneurologicfindingspointtoincreased intracranialorintraocularpressure(IOP).

C.Diagnosis 1. OrderroutinelaboratorytestssuchasCBC,electrolytes,glucoselevels,LFTs,if

1. Order routine laboratory tests such as CBC, electrolytes, glucose levels, LFTs, if appropriate, based on history and examination findings.

appropriate,basedonhistoryandexaminationfindings. 2. Orderapregnancytestinwomenofchild-bearingage. 3. Abdominalfilms—orderuprightandsupinefilmsinpatientswithacutevomiting

ifobstructionorperforationissuspected.

4. Orderotherdiagnostictestsdependingonclinicalfindings(e.g.,upperGI endoscopyforulcerdiseaseoroutletobstruction,ultrasoundforbiliarydisease, CTscanofheadforneurologicfindings).

5. Inatleast50%ofpatients,theabovetestsdonotrevealacause.Specialtestsfor GImotilitymaybeindicatedifthereissuspicionofamotilitydisorder.
======================================
CLINICALPEARL12-6

CausesofAcuteNausea/Vomiting

¢

Pregnancy(normalpregnancy,hyperemesisgravidarum) Metabolic:diabeticketoacidosis,Addisondisease,uremia,electrolytedisturbance(hypercalcemia, hypokalemia),hyperthyroidism GI:gastroenteritis(viral,foodpoisoning),PUD,GERD,gastroparesis(diabetics),gastricoutletobstruction, intestinalobstruction(SBO,pseudo-obstruction),ileus,peritonitis Acutevisceralconditions:pancreatitis,appendicitis,pyelonephritis,cholecystitis,cholangitis Neurologic:increasedintracranialpressure,vestibulardisturbance(vertigo),migraine AcuteMI Drugs:chemo,digoxin,ASA/NSAIDs,narcotics,antibiotics,excessivealcoholintake Psychiatric:eatingdisorder(bulimianervosa,anorexianervosa),anxiety Miscellaneous:motionsickness,systemicillness,radiationtherapy,postoperatively

Quick HIT

PossibleComplicationsofSevereorProlongedVomiting

Fluid/electrolytes—dehydration,metabolicalkalosis,hypokalemia Dentalcaries Aspirationpneumonitis GI:Mallory–Weisstears,Boerhaavesyndrome,Mallory–Weisssyndrome

D.Treatment 1. Mostcausesareself-limiting.Ifvomitingissevere,itmaycausedehydration,

requiringhospitalization.

2. Assesshydrationstatus—fluidreplacementisthefirststepinmanagement,NSis usedinmostcases(buttypeoffluidandelectrolyterepletionbasedonlaboratory findings).

3. Identifyandtreattheunderlyingcauseifpossible. 4. Medications—choiceofdrugdependsonthesuspectedcause(e.g.,promethazine

forhyperemesisgravidarum)

a. Prochlorperazine,promethazine,metoclopramide,ondansetron(especiallywith chemotherapy),erythromycin(prokinetic).

Quick HIT

Themostcommonelectrolyteabnormalityseenafterseverevomitingishypokalemiawithmetabolicalkalosis.

Hemorrhoids

A.GeneralCharacteristics 1. Varicoseveinsofanusandrectum 2. Twotypes

a. Externalhemorrhoids(painful)—dilatedveinsarisingfrominferior hemorrhoidalplexus;distaltodentateline(sensatearea)

b. Internalhemorrhoids(notpainful)—dilatedsubmucosalveinsofsuperiorrectal plexus;abovedentateline(insensatearea)

B.RiskFactors 1. Constipation/straining 2. Pregnancy 3. PortalHTN 4. Obesity 5. Prolongedsitting(especiallytruckdriversandpilots)orprolongedstanding 6. Analintercourse
======================================
C.ClinicalFeatures 1. Bleedingandrectalprolapse(mainsymptoms)

a. Brightredbloodperrectum b. Thisisusuallyharmless,butlookforirondeficiencyanemia(rare[AQ3]).

Occultrectalbleedingshouldpromptaninvestigationintomoreseriouscauses andshouldneverbeattributedtohemorrhoidsuntilotherconditionsareruled out

c. Bleedingisusuallypainless

2. Externalhemorrhoidsareusuallyasymptomaticunlessthrombosed,inwhichcase

theypresentassuddenpainfulswelling(mayulcerate,bleed).Painlastsfor severaldays,andthengraduallysubsides.Theresponsetosurgeryisrapid 3. Internalhemorrhoidsusuallydonotcausepain.Amassispresentwhenthey

prolapse

D.Treatment 1. Generalmeasurestoeasesymptoms

a. Sitzbath b. Applicationoficepackstoanalareaandbedrest c. Stoolsoftenerstoreducestrain d. High-fiber,high-fluiddiet e. Topicalsteroids

2. Rubberbandligationforinternalhemorrhoids—rubberbandsappliedto

hemorrhoidalbundle(s)leadstonecrosisandsloughingoflesion

3. Surgical(hemorrhoidectomy)—performsurgeryiftheconditiondoesnotrespond toconservativemethods,orifsevereprolapse,strangulation,verylargeanaltags, orfissureispresent.Surgerycanbeperformedinanoutpatientsetting

Quick  HIT  MostCommonCausesofLBP Musculoligamentousstrain Degenerativediscdisease Facetarthritis 

MUSCULOSKELETALPROBLEMS

OverviewofMusculoskeletalExamination

Maneuvers

LowBackPain

A.GeneralCharacteristics 1. SecondmostcommonreasonformedicalofficevisitsintheUnitedStates(Table

12-7).

2. Acutelowbackpain(LBP)referstosymptomspresentforlessthan4weeks, subacuteis4to12weeks,andchronicLBPreferstopainlastingmorethan12 weeks.ThenaturalhistoryofacuteandsubacuteLBPisveryfavorable. Managementofchronicbackpainisverychallenging.

3. RiskfactorsforchronicLBP:smoking,obesity,olderage,sedentarywork, physicallystrenuouswork,psychologicallystrenuouswork,loweducational attainment,worker’scompensationinsurance,jobdissatisfaction,psychological factors(depression,anxiety,etc.)

4. Majorityofpatientspresentwith“nonspecific”ormechanicalbackpain,meaning thereisnosignificantunderlyingcausesuchasneoplasmorinfectionorspine pathology.

5. Ifpatienthassignificantradicularlegpain,nervecompressionislikely.Ifleg symptomsaresevere,orifobjectiveweaknessispresent,anMRIoflumbarspine isobtained.AnMRIisunnecessaryinmostpatientswhopresentwithanacute episodeofpain.
======================================
Quick HIT

FactorsthatExacerbatePaininDiscHerniation

e

e

Maneuversthatincreaseintraspinalpressure,suchascoughingorsneezing Forwardflexion—sitting,driving,orlifting;worsenslegpain

Quick HIT

Majorityofpatientswithlumbardischerniationandsciaticaimprovewithconservativecare.Onlyabout10% willrequiresurgicalintervention.

B.Causes 1. TherearemanycausesofLBP.Mostpatientswhopresentwithbackpaindonot haveaspecificspinepathology,whichisreferredtoas“nonspecific”LBP. 2. ThefollowingconditionscanallcauseLBP.Notethatmanypatientswiththese imagingfindingsdonothavebackpain.Therefore,imagingfindingsdonot

necessarilycorrelatewithsymptoms.Forexample,manypatientswith degenerativediscdiseaseorspondylolisthesishavenobackpain.

a. Degenerativediscdisease(osteoarthritis)—manypeoplewithsevere degenerativediscdiseasedonothavebackpain.Surgeryiscontroversialforthis indication.

b. Spondylolisthesis—forwardslippageofcephaladvertebraonthecaudal vertebra.MostcommonatL4–L5andL5–S1.Spinalstenosisoftencoexists, leadingtoneurogenicclaudication.

c. Lumbardischerniation—radicularlegpain(commonlyreferredtoassciatica)is thepredominantfinding,althoughsomepatientshavebackpainaswell.Back painwithoutanyradicularpainisuncommonbutcanoccur.Mostcommonat L4–L5andL5–S1.Treatmentisanti-inflammatorymedication,physicaltherapy, andepiduralsteroidinjections.Surgeryindicatedwhenconservativetreatment failsorifpatienthasprogressiveneurologicdeficits.

Quick HIT

Patientswithspinalstenosishavelegpainwithbackextension—painworsenswithstandingorwalking(relief withbendingorsitting).

Quick HIT

Pathologyinotherorgansystemscancausebackpainandshouldberuledout:

e

«

¢

¢

Vasculardisease(aorticaneurysm,aorticdissection) Pancreaticdisease Urologicdisease(prostateinfection,renalcalculi) Gynecologic/obstetricdisease(endometriosis,ectopicpregnancy,pelvicinflammatorydisease)

d. Spinalstenosis—narrowingofspinalcanalduetodegenerativechangeswhich causesneurogenicclaudication.Backpainmaycoexist,butpredominantfinding isneurogenicclaudication.
======================================
e

e

Neurogenicclaudicationreferstoradicularlegorbuttockpainthatiscaused byspinalstenosis.Itcanmanifestaspain,cramping,numbness,or paresthesias,particularlyworsewithwalkingandrelievedwithsitting. Forwardflexionofspineimprovessymptoms(patientsleanonshoppingcart). Treatwithepiduralsteroidinjectionsifitisaffectingpatient’squalityoflife. Surgeryisveryeffectiveifconservativetreatmentfails.

TABLE12-6 ImportantMusculoskeletalPhysicalExaminationManeuvers

General

Importantaspectsincludeobservation(asymmetry,atrophy,etc.),palpationofimportantlandmarks(jointline, surroundingmusclesandtendons,etc.),activeandpassiverangeofmotion,assessmentofmusclestrength,and specialtesting(below)whenadiagnosisissuspected.

Neck

Spurling maneuver

e

e

Technique:patientaskedtoextendneck,rotateandtilttosideofpainwhiledownward pressureisappliedontohead Highspecificitybutlowsensitivityforcervicalrootcompression,whichissuggestedby reproductionofthepainbelowtheshoulderjoint(radicularpain)
======================================
e

stressasthekneeisextended.Thisisrepeatedwithinternalrotation. Apainfulclickorjointlinetendernesssuggestsameniscalinjury.

Quick HIT

ChronicLBP:ImagingfindingsonMRIdonotnecessarilycorrelatewithpresenceorseverityofpain. Psychosocialvariablesaremuchstrongerpredictorsofpainanddisability.

e. Musculoligamentousstrain—usuallyafteranepisodeofbending/twisting, patientfeelstheback“giveway,”oftenwhenliftingaheavyobject,with immediateonsetofbackpain.Radiationofpainmayoccurtobuttock/upper posteriorthightokneelevel—thisiscalled“referredpain”frommusclespasm. Paintypicallydoesnotradiatedistaltothekneebecausenonerveroot compressionispresent.

f. Vertebralcompressionfracture—acutebackpaincausedbyminorstressin elderlyorinpatientsonlong-termsteroidtreatment.Painisatthelevelofthe fracturewithlocalradiationacrossthebackandaroundthetrunk(rarelyto legs).

e

¢

e

Canoccurwithminimalornotraumainpatientswithosteoporosis. Multiplecompressionfracturescanleadtoseverekyphosisinthethoracic spine. Treatmentoptionsincludebracing(ifpatient’sbodyhabitusallows), analgesics,andgivingthefracturetimetoheal.Mostfractureshealin6to8 weeksandsymptomsgraduallyimprove.Interventionaloptionsinclude kyphoplasty/vertebroplasty(injectionofcementintovertebralbody).Recent randomizedcontrolledtrialshavebroughttheefficacyoftheseinterventions intoquestion.

g. Neoplasms—mostcommonspinaltumorbyfarismetastaticcarcinoma— commonprimaryneoplasmsthatmetastasizetospineincludebreast,lung, prostate,kidney,andthyroid.

h. Infection—discitisorosteomyelitis.

e

e

e

e

SuspectinpatientswithhistoryofIVdruguse,dialysis,indwellingcatheter; mostcommonorganismisS.aureus. LaboratoryteststoorderincludeCBCwithdifferential,ESR,andCRP. Ifsuspicionishigh,MRIshouldbeobtained. Epiduralabscessinthecervicalandthoracicspinecanleadtorapidneurologic deteriorationandinmostcases,requiressurgicaldecompression;epidural abscessinthelumbarspinecanoftenbemedicallymanagedwithantibioticsif therearenoneurologicdeficitsandpatientisnotseptic.

Quick HIT

MajorSegmentalInnervationoftheLowerLimb
======================================
Hipflexion—L2 Kneeextension—L3 Ankledorsiflexion—L4andL5 Greattoedorsiflexion—L5 Ankleplantarflexion—S1

C.BackExamination 1. Themaingoalofthehistoryandphysicalexaminationistoruleoutanystructural

orsystemicconditionsthatcanbethesourceofbackpain.Theneurologic examinationisveryimportant,andanyweaknessshouldbedocumented.

2. Thestraightlegraisecansuggestnerverootcompression.Thetestispositiveif radiculopathyisreproducedwhenthelegiselevated30to60degreeswiththe patientsupine.Ifpatientisinseverepainandcannottolerateevenaslight elevationofthelegduringthistest,itishighlysuggestiveofnerveroot compression.

D.DiagnosticTests 1. Imagingisnotnecessaryduringthefirst4to6weeksintheabsenceofanyofthe following—progressiveneurologicdeficitsordisablingsymptoms,osteoporosis orprolongedsteroiduse,constitutionalsymptoms(unexplainedfeverorweight loss),historyofmalignancy,recenttrauma,IVdruguse(seealsoClinicalPearl 12-7).

2. MRIisindicatedifpatienthasfailedacourseofconservativetreatment(rest, physicaltherapy,NSAIDs)foratleast3months.Patientswithneurologicsignsor symptomsshouldhaveanMRIsooner,dependingontheseverityandacuteness ofclinicalfindings.

CLINICALPEARL12-7

CaudaEquinaSyndrome

¢

¢

Causedbyseverestenosisinthelumbarspine,mostcommonlyduetoanacutedischerniation. Patientspresentwithseverebackorlegpain(uni-orbilateral),withorwithoutweaknessinthelegs.Thekey findingsarebladderdysfunction(retention,incontinence)andsaddleanesthesia(numbnessinperinealor buttockregion). Symptomscanhaveacuteonset,orstartwithlegpaininitiallyandovertheensuingdays,progressto weaknessandbladderdysfunction. Thisisasurgicalemergency.AnMRIshouldbeobtainedimmediately.

Ingeneral,radiologicimagingisunnecessaryinevaluationofLBP.Imagingisappropriateifsymptomsdonot resolvewithin1monthorifthereareneurologicsigns/symptoms.

E.Treatment 1. MostpatientswithacuteLBPhaveimprovementorresolutionwithin3to6weeks

andaremanagedwithNSAIDs,acetaminophen,activitymodification,and gradualreturntoactivities.Narcoticanalgesicsandmusclerelaxantsshouldbe usedjudiciously,ifatall.Patientsshouldbeadvisedtocontinueordinary activitieswithinthelimitspermittedbypain.Ifsymptomsdonotimprovein4to 6weeks,acourseofphysicaltherapyforcore-strengtheningexercisesmaybe helpful.

2. Ifneurologicdeficitspresent,particularlyifthesedeficitsareprogressive,amore aggressiveapproachisindicated.AnMRIshouldbeobtained,andifnerverootor spinalcordcompressionispresent,evaluationbyaspinespecialistis recommended.

3. ThetreatmentofchronicnonspecificLBPischallenging.Mostpatientswith chronicLBPwithorwithoutradiculopathyaretreatedconservatively(with physicaltherapy,NSAIDs,injections).

a. Physicaltherapyisfocusedoncore-strengtheningexercisesandaerobic conditioning.

b. Thereissomeevidencethatmassagetherapy,chiropractics,andacupuncture maybehelpfulintheshortterm,butstudieshavenotbeenabletoshowlong- termbenefits.

c. Ifconservativemeasuresfailandsymptomspersistforatleast1year,surgery canbeconsidered,dependingonfindingsonimagingstudiesanddegreeof disability.Ingeneral,outcomesfromsurgeryaremorepredictableand successfulwhensurgeryisdoneforradiculopathy(todecompressnerveroots) thanforLBPperse.Surgery(fusion)fordegenerativediscdiseaseandchronic LBPiscontroversial,andrandomizedcontrolledtrialshaveNOTshown significantbenefits.Averysmallpercentageofpatientsmaybenefitfrom surgerybutcarefulpatientselectioniscriticalandinformedconsentabout expectedoutcomesisrecommended.
======================================
Quick HIT

ItishelpfultodifferentiatepatientswithpredominantlyLBPfromthosewithpredominantlylegpain.When conservativetreatmenthasfailed,surgeryisofteneffectiveforlegpain,butresultsforLBParelesspredictable.

ManagementofLBP

Avoidprolongedinactivity(leadstodeconditioning).Inthefirstweek,attemptawalkingroutine(20minutes, threetimesperday,interspersedwithbedrest).

CommonDisordersoftheCervicalSpine

A.GeneralCharacteristics 1. Spondylosis(osteoarthritis)ofthecervicalspineisverycommonandisnot

1. Spondylosis (osteoarthritis) of the cervical spine is very common and is not necessarily a source of neck pain. Patients with spondylosis of the cervical spine present with axial neck pain, cervical radiculopathy, or cervical myelopathy.

necessarilyasourceofneckpain.Patientswithspondylosisofthecervicalspine presentwithaxialneckpain,cervicalradiculopathy,orcervicalmyelopathy. 2. Chronicaxialneckpain(withoutradiatingarmpain)iscommonandjustlike

chronicLBPcanbedifficulttotreat.Manyoftheprinciplesdiscussedabovefor nonspecificLBPapplytononspecificneckpainaswell.Surgeryisnotagood optionforpatientswithneckpainwithoutradiculararmsymptoms.

3. Themostcommoncauseofacuteneckpainiscervicalstrainwhichisusually self-limitingandresolveswithtime.Physicaltherapycanbehelpfulifsymptoms lastlongerthan2to4weeks.

B.CervicalRadiculopathy 1. Compressionofaspinalnerveleadstoarmpain,numbness,tingling,or

weakness.Mostcommoncomplaintisunilateralneckpainradiatingtothearmin adermatomalpattern.

2. Themostcommoncauseiscervicalspondylosis(osteoarthritis)anddisc herniation.Differentialdiagnosisincludesshoulderpathology(impingement syndrome,rotatorcuffdisease),peripheralnerveentrapment(carpaltunnelor cubitaltunnelsyndrome),thoracicoutletsyndrome,zoster,andPancoasttumor (canpresentwithbrachialplexussymptoms).

3. ThebesttesttodiagnosenerverootcompressionisMRIofcervicalspine. 4. Mostpatientscanbetreatedconservatively(NSAIDs,time,physicaltherapy, epiduralinjections).Surgeryishelpfulinpatientswhodonotrespondto conservativemanagementorwhohavesignificantweaknessinoneormore musclegroups.

5. Itisveryunusualforapatientwithcervicalradiculopathytoprogressto myelopathy.Itappearsthatthesearetwodistinctentities.
======================================
Quick HIT

ShoulderimpingementsyndromeisoftenconfusedwithcervicalradiculopathyinvolvingtheC5nerveroot.Ifin doubt,injecttheshoulder(subacromialspace)withcortisonetoseeifsymptomsresolve.

C.CervicalMyelopathy 1. Neurologicdysfunctionsecondarytospinalcordcompression(cervicalstenosis)

inthecervicalspine.DiagnosismadebyMRIofcervicalspine.

2. Earliestsymptomisgaitdisturbance.Patientsfeelunsteadywhenambulating.

Othersymptomsincludelossofhanddexterity(clumsiness,difficultwith buttoningshirts,changesinhandwriting),withbowelandbladderdysfunction beinglatefindings.

a. Painisnotacommonfindingsopatientsmaygoundiagnoseduntilthe myelopathyissevere.

3. Patientsoftenstartrelyingonacaneorwalker(duetounsteadygait),andif untreatedmayeventuallylosetheabilitytowalk.Frankweaknessisalate finding.Initsmostadvancedstage,patientsbecomenonambulatory,withlossof functionaluseofupperextremities,andbowelandbladderfunction.

4. Naturalhistoryisgradualdeterioration.Treatmentissurgerytodecompressthe spinalcordwhendiagnosisismade.Conservativetreatmentdoesnotplayarole inthetreatmentofcervicalstenosiswithmyelopathy.Maingoalofsurgeryisto preventfurtherneurologicworseningwhichiswhyitisimportanttomakethe diagnosisearly.Oncethepatientlosestheabilitytoambulate,itisunlikelyto returnevenwithsurgery.

Quick HIT

Gaitunsteadinessinelderlypatientsisoftennotinvestigatedandattributedto“oldage.”Wheneveranelderly patientbeginstorelymoreonassistivedevicesforwalking,considercervicalstenosisandorderanMRI.Refer forsurgicalconsultationifstenosisispresent.

KneePain

A.Causes 1. Osteoarthritis—mostcommoncauseofkneepaininolderpatients(seebelow)

(seeClinicalPearl12-8).

2. Patellofemoralpain—verycommoncauseofanteriorkneepain;worsewith climbinganddescendingstairs.Physicaltherapyaimedatquadriceps/hamstrings rehabilitation(stretching/strengthening)isveryeffective.

injuryorsecondarytoadegenerativeprocess(thelatterbeingacommoncauseof kneepaininolderpatients).Keyfeaturesincluderecurrentkneeeffusions, tendernessalongmedialorlateraljointlines,andapositiveMcMurraytest.Ifno arthriticchangesarepresent,surgery(arthroscopicmeniscectomyorrepair)is effective.Surgeryislesseffectivewhenconcomitantarthriticchangesarepresent andresultsarelesspredictable.

4. Rheumatoidarthritis,psoriaticarthritis,SLE. 5. Acutemonoarticulararthritis—septicarthritis,disseminatedgonorrhea,gout,

pseudogout,rheumaticfever,seronegativespondyloarthropathy,Lymedisease.

changesintheoverlyingcartilage.Thebone/cartilagepiecemayseparatefromthe underlyingboneandbecomealoosebodyinthejoint,causingsymptomsofpain, catching,andpopping.Treatmentoptionsarelimitedbutarthroscopicsurgerycan help.Iftheloosefragmentisinthejoint,arthroscopicremovaloffragmentis indicated.
======================================
Quick HIT

Patellofemoralpainisaverycommoncauseofanteriorkneepain.Sendthesepatientstophysicaltherapyto strengthen/stretchquadricepsandhamstrings.

CLINICALPEARL12-8

CausesofArthritis

Osteoarthritis(mostcommoncause) Systemicimmunedisease—rheumatoidarthritis,SLE,seronegativespondyloarthropathies(e.g.,reactive arthritis,ankylosingspondylitis,IBD) Crystaldisease—gout,pseudogout Infectious—septicarthritis,Lymedisease Trauma Charcotjoint(diabetes) Pediatricorthopedicconditionssuchascongenitalhipdysplasia,Legg–Calvé–Perthesdisease,slippedcapital

Trauma

e

¢

femoralepiphysis(SCFE) Hematologic—sicklecelldisease(avascularnecrosisoffemoralhead),hemophilia(recurrenthemarthrosis) Depositiondiseases—Wilsondisease,hemochromatosis

7. Iliotibial(IT)bandsyndrome—painoverthelateralknee(wheretheITband attachestotheproximaltibia),primarilyinrunnersandcyclists.

8. Osgood–Schlatterdiseaseinadolescents—resolveswithskeletalmaturity. 9. Bakercyst—causedbyintra-articularpathology(e.g.,meniscustear).

a. Rupturecancausepain/swelling,andifitextendsintothecalf,maymimic thrombophlebitisoracutedeepvenousthrombosis.

b. Majorityresolvesspontaneously. 10. Patellartendinitis(“jumper’sknee”).

a. Commoncauseofanteriorkneepain(atinferiorpoleofpatella). b. Runningandjumpingsports—an“overuse”injury. c. Treatmentisactivitymodificationandquadriceps/hamstringrehabilitation

(stretching/strengtheningprogram).

11. Plicasyndrome—adiagnosisofexclusion,typicallyseeninathletesorwith overuseinjuries,sometimesaftertrauma.MRIandexaminationfindingsare unreliable.Patientshavepainalongthemedialpatellaandafeelingofsnapping ofthekneewithwalking,withorwithoutintermittenteffusion.Treatmentis conservative(physicaltherapy),anti-inflammatorymedications,steroid injections.Ifconservativetreatmentfails,arthroscopicreleaseofplicacanbe helpful.

Quick HIT

Recurrentkneeeffusionisasignofintra-articularpathologyandfurtherinvestigationiswarranted.

B.Diagnosis 1. Radiographs—ifdegenerativediseaseissuspectedorifthereisahistoryof

traumaoracuteinjury.

2. MRI—ifanyligamentousinstabilityisapparentorameniscaltearissuspected. 3. Kneeaspiration(“tap”)—usethisforanalysisofsynovialfluidifsepticjointis

suspected.Ingeneral,synovialfluidexaminationisrecommendedfor monoarticularjointswelling.Itmayrelievesymptoms.
======================================
AnkleSprains

A.GeneralCharacteristics 1. Thelateralsideoftheankleconsistsofthreeligaments:anteriortalofibular ligament(ATFL),calcaneofibularligament(CFL),andposteriortalofibular ligament.TheATFLismostcommonlyinjured.

2. Themedialsideligaments(deltoidligaments)aretypicallynotinjuredinaclassic inversionanklesprain.

3. Classificationintothreegradesisbasedonseverity.

a. Grade1:partialruptureofATFL. b. Grade2:completeruptureofATFLandpartialruptureofCFL. c. Grade3:completeruptureofbothATFLandCFL.

Quick HIT

ByfollowingtheOttawaanklerules,unnecessaryradiographsoftheankleareavoidedandclinicallysignificant fracturesarenotmissed.

B.Diagnosis 1. Patientstypicallyhavetendernessdirectlyovertheinjuredligament.ATFLis

locatedjustattheanteriortipofthedistalfibula.

2. Ankleradiographsarenotnecessaryifthefollowingconditionsaremet(Ottawa anklerules):

a. Patientisabletowalkfourstepsatthetimeofinjuryandatthetimeof evaluation.

b. Thereisnobonytendernessoverdistal6cmofeithermalleolus. c. Thereisnobonytendernessatthebaseof5thmetatarsalornavicularbone.

Quick HIT

Treatmentofallacuteanklesprains(evenseveresprains)involvesRICEandphysicaltherapy.Surgeryisrarely, ifever,neededacutely.Recurrentanklesprains,however,requireevaluationforpossiblesurgery.

C.Treatment 1. Rest,ice,compression,elevation(RICE)intheacuteperiod,thencontrolledpain-

freerange-of-motionexerciseswithgradualreturntoweightbearing.

2. Physicaltherapyaftertheacutephaseofswellinghassubsidedtoregainfull rangeofmotion,strength,andproprioception.Physicaltherapyinvolvesperoneal tendonstrengtheningandproprioceptivetraining.

3. Surgeryisrarelynecessaryacutely,evenforgrade3sprains.

4. Chronicankleinstability(recurrentanklesprains)needsfurtherevaluationbyan orthopedicsurgeon.

Quick HIT

ImpingementSyndrome

Commoncauseofshoulderpain Duetoimpingementofgreatertuberosityonacromion Painwithoverheadactivity Mayleadtorotatorcuffpathologyovertime Steroidinjectionsoffertemporaryrelief Surgery(acromioplasty)isveryeffective

TendinitisandBursitis
======================================
A.Tendinitis 1. Supraspinatus(rotatorcuff)tendinitis—impingementsyndrome.

a. Mostcommoncauseofshoulderpain. b. Painoccurssubacromiallyandonthelateralaspectoftheshoulderwitharm abduction;painispoorlylocalized(difficultforpatienttopinpoint)withan insidiousonset.Itisgenerallylocatedoverthelateraldeltoid.

c. Thisisseeninelderlypatients(degenerationoftendons)andinyoungpatients whodoalotofoverhandlifting/throwing(sportsorworkrelated).

d. Painmaybereferredtothelateralarm. e. Ifweaknessispresentonshoulderabduction,arotatorcufftearshouldbe

suspected.(MRIisthebesttestfordiagnosisofrotatorcufftear.)

f. Treatment:physicaltherapy(strengthenshouldermusculature),subacromial steroidinjection.Arthroscopicsurgeryishelpfulifconservativetreatmentfails.

2. Lateralepicondylitisattheelbow(“tenniselbow”).

a. Causedbyinflammation/degenerationoftheextensortendonsoftheforearm, whichoriginatesfromthelateralepicondyle;resultsfromexcessive/repetitive supination/pronation.

b. Splintingtheforearm(counterforcebrace)istheinitialtreatment(donotsplint orwraptheelbowitself).

c. Physicaltherapyisoftenhelpful—strengthening/stretchingextensorsofforearm.

This,alongwithactivitymodification,typicallyleadstoresolutionofpain. d. Injectionsonlyifphysicaltherapyfails.Surgeryiseffectivebutonlyusedifall conservativemeasureshavebeenexhausted.Surgeryisrarelynecessaryforthis condition.

3. Medialepicondylitisattheelbow(“golfer’selbow”).

a. Paindistaltomedialepicondyle(originofflexormusclesoftheforearm). b. Exacerbatedbywristflexion;causedbyoveruseoftheflexorpronatormuscle group.Treatmentsimilartolateralepicondylitis(physicaltherapy,activity modification).

4. DeQuervaintenosynovitis

a. Painattheradialaspectofthewrist(especiallywithpinchgripping)inregionof radialstyloid;commonforpaintoradiatetoelboworintothumb.

b. Duetoinflammationoftheabductorpollicislongusandextensorpollicisbrevis tendons.

c. PositiveFinkelsteintest—havethepatientclenchthethumbundertheother fingerswhenmakingafist.Thenulnarlydeviatethewrist.Thetestispositiveif painisreproduced.

d. TreatmentisthumbspicasplintandNSAIDs.Localcortisoneinjectionscanbe helpful.Surgerydoneifconservativemeasuresfailandisusuallyeffective.
======================================
Quick HIT

Hiposteoarthritispresentswithgroinpain.Lateralhippain(overthegreatertrochanter)orinthebuttockregion isnotduetoosteoarthritis.Beforediagnosingosteoarthritisofthehipassourceofpain,makecertainpatient’s symptomsareprimarilyinthegroin.

B.Bursitis 1. Olecranonbursitis—swelling(andperhapspain)atpointofelbow;spongy“bag

offluid”overolecranon(duetoeffusionintotheolecranonbursa).

a. Treatmentisconservative. b. Ifinfectionissuspected,drainagemaybenecessary.

2. Trochantericbursitis—thisisaverycommoncauseoflateralhippain.Thegreater trochanterisexquisitelypainfulonpalpation.

a. Causesincludetrauma,overuseinjury,weaknessofhipmusculature.Inmany cases,noincitingeventispresentandtheonsetisinsidious.

b. TreatmentisNSAIDsandactivitymodification.Ifsymptomspersist,local cortisoneinjectionsintothebursaareveryeffectiveinprovidingrelief.

Quick HIT

Differentialdiagnosisofhandnumbness(asseenincarpaltunnelsyndrome): Cervicalradiculopathy(nerverootcompressioninthecervicalspine) Peripheralneuropathy(diabetes) Mediannervecompressioninforearm

CarpalTunnelSyndrome

A.GeneralCharacteristics 1. Causedbymediannervecompressionwithinthetightconfinesofthecarpal

tunnel,causingnumbnessandpaininmediannervedistribution.Iflongstanding andsevere,atrophyofthenarmusclesmaybeseen.

2. Associatedconditionsincludehypothyroidism,diabetes,repetitiveuseofhandsin certainactivities,pregnancy,recenttrauma,orfractureofthewrist.

Quick HIT

AnegativePhalentestorTinelsigndoesnotexcludecarpaltunnelsyndrome.

B.ClinicalFeatures 1. Numbness,pain,ortinglinginthemediannervedistribution—usuallyworseat night;sometimespatienthaspain/numbnessalongtheentirearm(asfarasthe shoulder).

2. Muscleweaknessandthenaratrophymaydeveloplater.

C.Diagnosis 1. Physicalexamination

a. Tinelsign—tapovermediannerveatwristcrease;causesparesthesiasin mediannervedistribution

b. Phalentest—palmarflexionofthewristfor1minute;causesparesthesiasin mediannervedistribution

2. Electromyography(EMG)andnerveconductionvelocity(NCV)study

a. Fordefinitivediagnosis b. Indicatedifdiagnosisisnotclearfromclinicalfindingsorifpatientdevelops

weaknessorpersistentsymptoms
======================================
D.Treatment 1. Wristsplints(volarcarpalsplint)shouldbewornatnightduringsleep.The

purposeistopreventwristflexionduringsleep(whichcompressesthenerve).

2. Anti-inflammatorymedications(NSAIDs). 3. Localcorticosteroidinjection—reliefcanbelongterminsomepatients. 4. Surgicalreleaseisveryeffective.Considerthisoptionforpatientswhohave persistentsymptomsorifthesymptomsarelimitingthepatient’sactivitiesor qualityoflife.

Osteoarthritis

A.GeneralCharacteristics 1. Osteoarthritis(OA)ischaracterizedbydegenerationofcartilage(duetowear

andtear)andbyhypertrophyofboneatthearticularmargins.

2. Byage65,morethan75%ofthepopulationhasradiographicevidenceof osteoarthritisinweight-bearingjoints(hips,knees,lumbarspine).

3. Anyjointcanbeaffected,butweight-bearingjointsaremostcommonlyinvolved (hips,knees,cervical,andlumbarspine).

B.RiskFactors 1. Age 2. Obesity 3. Excessivejointloading(manuallabor,athletes,etc.) 4. Trauma

a. Repeatedmicrotrauma—inmanycases,apatient’soccupationorathletic activitiesrequiresrepetitivemotions(suchasrepeatedkneebending)that predisposethepatienttodegenerativejointdiseaseinlateryears

b. Macrotrauma(fractures,ligamentinjuries)—intra-articularfracturescancause OA

5. Geneticpredisposition 6. Alteredjointanatomyorinstability(developmentalhipdysplasia,dislocationdue

totrauma,rheumatoidarthritis,gout,pseudogout)

7. Depositiondiseasescausechondrocyteinjury,ormakethecartilagestiffer (hemochromatosis,ochronosis,alkaptonuria,Wilsondisease,Gaucherdisease, gout,CPPD)

8. Hemophilia(hemarthroses)

Quick HIT

Thefollowingcancontributetoorexacerbateforcestothecartilage:

¢

e

¢

Compromisedpainsensationorproprioception Ligamentallaxity Fallsofveryshortdistances(becausetheydonotprovideampleopportunityforcompensatorymovementsto decreasetheimpactload)

C.ClinicalFeatures 1. Jointpain(oftenmonoarticular)

a. Thisiscausedbymovementofonejointsurfaceagainstanother(boneonbone) becauseofcartilageloss.Therearenopainfibersincartilage,soitsinsidious

destructionovertimegoesunnoticed.Onceitiscompletelywornout,thebones (whichdohavepainfibers)startrubbingagainsteachother,producingthepain ofosteoarthritis
======================================
Quick HIT

Ifthespineisinvolved,nerverootsmaybecomecompressedandleadtoradicularpain.

b. Deep,dullachethatisrelievedwithrestandworsenedwithactivity c. Insidiousonset,withgradualprogressionovermanyyears

2. Stiffnessinthemorningorafteraperiodofinactivity(Note:morningstiffness lasting>30minutesmaysuggestaninflammatoryarthritissuchasrheumatoid arthritis)

3. Limitedrangeofmotion(latestages)duetobonyenlargementofjoints (osteophytes);bonycrepitusmaybepresent

4. Nosystemicsymptoms;noerythemaorwarmth.Swellingmaybepresentand suggestsinflammation

Quick HIT

Hiposteoarthritiscausespaininthegroin(notlateralhiporbuttock).Ifpatientistenderoverthelateralaspect ofhip,suspectgreatertrochantericbursitis.

D.Diagnosis 1. Plainradiographsaretheinitialtestsandshouldbeobtainedinallpatients

suspectedofhavingosteoarthritis(Figure12-4).Ideally,radiographsshouldbe obtainedinthestandingposition(forlowerextremities).Findingsinclude:

a. Jointspacenarrowing(duetolossofcartilage)—keyfindingonradiographs b. Osteophytes c. Sclerosisofsubchondralbonyendplatesadjacenttodiseasedcartilage—most

severeatpointsofmaximumpressure

d. Subchondralcysts—occurasaresultofincreasedtransmissionofintra- articularpressuretothesubchondralbone

2. Allbloodtestsarenormal 3. MRIofthespineifindicated(neurologicfindings,beforesurgery)

Quick HIT

Radiographicfindingsinosteoarthritis:jointspacenarrowing,osteophytes,subchondralsclerosis,subchondral cysts.

E.Treatment 1. Nonpharmacologictreatment.

a. Avoidactivitiesthatinvolveexcessiveuseofthejoint. b. Weightlossisveryimportant. c. Physicaltherapycanbebeneficial.Goalsaretomaintainrangeofmotionand

Cc. Physical therapy can be beneficial. Goals are to maintain range of motion and muscle strength. Swimming is an ideal exercise (involves minimal involvement of weight-bearing joints); avoid excessive walking.

musclestrength.Swimmingisanidealexercise(involvesminimalinvolvement ofweight-bearingjoints);avoidexcessivewalking. d. Usecanesorcrutchestoreduceweightonthejoint.

Quick HIT
======================================
Common(butUseless)“Pimp”Information

¢

e

Bouchardnodes:Bonyovergrowthandsignificantosteoarthriticchanges(i.e.,osteophytes)atthePIPjoints Heberdennodes:Bonyovergrowthandsignificantosteoarthriticchanges(i.e.,osteophytes)attheDIPjoints

2. Pharmacologictreatment.

a. Acetaminophenisthefirst-lineagent. b. NSAIDsarejustaseffectiveasacetaminophen(butGIbleedingisaconcern

withlong-termuse).OfselectiveCOX-2inhibitors,onlycelecoxibremainson themarketbutisrarelyused.Alltheothershavebeenremovedfromthemarket duetoincreasedriskofcardiovascularevents.MainbenefitofselectiveCOX-2 inhibitorsisadecreaseingastric/duodenalulcersandadecreaseinGI symptoms,withthesame(notsuperior)analgesicandanti-inflammatoryeffects ofthenonselectiveNSAIDs.

c. Intra-articularinjectionsofcorticosteroidsareveryhelpful,butmorethanthree tofourinjectionsperyearisnotrecommended.Patientsmayhaveupto3 monthsofpainreliefwitheachinjection.InelderlypatientswithsevereOAwho arenotgoodsurgicalcandidatesforjointreplacement,morefrequentinjections arejustifiedifitprovidesgoodpaincontrol.

d. Viscosupplementation—hyaluronicacidisinjectedintothekneejointand augmentstheviscoelasticpropertiesofnormalsynovialfluid.Recentstudies showgoodpainrelief,butresultsarevariable.

Quick HIT

Withosteoarthritisofthehips,thepainisinthegroinregionandsometimesradiatestotheanteriorthigh.

Quick HIT

Forleftkneeorhippain,thecaneshouldbeheldintherighthand.

3. Surgeryforseriousdisability.

a. Totaljointreplacementmaybeperformedifconservativetherapyfailstocontrol pain.Itshouldbedelayedaslongaspossiblebecausearevisionmaybeneeded 15to20yearsaftersurgery.Totalhipandkneereplacementsareamongthe mostsuccessfulproceduresinorthopedicswithreliablepainrelief.

Quick HIT

Althoughx-raysarediagnosticofOA,notallpatientswithx-rayfindingsofOAhavesymptoms.Thereisno consistentcorrelationbetweensymptomsandseverityofx-rayfindings.

4. Nutritionalproducts—glucosamineandchondroitinsulfate.

a. Over-the-counterproductsthatmanypatientsclaimtoimprovearthritis symptoms,althoughhigh-qualityrandomizedtrialshavenotshownany meaningfulbenefit.
======================================
FIGURE 12.4

A:RightkneeAPradiographshowingosteoarthritis.Note medialjointspacenarrowing,osteophyteformation(curvedarrow), andirregulararticularsurfaces(straightarrow).B:PelvicAP radiograph.Bilateralosteoarthritisofthehip.Notenarrowingofhip jointspaces,osteophytes(curvedarrows),andosteophytesinthe lumbarspine(doublecurvedarrows).Alsonotesubchondralcystsand sclerosisofthefemoralheads. (AfromErkonenWE,SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.

Philadelphia,PA:LippincottWilliams&Wilkins;1998:287,Figure11–72;BfromErkonenWE, SmithWL.Radiology101:TheBasicsandFundamentalsofImaging.Philadelphia,PA:Lippincott Williams&Wilkins;1998:288,Figure11–73A.)

Williams&Wilkins;1998:288,Figure11–73A.)

Osteoporosis

A.GeneralCharacteristics 1. Decreasedbonemass/qualitycausesincreasedbonefragilityandfracturerisk.In osteoporosis,thebonemineraldensityisatleast2.5standarddeviationsbelow thatofyoung,normalindividuals.

Quick HIT

Itisoftendifficulttodifferentiatebetweenprimaryandsecondaryosteoporosis,andthetwomaycoexist.Itis besttoattempttoidentifyanypredisposingconditionsandeliminatethemifpossible.

2. Mechanism:failuretoattainoptimal(peak)bonemassbeforeage30,orrateof boneresorptionexceedsrateofboneformationafterpeakbonemassisattained

3. Mostosteoporoticpatientsarepostmenopausalwomenandelderlymen

Quick HIT

Someelderlypatientshaveprogressivekyphosis(hunchbackdeformity)becausetheyhavemultiplevertebral compressionfractures.

4. Classification

a. Primaryosteoporosis(twotypesthatareimpracticalclinically)

e

e

TypeI(mostofteninpostmenopausalwomen51to75yearsofage)—excess lossoftrabecularbone;vertebralcompressionfracturesandCollesfractures arecommon TypeII(mostofteninmenandwomenover70yearsofage)—equallossof bothcorticalandtrabecularbone;fracturesoffemoralneck,proximal humerus,andpelvismostcommon

b. Secondaryosteoporosis—anobviouscauseispresent,suchasexcesssteroid therapy/Cushingsyndrome,immobilization,hyperthyroidism,long-term heparin,hypogonadisminmen,andvitaminDdeficiency

Quick HIT

Osteoporosisisa“silent”disease.Itisasymptomaticuntilafractureoccurs.
======================================
B.RiskFactors 1. Estrogendepletion

a. Postmenopausalstate—allwomenareestrogendeficientaftermenopause;

however,osteoporosisdoesnotdevelopinallwomen

b. Historyofathleticamenorrhea,eatingdisorders,oligomenorrhea c. Earlymenopause

Quick HIT

AnexerciseprogramalongwithcalciumandvitaminDsupplementationisthemainstayofthetherapyfor preventionortreatmentofosteoporosis.

2. Femalegender—womenhavealowerpeakbonemassandsmallervertebralend

plates

3. Calciumdeficiency/vitaminDdeficiency 4. Decreasedpeakbonemass 5. Heritableriskfactors—familyhistory,EuropeanorAsianancestry,thin/slight

build

6. Decreasedphysicalactivity(prolongedimmobility) 7. Endocrine—hypogonadisminmen(withlowtestosterone),hyperthyroidism(see

ClinicalPearl12-9)

8. Smokingandalcoholabuse 9. Medications—corticosteroids,prolongedheparinuse

Quick HIT

ThePROOFtrialshowedthefollowingregardingcalcitonin:

¢

e

e

Noeffectathip Showntodecreaseriskofvertebralfracturesbyasmuchas40% Slightincreaseinbonedensityatlumbarvertebrae

Quick HIT

Recommendthefollowingtoallpatientswithosteoporosis:

©

¢

e

e

Dailycalcium DailyvitaminD Weight-bearingexercise Smokingcessation

C.ClinicalFeatures 1. Vertebralbodycompressionfractures(ofthemiddleandlowerthoracicandupper

lumbarspine)arethemostcommon.Veryrareincervicalspine

a. Resultinpainanddeformity,includingkyphosis b. Severebackpainafterminortrauma c. Restrictedspinalmovement,lossofheight

2. Collesfracture(distalradiusfracture)—usuallyduetofallonoutstretchedhand; morecommoninpostmenopausalwomen

3. Hipfractures—femoralneck,intertrochantericfractures 4. Increasedincidenceoflongbonefractures—humerus,femur,tibia

Quick HIT

Ofallfragilityfractures,hipfractureshavehighestmorbidityandmortality.

CLINICALPEARL12-9

OsteoporoticFractureRiskAssessment Validatedriskfactorsforosteoporoticfractureriskthatareindependentofbonemineraldensityare:

Advancedage Previousosteoporoticfracture Long-termsteroidtherapy Cigarettesmoking Lowbodyweight(<58kg) Familyhistoryofhipfracture Excessalcoholintake Rheumatoidarthritis Secondaryosteoporosis
======================================
D.Diagnosis 1. DEXA(dual-energyx-rayabsorptiometry)scanisthegoldstandard.

a. Verypreciseformeasuringbonedensity. b. Indicationsforbonemineraldensitymeasurement:

e

e

e

Allwomen65andolder. Postmenopausalwomen<65withoneormoreriskfactorsforfracture. Menwithriskfactorsforfracture.

Quick HIT

IfDEXAscanisnormalandnoriskfactors,repeatDEXAin3to5years.

c. Sitesselectedarefemoralneckandlumbarspine.Comparethedensityofbone withastandardcontrol,whichisthebonedensityofahealthy30-year-old person.

d. Canrangefromnormaltoosteopeniatoosteoporosis.T-scoresareused accordingtoWHOclassification(seeTable12-8).

WHOclassification(T-scores)areusedinallpostmenopausaland

perimenopausalwomen,andinmenoverage50.Inallotherpatients (includingpremenopausalwomen),z-scoresareused.

2. Ruleoutsecondarycauses—checkcalcium,phosphorus,alkalinephosphatase, TSH,vitaminD,freePTH,creatinine,CBC.

Quick HIT

Unfortunately,mostpatientswithfragilityfracturesdonotsubsequentlyreceiveosteoporosistherapy,despite datashowingabeneficialeffectinreducingtheriskofasecondfracture.

E.Treatment 1. Nonpharmacologictherapy

a. Diet—adequatecalorieintake,avoidmalnutrition Supplementalelementalcalcium(1,200mg/day) 800internationalunitsofvitaminDdaily

b. Exercise—weight-bearingexercisefor30minutes,atleast3timesaweek,to stimulateboneformation

c. Smokingcessationiscritical—smokingacceleratesboneloss d. Eliminateorreducealcoholintake

2. Pharmacologictherapy

a. Indicatedinthefollowingpatients:

e

e

Postmenopausalwomenwithestablishedosteoporosis(T-score−2.5orless)or fragilityfracture(hiporvertebral) High-riskpostmenopausalwomenwithosteopenia(T-scorebetween−1.0and −2.5)

b. Bisphosphonatesinhibitboneresorptionandarefirst-linetreatment

e

e

e

e

Theydecreaseosteoclasticactivity(viabindingtohydroxyapatite)and decreasetheriskoffractures Oralbisphosphonates(alendronate,risedronate)arepreferredinmostpatients Sideeffectsincludereflux,esophagealirritation,andulceration Ifpatientcannottolerateoralbisphosphonates,useIVbisphosphonates(IV zoledronicacid)

c. PTHtherapyorhumanrecombinantPTHtherapy
======================================
e

e

PTHisaneffectivedrugthatincreasesbonemineraldensityandreduces fracturerisk.Duetohighcost,subcutaneousadministration,andlong-term safetyconcerns,itisnotafirst-linedrug Indicatedinpatientswithsevereosteoporosis(T-scorelessthan−2.5)who cannottoleratebisphosphonates,orwhocontinuetofracturedespitebeingon bisphosphonatesfor1year

Maximumdurationoftreatmentis24months,becauseofconcernfor osteosarcomas,whichhavebeenobservedinrats.AfterstoppingPTH,can restartbisphosphonates

d. Calcitonin(canbeadministeredbynasalspray)—long-termbenefitsare minimal,butitisusefulasshort-termtherapy,especiallyinelderlyfemale patientswithvertebralcompressionfracture.Itislesspopularandnot commonlyused

e. Estrogen–progestintherapyisnolongerafirst-lineapproachforthetreatmentof osteoporosisinpostmenopausalwomenbecauseofincreasedriskofbreast cancer,stroke,venousthromboembolism,andperhapsCAD
======================================
DiseasesoftheEye

Age-RelatedMacularDegeneration

Mostcommoncauseofvisionlossinpeopleover65yearsofageindeveloped countries. Age-relatedmaculardegeneration(ARMD)ischaracterizedbylossofcentralvision (becausethemaculaisaffected).Blurredvision,distortion,andscotomaare common.Completelossofvisionalmostneveroccurs.Peripheralvisionis preserved. Themainriskfactorisadvancedage.Otherriskfactorsarefemalegender, Caucasianrace,smoking,HTN,andfamilyhistory. Twocategories:exudative(“wet”)andnonexudative(“dry”)maculardegeneration. ExudativeARMDcausessuddenvisuallossduetoleakageofserousfluidandblood asaresultofabnormalvesselformation(neovascularization)undertheretina. NonexudativeARMDischaracterizedbyatrophyanddegenerationofthecentral retina.Yellowish-whitedepositscalleddrusenformunderthepigmentepithelium andcanbeseenwithanophthalmoscope. Intraocularinjectionsofmedications(anti-VEGFinhibitors)havesupplantedlaser photocoagulationandothertherapiesforwetARMD. Over-the-counterformulationsofvitaminsarerecommendedfordryandwet ARMD.

Quick HIT

Mostcommoncausesofvisualimpairment/lossindevelopedcountries:

e

«

e

¢

Diabeticretinopathy(mostcommoncauseinadults<65years) ARMD(mostcommoncauseinadults>65years) Cataracts Glaucoma

Glaucoma

A.GeneralCharacteristics 1. Glaucomaisoneofthemostimportantcausesofblindnessworldwide.Itisa complexdiseasetypicallycharacterizedbyincreasedIOP,damagetotheoptic nerve,andirreversiblevisionloss.

2. Thepathogenesisofopticnervedamageinglaucomaisnotfullyunderstood. Ischemiamayplayamajorrole.Overtime,thereisalossofganglioncells, leadingtoatrophyoftheopticdiscandenlargementoftheopticcup,called “cupping.”

Quick HIT

Age-RelatedMacularDegeneration

The“wet”formofARMDcandevelopatanytime,sopatientswith“dry”ARMDmustbemonitoredclosely. Supplementsofcertainvitaminscontainingantioxidantsarethoughttobebeneficial,butapreventativeor therapeuticeffecthasnotbeenproven. Ranibizumab(andseveralotherrelateddrugs),givenasrepeatedintraocularinjections,havebeen showntobeeffectiveintreating“wet”ARMD.

3. Therearemanytypesofglaucoma,buttheygenerallyfallintothefollowingtwo categories:

a. Open-angleglaucoma—accountsfor90%ofallcases.
======================================
e

e

Characterizedbyimpairedoutflowofaqueoushumorfromtheeye. Absenceofsymptomsearlyinthecoursecanleadtodelayindiagnosisand “silent”progression.

Quick HIT

GlaucomaisthemostcommoncauseofirreversibleblindnessinAfricanAmericans.

b. Closed-angleglaucoma.

e

e

e

Acuteangle-closureglaucoma—characterizedbyveryrapidincreaseinIOP duetoocclusionoftheanteriorchamberangle(betweenthecorneaandthe iriswherethetrabecularmeshworkislocated)andobstructionofoutflowof aqueoushumor. Thisisanophthalmologicemergencythatcanleadtoirreversiblevision losswithinhoursifuntreated. Maybeprecipitatedbydilationoftheirisinapatientwithapre-existing anatomicallynarrowanteriorchamberangle.

B.RiskFactors 1. Olderage(over50years) 2. African-Americanrace(increasedincidenceofopen-angleglaucoma) 3. AsianorEskimoancestry(increasedincidenceofacuteangle-closureglaucoma) 4. Familyhistoryofglaucoma 5. Historyofsignificanteyetraumaorintraocularinflammation 6. Steroidmedications

C.ClinicalFeatures 1. Open-angleglaucoma

a. Painless,increasedIOP(maybetheonlysign),characteristicchangesinoptic nerve

b. Progressiveandinsidiousvisualfieldloss(usuallysparingcentralvisionuntil end-stagedisease)

Quick HIT

Patientswithacuteangle-closureglaucomamayhavesevereabdominalpainandnausea,andtheyare occasionallymisdiagnosedashavinganacutesurgicalabdomen(e.g.,appendicitis).

2. Closed-angleglaucoma

a. Red,painfuleye b. Suddendecreaseinvisualacuity(blurredvision),seeing“halos,”markedly

elevatedIOP

c. Nauseaandvomiting(common),headache d. Involvedpupilisdilatedandnonreactive(inmid-dilation)

D.Diagnosis 1. TonometrymeasuresIOP;shouldbeperformedregularlyinpatientswithorat

riskforglaucoma.

2. Ophthalmoscopy—evaluatetheopticnerveforglaucomatousdamage. 3. Gonioscopyisusedtovisualizetheanteriorchamberandhelpsdeterminethe

causeofglaucoma.Itrequiresskilltoperform.

4. Visualfieldtestingshouldbeperformedinallpatientsinwhomglaucomais suspectedandregularlyineveryonewithglaucomatomonitordisease progression.

5. Imaging(OCT)oftheopticnervealsoishelpfulinassessingandmonitoring progressionofaxonallossoftheopticnerveinglaucomapatients.
======================================
E.Treatment 1. Chronicopen-angleglaucoma(inescalatingorder).

a. Topicalmedications—mostpatientsarefirsttreatedtopicallywithaβ-blocker, α-agonist,carbonicanhydraseinhibitor,and/orprostaglandinanalogueby themselvesorincombinationtoreachthetargetpressure.

b. Laserorsurgicaltreatmentforrefractorycases.

Quick HIT

ThegoaloftreatmentistocontrolIOP,andtherebypreventfurtheropticnerveandvisualfieldloss.

2. Acuteangle-closureglaucoma.

a. Anophthalmicemergency—refertoanophthalmologistimmediately. EmergentlylowertheIOP.Medicaltreatmentincludestimolol,brimonidine, dorzolamide,pilocarpine,and/orprednisolonedrops.CangiveIVacetazolamide andoralmannitolifIOPisstillelevatedafterpreviousmeasures.

b. Laserorsurgicaliridectomyisadefinitivetreatment.

Cataracts

Opacificationsofthenaturallensoftheeye:halfofpeopleoverage75have cataracts(Figure12-5). Thereisalossofvisualacuitythatprogressesslowlyovermanyyears.Patients maycomplainofglareanddifficultydrivingatnight. Riskfactorsincludeoldage,cigarettesmoking,glucocorticoiduse,prolongedUV radiationexposure,trauma,diabetes,Wilsondisease,Downsyndrome,andcertain metabolicdiseases. Surgeryisthedefinitivetreatmentandisveryeffectiveinrestoringvision.Itis indicatedifvisuallossissignificanttothepatientandinterfereswithdailyor occupationalactivities.Itinvolvesextractionofthecataractwithimplantationofan artificialintraocularlens.

FIGURE 12.5

Cataract.

(FromTasmanW,JaegerE.TheWillsEyeHospitalAtlasofClinicalOphthalmology.2nded. Philadelphia,PA:LippincottWilliams&Wilkins,2001,Figure12-2.)

RedEye

A.GeneralCharacteristics 1. Manycausesofredeyearebenign,buttheinitialgoalinevaluationshouldbeto

identifyconditionsthatrequire(emergentornonemergent)referraltoan ophthalmologist.

2. Conjunctivitisisthemostcommoncauseofredeye,butalwaysattemptto excludeother,moreseriouscauses.

3. Thefollowingconditionsrequireareferraltoanophthalmologist:

a. Eyepainthatdoesnotrespondtotherapy.

Quick HIT

“SecondSight”

«

e

Somepatientswithcataractsbecomeincreasinglynear-sightedandmaynolongerrequirereadingglasses. Thisisreferredtoas“secondsight.” Thisphenomenonisduetothecataractincreasingtherefractivepowerofthelensoftheeye.
======================================
b. Flashers,floaters,orasuddendecreaseinvisualacuity. c. Historyofrecenteyesurgery—especiallyifinfectionissuspected. d. Cornealopacification,cornealulcer,orcornealforeignbodythatcannotbe

removed.

e. Historyofpenetratingtraumaorsignificantblunttrauma. f. Historyofchemicalexposure(especiallyalkaliagents). g. Orbitalcellulitis. h. Presenceofhypopyonorciliaryflush(suggestsacuteglaucoma,corneal

Presence of hypopyon or ciliary flush (suggests acute glaucoma, corneal inflammation, or iridocyclitis)

inflammation,oriridocyclitis) i. Asymmetricorunreactivepupils.

4. Alwayscheckvisualacuity,pupilsize,andreactivity.Evertlidstolookfora foreignbody.

Quick HIT

Ingeneral,steroideyedropsshouldonlybeadministeredbyanophthalmologist.

B.DifferentialDiagnosis 1. Conjunctivitis—seebelow 2. Subconjunctivalhemorrhage

a. Causedbyruptureofsmallconjunctivalvessels;inducedbyValsalvamaneuver traumaor,lesscommonly,coagulopathiesorHTN

b. Causesfocalunilateralblotchyrednessoftheconjunctiva(looksworsethanit is)

c. Usuallyself-limitingandresolvesinafewweeks

3. Keratoconjunctivitissicca(dryeye)

a. Verylongdifferentialdiagnosis,includingmedications(e.g.,anticholinergicsor antihistamines),autoimmunediseases(e.g.,Sjögren’s),CNVorVIIlesions

b. Theeyemayappearnormal,ormaybemildlyinjected c. Patientsmaycomplainofaforeignbodysensation d. Treatwithartificialtearsduringtheday.Consideralubricatingointmentat

night.Manyothertreatmentsareavailable

4. Acuteangle-closureglaucoma(seeabove)—consultanophthalmologist immediately

5. Blepharitis

a. Inflammationoftheeyelid;oftenassociatedwithinfectionwithStaphylococcus spp.

b. Usuallydiagnosedbycarefulexaminationoftheeyelidmargins,whicharered andoftenswollenwithcrustingthatstickstothelashes

c. Treatwithlidscrubsandwarmcompresses.Givetopicalantibioticsforsevere

cases 6. Episcleritis

a. Inflammationofvesselsliningtheepisclera(theliningjustbeneaththe conjunctiva)

b. Thoughttobeanautoimmuneprocess—maybeseenwithconnectivetissue diseases,butusuallyidiopathic

c. Causesredness,irritation,dullache,andpossiblewaterydischarge d. Thescleramayappearblotchywithareasofrednessovertheepiscleralvessels e. Usuallyself-limiting;NSAIDsmayprovidesymptomaticrelief f. Referthepatientforevaluationbyanophthalmologist

7. Scleritis

a. Inflammationofthescleraisassociatedwithsystemicimmunologicdisease, suchasrheumatoidarthritis

b. Itcausessignificanteyepain(severe,deeppain).Onexamination,thereis ocularrednessandpainonpalpationoftheeyeball.Itcancausevisual impairment

c. Referthepatientforpromptevaluationbyanophthalmologist.Treatment
======================================
involvestopicalandsometimessystemiccorticosteroids 8. Acuteanterioruveitis(alsoknownasiritisoriridocyclitis)

a. Inflammationoftheirisandciliarybody;morecommonintheyoungand middle-aged

b. Associatedwithconnectivetissuediseases(e.g.,sarcoidosis,ankylosing spondylitis,Reitersyndrome,andIBD)

c. Clinicalfindings:ciliaryflush(rednessmostprominentaroundthecornea), blurredvision,painandphotophobia;constrictedpupilcomparedwith contralateraleye

d. Referthepatientforpromptevaluationbyanophthalmologist

9. Herpessimplexkeratitis

a. CausedbyHSV-1;maypresentsimilarlytoviralconjunctivitis,exceptusually unilateral

b. Presentswithocularirritationandphotophobia.Painmaybeabsent c. Lookforclassicdendriticulceronthecornea;canresultinirreversible

visionlossifuntreated

d. Warrantssemiurgentophthalmologyreferral e. Treatwithtopicalantiviraleyedropsorganciclovirgel.Consideroralacyclovir

orvalcylovirforthosewhocannottolerateoradministertopicaltherapy.

Quick HIT

Viralconjunctivitisishighlycontagious!Patientsshouldavoidanydirectorindirecteyecontactwithothers. Encouragestrictpersonalhygieneandfrequenthandwashing.Cleanallsurfacesandequipmentincontactwith thepatientassoonasthepatientleavestheoffice.

Conjunctivitis

A.GeneralCharacteristics 1. Conjunctivitisisthemostcommoncauseofredeye. 2. Conjunctivitisgenerallyreferstoinflammationofthetransparentmembranethat

linestheinsideoftheeyelids(palpebralconjunctiva)andtheglobe(bulbar conjunctiva).

Quick HIT

Whenapatientpresentswithredanditchyeyes,tearing,andnasalcongestion,thinkallergicconjunctivitis.

B.Causes 1. Viralconjunctivitis(seealsoClinicalPearl12-10).

a. Themostcommonformofconjunctivitis.Adenovirusisthemostcommon organism.

b. InquireaboutarecenthistoryofURI. c. Hyperemiaofoneorbotheyes,usuallyoneeyefollowedbyspreadtotheother

inafewdaysiscommon.Waterydischargeisfrequentlypresent.

d. Apalpablepreauricularlymphnodemaybepresent.

Quick HIT

Wearingcontactlensesovernightdramaticallyincreasesaperson’sriskfordevelopingcornealinfectionand ulceration.

e. Itisusuallyself-limited,butsomepatientsdevelopmembranousconjunctivitis thatrequirestopicalsteroidsandstrippingofthemembranes.

2. Bacterialconjunctivitis.

a. MostcommonlycausedbyS.aureusinadults,thoughothercommonorganisms includeS.pneumoniae,H.influenzae,andM.catarrhalis.

b. Rapidonsetofirritation,hyperemia,andtearing. c. Characterizedbyamucopurulentexudatewithcrusting.
======================================
CLINICALPEARL12-10

DoNotSendaPatientHomeWhoHasaRapidOnsetofCopious,Purulent Exudate!

e

e

Thisisconsistentwithhyperacutebacterialconjunctivitis,causedbyNeisseriagonorrhoeae. Thetypicalpatientisasexuallyactiveyoungadult.

«

¢

e

Symptomsprogressrapidlytosevereredness,swelling,andpain. Thiswarrantsimmediateattentionfromanophthalmologist. Ifuntreated,itcanleadtocornealscarringandblindness.

3. Chlamydialconjunctivitis—twoimportantforms.

a. Trachoma(causedbyChlamydiatrachomatisserotypesA,B,andC)

Mostcommoncauseofblindnessworldwideduetochronicscarring.

b. Inclusionconjunctivitis(C.trachomatisserotypesDtoK).

Mainlytransmittedbygenital-hand-eyecontactinpatientswithsexually transmittedinfection(STI).

4. Allergicconjunctivitis.

a. Verycommoninpatientswithatopicdisease;usuallyseasonal. b. Itistypicallycharacterizedbyredness,itching,tearing,andnasalconjunctivitis.

Eyelidedemamayalsobepresent.Itistypicallybilateral.

5. Conjunctivitissecondarytoirritants(e.g.,contactlenses,chemicals,foreign bodies,dryness).

C.Treatment 1. Viralconjunctivitis:coldcompress,stricthandwashing;topicalantibioticsif

bacterialsuperinfectionissuspected

2. Bacterialconjunctivitis

a. Acute—usebroad-spectrumtopicalantibiotics(e.g.,erythromycin, ciprofloxacin,sulfacetamide).Therapycanbealteredbasedoncultureresults

b. Hyperacute—treatgonococcalconjunctivitiswithaone-timedoseof ceftriaxone,1gIM,aswellastopicaltherapy.

3. Chlamydialconjunctivitis

a. Adultsandadolescents—oraltetracycline,doxycycline,orerythromycinfor2 weeks

b. Treatsexualpartner(s)forSTI

4. Allergicconjunctivitis

a. Removetheallergen,ifpossible.Advisetheuseofcoldcompresses b. Treatwithtopicalantihistaminesormastcellstabilizers c. Systemicantihistaminescanbeeffectiveaswell d. TopicalNSAIDsmaybeausefuladjuncttotreatment

AmaurosisFugax

Somevariabilitywithhowthisisdefined,butgenerallyreferstosudden,transient lossofvisioninoneorbotheyes Causesoftransientmonocularvisionlossincludecarotidarterydisease(cholesterol plaqueembolization),cardioembolicphenomenon,giantcell(temporal)arteritis, andothers Ordercarotidultrasonographyandcardiacworkup(e.g.,lipidprofile,ECG)
======================================
SleepDisorders ObstructiveSleepApnea

A.GeneralCharacteristics 1. Intermittentobstructionoftheairflow(typicallyattheleveloftheoropharynx)

producesperiodsofapneaduringsleep.

2. Eachapneicperiodisusually20to30secondslong(butmaybelonger)and resultsinhypoxia,whicharousesthepatientfromsleep.Thisoccursmultiple (sometimeshundredsof)timesovernight.

B.RiskFactors 1. Obesity(especiallyaroundtheneck)—althoughnonobesepatientscanalsohave

OSA

2. Structuralabnormalities—enlargedtonsils,uvula,softpalate;nasalpolyps; hypertrophyofmusclesinthepharynx;deviatedseptum;deepoverbitewithsmall chin

3. Familyhistory 4. Alcoholandsedativesworsenthecondition 5. Hypothyroidism(multifactorial)

C.ClinicalFeatures 1. Snoring 2. Daytimesleepinessduetodisruptednocturnalsleep 3. Personalitychanges,decreasedintellectualfunction,decreasedlibido 4. Repeatedoxygendesaturationandhypoxemiacanleadtosystemicand

Repeated oxygen desaturation and hypoxemia can lead to systemic and pulmonary HTN as well as cardiac arrhythmias

pulmonaryHTNaswellascardiacarrhythmias 5. Otherfeatures:morningheadaches,polycythemia

D.DiagnosisPolysomnography(overnightsleepstudyinasleeplaboratory)confirms thediagnosis.

E.Treatment 1. Allpatientsshouldundergobehaviormodification,whichincludesweightloss

andexercise,avoidingalcoholandsedatives,andsleepinginanonsupineposition 2. MildtomoderateOSA

a. Shouldbeofferedpositiveairwaypressuretherapy b. Ifpatientrefusesorthereareissueswithcompliance,anoralappliancecanbe

offered

3. SevereOSA

a. Continuouspositiveairwaypressureprovidespositivepressure,thus preventingocclusionoftheupperpharynx.Thisisthepreferredtherapyforthe majorityofpatientsbecauseitisnoninvasiveandhasprovenefficacy.Itis poorlytoleratedbysomeduetonoiseanddiscomfort

b. Uvulopalatopharyngoplasty—removalofredundanttissueinoropharynxto allowformoreairflow

c. Tracheostomyisalastresortforthoseinwhomallothertherapieshavefailedor whohavelife-threateningOSA(severehypoxemiaorarrhythmias)

Quick HIT

ComplicationsofOSA

e

e

Increasedpulmonaryvascularresistance(duetohypoxemia);overtime,canleadtopulmonaryHTNand eventuallycorpulmonale(morelikelyifthepatientisobese) SystemicHTN(duetoincreaseinsympathetictone)
======================================
Narcolepsy

A. Inheriteddisorder(ofvariablepenetrance)ofREMsleepregulation(i.e.,REMsleep involuntarilyoccursatrandomandinappropriatetimes)

B. Resultsinexcessivesleepinessduringtheday C. Characterizedbythefollowingfeatures:

1. Involuntary“sleepattacks”atanytimeofday(duringanyactivity,including driving)thatlastseveralminutes

2. Cataplexy,whichislossofmuscletonethatgenerallyoccurswithanintense emotionalstimulus(e.g.,laughter,anger)

3. Sleepparalysis,inwhichpatientcannotmovewhenwakingup 4. Hypnagogichallucinationsthatarevivid(visualorauditory)—“dreams”while

awake

D. Thedisordercanrangefrommildtosevere E. Automobileaccidentsareamajorproblem F. Treatment:modafinil(useissupportedbyRCTs),methylphenidate(Ritalin),or

amphetamines;plannednapsduringthedaymaypreventsleepattacks

Insomnia

A.Causes 1. Acuteortransientinsomniaisusuallyduetopsychologicalstressortravelover

timezones(“jetlag”)

2. Chroniccauses

a. Secondaryinsomniaaccountsforover90%ofallcases

e

e

e

Psychiatricconditions—depression,anxietydisorders,posttraumaticstress disorder,manicphaseofbipolardisorder,schizophrenia,obsessive-compulsive disorder Medicationsandsubstanceabuse—alcohol,sedatives(withprolongeduse, patientsdeveloptoleranceandwithdrawalreboundinsomnia),caffeine,β- blockers,stimulantdrugs(amphetamines),decongestants,someSSRIs, nicotine Medicalproblems—advancedCOPD,renalfailure,CHF,chronicpain Other—fibromyalgia,chronicfatiguesyndrome(CFS)

¢

b. Primaryinsomniaisadiagnosisofexclusion.DSM-5definesitas dissatisfactionwithsleepandoneofthefollowing:difficultyinitiatingsleep, difficultymaintainingsleep,orearly-morningawakeningsandasubsequent inabilitytofallbackasleep

e

e

Bydefinition,itisnonrestorativesleepthatoccursthreenightsperweekforat least3monthsintheabsenceofothermedical,psychiatric,orsleepdisorders, andthatcausesclinicallysignificantdistressandsocialoroccupational impairment Patientsworryexcessivelyaboutnotfallingasleepandbecomepreoccupied withit.Thecauseisunknown

Quick HIT

Questionstoaskthepatientwithinsomnia—sleephistory,timingofinsomnia,sleephabits
======================================
B.Treatment 1. Treattheunderlyingcause,iffound. 2. Considerapsychiatricevaluationifpsychiatriccausesorprimaryinsomniaare

suspected.

3. Usesedative–hypnoticmedicationssparinglyandwithcautionforsymptomatic relief.Usethesmallestdosepossible,andavoiduseforlongerthan2to3weeks.

MiscellaneousTopics

Obesity

A.General 1. Consideredtobeaglobalepidemic,particularlyindevelopednations 2. Healthhazardsassociatedwithobesity:HTN,heartdisease,hyperlipidemia,type

2diabetes,stroke,osteoarthritis,liverdisease,cancer,OSA,obesity hypoventilationsyndrome,anddepression

3. Obesityisassociatedwithasignificantincreaseinmortality 4. BodyMassIndex(BMI)=weightdividedbyheightsquared(kg/m2)

a. Underweight:BMIlessthan18.5 b. Normal:18.5to24.9 c. Overweight:25to29.9 d. Obese:30andover

¢

¢

¢

ObesityclassI:30to34.9 ObesityclassII:35to39.9 ObesityclassIII:40andover

B.Treatment 1. Diet,exercise,andlifestylemodificationaremainstaysoftreatment. 2. Drugtherapy—forpatientswhohavenotsucceededinlosingweightwithdietand

exercise.Orlistatisafirst-lineagentandcanbecontinuedforupto4years.

3. Bariatricsurgery.

a. Bariatricsurgeryiseffectiveinreducingcomorbiditiesassociatedwithobesity, includingHTN,diabetes,OSA,andhyperlipidemia.Thistranslatesintoa29% reductioninmortality.Onlyindicatedinpatientswhohaveearnestlytriedother meansoflosingweightandhavebeenunsuccessful.

b. BestevidenceisforpatientswithBMIover40. c. Bariatricsurgeryisbasedontwomechanisms:restrictionofintake(viaasmall stomachreservoir)andmalabsorption(viadecreasingsmallbowellength). Restrictivetechniquesaretechnicallyeasier,havelowercomplicationrates,but resultinlessweightlossthanmalabsorptivetechniques[AQ4].

d. MostcommonprocedureisthelaparoscopicRoux-en-Ygastricbypass.The laparoscopicadjustablegastricbanding(LapBand)hasfewercomplications,is reversible,butisnotaseffectiveinachievingweightlossascomparedwiththe gastricbypass.

HearingLoss/ImpairedHearing

A.GeneralCharacteristics—twotypesofhearingloss 1. Conductivehearingloss

a. Causedbylesionsintheexternalormiddleear b. Duetointerferencewithmechanicalreceptionoramplificationofsound,which occurswithdiseaseoftheauditorycanal,tympanicmembrane,orossicles 2. Sensorineuralhearingloss—duetolesionsinthecochleaorCNVIII(auditory

branch)
======================================
B.Causes 1. Conductivehearingloss

a. Externalcanal

e

e

e

Cerumenimpaction—buildupobstructstheauditorycanal(mostcommon cause) Otitisexterna Exostoses—bonyoutgrowthsofexternalauditorycanalrelatedtorepetitive exposuretocoldwater(e.g.,scubadivers,swimmers)

Quick HIT

TympanicMembranePerforation

e

e

e

History:pain,conductivehearingloss,tinnitus Examination:bleedingfromtheear,clotinthemeatus,visibletearinthetympanicmembrane Ninetypercenthealspontaneouslywithin6weeks.Surgeryisappropriateforlargerperforations.

b. Tympanicmembraneperforation

e

e

Usuallyduetotrauma(directorindirect) Maybesecondarytomiddleearinfection

c. Middleear

e

e

e

Anycauseofmiddleeareffusion(fluidinmiddleearinterfereswithsound conduction)—otitismedia,allergicrhinitis Otosclerosis—bonyfusion(immobilization)ofthestapestotheovalwindow; anautosomaldominantcondition(variablepenetrance);correctedwith surgery;rarelyprogressestodeafness Other—neoplasms,congenitalmalformationofthemiddleear

2. Sensorineuralhearingloss

a. Presbycusis(mostcommoncause)

Gradual,symmetrichearinglossassociatedwithaging—mostcommoncause

e

e

ofdiminishedhearinginelderlypatients Pathology—degenerationofsensorycellsandnervefibersatthebaseofthe cochlea Hearinglossismostnoticeableathighfrequencieswithslowprogressionto lowerfrequencies

Quick HIT

HearingImpairment

e

e

History:medications;historyofheadtrauma,infection(otitismedia,otitisexterna);noiseexposure (occupationalorrecreational) Physicalexamination:inspectauditorycanal(impactedcerumen,exostoses);examinetympanicmembrane (inflammation,perforation,scarring);assessmiddleear(fluid)

b. Noise-inducedhearingloss

e

e

Chronic,prolongedexposuretosoundlevels>85dB HaircellsintheorganofCortiaredamaged

c. Infection—viralorbacterialinfectionofcochlearstructuresorlabyrinth d. Drug-inducedhearingloss

e

e

Aminoglycosideantibiotics,furosemide,ethacrynicacid;cisplatin,quinidine Aspirincancausetinnitusandreversiblehearingimpairment

e. Injurytoinnerearorcochlearnerve(e.g.,skullfracture) f. Congenital(TORCHinfections) g. Ménièredisease
======================================
e

e

e

Fluctuating,unilateralhearingloss Sensorineuralhearingloss,senseofpressure/fullnessinear,tinnitus,vertigo Vertigousuallyrespondstodietarysaltrestrictionandmeclizine,buthearing lossisprogressive

h. CNScauses—acousticneuromas,meningitis,auditorynerveneuritis(multiple sclerosis,syphilis),meningioma

C.ClinicalFeatures 1. Conductivehearingloss

a. Decreasedperceptionofsound(especiallyforlow-frequencysounds) b. Canhearloudnoiseswell 2. Sensorineuralhearingloss

a. Difficultyhearingloudnoises;shoutingmayexacerbatetheproblem(annoyed byloudspeech)

b. Canhearsounds,buthastroubledecipheringwords(poorspeech discrimination)

c. Moredifficultywithhigh-frequencysounds(doorbells,phones,child’svoice, femalevoice)

d. Tinnitusisoftenpresent

D.Diagnosis 1. Whispertest—askthepatienttorepeatwordswhisperedintothetestedear(mask

theotherear)(seeClinicalPearl12-11)

2. Anaudiogramisanessentialcomponentoftheevaluation 3. MRI—inselectedcases(e.g.,ifCNStumorormultiplesclerosisissuspected)

E.Treatment 1. Cerumenimpactionisbesttreatedbyirrigationafterseveraldaysofsoftening

withcarbamideperoxide(Debrox)ortriethanolamine(Cerumenex)

2. Conductivehearingloss a. Treatunderlyingcause b. Surgicaltechniquessuchastympanoplasty(reconstructsmiddleear)forpatients

withchronicotitismedia;stapedectomyforotosclerosis

c. Hearingaids

3. Sensorineuralhearingloss a. Treatunderlyingcause b. Hearingaids c. Cochlearimplants—transducesoundstoelectricalenergy,stimulatesCNVIII

UrinaryIncontinence

A.GeneralCharacteristics 1. Therearefivemajortypesofincontinence(urge,stress,overflow,functional,and

mixed).Manypatientshavemorethanonetype.

2. MaleincontinenceisusuallyduetoBPHorneurologicdisease.Aurology evaluationisindicatedforincontinentmalepatients.

3. Femaleincontinenceisusuallyduetohormonalchanges,pelvicfloordysfunction orlaxity,oruninhibitedbladdercontractions(detrusorcontractions)secondaryto aging.

Quick HIT

Themostcommoncauseofincontinenceinelderlypatientsisurgeincontinence.Inwomen<70yearsofage, themostcommoncauseisstressincontinence.
======================================
CLINICALPEARL12-11

RinneandWeberTests

Conductiveloss

e

«

AbnormalRinnetest—boneconductionisbetterthanairconduction Weber—soundlateralizestotheaffectedside(tuningforkisperceivedmoreloudlyintheearwitha conductivehearingloss)

Sensorineuralloss

e

e

NormalRinnetest—airconductionisbetterthanboneconduction Weber—soundlateralizestotheunaffectedside

B.RiskFactors 1. Age—diminishedsizeofbladder,earlierdetrusorcontractions,postmenopausal

genitourinaryatrophy

2. Recurrenturinarytractinfections 3. Immobility,decreasedmentalstatus,dementia,stroke,Parkinsondisease,

3. Immobility, decreased mental status, dementia, stroke, Parkinson disease, depression

depression 4. DM,CHF 5. Multiparity,historyofprolongedlabor

Quick HIT

EvaluatingaPatientwithUrinaryIncontinence Inquireaboutthehistoryofdiabetes,multiplesclerosis,Parkinsondisease,stroke,spinalcordinjuryordisease, andpelvicsurgery.

6. Pelvicfloordysfunctioninwomen,BPHandprostatecancerinmen 7. Medications

a. Diureticsincreasebladderfilling,increasingtheepisodesofincontinence b. Anticholinergicsandadrenergicscauseurinaryretention c. β-Blockersdiminishsphinctertone d. Calciumchannelblockersandnarcoticscandecreasedetrusorcontraction e. Alcohol,sedatives,hypnotics(depressmentation)

Quick HIT

e

e

Ifurgencyofurinationistheprominentfinding,suspecturgeincontinence. Ifincreasedintra-abdominalpressure(cough,laugh)causesurineloss,suspectstressincontinence.

C.TypesofUrinaryIncontinence 1. Urgeincontinence(alsocalleddetrusorinstability)

a. Mostcommontypeinelderlyandnursing-homepatients b. Multiplecauses(oftenidiopathic),includingdementia,stroke,severeillness,

Parkinsondisease

c. Mechanism:involuntaryanduninhibiteddetrusorcontractionsresultin involuntarylossofurine

Quick HIT

Elderlywomencommonlyhavebothurgeandstressincontinence.

d. Clinicalfeatures:suddenurgetourinate(e.g.,patientsareunabletomakeitto thebathroom),alossoflargevolumesofurinewithsmallpostvoidresidual,and nocturnalwetting

e. Diagnosticstudyofchoiceisurodynamicstudy f. Managementisinitiallywithbladder-trainingexercises(thegoalbeingto increasetheamountoftimebetweenvoiding).Ifthisisunsuccessful, medicationsincludeanticholinergics(oxybutynin)andTCAs(imipramine).

2. Stressincontinence
======================================
a. Occursmostlyinwomen(aftermultipledeliveriesofchildren) b. Mechanism:Weaknessofthepelvicdiaphragm(pelvicfloor)leadstolossof

bladdersupport(withresultanthypermobilityofthebladderneck).Thiscauses theproximalurethratodescendbelowthepelvicfloorsothatanincreasein intra-abdominalpressureistransmittedmostlytothebladder(insteadofan equaltransmissiontothebladderandurethra)

c. Clinicalfeatures:involuntaryurineloss(onlyinspurts)duringactivitiesthat increaseintra-abdominalpressure(cough,laugh,sneeze,exercise);small postvoidvolume

d. Ruleoutinfectionwithaurinalysis e. Management:Kegelexercises(multiplecontractionsofpelvicfloormusclesas

ifthepatientwereinterruptingflowofurine)tostrengthenpelvicfloor musculature;estrogenreplacementtherapy;useofapessary;surgery(thereare variousoptions,andapopularoptionisthemidurethralsling)

3. Overflowincontinence

a. Commonindiabeticpatientsandpatientswithneurologicdisorders b. Mechanism:Inadequatebladdercontraction(duetoimpaireddetrusor

contractility)orabladderoutletobstructionleadstourinaryretentionand subsequentoverdistentionofthebladder.Bladderpressureincreasesuntilit exceedsurethralresistance,andthenurineleakageoccurs

c. Causes:neurogenicbladder(diabeticpatients,lowermotorneuronlesions), medications(anticholinergics,α-agonists,andepidural/spinalanesthetics), obstructiontourineflow(BPH,prostatecancer,urethralstrictures,severe constipationwithfecalimpaction)

d. Clinicalfeatures:nocturnalwetting,frequentlossofsmallamountofurine; largepostvoidresidual(usuallyexceeds100mL)

e. Management(primarilymedical):intermittentself-catheterizationisthebest management;cholinergicagents(e.g.,bethanechol)toincreasebladder contractions;α-blockers(e.g.,terazosin,doxazosin)todecreasesphincter resistance

4. Functionalincontinence—secondarytodisablinganddebilitatingdiseases

D.Diagnosis 1. Urinalysis(allpatients)—toexcludeinfectionandhematuria 2. Postvoidurinecatheterization—recordtheresidualvolume.Normalresidual volumeislessthan50mL.Aurinevolumegreaterthan50mLmayindicate urinaryobstructionorahypotonicbladder

3. Urinecultures—ifdysuriaandpositiveurinalysis(WBCsinurine) 4. Renalfunctionstudies(BUN/Cr),glucoselevels 5. Voidingrecordisuseful—time,volumeofepisodes,recordoforalintake,

medications,associatedactivities

6. Performfurthertestingincarefullyselectedpatientsinwhomthecauseisnot identified.Testsincludecystometry,uroflowmeasurement/urethralpressure profile,imagingstudiessuchasintravenouspyelogram,andvoiding cystourethrogram,asneeded
======================================
Quick HIT

Laboratorystudiesinworkupoffatigue:

CBC(anemia) TSH(hypothyroidism) Fastingglucose(diabetesmellitus) BMP(electrolyteabnormalities) Urinalysis,BUN/creatinine(renaldisease) LFT(liverdisease)

Fatigue

A.GeneralCharacteristics 1. Fatiguereferstoalackofenergyorasenseofbeingtired—differentiatethisfrom

muscularweakness.Itisnotdirectlyrelatedtoexertion

2. Differentialdiagnosis

a. Psychiatriccauses—depression(mostcommoncause);anxietyandsomatization b. Endocrinecauses—hypothyroidism,poorlycontrolledDM,apathetic hyperthyroidismofelderlypatients,Addisondisease,hypopituitarism, hyperparathyroidism,andothercausesofhypercalcemia

c. Hematologic/oncologiccauses—severeanemia,occultmalignancy(e.g., pancreaticcarcinoma)

d. Metaboliccauses—chronicrenalfailure,hepatocellularfailure e. Infectiousdiseases—mononucleosis,viralhepatitis,HIV,syphilis,hepatitisB

andC,CMV,parasiticdisease,tuberculosisandsubacutebacterialendocarditis, Lymedisease

f. Cardiopulmonarydisease—OSA,CHF g. Medications—antihypertensivemedications(clonidine,methyldopa),

antidepressants(amitriptyline,doxepin,trazodonearemoresedating),hypnotics, β-blockers,antihistamines,drugabuse/withdrawal

h. Othercauses:CFS,fibromyalgia,sleepdisturbances(sleepapnea,narcolepsy, insomnia)

Quick HIT

EtiologyofChronicFatigue

©

¢

¢

e

Only5%ofcasesarediagnosedasCFS. Mostcasesofchronicfatigueareduetodepression,anxiety,orboth(uptotwo-thirdsofcases). Between20%and25%ofcasesareidiopathic,yetdonotfitthecriteriaforCFS. Lessthan5%areduetoanunidentifiedmedicalillness.

3. Chronicfatiguesyndrome(CFS)

a. CFSisprofoundfatigueforlongerthan6monthsthatisnotduetoamedicalor psychiatricdisorder.Morecommoninwomen

b. Causeisunknown.Aflu-likeillnessmayactasthetriggeringevent,but

infectionhasnotbeenestablishedastheprovencause.Othertheoriespointto immunologicdisturbanceorendocrinedysfunctionaspossiblecauses c. CFSisadiagnosisofexclusion—ruleoutothercausesbeforemakinga

diagnosisofCFS

d. Mostpatientsexperiencepartialrecoverywithin2years,butrelapsescanoccur atanytime

e. Therearespecificcriteriafordiagnosis.Thekeyfeaturesinclude:
======================================
e

e

Newordefiniteonsetofunexplainedfatigue,notalleviatedbyrest,notdueto exertion,andsignificantlyaffectingqualityoflife Fourormoreofthefollowingsymptoms(foratleast6months):diminished short-termmemoryorconcentration,musclepain,sorethroat,tenderlymph nodes,unrefreshingsleep,jointpain(withoutredness/swelling),headaches, postexertionalmalaiseforlongerthan24hours

f. DepressioniscommoninpatientswithCFS

B.Diagnosis 1. Basiclaboratoryteststoexcludeothercauses—considerCBC,LFTs,serum

electrolytes,calcium,TSH,erythrocytesedimentationrate,andHIVtesting(if indicated).

2. Extensivetestingotherthantheaboveisnotindicated.

C.Treatment 1. Treattheunderlyingdisorder,ifknown 2. TreatCFSandpatientswithidiopathicfatigueasfollows:

a. Cognitivebehavioraltherapy,includingexercise,social,andpsychological behaviormodifications

b. Antidepressants,asappropriate c. NSAIDsforreliefofheadache,arthralgias

ErectileDysfunction

A.GeneralCharacteristics 1. Erectiledysfunctionistherecurringinabilitytoachieveandmaintainanerection

sufficientforsatisfactorysexualperformance.

2. ItisthoughtthatuptohalfofallmenintheUnitedStatesbetweentheagesof40 and70havesomeformoferectiledysfunction.Prevalenceincreaseswithage. 3. Pathophysiology—oncethoughttobepsychogenicinorigin,itisnowknownthat mostcases(80%)areorganic.Anormalerectionislargelydependentonthe healthypenileandsystemicvasculature.

4. Somecasesoferectiledysfunctionarepsychogenic.

B.RiskFactors 1. Themostimportantriskfactorsarethosethatcontributetoatherosclerosis(e.g.,

HTN,smoking,hyperlipidemia,diabetes)

2. Medications—antihypertensives(mayindirectlylowerintracavernosalpressure byvirtueofloweringsystemicBP)

3. Hematologic—sicklecelldisease 4. Historyofpelvicsurgeryorperinealtrauma 5. Alcoholabuse 6. Anycauseofhypogonadism/lowtestosteronestate,includinghypothyroidism 7. Congenitalpenilecurvature

C.Diagnosis 1. Detailedhistoryandexamination,includingadigitalrectalexaminationand

neurologicexamination.AssessforsignsofPAD.

2. Laboratorytests—obtainaCBC,chemistrypanel,fastingglucose,andlipid profile.Ifthereishypogonadismorlossoflibido,orderserumtestosterone, prolactinlevels,andthyroidprofile.

3. Nocturnalpeniletumescence—ifnormalerectionsoccurduringsleep,a psychogeniccauseislikely.Ifnot,thecauseisprobablyorganic.

4. Considervasculartesting—evaluatearterialinflowandvenoustrappingofblood. Testsincludeintracavernosalinjectionofvasoactivesubstances,duplex ultrasound,andarteriography.

5. Psychologicaltestingmaybeappropriateinsomecases.
======================================
D.Treatment 1. Treattheunderlyingcause.Addressatheroscleroticriskfactors. 2. First-linetreatmentiswithphosphodiesteraseinhibitorssuchassildenafilcitrate (Viagra),whichactsbyincreasingcGMPlevels,causingincreasednitricoxide

releaseandpenilesmoothmusclerelaxation.Itcanbetaken30to60minutes beforeanticipatedintercourse.Itiscontraindicatedwithuseofnitratesbecause togethertheycancauseprofoundhypotension.

3. Intracavernosalinjectionsofvasoactiveagents(patientlearnstoself-administer). 4. Vacuumconstrictiondevicesareringsplacedaroundthebaseofthepenisthat

4. Vacuum constriction devices are rings placed around the base of the penis that enhance venous trapping of blood; they may interfere with ejaculation.

enhancevenoustrappingofblood;theymayinterferewithejaculation. 5. Psychologicaltherapymaybeindicatedtoreduceperformanceanxietyand addressunderlyingfactorsthatmaybecausingorcontributingtoerectile dysfunction.

6. Hormonalreplacement(e.g.,testosterone)inpatientswithdocumented hypogonadism.

7. Penileimplantsforpatientswhohavenotrespondedtotheabove.

Quick HIT

AlcoholandLipidLevels Modestalcoholintake(maximumof1to2drinksperday)isassociatedwithanincreaseinHDL.Ontheother hand,alcoholuseincreasesTGlevels.

Alcoholism

A.GeneralCharacteristics 1. Tentofifteenpercentofpeoplehavealcoholism(alcoholabuseordependence). Thereisageneticcomponenttoalcoholism—closerelativesofalcoholics (especiallysons)areatincreasedriskforalcoholism

2. Screeningforalcoholism—askallpatientsaboutalcoholuse.Ifalcoholismis suspected,useoneofthefollowingscreeningmethods

a. CAGE(Anymorethanonepositiveanswermaysuggestalcoholabuse)

¢

e

¢

e

Cutdown?(Haveyoueverfelttheneedtocutdownonyourdrinking?) Annoyed?(Haveyoueverfeltannoyedbycriticismsofyourdrinking?) Guilty?(Haveyoueverfeltguiltyaboutdrinking?) Eye-opener?(Haveyoueverfelttheneedtohaveadrinkfirstthinginthe morning?)

b. MAST(MichiganAlcoholismScreeningTest)questionnaire—a25-item questionnairethatalsohelpsidentifyalcoholism

Quick HIT

LaboratoryFindingsinAlcoholics

Anemia
======================================
Anemia Macrocytic(mostcommon)—duetofolatedeficiency Microcytic—duetoGIbleeding LFTs—increasedGGT;AST–ALTratiois2:1 Hypertriglyceridemia Hyperuricemia,hypocalcemia Thiaminedeficiency Decreasedtestosteronelevel

B.Complications 1. GI—gastritis,esophagitis,PUD,alcoholicliverdisease(alcoholichepatitis, cirrhosis,portalHTN),pancreatitis(acuteandchronic),Mallory–Weisstears 2. Cardiac—alcoholiccardiomyopathy,essentialHTN(morethanthreedrinksper

daysignificantlyincreasesBP)

3. CNS

a. Wernickeencephalopathy—oftenreversible

e

e

e

Causedbythiaminedeficiency Manifestsasnystagmus,ataxia,ophthalmoplegia,confusion Canbeprecipitatedbyadministeringglucoseinalcoholicswithoutfirstgiving thiaminereplacement

b. Korsakoffpsychosis—irreversible

e

e

e

Causedbythiaminedeficiency Alcohol-inducedamnesticdisorder Mostlyaffectsshort-termmemory;confabulationiscommon

4. Pulmonary—pneumonia,aspiration 5. Nutritionaldeficiencies(vitamins,minerals)—especiallythiaminedeficiency,

hypomagnesemia,andfolatedeficiency

6. Peripheralneuropathy—duetothiaminedeficiency 7. Sexualdysfunction—impotence,lossoflibido 8. Psychiatric—depression,anxiety,insomnia 9. Increasedriskofmalignancy—esophagus,oral,liver,lung 10. Frequentfalls,minorinjuries,motorvehicleaccidents

C.Treatment 1. AlcoholicsAnonymous(AA)(seealsoClinicalPearl12-12) 2. Naltrexoneisagoodfirst-linedrugthatimprovesabstinenceratesbyreducingthe

cravingforalcohol

3. Acamprosateisanotherfirst-linedrugthatisagoodoptioninpatientswithliver disease(naltrexonecontraindicated)

4. Otheroptions:baclofen,disulfiram,topiramate,gabapentin,SSRIs,and ondansetron

accumulationofacetaldehyde.Afewminutesafterdrinkingalcohol,patient experiencesshortnessofbreath,flushing,palpitations,andtachycardia.Ifmore alcoholisconsumed,headacheandnausea/vomitingensue.Symptomslastabout 90minutes.Itisappropriateforshort-termuseandshouldnotbetaken chronically.Itiscontraindicatedinpatientswithheartdisease

5. Drugsforwithdrawal—benzodiazepines—besttouselong-actingagents (diazepam)

6. Correctionoffluidimbalance,vitaminsupplementation(thiamine,folate, multivitamins)
======================================
CLINICALPEARL12-12

AlcoholWithdrawal

e

©

e

Featuresincludetachycardia,sweating,anxiety,hallucinations. Goalistopreventprogressiontodeliriumtremens(DT),whichisamedicalemergency(mortalityrate,20%). DToccursin5%ofalcoholicwithdrawals. DTisdeliriumdevelopingwithinaweekofthelastalcoholintake,usually2to4daysafterthelastdrink.DT ischaracterizedbytactilehallucinations,visualhallucinations,confusion,sweating,increasedtachycardia, andelevatedBP. Riskfactorsarepancreatitis,hepatitis,orotherillness.DTisrareinhealthypeople.

e

¢

e

Givebenzodiazepinesifwithdrawalsymptomsarepresent.PreventionofDTisthebesttreatment. Dietisimportantintreatment(highincalorie,highincarbohydrates,multivitamins).

Smoking

A.HealthRisksAssociatedwithCigaretteSmoking 1. Cardiovasculardisease—CAD,acuteMI,andstroke;thereisadose-dependent

relationshipbetweensmokingandcardiovasculardisease

2. COPDriskincreaseswithsmokinginadose-dependentmanner 3. Malignancy—smokingincreasestheriskoflungcancer,headandneckcancer,GI

cancers(laryngeal/pharyngeal,esophageal,gastric,pancreatic,hepatic, colorectal),GUcancers(renal,ureter,bladder,penile,cervical),andmyeloid leukemia

4. PUD 5. Osteoporosis—decreasespeakbonemassandincreasestherateofboneloss 6. Prematureskinaging 7. PAD,Buergerdisease 8. Adverseeffectsduringpregnancy—smokingincreasestheriskofspontaneous

abortion,fetaldeath,neonataldeath,suddeninfantdeathsyndrome,andlowbirth weight

9. Infections,especiallyrespiratory

Quick HIT

Mostimportantcausesofsmoking-relatedmortalityarelungcancer,COPD,andASCVD.

B.SmokingCessation 1. Varenicline—partialagonistattheα-4–β-2subunitofthenicotinicacetylcholine receptor.Itsefficacyhasbeendemonstratedinseveralrandomizedcontrolled trials.Consideredfirst-linetherapy(nicotinereplacementisthealternative).

Quick HIT

Behavioralmodificationiscrucialforlong-termsmokingcessation.Thepatchorgumshouldbeusedin conjunctionwithasmokingwithdrawalclinic(behavioralprogram).Quitratesarehigherwiththiscombination.

2. Nicotinereplacementtherapy.

a. Bothalong-actingagent(nicotinepatch)andashort-actingagent(nicotinegum orlozenge)shouldbeusedtogetherforhigherquitrates.

b. Nicotinepatch.

©

¢

Quitratesare2.5timeshigherat6monthsthanwithplacebo. Continuousnicotinedeliveryweansthepatientfromnicotine,andthedoseis graduallydecreased.Therearenopeaksortroughsasassociatedwithsmoking,
======================================
e

e

soiteliminatesnicotinewithdrawalsymptoms. Thepatchshouldbewornfor16hoursperday(shouldnotbewornduring sleepatnightbecauseitcancauseheadaches).Thestrongestdose(21-mg patch)isusedfor1monthorso,thenisgraduallytaperedtoalowerdose(14- mgpatch)forafewweeks,andfinallytothelowestdose(7-mgpatch)fora fewweeks.Oncethehabitisbroken,thepatchuseisstopped. Thepatientshouldnotcontinuetosmokewhileusingthepatch(therehave beencasereportsofMIsinthesepatients).

c. Nicotinechewinggumorlozenge.

Gumisusedwheneverthereisanurgetosmoke.Useiscontinuedfor2to4 months.

3. Bupropion(Zyban).

a. Quitratesaresimilartothatofnicotinereplacementtherapy(twicethatof placebo).

b. Thepatientcontinuestreatmentforupto2months. c. Thepatientcantakebupropionincombinationwithnicotinereplacement

therapy—combinedusemayresultinhigherquitratesthaneithermethodalone.

d. Adverseeffectsmayincludedrymouth,insomnia,andheadaches.

HealthMaintenance

A.ScreeningforHypertension 1. TheUnitedStatesPreventiveServicesTaskForce(USPSTF)recommends

screeningalladults18yearsofageandolderforHTN.However,otherauthorities donotrecommendscreeningforHTNuntilmiddleage.

2. Therecommendedintervalis2yearsforadultswithanormalBP,and1yearfor adultswithprehypertension.

B.ScreeningforHyperlipidemia 1. USPSTF2008guidelinesrecommendscreeningallmen≥35andwomenatrisk

forCAD≥45(gradeA);theguidelinesalsorecommendscreeningmenaged20to 35atincreasedriskforCADandwomenaged20to45atincreasedriskforCAD (gradeB).

2. ACC/AHA2013guidelinesstatethatitisreasonabletoassesscardiovascular diseaseriskinhealthypatientsaged20to79every4to6years.

3. MeasureanonfastingtotalcholesterolandHDLcholesterolevery5years.

a. Iftotalcholesterolis<200mg/dLandHDLis>35mg/dL,repeatscreeningin5 years.

b. Iftotalcholesterolis>240mg/dLorbetween200and240withmultiplerisk factors,getacompletelipoproteinprofile(TGlevelsandcalculationofLDL).

c. CalculatingLDLlevelisnotnecessaryforscreening. d. ScreenmorefrequentlyifthepatienthasincreasedriskofCAD(e.g.,smokers,

diabeticpatients,familyhistoryofCAD,HTN).

4. AdultswithCAD—obtainacompletelipoproteinprofile.
======================================
Quick HIT

ForCRCscreening,acolonoscopyisequivalenttoflexiblesigmoidoscopyplusbariumenemabutismore expensive.

C.ColorectalCancerScreening/surveillance 1. Average-riskpatients50to75yearsofage—anyofthefollowing(USPSTF2008

guidelines):

a. Colonoscopyevery10years b. Flexiblesigmoidoscopyevery5yearsandfecaloccultbloodtestevery3years c. Fecaloccultbloodtesteveryyear

2. Moderate-riskpatients

a. Patientswithsingleormultiplepolyps,personalhistoryofCRC—initial colonoscopy;repeatat3years—ifnormal,thencolonoscopyevery5years

b. FamilyhistoryofCRCoradenomatouspolypsinfirst-degreerelatives— colonoscopyatage40or10yearsyoungerthantheyoungestcaseinfamily;if normal,repeatin3to5years

Quick HIT

Colonoscopyisthebestofallcoloncancerscreeningmethods.Sigmoidoscopywillmiss40%ofcancers.Fecal occultbloodtestingwilldetectcancerbutifpositive,acolonoscopyisneeded.

3. High-riskpatients

a. Familieswithfamilialadenomatouspolyposis—genetictestingatage10; considercolectomyifpositivegenetictestingorpolyposisisconfirmed;ifnot, colonoscopyevery1to2yearsbeginningatpuberty

b. FamilieswithhereditarynonpolyposisCRC—genetictestingatage21;if positive,colonoscopyevery2yearsuntilage40,andtheneveryyearthereafter

c. Patientswithulcerativecolitis—colonoscopy8yearsafterdiseaseonset,then everyyearthereafter

D.ProstateCancerScreening 1. Thisiscontroversial 2. TheUSPSTFnowrecommendsagainstprostatecancerscreeningwithprostate-

specificantigen(PSA)

3. Othergroupsstatethatthereisinsufficientevidencefororagainstscreeningwith PSA,andthatthephysicianshouldengagethepatientinthedecisiontoscreen

E.LungCancerScreening 1. USPSTF2013guidelines—high-riskadults55to80yearsofageshould

receiveanannuallow-doseCTscan.

High-riskadultsarethosewitha30pack-yearsmokinghistoryandwhoare currentlysmokingorquitwithinthepast15years;oncethepatienthas stoppedsmokingfor>15years,annualscreeningcanbediscontinued.

F.Women’sHealth 1. Breastcancer

a. USPSTF—mammogramevery2yearsforwomen50to74yearsofage InagreementwiththeAmericanCollegeofPhysiciansandAmerican AcademyofFamilyPhysicians

b. AmericanCancerSociety,NationalCancerInstitute,NationalComprehensive CancerNetwork,AmericanCollegeofObstetriciansandGynecologists, AmericanMedicalAssociation:recommendroutinescreeningeveryyear

startingattheageof40

c. Recommendationsforclinicalbreastexamination(CBE)andbreastself- examination(BSE)varybasedonexpertgrouprecommendations;USPSTF statesthatthereisinsufficientevidencetorecommendfororagainstCBE,and somegroups(e.g.,WHO)recommendagainstBSE

2. Cervicalcancer

a. Startatage21,irrespectiveofsexualhistory b. Ages21to29,Papsmearevery3years c. Ages30to65,Papsmearevery3yearsorPapsmear+HPVtestingevery5

years

d. Candiscontinuescreeningatage65ifadequatenegativepriorscreening(3 negativePapsmearsor2negativePapsmearswithnegativeHPVtesting withintheprevious10years,withthemostrecenttestwithintheprevious5 years)

3. Ovariancancer
======================================
a. Routinescreeningisnotrecommended

G.SexuallyTransmittedInfections 1. Allmenandwomenaged15to65yearsshouldbescreenedforHIV;more

frequentscreeningshouldbeofferedforthoseatrisk.

2. Allsexuallyactivewomen<24yearsoldshouldbescreenedforchlamydia andgonorrhea.Insufficientevidencetomaketheserecommendationsfor men.

3. Asymptomaticmenandwomenwithriskfactorsshouldbescreenedfor syphilis.

H.Miscellaneous 1. Screeningfordiabetesmellitus:

a. Theupdated2015USPSTFguidelinesrecommendscreeningfordiabetesaspart ofacardiovascularriskassessmentinnonpregnantadultsaged40to70whoare overweightorobese.

b. TheAmericanDiabetesAssociationrecommendsscreeningalladultswitha BMI≥25kg/m2andatleastoneriskfactorfordiabetesevery3yearswith hemoglobinA1c,fastingplasmaglucose,ora2-houroralglucosetolerancetest (OGTT).Adultswithoutriskfactorsshouldbescreenedstartingattheageof45.

2. TheUSPSTFrecommendsscreeningforhepatitisBvirusinpatientsatrisk— injectiondrugusers,menwhohavesexwithmen(MSM),hemodialysis.

3. TheUSPSTFrecommendsscreeningforhepatitisCvirusinpatientsatriskanda one-timescreeninginpatientsbornbetween1945and1965.

4. Inelderlypatients,assessriskfactorsforPAD,osteoporosis,stroke,andCAD.

5. Osteoporosis—DEXAscanstartingatage65inwomen(seeosteoporosissection fordetails).

6. AAAscreeningwithaone-timeultrasoundinmenaged65to75whohaveever smoked.

7. TheUSPSTFrecommendsscreeningalladultsfordepressionandalcoholmisuse (andprovidingappropriatetreatmentandfollow-up).TheUSPSTFdoesnot recommendfororagainstscreeningfordementia.

8. RoutinescreeningforthyroiddiseaseisnotrecommendedbytheUSPSTF, thoughsomeexpertgroupsrecommendit.

Quick HIT

Rememberthatfunctionallyoranatomicallyasplenicindividualsareatriskforinfectionwithencapsulated organisms,sotheyshouldreceivetheH.influenzaetypeB(HIB)vaccine,meningococcalandpneumococcal vaccines.

I.Vaccinations 1. Vaccinationismostcommonlyassociatedwithchildrenbutisveryimportantin

adultsaswell,especiallyelderlypatientsandthosewithchronicmedical problems.

2. Themostimportantvaccinationstoknowareinfluenza,pneumococcal polysaccharide,hepatitisB,andtetanus;forwhoshouldreceivethemandwhen, seeTable12-9.

TABLE12-8 Vaccines

3. Meningococcalvaccineisindicatedforadultswithasplenia,militaryrecruits, residentsofcollegedormitories,terminalcomplementdeficiency,travelersto MeccaorMedinainSaudiArabiafortheHajj.

4. HepatitisAandBvaccinesareindicatedinadultswithchronicliverdisease, homosexualmen,injectiondrugusers,andhouseholdcontactswithhepatitisAor B.

5. Therearemanymisconceptionsaboutcontraindicationstovaccination.The followingarenotcontraindicationstovaccination.
======================================
a. Mildillness(e.g.,commoncold,low-gradefever,milddiarrhea). b. Convalescentphaseofanillness. c. Recentexposuretoacommunicabledisease. d. Breastfeeding. e. Currentantibiotictherapy.

f. Historyofanonspecificreactiontopenicillin.

Quick HIT

Mostimportantvaccinesinadultsareinfluenzaandpneumococcus.

APPENDIX

RadiographicInterpretation ChestRadiograph

A.Views:ObtainPAandlateralviewsforallpatientswhoarewellenoughtobe transportedtotheradiologydepartmentandmaintainanuprightposition.Obtain anAPfilm(i.e.,portablechestradiograph[CXR])forallpatientswhoaretooillto betransportedandpositionedforaPAfilm.

B.AlwaysTrytoCompareaPatient’sCXRWithaPreviousFilmtonoteany changesinconditionandtoassesswhetherchangesareneworchronic.

C.Density:Thelowerthedensity,themoreradiolucent(ortransparent)theobject willappearonplainradiographs.Followingarestructuresinthebody(main composition)listedfrommostradiolucenttomostradiopaque:Air(lungs,trachea, gastricbubble),fat(breasts),fluid(mostofthestructureshavehighfluidcontent [e.g.,vessels,heart,softtissues]),bone,metallicforeignbodies(e.g.,bullets, orthopedichardware).

D.AssessmentoftheFilm’sQuality 1. Assesspenetration.

a. Theintervertebralspacesshouldbevisibleonagood-qualityfilm. b. Theoutlineofthevertebralbodiesshouldbevisiblewithin(orthrough)the

b. The outline of the vertebral bodies should be visible within (or through) the cardiac silhouette.

cardiacsilhouette. 2. Assessinspiratoryeffort.

a. ACXRisusuallytakenattheendofafull,deepinspiration.Youshouldbeable toseeatleastnineposteriorribsontherightsideabovethediaphragm.In general,ifthediaphragmiscrossingthetenthribposteriorly(ortheeighthrib anteriorly),inspiratoryeffortisoptimal.

b. Patientswhoareillmaynotbeabletoholdafull,deepbreathfortheCXR, leadingtoapoorinspiratoryeffort.

c. Theheartappearslargerthanitactuallyiswhenthereispoorinspiratoryeffort, whichcanbemisleading.

3. Assessforrotation.

a. Thereshouldbesymmetricalspacingoftheclaviclesoneithersideofthe sternum,otherwisethepatientisrotated.

b. Imagineahorizontallineconnectingtheclavicularheadsandaverticalline downthemidlineconnectingthespinousprocessesofthevertebrae—theselines shouldbeperpendiculartooneanother.
======================================
Quick HIT

Properpositionoflines,tubes,andcatheters

e

¢

e

«

Endotrachealtube—thetipshouldbeapproximately4to6cmabovethetrachealcarina(thisisaboutthe leveloftheclavicularheads)whenthepatient’sheadisneitherflexednorextended.Theendotrachealtube tipcanmoveupto2cmwithextensionorflexionofthehead. Centralline—thetipshouldbejustabovetherightatriuminthesuperiorvenacava.Ifplaceddeeperintothe rightatrium,thereisahigherchanceofarrhythmiasorcardiacperforation. Swan–Ganzcatheter—thetipshouldbewithintherightorleftmainpulmonaryarterieswithinthe mediastinalshadow.Ifmoredistaltothisthereishigherchanceofpulmonaryinfarctionorvesselrupture. Nasogastrictube—thetipshouldbedistaltotheesophagogastricjunctioninthestomach.Agoodruleof thumbistoensurethenasogastrictubetipisbelowthediaphragmanddoesnottraversethecourseofthe carinaintothelung.

E.ExaminationofthePA/APCXR(FigureA-1):Nooneapproachisstandard.Be suretoobservethefollowingpoints:

1. Examinebones:shoulders,clavicles,cervicalandthoracicspine,andribs—onPA films,thehorizontalribsareposterior(anteriorribsareangleddownward).

2. Evaluatecardiacsize:thetransversediameterofthecardiacsilhouetteshouldnot bemorethanhalfthetransversediameterofthethorax;thisisthecardiothoracic ratio.(AlargercardiothoracicratioisacceptableforanAPfilmbecausethe cardiacsilhouetteislargeronanAPfilm.)

FIGURE A.1

A:PACXRwithdiagrammaticoverlay:1,firstrib;2,upper portionofmanubrium;3,trachea;4,rightmainbronchus;5,leftmain

bronchus;6,mainpulmonaryartery;7,leftpulmonaryartery;8,right interlobarpulmonaryartery;9,rightpulmonaryvein;10,aorticarch. B:CXRofthesamesubjectwithoutdiagrammaticoverlay.C:Lateral CXRofthesamepatientasinA:1,trachea;2,rightupperlobe bronchus;3,leftupperlobebronchus;4,rightpulmonaryartery;5,left pulmonaryartery;6,inferiorvenacava;7,ascendingaorta;8, descendingaorta.D:SamelateralCXRwithoutdiagrammaticoverlay. E:TechnicaladequacyofaCXR:1,atechnicallyadequateCXRshould belabeledwiththepatient’sname,date,andasidemarker;2,the midportionoftherighthemidiaphragmshouldbebelowthe10thrib;3, vertebralbodiesshouldbevisualizedthroughoutthespine;4, pulmonaryvesselsshouldbevisibletotheouterthirdofthelung;5,the thoracicspinousprocessesshouldbemidwaybetweentheheadsofthe clavicle. (AandBfromGeorgeRB,LightRW,MatthayMA,etal.Chestmedicine—EssentialsofPulmonary

andCriticalCareMedicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:69, Figure5.1AandB;

CandDfromGeorgeRB,LightRW,MatthayMA,etal.ChestMedicine—EssentialsofPulmonary andCriticalCareMedicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:70, Figure5.2AandB;EfromHumesDH,DuPontHL,GardnerLB,etal.Kelley’sTextbookofInternal Medicine.4thed.Philadelphia,PA:LippincottWilliams&Wilkins;2000:2570,Figure386.3.)

3. Checkformediastinalwidening,whichmaybepresentinaorticdissection, trauma,andmediastinalmassessuchaslymphoma.

4. Evaluatethepositionofthetrachea;itshouldbeinthemidline. 5. Comparerightandleftlungfields.Itisbesttodividethelungfieldsintothirds

. Compare right and left lung fields. It is best to divide the lung fields into thirds (horizontally) and compare the two sides.
======================================
(horizontally)andcomparethetwosides. a. Lookforanyinfiltratesorconsolidation. b. Congestion—lookforenlargedcardiacsilhouette,pulmonaryvesselsthatare

morevisibleandextendfurtherintothelungfieldthannormal(“cephalization” ofthepulmonaryvessels).

c. Pneumothorax—lookforalinedemarcatingfreeair(hyperlucentwithno pulmonaryvascularmarkings)inthepleuralspace.

d. Pleuraleffusion—examinethecostophrenicangles;theyshouldbesharpand clearwithoutanyblunting.

e. Lookatthediaphragms—therightdiaphragmisnormallyslightlyhigherthan theleftduetopresenceoftheliver.

F.ExaminationoftheLateralFilm(seeFigureA-1). 1. Lookatthecardiacsilhouette.

a. Anteriorborder—formedbytherightventricle. b. Posteroinferiorborder—formedbytheleftventricle. c. Posterosuperiorborder—formedbytheleftatrium. d. Therightatriumcannotbeseen.

2. Lookatthetrachea. 3. Examinetheretrosternalandretrocardiacspacesforanyabnormalities. 4. Examinethediaphragms—notethattheanteriorportionoftheleft

hemidiaphragmisnotvisiblebecauseofthecardiacsilhouette.Theentireright hemidiaphragmshouldbevisible,however.

AbdominalRadiographs

A.TheStandardAbdominalFilm—KUB—isasupineview,whichisidealfor seeingthegaspattern.

B.OrderanObstructionSeries(includesPACXR,aswellassupineandupright abdominalfilms)toevaluatethegaspatternandtolookforthefollowing:

1. Freeintraperitonealair(seelater)—freeairisseenunderthediaphragmonthe CXR.Ifthepatientistooilltobeupright,orderaleftlateraldecubitusfilm instead(airrisestothenondependentarea).

2. Air–fluidlevels—seenontheuprightfilm(seelater).

C.MostImportantThingstoLookforonAbdominalFilms 1. Air–fluidlevels—signofobstruction;ifprominentandmultiple,mechanical

obstructionismorelikelythanileus.

2. Freeairunderthediaphragm(perforationofaviscous)—thisisasurgical emergency.

3. Dilatedloopsofbowel(obstruction,ileus)—itmaybedifficulttodistinguish mechanicalobstructionfromileus.Thefollowingmayhelp:

a. Ifairisinthesmallintestine,colon,andrectum,ileusismorelikelybecause ileusdistentioninvolvestheentireGItract.

b. Insmallbowelobstruction,therearedistendedloopsofsmallbowelproximalto thesiteofobstructionandmultipleair–fluidlevelsonuprightordecubitusfilms. Colonicgasisusuallyminimal.

c. Inlargebowelobstruction,lookforhaustralmarkings—theyspanone-halfto two-thirdsofthediameteroflargebowel—aswellasthecolonicshadowonthe peripheryorinthepelvis.

d. Inanileus,thedilatedloopsarescatteredandlackorganization(e.g.,likea“bag ofpopcorn”);inmechanicalobstruction,dilatedloopsarestackedontopofone another(e.g.,likea“bagofsausages”).

e. Toolittlegasintheabdomencanbeduetohighobstruction.
======================================
ElectrocardiogramInterpretation ElectrocardiogramPearls

A.AlwaysLookforanOldElectrocardiogram(ECG)WithWhichtoCompare theCurrentECG.Thisiscriticalinassessingwhetheranysignificantchanges haveoccurred.

B.DetermineRate 1. Countthenumberoflargeblocks(withfivelittlesquares)betweeneachRwave. Dividethisnumberby300(thedistancebetweenlargeblocksrepresents1/300 minute).Therefore,iftherearefourblocksbetweeneachRwave,thereis4/300 or1/75minutebetweeneachRwave,whichmeansthattherateis75.(Notethat thisisthesameasthe300-150-75-60-50rule.)

2. Iftherateisirregular,countthenumberofbeatsin6secondsandmultiplyby10. 3. Eachblockis1mm(0.04seconds),sofiveboxesequal0.20seconds. 4. Tachycardiaisdefinedasarate>100beats/min. 5. Bradycardiaisdefinedasarateof<60beats/min.

C.DetermineRhythm(lookatleadII)—istherhythmregularorirregular?Notethat rhythmsmayberegularlyirregularorirregularlyirregularaswell.(SeeChapter1, Arrhythmiassection.)

D.DetermineAxis 1. LookattheQRScomplexinleadsIandaVF. 2. Ifbotharemainlypositive,thentheaxisisnormal. 3. IfmainlypositiveinleadIandmainlynegativeinaVF,theaxisisdeviatedtothe

left.

4. IfmainlynegativeinleadIandmainlypositiveinaVF,theaxisisdeviatedtothe right.

5. IfmainlynegativeinbothIandaVF,thenthereisextremerightaxisdeviation. 6. IfleadaVFisisoelectric(meaningitisneitherpositivenornegative),lookatlead IIasthe“tiebreaker”sinceleadIIisalsoaninferiorlead.Thesamerulesapply forleadIIasforleadaVF.

E.Intervals 1. P-Rinterval—thisshouldbe<0.2seconds.

a. Infirst-degreeheartblock,theP-Rintervalis>0.2seconds(onelargebox). b. Insecond-degreeAVblock(WenckebachorMobitztypeI),thereisa

progressivelengtheningoftheP-RintervalfollowedbyadroppedQRS complex.

c. IntheMobitztypeIIformofsecond-degreeheartblock,theP-Rintervalis constant,butnoteveryPwaveisfollowedbyaQRScomplex.Theremaybe two,three,orevenmorePwavesbeforeaQRS,buttheratioofPwavestoQRS complexes(e.g.,2:1,3:1)isconstant.

d. Inthird-degreeheartblock,thereisnorelationshipbetweenatrial(Pwaves) andventricular(QRS)activity.

2. QRScomplex—thisshouldbe<0.12seconds.

a. ProlongationoftheQRScomplexisseeninbundlebranchblock,ventricular rhythms,andpacedrhythms.

b. Inrightbundlebranchblock(RBBB),lookforawidenedQRScomplex,an rSRwaveinthechestleads,andawideSwaveinleadI.

c. Inleftbundlebranchblock(LBBB),lookforawidenedQRScomplexand lossofQwaveswithbroad,notchedRwavesinleadsI,V5,orV6.

3. QTinterval—thenormalQTintervalshouldbelessthanhalfoftheR-Rinterval (<0.42seconds).ProlongationoftheQTintervalmaybeseeninthefollowing.

a. Medications:tricyclicantidepressants,phenothiazines,nonsedating
======================================
antihistamines;classIA,IC,andIIIantiarrhythmics. b. Electrolytedisturbances:hypocalcemia,hypokalemia. c. CongenitallongQTsyndromes. d. Other:ischemia,significantbradyarrhythmias,andcertainCNSlesions.

F.ExamineWaves 1. Pwaves—thereshouldbeonePwaveforeachQRScomplexinanormalsinus

rhythm.

a. Leftatrialenlargement—widePwave(>0.12seconds)inleadIIoradiphasic PwavewithadeepterminalcomponentinV1.

b. Rightatrialenlargement—tallPwave(>2.5mm)inleadIIoradiphasicP wavewithalargeinitialcomponentinV1.

c. Wanderingatrialpacemaker(ifHR<100)—atleastthreedifferentP-wave morphologiesarepresent.ThisisalsocalledmultifocalatrialtachycardiaifHR >100.

2. Qwaves—indicatemyocardialnecrosis(acuteoroldMI).

a. Tobeconsideredsignificant,theymustbe>0.04secondswideand>25%ofthe QRSamplitude.

b. IsolatedQwavesincertainleadsmaybenormal,especiallyinaVR.

3. QRScomplex.

a. Shouldbenarrow(<0.12seconds)witharegularmorphology.

b. Thefollowingareindicatorsofleftventricularhypertrophy(LVH).Thereare multiplecriteriafordiagnosingLVH(notalllistedhere),butonlyoneneedsto bemetforadiagnosisofLVH.

RwaveinV5orV6>26mmhigh. SwaveinV1+RwaveinV5orV6>35mmhighinadults(>age30) RwaveinaVL≥11mm Leftaxisdeviationisoftenpresent(thisdoesnotneedtobemetforLVHtobe present).

c. Thefollowingareindicatorsofrightventricularhypertrophy(RVH)(assuming QRSduration<120ms,sinceRBBBcanproducethesechangesaswell)

Rwave≥7mminV1. R/SratioinV1≥1. ProgressivedecreaseinR-waveheightacrosstheprecordialleads. Rightaxisdeviationisoftenpresent.

4. STsegments

a. STsegmentdepressioncanoccurinthefollowingconditions:

Myocardialischemia SubendocardialMI Digoxineffect Hypokalemia LBBBorRBBB

b. STsegmentelevationisakeyindicatorofmyocardialnecrosis—itisahallmark ofacutetransmuralMI,butmaypersistinanoldMI.

e

e

e

e

e

e

STsegmentelevationsinI,aVL,V5,andV6areconsistentwithalateralwall MI(leftcircumflexcoronaryartery). STsegmentelevationsinV1toV4areconsistentwithananteriorwallMI(left anteriordescendingcoronaryartery). STsegmentelevationsinII,III,andaVFareconsistentwithaninferiorwall MI(terminalbranchesofrightorleftcoronaryartery). DiffuseSTsegmentelevationsmaybepresentinpericarditis. Small,concaveSTsegmentelevationsmaybeanormalfindinginyoung people(earlyrepolarization). IfLBBBispresent,STsegmentelevationsmaybepresentandarean unreliableindicatorofischemia/infarction.
======================================
Quick HIT

LargeRwavesandSTsegmentdepressionsinV1orV2suggestaposteriorwallMI.

5. Twaves

a. PeakedTwavesmaybepresentinthefollowingsituations: VeryearlystagesofMI(beforetrueinfarctionoccurs). Hyperkalemia Hypermagnesemia

b. T-waveinversionsmaybepresentinthefollowingsituations:

Myocardialischemia/infarction Pericarditis Cardiomyopathy Intracranialbleeding Electrolytedisturbances,acidosis LBBB,LVH SmallT-waveinversionsmaybenormalinthelimbleads

IntravenousTherapy

A.FormsofIVTherapy 1. “Intravenous(IV)push”—thisisadministrationofamedicationdirectlyintothe IVaccess.Itistypicallyusedinemergencysituationswhenarapidresponseis neededorwhenaloadingdoseofamedicationistobegiven,followedbya continuousinfusion.

2. Continuousadministration—electronicdevicesdeliverfluidormedicationata presetvolumeperhour.

3. Intermittentadministrationcanbeaccomplishedviaanumberofmethods.

a. Heparinlockorsalinelock—thisisusedwhenthepatientnolongerneedsIV fluidsandIVmedicationscanbegivenintermittently.TheIVlineiskeptopen withsalineorheparinwhennomedicationisbeinggiven.

b. Piggyback—amedicationorsolutionisgiventhroughanotherestablished primaryinfusion.Thefirstbagthatishungistheprimaryinfusion.Tubesfrom boththeprimarybagandthepiggybackbagconnecttoacommontubethat feedsintothepatient’svein.

c. Nontunneledcentralcatheter—theexitsiteofthecatheterisattheskin. Locationsincludeinternaljugular(IJ),femoral,andsubclavianveins.

subclavianvein,buttheendofthecatheteristhen“tunneled”inthe subcutaneoustissuesothatitexitstheskinawayfromthesiteofveininsertion. Withbothnontunneledandtunneledcentralcatheters,thereiseasyaccessbut alsotheriskofinfectionattheexitsite(althoughinfectionriskislowerwitha tunneledcentralcatheter).

e. Ports—thecatheterisinsertedintoacentralveinandistunneledsubcutaneously. Thereisnotanexitsitebecausethecatheterattachestotheport(chamber)that isplacedsubcutaneouslyaswell.Toadministermedication,ananestheticagent isusedtonumbtheskin,andtheneedleisinsertedintothechamber.Oftenused forchemotherapyadministration.Port-a-Cathisanexample.Thereislessriskof infection(noexitsite),butaccessismoredifficultandmustbeperformedbya trainedmedicalprofessional.

f. Peripherallyinsertedcentralcatheter(PICC)line—theseareoftenusedto administerIVantibioticsathome(orbloodproducts,othermedications,or chemotherapy).Locationsincludecephalic,basilic,orbrachialveins.APICCis insertedthroughtheveinsoftheantecubitalfossa,andthetipisadvancedinto thesupervenacava.Itcanbeleftinplaceforweekstomonths.

B.ComplicationsofIVTherapy 1. Thrombophlebitis—manifestedbyredness,swelling,andpainatIVsite;canbe

preventedbychangingtheIVevery2to3days.TreatbyremovingtheIVand applyingwarmcompresses.

2. Infiltration—medication/fluidleaksintothesurroundingtissue.Ifitissignificant andinvolvesalargearea,itmayleadtocompartmentsyndrome.

3. Blockage 4. Airembolus
======================================
CentralVenousLine

A.Indications 1. Hemodynamicmonitoring(e.g.,placementofapulmonaryarterycatheter) 2. Transvenouspacing 3. Emergentorshort-termhemodialysis 4. EmergentdeliveryofIVmedications(particularlyincardiacarrest)—iffeasible, itisgenerallypreferabletohaveacentralvenouscatheteroveraperipheral catheterfortheadministrationofdrugsincardiacarrestbecausethemedicationis deliveredtotheheartandthearterialvasculaturemorerapidly

5. ToadministerTPN—thehighconcentrationmakesitdifficulttoadministerthis throughperipheralveins

6. Administrationofmedicationsthatcanbeharmfulifgivenperipherally

a. Irritatingmedications,whichcancausethrombophlebitisinperipheralveins (e.g.,high-concentrationpotassiumchloride,chemotherapy)

b. Vasopressors—causearterialvasoconstrictionandshouldnotbegiventhrough peripherallines,becauseifinfiltrationoccursinaperipheralline,itmaycause compartmentsyndromeorsofttissuenecrosis

7. Volumereplacement(fluidorblood)—iflargevolumesoffluidmustbegiven rapidly,large-diametercentralcathetersareneeded,particularlyifthepatientdoes nothaveadequateperipheralaccess.(Butingeneral,peripheralIVsareidealfor rapidfluidresuscitationsincetheflowrateoffluidsisinverselyproportionalto thelengthofthecatheter.)

8. Althoughroutineorfrequentblooddrawsarenotanindicationforcentralvenous lineplacement,analready-existingcentrallinecanbeusedforthispurpose

Quick HIT

Immediatelyafterplacingacentralline(IJorsubclavian),obtainaCXRtocheckforpneumothoraxandto ensureproperpositionofthecathetertip.Thecathetertipshouldbeinthesuperiorvenacavajustabovethe rightatrium. Whenremovingaline,thepatientshouldbeinTrendelenburgpositionandshouldexhaleorhumduring removaltopreventanairembolism.

B.Sites 1. IJvein 2. Subclavianvein 3. Femoralvein

Quick HIT

PulmonaryArteryLine

e

e

e

Acentralcatheterthatisinsertedthroughoneofthelargeveins,threadedthroughtherightventricle,andinto thepulmonaryartery. Alsoknownasa“Swan–Ganzcatheter.” Usedtomeasurevarioushemodynamicparameters,includingcentralvenouspressure,pulmonarycapillary wedgepressure(PCWP),cardiacindexandoutput,strokevolume,andsystemicvascularresistance.
======================================
C.Complications 1. Pneumothorax

a. CanoccurwithsubclavianlinesandIJlines(butmorecommonwithsubclavian lines);obviouslydoesnotoccurwithfemorallines

b. NotethatpatientswithelevatedPEEPhavehyperinflatedlungs,andtheapexof thelungsismoresuperiorthannormal,increasingthechancesofaniatrogenic pneumothorax

2. Venousairembolism—ifairissuckedintothevenacava,itcanbepumped throughtherightventricleintothelungs,leadingtopulmonaryembolism(PE)of air.Thisisapotentiallylife-threateningcomplication.Ifthepatienthasapatent foramenovale,itcanresultinaparadoxicalairembolismtothebrain

3. Punctureofadjacentartery(carotid,subclavian,orfemoral)—dependingonthe site,thiscanleadtocomplicationsincludinghemothorax(subclavian)and hematoma(IJandfemoral).Applycompressionifthisoccurs.Vascularsurgery consultationisneeded

4. Infection—centrallinescancausecentralline–associatedbloodstreaminfections whichmayleadtosepsis,whichcanbelife-threatening

5. Deepveinthrombosisandthrombophlebitis 6. Cardiacarrhythmias—thiscanoccurduringinsertioniftheguidewireistoodeep andirritatesthemyocardium.Patientshouldalwaysbeoncardiacmonitorduring centrallineinsertion

Quick HIT

Therearetwomeansofprovidingnutritionforapatientwhocannoteat:enteralnutritionandparenteral nutrition.

ArterialLines

Definition—IVcatheters(sameonesusedforperipherallines)thatareinsertedinto theradialartery(rarelyinulnarorbrachialartery). Uses—arteriallineshavetwomajoruses.

BPmonitoringisthemostimportant—arteriallinesgivemoreaccurateand instantaneousreadingsthannoninvasivebloodpressurecuffs.Apatienton vasopressorsgenerallyshouldhaveanA-lineforproperBPmonitoring. Usedforfrequentbloodgasdraws.

NutritionalSupport

A.EnteralNutrition(administeredintotheGItract) 1. Enteralnutritionispreferredoverparenteralnutritionbecausetheintestineisused

inaphysiologicmanner.

2. Therearetwomethodsofadministeringenteralnutrition.

a. Nasoenterictubes(e.g.,nasogastricornasojejunaltubes)—bestforshort-term nutrition.

b. Enterostomytubes(e.g.,PEG/G-tubes,J-tubes)—forlong-termsupport.

3. Therearemanydifferentformulasavailablefortubefeeds—specialformulascan beprovidedforpatientswithrenaldisease,liverdisease,CHF,andsoon.

4. Tubefeedscanbedeliveredintermittently(inboluses)orcontinuously.

a. Intermittentfeeding(intothestomach)requiresclosemonitoring(bynurses). Thereisnoclearconsensusonanappropriatecutofflevelforasafegastric residualvolume,butingeneralgastricresidualsshouldbecheckedevery6to8 hoursandtubefeedsshouldbeheldiftheresidualis>500mL.Ahighresidual volumeshouldpromptarecheckin1hourbutdoesnotalwaysnecessitate stoppingthetubefeeds.

b. Continuousfeeding(intoduodenumorjejunum)hasalowerriskofaspiration thanintermittentfeeding.
======================================
Quick HIT

e

e

PEGtube—thetubeisinsertedwiththehelpofanendoscopethroughthemouth.Alternatively,itcanalsobe donethroughanopenabdominalincision,whichiscalledopengastrostomy. TheJ-tube(jejunostomy)isplacedintheintestineandcanonlybedonethroughanopenabdominalprocedure.

5. Complicationsofenteralnutrition.

a. Intolerancetotubefeeds—checkfordiarrhea,constipation,nausea,vomiting, abdominalpain,ordistention.

b. Malpositioningoftube(intrachea/bronchus). c. Aspirationpneumonia(theriskofaspirationisnotlessenedbyenteralfeeding

comparedtooralfeeding).

d. Overloadofsolutes—duetohighrateofhyperosmolarfeedings(cancause diarrhea,electrolyteimbalance,hyperglycemia).

B.ParenteralNutrition(administeredintothevein) 1. ThetermTPN(totalparenteralnutrition)isusedforahigh-concentrationsolution thatcanbegivenalonetomeetthebody’scaloricdemands.TPNcanalsoplaya supplementaryrolewhenenteralfeedingaloneisinadequate.

2. Itisusedifthepatientcannoteatforprolongedperiodsorcannottolerateenteral feedings,andinseverelymalnourishedpatients.

3. Therearetwowaysofadministration.

a. Central—viacentralvenouscatheter(e.g.,subclavianvein)—preferredin patientswhorequirelong-termsupport.

b. Peripheral—viaperipheralline—onecannotadministerasmuchproteinor calorieswiththisaswithacentralline.Itshouldonlybeusedforashort-term period.TPNcannotbeadministeredinaperipheralline.

4. Complicationsofparenteralnutrition

a. Electrolyteimbalances,volumedisturbances b. Hyperglycemia c. Complicationsassociatedwithplacingacentralline(e.g.,pneumothorax) d. Infectionofcentral(orperipheral)line(higherratesofinfection,especiallywith

fungalorganisms,thanusualduetopresenceofnutrientsandglucose).

GuidetoAntibacterialAntibioticTherapy
======================================
A.CellWallInhibitors 1. Penicillins(seeTableA-1) a. Mechanismofaction

Aβ-lactamantibiotic Inhibitcross-linkage(transpeptidationstep)ofbacterialcellwallsastheyare synthesized Bacterialcellwallslosestructuralandosmoticintegrity Celllysisultimatelyoccurs Toachievethedesiredeffect,penicillinsmustfirstbindtoproteinslocated insidethebacterialcellwall.Theseproteinsarecalledpenicillin-binding proteins

b. Antimicrobialcoverage(notexhaustive)

Moreeffectiveagainstgram-positivethangram-negativeorganisms.Effective againstviridansgroupstreptococci,Streptococcuspyogenes,oralanaerobes, syphilis,Leptospira Actssynergisticallywithaminoglycosides PenicillinGisalong-actingintramuscularformofpenicillinwhichisthedrug ofchoicetotreatsyphilis.Becauseofmicrobialresistance,itisusedless commonlytotreatrespiratorytractinfectionscausedbystreptococcalspecies, suchaspharyngitissecondarytoS.pyogenesorpneumococcalpneumonia PenicillinVistheoralformofpenicillinGwhichhassomeanaerobicactivity, soitismoreusefulfordentalinfections Penicillinsarenotgoodchoicesforempiriccoverageformostinfectionsdue towidespreadresistance Ampicillinandamoxicillinhaveextendedgram-negativeactivity.Ampicillinis typicallygivenIV,whileamoxicillinisanoraldrugoftenusedtotreat outpatientupperrespiratorytractinfectionscausedbystreptococcus.They coverthesameorganismsaspenicillin,inadditiontoEscherichiacoli,Lyme diseaseandfewothergram-negativerods(Haemophilusinfluenzae,Listeria, E.coli,Proteus,Salmonella) Penicillinase-resistantpenicillins(PRPs)includeoxacillin,cloxacillin, dicloxacillin,andnafcillin Penicillinsaregenerallyineffectiveagainstintracellularbacteria

TABLEA-1 ImportantAntibiotics

Penicillins Vancomycin Tetracyclines Macrolides Clindamycin Cephalosporins Fluoroquinolones Aminoglycosides TMP/SMX Metronidazole Cell wall inhibitors (interfere with transpeptidation) Cell wall inhibitor (see text) Inhibit 30 S bacterial ribosomal subunit Inhibit 50 S bacterial ribosomal subunit Inhibits 50 S bacterial ribosomal subunit Cell wall inhibitors (similar to penicillins) Inhibit bacterial DNA-gyrase Inhibit 30 S bacterial ribosomal subunit Blocks bacterial DNA synthesis through action on folate pathway (two steps) Products of reduction reaction kill susceptible bacteria and protozoans *Note that these are not necessarily the most common side effects, Depends on extension of antimicrobial spectrum Oral and respiratory infections Streptococcal infections Syphilis MRSA Enterococcal infections Endocarditis (used with aminoglycoside} Alternative if penicillin alleray present Chlamydia Rickettsiae Lyme disease Topical use for acne vulgaris Atypical pneumonia Alternative to penicillin (i.e., allergy) Anaerobes, staphylococci, streptococci Depends on generation: First: Similar to penicillins, surgical prophylaxis, streptococci and staphylococci infections Second: Pneumonia in elderly patients, recurrent pneumonia Third: Gonorrhea, meningitis Fourth: Broad-spectrum, including streptococci, staphylococci, and pseudomonas UTIs Diarrhea secondary to gram- negative rods Penicillin-resistant pneumonia Some with anti-Pseudomonas activity Gram-negative sepsis Endocarditis (with vancomycin) Complicated UTIs P carinii pneumonia UTls Anaerobes Trichomonas histolytica and Giardia Hypersensitivity reactions “Red man” syndrome Deposition in bones and teeth of children >8 yrs old, fetuses Gl upset C. difficile colitis, Pseudomembranous colitis Possible cross-sensitivity with penicillin A few promote bleeding diathesis, correctable with vitamin K Damage to cartilage in children Tendon rupture Nephrotoxicity Ototoxicity Rash Stevens—Johnson syndrome Metallic taste Disulfiram-like effect
======================================
Quick HIT

Bestantibioticsforgram-positivecocci(StaphandStrep):

1. PRPs(oxacillin,nafcillin,etc.) 2. First-generationcephalosporins 3. Fluoroquinolones

c. Adversereactions

Hypersensitivityreactions—typeIhypersensitivityreactionmaypresentas rash,angioedema,orevenanaphylaxis Diarrhea Interstitialnephritis

d. Otherfeatures

Penicillinsareusedtotreatotitismedia,UTIinpregnantwomen,dental infections,enterococcalinfections,Listeriamonocytogenes,Lymedisease Penicillinisusedasprophylaxisagainstinfectioninpatientswithsicklecell disease Bacteriagainresistancetopenicillinsthroughalterationsinpenicillin-binding proteins—forexample,MRSA Resistanceisalsoconferredbyβ-lactamases,enzymesthathydrolyzethe penicillin’sβ-lactamring.Thiscanbeovercomewiththeadditionofaβ- lactamaseinhibitor,forexample,ampicillin-sulbactamoramoxicillin- clavulanate.

e. Examples(listofexamplesisnotexhaustive)

Penicillin G

PenicillinG PenicillinV Ampicillin Amoxicillin Methicillin Nafcillin Oxacillin Piperacillin

Quick HIT

HypersensitivityReactionstoPenicillin TypeIhypersensitivityreaction. Thismaypresentwithrash,angioedema,orevenanaphylaxis. Cross-reactionswithotherβ-lactamantibioticscanoccur. Nausea,vomiting,anddiarrheaarenothypersensitivityreactions. Itmaydevelopatanytime,evenifpasttreatmentswithpenicillinwereuneventful.

2. Cephalosporins

a. Mechanismofaction

Similarmechanismofactiontopenicillin Aswithpenicillin,theβ-lactamringconfersbactericidalactivity

b. Antimicrobialcoverage(notnecessarilyexhaustive—thisappliestotherestof antimicrobialsection)

Cephalosporinsareclassifiedaccordingtoantimicrobialactivityandβ- lactamaseresistanceinto“generations” First-generationcephalosporinsgenerallyserveassubstitutesforpenicillin, andalsohavecoverageagainstProteus,Klebsiella,andE.coli.Cefazolinis theonlyparenteralfirst-generationcephalosporinavailableintheUnitedStates Second-generationcephalosporinshavemoregram-negativeactivityandless gram-positiveactivitythanfirst-generationcephalosporins.Theyareusedto treatH.influenzae,Neisseriagonorrhoeae,andEnterobacterspp. Third-generationcephalosporinshaveevenmoregram-negativeactivity,less gram-positiveactivity,andareabletocrosstheblood–brainbarrier.(First- andsecond-generationcephalosporinsdonotpenetratetheCSFand shouldnotbeusedtotreatinfectionsofthecentralnervoussystem) Fourth-generationcephalosporinsarethemostbroad-spectrum,including activityagainstPseudomonas,Neisseria,andmethicillin-sensitive Staphylococcusaureus,aswellasmostoftheabove-mentionedorganisms.It hasbetterstaphylococcalcoveragethanthird-generationdrugs Fifth-generationcephalosporinsareanewclassofdrugswhichshowhigh activityagainstMRSA
======================================
Quick HIT

Bestantibioticsforanaerobes: a. Penicillin(G,VK,amoxicillin,ampicillin) b. Clindamycin c. Metronidazole(forabdominal/GI)

Quick HIT

Allcephalosporins(everygeneration)willcoverviridansgroupstreptococci,groupA,B,andCstreptococci,E. coli,Klebsiella,Proteusmirabilis.

Quick HIT

Third-andfourth-generationcephalosporinsarenotusefulfortreatinginfectionsduetogram-positivecocci (exceptforStreptococcusspecies)orAcinetobacter.

c. Adversereactions

Hypersensitivityreactions—allergiccross-reactionwithpenicillincanoccur in10%ofcephalosporins Certaincephalosporins(especiallythesecondgeneration)canpromotea bleedingdiathesis,whichisreversiblewithvitaminK,butthisisrare Somesecond-generationcephalosporinsmaycauseadisulfiram-likereaction toalcohol d. Otherfeatures

First-generationcephalosporinsareusedforsurgicalprophylaxisormild cellulitis Mostformsofcephalosporinsmustbeadministeredintravenously Cefuroximeissometimesusedtotreatcommunity-acquiredpneumonia Cefoxitincanbeusedforabdominalinfections,suchasperitonitis CeftriaxonecanbegivenasanIMinjectiontotreatgonorrhea.Intravenouslyit playsanimportantroleinempirictreatmentformeningitis Third-generationantibioticsareoneoftheclassesofdrugswhichhavebeen showntohavethehighestassociationwithantibiotic-inducedClostridium difficileinfection Becauseofitsbroadcoverage(includingpseudomonas),cefepimeisagood choiceforempirictherapyinnosocomialinfectionsaswellasfebrile neutropenia Fifth-generationcephalosporinsarecurrentlyapprovedtotreatuncomplicated skinandsofttissueinfections,thoughtheirMRSAactivityoffersgreatpromise

e. Examples(listofexamplesisnotexhaustive)

Firstgeneration:cefazolin,cephalexin,cefadroxil Secondgeneration:cefaclor,cefoxitin,cefuroxime,cefotetan,cefprozil Thirdgeneration:ceftriaxone,cefixime,cefotaxime,ceftazidime,cefdinir, cefpodoxime Fourthgeneration:cefepimeistheonlyfourth-generationcephalosporin Fifthgeneration:ceftaroline,ceftobiprole

3. Miscellaneouscellwallinhibitors

a. Vancomycin

Inhibitscellwallsynthesisbyinterferingwithcross-linkageofpeptidoglycan chains(differentsiteofactionfrompenicillin),alsodamagescellmembranes Mainuseistotreatstaphylococcalinfectionsresistanttootherβ-lactams,such asMRSA,orifpenicillinallergyispresent;notusedforgram-negative organisms OralvancomyciniseffectivetotreatC.difficileinfectionsofthebowel Actssynergisticallywithaminoglycosidestotreatenterococcalinfections Adversereactionsincludefever,nephrotoxicity,ototoxicity,and“redman

syndrome”(flushingduetoinfusion-inducedhistaminerelease).Treatred mansyndromebyslowingtheinfusionandgivingantihistamines(i.e., diphenhydramine) Serumlevelsmustbefollowedupinprolongedtherapy,anddosesmustbe adjustedforrenalinsufficiency Vancomycinresistanceisanemerging,ominousphenomenon.Many enterococcihavedevelopedresistancetovancomycincreatingvancomycin- resistantenterococci(VRE)
======================================
Quick HIT

TreatMRSAwithvancomycin.TreatMSSAwithapenicillinsuchasoxacillinornafcillin.

b. Carbapenems

Syntheticβ-lactamsdesignedtobemoreresistanttoβ-lactamasesand penicillinases Examplesincludeimipenem,ertapenem,doripenem,andmeropenem Imipenemisalwayscombedwithcilastatintopreventrenaltoxicityassociated withthemetabolismofimipenem Carbapenemshavebroad-spectrumantimicrobialcoverage,including penicillin-resistantpneumococci,Pseudomonas(exceptertapenem),anaerobes, andEnterobacterinfections Theyareusedempiricallyforpatientsinwhomgram-negativesepsisis suspected Theymaycausenausea,vomiting,andsometimesneutropenia Theyreducetheseizurethreshold(especiallyimipenem)

c. Monobactams

AztreonamiscurrentlytheonlyavailablepreparationintheUnitedStates Containsonlyoneofthetwostructuralringsfoundinotherβ-lactams,hence thename.Itretainsresistancetoβ-lactamases Narrowspectrumofactivity:Primarilyaerobicgram-negativerods,including Pseudomonas,Klebsiella,andSerratia Lesscross-reactivitywithpenicillinthanotherβ-lactamantibioticsmakesit usefulforpatientswithpenicillinallergies

d. β-Lactamaseinhibitors

Examplesincludesulbactam,tazobactam,andclavulanicacid Notusedbythemselves,butrathercombinedwithpenicillinstoenhance antimicrobialactivity(e.g.,amoxicillin+clavulanicacid=Augmentin)

Not used by themselves, but rather combined with penicillins to enhance antimicrobial activity (e.g., amoxicillin + clavulanic acid = Augmentin) Bacitracin

e. Bacitracin

Inhibitsbacterialcellwallsynthesisbyinhibitingtransportofpeptidoglycans Effectiveagainstgram-positiveorganisms Usedtopicallyonly(becauseitissonephrotoxic)

Quick HIT

Piperacillinandticarcillinarealwaysusedincombinationwithaβ-lactamaseinhibitor(e.g.,tazobactam, clavulanicacid).

B.ProteinSynthesisInhibitors 1. Tetracycline

a. Mechanismofaction

Inhibitsproteinsynthesisbybindingto30Ssubunitofbacterialribosome Bacteriostatic

b. Antimicrobialcoverage

Effectiveagainstcertainintracellularbacteria:Chlamydia,rickettsialdiseases (e.g.,RockyMountainspottedfever),mycoplasma,spirochetes Treatsgram-negativeVibriocholerae AlsotreatsspirochetecausingLymedisease(Borreliaburgdorferi) Oftenusedtotreatuncomplicatedrespiratorytractinfectionssuchassinusitis andbronchitis Tigecyclineisbroad-spectrum(includingMRSAandVRE)andisableto evadetheresistancemechanismswhichrendertheothertetracyclinesless active

c. Adversereactions

GI—epigastricpain,nausea,vomiting Depositsoccurincalcifiedtissues(e.g.,teethandbonesofthefetusifgiven duringpregnancyandpotentiallyinanychild<8yearsold).Thiscanresultin permanentdiscolorationofteeth,stuntingofgrowth,andskeletaldeformities Phototoxicity Hepatotoxicity—mayoccurinpregnantwomen

d. Cautions
======================================
Donotgivetopregnantwomenorchildren<8yearsold Donotgivetopatientswithrenalinsufficiency(exceptdoxycycline) Decreasedabsorptionoccursiftakenwithmilkandantacids Resistanceiscommon

e. Examples

Tetracycline Doxycycline

Minocycline Tigecyclineisanewantibioticinarelatedclassofdrugscalledglycylcyclines.

2. Macrolides

a. Mechanismofaction

Inhibitproteinsynthesisbybindingto50Ssubunitofbacterialribosome Bacteriostatic(maybebactericidalathighdoses)

b. Antimicrobialcoverage

Goodattreatingintracellularpathogens,suchasMycoplasma,Chlamydia,and Legionella Erythromycinandclarithromycinhaveactivityagainststaphylococciand streptococci ClarithromycinisthetreatmentofchoiceforMycoplasmapneumonia (“walkingpneumonia”)andLegionellaspp. ErythromycinisalsoappropriateasanalternativetopenicillinGifthereisa penicillinallergy(e.g.,treatmentofchlamydiainpregnancy,toavoid tetracycline) Duetoadverseeventsandfrequentdosing,erythromycinisbeingusedless oftenasanantibiotic.ItisstillregularlyusedasaGIstimulanthowever Clarithromycinisoneofthedrugsusedintherapyforeradicationof Helicobacterpylori AzithromycinandclarithromycinhaveactivityagainstH.influenzae AzithromycinalsotreatsMoraxellacatarrhalis

c. Adversereactions

GIsideeffectsarethemostcommonandincludeepigastricpain,nausea,and vomiting(particularlywitherythromycin) Cholestasis ProlongationofQTinterval,especiallywitherythromycin

d. Cautions

Erythromycinshouldnotbeprescribedtopatientswithliverfailurebecauseit ismetabolizedintheliver Erythromycinandclarithromycininteractwithmanydrugsduetotheir inhibitoryeffectontheP-450system

e. Examples

Azithromycin Clarithromycin Erythromycin 3. Aminoglycosides

a. Mechanismofaction

Inhibitproteinsynthesisbybindingto30Ssubunitofbacterialribosome Bactericidal

b. Antimicrobialcoverage

e

e

e

Treatgram-negativeaerobes,suchasE.coli,Pseudomonas,Acinetobacter,or Klebsiella.Usedforempiriccoverageforgram-negativesepsiswhenresistant organismsaresuspected Sometimesusedincombinationwithampicillinorotherβ-lactamsfor complicatedUTIs,meningitis,orotherseriousinfections Noactivityagainstanaerobes

c. Adversereactions

¢

¢

Ototoxicity—maycauseirreversiblehearingloss,especiallyifinfusedtoo quickly.Baselineandfollow-uphearingtestsarerequiredforpatientson aminoglycosideslongterm Nephrotoxicity—maycauserenalinsufficiencyoracutetubularnecrosis. Aminoglycosidetoxicityisdose-related,sobesuretoadjustdoseforrenal dysfunction
======================================
Quick HIT

Mostcommonapplicationofaminoglycosidesfortreatingseriousinfectionscausedbyaerobicgram-negative rods:

e Sepsis

Sepsis ComplicatedUTI Pneumonia Osteomyelitis Complicatedintra-abdominalinfections

d. Otherpoints

¢

e

Mostaregivenparenterally. Checkpeakandtroughlevelstoavoiddrugtoxicities

e. Examples

e

e

e

e

e

Gentamicin Streptomycin Tobramycin Amikacin Neomycin

4. Miscellaneousproteinsynthesisinhibitors

a. Clindamycin

e

e

Bindsto50Ssubunitofribosome,inhibitingbacterialproteinsynthesis Keyfeatureisactivityagainstanaerobicbacteria.Inadditiontoanaerobes,can

e

e

beusedforstreptococcalandstaphylococcalinfections(maybehelpfulto inhibitbacterialtoxinproduction) Itcanalsobeusedtotreatmanytypesofgram-positivecocci.Ifthepatientis allergictocephalexin(Keflex),clindamycincanbegiveninstead Themostnotableadverseeffectisitspotentialtocauseantibiotic-associated diarrhea,includingC.difficilecolitis.

b. Chloramphenicol

Itbindsto50Sbacterialribosomalsubunit,butmayalsointerferewithhuman ribosomalactivity,andsoithasthepotentialtobehighlytoxic Broad-spectrumantimicrobialcoverage,includinganaerobesandrickettsiae; readilypenetratestheCSF Adverseeffectsmaybesevereandevenfatal:aplasticanemiaandgraybaby syndrome(cyanosisduetorespiratorydepressionandcardiovascularcollapse) InhibitstheP-450system,potentiatingtheeffectofmanyimportantdrugs

e

e

e

c. Linezolid

e

e

e

Hasgreatcoverageofgram-positivebacteria,includingstreptococci, enterococci,andMRSA Mostseriousreportedadverseeffectisthrombocytopenia(monitorblood countswithprolongedtherapy).Peripheralneuropathyhasalsobeenreported withextendedtreatmentregimens Linezolidinhibitsmonoamineoxidase.Thismayleadtoserotoninsyndrome whengivenwithpro-serotoninagentssuchasSSRIs Greatoralbioavailability

¢

C.Fluoroquinolones 1. Mechanismofaction—directinhibitorsofbacterialDNAsynthesis

a. InhibitbacterialDNAgyraseandtopoisomeraseIV,blockingreplicationof bacterialDNA

b. Bactericidal

2. Antimicrobialcoverage

a. Haveexcellentactivityagainstgram-negativeorganisms,including Pseudomonas,E.coli,Proteus,Legionella,andgonorrhea.Gram-positive coverageisvariable.Certainfluoroquinolones(e.g.,levofloxacin,moxifloxacin) havegoodgram-positivecoverageandareexcellentagentsforcommunity- acquiredpneumonia.Onlymoxifloxacinhasanaerobiccoverage

b. CommonlyusedtotreatUTIs.Ciprofloxacinalsotreatsacutediarrheadueto entericbacteria(traveler’sdiarrhea)

c. Besttherapyforcommunity-acquiredpneumonia
======================================
Quick HIT

FluoroquinolonesareonlyantimicrobialagentsinclinicalusethataredirectinhibitorsofbacterialDNA synthesis.

3. Adversereactions

a. GI—nausea,vomiting,diarrhea b. CNS—dizziness,headache,lightheadedness,agitation c. Nephrotoxicity d. Hypoglycemiccoma e. Cartilagedamageinchildrenhasnotbeenshowninhumans,althoughanimal

studiessuggestthis

f. Tendinitisandtendonrupture g. Cautions

Significantlyreducedabsorptionifconsumedwithdivalentcations,suchas antacidsthatcontainmagnesium Mustbeadjustedforrenalinsufficiency Donotgivetonursingmothersandtochildren(althoughthelatterisevolving, especiallyinchildrenwithcysticfibrosis) Absolutelycontraindicatedinpregnantpatientsbecauseanimalstudiesshow cartilagedamage

h. Examples

Levofloxacin Ciprofloxacin Ofloxacin Moxifloxacin Gemifloxacin

Quick HIT

Bestantibioticsforgram-negativerods(E.coli,Klebsiella,Proteus,Enterobacter,Pseudomonas):

Fluoroquinolones Aminoglycosides Carbapenems Piperacillin Aztreonam Cephalosporins

D.AntituberculosisAntibiotics 1. Principlesoftherapy.

a. Nevertreattuberculosiswithonlyoneantibiotic.Usemultidrugtherapy

becausedrugresistanceissuchaproblemwithMycobacteriumtuberculosis.

b. Treatactivetuberculosiswiththreetofourantibiotics(isoniazid[INH], rifampin,pyrazinamide[PZA],andsometimesethambutol)for2months, followedbyrifampinandINHfor4months.

c. SinceM.tuberculosisisaslow-growingorganism,therequireddurationof treatmentislongerthanitisinotherbacterialinfections.

2. Importantfirst-lineantituberculosisagents(manysecond-lineagentsalsoexist).

a. INH

Attackstheenzymethatproducesthemycolicacidsthatcomprisethe mycobacterialcellwalls. ResistancetoINHdevelopsrapidlyifitisusedalone. INHisdrugofchoicefortreatmentoflatentTB. Themostimportantadversereactionisdrug-inducedhepatitis,whichcanbe fatal. Itmaycausearelativepyridoxine(vitaminB6)deficiency,resultingin peripheralneuropathy.Thisisreversiblewithpyridoxineadministration.

e

e

e

e

e It may cause a relative pyridoxine (vitamin Bg) deficiency, resulting in peripheral neuropathy. This is reversible with pyridoxine administration. Rifampin

b. Rifampin
======================================
e

e

e

e

e

InhibitsbacterialRNAsynthesisbyblockingRNApolymerase. Inadditiontoitsroleasanantituberculosisagent,rifampinisusedas prophylaxisforclosecontactsofpatientswithmeningococcalmeningitis. RifampinisalsoactiveagainstMycobacteriumleprae,whichcausesleprosy. Maystaintearsorurineanorange-redcolor;induceshepaticmicrosomal enzymesanddecreasesthehalf-lifeofmanymedications. RifampinisapowerfulinducerofthecytochromeP-450enzymesystem,so drugsinteractionsshouldbemonitoredcarefully.

c. PZA

e

e

e

e

Inhibitsfattyacidsynthesisofevenslow-growingM.tuberculosisatadifferent stepthanINH. Activeagainsttuberclebacilliresidinginmacrophages. Maycausehyperuricemia,resultinginagoutyattack. Potentiallyhepatotoxic

d. Ethambutol

e

e

e

e

Inhibitsanessentialcomponentofthemycobacterialcellwall. Itmaycauseopticneuritis,resultingindiminishedvisualabilityaswellas red-greencolorblindness.Periodicvisualtestingmaybenecessary. Itmayalsoprecipitateagoutyattack. AlsousedinthetreatmentofMycobacteriumaviumintracellulare.

E.MiscellaneousAntibiotics

1. Trimethoprim(TMP)

a. TMPinhibitsdihydrofolicacidreductase,blockingbacterialDNAsynthesis. b. Itworkssynergisticallywithsulfonamides. c. TMPwasformerlyusedalonetotreatUTIsbutnowismostcommonlyusedin combinationwithsulfamethoxazole(SMX).SMXinhibitsasecond,uniquestep inbacterialfolatesynthesis,creatingasynergisticeffect.

d. TMP/SMXisusedbothforprophylaxisandtreatmentofPneumocystisjirovecii (formerlycarinii).

e. Itmaycausefolatedeficiency,resultinginmegaloblasticanemia. f. TMP/SMXisusedtotreatS.aureus(includingsomeMRSA),UTIs,

Pneumocystiscariniipneumonia,Shigella,andSalmonella,amongother infections.

g. SideeffectsofTMPincludehematologic(bonemarrowsuppression),renal (inhibitionofcreatininesecretion),andhyperkalemia.

2. Sulfonamides

a. Structuralanalogsofp-aminobenzoicacidthatinhibittheenzyme dihydropteroatesynthase,whichisnecessaryforfolicacid,andthusDNA synthesis.

b. Treatbothgram-positiveandgram-negativebacteria,althoughresistanceto sulfonamidesisincreasinglycommon.

c. Mostsulfonamidesthatwereonceusedalonehavebeenreplacedbythe combinationofTMP/SMX.

d. Someformsofsulfonamidesarestillgivenasmonotherapy,suchassilver sulfadiazine(topicalsolution)inburnpatientstopreventinfection,andsodium sulfacetamide(ophthalmicointment)forbacterialconjunctivitis.

e. Themostcommonadversereactionsarerash,photosensitivity,nausea, vomiting,anddiarrhea.
======================================
f. ArarebutdreadedassociatedadversereactionisStevens–Johnsonsyndrome. g. DonotgivetopatientswithG6PDbecausetheycanprecipitateahemolytic

Do not give to patients with G6PD because they can precipitate a hemolytic response.

response. 3. Metronidazole

a. Formsacytotoxiccompoundthroughanoxidation–reductionactionwhich damagesDNA.Bactericidal.

b. Effectiveagainstanaerobicbacteriaaswellascertainprotozoalorganismssuch asEntamoebahistolytica,Giardia,andTrichomonas.

c. OralformveryusefulinthetreatmentofC.difficilediarrhealinfections. d. Adverseeffects—resultsinadisulfiram-likereactionifconsumedwith

alcohol.Mayalsocauseheadacheandametallictaste.Hepatitisandpancreatitis areextremelyrare.Warfarineffectsareenhancedwithconcomitantuseof metronidazoleduetoinhibitionofwarfarinmetabolism—warfarinlevelsshould

becloselymonitored.

4. Nitrofurantoin

a. Worksbyacomplexmechanismtoinactivateseveralbacterialenzymesystems includingacetylCoA.

b. PrimaryuseisforuncomplicatedlowerurinarytractinfectionscausedbyE. coliorothercommoncommunity-acquiredorganisms.Donotusefor pyelonephritisorinfectionsoutsideoftheurinarysystem.

5. TableA-1listsmechanismsofaction,uses,andadversereactionsforimportant antibiotics.

PhysicalExaminationPearls HeartSounds

A.FormurmurofmitralstenosisandtohearS3andS4,usethebellofthe stethoscope.

B.Forpericardialfrictionrubs,aortic/mitralregurgitationmurmurs,andtohearS1 andS2,usethediaphragmofthestethoscope.

C.VentricularsystoletakesplacebetweenS1andS2,andventriculardiastolebetween S2andS1.Rememberthatdiastolelastslongerthansystole;thisdistinctionmakes iteasytoidentifythetwosounds.

D.HowtodifferentiateS3andS4(thelinesrepresentdurationofpausebetween sounds):S3comesimmediatelyafterS2,andS4comesimmediatelybeforeS1.

1. S1—S2–S3 2. S4–S1—S2

E.SplittingofS2duringinspirationandparadoxicalsplittingofS2. 1. Thesecondheartsoundhastwoparts:Aorticvalveclosure,thenpulmonicvalve

closure.

2. Withinspiration,thereisincreasedbloodreturntotherightheart.Thisincreased flowdelayspulmonaryvalveclosure,whichresultsinthenormalsplittingofS2 duringinspiration.

3. ParadoxicalsplittingofS2referstothenarrowingofthissplitduringinspiration (insteadofthenormalwideningthatoccurs).Thiscanoccurasaresultofdelayed aorticclosure(asseeninLBBB,aorticstenosis,andhypertension).
======================================
Quick HIT

e

©

S1=mitralvalveclosure S2=aorticvalveclosure(pulmonicvalveclosurecontributes)

Quick HIT

e

e

¢

¢

Aorticarea=rightsecondintercostalspaceclosetosternum Pulmonicarea=leftsecondintercostalspaceclosetosternum Tricuspidarea=leftfourthandfifthintercostalspace Mitralarea=apex

F.ItiseasiertohearS3,S4,andmurmurofmitralstenosisifthepatientislyingonhis orherleftside.Usethebellofthestethoscopeandapplylightpressureatthe apicalimpulse.S3disappearsifalotofpressureisapplied.

Murmurs

A.Grade1—veryfaint;onlyacardiologistcanhearit

B.Grade2—quiet

C.Grade3—moderatelyloud

D.Grade4—loud;associatedwithathrill

E.Grade5—veryloud;canhearitwithstethoscopepartiallyoffthechest

F.Grade6—heardwithstethoscopeentirelyoffthechest

BreathSounds

A.VesicularBreathSounds 1. Soft,low-pitched 2. Audiblethroughoutmostlungfields 3. Heardduringallofinspirationandfirstthirdofexpiration

B.BronchialBreathSounds 1. Loud,high-pitched 2. Longerexpiratorythaninspiratoryphase(oppositeofvesicularsounds) 3. Hearagapbetweeninspirationandexpiration 4. Heardincentralareas(overtrachea) 5. Bronchialsoundsareabnormalifheardovertheperipherallungareas(whereonly

vesicularsoundsshouldbeheard).Thissuggestsanareaofconsolidation

C.BronchovesicularSounds 1. Intermediatepitch 2. Equaldurationofinspiratoryandexpiratoryphases

D.AdventitiousBreathSounds 1. Rales(alsocalledcrackles)

a. Canbeheardduringinspirationorexpiration;intermittent(discontinuous) sounds

b. Usuallyduetoexcessivefluidinthelungsoratelectasis c. Causesincludepneumonia,CHF,interstitiallungdisease(usuallydry,“Velcro-

like”crackles)

d. Sometimesdifferentiatedbasedonsound—finecracklesarehigh-pitched,soft, andbriefinduration;coarsecracklesarelower-pitched,louder,andlongerin duration

2. Wheezeshaveahissingormusicalsoundcausedbyairmovingthroughnarrowed airways.Asthmaisthemostcommoncause

3. Rhonchihaveasnoringqualityandlowerpitch,andareduetohighmucus productioninthelargeairways(e.g.,chronicbronchitis)

AbdominalExamination

A.Inspect—lookforscars.

B.Auscultate—listentobowelsounds;thisisanonspecificpartoftheabdominal examination.
======================================
C.Palpate—feelallquadrants,thenpalpatemoredeeplyinallquadrants. 1. Istheabdomensoft?Arigidabdomenmaybeasignofaperforatedviscusor

peritonealinflammation(acuteabdomen).

2. Checkfortendernessinallquadrants. 3. Checkforreboundtenderness—doesithurtwhenyoupushdownorletgo?Pain

onwithdrawalofthehandisreboundtendernessandsuggestsperitoneal inflammation.

4. Isthereguarding?Guardingreferstoanareaofrigidityandissignificantwhenit isinvoluntary(i.e.,notduetovoluntarymuscularcontraction).

NeurologicExamination

A.EvaluatetheFollowing: 1. Levelofconsciousness,speechfluency 2. Pupillarysizeandreactivity,extraocularmusclemovement—giveinformation

aboutfunctionofthebrainstem,especiallyCNsIIIandVI

3. Completecranialnerveexamination 4. Musclestrengthtesting 5. Truncalataxia,pronatordriftofarm(sensitivetestofmotorweakness) 6. Sensation 7. Cerebellartesting—fingertonoseandheeltoshin;testgaitonambulation,heel-

to-toewalkingisgoodfordetectingmildataxia

8. Deeptendonreflexes—asymmetrysuggestscorticospinaltractdysfunction(upper motorneuronlesion)

9. Babinskisign—toesshouldnormallyflex.Iftheyextend,thisisapositive Babinskisign

B.UpperandLowerMotorNeuronDefects(SeeTableA-2) 1. Deeptendonreflexes a. Gradingofreflexes 0=Noreflex 1=Diminishedreflexes 2=Normal 3=Increasedreflexes 4=Hyperactivereflexes

b. Locations

Biceps(C5) Brachioradialis(C6) Triceps(C7) Patellar(kneejerk)(L4) Ankle(S1) c. Musclestrength

0=Nocontraction 1=Flickerofcontraction(muscleis“firing”) 2=Moveslimbwhengravityiseliminated 3=Moveslimbagainstgravity(butnotagainstanyresistance) 4=Moveslimbagainstgravityandsomeresistance 5=Normalmusclestrength;moveslimbagainstmaximalresistance

Quick HIT

Ifyoucannotelicitlowerextremityreflexes,havethepatientlockthefingersandpullhisorherarmsapart(to distractthem)asyoutryagain.

TABLEA-2 UpperVersusLowerMotorNeuronDefects
======================================
Preauricular Occipital Posterior auricular Tonsillar Superficial cervical Submental IN Submandibular Posterior cervical Supraclavicular Deep cervical chain

FIGURE A.2

Palpationofthelymphnodesinaphysicalexamination.

(FromBickleyLS,SzilagyiPG.Bates’GuidetoPhysicalExaminationandHistoryTaking.8thed. Philadelphia,PA:LippincottWilliams&Wilkins,2003:203.)

C.PalpationofLymphNodes(FigureA-2)

TumorMarkers

Tumor markers and the cancers they differentiate, as well as their usefulness, are coveredinTableA-3.

WorkupandManagementofCommonProblems OnTheWards

eee

Refertorespectivesectionsineachchapterforamorethoroughdiscussion.

Hypotension

A.Causes:Allcausesofshock(sepsis,hypovolemia,cardiogenic,anaphylactic, neurogenic),medication(β-blockers,calciumchannelblockers,nitrates,morphine, sedatives,epiduralinfusion)

TABLEA-3 TumorMarker

CEA Colorectal cancer Lacks sensitivity and specificity—this Effective for monitoring disease process—a is not an effective screening test; levels decrease in CEA indicates a favorable response to may be elevated in other malignancies surgery, and an increase in CEA indicates disease and in some nonmalignant diseases progression © Prognosis—the risk of recurrence is higher if the CEA level was elevated before surgery AFP HCC and nonseminomatous — Not specific; can be elevated in nonma- Highly elevated AFP levels are present almost germ cell tumors of testis lignant diseases such as cirrhosis and exclusively in primary HCC and NSGCT of the testis (NSGCT) hepatitis CA-125 Ovarian cancer Neither sensitive nor specific for Very useful for monitoring the response to therapy ovarian cancer, therefore not useful for (after surgery or chemotherapy}—a decrease screening—a normal CA-125 does not in CA-125 after treatment indicates shrinkage exclude ovarian cancer of the tumor, and an increase indicates disease progression or recurrence © Between 80% and 90% of women 50 yrs of age with a pelvic mass and an increased CA-125 will be found to have ovarian cancer Prostate-specific See prostate section antigen (PSA) CA 19-9 Pancreatic cancer Low specificity—this is elevated in 73% of patients with pancreatic cancer have CA 19-9 colorectal, pancreatic, and gastric cancer, —_ levels greater than 100 U/mL as well as pancreatitis and ulcerative colitis B-hCG Gestational trophoblastic Elevated in pregnancy This has a high sensitivity for diagnosis of disease, gonadal germ cell choriocarcinoma and trophoblastic neoplasm after tumor evacuation of a molar pregnancy Either hCG or AFP is elevated in 90% of patients with NSGCT of the testis ¢ hCG may be elevated in either seminomatous germ cell tumors or NSGCTs, but AFP is only elevated in NSGCTs
======================================
B.Management 1. Quicklyassessmentalstatus—howsymptomaticisthepatient? 2. Obtainafullsetofvitals,includingBPinbotharms.Expectacompensatory

tachycardia.Bradycardiamayresultinreducedcardiacoutput.

3. DeterminebaselineBP(maynotbesignificantlydifferent). 4. ConsiderECG,CXR,arterialbloodgas(ABG),bloodculture(iffebrile),and

CBC(ifbleedingissuspected).

5. Treatmentshouldbedirectedtowardthecause. 6. Ifpatientissymptomatic,thereverseTrendelenburgpositionmaybehelpful. 7. ConsiderNSbolus(500mLor1L)—repeatthisifBPdoesnotimprove(butbe

Consider NS bolus (500 mL or 1 L)—+tepeat this if BP does not improve (but be careful in patients with CHF or cardiogenic shock).

carefulinpatientswithCHForcardiogenicshock). 8. Discontinueorholdantihypertensivemedications. 9. VasopressorsmaybeneededifthereisnoresponsetoIVfluids. 10. Ifhypotensionisprofoundorpersistsdespitefluidtherapy,considertransferring

thepatienttotheICU.

11. Putthepatientonacardiacmonitor.

Hypertension

A.Causes 1. Failuretoadminister,order,ortakeantihypertensivemedications 2. Pain,agitation 3. Hypertensiveemergencies(manifestedbyMI,aorticdissection,encephalopathy,

hemorrhagicCVA,oracuteCHFexacerbation)

4. Deliriumtremensoralcohol/benzodiazepinewithdrawal 5. Eclampsiaorpreeclampsia 6. Cocaine,amphetamineuse

B.Management 1. AlwaysrechecktheBPwithaproperlyfittingcufftoconfirmHTN.Checkother

vitalsigns.

2. Checkthepatient’smedicationrecordtoensureappropriatecompliancewith therapy.

3. Checkforsignsofend-organdamageduetoHTN,whichindicatethata hypertensiveemergencyisoccurring:chestpain/ECGchanges,neurologic examinationfindings/encephalopathy,acuterenalinsufficiencyorfailure, papilledema.

Quick HIT

Withhypotensionorhypertension,treatthepatient,nottheBPreading.Asymptomaticpatientswithhypotension oftendonotrequiretreatment.

4. Considerthefollowingtestsasappropriate,giventhepresentation:ECG,renal functionpanel,cardiacenzymes,CXR,CTofthehead.

5. Treatpainandagitationasneeded. 6. IfHTNismildandthepatientisasymptomatic,observationwithfollow-upmay

beappropriate.

7. Oralantihypertensivemedications(e.g.,α-blockers,calciumchannelblockers, ACEinhibitors,ororalβ-blockers)canbegivenformostcasesofhypertension. Followresponseandrepeatmedicationasneeded.Becarefulnottoovertreat hypertension,especiallywhenlongstanding.

8. NeverignoresymptomaticHTNorhypertensiveemergencies.BPmustbe reducedquicklybutcarefully.(Reducemeanarterialpressurebynomorethan 25%inthefirst2hours.)ThisshouldbedoneintheICU,withIVlabetalol, nitroprusside,orenalaprilat,oradditionaldosesofthepatient’scurrentregimen.

9. ReduceordiscontinueIVfluidsifvolumeoverloadissuspected.

BecarefulnottolowerBPtooquicklyinahypertensivepatient.
======================================
ChestPain

A.Causes 1. Heart/vascular:Angina,MI,pericarditis,aorticdissection 2. GI:Gastroesophagealrefluxdisease,diffuseesophagealspasm,pepticulcer

disease,gallbladderdisease,acutecholecystitis

3. Chestwall:Costochondritis,ribfracture,musclestrain,herpeszoster 4. Psychiatric:Anxiety,somatization 5. Pulmonary:PE,pneumothorax,pleuritis 6. Cocaineuse:CancauseanginaorMI

B.Management 1. Asalways,checkvitalsigns.Inmostcases,obtaina12-leadECG.Comparewith anoldECG.Getmoreinformationaboutthepatient’scardiachistoryandcurrent historyofchestpain.

2. Ordercardiacenzymes(troponin)×3,every8hours,ifunstableanginaorMIis suspected.

3. ConsiderCXR(pneumothorax,widenedmediastinum,pleuraleffusion).Consider ABGorCTscan/scanifPEissuspected.

4. Ifmyocardialischemiaissuspected:

a. OxygenifSpO2<90%,2LbyNC,titrateupasneeded. b. Nitroglycerin(sublingual)forpain;ifpaincontinues,cangivemorphineIVor

nitroglycerinIVinfusionuntilfreeofchestpain.

c. KeepsystolicBP>90mmHg. d. Aspirin e. Heparin—givealoadingdose,thenstartadrip.CheckthePTTatbaselineand in6hours.Ensuretherearenocontraindicationstoanticoagulationpriorto starting(recentintracranialhemorrhage,activebleeding).

f. Putthepatientonacardiacmonitor,andconsidertransfertoacardiaccareunit.

5. Treatothersuspectedconditionsappropriately.SeediscussionsofPE,aortic dissection,pneumothorax,GERD,andPUD.

Tachycardia

A.Types:Determinewhetherthetachycardiaisanarroworwidecomplex.Obtainan ECG—isitregular?Ifwide,treatlikeventriculartachycardia(VT).Ifnarrow, determinewhetherthetachycardiaissinusornon-sinus.

B.SinusTachycardia 1. HR>100,hardlyever>200beats/min. 2. SinusPwavesprecedeeachQRScomplex. 3. Causesincludepain,exercise,anxiety,panicattacks,dehydration,PE,volume loss(bleeding),hyperthyroidism,fever,anemia,albuterol,decongestants,and substancewithdrawal.

4. Treattheunderlyingcause.Inolderpatientswithcardiacdisease,consideraβ- blockertopreventtheincreaseinmyocardialO2demandthatoccursatahighHR. Neverstartaβ-blockerto“treatthetachycardia”unlessyouhaveruledoutall seriouscausesabove.

C.NarrowComplexNon-SinusTachycardia 1. Alsoknownassupraventriculartachycardias(SVT).Maybeduetoatrialflutter,

atrialfibrillation,AVreentranttachycardia(AVRT),orAVnodalreentrant tachycardia(AVNRT).

2. Treatmentsvaryaccordingtothearrhythmia.

a. AVRTorAVNRT—treatwithvagalmaneuversorIVadenosine.Priortoany treatment,ensurepatientisonacardiacmonitorandthecrashcartisatbedside. AVnodalblockersmayalsobeused.

b. Atrialfibrillation—controltheratewithaβ-blocker,DCcardioversion, anticoagulation.

c. Atrialflutter—treataswithatrialfibrillation. d. VT—ifthepatientisstable,giveIVamiodarone.Ifthepatientisunstable,

performDCcardioversion.
======================================
D.WideComplexTachycardia 1. Eitherventriculartachycardia(VT)orsupraventriculartachycardiawith

aberration(earlyreentrantpathway)

2. TreatallwidecomplextachycardiasasVTunlessprovenotherwise.Ifpatientis stable,giveantiarrhythmicssuchasIVamiodarone.Ifthepatientisunstable, performcardioversion.

3. Ventricularfibrillation—performimmediatedefibrillationandCPR.

Oliguria

A.TypicallyDefinedasUrineOutput<400mL/dayor<0.05mL/kg/hr

B.Causes 1. Prerenal:hypotension,hypovolemia,cardiorenalsyndrome,renalarterial

occlusion.

2. Renal:glomerulonephritis,acutetubularnecrosis,acuteinterstitialnephritis, vascularinsult,andsoon.

3. Postrenal:obstructionoflowerorupper(bilateral)urinarytract.

C.Management 1. Checkothervitalsigns. 2. Inquireaboutpotentialprecipitatingfactors—forexample,recentIVcontrast

administration,newmedications(NSAIDs,ACEinhibitors,antibiotics),surgery, recentintakeandoutput,othercomorbidconditions(e.g.,sepsis,CHF).

3. Palpatethebladder,checkapost-voidresidual,andconsiderinsertionofaFoley catheterifobstructionissuspected.IfthepatientalreadyhasaFoleycatheter, flushitwith2to30mLofsalinetomakesureitisnotclogged.Ifurineflows aftertheFoleyplacementorflushing,obstructionwasmostlikelythecause. 4. Orderserumandurinechemistriesandarenalfunctionpanel.Calculatethe

fractionalexcretionofsodium(FeNa<1%isconsistentwithprerenalcauses).If thepatientisondiuretics,calculatethefractionalexcretionofurea(astheFeNais nolongerreliable).

5. Considerarenalultrasoundtoexcludehydronephrosis. 6. Ifprerenalcausesaresuspected,giveanIVfluidchallenge(250to500mLof

NS).Repeatbolusesandmaintenancefluidsmayberequired.

7. IfCHFandcardiorenalsyndromeissuspected,considerdiuresis(e.g.,furosemide 20to60mgIV).

8. Stopoffendingagents(nephrotoxicdrugs). 9. GiveIVfluidsifradiocontrast-inducedATNissuspected. 10. Treatelectrolytedisturbancesanddetermineifthereisanindicationfordialysis.

FeverintheHospitalizedPatient

A.Causes 1. Infection:Likelysourcesarecentrallines,peripheralIVlines,pneumonia,Foley catheter,urinarytract,wounds,heartvalves,GItract(diverticulitis),joints(septic arthritis).

2. Noninfectiouscauses:PE/DVT,medications(especiallyantibiotics),neoplasms, connectivetissuedisorders,postoperativeatelectasis.
======================================
B.Diagnosis 1. Checkvitalsigns(tachycardiaisanexpectedphysiologicresponsetofever).

Screenforsepsiscriteria(tachycardia,fever,elevatedWBCcount,tachypnea)and treataccordingly.

2. Evaluateforsignsandsymptomsoflocalizingdisease—forexample,cough, abdominalpain,dysuria,meningealsigns,jointpain,diarrhea,cellulitis.

3. ConsiderCBC,urinalysis,CXR,cultures(blood×2,urine,sputum,allportsofall lines,anyfluidcollections),withsensitivitypanels.

4. Lumbarpunctureifmeningitisisapossiblecause;CToftheabdomenifintra- abdominalinfectionissuspected.

C.Therapies 1. Acetaminophenisappropriateinmostcases. 2. Ifthepatientisill-appearing,hemodynamicallyunstableorneutropenic,start broad-spectrumantimicrobialtreatmentempiricallyassoonasculturesare obtained.TransfertoanICUifpatientisinsepticshock.

3. Ifthepatientisonanantibioticandthefeverspikesagain,consideradding anotherantibioticorchangingtheantibioticaltogether.Antifungalagentsmaybe required.

4. RemoveorreplaceIVlinesandindwellingcatheters.Culturetipsofcentrallines. 5. Ifnosignsofinfectionandpatientishemodynamicallystable,treatunderlying

etiologyorcontinuediagnosticworkup.

Hypoglycemia

Usuallyduetoexcessinsulinororalhypoglycemicadministration(relativeto dietaryintake)indiabeticpatients. Ifthepatientcandrinkandhypoglycemiaismild,givejuice.Considergiving50mL ofD50Wintravenouslyifthepatientissymptomatic. IfthepatientisNPOorhypoglycemiapersists,startD5WorD10Wat100mL/hr. IfthereisnoIVaccessandthepatientcannotdrink/eat,giveglucagon(0.5to1.0 mgSCorIM). Reviewandmodifyinsulinandoralhypoglycemicregimens.

ChangeinMentalStatus(Confusion)

A.Causes 1. Medicationsandintoxications:sedatives,narcotics,insulin,oralhypoglycemics, H2blockers,TCAs,anticholinergics,corticosteroids,hallucinogens,cocaine, alcohol,methanol,ethyleneglycol

2. Hypoxia—verycommon 3. Postoperativedelirium—compoundedbypainmedications 4. Hypotension—withreducedcerebralperfusion 5. Substancewithdrawal—forexample,alcohol,benzodiazepines 6. Hypercapnia 7. Infection—sepsis,meningitis,encephalitis,UTI,intracerebralabscess 8. Trauma—headtrauma,burns 9. Metabolicdisturbances—acidosis,hypoglycemia,sodium,calcium,magnesium,

hypo/hypernatremia,ammonia(liverfailure)

10. Hyperthyroidismorhypothyroidism,thyroidstorm 11. Neurologiccauses—CVA,subarachnoidhemorrhage,increasedICP,subclinical

seizure

12. Dehydrationandmalnutrition—deficienciesofthiamine,vitaminB12 13. ICUpsychosis,sundowning
======================================
B.Management 1. Determineifthereisabaselinehistoryofdementia—anyrecentfall? 2. Checkvitals;performafocusedexamination(includingneurologicexamination

andmentalstatus).

3. Considerpulseoxygen(“pulseox”),ABG,electrolytes,fingerstick,CXR,blood cultures,LFTs,urinetoxicologyscreen.

4. ConsideraCToftheheadtoruleoutCVAorintracranialmassorbleed. 5. Correctreversiblecausesandstopoffendingmedications(ifpossible). 6. Considernaloxone(2mgIV),dextrose(D50),andoxygen. 7. IfpatientiscombativeorispullingoutIVs,considerhaloperidol(Haldol)or

possiblyrestraintsifnecessary.

8. ConsiderspotEEGtoevaluateforsubclinicalseizure.

ShortnessofBreath/AcuteHypoxia

A.Causes 1. Cardiac:PE,CHFexacerbation,MI,arrhythmia 2. Pulmonary:pneumonia,bronchospasm,pleuraleffusion,pulmonaryedema,

pneumothorax,upperairwayobstruction,hyperventilation

3. Oversedation:narcotics,benzodiazepines(determineexactlyhowmuchsedating medicationthepatienthasreceived)

4. Systemiccauses:severechronicanemia,sepsis,diabeticketoacidosis 5. Othercauses:ribfracture,anxiety,panicattacks

Quick HIT

Case-controlstudiesandcohortstudiesareoftenreferredtoas“observationalstudies.”

B.Management 1. Performpulseoximetryimmediately.Iflow,orifthepatientappearsill,obtainan ABGandgivesupplementaloxygen(titrateaccordingtoresponse).Consider bilevelpositiveairwaypressureincasesofCOPDorCHFexacerbation.

2. RememberABCs—intubateifnecessary. 3. Considernebulizertreatments,furosemide,andnaloxoneasappropriate. 4. PerformportableCXRimmediatelyunlesshypoxiaisreadilyresolved(e.g.,with

naloxone).

5. ConsiderECG,CBC(anemia,infection);scan(orCTAchest)ifPEsuspected. 6. Consideranxiolyticsifanxiety-relatedhyperventilationissuspectedandthe

patientisstable.

Quick HIT

Randomizationisimportantbecauseitleavespatientassignmenttoeitherexperimentalorcontrolgroup completelytochance.Whenanyelementofhumanintrusionorjudgmententerstheprocessofpatient assignment,biasisintroduced.

BasicStatisticsandEvidence-BasedMedicine

A.Evidence-BasedMedicinehasbeendefinedas“theconscientious,explicit,and judicioususeofcurrentbestevidenceinmakingdecisionsaboutthecareof individualpatients”(SacketD.BMJ.1996;312:71).

Quick  HIT  Hierarchyofevidence(fromhighesttolowest)  1. Meta-analysisofrandomizedcontrolledtrials 2. Randomizedcontrolledtrials 3. Cohortstudies 4. Case-controlstudies 5. Caseseries 6. Expertopinion 
======================================
B.TypesofResearchStudies 1. Caseseries—thesemaydescribetheresultsofaspecifictreatment,determine

long-termoutcomeofatreatmentorprocedure,ordescribethecomplicationrates ofaprocedureorthenaturalhistoryofadisease(seealsoClinicalPearlsA-1and A-2).

a. Sizeofacaseseriescanrangefromtwoorthreepatientstothousandsof patients.Acasereportisthedescriptionofarareorinterestingcase.

b. Majordisadvantageisthelackofacomparisongroupsoonecannotreach definitiveconclusionsabouttreatmentefficacy.Caseseriesarepronetomany biases.

c. Verycommoninsurgicalresearch.

2. Cross-sectionalstudies—subjectsarestudiedataspecificpointintime (“snapshot”ofapopulation).

3. Case-controlstudies.

a. Patientsareselectedbecausetheyhaveacertainoutcome,andtheirhistoryis retrospectivelyreviewedtoidentifyexposuresorriskfactorsthatmaybe associatedwiththatoutcome.

b. Bydefinition,case-controlstudiescanbeonlyretrospective. c. Goodforrarediseasesandfordiseaseswithlonglatentperiods. d. Verysusceptibletobiasbecausebothexposureanddiseasedevelopment

occurredpriortoinitiationofthestudy.

Quick HIT

Thebasicdifferencebetweenarandomizedcontrolledtrialandaprospectivecohortstudyisthemannerinwhich patientsareassignedtoeithergroup.

e

e

Inarandomizedcontrolledtrial,patientsareassignedtoeithertheexperimentalorcontrolgrouprandomly, withoutinputfromphysicianorpatient. Inacohortstudy,thetreatmentdecisionisnotrandomandisdeterminedbytherecommendationsofthe physician,aswellasthewishesofthepatient,amongotherfactors.

4. Cohortstudies.

a. Subjectsareselectedaccordingtoexposure(e.g.,anewmedication,a procedure)andarefollowedovertimetoobservethedevelopmentor progressionofdisease.

b. Cohortstudiescanbeprospectiveorretrospective. c. Prospectivecohortstudiesfollowpatientsovertimetoobserveacertain outcome,butpatientassignmentintothetwotreatmentgroupsisnot randomized,soconfoundingvariablesmaybeunequallydistributed(seelater).

5. Randomizedcontrolledtrial.

5. Randomizedcontrolledtrial.

a. Atypeofcohortstudyinvolvingacontrolgroupandaninterventiongroup. b. Patientassignmentintoeithergroupisleftcompletelytochance(ifproperly done).Therefore,knownandunknownconfoundersarelikelytobeequally distributed.

c. Methodologicallysuperiortootherstudydesignsbecauseitisleastsusceptible
======================================
tobias. 6. Meta-analyses

a. Meta-analysescombinedatafromseveralindividualstudiestoestimatean overalleffect.

b. Thestrengthofameta-analysisisonlyasgoodasthequalityoftheprimary studiesitanalyzes(e.g.,ameta-analysisof14flawed,biasedstudieswill produceabiasedestimateofeffect).

c. Ameta-analysisofwell-conductedrandomizedcontrolledtrialsisthehighest levelofevidence.

Quick HIT

Thenullhypothesispostulatesthatthereisnodifferencebetweentwogroups.Thishypothesisiseitherrejected ornotrejectedbyastudy.

CLINICALPEARLA-1

ConsolidationofStandardsforReportingTrials(CONSORT)Statement

e

e

e

Publishedin1996,revisedin2001(JAMA.2001;285:1987). Twenty-one–pointchecklistofessentialitemsthatrandomizedcontrolledtrialreportsshouldincludeto facilitatetheirappraisalandinterpretation. ManyjournalshaveendorsedCONSORT,buttherigorofenforcementvaries.

CLINICALPEARLA-2

CochraneLibrary(www.cochrane.org) Regularlyupdatedevidence-basedmedicinedatabase Includesrandomizedcontrolledtrialsandsystematicreviewsinallspecialtiesofmedicinetodeterminehow strongtheevidenceisforvariousmedicaltreatments Consistsofaninternationalnetworkofresearchersandphysicianswhogatherandevaluatetheevidencein medicalresearch

C.SensitivityandSpecificity 1. Sensitivity=a/(a+c)(seeTableA-4).Testswithhighsensitivityareusedfor

screening.Theymayyieldfalse-positiveresultsbutdonotmisspeoplewiththe disease(lowfalse-negativerate).

2. Specificity=d/(b+d).Testswithhighspecificityareusedfordisease confirmation.

3. Positivepredictivevalue(PPV)=a/(a+b).

a. Ifthetestispositive,whatistheprobabilitythatthepatienthasthedisease? b. PPVdependsontheprevalence(thehighertheprevalence,thegreaterthePPV) andthesensitivity/specificityofthetest(e.g.,anoverlysensitivetestyields morefalse-positiveresultsandhasalowerPPV).

4. Negativepredictivevalue(NPV)=d/(c+d).

a. Iftestisnegative,whatistheprobabilitythatpatientdoesnothavethedisease? AhighNPVisveryimportantforascreeningtest.

b. NPValsodependsonprevalenceofdisease(higherprevalence=lowerNPV) andthesensitivity/specificityofthetest(themoresensitivethetest,thefewer thenumberoffalse-negativeresults,andthehighertheNPV).
======================================
Quick HIT

Clinicalsignificanceisunrelatedtostatisticalsignificance.Astudymayobtainstatisticalsignificancefor differencesthathavenoclinicalsignificance(e.g.,41%vs.42%infectionratefortwogroups).Withalarge enoughsamplesize,anystudywillobtainstatisticalsignificance.

D.Type1and2Errors

1. Type1(α)error:Nullhypothesisisrejectedeventhoughitistrue(false-positive finding).

a. Pvalueisthechanceofatype1erroroccurring. b. IfthePvalueis≤0.05,itisunlikelythatatype1errorhasbeenmade(i.e.,a

type1errorismadefiveorfewertimesoutof100attempts).

2. Type2(β)error:Nullhypothesisisnotrejectedeventhoughitisfalse(afalse- negativefinding).

a. Atype2errorresultswhenthePvaluefailstoreachstatisticalsignificanceeven thoughthegroupsbeingcomparedaretrulydifferent.Atype2errorusually occurswhensamplesizeistoosmall.

b. Thelikelihoodofavoidingatype2erroristermedthestatisticalpowerofa study.

Quick HIT

Ifastudyhasapowerof80%,thismeansthatifadifferenceofaparticularstatedmagnitudeexistsbetween groups,thereisan80%chanceofcorrectlydetectingit.

Quick HIT

Thelackofstatisticalpower(i.e.,samplesizetoosmall)invalidatesastudybecauseitcanleadtostatistical insignificancewhenthereactuallyisaclinicallymeaningfuldifference.

E.StatisticalPower 1. Astudywith“negative”result(nodifferencebetweengroups)musthaveadequate

powertodetectclinicallymeaningfuldifferences.

2. Conventionally,aβ-errorrateof20%ischosen,whichcorrespondswithastudy powerof80%.Astudypoweroflessthan80%isbelievedtohavean unacceptablyhighriskoffalse-negativeresults(i.e.,astudyfoundnodifference betweentwogroups,whenthereactuallywasadifference).

TABLEA-4 SensitivityandSpecificity
======================================
3. Factorsthataffectthepowerofastudy.

a. Samplesize—whensamplesizeissmall,astudyissusceptibletotype2error,

whichiswhysamplesizecalculationisdonepriortothestudybeinginitiated. b. Levelofstatisticalsignificance—conventionally,aPvalueof0.05ischosen,

althoughthisissomewhatarbitrary.

c. Variabilityofthesampledata—thelowerthevariability,thefewersubjectsare neededtodemonstratesignificantdifferencesiftheydoindeedexist.

d. Effectsizechosenbyresearcher—thisisbasedonpre-existingdataandclinical judgmentandisbeyondthescopeofthisdiscussion.

Quick HIT

ThinkoftheCIasaweatherforecast:avagueforecastof“warmwithpossibilityofrain”(thisisa“wide”CI)is morelikelytoholdtruebutisnotveryprecise.However,aforecastof“70degreeswith30%chanceofrain” (narrowCI)ismuchmoreprecisebuthasalowerlikelihoodofholdingtrue.

F.ConfidenceInterval 1. Theconfidenceinterval(CI)allowsthereadertoapplytheresultsofastudyto

the“true”populationfromwhichthesampleinthestudywastaken.

2. ThemostcommonCIis95%,whichmeansthattheCI(i.e.,therange)reportedin thestudyholdstruefor95of100samplessimilartotheoneinthestudy.

3. A“wider”CIincreasesthecertaintyoftheestimate(i.e.,itismorelikelythatthe populationfromwhichthesamplewasselectedwouldfallwithinthereported interval),butlowersitsprecision(seeQuickHit).AverywideCIshouldbe interpretedwithcaution(alargersamplesizemaybeneededtomaintainpower).

4. ThelargertheCI,thelesspowerastudyhastodetectdifferencesbetweentwo groups.ThewidthoftheCIdependsonsamplesize;thelargerthesamplesize (morelikelytohavepower),thenarrowertheCI.

Quick HIT

Selectionbiasreferstodifferencesincharacteristicsofsubjectsincluded/excludedordifferencesbetween selectedcomparisongroups.

G.AssociationVersusCorrelation 1. Associationisusedfordescribingrelationshipsbetweencategoricalvariables;

correlationdescribesrelationshipsbetweencontinuousvariables.

2. Neitherassociationnorcorrelationimpliescausation.Thesetermsdescribeonly therelationshipandstrengthofthisrelationship.

3. Correlationisamatterof“degree.”Itcanrangefrom−1.00(inverse proportionality)to+1.00(proportionalrelationship).Zerosignifiesnocorrelation.
======================================
Quick HIT

SelectionBias Ideally,comparisongroupsshouldbeidenticalinallrespectsotherthanfactorunderinvestigation.Inreality,this comparisongroupdoesnotexistduetoconfoundingvariables.Therefore,randomizedcontrolledtrialsare preferredtominimizeconfounding.

H.Causality.Itisverydifficulttoprovecausality.Thefollowingfactorshelpassess causality,butnonecangiveindisputableevidenceofacause-and-effect relationship:

1. Strengthofassociation 2. Biologicplausibility—doestheassociationmakebiologicsense? 3. Consistencyoftheassociationacrossdifferentstudies 4. Dose–responserelationship 5. Experimentalevidencetosupportcausality—forexample,ifyoueliminatean

exposure,doesthisreducetheincidenceofaparticulardisease?

6. Temporalsequence(veryimportant)—thecausativefactormustprecedethe effect.

7. Experimentalevidence—hasarandomizedcontrolledtrial(highestlevelof evidence)beenperformed?

Quick HIT

Theonlyinherentadvantageofrandomizedcontrolledtrialsoverobservationalstudiesisthereductionin confounding.

I.Bias 1. Astudythatisbiasedlacksinternalvalidity.Biascanbeintroducedinthedesign ofastudyorduringthestatisticalanalysisbecauseofthelackofstatisticalpower (inadequatesamplesize).Inaddition,conflictofinterestcanintroducebiasand affectthevalidityofastudy.Criticalappraisalofmedicalliteratureessentially requirestheabilitytoidentifybias.

2. Therearefourmaintypesofbias:Selectionbias,performancebias,detection bias,andattritionbias(seeClinicalPearlA-3).

3. Aconfoundingvariableisafactorotherthantheinterventionunderinvestigation thatobscurestheprimarycomparison.

a. Commonconfoundingvariablesincludeage,gender,comorbidities,smoking, andsocioeconomicstatus.

b. Atrueconfoundingvariablemustmeettwocriteria:Itmustbeassociatedwith theexplanatory(independent)variable,anditshouldbeariskfactorforthe outcomeofinterest.

c. Randomizedcontrolledtrialscontrolforbothknownandunknown confounders.

CLINICALPEARLA-3

TypesofBias

¢

¢

¢

¢

Selectionbias—occurswhentherearedifferencesinthecharacteristicsofsubjectsbetweencomparison groupsofastudy.Unequaldistributionofconfoundingvariablesamongthetwogroupsleadstoselectionbias. Performancebias—occurswhensubjectsincomparisongroupsaregivendifferentcare(otherthanthe interventionthatisbeingstudied).Forexample,onlyonegroupmayreceivecounselinginadditiontothe interventionthatisbeingstudied(thecounselingmayaffecttheoutcomeinsomeway).Blindingisimportant inpreventingperformancebias(patientandinvestigatorsarenotawareofthetreatmentrendered). Detectionbias—referstoinconsistencyinoutcomeassessment.Useofvalidatedoutcomemeasuresand blindingofoutcomeassessorshelppreventdetectionbias. Attritionbias—referstopatientdrop-outsorexclusionfromastudy.Thereisnorecognizeddrop-outratethat isdeemed“acceptable.”Drop-outsshouldbekepttoaminimum,butiftheydooccur,intent-to-treatanalysis iscriticaltomaintaintheintegrityofrandomization(seetext).

4. Minimizingbiasinrandomizedclinicaltrialshingesonthefollowing:

a. Properrandomization—eachpatientshouldhaveanequalchanceofreceiving eithertreatment.

b. Concealmentofallocation—thepersonenrollingpatientsintostudyshouldbe unawareofnext“assignment”intoeithertheexperimentalorcontrolgroup.This canbedonewithsealedopaqueenvelopes,remoteallocation(callmadetoa separatedepartmenttodeterminepatientallocation),orcomputerizedallocation.

followingparticipantscanpotentiallybeblindeddependingonthenatureofthe study:Patients,physicians,datacollectors,assessorsofoutcome,dataanalysts. Astudyshoulddescribepreciselywhichparticipantswereblinded.Termssuch as“double”and“triple”blinding,ifnotdefined,areconfusingandshouldbe avoidedbecausetextbooksandphysiciansoftenhavevaryinginterpretationsof theseterms.

d. Intent-to-treatanalysis—drop-outsareanalyzedingroupstowhichtheywere initiallyassigned.Excludingdrop-outsfromanalysisthreatensthebalancethat randomizationachieves.Drop-outsoftendoworsethanpatientswhoremain, andexcludingthemcreatesbias.
======================================
Quick HIT

Whenevaluatingarandomizedclinicaltrial,gothroughthischecklisttoassesswhetherastudyisbiased:

e

e

e

¢

Properrandomization Concealmentofallocation Blinding Completenessoffollow-upandintent-to-treatanalysis

Quick HIT

Intent-to-TreatAnalysis Patientsareanalyzedwiththegrouptowhichtheywererandomlyassigned,regardlessofwhethertheyactually receivedthattreatmentorcompletedthestudy.

J.GlossaryofCommonStatisticalTerms 1. Mean—theaverage 2. Median—valuecorrespondingtothemiddlecaseormiddleobservation(i.e.,50%

ofvaluesarelessthanand50%ofthevaluesaremorethanthemedian).

3. Mode—valuethatoccursmostoften 4. Standarddeviation(SD)—usedfornormaldistributions.AnSDof±1includes

about68%oftheobservations,anSDof±2includesabout95%ofthe observations,andanSDof±3includesabout99.7%oftheobservations.

5. Incidence—numberofnewcasesofadiseaseperyear. 6. Prevalence—overallproportionofthepopulationwhohavethedisease. 7. Relativerisk—incidenceinexposedgroup/incidenceinunexposedgroup.

Relative risk—incidence in exposed group/incidence in unexposed group. Relative risk can be calculated only after a prospective or experimental study.

Relativeriskcanbecalculatedonlyafteraprospectiveorexperimentalstudy. 8. Oddsratio—amethodofestimatingtherelativeriskinretrospectivestudies.Itis theprobabilityofaneventhappeningdividedbytheprobabilityoftheeventnot happening.

9. Reliability—abilityofatestormeasuretoreproducethesameresultsunderthe sameconditions.

10. Validity—extenttowhichastudycorrectlyrepresentstherelationshipsbeing assessed.

a. Internalvalidity—astudythatsuffersfrombiaslacksinternalvalidity. b. Externalvalidity—astudymayhaveinternalvaliditybutitsresultsmaynotbe

generalizedtoalargerpopulation(lacksexternalvalidity).
======================================
End-of-LifeIssuesandInformedConsent

1. Advancedirectivesareinstructionsgivenbypatientsthatspecifywhatactionsto takefortheirhealthiftheyarenotabletomakedecisionsduetoillness.

a. Alivingwillleavesinstructionsfortreatment,outliningthepatient’swishes.A livingwillmayspecifythatpatientdoesnotwanttobeonaventilator,ordoes notwantabloodtransfusion.Theseinstructionsshouldberespectedevenifa familymemberdisagreeswiththem.

b. Apowerofattorney(healthcareproxy)—personappointedbypatienttomake decisionsontheirbehalf.

c. Ethicscommitteeisusedwhenpatienthaslostdecision-makingcapacityand thereisnoadvancedirective.Inmostsituationsthenextofkinbecomesthe patient’ssurrogatedecisionmaker.

d. Courtorder—whenpatienthasnocapacitytounderstandandthefamilyisin disagreementandthereisnohealthcareproxyspecified.

e. Stateappointedguardian—whenthepatientlacksdecision-makingcapacityand isunrepresented,forexample,thereisnonextofkinavailableorfamilydeclines toparticipateinhealthcaredecisionmaking.

2. Anadultwhocanparticipateinthediscussionregardingtherisksandbenefitsof treatmentdecisionshasultimatedecision-makingcapacityabouthisorherown medicalcare.Notethatdecision-makingcapacityisspecifictotheparticular decisionathand(meaning,apatientmayhavecapacitytomakeonedecisionbut lackcapacitytomakeanotherdecisionifunabletounderstandthebenefitsof treatmentorrisksofforegoingtreatment).Ifsuchanadultrefusesatreatment, respecthisorherwishes,evenifthattreatmentisclearlyindicatedorthestandard ofcare.Forexample,neverforceaJehovah’sWitnesstoacceptbloodproducts. Patientscanrefusemedicalcareevenifthisrefusalresultsintheirdeathor disability.

a. Allmedicalinterventions(includingartificialnutritionandhydration)maybe terminatedatthepatient’srequest.

b. Ifapatientwhoismentallyincapacitatedisinapersistentvegetativestateor comatose,familymembers(evenifnotformallyappointedasproxydecision makers)canwithdrawlife-sustainingtreatmentsbasedonpriorconversations withthepatientortheirunderstandingofthepatient’svalues.

DNR(donotresuscitate)—refersonlytowithholdingcardiopulmonaryresuscitation.

3. Definitionofdeath:Anindividualwhohassustainedeither(1)irreversible cessationofcirculatoryandrespiratoryfunctions,or(2)irreversiblecessationof allthefunctionsoftheentirebrain,includingthebrainstem.Todeclarean individualdead,eithertheheartandlungsORthebrainandbrainstemstop functioningpermanently.

4. Informedconsent.

a. Everyprocedureneedsinformedconsent.Onlythepersonperformingthe procedureshouldobtainconsent.

b. Informedconsentshouldincludethefollowing:
======================================
e

e

e

e

Thediagnosisormedicalproblemforwhichthephysicianisrecommending treatment. Adescriptionoftheproposedtreatmentorprocedure,includingitspurpose, duration,methods,andimplementsused,aswellastheprobabilityofsuccess. Allmaterialrisksoftheprocedureortreatment. Anyreasonablealternativestotheproposedprocedure Therisksofnotbeingtreated.

e

healthcarepowerofattorneycanconsentorrefuse.Ifthereisuncertaintyabout apatient’scompetence,psychiatricevaluationmaybenecessary.Ifapatientis determinedtobeincompetent,andifthereisnoPOA,thewishesoffamily(or nextofkin)shouldberespected.Ifthereisdisagreementamongfamily members,consultthehospitalethicscommittee.

d. Ifanadultregainscapacity,thenthedutyofinformedconsentreturnstothe patientandthehealthcarePOAcannotmakedecisions.

e. Emergencies:Consentisnotneededinanemergency,itisimplied.Ifapediatric patientneedsemergenttreatmentandparentisnotavailableforconsent, physicianmayproceedtotreatpatientwithoutconsent.

f. Rememberthatminors(under18)cannotmakedecisionsorconsenttoorrefuse medicaltreatments.Onlyparentsorlegalguardianscanconsent.Patientsunder 18donotrequireparentalconsentinthefollowingsituations:

e

Theyareemancipated(married,livingontheirownandfinancially independent,raisingchildren,servinginarmedforces). HaveanSTD. Wantcontraception. Arepregnantandneedprenatalcare. Wantdrugtxorcounseling(substanceabusetreatment). Havepsychiatricillness.

Questions

upbloodandweakness”forthepast3weeks.Hereportsatleastfivetosix episodesevery2to3daysofcoughingofbrightredblood,approximatelyoneto twotablespoonseachtime.Thepatientdeniesanychestpain,fevers,chills,or recenttravel.Hehasmilddyspneaatbaseline.Hehasrecentlydevelopedlower extremitymusclecrampsandhehasdifficultyrisingfromachair.Pastmedical historyissignificantforCOPDdiagnosed5yearsagoandHTN.Hehasa40- pack-yearsmokinghistoryandcurrentlysmokes1packperday.Examinationis notableforend-expiratorywheezingandaprolongedexpiratoryphaseonlung auscultation.Hehas3/5hipflexionanddecreaseddeeptendonreflexesbilaterally inlowerextremities.Laboratorytestsarenormalincludingelectrolytes.CXR revealstypicalchangesseeninCOPD(flatteneddiaphragms,hyperinflation)and aperihilarmass.Whatisthemostlikelydiagnosis?
======================================
A. Bronchialcarcinoid B. Adenocarcinoma C. Largecellcarcinoma D. Squamouscellcarcinoma E. Smallcellcarcinoma

2. A67-year-oldmalepresentstotheEDwithLLQpainthatbeganafewhoursago. HisPMHissignificantforhypertension,CHF,andrenalcalculi.Hereportsone episodeofbloodinhisstoolsafewmonthsago.Vitalsignsareasfollows: Temperature=101.1°F,BP=130/76mmHg,pulse=70.Onphysical examination,hehasguardingandtendernesstopalpationintheLLQbutno epigastrictendernessorflanktenderness.Hisexaminationisotherwise unremarkable.Hisstoolisnegativeforoccultblood.Urinalysisrevealsno leukocytesorRBCsandGramstainisnegative.Laboratorytestsreveala leukocytecountof16,000cells/μLandnormalelectrolytesandrenalfunction. Whatisthenextstepinmanagingthispatient?

A. Checkaserumlactate B. Obtainaretroperitonealultrasound C. Preparethepatientforcolonoscopy D. Obtaincontrast-enhancedCToftheabdomen E. Proceedtotheoperatingroom

3. A64-year-oldfemalewithahistoryofHTN,CAD,andCHFpresentstotheED withachiefcomplaintofleft-sidedchestpainthatbegan4to5hoursago.She hasahistoryofperiodicepisodesofchestpainforwhichshetakessublingual nitroglycerin,buttoday’sepisodehasbeenmoresevere,haslastedlonger,andis notrelievedbynitroglycerin.Shedeniesnausea/vomiting,anyradiationofthe pain,ordiaphoresis.Temperature=97.8°F,BP=136/76mmHg,HR=105,RR= 20.Physicalexaminationincludesclearlungsonauscultation,noJVPelevation, andnoLEswelling.ECGshowsQwavesinlateralleadsandnoSTelevation. Troponinis0.50ng/mL.Aspirinisgiven.Whatisthemostimportantintervention indicatedatthistime?

A. Alteplase B. Heparin C. Hydralazine D. Furosemide E. Digoxin

slurredspeech.Hissymptomsstarted5hoursagoandhavenotimproved.Hehas amedicalhistorysignificantforhypertensionanddiabetes.Neurologic examinationconfirmsRUEparesisanddysarthria.Restofexaminationisnormal. Vitals:BP190/100mmHg,HR75.Labsarenotableforglucoseof135mg/dL, A1c7.3%.CTheadshowsanareaofischemiawithoutassociatedhemorrhage. Homemedicationsincludemetforminandlisinopril.Whatisthemostimportant interventionatthispoint?
======================================
A. Insulin B. Heparin C. Aspirin D. Alteplase E. Labetalol

5. A58-year-oldmalepresentstoyourofficewithweaknessinhislegsandahistory offrequentfallsoverthepastfewmonths.Healsocomplainsoffatigueattheend oftheday.Hedeniesanybackpain.Hedoesnotdrinkalcoholorsmoke.His medicalhistoryissignificantforgastriccarcinomaforwhichheunderwenttotal gastrectomy2yearsagoandtherearenosignsofrecurrence.Onphysical examination,heisfoundtohaveconjunctivalpallor,increaseddeeptendon reflexes,andmildweaknessofhislowerextremities,alongwithdiminished vibratorysenseinhistoes.Cerebellartestingisnormal.Hisexaminationis otherwiseunremarkable.Whatwouldbethebesttestinconfirmingthecauseof hissymptoms?

A. Folate

B. CBCwithmeancorpuscularvolume C. IntrinsicfactorAb D. MRIlumbarspine E. Methylmalonicacid

weakness.Hersymptomshavedevelopedgraduallyoverthepastyearandshehas largelyignoredthem.Shereportsarecentweightgainof25lboverthepastyear andhasbeenfeelingmelancholyforthepastfewmonths.Shehasalsohadback painforthepastseveralmonths.HermedicalhistoryissignificantformildHTN andinsulin-dependentDM.Physicalexaminationrevealsmildobesity,withfat depositionmainlyaroundthetrunkandtheposteriorneck.Younotesomefacial hairandscatteredpurplestriaeontheabdomen.Radiographsrevealacompressed fractureatthelevelofT11.Vitalsignsareasfollows:BP=140/85mmHg,pulse =70.Whatwouldbethemostappropriatenexttestinthispatient?

A. SerumACTH B. MRIbrain C. CTabdomen D. 24-hoururine-freecortisol E. CRHstimulationtest

isbroughttotheEDwithsevere,crushingchestpainthathaslastedfor90 minutes.Hestatesthathefeltillalldayandthenstartedexperiencingpaininhis jaw,whichprogressedtochestpainwithradiationtotheleftarmassociatedwith nausea.Vitalsignsareasfollows:Temperature=97.4°F,HR=50,BP=85/45 mmHg,RR=22,pulseoximetry=98%onroomair.ExaminationrevealsJVP withoutelevation,normallungexamination,andnoperipheraledema.AnECG revealssignificantSTelevationsinleadsII,III,andaVF.Whatisthenextstepin managingthispatient?

A. Nitroglycerin B. Normalsaline C. Furosemide D. Metoprolol E. Morphine

8. A45-year-oldfemalewithhistoryofDM,alcoholabuse,andCOPDisevaluated forconfusionintheED.Sheliveswitharoommatewhostatesthepatientwas actingdifferentlyfrombaseline.Thepatientisagitated,notoriented,andnot respondingtoquestionsappropriately.VitalsT37.5°C,P110,RR30.Physical examinationrevealslungswithminimalend-expiratorywheezing.Physical examinationisotherwisenormal.UAiswithinnormallimits.Labs:Na140

mEq/L,Cl105mEq/L,K5mEq/L,HCO315mEq/L,BUN20mg/dL,Cr1 mg/dL.ABG:pH7.30,PCO225mmHg,PO285mmHg.Whatisthenext appropriatemedicalintervention?
======================================
A. Fomepizole B. Acetylcysteine C. Albuterol D. Sodiumbicarbonate E. Insulin

issignificantforHTN,forwhichhetakesmetoprolol.Hehasneverhadscreening forcolorectalcancerpreviously.Onexamination,therearenopalpablemassesin theabdomen,notenderness,andbowelsoundsarenormal.Hedeniesanychange inbowelhabits.Theremainderofhisphysicalexaminationisunremarkable.Heis givenfecaloccultbloodtestingandtwoofthreesamplesarepositive.Whatisthe appropriatenextstepinmanagingthispatient?

A. Flexiblesigmoidoscopy B. Digitalrectalexamination C. Videocapsuleendoscopy D. CTcolonography E. Colonoscopy

nausea/vomiting/diarrhea.HisPMHissignificantforstrokeHTNand osteoarthritisofhisknees.Medicationsincludeenalaprilandadailyaspirintablet. Vitalsignsareasfollows:RR=20,BP=155/90mmHg,pulse=70.Hisphysical examinationrevealsepigastrictenderness,noabdominaldistention,andrectal examinationispositivefordarkstoolthatisguaiacpositive.Laboratorytests revealhemoglobinof10.2g/dL,hematocritof30.0%,platelets190×103/μL. LFTresultsarenormal.Na135mEq/L,K4.5mEq/L,Cl105mEq/L,HCO322 mEq/L,BUN30mg/dL,Cr1.2mg/dL.Whatisthenextrecommendedstepin managingthispatient?

A. IVomeprazole B. IVoctreotide C. Platelettransfusion D. RBCtransfusion E. Normalsaline

11. A45-year-oldfemaleisadmittedtothehospitalwithabdominalswelling.Shehas notpreviouslysoughtmedicalcareandhadbeenwelluntil3monthsagowhen swellingbegan.Swellinggraduallybeganandhasworsenedtothepointthatshe

isnowshortofbreathandhasdifficultymobilizing.ShewasborninMexicobut hasbeenlivingintheUnitedStatesforthepast20years.Shedeniesanyuseof medications.Sheadmitstosocialdrinkingbutdeniesdailyuse.Lungexamination revealsdecreasedbreathsoundsatthebases.Cardiacexaminationrevealsno murmurs,JVP2cmabovesternalangle.Abdomenismoderatelydistendedwitha positivefluidwave;liverisunabletobepalpated.Skinexaminationdoesnot revealtelangiectasias.Adiagnostic/therapeuticparacentesisisperformedwhich revealsthefollowing:serumalbumin2.5g/dL,serumtotalprotein5.0g/dL, ascitestotalprotein2.3g/dL,ascitesalbumin1.6g/dL.Whattestisthemost likelytorevealthecauseofherascites?
======================================
A. Echocardiogram B. Pelvicultrasound C. Liverbiopsy D. PPD E. 24-hoururineprotein

12. A65-year-oldmanpresentstotheEDwithlowerextremityweakness.His

symptomsstarted1weekpriorwhenhenoticeddifficultywalkingandhetripped once.Henowhasdifficultyraisinghislegsoffthefloorandisnowusinga wheelchair.Hedeniesanypaininhislowerextremitiesbutdoeshaveparesthesias inbothlegs.Hedeniesweaknesselsewhere.Hedeniesdyspneaoranyother associatedsymptoms.Priortothishehadanepisodeofnonbloodydiarrheaafew weekspriorbutthatisnowresolved.Hisonlypastmedicalhistoryis hypertensionforwhichhetakeshydrochlorothiazide.Cardiacexaminationis normal.Pulmonaryexaminationrevealsnonlaboredbreathing,clearlungfields, andO2saturation98%onroomair.Neurologicexaminationrevealsnormal speechwithoutdysarthriaandcranialnerveswithoutdeficits.Strengthis5/5in bilateralupperextremitiesinshoulder/elbow/wristflexionandextension,1/5 dorsiflexion/plantarflexionbilateralankles,1/5flexion/extensionknees,2/5hip flexion.Achillesandpatellarreflexesareabsentbilaterally.Sensoryexamination isnormal.Labsincludingelectrolytes,renalfunction,andbloodcountsare normal.CTheadisnegativeforstrokeandshowsnoacutefindings.Lumbar punctureisperformedandanalysisreveals3WBC/mm3,protein100mg/dL (normalrange<50mg/dL),Gramstainnegative.Whatisthemostappropriate therapy?

A. Prednisone B. IVIG C. Ciprofloxacin D. Pyridostigmine E. Botulismantitoxin

reportsahistoryofheavymenstrualbleedingsincemenarche.Hermotherhad similarsymptoms.Onfurtherquestioning,shestatesthatshehasepisodesof epistaxisaboutonceevery2weeksorsoandhasatendencytobruiseeasily.Her physicalexaminationisunremarkable.CBCresultsareasfollows:Hgb=7.9 g/dL,Hct=23.9%,MCV=69fL.Plateletcountis230,000/μL.PT—12seconds (normal).PTT—30seconds(normal).LFTsincludingbilirubinarenormal.What isthemostappropriatetesttoorder?

A. Fibrinogen B. Coombsantibody C. FactorIXlevel D. Mixingstudy E. Ristocetincofactoractivity

14.

A 43-year-old male presents to the ED with a complaint of headache. Headache

developedacutelyoverthepastfewhoursandissevereinnature.Painislocated bilateraltopofhisheadwithoutradiationelsewhere.Hedeniesanyassociated weakness.Hedeniesdoublevision,dizziness,nausea,andvomiting.Hedenies phonophobia/photophobia.Hehasnopriorhistoryofheadaches.Vitals:BP 144/90mmHg,T37.2°C.Examinationrevealsamiddle-agedmanindistress relatedtopain.Neurologicexaminationisnegativeforfocalweaknessorsensory deficit.Nonuchalrigidity.CNsareintact.CTbrainwithoutcontrastisobtained andnegativeforischemiaorhemorrhage.Whatisthenextmostappropriate intervention? A. Sumatriptan B. MRIbrain C. Cerebralangiogram D. CTbrainwithcontrast E. Lumbarpuncture

coughshehashadfor5years,anditisgettingworse.Thecoughisoften productiveofwaterymucus.Sheisalsobecomingmoreandmoreshortofbreath andcannotclimbaflightofstairswithouttakingarest.Shedenieschestpain, paroxysmalnocturnaldyspnea,fevers,chills,andweightloss.PMHissignificant forHTNanda35-pack-yearhistoryofcigarettesmoking.Vitalsignsareas follows:Temperature=99.0°F,HR=75,RR=21,BP=158/82mmHg.O2 saturationis94%atrestandreachesanadirof90%withactivity.Physical examinationrevealsanobesewomaninnoacutedistress.Onlungauscultation, therearecoarsebreathsoundsbilaterallybutnowheezesorcrackles.Chest radiographissignificantforprominentlungmarkingsatthebases.PFTsshow

FEV1/FVCratio0.60andFEV165%.Whatisthemosteffectivelong-term interventionforthiswoman?
======================================
A. Smokingcessation B. Tiotropiuminhaler C. Fluticasoneinhaler D. Oxygentherapy E. Azithromycin

surgery.Thepatienthadalong-standingmurmurandwasdiagnosedwithmitral stenosis.Heeventuallyunderwentrepairwithaprostheticvalveandhis symptomsofdyspneahaveresolved.Hehasresumedphysicalactivityandseeks tomaintainhiscurrenthealth.Hewantsadviceonfutureproceduresandpossible riskofinfection.Whichprocedurewillyouadvisewarrantssuchtreatmentsolely forendocarditisprophylaxis?

A. Colonoscopy B. Wisdomtoothextraction C. EGD D. Bronchoscopywithoutbiopsy E. Dilatationureteralstricture

17. A67-year-oldAfrican-Americanmalepresentstoyourofficewithcomplaintof righthippainforthelastweek.Hedeniesanyhistoryoffallsorinjury.Thepain cameonsuddenlyashewasgettingupfromachair.Priortothisepisode,he deniesanyhistoryofhippain.PMHissignificantforHTN,diabetes,and hypothyroidism.Hestartedusingacaneafewdaysagobutduetoincreasingpain isnowinawheelchair.Onphysicalexamination,hehasseverepainwithany attemptedmotionoftherighthipjoint.Pulsesarepalpablebilaterally,and neurologicexaminationisnormal.Radiographsoftherighthipareobtainedand shownormalbonedensitywithadisplacedfractureoftherightfemoralneck. Labs:Na+135mEq/L,Cl105mEq/L,HCO325mEq/L,Ca2+11.0mg/dL,Cr1.9 mg/dL,Hgb9.5g/dL,MCV90fL.Labsayearagowerecompletelynormal.He isup-to-dateonroutinehealthscreening.Inadditiontoobtaininganorthopedic surgeryreferralforrepairofthefracturewhatothertestingwouldbeindicated thatwouldbestexplainthepatient’sfindings?

A. SPEP B. 99mTcbonescan C. PTHrP D. PTH E. DEXA

18. A38-year-oldfemalepresentstoyourofficewithchiefcomplaintoffatigueand

weightgainforthepast5to6months.Herfatiguehasalsoaffectedher performanceatwork,whereshehasdifficultyconcentratingontasks.She recentlybeganlosinghair.Shefeelsmoretiredthanusualafterworkandhas difficultyplayingwithherchildrenintheevening.Shedidnothaveanyofthese symptomsuntil6monthsago.Shedenieshot/coldintolerance.Weighthasbeen relativelystablebutshehasgained∼10lbinthepast6monthsdespiteattempting toeathealthyandexerciseafewtimesweekly.Sheisgenerallyhappyanddenies anyrecentmoodchanges.PMHisinsignificant.Thepatientsmokesfivetosix cigarettesadayanddrinksalcoholsocially.Shetakesbirthcontrolpills.HR55, BP120/80mmHg,RR16,BMI31.Physicalexaminationrevealsapleasant female,orientedandappropriate.ENTexaminationrevealsnormalpharynx,no neckfullness,andnopalpablethyroidnodules.Abdomenissoft,nontender.Skin examinationrevealsnolesions/rashesandthereisnolowerextremityedema.She donatedbloodlastweekandwastoldthatherHgbwasnormal.Whatisthe appropriatenextstepinmanagingthispatient?
======================================
A. USthyroid B. TPO C. Thyroiduptakescan D. FNA E. TSH

19. A38-year-oldfemalepresentstotheEDwitha2-dayhistoryofshortnessof breathandchestpain.Shestatesthatshehasfelttiredforthepastcoupleof weeksbutisotherwisevagueinreportingherhistory.Shedeniesanyhistoryof smoking.PMHisunremarkable.Onphysicalexamination,shehasdiffuse wheezingbutnocalftendernessorlowerextremityedema.BP=126/74mmHg, pulse=80,RR=20,temperature=98.6°F.D-dimeriselevated.CXRrevealsno infiltrate.ShesubsequentlyundergoesaCTscanwhichrevealsan8-mmround nodulewithoutassociatedlymphadenopathyoreffusionsandnoevidenceof pulmonaryembolism.Therearenocalcificationsinthenodule.Sheistreated withalbuterolanddischargedhomeinstablecondition.Whatistheappropriate recommendationtothispatientuponoutpatientfollow-upwithherprimarycare physician?

A. Follow-upCTchest B. Bronchoscopy C. Needlebiopsy D. Follow-upCXR E. PET-CTscan

20. A75-year-oldfemalewithahistoryoftwoMIspresentstotheEDafterfainting.

Shereportsfatigueanddyspneafor2months.Shehasmildchestpainand dyspnea.A12-leadECGrevealsabradycardiawithaventricularrateof35bpm. BP80/55mmHg.Examinationreveals:General—milddistress,Heart—regular, bradycardia,nomurmurs,Lungs—clearwithoutcrackles/effusions,Skin—cold, clammy.HomemedicationsincludeASA,metoprolol,atorvastatin,andlisinopril. ECGisasbelow.Priorechocardiogramfrom6monthspriorshowedEFof29% withdiastolicdysfunction;valveswerenormalwithoutstenosisorregurgitation. LaboratorytestingrevealsnormalelectrolytesincludingMgandK.Troponinis elevated.Whatisthemostappropriatemanagement?

A. Echocardiogram B. Nitroglycerin C. Metoprolol D. Atropine E. ICD

21. A40-year-oldmalepresentstoyourofficewithacomplaintof“chestburning” andcoughforthepast5to6months.Thepainisnotrelatedtomealsandis intermittent.Triggersforhissymptomsincludedrinkingalcoholandlyingflatin bed.Hedeniesfoodgettingstuckuponswallowing.Hehastriedover-the-counter calciumcarbonateandusedranitidineasneededwithminimalreliefofsymptoms. Hedeniesanyrecentweightloss.Hedeniesanydarkorbloodystools.Heisa nonsmoker.Hedeniesanyhistoryofseasonalallergies,itchy/wateryeyes, sneezing,dyspnea,orpriordiagnosisofasthma.HisPMHissignificantforHTN, whichiscontrolledwithmetoprolol.Hedoesnottakeanyothermedications. Physicalexaminationisunremarkable.Howwouldyoutreatthispatient?
======================================
A. Helicobacterpyloriantigen B. EGD C. pHmonitoring D. Gastrinlevel E. Omeprazole

intermittentabdominalcramping/bloatingwithflatus.Shereportshavingloose, waterydiarrheaveryfrequentlyonandoffforseveralyears,buthersymptoms havebeenworserecently.Priortoinitialonsetshehadnormal,formeddaily bowelmovements.Herweightis75kgandonreviewofherrecordsitis7kgless thanwhenhersymptomsfirststarted.Shedeniesanybloodinthestool.Thereis nofamilyhistoryofIBDorcoloncancer.Thepatient’sonlypastmedicalhistory isdepressionforwhichsheisundergoingcounseling.Laboratoryevaluation revealsAST65U/L,ALT55U/L,TSH3.0mU/L,andCr1.0mg/dL.Blood countsshowHgb9.8g/dLwithMCV70fL.Vitals:T37°C,BP120/85mmHg, RR16.Physicalexaminationrevealsarashonextensorsurfacesofbothelbows witherythematousvesiclespresent.Astooltestforoccultbloodisnegative.She isacollegestudentandisstudyingforhermidtermexamination.Whattestshould bethenextintervention?

A. EGDwithsmallbowelbiopsy B. Colonoscopy C. Loperamide D. Sertraline E. Skinbiopsy

23. A65-year-oldCaucasianfemalewithahistoryofDM,HTN,andalargeanterior wallMI5yearsagopresentstothecliniccomplainingofshortnessofbreath.At baselinethepatientfindsitdifficulttodoanyhouseholdchores.Shehasshortness ofbreathatrestandishomeboundbecauseofhersymptoms.Vitalsignsare: Temperature=98.7°F,HR=62,RR=19,BP=160/85mmHg,oxygen saturation=90%onroomair.Therearebibasilarcrackleswithscattered expiratorywheezes.Thereisalso2+pittingedemaofthelowerextremities.JVP ismeasuredjustabovetheclavicle.AnECGrevealsleftventricularhypertrophy (LVH),withQwavesandT-waveinversionsinV1toV4anddiffusenonspecific STsegmentabnormalities.ACXRshowscardiomegalyandconsiderable congestionofthepulmonaryvasculature.Priorechocardiogramobtained1year priorshowsEF30%withwallmotionabnormalities.Labsarenormalincluding CBC,Cr,K.Thepatient’smedicationsincludelosartan,carvedilol,andaspirin. Whatisthemostimportantlong-terminterventionforthispatient?

A. Isosorbidedinitrate B. Spironolactone C. Hydralazine D. Digoxin E. Furosemide

24. A23-year-oldfemaleisinyourclinictobeevaluatedforwheezingandshortness

ofbreath.Shehasnohistoryofrespiratoryproblemspriortothepastfewmonths. Sherecentlyjoinedagymandbeganincreasingherphysicalactivity.Everytime sherunsshehassimilarsymptomsofwheezingandshortnessofbreath. Symptomsseemtolastthedurationoftheactivitybutwillresolveafterward.She hasnodyspneabetweenepisodes.Shedeniesrunnynose,sneezing,congestion. Shehasnofevers/chillsorsputumproduction.Shehasnoknownallergies.She doesnotsmoke.Physicalexaminationrevealsayoungfemalewithnorespiratory distress.Cardiacexaminationrevealsnormalrate,nomurmursareappreciated, andJVPisnotelevated.Lungexaminationrevealsnormalexpansion,goodair movementinalllungfieldswithoutrhonchiorwheezing.Peakflowinclinicis normal.PFTsareobtainedandshowFEV1/FVC0.8.FEV1is93%ofpredicted. TLCisnormal.Whatisthemostappropriatemanagement?
======================================
A. CXR B. Inhaledfluticasone C. Reassurance D. Inhaledalbuterolprn E. Inhaledsalmeterol

25. A35-year-oldfemaleundergoesroutinelaboratoryworkupforaninsurance physical.LabsrevealWBC5.0103/mm3,Hgb12.7g/dL,Cr1.0mg/dL. Urinalysisshows2+bacteriaandurineculturegrows105CFUEscherichiacoli. PMHisotherwisenegative.ShehashadoccasionalUTIsinthepastbutnonefor thepastyear.Heronlymedicationisoralcontraceptives.UrinehCGisnegative. Vitalsignsare:Temperature=98.6°F,BP=115/60mmHg,pulse=80,RR=20. Lungsarecleartoauscultationbilaterally.Bothheartrateandrhythmareregular, withoutmurmurs.Thepatientappearswellandisalertandoriented.Shehasno tendernessattherightcostovertebralangleandnosuprapubictenderness.Whatis theappropriatenextstepinmanagingthispatient?

A. Nitrofurantoin B. Ciprofloxacin C. Trimethoprim-sulfamethoxazole D. Notreatment E. Repeaturinalysisandculture

26. A45-year-oldfemaleisbroughttotheEDcomplainingoffatigue.Thepatienthas beenfeelingextremelyweakoverthepastfewdays.Todayshestoodupand almostfainted,promptinghervisit.Shehashadcough,rhinorrhea,andnasal congestionforthepastweek.Todayshealsobeganhavingnausea,vomiting,and severeabdominalpain.Pastmedicalhistoryissignificantforhypertension,CKD, andSLE.Homemedicationsarelisinopril,hydroxychloroquine,andprednisone 15mgdaily.Vitals:Temperature=38.5°C,BP=85/55mmHg,HR=126.

General—appearsweak,lethargic.Cardiac—tachycardic,regular,without murmurs.Lungs—occasionalrhonchi,nowheezing.Abdomen—diffuse tendernesswithnormalbowelsounds.Labs:Na124,K5.3,Cr3.0(baseline1.8). Hgbis11.1g/dL.ThepatientisdiagnosedwithinfluenzaandstartedonIVfluids. After2Lofnormalsalineherbloodpressureis90/60mmHg.Whatisthemost appropriatenextstep?

A. Cortisollevel B. IVhydrocortisone C. CTadrenalglands D. MRIpituitary E. Cosyntropinstimulationtest

.

A71-year-old female presents to the ED with a 2-day history of severe abdominal

pain.Paindevelopedsuddenlywithnoclearcorrelationtomeals.Hersymptoms weremildatfirst,becomingsevereinthenext6to10hours.Shehasnausea,but deniesvomitingordysphagia.HerpastmedicalhistoryissignificantforGERD, CHF,poorlycontrolledDM,andatrialfibrillation.Sheisafebrile.HR70,BP 135/85mmHg.Cardiacexaminationrevealsa3/6systolicmurmurinLaxillaand irregularlyirregularheartrate.Herabdominalexaminationrevealsverymild tendernessinthemidabdomen.Herstoolispositiveforblood.Laboratorystudies showHgb10.0g/dL,WBC17.5103/mm3,Na144mEq/L,Cl105mEq/L,K4.0 mEq/L,HCO320mEq/L,Cr1.1mg/dL,A1c12.6%,andINR1.6.Medications aremetoprolol,warfarin,insulin,andenalapril.Whatistheappropriatenextstep inevaluation? A. CTangiography B. Gastricemptyingstudy C. Colonoscopy D. EGD E. VitaminK

whichismostlycentrallylocatedandradiatestotherightsideofhisneck.The painworsenswithdeepbreathingandimproveswhenhesitsup.Hedenies nausea,vomiting,sweating,andSOB.Hehadanupperrespiratoryinfectionabout 2weeksagowhichresolvedwithouttreatment.PMHissignificantfor hyperlipidemia.Hetakeslovastatin.Hesmokeshalfapackofcigarettesaday. Vitalsignsare:Temperature=99.4°F,BP=125/80mmHg,pulse=84.Physical examinationissignificantforafrictionrubovertheleftsternalborderheardbest whenheleansforward.A12-leadECGshowsSTelevationinleadsI,II,III,aVL, V2,V3,V4,V5,andV6.EchocardiogramshowsEF50%withnoregionalwall motionabnormalitiesandnormalvalvularfunction.Thereisasmallpericardial

effusion.Whatisthemostappropriatenextstep?
======================================
A. Coronaryangiogram B. Drainageofpericardialeffusion C. Prednisone D. Azathioprine E. Ibuprofen

departmentwithcomplaintofchestpainandSOBthatstartedlastevening.His chestpainisontherightsideofthechestandisstabbinginquality,andthepain increaseswithinspiration.Heisshortofbreathevenatrest.Hedeniesany traumaticeventoroverexertion.Healsodeniesfevers,chills,andsputum.Hehas a35-pack-yearsmokinghistory.Hetakestiotropiumandalbuterolprn. Temperature=98.2°F,BP=130/80mmHg,HR=115,RR=24.Pulseoximetry shows84%oxygensaturationonroomair.Heis6ft2inand175lb,andhe otherwiseappearshealthy.PhysicalexaminationrevealsabsentbreathsoundsinR upperlungfield.Thereisminimalend-expiratorywheezinginbothlungswithout crackles.Nostridorisappreciated.Heartexaminationrevealsregulartachycardia withoutmurmurs.JVPisflat.Thereisnolowerextremityedema.Whatisthe appropriatenextstepinmanagingthispatient?

A. Albuterol–ipratropiumnebulizer B. Prednisone C. Chesttubeinsertion D. Azithromycin E. Pleurodesis

officeforevaluation.Heisdoingwell,exceptforsomepalpitationsoverthepast fewmonths.Hedeniesassociatedshortnessofbreathorsyncope.Hehasnever fallen.Onphysicalexamination,younoteanirregularlyirregularheartrhythm andamiddiastolicmurmurintheLaxilla.Examinationisotherwisenormal.You obtainanECG,whichconfirmstheirregularlyirregulararrhythmia.Thepatient hasnohistoryofbleedingandHgbisnormal.Whatistherecommended medicationtostartthepatienton?

A. Aspirin B. Dabigatran C. Clopidogrel D. Warfarin E. Fondaparinux

chestpainanddyspneainducedbyliftingweights,shovelingsnow,andrunning onatreadmill.Vitalsignsareasfollows:Temperature=98.3°F,HR=85,RR= 17,BP=165/85mmHg.Physicalexaminationrevealsa4/6crescendo– decrescendomurmurheardattherightuppersternalborderwithradiationtothe carotidarteries,weakanddelayedcarotidpulses,andanS4gallop.ECGreveals sinusrhythmwithoutarrhythmia.EchocardiogramrevealsEF45%andaortic valvearea0.8cm2.Priorcoronaryangiography1yearpriorshowed20%lesionin themid-LAD,30%RCAlesion,andnosignificantstenosisintheLcircumflex artery.Whatisthemosteffectiveinterventionstrategyforthispatient?
======================================
A. Nitroglycerin B. Aorticvalvereplacement C. Aspirin D. CarotidDoppler E. Coronaryarterybypassgrafting

32. A38-year-oldfemalepresentstoyourofficecomplainingofleftkneepainforthe past2to3months.Shedeniesanyhistoryofinjury.PMHissignificantforSLE. Shewasrecentlyincreasingherrunninginanattempttoloseweightbutherpain isnowlimitingheractivity.Shedescribesherpainasprimarily“aroundandunder mykneecap.”Shepointstoherpatellaandtheanterioraspectofherkneeasthe siteofherpain.Sheespeciallyhasdifficultyclimbinganddescendingstairs.She hasfullrangeofmotionwithoutpain.Shehasnotendernessalongmedialor lateraljointlines.Examinationrevealsnegativeanteriorandposteriordrawer tests,fullROMinflexionandextensionwithoutcrepitus,noeffusionorerythema present.X-raysofthekneerevealnormalalignmentwithpreservationofjoint space.Labs:Na135mEq/L,K4.0mEq/L,Cr2.3mg/dL.ANAispositive.ESR

10mm/hr.Whatisappropriatenextstepinthemanagementofthispatient?

A. Corticosteroidinjection B. Physicaltherapy C. Kneearthroscopy D. MRIknee E. Ibuprofen

33. A57-year-oldmalehadafastingplasmaglucoselevelof160mg/dL1monthago. Today,hisfastingglucoselevelis140mg/dL.Hismedicalhistoryissignificant forCHFandhyperlipidemia.Hiscurrentmedicationsincludeaspirin,lisinopril, andmetoprolol.Heis5ft11inandweighs215lb.BP142/79.Thispatientis asymptomatic,andhisphysicalexaminationisunremarkable.Labs:Na142 mEq/L,K4.0mEq/L,Cr1.7mg/dL.Urinemicroalbumin:Crratio>30mg/g.A1c 7.1%.Inadditiontolifestylechangesincludingincreaseinphysicalactivity,diet changes,andweightloss,howwouldyoumanagethispatient?

A. Hydrochlorothiazide B. Insulin C. Pioglitazone D. Metformin E. Lisinopril

historyofdrycough,SOB,andfatigue.Shehasa10-pack-yearsmokinghistory. Vitalsignsare:Temperature=98.2°F,BP=132/79mmHg,HR=74,RR=16. Pulseoximetryshows96%O2saturationonroomair.Examinationreveals cracklesbilaterallyinthelowerlungfields.Thereisnowheezing.Shehastwo tendererythematousnodulesonherleftlegmeasuringapproximately3×3cm. CXRshowsbilateralhilaradenopathy.Whatisthenextbesttestinorderto confirmthesuspectedunderlyingdiagnosisthatexplainsthepatient’s constellationofsymptoms?
======================================
A. Serumcalcium B. CTchest C. ACElevel D. Biopsyleglesion E. Biopsyhilaradenopathy

35. A68-year-oldmalewithahistoryoflungcancerundergoesfollow-uplabsafter recentcycleofchemotherapy.Hehasmilddifficultywithconcentrationoverthe pastweekbutisotherwiseabletocompleteallofhisdailytasks.Hedeniesany nausea,vomiting,orpositionallightheadedness.Hehasnoothersignificantpast medicalhistory.Hetakesnomedicationschronically.Vitalsignsareasfollows:

Temperature=99.8°F,RR=18,BP=135/88mmHg,pulse=76.On examination,heisalertandoriented.CardiacexaminationrevealsRRR,no murmurs,JVPnotelevated.Lungandabdominalexaminationisnormal.Thereis nolowerextremityedema.Skinturgorisnormal.Neurologicexaminationreveals 5/5strengthinallextremities,nofocaldeficitsandnormalgait.Laboratorytests revealthefollowing:WBC=8.3×103/mm3,Hgb=10.2g/dL,glucose=106 mg/dL,serumNa+=121mEq/L,K+=4.3mEq/L,BUN7.0mg/dL,Cr0.4 mg/dL.TSH2.0mU/L.Serumosmolality250mOsm/kg,urineNa45mEq/L, urineosmolality450mOsm/kg.Whatwouldbethemostappropriatemanagement ofthispatient?

A. AdministerIVnormal(0.9%)saline B. Initiatefluidrestriction C. Initiatehemodialysis D. Administerhypertonic(3%)saline E. Administerhydrochlorothiazide

36. A20-year-oldmalepresentsforevaluationafteranepisodeofdarkurine.Hefelt wellupuntil2weeksagowhenhehadasorethroatandmildfeverforwhichhe didnotseekmedicalcare.Urinarysymptomsstartedthedaypriortoevaluation. Hedeniescough,dyspnea,hemoptysis,jointpains,dysuria,andflankpain.He doeshavetworecentsexualpartnersbutusescondoms.Hehasnopriormedical historyanddeniesanyfamilyhistoryofrenaldiseases.BP145/90mmHg,HR 65,T37°C.Physicalexaminationrevealsawell-appearingmalewithnormal heartsounds,clearlungs,andmildlowerextremityedema.Therearenoskin lesions.Urinalysisthatisobtainedisdarkredincolor.Microscopicexamination ispositivefordeformedRBCsandRBCcasts.Cris1.6mg/dL.Whatisthemost likelytesttohelpaidinthediagnosisofthispatient?

A. ANCA B. Anti-GBM C. HIV D. Antistreptolysintiter E. IgAlevels

37. A31-year-oldfemalewithhypertensionpresentstoyourofficecomplainingof painfuljointsforthepast4to5months,affectingherwrists,ankles,andknees. Shealsoreportsseveraloutbreaksofarashoverherfaceoverthepastfew months.Heronlymedicationsarehydrochlorothiazideandacetaminophenas needed.Vitalsignsareasfollows:Temperature=99.2°F,RR=20,BP=145/83 mmHg,pulse=78.Physicalexaminationrevealsthreeulcersinhermouthand mildswellingoftheleftwristandankle.Shehas1+pittingedemainherlower extremitiesbilaterally.Examinationisotherwiseunremarkable.CBCrevealsa

WBCcountof2,300/mm3,Hgb12.2g/dL,andplatelets82,000/mm3.Whatisthe mostlikelydiagnosis?
======================================
A. Osteoarthritis B. Reactivearthritis C. Behçetdisease D. Gout E. SLE

complainsofatremorinhishandsthatdisappearswhenheuseshishandsfor writingorhandlingutensils.Hiswifethinkshestaresoftenanddoesnotshowas muchemotionasbefore.Hestillparticipatesinhisusualactivitiesandenjoys gardeningwithhiswife.Hisappetiteandsleephabitshaveremainedunchanged. Weightissimilartohislastclinicvisit.Shenoticesthatheisslowerinmoving thanbeforeandwalkssteadily.Onexamination,younoteamildrestingtremor andafixedexpressiononhisface.Thereisresistanceonpassiverangeofmotion withupperextremities.Gaitisslow,withoutimbalanceorfalling,andhisarm doesnotswingwhenwalking.Hescored26/30onMini-MentalStatus Examination.Whatisthebestinterventiontoimprovethepatient’ssymptoms?

A. Fluoxetine B. Carbidopa–levodopa C. Propranolol D. Memantine E. Deepbrainstimulation

39. A24-year-oldmalepresentstoyourofficehavingwithworseningRLQcramping abdominalpainforthepast2months.Hereportshavingdiarrheaonandofffor thepast1to2years.Hepreviouslyhadcolonoscopywithaterminalileumbiopsy showingulceration,acuteinflammation,andnoncaseatinggranulomas.Two monthsagohewasplacedonmesalamine.Hehaslost20lbsincethendespite attemptingtoincreasehisdietaryintake.Hedeniesanyothermedicalproblems andtakesnoothermedications.Hisphysicalexaminationrevealsmildtenderness intheRLQwithnormalbowelsounds.Therearenoanalfissuresorfistulae.His stoolisnegativeforoccultblood.Vitalsignsareasfollows:Temperature= 98.7°F,RR=15,BP=122/78mmHg,pulse=65.BMI21.Laboratorytest resultsshownormalliver/renalfunction.CBCshowsHgb9.9g/dL,MCV82fL, WBC10.1×103/mm3.X-rayabdomenrevealsnonspecificgaspatternwithout freeairordistendedbowelloops.CTenterographyrevealsthickenedmucosain distalileumwithadjacentmesentericstranding;thereisnofistula,abscess,orfree airpresent.Whatwouldbethesinglemosteffectiveinterventionrecommendedto thispatient?

A. Loperamide B. Azathioprine C. Infliximab D. Surgicalresection E. Ciprofloxacinandmetronidazole

40. A58-year-oldmalepresentstoyourofficewithcomplaintofleftwristpainforthe past3months.Hecannotrecallanyhistoryofinjuryortrauma.Heworksasacar mechanic.Healsohasanewgranddaughterwhois6monthsoldthathebabysits everyweekend.Heisanamateurgolferwhentimeallows.Hedeniesneckpain. Hehasnoassociatedparesthesiasorweakness.PMHissignificantformildHTN andchronickidneydiseasewithabaselineCrof2.5mg/dL.Examinationreveals normalsensationthroughoutbilateralupperextremities.Neck flexion/extension/rotationdoesnotreproducehissymptoms.Strengthtestingis normalinbilateralupperextremities.Thereisnoevidenceofmusclewastingon examinationofthehands.Withthepatientmakingafistsurroundingthethumb, ulnardeviationofthewristproducespainoverthedistalradialstyloid.Prolonged wristflexiondoesnotelicitpain.Palpationovertheflexorsurfaceofthewrist basedoesnotreproducethepatient’ssymptoms.Painisnotelicitedwithresisted wristextensionorflexion.Whatisthemostappropriatenextstepinmanagement?
======================================
A. Thumbspicasplint B. Wristsplint C. Counterforceforearmbrace D. Carpaltunnelcorticosteroidinjection E. Ibuprofen

41. Youareahospitalistcalledtoevaluatea74-year-oldfemaleforSOBand

increasingoxygenrequirements.Shedeniesanycoughorsputum.Thepatient wasadmittedyesterdaywithmultiplelegfracturesafteramotorvehicleaccident. Shehasbeenonstrictbedrestsinceadmissionwhileaplanismadeforsurgical repair.Shehasmildchestpainandfeelsshortofbreath.Pastmedicalhistoryis significantforCHFandCOPD.Sheiscompliantwithhermedicationswhich includetiotropium,furosemide,metoprolol,andinhaledfluticasone.Temperature =100.0°F,BP=116/74mmHg,pulse=120,RR=24,oxygensaturation=91% on5Lofoxygenvianasalcannula.Generalexaminationrevealsapatientwhois alerttonameandyearbutshedoesnotknowwheresheis.Mentalstatuson admissionwasnormalandshehasnohistoryofdementia.Sheismoderately tachypneic.Lungexaminationrevealsgoodairmovementthroughoutwithno wheezing,crackles,orconsolidation.JVPisnotelevated.Therearescattered petechiaeontheupperchest.Bilaterallowerextremitieshavesymmetric1+ edemawithoutcalftenderness.CTchestshowsscatteredground-glassopacities

withoutconsolidation,nosegmentalorsubsegmentalemboli,andnoeffusions. Whatistheappropriatenextstepinmanagement?

A. Albuterol B. Reductionoffracture C. Furosemide D. Levofloxacin E. IVheparin

symptomsseveraltimesoverthepastyearbutthisepisodeisworse.Hedenies anyassociatedchestpain,lightheadedness,orsyncope.Hedeniesanyhistoryof medicalproblemsandtakesnomedications.Examinationrevealsanadultmalein nosignificantdistress.Cardiacexaminationissignificantforregulartachycardia withnoJVPelevation.Lungsareclearwithoutcracklesorwheezing.Thereisno lowerextremityedema.ECGshows:__________________.Whatisthebest interventionatthispoint?

A. Valsalvamaneuver B. Adenosine C. Metoprolol D. Digoxin E. Cardioversion

43. A38-year-oldfemalepresentstoyourofficewithpaininherwrists,ankles,and kneesbilaterally.Shereportsnoticingnumbnessandmorningstiffnessinher handsabout1yearago,mostlyincoldweather.Thisstiffnessgraduallyspreadto herwrists,knees,andankles,withlesserinvolvementofhershoulders.The stiffnessandpainareworseinthemorningbutimproveasthedaywearson. Symptomshavegraduallyworsened.Somedaysshecannotgooutsideherhouse becauseofthepain.Shedeniesahistoryofrashorphotosensitivity.Sheoften feelstiredand“wornout.”MedicalhistoryissignificantforHTN,forwhichshe

takeshydrochlorothiazide.Onexamination,hermetacarpaljointsandwristsare swollenandtender,asareherkneesandanklesbilaterally.Herexaminationis otherwiseunremarkable.Labsrevealnormalliverandrenalfunction.CBCis unremarkable.ESR65mm/hr.CCPispositive.ANAisnegative.X-raysofhands showerosivechangesinMCPjoints.Whatisthemostimportantinterventionfor thispatienttocontrolherdisease?
======================================
A. Prednisone B. Corticosteroidinjection C. Indomethacin D. Hydroxychloroquine E. Physicaltherapy

44. A60-year-oldfemalepresentstotheEDwithacomplaintofRUQabdominalpain thatbeganseveralhoursago.ShehashadoccasionalRUQpainoverthepast3 monthsbutneverthissevere.HerPMHisonlysignificantforHTNand osteoarthritis.Onphysicalexamination,sheappearsill.Scleralicterusispresent. ShehasRUQabdominaltendernesswithoutperitonealsignsandbowelsounds arenormal.Therearenosurgicalscarsontheabdomen.Initialvitalsignsareas follows:Temperature=102.1°F,RR=16,BP=95/70mmHg,pulse=120. LaboratorytestsrevealALT136U/LandAST119U/L,ALP105U/L,direct bilirubin4.5mg/dL,andWBCcount16.8×103/mm3.Ultrasoundoftheabdomen showscommonbileductdilatationwithgallstonesobstructing.Piperacillin- tazobactamisstartedandthepatientisresuscitatedwithIVfluids.RepeatBP12 hoursafterantibioticsand4LofIVfluidsisBP=110/82mmHgandHR=85. Temperature=98.8°F.Whatisthenextstepinmanagingthispatient?

A. Cholecystectomy B. Liverbiopsy C. ERCP D. MRCP E. Percutaneoustranshepaticcholangiography

45. A42-year-oldfemalepresentstotheclinicforpre-employmentscreening.Sheis startinganewjobasabusdriverandneedstohaveaphysicalandTBtestbefore beinghired.Shedeniesanyfever,chills,sputum,andweightloss.Shewasborn inAmericaandhasnottraveledoutsideofthecountry.Shehasneverreceiveda tuberculosisvaccine.Shedeniesanycontactwithanyoneinfectedwith tuberculosis.ShedoesnotuseIVdrugs.RecentSTDtesting,includingHIV,was negative.Physicalexaminationisnormalincludinglungs.PPDtestingis performedandonreevaluationin48hoursthereis10mmofinduration.Whatis thebestrecommendationtothepatient?

A. AFBsputumculture

B. Rifampin,isoniazid,pyrazinamide,ethambutol C. Isoniazid D. Chestx-ray E. Nofurtherintervention

occasionalpaininbothkneesthatisusuallydullandresolveswith acetaminophen.Overthepastfewdays,hehashadswellingwhichhasmadeit difficulttomovethejoint.Hehadasimilarepisodeofswellingayearagothat resolvedonitsownbutthisepisodeismuchmoresevere.Hedeniesany precedingtrauma.Hedeniesanymorningstiffness.Hehaspaininhisrightknee aswell,butitismildanddoesnotbotherhimthatmuch.Onphysical examination,hehasamoderateeffusioninhisleftkneewitherythemaoverlying (noeffusionintherightknee).Hehascrepitusinbothknees.Strengthisnormal, andexaminationdoesnotindicateanyligamentousinstability.X-rayshowsmild narrowingofthejointspaceandcalcificationofthecartilage.Aspirationofthe effusionrevealsstraw-coloredfluid,25,000WBCs,85%PMNs,Gramstainand culturearenegative.Evaluationforcrystalsrevealsnointracellularnegatively birefringentcrystals,butdoesrevealmultipleintracellularpositivelybirefringent rhomboid-shapedcrystals.Whatisthemostappropriatelaboratorytesttoobtain?
======================================
A. Uricacid B. TSH C. ANA D. ESR E. HLA-B27

47. A62-year-oldfemalepresentstoyourclinicwithquestionsregardinghernew diagnosisofosteoporosis.Shehadahipfracture6monthsagoafterafall. Subsequently,shehadaprolongedhospitalcoursecomplicatedbyaDVTfor whichshecompletedtherapywithwarfarin.Shehashadnofurtherfallsandis backtoherbaselinelevelofactivityaftera1monthrehabilitationstay.Shehada DEXAscanwhichshowedaT-scoreof−2.6inthehipand−2.3invertebrae.Her pastmedicalhistoryincludesachalasiaforwhichshegetsdilatationsasneeded. Currentlysheonlytakesomeprazoleonadailybasis.Labsincludingrenal function,calcium,andvitaminDareallnormal.Sheisinquiringaboutfurther optionstopreventherfromhavingfractures.Whatistheappropriatemanagement ofthispatientbesidesrecommendingcontinuedsupplementationwithvitaminD andcalcium?

A. Zoledronicacid B. Alendronate C. Raloxifene

D. Calcitonin E. Estrogen

diagnosedwithcholecystitisandhasacholecystectomyperformed.Thefollowing dayshecomplainsofpalpitations.Onquestioningshehashadanirregularheart beatoff/onforthepastfewmonthsbutacutelyworsenedduringthisepisode.She alsonotesa15-lbweightlossoverthepastmonth.Shedeniesdizziness,syncope, dyspnea,orchestpain.Shehasaknownhistoryofhyperlipidemiabuthas otherwisebeenhealthy.MedicationsincludeASAandatorvastatin.Vitals: Temperature=102.4°F,BP=155/88mmHg,pulse=134.Oxygensaturationat roomair=96%.Physicalexamination:patientisagitatedandappearsconfused, sometimesansweringquestionsinappropriately.Skinisdiaphoretic.Neckis supplewithouttendernessandnopalpablenodulesorenlargement.Cardiac examinationrevealsanirregularrhythm,tachycardia,andnomurmurs.ECG confirmsatrialfibrillationwithrapidventricularresponse.TSHis<0.01mU/L. Whatisthemostappropriatenextstepinthemanagementofthispatient?

A. Radioactiveiodineuptakescan B. Iodine C. USthyroid D. Propranolol E. Thyroidectomy

officewithacomplaintoftwoepisodesofbloodyurineoverthepast24hours.He deniesanyflankpain,dysuria,fevers,orchills.Hisurinestreamisstrong,heis abletovoidcompletelyandhedeniestheneedtostart/stoporstrainduring urination.PMHissignificantforhyperlipidemia,HTN,diabetes,glaucoma,and osteoarthritis.Hehassmokedonepackofcigarettesperdayforthepast35to40 years.PhysicalexaminationrevealsnoCVAorsuprapubictenderness.Prostate examinationrevealsnontender,nonenlargedprostate.Urinalysisshowsgross hematuriawithoutproteinuria,pyuria,orRBCcasts.Cr1.1mg/dL.Urineculture isnegative.Whatistheappropriatenextstepinmanagingthispatient?
======================================
A. CTurography B. Ultrasoundkidneys C. Renalbiopsy D. PSA E. Prostatebiopsy

50. A57-year-oldmalepresentstoyourofficewitha2-weekhistoryofcough.The coughisassociatedwithclearsputum,occursdailyandhaspersistedoverthepast 2weeks.Hehasoccasionaldyspneaandwheezingattimes.Hedeniesmyalgias,

fevers,orchills.Hehasexperiencedchestdiscomfortduetoexcessivecoughing. PMHisnegativeandhetakesnomedicationsandspecificallydeniesanyhistory ofpulmonarydisease.Temperatureis99.1°F.RR18.O2saturationis96%on roomair.Onexamination,thepatientisinnorespiratorydistressandisbreathing comfortably.Auscultationoflungsrevealsscatteredrhonchiandwheezingbutno consolidation,egophony,orcrackles.CXRshowsnormalexpansionofthelungs withoutinfiltratesoreffusions.Peakflowis530L/min(expected556L/min). Whatisthemostappropriatemanagement?

A. Prednisone B. Oseltamivir C. Azithromycin D. Albuterol E. Sputumculture

51. A32-year-oldAfrican-Americanmale,whorecentlymovedtothearea,presents toyourofficeforthefirsttimeforaroutinecheckup.PMHissignificantfortype IIDM.Heis5ft9inandweighs215lb.Theonlymedicationhetakesis metformin.Hesmokeshalfapackofcigarettesaday;doesnotdrinkalcohol;and exercisessporadically,approximatelyonceevery2weeks.Hismotherdiedatthe ageof62duetoanMI.Hisfatheris73yearsofageandishealthy.Physical examinationisnormal.Vitalsignsare:BP=146/95,pulse=73,RR=19, temperature=98.2°F.Whichofthefollowinglifestylemodificationshasbeen showntoresultinthegreatestreductioninbloodpressure?

A. DietaryApproachestoStopHypertension(DASH)diet B. Weightloss C. Decreasingalcoholconsumption D. Increasingexercise E. Smokingcessation

52. Thepatientinthepreviousquestionreturnstoyourofficein6weeksforarepeat evaluation.Hehasnocomplaints.Hestatesthathehasbeenwalkingbrisklyfor 30minutesfourtimesaweek,haslost10lb,andhasbeeneatingahealthierdiet. Hislaboratoryresultsarewithinnormallimits.HemoglobinA1cis7.2.CXR, ECG,andurinalysisarenormal.HisBPtodayisbetween140/90and145/95. Physicalexaminationisunchangedfrom2monthsago.Whatisyour recommendedtreatment?
======================================
A. Lisinopril B. Amlodipine C. Hydrochlorothiazide D. Atenolol E. Propranolol

witha3-dayhistoryoffevers,dysuria,andvomiting.Shedeniesvaginal discharge,abdominalpain,ordiarrhea.Sheissexuallyactivewithherboyfriend. Vitalsignsareasfollows:Temperature=103°F,RR=20,BP=98/65,pulse= 100.Sheappearsillandisunabletotolerateliquids,butsheisalertandoriented. Herexaminationispositiveforsuprapubicaswellascostovertebralangle tendernessbilaterally.UrinalysisrevealsnumerousWBCsandbacteria,anditis positiveforWBCcastsandleukocyteesterase.Otherlaboratorystudyresultsare withinnormallimits,includinganegativeurinepregnancytest.Whatisthelikely diagnosis?

A. Pyelonephritis B. Nephrolithiasis C. Appendicitis D. Ectopicpregnancy E. Acuteinterstitialnephritis

54. A32-year-oldmalepresentstotheEDwithacomplaintofseverelowbackpain forthelast5weeks.Hereportsthatthepainismostseverewhenhefirstwakes upinthemorningandgraduallyimproveswithexercisethroughouttheday.He cannotrecallanytraumaorinsulttohisbackwhenthepainstarted.Hedeniesany painornumbnessinthelowerextremities.Bowelandbladderfunctionisnormal. Physicalexaminationrevealsamoderatelyoverweightmaleinsomedistress.He hasveryminimaltendernessonpalpationofhislowback.Neurologic examinationisnormal.Whatistheappropriatenextstepinmanagingthispatient?

A. Localheat B. Physicaltherapy C. Nonsteroidalanti-inflammatorydrugs(NSAIDs) D. Epiduralsteroidinjection E. Surgicallaminectomy

55. A29-year-oldmalewithahistoryofasthmapresentstotheEDwithsevereSOB forthepast2days.Healsocomplainsofsorethroat,generalizedmalaise,anda nonproductivecough.Hedenieschestpain,fever,andchills.Temperature= 98.9°F,HR=95,RR=33,BP=140/82,andO2saturation=90%onroomair. Breathingislabored,andheisspeakinginshortgasps.Lungauscultationreveals bilateraldiffuseexpiratorywheezing.Thereisnourticariaorangioedemaonskin examination.ABGisdrawn:7.42/43/70/22.Whatistheappropriatenextstepin managingthispatient?

A. Cautiousoxygenadministration,targetinganSaO2<94%toprevent hypercapnia

B. IVceftriaxoneandazithromycin
======================================
C. Subcutaneousepinephrineforbronchodilation D. Nebulizedipratropiumforbronchodilation E. Nebulizedalbuterolforbronchodilation

56. A22-year-oldfemalepresentstotheEDwithabruptonsetofarash,highfever, andvomiting.Vitalsignsareasfollows:Temperature=104°F,HR=118,RR= 22,BP=76/40,andpulseoximetry=98%onroomair.Onexamination,she appearsconfusedanddisoriented.Herskiniswarm,andthereisadiffusemacular rashoverherbody.SheisadmittedtotheICUandsubsequentlydevelops multisystemorgandysfunction.Whichofthefollowingorganismsismostlikely implicatedinthispatient’sdiagnosis?

A. Streptococcuspyogenes B. Neisseriameningitidis C. Staphylococcusaureus D. Streptococcuspneumoniae E. Rickettsiarickettsii

57. A33-year-oldCaucasianmalecomestotheclinicwitha4-dayhistoryofchest pain.Thepainradiatestotherightsideoftheneckandisworsenedbydeep inspirationandimprovedbyleaningforward.Severalweeksagohehadafever andcough,whichhavebothsinceimproved.Heisafebrile,BPis130/85,and pulseis88.Onexamination,thereisascratchingsoundheardovertheleftsternal borderonexpiration.ECGshowsSTelevationinleadsI,II,III,avL,andV2to V6.Thepatientisofferedtreatmentbutrefusesallmedications.Whichofthe followingisthemostcommoncomplicationifthisdiseaseremainsuntreated?

A. Cardiactamponade B. Recurrentpericarditis C. Constrictivepericarditis D. Ventricularfreewallrupture E. Valvularinsufficiency

presentstotheemergencydepartmentwithfevers,chills,andabdominalpain.The symptomsbeganabout1weekagoandhavebeengettingworse.Theabdominal painisassociatedwithnauseaandvomiting,andshehasnotbeenabletoeat.On examination,hertemperatureis102.1,bloodpressureis104/68mmHg,heartrate is94/min,andrespiratoryrateis16/min.Herabdominalexaminationshowsright- sidedpaintodeeppalpation,andshehassevereright-sidedcostovertebralangle tenderness.Laboratoriesdemonstratealeukocytosis(15,400/mm3)andurinalysis showsWBCs,WBCcasts,protein,andbacteria.DespiteIVceftriaxonefor5 days,thepatientremainsfebrile.Thepatient’surinecultureispositivefor

Escherichiacoliandissensitivetoceftriaxoneandciprofloxacin.Whatisthe appropriatenextstepinmanagement?
======================================
A. Renalbiopsy B. CTscanwithcontrast C. Continuethecurrentantibiotic D. Stopceftriaxoneandstartciprofloxacin E. Stopceftriaxoneandrecultureurine

tachycardia.Shenormallytakesinhaledfluticasoneandalbuterolforasthma, howeversheisnotcurrentlyrespondingtothealbuterol.Onexamination,she appearsanxiousandismoderatelyshortofbreath.Thereareloudbilateral wheezesonexamination,withaprolongedinspiratoryandexpiratoryphaseand useofaccessorymusclesofrespiration.Temperature=99.4°F,pulse=116,BP= 116/56,RR=36.Oxygensaturationis91%onroomair.Examinationshowsuse ofaccessorymusclesoninspiration.Anarterialbloodgasisobtainedandshowsa pHof7.4,PO2of60mmHg,andPCO2of40mmHg.Whatistheappropriate nextsteptobetakeninthemanagementofthispatient?

A. Increasesupplementaloxygenflowrate B. IVcorticosteroids C. Azithromycin D. Intubation E. Nebulizedalbuterol

60. A61-year-oldmanwithahistoryofchronicalcoholismandparathyroidadenoma presentswithpaininhisleftkneeforthelast2days.Hedeniesfevers,chills, nightsweats,oranyhistoryoftraumatotheknee,butdoesendorseabdominal painandconstipation.Physicalexaminationissignificantfortendernessand erythematousskinoverlyingtheleftknee.Thereisalsomarkedswellingofthe leftknee.Laboratoryfindingsrevealanelevatedcalciumlevel(12.1mg/dL).If jointaspirationisperformed,whichofthefollowingwillbeseenonsynovial fluidanalysis?

A. Negativelybirefringentneedle-shapedcrystals B. Positivelybirefringentrhomboid-shapedcrystals C. Neutrophilpredominancewithgram-positivecocci D. Negativelybirefringentneedle-shapedcrystalsANDgram-positivecocci E. Normalsynovialfluidfindings

61. A26-year-oldmanpresentstohisprimarycarephysiciancomplainingoffatigue, headache,andasorethroatforthepastweek.Thereisalsonauseaanddiarrhea, butnoweightloss,productivecough,ordifficultybreathing.Hedeniesanypast

medicalhistory,doesnottakeanymedications,andhasnorecentsickcontacts. Heissexuallyactiveandusescondomsinconsistently;hedrinksalcoholheavily ontheweekendsandadmitstopreviousIVdruguse.Onexamination,his temperatureis39°Candtherestofhisvitalsignsarenormal.Hehasnontender cervicalandaxillarylymphadenopathy,tonsillarexudates,andmild splenomegaly.Therearealsoseveralpainful,well-demarcatedulcerswithinhis mouthandamildmaculopapularrashoverhischestandarms.Arapidstreptest andamonospot(heterophileantibody)testarenegative;furtherscreeningfor chlamydia,gonorrhea,syphilis,andHIVisnegative.Whatisthelikelydiagnosis?
======================================
A. Hodgkinlymphoma B. Acuteretroviralsyndrome C. Infectiousmononucleosis D. Secondarysyphilis E. Upperrespiratoryinfection

62. A30-year-oldmedicalstudentisundergoingmedicalscreeninginordertostarta rotationatanewhospital.Shedeniesanycurrentsymptomsandreportsno previousmedicalproblems.SheisoriginallyfromSouthAfricaandher vaccinationsareup-to-date,includingaBCGvaccineshereceivedasachild.A purifiedproteinderivative(PPD)isplacedandread48hourslater,whichshows anareaofindurationthatis11mmwide.Whatisthemostappropriatenextstep inmanagement?

A. Startrifampin,isoniazid,pyrazinamide,andethambutol B. Obtainachestx-ray;ifnormal,reassurethepatient C. Obtainachestx-ray;ifnormal,startisoniazidandpyridoxinefor9months D. Startisoniazidandpyridoxinefor9months E. Reassurance

63. A35-year-oldmalepresentswithcomplaintofa6-monthhistoryoffatigueand lethargy.Hismedicalhistoryisunremarkable.Hedeniesmelenaandrecent traumaorsurgery.Hereportsthathedoesnotdrinkalcohol,smoke,ortakeany medications.Hisfamilyhistoryisnoncontributory.Heappearswellnourished. Vitalsignsareasfollows:RR=16,BP=130/80,pulse=70.Laboratorytest resultsareasfollows:Hb=7.6,Hct=22.8%,andMCV=68.Theremainderof hislaboratorytestresultsarenormal.Whichofthefollowingisthebestnextstep inmanagementofthispatient?

A. Serumironstudies B. Hemoglobinelectrophoresis C. Serumleadlevels D. Peripheralbloodsmear E. Stoolguaiactest

pain,primarilyintheepigastricregion.Shehashadtwoepisodesofvomitingin thepast5hours.Shedescribesthepainassharp,withoccasionalradiationtoher back.PMHissignificantforDM,HTN,alcoholism,asthma,andchroniclow backpain.Hercurrentmedicationsincludeinsulin,atenolol,albuterolinhaler,and oxycodone.Shehashadabdominalpainseveraltimesinthepastyear,butnever thissevereandneverassociatedwithvomiting.Onexamination,shehas tendernessintheepigastricregion.Thereismildguardingbutnorebound. Physicalexaminationisotherwiseunremarkable.Temperature=101.3°F,BP= 136/88,pulse=116.Sheisalertandorientedandisinobviousdistress.Whichof thefollowingisthemostspecificfindinginthiscondition?
======================================
A. Elevatedamylase B. ElevatedALT C. Elevatedlipase D. Positivefecalfattest E. Calcificationsonx-ray

fewmonths.Shedoesnothaveanyothercomplaints.Afterathoroughmedical history,sheadmitstomildconstipationthatisnottroublesomeforher.Shereports a5-lbweightgainoverthepast6months,whichsheattributestolivingamore sedentarylifeoflateduetoherfatigueandlethargy.Herphysicalexaminationis unremarkable;herthyroiddoesnotseemenlarged,althoughherfaceisslightly puffy.Whichofthefollowingisthebestnextstepinmanagement?

A. FreeT4levels B. Thyroid-stimulatinghormone(TSH)levels C. Thyroglobulinlevels D. Radioactiveiodineuptake(RAIU)scan E. Biopsy

developingfever,neckstiffness,confusion,andseveresensitivitytolight.Vital signsonadmissionareasfollows:Temperature=105°F,RR=20,BP=120/75, pulse=92,andpulseoximetry99%onroomair.Examinationrevealsaconfused malepatientwithnuchalrigidity.Afundoscopicexaminationshowsbilateral blurringoftheopticdiskmarginsandretinalvenousengorgement.Whichofthe followingisthenextbeststepinmanagement?

A. CTscan B. MRI C. Lumbarpuncture D. Administerempiricantibiotics

E. Administerempiricantiviraltherapy

67. A64-year-oldmalepresentswithbackpain,constipation,andslightconfusionfor thepast5to6months.Twodaysagohefellwhileshovelingsnow,andhehas paininhisrightarmaswell.Plainfilmsofthespineshowseveralsmalllytic lesionsinthevertebralbodiesattheL3toL4level.Righthumerusfilmsreveal lyticareasinthemetaphysisanddiaphysisoftherighthumerus.Thereisa fracturelinethroughtheabnormalareaonthehumerusfilm.Physical examinationrevealstendernessonpalpationofthelowbackandrighthumerus, butisotherwiseunremarkable.Thereisnosplenomegalyorlymphadenopathy. CBCresultsareasfollows:Hb=9.1g/dL,Hct=27.6%,MCV=90,platelet count=150,000/μL.Serumchemistriesareasfollows:Sodium=137mmol/L, potassium=4.1mmol/L,chloride=107mmol/L,CO2=24mmol/L,glucose= 89mg/dL,BUN=46mg/dL,Cr=3.5mg/dL.Whichofthefollowingadditional findingsdoyouexpectwiththispatient’scondition?

A. Mechanicalobstruction B. Electrolyteabnormality C. Hormonelevelabnormality D. Arterialbloodgasabnormality E. Venousbloodgasabnormality

2days.Thismorninghehadanepisodeoflossofcontrolofhisurine,followed byprogressiveweaknessinbilaterallowerextremities.Hislowbackpainis severeandsharp,anditradiatesintotherightlowerextremity.PMHissignificant formildasthma.Hehashadintermittentlowbackpainforthepast2yearsbut neverthissevereandneverassociatedwithweaknessorurinarysymptoms.On physicalexamination,hehasverylimitedmotionofhislumbarspinesecondary topain.Hehas3/5strengthingastrocnemiusmusclesbilaterallyand2/5strength withgreattoedorsiflexionbilaterally.Hehasdiminishedsensationthroughouthis lowerextremities,andreflexesarediminished.Rectaltoneisabsentasis sensationintheperinealarea.Whatisthenextbeststepinmanagementofthis patient’scondition?

A. Steroids B. Surgery C. MRIlumbarspine D. Bedrest E. NSAIDs

69. A67-year-oldfemalepresentstotheEDafteratransientepisodeofvisuallossin herrighteye.Shereportsthatshehashadright-sidedheadacheforseveral

months,forwhichshetakesibuprofen,withsomerelief.Onphysical examination,shehastendernessoverherscalpinthelefttemporalregionand complainsthatherjaw“getstiredwithchewing.”Neurologicexaminationis normalwithnofocaldeficits.Vitalsignsareasfollows:Temperature=101.1°F, HR=72,RR=16,BP=140/82.Whichofthefollowingisassociatedwiththis condition?
======================================
A. Aorticaneurysm B. Inflammatoryboweldisease C. HepatitisB D. Smokinghistory E. Alcoholhistory

70. A63-year-oldfemaleisbroughttotheEDbytherescuesquadafteranepisodeof syncopeathome.Herhusbandwitnessedtheevent.Hedescribesthepatientas fallingsuddenlytothefloorfromastandingposition.Shelostconsciousnessfor about5seconds,afterwhichsherapidlyregainedconsciousnessandwasoriented andappropriate.Thepatientremembersfeelinglightheaded,nauseous,and developing“tunnelvision”priortotheevent.Nobowelorbladderincontinence wasnoted.PMHissignificantforDM,HTN,anddepression.Shedeniesany chestpainorSOB.Vitalsignsare:Temperature=100.2°F,BP=118/68,pulse= 84,RR=18.Oxygensaturationonroomairis96%.Physicalexaminationis significantonlyforbruisingofherleftwristandthigh.Heartandlung examinationisnormal.Whichofthefollowingisthemostlikelydiagnosis?

A. Arrhythmia B. Orthostatichypotension C. Seizure D. Vasovagalsyncope E. Aorticstenosis

painforthelastyear,whichhasbecomeworseoverthepast3months.Shedenies anyweaknessorradiatingpaininherlowerextremities.Shecurrentlytakes oxycodoneforherbackpainwithinadequaterelief.Shehasdifficultysleepingat nightbecauseofthebackpain.PMHissignificantforHTN,forwhichshetakesa β-blocker.Thoracicandlumbarspineradiographsshowmultiplecompression fracturesatT8,T11,L3,andL4,aswellasdiffuseosteopenia.Laboratorystudies areasfollows:WBC8,hemoglobin9.7,hematocrit29%,platelets189,Na+142, K−4.1,BUN43,creatinine2.3,calcium14.3.Physicalexaminationreveals tendernessonpalpationofthoracicandlumbarspine.Shehaslimitedlumbar flexionduetopain.Neurologicexaminationisnormal.Whichofthefollowing wouldbeabnormalinthispatient’scondition?

A. CA-15-3 B. Carcinoembryonicantigen(CEA) C. Alkalinephosphatase D. Serumimmunoelectrophoresis E. Bonescan

72. A62-year-oldfemaleisbroughttotheEDbyEMSforconfusion,headache,and vomitingoverthepast12hours.Vitalsignsareasfollows:Temperature=96.9°F, HR=100,RR=22,BP=220/150.Sheisdisorientedanduncooperative. Examinationisotherwiseunremarkable.Whatisthemostlikelydiagnosis,and whatisthemostappropriatemanagement?
======================================
A. Hypertensiveurgency;gradualloweringofbloodpressurewithoralagents B. Hypertensiveurgency;rapidloweringofbloodpressurewithIVagents C. Hypertensiveemergency;gradualloweringofbloodpressurewithoralagents D. Hypertensiveemergency;rapidloweringofbloodpressurewithIVagents E. Hypertension;gradualloweringofbloodpressurewithoralagents

increasingproblemscaringforhimathome.Shereportsthathehasrecentlyhad urinaryincontinenceandhasbeen“clumsier”thanusual.Shestatesthathe behavesinappropriatelyattimes,andontwooccasionshehaswanderedoutside thehomeandhasgottenlost.Hemisplacesitemsfrequently,andhispersonality haschangedtobeingmorebelligerentanddemanding.Heseemstolackjudgment insocialsituations,andheneverhadthisprobleminthepast.Shestatesthatthese problemshavebecomeworsegraduallyoverthepast4months.Physical examinationisunremarkable.Whatisthelikelydiagnosis?

A. Pseudotumorcerebri B. Alzheimerdisease C. Normalpressurehydrocephalus D. Multi-infarctdementia E. Lewybodydementia

74. A73-year-oldfemaleisbroughttotheEDbyEMSwithacomplaintofSOBand progressivedyspnea.HermedicalhistoryissignificantforapreviousMI5years agoandmildCHF.Thepatienthasalsohadseveralepisodesofventricular tachycardiathatultimatelyrequiredcardioversion.Sheiscurrentlytakinga prophylacticmedicationandhasnothadanyrecurrentarrhythmias.Onphysical examination,sheisinmoderaterespiratorydistressandshehasdryrales throughoutherlungfields.Temperature=99.1°F,BP=138/75,pulse=96,RR= 28.CXRisnormal,butCTscanofthechestshowsdiffuseground-glassopacities. Whichofthefollowingiscontributingtothispatient’ssymptomsandclinical findings?

A. Digoxin B. Lisinopril C. Amiodarone D. Bleomycin E. Losartan

75. A39-year-oldfemalepresentstoyourofficewitha3-yearhistoryofheadaches. Theyoccuronceortwiceperweek,lastingseveralhours.Theheadachesare throbbingandareusuallyonherleftside.Duringtheseepisodes,thepatientis incapacitatedandmustliedowninadarkroomforseveralhours.Sheissensitive tolightduringtheepisodesandcannotmovebecauseofthepain.Sheisoften nauseatedandhasvomitedonseveraloccasions.Medicalhistoryissignificantfor hypothyroidism,forwhichshetakeslevothyroxine(Synthroid).Herphysical examinationisunremarkable,howeverthepatientendorsesanothersimilar headacheandbeginsvomitingneartheendoftheexamination.Whatisthe appropriatenextstepinmanagingthispatient?
======================================
A. Propranolol B. Amitriptyline C. Chlorpromazine D. Verapamil E. Sumatriptan

MedicalhistoryissignificantforpoorlycontrolledDM(20-yearhistory),HTN, andosteoarthritisofbilateralknees.Shealsohashadchronicrenalinsufficiency forthepast5years.Hercurrentmedicationsincludehydrochlorothiazide, lisinopril,insulin,andmetoprolol.Shehasbeentakingincreasingamountsof NSAIDsforthepastseveralweeksforherpainfulknees.Sheisobesewith2+ peripheralpittingedema.Sheappearsweakwithdrymucousmembranesandis tachycardic.Laboratorytestsrevealthefollowing:Na+=138,K+=4.6,Cl−= 104,HCO3 herlastvisit3monthsago,herCrwas2.3.Whichofthefollowingwouldbemost helpfulindeterminingtheetiologyofthispatient’srenalfailure?

A. Urinedipstick B. Urinesodium C. Fractionalexcretionofsodium(FENa) D. Renalultrasound E. Nofurtherworkupisnecessary

77. A64-year-oldfemalepresentstotheEDwithsuddenonsetofseverechestpain thatoccasionallyradiatestoherback.Shehasahistoryofanginaandtakes

nitroglycerin,butthistimethepainismuchworseandisnotrelievedwith nitroglycerin.PMHissignificantforHTN.Sheisafebrile,andHR=105,BP= 160/105,RR=17.Cardiacenzymesarenegative.CXRshowsawidened mediastinum.Whatisthelikelydiagnosis?

A. Myocardialinfarction B. Aorticdissection C. Stroke D. Acuteaorticregurgitation E. Hypertensiveemergency

thatbegansuddenlyafewdaysago.Thepainissharpandthrobbing.Hehasa historyofsicklecelldiseasewithfrequentpainfulcrisesrequiringhospitalization onceortwiceperyear.Hehasnoothermedicalproblems.Vitalsignsareas follows:Temperature=101.6°F,HR=94,RR=20,BP=132/84.Oxygen saturationis97%onroomair.Hisrightshinisverytender,asishislowbackin themidline.Hisexaminationisotherwiseunremarkable.CBCresultsareas follows:Hb=7,Hct=21%,MCV=94.Osteomyelitisoftherighttibiais ultimatelydiagnosed.Whatisthemostlikelycauseofthispatient’s osteomyelitis?

A. Listeria B. Salmonella C. Shigella D. Cryptosporidium E. Campylobacter

79. A42-year-oldmalepresentstoyourofficebecausehenoticeda“lump”inhis neck1monthago.Heendorsesweightlossandpalpitations,butdeniespainor dysphagia.Onphysicalexamination,younoteanontender,firmnoduleabout2 cminsizetotheleftofthemidlineintheregionofthethyroidgland.Vitalsigns areasfollows:BP=125/82,pulse=75.Hedoesnottakeanymedicationsand hasnosignificantmedicalhistory.Hedeniesanyfamilyhistoryofthyroiddisease orcancer.Hisroutineserumlaboratoryvalues(CBC,electrolytes,BUN, creatinine)arenormal.Thephysiciandecidestodoaradioactiveiodineuptake (RAIU)scan.Whichofthefollowingfeaturesisnotassociatedwithanincreased riskofmalignancy?
======================================
A. Hardandimmobilemass B. ColdnoduleonRAIU C. Cervicallymphadenopathy D. HotnoduleonRAIU E. Microcalcifications

intermittentneckandshoulderpainwithSOBthatnormallyoccurswhenshedoes choresaroundthehouseorclimbsstairs.Sheispreviouslyhealthyanddeniesany medicalconditions.Shedoesnotsmokeordrinkalcohol.Thepatientisup-to-date onvaccinationsandhadamammogramdoneatherpreviousappointment1year agothatwasnormal.BP=148/86andpulse=88.Shehadacolonoscopy performed6yearsagothatwasnormal.YouorderanECG,CXR,CBC,and electrolytes.Whatshouldberecommendedtothepatientathervisittoday?

A. Mammogram B. Colonoscopy C. Calciumandphosphoruslevels D. Dual-energyx-rayabsorptiometry(DEXA) E. CTscanofthechest

81. A54-year-oldmalewithahistoryofparathyroidadenomapresentstotheEDwith severepaininhisrightknee.Hesaysthatthepainisextremeandintolerable,and heisinobviousdistress.Onexamination,thereisexquisitetenderness,erythema, andswellingoftherightkneejointanditfeelsverywarmtothetouch.Thepain begansuddenlyafewhoursago.Hedeniesanypreviousepisodesorpaininany otherjoints.Hedeniesanytrauma.Medicalhistoryissignificantforosteoarthritis ofhisleftknee,forwhichhetakesibuprofen.Hedrinks6to7glassesofwineper day.Hedoesnottakeanyothermedications.Vitalsignsareasfollows: Temperature=100.5°F,RR=16,BP=140/85,pulse=78.Whichofthe followingisthebestnextstepinmanagementforthispatient?

A. Indomethacin B. Jointaspirationwithsynovialfluidanalysis C. Uricacidlevels D. Kneex-ray

thepastseveralmonths.Hetakesover-the-counterantacids,butsymptomshave beenworseoverthepastmonth.Hedeniesanyweightloss,vomiting, hematemesis,ormelena.Thediscomfortisworseaftereating.Medicalhistoryis noncontributory.Hetakesnoothermedications.Hesmokeshalfapackof cigarettesadayanddrinksalcoholsociallyaboutonceperweek.Physical examinationisunremarkableexceptformildepigastrictenderness.Whatisthe appropriatenextstepinmanagingthispatient?

A. Continueantacids B. Bariumswallowevaluation C. Empiric1-monthtrialwithprotonpumpinhibitor(PPI) D. UpperGIendoscopy

E. Observation

83. An81-year-oldfemalewasinamotorvehicleaccident3daysagoandsuffereda leftfemurfracture,forwhichshehadsurgeryonthesameday.Shehasbeen hospitalizedsincethedayofsurgeryandhasbeentakingpartindailyphysical therapywithoutdifficulty.Herfamily(husbandanddaughter)reportthatshehas notbeen“actinglikeherself”attimeswhentheycometovisither.Shebecomes agitatedandisbelligerenttowardthem,andshesometimeswonderswhysheisin thehospital.Shereportsseeing“creatures.”Atothertimes,thepatientisdoing verywell,andtheydonotnoticetheseinconsistencies.Thepatienthasahistory ofborderlineHTN.Currentmedicationsincludeastoolsoftenerandmorphinefor paincontrol.Onexamination,thepatientisalertandorientedtotime/place/person andisappropriatelyrespondingtoquestions.Shedeniesanyhallucinations. Neurologicexaminationisnormal.Whichofthefollowingistrueofthispatient’s condition?
======================================
A. Anticholinergicmedicationsarefirst-linetreatment B. Pathologicfindingsincludeneurofibrillarytanglesandβ-amyloidplaques C. Long-termmemoryisintact,butshort-termmemoryisaffected D. Thisisanirreversiblecondition E. Etiologiesincludeinfectionandpolypharmacy

84. A49-year-oldfemalepresentstotheEDwithcomplaintofsevereepigastricand RUQabdominalpain.Hersymptomsstarted3daysagobuthaveprogressively worsenedoverthepast12hours.Hersymptomsareworsewithmeals.Shehas hadtwoepisodesofvomitinginthepast12hoursandisnauseouscurrently.PMH issignificantfordiabetes,osteoarthritis,andHTN.Temperature=102.3°F,BP= 146/80,pulse=110,RR=16.Onphysicalexamination,thereissevereright upperquadrantpainondeeppalpation,mostpronouncedonpalpationafterdeep inspiration.Bowelsoundsarediminished.Thepatientislyingonhersideholding anemesisbasin.Whichofthefollowingiscausingthispatient’sdisorder?

A. Alcoholicliverdisease B. Gallstoneobstructioninthecysticduct C. Obstructionfromcarcinomaoftheheadofthepancreas D. Gallstoneobstructioninthecommonbileduct E. Pancreaticinflammation

85. A31-year-oldfemalepresentstoyourofficewithmultiplemusculoskeletalaches andpainsincluding,butnotlimitedto,hershoulders,elbows,knees,neck,and buttocks.Shehashadthesesymptomsforatleastthepastyear.Shedoesnotsleep verywellwhenthepainissevereandhasnoreliefwithNSAIDs.Shehastried exercisingmore,butthepainispersistent.Onpalpation,shehasmarked tendernessoverbothlateralepicondyles,theanterioraspectofherleftshoulder,

themedialaspectofherrightknee,herposteriorneck,andherleftgreater trochanter.Therearenoeffusionsatanyoftheabovesites.Routinelaboratorytest resultsarenormal.Whatistheappropriatenextstepinmanagingthispatient?

A. Prednisone B. Naproxen C. Amitriptyline D. Colchicine E. Steroidinjections

86. A52-year-oldmalewithalong-standinghistoryofalcoholabuseisbroughttothe EDbyhiswifeforvomitingblood.Hevomitedbrightredbloodatleasttwicethis morning.PMHissignificantforcirrhosis,HTN,andarthritis.Hehasnever vomitedbloodbefore.Onexamination,thepatientisawakebutappearsnervous andisinmoderatedistress.Delayedcapillaryrefillispresent.Youareableto determinethathehasvomitedapproximately2Lofbloodoverthepast6hours. Vitalsignsare:Temperature=99.2°F,BP=90/58,HR=134,RR=20.Pulse oximetryshows98%oxygenationonroomair.Whatistheappropriatenextstep inmanagingthispatient?
======================================
A. ImmediateupperGIendoscopy B. Administrationoffluids C. Helicobacterpyloriserologictesting D. Intravenous(IV)protonpumpinhibitor E. Reassurance

87. A57-year-oldfemalepresentstotheEDwithacomplaintofabdominalpainand vomiting.Thepainisdiffuseandpoorlylocalized.Shehashadthesesymptoms forthepastmonthandhasbeenconstipatedduringthistime.Shehasnothada bowelmovementorpassedgasin3days.ShehasnosignificantPMH.Vitalsigns are:Temperature=99.2°F,BP=128/78,HR=78,RR=16.Onphysical examination,thereisabdominaldistentionandnoguardingorrebound tenderness.Theremainderoftheexaminationisnormal.Whatisthenext appropriatestepinthemanagementofthispatient?

A. Abdominalultrasound B. Colonoscopy C. Abdominalx-ray D. Sigmoidoscopy E. CTscanofabdomen

88. A43-year-oldfemalewithahistoryofCrohndiseasepresentstotheEDwitha4- hourhistoryofleftflankpainradiatingtoherleftgroin.Thepainwassuddenin onsetbutwasmildatfirst.However,ithasbeenincreasinginseverityoverthe

past2to3hours.Thepainisnowconstantandexcruciating.Itwasassociated withnauseaandvomiting,butthepatientdeniesfevers/chills.Shedeniesseeing anygrossbloodinhisurine.Medicalhistoryisinsignificant.Vitalsignsareas follows:Temperature=98.1°F,RR=24,BP=148/88,pulse=93.Onphysical examination,thepatientisinobviousdistress,writhinginpain.Shehasmarked tendernessalongtheleftflank,buttheexaminationisotherwiseunremarkable. Urinalysisreveals2+heme.UrinesedimentrevealsnocastsbutmanyRBCsand fewWBCsperHPF.Laboratorytestsrevealthefollowing:WBC8.2,Hgb11.9, Hct36.1,BUN14,Cr0.9.Aurinepregnancytestisnegative.Whatisthemost likelydiagnosis? A. Pyelonephritis B. Nephrolithiasis C. Appendicitis D. Ectopicpregnancy E. Pancreatitis

complaintofacuteSOBandanxietythatstartedsuddenly2to3hoursagowhile shewasworkingaroundthehouse.Lastnightshedranksevenglassesofwine withherhusband.Shedenieschestpain.HerPMHisunremarkable,howevershe usesdiureticstohelp“preventbloating.”Shealsotakesoralcontraceptives.Vital signsare:Temperature=99.1°F,RR=34,BP=148/90,pulse=100.Oxygen saturationis94%onroomair.Onexamination,thepatientappearshealthy althoughinmoderaterespiratorydistress.Herexaminationisotherwise unremarkable.Laboratorytestsreveal:WBC=7.1,Hgb=12.2,Hct=37.3,Na+= −=25,BUN=14,Cr=0.9,glucose=106.ABGs 138,K+=4.7,Cl−=109,HCO3 areobtainedandreveal:pH=7.52,HCO3 andECGarenormal.Whichofthefollowingistheetiologyofheracid–base disturbance?
======================================
A. Accumulationofunmeasuredanionsduetohepaticmetabolismofalcohol B. Vomitingduetoalcoholtoxicity C. Hyperventilationsecondarytoanxiety D. Electrolyteimbalanceduetodiureticuse E. Hypoventilationfromrespiratorydepressionduetoalcoholintoxication

90. A63-year-oldmaleisbroughttotheEDbyhiswifeforalteredmentalstatus.The patientregularlydrinksalcoholandhasalong-standinghistoryofalcoholuse. Overthepast24hours,hehasbecomemoreconfusedandisnot“actinglike himself”accordingtohiswife.Shestatesthathehasneveractedlikethisbefore. Onfurtherquestioning,thepatienthadanepisodeofmassivehematemesislast yearthatrequiredadmissiontothehospital,necessitatingbloodtransfusionand

othertreatmentthatthewifedoesnotrecall.Onphysicalexamination,thepatient isarousableandisalerttopersonbutnottoplaceortime.Heiscachectic,with prominentveinsoverhisabdomen.Hehasasignificantascites.Thereareseveral dilatedsuperficialarteriolesscatteredthroughouthisbody.Whenthepatient extendshisarmsoutinfrontofhim,ajerkingmovementofthelimbsisobserved. Whichofthefollowingisthemostappropriatenextstepinmanagement?

A. Furosemide B. Thiamine C. Lactulose D. Morphine E. Hydromorphone

91. A65-year-oldobesefemalepresentstoyourofficewithachiefcomplaintoflow backpainandbilateralkneepainthatisworsewithactivityandrelievedbyrest. Shehashadthispainfor6or7months.Shedeniesanyrecenttraumaorany eventthatsherecallsprecipitatingthepain.Oneyearagoshesufferedadistal radiusfracturewhenshetrippedinherbedroomandlandedonheroutstretched leftarm.MedicalhistoryissignificantforHTN,forwhichshetakes hydrochlorothiazide.Shesmokesapproximately12cigarettesperdayandhasa 25-pack-yearhistoryofsmoking.Shedeniesanyalcoholuse.Shedoesnot exercise.Onphysicalexamination,shehasnoradicularsymptoms,andthe straight-legtestisnegative.Whatistheappropriatenextstepinmanagingthis patient?

A. Intra-articularcorticosteroidinjection B. Acetaminophen C. Naproxen D. Allopurinol E. Observation

92. A46-year-oldmalepresentstoyourofficewiththecomplaintoffatigueforthe past2months.Hedoesnotabusealcohol.Hismedicalhistoryissignificantfor HTN,forwhichhetakesmetoprolol.Hedeniesmelena,hematochezia,orany otherbloodloss.Hisfamilyhistoryisnoncontributory.Hehasnosymptomsother thanfatigue.Headmitshedoesnothaveagooddiet.Vitalsignsare:BP=135/85, pulse=70.Physicalexaminationisunremarkableexceptformildpallor.Stoolis negativeforoccultblood.Laboratorytestresultsare:Hb=9.2,Hct=27.6,MCV =117.ECGisnormal.Thepatientisstartedonfolicacidand4weekslater presentswithahemoglobinlevelof10.1mg/dL.However,hereportsanew“pins andneedles”sensationinhisdistaltoesandfingers.Whichofthefollowingisthe underlyingcauseofthepatient’scurrentsymptoms?

A. Inadequatetreatmentwithfolicacid
======================================
B. Irondeficiency C. Glucoseintolerance D. VitaminB12deficiency E. Peripheralneuropathyfromdiabetesmellitus

routinecheckup.Sheisnewtoyourofficeassherecentlymovedandpresentsto establishcare.Shetakesbloodpressuremedicationsbutcannotrecallthenames. Ontoday’svisit,herBPis142/96.Sheisasymptomaticexceptforlegswelling. Physicalexaminationrevealsbilateraledemaofthelowerextremities.She smokesonepackofcigarettesperdayandhasa20-pack-yearhistory.Family historyisnegative.Hertotalserumcholesterolconcentrationis175mg/dLand HDLis40mg/dL.Routinelaboratorytestresultsarewithinnormallimits.Which medicationismostlikelyresponsibleforthepatient’scomplaint?

A. Amlodipine B. Metoprolol C. Hydrochlorothiazide D. Metformin E. Glipizide

94. A73-year-oldmaleisbroughttotheEDinacoma.HewasdeliveredtotheED fromanursinghomeandwasreportedbythenursinghomestafftohavehada seizurethatlastedlessthan1minute.Hewassubsequentlyconfusedandsoon thereafterenteredacomatosestate.HismedicalhistoryissignificantfortypeII DMrequiringinsulin,HTN,andmildCHF.IntheED,thepatientisverylethargic andrespondsonlytopainstimuli.Hisvitalsignsarestable,andCBCand electrolytelevelsarenormal.Serumglucoseis16mg/dLandseruminsulinis elevated.C-peptideis0.2ng/mL(normalrange,0.5to3ng/mL).Urine sulfonylurealevelisundetectable.Whatisthelikelycauseofthispatient’s condition?

A. Factitioushypoglycemiafromsurreptitiousinjectionofinsulin B. Insulinoma C. Somatizationdisorder D. Glucagonoma E. Dehydration

95. A78-year-oldfemalepresentstoyourofficeforaroutinecheckup.Heronly complaintisburningwhensheurinatesthatshehashadforseveralweeks.Her medicalhistoryissignificantforHTNandDM.Shehasfourchildren,all deliveredvaginally.MedicationsincludehydrochlorothiazideforherHTN, insulin,andadailyaspirin.Shewearsadultpadsbecausesheloseslargevolumes

ofurinethroughoutthedayandusuallycannotreachthebathroomintime. Physicalexaminationisunremarkable.Vitalsignsareunremarkable.Routine laboratorytestresultsarewithinnormallimitsexceptforarandombloodglucose levelof210.Urinalysisshowspositivenitritesandbacteria.Shereceivesoral antibioticsforaurinarytractinfection.Aftercompletingthecourseofantibiotics, shegoesonarun,andfeelsa“pop”aboveherheelthatisassociatedwithsevere pain.Shehaspainanddifficultywithplantarflexionoftheaffectedfoot.Which ofthefollowingantibioticsismostlikelyresponsible?
======================================
A. Trimethoprim-sulfamethoxazole B. Metronidazole C. Tobramycin D. Ciprofloxacin E. Azithromycin

difficultyconcentratingatworkforseveralweeks.Shereportsa20-lbweightloss overthepast2to3months,despiteeatingmore.Whenquestioned,shereports thatshefrequentlyfeels“hotandsweaty”atworkandathome.Shedenieschest painorpalpitationsbutdoeshavediarrheafrequently.Vitalsignsare: Temperature=98.9°F,RR=15,BP=130/80,pulse=98.Sheappearsworried. Onphysicalexamination,shehaswarmandmoistskin.Shehasaslighthand tremor.Onpalpationofherthyroid,younoteadiffuselyenlargedthyroidgland thatisnontender.Whichofthefollowingisthebestnextstepinmanagement?

A. FreeT4levels B. Thyroid-stimulatinghormone(TSH)levels C. Thyroglobulinlevels D. Radioactiveiodineuptake(RAIU)scan E. Afine-needleaspiration(FNA)biopsy

fromapatientwithchronichepatitisB.ThepatientreceivedhisfinalhepatitisB vaccinationoftheseries7yearsago.Thepatienthadhistiterscheckedbefore clinicalrotations6monthsagoandwasfoundtobepositiveforanti-hepatitisB surfaceantibodies(HBsAbs).Whichofthefollowingisthebestnextstepinthe managementofthispatient?

A. HepatitisBimmunoglobulin(HBIG)now B. SerologictestingforHBsAg C. HepatitisBvaccination D. Reassurance

98. A71-year-oldfemaleisbroughttotheEDbyherhusbandforincreasedconfusion

overthepast3days.Thehusbandreportsthatthepatientfell4daysagoand immediatelyafterthefallshewasasymptomaticbutovertheensuingdayshas becomelethargicandmoreconfused.PMHissignificantforhyperlipidema.She underwentarighttotalhipreplacement5weeksagoandwasdiagnosedwitha DVT2weeksaftertheoperation.Medicationsincludewarfarinandatorvastatin. Twoweeksago,herINRwas2.7.Onexamination,patienthasslurredspeechand appearsconfused.Sheisorientedtopersonbutnottoplaceortime.Neurologic examinationisnormal.Theremainderofphysicalexaminationisnormal.Ahead CTisorderedwhichconfirmsthediagnosis.Whichofthefollowingisthe etiologyofthispatient’scondition?

A. Tearingofthemiddlemeningealartery B. Tearingofthebridgingveins C. Rupturedaneurysm D. Hypertensivehemorrhage E. Alzheimerdisease

productivecough,fever,andchillsforthepast2days.Thepatientliveswithhis wifeandisretired.PMHissignificantforDM,forwhichhetakesinsulin;CHF, withanejectionfractionof40%;andahistoryofrenalinsufficiency.Heisalert andoriented.Thereisnohistoryofsmokingoralcoholuse.Onphysical examination,thepatientislethargic.Hehascracklesovertheleftlowerlung. Cardiovascularexaminationisnormal.Vitalsignsare:Temperature=103.3°F,BP =82/54,HR=128,RR=24.Oxygensaturationonroomairis97%.CXRshows infiltratesandconsolidationintheleftlowerlobeofthelung.Laboratorytest resultsshowWBC15,hematocrit36,Na142,glucose167,BUN36,creatinine 1.5.Lactateiselevated.Whatisthelikelydiagnosisinthispatient?
======================================
A. Cardiogenicshock B. Pulmonaryembolism C. Sepsis D. Severesepsis E. Septicshock

Temperature=100.1°F,BP=166/88,pulse=130,RR=33.Yourushtoseethe patientandonyourarrival,oxygensaturationis79%ona100%oxygen nonrebreatherfacemask.Thenurseinformsyouthathisoxygensaturationwas 68%onroomair.Hecurrentlyhasheavilylaboredbreathingandappears cyanotic.Thenurseinformsyouthatthepatientwasadmitted2daysagofora severeCOPDexacerbation.Youdecidetoemergentlyintubatethepatient.Which ofthefollowingwillreducetheriskofdevelopingpneumoniainthispatient?

A. Placethepatientinasupineposition B. Avoiddailyattemptstoweanthepatientfromtheventilator C. Administeroralchlorhexidinesolutiontwicedaily D. Administerdailyomeprazole E. Avoidanyinstrumentationoftheairway,includingendotrachealsuctioning
======================================
Answers

1.

Answer: E. Small cell carcinoma. The patient most likely has small cell

carcinomagiventhemainriskfactorofastrongsmokinghistory,amasslocated inthecentral/proximalairwaysandtheweaknesssuggestiveofparaneoplastic Lambert–Eatonsyndrome.Otherassociatedparaneoplasticsyndromeswithsmall cellincludeCushing’sandSIADH. BronchialcarcinoidisnotclearlyassociatedwithsmokingorLambert–Eaton, althoughusuallypresentsasacentral/proximallesion.Largecellcarcinomaisnot associatedwithLambert–Eaton.Squamouscellcarcinomaisnotassociatedwith Lambert–Eatonbutistypicallyacentrallesion;thislungmalignancyisalsothe mostlikelylungcancerassociatedwithparaneoplastichypercalcemia.

2.

Answer: D. Obtain contrast-enhanced CT of the abdomen. The patient is

presentingwithtypicalsigns/symptomsofacutediverticulitis—fever, leukocytosis,LLQlocationofpain.Furthersuggestionismadebythefactthatthe patienthadapriorepisodeofrectalbleeding,likelyfromunderlying diverticulosis.CTscanwillhelpnotonlyconfirmthediagnosisbutalsotorule outotherprocessesandassessforanycomplicationsofdiverticulitis. Checkingtheserumlactatewillhelpassessforischemiabutwillnothelpyou confirmthediagnosisofdiverticulitis.Retroperitonealultrasoundwillassessfor hydronephrosisandpyelonephritisbuturinalysis/chemistryarenormalandthere isnosuggestionofobstruction/infectionregardlessofhishistoryofrenalstones. Colonoscopywouldbecontraindicatedinapatientwithacutediverticulitis becauseoftheriskofperforation.Proceedingtotheoperatingroomwouldbe prematureunlessthepatienthadsurgicalindicationssuchasfistula,stricture, largeabscess,orperforationrelatedtothediverticulitis.

3. Answer:B.Heparin.IVUFH(unfractionatedheparin)andsubqLMWHare showntodecreasemortalityinUA/NSTEMI.Inaddition,statins,ASA,β- blockersareshowntodosoaswell.ACEinhibitorshaveevidenceofbenefitand arerecommendedpriortodischarge. AlteplaseisNOTindicatedforUA/NSTEMIbutONLYforSTEMIwhenPCI isnotavailable.Hydralazine,furosemide,anddigoxinoffernomortalitybenefit inthissettingeither.

4. Answer:C.Aspirin.Aspirinisshowntoreducerecurrentstrokeandtodecrease mortalityandshouldbeadministeredwithin48hours.

Insulinisnotnecessaryasthelevelofglucoseelevationisnotcontributingto thecurrentpresentation;infact,aggressiveglycemiccontrolisassociatedwith worseoutcomes.Heparinhasnotbeenshowntoimproveoutcomesandisnot recommendedasanacutetreatmentforischemicstroke.Alteplasecanbe consideredbutonlyforsignificantdeficitswhenthepatientpresentswithin3 hoursofsymptomonsetandhasnocontraindications;thispatientpresentedtoo lateforthistobeatreatmentoption.Labetalolwouldnotbeuseddespitethe elevatedBPaspermissivehypertensionisallowedinthesettingofanacute ischemicstroke;BPupto220/120mmHgisgenerallytoleratedinitially.

Answer: E. Methylmalonic acid. The other answers will help narrow down your

differentialbutwillnotdefinitelygiveyourdiagnosis.Thepatienthasa gastrectomyandthuslossofintrinsicfactorleadingtoimpairedabsorptionofB12. Theneurologicsymptomsarearesultofthisdeficiencyandthefatigue/pallorare relatedtomacrocyticanemia.LaboratoryassessmentofB12,methylmalonicacid, orhomocysteinewouldallbeusefultoconfirmdeficiency;however, homocysteineisalsoelevatedinfolatedeficiencyandthusnotasspecific. Folatelevelcouldhelpconfirmadeficiencyinthisvitaminwhichdoescausea macrocyticanemiabutthisdeficiencyisnotassociatedwithneurologicdeficits; inaddition,folicacidisabsorbedinthesmallintestinenotthestomach.CBCwith meancorpuscularvolumemayhelpconfirmmacrocyticanemiabutthisisnot alwayspresentwithB12deficiency;inaddition,therearemultiplecausesof macrocytosisandanemiaandthiswillnotconfirmhisdiagnosis.Intrinsicfactor Abispresentinperniciousanemia;itisnotasensitivetestbutregardless,a positivetestwouldnotconfirmthecauseofhissymptoms.MRIlumbarspinehas nonspecificfindingsinB12deficiency;itmayhelpassessforcentral/foraminal stenosisbutwithoutbackpainthisisunlikelyandwouldthistestwouldnotassess hispallor/anemia.
======================================
Answer: D. 24-hour urine-free cortisol. The patient likely has Cushing

syndromegiventheconstellationofweightgain,striae(withoutpriorhistoryof pregnancy),new-onsetdiabetes,hypertension,andvertebralcompressionfracture indicativeofosteoporosis.ThediagnosisofCushingsyndromerequiresthatat leasttwoofthethreefirst-linetestsarepositive.Theseincludea24-hoururine- freecortisollevel,alow-dosedexamethasonesuppressiontest,oralatenight salivarycortisollevel. SerumACTHisnotusedforscreeningandisonlyhelpfulindeterminingthe etiologyoncethediagnosisofCushingsyndromehasbeenmade.Ithelps establishACTH-dependentfromACTH-independentetiologies,narrowingthe differentialdiagnosisandsubsequentevaluation.MRIbrainandCTabdomen mayhelpidentifypituitaryadenomaandadrenaladenoma,respectively,butthis

testisprematureatthispointasthediagnosisofCushingsyndromehasnotyet beenconfirmed.CRHstimulationtestisonlyusedoncehypercortisolismhas beenestablishedandACTHiselevatedasithelpsdistinguishCushingdisease versusectopicACTHproduction.

7. Answer:B.Normalsaline.ThepatientispresentingwithaninferiorMIas

evidencedbythelocationoftheSTelevationsonECG.Becausethepatientalso hasbradycardiaandhypotensionhealsohasevidenceofanassociatedright ventricularMI,whichisstronglyassociatedwithinferiorwallMIsand importantlyistreatedmuchdifferentlythanaleft-sidedMI.Thediagnosiscanbe confirmedwitharight-sidedECG,whichwouldshowSTelevationsinV3R- V6R.Itisimportanttorememberthathemodynamicinstabilitycanresultfrom increasedvagaltoneandsinusnodedysfunction.Thepatientispreloaddependent andIVfluidsareindicatedandwillincreasethepatient’ssystemicbloodpressure. TreatmentwithASA,fibrinolysisversusPCI,heparinareallindicatedaswell. Nitroglycerinwilldecreasepreloadandworsenthepatient’shemodynamics. Furosemideisnotindicatedasthepatienthasnosignsoffluidoverloadand diuresiswilldecreasepreload.Patientisalreadyshowingsignsofhemodynamic instabilityandmetoprololwillcausefurtherbradycardiaandhypotension. Morphinemaycausevasodilationandfurtherhypotension.

8. Answer:D.Sodiumbicarbonate.Thepatienthasevidenceofananiongap metabolicacidosis(HCO3isdecreasedandAGis15)aswellasarespiratory alkalosis(CO2isdecreased)consistentwithsalicylatetoxicity.Thisinvolves usingWinter’sformulaandtheexpectedPCO2inthisexampleis31±2; however,theactualPCO2is25confirmingthereisarespiratoryalkalosisaswell. Treatmentoptionsincludealkalinizationofurineandhemodialysis. Fomepizoleisindicatedformethanolorethyleneglycoltoxicity;however neitherofthesewouldalsocauserespiratoryalkalosis.Albuterolwilltreata COPDexacerbationalthoughthisusuallyleadstoretentionofCO2frominability toexpiresufficientlyandrespiratoryacidosiswouldbethedominantfindingin thatscenario.InsulinwillhelptreatDKAifthatwastheunderlyingdiagnosisbut ketonesarenotmentionedthusassumedtobenegativeandnottreatingsalicylate toxicityinatimelyfashionwillbedetrimental.

9. Answer:E.Colonoscopy.Thepatienthasnothadcolorectalcancerscreening andthiswouldcertainlybeindicatedatthistimegivenhisage(>50).Initial choicesforscreeningincludeFOBT,flexiblesigmoidoscopy,orcolonoscopy.In thisexample,thepatienthadapositivescreeningtestandrequiresacolonoscopy asitwillallowfullvisualizationoftheentirecolonfordiagnosticandtherapeutic (biopsyifneeded)purposes.

Flexiblesigmoidoscopywillmissmorethanhalfofthecolonandthereforeis notthebestanswer.Digitalrectalexaminationhasnoroleasitwillnotbe sensitiveenoughtocheckanythingbuttherectum.Videocapsuleendoscopyis notthebestnextstep;itwillallowvisualizationoftheentireGItractbutwillnot allowforbiopsyifneeded.CTcolonographywillnotbesensitiveenoughto detectsmalllesionsandagainwillnotallowforinterventionofnecessary.

10. Answer:A.IVomeprazole.ThepatientlikelyhasanupperGIbleedas
======================================
evidencedbyepigastricabdominalpain,melena,andlabsshowinganelevated BUN:Crratioof25inthesettingofASAuse.Acidsuppressionandupper endoscopy(EGD)aretheindicatedinterventions. IVoctreotideisnotindicatedasthepatienthasnosignsofliverdiseaseto suggestesophagealvaricesasthecauseofbleeding.Platelettransfusionwillnot reversetheeffectaspirinhashadonplateletsandtheplateletlevelpresentedis notlowenoughtoleadtobleeding.RBCtransfusionisnotnecessaryasthe patientishemodynamicallystableandtheHgbisnotlowenoughthatthepatient issymptomatic.Normalsalineisnotnecessaryasthepatientisalready hypertensiveanddoesnothavehypovolemia.

11. Answer:E.24-hoururineprotein.Thepatienthasascitesinthesettingofalow SAAG(<1.1g/dL)indicatingtheetiologyisnotportalhypertension,andlow asciticprotein(<2.5g/dL)indicatinglowproteinoverall.Theexpecteddiagnoses wouldbeseveremalnutritionorprotein-losingdisordersuchasnephrotic syndrome;thus,24-hoururineproteinisthemostappropriatetest. Echocardiogramwouldbehelpfulifthepatienthadhepaticcongestioninthe settingofelevatedSAAGandelevatedasciticprotein.Pelvicultrasoundtoassess forpotentialovarianmalignancywouldbeindicatedifpatienthadlowSAAGand elevatedasciticprotein.Liverbiopsywouldbehelpfultoassessforcausesof cirrhosisifpatienthadelevatedSAAGandlowasciticprotein.PPDwouldbe indicatedifpatienthadlowSAAGandelevatedasciticprotein.

12. Answer:B.IVIG.Thepatientispresentingwithanascendingparalysis,absent reflexes,andalbuminocytologicdissociationconsistentwithadiagnosisof Guillain–Barrésyndromeinthesettingofaprecedingdiarrhealillness.IVIGand plasmapheresisaretherecommendedtreatments. Prednisoneisnotrecommendedassteroidshavenotshownbenefit. Ciprofloxacinisnotindicatedastherearenosignsofinfection;therearemany precipitatingillnessesthatcantriggerthisdisorder.Pyridostigminewouldbe indicatedinmyastheniagravis.Botulismantitoxinwouldbebeneficialifthe patienthassymptomssuggestiveofbotulism,aDESCENDINGparalysis.

13. Answer:E.Ristocetincofactoractivity.Thepatientispresentingwith

mucocutaneousbleedingsuggestiveofvonWillebranddisease.vWDisan autosomaldominantdisorderandcanbeassociatedwithfactorVIIIdeficiency, sometimesmanifestedbyanincreasedPTTlevel.Ristocetintestingistheonly testmentionedthatassessplateletaggregation. FibrinogenlevelscanbelowinDICbutthesepatientsareusuallyacutelyill andPT/PTTwouldalsobeelevated.Coombstestingwillassessforcausesof anemiabutnotforbleeding;inaddition,bilirubinisnormalsuggestingagainst hemolysis.FactorIXlevelwouldbetestingforhemophiliaBbutthisisXlinked recessivesounlikelytoseeinsuccessivegenerationsoffemales;inaddition, hemarthrosisorhematomaswouldbemoreprominent.Mixingstudyisnot indicatedasthePT/PTTtimesarenormalsounlikelytohaveafactordeficiency.

14. Answer:E.Lumbarpuncture.Thepatienthasacuteheadachein“thunderclap”

fashionandsubarachnoidhemorrhageistheworrisomeconsideration.CTbrain showednohemorrhagebutLPwouldbethenextsteptoevaluatefor RBCs/xanthochromiaandforincreasedopeningpressure. Sumatriptanwouldbeusedformigrainesbutsymptomsarenotsuggestiveand rulingoutSAHisnecessary.MRIbrainmayhavecomparablesensitivitytoCT scanbutregardlessanegativescandemandsalumbarpuncturefordefinitive evaluation.CerebralangiogramwillbeusefulonceSAHisconfirmed,butis invasiveandwillnotbethenextstep.CTbrainwithcontrastisunlikelyto visualizeasmallaneurysmandisnotthenextstep.

15. Answer:A.Smokingcessation.Shehasevidenceofobstructivepulmonary diseaseasindicatedbyherFEV1/FVCratio<0.70.Notonlywillsmoking cessationdecreasetherateofdeclineinlungfunctionithasalsobeenshownto decreasemortality. Tiotropiuminhalerandfluticasoneinhalerarelikelytodecreasehersymptoms butwillhavenoeffectonmortality.Oxygentherapyhasbeenshowntodecrease mortalitybutisonlyindicatedifO2saturationis88%orbelow,otherwiseif89% andevidenceofcorpulmonale,pulmonaryhypertension,orelevatedhematocrit. AzithromycinwouldbeindicatedforaCOPDexacerbationifabacteriumwas thoughttobethecausebutthereisnosuggestionofinfectionintheprovided scenario.
======================================
16. Answer:B.Wisdomtoothextraction.Endocarditisprophylaxisrequiresahigh- risksituationPLUSaqualifyingprocedurewhichishighriskforbacteremiaand resultantendocarditis.Accordingtothe2008AHAguidelines,antibiotic prophylaxisisrecommendedforthefollowingcardiacconditions:certain congenitalheartdiseases,ahistoryofinfectiveendocarditis,valvediseaseina hearttransplantpatient,andaprostheticvalve.Thus,thispatientshouldreceive prophylaxissincehehasaprostheticvalveandisundergoingadentalprocedure.

Colonoscopy,EGD,aswellasGIproceduresingeneraldonotrequire prophylaxis.Bronchoscopyonlyrequiresprophylaxisifmucosawillbebroken, suchaswithbiopsy.DilatationureteralstricturesaswellasGUproceduresin generaldonotrequireantibioticssolelyforthepurposeofendocarditis prophylaxis.

17. Answer:A.SPEP(serumproteinelectrophoresis).Thepatientispresenting withapathologicfractureindicatingthatthereisweakeningoftheunderlying bonepriortoalowimpactinjury.Giventhelaboratoryfindings(hypercalcemia, normocyticanemia,renalfailure,andlowaniongap)itismostsuggestiveofthe patienthavingmultiplemyeloma;thus,SPEPwouldbetheidealtesttoconfirm. Bonescansdetectosteoblasticactivityandcanbefalselynegativeinmyeloma. PTHrPiscancerrelatedofwhichthereisnosuggestionofaseparateprimary malignancy;inaddition,thiswouldexplainonlythehypercalcemia.PTH elevationinhyperparathyroidismwouldexplainonlythehypercalcemia.DEXA wouldbeusefulifevaluatingforosteoporosisbutcorticalbonewasdescribedas normalindensitythusthisisunlikely,andtheinjurywasmostlikelyrelatedtoa lyticlesionatthesiteoffracture.

18. Answer:E.TSH.Thepatienthassymptomssuggestiveofhypothyroidism

(bradycardia,fatigue,weightgain,hairloss)andTSHisthebestinitialscreening test. USthyroidisnotnecessarywhenthephysicalexaminationisnormal.TPO wouldhelpconfirmHashimoto’sasapotentialcauseofhypothyroidismbut wouldnothelpconfirmhypothyroidismitselfaspatientsmayhaveelevated antibodiesbutnormalthyroidfunction.Thyroiduptakescanwouldbemore helpfulinevaluatinghyperthyroidism,suchasthyroiditisorGravesdisease.FNA isonlyindicatedifapatienthasanodulewithsizeorfeaturesworrisomefor malignancyandinneedoftissuediagnosis.

L9.

Answer: A. Follow-up CT chest. The patient has an indeterminate nodule

discoveredincidentallyandthisrequiresfurtherfollow-up.Thepatientislowrisk (<5%)asevidencedbyherlackofsmokinghistoryandyoungage.CTscan wouldbethemostappropriatefollow-up(FleischnerguidelinesandACCP guidelines).Ofnote,ifthepatientclearlyhasbenignpropertiessuchaspopcorn calcificationsuggestinghamartomanofurtherfollow-upisrequired. Bronchoscopyandneedlebiopsywouldbeindicatedifthepatienthadan intermediate/highmalignancyrisk,itwasenlargingorthepatientdesiredatissue diagnosis.CXRwouldnotbesensitiveenoughtofollowchangesinsize.PET-CT scanwouldalsobeindicatedifthereisintermediate/highriskofmalignancy.

20. Answer:D.Atropine.Thepatienthassymptomaticbradycardiawith

hypoperfusionleadingtohersymptoms;sherequiresincreaseinheartrateto maintaincardiacoutputandatropineistheonlychoicethatwouldbeableto providethis.Ifthismedicationwasineffectivethenepinephrine,dopamine,or transcutaneouspacingwouldallbealternativetreatments. Echocardiogramwillnothelptreatthepatientintheacutesettingasthepatient demandsurgentintervention;obtainingthistestwillonlydelaytreatment. Nitroglycerincanbeusedforchestpaininthesettingofanginatocause vasodilation,butwillcauseworsenedhypotensionandiscontraindicatedinthis patient.ICDisaconsiderationforthispatientforlong-termprimarypreventionof VF/VTgivenhersustaineddecreasedEF;however,itisnotanacutetreatmentfor thepatient’slife-threateningcondition.
======================================
21. Answer:E.Omeprazole.Hissymptomsaresuggestiveofgastroesophageal refluxwithacomponentoflaryngealrefluxaswell.Treatmentfailureisnot considereduntiltherehavebeenatleastseveralmonthsofscheduledPPIuse;he iscurrentlyonlyusingasneeded.PPIsaremoreeffectivethanH2blockersandif apatientfailsempirictreatmentthenonecanconsiderworkupforothercausesof hissymptoms. H.pyloriantigenwouldbeusefulifevaluatingforabdominalpainif gastritis/ulcerswerethesuspecteddiagnoses.EGDwouldbeindicatedifpatient wasfollowinglifestylechangesandtakingscheduledPPIbuthavingnoreliefin symptoms,orifhehadalarmsymptoms(melena,anemia,weightloss,or dysphagia).pHmonitoringcanalsobeusedforrefractorysymptomsafter appropriateempirictherapy.Gastrinlevelwouldonlybeindicatedifevaluating forsuspectedgastrinomaorwithmultiplegastroduodenalulcers.

22. Answer:A.EGDwithsmallbowelbiopsy.Thepatienthaschronicsymptoms suggestiveofceliacsprue(irondeficiency,transaminitis,anemia,anddermatitis herpetiformis).Thereisalsoanassociationwithpsychiatricissueswithceliac sprue.TTGserologywouldbereasonableandduodenalbiopsyisnecessaryfor confirmation. Colonoscopywouldnotbeabletoevaluateforadiagnosisofceliacsprue. Loperamidemayhelpdiarrheabutwillnotaddresstheunderlyingcauseofher symptomsandisthereforenotthebestanswer.Sertralinewouldnothelpin diagnosingortreatinghercondition;thereisalinkofIBSwithmooddisorders butIBSisadiagnosisofexclusionandonlyconsideredwhenlabs/examinationis normal.Skinbiopsymayconfirmdermatitisherpetiformisbutsmallbowelbiopsy wouldstillbeneededforthediagnosisofceliacsprue,asonemayhavethisskin conditionwithouthavingsprue.

23. Answer:B.Spironolactone.ThepatienthasstageIVsystolicheartfailureand spironolactoneisshowntodecreasemortalityinthesepatientsasitis
======================================
cardioprotective.β-Blockers,ACEinhibitors,andICDsarealsoshownto decreasemortalityinpatientswithsystolicheartfailure. Isosorbidedinitrateandhydralazineareshowntodecreasemortalityinclass III/IVheartfailureinAfricanAmericansbutthispatientisCaucasianandnot expectedtoreceivethatsamebenefit.Digoxinandfurosemidedonotdecrease mortalityinanyheartfailurepatients.

24. Answer:D.Inhaledalbuterolprn.Thepatienthasclassicsymptomsof

exercise-inducedbronchoconstrictionandwouldbenefitfrompre-exerciseinhaler usagetopreventsymptoms.ItisimportanttorememberthatPFTsmaybenormal betweenepisodeswhenthepatientisasymptomatic;achallengemaybeneededto objectivelyevaluatethebronchoconstriction. CXRisnotnecessaryasthelungexaminationisclearandshehasnosymptoms atbaseline.Inhaledfluticasoneisnotthebestanswerasthepatientonlyhas intermittentsymptomsrelatedtoactivity,notanysymptomsbetweenepisodesto suggestchronicasthma.Reassuranceisnotappropriateasthepatientclearlyhas symptomsthatlimitherlifestyleandarecausingairwayconstriction.Inhaled salmeterolisnotappropriateasthepatienthasnobaselinesymptomsbetween episodes;inaddition,treatmentofasthmawithLABAalone,withoutcotreatment withcorticosteroids,isassociatedwithincreasedmortality.

25. Answer:D.Notreatment.Itisnotrecommendedtoscreenforasymptomatic bacteriuriaastreatmentdoesnotofferbenefitbutdoesincludepotentialharm fromsideeffects,etc.Theonlypopulationinwhichtoscreenandtreat asymptomaticbacteriuriaispregnancy. Nitrofurantoinwouldbethedrugofchoiceforapatientwithuncomplicated cystitis.CiprofloxacinandTMP-SMXwouldbeconsiderationsforcystitisorfor pyelonephritis.Repeaturinalysisandculturewouldnotbeindicatedasscreening andtreatingasymptomaticpatientsdoesnotofferclinicalbenefit.

26. Answer:B.IVhydrocortisone.Thepatientispresentingwithacuteadrenal insufficiencyandthisisamedicalemergency.Thepatientmustbeadequately resuscitatedwithaggressiveIVnormalsalineinadditiontoreplacementof corticosteroids.Themostlikelycauseforthepatient’sadrenalinsufficiencyisher long-termuseofcorticosteroidsandinadequateresponseinthesettingofher acuteillness. Cortisollevelcanbecheckedbutmedicaltreatmentisthemostimportant interventionandismandatory.CTadrenalglandsandMRIpituitaryareunlikely toyieldfurtherinformationregardingthediagnosisinthepatient;inaddition, theywouldbeinappropriateastheywoulddelaythetreatmentofthepatientand leadtohighermorbidity/mortality.Cosyntropinstimulationtestcanbeusedto confirmthediagnosisofadrenalinsufficiencybutshouldNOTdelaytreatment;

dexamethasonecouldbeusedifthediagnosisisinquestionasitwillnotinterfere withinterpretationofthistest.

27. Answer:A.CTangiography.Thepatienthaspainoutofproportionto

examinationinthesettingofatheroscleroticriskfactorsforthrombosisaswellas atrialfibrillationwithasubtherapeuticINRwhichwouldberiskfactorsfor embolism;themostlikelydiagnosisisacutemesentericischemiaandCT angiographywouldbehelpfulinconfirmingthisdiagnosis. Gastricemptyingstudywouldbehelpfulinevaluatingforgastroparesiswhich thepatientisatriskforwithuncontrolledDM;however,thispatientispresenting withacuteabdominalpainandnotconsistentwiththatdiagnosis.EGDand colonoscopywouldhelpevaluateformanycausesofabdominalpainbutwill delaythetimetodiagnosisofmesentericischemiawhichisneededurgentlyto preventinfarction/necrosis.VitaminKwillreversewarfarininthesettingofthe patient’sbleedingbutgiventhescenariosuggestiveofmesentericischemiaand stablehemodynamics(INRisalsotherapeutic)thisisnotindicatedand anticoagulationwillbeusedifthrombosis/embolismisconfirmed.

pericarditis.Colchicinecanbeaddedtothisregimenforaddedbenefit. CoronaryangiogramisnotindicatedastherearenofocalSTelevationsorwall motionabnormalitiessuggestiveofanacuteMI.Drainageofpericardialeffusion isonlyindicatedinlargeeffusionscausinghemodynamiccompromiseorfor diagnosticpurposes.PrednisoneisnotindicatedunlessthepatientfailsNSAIDs orhascontraindicationstoreceivingthem.Azathioprinewouldonlybeusedifthe patienthadrecurrentpericarditisandwasunabletoweanoffofsteroids.
======================================
Answer: C. Chest tube insertion. It is important to recognize that the above

patientispresentingwithasymptomaticpneumothorax,inthissettingrelatedto hisunderlyingCOPDandlikelyblebrupture.CXRcanconfirmthediagnosisbut thiscanalsobemadeclinically.Supplementaloxygenwouldbeappropriate followedbyneedleaspirationorchesttubeinsertiontoremoveairfromthe pleuralspace. Albuterol–ipratropiumnebulizerandprednisonewouldhelptreatCOPD exacerbationbutthisisnotthediagnosispresented.Azithromycinwouldnotbe thebestanswerasthereisnosuggestionofinfectioninthispatient.Pleurodesisis onlyindicatediftherearerecurrentpneumothoraces.

30. Answer:D.Warfarin.ThepatienthasvalvularatrialfibrillationandaCHADS2-

VAScscoreof4,thuswarrantingsystemicanticoagulation.Warfarinisindicated andthemostappropriatechoice. Aspirinisnotadequateaswarfarinhassuperiorefficacyinstrokepreventionin

comparisontoaspirin.Dabigatranisoneoftheneweroralanticoagulantsthat couldbeconsideredasanalternativetowarfarinbutitisonlyusedinthesetting ofnonvalvularafib;thispatienthasevidenceofmitralstenosisonexamination andthisisthepresumedcauseofhisatrialfibrillation.Clopidogrelisinferiorto warfarinforstrokepreventioninthesettingofatrialfibrillation.Fondaparinuxis usedintreatment/prophylaxisforDVT,notforafibstrokeprevention.

31. Answer:B.Aorticvalvereplacement.Thepatienthassymptomaticaortic

stenosiswhichisanindicationforsurgery. Nitroglycerinwouldbeindicatedifhissymptomswererelatedsolelyto atheroscleroticdisease;however,vasodilationmayworsenhissystemicblood pressure.Aspirinwillpreventfurtheratheroscleroticdiseasebutwillnotfixhis valvulardisease.CarotidDopplerwillassessforcarotidstenosis;however,the murmurheardintheneckisreferredfromtheaorticvalve.Coronaryartery bypassgraftingissometimesdoneatthesametimeasavalvereplacementif significantatheroscleroticdiseaseispresent;however,hehasverymilddiseaseon priorangiogramandthisisnotindicated.

syndromeandPTisthemostappropriateintervention. Corticosteroidinjectionwouldbeunlikelytobehelpfulasthecauseofpainis notintra-articular;shedoeshaveanunderlyingautoimmunediseasebutthereis noeffusionandmarkersdonotshowsignificantinflammationtoheighten suspicionofSLEasthecause.KneearthroscopyandMRIkneearealso unwarrantedatthistimegiventhenormalexaminationandlackoftraumato suggestmeniscalorligamentousinjury.IbuprofeniscontraindicatedgivenCKD.

33. Answer:E.Lisinopril.Thepatienthasanewdiagnosisoftype2diabetesand requiresnotonlycontrolofhisglucosebutalsotreatmentforcomplications relatedtohisdisease.AnACEinhibitororARBwouldbeindicatedfor hypertension,CKD,ormicroalbuminuriaandthuslisinoprilisthebestanswer. Hydrochlorothiazideisnotthebestanswerasitdoesnothaverenoprotective featuresthatACEinhibitorsdo;inaddition,efficacydecreasesasGFRdecreases. InsulinisnotnecessarygivenrelativelycontrolledA1candlackofalifestyle interventiontrialyet.PioglitazoneiscontraindicatedinsettingofCHF.Metformin iscontraindicatedwithCKD.

34. Answer:E.Biopsyhilaradenopathy.Thepatient’sclinicalpictureisconsistent withpossiblesarcoidosis.Tissuebiopsyshowingnoncaseatinggranulomasalong withrulingoutotherdiseasesisessentialforthediagnosis.Oneofthemajorrisk factorsofsarcoidosisisbeingAfricanAmerican. Serumcalciumwillbeelevatedinasubsetofsarcoidpatientsbutthisisnot

sensitiveenoughtomakethediagnosis.CTchestwillyieldmoreinformationin regardtolungimagingbutwillnotconfirmadiagnosis.ACElevelisnot sensitiveenoughtoconfirmadiagnosis.Biopsyofaleglesionwhichiseasily accessiblewillrevealinflammationasthepatienthasfindingsconsistentwith erythemanodosum;however,thiswillNOTshownoncaseatinggranulomasso thiswillnotconfirmadiagnosisofsarcoid.

35. Answer:B.Initiatefluidrestriction.Thepatientiseuvolemicandhaslung
======================================
cancer,lowserumosmolality,andhighurineosmolalityallsuggestiveofSIADH asthecause.Hehasverymildsymptomsandcanbemanagedwithfluid restrictionandincreasedsaltintake. AdministeringIVnormal(0.9%)salineisnottheappropriateanswerassodium willbeexcretedbutwaterwillberetained;thus,worseninghyponatremia. Initiatinghemodialysisisnotappropriateasthepatienthasminimalsymptoms, hasnotfailedothertherapies,andbecauseitisinvasive.Administering hypertonic(3%)salineisnotnecessaryasthepatienthasminimalsymptoms;if thepatienthadmoreseveresymptomssuchasconfusion,lethargy,nausea,or vomitingthiswouldbeappropriate.Administeringhydrochlorothiazideisnot correctasthismedicationitselfisacauseofhyponatremia;loopdiureticssuchas furosemidecanbeusedtocorrectsodiumlevelsinSIADH.

36. Answer:D.Antistreptolysintiter.Thepatientispresentingwithhematuriain

thesettingofarecentinfectionandthemostlikelydiagnosisispoststreptococcal glomerulonephritis.Antistreptolysintitercanhelpconfirmrecentstrepinfection. ANCAisunlikelytobehelpfulasthepatientdoesnothaveothersymptoms suggestiveofasystemicvasculitis.Anti-GBMisalsounlikelytoassistinthe diagnosisasthepatienthasnoothersymptomstosuggestGoodpasture’sandthe timecoursefitsbestwithPSGN.HIVisassociatedwithrenaldisease,most specificallycollapsingvariantofFSGSbutthisisnephroticinpresentation.IgA levelsareunnecessaryasserumIgAlevelsarenotusefulinthediagnosisofIgA nephropathy;inaddition,theglomerulonephritisassociatedwithIgAdeposits happensmuchquickeraftertheinfection,usuallywithinseveraldays.

consistentwithalikelydiagnosisofSLE—oralulcers,malarrash,arthritis,edema suggestiveofrenalimpairment,aswellashematologicabnormalities. Osteoarthritisisunlikelygiventhepatient’syoungageandwouldnotexplain thepatient’smultipleothersymptoms.ReactivearthritisusuallyfollowsaGI/GU infectionandincludesarthritis,urethritis,anduveitis.Behçetdiseasecaninclude manysymptoms,mostnotablyoral/genitalulcerationsbutwouldbeunlikelyto includetheclassicmalarrashandisveryrareintheUnitedStates.Goutis possiblegivenheruseofHCTZandpotentialforhyperuricemiabutthiswould

notexplaintheotherfindings.

38. Answer:B.Carbidopa–levodopa.Thepatientispresentingwithsymptoms

consistentwithParkinson’sandmedicaltreatmentwouldberecommendedwith dopamineagonist. Fluoxetineisnotappropriateasthepatientdoesnothaveaclinicaldiagnosisof depression;hispsychomotorslowingaloneshouldnotbemisinterpretedas depressivesymptomsunlessthereareothersymptomssuchassadness,appetite changes,sleepdisturbance,ordisinterestinactivities.Propranololwouldbe beneficialinpatientswithessentialtremor.Memantinewouldbeindicatedonlyif patienthadmoderatetoseveredementia.Deepbrainstimulationisinvasiveand wouldnotbeconsideredunlesstherewereseveresymptomsinwhichthepatient hadfailedothermedicaltherapy.

39. Answer:C.Infliximab.ThepatienthasmoderatetosevereCrohndisease (anemia,abdominaltenderness,andweightloss)anddemandsappropriate therapytopreventcomplications.Infliximabisananti-TNFantibodythatis indicatedformoderatetosevereCrohndisease. Loperamideshouldnotbeusedinactiveinflammatoryboweldisease. Azathioprineislesslikelytooffercontrolofthepatient’ssymptomsthan infliximab;inaddition,thismedicationtakesupto6weekstoreachatherapeutic effectandneedstobegivenalongsidesteroids.Surgicalresectionisnotindicated asthepatienthasnoevidenceofabscess,perforation,orfistula.Ciprofloxacin andmetronidazoleismoreusefulinmilddiseaseandwillnottreattheunderlying inflammatoryprocessresponsibleforthepatient’ssymptoms.
======================================
40. Answer:A.Thumbspicasplint.Thepatienthasriskfactorsforseveralcauses ofpainrelatedtooveruseintheupperextremitybutexaminationrevealsa positiveFinkelsteintestwhichconfirmsadiagnosisofdeQuervaintenosynovitis. Thisisrelatedtoacombinationofrepetitivemotionsamechanicbutalso associatedwithcaringforandliftinghisgrandchild.Immobilizationofthethumb isthemostappropriateintervention. Wristsplintwouldbehelpfulifthepatienthadcarpaltunnelsyndrome. Counterforceforearmbracewouldbehelpfulifpatienthadlateral/medial epicondylitis.Carpaltunnelcorticosteroidinjectionisnothelpfulasthisisnotthe sourceofhispain.Ibuprofeniscontraindicatedgivenhisknownchronickidney disease.

41. Answer:B.Reductionoffracture.Thepatienthastheclassictriaddiagnostic forfatembolism:hypoxia,petechialrash,andneurologicabnormalities. Treatmentissupportiveandgiventhesourceisthemultiplelongbonefractures; theseshouldberepairedwhenthepatientisstabilized.

Albuterolisnotindicatedasthepatienthasnoevidenceofobstruction(e.g., wheezing)asacauseforheracutedecline.Furosemideisnotindicatedasthe patienthasnoevidenceofvolumeoverloadinthepulmonaryvasculature. Levofloxacinisnotindicatedasthereisnoevidenceofpulmonaryinfection.IV heparinwillbeineffectiveinimprovingthepatient’ssymptomsasitcannot dissolvefat,onlythrombi.

42. Answer:A.Valsalvamaneuver.ThepatienthasSVTlikelyrelatedtoAVNRT andhehasnoconcerningsymptoms.Initialattemptatterminationshoulduse vagalmaneuverssuchasValsalvamaneuverorcarotidsinusmassage. Adenosineisveryshortactingandcanbeusedifvagalmaneuversfailto terminatethearrhythmia.Metoprololwouldalsobeconsiderediftheabove measuresfailed.DigoxinwouldalsoinhibittheAVnodebuthasmorepotential sideeffectsthantheothermedicationsandisrarelyusedforthispurpose. Cardioversionwouldbereservedforhemodynamicinstabilityincluding hypotension,heartfailure,orangina.

43. Answer:D.Hydroxychloroquine.Thepatientispresentingwith

signs/symptomsfulfillingcriteriaforadiagnosisofrheumatoidarthritis.Themost importantinterventionisDMARDtherapy(disease-modifyingantirheumatoid drugs),especiallygiventhepatientalreadyhasevidenceofjointdamage. Prednisone,corticosteroidinjections,andindomethacinwillallhelpcontrol symptomsbutnotcontroljointdamage.Physicaltherapywillhelpimprove functionforthepatientbutwithoutDMARDtherapyherjointdamagewill continuetoworsen.

44. Answer:C.ERCP.Thepatienthascholangitissecondarytoobstructingcommon

bileductstoneandispresentingwithseveresepsis.Thepatientneeds hemodynamicsupport,antibiotics,andcontrolofthesourceofinfection.ERCPis thenextstepinordertorelievetheobstructionandallowdrainageofthebiliary system. Cholecystectomyisrecommendedeventuallytopreventrecurrencebutnotin theacutesettinggiventhehighmorbidityandmortality.Liverbiopsywillnotaid indiagnosisortreatment;thecauseoftransaminitisisevident.MRCPwillnotaid inmanagementasthediagnosisisalreadyconfirmed.Percutaneoustranshepatic cholangiographyissecondlinetoERCPasitcarrieshighermorbidityinregardto bleedingorperitonitis.

45. Answer:E.Nofurtherintervention.Thereisnofurtherworkuportreatment thatisrequiredatthispoint.Thepatientisinalow-riskcategorywithno identifiableriskfactorsandaPPDwouldonlybeconsideredpositiveif15mmor greater.

AFBsputumcultureisnotnecessarytoruleoutactivepulmonaryTBbecause thepatientisasymptomaticandhasanegativePPDtest.Rifampin,isoniazid, pyrazinamide,ethambutolwouldbeindicatedonlyifthepatienthadactive pulmonaryTB.Isoniazidwouldbeindicatedforprophylaxisifthepatienthada positiveTBtestwithoutanypulmonarysymptomsandanegativeCXR.Chestx- raywouldbeindicatedtoscreenforevidenceofpulmonaryTBifthePPDwas positive.

16.

Answer: B. TSH. The patient has calcium pyrophosphate dehydrate deposition
======================================
disease(CPPD,pseudogout).Thisisconfirmedbytheinflammatory arthrocentesiswithCPPDcrystalsandimagingfindingsshowingdeposition. Associateddisordersincludehemochromatosis,hypothyroidism,and hyperparathyroidismsolabsincludingferritin/transferrin/TSH/Caareall reasonabletoscreenforastreatmentofunderlyingdisordercanimprove symptoms. Uricacidwouldbehelpfulindetermininginitialtreatmentforgoutbutthisis nottheunderlyingdiagnosis.ANAandESRarenonspecificandwouldnotbe helpfulinguidingtherapy.HLA-B27isnotindicatedasthediagnosisofCPPDis confirmedandthiswillnotscreenforanyassociateddisease.

47. Answer:A.Zoledronicacid.Thepatienthasosteoporosisandahistoryofa

fracture;thus,everyattemptwouldbemadetostartthepatientonamedicationto reduceherriskoffractures.Zoledronicacidisabisphosphonatewhichwill reducebothvertebral/nonvertebralfractures;inaddition,itisgivenintravenously andismostappropriateinthispatientwithachalasia. AlendronateisaPObisphosphonateandwouldbecontraindicatedgiven achalasiaandtheriskofpillesophagitis.RaloxifeneisaSERMandhasevidence onlyforreductionofvertebralfracturesandwouldthusnotbeanidealchoice;in addition,itiscontraindicatedgiventhepriorhistoryofthromboembolicdisease. Calcitoninisinferiortobisphosphonatesandisnotthecorrectchoice.Estrogenis nolongerusedformanagementofosteoporosisgivenmanyrisks,oneofthem DVT/PE,andthismedicationwouldbecontraindicatedinthispatient.

48. Answer:D.Propranolol.Thepatientispresentingwiththyroidstorm,an endocrineemergency,andrequirestreatmentwithoutdelay.Thiswaslikely triggeredbyherrecentsurgery.Adrenergiceffectsofthyroidhormone(e.g., tachycardia)aswellasT4→T3conversionareblockedwiththistreatment. RAIUatthispointwilldelaytreatmentwhichisnotappropriategiventhe morbidity/mortalityassociatedwiththyroidstorm.Iodineisatreatmentoption usedinthyroidstorm;however,itshouldbegivenAFTERmethimazoleorPTU toavoiditsuseasasubstrateformorethyroidhormonesynthesis.USthyroidis alsounnecessaryandwilldelaytreatment.Thyroidectomyshouldonlybe

performedoncethehyperthyroidismistreatedgiventhemortalityrateassociated withsurgeryinthyroidstorm.

49. Answer:A.CTurography.Thepatienthashematuriaandwhetheritbegrossor microscopicdemandsfurtherworkup.Infectionhasbeenruledoutandbythefact thatcastsarenotseen,aglomerularcausehasbeenruledout.Toevaluatetherest oftheGUtractonemustperformurinecytology,cystoscopy,andCTurography. Ultrasoundofkidneyswillevaluatethekidneysrelativelywellbutmisssmall tumorsandwillbelesssensitiveinevaluatingtheureters.Renalbiopsyisnot indicatedinthisscenarioasaglomerularsourceofbleedingisunlikely;RBC castsordysmorphicRBCsonmicroscopywouldbesuggestiveofglomerular cause.PSAandprostatebiopsyareunlikelytoyieldacauseofthepatient’s bleedingandwouldnotevaluatetherestoftheGUtract.

50. Answer:D.Albuterol.Thepatienthasadiagnosisofacutebronchitisandthisis mostlikelyviralinnature.Symptomsarerelatedtohyperreactiveairwaysand shouldself-resolveinafewweeks;treatmentissymptomatic.Becauseofthe wheezingassociatedwithhissymptomsalbuterolwouldbetheappropriate choice. Prednisoneisnotindicatedasthepatienthasnounderlyingreactivelung disease,isnotindistress,andhispeakflowisnormal.Oseltamivirisnot indicatedbecausethepatientdoesnothavesymptomssuggestiveofinfluenza;in addition,heiswelloutsidetheappropriatewindowoftreatmentgivenhisrisk factors.AzithromycinoranyantibioticsisNOTindicatedasmostbronchitisis causedbyviruses;antibioticswouldbeindicatedifpertussiswassuspectedor pneumoniawasconfirmed.Sputumcultureisnotnecessaryasaviralcauseis muchmorelikely.
======================================
modificationsforpatientswithhypertension:Reducingdietarysodiumtolessthan 2.4gperday;increasingexercisetoatleast30minutesperday(4daysper week);limitingalcoholconsumptionto2drinksorlessperdayformenand1 drinkorlessperdayforwomen;followingtheDietaryApproachestoStop Hypertension(DASH)diet(highinfruits,vegetables,potassium,calcium,and magnesium;lowinfatandsalt);andachievingaweightlossgoalof10lb(4.5kg) ormore.Ofthese,weightlosshasshowntohavethehighestreductioninsystolic bloodpressure(reductionfrom5to20mmHg)inoverweightpatients.(A,C,D) Thesethreelifestylemodificationsarealsorecommendedanddohavea substantialeffectonreductionofsystolicpressure,justnotasmuchasweightloss does.(E)Smokingcessationshouldalwaysbeencouragedaspartofany comprehensivelifestylemodificationplan.

diureticsarethebestprovenfirst-linetreatmentinreducingmorbidityand mortality.Thiazidediureticsareespeciallyeffectiveinpreventingsecondary cardiovasculareventsinpatientswithhypertension.(D,E)Currentevidencedoes notsupporttheuseofβ-blockers,particularlyatenolol,asfirst-linetreatmentfor hypertension.(A,B)AlthoughthereisincreasingevidencethatACEinhibitors (lisinopril)andpossiblycalciumchannelblockers(amlodipine)maybeequivalent tothiazidediureticsinreducingmorbidityandmortality,therelativeexpenseof thesemedicationsmakesthiazidediureticsanidealfirst-linechoice.

suggestedbyfever,leukocytosis,andaurinedipstickshowinginfection(e.g., positivenitrites,positiveleukocyteesterase).ThepresenceofWBCcastsisalso seeninpyelonephritis,asisthephysicalexaminationfindingofcostovertebral angletenderness(CVA)tenderness.(B)Nephrolithiasis(kidneystones)produces acolickypainthatshootsdownintoeithergroinregion.Itdoesnotproducefever, leukocytosis,orurinedipstickfindingssuggestiveofinfection(howeveritoftenis positiveforblood).Calciumstonesarethemostcommontypeofkidneystones, andpatientswiththesestonesareencouragedtoincreasetheirdietaryintakeof calcium(inordertodecreaseoxalateabsorptionintheGItract).(C)Appendicitis ifaveryimportantdiagnosistoconsiderinyoungpatientswithabdominalpain, howeverdoesnotproducepositiveurinalysisfindings.(D)Ectopicpregnancycan oftenmimicthepainproducedinnephrolithiasis,howeverthisdiagnosisis unlikelygiventhenegativepregnancytest.(E)Acuteinterstitialnephritis(AIN) canindeedproduceWBCcastsintheurine,butalsoproducesurineeosinophils. AINisatypeofintrinsicrenalacutekidneyinjury(AKI)thatproducesfever, rash,arthralgias,and/oreosinophilia.Themostcommoncauseisanallergic reactiontomedications.

54. Answer:C.Nonsteroidalanti-inflammatorydrugs(NSAIDs).Backpainisa high-yieldtopicontheUSMLE.Backpainthatimproveswithexercise,but worsenswithrestinanotherwisehealthypatientlendscredencetothediagnosis ofankylosingspondylitis(AS).ASisaseronegativespondyloarthropathy (rheumatoidfactorisnegative)thatisasystemicrheumaticdisease.Ninety percentofpeopleexpresstheHLA-B27genotype.Itisalsothreetimesmore commoninmalesthanfemales.Inadditiontobackpain,patientscanalso experienceanterioruveitiscausingeyerednessandpain,inadditionto cardiovascularandlunginvolvement.Thefirst-linetreatmentforallseronegative spondyloarthropathiesisNSAIDsbutbiologicsanddisease-modifying antirheumaticdrugs(DMARDs)areeffectiveintreatingtheprogressionofthe disease.(A,B)Localheatandphysicaltherapyareespeciallyeffectiveinback

paincausedbydischerniation.Discherniationtypicallycausesanelectricity-like shootinglowerbackpain.(D,E)Epiduralsteroidinjectionsandsurgical laminectomyaretypicallyreservedforadvancedrefractorybackpainthatdoes notrespondtomoreconservativemeasuresinitially.

55. Answer:E.Nebulizedalbuterolforbronchodilation.Thispatientislikely
======================================
sufferingfromanasthmaexacerbationcausedinpartbyhisrecentexposuretoa viralillness.Therewerewheezesonexaminationwithnourticariaor angioedema,makingananaphylacticreactionunlikely.(C)Managementofan acuteasthmaexacerbationinvolvesoxygenadministrationaswellasintermittent orcontinuousnebulizedalbuterol,whichisthefirst-linetreatment.Ifthepatient failstorespondtoalbuterol,thenipratropiumandmagnesiumareadditional optionstopromotebronchodilation.Oralcorticosteroidsshouldalsobegivento reduceairwayinflammationduringandaftertheexacerbation.Responseto therapycanbemonitoredbyfollowingtheSaO2aswellaseithertheFEV1orthe peakexpiratoryflow(PEF).Arterialbloodgasesmayalsobeuseful;be concernedaboutthefindingofanormalPaCO2,whichisoftenindicativeof respiratoryfatigueleadingtotherequirementofintubation(hypoxemiashould causehyperventilationandhypocapnia).(A)Oxygenshouldbeadministeredto asthmaticswithatargetSaO2>90%.InCOPD,thetargetis90%to94%dueto theconcernforthedevelopmentofhypercapnia,howeverthisisnotseenin asthma.(B)Thispatientisunlikelytohavepneumoniagiventhatheisafebrile andhasnosuggestivefindingsofpneumoniaonlungexamination.(C) Subcutaneousepinephrineisusefulinanaphylaxis,buthasnobenefitover inhaledβ2-agonistsinasthmaforbronchodilation.(D)Ipratropiumisan anticholinergicandisthefirst-linetreatmentforCOPDexacerbation(although albuterolisoftenusedtoo);itmaybeusedasanadjunctivetherapyinasthma exacerbation,butalbuterolisthefirst-linetherapy.

subsequentdeteriorationareconsistentwithadiagnosisoftoxicshocksyndrome (TSS),whichiscausedbypreformedS.aureusexotoxin,TSST-1.TSSis associatedwithprolongedtamponuse.ForthepurposesofyourStep,always suspectprolongedtamponuseinyoungwomen.Thetoxinactsasasuperantigen, whichactivatesTcellsleadingtomassivecytokinerelease.TSStypically presentswithfever,vomiting,diarrhea,andthedevelopmentofadiffusemacular erythematousrash.ComplicationsofTSSincludeacuterespiratorydistress syndrome(ARDS),hypotension,disseminatedintravascularcoagulation(DIC), andhemorrhage.(A)StreptococcuspyogenesisveryrarelyassociatedwithTSS (onlygroupAStrepspeciesareassociatedwithTSS),butwhenitis,itisnot associatedwithtamponuse.(B)Neisseriameningitidiscancertainlypresentwith

feveranddiffuserash,howeveritisnotassociatedwithsuchahighfeveror tamponuse.(D)StreptococcuspneumoniaeisatypeofgroupBStrepspecies, andaccordingly,doesnotcauseTSS.(E)RockyMountainspottedfeverpresents withfeverandarashthatisfirstapparentintheextremitiesandmovescentrally.

57. Answer:B.Recurrentpericarditis.ThechestpainandECGaretypicalofacute pericarditis,whichcommonlypresentswithfever,pleuriticchestpain,new-onset pericardialeffusion,anddiffuseconcaveSTelevationsonECG.Mostcaseshave aninfectiousetiology,includingCoxsackieviruses,HIV,influenza, Staphylococcusaureus,Streptococcuspneumoniae,tuberculosis,andvarious fungi.Otherimportantcausesincludecancer,autoimmunediseases,post-MIor cardiacsurgery,radiationtherapy,anduremia.Allpatientsshouldbetreatedwith NSAIDsandcolchicinetoimprovesymptomsandpreventcomplications.Patients whoarenottreatedaremuchmorelikelytodeveloprecurrentpericarditis,which isdefinedasarecurrenceofsymptomsaftertheincitingevent(e.g.,virus)has passed.(A)Pericardialeffusionscommonlyaccompanyacutepericarditis, howevercardiactamponadeisararecomplication.(C)Constrictivepericarditisis apossibleoutcomeofanycauseofacutepericarditis,howeveritisnotthemost commoncomplication.(D)Freewallruptureisacomplicationofacute myocardialinfarction.(E)Pericarditisaffectsthepericardiumalthoughthe myocardiumissometimesaffectedaswell.However,therateofvalve involvementandcomplicationsislow.
======================================
progressedtoarenalorperinephricabscess,whichisindicatedbythepersistent fever.Patientswiththiscomplicationwillpresentwithsymptomstypicalof pyelonephritis(fevers,chills,flankpain,abdominalpain,anorexia, nausea/vomiting),butwillcontinuetobefebriledespitetreatmentwith appropriateantibiotics.Mostcasesofrenal/perinephricabscessesarecausedby urologicpathogens(e.g.,E.coliandotherentericgram-negativebacilli),however Staphylococcusaureusisalsocommonandarrivesatthekidneysby hematogenousspread.ThebestdiagnostictestisaCTscanoftheabdomenwith contrast,althougharenalultrasoundcanalsoidentifymanyrenal/perinephric abscesses.Iftheabscessissmall(<5cm),itcanbeobservedwithantibiotics alone;ifthepatientdoesnotrespondtoantibiotics,oriftheabscessislarge (≥5cm),bothantibioticsanddrainagearenecessary.Antibiotictherapyshould alwaysbebasedoncultureandsensitivitydatawhenavailable,howeverempiric therapyforrenal/perinephricabscessesisthesameasforpyelonephritis.Options includeafluoroquinolone,ceftriaxone,ampicillin–sulbactam,anaminoglycoside, orantistaphylococcalantibioticsifS.aureusissuspected.(A)WBCcastsdonot necessarilyindicateacuteinterstitialnephritisorglomerulonephritis;theymay

alsoindicateanupperurinarytractinfectionsuchaspyelonephritis.Therefore,a renalbiopsyisnotthenextstep.(C)Failuretodefervesceaftertreatmentwith antibioticsraisestheconcernforacomplicationofpyelonephritis,suchasarenal orperinephricabscess,andthereforefurtherdiagnosticworkupshouldbe pursued.(D,E)Theorganismissensitivetobothantibiotics,sothereisnobenefit ofchangingantibioticsorstoppingantibiotics.

59. Answer:D.Intubation.Thepatientinthisvignetteisexperiencinganacute asthmaexacerbationwithworrisomesymptoms/signs:loudwheezes,useof respiratoryaccessorymuscles,tachycardia,tachypnea,andpooroxygen saturation.Inaddition,thearterialbloodgasshowsanormalPaCO2whichisnot agoodsign;hypoxicpatientsshouldhyperventilatetomaintainoxygenation, whichcauseshypocapniaandarespiratoryalkalosis.Whenapatienthasanormal PaCO2,thisisasignthatthepatientistiringanddecompensating.Eventhough intubationshouldbeavoidedifpossible,thereisalowthresholdforintubating patientsthatareshowingsignsofrespiratoryfatigue.(A)Increasingtheoxygen flowratemightimproveoxygenation,butthepatientislikelystartingtodevelop hypercapnicrespiratoryfailure,whichisduetoinadequateventilation.Oncethe patientisonaventilator,ventilationiscontrolledprimarilybyadjustingthe respiratoryrateortidalvolume.Oxygenationcanbemaintainedbyadjustingthe FiO2andpositiveend-expiratorypressure(PEEP).(B)IVcorticosteroidsareused inacuteexacerbationsbutwillnotactimmediatelytopreventthispatientfrom furtherdecompensation.(C)Azithromycinandotherantibioticsareusedinacute COPDexacerbations,notacuteasthmaexacerbations.(E)Thisarterialbloodgas showsanormalPaCO2whichisnotagoodsign.Althoughnebulizedalbuterolis typicallyfirst-linetreatmentforacuteasthmaexacerbation,thispatientis decompensatingasevidencedbythearterialbloodgasandintubationmustbe pursuednext.

ahistoryofparathyroidadenomawhichislikelycausinghypercalcemia secondarytohyperparathyroidism.Patientswithhypercalcemiaareatriskfor developingpseudogout,arheumatologicdiseasewithdiversesymptomsandsigns arisingfromtheaccumulationofcalciumpyrophosphatedihydratecrystalsinthe connectivetissues.Itcommonlypresentswithacuteonset,painful monoarthropathyoftheknee.Jointaspirationwithsynovialfluidanalysis confirmsthediagnosis,showingrhomboid-shapedcrystalsthatarepositively birefringent.(A)Negativelybirefringentneedle-shapedcrystalsdescribegout, whichalsopresentswithacuteonsetmonoarthropathy,butusuallyaffectsthefirst metatarsophalangealjointofthefoot.Furthermore,goutisnottriggeredby hypercalcemia.(C,D)Neutrophilpredominantsynovialfluidwithgram-positive

cocciisdiagnosticofsepticarthritis.Thispatienthasnofever,makingseptic arthritishighlyunlikelyfromtheclinicalpicturealone.(E)Normalsynovialfluid findingsarenotthenorminthesettingofpseudogout.
======================================
61. Answer:B.Acuteretroviralsyndrome.AcuteHIVinfectioncanpresentina

varietyofways,buttypicalsymptomsofthe“acuteretroviralsyndrome”include amononucleosis-likesyndromewithfever,lymphadenopathy,headache, myalgias/arthralgias,sorethroat,andamaculopapularrash.Anotherlesssensitive butmorespecificfindingispainful,well-demarcatedmucocutaneousulcerations. Additionalcluestothediagnosisinthiscasearethepatient’shigh-riskbehaviors (unprotectedsex,IVdruguse)andnegativetestresultsforotherconditionsonthe differentialdiagnosis(mononucleosisduetoEBV,syphilis,andotherSTIs,etc.). DuringtheacutephaseofHIVinfection,theremaybeanegativescreeningtest (ELISAmaytakeweekstobecomepositive)withhighviralRNAlevels. Typically,thediagnosisofHIVismadewithahighlysensitivescreeningtest (e.g.,ELISA)followedbyamorespecificconfirmatorytest(e.g.,Westernblot). (A)Thefindingofdiffusenontenderlymphadenopathyismoreconsistentwitha systemicprocesssuchasaviralinfectionratherthanHodgkinlymphoma,which oftenpresentswithfocalorasymmetriclymphadenopathy.(C)Though heterophile-negativemononucleosisduetoCMVisapossibility,thefindingsof bothamaculopapularrashandmucocutaneousulcerationsmakeHIVmorelikely (bothmayoccurinCMVinfectionbutarelesscommonmanifestations,andGI ulcerationsusuallyoccurinthesettingofimmunosuppression).(D)Secondary syphilisislesslikelytohavemucocutaneousulcerationsandthescreeningtest wasnegative.AlthoughfalsenegativesarepossiblewithRPRandVDRLtests, theconstellationoffindingsmakesHIVinfectionmuchmorelikelythanafalse- negativesyphilistest.(E)Theseclinicalfindingsaremuchmoreseverethan typicalupperrespiratoryinfectionsymptoms.

for9months.Thereareacoupleimportantteachingpointsinthisvignette.First, screeningforTBisoftenperformedwithaPPDoraninterferongammarelease assay(IGRA).InpatientswithclosecontacttoapatientwithactiveTB,a concerningchestx-ray,orwhoareimmunosuppressed(viamedications,HIV infection,etc.),apositivetestis>5mm.Forthosepatientsathighrisk(healthcare workers,jailworkers,thehomeless,IVdrugusers,uncontrolleddiabetes,chronic kidneydisease,etc.),apositivetestis>10mm.Andforallotherswithoutrisk factors,apositivetestis>15mm.Thispatienthasanindurationof11mmandis ahealthcareworker,thereforeshewarrantsfurtherworkuptodifferentiateactive fromlatentTB.(Note:priorBCGvaccinationrarelyproducesaninduration>10 mmasanadult,andtheCDCrecommendsthatBCGvaccinationstatusshould

notinfluencetheworkupandtreatmentofTB.)Ifthechestx-rayisnegative,then thepatienthaslatentTBandshouldbetreatedwith9monthsofisoniazidand pyridoxine(vitaminB6,whichhelpstopreventisoniazid-inducedneuropathy). Alternatively,othertreatmentoptionsincludeisoniazidfor6months,isoniazide andrifapentinefor3months,orrifampinfor4months.(A)Treatmentofactive TBisbecomingcomplicatedwithMDRTB,howeveractiveTBisgenerally treatedwitha4-drugregimen(rifampin,isoniazid,pyrazinamide,ethambutol)for 2monthsfollowedupa2-drugregimen(rifampin,isoniazid)for4months.(B) Becausethispatientisahealthcareworker,sheshouldbetreatedforlatentTB giventheriskofreactivationandexposuretootherpatients.(D)Achestx-ray shouldbeperformedbeforestartingtreatmenttodifferentiatelatentfromactive TB.(E)ReassurancewouldonlybeappropriateifthePPDresultwasnegative.
======================================
63. Answer:A.Serumironstudies.Thepatientinthisquestionispresentingwitha microcyticanemia(MCV<80fL).Thedifferentialdiagnosisofmicrocytic anemiacanberememberedbythemnemonic“TAILS”(Thalassemia,Anemiaof chronicdisease,Iron-deficiencyanemia,Leadpoisoning,Sideroblasticanemia). Themostcommoncauseofmicrocyticanemiaisirondeficiencyandthebestnext stepisorderingironstudies:serumiron,totaliron-bindingcapacity(TIBC),and serumferritin.Iniron-deficiencyanemia,serumironistypicallylow,TIBCis increased,andserumferritinislow.Afteriron-deficiencyanemiaisconfirmed, theunderlyingcauseshouldbedetermined.Irondeficiencyisbyfarthemost commoncauseofmicrocyticanemia,soatrialofironsupplementationisoften performedinsteadofanextensiveworkup. (B)Hemoglobinelectrophoresiswouldbeusefulfordiagnosingthalassemia.β- ThalassemiatraitusuallyhasreducedorabsentHbA,elevatedlevelsofHbA2, andincreasedHbF.Clinicalmanifestationsgenerallyariseveryearlyinlife.(C) Althoughleadpoisoningisacauseofmicrocyticanemia,itisuncommonand shouldonlybesoughtafteriron-deficiencyanemiahasbeenruledout.(D) Peripheralbloodsmearisoftenusedtoexcludesideroblasticanemia,butthisisan uncommoncauseofmicrocyticanemia.(E)Stoolguaiactestshouldmostlikely havebeenperformedoninitialpresentation,butthispatient’syoungagemakes malignancyanunlikelydiagnosis.Consideringthispatient’salreadyknown microcyticanemiapresentonCBC,serumironstudiesshouldbeperformedin ordertoevaluatethecause.

64. Answer:C.Elevatedlipase.Thepatientinthisquestionispresentingwithsigns andsymptomsofacutepancreatitis(epigastricabdominalpainradiatingtothe back,nausea,andvomiting).Thevastmajorityofcases(80%)resultfrom gallstonesandalcohol.However,othercausesofacutepancreatitiscanbe rememberedwiththemnemonicGETSMASHED(Gallstones,Ethanol,Trauma,

Steroids,Mumps,Autoimmune,Scorpionbite,Hyperlipidemia,ERCP,Drugs [specificallydiuretics,gliptins,azathioprine,salicylates,steroids]).Acute pancreatitiscanbediagnosedthroughseveralmodalities:physicalexamination demonstratingepigastricpainradiatingtotheback,elevatedamylaseandlipase levels(typically3×higherthanthenormallimit),andabdominalimaging(CT) showingpancreaticenlargementwithheterogeneousenhancementwithIV contrast.Ultrasoundisalsohelpfulindiagnosinggallstonepancreatitisby visualizinggallstonesinthegallbladder.Lipasehasthegreatestspecificityofall possibletestsandisusuallymoreelevatedthanamylaseinacutepancreatitis.(A) Amylasecansometimesbenormalinacutepancreatitis(particularlyifthe etiologyishyperlipidemia).Furthermore,amylaseisnotspecifictothepancreas asthereisnotonlypancreaticamylase,butalsosalivaryamylase.(B)Although elevatedALTisveryusefulinsuggestinggallstonepancreatitis,itdoesnot encompassallthecausesofacutepancreatitisandthereforeisnotaspecifictest. (D)Positivefecalfattestistypicallypositive(>7g/day)inchronicpancreatitis, howeverchronicpancreatitispresentswithsymptomsofmalabsorption(as opposedtopain)andistypicallyduetoalcoholuse(neitherofwhichthispatient endorses).(E)Pancreaticcalcificationsareseeninchronicpancreatitis,notacute pancreatitis.
======================================
65. Answer:B.Thyroid-stimulatinghormone(TSH)levels.Thepatientinthis questionisdemonstratingclinicalmanifestationsofhypothyroidism.In approachingthediagnosisofthyroiddisorders,thefirststepistoorderaTSH level.TSHisthemostsensitivetesttodetectprimaryhypothyroidismand hyperthyroidism.BasedontheTSHlevel,additionaltestscanbeperformed.(A) FreeT4isimportantinthediagnosticworkupofthyroiddisordersandshouldbe thenexttestorderedifTSHcomesbackdecreased.IffreeT4isincreasedwitha decreasedTSHlevel,thisisdiagnosticofprimaryhyperthyroidism.IffreeT4is decreasedwithadecreasedTSHlevel,thencentralhypothyroidismisthe diagnosisandtheetiologyinvolvesthepituitaryglandorthehypothalamus. Finally,iffreeT4isnormalwithadecreasedTSH,thenthisissubclinical hypothyroidism.(C)Thyroglobulinisoftenincreasedingoiterand hyperthyroidismandisalsoatumormarkerforthyroidcancer.Itisnotthebest firsttestinworkingupthyroiddisorders.(D)Radioactiveiodineuptake(RAIU) scanisthenextbeststeponceprimaryhyperthyroidismisdiagnosed(increased freeT4withdecreasedTSH)asitcanhelpdifferentiatecausesof hyperthyroidism(Gravesvs.multinodulargoitervs.silentthyroiditis).(E) ThyroidbiopsyisfartooinvasiveofatestwithoutabaselineTSHlevel.

66. Answer:A.CTscan.Thesuspecteddiagnosishereismeningitis,andaCTscan shouldbeperformedfirsttoruleoutmasseffectbeforealumbarpunctureis

performed.Hehasahighfever,aswellasothersymptoms/signsofmeningitis (includingthemostsensitivetestformeningitis:thejoltaccentuationsign,in whichapatient’sheadacheintensifiesafteraquickheadjolt).Kernigand Brudzinskisignsarenotsensitive,buttheyarefairlyspecific.Onceadiagnosisof meningitisissuspectedandalumbarpunctureneedstobeperformed,aCTscan shouldbeperformedinpatientsthoughttobeathighriskforcerebralherniation. Riskfactorsincludepapilledema,previousCNSdisease,aseizureinthatpast week,immunosuppression,alteredmentalstatus,andfocalneurologicsigns.(C) Thispatienthasbothpapilledemaandimmunosuppression(methotrexate),and thereforeaCTscanshouldbeperformedbeforealumbarpuncturetoassessthe riskforcerebralherniationduringlumbarpuncture.(B)AnMRIprovidesbetter visualizationofthebrain,howeveritiscostlyandtime-consuming.Becausethe purposehereistoruleoutmasseffect,aCTscancandothisadequatelyand quickly.(D,E)Itismostappropriatetoadministerempiricantibiotics(and antiviralsifHSVencephalitisissuspected)shortlyafterbloodandCSFcultures aresent,howeverthelumbarpuncturehasnotbeenperformedyet.

withanemia,lowbackpain,increasederythrocytesedimentationrate(ESR),and renaldysfunction,suggestingthediagnosisofmultiplemyeloma.Aperipheral smearoftenshowstherouleauxformation(stackedappearanceofRBCs).This patientadditionallyispresentingwithconstipationandconfusion,bothsymptoms ofhypercalcemia(>10.2mg/dL),whichisseeninaboutone-thirdofpatientswith multiplemyeloma.Theetiologyofhypercalcemiainmultiplemyelomaisbone lysisfromhumoralfactorsreleasedbytheplasmacells.(A)Mechanical obstructionsecondarytomalignancyalsocancauseconstipation,butthepatient’s signsandsymptomsdonotlendcredencetocoloncancer.(C,D,E)Hormone levelandbloodgasabnormalitiesaretypicallynotseeninmultiplemyelomaand arenotassociatedwithconstipation.

consistentwithadiagnosisofcaudaequinasyndrome,aseriousneurologic conditioninwhichdamagetothecaudaequina(abundleofspinalnerves originatingintheconusmedullaris)causesacutelossoffunctionofthelumbar plexus.Themanagementofthisconditionisurgentsurgicaldecompression. However,thereareseveralphysicianswhoadvocateforsteroidspriortosurgical decompression.(A)Nonetheless,thereisnoevidencethatsteroidsareusefulin treatmentofcaudaequinasyndrome.(C)Imagingwillonlydelaythediagnosisof caudaequinasyndromeandincreasethelikelihoodoflong-termneurologic damage.(D,E)Giventhefindingofabsentrectaltoneandsaddleanesthesia, conservativemanagementwithNSAIDsandbedrestshouldbeavoidedascauda

equinasyndromeisaneurologicemergency.
======================================
69. Answer:A.Aorticaneurysm.Thepatientinthisquestionispresentingwith

signs,symptoms,andlaboratoryvaluesconsistentwithadiagnosisofgiant-cell arteritis(GCA),alsoknownastemporalarteritis.Symptomscaninclude headache,visualproblems,jawclaudication,fever,andtemporalscalptenderness. GCAisavasculitismostcommonlyinvolvinglargeandmediumarteriesofthe head,predominantlythebranchesoftheexternalcarotidartery.Adecreased temporalarterypulsecanbenotedaswell.ESRandC-reactiveproteinare commonlyelevated.High-dosecorticosteroidsshouldbestartedassoonasthe diagnosisissuspected(evenbeforeconfirmationbytemporalarterybiopsy)to preventirreversibleblindnesssecondarytoophthalmicarteryocclusion.GCAcan involvebranchesoftheaortaleadingtoaorticaneurysm,thuspatientsshould haveserialchestx-raysperformed.(B)Inflammatoryboweldiseaseincludes ulcerativecolitisandCrohndiseaseandisnotassociatedwithGCA.(C)Hepatitis Bisassociatedwithpolyarteritisnodosa(30%ofthetime),avasculitisof mediumandsmall-sizedarteries.(D)Asmokinghistoryisseenin thromboangiitisobliterans(Buergerdisease),whichpresentswithprogressive inflammationandthrombosisofsmallandmediumarteriesofthehandsandfeet. Ulcerationandgangrenearecommoncomplications.(E)Alcoholhasneverbeen showntobeassociatedwiththedevelopmentoftemporalarteritis.

70. Answer:D.Vasovagalsyncope.Syncopeisdefinedaslossofconsciousnessthat resultsfromcerebralhypoperfusion.Themostcommoncauseofsyncopeis neurocardiogenic(vasovagal)syncope,whichiscausedbyasuddensurgeof sympatheticactivitythattransientlyincreasesthecontractilityoftheleftventricle. Mechanoreceptorsintheleftventriclesensethisincreasedcontractilityandcause anexcessivevagalresponse,whichlowersheartrateandcontractility.This transientlydropsthebloodpressureandcausessyncope.Thesepatientstypically havesymptomsoflightheadedness,nausea,andnarrowingvisionbeforelosing consciousnessandcanusuallybracetheirfallsomewhat.Diagnosiscanbemade withthetilttabletest.(A,E)Cardiovascularcausesofsyncopeinclude arrhythmias,mechanicalheartdisease(e.g.,aorticstenosisandhypertrophic cardiomyopathy),pulmonaryembolism,aorticdissection,andcardiactamponade. Patientswithsudden-onsetsyncopeandtraumatotheface(indicatinganinability tobracethefall)shouldincreasethereader’ssuspicionforacardiacetiology.(B) Orthostatichypotensionusuallyoccursinthepresenceofhypovolemia, dysautonomia,and/orcertainmedications(e.g.,diureticsandβ-blockers). Diagnosiscanbemadeifsystolicbloodpressuredecreasesby≥20mmHgor diastolicbloodpressuredecreasesby≥10mmHgwhengoingfromasittingtoa standingposition,whichwasnotseeninthispatient.(C)Seizurestechnicallydo

notmeetthedefinitionofsyncope,sincetheyarenotcausedbyadisruptionin cerebralbloodflow.Historythatwouldindicateaseizureincludesapreceding aura,tonic–clonicmovementsduringtheepisode,andapostictalstate(confusion withgradualimprovementinneurologicfunction).

71. Answer:D.Serumimmunoelectrophoresis.Thepatientinthisquestionis presentingwithsignsandsymptomsconsistentwithadiagnosisofmultiple myeloma.CRABcanbeausefulmnemonicindiagnosingmultiplemyeloma: HyperCalcemia,Renalfailure,Anemia,Bonelesions(oftenpunchedoutlesionsin theskull).Serumandurineelectrophoresiswithimmunofixationmayreveala monoclonalspikeandisusefulforconfirmationofthediagnosis.(A)CA-15-3is atumormarkerforbreastcancer.(B)CEAisatumormarkerfor adenocarcinomas,particularlycolon(butalsolung,breast,andstomach).(C) AlkalinephosphatasewouldbeelevatedinPagetdisease,howeverPagetdisease isnotcharacterizedbyhypercalcemia(asseenwiththispatient).Furthermore, Pagetdiseaseischaracterizedbyamixedosteolyticandosteoblasticphage(where multiplemyelomaispurelyosteolytic).Asaresult,ratherthanshowingpunched outskulllesionsasseeninmultiplemyeloma,Pagetdiseasewillshowa“cotton wool”appearanceduetoirregularareasofsclerosis.(E)Anabnormalbonescan iscertainlynotdiagnosticofmultiplemyeloma;ratheritisusefulindiagnosing canceroftheboneorcancersthathavemetastasizedtothebone.
======================================
IVagents.Hypertensiveurgencyisdefinedasasystolicbloodpressure>180mm Hgand/oradiastolicbloodpressure>120mmHgwithnoend-organdamage. Hypertensiveemergencyisthesamedefinitionwiththeadditionofend-organ damage.Manyorgansareacutelyaffectedbyhighbloodpressure,includingthe brain(stroke),eyes(papilledema),heart(aorticdissection),lungs(pulmonary edema),andkidneys(renalfailure).Withintheumbrellatermofhypertensive emergency,thereareadditionaltermsforspecificend-organinvolvement: malignanthypertensionreferstohypertensiveemergencyinthepresenceof papilledema(otherophthalmologicfindingsincluderetinalexudatesand hemorrhage),andmalignantnephrosclerosisreferstorenaldamage.Thispatient hasahypertensiveemergencywithend-organinvolvementincludingthebrain (headache)andtheeyes(papilledema).(A,B,C,E)Themanagementof hypertensiveurgenciesandemergenciesisslightlydifferent.Inhypertensive urgency,thegoalistograduallylowerthebloodpressuretoachieveanormal valuewithinacoupleofdays.Oralantihypertensiveagentsaregivenwhile monitoringthereductioninbloodpressureoverhours.Someoptionsfororal medicationsincludelabetalol,captopril,clonidine,furosemide,andhydralazine. Inhypertensiveemergency,thereisongoingend-organdamageandtherefore

bloodpressureneedstobeloweredquickly.Thegoalinthissettingisto immediatelylowerbloodpressureusingIVagents,targetingadecreaseinmean arterialpressureby25%withinminutestohours.SomeoptionsforIV medicationsincludenitroprusside,nitroglycerin,calciumchannelblockers(e.g., nicardipine),labetalol,hydralazine,fenoldopam,andphentolamine.Because adaptivemechanismsoccurwithchronicallyelevatedbloodpressure,rapid loweringofbloodpressureisnotalwaystoleratedandcancausecerebral hypoperfusion.Ifthishappens,thebloodpressuremustbeloweredmore gradually.

73. Answer:C.Normalpressurehydrocephalus.Thepatientinthisquestionis

presentingwithdementia,urinaryincontinence,andgaitdisturbance.Thistriad, oftenrememberedby“wet,wacky,wobbly,”ischaracteristicofnormalpressure hydrocephalus(NPH).NPHisdiagnosedbyMRI,whichwillshowdilated ventricles.Asonewouldexpectfromthename,theopeningpressuremeasured duringlumbarpunctureisnormal.Treatmentgenerallyconsistsofrepeatedspinal tapstoimprovethesymptoms(bydecreasingthepressureexertedontheadjacent corticaltissuebytheenlargedventricles).(B)Alzheimerdiseaseisnotassociated withgaitproblemsorurinaryincontinence.(A)Pseudotumorcerebriisassociated withheadaches,notmemoryimpairmentordementia.Furthermore,itistypically seeninyoung,obesefemales.(D)Althoughthispatienthasahistoryof hypertension,itiswellcontrolledandthushersymptomsareunlikelytobea resultofmulti-infarctdementia.Thistypeofdementiatendstobeveryabruptin onsetandshowmultipleareasofincreasedT2-weighteddensityonMRIinthe periventricularregions.(E)Lewybodydementiaisthesecondmostcommon formofdementia(afterAlzheimer)closelyassociatedwithParkinsondisease.

74. Answer:C.Amiodarone.Amiodaroneisanantiarrhythmicmedicationthatmay beusedforprophylaxisortreatmentofseriousarrhythmias,especiallyventricular arrhythmias.Thispatienthasahistoryofventriculartachycardia,andtherefore hasanindicationtobetakingamiodarone.Thisdrughasmanytoxicities,and thereforewhenstartedthepatientmusthavebaselinepulmonaryfunctiontests, thyroidfunctiontests,andliverfunctiontestsduetothetoxicityinvolvingeachof theseorgans.Othernotablesideeffectsincludeblue-graydiscolorationofthe skin,cornealdeposits,andperipheralneuropathy.Thispatientdeveloped pulmonaryfibrosisasaresultofchronicamiodaroneuse.(A,B,E)Digoxin, lisinopril,andlosartanarenotassociatedwithpulmonaryfibrosis.(D)Bleomycin cancausepulmonaryfibrosis,butitisanantineoplasticdrugandthepatienthas noreasontobetakingthismedication.

75. Answer:C.Chlorpromazine.Thepatientinthisquestionislikelyhavingan acuteepisodeofamigraineheadache.Migrainesarecharacterizedbyunilateral,
======================================
pulsatingpainthatisoftenassociatedwithphotophobiaandanauraofneurologic symptomspriortotheonsetoftheheadache.Acuteattackscanrangeinduration from4to72hours.Acutetreatmentandprimarypreventivetreatmentvaryin migraineheadaches.Acuteattacksarebesttreatedwithintravenousantiemetic medications(chlorpromazineandprochlorperazine)and/ortriptans(sumatriptan). (E)Giventhatthispatientpresentswithvomiting,chlorpromazineisthebest choicesinceitcanbegiveninIVform,unlikesumatriptan.(A,B)Propranolol andamitriptylinearebothexcellentmedicationsusedformigraineprophylaxis, notforacuteepisodes.Thesewouldbeappropriatetogivetothepatientafterher acutemigraineepisoderesolvestopreventfurtherattacks.(D)Verapamilisa calciumchannelblockerthatisthefirst-linemedicationforclusterheadache prophylaxis.However,thispatientishavingamigraine,notaclusterheadache. Clusterheadachestypicallyinvolvepainaroundtheeyewitheyewatering,nasal congestion,andswelling.

76. Answer:C.Fractionalexcretionofsodium(FENa).Acutekidneyinjury(AKI)

isdefinedasanabruptrise(within48hours)inserumcreatinineby≥0.3mg/dL frombaseline,a≥50%increaseinserumcreatininefrombaseline,oroliguriaof <0.5cc/kg/hrfor>6hours.OnceAKIisrecognized,thenextstepindiagnosisis determiningwhethertheetiologyisprerenal,intrinsicrenal,orpostrenal.These termsreflecttheperceivedsightofpathology;prerenalAKIiscausedby decreasedbloodflowtothekidneys,intrinsicrenalAKIiscausedbydirect damagetothekidneyparenchyma(i.e.,totherenalvasculature, tubules/interstitium,orglomeruli),andpostrenalAKIiscausedbyanobstruction intheurinarytractleadingawayfromthekidneys.Thepatientinthisquestionis hypovolemic(tachycardiaanddrymucusmembranes).Inresponseto hypovolemia,therenalarteriolesvasoconstrict,decreasingbloodflowtothe kidneysanddecreasingtheglomerularfiltrationrate(GFR).PrerenalAKIisa resultofischemiafrompoorperfusion,howeveritcanprogresstoacutetubular necrosis(ATN),whichisaformofintrinsicrenalAKI.Besideshypovolemia,her dailyNSAIDmayalsobecontributingtotheAKIsinceNSAIDscauserenal vasoconstriction.OneofthebesttestsfordifferentiatingbetweenprerenalAKI andATNistheFENa.InprerenalAKI,sodiumisreabsorbedinanattemptto maintaincirculatingbloodvolume,andthereforetherewillbelittlesodiuminthe urine.(B)Althoughthisisoftenreflectedbytheurinesodium,thisvalueis affectedbyrenalwaterhandlingandurineoutput.FENaisabettertest,sinceit onlymeasuresthefractionofsodiumexcretionandisnotaffectedbyurine output.Ingeneral,lowFENavaluesindicateprerenalAKIandhighvalues indicateintrinsicrenalAKI(tubulardamageleadstosaltwasting).TheFENawill be<1%inprerenalAKIand>2%inATN.(Note:FENashouldnotbeusedinthe settingofdiuretics,butthefractionalexcretionofureamaybeusedinstead.)(A)

Aurinedipstickisahelpfulscreeningtoolforthingslikeproteinuriaorinfection, butitwillnothelptodifferentiatebetweenprerenalandintrinsicrenalAKI.(D)A renalultrasoundwouldbehelpfulinexcludingpostrenalAKI,whichisnot suspectedinthiscase.(E)ThediagnosisofprerenalAKIversusATNcannotbe madebyhistoryalone.

77. Answer:B.Aorticdissection.Themostimportantriskfactorforaortic
======================================
dissectioninthegeneralpopulationishypertension,howeverthereisahigh incidenceinpatientswithconnectivetissuedisease(e.g.,MarfanandEhlers– Danlossyndromes).Sharpchestpainradiatingtothebackisthefirstcluetothis diagnosis.Othersymptomsmayoccurbasedonwhicharteriesareoccludedby thedissectedflap.Finally,awidenedmediastinumisseenonchestx-ray.Other potentialmanifestationsnotseeninthispatientarecardiactamponadeandHorner syndrome(fromcompressionofthesuperiorcervicalganglion).Dissections involvingtheproximalaortarequireimmediatesurgicalintervention.(A,C,D) Allofthesediagnosesarearesultofthepatient’saorticdissection,butarenotthe underlying(primary)diagnosis.Acutecoronarysyndromes(ACS)mayoccur duringanaorticdissectionasaresultofinvolvementofoneormorecoronary arteries,andstrokecanoccurwithinvolvementofthecarotidarteries.Aortic regurgitationiscommoninpatientswithMarfansyndrome,andthiscanalso occurasaresultofadissectionintheascendingaorta.Ineithersituation,itisnot theprimarydiagnosis.(E)Hypertensiveemergencyrequiresasystolicblood pressure>180mmHgand/oradiastolicbloodpressure>120mmHg.

asplenismfrominfarction.Thisoftenresultsinimpairedimmunologicresponseto encapsulatedorganisms,suchasStreptococcuspneumoniae,Haemophilus influenzae,andNeisseriameningitidis.Furthermore,theyaremoreproneto invasiveSalmonellainfectionswhich,whenlocalized,canresultinosteomyelitis. Inadditiontotreatmentwithantibioticshere,thispatientshouldimmediatelybe treatedwithoxygen,aggressivehydration,andanalgesics(morphine).(A,C,D, E)Theseorganismsdonotcauseosteomyelitisinsicklecellpatients.

79. Answer:D.HotnoduleonRAIU.Thyroidnodulesarefairlycommonwitha5% to10%prevalence.Approximately5%ofthyroidnodulesaremalignant.(A,B, C,E)Factorsassociatedwithmalignancyincludehistoryofradiationtotheneck, malesex,hardandimmobilemass,agegreaterthan70years,worrisome ultrasoundfindingssuchasirregularbordersandmicrocalcifications,cervical lymphadenopathy,andcoldnoduleonRAIU.Coldnodulesarenonfunctionaland donotabsorbtheradioiodine.Hotnodules,ontheotherhand,areautonomous (toxic)andreadilyabsorbtheradioiodine.However,hotnodulesarebenignand notassociatedwithmalignancy.

osteoporosisincludesmoking,familyhistory,lowbodyweight,excessivealcohol use,andsecondaryorganiccausessuchasprematuremenopause,amongothers. Regardlessofsymptoms,theUSPSTFrecommendsaone-timescreeningfor osteoporosisinallwomenaged65yearsorolderwithDEXAscanofthespine andhips.AbonedensitywithT-score<2.5standarddeviationsbelowthemeanis associatedwithosteoporosisandaT-scorebetween1and2.5standarddeviations belowthemeanisassociatedwithosteopenia.(A)Thepatienthadanormal mammogramtheyearbefore.Mammogramsshouldbeperformedevery2years inheragegroup.(B)Thepatienthadacolonoscopy6yearsagothatwasnormal. Sheisdueforanothercolonoscopyin4years(reachingthe10-yearmarkafterher previousone).(C)Calciumandphosphoruslevelsarenormalinpatientswith osteoporosisandhavenovalueinscreeningforthecondition.(E)Thereisno historyorclinicalsuspicionhereforlungcancer,soaCTscanofthechestisnot warranted.

81. Answer:B.Jointaspirationwithsynovialfluidanalysis.Thispatientis
======================================
presentingwithsignsandsymptomsconsistentwithanacutegoutattack.The patient’salcoholuselendscredencetothehistoryofgoutyarthritis.Furthermore, thepatientispresentingwithacuterightkneepain,swelling,andlow-gradefever, allconfirmingthelikelydiagnosisofgout.Giventhatsepticarthritisand pseudogoutcanshowclinicalsimilaritiestogout,itisimperativetofirstperform jointaspirationandsynovialfluidanalysis.Synovialfluidanalysisofgoutwill demonstratealeukocytecountof2,000to50,000/mm3andnegatively birefringentneedle-shapedcrystalswithanegativeGramstainandnegative culture.(A)Indomethacin(anNSAID)isveryhelpfulintreatingacutegout. Nonetheless,thediagnosisofgoutmustfirstbeconfirmedbeforeadministering indomethacinespeciallywithitsside-effectprofile.(C)Uricacidlevelswill certainlybeelevatedingout(elevateduricacidistheunderlyingcauseofthe clinicalmanifestations),howeveruricacidlevelsdonothaveahighdegreeof sensitivityorspecificityfordiagnosinggout.(D)Anx-rayofthekneeisnotas specificassynovialfluidanalysisfordiagnosinggout.

patientinthisquestionispresentingwithdyspepsia(characterizedbyepigastric painandearlysatiety).Dyspepsiaisacommonpresentation,andonlyaminority ofpatientsarediagnosedwithanunderlyingetiologycontributingtothe dyspepsia.ThemostcommonetiologiesofdyspepsiaareGERD,NSAIDs,peptic ulcerdisease(PUD),andmalignancy.(D)Importantly,ifapatientpresentswith any“alarmsymptoms”suchasunexplainedweightloss,persistentvomiting, bloodloss,dysphagia,orfamilyhistoryofgastrointestinalcancer,thenhe/she

shouldundergoanupperGIendoscopytoevaluateformalignancy.Inpatients withoutthe“alarmsymptoms,”currentrecommendationsaretotestfor Helicobacterpyloriinregionswherethereisahighprevalenceofthebacteriaand begintreatmentwithaPPI.InregionswherethereisalowprevalenceofH. pylori,somephysicianswilltreatempiricallywithaPPI.Themostimportant thingtonotehereisthatpatientswhofaileitherofthesetreatmentoptionsafter4 to8weeksshouldundergoendoscopy.(A)Antacidshavenotalleviatedthis patient’ssymptomsandthereforearenotthecorrectanswerhere.(B)Barium swallowevaluationisnothelpfulindiagnosingtheetiologyofdyspepsia.(E) Thispatientissymptomaticandclearlynotrespondingtoover-the-counter antacids.Observationisinappropriate.

83. Answer:E.Etiologiesincludeinfectionandpolypharmacy.Thispatientis presentingwithsignsandsymptomsconsistentwithadiagnosisofdelirium, whichhasseveraletiologiesincludinginfection,surgery,trauma,or polypharmacysideeffects.Acuteonsetofsymptoms,fluctuatinglevelof consciousness,andpresenceofvisualhallucinationsfavoradiagnosisofdelirium overdementia.Additionally,sleep–wakecycledisturbanceisaprominentfeature ofdelirium.(D)Deliriumisreversible,whiledementia,bycontrast,isoften irreversible.Clinically,patientswithdementiashowgradualdeclineincognition withpreservedlevelofconsciousness.Giventhereversibilityofthedisease,the confusedpatientshouldbeassumedtohavedeliriumuntilprovenotherwise. Reversiblecausesofdeliriumshouldbeconsidered,includingmetabolic disorders,infections,medications,normalpressurehydrocephalus,vitamin deficiencies,orthyroiddysfunction,whichmaybepotentiallyreversiblecausesof dementia-likesymptoms.Deliriumoccursinupto20%ofacutehospital inpatientsandupto60%ofsurgicalpatientsintheperioperativeperiod. Identifyingandtreatingthecauseofdeliriumiscritical.(A)Anticholinergic medicationswillworsendelirium.(B)Neurofibrillarytanglesandβ-amyloid plaquesseenonpathologyareconsistentwithAlzheimerdementia,notdelirium. (C)Iflong-termmemoryisintact,butshort-termmemoryisaffected,thenthisis moreconsistentwithdementia.
======================================
questionispresentingwithacutecholecystitis.Heispresentingwithfever,right upperquadrantpainafterafattymealthatradiatestotherightscapula,and positiveMurphysign(painonpalpationintherightupperquadrantwithcessation ofinspiration).Additionalnonspecificfindingsincludevomiting,leukocytosis, andmildelevationintransaminases.Acutecholecystitisusuallyarisesfrom gallstoneformationthatobstructsthecysticduct.Thesymptomsoccurafter eatingafattymealbecausethefatstimulatesgallbladdercontraction,andinthe

presenceofcysticductobstruction,thisleadstocolickypain.Infectionresults fromstasisthatcontributestobacterialgrowthinthegallbladder.(D)Importantly, alkalinephosphataseisnotelevatedinthispatientwithacutecholecystitis. Assumeiflaboratoriesarenotshown,theyarenormal.Ifitwereelevated(in additiontototalbilirubinanddirectbilirubin),thismightindicatecommonbile ductobstructioninthesettingofjaundice(choledocolithiasis).(A)Alcoholicliver diseasedoesnotpresentwiththisconstellationofsymptoms.(C)Similarto commonbileductobstruction,obstructionfromacarcinomaoftheheadofthe pancreaswouldcauseseverelyelevatedalkalinephosphataselevelsandwould normallypresentwithweightlossandpainlessjaundice.(E)Pancreatitisshould definitelyberuledoutwithalipasecheck,butpaintypicallyisonlyepigastricin natureandradiatestotheback.

85. Answer:C.Amitriptyline.Thepatientinthisquestionispresentingwithsigns andsymptomsconsistentwithadiagnosisoffibromyalgia(FM).FMismore commoninmiddle-agedwomenandischaracterizedbychronicwidespreadpain andallodynia(aheightenedandpainfulresponsetopressure).Physical examinationistypicallynormalexceptforpointmuscletendernessinseveral areasincludingthemidtrapezius,lateralepicondyle,andgreatertrochanter, amongothers.Ofnote,FMhasnolaboratoryfindingsthatarediagnosticofthe condition.Thefirst-linetreatmentforFMispatienteducation,aerobicexercise, andgoodsleephygiene.Thispatienthasclearlyattemptedthose recommendationsbasedonthehistorysheprovides,sothefirst-linemedicationis atricyclicantidepressant(TCA)suchasamitriptyline.Severalotherdrugs (pregabalinandduloxetine)canbeattemptedifTCAsfailtoalleviatethepatient’s symptoms.(A,B,E)CorticosteroidsandNSAIDsareusefulintreating inflammatoryconditions,butFMisnotaninflammatorycondition(notassociated withelevatedinflammatorymarkerssuchasESR).(D)Colchicineisusefulin treatinggout,notFM.

86. Answer:B.Administrationoffluids.ThisisacommonquestionontheUSMLE thatemphasizestheimportanceofairway,breathing,andcirculation(ABCs)in themanagementofpatients(regardlessoftheunderlyingdisorder).Thispatient presentswithhypotensionanddelayedcapillaryrefill,indicatingthatthereis compromiseofhiscirculation.Thebestnextstepinmanagementofcirculatory compromise(inthiscasefromanupperGIbleed)isfluidresuscitation.Afterthe patientishemodynamicallystable,treatmentfortheactualunderlyingcondition canbeinitiated.(A,C,D)Alltheseanswerchoicesaddresstheunderlyingcause oftheupperGIbleeding(likelypepticulcerbleeding);however,thepatientmust bestabilizedbeforethesemodalitiesarepursued.(E)Thisisalife-threatening conditionandreassuranceisinappropriate.

signsandsymptomsconcerningforasmallbowelobstruction(SBO).Thetypical constellationofsymptomsincludesabdominalpain,vomiting,obstipation, abdominaldistention,anddiffusetenderness.Amildleukocytosisandelevated amylaseisoftenfoundinanSBO.Thebestinitialtestisanabdominalx-ray becauseitoftenrevealsdilatedbowelloopsandseveralair–fluidlevels. Treatmentinvolvessupportivecare,bowelrest,anddecompressionwitha nasogastrictube.Surgeryisreservedforthosepatientswhofailtoimprovewith theaforementionedtreatmentsand/ordevelopfindingsconsistentwith strangulation.(A,B,D,E)Theseoptionsarenotthebestinitialtestindiagnosing anSBO.
======================================
88. Answer:B.Nephrolithiasis.Thispatientispresentingwiththetypicalsymptoms ofakidneystone.PatientswithCrohndiseaseareatriskofdevelopingcalcium oxalatestonesduetoincreasedabsorptionofoxalateintheGItract(andtherefore increasedoxaluria),whichhastwocauses.First,malabsorptionofbilesaltsand GItractinflammationincreasemucosalpermeability.Second,fattyacids(alsoa resultofmalabsorption)bindintestinalcalcium,andsolesscalciumisavailable tobindandtrapintestinaloxalate.Thiscausesanincreaseinfreeoxalatethatcan beabsorbed,eventuallymakingitbacktothekidneystobeexcreted.Calcium stonesarethemostcommontypeofkidneystones,andpatientswiththesestones areencouragedtoincreasetheirdietaryintakeofcalcium(inordertodecrease oxalateabsorptionintheGItract).Ammoniummagnesiumphosphate(struvite) stonesarecausedbyurinarytractinfectionswithurease-positiveorganisms(e.g., Proteus,Klebsiella)andcanformstaghorncalculi.Uricacidstonesareassociated withhyperuricemia(e.g.,leukemia,gout).Cystinestonesareseeninthegenetic diseasecystinuriaandaretreatedbyalkalinizingtheurinewithacetazolamide. (A)Pyelonephritiswouldalsoproduceflankpain,butunlikenephrolithiasisit wouldalsoproducefever,leukocytosis,andaurinedipstickshowinginfection (e.g.,positivenitrites,positiveleukocyteesterase).(C)Appendicitisisimportant toconsiderinanyyoungpatientwithabdominalpain,howeveritwouldbe unusualforappendicitistocausehematuria.(D)Ectopicpregnanciescanmimic thepainofakidneystone,howeverthisdiagnosisisunlikelygiventhenegative pregnancytest.(E)Thiswouldbeanunusualpresentationofabdominalpainseen inpancreatitis,whichisusuallyepigastricandradiatingtotheback.

89. Answer:C.Hyperventilationsecondarytoanxiety.AccordingtotheABG,this patienthasanacuterespiratoryalkalosis(causedbylossofCO2whichis balancedbyincreasedexcretionofHCO3).Respiratoryalkalosiscanonlybe causedbyanincreaseinventilation(commonlycausedbyhighaltitudesor sympatheticstimulationlikeanxietyorpain).(A)Accumulationofunmeasured

anionsduetohepaticmetabolismofalcoholwouldcauseananiongapmetabolic acidosis(lowpHwithlowHCO3andlowCO2andanincreasedgap,calculatedby subtracting[Cl–+HCO3 –]fromNa+).(B)Vomitingcausesametabolicalkalosis fromlossofacidandchloride.MetabolicalkalosisischaracterizedbyhighpH, highHCO3,andhighCO2(respiratorycompensationbyhypoventilating).(D) Diureticsareassociatedwithametabolicalkalosisfromvolumecontraction.(E) HypoventilationcausesalowpHfromCO2retention.Thiswillcausea respiratoryacidosis,notalkalosisasseenwiththispatient.

90. Answer:C.Lactulose.Thispatientispresentingwithsignsandsymptomsof

cirrhosis(ascites,spiderangiomata)andhepaticencephalopathy(alteredmental statusandasterixis).Inhepaticencephalopathy,theliverisunabletoconvert ammoniaintoureaanditthereforeaccumulates,inadditiontoothertoxinsthe liverisunabletoclear.Itisoftenprecipitatedbyillnessorgastrointestinalbleed (asinthispatientwithhematemesis).Increasedammonialevelscanassistin makingthediagnosis,butthediagnosisisultimatelyclinicalandcancause confusioninthecorrectsettingofendstageliverdisease(ESLD).Treatment involvestreatingtheprecipitantanddecreasingserumammonialevels(however, evenifoneusesammoniatohelpwithdiagnosis,itisnotnecessarytofollow ammonialevels;rather,oneshouldfollowclinicalimprovement).Lactulose,a nonabsorbabledisaccharide,isusedbecausebacteriainthegutmetabolizeitinto acidiccompounds(lacticacid,aceticacid)thatpermittheabsorbableammoniato beconvertedintothenonabsorbableammonium,therebyenablingexcretionfrom thebody.(A)Furosemidewouldimprovetheascitesandvolumestatusina cirrhoticpatient,butisnothelpfulinthemanagementofhepaticencephalopathy. (B)ThiamineisusefulinthetreatmentofWernickeencephalopathy,anotherform ofencephalopathycharacterizedbyalteredmentalstatus,ataxia,andnystagmus andisassociatedwiththiaminedeficiency.Ofnote,asterixisisnotpresentin Wernickeencephalopathy.(D,E)Morphineandhydromorphonearenarcoticsthat wouldbechallengingforacirrhoticpatienttometabolize.
======================================
91. Answer:B.Acetaminophen.Thispatientisobese,greaterthan40yearsofage, andispresentingwithbilateralkneeandbackpain.Thefactthatthepainis worsenedwithactivityandrelievedbyrestsuggeststhatitismostlikely secondarytoosteoarthritis(OA).Ifshereportedmorningstiffnesslastinggreater than30minutesandhadsystemicsymptoms,rheumatoidarthritiswouldhave beenthelikelydiagnosis.OAisanoninflammatoryarthritisthatresultsineroding cartilageintheintra-articularjoints.Thiscausesjointcrepitus(a“grating”or poppingsound)thatoccurswhenthesurfacesofthejointgrindagainsteachother. Althoughthediagnosisisusuallymadeclinically,thetypicalchangesseenonx- rayincludejointspacenarrowing,subchondralsclerosis(increasedbone

formationaroundthejoint),subchondralcystformation,andosteophytes. Acetaminophenisthefirst-linetreatmentformildtomoderateOA.Itisjustas efficaciousasNSAIDsinalleviatingthepaininOAwithconsiderablyfewerside effects.(A)Intra-articularcorticosteroidinjectionsleadtoshort-termpainrelief thatlastsuptoafewmonths.ThisshouldnotbetheinitialtreatmentinOA.(C) NaproxenisanNSAIDandalthoughNSAIDshavebeenshowntobeefficacious inthetreatmentofOA,theirside-effectprofileconsistsofgastrointestinaland renalconsequencesthatmakethemsecond-linetreatments.(D)Allopurinolis usedintheprophylactictreatmentofgout.Itactsviainhibitionofxanthine oxidasewhichdecreasesproductionofuricacid.Itisnotusedinthetreatmentof OA.(E)Thispatientisclearlyinpainandwouldbenefitfrommedication,so observationisinappropriate.

92. Answer:D.VitaminB12deficiency.Thepatientinthisquestionlikelyhas

cobalamin(vitaminB12)deficiency.Thisresultsinamegaloblasticanemia.Long- termconsequencesofvitaminB12deficiencyincludeperipheralneuropathyand posteriorcolumndefectsfromabnormalmyelinsynthesis.Importantly,folicacid deficiencyisanothercauseofmacrocyticanemiaandtreatmentwithfolicacid canimprovetheactualanemiaofvitaminB12deficiencysincebothfolateand vitaminB12areinvolvedintheconversionofhomocysteinetomethionine. However,neurologicsymptomscanbeworsenedinvitaminB12deficiencywith thetreatmentoffolicacidsincevitaminB12isusedinotherbiologicprocessesas well.Asaresult,itiscriticaltoruleoutvitaminB12deficiencybeforeinitiating folicacid.VitaminB12deficiencyresultsfrominadequatevitaminB12intake(diet lackinginanimalproducts)andautoimmunegastritis.Thelossofgastricparietal cellssecondarytoautoimmunegastritiscausesintrinsicfactordeficiency(which isnecessaryforvitaminB12absorptionintheterminalileum).(A)Thepatient’s underlyingdisorderisvitaminB12deficiencyandnoamountoffolicacid supplementationwillimprovehisneurologicsymptoms.(B)Irondeficiencyisa microcyticanemia(MCV<80fL)andisnotassociatedwithperipheral neuropathy.(C,E)Althoughglucoseintolerancecommonlycausesperipheral neuropathy,thispatientdoesnothaveahistorythatsuggestsdiabetes.

usedasanantihypertensiveagent.Ithasahighincidenceofperipheraledemaasa sideeffect.(B)Metoprololisaselectiveβ1-blockerusedinhypertension,heart failure,andratecontrolforatrialfibrillation.Itcancausebradycardiaand hypotension,butavoidssomeoftheadverseeffectsofnonselectiveβ-blockers (e.g.,bronchospasm).Itrarelycausesperipheraledema.(C)Hydrochlorothiazide blockstheNa-Clchannelinthedistalconvolutedtubule,leadingtosodiumand

waterexcretion.Itisusedasanantihypertensiveagent,andcancauseorthostatic hypotension,hypercalcemia,hypokalemia,hyperlipidemia,andhyperglycemia. (D)Metforminisabiguanidedrugusedindiabetesandactsbydecreasinghepatic glucosesecretionandincreasinginsulinsensitivity.ItcausesGIsymptoms, vitaminB12deficiency,andlacticacidosisinpatientswithrenalfailure.(E) Glipizideisasulfonylureaantidiabeticdrug.Itblockspotassiumchannelsinislet cellsofthepancreas,leadingtoincreasedinsulinreleasethatcanresultin hypoglycemia.
======================================
94. Answer:A.Factitioushypoglycemiafromsurreptitiousinjectionofinsulin. Thepatientinthisquestionispresentingwithclinicalsymptomsandlaboratory findingsconsistentwithsurreptitiousinjectionofinsulin(elevatedinsulin, decreasedglucose,anddecreasedC-peptide).(B)Sincethispatientpresentswith adecreasedC-peptidelevel,thisisnotconsistentwithanENDOGENOUSsource ofinsulinsincepancreaticβ-cellsproduceproinsulin(whichbreaksdowninto insulinandC-peptide).Therefore,insulinomaisnotthediagnosissincethereare decreasedlevelsofC-peptideinthispatient.Notethatsurreptitioussulfonylurea usewillalsoproduceelevatedinsulinandC-peptidelevels(similartoinsulinoma) sincethisdrugessentiallystimulatesproinsulinsecretion.Thatiswhyitiscritical toorderaurinesulfonylurealevel,whichisundetectableinthispatient.(C,D) Somatizationdisorderandglucagonomadonotproducehypoglycemia.(E) Dehydrationcannotexplaintheseverehypoglycemiaseeninthispatient.

95. Answer:D.Ciprofloxacin.Onereportedadversereactionoffluoroquinolone antibioticsistendinopathy,andtheAchillestendonismostoftenaffected. FluoroquinolonescanalsocauseGIupset,dizziness,rash,andaprolongedQT interval.(A)Trimethoprim-sulfamethoxazolemaycauseStevens–Johnson syndrome,leukopenia,hyperkalemia,hypoglycemia,andhepatitis.Theincidence ofadversereactionsismuchhigherinHIVpatients.(B)Metronidazolecancause adisulfiram-likereactionwithalcohol.(C)Tobramycinandother aminoglycosidesmaycauserenalfailureandototoxicity.(E)Azithromycinand othermacrolidescancauseaprolongedQTintervalandhepatitis.

96. Answer:B.Thyroid-stimulatinghormone(TSH)levels.Thepatientinthis questionisdemonstratingclinicalmanifestationsofhyperthyroidism.In approachingthediagnosisofthyroiddisorders,thefirststepistoorderaTSH level.TSHisthemostsensitivetesttodetectprimaryhypothyroidismand hyperthyroidism.BasedontheTSHlevel,additionaltestscanbeperformed.(A) FreeT4isimportantinthediagnosticworkupofthyroiddisordersandshouldbe thenexttestorderedifTSHcomesbackdecreased.IffreeT4isincreasedwitha decreasedTSHlevel,thisisdiagnosticofprimaryhyperthyroidism.IffreeT4is decreasedwithadecreasedTSHlevel,thencentralhypothyroidismisthe

diagnosisandtheetiologyinvolvesthepituitaryglandorthehypothalamus. Finally,iffreeT4isnormalwithadecreasedTSH,thenthisissubclinical hypothyroidism.(C)Thyroglobulinisoftenincreasedingoiterand hyperthyroidismandisalsoatumormarkerforthyroidcancer.Itisnotthebest firsttestinworkingupthyroiddisorders.(D)Radioactiveiodineuptake(RAIU) scanisthenextbeststeponceprimaryhyperthyroidismisdiagnosed(increased freeT4withdecreasedTSH)asitcanhelpdifferentiatecausesof hyperthyroidism(Gravesvs.multinodulargoitervs.silentthyroiditis).(E)Afine- needleaspiration(FNA)biopsyisfartooinvasiveofatestwithouthavingbasic laboratoryvalues.

(positiveforHBsAb)andthereforereassuranceshouldbeoffered.Immunityto hepatitisBoccurswhenanti–hepatitisBsurfaceantibodies(HBsAbs)develop againsttherecombinanthepatitisBsurfaceantigen.Giventhepatient’s documentedhepatitisBvaccinationandpositivetitersforHBsAb,reassuranceis appropriate.(A,C)Ifthepatienthadunknownvaccinationhistory,heshould receivebothHBIG(passiveimmunity)andhepatitisBvaccine(activeimmunity). (B)ThepatienthasdocumentationalreadyrevealingpositivityforHBsAb. Therefore,ahepatitisBpanelisunnecessary.

98. Answer:B.Tearingofthebridgingveins.Thispatientissufferingfroma
======================================
subduralhematoma,whichiscausedbyblunttraumathattearsthebridgingveins, whichconnectthecorticalsuperficialveinstothesagittalsinusinthedura.This bloodwillslowlyextravasateintothesubduralspace,whichiswhythispatient’s fallwasrecorded4dayspriortoadmission.Epiduralhematomas,ontheother hand,becomeimmediatelysymptomatic(althoughtheclassicdescriptionof epiduralhematomasisthatofa“lucid”phasefollowedbyrapiddecline). Subduralhematomasmanifestsymptomaticallywithheadacheandgradual confusionandlossofconsciousness.Ofnote,subduralhematomasaremuchmore commoninelderlypatientsandalcoholicpatients(brainatrophyandfragilityof vasculature).Radiologicfindingsofasubduralhematomaincludeawhite crescentonnoncontrastCTofthehead.Also,amidlineshiftiscommonly appreciated.Treatmentisneurosurgicalhematomaevacuation.(A)Tearingofthe middlemeningealarteryistheunderlyingcauseofmostepiduralhematomas.(C) Rupturedaneurysmistheunderlyingcauseofasubarachnoidhemorrhage.(D)In additiontotheradiologicevidence,thisparticularpatienthasaninsignificantpast medicalhistoryandthereforehypertensivehemorrhageisnottherightanswer. (E)Alzheimerdiseasewouldnotpresentwiththisacutepresentation.Thispatient clearlyendorsestraumamakingahematomamuchmorelikelythanunderlying dementia.

99. Answer:D.Severesepsis.Thispatienthasseveresepsissecondaryto

pneumonia.Itisimportanttoknowthedefinitionsrelatedtothetopicofsepsis. Systemicinflammatoryresponsesyndrome(SIRS)isdefinedby2ormoreofthe following:(1)temperature>38°Cor<36°C;(2)aheartrate>90/min;(3)a respiratoryrate>20/minoraPaCO2<32mmHg;and(4)aserumleukocytecount >12,000/mm3or<4,000/mm3or>10%bands.The2016ThirdInternational ConsensusupdatedthedefinitionofsepsistobeaqSOFAscoreof2ormore (qSOFAincludesrespiratoryrateof22orhigher,alteredmentalstatus,orsystolic bloodpressure100mmHgorless).Despitetheseguidelines,manyprovidersstill usetheSIRSdefinitionofsepsisanditisthusstillimportanttoknowtheprevious definition.(C)Whenthereisasuspectedsourceofinfection,thedefinition becomessepsis.Severesepsisisthedefinitionforsepsiswithend-organ dysfunction,signifiedbyhypotensionorhypoperfusion(e.g.,oliguria,elevated serumlactate,etc.).Septicshockisseveresepsisthatdoesnotrespondto adequatefluidresuscitation.ThispatientmeetsSIRScriteriawithasuspected sourceofinfection(pneumonia)andhypotension;(E)IVfluidshavenotbeen administeredyet,sothedefinitionofsepticshockisnotmet.Septicshockisone typeofdistributiveshock,whichischaracterizedbyhypotensionwithflatneck veinsandwarmextremities(lowsystemicvascularresistance).(A,B)Both cardiogenicshockandpulmonaryembolism(atypeofobstructiveshock)are ruledoutbytheflatneckveins.Lastly,hypovolemicshockwouldpresentwith flatneckveinsandcoolextremities,sincesystemicvascularresistanceincreases inanattempttomaintainbloodpressure.

ventilationisthebiggestriskfactorfordevelopingHAP,andtheriskcanbe decreasedwithcertainmeasures.(A)Patientshouldbeplacedinasemirecumbent position(headofthebedelevated30degreesto45degrees)topreventaspiration events.(B)Dailyattemptstoweanapatientfromtheventilatorshouldbe performedtominimizethedurationofmechanicalventilation.(D)Omeprazole andotheragentsthatincreasethepHofgastriccontentshavebeenshownto increasetherateofHAP.Theyshouldbeavoidedifpossible.(E)Endotracheal suctioningofsubglotticsecretionsreducestheriskofVAP.Otherimportant preventivemeasuresincludefollowingproperhandhygieneprotocols,avoiding gastricoverdistention,andusingorotrachealintubationratherthannasotracheal intubation.

Note:Pagenumbersfollowedbyb,f,andtindicatesboxedmaterial,figure,andtable respectively.
======================================
A

ABCD2score,205b Abdominalaorticaneurysm(AAA),54–56

causes,55 clinicalfeatures,55 diagnosis,55 generalcharacteristics,54–55 treatment,55–56

Abdominalobesity,178 Abdominalpain

e

e

e

¢

inacutemesentericischemia,117 incolorectalcancer,113 inCRC,115 nontraumatic,approachtodiagnosisof,165f

Abdominalradiograph,494 acutepancreatitis,140 inchronicpancreatitis,142

©

e

Abdominalultrasound

e

e

inacutepancreatitis,140 incirrhosis,121

Acalculouscholecystitis,134 ACEinhibitors,10,21b

inangioedema,421,421f

Achalasia,149–150

e

e

e

e

e

causes,149 clinicalfeatures,149 diagnosis,149,149f generalcharacteristics,149 treatment,149–150

Achlorhydriasyndrome,181 Acid–basedisorders,319–322

e

e

e

e

metabolicacidosis,319–320,319b,320b,320f,321f metabolicalkalosis,322–323 respiratoryacidosis,323–324 respiratoryalkalosis,324

Acidosis,276b

e

®

metabolic,319–320 respiratory,323–324

Acidsuppressiontherapy,155,155b Acnevulgaris,415–416

Acromegaly,191–192,192b ACTHlevelandCushingsyndrome,198–199 ACTHtest,202 Actinickeratosis,431,431f AcuteAFibtreatment,23–24,23f,24b Acuteappendicitis,138–139 clinicalfeatures,138–139 diagnosisandtreatment,139 incidence,138 pathogenesis,138

e

e

e

e

Acutearterialocclusion,57–58,58t Acutebacterialarthritis,401t Acutebacterialmeningitis,373b Acutebronchitis,447 Acutecholecystitis,133–134 Acutecoronarysyndrome(ACS),6b Acutedecompensatedheartfailure,21 Acutegastritis,156 Acutegeneralizedexanthematouspustulosis(AGEP),423 Acutehyponatremia,194 Acuteinfectiousarthritis,399–401 Acuteinfectiousdiarrhea,pathogens,456t Acuteinterstitialnephritis(AIN),285 vs.chronicinterstitialnephritis,285b

e

Acutekidneyinjury(AKI),266

azotemia,266 causesof,267f initiation,276 intrinsicrenalfailure,268–269 postrenalfailure,269 prerenalfailure,267 treatment,272 vs.chronickidneydisease,273t Acuteleukemias,360–361,360b Acutelimbischemia,57–58 Acuteliverfailure,119–120

causes,119 diagnosis,119–120 generalcharacteristics,119 management,120

signs,120b

»

»

»

»
======================================
Acutelymphoblasticleukemia(ALL),360 Acutemesentericischemia,117–118 Acutemyelogenousleukemia(AML),360 Acutepancreatitis,139–142 causes,139–140,140b clinicalfeatures,140 complications,141 diagnosis,140–141 generalcharacteristics,139 prognosis,142 treatment,141–142

Acutepericarditis,14,35–36

causes,35 clinicalfeatures,35–36 complications,35 diagnosticcriteria,36,36b generalcharacteristics,35 treatment,36

Acutepromyelocyticleukemia(APL),348 Acuterespiratorydistresssyndrome(ARDS),97–100

causes,98–99 clinicalfeatures,99 complications,100 definition,98,100b diagnosis,99–100,99f diffuseinflammatoryprocess,97 pathophysiology,98 treatment,100

Acuterespiratoryfailure,94–97

causes,94–95 classification,95 clinicalfeatures,96 diagnosis,96 generalcriteriatodefine,94 pathophysiology,95–96 treatment,96–97

»

»

»

Acuterheumaticfever,46 Acutetubularnecrosis(ATN),269b Addisondisease.SeePrimaryadrenalinsufficiency

Adenocarcinoma,148 Adenomatouspolyps,114,115–116 Adenosine,sideeffectsof,28b Adrenaladenoma,201 Adrenalcrisis,202 Adrenalglands,diseasesof,197–204

adrenalinsufficiency,201–203 congenitaladrenalhyperplasia(CAH),203–204 Cushingsyndrome,197–199 pheochromocytoma,199–200 primaryhyperaldosteronism,200–201

Adrenalhyperplasia,201 Adrenalincidentaloma,201b Adrenalinsufficiency,201–203

e

e

e

e

causes,201–202 clinicalfeatures,202 diagnosis,202,202f treatment,202–203

Age-relatedmaculardegeneration(ARMD),472–473 Albumin,132 Alcoholicliverdisease-,121 Alcoholism,484–485 Alcoholwithdrawal,485b Aldosteroneantagonists,22b Alkalinephosphatase(ALK-P),124b,132 Alkalosis,320b

e

e

metabolic,323–324 respiratory,325

Alteredmentalstatus,219–221,219b

®

e

e

coma,220–221 delirium,218 differentialdiagnosisof,220b

Alveolarfillingdisease,93 Alzheimerdisease,217–218 Amaurosisfugax,476 AmbulatoryvenousHTN,61 Amebicliverabscess,128 Aminotransferases,130–132 Amyotrophiclateralsclerosis(ALS),234–235 Anaphylaxis,422

»

»

Anaplasticcarcinoma,190 Anemias,326–329

clinicalfeatures,326 diagnosis,326–328 evaluation,328f,329 hemolytic,335–336 macrocytic,333–334 microcytic,329–330 normocytic,332–333 symptomsof,325

»

»
======================================
Androgenexcessandmasculinization,198f Anginapectoris,stable,1–2

causes,1 clinicalfeaturesof,1 prognosticindicatorsof,1 riskfactorsfor,1 standardofcarefor,4b treatmentof,4–5

Anginapectoris,unstable,5–7

e

e

e

e

diagnosisof,6 NSTEMIvs.,6,6b pathophysiologyof,5,6 treatment,6–7

Angiodysplasiaofcolon,117 Angioedema,421,421f Angiotensin-convertingenzyme(ACE),91 AngiotensinIIreceptorblockers(ARBs),21b Anklesprains,465 Ankylosingspondylitis,259–260,259–260

complicationsof,260b

»

»

»

»

»

Anogenitalwart,426 Anorectaldisease,163 Anoscopy,147 Antacids,155 Antibacterialantibiotictherapy

e

e

e

e

antituberculosisantibiotics,506 cellwallinhibitors,499–503 fluoroquinolones,505–506 proteinsynthesisinhibitors,503–505

Antibiotics

»

»

»

»

»

»

»

e

e

incholangitis,135 inCOPD,73,74

Anticoagulationtherapy

inacuteAFib,24 inDVT,60 inpulmonaryembolism,108 Anti-GBMantibodydisease,93 Antimitochondrialantibodies(AMAs),137 Antineutrophilcytoplasmicantibodies(ANCA),92 Antiphospholipidantibodysyndrome,245b,350 Antiretroviraltherapy,391t Antisecretorydrugs,155,156 Antithrombin(AT)IIIdeficiency,350 AntitopoisomeraseI,246 Aorticdissection,53–54,53b,53f Aorticinsufficiency.SeeAorticregurgitation Aorticregurgitation,42–43,42b Aorticstenosis,41–42

e

e

e

causes,41 clinicalfeatures,41 diagnosis,41 management,41b pathophysiology,41 treatment,42

Aortoentericfistula,144b Aphasia,235–236 causesof,235b treatment,236 typesof,235

e

e

e

Aplasticanemia,332–333 Appendix,diseasesof,138–139 acuteappendicitis,138–139 carcinoidsyndrome,139 carcinoidtumors,139 Arrhythmias,12,21–22

e

e

e

prematureatrialcomplexes,21–22 prematureventricularcomplexes,22 Arterialbloodgas(ABG)analysis,111t

¢

¢

e

e

inacuterespiratoryfailure,96 inARDS,100

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

e

e

inasthma,75 inpulmonaryembolism(PE),105–106

Arterialembolism,117 Arterialthrombosis,117 Arteriography coronary,3b inGIbleeding,147

©

e

Arteriovenousmalformations.SeeAngiodysplasiaofcolon Arthritis,causesof,464b Asbestosis,92 Aspergillus,406–407 Aspirin
======================================
e

e

inMI,10 inPAD,57

Aspirin-sensitiveasthma,76b Asthma,74–77 causes,75 clinicalfeatures,74,74b complications,76b diagnosis,75 extrinsicvs.intrinsic,74 treatment,75–77,76b,76t Asymptomaticaneurysms,55 Asystole,13 Ataxia,215 Atheromatousocclusion,55b Atherosclerosis,accelerated,173 Atheroscleroticocclusivedisease,118 Atrialfibrillation,22–25 annualstrokerisk,25t causes,22 clinicalfeatures,23 diagnosis,23 generalcharacteristics,22 treatment,23–25,23f Atrialflutter,25–26,26f

diagnosis,26 generalcharacteristics,25 treatment,26 Atrialmyxoma,62

e

e

e

Atrialseptaldefect,48–49 Atypicalpneumoniasyndrome,365b Auerrods,361f Austinflintmurmur,42 Autoimmunehemolyticanemia(AIHA),341–342

e cold, 341

cold,341 warm,341

e

Autonomicneuropathy,175 Autosomaldominantpolycystickidneydisease(ADPKD),287–288 Autosomalrecessivepolycystickidneydisease(ARPKD),288–289 AVblock,13,32–33,32f AVnodalreentranttachycardia,26

B

Bariatricsurgery,179 Bariumenema,113,119 Bariumswallow

e

e

inachalasia,149 inpepticulcerdisease,154

Barrettesophagus,148b Barttersyndrome,314 Basalcellcarcinoma(BCC),432–433,432f β-blockers,4,6

e

e

e

inaorticdissection,54 inhyperthyroidism,183 inMI,10

Beckermusculardystrophy,225 Becktriad,40 Bernard-Souliersyndrome,345 Berylliosis,93 Bileductstricture,138 Biliarycolic,132,133b Biliarydyskinesia,138 Biliarytractobstruction,133 Biliarytree,cysticdilatationsof,138 Bilirubinmetabolism,129b Bitecells,340 Bitemporalhemianopsia,192 Bladdercancer,299 Bloodtransfusion,327b Blowingholosystolicmurmur,44 Blumershelf,158b Bodyfluidcompartments,302,303f Bodymassindex(BMI)classification,178b Boerhaavesyndrome,154 Botulism,379 Bradyarrhythmias,31–33 AVblock,32–33,32f sicksinussyndrome,31 sinusbradycardia,31

e

e

e

Bradyarrhythmiassicksinussyndrome,31 Breastcancer,354–355

riskfactors,354

typesof,355

Breathsounds,508 Brocaaphasia,235 Bronchiectasis,77,77b BronchodilatorsforCOPD,72,74 Bronchoprovocationtest,75 Brown-Séquardsyndrome,227 Browntumors,196f Budd–Chiarisyndrome,128–129 Budesonide,inCrohndisease,163 Bullouspemphigoid,425,425f BUN–creatinineratio,146 Bupropion(Zyban),486 Bursitis
======================================
e

e

olecranon,466 trochanteric,466

C

Cabergoline,191 Calcificationofsuprasellarregion,192b Calciumchannelblockers(CCBs),5 Calciummetabolism

e

e

e

e

hormonalcontrolof,310–311 hypercalcemia,312–313 hypocalcemia,311 normalserumcalcium,310

Candidiasis,405–406,406f Caplansyndrome,252b CAPRICORNtrial,11b Carcinoembryonicantigen(CEA),113 Carcinoidsyndrome,139,139b Carcinoidtumors,139 Carcinomaofgallbladder,135 Cardiacarrest,30b CardiacArrhythmiaSuppressionTrial(CAST)I,24b Cardiaccatheterization,6–7

e

e

e

e

aorticstenosis,41 cardiactamponade,39 inCHF,18 withcoronaryangiography,3,3b

Cardiacdisease,90b Cardiacenzymes,9,9b CardiacmonitoringforpatientwithacuteMI,9b Cardiacneoplasms,62 Cardiacpacemakers,31b Cardiactamponade,38–39

causes,38 clinicalfeatures,39 definition,38 pathophysiology,38 Cardiogenicshock,64–65 Cardiometabolicrisk,178 Cardiomyopathy,191 Cardiovasculardiseases,435–443

e

e

e

e

e

e

e

hyperlipidemias,440–443 hypertension,435–440 riskfactors,439b

Cardioversion,24–25

ventricularfibrillation,31 vs.defibrillation,24b CAREtrial,7b Carotidbruit,207 Carpaltunnelsyndrome,466 Cataracts,473,474f Catheter-relatedsepsis,412 Caudaequinasyndrome,463b Cavernoushemangiomas,126 CBDstones complications,134 signsandsymptoms,134 Cecalvolvulus,118 Celiacsprue,161 Cellulitis,62b,396 CentralDI,193–194 Centralpontinedemyelination,308 Centrilobularemphysema,69b Cerebrovascularaccident(CVA),24 Cervicalspine,disordersof,463–464 cervicalmyelopathy,464 cervicalradiculopathy,463 chronicaxialneckpain,463 spondylosis,463 Chancroid,395,396f Charcottriad,135 Chestpain,1,14–15,512–513 inacutepericarditis,35–36 differentialdiagnosis,14 inmyocardialinfarction,7 treatmentapproaches,14–15

Chestradiograph(CXR),38,491–494

inARDS,99–100,99f inasthma,75 inCHF,18,18f COPD,71,72f inhemoptysis,112 inILD,88,90f inlungcancer,79,79b

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

’

»

»

»

»

»

»

»

»

»

»

e

e

inpleuraleffusion,83 inpulmonaryembolism(PE),106

Child–Pughscore,120,120t Chlamydia,385 Cholangiocarcinoma,137–138 Cholangiography

incholangiocarcinoma,137 incholangitis,135 Cholangitis,134,135 Cholecystectomy,inacutecholecystitis,133–134 Cholecystitiscomplications,133b Cholecystokinin(CCK),138b Choledochalcysts,138 Choledocholithiasis,134,134t Cholelithiasis,132–133,134t Cholestasis,129b,132b Cholesterolembolizationsyndrome,58 Cholesterolstones,132 Cholesteroltreatmentguidelines,442t CHOPtherapy,359b ChronicAFib,24 Chronicarterialinsufficiency.SeePeripheralarterialdisease(PAD) Chronicbronchitis,69,70t Chroniccholecystitis,133 Chronicgastritis,157 Chronichyponatremia,194 Chronichypoxemia,103 Chroniclymphocyticleukemia,361 Chroniclymphocyticthyroiditis,185b,186,187 Chronicmesentericischemia,118 Chronicmyeloidleukemia,362–363 Chronicobstructivepulmonarydisease(COPD),69–74,69b,71b,74b
======================================
e

e

clinicalfeatures,69–70 clinicalmonitoringof,71b complications,74 diagnosis,70–71 flowvolumecurvesinpatientwith,72f generalcharacteristics,69 pathogenesis,69 riskfactors,69

e

©

takinghistoryofpatientswith,70b typesof,69,70t

Chronicpancreatitis,142–144

e

e

e

e

e

clinicalfeatures,142 complications,142–143 diagnosis,142,143f generalcharacteristics,142 treatment,143–144

»

»

»

’

»

Chronicthromboembolicdisease,103 Chronicthyroiditis,185 Chronicvenousinsufficiency,61–62 Churg–Strausssyndrome.SeeEosinophilicgranulomatosiswithpolyangiitis Chvosteksign,311 Cirrhosis,120–124

»

causes,121 Child–Pughscore,120,120t clinicalfeatures,121,121b complications,121–124 ascites,121–122,122b coagulopathy,123 esophageal/gastricvarices,121,122b HCC,124 hepaticencephalopathy,122–123 hepatorenalsyndrome,123 hyperestrinism,123 portalHTN,121 SBP—infectedasciticfluid,123

definition,120 hepaticfunctionalreserveassessment,120–121 irreversible,120 treatment,124

Coagulation,disordersof,347–348 coagulopathyofliverdisease,349 disseminatedintravascularcoagulation,347–348 hemophiliaA,346–347,347t hemophiliaB,347 hypercoagulablestates,350–351 laboratoryfindingsfor,348t vitaminKdeficiency,349 vonWillebranddisease,345–346,346t

Coagulopathyofliverdisease,349 Clonidine,inTourettesyndrome,216 Clubbingoffinger,89b,89f Clusterheadaches,444 Coalworker’spneumoconiosis,92 Coarctationofaorta,50,50b Coexistinghypocalcemia,317 “Coffeegrounds”emesis,145 “Cold”nodules,189b Colon,diseasesof,113–115 acutemesentericischemia,117–118 angiodysplasiaofcolon,116–117 chronicmesentericischemia,118 colonicpolyps,115–116 colonicvolvulus,118–119 colorectalcancer,113–115 diverticulosis,116–117 ogilviesyndrome,118 Colonicpolyps,115–116 Colonicvolvulus,118–119 Colonoscopy,113,147 Colorectalcancer(CRC),113–115 clinicalfeatures,114–115 generalcharacteristics,113 riskfactor,114 riskfactors,114 screening,113,113b treatment,115 Commoncold,447–448 Commonwart,426 Community-acquiredpneumonia(CAP),365 atypical,366b diagnosisof,366,367b sputumculture,366b treatment,368 typical,365
======================================
Compensatorymechanisms,65b Conductionaphasia,235 Congenitaladrenalhyperplasia(CAH),203–204 Congenitalheartdiseases,48–52,48b

atrialseptaldefect,48–49 coarctationofaorta,50 patentductusarteriosus,50–51 tetralogyoffallot,51–52 ventricularseptaldefect,49–50

Congestiveheartfailure(CHF),12,15–21

causeofdeathfrom,21b definition,15 diagnosis,18 heartfailurewithpreservedejectionfraction,17 heartfailurewithreducedejectionfraction,15–17 left-sided,17–18 medicationscontraindicatedin,23b NYHAclassification,17b pathophysiology,15,16f right-sided,18 treatment,19–20

e

e

e

e

generalprinciplesin,20b HFpEFtherapy,20–21 HFrEFtherapy,20b systolicdysfunction,19

»

’

»

»

Conjugatedhyperbilirubinemia,129–130 Conjugatedvs.unconjugatedbilirubin,129 Conjunctivitis,475 Connectivetissuediseases

e mixed, 247

mixed,247 scleroderma,244–246 Sjögrensyndrome,246–247 systemiclupuserythematosus,241–244

e

e

e

Constipation,455–457

complicationsof,457b

Constrictivepericarditis,36–37,37b

©

e

e

e

e

causes,36 clinicalfeatures,37 diagnosis,37 pathophysiology,36 treatment,37

Contactdermatitis,417–418,418f

»

e

e

allergic,417 irritant,417

Corkscrewesophagus,151 Coronaryangiogram,4f Coronaryangiography,cardiaccatheterizationwith,3,3b Coronaryarterybypassgrafting(CABG),5b,11b Coronaryischemia,1 Corpulmonale,104,104b Corriganpulse,42 Corticosteroids,inCrohndisease,163 Cortisol,197b Cough,446–447

acute,447 cause,446 chronic,446 diagnosis,446 treatment,446–447 Crampinglegpain,56 Craniopharyngioma,192 Creatinekinase-MB(CK-MB),9 CRHstimulationtest,199 Crigler–Najjarsyndrome,130 Crohndisease,162–163,162b,164t Cryoglobulinemicvasculitis,264–265 Cryptococcosis,407–408 Cryptogenicorganizingpneumonitis(COP),94 Crystal-inducedarthritides

©

e

gout,252–255 pseudogout,255,256f

Cushingdisease,199b Cushingsyndrome,197–199,324

causes,197–198 clinicalfeatures,198 diagnosis,198–199 generalcharacteristics,197 responsetodiagnostictestsin,199t treatment,199 Cysticfibrosis,77 Cytologicexaminationofsputum,79 Cytoprotection,156
======================================
D

Dawnphenomenon,168b D-dimerassay,107 Decompressionviasigmoidoscopy,119 Deepvenousthrombosis(DVT),59–61,61b

clinicalfeatures,59 complications,60 diagnosis,59–60 generalcharacteristics,59 treatment,60–61

Defibrillation,24b,31b Dementia

e

e

e

e

causesof,216b withLewybodies,218 vs.delirium,219t vs.forgetfulness,216b

Demyelinatingdisease

Guillain-barrésyndrome,223–224 multiplesclerosis,222–223 Dermatitisherpetiformis,161 Dermatomyositis,256 Dermatophytes,428–429,429t Desmopressin(DDAVP),194 indiabetesinsipidus,308 invonWillebranddisease,345 Diabetesinsipidus(DI),193–194 Diabetesmellitus(DM),167–173 acutecomplicationsof,176–178 diabeticketoacidosis,176–177 hyperosmolarhyperglycemicnonketoticsyndrome,177–178,177t

e

e

e

e

¢

e

e

chroniccomplications,173–176,173f macrovascularcomplications,173 microvascularcomplications,174–175 specifictreatmentof,175–176 chroniccomplicationsof,173–175

e

e

e

e

e

macrovascular,173 microvascular,174–175

e

e

e

classification,167 clinicalpresentation,169–170,169t diabeticketoacidosisand,176–177,177t

diabeticnephropathyand,174 diabeticneuropathyand,175 diabeticretinopathyand,174 diagnosis,169,169t monitoringglucoselevelsin,172b outpatientmanagementandmonitoring,168b pathogenesis,167 treatment,170–173

dietandexercise,170 insulin,171–173,171t oralhypoglycemicdrugs,170–171,171t surgical,173 Diabeticfoot,175 Diabeticketoacidosis(DKA),176–177,177t Diabeticnephropathy,174,175f Diabeticretinopathy,174 Dialysis,275–278

e

e

¢

hemodialysis,276–277 limitationsandcomplicationsof,277–278 peritoneal,277

Diarrhea,452–455,453b

acute,452 causes,453 chronic,452 diagnosis,453–455,454f laboratorytestsfor,454b,454f pathogenicorganismsfor,456t treatment,455

Diastolicdysfunction,17 Dietandexercise,170,179 Diffuseesophagealspasm(DES),150–151,150f Diffuseinterstitialfibrosis,flowvolumecurvesinpatientwith,72f Diffusetoxicgoiter.SeeGravesdisease Digoxin,22b,23b Dilatedcardiomyopathy,33 Directoralanticoagulants(DOACs),forAFib,24 Disseminatedintravascularcoagulation(DIC),347–348 Distalesophagealwebs.SeeSchatzkiring Distalsymmetricneuropathy,175 Diuretics

»

»

,

»

»

»

»

»

»

»

»

»

»
======================================
e

e

e

inacutedecompensatedheartfailure,20–21 inhypertrophiccardiomyopathy,34 insystolicdysfunction,20

Diverticulitis,116 Diverticulosis,116–117

¢

e

complications,116–117,116b vs.diverticulitis,116b

DLCO,111t Dresslersyndrome,14 Drugreactions,422–424

overview,422

DrugReactionwithEosinophiliaandSystemicSymptoms(DRESS),423 Dualantiplatelettherapy(DAPT),6 Duchennemusculardystrophy,225 Dukeclinicalcriteria,47,47t Duodenalvs.gastriculcers,155t Dyslipidemiasyndromes,440t Dyspepsia,450–451 GERDand,450 GIcauses,450 nonulcer,450b treatment,450–451 Dysphagia,149,153f Dyspnea,110–112

e

e

e

e

E

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

»

’

»

’

’

Eaton–Lambertsyndrome,79 ECG,37b,41,64

inacutepericarditis,36 inaorticregurgitation,43 inatrialflutter,26,26f incardiactamponade,39 inCHF,18 inmitralstenosis,40 inmultifocalatrialtachycardia,26,27f inmyocardialinfarction,8–9,8f,9t inpericardialeffusion,38 inprematureatrialcomplexes,21 inPSVT,27f inpulmonaryhypertension,103 resting,2 inrestrictivecardiomyopathy,34 stress,2 intetralogyoffallot,51 intricuspidregurgitation,45 inventricularfibrillation,30,30f inventriculartachycardia,29,29f

EctopicACTHproduction,198 Eisenmengerdisease,49 Electrolytes,276b Embolectomy,118 Embolicstroke,207 Embolisources,104b Embolization,57 Emphysema,69,70t Empyema,84 Encephalitis,375–376 Endocarditis,46b,47 Endoluminaladenocarcinomas,113 Endoscopy,fordyspepsia,450 Endoscopy,inpepticulcerdisease,154 Environmentalenteropathy.SeeTropicalsprue Environmentallungdisease,88,92–93,92b Eosinophilicgranulomatosiswithpolyangiitis,92 Eosinophilicpneumonia,93

Epididymitis,301 Epigastricpain,154,156 Epiphrenicdiverticula,153 Erysipelas,396–397 Erythemamultiforme(EM),423,423f Erythroderma,424 Esophagealcancer,148–149 Esophagealdiverticula,153–154 Esophagealhiatalhernias,151,152f Esophagealperforation,154 Esophagectomy,149 Esophagomyotomy,151 Esophagus,diseasesof,148–154

achalasia,149–150 diffuseesophagealspasm,150–151 esophagealcancer,148–149 esophagealdiverticula,153–154 esophagealhiatalhernias,151 esophagealperforation,154 Mallory–Weisssyndrome,151 Plummer–Vinsonsyndrome,151–152 Schatzkiring,152–153

Essentialthrombocythemia,364 Estrogenreplacementtherapy,441b Evidence-basedmedicine,516–519 Exercise-inducedischemia,2 ExercisestressECG,2b Exercisestresstesting,41 Exophthalmos,183f Expiratoryreservevolume(ERV),71f Externalcompressionstocking,62 Extracellularfluid(ECF),302 Extrinsicallergicalveolitis.SeeHypersensitivitypneumonitis Extrinsicasthma,74 Exudativeeffusion,82–83,83b,84
======================================
F

FacialNervePalsy,differentialdiagnosisfor,236b FactorVIIIcoagulantprotein,andvonWillebranddisease,346t Familialadenomatouspolyposis(FAP),CRCriskwith,114 Familialjuvenilepolyposiscoli,CRCriskwith,114 Fatigue,482–483 Fecalimmunochemicaltests(FIT),113 Fecaloccultbloodtesting(FOBT),113 Feltysyndrome,252b Feverofunknownorigin(FUO),408–411,411b Fiberopticbronchoscopy,79,112 Fibromyalgia,259 Fibrousthyroiditis,187 Fine-needleaspiration(FNA)biopsy,188,188b First-degreeAVblock,32,32f Fistulae,163 Flatwar,426 Flexiblesigmoidoscopy,113 Fluidreplacement,177,178,303 Focalnodularhyperplasia,126 Fogartyballooncatheter,59 Folatedeficiency,334–335 Follicularcarcinoma,189 Forcefuldilatation,150 Frank–Starlingrelationship,16f Freethyroxineindex(FTI),183 Freewallrupture,13

G

Gallbladderandbiliarytract,diseasesof,132–138

acalculouscholecystitis,134 acutecholecystitis,133–134 bileductstricture,138 biliarydyskinesia,138 carcinomaofgallbladder,135 cholangiocarcinoma,137–138 cholangitis,135 choledochalcysts,138 choledocholithiasis,134 cholelithiasis,132–133 primarybiliarycirrhosis(PBC),137 primarysclerosingcholangitis,135–136

GallstoneIleus,133b Gardnersyndrome,114 Gardnersyndrome,CRCriskwith,114 Gastriccancer,158 Gastriclymphoma,158 Gastricoutletobstruction,157t Gastriculcers,duodenalvs.,155t Gastrinoma.SeeZollinger–Ellisonsyndrome(ZES) Gastroenteritis,458b Gastroesophagealrefluxdisease(GERD),451–452

Barrettesophagusand,451 erosiveesophagitisand,451 esophagealulcerand,451 heartburnin,451 hiatalherniain,451 pepticstrictureand,451 pneumoniaand,452 treatment,452

Gastrointestinalbleeding,144–148,157t

causes,145 clinicalfeatures,145 diagnosis,146–147,146b,146f evaluation,146f factorsincreasingmortalityin,147b generalcharacteristics,144 treatment,147–148

Gastrointestinaldisorders,14b Gastrointestinalsystem,diseasesof,113–166

appendix,diseasesof,138–139 colon,diseasesof,113–115 esophagus,diseasesof,148–154 gallbladderandbiliarytract,diseasesof,132–138 gastrointestinalbleeding,144–148 inflammatoryboweldisease,162–166 liver,diseasesof,119–132 pancreas,diseasesof,139–144 smallintestine,diseasesof,158–161 stomach,diseasesof,154–158

Genitalwarts,385 Gilbertsyndrome,130 Glanzmannthrombasthenia,345 Glasgowcomascale,221t GlasgowComaScale,221t Glaucoma,473–473 closed-angle,472 diagnosis,473 open-angle,473 riskfactors,473 treatment,473 Globalaphasia,235 Glucagonoma,181 Gonococcalarthritis,400b Gonorrhea,385–386 Goodpasturedisease,93 Granulomas,ILDassociatedwith,89–92
======================================
e

e

e

e

eosinophilicgranulomatosiswithpolyangiitis,92 granulomatosiswithpolyangiitis,92 pulmonarylangerhanscellhistiocytosis,91–92 sarcoidosis,89–91

Granulomatosiswithpolyangiitis,92 Gravesdisease,182 Guillain-barrésyndrome,223–224

H

Haloperidol

e

e

indelirium,216 inTourettesyndrome,215

»

’

»

»

Hartnupsyndrome,287 Hashimotodisease,185 Hashimotothyroiditis,185b,186 Headache,443–446

cluster,444 differentialdiagnosisof,443b emergencyevaluationof,443b migraine,445–446 redflags,444b tension,443

Hearingimpairment,479b Hearingloss,479–480 Heartfailurewithpreservedejectionfraction(HFpEF),17,20–21 Heartfailurewithreducedejectionfraction(HFrEF),15–17,20b Heartmuscle,diseasesof,33–35 dilatedcardiomyopathy,33 hypertrophiccardiomyopathy,33–34 myocarditis,35 restrictivecardiomyopathy,34–35

e

e

e

e

»

’

»

»

»

Heinzbodies,340 Helicobacterpylorieradication,156t Helmetcells,335 Hematemesis,145 Hematochezia,145 Hematuria

»

»

»

»

»

’

causes,280 diagnosis,281–282 evaluation,281f gross,282b treatment,281 Hemobilia,127 Hemochromatosis,125–126 Hemodynamicmonitoring,64 Hemoglobin/hematocritlevel,146 Hemolyticanemias,335–336 Hemolytictransfusionreaction

’

e

e

acute,327b delayed,327b

Hemoptysis,112,112b Hemorrhagicpancreatitis,141 Hemorrhagicstroke

e

e

intracerebralhemorrhage,210–211 subarachnoidhemorrhage,211–212

Hemorrhagictamponade,39 Hemorrhoids,459–460 Heparin

administration,351 contraindicationsto,351 indicationsforuse,351 mechanismofaction,351 inMI,11,12b reversingeffectsof,351

Heparin-inducedthrombocytopenia,345 Hepaticabscess,135b Hepaticfunctionalreserveassessment,120–121 Hepatocellularadenoma,126 Hepatocellularcarcinoma(HCC),124,126–127

clinicalfeatures,127 diagnosisandtreatment,127 generalcharacteristics,126 prognosis,127b riskfactors,126–127

HereditarynonpolyposisCRC,114 Hereditaryspherocytosis,339 Herpessimplexvirus,391f Herpeszoster,428,428f Herpeticwhitlow,393b Hidradenitissuppurativa,417 High-dosedexamethasonesuppressiontest,199 High-outputheartfailure,15b Hiposteoarthritis,466b Hodgkinlymphoma,356–358 Hornersyndrome,78,227 “Hot”nodules,189b HumanparvovirusB19,338 Huntingtonchorea,214
======================================
Hürthlecelltumor,189b Hydatidlivercysts,128 Hydralazine,22b Hyperaldosteronism,201b Hypercalciuria,292b Hypercapnic(hypercarbic)respiratoryfailure,95 Hypercoagulablestates,350–351 Hyperglycemia,307 Hyperinsulinemichypoglycemia,laboratoryvaluesin,181t Hyperlipidemia,4 Hyperlipidemias,440–443,443t

clinicalfeatures,441 diagnosis,441 drugtherapy,443t HDLcholesterol,441 LDLcholesterol,441 treatment,442 Hypernatremia,193 Hyperosmolarhyperglycemicnonketoticsyndrome,177–178,177t Hyperoxaluria,292b Hyperphosphatemia,319 Hyperpigmentation,199b,202 Hyperplastic(metaplastic)polyps,115 Hyperprolactinemia,191 Hypersensitivity,ILDassociatedwith,93 Hypersensitivitypneumonitis,93,93b Hypertension(HTN),50,435–440

αblockers,438 βblockers,438 calciumchannelblockers,439 cottonwoolspots,436,437f definition,435b diagnosis,437–438 essential,435 pathophysiology,435b riskfactors,435 secondary,435 targetorgandamage,436 thiazidediuretics,438 treatment,438–440

e

e

vasodilators,439 whitecoat,439b

»

»

»

»

Hypertensiveemergency,52–53,53b Hypertensivenephrosclerosis,291 Hypertensiveurgencies,52,53b Hyperthyroidism,182–184,184b

causes,182 clinicalfeatures,182 diagnosis,183 Plummerdiseaseand,182 treatment

©

e

e

e

nonpregnantpatients,184 pharmacologic,183–184 radioiodine,184 surgical,184

Hypertonichyponatremia,307 Hypertrophiccardiomyopathy,33–34

e

e

e

e

clinicalfeatures,33 diagnosis,34 pathophysiology,33 treatment,34

Hypertrophicpulmonaryosteoarthropathy,79 Hypervolemia,305 Hypocalcemia,311–312

ECGin,311

Hypoglycemia,179–180,514

»

causes,179–180 clinicalfeatures,180 diagnosisandtreatment,180 generalcharacteristics,179 hyperinsulinemic,laboratoryvaluesin,181t insulinomaand,180 physiologicresponsesto,179b Hypoglycemicunawareness,180b Hypokalemia,181,313–314,315f

»

e

e

e

e

andarrhythmias,314 causes,313–314 clinicalfeatures,314 treatment,314

Hyponatremia,176,194b,306–308

»

causesandclassification,306 clinicalfeatures,307 diagnosis,307,308f treatment,308

Hypoparathyroidism,195–196 Hypopituitarism,190,192–193 Hypothyroidism,185–186 Hypotonichyponatremia,306–307 Hypovolemia,304–305 Hypovolemicshock,65–66
======================================
diagnosis,66 generalcharacteristics,65–66 hemodynamicchangesin,65t obstructive,66 treatment,66

Hypoxemia,95b,96f Hypoxemicrespiratoryfailure,95

I

IatrogenicCushingsyndrome,197 Idiopathicinflammatorymyopathies,256–258 Idiopathicpulmonaryfibrosis,93–94 Immunethrombocytopenicpurpura,344 Impedanceplethysmography,59 Inclusionbodymyositis,258 Infectiousmononucleosis,412–414,413t Infectiveendocarditis(IE),46–48

e

¢

e

e

e

classifications,46 complications,47 definition,46 diagnosisandtreatment,47,47t prophylaxis,48

Inferiorvenacavafilterplacement,inDVT,60 Inferiorvenacavainterruption,108–109 Inflammatoryboweldisease(IBD),162–166

CRCriskwith,114 Crohndisease,162–163 epidemiology,163b extraintestinalmanifestations,162b ulcerativecolitis(UC),163–166

Inflammatorypolyps,115 Influenza,372 Inhaledanticholinergicdrugs,inCOPD,71 Inhaledb2-agonists,inasthma,75,76 Inhaledcorticosteroids inasthma,75–76,76b inCOPD,72

e

e

Inotropy,64 Insomnia,478 Inspiratorycapacity(IC),71f Insulin,171–173,171t,177,178 Insulinoma,180–181 Intensiveinsulintherapy,172 Internuclearophthalmoplegia,222 Interstitiallungdisease(ILD),88–94,88b

e

e

alveolarfillingdisease,88,93 associatedwithgranulomas,89–92

associatedwithhypersensitivity,93 classification,88 clinicalfeatures,88 cryptogenicorganizingpneumonitis(COP),94 diagnosis,88–89,90f environmentallungdisease,92–93 generalcharacteristics,88 hypersensitivitylungdisease,88 idiopathicpulmonaryfibrosis,93–94 radiationpneumonitis,94

Interstitialpulmonaryinflammation,94 Interventricularseptum,ruptureof,13 Intoxications,276b Intra-abdominalabscess,379 Intra-aorticballoonpump,65b Intracellularfluid(ICF),302 Intracerebralhemorrhage(ICH),210–211,211f Intrinsicasthma,74 Irondeficiencyanemia,329 Ironoverload,125–126 Irritablebowelsyndrome,457–458 Ischemia

e

e

detectionmethods,3b markersfor,8

Ischemicheartdisease,1–15 anginapectoris,stable,1–2 anginapectoris,unstable,5–7 chestpain,14–15 diagnosis,2 myocardialinfarction,7–14

Ischemicstrokes,205–210 causesof,206–207,206f classesof,205 complications,208 deficitsseenin,207t riskfactors,205 treatment,208
======================================
Ischemiculceration,56 Isosorbidedinitrate,22b Isotonichyponatremia(pseudohyponatremia),307

J

»

Jaundice,129–130,144 causes,129–130,129b diagnosisandtreatment,130 generalcharacteristics,129

e

e

e

»

»

Jointpain,causesof,467 Jugularvenouspulse,64b

K

»

»

»

»

»

Kayexalate,317 Kayser–Fleischerring,124f Keratoacanthoma,432 Ketonemia,176 Klatskintumors,137b Kneepain,464–465

»

e

e

causes,464 diagnosis,465

Krukenbergtumor,158b

L

’

»

»

»

»

»

»

»

»

»

»

’

LactatedRingersolution,303 Lacunarstroke,207 Lambert-Eatonmyasthenicsyndrome,224b Largebowelobstruction,159f Laryngitis,449 Leftheartdisease,103 Left-sidedheartfailure,17–18 Legraisemaneuvers,33b Lerichesyndrome,55b Libman–Sacksendocarditis.SeeNonbacterialverrucousendocarditis Lichenplanus,420 Lipid-loweringtherapy,4 Liver,diseasesof,119–132

»

acuteliverfailure,119–120 Budd–Chiarisyndrome,128–129 cavernoushemangiomas,126 cirrhosis,120–124 focalnodularhyperplasia,126 hemobilia,127 hemochromatosis,125–126 hepatocellularadenoma,126 hepatocellularcarcinoma,126–127 jaundice,129–130 liverabscess,128 livercysts,127–128 liverfunctiontests,130–132 nonalcoholicsteatohepatitis,127 Wilsondisease,124–125

Liverabscess,128 Livercysts,127–128

e

e

hydatid,128 polycystic,127–128

Liverfunctiontests,130–132

albumin,132 ALK-P,132 ALTandAST,130–132 GGT,132 PT,132

Livertransplantation,incirrhosis,124

»

»

Lockedinsyndrome,221b Lowbackpain(LBP)

backexamination,462 causes,460–462,460b chronic,460 diagnostictests,460–463 management,463 treatment,463

Lowbackpain(LBP),460–463 LowerGIbleeding,144

e

e

causes,145 treatment,147

Low-molecular-weightheparin(LMWH),6,61b,108

e

e

indicationsforuse,351 mechanismofaction,351

Lueticheart,58–59 Lungabscess,369–370 Lungcancer,78–80

clinicalfeatures,78–79,78b diagnosis,78b pathologictypes,78 prognosis,80b riskfactors,78 staging,78 treatment,79–80 types,81t

»

»

Lungdisease,103 Lungneoplasms,78–82 lungcancer,78–80 mediastinalmasses,81–82 solitarypulmonarynodule,80–81,80f
======================================
e

e

e

»

»

»

»

’

»

Lungvolumes,71f Lymedisease,401–402,402f Lymphadenitis,397 Lymphangitis,62b Lymphocyticthyroiditis.SeeChroniclymphocyticthyroiditis Lymphogranulomavenereum,395 LynchsyndromeIandII,114

»

M

»

»

»

Macroadenoma,190 Macrovascularcomplications,173 Magnesiummetabolism,317–318

e

e

e

absorptionandbalance,317 hypermagnesemia,318 hypomagnesemia,317–318

»

»

’

»

»

»

»

»

»

Maintenancefluid,calculationof,305,310b Malaria,403–404 Malignanthepatoma.SeeHepatocellularcarcinoma Malignantmesothelioma,86–87,86b Mallory–Weisssyndrome,151 Maranticendocarditis.SeeNonbacterialthromboticendocarditis Marjolinulcer,433b MDIandnebulizers,76b Meancorpuscularvolume(MCV),328 Mechanicalventilation,100–102

»

©

e

e

e

complications,102 generalcharacteristics,100–101 keyparameters,102 ventilatorsettings,101–102,101b

’

’

»

’

»

»

Mediastinalmasses,81–82 Mediastinoscopy,79 Medullarycarcinoma,189 Medullaryspongekidney,289,289f Melanoma,433–434,434f Melena,145 Meningitis,373–375

»

acute,373 aseptic,373 bacterial,373 chronic,373 CSFfindingsin,374t treatment,374–375,375t

Metabolicacidosis,176,319–323,320b arterialbloodgasinterpretation,322b asthmaticchildand,323 causes,321 clinicalfeatures,322 diagnosis,322–323

e

e

e

pathophysiology,320,320f salicylateoverdoseand,322 treatment,323

Metabolicalkalosis,323–324

causes,323–324 clinicalfeatures,324 diagnosis,324 treatment,324 withvolumecontraction,324

MetabolicSyndromeX,2b Metastasesofgastriccarcinoma,158b Methacholinechallenge,111t Microadenoma,190,191b Microalbuminuria,174 Microvascularcomplications,174–175 Migraine,445–446

e

e

©

e

clinicalfeatures,445 treatment,445–446 types,445 visualaura,445b

Mineralocorticoids,200 Mitralregurgitation,43–44

causes,43 clinicalfeatures,43–44 diagnosisandtreatment,44 pathophysiology,43 Mitralstenosis,39–40 Mitralvalveprolapse,45,45b ModelforEnd-StageLiverDisease(MELD)score,120–121 Molluscumcontagiosum,427,427f Mononeuropathies,175 Montelukast—leukotrienemodifiers,76 Morphine,11 Movementdisorders,212–214
======================================
e

e

e

e

Huntingtonchorea,214 Parkinsondisease,212–214 Multifocalatrialtachycardia,26 Multinodulartoxicgoiter.SeePlummerdisease Multipleendocrineneoplasia(MEN)syndrome,200b Multiplemyeloma,355–356

e

e

»

»

»

»

Multipleorgandysfunctionsyndrome(MODS),67b Multiplesclerosis(MS),222–223

clinicalfeatures,222–223 course,222–223 demyelinationofCNSin,222 diagnosis,223,223b disease-modifyingtherapy,223b high-doseIVcorticosteroidsin,223 relapses,222b symptomatictherapyin,223 treatment,223

Murmurs,508 Myastheniagravis,224b Mycoticaneurysm,58 Myelodysplasticsyndromes,364 Myeloproliferativedisorders

myelodysplasticsyndromes,364 polycythemiavera,363 Myocardialinfarction,7–14

e

e

anteriorwall,8f asymptomatic,7 cardiacmonitoringforpatientwithacute,9b causesof,7 chestpainin,7 complications,12–14,12f diagnosis,8–9 indicationsfor,11b symptoms,7–8 treatment,10–11

Myocarditis,35 Myxedemacoma,185b

N

Narcolepsy,477 Narrowcomplextachycardias,30b Nasogastrictube,147 Nativevalveendocarditis,46 Nauseaandvomiting,458–459

causesof,458b complicationsof,459b NebulizersandMDI,76b Necrotizingfasciitis,397 NephrogenicDI,193–194 Nephrolithiasis diagnosis,293 presentation,293b riskfactors,292 treatment,294–295 typesofstones,292–293

e

¢

e

e

e

e

e

Nephroticsyndrome,278b,307 Neurocutaneoussyndromes

e

e

e

e

e

neurofibromatosistypeI,226 neurofibromatosistypeII,226 Sturge-Webersyndrome,226 tuberoussclerosis,226 VonHippel-Lindaudisease,226

Neurogenicshock,67 Neurologiclesion,237–240

brainstem,237 cerebellum,237 cerebralcortex,237,238f muscle,239–240 neuromuscularjunction,239 peripheralnerve,239 plexus,237–238 roots,238 spinalcord,237 subcorticallesions,237 Neuromusculardiseases

e

e

e

Beckermusculardystrophy,225 Duchennemusculardystrophy,225 myastheniagravis,224–225

Neutropenicfever,412 NewYorkHeartAssociation(NYHA)classification,17b Nicotinechewinggum,485 Nitrates,4–5

inachalasia,149 inacutedecompensatedheartfailure,21 inMI,11

Nitroglycerin,sublingual,14b,149 Nonalcoholicsteatohepatitis,127 Nonbacterialthromboticendocarditis,48 Nonbacterialverrucousendocarditis,48 Nonhemorrhagictamponade,39 Non-hodgkinlymphoma,358–359,359t Noninsulindiabetesmedications,170–171,171t Noninvasivepositivepressureventilation(NPPV),74,98b Nonneoplasticpolyps,115 Nonocclusivemesentericischemia,117 Non–smallcelllungcancer(NSCLC),78,79–80,79b,81t Nontraumaticabdominalpain,approachtodiagnosisof,165f Normalsaline(NS),303 NSTEMIvs.unstableanginapectoris,6,6b
======================================
O

Obesity,178–179,478–479 Obstructivelungdiseases,69–77

asthma,74–77 bronchiectasis,77 chronicobstructivepulmonarydisease,69–74 cysticfibrosis,77 vs.restrictivelungdisease,71t

Obstructiveshock,67–68 Obstructivesleepapnea(OSA),476–477

complications,477b

Odynophagia,148 Ogilviesyndrome,118 Oliguria,513–514 Opticneuritis,222b Oralglucocorticoids,165 Oralhypoglycemicdrugs,170–171,171t Oralsodiumloading,201 Orlistat,179 OrthodromicAVreentranttachycardia,26–27 Orthodromicreciprocatingtachycardia,28 Orthostaticsyncope,230b Osmoticdiuresis,309 Osteitisfibrosacystica,196f Osteoarthritis,467–469,469f clinicalfeatures,467–468 diagnosis,468 riskfactors,467 treatment,468–469 Osteomyelitis,398–399 Osteoporosis,469–472

e

e

e

e

e

e

e

e

bonemineraldensityT-scorecriteriafor,471b diagnosis,471 fractureriskin,470b treatment,471

Oxygendeliverysystems,97t OxygentherapyforCOPD,73,73b

P

Painlessjaundice,144b Painlessrectalbleeding,116 Painlessthyroiditis.SeeSubacutelymphocyticthyroiditis Palpablegallbladder,144 Pancoasttumor,78–79 Pancreas,diseasesof,139–144,167–181 acutediabeticcomplications,176–178 acutepancreatitis,139–142 chronicdiabeticcomplications,173–176 chronicpancreatitis,142–144 diabetesmellitus,167–173 glucagonoma,181 hypoglycemia,179–180 insulinoma,180–181 obesity,178–179 pancreaticcancer,144 somatostatinoma,181 VIPoma,181 Zollinger–Ellisonsyndrome(ZES),181

Pancreaticcancer,144 Pancreaticenzymes,143 Pancreaticnecrosis,141 Pancreaticpseudocyst,141 Panlobularemphysema,69b Papaverine,intra-arterialinfusionof,118 Papillarycarcinoma,189,189b Papillarymusclerupture,13–14 Papilledema,211b Paraesophagealhiatalhernia(type2),151,152f Paralyticileus,161 Paraneoplasticsyndromes,79 Parapneumoniceffusion,84 Parathyroidglands,diseasesof,195–197

e

e

hypoparathyroidism,195–196 primaryhyperparathyroidism,196–197

Parkinsondisease,212–214 Paroxysmalnocturnalhemoglobinuria(PNH),342 Paroxysmalsupraventriculartachycardia,26–28

causes,27

e

e

pathophysiology,26–27,28f treatment,28
======================================
Paroxysmaltachycardia,28 Partialseizure,232 Patellartendinitis,465 Patellofemoralpain,464 Patentductusarteriosus(PDA),50–51,51b Peakexpiratoryflowrate,75 Pediculosispubis,395–396 Pemphigusvulgaris,425,426f Penilecancer,300 Pepticulcerdisease,154–156,157t

causes,154 clinicalfeatures,154 complications,157t diagnosis,154–155 treatment,155–156

Percutaneouscoronaryintervention,5b,11b Perforation,157f,157t Pericardialdiseases,35–39 acutepericarditis,35–36 cardiactamponade,38–39 constrictivepericarditis,36–37 pericardialeffusion,37–38 Pericardialeffusion,37–38,37b

©

e

©

e

e

e

e

e

clinicalfeatures,37 diagnosis,38 generalcharacteristics,37 treatment,38

Pericardialfluidanalysis,38 Pericardialfrictionrub,36 Pericardiocentesis,39 Periodicacid-Schiffstain(PAS)–positivemacrophages,161 Peripheralarterialdisease(PAD),56–57,58t Peripheralneuropathy,175 Peristalsis,161 Perniciousanemia,333 Phalentest,467b Pharmacologicstresstest,3 Phenoxybenzamine,200

Phenytoin,234 Pheochromocytoma,199–200,200b Phlegmasiaceruleadolens,60 Phosphate,318–319

excretionandbalance,318 hyperphosphatemia,319 hypophosphatemia,318

Phosphodiesterase-4inhibitors,73 Phrenicnervepalsy,78 Physicalexaminationpearls

abdominalexamination,508–509 neurologicexamination,509–510,510f

Pigmentstones,132 Pimozide,inTourettesyndrome,216 Pituitaryadenomas,190 Pituitarygland,diseasesof,190–195

acromegaly,191–192 craniopharyngioma,192 diabetesinsipidus(DI),193–194 hyperprolactinemia,191 hypopituitarism,192–193 pituitaryadenomas,190 syndromeofinappropriatesecretionofantidiuretichormone(SIADH),194–195

Pityriasisrosea,420,420f Plantarwart,426 Plasmametanephrines,200 Plasmaosmolality,inDI,193 Plateletdisorders,342–343,343f Bernard–Souliersyndrome,345 Glanzmannthrombasthenia,345 heparin-inducedthrombocytopenia,345 immunethrombocytopenicpurpura,344 thrombocytopenia,342–343,344t thromboticthrombocytopenicpurpura,344–345

Pleura,diseasesof,82–87

empyema,84 malignantmesothelioma,86–87 pleuraleffusion,82–84,82f,83f pneumothorax,84–85 tensionpneumothorax,85–86

Pleuraleffusion,82–84
======================================
causes,83 chestradiograph,82f clinicalfeatures,83 diagnosis,83–84 exudative,82–83,83b,84 generalcharacteristics,82–83 transudative,82,83b,84 treatment,84

»

»

»

»

Pleuralfluidpearls,83b Plicasyndrome,465 Plummerdisease,182 Plummer–Vinsonsyndrome,151–152 Pneumoconiosis.SeeEnvironmentallungdisease Pneumonia,365–369

»

community-acquired,365 hospital-acquired,369 nosocomial,365 pleuraleffusionand,369 ventilator-associated,369

»

»

»

»

»

»

Pneumoniaseverityindex,368t Pneumothorax,84–85 Poliomyelitis,227–228 Polycysticlivercysts,127–128 Polycythemiavera,363 Polymyalgiarheumatica,258 Polymyositis,256

»

diagnosticcriteriafor,257b

»

»

»

’

»

'

»

»

Polyuria,193 Porcelaingallbladder,135b Posteriorreversibleencephalopathysyndrome(PRES),52 Postmyocardialinfarctionsyndrome.SeeDresslersyndrome Postnasaldrip,446b Postphlebiticsyndrome.SeeChronicvenousinsufficiency Postthromboticsyndrome,60 Potassiummetabolism,313–314 excretionofpotassium,313 hyperkalemia,314–315,316f hypokalemia,313–314,315f normalserumlevel,313

Prednisone,inDuchennemusculardystrophy,225 Predominantemphysema,70t Prematureatrialcomplexes(PACs),21–22 Prematureventricularcomplexes(PVCs),21–22,24b Primaryadrenalinsufficiency,201,201b Primarybiliarycirrhosis(PBC)

e

e

e

e

clinicalfeatures,137 diagnosisandtreatment,137 generalcharacteristics,137 vs.primarysclerosingcholangitis,136t

Primaryhyperaldosteronism,200–201 Primaryhyperparathyroidism,196–197,197b Primaryhypothyroidism,185 Primary(simple)pneumothorax,84–85 Primarysclerosingcholangitis(PSC),135–136

e

e

e

e

clinicalfeatures,136 diagnosisandtreatment,136 generalcharacteristics,135 vs.primarybiliarycirrhosis,136t

Prinzmetalangina,7 Progressivesupranuclearpalsy(PSP),213b Prolactin,191 Prolactinoma,191 Prophylaxisaftersurgery,60–61 Prostatecancer,296–298 Prostatitis,384–385

acutevs.chronic,384b

Prostheticvalveendocarditis,46–47 ProteinCdeficiency,350 ProteinSdeficiency,350 Proteinuria,174

e

e

e

classification,278 diagnosis,279 treatment,280
======================================
Prothrombintime(PT),132 Pseudoanemia,326 Pseudogout,255–256,256f Pseudohypoparathyroidism,195b Pseudomembranouscolitis,379–380 Psoriasis,418–419,419f

Psoriaticarthritis,261 PTHlevelsandprimaryhyperparathyroidism,197 Pulmonaryalveolarproteinosis,93 Pulmonaryangiography,107 Pulmonaryarterialhypertension(PAH),103 Pulmonaryarterycatheter,100 Pulmonaryaspiration,109–110 Pulmonaryembolism(PE),104–109

clinicalfeatures,105 courseandprognosis,105 diagnosis,105–106 generalcharacteristics,104–105 pathophysiology,105 riskfactors,105b sourcesofemboli,104,104b treatment,107–108 workup,106b,107f

Pulmonaryembolus(PE),60 Pulmonaryfunctiontests(PFTs),inasthma,75,75b Pulmonaryhypertension(HTN),49,51,102–104

classification,103 clinicalfeatures,103 definition,102 diagnosis,103 pathophysiologicprocesses,102–103,102b treatment,103–104

Pulmonarylangerhanscellhistiocytosis,91–92 Pulmonaryrehabilitation,forCOPD,73 Pulmonarystudies,111t Pulmonarytuberculosis,153 Pulmonaryvascularresistance(PVR),49 Pulmonaryvasculature,diseasesof,102–109

e

e

e

corpulmonale,104 pulmonaryembolism(PE),104–109 pulmonaryhypertension(HTN),102–104

Pulselesselectricalactivity(PEA),31b Pulseoximetry,111t Pulsevolumerecordings,57 Pulsusparadoxus,40 Pumpfailure,12

Pyelonephritis,382–384 P2Y12inhibitors,6,10,12 Pyodermagangrenosu,425 Pyogenicliverabscess,128

R

»

»

»

»

»

»

’

Rabies,404 Radiationpneumonitis,94 Radiationtherapy,inCRC,115 Radioactiveiodine,183,184,188–189,188f Radioactiveiodineablationtherapy,184 RadioactiveT3uptake,183 Radiocontrastagents,indiabeticpatients,174b Radiographicinterpretation

»

e

e

abdominalradiographs,494 chestradiograph,491–494

Radionuclidescanning

»

»

»

»

»

»

»

’

»

»

»

»

inacutecholecystitis,133b inGIbleeding,147 Ransoncriteria,140t Raynaudphenomenon,244 Reactivearthritis,260–261 Recurrentinfarction,13 Recurrentkneeeffusion,465b Redeye,474–475 Reed–Sternbergcells,357f Regionalenteritis.SeeCrohndisease Reitersyndrome,260–261 Renalarterystenosis,290 Renalcellcarcinoma,298 Renalcysts,simple,290 Renalpapillarynecrosis,285–286 Renaltubularacidosis(RTA),286–287,286t
======================================
e

e

»

»

©

©

©

type1,286 type2,287 type4,287

»

»

’

»

Renalveinthrombosis,290–291,296 Respiratoryacidosis,94b,324–325 Respiratoryalkalosis,325 Respiratoryfailure,94–102

e

¢

e

acute,94–97 acuterespiratorydistresssyndrome(ARDS),97–100 mechanicalventilation,100–102

Restenosis,5b

RestingECG,2 Restlesslegsyndrome,215 Restpain,56 Restrictivecardiomyopathy,34–35

causes,34 clinicalfeatures,34 diagnosis,34 generalcharacteristics,34 treatment,35

Restrictivelungdiseasevs.obstructivelungdiseases,71t Reticulocyteindex,326 Revascularization,5 methodsof,11b inMI,11

e

e

Reynoldspentad,135 Rhabdomyolysis,269b Rheumaticheartdisease,45–46 Rheumatoidarthritis(RA)

Boutonnièredeformity,249b clinicalfeatures,247–248,248f diagnosis,248,251b extra-articularmanifestationsin,250t juvenile,252 swan-neckdeformity,249f treatment,251–252 ulnardeviationofMCPjointsin,249f Riedelthyroiditis.SeeFibrousthyroiditis Right-sidedheartfailure,18 Rinnetest,480 Ristocetinassay,345 Rituximab,358b Rockymountainspottedfever,403 Rosacea,416,416f Rouleauxformation,356f

S

»

»

Salineinfusiontest,201 Sarcoidosis,89–91,91b clinicalfeatures,90 diagnosis,90–91 generalcharacteristics,89 stagingandtreatment,91

e

e

e

e

»

»

»

»

Scabies,430–431,430f Schatzkiring,152–153 Schistocytes,335 Scleroderma,291 diffuse,246t limited,246t

e

e

»

»

»

»

»

»

»

»

»

Seborrheicdermatitis,419,420b Seborrheickeratosis,431,432f Secondaryadrenalinsufficiency,202 Secondarybiliarycirrhosis,137b Secondaryhyperparathyroidism,197b Secondaryhypothyroidism,185 Secondary(complicated)pneumothorax,85 Second-degreeAVblock,32–33,32b,32f Secondsight,474b Seizures,231–234

»

aspectsofH&P,232b causes,231 diagnosis,233 epileptic,232–233 generalizedseizure,232 partialseizure,232 treatment,234

Selegiline,inParkinsondisease,213 Sepsis,67b,98b Septicphlebitis,62 Septicshock,66–67,66b,67b Seronegativespondyloarthropathies,259,260b Serumbiomarkers,evolutioninacuteMI,10f Severehypercapnia,94b Severehypoxemia,94b Shock

»

»

»

»

»

»

»

»

» Shock

cardiogenic,64–65

categoriesof,63 definition,62 hemodynamicchangesin,63t hypovolemic,65–66 initialapproachtopatientwith,63 neurogenic,67 obstructive,67–68 septic,66–67 signsandsymptoms,63 treatment,63–64 Sicklecellcrises,337 Sicklecelldisease,336–338,338f Sicklecellnephropathy,291 Sideroblasticanemia,332 Sigmoidoscopy,119 Silentthyroiditis.SeeSubacutelymphocyticthyroiditis Silicosis,92 Sinusbradycardia,13,31 Sinusitis,448–449,448b
======================================
acute,448 chronic,448 classifications,448 complications,448 diagnosis,448 treatment,449

Sinustachycardia,13 SisterMaryJosephnode,158b Sitesofmetastases,434b Sleepdisorders insomnia,478 narcolepsy,477 obstructivesleepapnea,476–477

e

e

e

Slidinghiatalhernias(type1),151,152f Smallbowelobstruction(SBO),158–161,158b

APsupinefilm,160f causes,159 clinicalfeatures,160,161b diagnosis,160–161 generalcharacteristics,158–159 treatment,161

Smallcelllungcancer(SCLC),81t prognosis,79b treatment,80 Smallintestine,diseasesof,158–161 celiacsprue,161 paralyticileus,161 smallbowelobstruction,158–161 tropicalsprue,161 whippledisease,161 Smoking,485–486 andcough,446–447 Smokingcessation inCOPD,71,72b,73f inPAD,57 Solitarypulmonarynodule,80–81,80f benignvs.malignant,81t clinicalfeatures,80 diagnosis,81 evaluation,80f Somatostatinoma,181 Somogyieffect,168b Sorethroat,449–450 Spinalcorddiseases Brown-Séquardsyndrome,227 Hornersyndrome,227 poliomyelitis,227–228 syringomyelia,226,227f transversemyelitis,227

Spirometry,75,111t Spitznevi,433b Splenicsequestrationcrisis,337 Spontaneouspneumothorax,84–85,85b Squamouscellcarcinoma(SCC),148,433,433f Squatting,33b,45 Standing,45 Statins,inMI,10 Statusepilepticus,234b Steatorrhea,142 Stevens-Johnsonsyndrome,423 Stomach,diseasesof,154–158

acutegastritis,156 chronicgastritis,157 gastriccancer,158 gastriclymphoma,158 pepticulcerdisease,154–156,157t

Streptococcuspneumoniae,community-acquiredpneumonia,365 Stressechocardiography,2 Stresstests,2,2b,6b

e

e

inCHF,18 types,3b

Strokes,205–212

e

e

hemorrhagic,210–212 ischemic,215–212

Sturge-Webersyndrome,226 Subacutegranulomatousthyroiditis.SeeSubacute(viral)thyroiditis Subacutelymphocyticthyroiditis,186 Subacute(viral)thyroiditis,186 Subarachnoidhemorrhage(SAH),211–212 Subclavianstealsyndrome,207b Subclinicalhypothyroidism,186b Suddencardiacdeath,30b Sulfasalazine,163,165 Superficialthrombophlebitis,62,62b Superiorvenacava(SVC)syndrome,78 Supplementaloxygen,74 Suppurativethrombophlebitis,62 Supraventriculartachycardias,28 Swellingoflowerleg,61 Syncope,229–232 causes,229–230 diagnosis,230–231 flowchart,231f vasovagal,229,230b
======================================
e

e

e

e

Syndromeofinappropriatesecretionofantidiuretichormone(SIADH),194–195, 194b

causes,194 clinicalfeatures,194,195b diagnosis,194–195 pathophysiology,194 treatment,195

»

»

»

»

»

»

»

»

»

SyndromeX,2b Syphilis,393–395,394f Syringomyelia,226,227f Systemiccorticosteroids,74 Systemicglucocorticoids,73b Systemicinflammatoryresponsesyndrome(SIRS),67b Systemiclupuserythematosus(SLE),241–244

butterflyrash,242f clinicalcourseof,241–242 diagnosis,242,243f drug-inducedlupus,241,245b epidemiologyof,241b treatment,243–244

Systolicdysfunction,15,17

diureticsfor,20 lifestylemodificationin,18 Systolicejectionmurmur,33

e

e

T

Tachyarrhythmias,22–31 atrialfibrillation,22–25 atrialflutter,25–26 multifocalatrialtachycardia,26 paroxysmalsupraventriculartachycardia,26–28 ventricularfibrillation,30–31 ventriculartachycardia,28–30 Wolff–Parkinson–White(WPW)Syndrome,28

Tachycardias,28b Tendinitis,466 Tensionpneumothorax,85–86

causes,85 chestradiograph,86f,87f clinicalfeatures,85 generalcharacteristics,85 treatment,85

Testicularcancer,299–300 Testiculartorsion,301 Tetanus,397–398 Tetralogyoffallot(TOF),51–52 Theophylline,72 Thionamides,183 Third-degreeAVblock,32f,33 Thoracentesis,84 Thrombocytopenia,342–343,344t Thrombolytics,intra-arterialinfusionof,118 Thrombolytictherapy

e

e

inDVT,60 inpulmonaryembolism,108

Thromboticstroke,207 Thromboticthrombocytopenicpurpura,344 Thumbprinting,118 Thyroid-associatedophthalmopathy(TAO),187 Thyroidcancer,189–190,189b Thyroidgland,diseasesof,182–190

cancer,189–190 hyperthyroidism,182–184 hypothyroidism,185–186 nodules,187–189

e

e

storm,184 thyroiditis,186–187

»

»

»

ThyroidhormonesandTBG,183b Thyroiditis,186–187 Thyroidnodules,187–189

»

»

»

»

»

’

»

’

»

»

»

diagnosis,188–189 generalcharacteristics,187 Thyroidscan,188–189,188f Thyroidstorm,184,184b Thyrotoxicosis,183f,184b Tineaversicolor,429–430,429f Tissuebiopsy,inILD,89 Tissueoxygenation,techniquestoimprove,97b Torsadesdepointes,29b Tourettesyndrome,215–216 Toxicepidermalnecrolysis(TEN),423 Toxicshocksyndrome,411–412 Tractiondiverticula,153 Transthoracicneedlebiopsy,79 Transudativeeffusion,82,83b,84 Transversemyelitis,227 Tremor,214–215,214t
======================================
e

e

»

»

e

e

e

essential,215 neurologicdiseasesand,215 physiologic,214

»

’

»

»

»

Tricuspidregurgitation(TR),44–45 Trigeminalneuralgia,236 Tropicalsprue,161 Troponins,9 TSHlevelandhypothyroidism,186b Tuberculosis(TB),370–372

»

clinicalfeatures,371 diagnosis,371 extrapulmonary,371 medications,372b primary,370 riskfactors,371 secondary,371 treatment,372

Tubulointerstitialdiseases,285–287

’

»

»

»

»

»

»

’

acuteinterstitialnephritis,285 Fanconisyndrome,287 Hartnupsyndrome,287 renalpapillarynecrosis,285–286 renaltubularacidosis,286

Tularemia,405t Tumorlysissyndrome,361b Tumormarkerelevation,127 Tumormarkers,510 Turcotsyndrome,114 Tympanicmembraneperforation,479b TypeIdiabetes,167–168,168t

e

e

clinicalpresentation,169–170,169t progressionof,170f

TypeIIdiabetes,167–168,168t

e

e

clinicalpresentation,170 treatment,170b

U

Ulcerativecolitis(UC),163–166

clinicalfeatures,164 complications,164 diagnosis,164 generalcharacteristics,163–164 treatment,165 vs.Crohndisease,164t Unconjugatedbilirubin,129 Unconjugatedhyperbilirubinemia,130 Upperendoscopy,147 Upperesophagealwebs.SeePlummer–Vinsonsyndrome UpperGIbleeding,144

causes,145 treatment,147 Urinalysis,279b Urinaryincontinence,480–482 functionalincontinence,482 overflowincontinence,481 stressincontinence,481 urgeincontinence,481

e

e

e

e

©

Urinarytractinfections(UTIs)

e

¢

e

e

e

clinicalfeatures,381 complications,382 diagnosis,381 riskfactors,380–381 treatment,382

Urinarytractobstruction,295–296

evaluationof,295b

Urineosmolality,270b,307 Urineoutputmonitoring,66b Urticaria,420,421f

V

»

»

»

Vaccinations,488,488t–489t Valsalvamaneuver,33b,45 Valvularheartdisease,39–48 aorticregurgitation,42–43 aorticstenosis,41–42 infectiveendocarditis,46–48 mitralregurgitation,43–44 mitralstenosis,39–40 mitralvalveprolapse,45 nonbacterialthromboticendocarditis,48 nonbacterialverrucousendocarditis,48 rheumaticheartdisease,45–46 tricuspidregurgitation,44–45 Variable-vesselvasculitis,265 Variantangina.SeePrinzmetalangina Vascularectasia.SeeAngiodysplasiaofcolon Vasculature,diseasesof,52–62

abdominalaorticaneurysm(AAA),54–56 acutearterialocclusion,57–58,58t aorticdissection,53–54,53b,53f cholesterolembolizationsyndrome,58 chronicvenousinsufficiency,61–62 deepvenousthrombosis,59–61 hypertensiveemergency,52–53,53b lueticheart,58–59 mycoticaneurysm,58 peripheralarterialdisease(PAD),56–57 superficialthrombophlebitis,62

Vasculitis,261–262
======================================
Behçetsyndrome,265 Churg-Strausssyndrome,264 cryoglobulinemicvasculitis,264–265 overview,261 polyarteritisnodosa,263 Takayasuarteritis,263 temporal/giantcellarteritis,262 types,262–265

»

»

Vasoactiveagents,103–104 Vaso-occlusivecrises,337

»

»

»

’

’

»

Vasovagalsyncope,229,230b Venography,59 Venousduplexultrasoundoflowerextremities,106 Venousstasisdisease.SeeChronicvenousinsufficiency Venousthrombosis,117 Venousulcers,61 Ventilation–perfusion(V/Q)scan,111t Ventilator-associatedpneumonia,368–369 Ventricularaneurysm,14 Ventricularassistdevice(VAD),21b Ventricularfibrillation,30–31

causes,30 clinicalfeatures,30 diagnosis,30,30f generalcharacteristics,30 recurrence,30 treatment,31

Ventricularpseudoaneurysm,14 Ventricularseptaldefect,49–50 Ventriculartachycardia,28–30

causes,28,29b clinicalfeatures,29 diagnosis,29,29f generalcharacteristics,28 monomorphic,30b nonsustained,29,30,30b sustained,29,30 treatment,29–30

Ventriculartachycardia(VT),12 Vertigo,228,228b,229t

e

e

central,228 peripheral,228

VIPoma,181 Viralconjunctivitis,475b Viralhepatitis

causesof,376 clinicalfeatures,377–378 diagnosis,378–379 treatment,378–379 Virchownode,158b

e

e

e

e

»

»

»

VitaminB12deficiency,333–334,334f VitaminKdeficiency,349 Volumedisorders,302–305

e

e

e

approachto,302–304,303f hypervolemia,305 hypovolemia,304–305

VonWillebranddisease(vWD),345–346,346t

W

Waldenströmmacroglobulinemia,356 Wanderingatrialpacemaker,26 Warfarin

administration,352 adverseeffects,352 indicationsforuse,352 mechanismofaction,352 reversingeffectsof,352

Warts

anogenital,426 common,426 flat,426 HPV,427,427f plantar,426 Warts,426–427 Waterdeprivationtest,inDI,193,193t Waterydiarrhea,181 Wegenergranulomatosis.SeeGranulomatosiswithpolyangiitis Wernickeaphasia,235 Whippledisease,161 Whitecoat,439b Widecomplextachycardia,30b Wilsondisease,124–125 Wolff–Parkinson–White(WPW)Syndrome,28

Z

»

»

Zenkerdiverticulum,153 Zollinger-Ellisonsyndrome(ZES),181